PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Mondor, I; Jorquera, A; Sene, C; Adriouch, S; Adams, RH; Zhou, B; Wienert, S; Klauschen, F; Bajenoff, M				Mondor, Isabelle; Jorquera, Audrey; Sene, Cynthia; Adriouch, Sahil; Adams, Ralf Heinrich; Zhou, Bin; Wienert, Stephan; Klauschen, Frederick; Bajenoff, Marc			Clonal Proliferation and Stochastic Pruning Orchestrate Lymph Node Vasculature Remodeling	IMMUNITY			English	Article							HIGH ENDOTHELIAL VENULES; FOLLICULAR DENDRITIC CELLS; MOUSE-BRAIN; TIP CELLS; ANGIOGENESIS; TISSUE; HOMEOSTASIS; MECHANISMS; EXPRESSION; GROWTH	Lymph node (LN) expansion during an immune response relies on the transient remodeling of its vasculature. Although the mechanisms driving LN endothelial cell division are beginning to be understood, a comprehensive view of LN endothelial cell dynamics at the single-cell level is lacking. Here, we used multicolored fluorescent fate-mapping models to track the behavior of blood endothelial cells during LN expansion upon inflammation and subsequent return to homeostasis. We found that expansion of the LN vasculature relied on the sequential assembly of endothelial cell proliferative units. This segmented growth was sustained by the clonal proliferation of high endothelial venule (HEV) cells, which act as local progenitors to create capillaries andHEVneo-vessels at the periphery of the LN. Return to homeostasis was accompanied by the stochastic death of pre-existing and neo-synthesized LN endothelial cells. Thus, our fate-mapping studies unravel-at a single-cell level-the complex dynamics of vascular-tree remodeling during LN expansion and contraction.	[Mondor, Isabelle; Jorquera, Audrey; Sene, Cynthia; Bajenoff, Marc] Aix Marseille Univ, CNRS, INSERM, CIML, F-13288 Marseille, France; [Adriouch, Sahil] INSERM, U905, F-76183 Rouen, France; [Adriouch, Sahil] Normandie Univ, Inst Res & Innovat Biomed, F-76183 Rouen, France; [Adams, Ralf Heinrich] Max Planck Inst Mol Biomed, D-48149 Munster, Germany; [Adams, Ralf Heinrich] Univ Munster, Fac Med, D-48149 Munster, Germany; [Zhou, Bin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Cell Biol, Shanghai 200031, Peoples R China; [Wienert, Stephan; Klauschen, Frederick] Charite, Inst Pathol, D-10117 Berlin, Germany	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Max Planck Society; University of Munster; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Bajenoff, M (corresponding author), Aix Marseille Univ, CNRS, INSERM, CIML, F-13288 Marseille, France.	bajenoff@ciml.univ-mrs.fr	Adams, Ralf H/AAE-9274-2019; Klauschen, Frederick/C-5637-2015; ADRIOUCH, Sahil/G-8999-2012	Klauschen, Frederick/0000-0002-9131-2389; ADRIOUCH, Sahil/0000-0002-0265-7773; Zhou, Bin/0000-0001-5278-5522	Agence National pour la Recherche (ANR-STROMA); Agence National pour la Recherche [ANR-10-INBS-04-01]; European Research Council under Horizon of the EU Framework Programme for Research and Innovation [647384-STROMA]	Agence National pour la Recherche (ANR-STROMA)(French National Research Agency (ANR)); Agence National pour la Recherche(French National Research Agency (ANR)); European Research Council under Horizon of the EU Framework Programme for Research and Innovation	We would like to thank Myriam Baratin and Rebecca Gentek for critical reading of the manuscript. This study was funded by grants from the Agence National pour la Recherche (ANR-STROMA and ANR-10-INBS-04-01 France Bio Imaging) and the European Research Council under Horizon 2020 of the EU Framework Programme for Research and Innovation (647384-STROMA).	ANDERSON AO, 1976, IMMUNOLOGY, V31, P731; ANDERSON ND, 1975, AM J PATHOL, V81, P131; Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Benahmed F, 2014, J IMMUNOL, V192, P4153, DOI 10.4049/jimmunol.1301765; Cahalan MD, 2002, NAT REV IMMUNOL, V2, P872, DOI 10.1038/nri935; Chen Q, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001374; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Chyou S, 2008, J IMMUNOL, V181, P3887, DOI 10.4049/jimmunol.181.6.3887; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; Erturk A, 2012, NAT PROTOC, V7, P1983, DOI 10.1038/nprot.2012.119; Forster R, 2012, TRENDS IMMUNOL, V33, P271, DOI 10.1016/j.it.2012.02.007; Ghigo C, 2013, J EXP MED, V210, P1657, DOI 10.1084/jem.20130403; GIRARD JP, 1995, IMMUNOL TODAY, V16, P449, DOI 10.1016/0167-5699(95)80023-9; Goede V, 1998, LAB INVEST, V78, P1385; Gretz JE, 1997, IMMUNOL REV, V156, P11, DOI 10.1111/j.1600-065X.1997.tb00955.x; Hama H, 2011, NAT NEUROSCI, V14, P1481, DOI 10.1038/nn.2928; Hampel S, 2011, NAT METHODS, V8, P253, DOI 10.1038/NMETH.1566; Hsu YC, 2014, CELL, V157, P935, DOI 10.1016/j.cell.2014.02.057; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jarjour M, 2014, J EXP MED, V211, P1109, DOI 10.1084/jem.20132409; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; Kretzschmar K, 2012, CELL, V148, P33, DOI 10.1016/j.cell.2012.01.002; Kumar V, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00282; Lacorre DA, 2004, BLOOD, V103, P4164, DOI 10.1182/blood-2003-10-3537; le Noble F, 2004, DEVELOPMENT, V131, P361, DOI 10.1242/dev.00929; Lee M, 2014, NAT IMMUNOL, V15, P982, DOI 10.1038/ni.2983; Liao S, 2006, J IMMUNOL, V177, P3369, DOI 10.4049/jimmunol.177.5.3369; Liu QZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7020; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; MEBIUS RE, 1991, J CELL BIOL, V115, P85, DOI 10.1083/jcb.115.1.85; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mionnet C, 2011, BLOOD, V118, P6115, DOI 10.1182/blood-2011-07-367409; Modlich U, 1996, LAB INVEST, V74, P771; Moussion C, 2011, NATURE, V479, P542, DOI 10.1038/nature10540; Naito H, 2012, EMBO J, V31, P842, DOI 10.1038/emboj.2011.465; Napp LC, 2012, CIRC RES, V110, P530, DOI 10.1161/CIRCRESAHA.111.263319; Pan YA, 2013, DEVELOPMENT, V140, P2835, DOI 10.1242/dev.094631; Patan S, 2004, CANC TREAT, V117, P3; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; SCHOEFL GI, 1972, J EXP MED, V136, P568, DOI 10.1084/jem.136.3.568; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Soderberg KA, 2005, P NATL ACAD SCI USA, V102, P16315, DOI 10.1073/pnas.0506190102; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Suchting S, 2007, P NATL ACAD SCI USA, V104, P3225, DOI 10.1073/pnas.0611177104; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Tepper OM, 2005, BLOOD, V105, P1068, DOI 10.1182/blood-2004-03-1051; THOMA R, 1893, UNTERSUCHUNGEN HIST; Von Andrian Ulrich H., 1996, Microcirculation (Philadelphia), V3, P287, DOI 10.3109/10739689609148303; Warnock RA, 1998, J EXP MED, V187, P205, DOI 10.1084/jem.187.2.205; Waskow C, 2010, METHODS MOL BIOL, V595, P413, DOI 10.1007/978-1-60761-421-0_27; Webster B, 2006, J EXP MED, V203, P1903, DOI 10.1084/jem.20052272; Xu C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6758	57	31	31	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					877	888		10.1016/j.immuni.2016.09.017	http://dx.doi.org/10.1016/j.immuni.2016.09.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27760341	Bronze			2022-12-18	WOS:000389473200018
J	Masamoto, Y; Arai, S; Sato, T; Yoshimi, A; Kubota, N; Takamoto, I; Iwakura, Y; Yoshimura, A; Kadowaki, T; Kurokawa, M				Masamoto, Yosuke; Arai, Shunya; Sato, Tomohiko; Yoshimi, Akihide; Kubota, Naoto; Takamoto, Iseki; Iwakura, Yoichiro; Yoshimura, Akihiko; Kadowaki, Takashi; Kurokawa, Mineo			Adiponectin Enhances Antibacterial Activity of Hematopoietic Cells by Suppressing Bone Marrow Inflammation	IMMUNITY			English	Article							SOCS3 MESSENGER-RNA; INSULIN-RESISTANCE; LISTERIA-MONOCYTOGENES; NEGATIVE REGULATOR; G-CSF; HOST-RESISTANCE; TNF-ALPHA; STAT3; MACROPHAGES; ACTIVATION	Obesity has been shown to increase the morbidity of infections, however, the underlying mechanisms remain largely unknown. Here we demonstrate that obesity caused adiponectin deficiency in the bone marrow (BM), which led to an inflamed BM characterized by increased tumor necrosis factor (TNF) production from bone marrow macrophages. Hematopoietic stem and progenitor cells (HSPCs) chronically exposed to excessive TNF in obese marrow aberrantly expressed cytokine signaling suppressor SOCS3, impairing JAK-STAT mediated signal transduction and cytokine-driven cell proliferation. Accordingly, both obese and adiponectin-deficient mice showed attenuated clearance of infected Listeria monocytogenes, indicating that obesity or loss of adiponectin is critical for exacerbation of infection. Adiponectin treatment restored the defective HSPC proliferation and bacterial clearance of obese and adiponectin-deficient mice, affirming the importance of adiponectin against infection. Taken together, our findings demonstrate that obesity impairs hematopoietic response against infections through a TNF-SOCS3-STAT3 axis, highlighting adiponectin as a legitimate target against obesity-related infections.	[Masamoto, Yosuke; Arai, Shunya; Sato, Tomohiko; Yoshimi, Akihide; Kurokawa, Mineo] Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo 1138655, Japan; [Masamoto, Yosuke; Sato, Tomohiko] Tokyo Univ Hosp, Dept Transfus Med, Tokyo 1138655, Japan; [Kubota, Naoto; Takamoto, Iseki; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1138655, Japan; [Iwakura, Yoichiro] Tokyo Univ Sci, Res Inst Biomed Sci, Div Expt Anim Immunol, Chiba 2780022, Japan; [Yoshimura, Akihiko] Keio Univ, Dept Microbiol & Immunol, Sch Med, Tokyo 1608582, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Tokyo University of Science; Keio University	Kurokawa, M (corresponding author), Univ Tokyo, Grad Sch Med, Dept Hematol & Oncol, Tokyo 1138655, Japan.	kurokawa-tky@umin.ac.jp	Yoshimi, Akihide/I-3792-2019; Yoshimura, Akihiko/K-5515-2013; Iwakura, Yoichiro/E-5457-2011	Yoshimi, Akihide/0000-0002-0664-7281; Iwakura, Yoichiro/0000-0002-9934-5775; Sato, Tomohiko/0000-0002-8244-075X	Japan Society for the Promotion of Science (JSPS) KAKENHI [24249055, 25221305]; Advanced Research & Development Programs for Medical Innovation (AMED-CREST); Kyowa Hakko Kirin Co Ltd.; Grants-in-Aid for Scientific Research [15H01481] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Advanced Research & Development Programs for Medical Innovation (AMED-CREST); Kyowa Hakko Kirin Co Ltd.(Kyowa Kirin Ltd); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr. T. Kitamura for PLAT-E packaging cells; Dr. K. Nakamura, Ms. M. Yamamoto, Ms. Y. Shimamura, and Dr. J. Iino for expert technical assistance; and Kyowa Hakko Kirin Co. Ltd. for recombinant human G-CSF. This work was supported in part by the Japan Society for the Promotion of Science (JSPS) KAKENHI (No. 24249055 and No. 25221305), Advanced Research & Development Programs for Medical Innovation (AMED-CREST). M.K. received lecture and advisory fee and research funding from Kyowa Hakko Kirin Co Ltd. S.A., N.K., and T.K. have also received research funding from Kyowa Hakko Kirin Co Ltd.	Adler BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090639; Bode JG, 1999, FEBS LETT, V463, P365, DOI 10.1016/S0014-5793(99)01662-2; Boettcher S, 2012, J IMMUNOL, V188, P5824, DOI 10.4049/jimmunol.1103253; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Crawford LJA, 2010, J LEUKOCYTE BIOL, V88, P807, DOI 10.1189/jlb.1109723; Croker BA, 2004, IMMUNITY, V20, P153, DOI 10.1016/S1074-7613(04)00022-6; DiMascio L, 2007, J IMMUNOL, V178, P3511, DOI 10.4049/jimmunol.178.6.3511; Ehlting C, 2007, J IMMUNOL, V178, P2813, DOI 10.4049/jimmunol.178.5.2813; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Hanna RN, 2012, CIRC RES, V110, P416, DOI 10.1161/CIRCRESAHA.111.253377; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Huttunen R, 2013, INT J OBESITY, V37, P333, DOI 10.1038/ijo.2012.62; Ikejima S, 2005, DIABETES, V54, P182, DOI 10.2337/diabetes.54.1.182; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Luo NL, 2013, ATHEROSCLEROSIS, V228, P124, DOI 10.1016/j.atherosclerosis.2013.02.026; Luo YB, 2015, CELL METAB, V22, P886, DOI 10.1016/j.cmet.2015.08.020; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Matsuda A, 2009, J SURG RES, V157, P227, DOI 10.1016/j.jss.2008.09.007; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; NAKANE A, 1988, INFECT IMMUN, V56, P2563, DOI 10.1128/IAI.56.10.2563-2569.1988; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Rossi A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069108; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Taniguchi T, 1997, LAB INVEST, V77, P647; Trottier MD, 2012, P NATL ACAD SCI USA, V109, P7622, DOI 10.1073/pnas.1205129109; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Whitmarsh RJ, 2011, CELL HOST MICROBE, V10, P224, DOI 10.1016/j.chom.2011.07.009; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723; Zhan YP, 2008, NAT CHEM BIOL, V4, P548, DOI 10.1038/nchembio.106; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869; Zhang HY, 2010, BLOOD, V116, P2462, DOI 10.1182/blood-2009-12-259630	42	31	32	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 21	2016	44	6					1422	1433		10.1016/j.immuni.2016.05.010	http://dx.doi.org/10.1016/j.immuni.2016.05.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP2SE	27317261	Bronze			2022-12-18	WOS:000378341200019
J	Li, YY; Wang, Y; Zou, LY; Tang, XY; Yang, Y; Ma, L; Jia, QZ; Ni, QS; Liu, SQ; Tang, LZ; Lin, R; Wong, E; Sun, W; Wang, LT; Wei, QF; Ran, HY; Zhang, LQ; Lian, HN; Huang, W; Wu, YZ; Li, QJ; Wan, Y				Li, Yuanyuan; Wang, Yu; Zou, Liyun; Tang, Xiangyu; Yang, Yi; Ma, Li; Jia, Qingzhu; Ni, Qingshan; Liu, Siqi; Tang, Lizhang; Lin, Regina; Wong, Elizabeth; Sun, Wei; Wang, Liting; Wei, Quanfang; Ran, Haiying; Zhang, Liqun; Lian, Hengning; Huang, Wei; Wu, Yuzhang; Li, Qi-Jing; Wan, Ying			Analysis of the Rab GTPase Interactome in Dendritic Cells Reveals Anti-microbial Functions of the Rab32 Complex in Bacterial Containment	IMMUNITY			English	Article							LISTERIA-MONOCYTOGENES; SH3 DOMAIN; PROTEIN; AUTOPHAGY; RECEPTOR; TRAFFICKING; ADAPTER; LINKS; ENDOSOME; CAPRIN-1	Dendritic cells (DCs) orchestrate complex membrane trafficking through an interconnected transportation network linked together by Rab GTPases. Through a tandem affinity purification strategy and mass spectrometry, we depicted an interactomic landscape of major members of the mammalian Rab GTPase family. When complemented with imaging tools, this proteomic analysis provided a global view of intracellular membrane organization. Driven by this analysis, we investigated dynamic changes to the Rab32 subnetwork in DCs induced by L. monocytogenes infection and uncovered an essential role of this subnetwork in controlling the intracellular proliferation of L. monocytogenes. Mechanistically, Rab32 formed a persistent complex with two interacting proteins, PHB and PHB2, to encompass bacteria both during early phagosome formation and after L. monocytogenes escaped the original containment vacuole. Collectively, we have provided a functional compartmentalization overview and an organizational framework of intracellular Rab-mediated vesicle trafficking that can serve as a resource for future investigations.	[Li, Yuanyuan; Wang, Yu; Yang, Yi; Ma, Li; Jia, Qingzhu; Ni, Qingshan; Tang, Lizhang; Sun, Wei; Wang, Liting; Wei, Quanfang; Ran, Haiying; Zhang, Liqun; Lian, Hengning; Huang, Wei; Wan, Ying] Third Mil Med Univ, Biomed Anal Ctr, Chongqing 400038, Peoples R China; [Li, Yuanyuan; Wang, Yu; Yang, Yi; Ma, Li; Jia, Qingzhu; Ni, Qingshan; Tang, Lizhang; Sun, Wei; Wang, Liting; Wei, Quanfang; Ran, Haiying; Zhang, Liqun; Lian, Hengning; Huang, Wei; Li, Qi-Jing; Wan, Ying] Chongqing Key Lab Cytom, Chongqing 400038, Peoples R China; [Zou, Liyun; Wu, Yuzhang] Third Mil Med Univ, Dept Immunol, Chongqing 400038, Peoples R China; [Tang, Xiangyu] Acad Mil Med Sci, Inst Med Equipment, Tianjin 300000, Peoples R China; [Liu, Siqi; Lin, Regina; Wong, Elizabeth; Li, Qi-Jing] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Army Medical University; Army Medical University; Academy of Military Medical Sciences - China; Duke University	Wan, Y (corresponding author), Third Mil Med Univ, Biomed Anal Ctr, Chongqing 400038, Peoples R China.; Li, QJ; Wan, Y (corresponding author), Chongqing Key Lab Cytom, Chongqing 400038, Peoples R China.; Li, QJ (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.	qi-jing.li@duke.edu; wanying.cn@gmail.com	li, yuanyuan/GZA-4435-2022; Liu, Siqi/AAL-6891-2020	Liu, Siqi/0000-0001-9727-9498; Tang, Xiangyu/0000-0002-6989-9865; Zou, liyun/0000-0001-5449-8869; Ni, Qingshan/0000-0002-7267-8932; Wu, Yuzhang/0000-0002-4049-0214	National Natural Science Foundation of China [31470857, 31028007]; National Program on Key Basic Research Project in China (973 Program) [2010CB911800]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project in China (973 Program)(National Basic Research Program of China); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are indebted to Drs. Daniel Portnoy and Michael Dustin for engineered L. monocytogenes strains. We also thank Drs. Youwen He, Yisong Wan, Shangshang Feng, and Jingran Zhou for their thoughtful suggestions. Q.-J.L. is a Whitehead Family Foundation Scholar. This work was supported by the National Natural Science Foundation of China (Grant Nos. 31470857 and 31028007) and the National Program on Key Basic Research Project in China (973 Program, 2010CB911800).	Beaumont KA, 2011, TRAFFIC, V12, P627, DOI 10.1111/j.1600-0854.2011.01172.x; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Bultema Jarred J, 2013, Small GTPases, V4, P16, DOI 10.4161/sgtp.22349; Buschow SI, 2012, J PROTEOMICS, V75, P1547, DOI 10.1016/j.jprot.2011.11.024; Campisi L, 2011, EUR J IMMUNOL, V41, P1594, DOI 10.1002/eji.201041036; Chua CEL, 2014, J BIOL CHEM, V289, P12375, DOI 10.1074/jbc.M114.548321; Derre I, 2005, INFECT IMMUN, V73, P4370, DOI 10.1128/IAI.73.7.4370-4380.2005; Dokainish H, 2007, CELL MICROBIOL, V9, P2497, DOI 10.1111/j.1462-5822.2007.00976.x; Flick K, 2013, CELL RES, V23, P870, DOI 10.1038/cr.2013.55; Freitag NE, 2009, NAT REV MICROBIOL, V7, P623, DOI 10.1038/nrmicro2171; Gomes LC, 2014, MOL CELL, V54, P224, DOI 10.1016/j.molcel.2014.03.009; Grant BD, 2009, NAT REV MOL CELL BIO, V10, P597, DOI 10.1038/nrm2755; Grosshans BL, 2006, P NATL ACAD SCI USA, V103, P11821, DOI 10.1073/pnas.0601617103; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Guichard A, 2010, NATURE, V467, P854, DOI 10.1038/nature09446; Hao YH, 2013, CELL, V152, P1051, DOI 10.1016/j.cell.2013.01.051; Huizing M, 2008, ANNU REV GENOM HUM G, V9, P359, DOI 10.1146/annurev.genom.9.081307.164303; Jabara HH, 2012, NAT IMMUNOL, V13, P612, DOI 10.1038/ni.2305; Jackson LK, 2008, P NATL ACAD SCI USA, V105, P14141, DOI 10.1073/pnas.0801872105; Jancic C, 2007, NAT CELL BIOL, V9, P367, DOI 10.1038/ncb1552; Kanno E, 2010, TRAFFIC, V11, P491, DOI 10.1111/j.1600-0854.2010.01038.x; Katoh H, 2013, J VIROL, V87, P489, DOI 10.1128/JVI.02186-12; Khundadze M, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003988; Kim DK, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004098; Lamsoul I, 2013, BLOOD, V122, P533, DOI 10.1182/blood-2012-11-466649; Lee RHK, 2007, EMBO J, V26, P3592, DOI 10.1038/sj.emboj.7601781; MacLeod DA, 2013, NEURON, V77, P425, DOI 10.1016/j.neuron.2012.11.033; Mantegazza AR, 2012, IMMUNITY, V36, P782, DOI 10.1016/j.immuni.2012.02.018; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Murk JLAN, 2004, TRAFFIC, V5, P936, DOI 10.1111/j.1600-0854.2004.00235.x; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Nozawa T, 2012, CELL MICROBIOL, V14, P1149, DOI 10.1111/j.1462-5822.2012.01792.x; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Ruan B, 2004, BIOCHEMISTRY-US, V43, P14539, DOI 10.1021/bi048177j; Salter RD, 2004, J LEUKOCYTE BIOL, V75, P240, DOI 10.1189/jlb.0703339; Sandoval CO, 2012, BIOCHEM SOC T, V40, P1426, DOI 10.1042/BST20120158; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Solomon S, 2007, MOL CELL BIOL, V27, P2324, DOI 10.1128/MCB.02300-06; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spano S, 2012, SCIENCE, V338, P960, DOI 10.1126/science.1229224; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Tio PH, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-25; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; Valiente-Echeverria F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5819; Velikkakath AKG, 2012, MOL BIOL CELL, V23, P896, DOI 10.1091/mbc.E11-09-0785; Waite JC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001326; Yeo JC, 2015, MOL BIOL CELL, V26, P952, DOI 10.1091/mbc.E14-10-1457; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang FR, 2011, NAT GENET, V43, P1247, DOI 10.1038/ng.973	55	31	32	3	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					422	437		10.1016/j.immuni.2016.01.027	http://dx.doi.org/10.1016/j.immuni.2016.01.027			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26885862	Bronze			2022-12-18	WOS:000370294000022
J	Bunin, A; Sisirak, V; Ghosh, HS; Grajkowska, LT; Hou, ZE; Miron, M; Yang, C; Ceribelli, M; Uetani, N; Chaperot, L; Plumas, J; Hendriks, W; Tremblay, ML; Hacker, H; Staudt, LM; Green, PH; Bhagat, G; Reizis, B				Bunin, Anna; Sisirak, Vanja; Ghosh, Hiyaa S.; Grajkowska, Lucja T.; Hou, Z. Esther; Miron, Michelle; Yang, Cliff; Ceribelli, Michele; Uetani, Noriko; Chaperot, Laurence; Plumas, Joel; Hendriks, Wiljan; Tremblay, Michel L.; Haecker, Hans; Staudt, Louis M.; Green, Peter H.; Bhagat, Govind; Reizis, Boris			Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells	IMMUNITY			English	Article							INTERFERON-PRODUCING CELLS; TRANSCRIPTION FACTOR E2-2; IFN-ALPHA PRODUCTION; VIRAL-INFECTION; CPG-DNA; SIGMA; LAR; SUBSETS; AUTOIMMUNITY; ACTIVATION	Plasmacytoid dendritic cells (pDCs) are primary producers of type I interferon (IFN) in response to viruses. The IFN-producing capacity of pDCs is regulated by specific inhibitory receptors, yet none of the known receptors are conserved in evolution. We report that within the human immune system, receptor protein tyrosine phosphatase sigma (PTPRS) is expressed specifically on pDCs. Surface PTPRS was rapidly downregulated after pDC activation, and only PTPRS- pDCs produced IFN-alpha. Antibody-mediated PTPRS crosslinking inhibited pDC activation, whereas PTPRS knockdown enhanced IFN response in a pDC cell line. Similarly, murine Ptprs and the homologous receptor phosphatase Ptprf were specifically co-expressed in murine pDCs. Haplodeficiency or DC-specific deletion of Ptprs on Ptprf-deficient background were associated with enhanced IFN response of pDCs, leukocyte infiltration in the intestine and mild colitis. Thus, PTPRS represents an evolutionarily conserved pDC-specific inhibitory receptor, and is required to prevent spontaneous IFN production and immune-mediated intestinal inflammation.	[Bunin, Anna; Sisirak, Vanja; Ghosh, Hiyaa S.; Grajkowska, Lucja T.; Hou, Z. Esther; Miron, Michelle; Yang, Cliff; Reizis, Boris] Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA; [Bunin, Anna; Green, Peter H.; Bhagat, Govind] Columbia Univ, Med Ctr, Dept Med, Celiac Dis Ctr, New York, NY 10032 USA; [Sisirak, Vanja; Grajkowska, Lucja T.; Reizis, Boris] NYU, Langone Med Ctr, Dept Pathol, New York, NY 10016 USA; [Sisirak, Vanja; Grajkowska, Lucja T.; Reizis, Boris] NYU, Langone Med Ctr, Dept Med, New York, NY 10016 USA; [Ceribelli, Michele; Staudt, Louis M.] NCI, Lymphoid Malignancy Branch, Ctr Canc Res, Rockville, MD 20852 USA; [Uetani, Noriko; Tremblay, Michel L.] McGill Univ, Goodman Canc Ctr, Montreal, PQ H3A 1A3, Canada; [Chaperot, Laurence; Plumas, Joel] EFS Rhone Alpes Grenoble, R&D Lab, F-38701 La Tronche, France; [Hendriks, Wiljan] Radboud Univ Nijmegen, Nijmegen Med Ctr, Dept Cell Biol, NL-6525 GA Nijmegen, Netherlands; [Haecker, Hans] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA; [Bhagat, Govind] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); McGill University; Radboud University Nijmegen; St Jude Children's Research Hospital; Columbia University	Reizis, B (corresponding author), Columbia Univ, Med Ctr, Dept Microbiol & Immunol, New York, NY 10032 USA.	boris.reizis@nyumc.org	chaperot, laurence/N-2927-2013; Sisirak, Vanja/O-9393-2016; Hendriks, Wiljan/Q-4325-2019; Hendriks, Wiljan J.A.J./A-5214-2013; Staudt, Louis/AAC-5324-2019; Bhagat, Govind/AAE-9493-2021; Sisirak, Vanja/L-7304-2019; Haecker, Hans/F-6826-2013; Sisirak, Vanja/GRJ-7805-2022	chaperot, laurence/0000-0002-1479-9410; Sisirak, Vanja/0000-0003-3070-6533; Hendriks, Wiljan/0000-0001-9481-8281; Hendriks, Wiljan J.A.J./0000-0001-9481-8281; Bhagat, Govind/0000-0001-6250-048X; Sisirak, Vanja/0000-0003-3070-6533; Haecker, Hans/0000-0001-5971-0451; Reizis, Boris/0000-0003-1140-7853	NIH [AI072571]; Irvington Institute Fellowship of the Cancer Research Institute; American Society of Hematology; NIH training grant [CA009503]; NATIONAL CANCER INSTITUTE [T32CA009503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072571, T32AI106711] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irvington Institute Fellowship of the Cancer Research Institute; American Society of Hematology; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. Ivaylo Ivanov for advice, Alexei Kartashov for help with statistical analysis, and T. and E. Reizis for help in scoring IRF7 translocation. Supported by NIH grant AI072571 (B.R.), Irvington Institute Fellowship of the Cancer Research Institute (V.S.), American Society of Hematology (H.S.G.) and NIH training grant CA009503 (C.Y.).	Aicher B, 1997, J CELL BIOL, V138, P681, DOI 10.1083/jcb.138.3.681; Balmelli C, 2011, IMMUNOLOGY, V132, P57, DOI 10.1111/j.1365-2567.2010.03339.x; Bar-On L, 2011, SEMIN IMMUNOL, V23, P58, DOI 10.1016/j.smim.2011.01.002; Baumgart DC, 2011, CLIN EXP IMMUNOL, V166, P46, DOI 10.1111/j.1365-2249.2011.04439.x; Blasius A, 2004, BLOOD, V103, P4201, DOI 10.1182/blood-2003-09-3108; Blasius AL, 2006, BLOOD, V107, P2474, DOI 10.1182/blood-2005-09-3746; Blasius AL, 2010, P NATL ACAD SCI USA, V107, P19973, DOI 10.1073/pnas.1014051107; Bogunovic M, 2012, IMMUNOL RES, V54, P37, DOI 10.1007/s12026-012-8323-5; Cao W, 2006, J EXP MED, V203, P1399, DOI 10.1084/jem.20052454; Cao W, 2009, J EXP MED, V206, P1603, DOI 10.1084/jem.20090547; Cervantes-Barragan L, 2012, P NATL ACAD SCI USA, V109, P3012, DOI 10.1073/pnas.1117359109; Chaperot L, 2006, J IMMUNOL, V176, P248, DOI 10.4049/jimmunol.176.1.248; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Coles CH, 2011, SCIENCE, V332, P484, DOI 10.1126/science.1200840; Colonna M, 2004, NAT IMMUNOL, V5, P1219, DOI 10.1038/ni1141; Di Domizio J, 2009, BLOOD, V114, P1794, DOI 10.1182/blood-2009-04-216770; Dzionek A, 2001, J EXP MED, V194, P1823, DOI 10.1084/jem.194.12.1823; Esashi E, 2012, EUR J IMMUNOL, V42, P573, DOI 10.1002/eji.201142045; Fujita H, 2013, EUR J IMMUNOL, V43, P93, DOI 10.1002/eji.201242699; Ganguly D, 2013, NAT REV IMMUNOL, V13, P566, DOI 10.1038/nri3477; Ghosh HS, 2014, J EXP MED, V211, P1623, DOI 10.1084/jem.20132121; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Gilliet M, 2008, NAT REV IMMUNOL, V8, P594, DOI 10.1038/nri2358; Gordts PLSM, 2014, CELL METAB, V20, P813, DOI 10.1016/j.cmet.2014.09.016; Kondo S, 2010, EUR J IMMUNOL, V40, P1296, DOI 10.1002/eji.200939743; Lang BT, 2015, NATURE, V518, P404, DOI 10.1038/nature13974; Liu YJ, 2005, ANNU REV IMMUNOL, V23, P275, DOI 10.1146/annurev.immunol.23.021704.115633; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Muise AM, 2007, CURR BIOL, V17, P1212, DOI 10.1016/j.cub.2007.06.013; Murchie R, 2014, P NATL ACAD SCI USA, V111, P693, DOI 10.1073/pnas.1315017111; Pellerin A, 2015, EMBO MOL MED, V7, P464, DOI 10.15252/emmm.201404719; Prete F, 2013, J EXP MED, V210, P355, DOI 10.1084/jem.20120363; Puttur F, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003648; Redecke V, 2013, NAT METHODS, V10, P795, DOI [10.1038/NMETH.2510, 10.1038/nmeth.2510]; Rhee I, 2012, NAT IMMUNOL, V13, P439, DOI 10.1038/ni.2246; Riboldi E, 2011, J BIOL CHEM, V286, P35329, DOI 10.1074/jbc.C111.290494; Ruhe JE, 2006, CELL SIGNAL, V18, P1515, DOI 10.1016/j.cellsig.2005.12.003; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Sawai CM, 2013, J EXP MED, V210, P2151, DOI 10.1084/jem.20130443; Sisirak V, 2014, J EXP MED, V211, P1969, DOI 10.1084/jem.20132522; Swiecki M, 2014, J IMMUNOL, V192, P4409, DOI 10.4049/jimmunol.1303135; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Takauji R, 2002, J LEUKOCYTE BIOL, V72, P1011; Tavano B, 2013, J IMMUNOL, V190, P2622, DOI 10.4049/jimmunol.1202391; Terszowski G, 2001, EUR J IMMUNOL, V31, P832, DOI 10.1002/1521-4141(200103)31:3<832::AID-IMMU832>3.0.CO;2-D; Uetani N, 2009, J CLIN INVEST, V119, P924, DOI 10.1172/JCI37196; Wang JM, 2014, EUR J IMMUNOL, V44, P1130, DOI 10.1002/eji.201344030; Zaru R, 2015, MOL CELL BIOL, V35, P132, DOI 10.1128/MCB.00773-14	50	31	32	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2015	43	2					277	288		10.1016/j.immuni.2015.07.009	http://dx.doi.org/10.1016/j.immuni.2015.07.009			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WW	26231120	Bronze, Green Submitted, Green Accepted			2022-12-18	WOS:000360101200011
J	Dopfer, EP; Minguet, S; Schamel, WWA				Dopfer, Elaine Pashupati; Minguet, Susana; Schamel, Wolfgang W. A.			A New Vampire Saga: The Molecular Mechanism of T Cell Trogocytosis	IMMUNITY			English	Editorial Material									[Dopfer, Elaine Pashupati; Minguet, Susana; Schamel, Wolfgang W. A.] CCI, BIOSS Ctr Biol Signalling Studies, Fac Biol, Dept Mol Immunol, D-79108 Freiburg, Germany; [Dopfer, Elaine Pashupati; Minguet, Susana; Schamel, Wolfgang W. A.] Max Planck Inst Immunbiol & Epigenet, D-79108 Freiburg, Germany	Max Planck Society	Schamel, WWA (corresponding author), CCI, BIOSS Ctr Biol Signalling Studies, Fac Biol, Dept Mol Immunol, Stubeweg 51, D-79108 Freiburg, Germany.	schamel@immunbio.mpg.de		Minguet, Susana/0000-0001-8211-5538				BELL GI, 1978, IMMUNITY, V200, P414; CONE RE, 1972, P NATL ACAD SCI USA, V69, P2556, DOI 10.1073/pnas.69.9.2556; Henson PM, 2005, CURR BIOL, V15, pR29, DOI 10.1016/j.cub.2004.12.017; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Martinez-Martin N, 2011, IMMUNITY, V35, P208, DOI 10.1016/j.immuni.2011.06.003; Monjas A, 2004, J BIOL CHEM, V279, P55376, DOI 10.1074/jbc.M409342200; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155	8	31	31	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 26	2011	35	2					151	153		10.1016/j.immuni.2011.08.004	http://dx.doi.org/10.1016/j.immuni.2011.08.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	813SC	21867922	Bronze			2022-12-18	WOS:000294387900003
J	Wuerzberger-Davis, SM; Chen, YH; Yang, DT; Kearns, JD; Bates, PW; Lynch, C; Ladell, NC; Yu, M; Podd, A; Zeng, H; Huang, TT; Wen, RR; Hoffmann, A; Wang, DM; Miyamoto, S				Wuerzberger-Davis, Shelly M.; Chen, Yuhong; Yang, David T.; Kearns, Jeffrey D.; Bates, Paul W.; Lynch, Candace; Ladell, Nicholas C.; Yu, Mei; Podd, Andrew; Zeng, Hu; Huang, Tony T.; Wen, Renren; Hoffmann, Alexander; Wang, Demin; Miyamoto, Shigeki			Nuclear Export of the NF-kappa B Inhibitor I kappa B alpha Is Required for Proper B Cell and Secondary Lymphoid Tissue Formation	IMMUNITY			English	Article							MICE LACKING JAK3; CD4(+) T-CELLS; C-REL; TRANSCRIPTION FACTOR; ORGAN DEVELOPMENT; LYMPHOTOXIN-ALPHA; DEFICIENT MICE; ACTIVATION; RECEPTOR; SIGNAL	The N-terminal nuclear export sequence (NES) of inhibitor of nuclear factor kappa B (NF-kappa B) alpha (I kappa B alpha) promotes NF-kappa B export from the cell nucleus to the cytoplasm, but the physiological role of this export regulation remains unknown. Here we report the derivation and analysis of genetically targeted mice harboring a germline mutation in I kappa B alpha NES. Mature B cells in the mutant mice displayed nuclear accumulation of inactive I kappa B alpha complexes containing a NF-kappa B family member, cReI, causing their spatial separation from the cytoplasmic I kappa B kinase. This resulted in severe reductions in constitutive and canonical NF-kappa B activities, synthesis of p100 and ReIB NF-kappa B members, noncanonical NF-kappa B activity, NF-kappa B target gene induction, and proliferation and survival responses in B cells. Consequently, mice displayed defective B cell maturation, antibody production, and formation of secondary lymphoid organs and tissues. Thus, I kappa B alpha nuclear export is essential to maintain constitutive, canonical, and noncanonical NF-kappa B activation potentials in mature B cells in vivo.	[Chen, Yuhong; Yu, Mei; Podd, Andrew; Zeng, Hu; Wen, Renren; Wang, Demin] BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA; [Wuerzberger-Davis, Shelly M.; Bates, Paul W.; Ladell, Nicholas C.; Miyamoto, Shigeki] Univ Wisconsin, Wisconsin Inst Med Res 6159, McArdle Lab Canc Res, Carbone Canc Ctr,Dept Oncol, Madison, WI 53705 USA; [Yang, David T.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53792 USA; [Kearns, Jeffrey D.; Lynch, Candace; Hoffmann, Alexander] Univ Calif San Diego, Dept Chem & Biochem, Signaling Syst Lab, La Jolla, CA 92093 USA; [Yu, Mei; Zeng, Hu; Wang, Demin] Nanjing Univ, Coll Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing 210093, Peoples R China; [Podd, Andrew; Wang, Demin] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA; [Huang, Tony T.] NYU, Dept Biochem, New York, NY 10016 USA	Versiti Blood Center of Wisconsin; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California San Diego; Nanjing University; Medical College of Wisconsin; New York University	Wang, DM (corresponding author), BloodCtr Wisconsin, Blood Res Inst, Milwaukee, WI 53226 USA.	demin.wang@bcw.edu; smiyamot@wisc.edu	Wang, Demin/AAX-4449-2020; Yu, Mei/K-2206-2017; Zeng, Hu/AAA-2706-2020	Wang, Demin/0000-0001-5549-3795; Zeng, Hu/0000-0002-9909-7732	National Institutes of Health [R01 CA081065, R56 CA081065, CA077474, R01 GM083681, T32 CA009614, R01 AI083453, P01 GM071862, R01 AI52327, R01 HL073284, R01 AI079087, P01 HL44612]; UWCCC [P30 CA14520]; Leukemia & Lymphoma Society; NATIONAL CANCER INSTITUTE [R01CA077474, T32CA009614, P30CA014520, R01CA081065, R56CA081065] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL044612, R01HL073284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083453, R01AI079087, R01AI052327] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083681, R01GM071573, P01GM071862] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UWCCC; Leukemia & Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Griep, P. Powers, C. Bartley, and M. Lye at the Transgenic Animal Facility at the University of Wisconsin Biotechnology Center for the gift of the TK-pflox8 targeting vector and assistance with the generation of the mutant mice, B. Seufzer for genotyping of the mice, and members of the S.M., OM., and R.W. labs for stimulating discussions. This work was supported in part by National Institutes of Health grants R01 CA081065, R56 CA081065, CA077474, and R01 GM083681 (S.M.), T32 CA009614 (D.Y.), R01 AI083453 and P01 GM071862 (A.H.), R01 AI52327 (R.W.), and R01 HL073284, R01 AI079087, and P01 HL44612 (D.W.), by UWCCC Core grant P30 CA14520 (G. Wilding, PI), and by Scholar Award from the Leukemia & Lymphoma Society (D.W.).	BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BANKS TA, 1995, J IMMUNOL, V155, P1685; Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200; Castro I, 2009, J IMMUNOL, V182, P7729, DOI 10.4049/jimmunol.0803281; Chen YH, 2008, BLOOD, V111, P4627, DOI 10.1182/blood-2007-12-128140; Chu CT, 2007, J NEUROPATH EXP NEUR, V66, P873, DOI 10.1097/nen.0b013e318156a3d7; Deenick EK, 2010, EUR J IMMUNOL, V40, P677, DOI 10.1002/eji.201040298; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Drayton DL, 2006, NAT IMMUNOL, V7, P344, DOI 10.1038/ni1330; Ferch U, 2007, NAT IMMUNOL, V8, P984, DOI 10.1038/ni1493; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; GRUMONT RJ, 1994, CELL GROWTH DIFFER, V5, P1321; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; Harhaj EW, 1999, MOL CELL BIOL, V19, P7088; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hori S, 2010, EUR J IMMUNOL, V40, P664, DOI 10.1002/eji.201040372; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Huxford T, 1998, CELL, V95, P759, DOI 10.1016/S0092-8674(00)81699-2; INOUE J, 1991, P NATL ACAD SCI USA, V88, P3715, DOI 10.1073/pnas.88.9.3715; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; Kelsall B, 2008, MUCOSAL IMMUNOL, V1, P460, DOI 10.1038/mi.2008.61; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; KONTGEN F, 1995, GENE DEV, V9, P1965, DOI 10.1101/gad.9.16.1965; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Malek S, 2001, J BIOL CHEM, V276, P45225, DOI 10.1074/jbc.M105865200; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Oliver AM, 1997, EUR J IMMUNOL, V27, P2366, DOI 10.1002/eji.1830270935; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Piao JH, 2007, J IMMUNOL, V178, P2272, DOI 10.4049/jimmunol.178.4.2272; Pohl T, 2002, P NATL ACAD SCI USA, V99, P4514, DOI 10.1073/pnas.072071599; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; Sen R, 2006, IMMUNITY, V25, P871, DOI 10.1016/j.immuni.2006.12.003; Stadanlick JE, 2008, NAT IMMUNOL, V9, P1379, DOI 10.1038/ni.1666; Tam WF, 2000, MOL CELL BIOL, V20, P2269, DOI 10.1128/MCB.20.6.2269-2284.2000; Tam WF, 2001, MOL CELL BIOL, V21, P4837, DOI 10.1128/MCB.21.14.4837-4846.2001; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; THOMIS DC, 1995, SCIENCE, V270, P794, DOI 10.1126/science.270.5237.794; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vang KB, 2010, J IMMUNOL, V184, P4074, DOI 10.4049/jimmunol.0903933; Visekruna A, 2010, EUR J IMMUNOL, V40, P671, DOI 10.1002/eji.200940260; Weih F, 2003, IMMUNOL REV, V195, P91, DOI 10.1034/j.1600-065X.2003.00064.x; Zeng H, 2008, J BIOL CHEM, V283, P24392, DOI 10.1074/jbc.M802344200; Zheng Y, 2003, J EXP MED, V197, P861, DOI 10.1084/jem.20021610; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750	49	31	31	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 25	2011	34	2					188	200		10.1016/j.immuni.2011.01.014	http://dx.doi.org/10.1016/j.immuni.2011.01.014			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	729YD	21333553	Green Accepted, Bronze			2022-12-18	WOS:000287989500009
J	Becart, S; Balancio, AJC; Charvet, C; Feau, S; Sedwick, CE; Altman, A				Becart, Stephane; Balancio, Ann J. Canonigo; Charvet, Celine; Feau, Sonia; Sedwick, Caitlin E.; Altman, Amnon			Tyrosine-Phosphorylation-Dependent Translocation of the SLAT Protein to the Immunological Synapse Is Required for NFAT Transcription Factor Activation	IMMUNITY			English	Article							T-CELL-RECEPTOR; NUCLEOTIDE-EXCHANGE FACTOR; ALDRICH-SYNDROME PROTEIN; NUCLEAR TRANSLOCATION; MEMBRANE LOCALIZATION; ACTIN POLYMERIZATION; SIGNALING PATHWAY; CHANNEL FUNCTION; PLASMA-MEMBRANE; FAMILY PROTEINS	SWAP-70-like adaptor of T cells (SLAT) is a guanine nucleotide exchange factor for Rho GTPases that regulates the development of T helper 1 (Th1) and Th2 cell inflammatory responses by controlling the Ca2+- NFAT signaling pathway. However, the mechanism used by SLAT to regulate these events is unknown. Here, we report that the T cell receptor (TCR)-induced translocation of SLAT to the immunological synapse required Lck-mediated phosphorylation of two tyrosine residues located in an immunoreceptor tyrosine-based activation motif-like sequence but was independent of the SLAT PH domain. This subcellular relocalization was coupled to, and necessary for, activation of the NFAT pathway. Furthermore, membrane targeting of the SLAT Dbl-homology (catalytic) domain was sufficient to trigger TCR-mediated NFAT activation and Th1 and Th2 differentiation in a Cdc42-dependent manner. Therefore, tyrosinephosphorylation-mediated relocalization of SLAT to the site of antigen recognition is required for SLAT to exert its pivotal role in NFAT-dependent CD4(+) T cell differentiation.	[Becart, Stephane; Balancio, Ann J. Canonigo; Charvet, Celine; Sedwick, Caitlin E.; Altman, Amnon] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Feau, Sonia] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology; La Jolla Institute for Immunology	Altman, A (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA.	amnon@liai.org			National Institutes of Health [Al68320]; Fondation pour la Recherche Medicale; Diabetes & Immune Disease National Research Institute; Philippe Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068320] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Diabetes & Immune Disease National Research Institute; Philippe Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank all the members of the Cell Biology Division for helpful comments, L. Fernandez, C. Kim, and B. Sears for assistance with flow cytometry and cell sorting, and C. Wulfing for providing recombinant Tat-Cdc42 CA protein. This work was supported by National Institutes of Health grant Al68320 (to A.A.) and fellowships from the Fondation pour la Recherche Medicale (to S.B.), the Diabetes & Immune Disease National Research Institute (S.B.), and the Philippe Foundation (to S.B.). This is manuscript number 987 from the La Jolla Institute for Allergy and Immunology.	Becart S, 2007, J CLIN INVEST, V117, P2164, DOI 10.1172/JCI31640; Borggrefe T, 1998, J BIOL CHEM, V273, P17025, DOI 10.1074/jbc.273.27.17025; Campbell PM, 1996, TRANSPLANTATION, V61, P933, DOI 10.1097/00007890-199603270-00016; Cannon JL, 2002, IMMUNOL REV, V186, P90, DOI 10.1034/j.1600-065X.2002.18609.x; Charvet C, 2005, J BIOL CHEM, V280, P15289, DOI 10.1074/jbc.M500275200; CHUVPILO S, 1993, NUCLEIC ACIDS RES, V21, P5694, DOI 10.1093/nar/21.24.5694; Dong XY, 2007, J BIOL CHEM, V282, P30303, DOI 10.1074/jbc.M704972200; Fanzo JC, 2006, J CLIN INVEST, V116, P703, DOI 10.1172/JCI24096; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Frost JA, 1997, EMBO J, V16, P6426, DOI 10.1093/emboj/16.21.6426; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; Gupta S, 2003, HUM IMMUNOL, V64, P389, DOI 10.1016/S0198-8859(03)00024-7; Huang W, 2005, J IMMUNOL, V174, P2602, DOI 10.4049/jimmunol.174.5.2602; Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859; Li BY, 2000, SCIENCE, V288, P2219, DOI 10.1126/science.288.5474.2219; Liu Y, 1997, J EXP MED, V185, P251, DOI 10.1084/jem.185.2.251; Marques CA, 2008, BLOOD, V111, P1413, DOI 10.1182/blood-2007-05-089458; Masuda ES, 1998, CELL SIGNAL, V10, P599, DOI 10.1016/S0898-6568(98)00019-9; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036; Nolz JC, 2007, J IMMUNOL, V179, P1104, DOI 10.4049/jimmunol.179.2.1104; Oka T, 2007, J BIOL CHEM, V282, P2011, DOI 10.1074/jbc.M605153200; Pearce G, 2006, NAT IMMUNOL, V7, P827, DOI 10.1038/ni1365; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sanna B, 2005, MOL CELL BIOL, V25, P865, DOI 10.1128/MCB.25.3.865-878.2005; Shinohara M, 2002, NATURE, V416, P759, DOI 10.1038/416759a; Silvin C, 2001, J BIOL CHEM, V276, P21450, DOI 10.1074/jbc.M010729200; Tanaka Y, 2003, IMMUNITY, V18, P403, DOI 10.1016/S1074-7613(03)00054-2; Trifari S, 2006, J IMMUNOL, V177, P7451, DOI 10.4049/jimmunol.177.10.7451; Tskvitaria-Fuller I, 2007, J IMMUNOL METHODS, V319, P64, DOI 10.1016/j.jim.2006.10.017; Tsukamoto H, 2004, J BIOL CHEM, V279, P48457, DOI 10.1074/jbc.M403087200; Turner H, 1998, J EXP MED, V188, P527, DOI 10.1084/jem.188.3.527; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Villalba M, 2000, EUR J IMMUNOL, V30, P1587, DOI 10.1002/1521-4141(200006)30:6<1587::AID-IMMU1587>3.0.CO;2-T; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; Wang HY, 2003, NAT IMMUNOL, V4, P366, DOI 10.1038/ni913; Yablonski D, 1998, EMBO J, V17, P5647, DOI 10.1093/emboj/17.19.5647; Yang TTC, 2005, MOL CELL BIOL, V25, P907, DOI 10.1128/MCB.25.3.907-920.2005; Yasuda K, 2000, J IMMUNOL, V165, P3226, DOI 10.4049/jimmunol.165.6.3226; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	43	31	31	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 14	2008	29	5					704	719		10.1016/j.immuni.2008.08.015	http://dx.doi.org/10.1016/j.immuni.2008.08.015			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	18976935	Green Accepted, Bronze			2022-12-18	WOS:000261036000009
J	Ljunggren, HG				Ljunggren, Hans-Gustaf			Cancer immunosurveillance: NKG2D breaks cover	IMMUNITY			English	Editorial Material							RECEPTOR	The idea of cancer immunosurveillance has regained interest in recent years. In this issue of Immunity, Guerra et al. (2008) present the first genetic evidence for surveillance of primary tumors by a natural killer cell-associated receptor.	Karolinska Inst, Dept Med, Ctr Infect Med, S-14186 Huddinge, Sweden	Karolinska Institutet	Ljunggren, HG (corresponding author), Karolinska Inst, Dept Med, Ctr Infect Med, S-14186 Huddinge, Sweden.	hans-gustaf.ljunggren@ki.se						ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bryceson YT, 2006, IMMUNOL REV, V214, P73, DOI 10.1111/j.1600-065X.2006.00457.x; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hayakawa Y, 2006, SEMIN IMMUNOL, V18, P176, DOI 10.1016/j.smim.2006.03.005; Kaplan-Lefko PJ, 2003, PROSTATE, V55, P219, DOI 10.1002/pros.10215; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; LIUNGGREN HG, 2007, NAT REV IMMUNOL, V7, P329	9	31	31	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR	2008	28	4					492	494		10.1016/j.immuni.2008.03.007	http://dx.doi.org/10.1016/j.immuni.2008.03.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18400193	Bronze			2022-12-18	WOS:000254939400009
J	Stephens, GL; Shevach, EM				Stephens, Geoffrey L.; Shevach, Ethan M.			Foxp3(+) regulatory T cells: Selfishness under scrutiny	IMMUNITY			English	Editorial Material							SELF; REPERTOIRES	The Foxp3(+) T cell lineage is thought to arise from self-specific precursors during development. By using a unique mouse model, Pacholczyk et al. (2007) present compelling evidence that self-specific cells are exceedingly rare among Foxp3(-) and, surprisingly, Foxp3(+) subsets.	NIAID, NIH, Cellular Immunol Sect, Immunol Lab, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Shevach, EM (corresponding author), NIAID, NIH, Cellular Immunol Sect, Immunol Lab, 9000 Rockville Pike, Bethesda, MD 20892 USA.	eshevach@niaid.nih.gov						Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; van Santen HM, 2004, J EXP MED, V200, P1221, DOI 10.1084/jem.20041022; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032	9	31	39	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP	2007	27	3					417	419		10.1016/j.immuni.2007.08.008	http://dx.doi.org/10.1016/j.immuni.2007.08.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17892850	Bronze			2022-12-18	WOS:000249843400007
J	McGeachy, MJ; Cua, DJ				McGeachy, Mandy J.; Cua, Daniel J.			T cells doing it for themselves: TGF-beta regulation of Th1 and Th17 cells	IMMUNITY			English	Editorial Material							DIFFERENTIATION; GENERATION; T(H)17; INNATE; IL-23	The source of TGF-beta, which regulates inflammation in various disease settings, is unclear. In this issue of Immunity, Li et al. (2007) find that not only does T cell-produced TGF-beta regulate Th1-cell-mediated inflammation, but it is also required for the generation of Th17 cells in vivo.	Schering Plough Biopharma, Palo Alto, CA 94304 USA	Merck & Company	Cua, DJ (corresponding author), Schering Plough Biopharma, 901 Calif Ave, Palo Alto, CA 94304 USA.	daniel.cua@spcorp.com						Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Laurence A, 2007, IMMUNITY, V26, P371, DOI 10.1016/j.immuni.2007.02.009; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001	10	31	43	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2007	26	5					547	549		10.1016/j.immuni.2007.05.003	http://dx.doi.org/10.1016/j.immuni.2007.05.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17521582	Bronze			2022-12-18	WOS:000246895900006
J	Regelmann, AG; Danzl, NM; Wanjalla, C; Alexandropoulos, K				Regelmann, Adam G.; Danzl, Nichole M.; Wanjalla, Celestine; Alexandropoulos, Konstantina			The hematopoietic isoform of Cas-Hef1-associated signal transducer regulates chemokine-induced inside-out signaling and T cell trafficking	IMMUNITY			English	Article							ADAPTER PROTEIN; LENTIVIRAL VECTORS; EFFECTOR MOLECULE; HIGH-TITER; R-RAS; LYMPHOCYTE; ADHESION; ACTIVATION; RAP1; MIGRATION	Leukocyte migration and trafficking is dynamically regulated by various chemokine and adhesion molecules and is vital to the proper function of the immune system. We describe a role for the Cas and Hef-1-associated signal transducer in hematopoietic cells (Chat-H) as a critical regulator of T lymphocyte migration, by using lentivirus-mediated RNA interference (RNAi). Impaired migration of Chat-H-depleted cells coincided with defective inside-out signaling shown by diminished chemokine-induced activation of the Rap-1 GTPase and integrin-mediated adhesion. Localization of Chat-H to the plasma membrane, association with its binding partner Crk-associated substrate in lymphocytes (CasL), and Chat-H-mediated CasL serine-threonine phosphorylation were required for T cell migration. These results identify Chat-H as a critical signaling intermediate acting upstream of Rap1 to regulate chemokine-induced adhesion and migration.	Columbia Univ Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA; Columbia Univ Coll Phys & Surg, Integrated Program Cellular Mol & Biophys Studies, New York, NY 10032 USA; Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA	Columbia University; Columbia University; Jefferson University	Alexandropoulos, K (corresponding author), Columbia Univ Coll Phys & Surg, Dept Pharmacol, 630 W 168th St, New York, NY 10032 USA.	ka141@columbia.edu			NIAID NIH HHS [R01 AI49387-01] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049387] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; Alexandropoulos K, 2003, IMMUNOL REV, V192, P181, DOI 10.1034/j.1600-065X.2003.00021.x; ARBONES ML, 1994, IMMUNITY, V1, P247, DOI 10.1016/1074-7613(94)90076-0; Bos JL, 2001, NAT REV MOL CELL BIO, V2, P369, DOI 10.1038/35073073; Bouton AH, 2001, ONCOGENE, V20, P6448, DOI 10.1038/sj.onc.1204785; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Cai DP, 1999, J IMMUNOL, V163, P2104; Cavalieri S, 2003, BLOOD, V102, P497, DOI 10.1182/blood-2003-01-0297; Dail M, 2004, J BIOL CHEM, V279, P41892, DOI 10.1074/jbc.M402929200; Dodelet VC, 1999, J BIOL CHEM, V274, P31941, DOI 10.1074/jbc.274.45.31941; Gotoh T, 2000, J BIOL CHEM, V275, P30118, DOI 10.1074/jbc.M003074200; Hamann A, 2000, EUR J IMMUNOL, V30, P3207, DOI 10.1002/1521-4141(200011)30:11<3207::AID-IMMU3207>3.0.CO;2-L; HAMANN A, 1988, J IMMUNOL, V140, P693; Hogg N, 2003, J CELL SCI, V116, P4695, DOI 10.1242/jcs.00876; Hwang MCC, 1996, J BIOL CHEM, V271, P8196, DOI 10.1074/jbc.271.14.8196; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Iwata S, 2000, J DERMATOL SCI, V23, P75, DOI 10.1016/S0923-1811(99)00096-1; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kinashi T, 2004, IMMUNOL LETT, V93, P1, DOI 10.1016/j.imlet.2004.02.008; Lehmann JCU, 2003, J IMMUNOL, V171, P2588, DOI 10.4049/jimmunol.171.5.2588; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu YM, 1999, J BIOL CHEM, V274, P10047, DOI 10.1074/jbc.274.15.10047; Minegishi M, 1996, J EXP MED, V184, P1365, DOI 10.1084/jem.184.4.1365; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sakakibara A, 2000, J BIOL CHEM, V275, P6404, DOI 10.1074/jbc.275.9.6404; Sakakibara A, 2003, J BIOL CHEM, V278, P6012, DOI 10.1074/jbc.M207942200; Sakakibara A, 2002, J CELL SCI, V115, P4915, DOI 10.1242/jcs.00207; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Zheng MZ, 2002, J BIOL CHEM, V277, P39599, DOI 10.1074/jbc.M202263200	32	31	32	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2006	25	6					907	918		10.1016/j.immuni.2006.09.014	http://dx.doi.org/10.1016/j.immuni.2006.09.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17174122	Bronze			2022-12-18	WOS:000243087500010
J	Teixeiro, E; Daniels, MA; Hausmann, B; Schrum, AG; Naeher, D; Luescher, I; Thome, M; Bragado, R; Palmer, E				Teixeiro, E; Daniels, MA; Hausmann, B; Schrum, AG; Naeher, D; Luescher, I; Thome, M; Bragado, R; Palmer, E			T cell division and death are segregated by mutation of TCR beta chain constant domains	IMMUNITY			English	Article							NF-KAPPA-B; FAS-LIGAND EXPRESSION; LYMPHOCYTE DEVELOPMENT; RECEPTOR SIGNALS; ACTIVATION; APOPTOSIS; CARMA1; AUTOIMMUNITY; RESPONSES; REGULATOR	We have studied the role of the T cell receptor (TCR) beta chain transmembrane and cytoplasmic domains (betaTM/Cyto) in T cell signaling. Upon antigen stimulation, T lymphocytes expressing a TCR with mutant betaTM and Cyto domains accumulate in large numbers and are specifically defective in undergoing activation induced cell death (AICD). The mutant TCR poorly recruits the protein adaptor Carma-1 and is subsequently impaired in activating NF-kappaB. This signaling defect leads to a reduced expression of Fas ligand (FasL) and to a reduction in AICD. These beta chain domains are involved in discriminating cell division and apoptosis.	Univ Basel Hosp, Dept Res, Lab Transplantat Immunol, CH-4031 Basel, Switzerland; Univ Lausanne, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland; Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; Fdn Jimenez Diaz, Dept Immunol, E-28040 Madrid, Spain	University of Basel; Ludwig Institute for Cancer Research; University of Lausanne; University of Lausanne	Palmer, E (corresponding author), Univ Basel Hosp, Dept Res, Lab Transplantat Immunol, Hebelstr 20, CH-4031 Basel, Switzerland.	ed.palmer@unibas.ch	Thome, Margot/F-8167-2011	Thome, Margot/0000-0002-5656-2139; Schrum, Adam/0000-0001-9276-1859; Daniels, Mark/0000-0002-5175-9901	NCI NIH HHS [F32 CA103374] Funding Source: Medline; NATIONAL CANCER INSTITUTE [F32CA103374] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Backstrom BT, 1998, SCIENCE, V281, P835, DOI 10.1126/science.281.5378.835; Backstrom BT, 1997, J EXP MED, V186, P1933, DOI 10.1084/jem.186.11.1933; Backstrom BT, 1996, IMMUNITY, V5, P437, DOI 10.1016/S1074-7613(00)80500-2; BOEHME SA, 1993, EUR J IMMUNOL, V23, P1552, DOI 10.1002/eji.1830230724; Che TJ, 2004, J BIOL CHEM, V279, P15870, DOI 10.1074/jbc.M310599200; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Combadiere B, 1998, J EXP MED, V187, P349, DOI 10.1084/jem.187.3.349; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; DIGIUSTO DL, 1994, MOL IMMUNOL, V31, P693, DOI 10.1016/0161-5890(94)90179-1; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Hsu SC, 1999, EUR J IMMUNOL, V29, P2948, DOI 10.1002/(SICI)1521-4141(199909)29:09<2948::AID-IMMU2948>3.0.CO;2-0; Iezzi G, 1999, EUR J IMMUNOL, V29, P4092, DOI 10.1002/(SICI)1521-4141(199912)29:12<4092::AID-IMMU4092>3.3.CO;2-1; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Irwin M, 2000, NATURE, V407, P645, DOI 10.1038/35036614; Itoh Y, 1997, J EXP MED, V186, P757, DOI 10.1084/jem.186.5.757; JAIN J, 1995, CURR OPIN IMMUNOL, V7, P333, DOI 10.1016/0952-7915(95)80107-3; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Jun JE, 2003, NAT IMMUNOL, V4, P1057, DOI 10.1038/ni1001; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kasibhatla S, 1999, J BIOL CHEM, V274, P987, DOI 10.1074/jbc.274.2.987; Kavurma MM, 2003, CELL DEATH DIFFER, V10, P36, DOI 10.1038/sj.cdd.4401179; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Lenardo M, 1999, ANNU REV IMMUNOL, V17, P221, DOI 10.1146/annurev.immunol.17.1.221; Lissy NA, 2000, NATURE, V407, P642, DOI 10.1038/35036608; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; Matsui K, 2000, J IMMUNOL, V164, P3002, DOI 10.4049/jimmunol.164.6.3002; Matsui K, 1998, J IMMUNOL, V161, P3469; Muppidi JR, 2004, NAT IMMUNOL, V5, P182, DOI 10.1038/ni1024; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Petersen TR, 2004, INT IMMUNOL, V16, P889, DOI 10.1093/intimm/dxh098; Pomerantz JL, 2002, EMBO J, V21, P5184, DOI 10.1093/emboj/cdf505; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; RodriguezTarduchy G, 1996, J BIOL CHEM, V271, P30417, DOI 10.1074/jbc.271.48.30417; Rothwarf D M, 1999, Sci STKE, V1999, pRE1, DOI 10.1126/stke.1999.5.re1; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; RUSSELL JH, 1993, P NATL ACAD SCI USA, V90, P4409, DOI 10.1073/pnas.90.10.4409; Suda T, 1996, J IMMUNOL, V157, P3918; Sytwu HK, 1996, IMMUNITY, V5, P17, DOI 10.1016/S1074-7613(00)80306-4; Teixeiro E, 1999, EUR J IMMUNOL, V29, P745, DOI 10.1002/(SICI)1521-4141(199903)29:03<745::AID-IMMU745>3.0.CO;2-0; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Valitutti S, 1996, J EXP MED, V183, P1917, DOI 10.1084/jem.183.4.1917; Wan YSY, 2003, IMMUNITY, V18, P331, DOI 10.1016/S1074-7613(03)00053-0; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Wong B, 1997, J EXP MED, V186, P1939, DOI 10.1084/jem.186.11.1939; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	49	31	31	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2004	21	4					515	526		10.1016/j.immuni.2004.08.014	http://dx.doi.org/10.1016/j.immuni.2004.08.014			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866AD	15485629	Bronze			2022-12-18	WOS:000224744400008
J	Ohneda, O; Ohneda, K; Nomiyama, H; Zheng, Z; Gold, SA; Arai, F; Miyamoto, T; Taillon, BE; McIndoe, RA; Shimkets, RA; Lewin, DA; Suda, T; Lasky, LA				Ohneda, O; Ohneda, K; Nomiyama, H; Zheng, Z; Gold, SA; Arai, F; Miyamoto, T; Taillon, BE; McIndoe, RA; Shimkets, RA; Lewin, DA; Suda, T; Lasky, LA			WECHE: A novel hematopoietic regulatory factor	IMMUNITY			English	Article							MURINE YOLK-SAC; STEM-CELLS; IN-VITRO; T-CELLS; EMBRYONIC HEMATOPOIESIS; MOUSE EMBRYO; PROGENITORS; DIFFERENTIATION; CHEMOKINES; INHIBITORS	Previously, we described AGM-derived endothelial cell lines that either inhibited or permitted the development of erythroid or B cells. We utilized a differential gene expression method to isolate a chemokine, termed WECHE, from one of these cell lines. WECHE inhibited the formation of erythroid cells but had no effect on either myeloid or B cell formation. WECHE repressed BFU-E development from either mouse fetal liver or bone marrow progenitor cells but had no effect on colony formation induced by IL-3 or IL-7. WECHE reduced HPP-CFC production from fetal liver-derived stem cells. WECHE hindered the growth of yolk sac-derived endothelial cells. WECHE was also chemotactic for bone marrow cells. Thus, WECHE is a novel chemokine that regulates hematopoietic differentiation.	Kumamoto Univ, Sch Med, Dept Cell Differentiat, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; Kumamoto Univ, Sch Med, Dept Biochem, Inst Mol Embryol & Genet, Kumamoto 8600811, Japan; Genentech Inc, Dept Mol Oncol, San Francisco, CA 94080 USA; CuraGen Corp, Dept Gene Discovery, New Haven, CT 06511 USA	Kumamoto University; Kumamoto University; Roche Holding; Genentech	Ohneda, O (corresponding author), Kumamoto Univ, Sch Med, Dept Cell Differentiat, Inst Mol Embryol & Genet, 2-2-1 Honjo, Kumamoto 8600811, Japan.	oohneda@kaiju.medic.kumamoto-u.ac.jp; lal@gene.com	Nomiyama, Hisayuki/F-2840-2013; Arai, Fumio/J-5241-2013; Ohneda, Kinuko/AAC-8822-2019; Suda, Toshio/H-6761-2013	Nomiyama, Hisayuki/0000-0002-2716-4043; Arai, Fumio/0000-0003-1936-4907; Suda, Toshio/0000-0001-7540-1771; McIndoe, Richard/0000-0002-3040-3631				ALUTI A, 1997, J EXP MED, V185, P111; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; COOK DN, 1995, SCIENCE, V269, P1583, DOI 10.1126/science.7667639; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; DIETERLEINLIEVR.F, 1993, SEMIN DEV BIOL, V4, P603; DUNLOP DJ, 1992, BLOOD, V79, P2221; DZIERZAK E, 1995, TRENDS GENET, V11, P359, DOI 10.1016/S0168-9525(00)89107-6; FENNIE C, 1995, BLOOD, V86, P4454, DOI 10.1182/blood.V86.12.4454.bloodjournal86124454; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; GODIN IE, 1993, NATURE, V364, P67, DOI 10.1038/364067a0; Hedrick JA, 1997, J IMMUNOL, V158, P1533; Kawabata T, 1999, P NATL ACAD SCI USA, V96, P5663, DOI 10.1073/pnas.96.10.5663; Kim CH, 1998, BLOOD, V91, P4434, DOI 10.1182/blood.V91.12.4434.412k45_4434_4443; Kim CH, 1998, BLOOD, V91, P100, DOI 10.1182/blood.V91.1.100.100_100_110; Labastie MC, 1998, BLOOD, V92, P3624, DOI 10.1182/blood.V92.10.3624.422k17_3624_3635; LASSILA O, 1978, NATURE, V272, P353, DOI 10.1038/272353a0; LIN GS, 1995, EUR J IMMUNOL, V25, P1508, DOI 10.1002/eji.1830250606; LORD BI, 1992, BLOOD, V79, P2605; Lu LS, 1996, P NATL ACAD SCI USA, V93, P14782, DOI 10.1073/pnas.93.25.14782; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; MARTIN C, 1978, CELL DIFFER DEV, V7, P115, DOI 10.1016/0045-6039(78)90012-X; MAYANI H, 1995, EXP HEMATOL, V23, P422; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; MEDVINSKY AL, 1993, NATURE, V364, P64, DOI 10.1038/364064a0; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, CURR OPIN IMMUNOL, V9, P216, DOI 10.1016/S0952-7915(97)80138-0; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; NAGASAWA T, 1994, P NATL ACAD SCI USA, V91, P2305, DOI 10.1073/pnas.91.6.2305; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Ohneda O, 1998, BLOOD, V92, P908; Pan Y, 1997, NATURE, V387, P611, DOI 10.1038/42491; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Patel VP, 1997, J EXP MED, V185, P1163, DOI 10.1084/jem.185.7.1163; PEAULT B, 1996, J HEMATOTHER, V5, P513; QUESNIAUX VFJ, 1993, BLOOD, V81, P1497; Rollins BJ, 1997, BLOOD, V90, P909, DOI 10.1182/blood.V90.3.909.909_909_928; Rossi DL, 1999, J IMMUNOL, V162, P5490; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; Shimkets RA, 1999, NAT BIOTECHNOL, V17, P798, DOI 10.1038/11743; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; VERFAILLIE CM, 1994, J EXP MED, V179, P643, DOI 10.1084/jem.179.2.643; Verfaillie CM, 1996, J LAB CLIN MED, V127, P148; Wineman J, 1996, BLOOD, V87, P4082, DOI 10.1182/blood.V87.10.4082.bloodjournal87104082; Wood HB, 1997, BLOOD, V90, P2300; YODER MC, 1994, BLOOD, V83, P2436; Yoder MC, 1997, P NATL ACAD SCI USA, V94, P6776, DOI 10.1073/pnas.94.13.6776; YOUNG PE, 1995, BLOOD, V85, P96, DOI 10.1182/blood.V85.1.96.bloodjournal85196; ZON LI, 1995, BLOOD, V86, P2876	50	31	34	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2000	12	2					141	150		10.1016/S1074-7613(00)80167-3	http://dx.doi.org/10.1016/S1074-7613(00)80167-3			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	289LA	10714680	Bronze			2022-12-18	WOS:000085621400004
J	Kang, CJ; Sheridan, C; Koshland, ME				Kang, CJ; Sheridan, C; Koshland, ME			A stage-specific enhancer of immunoglobulin J chain gene is induced by interleukin-2 in a presecretor B cell stage	IMMUNITY			English	Article							RECEPTOR-ALPHA GENE; RNA EXPRESSION; 3'ALPHA ENHANCER; TRANSCRIPTION; DIFFERENTIATION; BINDING; PROMOTER; DNA; ELEMENTS; PROTEIN	Interleukin-2 (IL-2)-induced transcription of the J chain gene was used as a model for analyzing cytokine regulation during B cell development. To determine whether IL-2 signals are targeted to a J chain gene enhancer as well as to its promoter, the sequences flanking the J chain gene were first examined for DNase I hypersensitivity. Of six sites identified, two strong ones, 7.5 kb upstream of the J chain gene, were found to be associated with an enhancer that is active only during the antigen-driven stages of B cell development. Further analyses of the enhancer in the IL-2-responsive presecretor BCL1 cells showed that the enhancer is activated at this stage by an IL-2 signal that functions by opening the enhancer chromatin and stimulating STATE to bind to a STATE element critical for the enhancer induction. Moreover, after this early induction stage, the enhancer was shown to be constitutively open and active in terminally differentiated plasma cells.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Kang, CJ (corresponding author), Seoul Natl Univ, Coll Pharm, Physiol Lab, Seoul 151742, South Korea.		Kang, ChangJoong/AAG-1171-2021	Kang, Chang Joong/0000-0002-2696-4508	PHS HHS [A107079] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ausubel FM, 1994, CURRENT PROTOCOLS MO; BERTON MT, 1990, J EXP MED, V172, P375, DOI 10.1084/jem.172.1.375; Bhattacharya S, 1996, NATURE, V383, P344, DOI 10.1038/383344a0; BLACKMAN MA, 1986, CELL, V47, P609, DOI 10.1016/0092-8674(86)90625-2; BROOKS K, 1983, NATURE, V302, P825, DOI 10.1038/302825a0; Brownell JE, 1996, CURR OPIN GENET DEV, V6, P176, DOI 10.1016/S0959-437X(96)80048-7; CAI H, 1995, NATURE, V376, P533, DOI 10.1038/376533a0; CORCES VG, 1995, NATURE, V376, P462, DOI 10.1038/376462a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; FORRESTER WC, 1994, SCIENCE, V265, P1221, DOI 10.1126/science.8066460; GIANNINI SL, 1993, J IMMUNOL, V150, P1772; GILMAN MZ, 1986, MOL CELL BIOL, V6, P4305, DOI 10.1128/MCB.6.12.4305; GROSSCHEDL R, 1985, CELL, V41, P885, DOI 10.1016/S0092-8674(85)80069-6; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; HAGMAN J, 1990, GENE DEV, V4, P978, DOI 10.1101/gad.4.6.978; Henderson AJ, 1995, CRIT REV EUKAR GENE, V5, P255, DOI 10.1615/CritRevEukarGeneExpr.v5.i3-4.30; Horvai AE, 1997, P NATL ACAD SCI USA, V94, P1074, DOI 10.1073/pnas.94.4.1074; HOU JZ, 1995, IMMUNITY, V2, P321, DOI 10.1016/1074-7613(95)90140-X; Jenuwein T, 1997, NATURE, V385, P269, DOI 10.1038/385269a0; LAMSON G, 1984, J EXP MED, V160, P877, DOI 10.1084/jem.160.3.877; LANSFORD RD, 1992, P NATL ACAD SCI USA, V89, P5966, DOI 10.1073/pnas.89.13.5966; Lecine P, 1996, MOL CELL BIOL, V16, P6829; LU J, 1995, MOL CELL BIOL, V15, P1651; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; MATSUI K, 1989, J IMMUNOL, V142, P2918; MCFADDEN HJ, 1991, P NATL ACAD SCI USA, V88, P11027, DOI 10.1073/pnas.88.24.11027; MINIE ME, 1986, MOL CELL BIOL, V6, P4031, DOI 10.1128/MCB.6.11.4031; Montminy M, 1997, NATURE, V387, P654, DOI 10.1038/42594; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NAKANISHI K, 1984, J EXP MED, V160, P1736, DOI 10.1084/jem.160.6.1736; NEURATH MF, 1995, P NATL ACAD SCI USA, V92, P5336, DOI 10.1073/pnas.92.12.5336; NILES MJ, 1995, P NATL ACAD SCI USA, V92, P2884, DOI 10.1073/pnas.92.7.2884; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Rinkenberger JL, 1996, IMMUNITY, V5, P377, DOI 10.1016/S1074-7613(00)80263-0; Sambrook J, 1989, MOL CLONING LAB MANU; SHAPIRO DJ, 1988, DNA-J MOLEC CELL BIO, V7, P47, DOI 10.1089/dna.1988.7.47; SOLDAINI E, 1995, J BIOL CHEM, V270, P10733, DOI 10.1074/jbc.270.18.10733; Speck NA, 1995, CRIT REV EUKAR GENE, V5, P337, DOI 10.1615/CritRevEukarGeneExpr.v5.i3-4.60; SPERISEN P, 1995, J BIOL CHEM, V270, P10743, DOI 10.1074/jbc.270.18.10743; TANGUAY RL, 1990, NUCLEIC ACIDS RES, V18, P5902, DOI 10.1093/nar/18.19.5902; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; WOTTON D, 1994, MOL CELL BIOL, V14, P840, DOI 10.1128/MCB.14.1.840; Zhang JJ, 1996, P NATL ACAD SCI USA, V93, P15092, DOI 10.1073/pnas.93.26.15092	43	31	34	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1998	8	3					285	295		10.1016/S1074-7613(00)80534-8	http://dx.doi.org/10.1016/S1074-7613(00)80534-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZD622	9529146	Bronze			2022-12-18	WOS:000072705300002
J	Horne, MC; Roth, PE; DeFranco, AL				Horne, MC; Roth, PE; DeFranco, AL			Assembly of the truncated immunoglobulin heavy chain D mu into antigen receptor-like complexes in pre-B cells but not in B cells	IMMUNITY			English	Article							PROTEIN-TYROSINE KINASE; GLUCOSE-REGULATED PROTEIN; LIGHT-CHAIN; GENE REARRANGEMENT; BINDING-PROTEIN; BONE-MARROW; LINEAGE CELLS; LYMPHOCYTES-B; CROSS-LINKING; SCID MICE	Rearrangements of the IgH locus with J(H) joined to reading frame 2 of D-H are greatly underrepresented in B cells. These rearrangements encode the truncated heavy chain D mu. In pre-B cells, we found D mu protein expressed on the cell surface and assembled into a complex with surrogate light chains, Ig alpha, and Ig beta. Cross-linking of either mu m- or D mu m-containing pre-B cell receptors triggered signal transduction reactions. In contrast, when expressed in mature B cell lines, D mu was not detected on the cell surface and did not efficiently bind K immunoglobulin light chains, but did associate with Ig alpha and Ig beta. These results characterize the interactions of D mu chain with other components of the B cell antigen receptor complex and suggest possible mechanisms by which D mu expression may interfere with B cell development.	UNIV CALIF SAN FRANCISCO, GEORGE WILLIAMS HOOPER FDN, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT MICROBIOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT IMMUNOL, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT BIOCHEM, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT BIOPHYS, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco				Horne, Mary/0000-0002-2799-3212	NIAID NIH HHS [AI20038] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI020038, R37AI020038] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BECKENGESER G, 1987, P NATL ACAD SCI USA, V84, P1060, DOI 10.1073/pnas.84.4.1060; BLUM JH, 1993, J BIOL CHEM, V268, P27236; BOLE DG, 1986, J CELL BIOL, V102, P1558, DOI 10.1083/jcb.102.5.1558; BROWN AMC, 1987, DNA CLONING, V3, P189; CHANG Y, 1992, EMBO J, V11, P1891, DOI 10.1002/j.1460-2075.1992.tb05241.x; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; CHERAYIL BJ, 1991, J EXP MED, V173, P111, DOI 10.1084/jem.173.1.111; CORCOS D, 1991, EUR J IMMUNOL, V21, P2711, DOI 10.1002/eji.1830211110; DECKER DJ, 1991, J IMMUNOL, V146, P350; DEFRANCO AL, 1993, ANNU REV CELL BIOL, V9, P377, DOI 10.1146/annurev.cellbio.9.1.377; EHLICH A, 1994, CURR BIOL, V4, P573, DOI 10.1016/S0960-9822(00)00129-9; ERA T, 1991, EMBO J, V10, P337, DOI 10.1002/j.1460-2075.1991.tb07954.x; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; GOLD MR, 1991, P NATL ACAD SCI USA, V88, P3436, DOI 10.1073/pnas.88.8.3436; GOLD MR, 1990, NATURE, V345, P810, DOI 10.1038/345810a0; GROSSCHEDL R, 1984, CELL, V38, P647, DOI 10.1016/0092-8674(84)90259-9; GU H, 1990, EMBO J, V9, P2133, DOI 10.1002/j.1460-2075.1990.tb07382.x; GU H, 1991, CELL, V65, P47, DOI 10.1016/0092-8674(91)90406-O; HAAS IG, 1983, NATURE, V306, P387, DOI 10.1038/306387a0; HAASNER D, 1994, INT IMMUNOL, V6, P21, DOI 10.1093/intimm/6.1.21; HARDY RR, 1989, CURR TOP MICROBIOL, V152, P19; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HAUGHTON G, 1986, IMMUNOL REV, V93, P35, DOI 10.1111/j.1600-065X.1986.tb01501.x; HENDERSHOT LM, 1988, MOL CELL BIOL, V8, P4250, DOI 10.1128/MCB.8.10.4250; HENDERSHOT LM, 1990, J CELL BIOL, V111, P829, DOI 10.1083/jcb.111.3.829; HUTCHCROFT JE, 1992, J BIOL CHEM, V267, P8613; HUTCHCROFT JE, 1991, J BIOL CHEM, V266, P14846; ICHIHARA Y, 1989, EUR J IMMUNOL, V19, P1849, DOI 10.1002/eji.1830191014; IGLESIAS A, 1991, EMBO J, V10, P2147, DOI 10.1002/j.1460-2075.1991.tb07749.x; KAARTINEN M, 1985, IMMUNOL TODAY, V6, P324, DOI 10.1016/0167-5699(85)90127-6; KARASUYAMA H, 1994, CELL, V77, P133, DOI 10.1016/0092-8674(94)90241-0; KARASUYAMA H, 1990, J EXP MED, V172, P969, DOI 10.1084/jem.172.3.969; KITAMURA D, 1992, NATURE, V356, P154, DOI 10.1038/356154a0; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KNITTLER MR, 1992, EMBO J, V11, P1573, DOI 10.1002/j.1460-2075.1992.tb05202.x; LASSOUED K, 1993, CELL, V73, P73, DOI 10.1016/0092-8674(93)90161-I; LAW DA, 1993, CURR BIOL, V3, P645, DOI 10.1016/0960-9822(93)90062-S; LAW DA, 1992, MOL IMMUNOL, V29, P917, DOI 10.1016/0161-5890(92)90130-P; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; MATSUO T, 1993, J IMMUNOL, V150, P3766; MEEK K, 1990, SCIENCE, V250, P820, DOI 10.1126/science.2237433; MELCHERS F, 1989, COLD SH Q B, V54, P183; MISENER V, 1991, INT IMMUNOL, V3, P1129, DOI 10.1093/intimm/3.11.1129; MORRISON DK, 1989, CELL, V58, P649, DOI 10.1016/0092-8674(89)90100-1; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; NOMURA J, 1991, INT IMMUNOL, V3, P117, DOI 10.1093/intimm/3.2.117; OI VT, 1980, J EXP MED, V151, P1260, DOI 10.1084/jem.151.5.1260; PADLAN EA, 1990, PROTEINS, V7, P112, DOI 10.1002/prot.340070203; PAPAVASILIOU F, 1995, SCIENCE, V268, P408, DOI 10.1126/science.7716544; PILLAI S, 1987, NATURE, V329, P172, DOI 10.1038/329172a0; PILLAI S, 1988, CURR TOP MICROBIOL, V137, P136; REICHMANFRIED M, 1993, INT IMMUNOL, V5, P303, DOI 10.1093/intimm/5.3.303; REICHMANFRIED M, 1990, P NATL ACAD SCI USA, V87, P2730, DOI 10.1073/pnas.87.7.2730; RETH M, 1987, EMBO J, V6, P3299, DOI 10.1002/j.1460-2075.1987.tb02649.x; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; RETH M, 1991, Current Biology, V1, P198, DOI 10.1016/0960-9822(91)90233-M; RETH MG, 1984, NATURE, V312, P418, DOI 10.1038/312418a0; RETH MG, 1985, NATURE, V317, P353, DOI 10.1038/317353a0; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; ROGERS J, 1980, CELL, V20, P303, DOI 10.1016/0092-8674(80)90616-9; ROLINK A, 1993, CURR OPIN IMMUNOL, V5, P207, DOI 10.1016/0952-7915(93)90006-E; ROTH PE, 1993, J EXP MED, V178, P2007, DOI 10.1084/jem.178.6.2007; SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0; SHAPIRO AM, 1993, MOL CELL BIOL, V13, P5679, DOI 10.1128/MCB.13.9.5679; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; STEVENS TL, 1994, J IMMUNOL, V152, P4397; TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x; TAKEMORI T, 1990, EMBO J, V9, P2493, DOI 10.1002/j.1460-2075.1990.tb07428.x; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; TSUBATA T, 1991, EUR J IMMUNOL, V21, P1359, DOI 10.1002/eji.1830210605; TSUBATA T, 1992, INT IMMUNOL, V4, P637, DOI 10.1093/intimm/4.6.637; TSUBATA T, 1990, J EXP MED, V172, P973, DOI 10.1084/jem.172.3.973; TSUTSUMI A, 1992, CELL IMMUNOL, V139, P44, DOI 10.1016/0008-8749(92)90098-A; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; WARNER NL, 1979, IMMUNOL REV, V48, P197, DOI 10.1111/j.1600-065X.1979.tb00304.x; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043	77	31	31	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	1996	4	2					145	158		10.1016/S1074-7613(00)80679-2	http://dx.doi.org/10.1016/S1074-7613(00)80679-2			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TX225	8624805	Bronze			2022-12-18	WOS:A1996TX22500005
J	CHANG, Y; BOSMA, GC; BOSMA, MJ				CHANG, Y; BOSMA, GC; BOSMA, MJ			DEVELOPMENT OF B-CELLS IN SCID MICE WITH IMMUNOGLOBULIN TRANSGENES - IMPLICATIONS FOR THE CONTROL OF V(D)J RECOMBINATION	IMMUNITY			English	Article							KAPPA GENE REARRANGEMENT; LIGHT CHAIN GENES; PRE-B; BONE-MARROW; ALLELIC EXCLUSION; LINEAGE CELLS; FETAL LIVER; MOUSE; EXPRESSION; SEGMENTS	The inability of scid pro-B cells to progress to the pre-B and B cell stages is believed to be caused by a defective recombinase activity that fails to resolve chromosomal breaks resulting from attempted V(D)J recombination. In support of this model, we report that certain immunoglobulin transgenes, specifically those which strongly inhibit endogenous V-H-to-DJ(H) and V kappa-to-J kappa rearrangement in wild-type mice, allow scid pro-B cells to progress to the pre-B and B cell stages. this rescue of scid B cell differentiation is associated with a dramatic reduction in expression of the recombination activation genes, RAG1 and RAG2, and with reduced transcription of the kappa locus.			CHANG, Y (corresponding author), FOX CHASE CANC CTR,INST CANC RES,7701 BURHOLME AVE,PHILADELPHIA,PA 19111, USA.				NCI NIH HHS [CA06927, CA04946] Funding Source: Medline; NIAID NIH HHS [AI13323] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA004946, R37CA004946, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI013323] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; BLACKWELL TK, 1989, EMBO J, V8, P735, DOI 10.1002/j.1460-2075.1989.tb03433.x; BLUNT T, 1995, CELL, V80, P813, DOI 10.1016/0092-8674(95)90360-7; BOSMA MJ, 1991, ANNU REV IMMUNOL, V9, P323, DOI 10.1146/annurev.iy.09.040191.001543; CARMACK CE, 1994, J IMMUNOL, V147, P2024; CHEN C, 1994, J IMMUNOL, V152, P1970; CHEN JZ, 1993, CURR OPIN IMMUNOL, V5, P194, DOI 10.1016/0952-7915(93)90004-C; CHEN YY, 1994, GENE DEV, V8, P688, DOI 10.1101/gad.8.6.688; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; COFFMAN RL, 1981, NATURE, V289, P681, DOI 10.1038/289681a0; COLECLOUGH C, 1981, NATURE, V290, P372, DOI 10.1038/290372a0; CORCOS D, 1991, EUR J IMMUNOL, V21, P2711, DOI 10.1002/eji.1830211110; COSTA TEF, 1992, P NATL ACAD SCI USA, V89, P2205, DOI 10.1073/pnas.89.6.2205; CUMANO A, 1992, EMBO J, V11, P593, DOI 10.1002/j.1460-2075.1992.tb05091.x; EHLICH A, 1993, CELL, V72, P695, DOI 10.1016/0092-8674(93)90398-A; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; FEDDERSEN RM, 1990, MOL CELL BIOL, V10, P569, DOI 10.1128/MCB.10.2.569; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; GROSSCHEDL R, 1984, CELL, V38, P647, DOI 10.1016/0092-8674(84)90259-9; HARADA K, 1991, J EXP MED, V173, P409, DOI 10.1084/jem.173.2.409; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HARDY RR, 1986, HDB EXPT BIOL; HARRINGTON J, 1992, MOL CELL BIOL, V12, P4758, DOI 10.1128/MCB.12.10.4758; HENDRICKSON EA, 1991, P NATL ACAD SCI USA, V88, P4061, DOI 10.1073/pnas.88.10.4061; HENDRICKSON EA, 1990, MOL CELL BIOL, V10, P5397, DOI 10.1128/MCB.10.10.5397; KIRCHGESSNER CU, 1995, SCIENCE, V267, P1178, DOI 10.1126/science.7855601; KUDO A, 1987, EMBO J, V6, P2267, DOI 10.1002/j.1460-2075.1987.tb02500.x; KUROSAWA Y, 1982, J EXP MED, V155, P201, DOI 10.1084/jem.155.1.201; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; MALYNN BA, 1988, CELL, V54, P453, DOI 10.1016/0092-8674(88)90066-9; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NUSSENZWEIG MC, 1988, NATURE, V336, P446, DOI 10.1038/336446a0; ORLANDI R, 1989, P NATL ACAD SCI USA, V86, P3833, DOI 10.1073/pnas.86.10.3833; PENNYCOOK JL, 1993, J EXP MED, V178, P1007, DOI 10.1084/jem.178.3.1007; REICHMANFRIED M, 1993, INT IMMUNOL, V5, P303, DOI 10.1093/intimm/5.3.303; REICHMANFRIED M, 1990, P NATL ACAD SCI USA, V87, P2730, DOI 10.1073/pnas.87.7.2730; ROLINK A, 1991, CELL, V66, P1081, DOI 10.1016/0092-8674(91)90032-T; ROTH DB, 1992, CELL, V70, P983, DOI 10.1016/0092-8674(92)90248-B; RUSCONI S, 1985, NATURE, V314, P330, DOI 10.1038/314330a0; SAKAGUCHI N, 1988, NATURE, V324, P579; SAKANO H, 1981, NATURE, V290, P562, DOI 10.1038/290562a0; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; SCHLISSEL M, 1993, GENE DEV, V7, P2520, DOI 10.1101/gad.7.12b.2520; SCHLISSEL MS, 1994, J IMMUNOL, V153, P1645; SCHLISSEL MS, 1989, CELL, V58, P1001, DOI 10.1016/0092-8674(89)90951-3; SCHUPPEL R, 1987, EUR J IMMUNOL, V17, P739, DOI 10.1002/eji.1830170527; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; STALL AM, 1984, J IMMUNOL, V132, P787; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; VANNESS BG, 1981, CELL, V27, P593, DOI 10.1016/0092-8674(81)90401-3; WANG LC, 1993, MOL CELL BIOL, V13, P3890, DOI 10.1128/MCB.13.7.3890; WILSON A, 1994, J EXP MED, V179, P1355, DOI 10.1084/jem.179.4.1355; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; YANCOPOULOS GD, 1984, NATURE, V311, P727, DOI 10.1038/311727a0; YOUNG F, 1994, GENE DEV, V8, P1043, DOI 10.1101/gad.8.9.1043	59	31	31	0	2	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	JUN	1995	2	6					607	616		10.1016/1074-7613(95)90005-5	http://dx.doi.org/10.1016/1074-7613(95)90005-5			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RE538	7796294	Bronze			2022-12-18	WOS:A1995RE53800006
J	LINDEMAN, GJ; ADAMS, JM; CORY, S; HARRIS, AW				LINDEMAN, GJ; ADAMS, JM; CORY, S; HARRIS, AW			B-LYMPHOID TO GRANULOCYTIC SWITCH DURING HEMATOPOIESIS IN A TRANSGENIC MOUSE STRAIN	IMMUNITY			English	Article							COLONY-STIMULATING FACTOR; HELIX-ZIPPER PROTEIN; CELLS-INVITRO; SCID MICE; GENE; MYC; DIFFERENTIATION; EXPRESSION; POPULATION; LEUKEMIA	B-lymphoid and myeloid development are markedly perturbed in a unique transgenic mouse strain, max 41. Pro-B, pre-B, and B lymphocytes were severely reduced but granulocytes were greatly elevated. This phenotype could be adoptively transferred with bone marrow cells. It was not alleviated by bcl-2 or myc transgenes that promote lymphocyte survival or proliferation. Bitransgenic myc/max 41 mice developed pre-B cell lymphoma. An accompanying massive granulocytosis unexpectedly proved to be clonally derived from the pre-B lymphoma cells. These observations suggest that B lymphopoiesis in max 41 mice has been diverted to granulocyte production. Since neither cell type expressed the transgene, this novel lymphomyeloid deviation probably reflects insertional alteration of a hematopoietic regulatory gene.			LINDEMAN, GJ (corresponding author), WALTER & ELIZA HALL INST MED RES, PO ROYAL MELBOURNE HOSP, MELBOURNE, VIC 3050, AUSTRALIA.		Adams, Jerry M/E-1199-2013; Cory, Suzanne/E-1642-2013	Cory, Suzanne/0000-0002-6818-3451; Adams, Jerry/0000-0002-4360-8628; Lindeman, Geoffrey/0000-0001-9386-2416	NCI NIH HHS [CA43540] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA043540] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ADAMS JM, 1991, BIOCHIM BIOPHYS ACTA, V1072, P9, DOI 10.1016/0304-419X(91)90004-5; ALLEN JD, 1993, BLOOD, V81, P3242; AMATI B, 1992, NATURE, V359, P423, DOI 10.1038/359423a0; AYER DE, 1993, GENE DEV, V7, P2110, DOI 10.1101/gad.7.11.2110; BILLIPS LG, 1990, BLOOD, V75, P611; BLACKWOOD EM, 1991, SCIENCE, V251, P1211, DOI 10.1126/science.2006410; BOSMA GC, 1988, J EXP MED, V167, P1016, DOI 10.1084/jem.167.3.1016; BOYD AW, 1982, NATURE, V297, P691, DOI 10.1038/297691a0; BRINSTER RL, 1985, P NATL ACAD SCI USA, V82, P4438, DOI 10.1073/pnas.82.13.4438; CUMANO A, 1992, EMBO J, V11, P593, DOI 10.1002/j.1460-2075.1992.tb05091.x; CUSTER RP, 1985, AM J PATHOL, V120, P464; DAVIDSON WF, 1988, J EXP MED, V168, P389, DOI 10.1084/jem.168.1.389; DEDERA DA, 1993, CELL, V74, P833, DOI 10.1016/0092-8674(93)90463-Z; DORSHKIND K, 1991, J IMMUNOL, V146, P4204; DOSIK H, 1972, SEMIN HEMATOL, V9, P309; ERSLEV AJ, 1990, HEMATOLOGY, P37; GILFILLAN S, 1990, P NATL ACAD SCI USA, V87, P7319, DOI 10.1073/pnas.87.18.7319; GREAVES MF, 1986, BLOOD, V67, P1; GRIDLEY T, 1991, NEW BIOL, V3, P1025; HARDY RR, 1989, CURR TOP MICROBIOL, V152, P19; HARIHARAN IK, 1989, MOL CELL BIOL, V9, P2798, DOI 10.1128/MCB.9.7.2798; HARRIS AW, 1988, J EXP MED, V167, P353, DOI 10.1084/jem.167.2.353; HAYAKAWA K, 1986, EUR J IMMUNOL, V16, P450, DOI 10.1002/eji.1830160423; HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T; HUANG E, 1990, CELL, V63, P225, DOI 10.1016/0092-8674(90)90303-V; Katoh S, 1990, Dev Immunol, V1, P113, DOI 10.1155/1990/28760; KITA K, 1993, LEUKEMIA, V7, P251; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; KLINKEN SP, 1988, CELL, V53, P857, DOI 10.1016/S0092-8674(88)90309-1; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; LEE E T, 1972, Computer Programs in Biomedicine, V2, P315, DOI 10.1016/0010-468X(72)90019-0; LEE JJ, 1992, DEVELOPMENT, V115, P277; LEE MY, 1993, BLOOD, V82, P2062; LO D, 1992, AM J PATHOL, V141, P1237; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NEWMAN SL, 1982, J EXP MED, V156, P430, DOI 10.1084/jem.156.2.430; NICOLA NA, 1982, BLOOD, V60, P1019; OGAWA M, 1993, BLOOD, V81, P2844; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x; SCHNIEKE A, 1983, NATURE, V304, P315, DOI 10.1038/304315a0; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; STRASSER A, 1991, CELL, V67, P889, DOI 10.1016/0092-8674(91)90362-3; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; STRASSER A, 1994, NATURE, V368, P457, DOI 10.1038/368457a0; VASICEK TJ, 1992, J EXP MED, V175, P1169, DOI 10.1084/jem.175.5.1169; WOYCHIK RP, 1990, NATURE, V346, P850, DOI 10.1038/346850a0; YAMADA G, 1991, P NATL ACAD SCI USA, V88, P532, DOI 10.1073/pnas.88.2.532	51	31	31	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	1994	1	6					517	527		10.1016/1074-7613(94)90094-9	http://dx.doi.org/10.1016/1074-7613(94)90094-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK171	7895160				2022-12-18	WOS:A1994PK17100009
J	Buechler, MB; Fu, WX; Turley, SJ				Buechler, Matthew B.; Fu, Wenxian; Turley, Shannon J.			Fibroblast-macrophage reciprocal interactions in health, fibrosis, and cancer	IMMUNITY			English	Review							TUMOR-ASSOCIATED MACROPHAGES; COLONY-STIMULATING FACTOR; FACTOR RECEPTOR-LIGAND; GROWTH-FACTOR; FUNDAMENTAL PROPERTIES; PULMONARY-FIBROSIS; MALIGNANT FIBROBLAST; STROMAL CELLS; TISSUE; AMPHIREGULIN	Fibroblasts and macrophages are present in all tissues, and mounting evidence supports that these cells engage in direct communication to influence the overall tissue microenvironment and affect disease outcomes. Here, we review the current understanding of the molecular mechanisms that underlie fibroblast-macrophage interactions in health, fibrosis, and cancer. We present an integrated view of fibroblast-macrophage interactions that is centered on the CSF1-CSF1R axis and discuss how additional molecular programs linking these cell types can underpin disease onset, progression, and resolution. These programs may be tissue and context dependent, affected also by macrophage and fibroblast origin and state, as seen most clearly in cancer. Continued efforts to understand these cells and the means by which they interact may provide therapeutic approaches for the treatment of fibrosis and cancer.	[Buechler, Matthew B.; Fu, Wenxian; Turley, Shannon J.] Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech	Buechler, MB; Fu, WX; Turley, SJ (corresponding author), Genentech Inc, Dept Canc Immunol, San Francisco, CA 94080 USA.	buechler.matthew@gene.com; fu.wenxian@gene.com; turley.shannon@gene.com		Fu, Wenxian/0000-0003-0684-8929; Buechler, Matthew/0000-0003-1902-622X				Afik R, 2016, J EXP MED, V213, P2315, DOI 10.1084/jem.20151193; Aghajanian H, 2019, NATURE, V573, P430, DOI 10.1038/s41586-019-1546-z; Allaoui R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13050; Aoki H, 2006, J CELL BIOCHEM, V99, P221, DOI 10.1002/jcb.20906; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Arina A, 2016, P NATL ACAD SCI USA, V113, P7551, DOI 10.1073/pnas.1600363113; Atabai K, 2009, J CLIN INVEST, V119, P3713, DOI 10.1172/JCI40053; Augsten M, 2009, P NATL ACAD SCI USA, V106, P3414, DOI 10.1073/pnas.0813144106; Ayaub EA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13511-z; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Bellomo A, 2020, IMMUNITY, V53, P127, DOI 10.1016/j.immuni.2020.06.008; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Bleriot C, 2020, IMMUNITY, V52, P957, DOI 10.1016/j.immuni.2020.05.014; Buckley CD, 2015, ANNU REV IMMUNOL, V33, P715, DOI 10.1146/annurev-immunol-032713-120252; Buechler MB, 2021, NATURE, V593, P575, DOI 10.1038/s41586-021-03549-5; Buechler MB, 2019, IMMUNITY, V51, P119, DOI 10.1016/j.immuni.2019.05.010; Buechler MB, 2018, SEMIN IMMUNOL, V35, P48, DOI 10.1016/j.smim.2017.11.001; Cannarile MA, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0257-y; Carrel A, 1926, J EXP MED, V44, P285, DOI 10.1084/jem.44.3.285; Carrel A, 1928, J EXP MED, V48, P105, DOI 10.1084/jem.48.1.105; Carrel A, 1928, J EXP MED, V48, P285, DOI 10.1084/jem.48.2.285; Carrel A, 1926, J EXP MED, V44, P261, DOI 10.1084/jem.44.2.261; Casazza A, 2013, CANCER CELL, V24, P695, DOI 10.1016/j.ccr.2013.11.007; Cassetta L, 2018, NAT REV DRUG DISCOV, V17, P887, DOI 10.1038/nrd.2018.169; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Chen YL, 2015, J CLIN INVEST, V125, P1147, DOI 10.1172/JCI74725; Costa A, 2018, CANCER CELL, V33, P463, DOI 10.1016/j.ccell.2018.01.011; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Croft AP, 2019, NATURE, V570, P246, DOI 10.1038/s41586-019-1263-7; Dai X-M, 2003, ENCY HORMONES, P274; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Davidson S, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107628; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; Denton CP, 2018, ANN RHEUM DIS, V77, P1362, DOI 10.1136/annrheumdis-2018-213031; Derynck R, 2021, NAT REV CLIN ONCOL, V18, P9, DOI 10.1038/s41571-020-0403-1; Ding L, 2016, J IMMUNOL, V197, P303, DOI 10.4049/jimmunol.1502479; Djurec M, 2018, P NATL ACAD SCI USA, V115, pE1147, DOI 10.1073/pnas.1717802115; Dominguez CX, 2020, CANCER DISCOV, V10, P232, DOI 10.1158/2159-8290.CD-19-0644; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Dufour AM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01865; Elkabets M, 2011, J CLIN INVEST, V121, P784, DOI 10.1172/JCI43757; Elyada E, 2019, CANCER DISCOV, V9, P1102, DOI 10.1158/2159-8290.CD-19-0094; Engblom C, 2016, NAT REV CANCER, V16, P447, DOI 10.1038/nrc.2016.54; Feig C, 2013, P NATL ACAD SCI USA, V110, P20212, DOI 10.1073/pnas.1320318110; Frangogiannis NG, 2020, J EXP MED, V217, DOI 10.1084/jem.20190103; Gasse P, 2007, J CLIN INVEST, V117, P3786, DOI 10.1172/JCI32285; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; GOUD TJLM, 1975, J EXP MED, V142, P1180, DOI 10.1084/jem.142.5.1180; Guilliams M, 2021, NAT IMMUNOL, V22, P118, DOI 10.1038/s41590-020-00849-2; Guilliams M, 2020, IMMUNITY, V52, P434, DOI 10.1016/j.immuni.2020.02.015; Guzy RD, 2017, J BIOL CHEM, V292, P10364, DOI 10.1074/jbc.M117.791764; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Heinrich MC, 2003, SCIENCE, V299, P708, DOI 10.1126/science.1079666; Heldin CH, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-97; Hinz B, 2020, NAT REV RHEUMATOL, V16, P11, DOI 10.1038/s41584-019-0324-5; Ireland LV, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00131; Ivey MJ, 2019, AM J PHYSIOL-HEART C, V317, pH330, DOI 10.1152/ajpheart.00054.2019; Iwayama T, 2015, GENE DEV, V29, P1106, DOI 10.1101/gad.260554.115; Jones AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119314; Kalluri R, 2016, NAT REV CANCER, V16, P582, DOI 10.1038/nrc.2016.73; Khan K, 2012, ANN RHEUM DIS, V71, P1235, DOI 10.1136/annrheumdis-2011-200955; Klichinsky M, 2020, NAT BIOTECHNOL, V38, P947, DOI 10.1038/s41587-020-0462-y; Kumar V, 2017, CANCER CELL, V32, P654, DOI 10.1016/j.ccell.2017.10.005; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lee JW, 2019, NATURE, V567, P249, DOI 10.1038/s41586-019-1004-y; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liu L, 2018, BASIC RES CARDIOL, V113, DOI 10.1007/s00395-018-0669-y; Ma FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035144; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Maller O, 2021, NAT MATER, V20, P548, DOI 10.1038/s41563-020-00849-5; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; MARTINET Y, 1987, NEW ENGL J MED, V317, P202, DOI 10.1056/NEJM198707233170404; McKleroy W, 2013, AM J PHYSIOL-LUNG C, V304, pL709, DOI 10.1152/ajplung.00418.2012; Metchnikoff Olga, 1921, LIFE ELIE METCHNIKOF; Meziani L, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02120-2017; Miller BW, 2015, EMBO MOL MED, V7, P1063, DOI 10.15252/emmm.201404827; Minutti CM, 2019, IMMUNITY, V50, P645, DOI 10.1016/j.immuni.2019.01.008; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Neubert NJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan3311; Nielsen SR, 2016, NAT CELL BIOL, V18, P549, DOI 10.1038/ncb3340; Olson LE, 2009, DEV CELL, V16, P303, DOI 10.1016/j.devcel.2008.12.003; Papadopoulos KP, 2017, CLIN CANCER RES, V23, P5703, DOI 10.1158/1078-0432.CCR-16-3261; Pelon F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14134-w; Peranzoni E, 2018, P NATL ACAD SCI USA, V115, pE4041, DOI 10.1073/pnas.1720948115; Perugorria MJ, 2008, HEPATOLOGY, V48, P1251, DOI 10.1002/hep.22437; Pickup MW, 2013, CANCER RES, V73, P5336, DOI 10.1158/0008-5472.CAN-13-0012; Poole JA, 2020, AM J PHYSIOL-LUNG C, V318, pL180, DOI 10.1152/ajplung.00039.2019; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Quaranta V, 2018, CANCER RES, V78, P4253, DOI 10.1158/0008-5472.CAN-17-3876; Ren GW, 2012, CELL STEM CELL, V11, P812, DOI 10.1016/j.stem.2012.08.013; Ries CH, 2014, CANCER CELL, V25, P846, DOI 10.1016/j.ccr.2014.05.016; Rinkevich Y, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2151; ROBINSON W, 1967, J CELL PHYSIOL, V69, P83, DOI 10.1002/jcp.1040690111; ROBINSON WA, 1969, BLOOD-J HEMATOL, V33, P396, DOI 10.1182/blood.V33.3.396.396; Ronca R, 2018, CURR OPIN ONCOL, V30, P45, DOI 10.1097/CCO.0000000000000420; Roth P, 1992, Curr Top Microbiol Immunol, V181, P141; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Ryan GR, 2001, BLOOD, V98, P74, DOI 10.1182/blood.V98.1.74; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Salvador F, 2017, CANCER RES, V77, P5846, DOI 10.1158/0008-5472.CAN-16-3152; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; SHAW RJ, 1991, AM REV RESPIR DIS, V143, P167, DOI 10.1164/ajrccm/143.1.167; SHERIDAN JW, 1971, J CELL PHYSIOL, V78, P451, DOI 10.1002/jcp.1040780314; Soriano P, 1997, DEVELOPMENT, V124, P2691; STANLEY ER, 1978, NATURE, V274, P168, DOI 10.1038/274168a0; STANLEY ER, 1977, J BIOL CHEM, V252, P4305; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Uderhardt S, 2019, CELL, V177, P541, DOI 10.1016/j.cell.2019.02.028; Vickman RE, 2020, PROSTATE, V80, P173, DOI 10.1002/pros.23929; VIGNAUD JM, 1994, CANCER RES, V54, P5455; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; WIKTORJEDRZEJCZAK W, 1990, P NATL ACAD SCI USA, V87, P4828, DOI 10.1073/pnas.87.12.4828; Wilson MS, 2010, J EXP MED, V207, P535, DOI 10.1084/jem.20092121; Winkler J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18794-x; WITKOWSKI JA, 1980, MED HIST, V24, P129, DOI 10.1017/S0025727300040126; Wu SZ, 2020, EMBO J, V39, DOI 10.15252/embj.2019104063; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yang XG, 2016, CANCER RES, V76, P4124, DOI 10.1158/0008-5472.CAN-15-2973; Young HL, 2017, J EXP MED, V214, P1691, DOI 10.1084/jem.20160855; Young LR, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88947; Yue X., 2010, CURR ENZYM INHIB, V6, P67, DOI [10.2174/157340810791233033, DOI 10.2174/157340810791233033]; Zhang L, 2020, CELL, V181, P442, DOI 10.1016/j.cell.2020.03.048; Zhang RS, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1435-2; Zhou X, 2018, CELL, V172, P744, DOI 10.1016/j.cell.2018.01.015; Zhou Y, 2012, J BIOL CHEM, V287, P41991, DOI 10.1074/jbc.M112.356824; Zhu Y, 2019, GUT, V68, P1653, DOI 10.1136/gutjnl-2019-318419; Zhu Y, 2017, IMMUNITY, V47, P323, DOI 10.1016/j.immuni.2017.07.014	133	30	30	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					903	915		10.1016/j.immuni.2021.04.021	http://dx.doi.org/10.1016/j.immuni.2021.04.021		MAY 2021	13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33979587	Bronze			2022-12-18	WOS:000652019500009
J	Guthmiller, JJ; Lan, LDYL; Fernandez-Quintero, ML; Han, J; Utset, HA; Bitar, DJ; Hamel, NJ; Stovicek, O; Li, L; Tepora, M; Henry, C; Neu, KE; Dugan, HL; Borowska, MT; Chen, YQ; Liu, STH; Stamper, CT; Zheng, NY; Huang, M; Palm, AKE; Garcia-Sastre, A; Nachbagauer, R; Palese, P; Coughlan, L; Krammer, F; Ward, AB; Liedl, KR; Wilson, PC				Guthmiller, Jenna J.; Lan, Linda Yu-Ling; Fernandez-Quintero, Monica L.; Han, Julianna; Utset, Henry A.; Bitar, Dalia J.; Hamel, Natalie J.; Stovicek, Olivia; Li, Lei; Tepora, Micah; Henry, Carole; Neu, Karlynn E.; Dugan, Haley L.; Borowska, Marta T.; Chen, Yao-Qing; Liu, Sean T. H.; Stamper, Christopher T.; Zheng, Nai-Ying; Huang, Min; Palm, Anna-Karin E.; Garcia-Sastre, Adolfo; Nachbagauer, Raffael; Palese, Peter; Coughlan, Lynda; Krammer, Florian; Ward, Andrew B.; Liedl, Klaus R.; Wilson, Patrick C.			Polyreactive Broadly Neutralizing B cells Are Selected to Provide Defense against Pandemic Threat Influenza Viruses	IMMUNITY			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; HUMAN MONOCLONAL-ANTIBODIES; BINDING; AUTOREACTIVITY; REGION; RECOGNITION; MECHANISM; EPITOPES; AFFINITY; HUMANS	Polyreactivity is the ability of a single antibody to bind to multiple molecularly distinct antigens and is a common feature of antibodies induced upon pathogen exposure. However, little is known about the role of polyreactivity during anti-influenza virus antibody responses. By analyzing more than 500 monoclonal antibodies (mAbs) derived from B cells induced by numerous influenza virus vaccines and infections, we found mAbs targeting conserved neutralizing influenza virus hemagglutinin epitopes were polyreactive. Polyreactive mAbs were preferentially induced by novel viral exposures due to their broad viral binding breadth. Polyreactivity augmented mAb viral binding strength by increasing antibody flexibility, allowing for adaption to imperfectly conserved epitopes. Lastly, we found affinity-matured polyreactive B cells were typically derived from germline polyreactive B cells that were preferentially selected to participate in B cell responses over time. Together, our data reveal that polyreactivity is a beneficial feature of antibodies targeting conserved epitopes.	[Guthmiller, Jenna J.; Utset, Henry A.; Bitar, Dalia J.; Hamel, Natalie J.; Stovicek, Olivia; Li, Lei; Tepora, Micah; Henry, Carole; Neu, Karlynn E.; Chen, Yao-Qing; Zheng, Nai-Ying; Huang, Min; Palm, Anna-Karin E.; Wilson, Patrick C.] Univ Chicago, Dept Med, Sect Rheumatol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Lan, Linda Yu-Ling; Neu, Karlynn E.; Dugan, Haley L.; Stamper, Christopher T.; Wilson, Patrick C.] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Fernandez-Quintero, Monica L.; Liedl, Klaus R.] Univ Innsbruck, Ctr Mol Biosci Innsbruck, Inst Gen Inorgan & Theoret Chem, A-6020 Innsbruck, Austria; [Han, Julianna; Ward, Andrew B.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Borowska, Marta T.] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA; [Liu, Sean T. H.; Garcia-Sastre, Adolfo; Nachbagauer, Raffael; Palese, Peter; Coughlan, Lynda; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Icahn Sch Med Mt Sinai, Tisch Canc Ctr, New York, NY 10029 USA; [Coughlan, Lynda] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Coughlan, Lynda] Univ Maryland, Sch Med, Ctr Vaccine Dev & Global Hlth, Baltimore, MD 21201 USA	University of Chicago; University of Chicago; University of Innsbruck; Scripps Research Institute; University of Chicago; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Wilson, PC (corresponding author), Univ Chicago, Dept Med, Sect Rheumatol, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Wilson, PC (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	wilsonp@uchicago.edu	Nachbagauer, Raffael/H-7798-2019; Krammer, Florian/H-3237-2019; Liedl, Klaus/ABB-4725-2021; Liedl, Klaus R/F-3099-2015; Li, Lei/AGZ-4207-2022; Wilson, Patrick/HGC-3157-2022; Ward, Andrew/ABD-7728-2021	Nachbagauer, Raffael/0000-0001-5568-5420; Krammer, Florian/0000-0003-4121-776X; Liedl, Klaus/0000-0002-0985-2299; Liedl, Klaus R/0000-0002-0985-2299; Li, Lei/0000-0002-8828-5199; Ward, Andrew/0000-0001-7153-3769; Hamel, Natalie/0000-0001-9152-9484; Coughlan, Lynda/0000-0001-9880-6560; chen, Yao-qing/0000-0002-4659-1550; Utset, Henry/0000-0003-0607-3086; Liu, Sean/0000-0002-3842-6838; Han, Julianna/0000-0002-3402-2609; Stovicek, Olivia/0000-0001-6413-855X; Guthmiller, Jenna/0000-0001-7566-3536	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health [U19AI082724, U19AI109946, U19AI057266, P01 AI097092, R01AI145870-01, T32AI007244-36]; NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN272201400005C, HHSN272201400008C]; NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) [75N93019C00051]; Austrian Science Fund [P30565]; Bill and Melinda Gates Foundation [OPP1084518]; Bill & Melinda Gates Foundation	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS); NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC); Austrian Science Fund(Austrian Science Fund (FWF)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR)	This project was funded in part by the National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health grant numbers U19AI082724 (P.C.W.), U19AI109946 (P.C.W.), U19AI057266 (P.C.W.), P01 AI097092 (P.P.), R01AI145870-01 (P.P.), and T32AI007244-36 (J.H.); and the NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) grant number HHSN272201400005C (P.C.W.) and HHSN272201400008C (L.C., F.K., A.G.-S., P.P.). This work was also partially supported by the NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC; 75N93019C00051, F.K., A.G.-S., P.P., A.B.W., P.C.W.). Work related to MD simulations were funded by the Austrian Science Fund grant number P30565 (K.R.L.). We are thankful to the teams at PATH, GlaxoSmithKline, Cincinnati Children's Hospital Medical Center, and Duke University for their participation in the chimeric HA vaccine trial NCT03300050, which was funded by the Bill and Melinda Gates Foundation (OPP1084518). This work is based on research funded in part by the Bill & Melinda Gates Foundation. The findings and conclusions contained within are those of the authors and do not necessarily reflect positions or policies of the Gates Foundation. We thank Sarah Andrews, Jens Wrammert, and Rafi Ahmed for participation in acquiring samples from 2009 MIV and 2010 TIV studies. We thank Erin Adams, Albert Bendelac, Steven Erickson, Christopher Boughter, and Nancy D. Pomarici for fruitful discussion and their support in this project. We also thank Elena Solomaha in the University of Chicago Biophysics Core Facility for her assistance.	ADELMAN SA, 1976, J CHEM PHYS, V64, P2375, DOI 10.1063/1.432526; Aguilera I, 2001, IMMUNOLOGY, V102, P273, DOI 10.1046/j.1365-2567.2001.01159.x; Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Andrews SF, 2015, J VIROL, V89, P3308, DOI 10.1128/JVI.02871-14; Angeletti D, 2019, P NATL ACAD SCI USA, V116, P13474, DOI 10.1073/pnas.1816300116; Bajic G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40175-8; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bernstein DI, 2020, LANCET INFECT DIS, V20, P80, DOI 10.1016/S1473-3099(19)30393-7; Bradley T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14670-w; Capolunghi F, 2008, J IMMUNOL, V180, P800, DOI 10.4049/jimmunol.180.2.800; Chen J, 2014, J VIROL, V88, P1249, DOI 10.1128/JVI.02664-13; Chen YQ, 2018, CELL, V173, P417, DOI 10.1016/j.cell.2018.03.030; CHOTHIA C, 1987, J MOL BIOL, V196, P901, DOI 10.1016/0022-2836(87)90412-8; CHOTHIA C, 1989, NATURE, V342, P877, DOI 10.1038/342877a0; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; De Marco D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034415; Deng YJ, 2000, CLIN EXP IMMUNOL, V119, P69, DOI 10.1046/j.1365-2249.2000.01096.x; Dennison SM, 2011, J VIROL, V85, P1340, DOI 10.1128/JVI.01680-10; Dimitrov JD, 2013, J IMMUNOL, V191, P993, DOI 10.4049/jimmunol.1300880; Dunand CJH, 2015, J CLIN INVEST, V125, P1255, DOI 10.1172/JCI74374; Duty JA, 2009, J EXP MED, V206, P139, DOI 10.1084/jem.20080611; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Ellebedy AH, 2014, P NATL ACAD SCI USA, V111, P13133, DOI 10.1073/pnas.1414070111; Guthmiller JJ, 2019, METHODS MOL BIOL, V1904, P109, DOI 10.1007/978-1-4939-8958-4_5; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; Hamelberg D, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2789432; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Henry C, 2019, CELL HOST MICROBE, V25, P357, DOI 10.1016/j.chom.2019.01.002; Impagliazzo A, 2015, SCIENCE, V349, P1301, DOI 10.1126/science.aac7263; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Kaur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125618; Koelsch K, 2007, J CLIN INVEST, V117, P1558, DOI 10.1172/JCI27628; Labute P, 2009, PROTEINS, V75, P187, DOI 10.1002/prot.22234; Li GM, 2012, P NATL ACAD SCI USA, V109, P9047, DOI 10.1073/pnas.1118979109; Liao HX, 2011, J EXP MED, V208, P2237, DOI 10.1084/jem.20110363; Liu MF, 2015, J VIROL, V89, P784, DOI 10.1128/JVI.02378-14; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Mena I, 2016, ELIFE, V5, DOI 10.7554/eLife.16777; Miao YL, 2014, J CHEM THEORY COMPUT, V10, P2677, DOI 10.1021/ct500090q; Millman KJ, 2011, COMPUT SCI ENG, V13, P9, DOI 10.1109/MCSE.2011.36; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Muellenbeck MF, 2013, J EXP MED, V210, P389, DOI 10.1084/jem.20121970; Nachbagauer R, 2018, J VIROL, V92, DOI [10.1128/JVI.00949-18, 10.1128/jvi.00949-18]; Neu KE, 2019, J CLIN INVEST, V129, P93, DOI 10.1172/JCI121341; Ng S, 2019, NAT MED, V25, P962, DOI 10.1038/s41591-019-0463-x; Ovchinnikov V, 2018, ELIFE, V7, DOI 10.7554/eLife.33038; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Paules CI, 2017, IMMUNITY, V47, P599, DOI 10.1016/j.immuni.2017.09.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Planchais C, 2019, CELL REP, V27, P572, DOI 10.1016/j.celrep.2019.03.032; Prigent J, 2018, CELL REP, V23, P2568, DOI 10.1016/j.celrep.2018.04.101; Raymond DD, 2018, P NATL ACAD SCI USA, V115, P168, DOI 10.1073/pnas.1715471115; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Roskin KM, 2020, NAT IMMUNOL, V21, P199, DOI 10.1038/s41590-019-0581-0; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Sangesland M, 2019, IMMUNITY, V51, P735, DOI 10.1016/j.immuni.2019.09.001; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schmidt AG, 2015, CELL, V161, P1026, DOI 10.1016/j.cell.2015.04.028; Schroeder KMS, 2017, J EXP MED, V214, P2283, DOI 10.1084/jem.20161190; SHLOMCHIK MJ, 1987, P NATL ACAD SCI USA, V84, P9150, DOI 10.1073/pnas.84.24.9150; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Smith MJ, 2015, DIABETES, V64, P1703, DOI 10.2337/db13-1798; Stein A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063090; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Tan HX, 2019, J CLIN INVEST, V129, P850, DOI 10.1172/JCI123366; Thomson CA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00087; Tiller T, 2007, IMMUNITY, V26, P205, DOI 10.1016/j.immuni.2007.01.009; Verkoczy L, 2010, P NATL ACAD SCI USA, V107, P181, DOI 10.1073/pnas.0912914107; Volpe Joseph M, 2009, Immunome Res, V5, P1, DOI 10.1186/1745-7580-5-1; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Weitzner BD, 2017, NAT PROTOC, V12, P401, DOI 10.1038/nprot.2016.180; Weitzner BD, 2014, PROTEINS, V82, P1611, DOI 10.1002/prot.24534; Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu NC, 2018, CELL HOST MICROBE, V24, P569, DOI 10.1016/j.chom.2018.09.010; Zarnitsyna V.I., 2015, PHILOS T R SOC LON B, V370, P370; Zhang J., 1994, CELL RES, V4, P31, DOI DOI 10.1038/CR.1994.4; Zhang J, 2009, J AUTOIMMUN, V33, P270, DOI 10.1016/j.jaut.2009.03.011; Zhang RJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf0618	89	30	30	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1230	+		10.1016/j.immuni.2020.10.005	http://dx.doi.org/10.1016/j.immuni.2020.10.005			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33096040	Green Published, hybrid			2022-12-18	WOS:000599363300012
J	Shemer, A; Scheyltjens, I; Frumer, GR; Kim, JS; Grozovski, J; Ayanaw, S; Dassa, B; Van Hove, H; Chappell-Maor, L; Boura-Halfon, S; Leshkowitz, D; Mueller, W; Maggio, N; Movahedi, K; Jung, S				Shemer, Anat; Scheyltjens, Isabelle; Frumer, Gal Ronit; Kim, Jung-Seok; Grozovski, Jonathan; Ayanaw, Serkalem; Dassa, Bareket; Van Hove, Hannah; Chappell-Maor, Louise; Boura-Halfon, Sigalit; Leshkowitz, Dena; Mueller, Werner; Maggio, Nicola; Movahedi, Kiavash; Jung, Steffen			Interleukin-10 Prevents Pathological Microglia Hyperactivation following Peripheral Endotoxin Challenge	IMMUNITY			English	Article							LONG-TERM POTENTIATION; SYSTEMIC INFLAMMATION; TISSUE MACROPHAGES; GENE-EXPRESSION; T-CELLS; IN-VIVO; IL-10; ACTIVATION; LIPOPOLYSACCHARIDE; DEFICIENCY	Microglia, the resident macrophages of the brain parenchyma, are key players in central nervous system (CNS) development, homeostasis, and disorders. Distinct brain pathologies seem associated with discrete microglia activation modules. How microglia regain quiescence following challenges remains less understood. Here, we explored the role of the interleukin-10 (IL-10) axis in restoring murine microglia homeostasis following a peripheral endotoxin challenge. Specifically, we show that lipopolysaccharide (LPS)-challenged mice harboring IL-10 receptor-deficient microglia displayed neuronal impairment and succumbed to fatal sickness. Addition of a microglial tumor necrosis factor (TNF) deficiency rescued these animals, suggesting a microglia-based circuit driving pathology. Single cell transcriptome analysis revealed various IL-10 producing immune cells in the CNS, including most prominently Ly49D(+) NK cells and neutrophils, but not microglia. Collectively, we define kinetics of the microglia response to peripheral endotoxin challenge, including their activation and robust silencing, and highlight the critical role of non-microglial IL-10 in preventing deleterious microglia hyperactivation.	[Shemer, Anat; Frumer, Gal Ronit; Kim, Jung-Seok; Grozovski, Jonathan; Ayanaw, Serkalem; Chappell-Maor, Louise; Boura-Halfon, Sigalit; Jung, Steffen] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Scheyltjens, Isabelle; Van Hove, Hannah; Movahedi, Kiavash] VIB Ctr Inflammat Res, Myeloid Cell Immunol Lab, Brussels, Belgium; [Scheyltjens, Isabelle; Van Hove, Hannah; Movahedi, Kiavash] Vrije Univ Brussel, Lab Cellular & Mol Immunol, Brussels, Belgium; [Dassa, Bareket; Leshkowitz, Dena] Weizmann Inst Sci, Bioinformat Unit, Life Sci Core Facil, IL-76100 Rehovot, Israel; [Mueller, Werner] Univ Manchester, Fac Biol Med & Hlth, Manchester M13 9PT, Lancs, England; [Maggio, Nicola] Tel Aviv Univ, Dept Neurol, Chaim Sheba Med Ctr, Sackler Fac Med, IL-5262 Tel Aviv, Israel; [Maggio, Nicola] Tel Aviv Univ, Sagol Sch Neurosci, IL-5262 Tel Aviv, Israel	Weizmann Institute of Science; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Weizmann Institute of Science; University of Manchester; Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University	Jung, S (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	s.jung@weizmann.ac.il	Jung, Steffen/K-1409-2012; Muller, Werner/B-9044-2008; Movahedi, Kiavash/AAQ-4942-2020	Jung, Steffen/0000-0003-4290-5716; Muller, Werner/0000-0002-1297-9725; Movahedi, Kiavash/0000-0002-0826-4399; Scheyltjens, Isabelle/0000-0002-2260-2921; Van Hove, Hannah/0000-0002-0412-6474; Kim, Jung-Seok/0000-0003-0284-1658	H. Drake Professional Chair of Immunology; Israel Science Foundation [887/11]; European Research Council [Adv ERC 340345]; International Progressive MS Alliance (PMSA); Minerva Foundation; Deutsche Forschungsgemeinschaft (DFG) [CRC/TRR167]; American Brain Foundation; Blythe Brenden-Mann Foundation; Estate of David Levinson; Innoviris (Attract BB2B); FWO fellowships; Weizmann Institute; Manchester University	H. Drake Professional Chair of Immunology; Israel Science Foundation(Israel Science Foundation); European Research Council(European Research Council (ERC)European Commission); International Progressive MS Alliance (PMSA); Minerva Foundation; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); American Brain Foundation; Blythe Brenden-Mann Foundation; Estate of David Levinson; Innoviris (Attract BB2B); FWO fellowships(FWO); Weizmann Institute; Manchester University	We would like to thank allmembers of the Jung Laboratory, as well as A. Zeisel, Technion, Haifa, and M. Prinz, University of Freiburg, for advice and helpful discussion. We also thank the staff of the Weizmann Animal facility, the FACS facility and M. Tsoory of the Weizmann Veterinary Services for expert technical help. We thank S. Nedospasow for provision of the Tnf<SUP>fl/fl</SUP> mice. We thank Lord Alliance for the 'Get Together' initiative funding exchange between the Weizmann Institute and Manchester University. S. Jung is the Incumbent of the Henry. H. Drake Professional Chair of Immunology. The Jung laboratory was supported by the Israel Science Foundation (887/11), the European Research Council (Adv ERC 340345), a collaborative network grant of the International Progressive MS Alliance (PMSA), the Minerva Foundation, the Deutsche Forschungsgemeinschaft (DFG) (CRC/TRR167 'NeuroMac'), the American Brain Foundation, the Roland N. Karlen Foundation, the Blythe Brenden-Mann Foundation, and the Estate of David Levinson. K. Movahedi was supported by Innoviris (Attract BB2B 2015-2), I. Scheyltjens and H. Van Hove are supported by FWO fellowships.	Ajami B, 2018, NAT NEUROSCI, V21, P541, DOI 10.1038/s41593-018-0100-x; Anderson WD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00233; Banks WA, 2010, BRAIN BEHAV IMMUN, V24, P102, DOI 10.1016/j.bbi.2009.09.001; Bernshtein B, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6571; BOGDAN C, 1991, J EXP MED, V174, P1549, DOI 10.1084/jem.174.6.1549; Bohlen CJ, 2017, NEURON, V94, P759, DOI 10.1016/j.neuron.2017.04.043; Bok S, 2017, ONCOTARGET, V8, P111508, DOI 10.18632/oncotarget.22851; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buras JA, 2005, NAT REV DRUG DISCOV, V4, P854, DOI 10.1038/nrd1854; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Butovsky O, 2018, NAT REV NEUROSCI, V19, P622, DOI 10.1038/s41583-018-0057-5; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585; Chakrabarty P, 2015, NEURON, V85, P519, DOI 10.1016/j.neuron.2014.11.020; Chawla, 2013, BIOINFORMATICS; Chiu IM, 2013, CELL REP, V4, P385, DOI 10.1016/j.celrep.2013.06.018; Cossarizza A, 2017, EUR J IMMUNOL, V47, P1584, DOI 10.1002/eji.201646632; Davalos D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2230; Engelhardt KR, 2013, J ALLERGY CLIN IMMUN, V131, P825, DOI 10.1016/j.jaci.2012.09.025; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Guillot-Sestier MV, 2015, NEURON, V85, P534, DOI 10.1016/j.neuron.2014.12.068; Haimon Z., 2018, NAT IMMUNOL, V159, P1312; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Hannestad J, 2012, NEUROIMAGE, V63, P232, DOI 10.1016/j.neuroimage.2012.06.055; Haruwaka K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13812-z; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Holtman IR, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0203-5; Houle M, 1999, INFLAMMATION, V23, P241; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kasten KR, 2010, BIOCHEM BIOPH RES CO, V393, P28, DOI 10.1016/j.bbrc.2010.01.066; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kohen R, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2728-2; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Kreisel T., 2019, MOL PSYCHIATR, V19, P1; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Lobo-Silva D, 2017, GLIA, V65, P1439, DOI 10.1002/glia.23172; Lobo-Silva D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0763-8; Lockhart PB, 2008, CIRCULATION, V117, P3118, DOI 10.1161/CIRCULATIONAHA.107.758524; Lodge PA, 1996, J LEUKOCYTE BIOL, V60, P502, DOI 10.1002/jlb.60.4.502; Lun Aaron T L, 2016, F1000Res, V5, P2122; Lyons A, 2007, J NEUROSCI, V27, P8309, DOI 10.1523/JNEUROSCI.1781-07.2007; Maggio N, 2007, J NEUROSCI, V27, P5757, DOI 10.1523/JNEUROSCI.0155-07.2007; Maggio N, 2018, J MOL MED, V96, P1039, DOI 10.1007/s00109-018-1674-1; Maggio N, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00046; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Michaud JP, 2015, NEURON, V85, P450, DOI 10.1016/j.neuron.2015.01.021; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Murray PJ, 2006, CURR OPIN PHARMACOL, V6, P379, DOI 10.1016/j.coph.2006.01.010; Nabekura T, 2014, J EXP MED, V211, P2455, DOI 10.1084/jem.20140798; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; Pils MC, 2010, EUR J IMMUNOL, V40, P443, DOI 10.1002/eji.200939592; Prinz M, 2019, CELL, V179, P292, DOI 10.1016/j.cell.2019.08.053; Richwine AF, 2009, BRAIN BEHAV IMMUN, V23, P794, DOI 10.1016/j.bbi.2009.02.020; Roers A, 2004, J EXP MED, V200, P1289, DOI 10.1084/jem.20041789; Ryu JK, 2018, NAT IMMUNOL, V19, P1212, DOI 10.1038/s41590-018-0232-x; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sandiego CM, 2015, P NATL ACAD SCI USA, V112, P12468, DOI 10.1073/pnas.1511003112; Saraiva M, 2020, J EXP MED, V217, DOI 10.1084/jem.20190418; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113; Shemer A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07548-5; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Skelly DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069123; Song WM, 2018, NAT IMMUNOL, V19, P1048, DOI 10.1038/s41590-018-0212-1; Sousa C, 2018, EMBO REP, V19, DOI 10.15252/embr.201846171; Srinivasan R, 2016, NEURON, V92, P1181, DOI 10.1016/j.neuron.2016.11.030; Sriram K, 2006, FASEB J, V20, P670, DOI 10.1096/fj.05-5106com; Strehl A, 2014, EXP NEUROL, V261, P230, DOI 10.1016/j.expneurol.2014.04.033; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Teles R, 2011, ORAL DIS, V17, P450, DOI 10.1111/j.1601-0825.2010.01784.x; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4; Vereker E, 2000, J BIOL CHEM, V275, P26252, DOI 10.1074/jbc.M002226200; Wolf Y, 2017, NAT IMMUNOL, V18, P665, DOI 10.1038/ni.3746; Wu YE, 2017, NEURON, V96, P313, DOI 10.1016/j.neuron.2017.09.026; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhou K, 2017, J CEREBR BLOOD F MET, V37, P967, DOI 10.1177/0271678X16648712; ZHOU YY, 2019, NAT COMMUN, V10, DOI DOI 10.1038/S41467-019-09234-6; Zigdon H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120194; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	90	30	31	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					1033	+		10.1016/j.immuni.2020.09.018	http://dx.doi.org/10.1016/j.immuni.2020.09.018			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33049219	Bronze			2022-12-18	WOS:000599348200014
J	Bellomo, A; Mondor, I; Spinelli, L; Lagueyrie, M; Stewart, BJ; Brouilly, N; Malissen, B; Clatworthy, MR; Bajenoff, M				Bellomo, Alicia; Mondor, Isabelle; Spinelli, Lionel; Lagueyrie, Marine; Stewart, Benjamin J.; Brouilly, Nicolas; Malissen, Bernard; Clatworthy, Menna R.; Bajenoff, Marc			Reticular Fibroblasts Expressing the Transcription Factor WT1 Define a Stromal Niche that Maintains and Replenishes Splenic Red Pulp Macrophages	IMMUNITY			English	Article							TISSUE-RESIDENT MACROPHAGES; STIMULATING FACTOR-I; FLUORESCENT PROTEIN; ELECTRON-MICROSCOPY; GENE-EXPRESSION; SPI-C; RECEPTOR; CELLS; HOMEOSTASIS; CHEMOKINE	Located within red pulp cords, splenic red pulp macrophages (RPMs) are constantly exposed to the blood flow, clearing senescent red blood cells (RBCs) and recycling iron from hemoglobin. Here, we studied the mechanisms underlying RPM homeostasis, focusing on the involvement of stromal cells as these cells perform anchoring and nurturing macrophage niche functions in lymph nodes and liver. Microscopy revealed that RPMs are embedded in a reticular meshwork of red pulp fibroblasts characterized by the expression of the transcription factor Wilms' Tumor 1 (WT1) and colony stimulating factor 1 (CSF1). Conditional deletion of Csf1 in WT1(+) red pulp fibroblasts, but not white pulp fibroblasts, drastically altered the RPM network without altering circulating CSF1 levels. Upon RPM depletion, red pulp fibroblasts transiently produced the monocyte chemoattractants CCL2 and CCL7, thereby contributing to the replenishment of the RPM network. Thus, red pulp fibroblasts anchor and nurture RPM, a function likely conserved in humans.	[Bellomo, Alicia; Mondor, Isabelle; Spinelli, Lionel; Lagueyrie, Marine; Malissen, Bernard; Bajenoff, Marc] Aix Marseille Univ, CIML, INSERM, CNRS, Marseille, France; [Stewart, Benjamin J.; Clatworthy, Menna R.] Univ Cambridge, Dept Med, Mol Immun Unit, Cambridge, England; [Stewart, Benjamin J.; Clatworthy, Menna R.] Cambridge Univ Hosp NHS Fdn Trust, Cambridge, England; [Stewart, Benjamin J.; Clatworthy, Menna R.] NIHR Cambridge Biomed Res Ctr, Cambridge, England; [Stewart, Benjamin J.; Clatworthy, Menna R.] Wellcome Sanger Inst, Wellcome Genome Campus, Hinxton, England; [Brouilly, Nicolas] Aix Marseille Univ, CNRS, Inst Biol Dev Marseille, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Cambridge; University of Cambridge; University of Cambridge; Wellcome Trust Sanger Institute; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Bajenoff, M (corresponding author), Aix Marseille Univ, CIML, INSERM, CNRS, Marseille, France.	bajenoff@ciml.univ-mrs.fr	; Malissen, Bernard/AAK-4659-2020	Stewart, Benjamin J/0000-0003-4522-0085; Clatworthy, Menna/0000-0002-3340-9828; Malissen, Bernard/0000-0003-1340-9342	Agence National pour la Recherche [ANR-17-CE15-001501, ANR-10-INBS-04-01]; Fondation pour la Recherche Medicale (FRM); European Research Council (ERC) [647257-STROMA]; INSERM; CNRS; Aix-Marseille University; MRC [MR/S035842/1] Funding Source: UKRI	Agence National pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Research Council (ERC)(European Research Council (ERC)European Commission); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille University; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Andrea Brendolan (Ospedale San Raffaele, Milan, Italy) and Burkhard Ludewig (Institute of Immunobiology, Kantonsspital St. Gallen, Switzerland) for providing spleens of Nkx2.5<SUP>Cre</SUP> RosaYFP mice and Ccl19<SUP>Cre</SUP> mice, respectively; the CIML core facilities for animal housing and flow cytometry; the ImagImm photonic microscopy facility of the Centre d'Immunologie de Marseille-Luminy; and Rebecca Gentek for critical comments on the manuscript. The electron microscopy experiments were performed at the Plateforme d'Imagerie Commune des Sites de Luminy-France BioImaging core facility (Institut de Biologie du Developpement de Marseille, Aix-Marseille Universite), a member of the France-BioImaging National Research Infrastructure. This study was funded by grants from the Agence National pour la Recherche (ANR-10-INBS-04-01 France Bio Imaging and ANR-17-CE15-001501), the Fondation pour la Recherche Medicale (FRM), and from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program grant agreement 647257-STROMA. This work was supported by institutional grants from INSERM, CNRS, and Aix-Marseille University to the CIML. The authors declare no conflict of interest.	A-Gonzalez N, 2018, CELL IMMUNOL, V330, P151, DOI 10.1016/j.cellimm.2018.05.005; Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bakovic D, 2005, CLIN EXP PHARMACOL P, V32, P944, DOI 10.1111/j.1440-1681.2005.04289.x; Baranska A, 2018, J EXP MED, V215, P1115, DOI 10.1084/jem.20171608; Baratin M, 2017, IMMUNITY, V47, P349, DOI 10.1016/j.immuni.2017.07.019; Bharathavikru R, 2017, GENE DEV, V31, P347, DOI 10.1101/gad.291500.116; Bhattacharya S, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.15; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Buechler MB, 2019, IMMUNITY, V51, P119, DOI 10.1016/j.immuni.2019.05.010; Cain DW, 2013, J IMMUNOL, V191, P4665, DOI 10.4049/jimmunol.1300581; Camara A, 2019, IMMUNITY, V50, P1467, DOI 10.1016/j.immuni.2019.05.008; Castagnaro L, 2013, IMMUNITY, V38, P782, DOI 10.1016/j.immuni.2012.12.005; CECCHINI MG, 1994, DEVELOPMENT, V120, P1357; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Chau YY, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002404; CHEN L, 1972, AM J ANAT, V134, P425, DOI 10.1002/aja.1001340404; Cheng HW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09728-3; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Coelho FM, 2013, BLOOD, V121, P4101, DOI 10.1182/blood-2012-10-465336; Dai XM, 2004, BLOOD, V103, P1114, DOI 10.1182/blood-2003-08-2739; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; David CJ, 2018, NAT REV MOL CELL BIO, V19, P419, DOI 10.1038/s41580-018-0007-0; DeFalco T, 2015, CELL REP, V12, P1107, DOI 10.1016/j.celrep.2015.07.015; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Endo-Umeda K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27615-7; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Fang WB, 2011, CLIN EXP METASTAS, V28, P351, DOI 10.1007/s10585-011-9373-0; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Ghigo C, 2013, J EXP MED, V210, P1657, DOI 10.1084/jem.20130403; Golub R, 2018, TRENDS IMMUNOL, V39, P503, DOI 10.1016/j.it.2018.02.007; GREENWAY CV, 1969, J PHYSIOL-LONDON, V204, P169, DOI 10.1113/jphysiol.1969.sp008906; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Guilliams M, 2020, IMMUNITY, V52, P434, DOI 10.1016/j.immuni.2020.02.015; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Hara T, 2006, INT IMMUNOL, V18, P301, DOI 10.1093/intimm/dxh369; Harris SE, 2012, BONE, V50, P42, DOI 10.1016/j.bone.2011.09.038; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hastie ND, 2017, DEVELOPMENT, V144, P2862, DOI 10.1242/dev.153163; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Humblin E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01070-w; Inra CN, 2015, NATURE, V527, P466, DOI 10.1038/nature15530; Jarjour M, 2014, J EXP MED, V211, P1109, DOI 10.1084/jem.20132409; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Katakai T, 2008, J IMMUNOL, V181, P6189, DOI 10.4049/jimmunol.181.9.6189; Kim J, 1999, MOL CELL BIOL, V19, P2289; Kim Jung Ha, 2014, J Bone Metab, V21, P233, DOI 10.11005/jbm.2014.21.4.233; Kohyama M, 2009, NATURE, V457, P318, DOI 10.1038/nature07472; Kurihara T, 1996, J BIOL CHEM, V271, P11603, DOI 10.1074/jbc.271.20.11603; Kurotaki D, 2015, MICROBIOL IMMUNOL, V59, P55, DOI 10.1111/1348-0421.12228; Kurotaki D, 2011, J IMMUNOL, V186, P2229, DOI 10.4049/jimmunol.1001345; Lai SM, 2018, CELL REP, V25, P3099, DOI 10.1016/j.celrep.2018.11.059; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Lin WY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02019; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; LOPEZCASILLAS F, 1991, CELL, V67, P785, DOI 10.1016/0092-8674(91)90073-8; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Medina-Contreras O, 2011, J CLIN INVEST, V121, P4787, DOI 10.1172/JCI59150; Melsted P, 2019, BIOINFORMATICS, V35, P4472, DOI 10.1093/bioinformatics/btz279; Mondor I, 2019, IMMUNITY, V50, P1453, DOI 10.1016/j.immuni.2019.04.002; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Okada T, 2007, J IMMUNOL, V178, P2973, DOI 10.4049/jimmunol.178.5.2973; Robinson N, 2012, NAT IMMUNOL, V13, P954, DOI 10.1038/ni.2397; Rubin J, 1996, CALCIFIED TISSUE INT, V59, P291, DOI 10.1007/s002239900125; Sakai M, 2019, IMMUNITY, V51, P655, DOI 10.1016/j.immuni.2019.09.002; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Sontake V, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121252; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Suzuki T, 1972, Nihon Ketsueki Gakkai Zasshi, V35, P506; SUZUKI T, 1977, CELL TISSUE RES, V182, P441; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; T'Jonck W, 2018, CELL IMMUNOL, V330, P43, DOI 10.1016/j.cellimm.2018.02.005; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; van den Brink SC, 2017, NAT METHODS, V14, P935, DOI 10.1038/nmeth.4437; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Yamamoto M., 2011, PLOS ONE, V6; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu XY, 2017, IMMUNITY, V47, P903, DOI 10.1016/j.immuni.2017.10.007; Zanocco-Marani T, 1999, CANCER RES, V59, P5331; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou X, 2018, CELL, V172, P744, DOI 10.1016/j.cell.2018.01.015	102	30	31	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					127	+		10.1016/j.immuni.2020.06.008	http://dx.doi.org/10.1016/j.immuni.2020.06.008			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32562599	Bronze, Green Published			2022-12-18	WOS:000551116800015
J	Loo, CS; Gatchalian, J; Liang, YQ; Leblanc, M; Xie, MJ; Ho, J; Venkatraghavan, B; Hargreaves, DC; Zheng, Y				Loo, Chin-San; Gatchalian, Jovylyn; Liang, Yuqiong; Leblanc, Mathias; Xie, Mingjun; Ho, Josephine; Venkatraghavan, Bhargav; Hargreaves, Diana C.; Zheng, Ye			A Genome-wide CRISPR Screen Reveals a Role for the Non-canonical Nucleosome-Remodeling BAF Complex in Foxp3 Expression and Regulatory T Cell Function	IMMUNITY			English	Article							TRANSCRIPTION FACTOR FOXP3; DNA-BINDING PROTEINS; GENE-EXPRESSION; CIS-ELEMENT; INDUCTION; DIFFERENTIATION; DEGRADATION; METHYLATION; ACTIVATION; CHROMATIN	Regulatory T (Treg) cells play a pivotal role in suppressing auto-reactive T cells and maintaining immune homeostasis. Treg cell development and function are dependent on the transcription factor Foxp3. Here, we performed a genome-wide CRISPR loss-of-function screen to identify Foxp3 regulators in mouse primary Treg cells. Foxp3 regulators were enriched in genes encoding subunits of the SWI/SNF nucleosome-remodeling and SAGA chromatin-modifying complexes. Among the three SWI/SNF-related complexes, the Brd9-containing non-canonical (nc) BAF complex promoted Foxp3 expression, whereas the PBAF complex was repressive. Chemical-induced degradation of Brd9 led to reduced Foxp3 expression and reduced Treg cell function in vitro. Brd9 ablation compromised Treg cell function in inflammatory disease and tumor immunity in vivo. Furthermore, Brd9 promoted Foxp3 binding and expression of a subset of Foxp3 target genes. Our findings provide an unbiased analysis of the genetic networks regulating Foxp3 and reveal ncBAF as a target for therapeutic manipulation of Treg cell function.	[Loo, Chin-San; Liang, Yuqiong; Leblanc, Mathias; Xie, Mingjun; Venkatraghavan, Bhargav; Zheng, Ye] Salk Inst Biol Studies, NOMIS Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Gatchalian, Jovylyn; Ho, Josephine; Hargreaves, Diana C.] Salk Inst Biol Studies, Mol & Cellular Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Loo, Chin-San] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	Salk Institute; Salk Institute; University of California System; University of California San Diego	Zheng, Y (corresponding author), Salk Inst Biol Studies, NOMIS Ctr Immunobiol & Microbial Pathogenesis, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Hargreaves, DC (corresponding author), Salk Inst Biol Studies, Mol & Cellular Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dhargreaves@salk.edu; yzheng@salk.edu		Loo, Chin San/0000-0001-7915-2995	Albert G. and Olive H. Schlink Foundation; Salk Institute T32 Cancer Training Grant [T32CA009370]; NIGMS NRSA [F32 GM128377-01]; National Institutes of Health [GM128943, AI151123, CA228211, CA184043, AI107027, OD023689]; Pew-Stewart Scholar Award for Cancer Research; V Foundation for Cancer Research [V2016-006]; Leona M. and Harry B. Helmsley Charitable Trust; NOMIS Foundation; Crohn's and Colitis Foundation; National Cancer Institute [CA014195]	Albert G. and Olive H. Schlink Foundation; Salk Institute T32 Cancer Training Grant; NIGMS NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew-Stewart Scholar Award for Cancer Research; V Foundation for Cancer Research; Leona M. and Harry B. Helmsley Charitable Trust; NOMIS Foundation; Crohn's and Colitis Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank C. Gordon for mouse colony management; B. Kuo and X. Hu for assistance with plasmid extraction and mouse dissection; N. Hah and G. Chou for assistance with RNA-seq, ChIP-seq, and CRISPR screen experiments; E. Shifrut and A. Marson (UCSF) for providing the R script to generate the sgRNA distribution histograms; A. Williams and M. Shokhirev for bioinformatics assistance; M. Downes and R.M. Evans for helpful discussions; and A. Cao for graphic art assistance. C.-S.L. was partly supported by the Albert G. and Olive H. Schlink Foundation. J.G. was supported by Salk Institute T32 Cancer Training Grant T32CA009370 and NIGMS NRSA F32 GM128377-01. D.C.H. was supported by the National Institutes of Health (GM128943, AI151123, CA228211, and CA184043), the Pew-Stewart Scholar Award for Cancer Research, the V Foundation for Cancer Research (V2016-006), and the Leona M. and Harry B. Helmsley Charitable Trust. Y.Z. was supported by the NOMIS Foundation, the Crohn's and Colitis Foundation, the Leona M. and Harry B. Helmsley Charitable Trust, and the National Institutes of Health (AI107027, AI151123, and OD023689). This work was also supported by the National Cancer Institute funded Salk Institute cancer core facilities (CA014195).	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Chaiyachati BH, 2013, EMBO J, V32, P395, DOI 10.1038/emboj.2012.350; Chapman NM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04392-5; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen ZJ, 2013, IMMUNITY, V39, P272, DOI 10.1016/j.immuni.2013.08.006; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Cortez JT, 2020, NATURE, V582, P416, DOI 10.1038/s41586-020-2246-4; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Fujita T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103084; Gatchalian J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07528-9; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Helmlinger D, 2017, TRENDS BIOCHEM SCI, V42, P850, DOI 10.1016/j.tibs.2017.09.001; Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Josefowicz SZ, 2009, J IMMUNOL, V182, P6648, DOI 10.4049/jimmunol.0803320; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Koutelou E, 2010, CURR OPIN CELL BIOL, V22, P374, DOI 10.1016/j.ceb.2010.03.005; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Lee HM, 2012, IMMUNITY, V37, P475, DOI 10.1016/j.immuni.2012.07.009; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li W, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0843-6; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Liston A, 2008, P NATL ACAD SCI USA, V105, P11903, DOI 10.1073/pnas.0801506105; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Long MX, 2009, IMMUNITY, V31, P921, DOI 10.1016/j.immuni.2009.09.022; Michel BC, 2018, NAT CELL BIOL, V20, P1410, DOI 10.1038/s41556-018-0221-1; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Ouyang WM, 2010, IMMUNITY, V32, P642, DOI 10.1016/j.immuni.2010.04.012; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Remillard D, 2017, ANGEW CHEM INT EDIT, V56, P5738, DOI 10.1002/anie.201611281; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shifrut E, 2018, CELL, V175, P1958, DOI 10.1016/j.cell.2018.10.024; Spahn PN, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16193-9; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun IH, 2018, J IMMUNOL, V201, P481, DOI 10.4049/jimmunol.1701477; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; van Loosdregt J, 2014, TRENDS IMMUNOL, V35, P368, DOI 10.1016/j.it.2014.06.005; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Webster KE, 2009, J EXP MED, V206, P751, DOI 10.1084/jem.20082824; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08880-0	61	30	31	6	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					143	+		10.1016/j.immuni.2020.06.011	http://dx.doi.org/10.1016/j.immuni.2020.06.011			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32640256	Green Published, Bronze			2022-12-18	WOS:000551116800016
J	Perniss, A; Liu, SY; Boonen, B; Keshavarz, M; Ruppert, AL; Timm, T; Pfeil, U; Soultanova, A; Kusumakshi, S; Delventhal, L; Aydin, O; Pyrski, M; Deckmann, K; Hain, T; Schmidt, N; Ewers, C; Gunther, A; Lochnit, G; Chubanov, V; Gudermann, T; Oberwinkler, J; Klein, J; Mikoshiba, K; Leinders-Zufall, T; Offermanns, S; Schutz, B; Boehm, U; Zufall, F; Bufe, B; Kummer, W				Perniss, Alexander; Liu, Shuya; Boonen, Brett; Keshavarz, Maryam; Ruppert, Anna-Lena; Timm, Thomas; Pfeil, Uwe; Soultanova, Aichurek; Kusumakshi, Soumya; Delventhal, Lucas; Aydin, Oeznur; Pyrski, Martina; Deckmann, Klaus; Hain, Torsten; Schmidt, Nadine; Ewers, Christa; Guenther, Andreas; Lochnit, Geunter; Chubanov, Vladimir; Gudermann, Thomas; Oberwinkler, Johannes; Klein, Jochen; Mikoshiba, Katsuhiko; Leinders-Zufall, Trese; Offermanns, Stefan; Schuetz, Burkhard; Boehm, Ulrich; Zufall, Frank; Bufe, Bernd; Kummer, Wolfgang			Chemosensory Cell-Derived Acetylcholine Drives Tracheal Mucociliary Clearance in Response to Virulence-Associated Formyl Peptides	IMMUNITY			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; NITRIC-OXIDE; BITTER TASTE; BORDETELLA-PSEUDOHINZII; TRANSGENIC MICE; MOUSE NASAL; RECEPTORS; VOMERONASAL; EPITHELIUM; IMMUNE	Mucociliary clearance through coordinated ciliary beating is a major innate defense removing pathogens from the lower airways, but the pathogen sensing and downstream signaling mechanisms remain unclear. We identified virulence-associated formylated bacterial peptides that potently stimulated ciliary-driven transport in the mouse trachea. This innate response was independent of formyl peptide and taste receptors but depended on key taste transduction genes. Tracheal cholinergic chemosensory cells expressed these genes, and genetic ablation of these cells abrogated peptide-driven stimulation of mucociliary clearance. Trpm5-deficient mice were more susceptible to infection with a natural pathogen, and formylated bacterial peptides were detected in patients with chronic obstructive pulmonary disease. Optogenetics and peptide stimulation revealed that ciliary beating was driven by paracrine cholinergic signaling from chemosensory to ciliated cells operating through muscarinic M3 receptors independently of nerves. We provide a cellular and molecular framework that defines how tracheal chemosensory cells integrate chemosensation with innate defense.	[Perniss, Alexander; Keshavarz, Maryam; Pfeil, Uwe; Soultanova, Aichurek; Delventhal, Lucas; Aydin, Oeznur; Deckmann, Klaus; Kummer, Wolfgang] Justus Liebig Univ, Inst Anat & Cell Biol, German Ctr Lung Res, D-35385 Giessen, Germany; [Liu, Shuya; Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Dept Pharmacol, D-61231 Bad Nauheim, Germany; [Liu, Shuya] Univ Med Ctr Hamburg Eppendorf, Dept Med 3, D-20251 Hamburg, Germany; [Boonen, Brett; Pyrski, Martina; Leinders-Zufall, Trese; Zufall, Frank; Bufe, Bernd] Univ Saarland, Ctr Integrat Physiol & Mol Med, D-66421 Homburg, Germany; [Ruppert, Anna-Lena; Schuetz, Burkhard] Philipps Univ, Inst Anat & Cell Biol, D-35037 Marburg, Germany; [Timm, Thomas; Lochnit, Geunter] Justus Liebig Univ, Inst Biochem, D-35385 Giessen, Germany; [Kusumakshi, Soumya; Boehm, Ulrich] Saarland Univ, Ctr Mol Signaling PZMS, Expt Pharmacol, D-66421 Homburg, Germany; [Hain, Torsten] Justus Liebig Univ, Inst Med Microbiol, German Ctr Infect Res, D-35385 Giessen, Germany; [Schmidt, Nadine; Ewers, Christa] Justus Liebig Univ, Inst Hyg & Infect Dis Anim, D-35392 Giessen, Germany; [Guenther, Andreas] Justus Liebig Univ, Dept Internal Med, German Ctr Lung Res, Ctr Interstitial & Rare Lung Dis, D-35385 Giessen, Germany; [Guenther, Andreas] Agaples Lung Clin Waldhof Elgershausen, D-35753 Greifenstein, Germany; [Chubanov, Vladimir; Gudermann, Thomas] Ludwig Maximilians Univ Munchen, Walther Straub Inst Pharmacol & Toxicol, German Ctr Lung Res, D-80336 Munich, Germany; [Oberwinkler, Johannes] Philipps Univ, Inst Physiol & Pathophysiol, D-35037 Marburg, Germany; [Klein, Jochen] Goethe Univ Frankfurt, Dept Pharmacol & Clin Pharm, FB14, D-60438 Frankfurt, Germany; [Mikoshiba, Katsuhiko] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Lab Cell Calcium Signaling, Shanghai 201210, Peoples R China; [Bufe, Bernd] Univ Appl Sci, Dept Informat & Microsyst Technol, D-67659 Kaiserslautern, Germany	Justus Liebig University Giessen; Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; Saarland University; Philipps University Marburg; Justus Liebig University Giessen; Universitatsklinikum des Saarlandes; German Center for Infection Research; Justus Liebig University Giessen; Justus Liebig University Giessen; Justus Liebig University Giessen; University of Munich; Philipps University Marburg; Goethe University Frankfurt; ShanghaiTech University; University of Kaiserslautern	Kummer, W (corresponding author), Justus Liebig Univ, Inst Anat & Cell Biol, German Ctr Lung Res, D-35385 Giessen, Germany.	wolfgang.kummer@anatomie.med.uni-giessen.de	Leinders-Zufall, Trese/S-3664-2019; Schütz, Burkhard/AAA-8078-2019; Zufall, Frank/AAE-5290-2021; Leinders-Zufall, Trese/B-4103-2009; Bufe, Bernd/N-6685-2018	Leinders-Zufall, Trese/0000-0002-0678-362X; Schütz, Burkhard/0000-0003-4473-1959; Zufall, Frank/0000-0002-4383-8618; Leinders-Zufall, Trese/0000-0002-0678-362X; Oberwinkler, Johannes/0000-0002-8541-3626; Ewers, Christa/0000-0001-6167-1340; Pyrski, Martina/0000-0002-5751-178X; Boonen, Brett/0000-0002-5026-3963; Bufe, Bernd/0000-0003-1610-0658; Liu, Shuya/0000-0001-6897-036X	German Research Foundation [DFG SFB-TR84, SFB-TR152, 239283807, SFB 894, SFB1021, SCHU1259/10-1]; German Center for Lung Research (DZL) [ALI-1.1, FKZ 82DZL0003A4, PH-2.7]	German Research Foundation(German Research Foundation (DFG)); German Center for Lung Research (DZL)	We thank T. Papadakis, M. Bodenbenner, S. Wiegand (Giessen), H. Lau (Frankfurt), and O. Maurer (Greifenstein) for excellent technical assistance; P. Schmidt (Giessen) for help with cell sorting and RT-PCR; G. Michel and the FACS core facility (Giessen) for help with cell sorting; and M. Pieper and P. Konig (University of Luebeck, Germany) for programming the MATLAB GUI to analyze ciliary beat frequency. For providing mice, we thank I. Matsumoto (Monell Chemical Senses Center, Philadelphia, PA, USA; Pou2f3<SUP>tm1Abek</SUP>), R.F. Margolskee (Monell Chemical Senses Center; Tg(Trpm5-EGFP)#Sdmk), D. Wu (Yale University School of Medicine, USA; PLCb2<SUP>-/-</SUP>), and A. Godecke (Heinrich-Heine-University, Dusseldorf, Germany; Nos3<SUP>-/-</SUP>), as well as W. Meyerhof (Saarland University) for all Tas2r plasmids. This work was supported by the German Research Foundation (DFG SFB-TR84, project A6 to W.K. and project B8 to T.H.; SFB-TR152, project 239283807 to V.C., T.G., T.L.-Z., U.B., and F.Z.; SFB 894, project A17 to F.Z. and T.L.-Z.; SFB1021, project Z02 to T.H.; and SCHU1259/10-1 to B.S.) and the German Center for Lung Research (DZL, ALI-1.1 to W.K. and FKZ 82DZL0003A4 and PH-2.7 to T.G.).	Bailey KL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-49; Balentova S, 2013, RESP PHYSIOL NEUROBI, V189, P195, DOI 10.1016/j.resp.2013.07.006; Bankova LG, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat9453; Bhashyam AR, 2010, AUTON NEUROSCI-BASIC, V154, P74, DOI 10.1016/j.autneu.2009.12.002; Bozicevic A, 2017, J NAT PROD, V80, P2953, DOI 10.1021/acs.jnatprod.7b00495; Brockschniedier D, 2006, GENESIS, V44, P322, DOI 10.1002/dvg.20218; Bufe B, 2002, NAT GENET, V32, P397, DOI 10.1038/ng1014; Bufe B, 2005, CURR BIOL, V15, P322, DOI 10.1016/j.cub.2005.01.047; Bufe B, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12842-x; Bufe Bernd, 2016, BioMolecular Concepts, V7, P205, DOI 10.1515/bmc-2016-0013; Bufe B, 2015, J BIOL CHEM, V290, P7369, DOI 10.1074/jbc.M114.626747; Bufe B, 2012, J BIOL CHEM, V287, P33644, DOI 10.1074/jbc.M112.375774; Carey RM, 2017, AM J RHINOL ALLERGY, V31, P211, DOI 10.2500/ajra.2017.31.4453; Chamero P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09638-8; Chawla K, 2014, J CLIN DIAGN RES, V8, pDC20, DOI 10.7860/JCDR/2014/10780.5320; Clapp TR, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-7; Clark SE, 2016, COMPARATIVE MED, V66, P361; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Deckmann K, 2014, P NATL ACAD SCI USA, V111, P8287, DOI 10.1073/pnas.1402436111; Dewan KK, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007696; Dillon WC, 1996, CHEST, V110, P930, DOI 10.1378/chest.110.4.930; ELJAMAL M, 1994, J APPL PHYSIOL, V77, P1239, DOI 10.1152/jappl.1994.77.3.1239; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Freund JR, 2018, J BIOL CHEM, V293, P9824, DOI 10.1074/jbc.RA117.001005; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Gao JL, 1999, J EXP MED, V189, P657, DOI 10.1084/jem.189.4.657; Gertsberg I, 2004, J GEN PHYSIOL, V124, P527, DOI 10.1085/jgp.200409153; Godecke A, 1998, CIRC RES, V82, P186; Gu XL, 2014, AM J RESP CELL MOL, V50, P637, DOI 10.1165/rcmb.2013-0199OC; Hartzell Joshua D, 2007, MedGenMed, V9, P4; Hayashimoto N, 2012, RES VET SCI, V93, P624, DOI 10.1016/j.rvsc.2011.11.001; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Hollenhorst MI, 2020, FASEB J, V34, P316, DOI 10.1096/fj.201901314RR; Hollenhorst MI, 2012, BRIT J PHARMACOL, V166, P1388, DOI 10.1111/j.1476-5381.2012.01883.x; Ivanov YV, 2016, INT J SYST EVOL MICR, V66, P5452, DOI 10.1099/ijsem.0.001540; Jiang HP, 1997, P NATL ACAD SCI USA, V94, P7971, DOI 10.1073/pnas.94.15.7971; Jiao J, 2011, EXP CELL RES, V317, P2548, DOI 10.1016/j.yexcr.2011.07.007; Kaske S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-49; Kinnamon SC, 2012, ACTA PHYSIOL, V204, P158, DOI 10.1111/j.1748-1716.2011.02308.x; Klein MK, 2009, EUR RESPIR J, V33, P1113, DOI 10.1183/09031936.00015108; Krasteva G, 2012, LIFE SCI, V91, P992, DOI 10.1016/j.lfs.2012.06.014; Krasteva G, 2011, P NATL ACAD SCI USA, V108, P9478, DOI 10.1073/pnas.1019418108; Krasteva-Christ G, 2015, INT IMMUNOPHARMACOL, V29, P158, DOI 10.1016/j.intimp.2015.05.028; Kusumakshi S, 2015, CHEM SENSES, V40, P413, DOI 10.1093/chemse/bjv023; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lasconi C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45456-w; Lee RJ, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam7703; Lee RJ, 2014, INNATE IMMUN-LONDON, V20, P606, DOI 10.1177/1753425913503386; Lee RJ, 2012, J CLIN INVEST, V122, P4145, DOI 10.1172/JCI64240; Lei WW, 2018, P NATL ACAD SCI USA, V115, P5552, DOI 10.1073/pnas.1720758115; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Liberles SD, 2009, P NATL ACAD SCI USA, V106, P9842, DOI 10.1073/pnas.0904464106; Lietsche J, 2016, NEUROSCI LETT, V611, P69, DOI 10.1016/j.neulet.2015.11.028; Liu SY, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00739; Lossow K, 2016, J BIOL CHEM, V291, P15358, DOI 10.1074/jbc.M116.718544; Ma L, 2019, ANIM MODEL EXP MED, V2, P217, DOI 10.1002/ame2.12075; Matsumoto I, 2011, NAT NEUROSCI, V14, P685, DOI 10.1038/nn.2820; Mcnulty M.C., 2015, OPEN FORUM INFECT DI, V2, P1731; MERCER RR, 1994, AM J RESP CELL MOL, V10, P613, DOI 10.1165/ajrcmb.10.6.8003339; Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6; Moine F, 2018, BMC BIOL, V16, DOI 10.1186/s12915-017-0479-y; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; Oliveira MJR, 2003, LUNG, V181, P275, DOI 10.1007/s00408-003-1030-1; OPREMCAK LB, 1983, CAN J MICROBIOL, V29, P415, DOI 10.1139/m83-067; PACK RJ, 1981, J ANAT, V132, P71; Perniss A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23830-4; Peto L, 2014, T ROY SOC TROP MED H, V108, P326, DOI 10.1093/trstmh/tru058; Pyrski M, 2017, MOL CELL NEUROSCI, V80, P75, DOI 10.1016/j.mcn.2017.02.002; Qian XW, 2018, INNATE IMMUN-LONDON, V24, P122, DOI 10.1177/1753425918759181; Riviere S, 2009, NATURE, V459, P574, DOI 10.1038/nature08029; Saunders CJ, 2014, P NATL ACAD SCI USA, V111, P6075, DOI 10.1073/pnas.1402251111; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; SEKIYA K, 1989, MICROBIOL IMMUNOL, V33, P111, DOI 10.1111/j.1348-0421.1989.tb01503.x; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shen JC, 2012, INT FORUM ALLERGY RH, V2, P104, DOI 10.1002/alr.21002; Singh Lavan, 2016, Med J Armed Forces India, V72, pS59, DOI 10.1016/j.mjafi.2016.05.002; Stempel H, 2016, J BIOL CHEM, V291, P9762, DOI 10.1074/jbc.M116.714493; STENGEL PW, 2002, AM J PHYSIOL-REG I, V282, pR144; Tallini YN, 2006, PHYSIOL GENOMICS, V27, P391, DOI 10.1152/physiolgenomics.00092.2006; Tizzano M, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-3; Tizzano M, 2010, P NATL ACAD SCI USA, V107, P3210, DOI 10.1073/pnas.0911934107; Torres A, 2014, EUR J CLIN MICROBIOL, V33, P1065, DOI 10.1007/s10096-014-2067-1; Trouillet AC, 2019, P NATL ACAD SCI USA, V116, P5135, DOI 10.1073/pnas.1821492116; Tsang KW, 2002, CHEST, V121, P88, DOI 10.1378/chest.121.1.88; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Wang G, 2016, DEV CELL, V38, P453, DOI 10.1016/j.devcel.2016.07.014; Webley WC, 2009, EUR RESPIR J, V33, P360, DOI 10.1183/09031936.00019508; Weiss E, 2018, TRENDS IMMUNOL, V39, P815, DOI 10.1016/j.it.2018.08.005; Wijers CDM, 2017, CHRON RESP DIS, V14, P392, DOI 10.1177/1479972317694621; Yamashita J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189340; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4; Zhao SL, 2011, NAT METHODS, V8, P745, DOI 10.1038/nmeth.1668; Zheng X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12505-x; Zurborg S, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-66	96	30	30	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 14	2020	52	4					683	+		10.1016/j.immuni.2020.03.005	http://dx.doi.org/10.1016/j.immuni.2020.03.005			28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LE5TM	32294408	Bronze			2022-12-18	WOS:000526782600012
J	Diefenbach, A; Gnafakis, S; Shomrat, O				Diefenbach, Andreas; Gnafakis, Stylianos; Shomrat, Omer			Innate Lymphoid Cell-Epithelial Cell Modules Sustain Intestinal Homeostasis	IMMUNITY			English	Review							ROR-GAMMA-T; STEM-CELLS; ENTEROENDOCRINE CELLS; TUFT CELLS; 1-METHOXY-3-INDOLYLMETHYL GLUCOSINOLATE; IMMUNOLOGICAL CONTROL; MUCOSAL IMMUNITY; TYPE-2 IMMUNITY; MOUSE MODEL; FOOD-INTAKE	The intestines have the essential but challenging mission of absorbing nutrients, restricting damage from food-derived toxins, promoting colonization by symbionts, and expelling pathogens. These processes are often incompatible with each other and must therefore be prioritized in view of the most crucial contemporary needs of the host. Recent work has shown that tissue-resident innate lymphoid cells (ILCs) constitute a central sensory module allowing adaptation of intestinal organ function to changing environmental input. Here, we propose a conceptual framework positing that the various types of ILC act in distinct modules with intestinal epithelial cells, collectively safeguarding organ function. Such homeostasis-promoting circuitry has high potential to be plumbed for new therapeutic approaches to the treatment of immune-mediated inflammatory diseases.	[Diefenbach, Andreas; Gnafakis, Stylianos; Shomrat, Omer] Charite Univ Med Berlin, Dept Microbiol Infect Dis & Immunol, Lab Innate Immun, Hindenburgdamm 30, D-12203 Berlin, Germany; [Diefenbach, Andreas; Gnafakis, Stylianos; Shomrat, Omer] BIH, Anna Louisa Karsch Str 2, D-10117 Berlin, Germany; [Diefenbach, Andreas; Gnafakis, Stylianos; Shomrat, Omer] Deutsch Rheuma Forschungszentrum, Mucosal & Dev Immunol, Charite Pl 1, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Deutsches Rheuma-Forschungszentrum (DRFZ)	Diefenbach, A (corresponding author), Charite Univ Med Berlin, Dept Microbiol Infect Dis & Immunol, Lab Innate Immun, Hindenburgdamm 30, D-12203 Berlin, Germany.; Diefenbach, A (corresponding author), BIH, Anna Louisa Karsch Str 2, D-10117 Berlin, Germany.; Diefenbach, A (corresponding author), Deutsch Rheuma Forschungszentrum, Mucosal & Dev Immunol, Charite Pl 1, D-10117 Berlin, Germany.	andreas.diefenbach@charite.de	Diefenbach, Andreas/T-2589-2018	Diefenbach, Andreas/0000-0002-9176-9530				Al Nabhani Z, 2019, IMMUNITY, V50, P1276, DOI 10.1016/j.immuni.2019.02.014; Allaire JM, 2018, TRENDS IMMUNOL, V39, P677, DOI 10.1016/j.it.2018.04.002; Ananthakrishnan AN, 2018, NAT REV GASTRO HEPAT, V15, P39, DOI 10.1038/nrgastro.2017.136; Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bauche D, 2018, IMMUNITY, V49, P342, DOI 10.1016/j.immuni.2018.07.007; Bezencon C, 2008, J COMP NEUROL, V509, P514, DOI 10.1002/cne.21768; Birchenough GMH, 2016, SCIENCE, V352, P1535, DOI 10.1126/science.aaf7419; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Bosch TCG, 2011, ZOOLOGY, V114, P185, DOI 10.1016/j.zool.2011.04.001; Boudry G, 2004, J NUTR, V134, P2256, DOI 10.1093/jn/134.9.2256; Branzk N, 2018, IMMUNOL REV, V286, P86, DOI 10.1111/imr.12718; CHAYVIALLE JA, 1980, GASTROENTEROLOGY, V79, P844; Clevers HC, 2013, ANNU REV PHYSIOL, V75, P289, DOI 10.1146/annurev-physiol-030212-183744; Conde J, 2010, EXPERT REV CLIN IMMU, V6, P801, DOI [10.1586/eci.10.48, 10.1586/ECI.10.48]; Darwich AS, 2014, DRUG METAB DISPOS, V42, P2016, DOI 10.1124/dmd.114.058404; Delgado M, 2004, PHARMACOL REV, V56, P249, DOI 10.1124/pr.56.2.7; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; FARO CJ, 2000, AM J PHYSIOL-REG I, V278, pR11; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Gehart H, 2019, CELL, V176, P1158, DOI 10.1016/j.cell.2018.12.029; Gehart H, 2019, NAT REV GASTRO HEPAT, V16, P19, DOI 10.1038/s41575-018-0081-y; Gerbe F, 2016, NATURE, V529, P226, DOI 10.1038/nature16527; Glatt H, 2011, CHEM-BIOL INTERACT, V192, P81, DOI 10.1016/j.cbi.2010.09.009; Godinho-Silva C, 2019, NATURE, V574, P254, DOI 10.1038/s41586-019-1579-3; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Gronke K, 2019, NATURE, V566, P249, DOI 10.1038/s41586-019-0899-7; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hartman C, 2009, WORLD J GASTROENTERO, V15, P2570, DOI 10.3748/wjg.15.2570; Hernandez P, 2018, EUR J IMMUNOL, V48, P15, DOI 10.1002/eji.201747183; Hernandez PP, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau5265; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Ilzarbe L, 2017, J PSYCHOSOM RES, V102, P47, DOI 10.1016/j.jpsychores.2017.09.006; Innocentin YLS, 2011, CELL, V147, P629, DOI 10.1016/j.cell.2011.09.025; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Iwasaki Mari, 2019, F1000Res, V8, DOI 10.12688/f1000research.18039.1; Johansson MEV, 2016, NAT REV IMMUNOL, V16, P639, DOI 10.1038/nri.2016.88; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Knoop KA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aao1314; Korn LL, 2014, MUCOSAL IMMUNOL, V7, P1045, DOI 10.1038/mi.2013.121; Kulkarni DH, 2020, MUCOSAL IMMUNOL, V13, P271, DOI 10.1038/s41385-019-0240-7; Kulkarni DH, 2018, MUCOSAL IMMUNOL, V11, P1103, DOI 10.1038/s41385-018-0007-6; Kumar P, 2013, MUCOSAL IMMUNOL, V6, P69, DOI 10.1038/mi.2012.49; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lei WW, 2018, P NATL ACAD SCI USA, V115, P5552, DOI 10.1073/pnas.1720758115; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Manocha M, 2013, MUCOSAL IMMUNOL, V6, P146, DOI 10.1038/mi.2012.58; Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437; McDermott JR, 2006, GUT, V55, P492, DOI 10.1136/gut.2005.081752; Mcgee HM, 2013, J INVEST DERMATOL, V133, P1321, DOI 10.1038/jid.2012.463; MCHUGH K, 1993, AM J PHYSIOL, V265, pR1001, DOI 10.1152/ajpregu.1993.265.5.R1001; MCHUGH KJ, 1993, AM J PHYSIOL, V264, pR871, DOI 10.1152/ajpregu.1993.264.5.R871; McIntosh BE, 2010, ANNU REV PHYSIOL, V72, P625, DOI 10.1146/annurev-physiol-021909-135922; Metidji A, 2018, IMMUNITY, V49, P353, DOI 10.1016/j.immuni.2018.07.010; Mora JR, 2003, NATURE, V424, P88, DOI 10.1038/nature01726; Nadjsombati MS, 2018, IMMUNITY, V49, P33, DOI 10.1016/j.immuni.2018.06.016; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; O'Hara JR, 2006, CELL MICROBIOL, V8, P646, DOI 10.1111/j.1462-5822.2005.00657.x; Oeser K, 2015, MUCOSAL IMMUNOL, V8, P672, DOI 10.1038/mi.2014.101; Pelaseyed T, 2014, IMMUNOL REV, V260, P8, DOI 10.1111/imr.12182; Pham TAN, 2014, CELL HOST MICROBE, V16, P504, DOI 10.1016/j.chom.2014.08.017; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Posovszky C, 2015, HORM RES PAEDIAT, V83, P1, DOI 10.1159/000368898; Potter SS, 2018, NAT REV NEPHROL, V14, P479, DOI 10.1038/s41581-018-0021-7; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Sasaki N, 2016, P NATL ACAD SCI USA, V113, pE5399, DOI 10.1073/pnas.1607327113; Sato T, 2011, NATURE, V469, P415, DOI 10.1038/nature09637; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Savage AK, 2017, J IMMUNOL, V199, P1912, DOI 10.4049/jimmunol.1700155; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Sawa S, 2010, SCIENCE, V330, P665, DOI 10.1126/science.1194597; Schiering C, 2017, NATURE, V542, P242, DOI 10.1038/nature21080; Schneider C, 2018, CELL, V174, P271, DOI 10.1016/j.cell.2018.05.014; Schumacher F, 2014, ARCH TOXICOL, V88, P823, DOI 10.1007/s00204-013-1149-7; Seillet C, 2020, NAT IMMUNOL, V21, P168, DOI 10.1038/s41590-019-0567-y; Shajib MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072774; Sicard JF, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00387; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Talbot J, 2020, NATURE, V579, P575, DOI 10.1038/s41586-020-2039-9; Teng F, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax1215; Tsai PY, 2017, CELL HOST MICROBE, V21, P671, DOI 10.1016/j.chom.2017.05.009; van Es JH, 2012, NAT CELL BIOL, V14, P1099, DOI 10.1038/ncb2581; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Waddell A, 2019, J IMMUNOL, V202, P598, DOI 10.4049/jimmunol.1800292; Wang HQ, 2007, GUT, V56, P949, DOI 10.1136/gut.2006.103226; Wang QL, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay7501; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Wang YH, 2017, SCIENCE, V357, P913, DOI 10.1126/science.aan0677; Wheatcroft J, 2005, NEUROGASTROENT MOTIL, V17, P863, DOI 10.1111/j.1365-2982.2005.00719.x; Wlodarska M, 2014, CELL, V156, P1045, DOI 10.1016/j.cell.2014.01.026; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Worthington JJ, 2018, MUCOSAL IMMUNOL, V11, P3, DOI 10.1038/mi.2017.73; Worthington JJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003122; Yilmaz OH, 2012, NATURE, V486, P490, DOI 10.1038/nature11163; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zha JM, 2019, CELL MOL GASTROENTER, V7, P255, DOI 10.1016/j.jcmgh.2018.09.006; Zhang XY, 2019, INT J MOL MED, V43, P1657, DOI 10.3892/ijmm.2019.4092; Zhu PP, 2019, NAT IMMUNOL, V20, P183, DOI 10.1038/s41590-018-0297-6; Zwarycz B, 2019, CELL MOL GASTROENTER, V7, P1, DOI 10.1016/j.jcmgh.2018.06.008	121	30	30	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					452	463		10.1016/j.immuni.2020.02.016	http://dx.doi.org/10.1016/j.immuni.2020.02.016			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32187516	Bronze			2022-12-18	WOS:000520600200008
J	Oherle, K; Acker, E; Bonfield, M; Wang, T; Gray, J; Lang, I; Bridges, J; Lewkowich, I; Xu, Y; Ahlfeld, S; Zacharias, W; Alenghat, T; Deshmukh, H				Oherle, Katherine; Acker, Elizabeth; Bonfield, Madeline; Wang, Timothy; Gray, Jerilyn; Lang, Ian; Bridges, James; Lewkowich, Ian; Xu, Yan; Ahlfeld, Shawn; Zacharias, William; Alenghat, Theresa; Deshmukh, Hitesh			Insulin-like Growth Factor 1 Supports a Pulmonary Niche that Promotes Type 3 Innate Lymphoid Cell Development in Newborn Lungs	IMMUNITY			English	Article							ROR-GAMMA-T; COMPUTATIONAL PLATFORM; DIFFERENTIATION; PROGENITOR; EXPRESSION; HOMEOSTASIS; ACTIVATION; GENERATION; MURINE; LIFE	Type 3 innate lymphoid cells (ILC3s) are critical for lung defense against bacterial pneumonia in the neonatal period, but the signals that guide pulmonary ILC3 development remain unclear. Here, we demonstrated that pulmonary ILC3s descended from ILC precursors that populated a niche defined by fibroblasts in the developing lung. Alveolar fibroblasts produced insulin-like growth factor 1 (IGF1), which instructed expansion and maturation of pulmonary ILC precursors. Conditional ablation of IGF1 in alveolar fibroblasts or deletion of the IGF-1 receptor from ILC precursors interrupted ILC3 biogenesis and rendered newborn mice susceptible to pneumonia. Premature infants with bronchopulmonary dysplasia, characterized by interrupted postnatal alveolar development and increased morbidity to respiratory infections, had reduced IGF1 concentrations and pulmonary ILC3 numbers. These findings indicate that the newborn period is a critical window in pulmonary immunity development, and disrupted lung development in prematurely born infants may have enduring effects on host resistance to respiratory infections.	[Oherle, Katherine; Acker, Elizabeth; Bonfield, Madeline; Wang, Timothy; Gray, Jerilyn; Lang, Ian; Bridges, James; Xu, Yan; Ahlfeld, Shawn; Deshmukh, Hitesh] Cincinnati Childrens Hosp Med Ctr, Div Neonatol, Cincinnati, OH 45219 USA; [Bridges, James; Xu, Yan; Zacharias, William; Deshmukh, Hitesh] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45219 USA; [Lewkowich, Ian; Alenghat, Theresa] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45219 USA; [Alenghat, Theresa; Deshmukh, Hitesh] Cincinnati Childrens Hosp Med Ctr, Ctr Inflammat & Tolerance, Cincinnati, OH 45219 USA; [Wang, Timothy; Bridges, James; Lewkowich, Ian; Xu, Yan; Ahlfeld, Shawn; Alenghat, Theresa; Deshmukh, Hitesh] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA; [Zacharias, William] Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH 45267 USA; [Bonfield, Madeline] Univ Cincinnati, Coll Med, Immunol Grad Program, Cincinnati, OH 45267 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Deshmukh, H (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Neonatol, Cincinnati, OH 45219 USA.; Deshmukh, H (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45219 USA.; Deshmukh, H (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Inflammat & Tolerance, Cincinnati, OH 45219 USA.; Deshmukh, H (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45267 USA.	hitesh.deshmukh@cchmc.org		Bonfield, Madeline/0000-0003-0940-7707; Bridges, James P./0000-0002-4815-117X; Deshmukh, Hitesh/0000-0001-9632-164X; Zacharias, William/0000-0002-2643-0610; , Yan/0000-0003-2025-027X	Children's Hospital Research Foundation [K08HD084686, R01HL142708]; Francis Family Foundation [R01DK114213, DK116868]; Pew Charitable Trust; Burroughs Wellcome Fund [R01HL131634, R01HL122300, K08HL140178, U01 HL122642]	Children's Hospital Research Foundation; Francis Family Foundation; Pew Charitable Trust; Burroughs Wellcome Fund(Burroughs Wellcome Fund)	We thank the Children's Hospital Research Foundation's Flow Cytometry and Cell Sorting Core Laboratory, Imaging core and Nikon Center of Excellence for technical advice and support. We thank J. Whitsett, C. Chougnet and S. Way for their helpful comments. We thank the physicians, nurses, and staff of CCHMC Pulmonary Medicine Division, Biorepository for Investigation of Neonatal Diseases of Lung (BRINDL) and all the participating patients and their families. H.D. is supported by K08HD084686, R01HL142708, and Francis Family Foundation. T.A. is supported by R01DK114213, DK116868, and Pew Charitable Trust. T.A. holds an Investigator in the Pathogenesis of Infectious Disease Award from the Burroughs Wellcome Fund. J.B. is supported by R01HL131634. I. Lewkowich is supported by R01HL122300. W.Z. is supported by K08HL140178. Y.X. is supported by U01 HL122642.	Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Aliahmad P, 2010, NAT IMMUNOL, V11, P945, DOI 10.1038/ni.1930; Ardini-Poleske ME, 2017, AM J PHYSIOL-LUNG C, V313, pL733, DOI 10.1152/ajplung.00139.2017; Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Bando JK, 2016, NAT IMMUNOL, V17, P783, DOI 10.1038/ni.3484; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bertoncello I., 2011, CURR PROTOC STEM CEL; Bilbao D, 2014, EMBO MOL MED, V6, P1423, DOI 10.15252/emmm.201303376; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chea S, 2016, CELL REP, V14, P1500, DOI 10.1016/j.celrep.2016.01.015; Chea S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/368427; Chen K, 2013, ANNU REV IMMUNOL, V31, P605, DOI 10.1146/annurev-immunol-032712-100019; Chu C, 2018, CELL REP, V23, P3750, DOI 10.1016/j.celrep.2018.05.099; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cox AM, 2017, PEDIATR PULM, V52, P616, DOI 10.1002/ppul.23654; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cupedo T, 2004, J IMMUNOL, V173, P2968, DOI 10.4049/jimmunol.173.5.2968; CYSTER JG, 1994, NATURE, V371, P389, DOI 10.1038/371389a0; Dahlgren MW, 2019, IMMUNITY, V50, P707, DOI 10.1016/j.immuni.2019.02.002; De Grove KC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145961; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037; DiGirolamo DJ, 2007, J BIOL CHEM, V282, P31666, DOI 10.1074/jbc.M705219200; Du YN, 2017, THORAX, V72, P481, DOI 10.1136/thoraxjnl-2016-209598; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Endale M, 2017, DATA BRIEF, V13, P415, DOI 10.1016/j.dib.2017.06.001; Endale M, 2017, DEV BIOL, V425, P161, DOI 10.1016/j.ydbio.2017.03.020; Felton JM, 2018, THORAX, V73, P1081, DOI 10.1136/thoraxjnl-2017-211097; Frank DB, 2016, CELL REP, V17, P2312, DOI 10.1016/j.celrep.2016.11.001; Galvis LA, 2015, DEVELOPMENT, V142, P1458, DOI 10.1242/dev.122077; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Gessner BD, 2007, THORAX, V62, P231, DOI 10.1136/thx.2005.053363; GeurtsvanKessel CH, 2008, J EXP MED, V205, P1621, DOI 10.1084/jem.20071365; dos Santos ABG, 2013, ANN ANAT, V195, P596, DOI 10.1016/j.aanat.2013.05.003; Gray J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf9412; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Guo MZ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004575; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Harly C, 2018, J EXP MED, V215, P249, DOI 10.1084/jem.20170832; Hegab AE, 2015, STEM CELL RES, V15, P109, DOI 10.1016/j.scr.2015.05.005; Herriges M, 2014, DEVELOPMENT, V141, P502, DOI 10.1242/dev.098186; Hoorweg K, 2015, J IMMUNOL, V195, P4257, DOI 10.4049/jimmunol.1402584; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Ishizuka IE, 2016, ANNU REV IMMUNOL, V34, P299, DOI 10.1146/annurev-immunol-041015-055549; Islam JY, 2015, AM J RESP CRIT CARE, V192, P134, DOI 10.1164/rccm.201412-2142PP; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Kaplan SL, 2010, PEDIATRICS, V125, P429, DOI 10.1542/peds.2008-1702; Khan JA, 2016, SCIENCE, V351, P176, DOI 10.1126/science.aad0084; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koga S, 2018, J EXP MED, V215, P1609, DOI 10.1084/jem.20172310; Kollmann TR, 2017, IMMUNITY, V46, P350, DOI 10.1016/j.immuni.2017.03.009; Kotas ME, 2018, IMMUNITY, V48, P1081, DOI 10.1016/j.immuni.2018.06.002; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Lambert L., 2015, THESIS; LANDRETH KS, 1992, BLOOD, V80, P1207; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Liu JL, 1998, MOL ENDOCRINOL, V12, P1452, DOI 10.1210/me.12.9.1452; Lloyd CM, 2017, IMMUNITY, V46, P549, DOI 10.1016/j.immuni.2017.04.005; Lopez-Lastra S, 2017, BLOOD ADV, V1, P601, DOI 10.1182/bloodadvances.2017004358; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mahlakoiv T, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax0416; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; Mielke LA, 2013, J IMMUNOL, V191, P4383, DOI 10.4049/jimmunol.1301228; MURPHY WJ, 1992, P NATL ACAD SCI USA, V89, P4481, DOI 10.1073/pnas.89.10.4481; Ni F, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2484; Opiela SJ, 2009, BLOOD, V113, P5635, DOI 10.1182/blood-2008-08-173658; Paget C, 2013, MUCOSAL IMMUNOL, V6, P1054, DOI 10.1038/mi.2013.59; Park JY, 2019, CELL REP, V27, P2548, DOI 10.1016/j.celrep.2019.05.012; Rana BMJ, 2019, J EXP MED, V216, P1999, DOI 10.1084/jem.20190689; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinette ML, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14601; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Ruiz-Camp J, 2017, TRANSGENIC RES, V26, P165, DOI 10.1007/s11248-016-9987-8; Saluzzo S, 2017, CELL REP, V18, P1893, DOI 10.1016/j.celrep.2017.01.071; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schneider C, 2019, IMMUNITY, V50, P1425, DOI 10.1016/j.immuni.2019.04.019; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Short K, 2013, DEVELOPMENT, V140, P471, DOI 10.1242/dev.088500; Sitnicka E, 2002, IMMUNITY, V17, P463, DOI 10.1016/S1074-7613(02)00419-3; Song JM, 2010, CELL HOST MICROBE, V8, P369, DOI 10.1016/j.chom.2010.09.003; Soon L, 1999, MOL CELL BIOL, V19, P3816; Spadaro O, 2017, CELL REP, V19, P225, DOI 10.1016/j.celrep.2017.03.046; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]; Van Maele L, 2014, J INFECT DIS, V210, P493, DOI 10.1093/infdis/jiu106; von Burg N, 2014, P NATL ACAD SCI USA, V111, P12835, DOI 10.1073/pnas.1406908111; Vrijlandt EJLE, 2013, AM J RESP CRIT CARE, V187, P1234, DOI 10.1164/rccm.201211-2070OC; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walker JA, 2019, IMMUNITY, V51, P104, DOI 10.1016/j.immuni.2019.05.002; Warner BB, 1998, AM J PHYSIOL-LUNG C, V275, pL110, DOI 10.1152/ajplung.1998.275.1.L110; Whitsett JA, 2015, AM J RESP CELL MOL, V53, P1, DOI 10.1165/rcmb.2015-0128PS; Xiong HZ, 2016, CELL, V165, P679, DOI 10.1016/j.cell.2016.03.017; Xu W, 2019, IMMUNITY, V50, P1054, DOI 10.1016/j.immuni.2019.02.022; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yu XF, 2014, ELIFE, V3, DOI 10.7554/eLife.04406; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105	106	30	32	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 18	2020	52	2					275	+		10.1016/j.immuni.7020.01.005	http://dx.doi.org/10.1016/j.immuni.7020.01.005			29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN8FZ	32075728				2022-12-18	WOS:000515082000011
J	Wang, XH; Ni, L; Wan, SY; Zhao, XH; Ding, X; Dejean, A; Dong, C				Wang, Xiaohu; Ni, Lu; Wan, Siyuan; Zhao, Xiaohong; Ding, Xiao; Dejean, Anne; Dong, Chen			Febrile Temperature Critically Controls the Differentiation and Pathogenicity of T Helper 17 Cells	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; T(H)17 CELLS; R PACKAGE; FEVER; INDUCTION; HYPERTHERMIA; GENERATION; DEFICIENCY; PREVENTS; IMMUNITY	Fever, an evolutionarily conserved physiological response to infection, is also commonly associated with many autoimmune diseases, but its role in T cell differentiation and autoimmunity remains largely unclear. T helper 17 (Th17) cells are critical in host defense and autoinflammatory diseases, with distinct phenotypes and pathogenicity. Here, we show that febrile temperature selectively regulated Th17 cell differentiation in vitro in enhancing interleukin-17 (IL-17), IL-17F, and IL-22 expression. Th17 cells generated under febrile temperature (38.5 degrees C-39.5 degrees C), compared with those under 37 degrees C, showed enhanced pathogenic gene expression with increased pro-inflammatory activities in vivo. Mechanistically, febrile temperature promoted SUMOylation of SMAD4 transcription factor to facilitate its nuclear localization; SMAD4 deficiency selectively abrogated the effects of febrile temperature on Th17 cell differentiation both in vitro and ameliorated an autoimmune disease model. Our results thus demonstrate a critical role of fever in shaping adaptive immune responses with implications in autoimmune diseases.	[Wang, Xiaohu; Ni, Lu; Wan, Siyuan; Zhao, Xiaohong; Ding, Xiao; Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China; [Wang, Xiaohu; Ni, Lu; Wan, Siyuan; Zhao, Xiaohong; Ding, Xiao; Dong, Chen] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Dejean, Anne] Inst Pasteur, INSERM U993, Dept Cell Biol & Infect, Nucl Org & Oncogenesis Lab, F-75015 Paris, France; [Dong, Chen] Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Wang, XH (corresponding author), Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China.; Wang, XH (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.; Dong, C (corresponding author), Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China.	wangxhu@tsinghua.edu.cn; chendong@tsinghua.edu.cn	dong, chen/B-3181-2009; Dejean, Anne/L-5145-2018	dong, chen/0000-0002-0084-9130; 	National Key Research and Development Program of China [2016YFC0906200]; National Natural Science Foundation of China [31630022, 31991173, 31821003, 91642201, 31570884]; Beijing Municipal Commission of Science and Technology, China [Z181100001318007, Z181100006318015, Z171100000417005]; Beijing Natural Science Foundation, China [5172017]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commission of Science and Technology, China; Beijing Natural Science Foundation, China(Beijing Natural Science Foundation)	We thank all the Dong lab members for their help. This work was supported by grants from the National Key Research and Development Program of China (2016YFC0906200 to C.D.), the National Natural Science Foundation of China (31630022, 31991173, 31821003, and 91642201 to C.D.; 31570884 to X.W.), Beijing Municipal Commission of Science and Technology, China (Z181100001318007, Z181100006318015, and Z171100000417005 to C.D.), and Beijing Natural Science Foundation, China (5172017 to X.W.).	Bai XF, 2000, J CLIN INVEST, V105, P1227, DOI 10.1172/JCI9012; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Demarque MD, 2011, GASTROENTEROLOGY, V140, P286, DOI 10.1053/j.gastro.2010.10.002; Doi Y, 2008, P NATL ACAD SCI USA, V105, P8381, DOI 10.1073/pnas.0803454105; Eming SA, 2017, SCIENCE, V356, P1026, DOI 10.1126/science.aam7928; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Evans SS, 2015, NAT REV IMMUNOL, V15, P335, DOI 10.1038/nri3843; Evans SS, 2000, INT J HYPERTHER, V16, P45, DOI 10.1080/026567300285411; Evans SS, 2001, BLOOD, V97, P2727, DOI 10.1182/blood.V97.9.2727; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hahn JN, 2011, J CLIN INVEST, V121, P4030, DOI 10.1172/JCI45114; Hansen W, 2006, J IMMUNOL, V177, P209, DOI 10.4049/jimmunol.177.1.209; Hasday JD, 2014, COMPR PHYSIOL, V4, P109, DOI 10.1002/cphy.c130019; Hatzfeld-Charbonnier AS, 2007, J LEUKOCYTE BIOL, V81, P1179, DOI 10.1189/jlb.0506347; Jiang Y, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03852-2; Kleinewietfeld M, 2013, NATURE, V496, P518, DOI 10.1038/nature11868; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li P, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00460; Limper M, 2010, J INFECTION, V60, P409, DOI 10.1016/j.jinf.2010.03.016; Lin CD, 2019, IMMUNITY, V50, P137, DOI 10.1016/j.immuni.2018.11.013; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Mace TA, 2011, J LEUKOCYTE BIOL, V90, P951, DOI 10.1189/jlb.0511229; Malhotra N, 2010, J BIOL CHEM, V285, P29044, DOI 10.1074/jbc.C110.156745; Martinez GJ, 2010, J BIOL CHEM, V285, P29039, DOI 10.1074/jbc.C110.155820; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Miller DH, 2003, NEW ENGL J MED, V348, P15, DOI 10.1056/NEJMoa020696; Miyamoto K, 2006, BRAIN, V129, P1984, DOI 10.1093/brain/awl170; Mondal S, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar8278; Ni J, 2007, J NEUROIMMUNOL, V186, P94, DOI 10.1016/j.jneuroim.2007.03.012; Pasikhova Y, 2017, CANCER CONTROL, V24, P193, DOI 10.1177/107327481702400212; Reppert S, 2015, EUR J IMMUNOL, V45, P1426, DOI 10.1002/eji.201445150; Saitoh H, 2000, J BIOL CHEM, V275, P6252, DOI 10.1074/jbc.275.9.6252; Shang J, 2017, WIEN KLIN WOCHENSCHR, V129, P201, DOI 10.1007/s00508-016-1159-6; Singh IS, 2013, INT J HYPERTHER, V29, P423, DOI 10.3109/02656736.2013.808766; Stockinger B, 2017, NAT REV IMMUNOL, V17, P535, DOI 10.1038/nri.2017.50; Sugimoto N, 2006, INT IMMUNOL, V18, P1197, DOI 10.1093/intimm/dxl060; Tubridy N, 1999, NEUROLOGY, V53, P466, DOI 10.1212/WNL.53.3.466; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Wedepohl S, 2012, EUR J CELL BIOL, V91, P257, DOI 10.1016/j.ejcb.2011.02.007; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang S, 2018, IMMUNOLOGY, V155, P24, DOI 10.1111/imm.12938; Zhang S, 2017, NATURE, V551, P105, DOI 10.1038/nature24283; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu QY, 2017, ONCOL LETT, V13, P159, DOI 10.3892/ol.2016.5428	56	30	32	4	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 18	2020	52	2					328	+		10.1016/j.immuni.2020.01.006	http://dx.doi.org/10.1016/j.immuni.2020.01.006			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN8FZ	32049050	Bronze			2022-12-18	WOS:000515082000014
J	Tran, TM; Guha, R; Portugal, S; Skinner, J; Ongoiba, A; Bhardwaj, J; Jones, M; Moebius, J; Venepally, P; Doumbo, S; DeRiso, EA; Li, SP; Vijayan, K; Anzick, SL; Hart, GT; O'Connell, EM; Doumbo, OK; Kaushansky, A; Alter, G; Feigner, PL; Lorenzi, H; Kayentao, K; Traore, B; Kirkness, EF; Crompton, PD				Tran, Tuan M.; Guha, Rajan; Portugal, Silvia; Skinner, Jeff; Ongoiba, Aissata; Bhardwaj, Jyoti; Jones, Marcus; Moebius, Jacqueline; Venepally, Pratap; Doumbo, Safiatou; DeRiso, Elizabeth A.; Li, Shanping; Vijayan, Kamalakannan; Anzick, Sarah L.; Hart, Geoffrey T.; O'Connell, Elise M.; Doumbo, Ogobara K.; Kaushansky, Alexis; Alter, Galit; Feigner, Phillip L.; Lorenzi, Hernan; Kayentao, Kassoum; Traore, Boubacar; Kirkness, Ewen F.; Crompton, Peter D.			A Molecular Signature in Blood Reveals a Role for p53 in Regulating Malaria-Induced Inflammation	IMMUNITY			English	Article							GENE-EXPRESSION; ACQUIRED-IMMUNITY; T-CELLS; ASSOCIATION; INFECTION; RESISTANCE; SUPPRESSOR; PROTECTION; ANTIBODIES; PACKAGE	Immunity that controls parasitemia and inflammation during Plasmodium falciparum (Pt) malaria can be acquired with repeated infections. A limited understanding of this complex immune response impedes the development of vaccines and adjunctive therapies. We conducted a prospective systems biology study of children who differed in their ability to control parasitemia and fever following Pf infection. By integrating whole-blood transcriptomics, flow-cytometric analysis, and plasma cytokine and antibody profiles, we demonstrate that a preinfection signature of B cell enrichment, upregulation of T helper type 1 (Th1) and Th2 cell-associated pathways, including interferon responses, and p53 activation associated with control of malarial fever and coordinated with Pf-specific immunoglobulin G (IgG) and Fc receptor activation to control parasitemia. Our hypothesis-generating approach identified host molecules that may contribute to differential clinical outcomes during Pf infection. As a proof of concept, we have shown that enhanced p53 expression in monocytes attenuated Plasmodiuminduced inflammation and predicted protection from fever.	[Tran, Tuan M.; Guha, Rajan; Portugal, Silvia; Skinner, Jeff; Moebius, Jacqueline; Li, Shanping; Hart, Geoffrey T.; Crompton, Peter D.] NIAID, Malaria Infect Biol & Immun Sect, Lab Immunogenet, NIH, Rockville, MD 20852 USA; [Tran, Tuan M.; Bhardwaj, Jyoti] Indiana Univ, Sch Med, Dept Med, Div Infect Dis, Indianapolis, IN 46202 USA; [Tran, Tuan M.; Bhardwaj, Jyoti] Indiana Univ, Sch Med, Dept Pediat, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46202 USA; [Portugal, Silvia] Heidelberg Univ Hosp, Ctr Infect Dis Parasitol, D-69120 Heidelberg, Germany; [Ongoiba, Aissata; Doumbo, Safiatou; Doumbo, Ogobara K.; Kayentao, Kassoum; Traore, Boubacar] Univ Sci, Tech & Technol Bamako, Mali Int Ctr Excellence Res, BP 1805,Point G, Bamako, Mali; [Jones, Marcus; Venepally, Pratap; Kirkness, Ewen F.] J Craig Venter Inst, Genom Med Grp, Rockville, MD 20850 USA; [DeRiso, Elizabeth A.; Alter, Galit] MIT, Ragon Inst, Massachusetts Gen Hosp, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [DeRiso, Elizabeth A.; Alter, Galit] Harvard Univ, Cambridge, MA 02139 USA; [Vijayan, Kamalakannan; Kaushansky, Alexis] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98109 USA; [Anzick, Sarah L.] NIAID, Rocky Mt Labs, Genom Unit, NIH, Hamilton, MT 59840 USA; [Hart, Geoffrey T.] Univ Minnesota, Dept Med, Div Infect Dis & Int Med, Ctr Immunol, Box 736 UMHC, Minneapolis, MN 55455 USA; [O'Connell, Elise M.] NIAID, Lab Parasit Dis, NIH, Bethesda, MD 20892 USA; [Feigner, Phillip L.] Univ Calif Irvine, Sch Med, Div Infect Dis, Irvine, CA 92697 USA; [Lorenzi, Hernan] J Craig Venter Inst, Dept Infect Dis, Rockville, MD 20850 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Ruprecht Karls University Heidelberg; J. Craig Venter Institute; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Seattle Children's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Irvine; J. Craig Venter Institute	Tran, TM; Crompton, PD (corresponding author), NIAID, Malaria Infect Biol & Immun Sect, Lab Immunogenet, NIH, Rockville, MD 20852 USA.	tuantran@iu.edu; pcrompton@niaid.nih.gov	Guha, Rajan/AAH-7054-2021; DOUMBO, Safiatou/ABH-6825-2020; Guha, Rajan/AAK-3442-2021; BHARDWAJ, JYOTI/CAF-9753-2022; Tran, Tuan M./H-9439-2019	Guha, Rajan/0000-0003-0252-3721; Tran, Tuan M./0000-0002-1928-861X; Vijayan, Kamalakannan/0000-0002-0052-7780; Skinner, Jeff/0000-0001-5697-0442; BHARDWAJ, JYOTI/0000-0001-6578-8423	National Institute of Allergy and Infectious Diseases (NIAID), NIH, Department of Health and Human Services [HHSN272200900007C, U19AI110819]; Division of Intramural Research; NIAID [K08AI125682, U19AI089686, R01AI095916]; Doris Duke Charitable Foundation Clinical Scientist Development Award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI125682, R01AI095916, U19AI089686, U19AI110819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101183] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID), NIH, Department of Health and Human Services; Division of Intramural Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Doris Duke Charitable Foundation Clinical Scientist Development Award(American Heart AssociationDoris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the residents of Kalifabougou, Mali for participating in this study. This project was supported with federal funds from the National Institute of Allergy and Infectious Diseases (NIAID), NIH, Department of Health and Human Services under contract number HHSN272200900007C, award number U19AI110819, and the Division of Intramural Research. T.M.T. was also supported by K08AI125682 (NIAID) and the Doris Duke Charitable Foundation Clinical Scientist Development Award. Protein microarray experiments were funded by NIAID grants U19AI089686 and R01AI095916 (P.L.F.). Super p53 mice were kindly provided by David G. Kirsch (Duke University). Recombinant Pf antigens were kindly provided by David L. Narum (Laboratory of Malaria Immunology and Vaccinology, NIAID, NIH) and Gavin J. Wright (Wellcome Trust Sanger Institute).	Arora G, 2018, ELIFE, V7, DOI 10.7554/eLife.36806; Band G, 2015, NATURE, V526, P253, DOI 10.1038/nature15390; Bashirova AA, 2014, IMMUNOGENETICS, V66, P1, DOI 10.1007/s00251-013-0730-9; Becart S, 2007, J CLIN INVEST, V117, P2164, DOI 10.1172/JCI31640; Bediako Y, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1292-y; Boyle MJ, 2015, IMMUNITY, V42, P580, DOI 10.1016/j.immuni.2015.02.012; Brown EP, 2012, J IMMUNOL METHODS, V386, P117, DOI 10.1016/j.jim.2012.09.007; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Crompton PD, 2014, ANNU REV IMMUNOL, V32, P157, DOI 10.1146/annurev-immunol-032713-120220; D'Ombrain MC, 2008, CLIN INFECT DIS, V47, P1380, DOI 10.1086/592971; Dijsselbloem N, 2007, J IMMUNOL, V178, P5048, DOI 10.4049/jimmunol.178.8.5048; Doumbo S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003154; Drame PM, 2016, AM J TROP MED HYG, V94, P1301, DOI 10.4269/ajtmh.15-0746; Easton AV, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1314-y; Fischer M, 2017, ONCOGENE, V36, P3943, DOI 10.1038/onc.2016.502; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Griffiths MJ, 2005, J INFECT DIS, V191, P1599, DOI 10.1086/429297; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Hart GT, 2019, J EXP MED, V216, P1280, DOI 10.1084/jem.20181681; Idaghdour Y, 2012, P NATL ACAD SCI USA, V109, P16786, DOI 10.1073/pnas.1204945109; Jagannathan P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10624-3; Jagannathan P, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009793; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Kaushansky A, 2013, CELL REP, V3, P630, DOI 10.1016/j.celrep.2013.02.010; Keenan K, 2013, METHODS ECOL EVOL, V4, P782, DOI 10.1111/2041-210X.12067; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Komarova EA, 2005, FASEB J, V19, P1030, DOI 10.1096/fj.04-3213fje; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langhorne J, 2008, NAT IMMUNOL, V9, P725, DOI 10.1038/ni.f.205; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee HJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3619; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu G, 2009, J IMMUNOL, V182, P5063, DOI 10.4049/jimmunol.0803526; Madenspacher JH, 2013, J EXP MED, V210, P891, DOI 10.1084/jem.20121674; Nallandhighal S, 2019, J INFECT DIS, V219, P154, DOI 10.1093/infdis/jiy468; Neph S, 2012, CELL, V150, P1274, DOI 10.1016/j.cell.2012.04.040; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Obeng-Adjei N, 2015, CELL REP, V13, P425, DOI 10.1016/j.celrep.2015.09.004; Ockenhouse CF, 2006, INFECT IMMUN, V74, P5561, DOI 10.1128/IAI.00408-06; Ono T, 2007, EXP PARASITOL, V115, P310, DOI 10.1016/j.exppara.2006.09.008; Perez-Mazliah D, 2015, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00671; Portugal S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004079; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Robbiani DF, 2015, CELL, V162, P727, DOI 10.1016/j.cell.2015.07.019; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; SCHOLL PR, 1993, P NATL ACAD SCI USA, V90, P8847, DOI 10.1073/pnas.90.19.8847; Sergushichev A., 2016, ALGORITHM FAST PRERA, DOI [10.1101/060012, DOI 10.1101/060012]; Shaukat AM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-207; Smit AFA, 2015, REPEATMASKER OPEN 4; Stanisic DI, 2014, J INFECT DIS, V210, P295, DOI 10.1093/infdis/jiu083; Stroncek DF, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0241-y; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tanaka Y, 2003, IMMUNITY, V18, P403, DOI 10.1016/S1074-7613(03)00054-2; Timmann C, 2012, NATURE, V489, P443, DOI 10.1038/nature11334; Tran TM, 2016, SCI REP-UK, V6, DOI 10.1038/srep31291; Tran TM, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-393; Tran TM, 2013, CLIN INFECT DIS, V57, P40, DOI 10.1093/cid/cit174; Trani TM, 2012, TRENDS PARASITOL, V28, P248, DOI 10.1016/j.pt.2012.03.006; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Weiner J, 2016, PEERJ PREPRINTS, V4, DOI 10.7287/peerj.preprints.2420v1; WHO, 2018, WORLD MAL REP 2018; Wu D, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks461; Yamagishi J, 2014, GENOME RES, V24, P1433, DOI 10.1101/gr.158980.113; Zheng SJ, 2005, DIABETES, V54, P1423, DOI 10.2337/diabetes.54.5.1423	71	30	31	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					750	+		10.1016/j.immuni.2019.08.009	http://dx.doi.org/10.1016/j.immuni.2019.08.009			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31492649	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000490141700019
J	Liu, SS; Lv, XX; Liu, C; Qi, J; Li, YX; Wei, XP; Li, K; Hua, F; Cui, B; Zhang, XW; Yu, JJ; Yu, JM; Wang, F; Shang, S; Zhao, CX; Hou, XY; Yao, ZG; Li, PP; Li, X; Huang, B; Hu, ZW				Liu, Shan-shan; Lv, Xiao-xi; Liu, Chang; Qi, Jie; Li, Yun-xuan; Wei, Xu-peng; Li, Ke; Hua, Fang; Cui, Bing; Zhang, Xiao-wei; Yu, Jiao-jiao; Yu, Jin-mei; Wang, Feng; Shang, Shuang; Zhao, Chen-xi; Hou, Xue-ying; Yao, Zhi-gang; Li, Ping-ping; Li, Xia; Huang, Bo; Hu, Zhuo-wei			Targeting Degradation of the Transcription Factor C/EBP beta Reduces Lung Fibrosis by Restoring Activity of the Ubiquitin-Editing Enzyme A20 in Macrophages	IMMUNITY			English	Article							NF-KAPPA-B; PULMONARY-FIBROSIS; ALTERNATIVE ACTIVATION; INFLAMMATION; POLARIZATION; EXPRESSION; ALPHA; RESOLUTION; INHIBITION; REGULATOR	Although recent progress provides mechanistic insights into the pathogenesis of pulmonary fibrosis (PF), rare anti-PF therapeutics show definitive promise for treating this disease. Repeated lung epithelial injury results in injury-repairing response and inflammation, which drive the development of PF. Here, we report that chronic lung injury inactivated the ubiquitin-editing enzyme A20, causing progressive accumulation of the transcription factor C/EBP beta in alveolar macrophages (AMs) from PF patients and mice, which upregulated a number of immunosuppressive and profibrotic factors promoting PF development. In response to chronic lung injury, elevated glycogen synthase kinase-3 beta (GSK-3 beta) interacted with and phosphorylated A20 to suppress C/EBP beta degradation. Ectopic expression of A20 or pharmacological restoration of A20 activity by disturbing the A20-GSK-3 beta interaction accelerated C/EBP beta degradation and showed potent therapeutic efficacy against experimental PF. Our study indicates that a regulatory mechanism of the GSK-3 beta-A20-C/EBP beta axis in AMs may be a potential target for treating PF and fibroproliferative lung diseases.	[Liu, Shan-shan; Lv, Xiao-xi; Liu, Chang; Li, Yun-xuan; Hua, Fang; Cui, Bing; Zhang, Xiao-wei; Yu, Jiao-jiao; Yu, Jin-mei; Wang, Feng; Shang, Shuang; Zhao, Chen-xi; Hou, Xue-ying; Li, Ping-ping; Hu, Zhuo-wei] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Mol Immunol & Pharmacol Grp, Beijing 100050, Peoples R China; [Liu, Shan-shan; Lv, Xiao-xi; Liu, Chang; Li, Yun-xuan; Li, Ke; Hua, Fang; Cui, Bing; Zhang, Xiao-wei; Yu, Jiao-jiao; Yu, Jin-mei; Wang, Feng; Shang, Shuang; Zhao, Chen-xi; Hou, Xue-ying; Li, Ping-ping; Hu, Zhuo-wei] Peking Union Med Coll, Beijing 100050, Peoples R China; [Qi, Jie; Li, Xia] Shandong Univ, Marine Coll, Dept Pharm, Weihai 264209, Peoples R China; [Wei, Xu-peng] Hebei Univ, Pharm Coll, Dept Pharm, Baoding 071000, Peoples R China; [Li, Ke] Chinese Acad Med Sci, Inst Med Biotechnol, NHC Key Lab Biotechnol Antibiot, Beijing 100050, Peoples R China; [Yao, Zhi-gang] Capital Med Univ, Beijing Friendship Hosp, Dept Resp Med, Beijing 100050, Peoples R China; [Huang, Bo] Chinese Acad Med Sci, Inst Basic Med, Dept Immunol, Beijing 100005, Peoples R China; [Huang, Bo] Chinese Acad Med Sci, Inst Basic Med, Natl Key Lab Med Mol Biol, Beijing 100005, Peoples R China; [Huang, Bo] Peking Union Med Coll, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Shandong University; Hebei University; Chinese Academy of Medical Sciences - Peking Union Medical College; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Hu, ZW (corresponding author), Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Mol Immunol & Pharmacol Grp, Beijing 100050, Peoples R China.; Hu, ZW (corresponding author), Peking Union Med Coll, Beijing 100050, Peoples R China.	huzhuowei@imm.ac.cn	Cui, Bing/F-3599-2018; Li, Ping/GYV-4914-2022	Cui, Bing/0000-0001-8374-7801; 	National Key R&D Program of China [2017YFA0205400]; National Natural Science Foundation of China [81530093, 81773781, 81803604, 81503128, 81622010, 81770800]; Chinese Academy of Medical Sciences (CAMS) Central Public-Interest Scientific Institution Basal Research Fund (Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, CAMS Key Lab) [2017PT31046]; CAMS Innovation Fund for Medical Sciences [2016-I2M-1-007, 2016-I2M-1-008, 2016-I2M-1-010, 2016-I2M-3-008, 2016-I2M-1011, 2016-I2M-4-001]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Sciences (CAMS) Central Public-Interest Scientific Institution Basal Research Fund (Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, CAMS Key Lab); CAMS Innovation Fund for Medical Sciences	This work was supported by grants from the National Key R&D Program of China (2017YFA0205400), the National Natural Science Foundation of China (81530093 and 81773781 to Z.-W. H., 81803604 to S.-S. L., 81503128 to X.-X. L., and 81622010 and 81770800 to P.-P. L.), the Chinese Academy of Medical Sciences (CAMS) Central Public-Interest Scientific Institution Basal Research Fund (2017PT31046, Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, CAMS Key Lab), and the CAMS Innovation Fund for Medical Sciences (2016-I2M-1-007 to Z.-W.H., F.H., C.-X.Z., and B.H.; 2016-I2M-1-008 to X.-X.L.; 2016-I2M-1-010 to X.-W.Z.; 2016-I2M-3-008 to B.C., J.-J.Y., S.-S.L., J.-M.Y., and X.-Y.H.; 2016-I2M-1011 to K.L.; and 2016-I2M-4-001 to P.-P.L.).	Cao ZW, 2016, NAT MED, V22, P154, DOI 10.1038/nm.4035; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Fu DC, 2015, J BIOL CHEM, V290, P10200, DOI 10.1074/jbc.M115.638577; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; He C, 2013, J BIOL CHEM, V288, P20745, DOI 10.1074/jbc.M112.410720; Hua F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8951; Huang H, 2010, HYPERTENSION, V56, P232, DOI 10.1161/HYPERTENSIONAHA.110.149963; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Jung SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3562; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/expphysiol.2010.053793, 10.1113/jphysiol.2010.192278]; Kulathu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2567; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Lee SH, 2014, EXP LUNG RES, V40, P117, DOI 10.3109/01902148.2014.881930; Li K, 2014, INT J CANCER, V134, P692, DOI 10.1002/ijc.28382; Lv XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063516; Ma A, 2012, NAT REV IMMUNOL, V12, P774, DOI 10.1038/nri3313; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Maelfait J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005410; Malcomson B, 2016, P NATL ACAD SCI USA, V113, pE3725, DOI 10.1073/pnas.1520289113; McCubbrey AL, 2018, AM J RESP CELL MOL, V58, P66, DOI 10.1165/rcmb.2017-0154OC; McQuattie-Pimentel AC, 2018, AM J RESP CELL MOL, V58, P5, DOI 10.1165/rcmb.2017-0328ED; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Mora AL, 2006, AM J RESP CELL MOL, V35, P466, DOI 10.1165/rcmb.2006-0121OC; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Osborn-Heaford HL, 2015, FREE RADICAL BIO MED, V86, P47, DOI 10.1016/j.freeradbiomed.2015.04.031; Pardo A, 2016, ANN AM THORAC SOC, V13, pS417, DOI 10.1513/AnnalsATS.201605-341AW; Putman RK, 2016, JAMA-J AM MED ASSOC, V315, P672, DOI 10.1001/jama.2016.0518; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Richeldi L, 2017, LANCET, V389, P1941, DOI 10.1016/S0140-6736(17)30866-8; Rodriguez MS, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.366; Ruffell D, 2009, P NATL ACAD SCI USA, V106, P17475, DOI 10.1073/pnas.0908641106; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Shrikhande GV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014240; Spagnolo P, 2017, LANCET RESP MED, V5, P372, DOI 10.1016/S2213-2600(17)30122-4; Toda M, 2018, J CLIN BIOCHEM NUTR, V63, P58, DOI 10.3164/jcbn.17-111; Vande Walle L, 2014, NATURE, V512, P69, DOI 10.1038/nature13322; Wang XH, 2017, INFLAMMATION, V40, P840, DOI 10.1007/s10753-017-0528-2; Wang Y, 2017, MOL MED REP, V16, P4964, DOI 10.3892/mmr.2017.7184; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2015, NATURE, V528, P370, DOI 10.1038/nature16165; Wollin L, 2015, EUR RESPIR J, V45, P1434, DOI 10.1183/09031936.00174914; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Yang HZ, 2012, AM J PATHOL, V180, P275, DOI 10.1016/j.ajpath.2011.09.019; Ye S, 2012, J BIOL CHEM, V287, P26740, DOI 10.1074/jbc.M112.383265; Yuk JM, 2015, IMMUNITY, V43, P80, DOI 10.1016/j.immuni.2015.07.003; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459	46	30	34	6	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					522	+		10.1016/j.immuni.2019.06.014	http://dx.doi.org/10.1016/j.immuni.2019.06.014			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31471107	Bronze			2022-12-18	WOS:000486184600014
J	Adoue, V; Binet, B; Malbec, A; Fourquet, J; Romagnoli, P; van Meerwijk, JPM; Amigorena, S; Joffre, OP				Adoue, Veronigue; Binet, Benedicte; Malbec, Agathe; Fourquet, Joanna; Romagnoli, Paola; van Meerwijk, Joost P. M.; Amigorena, Sebastian; Joffre, Olivier P.			The Histone Methyltransferase SETDB1 Controls T Helper Cell Lineage Integrity by Repressing Endogenous Retroviruses	IMMUNITY			English	Article							H3 LYSINE-9 METHYLATION; ENRICHMENT ANALYSIS; EPIGENETIC CONTROL; EXPRESSION; ELEMENTS; TRANSCRIPTION; CONTRIBUTES; COMMITMENT; LANDSCAPE; HP1-GAMMA	Upon activation, naive CD4(+) T cells differentiate into distinct T cell subsets via processes reliant on epige-netically regulated, lineage-specific developmental programs. Here, we examined the function of the histone methyltransferase SETDB1 in T helper (Th) cell differentiation. Setdb1(-/-) naive CD4(+) T cells exhibited exacerbated Th1 priming, and when exposed to a Th1-instructive signal, Setdb1(-/-) Th2 cells crossed lineage boundaries and acquired a Th1 phenotype. SETDB1 did not directly control Th1 gene promoter activity but relied instead on deposition of the repressive H3K9me3 mark at a restricted and cell-type-specific set of endogenous retroviruses (ERVs) located in the vicinity of genes involved in immune processes. Refined bioinformatic analyses suggest that these retrotransposons regulate Th1 gene cis-regulatory elements or act as Th1 gene enhancers. Thus, H3K9me3 deposition by SETDB1 ensures Th cell lineage integrity by repressing a repertoire of ERVs that have been exapted into cis-regulatory modules to shape and control the Th1 gene network.	[Adoue, Veronigue; Binet, Benedicte; Malbec, Agathe; Fourquet, Joanna; Romagnoli, Paola; van Meerwijk, Joost P. M.; Joffre, Olivier P.] Univ Paul Sabatier Toulouse III, INSERM, CNRS, Ctr Physiopathol Toulouse Purpan, Toulouse, France; [Amigorena, Sebastian] Inst Curie, Ctr Rech, F-75005 Paris, France; [Amigorena, Sebastian] INSERM, U932, F-75005 Paris, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite	Adoue, V; Joffre, OP (corresponding author), Univ Paul Sabatier Toulouse III, INSERM, CNRS, Ctr Physiopathol Toulouse Purpan, Toulouse, France.	veronique.adoue@inserm.fr; olivier.joffre@inserm.fr	Fourquet, Joanna/AAH-1883-2021; van Meerwijk, Joost P.M./K-1345-2014; Joffre, Olivier P/K-1235-2014	van Meerwijk, Joost P.M./0000-0001-8231-1897; Joffre, Olivier P/0000-0003-1168-8165; Adoue, Veronique/0000-0003-3548-7456	Agence Nationale de la Recherche JCJC ''EpiTreg'' [ANR-14-CE14-0021-01]; Region Occitanie NVEQ 2014; Fondation pour la Recherche Medicale (FRM) [AJE201212]; Association pour la Recherche sur le Cancer (ARC) [DOC20160604329]; Region Midi-Pyrenees; FRM [FDT20170437348]	Agence Nationale de la Recherche JCJC ''EpiTreg''; Region Occitanie NVEQ 2014; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Association pour la Recherche sur le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Region Midi-Pyrenees(Region OccitanieRegion Provence-Alpes-Cote d'Azur); FRM(Fondation pour la Recherche Medicale)	We greatly acknowledge T. Jenuwein (Max Planck Institute, Freiburg, Germany) for providing the Suv39h1-deficient mice. We also thank F.-E. L'Faqihi-Olive, V. Duplan-Eche, and A.-L. Iscache for technical assistance at the flow-cytometry facility of INSERM U1043, the personnel of the US006 ANEXPLO/CREFRE animal facility for expert animal care, and D. Rozet for administrative assistance. We are grateful to the GeT and Bioinformatics platforms from Genotoul (Toulouse, Region Occitanie, France) and to the Transcriptomic & Genomic Platform Marseille Luminy (Marseille, France) for providing sequencing, computing, and storage resources. We acknowledge M. Lebeurrier for bioinformatic analysis at the Genomic and Transcriptomic platform from the Center for Physiopathology of Toulouse Purpan (Toulouse, Region Occitanie, France). We are also grateful to members of the T-Cell-Mediated Immune Tolerance laboratory for advice and discussions. We would like to thank D. Dunia for his careful reading of the manuscript. This work was supported by Agence Nationale de la Recherche JCJC ''EpiTreg'' (ANR-14-CE14-0021-01) to O.P.J., Region Occitanie NVEQ 2014 to O.P.J., and Fondation pour la Recherche Medicale (FRM) AJE201212 to O.P.J. B.B. was funded by a fellowship from the Association pour la Recherche sur le Cancer (ARC, DOC20160604329). A.M. was supported by fellowships from the Region Midi-Pyrenees and FRM (FDT20170437348).	Akalin A, 2015, BIOINFORMATICS, V31, P1127, DOI 10.1093/bioinformatics/btu775; Allan RS, 2012, NATURE, V487, P249, DOI 10.1038/nature11173; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Bulut-Karslioglu A, 2014, MOL CELL, V55, P277, DOI 10.1016/j.molcel.2014.05.029; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Chuong EB, 2016, SCIENCE, V351, P1083, DOI 10.1126/science.aad5497; Collins PL, 2015, P NATL ACAD SCI USA, V112, P8367, DOI 10.1073/pnas.1422187112; Goke J, 2015, CELL STEM CELL, V16, P135, DOI 10.1016/j.stem.2015.01.005; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Ihaka R, 2012, J COMPUT GRAPH STAT, V5, P299; Imbeault M, 2017, NATURE, V543, P550, DOI 10.1038/nature21683; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu J, 2015, J NEUROSCI, V35, P352, DOI 10.1523/JNEUROSCI.2606-14.2015; Loyola A, 2009, EMBO REP, V10, P769, DOI 10.1038/embor.2009.90; Lun ATL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1191; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Matsui T, 2010, NATURE, V464, P927, DOI 10.1038/nature08858; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McLeay RC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-165; Mozzetta C, 2015, NAT REV MOL CELL BIO, V16, P499, DOI 10.1038/nrm4029; O'Shea JJ, 2011, NAT REV IMMUNOL, V11, P239, DOI 10.1038/nri2958; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Rebollo R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002301; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Saint-Andre V, 2011, NAT STRUCT MOL BIOL, V18, P337, DOI 10.1038/nsmb.1995; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Xiao X, 2016, IMMUNITY, V44, P1271, DOI 10.1016/j.immuni.2016.05.013; YOUNG HA, 1994, J IMMUNOL, V153, P3603; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu YN, 2012, MOL CELL, V46, P408, DOI 10.1016/j.molcel.2012.05.011	51	30	32	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					629	+		10.1016/j.immuni.2019.01.003	http://dx.doi.org/10.1016/j.immuni.2019.01.003			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30737147	Green Published, Bronze			2022-12-18	WOS:000461660500014
J	Postat, J; Olekhnovitch, R; Lemaitre, F; Bousso, P				Postat, Jeremy; Olekhnovitch, Romain; Lemaitre, Fabrice; Bousso, Philippe			A Metabolism-Based Quorum Sensing Mechanism Contributes to Termination of Inflammatory Responses	IMMUNITY			English	Article							NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; IN-VIVO; SUCCINATE-DEHYDROGENASE; LEISHMANIA-MAJOR; DENDRITIC CELLS; MITOCHONDRIAL RESPIRATION; CYTOKINE PRODUCTION; MICE; INFECTION	Recruitment of immune cells with antimicrobial activities is essential to fight local infections but has the potential to trigger immunopathology. Whether the immune system has the ability to sense inflammation intensity and self-adjust accordingly to limit tissue damage remains to be fully established. During local infection with an intracellular pathogen, we have shown that nitric oxide (NO) produced by recruited monocyte-derived cells was essential to limit inflammation and cell recruitment. Mechanistically, we have provided evidence that NO dampened monocyte-derived cell cytokine and chemokine production by inhibiting cellular respiration and reducing cellular ATP: ADP ratio. Such metabolic control operated at the tissue level but only when a sufficient number of NO-producing cells reached the site of infection. Thus, NO production and activity act as a quorum sensing mechanism to help terminate the inflammatory response.	[Postat, Jeremy; Olekhnovitch, Romain; Lemaitre, Fabrice; Bousso, Philippe] Inst Pasteur, Dynam Immune Responses Unit, F-75015 Paris, France; [Postat, Jeremy; Olekhnovitch, Romain; Lemaitre, Fabrice; Bousso, Philippe] INSERM, U1223, F-75015 Paris, France; [Postat, Jeremy; Olekhnovitch, Romain] Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, Rue Dr Roux, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Bousso, P (corresponding author), Inst Pasteur, Dynam Immune Responses Unit, F-75015 Paris, France.; Bousso, P (corresponding author), INSERM, U1223, F-75015 Paris, France.	philippe.bousso@pasteur.fr	BOUSSO, Philippe/M-6547-2014; Postat, Jérémy/AAC-1762-2019	BOUSSO, Philippe/0000-0002-6362-561X; Postat, Jérémy/0000-0001-8875-631X	Technology Core of the Center for Translational Science (CRT) at Institut Pasteur; Institut Pasteur, Inserm; Starting (Lymphocytecontact) from the European Research Council; Advanced Grant (ENLIGHTEN) from the European Research Council	Technology Core of the Center for Translational Science (CRT) at Institut Pasteur; Institut Pasteur, Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)); Starting (Lymphocytecontact) from the European Research Council; Advanced Grant (ENLIGHTEN) from the European Research Council	We thank C. Demangel and members of the Bousso laboratory for critical review of the manuscript. We acknowledge the mouse facility and the Technology Core of the Center for Translational Science (CRT) at Institut Pasteur for support in conducting this study and the specific contribution of B. Charbit, T. Stephen, S. Novault, and S. Schmutz. The work was supported by Institut Pasteur, Inserm, and by a Starting (Lymphocytecontact) and an Advanced Grant (ENLIGHTEN) from the European Research Council.	Amiel E, 2014, J IMMUNOL, V193, P2821, DOI 10.4049/jimmunol.1302498; Bagaitkar J, 2015, BLOOD, V126, P2724, DOI 10.1182/blood-2015-05-644773; Banick PD, 1997, J CELL PHYSIOL, V172, P12, DOI 10.1002/(SICI)1097-4652(199707)172:1<12::AID-JCP2>3.0.CO;2-G; Belkaid Y, 2000, J IMMUNOL, V165, P969, DOI 10.4049/jimmunol.165.2.969; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Braverman J, 2017, J IMMUNOL, V199, P1805, DOI 10.4049/jimmunol.1700515; Brown GC, 1999, BBA-BIOENERGETICS, V1411, P351, DOI 10.1016/S0005-2728(99)00025-0; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Burnett SH, 2004, J LEUKOCYTE BIOL, V75, P612, DOI 10.1189/jlb.0903442; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; Dal-Secco D, 2015, J EXP MED, V212, P447, DOI 10.1084/jem.20141539; De Trez C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000494; EIGLER A, 1995, J IMMUNOL, V154, P4048; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Giustizieri ML, 2002, AM J PATHOL, V161, P1409, DOI 10.1016/S0002-9440(10)64416-1; Harbort CJ, 2015, BLOOD, V126, P2842, DOI 10.1182/blood-2015-05-645424; Kobayashi Y, 2010, J LEUKOCYTE BIOL, V88, P1157, DOI 10.1189/jlb.0310149; KOMURO K, 1975, IMMUNOGENETICS, V1, P452; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; KUBES P, 1991, P NATL ACAD SCI USA, V88, P4651, DOI 10.1073/pnas.88.11.4651; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; LAUBACH VE, 1995, P NATL ACAD SCI USA, V92, P10688, DOI 10.1073/pnas.92.23.10688; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; LIEW FY, 1990, J IMMUNOL, V144, P4794; Lu GM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7676; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Mishra BB, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.72; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Misslitz A, 2000, MOL BIOCHEM PARASIT, V107, P251, DOI 10.1016/S0166-6851(00)00195-X; Morgenstern DE, 1997, J EXP MED, V185, P207, DOI 10.1084/jem.185.2.207; Muller AJ, 2013, CELL HOST MICROBE, V14, P460, DOI 10.1016/j.chom.2013.09.008; Na YR, 2018, CANCER LETT, V413, P46, DOI 10.1016/j.canlet.2017.10.044; Olekhnovitch R, 2015, TRENDS PARASITOL, V31, P653, DOI 10.1016/j.pt.2015.08.001; Olekhnovitch R, 2014, J CLIN INVEST, V124, P1711, DOI 10.1172/JCI72058; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Sancho D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00527; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Sorensen M, 2003, FEBS LETT, V552, P110, DOI 10.1016/S0014-5793(03)00856-1; Speyer CL, 2003, AM J PATHOL, V163, P2319, DOI 10.1016/S0002-9440(10)63588-2; Sugimoto MA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00160; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tantama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3550; Thomassen MJ, 1997, AM J RESP CELL MOL, V17, P279, DOI 10.1165/ajrcmb.17.3.2998m; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Van den Bossche J, 2016, CELL REP, V17, P684, DOI 10.1016/j.celrep.2016.09.008; Warnatsch A, 2017, IMMUNITY, V46, P421, DOI 10.1016/j.immuni.2017.02.013; WEI XQ, 1995, NATURE, V375, P408, DOI 10.1038/375408a0	59	30	31	4	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					654	+		10.1016/j.immuni.2018.07.014	http://dx.doi.org/10.1016/j.immuni.2018.07.014			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30266340	Green Submitted, Bronze			2022-12-18	WOS:000447386700012
J	Diefenbach, A; Colonna, M; Romagnani, C				Diefenbach, Andreas; Colonna, Marco; Romagnani, Chiara			The ILC World Revisited	IMMUNITY			English	News Item							INNATE LYMPHOID-CELLS		[Diefenbach, Andreas] Charite Univ Med Ctr Berlin, Inst Microbiol, Hindenburgdamm 27, D-12203 Berlin, Germany; [Diefenbach, Andreas; Romagnani, Chiara] German Rheumatism Res Ctr, Charitepl 1, D-10117 Berlin, Germany; [Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA; [Romagnani, Chiara] Charite Univ Med Ctr Berlin, Dept Med 1, Hindenburgdamm 30, D-12203 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Washington University (WUSTL); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Diefenbach, A (corresponding author), Charite Univ Med Ctr Berlin, Inst Microbiol, Hindenburgdamm 27, D-12203 Berlin, Germany.; Diefenbach, A; Romagnani, C (corresponding author), German Rheumatism Res Ctr, Charitepl 1, D-10117 Berlin, Germany.; Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63108 USA.; Romagnani, C (corresponding author), Charite Univ Med Ctr Berlin, Dept Med 1, Hindenburgdamm 30, D-12203 Berlin, Germany.	andreas.diefenbach@charite.de; mcolonna@wustl.edu; romagnani@drfz.de	Diefenbach, Andreas/T-2589-2018; Romagnani, Chiara/E-4708-2016	Diefenbach, Andreas/0000-0002-9176-9530; Romagnani, Chiara/0000-0002-5167-7463	European Molecular Biology Organization; Deutsche Forschungsgemeinschaft; European Federation of Immunological Societies	European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Federation of Immunological Societies	We thank the other speakers, including I. Amit, D. Artis, Y. Belkaid, G. Belz, A. Bendelac, A. Chawla, J. Di Santo, G. Eberl, D. Finke, A. Hanash, L. Hooper, Y. Huang, B. Kee, S. Koyasu, D. Littman, P. Liu, R. Locksley, B. Ludewig, G. Sonnenberg, H. Spits, J. Sun, H. Veiga-Fernandes, and E. Vivier, together with the participants of the 2nd EMBO Conference on Innate Lymphoid Cells, for sharing largely unpublished data and for the lively discussions. We gratefully acknowledge the help of T. Durez, J. Hirscher, and K. Moser in organizing the meeting. We thank the members of the Romagnani and Diefenbach laboratories for their help during the meeting. This meeting was supported by generous grants from the European Molecular Biology Organization, the Deutsche Forschungsgemeinschaft, and the European Federation of Immunological Societies.	Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; O'Sullivan TE, 2016, IMMUNITY, V45, P428, DOI 10.1016/j.immuni.2016.06.016; Seillet C, 2016, CELL REP, V17, P436, DOI 10.1016/j.celrep.2016.09.025; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Withers DR, 2016, NAT MED, V22, P319, DOI 10.1038/nm.4046	9	30	32	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2017	46	3					327	332		10.1016/j.immuni.2017.03.008	http://dx.doi.org/10.1016/j.immuni.2017.03.008			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6QR	28329694	Bronze			2022-12-18	WOS:000396818100001
J	Lu, Y; Biancotto, A; Cheung, F; Remmers, E; Shah, N; McCoy, JP; Tsang, JS				Lu, Yong; Biancotto, Angelique; Cheung, Foo; Remmers, Elaine; Shah, Naisha; McCoy, J. Philip; Tsang, John S.			Systematic Analysis of Cell-to-Cell Expression Variation of T Lymphocytes in a Human Cohort Identifies Aging and Genetic Associations	IMMUNITY			English	Article							FLOW-CYTOMETRY; IMMUNE; HETEROGENEITY; ARCHITECTURE; VARIABILITY; CCR7; MACROPHAGES; POPULATIONS; RESPONSES; RESOURCE	Cell-to-cell expression variation (CEV) is a prevalent feature of even well-defined cell populations, but its functions, particularly at the organismal level, are not well understood. Using single-cell data obtained via high-dimensional flow cytometry of T cells as a model, we introduce an analysis framework for quantifying CEV in primary cell populations and studying its functional associations in human cohorts. Analyses of 840 CEV phenotypes spanning multiple baseline measurements of 14 proteins in 28 T cell subpopulations suggest that the quantitative extent of CEV can exhibit substantial subject-to-subject differences and yet remain stable within healthy individuals over months. We linked CEV to age and disease-associated genetic polymorphisms, thus implicating CEV as a biomarker of aging and disease susceptibility and suggesting that it might play an important role in health and disease. Our dataset, interactive figures, and software for computing CEV with flow cytometry data provide a resource for exploring CEV functions.	[Lu, Yong; Shah, Naisha; Tsang, John S.] NIAID, Syst Genom & Bioinformat Unit, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Biancotto, Angelique; Cheung, Foo; McCoy, J. Philip; Tsang, John S.] NIH, Trans NIH Ctr Human Immunol Autoimmun & Inflammat, Bethesda, MD 20892 USA; [Remmers, Elaine] NHGRI, NIH, Bethesda, MD 20892 USA; [McCoy, J. Philip] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Tsang, JS (corresponding author), NIAID, Syst Genom & Bioinformat Unit, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Tsang, JS (corresponding author), NIH, Trans NIH Ctr Human Immunol Autoimmun & Inflammat, Bethesda, MD 20892 USA.	john.tsang@nih.gov	mccoy, john philip/ABD-9348-2021; biancotto, angelique/C-4632-2011	biancotto, angelique/0000-0003-2271-009X; Remmers, Elaine F/0000-0002-9522-1249	intramural program of the NIAID; NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL005905] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001152] Funding Source: NIH RePORTER	intramural program of the NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Adrian Wiestner for providing healthy samples for age-association validation; Candace Liu for help with figures and software testing; Pamela Schwartzberg, Nicolas van Panhuys, and Ronald Germain for comments on the manuscript; and members of the J.S.T. lab and the Trans-NIH Center for Human Immunology (CHI) for discussions. This work was funded by the intramural program of the NIAID and of NIH institutes supporting the CHI.	Acar M, 2008, NAT GENET, V40, P471, DOI 10.1038/ng.110; Agius E, 2009, J EXP MED, V206, P1929, DOI 10.1084/jem.20090896; Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Ansel J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000049; Antebi YE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001616; Arkin A, 1998, GENETICS, V149, P1633; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1; Biancotto A, 2012, MODERN PATHOL, V25, P246, DOI 10.1038/modpathol.2011.164; Biancotto A, 2011, J IMMUNOL METHODS, V363, P245, DOI 10.1016/j.jim.2010.06.010; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537; Duraisingham SS, 2013, CURR TOP MICROBIOL, V363, P117, DOI 10.1007/82_2012_250; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Germain RN, 2011, NAT IMMUNOL, V12, P369, DOI 10.1038/ni0511-369; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; HARTIGAN JA, 1985, ANN STAT, V13, P70, DOI 10.1214/aos/1176346577; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hulse AM, 2013, GENETICS, V193, P95, DOI 10.1534/genetics.112.146779; Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Mehta K, 1996, FASEB J, V10, P1408, DOI 10.1096/fasebj.10.12.8903511; Menning A, 2007, EUR J IMMUNOL, V37, P1575, DOI 10.1002/eji.200737201; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785; Orru V, 2013, CELL, V155, P242, DOI 10.1016/j.cell.2013.08.041; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj T, 2014, SCIENCE, V344, P519, DOI 10.1126/science.1249547; Rebhahn JA, 2014, EUR J IMMUNOL, V44, P2216, DOI 10.1002/eji.201444645; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Sakaguchi S, 2005, NAT IMMUNOL, V6, P345, DOI 10.1038/ni1178; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Satija R, 2014, TRENDS IMMUNOL, V35, P219, DOI 10.1016/j.it.2014.03.004; Scalzo-Inguanti K, 2011, EUR J IMMUNOL, V41, P1298, DOI 10.1002/eji.201040726; Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589; Schneider MA, 2007, J EXP MED, V204, P735, DOI 10.1084/jem.20061405; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Spidlen J, 2012, CYTOM PART A, V81A, P727, DOI 10.1002/cyto.a.22106; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; Suzuki M, 2012, J IMMUNOL, V189, P2118, DOI 10.4049/jimmunol.1200122; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Triplett TA, 2012, EUR J IMMUNOL, V42, P1893, DOI 10.1002/eji.201242444; Tsang JS, 2015, TRENDS IMMUNOL, V36, P479, DOI 10.1016/j.it.2015.06.005; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Vu V, 2015, CELL, V162, P391, DOI 10.1016/j.cell.2015.06.037; Welter D, 2014, NUCLEIC ACIDS RES, V42, pD1001, DOI 10.1093/nar/gkt1229; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Ye CJ, 2014, SCIENCE, V345, P1311, DOI 10.1126/science.1254665	57	30	30	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					1162	1175		10.1016/j.immuni.2016.10.025	http://dx.doi.org/10.1016/j.immuni.2016.10.025			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851916	Green Accepted, Bronze			2022-12-18	WOS:000389473500024
J	Kumamoto, Y; Camporez, JPG; Jurczak, MJ; Shanabrough, M; Horvath, T; Shulman, GI; Iwasaki, A				Kumamoto, Yosuke; Camporez, Joao Paulo G.; Jurczak, Michael J.; Shanabrough, Marya; Horvath, Tamas; Shulman, Gerald I.; Iwasaki, Akiko			CD301b(+) Mononuclear Phagocytes Maintain Positive Energy Balance through Secretion of Resistin-like Molecule Alpha	IMMUNITY			English	Article							KILLER T-CELLS; ALTERNATIVELY ACTIVATED MACROPHAGES; INDUCED INSULIN-RESISTANCE; ADIPOSE-TISSUE MACROPHAGES; DERMAL DENDRITIC CELLS; DIET-INDUCED OBESITY; GLUCOSE-HOMEOSTASIS; TYPE-2 INFLAMMATION; HEPATIC STEATOSIS; METABOLIC DISEASE	Mononuclear phagocytes (MNPs) are a highly heterogeneous group of cells that play important roles in maintaining the body's homeostasis. Here, we found CD301b (also known as MGL2), a lectin commonly used as a marker for alternatively activated macrophages, was selectively expressed by a subset of CD11b(+) CD11c(+) MHCII+ MNPs in multiple organs including adipose tissues. Depleting CD301b(+) MNPs in vivo led to a significant weight loss with increased insulin sensitivity and a marked reduction in serum Resistin-like molecule (RELM) a, a multifunctional cytokine produced by MNPs. Reconstituting RELM alpha in CD301b(+) MNP-depleted animals restored body weight and normoglycemia. Thus, CD301b(+) MNPs play crucial roles in maintaining glucose metabolism and net energy balance.	[Kumamoto, Yosuke; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA; [Camporez, Joao Paulo G.; Jurczak, Michael J.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Shanabrough, Marya; Horvath, Tamas] Yale Univ, Sch Med, Comparat Med Sect, New Haven, CT 06510 USA; [Shulman, Gerald I.; Iwasaki, Akiko] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Yale University; Yale University; Yale University; Howard Hughes Medical Institute	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06510 USA.; Iwasaki, A (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019; Shulman, Gerald I./P-7176-2019	Iwasaki, Akiko/0000-0002-7824-9856; Shulman, Gerald I./0000-0003-1529-5668; Kumamoto, Yosuke/0000-0001-9369-4934; Camporez, Joao Paulo/0000-0003-3486-4301	HHMI; NIH [AI054359]; MMPC NIH [DK059635]; Pilot and Feasibility Project Grants from Diabetes Research Center at Yale; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK045735, U24DK059635] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MMPC NIH; Pilot and Feasibility Project Grants from Diabetes Research Center at Yale; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Wang Guillin and Yong Kong for microarray analysis, and Daniel Okin and Ruslan Medzhitov for critical reading of the manuscript. This study was funded by support from HHMI and grants from NIH AI054359, MMPC NIH DK059635, and Pilot and Feasibility Project Grants from Diabetes Research Center at Yale.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Biswas SK, 2012, CELL METAB, V15, P432, DOI 10.1016/j.cmet.2011.11.013; Blagoev B, 2002, J BIOL CHEM, V277, P42011, DOI 10.1074/jbc.M206975200; Bobr A, 2010, J IMMUNOL, V185, P4724, DOI 10.4049/jimmunol.1001802; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Bruss MD, 2010, AM J PHYSIOL-ENDOC M, V298, pE108, DOI 10.1152/ajpendo.00524.2009; Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Denda-Nagai K, 2010, J BIOL CHEM, V285, P19193, DOI 10.1074/jbc.M110.113613; Feng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024358; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; Holcomb IN, 2000, EMBO J, V19, P4046, DOI 10.1093/emboj/19.15.4046; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Ji YW, 2012, J BIOL CHEM, V287, P13561, DOI 10.1074/jbc.M112.350066; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Kumamoto Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005619; Lee BC, 2016, CELL METAB, V23, P685, DOI 10.1016/j.cmet.2016.03.002; Lee MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5410; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Mantovani A, 2016, NAT IMMUNOL, V17, P215, DOI 10.1038/ni.3354; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Munitz A, 2008, J ALLERGY CLIN IMMUN, V122, P1200, DOI 10.1016/j.jaci.2008.10.017; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nair MG, 2006, J IMMUNOL, V177, P1393, DOI 10.4049/jimmunol.177.3.1393; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Odegaard JI, 2008, CELL METAB, V7, P496, DOI 10.1016/j.cmet.2008.04.003; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Odegaard JI, 2011, ANNU REV PATHOL-MECH, V6, P275, DOI 10.1146/annurev-pathol-011110-130138; Ohmura K, 2010, ARTERIOSCL THROM VAS, V30, P193, DOI 10.1161/ATVBAHA.109.198614; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Osborne LC, 2013, J IMMUNOL, V190, P2292, DOI 10.4049/jimmunol.1200706; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000393; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Raes G, 2002, J LEUKOCYTE BIOL, V71, P597; Raes G, 2005, J LEUKOCYTE BIOL, V77, P321, DOI 10.1189/jlb.0304212; Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746; Riol-Blanco L, 2014, NATURE, V510, P157, DOI 10.1038/nature13199; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Satoh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030568; Schipper HS, 2012, J CLIN INVEST, V122, P3343, DOI 10.1172/JCI62739; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; STEIN M, 1992, J EXP MED, V176, P287, DOI 10.1084/jem.176.1.287; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Steppan CM, 2001, P NATL ACAD SCI USA, V98, P502, DOI 10.1073/pnas.98.2.502; Strodthoff D, 2013, ARTERIOSCL THROM VAS, V33, P1189, DOI 10.1161/ATVBAHA.112.301105; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wensveen FM, 2015, NAT IMMUNOL, V16, P376, DOI 10.1038/ni.3120; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu L, 2012, P NATL ACAD SCI USA, V109, pE1143, DOI 10.1073/pnas.1200498109; Wueest S, 2014, AM J PHYSIOL-REG I, V306, pR861, DOI 10.1152/ajpregu.00533.2013; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	71	30	30	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					583	596		10.1016/j.immuni.2016.08.002	http://dx.doi.org/10.1016/j.immuni.2016.08.002			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27566941	Green Accepted, Bronze			2022-12-18	WOS:000388454300015
J	Koltsova, EK; Ley, K				Koltsova, Ekaterina K.; Ley, Klaus			The Mysterious Ways of the Chemokine CXCL5	IMMUNITY			English	Editorial Material							DUFFY ANTIGEN; LUNG INJURY; INFLAMMATION	The chemokine receptor CXCR2 binds several chemokines, some of them with functions yet to be defined. In this issue of Immunity, Mei et al. (2010) generated CXCL5-deficient mice and described a prominent role of CXCL5 in the regulation of CXCR2-dependent neutrophil trafficking during pulmonary host defense.	[Koltsova, Ekaterina K.; Ley, Klaus] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Ley, K (corresponding author), La Jolla Inst Allergy & Immunol, Div Inflammat Biol, 9420 Athena Circle Dr, La Jolla, CA 92037 USA.	klaus@liai.org						Fukuma N, 2003, BIOCHEM BIOPH RES CO, V303, P137, DOI 10.1016/S0006-291X(03)00293-6; Jeyaseelan S, 2005, AM J RESP CELL MOL, V32, P531, DOI 10.1165/rcmb.2005-0063OC; Mayr FB, 2008, CRIT CARE MED, V36, P159, DOI 10.1097/01.CCM.0000297875.55969.DB; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; Qiu YS, 2007, THORAX, V62, P475, DOI 10.1136/thx.2006.066670; Quinton LJ, 2004, AM J PHYSIOL-LUNG C, V286, pL465, DOI 10.1152/ajplung.00153.2003; Reutershan J, 2006, J CLIN INVEST, V116, P695, DOI 10.1172/JCI27009; Reutershan J, 2009, EUR J IMMUNOL, V39, P1597, DOI 10.1002/eji.200839089; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Zarbock A, 2007, CRIT CARE MED, V35, P2156, DOI 10.1097/01.CCM.0000280570.82885.32	10	30	30	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 23	2010	33	1					7	9		10.1016/j.immuni.2010.07.012	http://dx.doi.org/10.1016/j.immuni.2010.07.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	632JD	20643334	Bronze			2022-12-18	WOS:000280418100004
J	Battaglia, M; Roncarolo, MG				Battaglia, Manuela; Roncarolo, Maria Grazia			The Fate of Human Treg Cells	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; EXPRESSION	In this issue of Immunity, Miyara. et al. (2009) demonstrate that FoxP3(+) cells in human peripheral blood are heterogeneous in function, and CD45RA expression defines their different stages of differentiation.	[Battaglia, Manuela; Roncarolo, Maria Grazia] San Raffaele Telethon Inst Gene Therapy HSR TIGET, I-20132 Milan, Italy; [Battaglia, Manuela] San Raffaele Diabet Res Inst HSR DRI, I-20132 Milan, Italy; [Roncarolo, Maria Grazia] Univ Vita Salute San Raffaele, I-20132 Milan, Italy	Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University	Roncarolo, MG (corresponding author), San Raffaele Telethon Inst Gene Therapy HSR TIGET, I-20132 Milan, Italy.	m.roncarolo@hsr.it		RONCAROLO, Maria Grazia/0000-0002-2193-9186; Battaglia, Manuela/0000-0003-4535-3152	Telethon [TGT06E02] Funding Source: Medline	Telethon(Fondazione Telethon)		Ayyoub M, 2009, P NATL ACAD SCI USA, V106, P8635, DOI 10.1073/pnas.0900621106; Baecher-Allan C, 2006, J IMMUNOL, V176, P4622, DOI 10.4049/jimmunol.176.8.4622; Fritzsching B, 2006, BLOOD, V108, P3371, DOI 10.1182/blood-2006-02-005660; Haas J, 2007, J IMMUNOL, V179, P1322, DOI 10.4049/jimmunol.179.2.1322; Hoffmann P, 2009, EUR J IMMUNOL, V39, P1088, DOI 10.1002/eji.200838904; Ito T, 2008, IMMUNITY, V28, P870, DOI 10.1016/j.immuni.2008.03.018; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Seddiki N, 2006, BLOOD, V107, P2830, DOI 10.1182/blood-2005-06-2403; Valmori D, 2005, J CLIN INVEST, V115, P1953, DOI 10.1172/JCI23963; Voo KS, 2009, P NATL ACAD SCI USA, V106, P4793, DOI 10.1073/pnas.0900408106	10	30	32	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2009	30	6					763	765		10.1016/j.immuni.2009.06.006	http://dx.doi.org/10.1016/j.immuni.2009.06.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19538927	Bronze			2022-12-18	WOS:000267270700005
J	Axtell, RC; Steinman, L				Axtell, Robert C.; Steinman, Lawrence			Type 1 interferons cool the inflamed brain	IMMUNITY			English	Editorial Material									[Axtell, Robert C.; Steinman, Lawrence] Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Steinman, Lawrence] Stanford Univ, Interdept Program Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Steinman, L (corresponding author), Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	steinman@stanford.edu	Axtell, Robert/AAJ-5053-2021	Steinman, Lawrence/0000-0002-2437-2250				AMASON BG, 1999, ANNU REV MED, V50, P291; Benveniste Etty N, 2007, Sci STKE, V2007, ppe70, DOI 10.1126/stke.4162007pe70; Dondi E, 2003, J IMMUNOL, V170, P749, DOI 10.4049/jimmunol.170.2.749; GUO B, 2008, IN PRESS J CLIN INVE, DOI DOI 10.1172/JC133342; Han MH, 2008, NATURE, V451, P1076, DOI 10.1038/nature06559; Ousman SS, 2007, NATURE, V448, P474, DOI 10.1038/nature05935; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Rivieccio MA, 2005, J IMMUNOL, V174, P3719, DOI 10.4049/jimmunol.174.6.3719; Teige I, 2003, J IMMUNOL, V170, P4776, DOI 10.4049/jimmunol.170.9.4776; Zhang XM, 2007, J EXP MED, V204, P1107, DOI 10.1084/jem.20062013	10	30	31	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2008	28	5					600	602		10.1016/j.immuni.2008.04.006	http://dx.doi.org/10.1016/j.immuni.2008.04.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	302XS	18482563	Bronze			2022-12-18	WOS:000256003900004
J	Zamoyska, R				Zamoyska, Rose			Why is there so much CD45 on T cells?	IMMUNITY			English	Editorial Material							SRC-FAMILY KINASES; ACTIVATION; WEDGE; MICE; LCK; FYN	The balance between kinases and phosphatases is crucial for regulating lymphocyte signaling. In this issue, McNeill et al. (2007) show that the transmembrane phosphatase CD45 has a role as both positive and negative regulator of T cell signaling.	Natl Inst Med Res, MRC, London NW7 1AA, England	MRC National Institute for Medical Research	Zamoyska, R (corresponding author), Natl Inst Med Res, MRC, Mill Hill, London NW7 1AA, England.	rzamoys@nimr.mrc.ac.uk		Zamoyska, Rose/0000-0001-9816-2638	Medical Research Council [MC_U117512793] Funding Source: Medline; MRC [MC_U117512793] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ashwell JD, 1999, IMMUNOL TODAY, V20, P412, DOI 10.1016/S0167-5699(99)01505-4; Hermiston ML, 2005, IMMUNITY, V23, P635, DOI 10.1016/j.immuni.2005.11.001; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Kozieradzki I, 1997, J IMMUNOL, V158, P3130; Majeti R, 2000, CELL, V103, P1059, DOI 10.1016/S0092-8674(00)00209-9; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Ogilvy S, 2003, J IMMUNOL, V171, P1792, DOI 10.4049/jimmunol.171.4.1792; Palacios EH, 2004, ONCOGENE, V23, P7990, DOI 10.1038/sj.onc.1208074; Wallace VA, 1997, J IMMUNOL, V158, P3205; Zamoyska R, 2003, IMMUNOL REV, V191, P107, DOI 10.1034/j.1600-065X.2003.00015.x	10	30	33	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2007	27	3					421	423		10.1016/j.immuni.2007.08.009	http://dx.doi.org/10.1016/j.immuni.2007.08.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17892852	Bronze			2022-12-18	WOS:000249843400009
J	Stockinger, B				Stockinger, Brigitta			Good for goose, but not for gander: IL-2 interferes with Th17 differentiation	IMMUNITY			English	Editorial Material							GROWTH-FACTOR-BETA; T-CELLS; T(H)17	In this issue of Immunity, Laurence et al. (2007) examined the effects of interleukin-2 on differentiation of the T helper 17 (Th17) cells and found that this essential growth factor for all other T cell subsets blocks the development of Th17 T cells.	MRC Natl Inst Med Res, Div Mol Immunol, London NW7 1AA, England	MRC National Institute for Medical Research	Stockinger, B (corresponding author), MRC Natl Inst Med Res, Div Mol Immunol, Mill Hill, London NW7 1AA, England.	bstocki@nimr.mrc.ac.uk		Stockinger, Brigitta/0000-0001-8781-336X				Barthlott T, 2005, INT IMMUNOL, V17, P279, DOI 10.1093/intimm/dxh207; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; BRABLETZ T, 1993, MOL CELL BIOL, V13, P1155, DOI 10.1128/MCB.13.2.1155; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Villarino AV, 2007, J EXP MED, V204, P65, DOI 10.1084/jem.20061198	7	30	36	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	2007	26	3					278	279		10.1016/j.immuni.2007.03.001	http://dx.doi.org/10.1016/j.immuni.2007.03.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	150PG	17376391	Bronze			2022-12-18	WOS:000245228100004
J	Rock, KL				Rock, Kenneth L.			Exiting the outside world for cross-presentation	IMMUNITY			English	Editorial Material							ENDOPLASMIC-RETICULUM; ANTIGENS; MOLECULES; CELLS	How are extracellular proteins cross-presented on MHC class I molecules? In this issue of Immunity, Ackerman et al. (2006) demonstrate that the ER-associated degradation (ERAD) export pathway operates in the phagosomes of dendritic cells and transfers antigens into the MHC class I pathway.	Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Rock, KL (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.							Ackerman AL, 2005, NAT IMMUNOL, V6, P107, DOI 10.1038/ni1147; Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; BEVAN MJ, 1976, J EXP MED, V143, P1283, DOI 10.1084/jem.143.5.1283; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; Rock KL, 2005, IMMUNOL REV, V207, P166, DOI 10.1111/j.0105-2896.2005.00301.x; ROCK KL, 1990, SCIENCE, V249, P918, DOI 10.1126/science.2392683; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Touret N, 2005, CELL, V123, P157, DOI 10.1016/j.cell.2005.08.018; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218	10	30	31	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2006	25	4					523	525		10.1016/j.immuni.2006.09.003	http://dx.doi.org/10.1016/j.immuni.2006.09.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17046678	Bronze			2022-12-18	WOS:000241481500002
J	Aguzzi, A; Heikenwalder, M				Aguzzi, A; Heikenwalder, M			Prions, cytokines, and chemokines: A meeting in lymphoid organs	IMMUNITY			English	Review							FOLLICULAR DENDRITIC CELLS; CREUTZFELDT-JAKOB-DISEASE; TUMOR-NECROSIS-FACTOR; INFECTED NEUROBLASTOMA-CELLS; B-CELL; PROTEIN ACCUMULATION; LYMPHOTOXIN-ALPHA; BLOOD-TRANSFUSION; SCRAPIE AGENT; T-CELL		Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Aguzzi, A (corresponding author), Univ Zurich Hosp, Inst Neuropathol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	adriano@pathol.unizh.ch	Heikenwalder, Mathias/AAA-2269-2020; Aguzzi, Adriano/A-3351-2008	Aguzzi, Adriano/0000-0002-0344-6708				Aguzzi A, 2004, NAT REV IMMUNOL, V4, P725, DOI 10.1038/nri1437; Aguzzi A, 2004, J CLIN INVEST, V114, P153, DOI [10.1172/JCI22438, 10.1172/JCI200422438]; Aguzzi A, 2004, NAT CELL BIOL, V6, P290, DOI 10.1038/ncb0404-290; Aguzzi A, 2004, CELL, V116, P313, DOI 10.1016/S0092-8674(03)01031-6; Aguzzi A, 2003, NATURE, V423, P127, DOI 10.1038/423127a; Aguzzi A, 2001, J CLIN INVEST, V108, P661, DOI 10.1172/JCI200113919; Aguzzi A, 2003, ADV IMMUNOL, V81, P123, DOI 10.1016/S0065-2776(03)81004-0; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Aucouturier P, 2001, J CLIN INVEST, V108, P703, DOI 10.1172/JCI13155; Beekes M, 2000, NEUROSCI LETT, V278, P181, DOI 10.1016/S0304-3940(99)00934-9; Blattler T, 1997, NATURE, V389, P69, DOI 10.1038/37981; BLUETHMANN H, 1994, J LEUKOCYTE BIOL, V56, P565, DOI 10.1002/jlb.56.5.565; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; BROWNING JL, 1993, CELL, V72, P847, DOI 10.1016/0092-8674(93)90574-A; BROWNING JL, 1995, J IMMUNOL, V154, P33; Bruce ME, 2001, LANCET, V358, P208, DOI 10.1016/S0140-6736(01)05411-3; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; CASHMAN NR, 1990, CELL, V61, P185, DOI 10.1016/0092-8674(90)90225-4; Caughey B, 2003, J VIROL, V77, P5499, DOI 10.1128/JVI.77.9.5499-5502.2003; CAUGHEY B, 1992, J NEUROCHEM, V59, P768, DOI 10.1111/j.1471-4159.1992.tb09437.x; CAUGHEY B, 1993, J VIROL, V67, P643, DOI 10.1128/JVI.67.2.643-650.1993; CLARKE MC, 1971, RES VET SCI, V12, P195; CLARKE MC, 1984, VET MICROBIOL, V9, P215, DOI 10.1016/0378-1135(84)90039-7; COLE S, 1985, NEUROPATH APPL NEURO, V11, P213, DOI 10.1111/j.1365-2990.1985.tb00019.x; COZET C, 2004, J CELL SCI, V117, P5591; Cupedo T, 2004, IMMUNITY, V21, P655, DOI 10.1016/j.immuni.2004.09.006; Cupedo T, 2004, J IMMUNOL, V173, P4889, DOI 10.4049/jimmunol.173.8.4889; Cyster JG, 1999, CURR TOP MICROBIOL, V246, P87; Daude N, 2003, J CELL SCI, V116, P2775, DOI 10.1242/jcs.00494; DETOGNI P, 1994, SCIENCE, V264, P703, DOI 10.1126/science.8171322; DICKINSON AG, 1972, NATURE-NEW BIOL, V237, P244, DOI 10.1038/newbio237244a0; Enari M, 2001, P NATL ACAD SCI USA, V98, P9295, DOI 10.1073/pnas.151242598; FELTEN SY, 1988, PROG ALLERGY, V43, P14; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Forster R, 1996, CELL, V87, P1037, DOI 10.1016/S0092-8674(00)81798-5; FRASER H, 1987, VET MICROBIOL, V13, P211, DOI 10.1016/0378-1135(87)90084-8; Frigg R, 1999, J VIROL, V73, P9584, DOI 10.1128/JVI.73.11.9584-9588.1999; Fu YX, 1999, ANNU REV IMMUNOL, V17, P399, DOI 10.1146/annurev.immunol.17.1.399; Fu YX, 1997, J EXP MED, V185, P2111, DOI 10.1084/jem.185.12.2111; Furukawa H, 2004, J BIOL CHEM, V279, P23661, DOI 10.1074/jbc.M400187200; Futterer A, 1998, IMMUNITY, V9, P59, DOI 10.1016/S1074-7613(00)80588-9; Glatzel M, 2001, NEURON, V31, P25, DOI 10.1016/S0896-6273(01)00331-2; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Gommerman JL, 2003, NAT REV IMMUNOL, V3, P642, DOI 10.1038/nri1151; Gommerman JL, 2002, J CLIN INVEST, V110, P1359, DOI 10.1172/JCI200215975; Heggebo R, 2003, J COMP PATHOL, V128, P172, DOI 10.1053/jcpa.2002.0625; Heikenwalder M, 2004, NAT MED, V10, P187, DOI 10.1038/nm987; HEIKENWALDER M, 2005, IN PRESS SCIENC 0120; Heinen E, 1995, CURR TOP MICROBIOL, V201, P15; Heppner FL, 2001, NAT MED, V7, P976, DOI 10.1038/nm0901-976; Heppner FL, 2001, SCIENCE, V294, P178, DOI 10.1126/science.1063093; Hill AF, 1997, LANCET, V349, P99, DOI 10.1016/S0140-6736(97)24002-X; Houston F, 2000, LANCET, V356, P999, DOI 10.1016/S0140-6736(00)02719-7; Huang FP, 2002, J GEN VIROL, V83, P267, DOI 10.1099/0022-1317-83-1-267; Kaeser PS, 2001, J VIROL, V75, P7097, DOI 10.1128/JVI.75.15.7097-7106.2001; Kerneis S, 1997, SCIENCE, V277, P949, DOI 10.1126/science.277.5328.949; KIMBERLIN RH, 1986, J GEN VIROL, V67, P255, DOI 10.1099/0022-1317-67-2-255; KIMBERLIN RH, 1989, VIRUS RES, V12, P201, DOI 10.1016/0168-1702(89)90039-7; KITAMOTO T, 1991, J VIROL, V65, P6292, DOI 10.1128/JVI.65.11.6292-6295.1991; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Klein MA, 1998, NAT MED, V4, P1429, DOI 10.1038/4022; Klein MA, 1997, NATURE, V390, P687, DOI 10.1038/37789; Koni PA, 1997, IMMUNITY, V6, P491, DOI 10.1016/S1074-7613(00)80292-7; Kratz A, 1996, J EXP MED, V183, P1461, DOI 10.1084/jem.183.4.1461; LAVELLE GC, 1972, INFECT IMMUN, V5, P319, DOI 10.1128/IAI.5.3.319-323.1972; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Mabbott NA, 2000, NAT MED, V6, P719, DOI 10.1038/77401; Mabbott NA, 2003, NAT MED, V9, P1463, DOI 10.1038/nm1203-1463; Mabbott NA, 1998, IMMUNOL TODAY, V19, P201, DOI 10.1016/S0167-5699(98)01253-5; Mabbott NA, 2003, J VIROL, V77, P6845, DOI 10.1128/JVI.77.12.6845-6854.2003; Mabbott NA, 2001, NAT MED, V7, P485, DOI 10.1038/86562; Mabbott NA, 2002, J VIROL, V76, P5131, DOI 10.1128/JVI.76.10.5131-5139.2002; Mackay F, 1998, NATURE, V395, P26, DOI 10.1038/25630; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; MANSON J, 1992, DEVELOPMENT, V115, P117; MANUELIDIS EE, 1978, NATURE, V271, P778, DOI 10.1038/271778a0; McBride PA, 1999, NEUROSCI LETT, V265, P135, DOI 10.1016/S0304-3940(99)00223-2; McGovern G, 2004, J COMP PATHOL, V130, P181, DOI 10.1016/j.jcpa.2003.11.001; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; Meier P, 2003, CELL, V113, P49, DOI 10.1016/S0092-8674(03)00201-0; MOHRI S, 1987, J GEN VIROL, V68, P1187, DOI 10.1099/0022-1317-68-4-1187; Montrasio F, 2000, SCIENCE, V288, P1257, DOI 10.1126/science.288.5469.1257; Montrasio F, 2001, P NATL ACAD SCI USA, V98, P4034, DOI 10.1073/pnas.051609398; MULLER U, 1987, NATURE, V325, P265, DOI 10.1038/325265a0; Neutra MR, 1996, CELL, V86, P345, DOI 10.1016/S0092-8674(00)80106-3; Ngo VN, 1999, J EXP MED, V189, P403, DOI 10.1084/jem.189.2.403; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Peretz D, 2001, NATURE, V412, P739, DOI 10.1038/35089090; Polymenidou M, 2004, P NATL ACAD SCI USA, V101, P14670, DOI 10.1073/pnas.0404772101; Prinz M, 2003, NATURE, V425, P957, DOI 10.1038/nature02072; Prinz M, 2003, AM J PATHOL, V162, P1103, DOI 10.1016/S0002-9440(10)63907-7; Prinz M, 2003, EMBO REP, V4, P195, DOI 10.1038/sj.embor.embor731; Prinz M, 2002, P NATL ACAD SCI USA, V99, P919, DOI 10.1073/pnas.022626399; Priola SA, 2000, SCIENCE, V287, P1503, DOI 10.1126/science.287.5457.1503; Raeber AJ, 1999, EMBO J, V18, P2702, DOI 10.1093/emboj/18.10.2702; RUDDLE NH, 1967, SCIENCE, V157, P1060, DOI 10.1126/science.157.3792.1060; RUDDLE NH, 1968, J EXP MED, V128, P1267, DOI 10.1084/jem.128.6.1267; Serban A, 2004, J BIOL CHEM, V279, P48817, DOI 10.1074/jbc.M409107200; Sethi S, 2002, LANCET, V360, P229, DOI 10.1016/S0140-6736(02)09513-2; Shaked GM, 2001, J BIOL CHEM, V276, P31479, DOI 10.1074/jbc.C100278200; Shakhov AN, 2000, J LEUKOCYTE BIOL, V68, P151; Sigurdson CJ, 2002, J GEN VIROL, V83, P2617, DOI 10.1099/0022-1317-83-10-2617; Soto C, 2000, LANCET, V355, P192, DOI 10.1016/S0140-6736(99)11419-3; Supattapone S, 2001, J VIROL, V75, P3453, DOI 10.1128/JVI.75.7.3453-3461.2001; Tagliavini F, 1997, SCIENCE, V276, P1119, DOI 10.1126/science.276.5315.1119; WARE CF, 1992, J IMMUNOL, V149, P3881; Weissmann C, 2001, PHILOS T R SOC B, V356, P177, DOI 10.1098/rstb.2000.0763; White AR, 2003, NATURE, V422, P80, DOI 10.1038/nature01457; WORM M, 1994, INT IMMUNOL, V6, P1883, DOI 10.1093/intimm/6.12.1883	111	30	31	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2005	22	2					145	154		10.1016/j.immuni.2004.12.007	http://dx.doi.org/10.1016/j.immuni.2004.12.007			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	904PG	15723804	Bronze			2022-12-18	WOS:000227509600002
J	Sollid, LM				Sollid, LM			Intraepithelial lymphocytes in Celiac disease: License to kill revealed	IMMUNITY			English	Editorial Material							T-CELLS; NKG2D; ACTIVATION; RECEPTOR; GLIADIN	Infiltration of lymphocytes in the small intestinal epithelium is a hallmark of active celiac disease. In this issue of Immunity, two papers uncover mechanisms controlling the cytolytic potential of these cells and provide evidence that lymphocyte killing of enterocytes is an important part of the celiac disease pathogenesis.	Univ Oslo, Rikshosp, Inst Immunol, N-0027 Oslo, Norway	University of Oslo; National Hospital Norway	Sollid, LM (corresponding author), Univ Oslo, Rikshosp, Inst Immunol, N-0027 Oslo, Norway.		Sollid, Ludvig/N-9691-2015	Sollid, Ludvig/0000-0001-8860-704X				Arentz-Hansen H, 2000, J EXP MED, V191, P603, DOI 10.1084/jem.191.4.603; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 1996, P NATL ACAD SCI USA, V93, P12445, DOI 10.1073/pnas.93.22.12445; Hue S, 2004, IMMUNITY, V21, P367, DOI 10.1016/j.immuni.2004.06.018; Jabri B, 2000, GASTROENTEROLOGY, V118, P867, DOI 10.1016/S0016-5085(00)70173-9; Lundqvist C, 1996, J IMMUNOL, V157, P1926; Maiuri L, 2003, LANCET, V362, P30, DOI 10.1016/S0140-6736(03)13803-2; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Oberhuber G, 1996, AM J PATHOL, V148, P1351; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Sollid LM, 2002, NAT REV IMMUNOL, V2, P647, DOI 10.1038/nri885	14	30	33	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	SEP	2004	21	3					303	304		10.1016/S1074-7613(04)00239-0	http://dx.doi.org/10.1016/S1074-7613(04)00239-0			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	856GY	15357941				2022-12-18	WOS:000224034900001
J	Vinuesa, CG; Goodnow, CC				Vinuesa, CG; Goodnow, CC			Illuminating autoimmune regulators through controlled variation of the mouse genome sequence	IMMUNITY			English	Review							SYSTEMIC-LUPUS-ERYTHEMATOSUS; COMBINED IMMUNE-DEFICIENCY; FUNCTIONAL ANNOTATION; SUSCEPTIBILITY LOCUS; CO-RECEPTORS; INSULIN GENE; HUMAN THYMUS; MOTH-EATEN; MUTATIONS; ASSOCIATION	Gene variants in mice that have strong, Mendelian effects on autoimmune susceptibility have been one of the most productive entry points for identifying genes and processes regulating human autoimmunity. With the tools now available to map and identify new mouse Mendelian gene variants, the handful of spontaneous mutations accumulated over several decades have all been identified, and the main bottleneck lies in producing new Mendelian immune variants. We outline here a strategy to generate large sets of functional variants in genes controlling lupus and humoral immunity, based upon limited variation of the mouse genome sequence with the chemical mutagen, ENU, combined with a set of sensitive immunological screens.	Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; Australian Natl Univ, Australian Phenom Facil, Canberra, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research; Australian National University	Goodnow, CC (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Mills Rd, Canberra, ACT 2601, Australia.	chris.goodnow@anu.edu.au	Goodnow, Christopher C/V-8108-2018; Vinuesa, Carola G/B-1108-2010	Goodnow, Christopher C/0000-0001-5296-6155; Vinuesa, Carola G/0000-0001-9799-0298				Aaltonen J, 1997, NAT GENET, V17, P399, DOI 10.1038/ng1297-399; Aguado E, 2002, SCIENCE, V296, P2036, DOI 10.1126/science.1069057; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Arbuckle MR, 2003, NEW ENGL J MED, V349, P1526, DOI 10.1056/NEJMoa021933; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Beier DR, 2000, MAMM GENOME, V11, P594, DOI 10.1007/s003350010113; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; BENNETT ST, 1995, NAT GENET, V9, P284, DOI 10.1038/ng0395-284; Botto M, 2002, IMMUNOBIOLOGY, V205, P395, DOI 10.1078/0171-2985-00141; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Chambers CA, 2001, ANNU REV IMMUNOL, V19, P565, DOI 10.1146/annurev.immunol.19.1.565; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Coghill EL, 2002, NAT GENET, V30, P255, DOI 10.1038/ng847; Corneo B, 2001, BLOOD, V97, P2772, DOI 10.1182/blood.V97.9.2772; Eaves IA, 2002, GENOME RES, V12, P232, DOI 10.1101/gr.214102. Article published online before print in January 2002; Feldmann M, 2001, ANNU REV IMMUNOL, V19, P163, DOI 10.1146/annurev.immunol.19.1.163; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; GRAMMER A, 2004, KEYSTONE S, V166, P64; Greenwald RJ, 2002, CURR OPIN IMMUNOL, V14, P391, DOI 10.1016/S0952-7915(02)00341-2; HITOTSUMACHI S, 1985, P NATL ACAD SCI USA, V82, P6619, DOI 10.1073/pnas.82.19.6619; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Huttley GA, 2000, NAT GENET, V25, P410, DOI 10.1038/78092; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Justice MJ, 1999, HUM MOL GENET, V8, P1955, DOI 10.1093/hmg/8.10.1955; Justice MJ, 2000, MAMM GENOME, V11, P484, DOI 10.1007/s003350010094; Kelly JA, 2002, GENES IMMUN, V3, pS71, DOI 10.1038/sj.gene.6363885; Liston A, 2003, NAT IMMUNOL, V4, P350, DOI 10.1038/ni906; Martin AL, 1996, LUPUS, V5, P22, DOI 10.1177/096120339600500106; McMurray RW, 2003, ARTHRITIS RHEUM-US, V48, P2100, DOI 10.1002/art.11105; MEYER O, 1985, CLIN EXP IMMUNOL, V62, P678; Mohan C, 1999, J CLIN INVEST, V103, P1685, DOI 10.1172/JCI5827; Mohan C, 2001, CURR OPIN RHEUMATOL, V13, P352, DOI 10.1097/00002281-200109000-00003; Morahan G, 2001, NAT GENET, V27, P218, DOI 10.1038/84872; Morel L, 2000, Int Rev Immunol, V19, P423, DOI 10.3109/08830180009055506; Nadeau JH, 2001, SCIENCE, V291, P1251, DOI 10.1126/science.1058244; Nagamine K, 1997, NAT GENET, V17, P393, DOI 10.1038/ng1297-393; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; Neuhaus IM, 1998, MAMM GENOME, V9, P150, DOI 10.1007/s003359900706; Notarangelo LD, 2000, IMMUNOL REV, V178, P39, DOI 10.1034/j.1600-065X.2000.17812.x; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Okazaki T, 2002, CURR OPIN IMMUNOL, V14, P779, DOI 10.1016/S0952-7915(02)00398-9; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Papathanasiou P, 2003, IMMUNITY, V19, P131, DOI 10.1016/S1074-7613(03)00168-7; Plotz PH, 2003, NAT REV IMMUNOL, V3, P73, DOI 10.1038/nri976; POPP RA, 1983, GENETICS, V105, P157; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Pugliese A, 1997, NAT GENET, V15, P293, DOI 10.1038/ng0397-293; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Rozzo SJ, 2001, IMMUNITY, V15, P435, DOI 10.1016/S1074-7613(01)00196-0; Sakaguchi N, 2003, NATURE, V426, P454, DOI 10.1038/nature02119; Santiago-Raber ML, 2001, J IMMUNOL, V167, P4067, DOI 10.4049/jimmunol.167.7.4067; Scofield RH, 2003, BLOOD, V101, P992, DOI 10.1182/blood-2002-04-1003; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Silveira PA, 2001, IMMUNOGENETICS, V53, P741, DOI 10.1007/s00251-001-0391-y; Sommers CL, 2002, SCIENCE, V296, P2040, DOI 10.1126/science.1069066; Theofilopoulos AN, 1999, P ASSOC AM PHYSICIAN, V111, P228, DOI 10.1046/j.1525-1381.1999.99244.x; Todd JA, 2001, IMMUNITY, V15, P387, DOI 10.1016/S1074-7613(01)00202-3; Toellner KM, 1998, J EXP MED, V187, P1193, DOI 10.1084/jem.187.8.1193; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Vafiadis P, 1997, NAT GENET, V15, P289, DOI 10.1038/ng0397-289; Wang J, 1999, CELL, V98, P47, DOI 10.1016/S0092-8674(00)80605-4; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yokoi N, 2002, NAT GENET, V31, P391, DOI 10.1038/ng927	69	30	31	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2004	20	6					669	679		10.1016/j.immuni.2004.05.012	http://dx.doi.org/10.1016/j.immuni.2004.05.012			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	831OY	15189733	Bronze			2022-12-18	WOS:000222205300004
J	Oh, DY; Fong, L				Oh, David Y.; Fong, Lawrence			Cytotoxic CD4(+) T cells in cancer: Expanding the immune effector toolbox	IMMUNITY			English	Review							CD4+T CELLS; IN-VIVO; B-CELLS; LYMPHOCYTES; EXPRESSION; MELANOMA; PERFORIN; IMMUNOTHERAPY; RECOGNITION; LANDSCAPE	Cytotoxic T cells are important effectors of anti-tumor immunity. While tumor killing is ascribed to CD8(+) T cell function, pre-clinical and clinical studies have identified intra-tumoral CD4(+) T cells that possess cytotoxic programs and can directly kill cancer cells. Cytotoxic CD4(+) T cells are found in other disease settings including infection and autoimmunity. Here, we review the phenotypic and functional characteristics of cytotoxic CD4(+) T cells in non-cancer and cancer contexts. We conduct a comparative examination of cytolytic mechanisms of cytotoxic CD4(+) T cells across disease states and synthesize features that define these cells independent of context. We discuss regulatory mechanisms driving ontogeny and effector function and evidence for the clinical relevance of cytotoxic CD4(+) T cells in cancer. In this context, we highlight important gaps in understanding in the biology of cytotoxic CD4(+) T cells as well as the potential use of these cells in immunotherapies for specific cancers.	[Oh, David Y.; Fong, Lawrence] Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Fong, L (corresponding author), Univ Calif San Francisco, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA.	lawrence.fong@ucsf.edu			NIH [K08AI139375, R35CA253175]; Prostate Cancer Foundation; Damon Runyon Clinical Investigator Award; Prostate Cancer Foun-dation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; Damon Runyon Clinical Investigator Award; Prostate Cancer Foun-dation	D.Y.O. is supported by NIH K08AI139375, a Young Investigator Award from the Prostate Cancer Foundation, and the Damon Runyon Clinical Investigator Award. L.F. is supported by NIH R35CA253175 and the Prostate Cancer Foun-dation.	Adhikary D, 2006, J EXP MED, V203, P995, DOI 10.1084/jem.20051287; Alspach E, 2019, NATURE, V574, P696, DOI 10.1038/s41586-019-1671-8; Aslan N, 2006, J VIRAL HEPATITIS, V13, P505, DOI 10.1111/j.1365-2893.2006.00723.x; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Brown DM, 2012, J VIROL, V86, P6792, DOI 10.1128/JVI.07172-11; Brown DM, 2009, CELL IMMUNOL, V257, P69, DOI 10.1016/j.cellimm.2009.03.002; Cachot A, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe3348; Cheroutre H, 2013, SEMIN IMMUNOL, V25, P273, DOI 10.1016/j.smim.2013.10.022; Cohen AD, 2019, J CLIN INVEST, V129, P2210, DOI 10.1172/JCI126397; Cruz-Guilloty F, 2009, J EXP MED, V206, P51, DOI 10.1084/jem.20081242; Della-Torre E, 2018, ARTHRITIS RHEUMATOL, V70, P1133, DOI 10.1002/art.40469; Donnarumma T, 2016, CELL REP, V17, P1571, DOI 10.1016/j.celrep.2016.10.013; Guedan S, 2014, BLOOD, V124, P1070, DOI 10.1182/blood-2013-10-535245; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Hashimoto K, 2019, P NATL ACAD SCI USA, V116, P24242, DOI 10.1073/pnas.1907883116; Hegde NR, 2005, J EXP MED, V202, P1109, DOI 10.1084/jem.20050162; Hirschhorn-Cymerman D, 2012, J EXP MED, V209, P2113, DOI 10.1084/jem.20120532; Hollern DP, 2019, CELL, V179, P1191, DOI 10.1016/j.cell.2019.10.028; Hunder NN, 2008, NEW ENGL J MED, V358, P2698, DOI 10.1056/NEJMoa0800251; Jellison ER, 2005, J IMMUNOL, V174, P614, DOI 10.4049/jimmunol.174.2.614; Johnson DB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10582; Khanna R, 1997, INT IMMUNOL, V9, P1537, DOI 10.1093/intimm/9.10.1537; Kitano S, 2013, CANCER IMMUNOL RES, V1, P235, DOI 10.1158/2326-6066.CIR-13-0068; Knochelmann HM, 2018, CELL MOL IMMUNOL, V15, P458, DOI 10.1038/s41423-018-0004-4; Krensky AM, 2009, TISSUE ANTIGENS, V73, P193, DOI 10.1111/j.1399-0039.2008.01218.x; Kwek SS, 2015, CANCER IMMUNOL RES, V3, P1008, DOI 10.1158/2326-6066.CIR-14-0227; Landais E, 2004, BLOOD, V103, P1408, DOI 10.1182/blood-2003-03-0930; Leko V, 2019, J IMMUNOL, V202, P3458, DOI 10.4049/jimmunol.1801022; Liakou CI, 2008, P NATL ACAD SCI USA, V105, P14987, DOI 10.1073/pnas.0806075105; Long HM, 2005, J VIROL, V79, P4896, DOI 10.1128/JVI.79.8.4896-4907.2005; Lu YC, 2017, J CLIN ONCOL, V35, P3322, DOI 10.1200/JCO.2017.74.5463; Maehara T, 2020, J CLIN INVEST, V130, P2451, DOI 10.1172/JCI131700; Marshall NB, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/954602; Martens A, 2016, CLIN CANCER RES, V22, P4848, DOI 10.1158/1078-0432.CCR-16-0249; McKinstry KK, 2012, J CLIN INVEST, V122, P2847, DOI 10.1172/JCI63689; Medley QG, 1996, P NATL ACAD SCI USA, V93, P685, DOI 10.1073/pnas.93.2.685; Mogilenko DA, 2021, IMMUNITY, V54, P99, DOI 10.1016/j.immuni.2020.11.005; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Nelson MH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba7443; Niiya H, 2005, EXP HEMATOL, V33, P811, DOI 10.1016/j.exphem.2005.04.004; Oh DY, 2020, CELL, V181, P1612, DOI 10.1016/j.cell.2020.05.017; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Patil VS, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan8664; Pipkin ME, 2010, IMMUNOL REV, V235, P55, DOI 10.1111/j.0105-2896.2010.00905.x; Puram SV, 2017, CELL, V171, P1611, DOI 10.1016/j.cell.2017.10.044; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Qui HZ, 2011, J IMMUNOL, V187, P3555, DOI 10.4049/jimmunol.1101244; Raveney BJE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9437; Reis BS, 2014, IMMUNITY, V41, P244, DOI 10.1016/j.immuni.2014.06.017; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Rodig SJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3342; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Saez-Borderias A, 2006, EUR J IMMUNOL, V36, P3198, DOI 10.1002/eji.200636682; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Sato V, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121062; Sledzinska A, 2020, IMMUNITY, V52, P151, DOI 10.1016/j.immuni.2019.12.007; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Suni MA, 2001, EUR J IMMUNOL, V31, P2512, DOI 10.1002/1521-4141(200108)31:8<2512::AID-IMMU2512>3.0.CO;2-M; Takeuchi A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00194; Takeuchi A, 2016, J EXP MED, V213, P123, DOI 10.1084/jem.20150519; Tran E, 2014, SCIENCE, V344, P641, DOI 10.1126/science.1251102; van Leeuwen EMM, 2004, J IMMUNOL, V173, P1834, DOI 10.4049/jimmunol.173.3.1834; van Leeuwen EMM, 2006, BLOOD, V108, P3121, DOI 10.1182/blood-2006-03-006809; Vitiello GA, 2020, J EXP MED, V217, DOI 10.1084/jem.20190456; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Yang D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01379-y; Zappasodi R, 2018, CANCER CELL, V33, P1017, DOI 10.1016/j.ccell.2018.05.009; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x; Zhang QM, 2019, CELL, V179, P829, DOI 10.1016/j.cell.2019.10.003; Zhang YY, 2021, CANCER CELL, V39, P1578, DOI 10.1016/j.ccell.2021.09.010; Zhou Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20059-6	71	29	29	3	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2701	2711		10.1016/j.immuni.2021.11.015	http://dx.doi.org/10.1016/j.immuni.2021.11.015		DEC 2021	11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34910940	hybrid, Green Accepted			2022-12-18	WOS:000731645300010
J	Antia, R; Halloran, ME				Antia, Rustom; Halloran, M. Elizabeth			Transition to endemicity: Understanding COVID-19	IMMUNITY			English	Editorial Material							SARS-COV-2	The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and its associated disease, coronavirus disease 2019 (COVID-19), has caused a devastating pandemic worldwide. Here, we explain basic concepts underlying the transition from an epidemic to an endemic state, where a pathogen is stably maintained in a population. We discuss how the number of infections and the severity of disease change in the transition from the epidemic to the endemic phase and consider the implications of this transition in the context of COVID-19.	[Antia, Rustom] Emory Univ, Atlanta, GA 30322 USA; [Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Halloran, M. Elizabeth] Univ Washington, Seattle, WA 98195 USA	Emory University; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Antia, R (corresponding author), Emory Univ, Atlanta, GA 30322 USA.	rantia@emory.edu						Antia A, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006601; Bubar KM, 2021, SCIENCE, V371, P916, DOI 10.1126/science.abe6959; CLIFF A, 1984, SCI AM, V250, P138, DOI 10.1038/scientificamerican0584-138; Cromer D, 2021, NAT REV IMMUNOL, V21, P395, DOI 10.1038/s41577-021-00550-x; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Elizabeth Halloran M., 2009, DESIGN ANAL VACCINE; Galanti M, 2021, J INFECT DIS, V223, P409, DOI 10.1093/infdis/jiaa392; Glynn JR, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00668-y; Keeling M., 2008, MODELING INFECT DIS; Lavine JS, 2021, SCIENCE, V371, P741, DOI 10.1126/science.abe6522; MAY RM, 1982, NATURE, V300, P481, DOI 10.1038/300481a0; Saad-Roy CM, 2020, SCIENCE, V370, P811, DOI 10.1126/science.abd7343; Shaman J, 2020, SCIENCE, V370, P527, DOI 10.1126/science.abe5960; Vijgen L, 2005, J VIROL, V79, P1595, DOI 10.1128/JVI.79.3.1595-1604.2005; Yewdell JW, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009509	15	29	29	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2172	2176		10.1016/j.immuni.2021.09.019	http://dx.doi.org/10.1016/j.immuni.2021.09.019		OCT 2021	5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34626549	Green Published, Bronze			2022-12-18	WOS:000706854100002
J	Borst, K; Dumas, AA; Prinz, M				Borst, Katharina; Dumas, Anaelle Aurelie; Prinz, Marco			Microglia: Immune and non-immune functions	IMMUNITY			English	Review							ASTROCYTE-TARGETED PRODUCTION; MACROPHAGE ONTOGENY; TAM RECEPTORS; CELL; BRAIN; CNS; REVEALS; CLEARANCE; DIFFERENTIATION; DEMYELINATION	As resident macrophages of the central nervous system (CNS), microglia are associated with diverse functions essential to the developing and adult brain during homeostasis and disease. They are aided in their tasks by intricate bidirectional communication with other brain cells under steady-state conditions as well as with infiltrating peripheral immune cells during perturbations. Harmonious cell-cell communication involvingmicroglia are considered crucial tomaintain the healthy state of the tissue environment and to overcome pathology such as neuroinflammation. Analyses of such intercellular pathways have contributed to our understanding of the heterogeneous but context-associated microglial responses to environmental cues across neuropathology, including inflammatory conditions such as infections and autoimmunity, as well as immunosuppressive states as seen in brain tumors. Here, we summarize the latest evidence demonstrating how these interactions drive microglia immune and non-immune functions, which coordinate the transition from homeostatic to disease-related cellular states.	[Borst, Katharina; Dumas, Anaelle Aurelie; Prinz, Marco] Univ Freiburg, Med Fac, Inst Neuropathol, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, Signalling Res Ctr BIOSS, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, CIBSS, Freiburg, Germany; [Prinz, Marco] Univ Freiburg, Fac Med, Ctr Basics NeuroModulat NeuroModulBas, Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg	Borst, K; Dumas, AA; Prinz, M (corresponding author), Univ Freiburg, Med Fac, Inst Neuropathol, Freiburg, Germany.; Prinz, M (corresponding author), Univ Freiburg, Signalling Res Ctr BIOSS, Freiburg, Germany.; Prinz, M (corresponding author), Univ Freiburg, CIBSS, Freiburg, Germany.; Prinz, M (corresponding author), Univ Freiburg, Fac Med, Ctr Basics NeuroModulat NeuroModulBas, Freiburg, Germany.	katharina.borst@uniklinik-freiburg.de; anaelle.dumas@uniklinik-freiburg.de; marco.prinz@uniklinik-freiburg.de						Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2018, NAT NEUROSCI, V21, P541, DOI 10.1038/s41593-018-0100-x; Akkari L, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw7843; Allende ML, 2021, CELL SIGNAL, V78, DOI 10.1016/j.cellsig.2020.109879; Alvarez-Castelao B, 2017, NAT BIOTECHNOL, V35, P1196, DOI 10.1038/nbt.4016; Antunes ARP, 2021, NAT NEUROSCI, V24, P595, DOI 10.1038/s41593-020-00789-y; Askew K, 2017, CELL REP, V18, P391, DOI 10.1016/j.celrep.2016.12.041; Ayata P, 2018, NAT NEUROSCI, V21, P1049, DOI 10.1038/s41593-018-0192-3; Balzano M, 2017, J FOOD COMPOS ANAL, V59, P88, DOI 10.1016/j.jfca.2017.01.013; Baxter PS, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108882; Beckmann N, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0510-8; Bennett FC, 2018, NEURON, V98, P1170, DOI 10.1016/j.neuron.2018.05.014; Berghoff SA, 2021, NAT NEUROSCI, V24, P47, DOI 10.1038/s41593-020-00757-6; Bottcher C, 2019, NAT NEUROSCI, V22, P78, DOI 10.1038/s41593-018-0290-2; Bohlen CJ, 2017, NEURON, V94, P759, DOI 10.1016/j.neuron.2017.04.043; Bowman RL, 2016, CELL REP, V17, P2445, DOI 10.1016/j.celrep.2016.10.052; Brown DG, 2019, ELIFE, V8, DOI 10.7554/eLife.47117; Buonfiglioli A, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01156-z; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Cantuti-Castelvetri L, 2018, SCIENCE, V359, P684, DOI 10.1126/science.aan4183; Carrillo-Jimenez A, 2019, CELL REP, V29, P697, DOI 10.1016/j.celrep.2019.09.013; Chao CC, 2019, CELL, V179, P1483, DOI 10.1016/j.cell.2019.11.016; Cheadle L, 2020, NEURON, V108, P451, DOI 10.1016/j.neuron.2020.08.002; Cheng BY, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.633796; Chhatbar C, 2018, CELL REP, V25, P118, DOI 10.1016/j.celrep.2018.09.003; Clark IC, 2021, SCIENCE, V372, P360, DOI 10.1126/science.abf1230; Jordao MJC, 2019, SCIENCE, V363, P365, DOI 10.1126/science.aat7554; Cserep C, 2020, SCIENCE, V367, P528, DOI 10.1126/science.aax6752; Damisah EC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba3239; Darmanis S, 2017, CELL REP, V21, P1399, DOI 10.1016/j.celrep.2017.10.030; Ding X, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22301-1; Dong YF, 2021, NAT NEUROSCI, V24, P489, DOI 10.1038/s41593-021-00801-z; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Eyo UB, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109080; Eyo UB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19205-4; Fekete R, 2018, ACTA NEUROPATHOL, V136, P461, DOI 10.1007/s00401-018-1885-0; Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Friebel E, 2020, CELL, V181, P1626, DOI 10.1016/j.cell.2020.04.055; Friedrich M, 2021, NAT CANCER, V2, P723, DOI 10.1038/s43018-021-00201-z; Fuger P, 2017, NAT NEUROSCI, V20, P1371, DOI 10.1038/nn.4631; Galli E, 2019, NAT MED, V25, P1290, DOI 10.1038/s41591-019-0521-4; Gangoso E, 2021, CELL, V184, P2454, DOI 10.1016/j.cell.2021.03.023; Gao H, 2017, CELL REP, V18, P198, DOI 10.1016/j.celrep.2016.11.083; Garber C, 2019, NAT NEUROSCI, V22, P1276, DOI 10.1038/s41593-019-0427-y; Gerrits E, 2021, ACTA NEUROPATHOL, V141, P681, DOI 10.1007/s00401-021-02263-w; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goldmann T, 2013, NAT NEUROSCI, V16, P1618, DOI 10.1038/nn.3531; Goldmann T, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/208093; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Greter M, 2012, IMMUNITY, V37, P1050, DOI 10.1016/j.immuni.2012.11.001; Guldner IH, 2020, CELL, V183, P1234, DOI 10.1016/j.cell.2020.09.064; Gunner G, 2019, NAT NEUROSCI, V22, P1075, DOI 10.1038/s41593-019-0419-y; Guo XF, 2019, NEURO-ONCOLOGY, V21, P1250, DOI 10.1093/neuonc/noz080; Guttikonda SR, 2021, NAT NEUROSCI, V24, P343, DOI 10.1038/s41593-020-00796-z; Hagemeyer N, 2017, ACTA NEUROPATHOL, V134, P441, DOI 10.1007/s00401-017-1747-1; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Huang YT, 2021, NAT IMMUNOL, V22, P586, DOI 10.1038/s41590-021-00913-5; Iida T, 2019, EUR J NEUROSCI, V49, P1400, DOI 10.1111/ejn.14325; Jafari M, 2021, NAT NEUROSCI, V24, P355, DOI 10.1038/s41593-020-00780-7; Jha MK, 2019, NEUROSCIENTIST, V25, P227, DOI 10.1177/1073858418783959; Kana V, 2019, J EXP MED, V216, P2265, DOI 10.1084/jem.20182037; Kano S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aar2124; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kierdorf K, 2019, J EXP MED, V216, P2223, DOI 10.1084/jem.20191535; Kierdorf K, 2019, NAT REV NEUROSCI, V20, P547, DOI 10.1038/s41583-019-0201-x; Kierdorf K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058544; Kim JS, 2021, IMMUNITY, V54, P176, DOI 10.1016/j.immuni.2020.11.007; Klemm F, 2020, CELL, V181, P1643, DOI 10.1016/j.cell.2020.05.007; Komuczki J, 2019, IMMUNITY, V50, P1289, DOI 10.1016/j.immuni.2019.04.006; Kracht L, 2020, SCIENCE, V369, P530, DOI 10.1126/science.aba5906; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Lehrman EK, 2018, NEURON, V100, P120, DOI 10.1016/j.neuron.2018.09.017; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Li T, 2020, EMBO J, V39, DOI 10.15252/embj.2019104136; Liddelow SA, 2020, TRENDS IMMUNOL, V41, P820, DOI 10.1016/j.it.2020.07.006; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu YU, 2019, NAT NEUROSCI, V22, P1771, DOI 10.1038/s41593-019-0511-3; Lloyd AF, 2019, NAT REV NEUROL, V15, P447, DOI 10.1038/s41582-019-0184-2; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Masuda T, 2020, NAT IMMUNOL, V21, P802, DOI 10.1038/s41590-020-0707-4; Masuda T, 2019, NATURE, V566, P388, DOI 10.1038/s41586-019-0924-x; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922; McAlpine CS, 2021, NATURE, V595, P701, DOI 10.1038/s41586-021-03734-6; Merlini M, 2021, NAT NEUROSCI, V24, P19, DOI 10.1038/s41593-020-00756-7; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Mohebiany AN, 2020, CELL REP, V30, P1585, DOI 10.1016/j.celrep.2019.12.097; Moseman EA, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abb1817; Mrdjen D, 2018, IMMUNITY, V48, P599, DOI 10.1016/j.immuni.2018.02.014; Mundt S, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau8380; Nemes-Baran AD, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108047; Nguyen PT, 2020, CELL, V182, P388, DOI 10.1016/j.cell.2020.05.050; Norris GT, 2018, J EXP MED, V215, P1789, DOI 10.1084/jem.20172244; Nugent AA, 2020, NEURON, V105, P837, DOI 10.1016/j.neuron.2019.12.007; O'Koren EG, 2019, IMMUNITY, V50, P723, DOI 10.1016/j.immuni.2019.02.007; Ochocka N, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21407-w; Olah M, 2012, GLIA, V60, P306, DOI 10.1002/glia.21266; Pan J, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01774-9; Paolicelli RC, 2011, SCIENCE, V333, P1456, DOI 10.1126/science.1202529; Parhizkar S, 2019, NAT NEUROSCI, V22, P191, DOI 10.1038/s41593-018-0296-9; Pasciuto E, 2020, CELL, V182, P625, DOI 10.1016/j.cell.2020.06.026; Perga S, 2021, BRAIN PATHOL, V31, P283, DOI 10.1111/bpa.12906; Petkovic F, 2017, J NEUROIMMUNOL, V310, P97, DOI [10.1016/j.jneuroim.2017.07.003, 10.1016/j.joeuroim.2017.07.003]; Petkovic F, 2016, GLIA, V64, P2104, DOI 10.1002/glia.23043; Poliani PL, 2015, J CLIN INVEST, V125, P2161, DOI 10.1172/JCI77983; Prinz M, 2021, ANNU REV IMMUNOL, V39, P251, DOI 10.1146/annurev-immunol-093019-110159; Prinz M, 2019, CELL, V179, P292, DOI 10.1016/j.cell.2019.08.053; Prinz M, 2017, NAT NEUROSCI, V20, P136, DOI 10.1038/nn.4475; Qu WH, 2020, J NEUROSCI, V40, P9552, DOI 10.1523/JNEUROSCI.2193-20.2020; Quail DF, 2016, SCIENCE, V352, DOI 10.1126/science.aad3018; Reu P, 2017, CELL REP, V20, P779, DOI 10.1016/j.celrep.2017.07.004; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Safaiyan S, 2016, NAT NEUROSCI, V19, P995, DOI 10.1038/nn.4325; Sankowski R, 2019, NAT NEUROSCI, V22, P2098, DOI 10.1038/s41593-019-0532-y; Schirmer L, 2019, NATURE, V573, P75, DOI 10.1038/s41586-019-1404-z; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Schwabenland M, 2021, IMMUNITY, V54, P1594, DOI 10.1016/j.immuni.2021.06.002; Scott-Hewitt N, 2020, EMBO J, V39, DOI 10.15252/embj.2020105380; Shemer A, 2020, IMMUNITY, V53, P1033, DOI 10.1016/j.immuni.2020.09.018; Shen K, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108835; Sheng L, 2019, FASEB J, V33, P10425, DOI 10.1096/fj.201900527R; Sobue A, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-020-01099-x; Soreq L, 2017, CELL REP, V18, P557, DOI 10.1016/j.celrep.2016.12.011; Steinbach K, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav5519; Stowell RD, 2019, NAT NEUROSCI, V22, P1782, DOI 10.1038/s41593-019-0514-0; Takata K, 2017, IMMUNITY, V47, P183, DOI 10.1016/j.immuni.2017.06.017; Tan IL, 2021, ONCOGENE, V40, P396, DOI 10.1038/s41388-020-01536-0; Tay TL, 2017, NAT NEUROSCI, V20, P793, DOI 10.1038/nn.4547; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Voet S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04376-5; von Saucken VE, 2020, NEUROBIOL DIS, V145, DOI 10.1016/j.nbd.2020.105072; Wallace J, 2020, ELIFE, V9, DOI 10.7554/eLife.50531; Wallmann T, 2018, ISCIENCE, V9, P71, DOI 10.1016/j.isci.2018.10.011; Waltl I, 2018, BRAIN BEHAV IMMUN, V74, P186, DOI 10.1016/j.bbi.2018.09.006; Wang C, 2020, SCIENCE, V367, P688, DOI 10.1126/science.aaz2288; Wang J, 2020, NEURON, V108, P876, DOI 10.1016/j.neuron.2020.09.016; Wang LB, 2021, CANCER CELL, V39, P509, DOI 10.1016/j.ccell.2021.01.006; Weinhard L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03566-5; Werneburg S, 2020, IMMUNITY, V52, P167, DOI 10.1016/j.immuni.2019.12.004; Wheeler DL, 2018, J CLIN INVEST, V128, P931, DOI 10.1172/JCI97229; Wheeler MA, 2019, CELL, V176, P581, DOI 10.1016/j.cell.2018.12.012; Wieghofer P, 2021, EMBO J, V40, DOI 10.15252/embj.2020105123; Winkles JA, 2008, NAT REV DRUG DISCOV, V7, P411, DOI 10.1038/nrd2488; Wlodarczyk A, 2017, EMBO J, V36, P3292, DOI 10.15252/embj.201696056; Wolf Y, 2018, EUR J IMMUNOL, V48, P1308, DOI 10.1002/eji.201847540; Yan D, 2017, ONCOGENE, V36, P6049, DOI 10.1038/onc.2017.261; Yao MJ, 2020, CELL, V180, P502, DOI 10.1016/j.cell.2019.12.024; Zhang JQ, 2020, FRONT CELL NEUROSCI, V14, DOI 10.3389/fncel.2020.00195	155	29	31	19	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2194	2208		10.1016/j.immuni.2021.09.014	http://dx.doi.org/10.1016/j.immuni.2021.09.014		OCT 2021	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34644556	Bronze			2022-12-18	WOS:000706854100009
J	Schenkel, JM; Herbst, RH; Canner, D; Li, A; Hillman, M; Shanahan, SL; Gibbons, G; Smith, OC; Kim, JY; Westcott, P; Hwang, WL; Freed-Pastor, WA; Eng, G; Cuoco, MS; Rogers, P; Park, JK; Burger, ML; Rozenblatt-Rosen, O; Cong, L; Pauken, KE; Regev, A; Jacks, T				Schenkel, Jason M.; Herbst, Rebecca H.; Canner, David; Li, Amy; Hillman, Michelle; Shanahan, Sean-Luc; Gibbons, Grace; Smith, Olivia C.; Kim, Jonathan Y.; Westcott, Peter; Hwang, William L.; Freed-Pastor, William A.; Eng, George; Cuoco, Michael S.; Rogers, Patricia; Park, Jin K.; Burger, Megan L.; Rozenblatt-Rosen, Orit; Cong, Le; Pauken, Kristen E.; Regev, Aviv; Jacks, Tyler			Conventional type I dendritic cells maintain a reservoir of proliferative tumor-antigen specific TCF-1(+) CD8(+) T cells in tumor-draining lymph nodes	IMMUNITY			English	Article							SUBSETS; DIFFERENTIATION; IMMUNOTHERAPY; PROGENITORS; DYSFUNCTION; EXHAUSTION; MIGRATION; RESPONSES; PD-L1	In tumors, a subset of CD8(+) T cells expressing the transcription factor TCF-1 drives the response to immune checkpoint blockade. We examined the mechanisms that maintain these cells in an autochthonous model of lung adenocarcinoma. Longitudinal sampling and single-cell sequencing of tumor-antigen specific TCF-1(+) CD8(+) T cells revealed that while intratumoral TCF-1(+) CD8(+) T cells acquired dysfunctional features and decreased in number as tumors progressed, TCF-1(+) CD8(+) T cell frequency in the tumor draining LN (dLN) remained stable. Two discrete intratumoral TCF-1(+) CD8(+) T cell subsets developed over time-a proliferative SlamF6(+) subset and a non-cycling SlamF6(-) subset. Blocking dLN egress decreased the frequency of intratumoral SlamF6(+) TCF-1+ CD8(+) T cells. Conventional type I dendritic cell (cDC1) in dLN decreased in number with tumor progression, and Flt3L+anti-CD40 treatment recovered SlamF6(+) T cell frequencies and decreased tumor burden. Thus, cDC1s in tumor dLN maintain a reservoir of TCF-1(+) CD8(+) T cells and their decrease contributes to failed anti-tumor immunity.	[Schenkel, Jason M.; Canner, David; Li, Amy; Hillman, Michelle; Shanahan, Sean-Luc; Gibbons, Grace; Smith, Olivia C.; Kim, Jonathan Y.; Westcott, Peter; Hwang, William L.; Freed-Pastor, William A.; Eng, George; Park, Jin K.; Burger, Megan L.; Regev, Aviv; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, 500 Main St, Cambridge, MA 02139 USA; [Schenkel, Jason M.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Schenkel, Jason M.; Herbst, Rebecca H.; Li, Amy; Park, Jin K.] Harvard Med Sch, 25 Shattuck St, Boston, MA 02115 USA; [Herbst, Rebecca H.; Hwang, William L.; Cuoco, Michael S.; Rogers, Patricia; Rozenblatt-Rosen, Orit; Regev, Aviv] Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA; [Canner, David; Li, Amy; Regev, Aviv; Jacks, Tyler] MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Hwang, William L.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Freed-Pastor, William A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Eng, George] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Cong, Le] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Pauken, Kristen E.] Harvard Med Sch, Blavatnik Inst, Dept Immunol, Boston, MA 02115 USA; [Pauken, Kristen E.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Pauken, Kristen E.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Regev, Aviv] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA; [Herbst, Rebecca H.] Immunai, 180 Varick St, New York, NY 10014 USA; [Canner, David] Soleus Capital, 11 Elery St, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Stanford University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Roche Holding; Genentech	Regev, A; Jacks, T (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 500 Main St, Cambridge, MA 02139 USA.; Regev, A (corresponding author), Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA.; Regev, A; Jacks, T (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Regev, A (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	aviv.regev.sc@gmail.com; tjacks@mit.edu	Rozenblatt-Rosen, Orit/HDN-4182-2022; Cong, Le/M-9981-2013	Smith, Olivia/0000-0002-2788-9917; Herbst, Rebecca/0000-0002-1004-8919; Cong, Le/0000-0003-4725-8714	Howard Hughes Medical Institute; Klarman Cell Observatory at the Broad Institute; Ludwig Center at MIT; National Institutes of Health [PO1-CA42063]; National Cancer Institute, a NIH [T32GM007287, T32CA251062]; NCI [K08CA256044]; National Science Foundation Fellowship; Cancer Center Support [P30-CA14051]	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Klarman Cell Observatory at the Broad Institute; Ludwig Center at MIT; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute, a NIH; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation Fellowship(National Science Foundation (NSF)); Cancer Center Support	We thank M. Singer and S. Riesenfeld for thoughtful discussion and technical advice; S. Levine at the MIT BioMicro Center for sequencing support; C. Otis and S. Saldi in the Broad Flow Cytometry Core and G. Paradis in the Koch Institute Flow Cytometry Facility for flow cytometry assistance; K. Cormier and C. Condon from the Hope Babette Tang (1983) Histology Facility for histology assistance; L. Gaffney and A. Hupalowska for artwork and advice on figures; K. Anderson, J. Teixeira, M. Magendantz, and K. Yee for administrative and logistical support. This work was supported by the Howard Hughes Medical Institute (T.J. and A.R.), the Klarman Cell Observatory at the Broad Institute (A.R.), and The Ludwig Center at MIT (A.R.). This work was supported by grant PO1-CA42063 from the National Institutes of Health and supported in part by Cancer Center Support grant P30-CA14051 from the National Cancer Institute, a NIH Pre-Doctoral Training Grant T32GM007287 (A.L.), an Oncopathology Training Grant T32CA251062 (J.M.S), NCI K08CA256044 (J.M.S.), and a National Science Foundation Fellowship (D.C.). T.J. is a Daniel K. Ludwig Scholar.	Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Bielecki P, 2021, NATURE, V592, P128, DOI 10.1038/s41586-021-03188-w; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Burger ML, 2021, CELL, V184, P4996, DOI 10.1016/j.cell.2021.08.020; Czechowicz A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08201-x; Dey KK, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006599; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; DuPage M, 2011, CANCER CELL, V19, P72, DOI 10.1016/j.ccr.2010.11.011; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Fransen MF, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124507; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Kallies A, 2020, NAT REV IMMUNOL, V20, P128, DOI 10.1038/s41577-019-0223-7; Kamphorst AO, 2017, P NATL ACAD SCI USA, V114, P4993, DOI 10.1073/pnas.1705327114; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kurtulus S, 2019, IMMUNITY, V50, P181, DOI 10.1016/j.immuni.2018.11.014; Li A, 2019, CELL REP, V29, P2998, DOI 10.1016/j.celrep.2019.10.120; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li FB, 2011, SCIENCE, V333, P1030, DOI 10.1126/science.1206954; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Mayoux M, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aav7431; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Oh SA, 2020, NAT CANCER, V1, P681, DOI 10.1038/s43018-020-0075-x; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Penaloza-MacMaster P, 2015, J IMMUNOL, V195, P1054, DOI 10.4049/jimmunol.1403237; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Pritchard JK, 2000, GENETICS, V155, P945; Ribas A, 2018, SCIENCE, V359, P1350, DOI 10.1126/science.aar4060; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Schwab SR, 2007, NAT IMMUNOL, V8, P1295, DOI 10.1038/ni1545; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Singer M, 2017, CELL, V171, P1221, DOI 10.1016/j.cell.2017.11.006; Sundblad V, 2017, J IMMUNOL, V199, P3721, DOI 10.4049/jimmunol.1701172; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Valpione S, 2020, NAT CANCER, V1, P210, DOI 10.1038/s43018-019-0022-x; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Worbs T, 2017, NAT REV IMMUNOL, V17, P30, DOI 10.1038/nri.2016.116; Wu TD, 2020, NATURE, V579, P274, DOI 10.1038/s41586-020-2056-8; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3	53	29	30	15	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2338	+		10.1016/j.immuni.2021.08.026	http://dx.doi.org/10.1016/j.immuni.2021.08.026		OCT 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34534439	Bronze, Green Accepted			2022-12-18	WOS:000706854100019
J	DiPiazza, AT; Leist, SR; Abiona, OM; Moliva, JI; Werner, A; Minai, M; Nagata, BM; Bock, KW; Phung, E; Schafer, A; Dinnon, KH; Chang, LA; Loomis, RJ; Boyoglu-Barnum, S; Alvarado, GS; Sullivan, NJ; Edwards, DK; Morabito, KM; Mascola, JR; Carfi, A; Corbett, KS; Moore, IN; Baric, RS; Graham, BS; Ruckwardt, TJ				DiPiazza, Anthony T.; Leist, Sarah R.; Abiona, Olubukola M.; Moliva, Juan, I; Werner, Anne; Minai, Mahnaz; Nagata, Bianca M.; Bock, Kevin W.; Phung, Emily; Schafer, Alexandra; Dinnon, Kenneth H., III; Chang, Lauren A.; Loomis, Rebecca J.; Boyoglu-Barnum, Seyhan; Alvarado, Gabriela S.; Sullivan, Nancy J.; Edwards, Darin K.; Morabito, Kaitlyn M.; Mascola, John R.; Carfi, Andrea; Corbett, Kizzmekia S.; Moore, Ian N.; Baric, Ralph S.; Graham, Barney S.; Ruckwardt, Tracy J.			COVID-19 vaccinemRNA-1273 elicits a protective immune profile inmice that is not associated with vaccine-enhanceddiseaseuponSARS-CoV-2 challenge	IMMUNITY			English	Article							SYNCYTIAL VIRUS RSV; G-GLYCOPROTEIN; T-CELLS; MEASLES-VIRUS; SARS-COV; IMMUNIZATION; DISEASE; MICE; SPIKE; EOSINOPHILIA	Vaccine-associated enhanced respiratory disease (VAERD) was previously observed in some preclinical models of severe acute respiratory syndrome (SARS) and MERS coronavirus vaccines. We used the SARS coronavirus 2 (SARS-CoV-2) mouse-adapted, passage 10, lethal challenge virus (MA10) mouse model of acute lung injury to evaluate the immune response and potential for immunopathology in animals vaccinated with research-grade mRNA-1273. Whole-inactivated virus or heat-denatured spike protein subunit vaccines with alum designed to elicit low-potency antibodies and Th2-skewed CD4(+) T cells resulted in reduced viral titers and weight loss post challenge but more severe pathological changes in the lung compared to saline-immunized animals. In contrast, a protective dose of mRNA-1273 induced favorable humoral and cellular immune responses that protected from viral replication in the upper and lower respiratory tract upon challenge. A subprotective dose of mRNA-1273 reduced viral replication and limited histopathological manifestations compared to animals given saline. Overall, our findings demonstrate an immunological signature associated with antiviral protection without disease enhancement following vaccination with mRNA-1273.	[DiPiazza, Anthony T.; Abiona, Olubukola M.; Moliva, Juan, I; Werner, Anne; Phung, Emily; Chang, Lauren A.; Loomis, Rebecca J.; Boyoglu-Barnum, Seyhan; Alvarado, Gabriela S.; Sullivan, Nancy J.; Morabito, Kaitlyn M.; Mascola, John R.; Corbett, Kizzmekia S.; Graham, Barney S.; Ruckwardt, Tracy J.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Leist, Sarah R.; Schafer, Alexandra; Dinnon, Kenneth H., III; Baric, Ralph S.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Minai, Mahnaz; Nagata, Bianca M.; Bock, Kevin W.; Moore, Ian N.] NIAID, Infect Dis Pathogenesis Sect, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Edwards, Darin K.; Carfi, Andrea] Moderna Inc, Cambridge, MA 02139 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Graham, BS; Ruckwardt, TJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	bgraham@mail.nih.gov; truckwardt@mail.nih.gov		Werner, Anne/0000-0003-2322-6830; Chang, Lauren/0000-0002-3287-3987	Vaccine Research Center, National Institute of Allergy and Infectious Diseases; NIH [U01 AI149644, U54 CA260543]	Vaccine Research Center, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by intramural funding from the Vaccine Research Center, National Institute of Allergy and Infectious Diseases, and NIH grant numbers U01 AI149644 (R.S.B.) and U54 CA260543 (R.S.B.). The following reagents were obtained through BEI Resources NIAID, NIH: SARSCoV and formaldehyde-and UV-inactivated, purified, NR-3882 and NR3883. The graphical abstract and some figure panels were created using https://biorender.com.We thank DMID, NIAID for the provision of formalin-inactivated SARS-CoV-2.	Anderson EJ, 2020, NEW ENGL J MED, V383, P2427, DOI 10.1056/NEJMoa2028436; Arvin AM, 2020, NATURE, V584, P353, DOI 10.1038/s41586-020-2538-8; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bolles M, 2011, J VIROL, V85, P12201, DOI 10.1128/JVI.06048-11; Bottcher E, 2006, J VIROL, V80, P9896, DOI 10.1128/JVI.01118-06; Braun J, 2020, NATURE, V587, P270, DOI 10.1038/s41586-020-2598-9; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Chen P, 2021, NEW ENGL J MED, V384, P229, DOI 10.1056/NEJMoa2029849; Chen ZY, 2020, NAT REV IMMUNOL, V20, P529, DOI 10.1038/s41577-020-0402-6; COFFMAN RL, 1993, ADV IMMUNOL, V54, P229, DOI 10.1016/S0065-2776(08)60536-2; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Corbett KS, 2020, NEW ENGL J MED, V383, P1544, DOI 10.1056/NEJMoa2024671; Corbett Kizzmekia S, 2020, bioRxiv, DOI [10.1038/s41586-020-2622-0, 10.1101/2020.06.11.145920]; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Dan JM, 2016, J IMMUNOL, V197, P983, DOI 10.4049/jimmunol.1600318; de Araujo-Souza PS, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/849573; de Swart RL, 2002, J VIROL, V76, P11561, DOI 10.1128/JVI.76.22.11561-11569.2002; Deming D, 2006, PLOS MED, V3, P2359, DOI 10.1371/journal.pmed.0030525; Dinnon Kenneth H, 2020, bioRxiv, DOI 10.1101/2020.05.06.081497; DiPiazza AT, 2021, BIOCHEM BIOPH RES CO, V538, P211, DOI 10.1016/j.bbrc.2020.10.060; FULGINITI VA, 1967, J AMER MED ASSOC, V202, P1075, DOI 10.1001/jama.202.12.1075; Graham BS, 2020, SCIENCE, V368, P945, DOI 10.1126/science.abb8923; GRAHAM BS, 1993, J IMMUNOL, V151, P2032; Haynes BF, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abe0948; Honda-Okubo Y, 2015, J VIROL, V89, P2995, DOI 10.1128/JVI.02980-14; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Jameson SC, 2009, IMMUNITY, V31, P859, DOI 10.1016/j.immuni.2009.11.007; Johnson TR, 2004, J VIROL, V78, P6024, DOI 10.1128/JVI.78.11.6024-6032.2004; Johnson TR, 2003, J IMMUNOL, V170, P2037, DOI 10.4049/jimmunol.170.4.2037; Johnson TR, 1999, J VIROL, V73, P8485, DOI 10.1128/JVI.73.10.8485-8495.1999; Keech C, 2020, NEW ENGL J MED, V383, P2320, DOI 10.1056/NEJMoa2026920; KIM HW, 1969, AM J EPIDEMIOL, V89, P422, DOI 10.1093/oxfordjournals.aje.a120955; Laczko D, 2020, IMMUNITY, V53, P724, DOI 10.1016/j.immuni.2020.07.019; Lambert PH, 2020, VACCINE, V38, P4783, DOI 10.1016/j.vaccine.2020.05.064; Law JC, 2021, J IMMUNOL, V206, P37, DOI 10.4049/jimmunol.2001067; Lederer K, 2020, IMMUNITY, V53, P1281, DOI 10.1016/j.immuni.2020.11.009; Lee JH, 2021, J EXP MED, V218, DOI 10.1084/jem.20201254; Leist SR, 2020, CELL, V183, P1070, DOI 10.1016/j.cell.2020.09.050; Lipsitch M, 2020, NAT REV IMMUNOL, V20, P709, DOI 10.1038/s41577-020-00460-4; Mosmann TR, 2009, IMMUNOL RES, V45, P173, DOI 10.1007/s12026-009-8098-5; Munoz FM, 2021, VACCINE, V39, P3053, DOI 10.1016/j.vaccine.2021.01.055; NADER PR, 1968, J PEDIATR-US, V72, P22, DOI 10.1016/S0022-3476(68)80396-8; Nakiboneka R, 2019, VACCINE, V37, P113, DOI 10.1016/j.vaccine.2018.11.024; Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382; Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114; Pardi N, 2018, J EXP MED, V215, P1571, DOI 10.1084/jem.20171450; Peeples L, 2020, P NATL ACAD SCI USA, V117, P8218, DOI 10.1073/pnas.2005456117; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Polack FP, 2003, NAT MED, V9, P1209, DOI 10.1038/nm918; Ruckwardt TJ, 2019, IMMUNITY, V51, P429, DOI 10.1016/j.immuni.2019.08.007; Sanders RW, 2021, CELL HOST MICROBE, V29, P327, DOI 10.1016/j.chom.2021.02.002; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Smatti MK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02991; Vogel A.B., 2020, PREFUSION SARS COV 2, V2008, DOI [10.1101/2020.09.08.280818(2020, DOI 10.1101/2020.09.08.280818(2020]; Wang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8712; Weinreich DM, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMoa2108163; Whitmire JK, 2005, J EXP MED, V201, P1053, DOI 10.1084/jem.20041463; Widge AT, 2021, NEW ENGL J MED, V384, P80, DOI 10.1056/NEJMc2032195; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Yang L, 2004, EUR J IMMUNOL, V34, P1617, DOI 10.1002/eji.200424939; Yasui F, 2008, J IMMUNOL, V181, P6337, DOI 10.4049/jimmunol.181.9.6337; Zellweger RM, 2020, EXPERT REV VACCINES, V19, P691, DOI 10.1080/14760584.2020.1800463; Zhou TQ, 2020, CELL REP, V33, DOI [10.1101/2020.06.22.166033, 10.1016/j.celrep.2020.108322]	64	29	29	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1869	+		10.1016/j.immuni.2021.06.018	http://dx.doi.org/10.1016/j.immuni.2021.06.018		AUG 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34270939	Bronze, Green Submitted, Green Published			2022-12-18	WOS:000684589700021
J	Chiou, SH; Tseng, D; Reuben, A; Mallajosyula, V; Molina, IS; Conley, S; Wilhelmy, J; McSween, AM; Yang, XB; Nishimiya, D; Sinha, R; Nabet, BY; Wang, CL; Shrager, JB; Berry, MF; Backhus, L; Lui, NS; Wakelee, HA; Neal, JW; Padda, SK; Berry, GJ; Delaidelli, A; Sorensen, PH; Sotillo, E; Tran, P; Benson, JA; Richards, R; Labanieh, L; Klysz, DD; Louis, DM; Feldman, SA; Diehn, M; Weissman, IL; Zhang, JJ; Wistuba, II; Futreal, PA; Heymach, JV; Garcia, KC; Mackall, CL; Davis, MM				Chiou, Shin-Heng; Tseng, Diane; Reuben, Alexandre; Mallajosyula, Vamsee; Molina, Irene S.; Conley, Stephanie; Wilhelmy, Julie; McSween, Alana M.; Yang, Xinbo; Nishimiya, Daisuke; Sinha, Rahul; Nabet, Barzin Y.; Wang, Chunlin; Shrager, Joseph B.; Berry, Mark F.; Backhus, Leah; Lui, Natalie S.; Wakelee, Heather A.; Neal, Joel W.; Padda, Sukhmani K.; Berry, Gerald J.; Delaidelli, Alberto; Sorensen, Poul H.; Sotillo, Elena; Tran, Patrick; Benson, Jalen A.; Richards, Rebecca; Labanieh, Louai; Klysz, Dorota D.; Louis, David M.; Feldman, Steven A.; Diehn, Maximilian; Weissman, Irving L.; Zhang, Jianjun; Wistuba, Ignacio I.; Futreal, P. Andrew; Heymach, John, V; Garcia, K. Christopher; Mackall, Crystal L.; Davis, Mark M.			Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery	IMMUNITY			English	Article							RNA-SEQ; LYMPHOCYTES; TUMOR; VIRUS; IDENTIFICATION; MICROBIOME; RECOGNITION; PHENOTYPE; EPITOPES; SEQUENCE	To identify disease-relevant T cell receptors (TCRs) with shared antigen specificity, we analyzed 778,938 TCRb chain sequences from 178 non-small cell lung cancer patients using the GLIPH2 (grouping of lymphocyte interactions with paratope hotspots 2) algorithm. We identified over 66,000 shared specificity groups, of which 435 were clonally expanded and enriched in tumors compared to adjacent lung. The antigenic epitopes of one such tumor-enriched specificity group were identified using a yeast peptide-HLA A*02:01 display library. These included a peptide from the epithelial protein TMEM161A, which is overexpressed in tumors and cross-reactive epitopes from Epstein-Barr virus and E. coli. Our findings suggest that this cross-reactivity may underlie the presence of virus-specific T cells in tumor infiltrates and that pathogen cross-reactivity may be a feature of multiple cancers. The approach and analytical pipelines generated in this work, as well as the specificity groups defined here, present a resource for understanding the T cell response in cancer.	[Chiou, Shin-Heng; Mallajosyula, Vamsee; Molina, Irene S.; McSween, Alana M.; Wang, Chunlin; Louis, David M.; Davis, Mark M.] Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Tseng, Diane; Wakelee, Heather A.; Neal, Joel W.; Padda, Sukhmani K.] Stanford Univ, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Reuben, Alexandre; Zhang, Jianjun; Heymach, John, V] MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Div Canc Med, Houston, TX 77030 USA; [Conley, Stephanie; Sinha, Rahul; Diehn, Maximilian; Weissman, Irving L.] Stanford Univ, Inst Stem Cell Biol, Stanford, CA 94305 USA; [Conley, Stephanie; Sinha, Rahul; Diehn, Maximilian; Weissman, Irving L.] Stanford Univ, Regenerat Med Inst, Stanford, CA 94305 USA; [Wilhelmy, Julie] Stanford Univ, Stanford Genome Technol Ctr, Stanford, CA 94305 USA; [Yang, Xinbo; Nishimiya, Daisuke; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol & Struct Biol, Stanford, CA 94305 USA; [Nabet, Barzin Y.; Diehn, Maximilian] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Shrager, Joseph B.; Backhus, Leah; Lui, Natalie S.; Benson, Jalen A.] Stanford Univ, Dept Cardiothorac Surg Thorac Surg, Stanford, CA 94305 USA; [Shrager, Joseph B.; Berry, Mark F.; Backhus, Leah; Lui, Natalie S.; Wakelee, Heather A.; Neal, Joel W.; Diehn, Maximilian] Stanford Canc Inst, Stanford, CA 94305 USA; [Berry, Gerald J.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Delaidelli, Alberto; Sorensen, Poul H.] British Columbia Canc Res Ctr, Dept Mol Oncol, Vancouver, BC V5Z 1L3, Canada; [Sotillo, Elena; Tran, Patrick; Richards, Rebecca; Labanieh, Louai; Klysz, Dorota D.; Mackall, Crystal L.] Stanford Univ, Ctr Canc Cell Therapy, Stanford Canc Inst, Stanford, CA 94305 USA; [Richards, Rebecca; Feldman, Steven A.; Mackall, Crystal L.] Stanford Univ, Dept Pediat, Stanford, CA 94305 USA; [Labanieh, Louai] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Mackall, Crystal L.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Zhang, Jianjun; Futreal, P. Andrew] MD Anderson Canc Ctr, Dept Genom Med, Div Canc Med, Houston, TX 77030 USA; [Wistuba, Ignacio I.] MD Anderson Canc Ctr, Dept Translat Mol Pathol, Div Pathol & Lab Med, Houston, TX 77030 USA; [Garcia, K. Christopher; Davis, Mark M.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Chiou, Shin-Heng] Rutgers State Univ, Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA; [Tseng, Diane] Univ Washington, Fred Hutchinson Canc Res Ctr, Div Clin Res, Dept Med,Div Med Oncol, Seattle, WA 98109 USA	Stanford University; Stanford University; University of Texas System; UTMD Anderson Cancer Center; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University; British Columbia Cancer Agency; Stanford Cancer Institute; Stanford University; Stanford University; Stanford University; Stanford University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Howard Hughes Medical Institute; Stanford University; Stanford University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Davis, MM (corresponding author), Stanford Univ, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.; Davis, MM (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.; Davis, MM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	mmdavis@stanford.edu	Tseng, Diane/AAE-2010-2020	Sotillo, Elena/0000-0002-3993-1932; Mallajosyula, Vamsee/0000-0002-0658-3652; Davis, Mark/0000-0001-6868-657X; Tseng, Diane/0000-0002-4420-6399; Berry, Gerald/0000-0002-6176-2629; Klysz, Dorota/0000-0002-6733-6110	Virginia and D.K. Ludwig Fund for Cancer Research; Howard Hughes Medical Institute; St. Baldrick's-Stand Up to Cancer Dream Team Translational Research grant [SU2C-AACR-DT-27-17]; Lung Cancer Research Foundation scientific grant; Ellie Guardino Cancer Foundation Award from the Stanford Cancer Institute; Stanford School of Medicine Honorary Dean's Fellowship; Conquer Cancer Foundation of ASCO Young Investigator Award; National Cancer Institute of the National Institutes of Health [R01CA234629-01]; AACR-Johnson & Johnson Lung Cancer Innovation Science grant [18-90-52-ZHAN]; Cancer Prevention and Research Institute of Texas Multi-Investigator Research Award grant [RP160668]; University of Texas Lung Specialized Programs of Research Excellence grant [P50CA70907]; NIH [S10RR025518-01, S10RR027431-01, 1 S10 RR025468-01, U54 CA232568-01, 5P30CA124435, 5RO1AI03867, U19 AI057229]; Rutgers Cancer Institute of New Jersey [P30CA072720-5921]; American Association for Cancer Research; Parker Institute for Cancer Immunotherapy	Virginia and D.K. Ludwig Fund for Cancer Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); St. Baldrick's-Stand Up to Cancer Dream Team Translational Research grant; Lung Cancer Research Foundation scientific grant; Ellie Guardino Cancer Foundation Award from the Stanford Cancer Institute; Stanford School of Medicine Honorary Dean's Fellowship; Conquer Cancer Foundation of ASCO Young Investigator Award; National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AACR-Johnson & Johnson Lung Cancer Innovation Science grant; Cancer Prevention and Research Institute of Texas Multi-Investigator Research Award grant; University of Texas Lung Specialized Programs of Research Excellence grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rutgers Cancer Institute of New Jersey; American Association for Cancer Research; Parker Institute for Cancer Immunotherapy	This work was supported by Parker Institute for Cancer Immunotherapy, Virginia and D.K. Ludwig Fund for Cancer Research, the Howard Hughes Medical Institute, NIH U54 CA232568-01, NIH 5P30CA124435 (C.L.M.), NIH 5RO1AI03867, NIH U19 AI057229, and a St. Baldrick's-Stand Up to Cancer Dream Team Translational Research grant (SU2C-AACR-DT-27-17). Stand Up to Cancer is a division of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the scien-tific partner of SU2C. C.L.M. and M.M.D. are members of the Parker Institute for Cancer Immunotherapy, which provided partial funding for this project. D.T. was funded by a Lung Cancer Research Foundation scientific grant, Ellie Guardino Cancer Foundation Award from the Stanford Cancer Institute, a Stanford School of Medicine Honorary Dean's Fellowship, and a Conquer Cancer Foundation of ASCO Young Investigator Award. Any opinions, findings, and conclusions expressed in this material are those of the author(s) and do not necessarily reflect those of the American Society of Clinical Oncology or the Conquer Cancer Foundation. This work was also funded in part by the National Cancer Institute of the National Institutes of Health Research Project grant (R01CA234629-01), the AACR-Johnson & Johnson Lung Cancer Innovation Science grant (18-90-52-ZHAN), the Cancer Prevention and Research Institute of Texas Multi-Investigator Research Award grant (RP160668), and the University of Texas Lung Specialized Programs of Research Excellence grant (grant number P50CA70907). Flow cytometry and cell-sorting services were provided by (1) the Stanford Shared FACS Facility supported by the NIH S10 Shared Instrument Grants (S10RR025518-01 and S10RR027431-01) and (2) the Flow Cytometry & Cell Sorting Core Facility, a shared resource of Rutgers -Robert Wood Johnson Medical School and the Rutgers Cancer Institute of New Jersey (P30CA072720-5921), and also supported by NIH Shared Instrumentation grant (1 S10 RR025468-01).	Altman John D, 2003, Curr Protoc Immunol, VChapter 17, DOI 10.1002/0471142735.im1703s53; Anagnostou V, 2019, CANCER RES, V79, P1214, DOI 10.1158/0008-5472.CAN-18-1127; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andersen RS, 2012, CANCER RES, V72, P1642, DOI 10.1158/0008-5472.CAN-11-2614; Arstila TP, 1999, SCIENCE, V286, P958, DOI 10.1126/science.286.5441.958; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Bessell CA, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.135597; Cameron SJS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177062; Choi I, 2020, NATURE, DOI 10.1038/s41586-020-03075-w; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Corridoni D, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1003-4; COULIE PG, 1994, J EXP MED, V180, P35, DOI 10.1084/jem.180.1.35; COULIE PG, 1995, P NATL ACAD SCI USA, V92, P7976, DOI 10.1073/pnas.92.17.7976; Dickson RP, 2016, ANNU REV PHYSIOL, V78, P481, DOI 10.1146/annurev-physiol-021115-105238; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Emerson RO, 2017, NAT GENET, V49, P659, DOI 10.1038/ng.3822; Fluckiger A, 2020, SCIENCE, V369, P936, DOI 10.1126/science.aax0701; Gee MH, 2018, CELL, V172, P549, DOI 10.1016/j.cell.2017.11.043; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Harjanto S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086655; Hellmann MD, 2020, CLIN CANCER RES, V26, P2849, DOI 10.1158/1078-0432.CCR-19-3418; Huang H, 2020, NAT BIOTECHNOL, V38, P1194, DOI 10.1038/s41587-020-0505-4; Joglekar AV, 2019, NAT METHODS, V16, P191, DOI 10.1038/s41592-018-0304-8; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Joshi K, 2019, NAT MED, V25, P1549, DOI 10.1038/s41591-019-0592-2; Jurtz V, 2017, J IMMUNOL, V199, P3360, DOI 10.4049/jimmunol.1700893; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P3515, DOI 10.1073/pnas.91.9.3515; Kheir F, 2019, CANCERS, V11, DOI 10.3390/cancers11060759; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; KOZIEL MJ, 1995, J CLIN INVEST, V96, P2311, DOI 10.1172/JCI118287; Kula T, 2019, CELL, V178, P1016, DOI 10.1016/j.cell.2019.07.009; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li GD, 2019, NAT METHODS, V16, P183, DOI 10.1038/s41592-018-0305-7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; McCarthy Edward F, 2006, Iowa Orthop J, V26, P154; Mogilenko D.A., 2020, COMPREHENSIVE PROFIL; MURRAY RJ, 1992, J EXP MED, V176, P157, DOI 10.1084/jem.176.1.157; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Newman JH, 2020, P NATL ACAD SCI USA, V117, P1119, DOI 10.1073/pnas.1904022116; Oakes T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01267; OHASHI PS, 1991, CELL, V65, P305, DOI 10.1016/0092-8674(91)90164-T; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; REHERMANN B, 1995, J EXP MED, V181, P1047, DOI 10.1084/jem.181.3.1047; Reuben A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14273-0; Reynisson B, 2020, NUCLEIC ACIDS RES, V48, pW449, DOI 10.1093/nar/gkaa379; Riquelme E, 2019, CELL, V178, P795, DOI 10.1016/j.cell.2019.07.008; Robins HS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001442; ROCKEN M, 1992, NATURE, V359, P79, DOI 10.1038/359079a0; Rosato PC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08534-1; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Savage PA, 2008, SCIENCE, V319, P215, DOI 10.1126/science.1148886; Scheper W, 2019, NAT MED, V25, P89, DOI 10.1038/s41591-018-0266-5; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sewell AK, 2012, NAT REV IMMUNOL, V12, P668, DOI 10.1038/nri3279; Sharma P, 2020, NAT REV IMMUNOL, V20, P75, DOI 10.1038/s41577-020-0275-8; Shugay M, 2018, NUCLEIC ACIDS RES, V46, pD419, DOI 10.1093/nar/gkx760; Sibener LV, 2018, CELL, V174, P672, DOI 10.1016/j.cell.2018.06.017; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Song I, 2017, NAT STRUCT MOL BIOL, V24, P395, DOI 10.1038/nsmb.3383; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Witwicka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128275; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001	75	29	29	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					586	+		10.1016/j.immuni.2021.02.014	http://dx.doi.org/10.1016/j.immuni.2021.02.014		MAR 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33691136	hybrid, Green Published			2022-12-18	WOS:000627409300022
J	Legoux, F; Salou, M; Lantz, O				Legoux, Francois; Salou, Marion; Lantz, Olivier			MAIT Cell Development and Functions: the Microbial Connection	IMMUNITY			English	Review							INVARIANT T-CELLS; I-RELATED MOLECULE; RECEPTOR HETEROGENEITY; ANTIGEN PRESENTATION; MULTIPLE LAYERS; TISSUE-REPAIR; MR1; IMMUNITY; TCR; RIBOFLAVIN	Mucosal-associated invariant T (MAIT) cells are an evolutionarily conserved T cell subset, which reacts to most bacteria through T cell receptor (TCR)-mediated recognition of metabolites derived from the vitamin B2 biosynthetic pathway. Microbiota-derived signals affect all stages of MAIT cell biology including intrathymic development, peripheral expansion, and functions in specific organs. In tissues, MAIT cells can integrate multiple signals and display effector functions involved in the defense against infectious pathogens. In addition to anti-bacterial activity, MAIT cells improve wound healing in the skin, suggesting a role in epithelium homeostasis through bi-directional interactions with the local microbiota. In humans, blood MAIT cell frequency is modified during several auto-immune diseases, which are often associated with microbiota dysbiosis, further emphasizing the potential interplay of MAIT cells with the microbiota. Here, we will review how microbes interact with MAIT cells, from initial intra-thymic development to tissue colonization and functions.	[Legoux, Francois; Salou, Marion; Lantz, Olivier] PSL Univ, Inst Curie, INSERM, U932, F-75005 Paris, France; [Lantz, Olivier] Inst Curie, Lab Immunol Clin, F-75005 Paris, France; [Lantz, Olivier] Inst Curie, Ctr Invest Clin Biotherapie, CIC BT1428, F-75005 Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Lantz, O (corresponding author), PSL Univ, Inst Curie, INSERM, U932, F-75005 Paris, France.; Lantz, O (corresponding author), Inst Curie, Lab Immunol Clin, F-75005 Paris, France.; Lantz, O (corresponding author), Inst Curie, Ctr Invest Clin Biotherapie, CIC BT1428, F-75005 Paris, France.	olivier.lantz@curie.fr		Salou, Marion/0000-0003-3546-0886; Lantz, olivier/0000-0003-3161-7719	Institut National de la Santeet de la Recherche Medicale; Institut Curie; Agence Nationale de la Recherche (ANR) (Generic call [MAIT]); Institut national du cancer (INCA); Agence Nationale de la Recherche (ANR) (Generic call [NEOMAIT]); Agence Nationale de la Recherche (ANR) (Generic call [DIABMAIT]); Agence Nationale de la Recherche (ANR) (JCJC MAIT); Agence Nationale de la Recherche (ANR) (Labex DCBIOL)	Institut National de la Santeet de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Curie; Agence Nationale de la Recherche (ANR) (Generic call [MAIT])(French National Research Agency (ANR)); Institut national du cancer (INCA)(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche (ANR) (Generic call [NEOMAIT])(French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR) (Generic call [DIABMAIT])(French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR) (JCJC MAIT)(French National Research Agency (ANR)); Agence Nationale de la Recherche (ANR) (Labex DCBIOL)(French National Research Agency (ANR))	This work was supported by the Institut National de la Santeet de la Recherche Medicale, Institut Curie, Agence Nationale de la Recherche (ANR) (Generic call [MAIT, NEOMAIT and DIABMAIT], JCJC MAIT and Labex DCBIOL) and by Institut national du cancer (INCA).	Alferink J, 1998, SCIENCE, V282, P1338, DOI 10.1126/science.282.5392.1338; Annibali V, 2011, BRAIN, V134, P542, DOI 10.1093/brain/awq354; Aron-Wisnewsky J, 2019, GUT, V68, P70, DOI 10.1136/gutjnl-2018-316103; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Awad W, 2020, NAT IMMUNOL, V21, P400, DOI 10.1038/s41590-020-0616-6; Ben Youssef G, 2018, J EXP MED, V215, P459, DOI 10.1084/jem.20171739; Beura LK, 2014, CELL, V157, P1488, DOI 10.1016/j.cell.2014.05.026; Bottcher K, 2018, HEPATOLOGY, V68, P172, DOI 10.1002/hep.29782; Boudinot P, 2016, P NATL ACAD SCI USA, V113, pE2983, DOI 10.1073/pnas.1600674113; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Chen Z, 2017, MUCOSAL IMMUNOL, V10, P58, DOI 10.1038/mi.2016.39; Chua WJ, 2012, INFECT IMMUN, V80, P3256, DOI 10.1128/IAI.00279-12; Constantinides MG, 2019, SCIENCE, V366, P445, DOI 10.1126/science.aax6624; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Crowther MD, 2020, NAT IMMUNOL, V21, P178, DOI 10.1038/s41590-019-0578-8; Cui Y, 2015, J CLIN INVEST, V125, P4171, DOI 10.1172/JCI82424; D'Souza C, 2018, J IMMUNOL, V200, P1901, DOI 10.4049/jimmunol.1701512; Davalos-Misslitz ACM, 2007, BLOOD, V110, P4351, DOI 10.1182/blood-2007-01-070284; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Dias J, 2017, P NATL ACAD SCI USA, V114, pE5434, DOI 10.1073/pnas.1705759114; Dusseaux M, 2011, BLOOD, V117, P1250, DOI 10.1182/blood-2010-08-303339; Eckle SBG, 2014, J EXP MED, V211, P1585, DOI 10.1084/jem.20140484; Fournie JJ, 1996, RES IMMUNOL, V147, P338, DOI 10.1016/0923-2494(96)89648-9; Franciszkiewicz K, 2016, IMMUNOL REV, V272, P120, DOI 10.1111/imr.12423; Georgel P, 2011, MOL IMMUNOL, V48, P769, DOI 10.1016/j.molimm.2010.12.002; Gherardin NA, 2018, IMMUNOL CELL BIOL, V96, P507, DOI 10.1111/imcb.12021; Gherardin NA, 2016, IMMUNITY, V44, P32, DOI 10.1016/j.immuni.2015.12.005; Godfrey DI, 2019, NAT IMMUNOL, V20, P1110, DOI 10.1038/s41590-019-0444-8; Gold MC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000407; Green JA, 2017, J EXP MED, V214, P3565, DOI 10.1084/jem.20170356; Grimaldi D, 2014, INTENS CARE MED, V40, P192, DOI 10.1007/s00134-013-3163-x; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Gutierrez-Arcelus M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08604-4; Harriff MJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao2556; Harrison OJ, 2019, SCIENCE, V363, P43, DOI 10.1126/science.aat6280; Hegde P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04450-y; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hinks TSC, 2019, CELL REP, V28, P3249, DOI 10.1016/j.celrep.2019.07.039; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Howson LJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02540-x; Huang SX, 2009, P NATL ACAD SCI USA, V106, P8290, DOI 10.1073/pnas.0903196106; Jin CC, 2019, CELL, V176, P998, DOI 10.1016/j.cell.2018.12.040; Keller AN, 2017, NAT IMMUNOL, V18, P402, DOI 10.1038/ni.3679; Kelly J, 2019, IMMUNOL CELL BIOL, V97, P689, DOI 10.1111/imcb.12281; Kiselev VY, 2019, NAT REV GENET, V20, P273, DOI 10.1038/s41576-018-0088-9; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Koay HF, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay6039; Koay HF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10198-w; Koay HF, 2016, NAT IMMUNOL, V17, P1300, DOI 10.1038/ni.3565; Kurioka A, 2015, MUCOSAL IMMUNOL, V8, P429, DOI 10.1038/mi.2014.81; Kurioka A, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.51; Lamichhane R, 2020, EUR J IMMUNOL, V50, P178, DOI 10.1002/eji.201948279; Lamichhane R, 2019, CELL REP, V28, P3061, DOI 10.1016/j.celrep.2019.08.054; Lantz O, 2019, CURR OPIN IMMUNOL, V58, P75, DOI 10.1016/j.coi.2019.04.016; Lantz O, 2018, IMMUNOL CELL BIOL, V96, P564, DOI 10.1111/imcb.1034; Law BMP, 2019, J AM SOC NEPHROL, V30, P1322, DOI 10.1681/ASN.2018101064; Le Bourhis L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003681; Le Bourhis L, 2010, NAT IMMUNOL, V11, P701, DOI 10.1038/ni.1890; Le Nours J, 2019, SCIENCE, V366, P1522, DOI 10.1126/science.aav3900; Lee CH, 2018, ELIFE, V7, DOI 10.7554/eLife.32532; Leeansyah E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005072; Legoux F, 2019, SCIENCE, V366, P494, DOI 10.1126/science.aaw2719; Legoux F, 2019, NAT IMMUNOL, V20, P1244, DOI 10.1038/s41590-019-0465-3; Leng TQ, 2019, CELL REP, V28, P3077, DOI 10.1016/j.celrep.2019.08.050; Lepore M, 2017, ELIFE, V6, DOI 10.7554/eLife.24476; Lepore M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4866; Linehan JL, 2018, CELL, V172, P784, DOI 10.1016/j.cell.2017.12.033; Liu RX, 2017, NAT MED, V23, P859, DOI 10.1038/nm.4358; Loh L, 2016, P NATL ACAD SCI USA, V113, P10133, DOI 10.1073/pnas.1610750113; Lu BT, 2020, MUCOSAL IMMUNOL, V13, P824, DOI 10.1038/s41385-020-0273-y; Lu Y, 2019, NAT IMMUNOL, V20, P447, DOI 10.1038/s41590-019-0334-0; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Magalhaes I, 2015, J CLIN INVEST, V125, P1752, DOI 10.1172/JCI78941; Mak JYW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14599; Mao AP, 2016, P NATL ACAD SCI USA, V113, P7602, DOI 10.1073/pnas.1601504113; Martin E, 2009, PLOS BIOL, V7, P525, DOI 10.1371/journal.pbio.1000054; Matzinger P, 2011, NAT REV IMMUNOL, V11, P221, DOI 10.1038/nri2940; McSharry BP, 2020, CELL REP, V30, P2948, DOI 10.1016/j.celrep.2020.02.017; McWilliam HEG, 2016, NAT IMMUNOL, V17, P531, DOI 10.1038/ni.3416; Meermeier EW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12506; Meierovics A, 2013, P NATL ACAD SCI USA, V110, pE3119, DOI 10.1073/pnas.1302799110; Meierovics AI, 2016, J EXP MED, V213, P2793, DOI 10.1084/jem.20160637; Mekinian A, 2017, SCAND J IMMUNOL, V86, P216, DOI 10.1111/sji.12585; Mexhitaj I, 2019, BRAIN, V142, P617, DOI 10.1093/brain/awz017; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Miyazaki Y, 2011, INT IMMUNOL, V23, P529, DOI 10.1093/intimm/dxr047; Mondot S, 2016, IMMUNOGENETICS, V68, P537, DOI 10.1007/s00251-016-0927-9; Nejman D, 2020, SCIENCE, V368, P973, DOI 10.1126/science.aay9189; Pellicci DG, 2020, NAT REV IMMUNOL, V20, P756, DOI 10.1038/s41577-020-0345-y; PORCELLI S, 1993, J EXP MED, V178, P1, DOI 10.1084/jem.178.1.1; Rahimpour A, 2015, J EXP MED, V212, P1095, DOI 10.1084/jem.20142110; Reantragoon R, 2013, J EXP MED, V210, P2305, DOI 10.1084/jem.20130958; Reantragoon R, 2012, J EXP MED, V209, P761, DOI 10.1084/jem.20112095; Riva A, 2018, GUT, V67, P918, DOI 10.1136/gutjnl-2017-314458; Rouxel O, 2017, NAT IMMUNOL, V18, P1321, DOI 10.1038/ni.3854; Salerno-Goncalves R, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00398; Salio M, 2020, P NATL ACAD SCI USA, V117, P10465, DOI 10.1073/pnas.2003136117; Salou M, 2019, TRENDS IMMUNOL, V40, P975, DOI 10.1016/j.it.2019.09.001; Salou M, 2019, J EXP MED, V216, P133, DOI 10.1084/jem.20181483; Salou M, 2017, CURR OPIN IMMUNOL, V48, P7, DOI 10.1016/j.coi.2017.07.009; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schmaler M, 2018, MUCOSAL IMMUNOL, V11, P1060, DOI 10.1038/s41385-018-0020-9; Seach N, 2013, J IMMUNOL, V191, P6002, DOI 10.4049/jimmunol.1301212; Serriari NE, 2014, CLIN EXP IMMUNOL, V176, P266, DOI 10.1111/cei.12277; Seshadri C, 2017, GENES IMMUN, V18, P8, DOI 10.1038/gene.2016.41; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sobkowiak MJ, 2019, EUR J IMMUNOL, V49, P133, DOI 10.1002/eji.201847759; Solis AG, 2019, NATURE, V573, P69, DOI 10.1038/s41586-019-1485-8; Soudais C, 2015, J IMMUNOL, V194, P4641, DOI 10.4049/jimmunol.1403224; Tastan C, 2018, MUCOSAL IMMUNOL, V11, P1591, DOI 10.1038/s41385-018-0072-x; Thomas SY, 2011, J EXP MED, V208, P1179, DOI 10.1084/jem.20102630; Tilloy F, 1999, J EXP MED, V189, P1907, DOI 10.1084/jem.189.12.1907; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Treiner E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00503; Tsukamoto K, 2013, IMMUNOGENETICS, V65, P115, DOI 10.1007/s00251-012-0666-5; Turtle CJ, 2011, BLOOD, V118, P2752, DOI 10.1182/blood-2011-02-334698; Tuttle KD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05026-6; Uchimura Y, 2018, IMMUNITY, V49, P545, DOI 10.1016/j.immuni.2018.08.004; Ussher JE, 2018, IMMUNOL CELL BIOL, V96, P630, DOI 10.1111/imcb.12008; Ussher JE, 2016, EUR J IMMUNOL, V46, P1600, DOI 10.1002/eji.201545969; Ussher JE, 2014, EUR J IMMUNOL, V44, P195, DOI 10.1002/eji.201343509; Vahl JC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001589; Van Dyken SJ, 2013, ANNU REV IMMUNOL, V31, P317, DOI 10.1146/annurev-immunol-032712-095906; van Wilgenburg B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07207-9; van Wilgenburg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11653; Voillet V, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98487; Walker LJ, 2012, BLOOD, V119, P422, DOI 10.1182/blood-2011-05-353789; Wang HG, 2018, ELIFE, V7, DOI 10.7554/eLife.34793; Wang HM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw0402; Wang HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05202-8; Weinreich MA, 2008, J IMMUNOL, V181, P2265, DOI 10.4049/jimmunol.181.4.2265; Willing A, 2018, J IMMUNOL, V200, P974, DOI 10.4049/jimmunol.1701213; Willing A, 2014, EUR J IMMUNOL, V44, P3119, DOI 10.1002/eji.201344160; Winter SJ, 2019, IMMUNOL CELL BIOL, V97, P190, DOI 10.1111/imcb.12211; Xiao XX, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02070; Yan JM, 2020, CANCER DISCOV, V10, P124, DOI 10.1158/2159-8290.CD-19-0569; Zhao F, 2012, IMMUNITY, V36, P1003, DOI 10.1016/j.immuni.2012.05.017	137	29	30	2	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					710	723		10.1016/j.immuni.2020.09.009	http://dx.doi.org/10.1016/j.immuni.2020.09.009			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	33053329	Green Published, Bronze			2022-12-18	WOS:000581062800006
J	Goepfert, A; Lehmann, S; Blank, J; Kolbinger, F; Rondeau, JM				Goepfert, Arnaud; Lehmann, Sylvie; Blank, Jutta; Kolbinger, Frank; Rondeau, Jean-Michel			Structural Analysis Reveals that the Cytokine IL-17F Forms a Homodimeric Complex with Receptor IL-17RC to Drive IL-17RA-Independent Signaling	IMMUNITY			English	Article							DIFFERENTIAL ROLES; INTERLEUKIN 17; ACTIVATION; EXPRESSION; DISCOVERY; PROTEIN; DOMAIN; SUITE; AXIS	Interleukin-17A (IL-17A), IL-17F, and IL-17A/F heterodimers are key cytokines of the innate and adaptive immune response. Dysregulation of the IL-17 pathway contributes to immune pathology, and it is therefore important to elucidate the molecular mechanisms that govern IL-17 recognition and signaling. The receptor IL-17RC is thought to act in concert with IL-17RA to transduce IL-17A-, IL-17F-, and IL-17A/F-mediated signals. We report the crystal structure of the extracellular domain of human IL-17RC in complex with IL-17F. In contrast to the expected model, we found that IL-17RC formed a symmetrical 2:1 complex with IL-17F, thus competing with IL-17RA for cytokine binding. Using biophysical techniques, we showed that IL-17A and IL-17A/F also form 2:1 complexes with IL-17RC, suggesting the possibility of IL-17RA-independent IL-17 signaling pathways. The crystal structure of the IL-17RC:IL-17F complex provides a structural basis for IL-17F signaling through IL-17RC, with potential therapeutic applications for respiratory allergy and inflammatory bowel diseases.	[Goepfert, Arnaud; Lehmann, Sylvie; Blank, Jutta; Kolbinger, Frank; Rondeau, Jean-Michel] Novartis Pharma AG, Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Goepfert, Arnaud] Galapagos SASU, 102 Ave Gaston Roussel, F-93230 Romainville, France	Novartis; Galapagos NV	Rondeau, JM (corresponding author), Novartis Pharma AG, Novartis Inst BioMed Res, CH-4002 Basel, Switzerland.	jeanmichel.rondeau@novartis.com		GOEPFERT, Arnaud/0000-0003-0599-0376	Novartis Institutes for BioMedical Research (NIBR) Postdoc Office	Novartis Institutes for BioMedical Research (NIBR) Postdoc Office	We thank Felix Freuler and Simon Haenni for the cloning of IL-17RC variants, Sylvia Buhr for TR-FRET measurements, Sandra Kapps-Fouthier for support with protein expression and labeling, and Rene Hemmig for support with SEC-MALS analysis. We are grateful to Eva Munoz (AFFINImeter) for expert assistance with ITC data analysis, Vincent Olieric (Swiss Light Source) for his help with native SAD data collection and analysis, and Pr. Dr. Timm Maier (Biozentrum, Basel) for stimulating discussions and advice. This work was supported by a Presidential Postdoc Fellowship awarded to A.G by the Novartis Institutes for BioMedical Research (NIBR) Postdoc Office.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Beringer A, 2016, TRENDS MOL MED, V22, P230, DOI 10.1016/j.molmed.2016.01.001; Bloch Y, 2018, IMMUNITY, V48, P45, DOI 10.1016/j.immuni.2017.12.008; Bricogne G., 2011, BUSTER VERSION 2 11; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; De Luca A, 2017, CELL REP, V20, P1667, DOI 10.1016/j.celrep.2017.07.063; DeLano W. L, 2002, PYMOL MOL GENETICS G; Ely LK, 2009, NAT IMMUNOL, V10, P1245, DOI 10.1038/ni.1813; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Goepfert A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08360-9; Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022; Haudenschild D, 2002, J BIOL CHEM, V277, P4309, DOI 10.1074/jbc.M109372200; Ho AW, 2010, J IMMUNOL, V185, P1063, DOI 10.4049/jimmunol.0903739; Ho AW, 2010, SEMIN IMMUNOPATHOL, V32, P33, DOI 10.1007/s00281-009-0185-0; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Liu SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2880; Manigart S, 2008, ELGAR ORIG REF, P17; Maxwell JR, 2015, IMMUNITY, V43, P739, DOI 10.1016/j.immuni.2015.08.019; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Monin L, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028522; Novatchkova M, 2003, TRENDS BIOCHEM SCI, V28, P226, DOI 10.1016/S0968-0004(03)00067-7; O'Hara Hall Aisling, 2019, Nat Immunol, V20, P374, DOI 10.1038/s41590-019-0332-2; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Pickens SR, 2010, J IMMUNOL, V184, P3233, DOI 10.4049/jimmunol.0903271; Skiniotis G, 2005, NAT STRUCT MOL BIOL, V12, P545, DOI 10.1038/nsmb941; Srinivasan Mythily, 2012, Int J Pept, V2012, P634769, DOI 10.1155/2012/634769; Su Y, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau9657; Tang C, 2018, NAT IMMUNOL, V19, P755, DOI 10.1038/s41590-018-0134-y; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Veldhoen M, 2017, NAT IMMUNOL, V18, P612, DOI 10.1038/ni.3742; Verstraete K, 2012, NAT REV CANCER, V12, P753, DOI 10.1038/nrc3371; Vonrhein C, 2011, ACTA CRYSTALLOGR D, V67, P293, DOI 10.1107/S0907444911007773; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Weinert T, 2015, NAT METHODS, V12, P131, DOI 10.1038/nmeth.3211; WILLIAMSON MP, 1994, BIOCHEM J, V297, P249, DOI 10.1042/bj2970249; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Yao ZB, 1997, CYTOKINE, V9, P794, DOI 10.1006/cyto.1997.0240; You ZB, 2006, CANCER RES, V66, P175, DOI 10.1158/0008-5472.CAN-05-1130; Zrioual S, 2008, J IMMUNOL, V180, P655, DOI 10.4049/jimmunol.180.1.655	53	29	29	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					499	+		10.1016/j.immuni.2020.02.004	http://dx.doi.org/10.1016/j.immuni.2020.02.004			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32187518	Bronze			2022-12-18	WOS:000520600200012
J	Lai, JJ; Cruz, FM; Rock, KL				Lai, Jiann-Jyh; Cruz, Freidrich M.; Rock, Kenneth L.			Immune Sensing of Cell Death through Recognition of Histone Sequences by C-Type Lectin-Receptor-2d Causes Inflammation and Tissue Injury	IMMUNITY			English	Article							INDUCED LIVER-INJURY; OSTEOCLAST INHIBITORY LECTIN; TOLL-LIKE; EXTRACELLULAR HISTONES; F-ACTIN; ENDOGENOUS ADJUVANTS; NLRP3 INFLAMMASOME; CROSS-PRESENTATION; DYING CELLS; RECEPTOR	The immune system monitors the health of cells and is stimulated by necrosis. Here we examined the receptors and ligands driving this response. In a targeted screen of C-type lectin receptors, a Clec2d reporter responded to lysates from necrotic cells. Biochemical purification identified histones, both free and bound to nucleosomes or neutrophil extracellular traps, as Clec2d ligands. Clec2d recognized poly-basic sequences in histone tails and this recognition was sensitive to post-translational modifications of these sequences. As compared with WT mice, Clec2d(-/-) mice exhibited reduced proinflammatory responses to injected histones, and less tissue damage and improved survival in a hepatotoxic injury model. In macrophages, Clec2d localized to the plasma membrane and endosomes. Histone binding to Clec2d did not stimulate kinase activation or cytokine production. Rather, histone-bound DNA stimulated endosomal Tlr9-dependent responses in a Clec2d-dependent manner. Thus, Clec2d binds to histones released upon necrotic cell death, with functional consequences to inflammation and tissue damage.	[Lai, Jiann-Jyh; Cruz, Freidrich M.; Rock, Kenneth L.] Univ Massachusetts, Med Sch, Dept Pathol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Rock, KL (corresponding author), Univ Massachusetts, Med Sch, Dept Pathol, Worcester, MA 01605 USA.	kenneth.rock@umassmed.edu			National Institutes of Health [AI129966];  [PL2-3]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 	We would like to thank Dr. Caetano Reis e Sousa for providing the MSCV-Clec9a/CD3 and MSCV-Dectin-1/CD3 chimeric plasmids; Dr. Matthew Gillespie and Dr. James Carlyle for providing Clec2d<SUP>-/-</SUP> mice; Dr. Shizuo Akira for making available Tlr9<SUP>-/-</SUP> mice; Dr. Ann Marshak-Rothstein for anti-histone antibodies (PL2-3); Dr. Kate Fitzgerald for critical review of the manuscript; Dr. Diego J. Farfan-Arribas, Dr. Jeff Colbert, and Dr. Vicky Kartsogiannis for helpful discussion and technical assistance; and Yu-Hui Chen for help with statistical analysis. This work was supported by the National Institutes of Health (AI129966).	Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Alcover A, 2018, ANNU REV IMMUNOL, V36, P103, DOI 10.1146/annurev-immunol-042617-053429; Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; Allam R, 2012, J AM SOC NEPHROL, V23, P1375, DOI 10.1681/ASN.2011111077; Augusto LA, 2003, BIOCHEMISTRY-US, V42, P3929, DOI 10.1021/bi0268394; Babelova A, 2009, J BIOL CHEM, V284, P24035, DOI 10.1074/jbc.M109.014266; BAMEZAI A, 1989, J IMMUNOL, V143, P3107; Bannister AJ, 2011, CELL RES, V21, P381, DOI 10.1038/cr.2011.22; Bauer F, 2001, PROTEIN SCI, V10, P2470, DOI 10.1110/ps.ps.24401; Brown GD, 2018, NAT REV IMMUNOL, V18, P374, DOI 10.1038/s41577-018-0004-8; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Chen Z, 2017, ANNU REV BIOMED ENG, V19, P195, DOI 10.1146/annurev-bioeng-071516-044720; Chervona Y, 2012, AM J CANCER RES, V2, P589; DESJARDINS M, 1994, J CELL BIOL, V124, P677, DOI 10.1083/jcb.124.5.677; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gange CT, 2004, J BIOL CHEM, V279, P29043, DOI 10.1074/jbc.M312518200; Hanc P, 2015, IMMUNITY, V42, P839, DOI 10.1016/j.immuni.2015.04.009; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Huang H, 2013, J IMMUNOL, V191, P2665, DOI 10.4049/jimmunol.1202733; Huang H, 2011, HEPATOLOGY, V54, P999, DOI 10.1002/hep.24501; Huse M, 2009, J CELL SCI, V122, P1269, DOI 10.1242/jcs.042762; Jaeschke H, 2014, J CLIN TRANSL HEPATO, V2, P153, DOI 10.14218/JCTH.2014.00014; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Kartsogiannis V, 2008, J BIOL CHEM, V283, P30850, DOI 10.1074/jbc.M801761200; Kataoka H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104741; Khan Shafqat Ali, 2015, World J Biol Chem, V6, P333, DOI 10.4331/wjbc.v6.i4.333; Kim SJ, 2016, BIOMOL THER, V24, P387, DOI 10.4062/biomolther.2015.176; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kono H, 2010, J CLIN INVEST, V120, P1939, DOI 10.1172/JCI40124; Kono H, 2010, J IMMUNOL, V184, P4470, DOI 10.4049/jimmunol.0902485; Krenkel Oliver, 2014, Hepatobiliary Surg Nutr, V3, P331, DOI 10.3978/j.issn.2304-3881.2014.11.01; Kuraishy A, 2011, IMMUNITY, V35, P467, DOI 10.1016/j.immuni.2011.09.006; Land W.G., 2003, TRANSPORT REV, V17, P67, DOI [10.1016/S0955-470X(02)00009-5, DOI 10.1016/S0955-470X(02)00009-5]; LINCH DC, 1987, IMMUNOL REV, V95, P137, DOI 10.1111/j.1600-065X.1987.tb00503.x; Liu ZX, 2006, HEPATOLOGY, V43, P1220, DOI 10.1002/hep.21175; LOSMAN MJ, 1992, J IMMUNOL, V148, P1561; Marques PE, 2012, HEPATOLOGY, V56, P1971, DOI 10.1002/hep.25801; Masson MJ, 2008, HEPATOLOGY, V48, P889, DOI 10.1002/hep.22400; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Mir AR, 2015, CLIN CHIM ACTA, V450, P25, DOI 10.1016/j.cca.2015.07.029; Okubo K, 2018, NAT MED, V24, P232, DOI 10.1038/nm.4462; Ostrop J, 2017, J IMMUNOL, V198, P1403, DOI 10.4049/jimmunol.1601665; Peng Y, 2007, J AUTOIMMUN, V29, P303, DOI 10.1016/j.jaut.2007.07.017; Ramachandran Anup, 2017, J Clin Transl Res, V3, P157, DOI 10.18053/jctres.03.2017S1.002; Rauvala H, 2007, CURR MOL MED, V7, P725, DOI 10.2174/156652407783220750; Rock KL, 2008, ANNU REV PATHOL-MECH, V3, P99, DOI 10.1146/annurev.pathmechdis.3.121806.151456; Rock KL, 2011, IMMUNOL REV, V243, P191, DOI 10.1111/j.1600-065X.2011.01040.x; Rock KL, 2010, ANNU REV IMMUNOL, V28, P321, DOI 10.1146/annurev-immunol-030409-101311; ROCK KL, 1990, J IMMUNOL, V145, P804; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Schulz O, 2018, CELL REP, V24, P419, DOI 10.1016/j.celrep.2018.06.038; Shi Y, 2002, EUR J IMMUNOL, V32, P155, DOI 10.1002/1521-4141(200201)32:1<155::AID-IMMU155>3.0.CO;2-P; Shi Y, 2000, P NATL ACAD SCI USA, V97, P14590, DOI 10.1073/pnas.260497597; Silk E, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.52; Sirois CM, 2013, J EXP MED, V210, P2447, DOI 10.1084/jem.20120201; Sollberger G, 2018, DEV CELL, V44, P542, DOI 10.1016/j.devcel.2018.01.019; Sulciner ML, 2018, J EXP MED, V215, P115, DOI 10.1084/jem.20170681; Tsan MF, 2004, J LEUKOCYTE BIOL, V76, P514, DOI 10.1189/jlb.0304127; Tsan MF, 2007, J ENDOTOXIN RES, V13, P6, DOI 10.1177/0968051907078604; van der Vlag J, 2011, SEMIN NEPHROL, V31, P376, DOI 10.1016/j.semnephrol.2011.06.009; Wen ZM, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.303; Wen ZM, 2013, J CELL BIOCHEM, V114, P2384, DOI 10.1002/jcb.24588; Woolbright BL, 2017, J HEPATOL, V66, P836, DOI 10.1016/j.jhep.2016.11.017; Xu J, 2011, J IMMUNOL, V187, P2626, DOI 10.4049/jimmunol.1003930; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Yang D, 2013, EUR J IMMUNOL, V43, P1412, DOI 10.1002/eji.201243138; Yang RK, 2019, HEPATOL INT, V13, P42, DOI 10.1007/s12072-018-9911-9; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zanoni I, 2017, IMMUNITY, V47, P697, DOI 10.1016/j.immuni.2017.09.010; Zelenay S, 2013, TRENDS IMMUNOL, V34, P329, DOI 10.1016/j.it.2013.03.005; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644; Zhang C, 2018, CELL MOL IMMUNOL, V15, P973, DOI 10.1038/cmi.2017.22; Zhou H, 2002, J BIOL CHEM, V277, P48808, DOI 10.1074/jbc.M209059200	79	29	30	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					123	+		10.1016/j.immuni.2019.11.013	http://dx.doi.org/10.1016/j.immuni.2019.11.013			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31859049	Green Accepted, Bronze			2022-12-18	WOS:000507384600013
J	Nabekura, T; Riggan, L; Hildreth, AD; O'Sullivan, TE; Shibuya, A				Nabekura, Tsukasa; Riggan, Luke; Hildreth, Andrew D.; O'Sullivan, Timothy E.; Shibuya, Akira			Type 1 Innate Lymphoid Cells Protect Mice from Acute Liver Injury via Interferon-gamma Secretion for Upregulating Bcl-xL Expression in Hepatocytes	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; NK CELLS; IFN-GAMMA; T-BET; TISSUE RESIDENCY; P2X7 RECEPTOR; DIFFERENTIATION; HOMEOSTASIS; IMMUNITY; DNAM-1	Although type 1 innate lymphoid cells (ILC1s) have been originally found as liver-resident ILCs, their pathophysiological role in the liver remains poorly investigated. Here, we demonstrated that carbon tetrachloride (CCl4) injection into mice activated ILC1s, but not natural killer (NK) cells, in the liver. Activated ILC1s produced interferon-gamma (IFN-gamma) and protected mice from CCl4-induced acute liver injury. IFN-gamma released from activated ILC1s promoted the survival of hepatocytes through upregulation of Bcl-xL. An activating NK receptor, DNAM-1, was required for the optimal activation and IFN-gamma production of liver ILC1s. Extracellular adenosine triphosphate accelerated interleukin-12-driven IFN-gamma production by liver ILC1s. These findings suggest that ILC1s are critical for tissue protection during acute liver injury.	[Nabekura, Tsukasa; Shibuya, Akira] Univ Tsukuba, Life Sci Ctr Survival Dynam, Tsukuba Adv Res Alliance, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan; [Nabekura, Tsukasa; Shibuya, Akira] Univ Tsukuba, Fac Med, Dept Immunol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan; [Nabekura, Tsukasa; Shibuya, Akira] Univ Tsukuba, R&D Ctr Innovat Drug Discovery, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan; [Riggan, Luke; Hildreth, Andrew D.; O'Sullivan, Timothy E.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [O'Sullivan, Timothy E.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA	University of Tsukuba; University of Tsukuba; University of Tsukuba; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Shibuya, A (corresponding author), Univ Tsukuba, Life Sci Ctr Survival Dynam, Tsukuba Adv Res Alliance, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.; Shibuya, A (corresponding author), Univ Tsukuba, Fac Med, Dept Immunol, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.; Shibuya, A (corresponding author), Univ Tsukuba, R&D Ctr Innovat Drug Discovery, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	ashibuya@md.tsukuba.ac.jp			Japan Society for the Promotion of Science (JSPS) KAKENHI [JP16H06387, 18H05022]; Naito Foundation; Kato Memorial Bioscience Foundation; Life Science Foundation of Japan; Uehara Memorial Foundation; Kanae Foundation for the Promotion of Medical Science; National Institutes of Health [AI145997, P30 DK063491]	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Naito Foundation(Naito Memorial Foundation); Kato Memorial Bioscience Foundation; Life Science Foundation of Japan(Life Science Foundation of Japan); Uehara Memorial Foundation(Uehara Memorial Foundation); Kanae Foundation for the Promotion of Medical Science; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Tsuyoshi Kiniwa (RIKEN, Japan) and Yun-Wen Zheng (University of Tsukuba, Japan) for helpful comments on the isolation and the culture of hepatocytes, respectively. We thank Eric Vivier, Steven L. Reiner, and Klaas P.J.M. van Gisbergen for mice. We also thank Yumi Yamashita-Kanemaru and Fumie Abe (University of Tsukuba, Japan) for veterinary procedures. This work was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI grant numbers JP16H06387 and 18H05022 (A.S.); the Naito Foundation, the Kato Memorial Bioscience Foundation, Life Science Foundation of Japan, the Uehara Memorial Foundation, and the Kanae Foundation for the Promotion of Medical Science (T.N.); and the National Institutes of Health grant numbers AI145997 and P30 DK063491 (T.E.O.).	Abt MC, 2015, CELL HOST MICROBE, V18, P27, DOI 10.1016/j.chom.2015.06.011; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Baroni GS, 1996, HEPATOLOGY, V23, P1189; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Boulenouar S, 2017, IMMUNITY, V46, P273, DOI 10.1016/j.immuni.2017.01.008; Cekic C, 2016, NAT REV IMMUNOL, V16, P177, DOI 10.1038/nri.2016.4; Cheng CW, 2011, J HEPATOL, V54, P746, DOI 10.1016/j.jhep.2010.07.018; Colonna M, 2018, IMMUNITY, V48, P1104, DOI 10.1016/j.immuni.2018.05.013; Correa G, 2017, IMMUNOBIOLOGY, V222, P676, DOI 10.1016/j.imbio.2016.12.007; DALTON DK, 1993, SCIENCE, V259, P1739, DOI 10.1126/science.8456300; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Di Virgilio F, 2017, IMMUNITY, V47, P15, DOI 10.1016/j.immuni.2017.06.020; Donnelly-Roberts DL, 2007, BRIT J PHARMACOL, V151, P571, DOI 10.1038/sj.bjp.0707265; Ebbo M, 2017, NAT REV IMMUNOL, V17, P665, DOI 10.1038/nri.2017.86; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Geiger TL, 2014, J EXP MED, V211, P1723, DOI 10.1084/jem.20140212; Ghiassi-Nejad Z, 2013, HEPATOLOGY, V57, P786, DOI 10.1002/hep.26056; Gordon SM, 2012, IMMUNITY, V36, P55, DOI 10.1016/j.immuni.2011.11.016; Grossman HJ, 1998, J GASTROEN HEPATOL, V13, P1058, DOI 10.1111/j.1440-1746.1998.tb00570.x; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Heymann F, 2016, NAT REV GASTRO HEPAT, V13, P88, DOI 10.1038/nrgastro.2015.200; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; Horras CJ, 2011, CYTOKINE GROWTH F R, V22, P35, DOI 10.1016/j.cytogfr.2011.01.001; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Ishida Y, 2002, FASEB J, V16, DOI 10.1096/fj.02-0046com; Jiao YH, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00426; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Knockaert L, 2012, LAB INVEST, V92, P396, DOI 10.1038/labinvest.2011.193; Kovalovich K, 2001, J BIOL CHEM, V276, P26605, DOI 10.1074/jbc.M100740200; Kusters S, 1996, GASTROENTEROLOGY, V111, P462, DOI 10.1053/gast.1996.v111.pm8690213; Liang BF, 2012, J IMMUNOL, V189, P4444, DOI 10.4049/jimmunol.1201181; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; MOREAU JL, 1987, EUR J IMMUNOL, V17, P929, DOI 10.1002/eji.1830170706; Nabekura T, 2016, J EXP MED, V213, P2745, DOI 10.1084/jem.20160726; Nabekura T, 2016, IMMUNITY, V45, P74, DOI 10.1016/j.immuni.2016.06.024; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; O'Sullivan TE, 2016, IMMUNITY, V45, P428, DOI 10.1016/j.immuni.2016.06.016; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Peters CP, 2016, IMMUNOL LETT, V172, P124, DOI 10.1016/j.imlet.2015.10.004; Ramana CV, 2002, TRENDS IMMUNOL, V23, P96, DOI 10.1016/S1471-4906(01)02118-4; Ravens I, 2003, BIOCHEM BIOPH RES CO, V312, P1364, DOI 10.1016/j.bbrc.2003.11.067; Reynders A, 2011, EMBO J, V30, P2934, DOI 10.1038/emboj.2011.201; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Savio LEB, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00052; Seillet C, 2016, CURR TOP MICROBIOL, V395, P37, DOI 10.1007/82_2015_474; Seillet C, 2014, J IMMUNOL, V192, P2667, DOI 10.4049/jimmunol.1302605; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Song JM, 2010, CELL HOST MICROBE, V8, P369, DOI 10.1016/j.chom.2010.09.003; Soriani A, 2014, J IMMUNOL, V193, P950, DOI 10.4049/jimmunol.1400271; Spits H, 2016, NAT IMMUNOL, V17, P758, DOI 10.1038/ni.3482; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Takeda K, 2001, NAT MED, V7, P94, DOI 10.1038/83416; Victorino F, 2015, J IMMUNOL, V195, P4973, DOI 10.4049/jimmunol.1500651; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Zhang ZG, 2015, J EXP MED, V212, P2165, DOI 10.1084/jem.20150792	65	29	32	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					96	+		10.1016/j.immuni.2019.11.004	http://dx.doi.org/10.1016/j.immuni.2019.11.004			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31810881	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000507384600011
J	Wang, W; Cohen, JA; Wallrapp, A; Trieu, KG; Barrios, J; Shao, FZ; Krishnamoorthy, N; Kuchroo, VK; Jones, MR; Fine, A; Bai, Y; Ai, XB				Wang, Wei; Cohen, Jonathan A.; Wallrapp, Antonia; Trieu, Kenneth G.; Barrios, Juliana; Shao, Fengzhi; Krishnamoorthy, Nandini; Kuchroo, Vijay K.; Jones, Matthew R.; Fine, Alan; Bai, Yan; Ai, Xingbin			Age-Related Dopaminergic Innervation Augments T Helper 2-Type Allergic Inflammation in the Postnatal Lung	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; GENE-EXPRESSION; DENDRITIC CELLS; RECEPTORS; TH2; DIFFERENTIATION; CATECHOLAMINES; STIMULATION; ANTAGONIST; ACTIVATION	Young children are more susceptible to developing allergic asthma than adults. As neural innervation of the peripheral tissue continues to develop after birth, neurons may modulate tissue inflammation in an age-related manner. Here we showed that sympathetic nerves underwent a dopaminergic-to-adrenergic transition during post-natal development of the lung in mice and humans. Dopamine signaled through a specific dopamine receptor (DRD4) to promote T helper 2 (Th2) cell differentiation. The dopamine-DRD4 pathway acted synergistically with the cytokine IL-4 by upregulating IL-2-STAT5 signaling and reducing inhibitory histone trimethylation at Th2 gene loci. In murine models of allergen exposure, the dopamine-DRD4 pathway augmented Th2 inflammation in the lungs of young mice. However, this pathway operated marginally after sympathetic nerves became adrenergic in the adult lung. Taken together, the communication between dopaminergic nerves and CD4(+) T cells provides an age-related mechanism underlying the susceptibility to allergic inflammation in the early lung.	[Wang, Wei; Cohen, Jonathan A.; Trieu, Kenneth G.; Krishnamoorthy, Nandini; Bai, Yan; Ai, Xingbin] Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA; [Wallrapp, Antonia; Kuchroo, Vijay K.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Wallrapp, Antonia; Kuchroo, Vijay K.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Barrios, Juliana; Shao, Fengzhi; Jones, Matthew R.; Fine, Alan] Boston Univ, Sch Med, Dept Med, Pulm Ctr, Boston, MA 02118 USA; [Fine, Alan] West Roxbury Vet Hosp, West Roxbury, MA USA; [Ai, Xingbin] Massachusetts Gen Hosp Children, Dept Pediat, Div Newborn Med, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Boston University	Ai, XB (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA.; Ai, XB (corresponding author), Massachusetts Gen Hosp Children, Dept Pediat, Div Newborn Med, Boston, MA 02114 USA.	xai@partners.org	Wang, Wei/N-9423-2019	Wang, Wei/0000-0001-9243-8672; Wallrapp, Antonia/0000-0002-3176-1553; Trieu, Kenneth/0000-0002-4851-1876; Jones, Matthew/0000-0003-4647-2962	NIH [R01HL132991, K08HL135443, F31HL126443]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL136725, T32HL007035, R01HL116163, F31HL126443, R01HL132991, K08HL135443] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank Manuela Cernadas for technical guidance regarding flow cytometry analysis. For RNA-seq, library construction, sequencing, and differential expression analysis were performed at the Translational Genomics Core of Partners Personalized Medicine, a not-for-profit, fee-for-service core facility at Partners HealthCare (Boston, MA). This project was supported by NIH grants (R01HL132991 to X.A., K08HL135443 to Y.B., and F31HL126443 to J.B.).	Aki D, 2018, NAT IMMUNOL, V19, P766, DOI 10.1038/s41590-018-0137-8; ANASTASSIOU ED, 1992, J IMMUNOL, V148, P2845; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; ANGELETTI PU, 1972, P NATL ACAD SCI USA, V69, P86, DOI 10.1073/pnas.69.1.86; Aven L, 2014, FASEB J, V28, P897, DOI 10.1096/fj.13-238212; Aven L, 2013, ORGANOGENESIS, V9, P194, DOI 10.4161/org.24842; BARBACID M, 1994, J NEUROBIOL, V25, P1386, DOI 10.1002/neu.480251107; Barrios J, 2017, FASEB J, V31, P4117, DOI 10.1096/fj.201700115R; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Becerra-Diaz Mireya, 2017, F1000Res, V6, P1014, DOI 10.12688/f1000research.11198.1; Bergquist J, 1998, RAPID COMMUN MASS SP, V12, P683, DOI 10.1002/(SICI)1097-0231(19980615)12:11<683::AID-RCM218>3.3.CO;2-E; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bourne JA, 2001, CNS DRUG REV, V7, P399; Buttari B, 2014, FASEB J, V28, P3038, DOI 10.1096/fj.13-243485; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Chavan SS, 2017, IMMUNITY, V46, P927, DOI 10.1016/j.immuni.2017.06.008; Chen T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5196; Church RJ, 2012, J IMMUNOL, V188, P4093, DOI 10.4049/jimmunol.1101873; Cohen L, 2007, AM J RESP CRIT CARE, V176, P138, DOI 10.1164/rccm.200607-1062OC; Contreras F, 2016, J IMMUNOL, V196, P4143, DOI 10.4049/jimmunol.1502420; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; Cote-Sierra J, 2004, P NATL ACAD SCI USA, V101, P3880, DOI 10.1073/pnas.0400339101; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; Dettman EJ, 2011, ONCOGENE, V30, P2859, DOI 10.1038/onc.2011.12; Fahy JV, 2015, NAT REV IMMUNOL, V15, P57, DOI 10.1038/nri3786; FELTEN DL, 1985, J IMMUNOL, V135, pS755; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Franz D, 2015, J NEUROIMMUNOL, V284, P18, DOI 10.1016/j.jneuroim.2015.05.003; Goto Y, 2007, NEUROPHARMACOLOGY, V53, P583, DOI 10.1016/j.neuropharm.2007.07.007; Hebel K, 2014, J IMMUNOL, V192, P5160, DOI 10.4049/jimmunol.1302539; Henriksson J, 2019, CELL, V176, P882, DOI 10.1016/j.cell.2018.11.044; Ho IC, 1998, J EXP MED, V188, P1859, DOI 10.1084/jem.188.10.1859; Huang Y, 2010, NEUROENDOCRINOL LETT, V31, P782; HYTTEL J, 1983, EUR J PHARMACOL, V91, P153, DOI 10.1016/0014-2999(83)90381-3; Ilani T, 2004, FASEB J, V18, DOI 10.1096/fj.04-1652fje; Josefsson E, 1996, IMMUNOLOGY, V88, P140, DOI 10.1046/j.1365-2567.1996.d01-653.x; Kim MN, 2018, AM J RESP CRIT CARE, V197, P994, DOI 10.1164/rccm.201703-0532OC; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Kustrimovic N, 2014, J NEUROIMMUNE PHARM, V9, P302, DOI 10.1007/s11481-014-9541-5; LEGROS G, 1990, J EXP MED, V172, P921, DOI 10.1084/jem.172.3.921; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Moreland RB, 2005, PHARMACOL BIOCHEM BE, V82, P140, DOI 10.1016/j.pbb.2005.08.001; Mori T, 2013, J DERMATOL SCI, V71, P37, DOI 10.1016/j.jdermsci.2013.03.008; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Muller J, 2008, CHEMBIOCHEM, V9, P723, DOI 10.1002/cbic.200700701; Nachtigall M, 2017, MEX INT CONF ARTIF I, P23, DOI 10.1109/MICAI-2017.2017.00012; Nakano K, 2009, INT IMMUNOL, V21, P645, DOI 10.1093/intimm/dxp033; OGREN SO, 1986, PSYCHOPHARMACOLOGY, V90, P287; Ohtake J, 2015, J ALLERGY CLIN IMMUN, V136, P1690, DOI 10.1016/j.jaci.2015.06.050; Papa I, 2017, NATURE, V547, P318, DOI 10.1038/nature23013; Patel KR, 2016, MUCOSAL IMMUNOL, V9, P1466, DOI 10.1038/mi.2016.11; Patel S, 1997, J PHARMACOL EXP THER, V283, P636; Radzikinas K, 2011, J NEUROSCI, V31, P15407, DOI 10.1523/JNEUROSCI.2745-11.2011; Rubinstein M, 1997, CELL, V90, P991, DOI 10.1016/S0092-8674(00)80365-7; Sarkar C, 2006, J IMMUNOL, V177, P7525, DOI 10.4049/jimmunol.177.11.7525; Sherrill JD, 2010, J ALLERGY CLIN IMMUN, V126, P160, DOI 10.1016/j.jaci.2010.04.037; Stern DA, 2008, LANCET, V372, P1058, DOI 10.1016/S0140-6736(08)61447-6; Talbot S, 2015, NEURON, V87, P341, DOI 10.1016/j.neuron.2015.06.007; Tortorolo L, 2005, AM J RESP CRIT CARE, V172, P233, DOI 10.1164/rccm.200412-1693OC; TUCK ML, 1986, AM HEART J, V112, P877, DOI 10.1016/0002-8703(86)90497-7; Tumes DJ, 2013, IMMUNITY, V39, P819, DOI 10.1016/j.immuni.2013.09.012; Van Dyken SJ, 2016, NAT IMMUNOL, V17, P1381, DOI 10.1038/ni.3582; Verjans E, 2015, ONCOTARGET, V6, P38538, DOI 10.18632/oncotarget.6041; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Watanabe T, 2015, AM J RESP CELL MOL, V53, P844, DOI 10.1165/rcmb.2015-0015OC; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8; Zhu JF, 2003, IMMUNITY, V19, P739, DOI 10.1016/S1074-7613(03)00292-9	68	29	31	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 17	2019	51	6					1102	+		10.1016/j.immuni.2019.10.002	http://dx.doi.org/10.1016/j.immuni.2019.10.002			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JW6ME	31757673	Green Accepted, Bronze			2022-12-18	WOS:000503162900015
J	Adams, NM; Geary, CD; Santosa, EK; Lumaquin, D; Le Luduec, JB; Sottile, R; van der Ploeg, K; Hsu, J; Whitlock, BM; Jackson, BT; Weizman, OE; Huse, M; Hsu, KC; Sun, JC				Adams, Nicholas M.; Geary, Clair D.; Santosa, Endi K.; Lumaquin, Dianne; Le Luduec, Jean-Benoit; Sottile, Rosa; van der Ploeg, Kattria; Hsu, Joy; Whitlock, Benjamin M.; Jackson, Benjamin T.; Weizman, Orr-El; Huse, Morgan; Hsu, Katharine C.; Sun, Joseph C.			Cytomegalovirus Infection Drives Avidity Selection of Natural Killer Cells	IMMUNITY			English	Article							NK CELLS; T-CELLS; FUNCTIONAL-HETEROGENEITY; MURINE CYTOMEGALOVIRUS; DENDRITIC CELLS; EXPANSION; TRANSPLANTATION; ACTIVATION; RECEPTOR; SUBSET	The process of affinity maturation, whereby T and B cells bearing antigen receptors with optimal affinity to the relevant antigen undergo preferential expansion, is a key feature of adaptive immunity. Natural killer (NK) cells are innate lymphocytes capable of "adaptive" responses after cytomegalovirus (CMV) infection. However, whether NK cells are similarly selected on the basis of their avidity for cognate ligand is unknown. Here, we showed that NK cells with the highest avidity for the mouse CMV glycoprotein m157 were preferentially selected to expand and comprise the memory NK cell pool, whereas low-avidity NK cells possessed greater capacity for interferon-gamma (IFN-gamma) production. Moreover, we provide evidence for avidity selection occurring in human NK cells during human CMV infection. These results delineate how heterogeneity in NK cell avidity diversifies NK cell effector function during antiviral immunity, and how avidity selection might serve to produce the most potent memory NK cells.	[Adams, Nicholas M.; Geary, Clair D.; Santosa, Endi K.; Lumaquin, Dianne; Le Luduec, Jean-Benoit; Sottile, Rosa; van der Ploeg, Kattria; Hsu, Joy; Whitlock, Benjamin M.; Jackson, Benjamin T.; Weizman, Orr-El; Huse, Morgan; Hsu, Katharine C.; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Adams, Nicholas M.; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Hsu, Katharine C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Hsu, Katharine C.] Weill Cornell Med Coll, Dept Med, New York, NY 10065 USA; [Sun, Joseph C.] Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University	Sun, JC (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA.; Sun, JC (corresponding author), Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA.; Sun, JC (corresponding author), Weill Cornell Med Coll, Dept Immunol & Microbial Pathogenesis, New York, NY 10065 USA.	sunj@mskcc.org	Sottile, Rosa/ABC-9810-2020	Sottile, Rosa/0000-0003-2950-9508; Hsu, Joy/0000-0001-6571-9276; Jackson, Benjamin/0000-0003-1089-4362; van der Ploeg, Kattria/0000-0002-3183-3190; LE LUDUEC, Jean-Benoit/0000-0002-1046-2941; Lumaquin-Yin, Dianne/0000-0002-5285-0467; Adams, Nicholas/0000-0001-5751-0480	Medical Scientist Training Program grant from the NIH National Institute of General Medical Sciences [T32GM007739]; F30 Predoctoral Fellowship from the NIH National Institute of Allergy and Infectious Diseases [F30 AI136239]; NIH [AI087644, AI123658, CA023766, AI100874, AI130043, P30CA008748]; Ludwig Center for Cancer Immunotherapy; American Cancer Society; Burroughs Wellcome Fund; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA023766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087644, F30AI136239, R01AI100874, R01AI130043] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Medical Scientist Training Program grant from the NIH National Institute of General Medical Sciences; F30 Predoctoral Fellowship from the NIH National Institute of Allergy and Infectious Diseases; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center for Cancer Immunotherapy; American Cancer Society(American Cancer Society); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Sun lab, Georg Gasteiger, and Christin Friedrich for experimental assistance and members of the Memorial Sloan Kettering Cancer Center (MSKCC) Natural Killer club for discussions. We thank Lewis Lanier for helpful discussions and comments on the manuscript. We thank Simon Grassmann and Veit Buchholz for sharing their manuscript with us before publication. Graphical abstract was created with BioRender. N.M.A., D.L., and B.T.J. were supported by a Medical Scientist Training Program grant from the NIH National Institute of General Medical Sciences (T32GM007739 to the Weill Cornell/Rockefeller/Sloan Kettering Tri-Institutional MD-PhD Program). N.M.A. was also supported by an F30 Predoctoral Fellowship from the NIH National Institute of Allergy and Infectious Diseases (F30 AI136239). M.H. was supported by NIH grant AI087644. K.C.H. was supported by NIH grants AI123658 and CA023766. J.C.S. was supported by the Ludwig Center for Cancer Immunotherapy, the American Cancer Society, the Burroughs Wellcome Fund, and the NIH (AI100874, AI130043, and P30CA008748).	Aguilar OA, 2017, CELL, V169, P58, DOI 10.1016/j.cell.2017.03.002; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; Biron CA, 2015, MED MICROBIOL IMMUN, V204, P345, DOI 10.1007/s00430-015-0412-3; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; BUKOWSKI JF, 1985, J EXP MED, V161, P40, DOI 10.1084/jem.161.1.40; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Day EK, 2007, J IMMUNOL, V179, P3203, DOI 10.4049/jimmunol.179.5.3203; Della Chiesa M, 2012, BLOOD, V119, P399, DOI 10.1182/blood-2011-08-372003; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Etzioni A, 2005, J PEDIATR-US, V146, P423, DOI 10.1016/j.jpeds.2004.11.022; Fodil-Cornu N, 2008, J IMMUNOL, V181, P6394, DOI 10.4049/jimmunol.181.9.6394; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Grassmann S, 2019, IMMUNITY, V50, P1391, DOI 10.1016/j.immuni.2019.04.015; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Hammer Q, 2018, NAT IMMUNOL, V19, P453, DOI 10.1038/s41590-018-0082-6; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Horowitz A, 2015, J IMMUNOL, V195, P4524, DOI 10.4049/jimmunol.1401990; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; Johnson LR, 2016, CELL REP, V17, P636, DOI 10.1016/j.celrep.2016.09.019; Kamimura Y, 2015, CELL REP, V10, P280, DOI 10.1016/j.celrep.2014.12.025; Karo JM, 2014, CELL, V159, P94, DOI 10.1016/j.cell.2014.08.026; Kedl RM, 2003, CURR OPIN IMMUNOL, V15, P120, DOI 10.1016/S0952-7915(02)00009-2; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; KIM S, 1981, CELL, V27, P573, DOI 10.1016/0092-8674(81)90399-8; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madera S, 2016, J EXP MED, V213, P225, DOI 10.1084/jem.20150712; Madera S, 2015, J IMMUNOL, V194, P1408, DOI 10.4049/jimmunol.1402001; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Min-Oo G, 2014, J EXP MED, V211, P2669, DOI 10.1084/jem.20141172; Muccio L, 2016, HAEMATOLOGICA, V101, P371, DOI 10.3324/haematol.2015.134155; Muntasell A, 2013, EUR J IMMUNOL, V43, P3268, DOI 10.1002/eji.201343773; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Oberle SG, 2016, CELL REP, V17, P627, DOI 10.1016/j.celrep.2016.09.072; Orr MT, 2010, NAT IMMUNOL, V11, P321, DOI 10.1038/ni.1849; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Prlic M, 2006, J EXP MED, V203, P2135, DOI 10.1084/jem.20060928; Rahim MMA, 2016, J IMMUNOL, V197, P2325, DOI 10.4049/jimmunol.1600776; Soneson C, 2015, F1000 RES, V4, P1521, DOI [10.12688/f1000research.7563.1, DOI 10.12688/F1000RESEARCH.7563.2]; Strauss-Albee DM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5722; Sun JC, 2012, J EXP MED, V209, P947, DOI 10.1084/jem.20111760; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; Viant C, 2017, J EXP MED, V214, P491, DOI 10.1084/jem.20160869; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	53	29	29	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1381	+		10.1016/j.immuni.2019.04.009	http://dx.doi.org/10.1016/j.immuni.2019.04.009			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31103381	Green Accepted, Bronze			2022-12-18	WOS:000471876100010
J	Arora, H; Wilcox, SM; Johnson, LA; Munro, L; Eyford, BA; Pfeifer, CG; Welch, I; Jefferies, WA				Arora, Hitesh; Wilcox, Sara Morgan; Johnson, Laura Alexandra; Munro, Lonna; Eyford, Brett Alexander; Pfeifer, Cheryl Gurine; Welch, Ian; Jefferies, Wilfred Arthur			The ATP-Binding Cassette Gene ABCF1 Functions as an E2 Ubiquitin-Conjugating Enzyme Controlling Macrophage Polarization to Dampen Lethal Septic Shock	IMMUNITY			English	Article							SIGNALING PATHWAYS; CELL-DEATH; ACTIVATION; SEPSIS; SUBPOPULATIONS; ENDOCYTOSIS; FAMILY; REGION; TISSUE; ABC50	Sepsis is a bi-phasic inflammatory disease that threatens approximately 30 million lives and claims over 14 million annually, yet little is known regarding the molecular switches and pathways that regulate this disease. Here, we have described ABCF1, an ATP-Binding Cassette (ABC) family member protein, which possesses an E2 ubiquitin enzyme activity, through which it controls the Lipopolysaccharide (LPS)-Toll-like Receptor-4 (TLR4) mediated gram-negative insult by targeting key proteins for K63-polyubiquitination. Ubiquitination by ABCF1 shifts the inflammatory profile from an early phase MyD88-dependent to a late phase TRIF-dependent signaling pathway, thereby regulating TLR4 endocytosis and modulating macrophage polarization from M1 to M2 phase. Physiologically, ABCF1 regulates the shift from the inflammatory phase of sepsis to the endotoxin tolerance phase, and modulates cytokine storm and interferon-beta (IFN-beta)-dependent production by the immunotherapeutic mediator, SIRT1. Consequently, ABCF1 controls sepsis induced mortality by repressing hypotension-induced renal circulatory dysfunction.	[Arora, Hitesh; Wilcox, Sara Morgan; Johnson, Laura Alexandra; Munro, Lonna; Eyford, Brett Alexander; Pfeifer, Cheryl Gurine; Jefferies, Wilfred Arthur] Univ British Columbia, Michael Smith Labs, 2185 East Mall, Vancouver, BC V6T 1Z4, Canada; [Arora, Hitesh; Munro, Lonna; Pfeifer, Cheryl Gurine; Jefferies, Wilfred Arthur] Vancouver Prostate Ctr, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada; [Arora, Hitesh; Wilcox, Sara Morgan; Jefferies, Wilfred Arthur] Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Arora, Hitesh; Wilcox, Sara Morgan; Johnson, Laura Alexandra; Munro, Lonna; Eyford, Brett Alexander; Pfeifer, Cheryl Gurine; Jefferies, Wilfred Arthur] Univ British Columbia, Ctr Blood Res, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Johnson, Laura Alexandra; Jefferies, Wilfred Arthur] Univ British Columbia, Dept Zool, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Jefferies, Wilfred Arthur] Univ British Columbia, Dept Med Genet, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada; [Arora, Hitesh; Munro, Lonna; Eyford, Brett Alexander; Pfeifer, Cheryl Gurine; Jefferies, Wilfred Arthur] Djavad Mowafaghian Ctr Brain Hlth, 2215 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada; [Welch, Ian] Univ British Columbia, Dept Pathol, 4145 Wesbrook Mall, Vancouver, BC V6T 1W5, Canada	University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia; University of British Columbia	Jefferies, WA (corresponding author), Univ British Columbia, Michael Smith Labs, 2185 East Mall, Vancouver, BC V6T 1Z4, Canada.; Jefferies, WA (corresponding author), Vancouver Prostate Ctr, 2660 Oak St, Vancouver, BC V6H 3Z6, Canada.; Jefferies, WA (corresponding author), Univ British Columbia, Dept Microbiol & Immunol, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.; Jefferies, WA (corresponding author), Univ British Columbia, Ctr Blood Res, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.; Jefferies, WA (corresponding author), Univ British Columbia, Dept Zool, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.; Jefferies, WA (corresponding author), Univ British Columbia, Dept Med Genet, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.; Jefferies, WA (corresponding author), Djavad Mowafaghian Ctr Brain Hlth, 2215 Wesbrook Mall, Vancouver, BC V6T 2B5, Canada.	wilf@msl.ubc.ca			Canadian Institutes of Health Research (CIHR) [MOP-86739, MOP-133634]; MITACS Accelerate Fellowship [IT06356]; Michael Smith Foundation for Health Research Postdoctoral Trainee Fellowship [16143]; Centre for Blood Research studentship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); MITACS Accelerate Fellowship; Michael Smith Foundation for Health Research Postdoctoral Trainee Fellowship; Centre for Blood Research studentship	We thank Dr. Antoine Dufour and K.B. Choi for helpful discussions and comments on the manuscript. This work was funded by operating grants to W.A.J. by the Canadian Institutes of Health Research (CIHR): MOP-86739 and MOP-133634. B.A.E. was supported by MITACS Accelerate Fellowship (IT06356) and Michael Smith Foundation for Health Research Postdoctoral Trainee Fellowship (16143). H.A. was supported by a Centre for Blood Research studentship.	Biswas SK, 2007, J IMMUNOL, V179, P4083, DOI 10.4049/jimmunol.179.6.4083; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Burroughs AM, 2008, J STRUCT BIOL, V162, P205, DOI 10.1016/j.jsb.2007.12.006; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Cavaillon JM, 2006, CRIT CARE, V10, DOI 10.1186/cc5055; Chen PC, 2010, J CLIN INVEST, V120, P4353, DOI 10.1172/JCI43910; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; den Haan JMM, 2012, J INNATE IMMUN, V4, P437, DOI 10.1159/000335216; Deng JP, 2004, AM J PHYSIOL-CELL PH, V287, pC730, DOI 10.1152/ajpcell.00562.2003; Doi K, 2016, J INTENSIVE CARE, V4, DOI 10.1186/s40560-016-0146-3; Dong Z, 2017, PROTEIN CELL, V8, P467, DOI 10.1007/s13238-017-0401-y; Duran-Struuck R, 2009, J AM ASSOC LAB ANIM, V48, P11; Ge YM, 1997, J INFECT DIS, V176, P1313, DOI 10.1086/514127; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Harty John, 2014, Ulster Med J, V83, P149; Heaton SM, 2016, J EXP MED, V213, P1, DOI 10.1084/jem.20151531; Heyman SN, 2012, NEPHROL DIAL TRANSPL, V27, P1721, DOI 10.1093/ndt/gfs100; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hotchkiss RS, 2003, SCAND J INFECT DIS, V35, P585, DOI 10.1080/00365540310015692; Huang W, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2016.97; Jantsch J, 2011, J LEUKOCYTE BIOL, V90, P551, DOI 10.1189/jlb.1210683; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Keskinov AA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156095; Lee MN, 2013, NAT IMMUNOL, V14, P179, DOI 10.1038/ni.2509; Levi M, 2010, SEMIN THROMB HEMOST, V36, P367, DOI 10.1055/s-0030-1254046; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lin YC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003973; Lorigados CB, 2019, SHOCK, V51, P381, DOI 10.1097/SHK.0000000000001151; Muthu K, 2008, J BURN CARE RES, V29, P12, DOI 10.1097/BCR.0b013e31815fa499; Nakayama T, 2013, CARDIOVASC RES, V99, P705, DOI 10.1093/cvr/cvt146; O'Hara SD, 2016, MBIO, V7, DOI 10.1128/mBio.01836-16; Ota M, 2007, IMMUNOGENETICS, V59, P45, DOI 10.1007/s00251-006-0178-2; Paytubi S, 2008, BIOCHEM J, V409, P223, DOI 10.1042/BJ20070811; Ramseyer VD, 2013, AM J PHYSIOL-RENAL, V304, pF1231, DOI 10.1152/ajprenal.00557.2012; Ren J, 2006, FRONT BIOSCI-LANDMRK, V11, P15, DOI 10.2741/1776; Richard M, 1998, GENOMICS, V53, P137, DOI 10.1006/geno.1998.5480; Sasai M, 2010, MOL IMMUNOL, V47, P1283, DOI 10.1016/j.molimm.2009.12.002; SCHMAUDERCHOCK EA, 1994, HISTOCHEM J, V26, P142, DOI 10.1007/BF00157963; Strijbis K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003446; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Trouplin V, 2013, JOVE-J VIS EXP, DOI 10.3791/50966; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Varpula M, 2005, INTENS CARE MED, V31, P1066, DOI 10.1007/s00134-005-2688-z; Wilcox SM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175918; Wittebole X, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/568396; Wray CJ, 2003, INT J BIOCHEM CELL B, V35, P698, DOI 10.1016/S1357-2725(02)00341-2; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yoo CH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04220; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zhong J, 2004, MOL CELL BIOL, V24, P9165, DOI 10.1128/MCB.24.20.9165-9175.2004	55	29	31	2	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					418	+		10.1016/j.immuni.2019.01.014	http://dx.doi.org/10.1016/j.immuni.2019.01.014			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30770245	Bronze			2022-12-18	WOS:000459006700016
J	Aronin, CEP; Zhao, YM; Yoon, JS; Morgan, NY; Prustel, T; Germain, RN; Meier-Schellersheim, M				Aronin, Caren E. Petrie; Zhao, Yun M.; Yoon, Justine S.; Morgan, Nicole Y.; Prustel, Thorsten; Germain, Ronald N.; Meier-Schellersheim, Martin			Migrating Myeloid Cells Sense Temporal Dynamics of Chemoattractant Concentrations	IMMUNITY			English	Article							PROTEIN-COUPLED RECEPTOR; HAPTOTACTIC CHEMOKINE GRADIENTS; STABLE CONCENTRATION GRADIENTS; DEFINED 3D MICROENVIRONMENT; LYMPHOID-TISSUE CHEMOKINE; EUKARYOTIC CHEMOTAXIS; LEUKOCYTE CHEMOTAXIS; DENDRITIC CELLS; T-CELLS; IN-VIVO	Chemoattractant-mediated recruitment of hematopoietic cells to sites of pathogen growth or tissue damage is critical to host defense and organ homeostasis. Chemotaxis is typically considered to rely on spatial sensing, with cells following concentration gradients as long as these are present. Utilizing a microfluidic approach, we found that stable gradients of intermediate chemokines (CCL19 and CXCL12) failed to promote persistent directional migration of dendritic cells or neutrophils. Instead, rising chemokine concentrations were needed, implying that temporal sensing mechanisms controlled prolonged responses to these ligands. This behavior was found to depend on G-coupled receptor kinase-mediated negative regulation of receptor signaling and contrasted with responses to an end agonist chemoattractant (C5a), for which a stable gradient led to persistent migration. These findings identify temporal sensing as a key requirement for long-range myeloid cell migration to intermediate chemokines and provide insights into the mechanisms controlling immune cell motility in complex tissue environments.	[Aronin, Caren E. Petrie; Zhao, Yun M.; Germain, Ronald N.] NIAID, LSB, LBS, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Yoon, Justine S.; Morgan, Nicole Y.] Natl Inst Biomed Imaging & Bioengn, Biomed Engn & Phys Sci Resource BEPS, MMU, NIH, Bethesda, MD 20892 USA; [Prustel, Thorsten; Meier-Schellersheim, Martin] NIAID, LSB, CBU, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Germain, RN (corresponding author), NIAID, LSB, LBS, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Meier-Schellersheim, M (corresponding author), NIAID, LSB, CBU, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	rgermain@niaid.nih.gov; mms@niaid.nih.gov	Germain, Ronald N./Z-1945-2019; Germain, Ronald/ABE-7090-2020		NIAID; NIBIB, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001076, ZIAAI000545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZICEB000012] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We thank T. Lammermann (LSB, NIAID), C.A. Parent, and P.V. Afonso (LCMB, NCI), P.M. Murphy (LMI, NIAID), and J.H. Kehrl (LIR, NIAID) for helpful discussions and critical review of the manuscript. We thank R.J. Lefkowitz (Duke Medical Center) for the beta-arrestin-2 deficient mice and J.H. Kehrl (LIR, NIAID) for the beta-arrestin-1 deficient mice. We thank D. Einhaus (LISB, NIAID) for organizational support. We thank the NIAID Biological Imaging Section for use of their post-collection analysis software and computers. This research was supported by the Intramural Research Programs of NIAID and NIBIB, NIH.	Abhyankar VV, 2008, LAB CHIP, V8, P1507, DOI 10.1039/b803533d; Amadi OC, 2010, BIOMED MICRODEVICES, V12, P1027, DOI 10.1007/s10544-010-9457-7; Armon L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028359; Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Bae SY, 2008, INT J LAB HEMATOL, V30, P139, DOI 10.1111/j.1751-553X.2007.00914.x; Balabanian K, 2008, J CLIN INVEST, V118, P1074, DOI 10.1172/JCI33187; Bohn LM, 1999, SCIENCE, V286, P2495, DOI 10.1126/science.286.5449.2495; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Byers MA, 2008, J IMMUNOL, V181, P4723, DOI 10.4049/jimmunol.181.7.4723; Campbell JJ, 1997, EUR J IMMUNOL, V27, P2571, DOI 10.1002/eji.1830271016; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Charest PG, 2006, CURR OPIN GENET DEV, V16, P339, DOI 10.1016/j.gde.2006.06.016; Chenoweth D E, 1983, Agents Actions Suppl, V12, P252; Comerford I, 2006, EUR J IMMUNOL, V36, P1904, DOI 10.1002/eji.200535716; Conner DA, 1997, CIRC RES, V81, P1021; Delano MJ, 2011, J IMMUNOL, V187, P911, DOI 10.4049/jimmunol.1100588; Ebrahimzadeh PR, 2000, J LEUKOCYTE BIOL, V67, P651, DOI 10.1002/jlb.67.5.651; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Haessler U, 2009, BIOMED MICRODEVICES, V11, P827, DOI 10.1007/s10544-009-9299-3; Kanegasaki S, 2003, J IMMUNOL METHODS, V282, P1, DOI 10.1016/j.jim.2003.07.008; Kavelaars A, 2003, J IMMUNOL, V171, P6128, DOI 10.4049/jimmunol.171.11.6128; Kohout TA, 2004, J BIOL CHEM, V279, P23214, DOI 10.1074/jbc.M402125200; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; LAUFFENBURGER D, 1987, J CELL SCI, V88, P415; LAUFFENBURGER DA, 1988, METHOD ENZYMOL, V162, P85; Levine H, 2006, P NATL ACAD SCI USA, V103, P9761, DOI 10.1073/pnas.0601302103; Lin F, 2008, J IMMUNOL, V181, P8335, DOI 10.4049/jimmunol.181.12.8335; Lindquist RL, 2004, NAT IMMUNOL, V5, P1243, DOI 10.1038/ni1139; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Ma L, 2004, BIOPHYS J, V87, P3764, DOI 10.1529/biophysj.104.045484; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; Meier-Schellersheim M, 2006, PLOS COMPUT BIOL, V2, P710, DOI 10.1371/journal.pcbi.0020082; Meinhardt H, 1999, J CELL SCI, V112, P2867; Milcent MD, 1999, BIOCHEM BIOPH RES CO, V259, P224, DOI 10.1006/bbrc.1999.0758; Nagira M, 1997, J BIOL CHEM, V272, P19518, DOI 10.1074/jbc.272.31.19518; Parent CA, 1999, SCIENCE, V284, P765, DOI 10.1126/science.284.5415.765; Peppel K, 1997, J BIOL CHEM, V272, P25425, DOI 10.1074/jbc.272.41.25425; Peters NC, 2008, SCIENCE, V321, P970, DOI 10.1126/science.1159194; Postma M, 2001, BIOPHYS J, V81, P1314, DOI 10.1016/S0006-3495(01)75788-8; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Robbiani DF, 2000, CELL, V103, P757, DOI 10.1016/S0092-8674(00)00179-3; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Saadi W, 2007, BIOMED MICRODEVICES, V9, P627, DOI 10.1007/s10544-007-9051-9; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Sarris M, 2012, CURR BIOL, V22, P2375, DOI 10.1016/j.cub.2012.11.018; Schwarz J, 2017, CURR BIOL, V27, P1314, DOI 10.1016/j.cub.2017.04.004; Sozzani S, 1998, J IMMUNOL, V161, P1083; Tanabe S, 1997, J IMMUNOL, V159, P5671; van de Pavert SA, 2010, NAT REV IMMUNOL, V10, P664, DOI 10.1038/nri2832; VICKER MG, 1989, J CELL SCI, V92, P1; VICKER MG, 1986, J CELL SCI, V84, P263; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Weber M, 2013, SCIENCE, V339, P328, DOI 10.1126/science.1228456; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Wu D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018805; Xu X, 2007, J CELL BIOL, V178, P141, DOI 10.1083/jcb.200611096; Yamada M, 2011, CELL MOL IMMUNOL, V8, P305, DOI 10.1038/cmi.2011.8; Yde P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-115; Yoshida R, 1998, J BIOL CHEM, V273, P7118, DOI 10.1074/jbc.273.12.7118; Zidar DA, 2009, P NATL ACAD SCI USA, V106, P9649, DOI 10.1073/pnas.0904361106; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	63	29	29	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					862	+		10.1016/j.immuni.2017.10.020	http://dx.doi.org/10.1016/j.immuni.2017.10.020			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29166587	Green Accepted, Bronze			2022-12-18	WOS:000416483700011
J	Denzin, LK; Khan, AA; Virdis, F; Wilks, J; Kane, M; Beilinson, HA; Dikiy, S; Case, LK; Roopenian, D; Witkowski, M; Chervonsky, AV; Golovkina, TV				Denzin, Lisa K.; Khan, Aly A.; Virdis, Francesca; Wilks, Jessica; Kane, Melissa; Beilinson, Helen A.; Dikiy, Stanislav; Case, Laure K.; Roopenian, Derry; Witkowski, Michele; Chervonsky, Alexander V.; Golovkina, Tatyana V.			Neutralizing Antibody Responses to Viral Infections Are Linked to the Non-classical MHC Class II Gene H2-Ob	IMMUNITY			English	Article							MAMMARY-TUMOR VIRUS; GENOME-WIDE ASSOCIATION; HEPATITIS-C INFECTION; HLA-DO; MICE LACKING; I/LNJ MICE; T-CELLS; INTRACELLULAR-TRANSPORT; ANTIGEN PRESENTATION; MURINE RETROVIRUS	Select humans and animals control persistent viral infections via adaptive immune responses that include production of neutralizing antibodies. The precise genetic basis for the control remains enigmatic. Here, we report positional cloning of the gene responsible for production of retrovirus-neutralizing antibodies in mice of the I/LnJ strain. It encodes the beta subunit of the non-classical major histocompatibility complex class II (MHC-II)-like molecule H2-O, a negative regulator of antigen presentation. The recessive and functionally null I/LnJ H2-Ob allele supported the production of virus-neutralizing antibodies independently of the classical MHC haplotype. Subsequent bioinformatics and functional analyses of the human H2-Ob homolog, HLA-DOB, revealed both loss-and gain-of-function alleles, which could affect the ability of their carriers to control infections with human hepatitis B (HBV) and C (HCV) viruses. Thus, understanding of the previously unappreciated role of H2-O (HLA-DO) in immunity to infections may suggest new approaches in achieving neutralizing immunity to viruses.	[Denzin, Lisa K.; Khan, Aly A.; Virdis, Francesca; Golovkina, Tatyana V.] State Univ NJ, Child Hlth Inst NJ, Rutgers Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08901 USA; [Kane, Melissa; Witkowski, Michele; Chervonsky, Alexander V.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA; [Beilinson, Helen A.; Case, Laure K.; Roopenian, Derry] Toyota Technol Inst, Chicago, IL 60637 USA; [Wilks, Jessica; Kane, Melissa; Case, Laure K.; Witkowski, Michele; Golovkina, Tatyana V.] Jackson Lab, Bar Harbor, ME 04609 USA; [Wilks, Jessica; Dikiy, Stanislav; Golovkina, Tatyana V.] Rockefeller Univ, Lab Retrovirol, New York, NY 10065 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Chicago; Toyota Technological Institute - Chicago; Jackson Laboratory; Rockefeller University	Golovkina, TV (corresponding author), State Univ NJ, Child Hlth Inst NJ, Rutgers Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08901 USA.	tgolovki@bsd.uchicago.edu	Dikiy, Stanislav/GWR-2104-2022	Dikiy, Stanislav/0000-0002-8287-6561; Kane, Melissa/0000-0002-4580-1210; Beilinson, Helen/0000-0002-2888-5256	PHS [CA134667, AI117535, AI061484, T32 AI 007090, P30 CA014599]; National Center for Advancing Translational Sciences of the National Institutes of Health [UL1 TR000430]; Robert Wood Johnson Foundation [67038]; NATIONAL CANCER INSTITUTE [R01CA134667, P30CA034196, P30CA014599] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007090, R01AI117535, R01AI061484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016400] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are thankful to Derek Sant'Angelo, Alexander Mankin, and members of the Golovkina, Chervonsky, and Denzin laboratories for discussions and to Louis Osorio, Emmily Shanks, and Kelly O'Grady for technical assistance. This work was supported by PHS grants CA134667 to T.V.G., AI117535 to T.V.G. and L.K.D., and AI061484 to L.K.D., by T32 AI 007090 to J.W., by P30 CA014599 to the University of Chicago, by the National Center for Advancing Translational Sciences of the National Institutes of Health through grant number UL1 TR000430 to the University of Chicago, and by the Robert Wood Johnson Foundation (grant number 67038) to the Child Health Institute of New Jersey. Whole-genome sequencing of mouse strains was performed by the University of Chicago Genomics Facility.	ACHAORBEA H, 1995, ANNU REV IMMUNOL, V13, P459, DOI 10.1146/annurev.iy.13.040195.002331; Alfonso C, 2000, ANNU REV IMMUNOL, V18, P113, DOI 10.1146/annurev.immunol.18.1.113; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Buggiano V, 1999, SCAND J IMMUNOL, V49, P269; Case LK, 2008, J VIROL, V82, P1438, DOI 10.1128/JVI.01991-07; Case LK, 2005, J IMMUNOL, V175, P7543, DOI 10.4049/jimmunol.175.11.7543; CHANG CH, 1994, J EXP MED, V180, P1367, DOI 10.1084/jem.180.4.1367; Chang SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099724; Chen XJ, 2002, J EXP MED, V195, P1053, DOI 10.1084/jem.20012066; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Ciupe SM, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003730; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; DEMBIC Z, 1985, EMBO J, V4, P127, DOI 10.1002/j.1460-2075.1985.tb02326.x; Denzin LK, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00465; Denzin LK, 1997, SCIENCE, V278, P106, DOI 10.1126/science.278.5335.106; DENZIN LK, 1994, IMMUNITY, V1, P595, DOI 10.1016/1074-7613(94)90049-3; Draghi NA, 2010, P NATL ACAD SCI USA, V107, P16607, DOI 10.1073/pnas.1004664107; Dudley JP, 2016, ILAR J, V57, P12, DOI 10.1093/ilar/ilv044; Duggal P, 2013, ANN INTERN MED, V158, P235, DOI 10.7326/0003-4819-158-4-201302190-00003; Eruslanov EB, 2004, CLIN EXP IMMUNOL, V135, P19, DOI 10.1111/j.1365-2249.2004.02328.x; Fallas JL, 2007, J IMMUNOL, V178, P1488, DOI 10.4049/jimmunol.178.3.1488; Fallas JL, 2004, J IMMUNOL, V173, P1549, DOI 10.4049/jimmunol.173.3.1549; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Finke D, 2003, P NATL ACAD SCI USA, V100, P199, DOI 10.1073/pnas.0134988100; Glazier KS, 2002, J EXP MED, V195, P1063, DOI 10.1084/jem.20012059; Golovkina TV, 1997, J VIROL, V71, P3895, DOI 10.1128/JVI.71.5.3895-3903.1997; Golovkina TV, 2000, J VIROL, V74, P2752, DOI 10.1128/JVI.74.6.2752-2759.2000; Gu YP, 2013, J IMMUNOL, V190, P126, DOI 10.4049/jimmunol.1200993; Guce AI, 2013, NAT STRUCT MOL BIOL, V20, P90, DOI 10.1038/nsmb.2460; Hammond C, 1998, J IMMUNOL, V161, P3282; HASENKRUG KJ, 1995, J VIROL, V69, P2617, DOI 10.1128/JVI.69.4.2617-2620.1995; Hashimoto K, 2002, GENESIS, V32, P152, DOI 10.1002/gene.10056; Hook LM, 2002, J VIROL, V76, P12112, DOI 10.1128/JVI.76.23.12112-12122.2002; Huang CF, 2006, CELL MOL IMMUNOL, V3, P97; Huang P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123513; JANEWAY CA, 1984, J IMMUNOL, V132, P662; Kamatani Y, 2009, NAT GENET, V41, P591, DOI 10.1038/ng.348; Kane M, 2011, IMMUNITY, V35, P135, DOI 10.1016/j.immuni.2011.05.011; KARLSSON L, 1991, NATURE, V351, P485, DOI 10.1038/351485a0; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Khalil H, 2002, TISSUE ANTIGENS, V60, P372, DOI 10.1034/j.1399-0039.2002.600504.x; Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lek M, 2016, NATURE, V536, P285, DOI 10.1038/nature19057; Li YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11664; Liljedahl M, 1996, EMBO J, V15, P4817, DOI 10.1002/j.1460-2075.1996.tb00862.x; Liljedahl M, 1998, IMMUNITY, V8, P233, DOI 10.1016/S1074-7613(00)80475-6; Logunova NN, 2005, J EXP MED, V202, P73, DOI 10.1084/jem.20050198; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Mellins ED, 2014, CURR OPIN IMMUNOL, V26, P115, DOI 10.1016/j.coi.2013.11.005; Miura T, 2009, J VIROL, V83, P140, DOI 10.1128/JVI.01471-08; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; Miyazawa M, 2008, VACCINE, V26, P2981, DOI 10.1016/j.vaccine.2008.01.004; Nikonenko BV, 2000, TUBERCLE LUNG DIS, V80, P15, DOI 10.1054/tuld.1999.0225; Oi V T, 1978, Curr Top Microbiol Immunol, V81, P115; Osburn WO, 2014, HEPATOLOGY, V59, P2140, DOI 10.1002/hep.27013; Pereyra FP, 2010, SCIENCE, V330, P1551, DOI 10.1126/science.1195271; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; PIAZZON I, 1994, J IMMUNOL, V153, P1553; Purdy A, 2003, J EXP MED, V197, P233, DOI 10.1084/jem.20021499; Radaeva TV, 2005, TUBERCULOSIS, V85, P65, DOI 10.1016/j.tube.2004.09.014; Robbins NF, 1996, HUM IMMUNOL, V45, P13, DOI 10.1016/0198-8859(95)00152-2; ROWE WP, 1970, VIROLOGY, V42, P1136, DOI 10.1016/0042-6822(70)90362-4; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Thomas DL, 2000, JAMA-J AM MED ASSOC, V284, P450, DOI 10.1001/jama.284.4.450; vanHam SM, 1997, CURR BIOL, V7, P950, DOI 10.1016/S0960-9822(06)00414-3; Villano SA, 1999, HEPATOLOGY, V29, P908, DOI 10.1002/hep.510290311; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Yalcin B, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r18; Zhou SH, 2009, J VIROL, V83, P1625, DOI 10.1128/JVI.01770-08	76	29	29	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					310	+		10.1016/j.immuni.2017.07.013	http://dx.doi.org/10.1016/j.immuni.2017.07.013			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28813660	Green Accepted, Bronze			2022-12-18	WOS:000407788300016
J	Huffaker, TB; O'Connell, RM				Huffaker, Thomas B.; O'Connell, Ryan M.			miR-155-SOCS1 as a Functional Axis: Satisfying the Burden of Proof	IMMUNITY			English	Editorial Material							INDUCED CYTIDINE DEAMINASE; MICRORNA-155; REGULATOR; CELLS	The importance of individual target genes for miRNA activity has been difficult to establish. In this issue of Immunity, Lu et al. (2015) disrupt the miR-155 binding site in the SOCS1 3' UTR in the mouse germline and show that this axis is important for T and NK cell function.	[Huffaker, Thomas B.; O'Connell, Ryan M.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	O'Connell, RM (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	ryan.oconnell@path.utah.edu						Dorsett Y, 2008, IMMUNITY, V28, P630, DOI 10.1016/j.immuni.2008.04.002; Escobar TM, 2014, IMMUNITY, V40, P865, DOI 10.1016/j.immuni.2014.03.014; Lu D, 2014, J EXP MED, V211, P2183, DOI 10.1084/jem.20140338; Lu LF, 2015, IMMUNITY, V43, P52, DOI 10.1016/j.immuni.2015.04.022; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Simpson LJ, 2014, NAT IMMUNOL, V15, P1162, DOI 10.1038/ni.3026; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Teng G, 2008, IMMUNITY, V28, P621, DOI 10.1016/j.immuni.2008.03.015; Vigorito E, 2013, IMMUNOL REV, V253, P146, DOI 10.1111/imr.12057	10	29	33	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					3	4		10.1016/j.immuni.2015.06.020	http://dx.doi.org/10.1016/j.immuni.2015.06.020			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26200005	Bronze			2022-12-18	WOS:000360101100002
J	Helmstetter, C; Flossdorf, M; Peine, M; Kupz, A; Zhu, JF; Hegazy, AN; Duque-Correa, MA; Zhang, Q; Vainshtein, Y; Radbruch, A; Kaufmann, SH; Paul, WE; Hofer, T; Lohning, M				Helmstetter, Caroline; Flossdorf, Michael; Peine, Michael; Kupz, Andreas; Zhu, Jinfang; Hegazy, Ahmed N.; Duque-Correa, Maria A.; Zhang, Qin; Vainshtein, Yevhen; Radbruch, Andreas; Kaufmann, Stefan H.; Paul, William E.; Hoefer, Thomas; Loehning, Max			Individual T Helper Cells Have a Quantitative Cytokine Memory	IMMUNITY			English	Article							NF-KAPPA-B; GENE-EXPRESSION; TRANSCRIPTION FACTOR; TH1 DEVELOPMENT; PROTEIN-LEVELS; RAPID ON/OFF; IFN-GAMMA; BET; RESPONSES; HETEROGENEITY	The probabilistic expression of cytokine genes in differentiated T helper (Th) cell populations remains ill defined. By single-cell analyses and mathematical modeling, we show that one stimulation featured stable cytokine nonproducers as well as stable producers with wide cell-to-cell variability in the magnitude of expression. Focusing on interferon-gamma (IFN-gamma) expression by Th1 cells, mathematical modeling predicted that this behavior reflected different cell-intrinsic capacities and not mere gene-expression noise. In vivo, Th1 cells sort purified by secreted IFN-gamma amounts preserved a quantitative memory for both probability and magnitude of IFN-gamma re-expression for at least 1 month. Mechanistically, this memory resulted from quantitatively distinct transcription of individual alleles and was controlled by stable expression differences of the Th1 cell lineage-specifying transcription factor T-bet. Functionally, Th1 cells with graded IFN-gamma production competence differentially activated Salmonella-infected macrophages for bacterial killing. Thus, individual Th cells commit to produce distinct amounts of a given cytokine, thereby generating functional intrapopulation heterogeneity.	[Helmstetter, Caroline; Peine, Michael; Hegazy, Ahmed N.; Loehning, Max] Charite, Dept Rheumatol & Clin Immunol, D-10117 Berlin, Germany; [Helmstetter, Caroline; Peine, Michael; Hegazy, Ahmed N.; Radbruch, Andreas; Loehning, Max] Leibniz Inst, German Rheumatism Res Ctr DRFZ, D-10117 Berlin, Germany; [Flossdorf, Michael; Zhang, Qin; Vainshtein, Yevhen; Hoefer, Thomas] German Canc Res Ctr, Div Theoret Syst Biol, D-69120 Heidelberg, Germany; [Flossdorf, Michael; Zhang, Qin; Vainshtein, Yevhen; Hoefer, Thomas] Heidelberg Univ, Bioquant Ctr, D-69120 Heidelberg, Germany; [Kupz, Andreas; Duque-Correa, Maria A.; Kaufmann, Stefan H.] Max Planck Inst Infect Biol, Dept Immunol, D-10117 Berlin, Germany; [Kupz, Andreas] James Cook Univ, Queensland Trop Hlth Alliance Res Lab, Smithfield, Qld 4878, Australia; [Zhu, Jinfang; Paul, William E.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Hegazy, Ahmed N.] Charite, Dept Gastroenterol Hepatol & Endocrinol, D-10117 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society; James Cook University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hofer, T (corresponding author), German Canc Res Ctr, Div Theoret Syst Biol, D-69120 Heidelberg, Germany.	t.hoefer@dkfz-heidelberg.de; loehning@drfz.de	Zhu, Jinfang/B-7574-2012; Löhning, Max/AAL-2967-2021; Höfer, Thomas/G-5665-2013; Kaufmann, Stefan HE/I-5454-2014	Zhu, Jinfang/0000-0002-0117-4745; Löhning, Max/0000-0001-6382-7281; Höfer, Thomas/0000-0003-3560-8780; Peine, Caroline/0000-0001-6267-3452; Kupz, Andreas/0000-0002-9259-7873; Vainshtein, Yevhen/0000-0001-7944-8892; Hegazy, Ahmed N./0000-0002-2946-8251; Radbruch, Andreas/0000-0001-5753-0000; Duque Correa, Maria Adelaida/0000-0002-0567-0412; Kaufmann, Stefan HE/0000-0001-9866-8268	German Federal Ministry of Education and Research (FORSYS and e: Bio/T-Sys); German Research Foundation [SFB618, TPC3, SFB650, TP28, LO1542/3-1, HO02050/4-1]; Volkswagen Foundation (Lichtenberg program); National Health and Medical Research Council of Australia through a CJ Martin Biomedical Early Career Fellowship [APP1052764]; EMBO long-term fellowship [ALTF 116-2012]; Marie Curie fellowship [FP7-PEOPLE-2012-IEF, 330621]; Division of Intramural Research, NIAID, NIH, USA; US National Science Foundation [NSF PHY11-25915]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001169, ZIAAI000493, ZIAAI000926] Funding Source: NIH RePORTER	German Federal Ministry of Education and Research (FORSYS and e: Bio/T-Sys); German Research Foundation(German Research Foundation (DFG)); Volkswagen Foundation (Lichtenberg program); National Health and Medical Research Council of Australia through a CJ Martin Biomedical Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Marie Curie fellowship(European Commission); Division of Intramural Research, NIAID, NIH, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); US National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank V. Holecska, S. Ebel, I. Panse, and U. Zedler for expert technical assistance and the FCCF at DRFZ for cell sorting. This work was supported by the German Federal Ministry of Education and Research (FORSYS and e: Bio/T-Sys), the German Research Foundation (SFB618, TPC3; SFB650, TP28; LO1542/3-1, and HO02050/4-1), and the Volkswagen Foundation (Lichtenberg program to M. L.). C. H., M. P., and M. A. D.-C. were fellows of the International Max Planck Research School for Infectious Diseases and Immunology. A. K. was supported by the National Health and Medical Research Council of Australia through a CJ Martin Biomedical Early Career Fellowship (APP1052764). A.N.H. is supported by an EMBO long-term fellowship (ALTF 116-2012) and a Marie Curie fellowship (FP7-PEOPLE-2012-IEF, Proposal 330621). J.Z. and W. E. P. are supported by the Division of Intramural Research, NIAID, NIH, USA. T. H. and M. F. are supported in part by the US National Science Foundation (NSF PHY11-25915). T. H. is a member of CellNetworks.	Afkarian M, 2002, NAT IMMUNOL, V3, P549, DOI 10.1038/ni794; Apostolou E, 2008, CELL, V134, P85, DOI 10.1016/j.cell.2008.05.052; Assenmacher M, 1998, EUR J IMMUNOL, V28, P1534, DOI 10.1002/(SICI)1521-4141(199805)28:05<1534::AID-IMMU1534>3.0.CO;2-R; Balasubramani A, 2010, IMMUNOL REV, V238, P216, DOI 10.1111/j.1600-065X.2010.00961.x; Balasubramani A, 2010, IMMUNITY, V33, P35, DOI 10.1016/j.immuni.2010.07.004; Barth TK, 2010, TRENDS BIOCHEM SCI, V35, P618, DOI 10.1016/j.tibs.2010.05.006; BUCY RP, 1994, J EXP MED, V180, P1251, DOI 10.1084/jem.180.4.1251; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Corbin GA, 2005, J IMMUNOL, V174, P718, DOI 10.4049/jimmunol.174.2.718; Dalton SR, 2012, EPIGENOMICS-UK, V4, P459, DOI [10.2217/EPI.12.36, 10.2217/epi.12.36]; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Pham D, 2012, J IMMUNOL, V189, P832, DOI 10.4049/jimmunol.1200854; Eckmann L, 2001, MICROBES INFECT, V3, P1191, DOI 10.1016/S1286-4579(01)01479-4; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Guo LY, 2005, J CLIN IMMUNOL, V25, P573, DOI 10.1007/s10875-005-8218-5; Harper CV, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000607; Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Hu-Li J, 2001, IMMUNITY, V14, P1, DOI 10.1016/S1074-7613(01)00084-X; Lohning M, 2008, J EXP MED, V205, P53, DOI 10.1084/jem.20071855; Lohning M, 2003, P NATL ACAD SCI USA, V100, P12307, DOI 10.1073/pnas.2035254100; Lohning M, 2002, ADV IMMUNOL, V80, P115, DOI 10.1016/S0065-2776(02)80014-1; Mariani L, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.13; Martins GA, 2005, J IMMUNOL, V175, P5981, DOI 10.4049/jimmunol.175.9.5981; Miller-Jensen K, 2011, TRENDS BIOTECHNOL, V29, P517, DOI 10.1016/j.tibtech.2011.05.004; Mullen AC, 2001, SCIENCE, V292, P1907, DOI 10.1126/science.1059835; Niesner U, 2008, J EXP MED, V205, P1889, DOI 10.1084/jem.20072468; O'Garra A, 2011, NAT IMMUNOL, V12, P288, DOI 10.1038/ni.2003; OPENSHAW P, 1995, J EXP MED, V182, P1357, DOI 10.1084/jem.182.5.1357; Peine M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001633; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Robinson D, 1997, IMMUNITY, V7, P571, DOI 10.1016/S1074-7613(00)80378-7; Shnyreva M, 2004, P NATL ACAD SCI USA, V101, P12622, DOI 10.1073/pnas.0400849101; Sigal A, 2006, NATURE, V444, P643, DOI 10.1038/nature05316; Slifka MK, 1999, NATURE, V401, P76, DOI 10.1038/43454; Suter DM, 2011, SCIENCE, V332, P472, DOI 10.1126/science.1198817; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Usui T, 2003, IMMUNITY, V18, P415, DOI 10.1016/S1074-7613(03)00057-8; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Zhao MW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001249; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zhu JF, 2012, IMMUNITY, V37, P660, DOI 10.1016/j.immuni.2012.09.007; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	46	29	29	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					108	122		10.1016/j.immuni.2014.12.018	http://dx.doi.org/10.1016/j.immuni.2014.12.018			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25607461	Green Accepted, Bronze			2022-12-18	WOS:000348197500015
J	Markiewicz, MA; Wise, EL; Buchwald, ZS; Pinto, AK; Zafirova, B; Polic, B; Shaw, AS				Markiewicz, Mary A.; Wise, Erica L.; Buchwald, Zachary S.; Pinto, Amelia K.; Zafirova, Biljana; Polic, Bojan; Shaw, Andrey S.			RAE-1 epsilon Ligand Expressed on Pancreatic Islets Recruits NKG2D Receptor-Expressing Cytotoxic T Cells Independent of T Cell Receptor Recognition	IMMUNITY			English	Article							TYPE-1 DIABETES-MELLITUS; NK CELLS; IN-VIVO; DOUBLE REPORTER; TUMOR-IMMUNITY; NEONATAL-RAT; KILLER-CELLS; ACTIVATION; COSTIMULATION; APOPTOSIS	The mechanisms by which cytotoxic T lymphocytes (CTLs) enter and are retained in nonlymphoid tissue are not well characterized. With a transgenic mouse expressing the NKG2D ligand retinoic acid early transcript 1 epsilon (RAE1 epsilon) in beta-islet cells of the pancreas, we found that RAE1 expression was sufficient to induce the recruitment of adoptively transferred CTLs to islets. This was dependent on NKG2D expression. by the CTLs and independent of antigen recognition. Surprisingly, the recruitment of CTLs resulted in the subsequent recruitment of a large number of endogenous lymphocytes. Whereas transgenic mice did not develop diabetes, RAE1 expression was sufficient to induce insulitis in older, unmanipulated transgenic mice that was enhanced by viral infection and pancreatic inflammation. These results demonstrate that the expression of an NKG2D ligand in islets is sufficient to recruit CTLs regardless of their antigen specificity and to induce insulitis.	[Markiewicz, Mary A.; Wise, Erica L.; Buchwald, Zachary S.; Pinto, Amelia K.; Shaw, Andrey S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Shaw, Andrey S.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Zafirova, Biljana; Polic, Bojan] Univ Rijeka, Fac Med, Dept Histol & Embryol, Rijeka 51000, Croatia	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); University of Rijeka	Shaw, AS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	shaw@pathology.wustl.edu	Pinto, Amelia/AAD-7059-2020; Pinto, Amelia K/O-6658-2018; Polic, Bojan/B-8622-2014	Pinto, Amelia/0000-0002-7147-3978; Pinto, Amelia K/0000-0002-7147-3978; Polic, Bojan/0000-0003-3930-9630; Markiewicz, Mary/0000-0001-5685-8573	NIH (Diabetes Research and Training Center) [P60 DK020579, R37 A1057966]; HHMI; Croatian Ministry of Science, Education and Sports [062-0621261-1271]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI057966] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020579, P30DK020579] Funding Source: NIH RePORTER	NIH (Diabetes Research and Training Center); HHMI(Howard Hughes Medical Institute); Croatian Ministry of Science, Education and Sports(Ministry of Science, Education and Sports, Republic of Croatia); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the NIH (Diabetes Research and Training Center P60 DK020579 to M.A.M. and .R37 A1057966 to ASS.), the HHMI (A.S.S.), and Croatian Ministry of Science, Education and Sports Grant 062-0621261-1271 (B.P.). We thank X. Wang and Y. Huang (Washington University School of Medicine) for their help with performing the BioPlex assays, H. Virgin and D. Kreamalmeyer (Washington University School of Medicine) for mice, and B. Calderon and E. Unanue (Washington University School of Medicine) for helpful advice and discussion.	Appay V, 2001, TRENDS IMMUNOL, V22, P83, DOI 10.1016/S1471-4906(00)01812-3; Bacon L, 2004, J IMMUNOL, V173, P1078, DOI 10.4049/jimmunol.173.2.1078; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Carayannopoulos LN, 2002, EUR J IMMUNOL, V32, P597, DOI 10.1002/1521-4141(200203)32:3<597::AID-IMMU597>3.3.CO;2-5; Carayannopoulos LN, 2002, J IMMUNOL, V169, P4079, DOI 10.4049/jimmunol.169.8.4079; Cemerski S, 2007, IMMUNITY, V26, P345, DOI 10.1016/j.immuni.2007.01.013; Cerwenka A, 2000, IMMUNITY, V12, P721, DOI 10.1016/S1074-7613(00)80222-8; Chalupny NJ, 2003, BIOCHEM BIOPH RES CO, V305, P129, DOI 10.1016/S0006-291X(03)00714-9; Champsaur M, 2010, IMMUNOL REV, V235, P267, DOI 10.1111/j.0105-2896.2010.00893.x; Cosman D, 2001, IMMUNITY, V14, P123, DOI 10.1016/S1074-7613(01)00095-4; Coudert JD, 2008, BLOOD, V111, P3571, DOI 10.1182/blood-2007-07-100057; Dai ZP, 2009, J EXP MED, V206, P793, DOI 10.1084/jem.20081648; DeNucci CC, 2009, CRIT REV IMMUNOL, V29, P87, DOI 10.1615/CritRevImmunol.v29.i2.10; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Diefenbach A, 2003, EUR J IMMUNOL, V33, P381, DOI 10.1002/immu.200310012; Ehrlich LIR, 2005, J IMMUNOL, V174, P1922, DOI 10.4049/jimmunol.174.4.1922; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Gilfillan S, 2002, NAT IMMUNOL, V3, P1150, DOI 10.1038/ni857; Groh V, 2003, P NATL ACAD SCI USA, V100, P9452, DOI 10.1073/pnas.1632807100; Groh V, 2001, NAT IMMUNOL, V2, P255, DOI 10.1038/85321; Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; Hyka-Nouspikel N, 2007, J IMMUNOL, V179, P3763, DOI 10.4049/jimmunol.179.6.3763; Jamieson AM, 2002, IMMUNITY, V17, P19, DOI 10.1016/S1074-7613(02)00333-3; Kassem SA, 2000, DIABETES, V49, P1325, DOI 10.2337/diabetes.49.8.1325; Kelly Colleen B, 2003, Methods Mol Med, V83, P3; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Lobe CG, 1999, DEV BIOL, V208, P281, DOI 10.1006/dbio.1999.9209; Markiewicz MA, 2005, J IMMUNOL, V175, P2825, DOI 10.4049/jimmunol.175.5.2825; Masopust D, 2004, J IMMUNOL, V172, P4875, DOI 10.4049/jimmunol.172.8.4875; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Nikitina-Zake L, 2004, ANN NY ACAD SCI, V1037, P161, DOI 10.1196/annals.1337.027; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; Petrik J, 1998, ENDOCRINOLOGY, V139, P2994, DOI 10.1210/en.139.6.2994; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; Raulet DH, 2003, NAT REV IMMUNOL, V3, P781, DOI 10.1038/nri1199; Rodacki M, 2007, DIABETES, V56, P177, DOI 10.2337/db06-0493; Scaglia L, 1997, ENDOCRINOLOGY, V138, P1736, DOI 10.1210/en.138.4.1736; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Sutherland CL, 2002, J IMMUNOL, V168, P671, DOI 10.4049/jimmunol.168.2.671; Takada A, 2008, J IMMUNOL, V180, P1678, DOI 10.4049/jimmunol.180.3.1678; Trudeau JD, 2000, DIABETES, V49, P1, DOI 10.2337/diabetes.49.1.1; Turley S, 2003, J EXP MED, V198, P1527, DOI 10.1084/jem.20030966; Verneris MR, 2004, BLOOD, V103, P3065, DOI 10.1182/blood-2003-06-2125; Wang JG, 2010, P NATL ACAD SCI USA, V107, P9317, DOI 10.1073/pnas.0913835107; Whang MI, 2009, J IMMUNOL, V182, P4557, DOI 10.4049/jimmunol.0802439; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Zafirova B, 2009, IMMUNITY, V31, P270, DOI 10.1016/j.immuni.2009.06.017	53	29	30	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 27	2012	36	1					132	141		10.1016/j.immuni.2011.11.014	http://dx.doi.org/10.1016/j.immuni.2011.11.014			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	885GG	22244846	Green Accepted, Bronze			2022-12-18	WOS:000299766000016
J	Zhu, JF; Paul, WE				Zhu, Jinfang; Paul, William E.			CD4(+) T Cell Plasticity-Th2 Cells Join the Crowd	IMMUNITY			English	Editorial Material							LINEAGE; DIFFERENTIATION		[Zhu, Jinfang; Paul, William E.] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Zhu, JF (corresponding author), NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA.	jfzhu@niaid.nih.gov; wpaul@niaid.nih.gov	Zhu, Jinfang/B-7574-2012	Zhu, Jinfang/0000-0002-0117-4745	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000493] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 AI999999] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Hegazy AN, 2010, IMMUNITY, V32, P116, DOI 10.1016/j.immuni.2009.12.004; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2008, BLOOD, V112, P1557, DOI 10.1182/blood-2008-05-078154	8	29	31	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 29	2010	32	1					11	13		10.1016/j.immuni.2010.01.001	http://dx.doi.org/10.1016/j.immuni.2010.01.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	550HW	20152167	Green Accepted, Bronze			2022-12-18	WOS:000274119900007
J	Mebius, RE				Mebius, Reina E.			Lymphoid Organs for Peritoneal Cavity Immune Response: Milky Spots	IMMUNITY			English	Editorial Material							CELLS	Milky spots are located in the omentum of the peritoneal cavity and their classification as lymphoid organs has been debated. In this issue of Immunity, Rangel-Moreno et al. (2009) provide compelling data to consider them as unique secondary lymphoid organs.	VUMC, Dept Mol Cell Bol & Immunol, NL-1081 BT Amsterdam, Netherlands		Mebius, RE (corresponding author), VUMC, Dept Mol Cell Bol & Immunol, Boechorststr 7, NL-1081 BT Amsterdam, Netherlands.	r.mebius@vumc.nl		Mebius, Reina/0000-0003-0451-7464				Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; BEELEN RHJ, 1980, J RETICULOENDOTH SOC, V28, P585; Berberich S, 2008, J IMMUNOL, V180, P2196, DOI 10.4049/jimmunol.180.4.2196; Browning JL, 2005, IMMUNITY, V23, P539, DOI 10.1016/j.immuni.2005.10.002; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; GEARHART PJ, 1975, J EXP MED, V141, P56, DOI 10.1084/jem.141.1.56; Hopken UE, 2004, J LEUKOCYTE BIOL, V76, P709, DOI 10.1189/jlb.1203643; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; Vondenhoff MF, 2009, J IMMUNOL, V182, P5439, DOI 10.4049/jimmunol.0801165; Williams R, 1986, Curr Probl Surg, V23, P789	10	29	30	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAY 22	2009	30	5					670	672		10.1016/j.immuni.2009.04.005	http://dx.doi.org/10.1016/j.immuni.2009.04.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19464991	Bronze			2022-12-18	WOS:000266356900009
J	Owen, DM; Gale, M				Owen, David M.; Gale, Michael, Jr.			Fighting the Flu with Inflammasome Signaling	IMMUNITY			English	Editorial Material							INFECTION; RESPONSES	A wide variety of stimuli induce the inflammasome, but little is known about its role in immune protection against viruses. In this issue of Immunity, Allen et al. (2009) and Thomas et al. (2009) describe a critical role for NLRP3 induction of the inflammasome and protection against influenza virus infection.	[Owen, David M.; Gale, Michael, Jr.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Owen, David M.] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	University of Washington; University of Washington Seattle; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gale, M (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	mgale@u.washington.edu		Gale, Michael/0000-0002-6332-7436; Owen, David/0000-0002-5724-0342				Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; Meylan E, 2008, EMBO REP, V9, P243, DOI 10.1038/embor.2008.23; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Wang JP, 2007, CELL MICROBIOL, V9, P1641, DOI 10.1111/j.1462-5822.2007.00961.x	11	29	31	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2009	30	4					476	478		10.1016/j.immuni.2009.03.011	http://dx.doi.org/10.1016/j.immuni.2009.03.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435BT	19371712	Bronze			2022-12-18	WOS:000265319000004
J	Krieg, AM				Krieg, Arthur M.			The toll of too much TLR7	IMMUNITY			English	Editorial Material							TOLL-LIKE-RECEPTOR-7; AUTOIMMUNITY; GENE	Toll-like receptor 7 (TLR7) detects viral RNA, but can be activated inappropriately by self-RNA, leading to autoimmunity. Deane et al. (2007) show that Tlr7 gene dosage is directly related to the risk of lupus in a mouse model.	Coll Pharmaceut Grp, Wellesley, MA 02481 USA		Krieg, AM (corresponding author), Coll Pharmaceut Grp, 93 Worcester St, Suite 101, Wellesley, MA 02481 USA.	akrieg@coleypharma.com	Krieg, Arthur M/K-8109-2019; Krieg, Art/R-6166-2019					Bekeredjian-Ding IB, 2005, J IMMUNOL, V174, P4043, DOI 10.4049/jimmunol.174.7.4043; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Kelley J, 2007, ARTHRITIS RHEUM, V56, P3375, DOI 10.1002/art.22916; Krieg AM, 2007, IMMUNOL REV, V220, P251, DOI 10.1111/j.1600-065X.2007.00572.x; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103	10	29	35	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV	2007	27	5					695	697		10.1016/j.immuni.2007.11.001	http://dx.doi.org/10.1016/j.immuni.2007.11.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235YA	18031693	Bronze			2022-12-18	WOS:000251269000004
J	Dinarello, CA				Dinarello, Charles A.			A signal for the caspase-1 inflammasome free of TLR	IMMUNITY			English	Editorial Material							INTERLEUKIN-1; DISEASE	Secretion of the proinflammatory cytokine IL-1 beta requires caspase-1 and Toll-like receptor (TLR) signaling. However, Kanneganti et al. (2007) find that bacteria can use pore-forming mechanisms to activate caspase-1 for the production of IL-1 beta precursor independently of TLRs.	Univ Colorado, Hlth Sci Ctr, Dept Med, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Dinarello, CA (corresponding author), Univ Colorado, Hlth Sci Ctr, Dept Med, 4200 E 9th Ave B168, Denver, CO 80262 USA.	cdinare333@aol.com	Dinarello, Charles/C-8524-2013					Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brough D, 2007, J CELL SCI, V120, P772, DOI 10.1242/jcs.03377; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Kanneganti TD, 2007, IMMUNITY, V26, P433, DOI 10.1016/j.immuni.2007.03.008; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200	10	29	35	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR	2007	26	4					383	385		10.1016/j.immuni.2007.04.005	http://dx.doi.org/10.1016/j.immuni.2007.04.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	162YW	17459804	Bronze			2022-12-18	WOS:000246126400001
J	Hasenkrug, KJ				Hasenkrug, Kim J.			The leptin connection: Regulatory T cells and autoimmunity	IMMUNITY			English	Editorial Material							IMMUNE-RESPONSE	Leptin is a cytokine-like hormone with proinflammatory properties linked to autoimmune diseases. In this issue of Immunity, De Rosa et al. (2007) elucidate an important new role for leptin in the anergy and hyporesponsiveness of regulatory T cells.	NIAID, NIH, Lab Persistent Viral Dis, Hamilton, MT 59840 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hasenkrug, KJ (corresponding author), NIAID, NIH, Lab Persistent Viral Dis, Hamilton, MT 59840 USA.	khasenkrug@nih.gov			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000753, Z01AI000753] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Palmer G, 2006, J IMMUNOL, V177, P2899, DOI 10.4049/jimmunol.177.5.2899; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sanna V, 2003, J CLIN INVEST, V111, P241, DOI 10.1172/JCI200316721; Tuzun A, 2004, J GASTROEN HEPATOL, V19, P429, DOI 10.1111/j.1440-1746.2003.03300.x	9	29	29	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB	2007	26	2					143	145		10.1016/j.immuni.2007.02.002	http://dx.doi.org/10.1016/j.immuni.2007.02.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	142DE	17307702	Bronze			2022-12-18	WOS:000244628600005
J	McHeyzer-Williams, LJ; McHeyzer-Williams, MG				McHeyzer-Williams, LJ; McHeyzer-Williams, MG			Developmentally distinct Th cells control plasma cell production in vivo	IMMUNITY			English	Article							MEMORY B-CELLS; RECEPTOR REPERTOIRE; EXPRESSION; LIGAND; INDUCTION; HELPER; MICE; LY-6; GENERATION; ACTIVATION	Differential Ly6C expression identifies a major phenotypic division in CD44(lo)CD62L(hi)D4(+) Th cells. Using two separate models of single subset adoptive transfer, we demonstrate the unique capacity of Ly6C(hi) Th cells to promote antigen-specific plasma cell production in vivo. In contrast, both compartments support germinal center formation and proliferate to equivalent levels upon TCR triggering in vivo and in vitro. Developmentally, CD4(+)CD8(-) thymocytes leave the thymus expressing low levels of Ly6C; 3 days later similar to50% stably upregulate Ly6C without cell division or TCR engagement in the periphery. Interestingly, antigen-specific Th cell clonotypes unevenly assort into these peripheral compartments, creating separate TCR repertoires that underpin peripheral functional diversity. Taken together, these data reveal a developmentally distinct Ly6C(hi) naive Th cell compartment subspecialized to regulate plasma cell production in vivo.	Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	McHeyzer-Williams, MG (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mcheyzer@scripps.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040215, R01AI047231] Funding Source: NIH RePORTER; NIAID NIH HHS [AI47231, AI40215] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Apostolopoulos J, 2000, IMMUNITY, V12, P223, DOI 10.1016/S1074-7613(00)80175-2; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; BAMEZAI A, 1995, P NATL ACAD SCI USA, V92, P4294, DOI 10.1073/pnas.92.10.4294; Bikah G, 2000, NAT IMMUNOL, V1, P402, DOI 10.1038/80841; BOHUSLAV J, 1993, EUR J IMMUNOL, V23, P825, DOI 10.1002/eji.1830230409; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Crotty S, 2003, NATURE, V421, P282, DOI 10.1038/nature01318; Driver DJ, 2001, J IMMUNOL, V167, P1393, DOI 10.4049/jimmunol.167.3.1393; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; GRUSBY MJ, 1993, P NATL ACAD SCI USA, V90, P3913, DOI 10.1073/pnas.90.9.3913; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Haynes L, 1999, J EXP MED, V190, P1013, DOI 10.1084/jem.190.7.1013; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; LEE SK, 1994, EMBO J, V13, P2167, DOI 10.1002/j.1460-2075.1994.tb06493.x; Mak TW, 2003, NAT IMMUNOL, V4, P765, DOI 10.1038/ni947; MALEK TR, 1986, J EXP MED, V164, P709, DOI 10.1084/jem.164.3.709; McHeyzer-Williams LJ, 2000, J EXP MED, V191, P1149, DOI 10.1084/jem.191.7.1149; McHeyzer-Williams LJ, 1999, J EXP MED, V189, P1823, DOI 10.1084/jem.189.11.1823; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; MCHEYZERWILLIAMS MG, 1991, NATURE, V350, P502, DOI 10.1038/350502a0; MCHEYZERWILLIAMS MG, 1993, J EXP MED, V178, P295, DOI 10.1084/jem.178.1.295; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Panus JF, 2000, J EXP MED, V192, P1301, DOI 10.1084/jem.192.9.1301; ROCK KL, 1989, IMMUNOL REV, V111, P195, DOI 10.1111/j.1600-065X.1989.tb00547.x; Rosen H, 2003, P NATL ACAD SCI USA, V100, P10907, DOI 10.1073/pnas.1832725100; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Savage PA, 2001, IMMUNITY, V14, P243, DOI 10.1016/S1074-7613(01)00106-6; Schlueter AJ, 1997, J IMMUNOL, V158, P4211; SCOLLAY R, 1995, IMMUNOL TODAY, V16, P268, DOI 10.1016/0167-5699(95)80179-0; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Tough DF, 1996, SCIENCE, V272, P1947, DOI 10.1126/science.272.5270.1947; WALUNAS TL, 1995, J IMMUNOL, V155, P1873; Woodland DL, 2003, CURR OPIN IMMUNOL, V15, P336, DOI 10.1016/S0952-7915(03)00037-2	37	29	29	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2004	20	2					231	242		10.1016/S1074-7613(04)00028-7	http://dx.doi.org/10.1016/S1074-7613(04)00028-7			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	821EI	14975244	Bronze			2022-12-18	WOS:000221442400011
J	Hedrick, SM				Hedrick, SM			T cell development: Bottoms-up	IMMUNITY			English	Review							TRANSGENIC MICE; CD4 SILENCER; POSTTRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; IDENTIFICATION; THYMOCYTES; MECHANISMS; CD8-ALPHA; ENHANCER; ELEMENT	An important but laborious approach to understanding the concepts underlying T cell lineage commitment is to characterize the cis-acting control elements governing the expression of CD4 and CD8. Previous studies on the CD4 gene have shown that lineage commitment information is directed by the intronic silencer; however, a similarly simple mechanism for controlling CD8 gene expression has not been uncovered. In this issue of Immunity, two groups have investigated the role of putative enhancers in the CD8 locus, The deletion of three different elements in the intergeneic region between CD8beta and CD8alpha provides evidence for control at the level of chromatin accessibility.	Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA; Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Hedrick, SM (corresponding author), Univ Calif San Diego, Dept Biol, La Jolla, CA 92093 USA.		Hedrick, Stephen M/E-9171-2010	Hedrick, Stephen/0000-0002-6345-8751				Bruniquel D, 1997, IMMUNOGENETICS, V47, P96, DOI 10.1007/s002510050332; Cibotti R, 2000, MOL CELL BIOL, V20, P3852, DOI 10.1128/MCB.20.11.3852-3859.2000; Donda A, 1996, EUR J IMMUNOL, V26, P493, DOI 10.1002/eji.1830260232; Duncan DD, 1996, IMMUNITY, V4, P301, DOI 10.1016/S1074-7613(00)80438-0; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Ellmeier W, 2002, IMMUNITY, V16, P623, DOI 10.1016/S1074-7613(02)00309-6; Gao MH, 1996, IMMUNOGENETICS, V45, P130, DOI 10.1007/s002510050180; Garefalaki A, 2002, IMMUNITY, V16, P635, DOI 10.1016/S1074-7613(02)00308-4; Hostert A, 1998, IMMUNITY, V9, P497, DOI 10.1016/S1074-7613(00)80633-0; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Hostert A, 1997, J IMMUNOL, V158, P4270; Kieffer LJ, 2002, J IMMUNOL, V168, P3915, DOI 10.4049/jimmunol.168.8.3915; Kieffer LJ, 1997, J IMMUNOL, V159, P4907; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; SAWADA S, 1991, MOL CELL BIOL, V11, P5506, DOI 10.1128/MCB.11.11.5506; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; SIU G, 1992, MOL CELL BIOL, V12, P1592, DOI 10.1128/MCB.12.4.1592; TAKAHAMA Y, 1992, SCIENCE, V258, P1456, DOI 10.1126/science.1439838; WURSTER AL, 1994, MOL CELL BIOL, V14, P6452, DOI 10.1128/MCB.14.10.6452; Zhang XL, 1998, J IMMUNOL, V161, P2254; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	21	29	29	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2002	16	5					619	622		10.1016/S1074-7613(02)00316-3	http://dx.doi.org/10.1016/S1074-7613(02)00316-3			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	555YJ	12049714	Bronze			2022-12-18	WOS:000175820400001
J	Ehrlich, R; Lemonnier, FA				Ehrlich, R; Lemonnier, FA			HFE - A novel nonclassical class I molecule that is involved in iron metabolism	IMMUNITY			English	Article							HEREDITARY HEMOCHROMATOSIS; T-CELLS; INTRAEPITHELIAL LYMPHOCYTES; IDIOPATHIC HEMOCHROMATOSIS; RECEPTOR; MHC; COMPLEX; MONOCYTES; OVERLOAD; ANTIGENS		Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel; Inst Pasteur, Unite Immunite Cellulaire Antivirale, F-75724 Paris 15, France	Tel Aviv University; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Ehrlich, R (corresponding author), Tel Aviv Univ, Raymond & Beverly Sackler Fac Exact Sci, Dept Cell Res & Immunol, IL-69978 Tel Aviv, Israel.							Adams PC, 2000, HEPATOLOGY, V31, P1160, DOI 10.1053/he.2000.6984; Arosa FA, 1997, CLIN EXP IMMUNOL, V107, P548, DOI 10.1046/j.1365-2249.1997.d01-967.x; Bahram S, 1999, P NATL ACAD SCI USA, V96, P13312, DOI 10.1073/pnas.96.23.13312; Bennett MJ, 2000, NATURE, V403, P46, DOI 10.1038/47417; BOISMENU R, 1994, SCIENCE, V266, P1253, DOI 10.1126/science.7973709; Braud VM, 1999, CURR OPIN IMMUNOL, V11, P100, DOI 10.1016/S0952-7915(99)80018-1; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Cairo G, 1997, BLOOD, V89, P2546, DOI 10.1182/blood.V89.7.2546; DeSilva DM, 1996, PHYSIOL REV, V76, P31, DOI 10.1152/physrev.1996.76.1.31; DESOUSA M, 1994, IMMUNOL LETT, V39, P105, DOI 10.1016/0165-2478(94)90094-9; Drakesmith H, 2000, BIOESSAYS, V22, P595, DOI 10.1002/1521-1878(200007)22:7<595::AID-BIES1>3.3.CO;2-5; Feder JN, 1999, IMMUNOL RES, V20, P175, DOI 10.1007/BF02786472; FEHLMANN M, 1985, P NATL ACAD SCI USA, V82, P8634, DOI 10.1073/pnas.82.24.8634; FILLET G, 1989, BLOOD, V74, P844; Fleming RE, 2000, P NATL ACAD SCI USA, V97, P2214, DOI 10.1073/pnas.040548097; Ghetie V, 1997, IMMUNOL TODAY, V18, P592, DOI 10.1016/S0167-5699(97)01172-9; Guy-Grand D, 1998, EUR J IMMUNOL, V28, P730, DOI 10.1002/(SICI)1521-4141(199802)28:02<730::AID-IMMU730>3.0.CO;2-U; Kim JK, 1999, EUR J IMMUNOL, V29, P2819, DOI 10.1002/(SICI)1521-4141(199909)29:09<2819::AID-IMMU2819>3.0.CO;2-6; KLAUSNER RD, 1993, CELL, V72, P19, DOI 10.1016/0092-8674(93)90046-S; KOMANO H, 1995, P NATL ACAD SCI USA, V92, P6147, DOI 10.1073/pnas.92.13.6147; Lebron JA, 1999, J MOL BIOL, V289, P1109, DOI 10.1006/jmbi.1999.2842; Moura E, 1998, EUR J CLIN INVEST, V28, P164; Moura E, 1998, BLOOD, V92, P2511, DOI 10.1182/blood.V92.7.2511.2511_2511_2519; Porto G, 1998, IMMUNOGENETICS, V47, P404, DOI 10.1007/s002510050376; Porto G, 1997, HEPATOLOGY, V25, P397, DOI 10.1002/hep.510250223; Richardson DR, 1997, BBA-REV BIOMEMBRANES, V1331, P1, DOI 10.1016/S0304-4157(96)00014-7; SALMERON A, 1995, J IMMUNOL, V154, P1675; Santos M, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P487; SCHREIBER AB, 1984, J CELL BIOL, V98, P725, DOI 10.1083/jcb.98.2.725; SIMON M, 1976, GUT, V17, P332, DOI 10.1136/gut.17.5.332; STAGSTED J, 1990, CELL, V62, P297, DOI 10.1016/0092-8674(90)90367-N; Ten Elshof AE, 1999, IMMUNOL REV, V167, P223; VANASBECK BS, 1984, J INFECTION, V8, P232, DOI 10.1016/S0163-4453(84)93955-0	33	29	30	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2000	13	5					585	588		10.1016/S1074-7613(00)00058-3	http://dx.doi.org/10.1016/S1074-7613(00)00058-3			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	378RY	11114371	Bronze			2022-12-18	WOS:000165598500001
J	Itano, A; Robey, E				Itano, A; Robey, E			Highly efficient selection of CD4 and CD8 lineage thymocytes supports an instructive model of lineage commitment	IMMUNITY			English	Article							T-CELL DEVELOPMENT; RECEPTOR TRANSGENIC MICE; POSITIVE SELECTION; NEGATIVE SELECTION; THYMIC SELECTION; LYMPHOCYTES; EXPRESSION; KINETICS; DIFFERENTIATION; APOPTOSIS	We undertook a kinetic analysis of the generation of mature T cells in TCR and coreceptor transgenic mice using BrdU labeling. We observed that the selection efficiency of mature CD4(-) CD8(+) and CD4(+)CD8(-) thymocytes could be as high as 40% and 90% of CD4(+)CD8(+) precursors, respectively. The surprisingly high efficiency of selection favors an instructional model of lineage commitment and is incompatible with a stochastic model in which the efficiency of selection would be no greater than 100% in both lineages combined.	Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Robey, E (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.			Itano, Andrea/0000-0002-4766-6876	NIAID NIH HHS [R01 AI32985] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI032985] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CHAN SH, 1994, EMBO J, V13, P4482, DOI 10.1002/j.1460-2075.1994.tb06770.x; CORBELLA P, 1994, IMMUNITY, V1, P269, DOI 10.1016/1074-7613(94)90078-7; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; ERNST B, 1995, J EXP MED, V182, P961, DOI 10.1084/jem.182.4.961; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; ITANO A, 1994, P NATL ACAD SCI USA, V91, P220, DOI 10.1073/pnas.91.1.220; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; JAMESON SC, 1995, ANNU REV IMMUNOL, V13, P93, DOI 10.1146/annurev.iy.13.040195.000521; JANEWAY CA, 1994, IMMUNITY, V1, P3, DOI 10.1016/1074-7613(94)90003-5; KELLY KA, 1993, EUR J IMMUNOL, V23, P1922, DOI 10.1002/eji.1830230829; LUCAS B, 1993, J IMMUNOL, V151, P4574; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; Marrack P, 1997, CURR OPIN IMMUNOL, V9, P250, DOI 10.1016/S0952-7915(97)80144-6; MCPHEE D, 1979, THYMUS, V1, P151; Mehr R, 1996, J THEOR BIOL, V181, P157, DOI 10.1006/jtbi.1996.0122; MERKENSCHLAGER M, 1994, P NATL ACAD SCI USA, V91, P11694, DOI 10.1073/pnas.91.24.11694; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nakajima H, 1999, J IMMUNOL, V162, P782; Penit C, 1997, J IMMUNOL, V159, P4848; ROBEY E, 1994, J EXP MED, V179, P1997, DOI 10.1084/jem.179.6.1997; Robey E, 1996, CELL, V87, P483, DOI 10.1016/S0092-8674(00)81368-9; Salmon P, 1999, J IMMUNOL, V163, P5312; SHORTMAN K, 1991, J EXP MED, V173, P323, DOI 10.1084/jem.173.2.323; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; TOUGH DF, 1994, J EXP MED, V179, P1127, DOI 10.1084/jem.179.4.1127; van Meerwijk JPM, 1998, J IMMUNOL, V160, P2730; van Meerwijk JPM, 1998, J IMMUNOL, V160, P3649; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1	30	29	29	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2000	12	4					383	389		10.1016/S1074-7613(00)80190-9	http://dx.doi.org/10.1016/S1074-7613(00)80190-9			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	309FH	10795736	Bronze			2022-12-18	WOS:000086757300003
J	RADOMSKA, HS; SHEN, CP; KADESCH, T; ECKHARDT, LA				RADOMSKA, HS; SHEN, CP; KADESCH, T; ECKHARDT, LA			CONSTITUTIVELY EXPRESSED OCT-2 PREVENTS IMMUNOGLOBULIN GENE SILENCING IN MYELOMA X T-CELL HYBRIDS	IMMUNITY			English	Article							HEAVY-CHAIN LOCUS; REMOTE ENHANCER POSITION; TRANSCRIPTION FACTOR; CONTAINING PROMOTERS; CONSERVED SEQUENCE; LYMPHOMA HYBRIDS; MAMMALIAN-CELLS; CONSTANT REGION; OCTAMER MOTIF; B-CELLS	Recent experiments involving disruption of the Oct-2 gene have shown that this largely B cell-restricted transcription factor is not required in the early stages of B cell development. However, B cells that lack Oct-2 may be blocked from differentiation past the surface immunoglobulin-positive stage. To identify a possible function for Oct-2 in the late stage immunoglobulin-secreting cell, we have used the method of somatic cell fusion. When the immunoglobulin-producing myeloma MPC11 is fused to a T lymphoma, Oct-2 production ceases, as does the expression of immunoglobulin, J chain, and several other B cell-specific gene products. In the present study, we show that by preventing the loss of Oct-2 in the hybrid cells, we can preserve expression of all other tested B cell-specific genes. These results establish a central role for Oct-2 in maintaining the genetic program of the immunoglobulin-secreting plasmacyte.	COLUMBIA UNIV,GRAD SCH ARTS & SCI,NEW YORK,NY 10027; UNIV PENN,SCH MED,HOWARD HUGHES MED INST,PHILADELPHIA,PA 19104; UNIV PENN,SCH MED,DEPT GENET,PHILADELPHIA,PA 19104	Columbia University; Howard Hughes Medical Institute; University of Pennsylvania; University of Pennsylvania	RADOMSKA, HS (corresponding author), CUNY HUNTER COLL,DEPT BIOL SCI,695 PK AVE,NEW YORK,NY 10021, USA.							ANNWEILER A, 1992, MOL CELL BIOL, V12, P3107, DOI 10.1128/MCB.12.7.3107; BERGMAN Y, 1990, EMBO J, V9, P849, DOI 10.1002/j.1460-2075.1990.tb08182.x; BULLA GA, 1992, GENE DEV, V6, P316, DOI 10.1101/gad.6.2.316; CANN GM, 1982, P NATL ACAD SCI-BIOL, V79, P6656, DOI 10.1073/pnas.79.21.6656; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CORCORAN LM, 1993, GENE DEV, V7, P570, DOI 10.1101/gad.7.4.570; DAVIDSON RL, 1974, ANNU REV GENET, V8, P195, DOI 10.1146/annurev.ge.08.120174.001211; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; ECKHARDT LA, 1992, FASEB J, V6, P2553, DOI 10.1096/fasebj.6.8.1592208; EISENBEIS CF, 1993, MOL CELL BIOL, V13, P6452, DOI 10.1128/MCB.13.10.6452; FALKNER FG, 1984, NATURE, V310, P71, DOI 10.1038/310071a0; FELDHAUS AL, 1993, EMBO J, V12, P2763, DOI 10.1002/j.1460-2075.1993.tb05937.x; GENETTA T, 1994, MOL CELL BIOL, V14, P6153, DOI 10.1128/MCB.14.9.6153; GERSTER T, 1990, EMBO J, V9, P1635, DOI 10.1002/j.1460-2075.1990.tb08283.x; HARTMAN SC, 1988, P NATL ACAD SCI USA, V85, P8047, DOI 10.1073/pnas.85.21.8047; HYMAN R, 1974, J NATL CANCER I, V52, P429, DOI 10.1093/jnci/52.2.429; JOHNSON DG, 1990, MOL CELL BIOL, V10, P982, DOI 10.1128/MCB.10.3.982; JUNKER S, 1989, EXP CELL RES, V180, P63, DOI 10.1016/0014-4827(89)90212-7; JUNKER S, 1988, EMBO J, V7, P3093, DOI 10.1002/j.1460-2075.1988.tb03175.x; JUNKER S, 1990, CELL, V61, P467, DOI 10.1016/0092-8674(90)90528-M; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; KUO CJ, 1992, NATURE, V355, P457, DOI 10.1038/355457a0; KURKULOS M, 1991, P NATL ACAD SCI USA, V88, P3038, DOI 10.1073/pnas.88.8.3038; LASKOV R, 1970, Journal of Experimental Medicine, V131, P515, DOI 10.1084/jem.131.3.515; LIEBERMAN SA, 1993, J IMMUNOL, V151, P2588; LIEBERSON R, 1991, NUCLEIC ACIDS RES, V19, P933, DOI 10.1093/nar/19.4.933; LILLYCROP KA, 1992, J BIOL CHEM, V267, P24960; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; Maniatis T., 1982, MOL CLONING; MARCU KB, 1980, CELL, V22, P187, DOI 10.1016/0092-8674(80)90167-1; MATSUUCHI L, 1986, P NATL ACAD SCI USA, V83, P456, DOI 10.1073/pnas.83.2.456; MATTHIAS P, 1993, MOL CELL BIOL, V13, P1547, DOI 10.1128/MCB.13.3.1547; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; MULLERIMMERGLUCK MM, 1990, EMBO J, V9, P1625, DOI 10.1002/j.1460-2075.1990.tb08282.x; MURRE C, 1991, MOL CELL BIOL, V11, P1156, DOI 10.1128/MCB.11.2.1156; NELSEN B, 1993, SCIENCE, V261, P82, DOI 10.1126/science.8316859; NIMAN HL, 1983, P NATL ACAD SCI-BIOL, V80, P4949, DOI 10.1073/pnas.80.16.4949; PARSLOW TG, 1984, P NATL ACAD SCI-BIOL, V81, P2650, DOI 10.1073/pnas.81.9.2650; PFISTERER P, 1994, EMBO J, V13, P1654, DOI 10.1002/j.1460-2075.1994.tb06429.x; PIERANI A, 1990, MOL CELL BIOL, V10, P6204, DOI 10.1128/MCB.10.12.6204; PONGUBALA JMR, 1992, MOL CELL BIOL, V12, P368, DOI 10.1128/MCB.12.1.368; PONGUBALA JMR, 1993, SCIENCE, V259, P1622, DOI 10.1126/science.8456286; RUEZINSKY D, 1991, GENE DEV, V5, P29, DOI 10.1101/gad.5.1.29; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; SELDMAN J, 1980, NATURE, V286, P779; SHEN LY, 1993, MOL CELL BIOL, V13, P3530, DOI 10.1128/MCB.13.6.3530; SHIN MK, 1993, GENE DEV, V7, P2006, DOI 10.1101/gad.7.10.2006; SUN XH, 1991, CELL, V64, P459, DOI 10.1016/0092-8674(91)90653-G; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; VANDOREN K, 1984, J VIROL, V50, P606, DOI 10.1128/JVI.50.2.606-614.1984; WEISS MC, 1992, NATURE, V355, P22, DOI 10.1038/355022d0; WESTIN G, 1987, NUCLEIC ACIDS RES, V15, P6787, DOI 10.1093/nar/15.17.6787; WIRTH T, 1991, NUCLEIC ACIDS RES, V19, P43, DOI 10.1093/nar/19.1.43; YU H, 1989, CELL, V58, P441, DOI 10.1016/0092-8674(89)90425-X; YU H, 1986, MOL CELL BIOL, V6, P4228, DOI 10.1128/MCB.6.12.4228; ZALLER DM, 1988, MOL CELL BIOL, V8, P1932, DOI 10.1128/MCB.8.5.1932; ZALLER DM, 1985, P NATL ACAD SCI USA, V82, P5088, DOI 10.1073/pnas.82.15.5088	57	29	29	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1994	1	8					623	634		10.1016/1074-7613(94)90034-5	http://dx.doi.org/10.1016/1074-7613(94)90034-5			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PT930	7600290				2022-12-18	WOS:A1994PT93000001
J	Almeida, L; Dhillon-LaBrooy, A; Castro, CN; Adossa, N; Carriche, GM; Guderian, M; Lippens, S; Dennerlein, S; Hesse, C; Lambrecht, BN; Berod, L; Schauser, L; Blazar, BR; Kalesse, M; Muller, R; Moita, LF; Sparwasser, T				Almeida, Luis; Dhillon-LaBrooy, Ayesha; Castro, Carla N.; Adossa, Nigatu; Carriche, Guilhermina M.; Guderian, Melanie; Lippens, Saskia; Dennerlein, Sven; Hesse, Christina; Lambrecht, Bart N.; Berod, Luciana; Schauser, Leif; Blazar, Bruce R.; Kalesse, Markus; Mueller, Rolf; Moita, Luis F.; Sparwasser, Tim			Ribosome-Targeting Antibiotics Impair T Cell Effector Function and Ameliorate Autoimmunity by Blocking Mitochondrial Protein Synthesis	IMMUNITY			English	Article							TRANSCRIPTION FACTOR; DNA; RESPIRATION; ACTIVATION; INHIBITION; MEMBRANE; PATHWAYS; ARGYRIN; CHLORAMPHENICOL; OXAZOLIDINONE	While antibiotics are intended to specifically target bacteria, most are known to affect host cell physiology. In addition, some antibiotic classes are reported as immunosuppressive for reasons that remain unclear. Here, we show that Linezolid, a ribosomal-targeting antibiotic (RAbo), effectively blocked the course of a T cell mediated autoimmune disease. Linezolid and other RAbos were strong inhibitors of T helper-17 cell effector function in vitro, showing that this effect was independent of their antibiotic activity. Perturbing mitochondria! translation in differentiating T cells, either with RAbos or through the inhibition of mitochondria! elongation factor G1 (mEF-G1) progressively compromised the integrity of the electron transport chain. Ultimately, this led to deficient oxidative phosphorylation, diminishing nicotinamide adenine dinucleotide concentrations and impairing cytokine production in differentiating T cells. In accordance, mice lacking mEF-G1 in T cells were protected from experimental autoimmune encephalomyelitis, demonstrating that this pathway is crucial in maintaining T cell function and pathogenicity.	[Almeida, Luis; Dhillon-LaBrooy, Ayesha; Castro, Carla N.; Carriche, Guilhermina M.; Guderian, Melanie; Berod, Luciana; Sparwasser, Tim] Hannover Med Sch, Ctr Expt & Clin Infect Res, Inst Infect Immunol, TWINCORE, D-30625 Hannover, Germany; [Almeida, Luis; Dhillon-LaBrooy, Ayesha; Castro, Carla N.; Carriche, Guilhermina M.; Guderian, Melanie; Berod, Luciana; Sparwasser, Tim] Helmholtz Ctr Infect Res, D-30625 Hannover, Germany; [Almeida, Luis; Dhillon-LaBrooy, Ayesha; Carriche, Guilhermina M.; Sparwasser, Tim] Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Univ Med Ctr, D-55131 Mainz, Germany; [Hesse, Christina] Fraunhofer Inst Toxicol & Expt Med Item, D-30625 Hannover, Germany; [Adossa, Nigatu; Schauser, Leif] QIAGEN, DK-8000 Aarhus C, Denmark; [Adossa, Nigatu] Univ Turku, Turku Ctr Biotechnol, Computat Biomed, Turku 20520, Finland; [Lippens, Saskia] VIB Imaging Core Facil Gent, B-9052 Ghent, Belgium; [Dennerlein, Sven] Univ Med Ctr, Dept Cellular Biochem, D-37073 Gottingen, Germany; [Lambrecht, Bart N.] VIB UGent, Ctr Inflammat Res, B-9052 Ghent, Belgium; [Berod, Luciana] Johannes Gutenberg Univ Mainz, Inst Mol Med, Univ Med Ctr, Mainz, Germany; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Div Blood & Marrow Transplantat, Minneapolis, MN 55454 USA; [Kalesse, Markus] Leibniz Univ Hannover, Inst Organ Chem, Hannover, Germany; [Kalesse, Markus] Helmholtz Ctr Infect Res HZI, D-38124 Braunschweig, Germany; [Mueller, Rolf] Saarland Univ, Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res, D-66123 Saarbrucken, Germany; [Mueller, Rolf] Saarland Univ, Dept Pharmaceut Biotechnol, D-66123 Saarbrucken, Germany; [Moita, Luis F.] Inst Gulbenkian Ciencias, Innate Immun & Inflammat Lab, Oeiras, Portugal	Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; Johannes Gutenberg University of Mainz; Fraunhofer Gesellschaft; University of Turku; University of Gottingen; Flanders Institute for Biotechnology (VIB); Ghent University; Johannes Gutenberg University of Mainz; University of Minnesota System; University of Minnesota Twin Cities; Leibniz University Hannover; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Saarland University; Instituto Gulbenkian de Ciencia	Sparwasser, T (corresponding author), Hannover Med Sch, Ctr Expt & Clin Infect Res, Inst Infect Immunol, TWINCORE, D-30625 Hannover, Germany.; Sparwasser, T (corresponding author), Helmholtz Ctr Infect Res, D-30625 Hannover, Germany.; Sparwasser, T (corresponding author), Johannes Gutenberg Univ Mainz, Inst Med Microbiol & Hyg, Univ Med Ctr, D-55131 Mainz, Germany.	rolf.mueller@helmholtz-hzi.de; sparwasser.office@uni-mainz.de	Moita, Luis F./L-1296-2013; Moita, Luis/HCI-2793-2022; Sparwasser, Tim D/AAA-4306-2022; Lambrecht, Bart N/K-2484-2014; Muller, Rolf/B-1559-2008	Moita, Luis F./0000-0003-0707-315X; Moita, Luis/0000-0003-0707-315X; Lambrecht, Bart N/0000-0003-4376-6834; Almeida, Luis/0000-0002-2605-4280; Lippens, Saskia/0000-0002-8261-3462; Castro, Carla Noemi/0000-0002-2689-9072; Adossa, Nigatu Ayele/0000-0001-8487-3973; Muller, Rolf/0000-0002-1042-5665	Braukmann-Wittenberg-Herz-Stiftung; Deutsche Forschungsgemeinschaft; Deutsche Forschungsgemeinschaft [CRC156]; Hannover School for Biomedical Drug Research (HSBDR); European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant [675395]; National Institutes of Health [R01 HL56067, R37 AI34495]; European Commission [ERC-2014-CoG 647888iPROTECTION]	Braukmann-Wittenberg-Herz-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Hannover School for Biomedical Drug Research (HSBDR); European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank all members of the Institute of Infection Immunology at TWINCORE for discussion and support. We would like to acknowledge the assistance of the Cell Sorting Core Facility of the Hannover Medical School supported in part by the Braukmann-Wittenberg-Herz-Stiftung and the Deutsche Forschungsgemeinschaft. We thank Heinrich Steinmetz from Helmholtz Center for Infection Research for providing Arg C, Peter Rehling from University Medical Center (Gottingen) for providing resources to conduct mitochondrial translation assays, and the Department of Prenatal Medicine and Midwifery of the Medical School Hannover (MHH) for providing human cord blood. We would also like to thank the Teichmann Lab at the Wellcome Trust Sanger Institute, Dora Pedroso at Instituto Gulbenkian de Cie<^> ncia, and Karsten Hiller's group at Technische Universitat Braunschweig for technical support. This work was supported by grants from the Deutsche Forschungsgemeinschaft (CRC156) to T.S.; A.D.-L. was supported by the Hannover School for Biomedical Drug Research (HSBDR) and L.A. has received funding from the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement no. 675395. B.R.B was supported by the National Institutes of Health R01 HL56067 and R37 AI34495. L.F.M. was supported by the European Commission Horizon 2020 (ERC-2014-CoG 647888iPROTECTION).	Almeida L, 2016, SEMIN IMMUNOL, V28, P514, DOI 10.1016/j.smim.2016.10.009; Appleby RD, 1999, EUR J BIOCHEM, V262, P108, DOI 10.1046/j.1432-1327.1999.00350.x; Araujo LF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31170-6; Armand R, 2004, TOXICOL APPL PHARM, V196, P68, DOI 10.1016/j.taap.2003.12.001; Bailis W, 2019, NATURE, V571, P403, DOI 10.1038/s41586-019-1311-3; Baixauli F, 2015, CELL METAB, V22, P485, DOI 10.1016/j.cmet.2015.07.020; Berod L, 2011, EUR J IMMUNOL, V41, P833, DOI 10.1002/eji.201040504; Bhargava K, 2004, PROTEIN EXPRES PURIF, V37, P368, DOI 10.1016/j.pep.2004.06.030; Bosso JA, 2004, ANTIMICROB AGENTS CH, V48, P281, DOI 10.1128/AAC.48.1.281-284.2004; Buchet K, 1998, J BIOL CHEM, V273, P22983, DOI 10.1074/jbc.273.36.22983; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Bystrzycka W, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122666; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen H, 2012, EUR J HUM GENET, V20, P607, DOI 10.1038/ejhg.2011.259; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chen X, 2017, CANCER LETT, V399, P20, DOI 10.1016/j.canlet.2017.04.003; D'Souza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001; Esposti M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096566; Desdin-Mico G, 2020, SCIENCE, V368, P1371, DOI 10.1126/science.aax0860; El-Hattab AW, 2017, BBA-MOL BASIS DIS, V1863, P1539, DOI 10.1016/j.bbadis.2017.02.017; Falagas ME, 2008, DRUG SAFETY, V31, P753, DOI 10.2165/00002018-200831090-00004; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fu XD, 2017, AM J CANCER RES, V7, P2395; Fu Z, 2019, CELL REP, V28, P159, DOI 10.1016/j.celrep.2019.06.024; Gao J, 2001, GENOMICS, V74, P109, DOI 10.1006/geno.2001.6536; Gardete S, 2014, J CLIN INVEST, V124, P2836, DOI 10.1172/JCI68834; Hagan T, 2019, CELL, V178, P1313, DOI 10.1016/j.cell.2019.08.010; Hakli S, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0145-6; Hashemian SM, 2018, DRUG DES DEV THER, V12, P1759, DOI 10.2147/DDDT.S164515; Hellinger WC, 1999, MAYO CLIN PROC, V74, P420, DOI 10.4065/74.4.420; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; JAGER E, 1975, N-S ARCH PHARMACOL, V290, P161, DOI 10.1007/BF00510548; Jelley-Gibbs DM, 2000, J IMMUNOL, V165, P5017, DOI 10.4049/jimmunol.165.9.5017; Josefsdottir KS, 2017, BLOOD, V129, P729, DOI 10.1182/blood-2016-03-708594; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Kuzin II, 2001, INT IMMUNOL, V13, P921, DOI 10.1093/intimm/13.7.921; Lamb R, 2015, ONCOTARGET, V6, P4569, DOI 10.18632/oncotarget.3174; Leach KL, 2007, MOL CELL, V26, P393, DOI 10.1016/j.molcel.2007.04.005; Liesa M, 2016, CELL, V166, P9, DOI 10.1016/j.cell.2016.06.035; Llobet L, 2017, REDOX BIOL, V13, P244, DOI 10.1016/j.redox.2017.05.026; Loizidou EZ, 2014, CHEM BIOL DRUG DES, V84, P99, DOI 10.1111/cbdd.12298; Mao YY, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012114; de Paula JMP, 2017, MED CLIN-BARCELONA, V149, P369, DOI 10.1016/j.medcli.2017.03.042; McKee EE, 2006, ANTIMICROB AGENTS CH, V50, P2042, DOI 10.1128/AAC.01411-05; Mestre L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01374; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Mutnick AH, 2002, DIAGN MICR INFEC DIS, V43, P65, DOI 10.1016/S0732-8893(02)00371-1; Nickeleit I, 2008, CANCER CELL, V14, P23, DOI 10.1016/j.ccr.2008.05.016; Nyfeler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042657; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Onodi-Nagy K, 2015, ALLERGY ASTHMA CL IM, V11, DOI 10.1186/1710-1492-11-1; Pacheu-Grau D, 2013, HUM MOL GENET, V22, P1132, DOI 10.1093/hmg/dds517; Pamer EG, 2016, SCIENCE, V352, P535, DOI 10.1126/science.aad9382; Perry CM, 2001, DRUGS, V61, P525, DOI 10.2165/00003495-200161040-00008; Priesnitz C, 2018, GENE DEV, V32, P1285, DOI 10.1101/gad.316547.118; Proserpio V, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0957-5; RANDLE PJ, 1963, LANCET, V1, P785; Richter-Dennerlein R, 2016, CELL, V167, P471, DOI 10.1016/j.cell.2016.09.003; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Ruiz-Pesini E, 2010, PHARMACOGENOMICS, V11, P1185, DOI [10.2217/pgs.10.115, 10.2217/PGS.10.115]; Sasse F, 2002, J ANTIBIOT, V55, P543, DOI 10.7164/antibiotics.55.543; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Sledzinska A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001674; Smith CP, 2005, EUKARYOT CELL, V4, P2078, DOI 10.1128/EC.4.12.2078-2086.2005; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Tarasenko TN, 2017, CELL METAB, V25, P1254, DOI 10.1016/j.cmet.2017.05.007; TEDESCO FJ, 1975, AM J DIG DIS, V20, P295, DOI 10.1007/BF01237785; Tsuboi M, 2009, MOL CELL, V35, P502, DOI 10.1016/j.molcel.2009.06.028; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wilcox MH, 2009, CLIN INFECT DIS, V48, P203, DOI 10.1086/595686; Wilson DN, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011536; Xu JP, 2008, J AM BOARD FAM MED, V21, P261, DOI 10.3122/jabfm.2008.04.070169; Yang LF, 2020, CELL METAB, V31, P809, DOI 10.1016/j.cmet.2020.02.017; YUNIS AA, 1973, J LAB CLIN MED, V81, P713; Zhang L, 2005, FEBS LETT, V579, P6423, DOI 10.1016/j.febslet.2005.09.103; Zimmermann P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00302	81	28	29	5	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					68	+		10.1016/j.immuni.2020.11.001	http://dx.doi.org/10.1016/j.immuni.2020.11.001		JAN 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33238133	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000607814000011
J	Braun, M; Aguilera, AR; Sundarrajan, A; Corvino, D; Stannard, K; Krumeich, S; Das, I; Lima, LG; Guzman, LGM; Li, KL; Li, R; Salim, N; Jorge, MV; Ham, S; Kelly, G; Vari, F; Lepletier, A; Raghavendra, A; Pearson, S; Madore, J; Jacquelin, S; Effern, M; Quine, B; Koufariotis, LT; Casey, M; Nakamura, K; Seo, EY; Holzel, M; Geyer, M; Kristiansen, G; Taheri, T; Ahern, E; Hughes, BGM; Wilmott, JS; Long, GV; Scolyer, RA; Batstone, MD; Landsberg, J; Dietrich, D; Pop, OT; Flatz, L; Dougall, WC; Veillette, A; Nicholson, SE; Moller, A; Johnston, RJ; Martinet, L; Smyth, MJ; Bald, T				Braun, Matthias; Aguilera, Amelia Roman; Sundarrajan, Ashmitha; Corvino, Dillon; Stannard, Kimberley; Krumeich, Sophie; Das, Indrajit; Lima, Luize G.; Guzman, Lizeth G. Meza; Li, Kunlun; Li, Rui; Salim, Nazhifah; Jorge, Maria Villancanas; Ham, Sunyoung; Kelly, Gabrielle; Vari, Frank; Lepletier, Ailin; Raghavendra, Ashwini; Pearson, Sally; Madore, Jason; Jacquelin, Sebastien; Effern, Maike; Quine, Brodie; Koufariotis, Lambros T.; Casey, Mika; Nakamura, Kyohei; Seo, Eun Y.; Holzel, Michael; Geyer, Matthias; Kristiansen, Glen; Taheri, Touraj; Ahern, Elizabeth; Hughes, Brett G. M.; Wilmott, James S.; Long, Georgina V.; Scolyer, Richard A.; Batstone, Martin D.; Landsberg, Jennifer; Dietrich, Dimo; Pop, Oltin T.; Flatz, Lukas; Dougall, William C.; Veillette, Andre; Nicholson, Sandra E.; Moller, Andreas; Johnston, Robert J.; Martinet, Ludovic; Smyth, Mark J.; Bald, Tobias			CD155 on Tumor Cells Drives Resistance to Immunotherapy by Inducing the Degradation of the Activating Receptor CD226 in CD8(+) T Cells	IMMUNITY			English	Article							LIPID RAFT RECRUITMENT; NATURAL-KILLER; DNAM-1 CD226; IMMUNOLOGICAL SYNAPSE; DENDRITIC CELLS; PVR CD155; KINASE-C; EXPRESSION; PROTEIN; DIFFERENTIATION	The activating receptor CD226 is expressed on lymphocytes, monocytes, and platelets and promotes antitumor immunity in pre-clinical models. Here, we examined the role of CD226 in the function of tumor-infiltrating lymphocytes (TILs) and resistance to immunotherapy. In murine tumors, a large proportion of CD8(+) TILs had decreased surface expression of CD226 and exhibited features of dysfunction, whereas CD226(hi) TILs were highly functional. This correlation was seen also in TILs isolated from HNSCC patients. Mutation of CD226 at tyrosine 319 (Y319) led to increased CD226 surface expression, enhanced anti-tumor immunity and improved efficacy of immune checkpoint blockade (ICB). Mechanistically, tumor-derived CD155, the ligand for CD226, initiated phosphorylation of Y319 by Src kinases, thereby enabling ubiquitination of CD226 by CBL-B, internalization, and proteasomal degradation. In pre-treatment samples from melanoma patients, CD226(+)CD8(+) T cells correlated with improved progression-free survival following ICB. Our findings argue for the development of therapies aimed at maintaining the expression of CD226.	[Braun, Matthias; Aguilera, Amelia Roman; Stannard, Kimberley; Das, Indrajit; Kelly, Gabrielle; Vari, Frank; Lepletier, Ailin; Raghavendra, Ashwini; Pearson, Sally; Madore, Jason; Quine, Brodie; Casey, Mika; Nakamura, Kyohei; Ahern, Elizabeth; Dougall, William C.; Smyth, Mark J.] QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Herston, Qld, Australia; [Braun, Matthias; Sundarrajan, Ashmitha; Corvino, Dillon; Stannard, Kimberley; Krumeich, Sophie; Salim, Nazhifah; Jorge, Maria Villancanas; Quine, Brodie; Bald, Tobias] QIMR Berghofer Med Res Inst, Oncol & Cellular Immunol Lab, Herston, Qld, Australia; [Lima, Luize G.; Ham, Sunyoung; Moller, Andreas] QIMR Berghofer Med Res Inst, Tumor Microenvironm Lab, Herston, Qld, Australia; [Guzman, Lizeth G. Meza; Li, Kunlun; Nicholson, Sandra E.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Guzman, Lizeth G. Meza; Li, Kunlun; Nicholson, Sandra E.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Li, Rui; Veillette, Andre] Inst Rech Clin Montreal, Lab Mol Oncol, Montreal, PQ, Canada; [Li, Rui; Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ, Canada; [Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ, Canada; [Jacquelin, Sebastien] QIMR Berghofer Med Res Inst, Gordon & Jessie Gilmour Leukemia Lab, Herston, Qld, Australia; [Effern, Maike; Holzel, Michael] Univ Bonn, Univ Hosp Bonn, Fac Med, Inst Expt Oncol, Bonn, Germany; [Effern, Maike] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Koufariotis, Lambros T.] QIMR Berghofer Med Res Inst, Med Genom Lab, Herston, Qld, Australia; [Seo, Eun Y.; Johnston, Robert J.] Bristol Myers Squibb, Immunooncol Discovery, Redwood City, CA USA; [Geyer, Matthias] Univ Bonn, Univ Hosp Bonn, Inst Biol Struct, Bonn, Germany; [Kristiansen, Glen] Univ Bonn, Univ Hosp Bonn, Inst Pathol, Bonn, Germany; [Taheri, Touraj] Univ Queensland Herston, Royal Brisbane & Womens Hosp, Pathol Queensland, Herston, Qld, Australia; [Ahern, Elizabeth; Hughes, Brett G. M.; Batstone, Martin D.] Univ Queensland Herston, Royal Brisbane & Womens Hosp, Herston, Qld, Australia; [Wilmott, James S.; Long, Georgina V.; Scolyer, Richard A.] Univ Sydney, Melanoma Inst Australia, Sydney, NSW, Australia; [Wilmott, James S.; Long, Georgina V.] Univ Sydney, Cent Clin Sch, Sydney, NSW, Australia; [Long, Georgina V.] Royal North Shore Hosp, Sydney, NSW, Australia; [Long, Georgina V.] Mater Hosp, Sydney, NSW, Australia; [Scolyer, Richard A.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Landsberg, Jennifer] Univ Bonn, Univ Hosp Bonn, Dept Dermatol & Allergy, Bonn, Germany; [Dietrich, Dimo] Univ Bonn, Univ Hosp Bonn, Dept Otolaryngol Head & Neck Surg, Bonn, Germany; [Pop, Oltin T.; Flatz, Lukas] Kantonsspital St Gallen, Inst Immunobiol, St Gallen, Switzerland; [Flatz, Lukas] Kantonsspital St Gallen, Dept Dermatol, St Gallen, Switzerland; [Martinet, Ludovic] INSERM, Canc Res Ctr Toulouse CRCT, UMR 1037, F-31000 Toulouse, France	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; Walter & Eliza Hall Institute; University of Melbourne; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; Universite de Montreal; QIMR Berghofer Medical Research Institute; University of Bonn; University of Melbourne; QIMR Berghofer Medical Research Institute; Bristol-Myers Squibb; University of Bonn; University of Bonn; Royal Brisbane & Women's Hospital; Royal Brisbane & Women's Hospital; Melanoma Institute Australia; University of Sydney; University of Sydney; Royal North Shore Hospital; University of Sydney; University of Bonn; University of Bonn; Kantonsspital St. Gallen; Kantonsspital St. Gallen; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Smyth, MJ (corresponding author), QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Herston, Qld, Australia.; Bald, T (corresponding author), QIMR Berghofer Med Res Inst, Oncol & Cellular Immunol Lab, Herston, Qld, Australia.	mark.smyth@qimrberghofer.edu.au; tobias.bald@qimrberghofer.edu.au	Jacquelin, Sebastien/AAB-9690-2021; Landsberg, Jenny/AGI-0216-2022; Scolyer, Richard/AAE-8511-2019; Martinet, ludovic/O-9693-2014; Hughes, Brett/A-4546-2015; Wilmott, James/AGA-8227-2022; vari, frank/E-6554-2015; Long, Georgina/C-1771-2013	Jacquelin, Sebastien/0000-0001-5087-3641; Landsberg, Jenny/0000-0001-8029-3883; Scolyer, Richard/0000-0002-8991-0013; Martinet, ludovic/0000-0002-0867-7724; Hughes, Brett/0000-0002-1811-0537; Wilmott, James/0000-0002-6750-5244; G Lima, Luize/0000-0002-4167-6723; Meza Guzman, Lizeth/0000-0003-0524-0444; Dougall, William/0000-0001-9487-251X; vari, frank/0000-0001-6077-046X; Corvino, Dillon/0000-0003-0683-1369; Casey, Mika/0000-0001-9013-750X; , Sandra/0000-0002-1314-2134; Taheri, Touraj/0000-0003-4771-9998; Ahern, Elizabeth Stephanie/0000-0002-2062-5695; Long, Georgina/0000-0001-8894-3545; Lepletier, Ailin/0000-0002-1371-7313; Geyer, Matthias/0000-0002-7718-5002	BioBank Core Facility of the University Hospital Bonn, Germany; Dr. Mildred Scheel Stiftung fuer Krebsforschung of the Deutsche Krebshilfe; Melanoma Research Alliance Young Investigator grant [693786]; Cancer Council Queensland project grant [1157048]; Canadian Institutes of Health Research [MT-14429, MOP-82906, FDN-143338]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [GRK 2168]; DFG [EXC2151-390873048]; NHMRC; Melanoma Institute Australia; New South Wales Ministry of Health; NSW Health Pathology; Cancer Institute NSW; Ainsworth Foundation; University of Sydney Medical Foundation; National Breast Cancer Foundation Australia [IIRS-18-159]; NHMRC [APP1185907, 1132519, 1173958, 1138757, 1124690]; Cancer Research Center of the University Hospital; University of Zurich; Swiss National Science Foundation [PP00P3_157448]	BioBank Core Facility of the University Hospital Bonn, Germany; Dr. Mildred Scheel Stiftung fuer Krebsforschung of the Deutsche Krebshilfe; Melanoma Research Alliance Young Investigator grant; Cancer Council Queensland project grant(Cancer Council Queensland); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Melanoma Institute Australia; New South Wales Ministry of Health; NSW Health Pathology; Cancer Institute NSW; Ainsworth Foundation; University of Sydney Medical Foundation(University of Sydney); National Breast Cancer Foundation Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Cancer Research Center of the University Hospital; University of Zurich; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	We would like to thank L. Town, A. Zaharia, K. Elder, P. Collins, M. Flynn, and S. Ng as well as the Core facilities at QIMR Berghofer for excellent technical assistance. We are grateful to Dr W.Y. Langdon from the University of Western Australia for providing the Cbl-b mutant mouse. The project was supported by the BioBank Core Facility of the University Hospital Bonn, Germany. M.B. is supported by a scholarship of the Dr. Mildred Scheel Stiftung fuer Krebsforschung of the Deutsche Krebshilfe. T.B. was supported by a NHMRC Early Career Research Fellowship (1138757) and project grant (1124690) and a Melanoma Research Alliance Young Investigator grant (693786). M.J.S. was supported by a NHMRC Investigator Award (1173958) and program grant (1132519). M.J.S. and I.D. were supported by a Cancer Council Queensland project grant (1157048). A.V. is supported by grants from the Canadian Institutes of Health Research (MT-14429, MOP-82906, FDN-143338) and holds the Canada Research Chair on Signaling in the Immune System. M.H. was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) within GRK 2168. M.E. was supported by a scholarship within GRK 2168. M.H. and M.G. are funded by the DFG under Germany's Excellence Strategy (EXC2151-390873048). J.S.W. is supported by a NHMRC fellowship, the Melanoma Institute Australia, the New South Wales Ministry of Health, NSW Health Pathology, Cancer Institute NSW, and the Ainsworth Foundation. R.A.S and G.V.L. are supported by NHMRC Practitioner Fellowship. G.V.L. is supported by the University of Sydney Medical Foundation and Melanoma Institute Australia. This work was funded by the National Breast Cancer Foundation Australia (IIRS-18-159) and NHMRC (APP1185907) to A.M. O.T.P. is supported by a grant from the Cancer Research Center of the University Hospital and the University of Zurich. L.F. is supported by a grant from the Swiss National Science Foundation (PP00P3_157448).	Vo AV, 2016, MOL IMMUNOL, V69, P70, DOI 10.1016/j.molimm.2015.11.009; Ardolino M, 2011, BLOOD, V117, P4778, DOI 10.1182/blood-2010-08-300954; Ashhurst T.M., 2017, TSNEPLOTS R SCRIPT; Attanasio J, 2016, IMMUNITY, V44, P1052, DOI 10.1016/j.immuni.2016.04.022; Auguie A., 2017, GRIDEXTRA MISCELLANE; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Bengsch B, 2018, IMMUNITY, V48, P1029, DOI 10.1016/j.immuni.2018.04.026; Best JA, 2013, NAT IMMUNOL, V14, P404, DOI 10.1038/ni.2536; Billingsley JM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004740; Blake SJ, 2016, CANCER DISCOV, V6, P446, DOI 10.1158/2159-8290.CD-15-0944; Blighe K., 2020, ENHACEDVOLCANO PUBLI; Bottino C, 2003, J EXP MED, V198, P557, DOI 10.1084/jem.20030788; Budczies J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051862; BURNS GF, 1985, J EXP MED, V161, P1063, DOI 10.1084/jem.161.5.1063; Canale FP, 2018, CANCER RES, V78, P115, DOI 10.1158/0008-5472.CAN-16-2684; Carlson M., 2019, ORG MM EG DB GENOME; Chan CJ, 2014, NAT IMMUNOL, V15, P431, DOI 10.1038/ni.2850; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Chiang JY, 2007, J CLIN INVEST, V117, P1029, DOI 10.1172/JCI29472; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Colaprico A, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1507; Croxford JL, 2013, BLOOD, V121, P2512, DOI 10.1182/blood-2012-08-449025; de Andrade LF, 2014, CANCER RES, V74, P7298, DOI 10.1158/0008-5472.CAN-14-1339; Diaz LR, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120757; Dolgalev, 2018, MSIGDBR MSIGDB GENE; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Dustin ML, 2014, CANCER IMMUNOL RES, V2, P1023, DOI 10.1158/2326-6066.CIR-14-0161; Effern M, 2020, IMMUNITY, V53, P564, DOI 10.1016/j.immuni.2020.07.007; Fay C., 2018, REMEDY RSTUDIO ADDIN; Gaud G, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar3083; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Glodde N, 2017, IMMUNITY, V47, P789, DOI 10.1016/j.immuni.2017.09.012; Gupta S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004828; He B, 2016, IMMUNITY, V45, P1341, DOI 10.1016/j.immuni.2016.11.009; Helmink BA, 2018, IMMUNITY, V48, P1077, DOI 10.1016/j.immuni.2018.06.003; Herneau T., 2020, PACKAGE SURVIVAL ANA; Hou SK, 2014, J BIOL CHEM, V289, P6969, DOI 10.1074/jbc.M113.498253; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Iguchi-Manaka A, 2008, J EXP MED, V205, P2959, DOI 10.1084/jem.20081611; Jacobsen A., 2019, CGDSR R BASED API AC; Jin H.S., 2020, CANC IMMUNOL RES S, V204, P165; Johnston RJ, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1036214; Kamran N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054406; Kassambara A., 2021, R PACKAGE VERSION 04; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kim JS, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1338994; Lakshmikanth T, 2009, J CLIN INVEST, V119, P1251, DOI 10.1172/JCI36022; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Lepletier A, 2020, CLIN CANCER RES, V26, P3671, DOI 10.1158/1078-0432.CCR-19-3925; Lepletier A, 2019, IMMUNOL CELL BIOL, V97, P152, DOI 10.1111/imcb.12205; Li XY, 2018, J CLIN INVEST, V128, P2613, DOI 10.1172/JCI98769; Loeser S, 2007, J EXP MED, V204, P879, DOI 10.1084/jem.20061699; Manrique S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00481-z; Markey KA, 2015, J IMMUNOL METHODS, V423, P40, DOI 10.1016/j.jim.2015.04.029; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799; Mognol GP, 2017, P NATL ACAD SCI USA, V114, pE2776, DOI 10.1073/pnas.1620498114; Moller A, 2009, ONCOGENE, V28, P289, DOI 10.1038/onc.2008.382; Morgan M., 2020, GENOMIC DATA COMMONS; Morgan M, 2018, SUMMARIZEDEXPERIMENT; Mueller K., 2020, STYLER NONINVASIVE P; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; Nakamura K, 2018, CANCER CELL, V33, P634, DOI 10.1016/j.ccell.2018.02.007; O'Donnell JS, 2019, NAT REV CLIN ONCOL, V16, P151, DOI 10.1038/s41571-018-0142-8; O'Leary CE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00618; Oksvold MP, 2008, MOL IMMUNOL, V45, P925, DOI 10.1016/j.molimm.2007.08.002; Pauken KE, 2014, CANCER CELL, V26, P785, DOI 10.1016/j.ccell.2014.11.016; Putz EM, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2016.1267892; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; Ralston KJ, 2004, J BIOL CHEM, V279, P33816, DOI 10.1074/jbc.M401040200; Ramsbottom KM, 2014, J IMMUNOL, V192, P553, DOI 10.4049/jimmunol.1302197; Riesenberg S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9755; Schmid-Burgk JL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12338; Schmid-Burgk JL, 2014, GENOME RES, V24, P1719, DOI 10.1101/gr.176701.114; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sergushichev A., 2016, ALGORITHM FAST PRERA, DOI [10.1101/060012, DOI 10.1101/060012]; Seth S, 2011, J BIOL CHEM, V286, P39153, DOI 10.1074/jbc.M111.264697; Shibuya A, 1996, IMMUNITY, V4, P573, DOI 10.1016/S1074-7613(00)70060-4; Shibuya A, 1998, J IMMUNOL, V161, P1671; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Shirakawa J, 2005, INT IMMUNOL, V17, P217, DOI 10.1093/intimm/dxh199; Shirakawa J, 2006, INT IMMUNOL, V18, P951, DOI 10.1093/intimm/dxl031; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; Singer M, 2016, CELL, V166, P1500, DOI 10.1016/j.cell.2016.08.052; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tahara-Hanaoka S, 2006, BLOOD, V107, P1491, DOI 10.1182/blood-2005-04-1684; Tahara-Hanaoka S, 2004, INT IMMUNOL, V16, P533, DOI 10.1093/intimm/dxh059; Thelen M, 2018, CANCER RES, V78, P5173, DOI 10.1158/0008-5472.CAN-18-0873; Thommen DS, 2018, CANCER CELL, V33, P547, DOI 10.1016/j.ccell.2018.03.012; Ushey K, 2020, RSTUDIOAPI SAFELY AC; Wang B, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat7061; Wang XC, 2019, J HEPATOL, V71, P731, DOI 10.1016/j.jhep.2019.05.015; Warnes G.R., 2019, GPLOTS VARIOUS R PRO; Weulersse M, 2020, IMMUNITY, V53, P824, DOI 10.1016/j.immuni.2020.09.006; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wickham H., 2016, R PACKAGE; Wickham H, 2018, ADV R; Wickham H, 2020, GRAMMAR DATA MANIPUL; Wilke CO., 2020, COWPLOT STREAMLINED; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang ZG, 2015, J EXP MED, V212, P2165, DOI 10.1084/jem.20150792; Zhu B, 2020, INT J ADV COMPUT SC, V11, P28	106	28	31	3	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					805	+		10.1016/j.immuni.2020.09.010	http://dx.doi.org/10.1016/j.immuni.2020.09.010			34	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	33053330	Bronze			2022-12-18	WOS:000581062800013
J	Kim, HM; Kim, YM				Kim, Ho Min; Kim, You-Me			HMGB1: LPS Delivery Vehicle for Caspase-11-Mediated Pyroptosis	IMMUNITY			English	Editorial Material							LIPOPOLYSACCHARIDE; CD14	Recognition of cytoplasmic lipopolysaccharide (LPS) by caspase-11 leads to pyroptosis and secretion of inflammatory mediators. In this issue of Immunity, Deng et al. (2018) report that high-mobility group box 1 (HMGB1) secreted by hepatocytes delivers extracellular LPS into the cytoplasm and mediates pyroptosis.	[Kim, Ho Min; Kim, You-Me] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, 291 Daehak Ro, Daejeon 34141, South Korea	Korea Advanced Institute of Science & Technology (KAIST)	Kim, HM; Kim, YM (corresponding author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, 291 Daehak Ro, Daejeon 34141, South Korea.	hm_kim@kaist.ac.kr; youmekim@kaist.ac.kr	Kim, You-Me/I-5553-2013; Kim, Ho Min/G-2712-2011	Kim, You-Me/0000-0001-8780-704X; 				Andersson U, 2018, SEMIN IMMUNOL, V38, P40, DOI 10.1016/j.smim.2018.02.011; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Deng MH, 2018, IMMUNITY, V49, P740, DOI 10.1016/j.immuni.2018.08.016; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Ryu JK, 2017, IMMUNITY, V46, P38, DOI 10.1016/j.immuni.2016.11.007; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Yi YS, 2017, IMMUNOLOGY, V152, P207, DOI 10.1111/imm.12787; Youn JH, 2008, J IMMUNOL, V180, P5067, DOI 10.4049/jimmunol.180.7.5067	10	28	30	3	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					582	584		10.1016/j.immuni.2018.09.021	http://dx.doi.org/10.1016/j.immuni.2018.09.021			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30332623	Bronze			2022-12-18	WOS:000447386700003
J	Perry, JSA; Russler-Germain, EV; Zhou, YW; Purtha, W; Cooper, ML; Choi, J; Schroeder, MA; Salazar, V; Egawa, T; Lee, BC; Abumrad, NA; Kim, BS; Anderson, MS; DiPersio, JF; Hsieh, CS				Perry, Justin S. A.; Russler-Germain, Emilie V.; Zhou, You W.; Purtha, Whitney; Cooper, Matthew L.; Choi, Jaebok; Schroeder, Mark A.; Salazar, Vanessa; Egawa, Takeshi; Lee, Byeong-Chel; Abumrad, Nada A.; Kim, Brian S.; Anderson, Mark S.; DiPersio, John F.; Hsieh, Chyi-Song			CD36 Mediates Cell-Surface Antigens to Promote Thymic Development of the Regulatory T Cell Receptor Repertoire and Allo-tolerance	IMMUNITY			English	Article							DENDRITIC-CELLS; SELF-ANTIGEN; CROSS-PRESENTATION; EPITHELIAL-CELLS; AIRE; EXPRESSION; SELECTION; P2Y(14); CD8(+); MICROENVIRONMENT	The development of T cell tolerance in the thymus requires the presentation of host proteins by multiple antigen-presenting cell (APC) types. However, the importance of transferring host antigens from transcription factor AIRE-dependent medullary thymic epithelial cells (mTECs) to bone marrow (BM) APCs is unknown. We report that antigen was primarily transferred from mTECs to CD8(alpha)(+) dendritic cells (DCs) and showed that CD36, a scavenger receptor selectively expressed on CD8(alpha)(+) DCs, mediated the transfer of cell-surface, but not cytoplasmic, antigens. The absence of CD8(alpha)(+) DCs or CD36 altered thymic T cell selection, as evidenced by TCR repertoire analysis and the loss of allo-tolerance in murine allogeneic BM transplantation (allo-BMT) studies. Decreases in these DCs and CD36 expression in peripheral blood of human allo-BMT patients correlated with graft-versus-host disease. Our findings suggest that CD36 facilitates transfer of mTEC-derived cell-surface antigen on CD8(alpha)(+) DCs to promote tolerance to host antigens during homeostasis and allo-BMT.	[Perry, Justin S. A.; Russler-Germain, Emilie V.; Zhou, You W.; Salazar, Vanessa; Hsieh, Chyi-Song] Washington Univ, Sch Med, Div Rheumatol, Dept Internal Med, St Louis, MO 63110 USA; [Purtha, Whitney; Anderson, Mark S.] Univ Calif San Francisco, Dept Med, Diabet Ctr, San Francisco, CA 94131 USA; [Cooper, Matthew L.; Choi, Jaebok; Schroeder, Mark A.; DiPersio, John F.] Washington Univ, Sch Med, Dept Internal Med, Div Oncol, St Louis, MO 63110 USA; [Egawa, Takeshi] Washington Univ, Dept Pathol & Immunol, Sch Med, St Louis, MO 63110 USA; [Lee, Byeong-Chel] Univ Pittsburgh, Sch Med, Canc Inst, Pittsburgh, PA 15260 USA; [Lee, Byeong-Chel] Univ Pittsburgh, Sch Med, Dept Med, Div Hematol & Oncol, Pittsburgh, PA 15260 USA; [Abumrad, Nada A.] Washington Univ, Sch Med, Ctr Human Nutr, Dept Med, St Louis, MO 63110 USA; [Kim, Brian S.] Washington Univ, Sch Med, Div Dermatol, Dept Med, St Louis, MO 63110 USA; [Kim, Brian S.] Washington Univ, Sch Med, Ctr Study Itch, St Louis, MO 63110 USA; [Perry, Justin S. A.] Univ Virginia, Sch Med, Ctr Cell Clearance, Charlottesville, VA 22908 USA; [Perry, Justin S. A.] Univ Virginia, Sch Med, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA	Washington University (WUSTL); University of California System; University of California San Francisco; Washington University (WUSTL); Washington University (WUSTL); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Virginia; University of Virginia	Hsieh, CS (corresponding author), Washington Univ, Sch Med, Div Rheumatol, Dept Internal Med, St Louis, MO 63110 USA.	chsieh@wustl.edu	Kim, Brian/GZK-6649-2022	Kim, Brian/0000-0002-8100-7161; Salazar, Vanessa/0000-0002-1947-6039; Choi, Jaebok/0000-0002-5590-087X	NIH National Institute of Allergy and Infectious Diseases (NIAID) [AI079187]; Burroughs Wellcome Fund; R01 Research Supplement to Promote Diversity in Health-Related Research [NIH NIAID AI079187-06S1]; National Cancer Institute [R35 CA210084-01, PO1 CA101937, P50 CA171963-01]; NATIONAL CANCER INSTITUTE [P01CA101937, R35CA210084, P50CA171963] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097244, R01AI079187, R37AI097457] Funding Source: NIH RePORTER	NIH National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); R01 Research Supplement to Promote Diversity in Health-Related Research; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Jinquin Luo (Div. of Biostatistics, WUSTL) for consultation regarding statistical analysis and Nicole Santacruz for expert technical assistance. Experimental support was provided by the Transgenic Facility of the Rheumatic Diseases Core Center. The PET scan studies presented in this work were conducted in the MIR Pre-Clinical PET-CT Facility of the Washington University School of Medicine. C.S.H. is supported by NIH National Institute of Allergy and Infectious Diseases (NIAID) AI079187 and the Burroughs Wellcome Fund; J.S.A.P. is the recipient of an R01 Research Supplement to Promote Diversity in Health-Related Research, NIH NIAID AI079187-06S1. J.F. DiP. is supported by the National Cancer Institute (R35 CA210084-01, PO1 CA101937, and P50 CA171963-01).	Abbracchio MP, 2003, TRENDS PHARMACOL SCI, V24, P52, DOI 10.1016/S0165-6147(02)00038-X; Albert ML, 1998, J EXP MED, V188, P1359, DOI 10.1084/jem.188.7.1359; Ardouin L, 2016, IMMUNITY, V45, P305, DOI 10.1016/j.immuni.2016.07.019; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Atibalentja DF, 2011, J IMMUNOL, V186, P1421, DOI 10.4049/jimmunol.1002587; Baba T, 2009, J IMMUNOL, V183, P3053, DOI 10.4049/jimmunol.0900438; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Belz GT, 2002, J IMMUNOL, V168, P6066, DOI 10.4049/jimmunol.168.12.6066; Bluestone JA, 2015, J CLIN INVEST, V125, P2250, DOI 10.1172/JCI78089; Chan AY, 2015, ANN NY ACAD SCI, V1356, P80, DOI 10.1111/nyas.12960; Cho J, 2014, J CLIN INVEST, V124, P3159, DOI 10.1172/JCI61636; Cooke KR, 1996, BLOOD, V88, P3230, DOI 10.1182/blood.V88.8.3230.bloodjournal8883230; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Dolan BP, 2006, J IMMUNOL, V176, P1447, DOI 10.4049/jimmunol.176.3.1447; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Ferris ST, 2014, IMMUNITY, V41, P657, DOI 10.1016/j.immuni.2014.09.012; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gardner JM, 2008, SCIENCE, V321, P843, DOI 10.1126/science.1159407; Giudicelli V, 2006, NUCLEIC ACIDS RES, V34, pD781, DOI 10.1093/nar/gkj088; GLIMCHER LH, 1983, J IMMUNOL, V130, P2287; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hubert FX, 2011, BLOOD, V118, P2462, DOI 10.1182/blood-2010-06-286393; HUMBLET C, 1994, INT IMMUNOL, V6, P1949, DOI 10.1093/intimm/6.12.1949; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Koble C, 2009, J EXP MED, V206, P1505, DOI 10.1084/jem.20082449; Lee BC, 2003, GENE DEV, V17, P1592, DOI 10.1101/gad.1071503; Lei Y, 2011, J EXP MED, V208, P383, DOI 10.1084/jem.20102327; Leventhal DS, 2016, IMMUNITY, V44, P847, DOI 10.1016/j.immuni.2016.01.025; Li LJ, 2012, P NATL ACAD SCI USA, V109, P12716, DOI 10.1073/pnas.1203468109; Li XD, 2015, TRENDS IMMUNOL, V36, P344, DOI 10.1016/j.it.2015.04.006; Lin JQ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10562; Mamedov IZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00456; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; Millet V, 2008, EUR J IMMUNOL, V38, P1257, DOI 10.1002/eji.200737982; Naik SH, 2005, J IMMUNOL, V174, P6592, DOI 10.4049/jimmunol.174.11.6592; Oh J, 2015, IMMUNE NETW, V15, P111, DOI 10.4110/in.2015.15.3.111; Perry JSA, 2016, IMMUNOL REV, V271, P141, DOI 10.1111/imr.12403; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Qu CF, 2009, J IMMUNOL, V182, P3650, DOI 10.4049/jimmunol.0801532; Richards DM, 2016, TRENDS IMMUNOL, V37, P114, DOI 10.1016/j.it.2015.12.005; RIGOTTI A, 1995, J BIOL CHEM, V270, P16221, DOI 10.1074/jbc.270.27.16221; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Schulz O, 2002, J IMMUNOL, V168, P6057, DOI 10.4049/jimmunol.168.12.6057; Vrisekoop N, 2014, IMMUNITY, V41, P181, DOI 10.1016/j.immuni.2014.07.007; Weissler KA, 2014, IMMUNOL REV, V259, P11, DOI 10.1111/imr.12177; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032	51	28	28	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					923	+		10.1016/j.immuni.2018.04.007	http://dx.doi.org/10.1016/j.immuni.2018.04.007			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29752065	Green Accepted, Bronze			2022-12-18	WOS:000432488600013
J	Maeda, K; Akira, S				Maeda, Kazuhiko; Akira, Shizuo			TLR7 Structure: Cut in Z-Loop	IMMUNITY			English	Editorial Material							SINGLE-STRANDED RNA; RECOGNITION; DNA		[Maeda, Kazuhiko; Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Host Def, Suita, Osaka 5650871, Japan; [Maeda, Kazuhiko; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Akira, S (corresponding author), Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Host Def, Suita, Osaka 5650871, Japan.; Akira, S (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan.	sakira@biken.osaka-u.ac.jp	Akira, Shizuo/C-3134-2009					Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Heil F, 2004, SCIENCE, V303, P1526, DOI 10.1126/science.1093620; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Ohto U, 2015, NATURE, V520, P702, DOI 10.1038/nature14138; Shibata T, 2016, INT IMMUNOL, V28, P211, DOI 10.1093/intimm/dxv062; Tanji H, 2015, NAT STRUCT MOL BIOL, V22, P109, DOI 10.1038/nsmb.2943; Tanji H, 2013, SCIENCE, V339, P1426, DOI 10.1126/science.1229159; Zhang ZK, 2016, IMMUNITY, V45, P737, DOI 10.1016/j.immuni.2016.09.011	10	28	28	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					705	707		10.1016/j.immuni.2016.10.003	http://dx.doi.org/10.1016/j.immuni.2016.10.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27760331	Bronze			2022-12-18	WOS:000389473200001
J	Tang, WH; Wang, HS; Claudio, E; Tassi, I; Ha, HL; Saret, S; Siebenlist, U				Tang, Wanhu; Wang, Hongshan; Claudio, Estefania; Tassi, Ilaria; Ha, Hye-lin; Saret, Sun; Siebenlist, Ulrich			The Oncoprotein and Transcriptional Regulator Bcl-3 Governs Plasticity and Pathogenicity of Autoimmune T Cells	IMMUNITY			English	Article							ROR-GAMMA-T; NF-KAPPA-B; CANDIDATE PROTOONCOGENE BCL-3; GERMINAL CENTER REACTIONS; CYTOKINE GM-CSF; INTESTINAL INFLAMMATION; SPLENIC MICROARCHITECTURE; EXPERIMENTAL COLITIS; MEDIATED-IMMUNITY; CROHNS-DISEASE	Bcl-3 is an atypical member of the I kappa B family that modulates transcription in the nucleus via association with p50 (NF-kappa B1) or p52 (NF-kappa B2) homodimers. Despite evidence attesting to the overall physiologic importance of Bcl-3, little is known about its cell-specific functions or mechanisms. Here we demonstrate a T-cell-intrinsic function of Bcl-3 in autoimmunity. Bcl-3-deficient T cells failed to induce disease in T cell transfer-induced colitis and experimental autoimmune encephalomyelitis. The protection against disease correlated with a decrease in Th1 cells that produced the cytokines IFN-gamma and GM-CSF and an increase in Th17 cells. Although differentiation into Th1 cells was not impaired in the absence of Bcl-3, differentiated Th1 cells converted to less-pathogenic Th17-like cells, in part via mechanisms involving expression of the ROR gamma t transcription factor. Thus, Bcl-3 constrained Th1 cell plasticity and promoted pathogenicity by blocking conversion to Th17-like cells, revealing a unique type of regulation that shapes adaptive immunity.	[Tang, Wanhu; Wang, Hongshan; Claudio, Estefania; Tassi, Ilaria; Ha, Hye-lin; Saret, Sun; Siebenlist, Ulrich] NIAID, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Siebenlist, U (corresponding author), NIAID, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	usiebenlist@niaid.nih.gov		tassi, ilaria/0000-0002-5803-9499	Intramural Research Program of NIAID; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000722] Funding Source: NIH RePORTER	Intramural Research Program of NIAID; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Glimcher and V. Lazarevic for providing the Rorc-luciferase reporter and the GFP-ROR gamma t retrovirus, E. Shevach for advice with the EAE model, H. Takayanagi and K. Okamoto for the IL-17-driven luciferase reporter, and BD Biosciences for alpha-p19 antibodies. Research was supported by the Intramural Research Program of NIAID, NIH.	Ahern PP, 2010, IMMUNITY, V33, P279, DOI 10.1016/j.immuni.2010.08.010; Bene L, 2011, PATHOL ONCOL RES, V17, P463, DOI 10.1007/s12253-011-9397-4; BOURS V, 1993, CELL, V72, P729, DOI 10.1016/0092-8674(93)90401-B; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Feng T, 2011, J IMMUNOL, V186, P6313, DOI 10.4049/jimmunol.1001454; Feng T, 2010, J EXP MED, V207, P1321, DOI 10.1084/jem.20092253; Fransen K, 2010, HUM MOL GENET, V19, P3482, DOI 10.1093/hmg/ddq264; Franzoso G, 1998, J EXP MED, V187, P147, DOI 10.1084/jem.187.2.147; Franzoso G, 1997, IMMUNITY, V6, P479, DOI 10.1016/S1074-7613(00)80291-5; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; FUJITA T, 1993, GENE DEV, V7, P1354, DOI 10.1101/gad.7.7b.1354; Griseri T, 2012, IMMUNITY, V37, P1116, DOI 10.1016/j.immuni.2012.08.025; Hinz M, 2012, IMMUNOL REV, V246, P59, DOI 10.1111/j.1600-065X.2012.01102.x; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ito H, 1997, J AUTOIMMUN, V10, P455, DOI 10.1016/S0896-8411(97)90152-9; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Izcue A, 2008, IMMUNITY, V28, P559, DOI 10.1016/j.immuni.2008.02.019; Kanno Y, 2012, ANNU REV IMMUNOL, V30, P707, DOI 10.1146/annurev-immunol-020711-075058; Kreisel D, 2011, J CLIN INVEST, V121, P265, DOI 10.1172/JCI42596; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Maldonado V, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-152; Marwaha AK, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00129; Morrison PJ, 2013, MUCOSAL IMMUNOL, V6, P1143, DOI 10.1038/mi.2013.11; Mukasa R, 2010, IMMUNITY, V32, P616, DOI 10.1016/j.immuni.2010.04.016; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; Palmer S, 2008, IMMUNOL RES, V42, P210, DOI 10.1007/s12026-008-8075-4; Pene F, 2011, J IMMUNOL, V186, P2412, DOI 10.4049/jimmunol.1001331; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1994, J EXP MED, V179, P589, DOI 10.1084/jem.179.2.589; Ruan QG, 2011, J EXP MED, V208, P2321, DOI 10.1084/jem.20110462; Ruan QG, 2010, DIABETES, V59, P2549, DOI 10.2337/db10-0480; Soma LA, 2006, HUM PATHOL, V37, P218, DOI 10.1016/j.humpath.2005.09.025; Tassi I., 2014, J IMMUNOL; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zhang XR, 2007, IMMUNITY, V27, P438, DOI 10.1016/j.immuni.2007.07.017; Zhang XR, 2013, J IMMUNOL, V191, P5984, DOI 10.4049/jimmunol.1300611; Zhu JF, 2010, IMMUNITY, V32, P11, DOI 10.1016/j.immuni.2010.01.001	43	28	28	0	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2014	41	4					555	566		10.1016/j.immuni.2014.09.017	http://dx.doi.org/10.1016/j.immuni.2014.09.017			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3HY	25367572	Bronze, Green Accepted			2022-12-18	WOS:000345504300010
J	van de Veerdonk, FL; Netea, MG				van de Veerdonk, Frank L.; Netea, Mihai G.			Diversity: A Hallmark of Monocyte Society	IMMUNITY			English	Editorial Material							BLOOD MONOCYTES; SEPSIS		[van de Veerdonk, Frank L.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 HP Nijmegen, Netherlands; [van de Veerdonk, Frank L.; Netea, Mihai G.] Nijmegen Inst Infect Inflammat & Immun N4i, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	van de Veerdonk, FL (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med, NL-6525 HP Nijmegen, Netherlands.	f.veerdonk@aig.umcn.nl; m.netea@aig.umcn.nl	Netea, Mihai/N-5155-2014; van de Veerdonk, Frank L/C-7256-2008	van de Veerdonk, Frank L/0000-0002-1121-4894				Baeten D, 2000, ARTHRITIS RHEUM, V43, P1233, DOI 10.1002/1529-0131(200006)43:6<1233::AID-ANR6>3.0.CO;2-9; Blumenstein M, 1997, SHOCK, V8, P73, DOI 10.1097/00024382-199707000-00012; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; FINGERLE G, 1993, BLOOD, V82, P3170; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Herra CM, 1996, J MED MICROBIOL, V44, P135, DOI 10.1099/00222615-44-2-135; Schlitt A, 2004, THROMB HAEMOSTASIS, V92, P419, DOI 10.1160/TH04-02-0095; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; ZIEGLERHEITBROC.L, 2010, BLOOD IN PRESS, DOI DOI 10.1182/BLOOD-2010-02-258558; ZieglerHeitbrock HWL, 1996, IMMUNOL TODAY, V17, P424, DOI 10.1016/0167-5699(96)10029-3	10	28	30	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 24	2010	33	3					289	291		10.1016/j.immuni.2010.09.007	http://dx.doi.org/10.1016/j.immuni.2010.09.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	662HP	20870168	Bronze			2022-12-18	WOS:000282798500001
J	Mabrouk, I; Buart, S; Hasmim, M; Michiels, C; Connault, E; Opolon, P; Chiocchia, G; Levi-Strauss, M; Chouaib, S; Karray, S				Mabrouk, Imed; Buart, Stephanie; Hasmim, Meriem; Michiels, Christelle; Connault, Elizabeth; Opolon, Paule; Chiocchia, Gilles; Levi-Strauss, Matthieu; Chouaib, Salem; Karray, Saoussen			Prevention of Autoimmunity and Control of Recall Response to Exogenous Antigen by Fas Death Receptor Ligand Expression on T Cells	IMMUNITY			English	Article							GERMINAL-CENTER; B-CELLS; DENDRITIC CELLS; APOPTOSIS; GENE; LYMPHOPROLIFERATION; CENTERS; LPR; BIM; ELIMINATION	Mice with mutations in the gene encoding Fas ligand (FasL) develop lymphoproliferation and systemic autoimmune diseases. However, the cellular subset responsible for the prevention of autoimmunity in FasL-deficient mice remains undetermined. Here, we show that mice with FasL loss on either B or T cells had identical life span as littermates, and both genotypes developed signs of autoimmunity. In addition, we show that T cell-dependent death was vital for the elimination of aberrant T cells and for controlling the numbers of B cells and dendritic cells that dampen autoimmune responses. Furthermore, we show that the loss of FasL on T cells affected the follicular dentritic cell network in the germinal centers, leading to an impaired recall response to exogenous antigen. These results disclose the distinct roles of cellular subsets in FasL-dependent control of autoimmunity and provide further insight into the role of FasL in humoral immunity.	[Mabrouk, Imed; Buart, Stephanie; Michiels, Christelle; Levi-Strauss, Matthieu; Karray, Saoussen] Univ Paris 05, Hop Necker, INSERM, U580, F-75015 Paris, France; [Buart, Stephanie; Hasmim, Meriem; Chouaib, Salem; Karray, Saoussen] Univ Paris Sud, Inst Gustave Roussy, INSERM, U753, F-94805 Villejuif, France; [Connault, Elizabeth; Opolon, Paule] Univ Paris Sud, Inst Gustave Roussy, UMR 8121, F-94805 Villejuif, France; [Chiocchia, Gilles] Univ Paris 05, Inst Cochin, CNRS 8104, INSERM,U567, F-75014 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Karray, S (corresponding author), Univ Paris 05, Hop Necker, INSERM, U580, 161 Rue Sevres, F-75015 Paris, France.	saoussen.karray@igr.fr	CHIOCCHIA, Gilles R/F-6287-2013; Chouaib, Salem/F-7939-2016	CHIOCCHIA, Gilles R/0000-0001-9973-0940; BUART, Stephanie/0000-0002-8834-7919; Mabrouk, Imed/0000-0002-8844-9376; Hasmim, Meriem/0000-0002-7920-2443; Karray, Saoussen/0000-0003-0107-4039	Association pour la Recherche contre le Cancer (ARC); INSERM; ARC [3318]	Association pour la Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le CancerFrench National Research Agency (ANR)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); ARC(Australian Research Council)	We are grateful to F. Zavala for advice and discussion. We warmly acknowledge the animal facility staff at INSERM U580 and at Institut Gustave Roussy, precisely B. Petit for mice immunization and follow up. I.M. was supported by a postdoctoral fellowship from Association pour la Recherche contre le Cancer (ARC). S,K. is an investigator of Centre National de la Recherche Scientifique. This work was supported by INSERM and by ARC grant 3318.	Adachi M, 1996, P NATL ACAD SCI USA, V93, P2131, DOI 10.1073/pnas.93.5.2131; Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Bonardelle D, 2005, J LEUKOCYTE BIOL, V78, P1052, DOI 10.1189/jlb.0904536; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; DANIEL PT, 1994, J IMMUNOL, V152, P5624; Eisenberg R A, 1994, Semin Immunol, V6, P49, DOI 10.1006/smim.1994.1008; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; FREEDMAN AS, 1990, SCIENCE, V249, P1030, DOI 10.1126/science.1697696; Fukuyama H, 1998, J IMMUNOL, V160, P3805; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Honig LS, 2000, AM J MED, V108, P317, DOI 10.1016/S0002-9343(00)00291-6; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Jonsson H, 2005, NAT MED, V11, P666, DOI 10.1038/nm1248; Karray S, 2004, J IMMUNOL, V172, P2118, DOI 10.4049/jimmunol.172.4.2118; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; LAGRESLE C, 1995, J IMMUNOL, V154, P5746; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Pestano GA, 1999, SCIENCE, V284, P1187, DOI 10.1126/science.284.5417.1187; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; SMITH KGC, 1995, P NATL ACAD SCI USA, V92, P11628, DOI 10.1073/pnas.92.25.11628; STEINBERG AD, 1980, J IMMUNOL, V125, P871; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Tew JG, 2001, TRENDS IMMUNOL, V22, P361, DOI 10.1016/S1471-4906(01)01942-1; Weant AE, 2008, IMMUNITY, V28, P218, DOI 10.1016/j.immuni.2007.12.014; Yang JP, 2006, P NATL ACAD SCI USA, V103, P147, DOI 10.1073/pnas.0509054103	39	28	29	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2008	29	6					922	933		10.1016/j.immuni.2008.10.007	http://dx.doi.org/10.1016/j.immuni.2008.10.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19013083	Bronze			2022-12-18	WOS:000262012400012
J	McManus, MT				McManus, MT			Small RNAs and immunity	IMMUNITY			English	Review							VIRUS-INDUCED LYMPHOMAS; SMALL INTERFERING RNA; DOUBLE-STRANDED-RNA; NONCODING RNA; CAENORHABDITIS-ELEGANS; MICRORNA GENES; MESSENGER-RNA; ANTISENSE RNA; C-ELEGANS; IDENTIFICATION	Small RNAs of 21-23 nucleotides are powerful regulators of gene expression and play essential roles in biological processes that include development, maintenance of genome stability, and viral adaptive defense mechanisms. Such small RNAs are simple in design yet rich in biology and have captivated the attention of biologists in many fields. This review discusses the potential roles of small RNAs in immune biology and speculates on their potential participation in lymphogenesis and antiviral mechanisms.	Univ Calif San Francisco, UCSF Diabet Ctr, Dept Microbiol & Immunol, San Francisco, CA 94122 USA	University of California System; University of California San Francisco	McManus, MT (corresponding author), Univ Calif San Francisco, UCSF Diabet Ctr, Dept Microbiol & Immunol, San Francisco, CA 94122 USA.	mmcmanus@diabetes.ucsf.edu	mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569				Allman D, 2002, IMMUNOL REV, V187, P75, DOI 10.1034/j.1600-065X.2002.18707.x; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2004, P NATL ACAD SCI USA, V101, P11755, DOI 10.1073/pnas.0404432101; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; CLURMAN BE, 1989, MOL CELL BIOL, V9, P2657, DOI 10.1128/MCB.9.6.2657; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; Dohner H, 2000, NEW ENGL J MED, V343, P1910, DOI 10.1056/NEJM200012283432602; Dong JT, 2001, PROSTATE, V49, P166, DOI 10.1002/pros.1131; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; GAUWERKY CE, 1989, P NATL ACAD SCI USA, V86, P8867, DOI 10.1073/pnas.86.22.8867; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Grishok A, 2000, SCIENCE, V287, P2494, DOI 10.1126/science.287.5462.2494; Haasch D, 2002, CELL IMMUNOL, V217, P78, DOI 10.1016/S0008-8749(02)00506-3; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Kawasaki H, 2004, NATURE, V431, P211, DOI 10.1038/nature02889; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Kumar M, 1998, MICROBIOL MOL BIOL R, V62, P1415, DOI 10.1128/MMBR.62.4.1415-1434.1998; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee T, 2004, MOL CELL, V14, P43, DOI 10.1016/S1097-2765(04)00161-3; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li HW, 2002, SCIENCE, V296, P1319, DOI 10.1126/science.1070948; Li WX, 2004, P NATL ACAD SCI USA, V101, P1350, DOI 10.1073/pnas.0308308100; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lim LP, 2003, GENE DEV, V17, P991, DOI 10.1101/gad.1074403; Lippman Z, 2004, NATURE, V431, P364, DOI 10.1038/nature02875; Lu SH, 2004, J VIROL, V78, P12868, DOI 10.1128/JVI.78.23.12868-12876.2004; Maillard I, 2003, IMMUNITY, V19, P781, DOI 10.1016/S1074-7613(03)00325-X; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; MATHEWS MB, 1991, J VIROL, V65, P5657, DOI 10.1128/JVI.65.11.5657-5662.1991; McManus MT, 2003, SEMIN CANCER BIOL, V13, P253, DOI 10.1016/S1044-579X(03)00038-5; McPherson JD, 2001, NATURE, V409, P934, DOI 10.1038/35057157; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Plasterk RHA, 2002, SCIENCE, V296, P1263, DOI 10.1126/science.1072148; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tam W, 2002, J VIROL, V76, P4275, DOI 10.1128/JVI.76.9.4275-4286.2002; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vargason JM, 2003, CELL, V115, P799, DOI 10.1016/S0092-8674(03)00984-X; Vastenhouw NL, 2004, TRENDS GENET, V20, P314, DOI 10.1016/j.tig.2004.04.011; Vastenhouw NL, 2003, CURR BIOL, V13, P1311, DOI 10.1016/s0960-9822(03)00539-6; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Ye KQ, 2003, NATURE, V426, P874, DOI 10.1038/nature02213; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434; Yoo BC, 2004, PLANT CELL, V16, P1979, DOI 10.1105/tpc.104.023614; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0	70	28	29	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2004	21	6					747	756		10.1016/j.immuni.2004.11.007	http://dx.doi.org/10.1016/j.immuni.2004.11.007			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881XB	15589164	Bronze			2022-12-18	WOS:000225901600003
J	Beutler, B				Beutler, B			SHIP, TGF-beta, and endotoxin tolerance	IMMUNITY			English	Editorial Material							NEGATIVE REGULATOR; RECEPTOR; LIPOPOLYSACCHARIDE; MICE		Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA	Scripps Research Institute	Beutler, B (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.							BEESON PB, 1947, J EXP MED, V86, P29, DOI 10.1084/jem.86.1.29; BEESON PB, 1947, J EXP MED, V86, P39, DOI 10.1084/jem.86.1.39; BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; Brint EK, 2004, NAT IMMUNOL, V5, P373, DOI 10.1038/ni1050; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Karaghiosoff M, 2003, NAT IMMUNOL, V4, P471, DOI 10.1038/ni910; Kinjyo I, 2002, IMMUNITY, V17, P583, DOI 10.1016/S1074-7613(02)00446-6; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; Pfeiffer R., 1892, Z HYG, V11, P393, DOI [10.1007/BF02284303, DOI 10.1007/BF02284303]; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Sato S, 2000, J IMMUNOL, V165, P7096, DOI 10.4049/jimmunol.165.12.7096; Sly LM, 2004, IMMUNITY, V21, P227, DOI 10.1016/j.immuni.2004.07.010; Wald D, 2003, NAT IMMUNOL, V4, P920, DOI 10.1038/ni968; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; ZIEGLERHEITBROCK HWL, 1995, J INFLAMM, V45, P13	16	28	28	1	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2004	21	2					134	135		10.1016/j.immuni.2004.07.014	http://dx.doi.org/10.1016/j.immuni.2004.07.014			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	848BK	15308094	Bronze			2022-12-18	WOS:000223441900002
J	Orkin, SH				Orkin, SH			Priming the hematopoietic pump	IMMUNITY			English	Editorial Material							PRECEDES COMMITMENT; LINEAGE COMMITMENT; STEM-CELLS; PROGENITORS; REGION; BETA		Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA; Harvard Univ, Sch Med, Howard Hughes Med Inst, Childrens Hosp, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA.							Delassus S, 1999, BLOOD, V94, P1495, DOI 10.1182/blood.V94.5.1495.417a08_1495_1503; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; JIMENEZ G, 1992, P NATL ACAD SCI USA, V89, P10618, DOI 10.1073/pnas.89.22.10618; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Orkin SH, 2000, NAT REV GENET, V1, P57, DOI 10.1038/35049577; Querfurth E, 2000, GENE DEV, V14, P2515, DOI 10.1101/gad.177200; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1	9	28	30	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2003	19	5					633	634		10.1016/S1074-7613(03)00302-9	http://dx.doi.org/10.1016/S1074-7613(03)00302-9			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	745CY	14614848	Bronze			2022-12-18	WOS:000186672200001
J	Evans, EJ; Hene, L; Sparks, LM; Dong, T; Retiere, C; Fennelly, JA; Manso-Sancho, R; Powell, J; Braud, VM; Rowland-Jones, SL; McMichael, AJ; Davis, SJ				Evans, EJ; Hene, L; Sparks, LM; Dong, T; Retiere, C; Fennelly, JA; Manso-Sancho, R; Powell, J; Braud, VM; Rowland-Jones, SL; McMichael, AJ; Davis, SJ			The T cell surface - How well do we know it?	IMMUNITY			English	Article							GENE-EXPRESSION; SERIAL ANALYSIS; PROTEIN; PROGENITOR; RECEPTOR; DATABASE; ANTIGEN; CLONING; VIEWS; SAGE	The overall degree of complexity of the T cell surface has been unclear, constraining our understanding of its biology. Using global gene expression analysis, we show that 111 of 374 genes encoding well-characterized leukocyte surface antigens are expressed by a resting cytotoxic T cell. Unexpectedly, of 97 stringently defined, T cell-specific transcripts with unknown functions that we identify, none encode proteins with the modular architecture characteristic of 80% of leukocyte surface antigens. Only two encode proteins with membrane topologies found exclusively in cell surface molecules. Our analysis indicates that the cell type-specific composition of the resting CD8(+) T cell surface is now largely defined, providing an insight into the overall compositional complexity of the mammalian cell surface and a framework for formulating systematic models of T cell surface-dependent processes, such as T cell receptor triggering.	Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Med Res Council Human Immunol Unit, Oxford OX3 9DU, England; St Thomas Hosp, Rayne Inst, Richard Dimbleby Dept Canc Res, Canc Res UK Lab, London SE1 7EH, England	University of Oxford; University of Oxford; Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Davis, SJ (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England.	sdavis@molbiol.ox.ac.uk	RETIERE, Christelle/L-5709-2015; braud, veronique M/I-4597-2013	RETIERE, Christelle/0000-0001-5943-6990; braud, veronique M/0000-0001-8213-3947; Dong, Tao/0000-0003-3545-3758				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Apweiler R, 2000, BIOINFORMATICS, V16, P1145, DOI 10.1093/bioinformatics/16.12.1145; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; BARCLAY AN, 1997, LEUCOCYTE ANTIGEN FA, V1; Bustin SA, 2002, TRENDS MOL MED, V8, P269, DOI 10.1016/S1471-4914(02)02334-1; Caron H, 2001, SCIENCE, V291, P1289, DOI 10.1126/science.1056794; Davis SJ, 1996, IMMUNOL TODAY, V17, P177, DOI 10.1016/0167-5699(96)80617-7; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Green CD, 2001, J IMMUNOL METHODS, V250, P67, DOI 10.1016/S0022-1759(01)00306-4; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hashimoto S, 1999, BLOOD, V94, P845, DOI 10.1182/blood.V94.3.845.415k09_845_852; Hogenesch JB, 2001, CELL, V106, P413, DOI 10.1016/S0092-8674(01)00467-6; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hutloff A, 1999, NATURE, V397, P263, DOI 10.1038/16717; Ikawa T, 1999, J EXP MED, V190, P1617, DOI 10.1084/jem.190.11.1617; Ishii M, 2000, GENOMICS, V68, P136, DOI 10.1006/geno.2000.6284; Kothapalli R, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-22; Lash AE, 2000, GENOME RES, V10, P1051, DOI 10.1101/gr.10.7.1051; Marchler-Bauer A, 2002, NUCLEIC ACIDS RES, V30, P281, DOI 10.1093/nar/30.1.281; Mason D., 2001, Tissue Antigens, V58, P425, DOI 10.1034/j.1399-0039.2001.580614.x; MOCHLYROSEN D, 1995, SCIENCE, V268, P247, DOI 10.1126/science.7716516; Nagai S, 2001, INT IMMUNOL, V13, P367, DOI 10.1093/intimm/13.3.367; Obata-Onai A, 2002, INT IMMUNOL, V14, P1085, DOI 10.1093/intimm/dxf086; Powell J, 1998, NUCLEIC ACIDS RES, V26, P3445, DOI 10.1093/nar/26.14.3445; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; Riggins GJ, 2001, HUM MOL GENET, V10, P663, DOI 10.1093/hmg/10.7.663; ROWLANDJONES S, 1995, NAT MED, V1, P59, DOI 10.1038/nm0195-59; Ryo A, 1999, FEBS LETT, V462, P182, DOI 10.1016/S0014-5793(99)01526-4; SANCHEZ MJ, 1994, J EXP MED, V180, P569, DOI 10.1084/jem.180.2.569; Schuler GD, 1996, SCIENCE, V274, P540, DOI 10.1126/science.274.5287.540; Schultz J, 2000, NUCLEIC ACIDS RES, V28, P231, DOI 10.1093/nar/28.1.231; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; Shaffer AL, 2001, IMMUNITY, V15, P375, DOI 10.1016/S1074-7613(01)00194-7; Shires J, 2001, IMMUNITY, V15, P419, DOI 10.1016/S1074-7613(01)00192-3; Staudt LM, 2000, ANNU REV IMMUNOL, V18, P829, DOI 10.1146/annurev.immunol.18.1.829; Staudt LM, 2002, ANNU REV MED, V53, P303, DOI 10.1146/annurev.med.53.082901.103941; Teague TK, 1999, P NATL ACAD SCI USA, V96, P12691, DOI 10.1073/pnas.96.22.12691; Trowsdale J, 2001, IMMUNITY, V15, P363, DOI 10.1016/S1074-7613(01)00197-2; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Velculescu VE, 1997, CELL, V88, P243, DOI 10.1016/S0092-8674(00)81845-0; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Williams A F, 1977, Contemp Top Mol Immunol, V6, P83; WILLIAMS AF, 1977, CELL, V12, P663, DOI 10.1016/0092-8674(77)90266-5; Zelenika D, 2002, J IMMUNOL, V168, P1069, DOI 10.4049/jimmunol.168.3.1069	45	28	31	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2003	19	2					213	223		10.1016/S1074-7613(03)00198-5	http://dx.doi.org/10.1016/S1074-7613(03)00198-5			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	714TF	12932355	Bronze			2022-12-18	WOS:000184929000009
J	Yu, X; Wang, L; Luo, Y; Roeder, RG				Yu, X; Wang, L; Luo, Y; Roeder, RG			Identification and characterization of a novel OCA-B isoform: Implications for a role in B cell signaling pathways	IMMUNITY			English	Article							BINDING TRANSCRIPTION FACTORS; FUNCTIONAL-CHARACTERIZATION; IMMUNOGLOBULIN PROMOTERS; 3'-IGH ENHANCER; POU DOMAIN; COACTIVATOR; PROTEINS; MEMBRANE; MYRISTOYLATION; ACTIVATION	OCA-B is a B lymphocyte-specific transcription coactivator that mediates tissue- and stage-restricted transcription of immunoglobulin genes. Earlier genetic studies revealed that OCA-B is essential for germinal center formation and production of secondary immunoglobulin isotypes. Biochemically purified OCA-B contains p35 and p34 isoforms, and a further analysis has now revealed that p35 is derived from a newly found isoform, p40. More importantly, it has been found that p35 is myristoylated in vivo and that this leads to dramatic changes (including localization to membrane compartments) in its properties. These results suggest that the p35 isoform of OCA-B has functions distinct from those of the nuclear p34 and that it might be a component of a signaling pathway that is required for late-stage B cell development.	Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10021 USA	Rockefeller University	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, 1230 York Ave, New York, NY 10021 USA.							Babb R, 1997, MOL CELL BIOL, V17, P7295, DOI 10.1128/MCB.17.12.7295; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; BOMAN AL, 1995, TRENDS BIOCHEM SCI, V20, P147, DOI 10.1016/S0968-0004(00)88991-4; Boutin JA, 1997, CELL SIGNAL, V9, P15, DOI 10.1016/S0898-6568(96)00100-3; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cepek KL, 1996, GENE DEV, V10, P2079, DOI 10.1101/gad.10.16.2079; Chasman D, 1999, GENE DEV, V13, P2650, DOI 10.1101/gad.13.20.2650; COCKERILL PN, 1990, MOL CELL BIOL, V10, P1293, DOI 10.1128/MCB.10.3.1293; CORCORAN LM, 1993, GENE DEV, V7, P570, DOI 10.1101/gad.7.4.570; Goldberg J, 1998, CELL, V95, P237, DOI 10.1016/S0092-8674(00)81754-7; Gstaiger M, 1996, EMBO J, V15, P2781, DOI 10.1002/j.1460-2075.1996.tb00638.x; GSTAIGER M, 1995, NATURE, V373, P360, DOI 10.1038/373360a0; HAUN RS, 1993, J BIOL CHEM, V268, P7064; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; KAMPS MP, 1985, P NATL ACAD SCI USA, V82, P4625, DOI 10.1073/pnas.82.14.4625; Kevil C, 1995, ONCOGENE, V11, P2339; KIM U, 1996, NATURE, V383, P543; Kretzschmar M, 1998, CURR OPIN GENET DEV, V8, P103, DOI 10.1016/S0959-437X(98)80069-5; Luo Y, 1998, MOL CELL BIOL, V18, P3803, DOI 10.1128/MCB.18.7.3803; LUO Y, 1992, CELL, V71, P231, DOI 10.1016/0092-8674(92)90352-D; LUO Y, 1995, MOL CELL BIOL, V15, P4115; Luo Y, 1999, COLD SPRING HARB SYM, V64, P119, DOI 10.1101/sqb.1999.64.119; MEHDI H, 1990, GENE, V91, P173, DOI 10.1016/0378-1119(90)90085-6; MURPHY S, 1992, MOL CELL BIOL, V12, P3247, DOI 10.1128/MCB.12.7.3247; Nielsen PJ, 1996, EUR J IMMUNOL, V26, P3214, DOI 10.1002/eji.1830261255; PFISTERER P, 1995, J BIOL CHEM, V270, P29870, DOI 10.1074/jbc.270.50.29870; PIERANI A, 1990, MOL CELL BIOL, V10, P6204, DOI 10.1128/MCB.10.12.6204; Qin XF, 1998, EMBO J, V17, P5066, DOI 10.1093/emboj/17.17.5066; Raju RVS, 1997, MOL CELL BIOCHEM, V176, P135, DOI 10.1023/A:1006891302017; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; STAUDT LM, 1986, NATURE, V323, P640, DOI 10.1038/323640a0; STAUDT LM, 1991, ANNU REV IMMUNOL, V9, P373; Stevens S, 2000, J IMMUNOL, V164, P6372, DOI 10.4049/jimmunol.164.12.6372; Stevens S, 2000, J IMMUNOL, V164, P5306, DOI 10.4049/jimmunol.164.10.5306; STRUBIN M, 1995, CELL, V80, P497, DOI 10.1016/0092-8674(95)90500-6; Tang H, 1999, IMMUNITY, V11, P517, DOI 10.1016/S1074-7613(00)80127-2; THELEN M, 1991, NATURE, V351, P320, DOI 10.1038/351320a0; VAJDY M, 1995, J EXP MED, V181, P41, DOI 10.1084/jem.181.1.41; Wedegaertner PB, 1998, BIOL SIGNAL RECEPT, V7, P125; Wegner M, 1993, CURR OPIN CELL BIOL, V5, P488, DOI 10.1016/0955-0674(93)90015-I	42	28	30	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2001	14	2					157	167		10.1016/S1074-7613(09)00090-9	http://dx.doi.org/10.1016/S1074-7613(09)00090-9			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404HZ	11239448				2022-12-18	WOS:000167092500006
J	Jasanoff, A; Song, SY; Dinner, AR; Wagner, G; Wiley, DC				Jasanoff, A; Song, SY; Dinner, AR; Wagner, G; Wiley, DC			One of two unstructured domains of Ii becomes ordered in complexes with MHC class II molecules	IMMUNITY			English	Article							ALPHA-BETA DIMERS; INVARIANT CHAIN; HLA-DR; DENDRITIC CELLS; PEPTIDE BINDING; CATHEPSIN-L; CLIP; DISSOCIATION; TRANSPORT; ANTIGENS	We studied the role of the invariant chain (Ii) protein's structure in its ability to form complexes with major histocompatibility complex class II molecules. Multidimensional nuclear magnetic resonance experiments demonstrated that Ii contains two unstructured, flexible domains: a 39 residue sequence that contains a region (CLIP) critical for Ii/class II complex formation and becomes rapidly ordered when Ii/class II complexes are assembled, and a 30 residue sequence that contains the insertion point for a protease inhibitor domain included in an alternative splice form of Ii. Mobility of these domains guarantees accessibility to CLIP and the inhibitor insert, and ordering of the CLIP-containing domain may provide protection against proteolysis and contribute, along with Ii's compact 118-192 domain, to allotype-independent class II binding.	Harvard Univ, Sch Med, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Comm Higher Degrees Biophys, Cambridge, MA 02138 USA; Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Cambridge, MA 02138 USA; Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Harvard University; Howard Hughes Medical Institute	Wiley, DC (corresponding author), Harvard Univ, Sch Med, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.				NIGMS NIH HHS [P01 GM047467, GM47467] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM047467] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Bevec T, 1996, J EXP MED, V183, P1331, DOI 10.1084/jem.183.4.1331; BIJLMAKERS MJE, 1994, J EXP MED, V180, P623, DOI 10.1084/jem.180.2.623; BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; Creighton T.E., 1993, PROTEINS STRUCTURES; CRESSWELL P, 1985, P NATL ACAD SCI USA, V82, P8188, DOI 10.1073/pnas.82.23.8188; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; FREISEWINKEL IM, 1993, P NATL ACAD SCI USA, V90, P9703, DOI 10.1073/pnas.90.20.9703; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; JASANOFF A, 1995, P NATL ACAD SCI USA, V92, P9900, DOI 10.1073/pnas.92.21.9900; Jasanoff A, 1998, EMBO J, V17, P6812, DOI 10.1093/emboj/17.23.6812; KAMPGEN E, 1991, P NATL ACAD SCI USA, V88, P3014, DOI 10.1073/pnas.88.8.3014; KOCH N, 1987, EMBO J, V6, P1677, DOI 10.1002/j.1460-2075.1987.tb02417.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KROPSHOFER H, 1995, SCIENCE, V270, P1357, DOI 10.1126/science.270.5240.1357; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MACHAMER CE, 1982, J IMMUNOL, V129, P2564; Nakagawa T, 1998, SCIENCE, V280, P450, DOI 10.1126/science.280.5362.450; NEEFJES JJ, 1990, CELL, V61, P171, DOI 10.1016/0092-8674(90)90224-3; Newcomb JR, 1996, J BIOL CHEM, V271, P24249, DOI 10.1074/jbc.271.39.24249; PARK SJ, 1995, P NATL ACAD SCI USA, V92, P11289, DOI 10.1073/pnas.92.24.11289; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; ROMAGNOLI P, 1994, J EXP MED, V180, P1107, DOI 10.1084/jem.180.3.1107; SADEGHNASSERI S, 1994, NATURE, V370, P647, DOI 10.1038/370647a0; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; Siebenkotten IM, 1998, J IMMUNOL, V160, P3355; SLOAN VS, 1995, NATURE, V375, P802, DOI 10.1038/375802a0; Stumptner P, 1997, EMBO J, V16, P5807, DOI 10.1038/sj.emboj.7590555; TEYTON L, 1990, NATURE, V348, P39, DOI 10.1038/348039a0; Thayer WP, 1999, J IMMUNOL, V162, P1502; VOGT AB, 1995, J IMMUNOL, V155, P4757; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; WITT SN, 1991, P NATL ACAD SCI USA, V88, P8164, DOI 10.1073/pnas.88.18.8164; Wuthrich K, 1986, NMR PROTEINS NUCL AC; XIA T, 1994, XEASY USER MANUAL	39	28	28	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	1999	10	6					761	768		10.1016/S1074-7613(00)80075-8	http://dx.doi.org/10.1016/S1074-7613(00)80075-8			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	212GU	10403651	Bronze			2022-12-18	WOS:000081209600014
J	De Simone, G; Andreata, F; Bleriot, C; Fumagalli, V; Laura, C; Garcia-Manteiga, JM; Di Lucia, P; Gilotto, S; Ficht, X; De Ponti, FF; Bono, EB; Giustini, L; Ambrosi, G; Mainetti, M; Zordan, P; Benechet, AP; Rava, M; Chakarov, S; Moalli, F; Bajenoff, M; Guidotti, LG; Ginhoux, F; Iannacone, M				De Simone, Giorgia; Andreata, Francesco; Bleriot, Camille; Fumagalli, Valeria; Laura, Chiara; Garcia-Manteiga, Jose M.; Di Lucia, Pietro; Gilotto, Stefano; Ficht, Xenia; De Ponti, Federico F.; Bono, Elisa B.; Giustini, Leonardo; Ambrosi, Gioia; Mainetti, Marta; Zordan, Paola; Benechet, Alexandre P.; Rava, Micol; Chakarov, Svetoslav; Moalli, Federica; Bajenoff, Marc; Guidotti, Luca G.; Ginhoux, Florent; Iannacone, Matteo			Identification of a Kupffer cell subset capable of reverting the T cell dysfunction induced by hepatocellular priming	IMMUNITY			English	Article							DENDRITIC CELLS; RNA-SEQ; IL-2; LIVER; EXPRESSION; ACTIVATION; INTERLEUKIN-2; RESPONSES; CROSS; FATE	Kupffer cells (KCs) are highly abundant, intravascular, liver-resident macrophages known for their scavenger and phagocytic functions. KCs can also present antigens to CD8(+) T cells and promote either tolerance or effector differentiation, but the mechanisms underlying these discrepant outcomes are poorly understood. Here, we used a mouse model of hepatitis B virus (HBV) infection, in which HBV-specific naive CD8(+) T cells recognizing hepatocellular antigens are driven into a state of immune dysfunction, to identify a subset of KCs (referred to as KC2) that cross-presents hepatocellular antigens upon interleukin-2 (IL-2) administration, thus improving the antiviral function of T cells. Removing MHC-I from all KCs, including KC2, or selectively depleting KC2 impaired the capacity of IL- 2 to revert the T cell dysfunction induced by intrahepatic priming. In summary, by sensing IL-2 and cross-presenting hepatocellular antigens, KC2 overcome the tolerogenic potential of the hepatic microenvironment, suggesting new strategies for boosting hepatic T cell immunity.	[De Simone, Giorgia; Andreata, Francesco; Fumagalli, Valeria; Laura, Chiara; Di Lucia, Pietro; Gilotto, Stefano; Ficht, Xenia; De Ponti, Federico F.; Bono, Elisa B.; Giustini, Leonardo; Ambrosi, Gioia; Mainetti, Marta; Zordan, Paola; Benechet, Alexandre P.; Rava, Micol; Moalli, Federica; Guidotti, Luca G.; Iannacone, Matteo] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [De Simone, Giorgia; Fumagalli, Valeria; Laura, Chiara; Guidotti, Luca G.; Iannacone, Matteo] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Bleriot, Camille; Chakarov, Svetoslav; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, 8A Biomed Grove,Immunos Bldg 3-4, Singapore 138648, Singapore; [Laura, Chiara; Garcia-Manteiga, Jose M.; Gilotto, Stefano] IRCCS San Raffaele Sci Inst, Ctr Omics Sci, I-20132 Milan, Italy; [Bajenoff, Marc] Aix Marseille Univ, CIML, INSERM, CNRS, F-13288 Marseille, France; [Ginhoux, Florent] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, 280 South Chongqing Rd, Shanghai 200025, Peoples R China; [Ginhoux, Florent] SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore 169856, Singapore; [Iannacone, Matteo] IRCCS San Raffaele Sci Inst, Expt Imaging Ctr, I-20132 Milan, Italy	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Chinese Academy of Sciences; Shanghai Jiao Tong University; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Iannacone, M (corresponding author), IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy.; Iannacone, M (corresponding author), Univ Vita Salute San Raffaele, I-20132 Milan, Italy.; Iannacone, M (corresponding author), IRCCS San Raffaele Sci Inst, Expt Imaging Ctr, I-20132 Milan, Italy.	iannacone.matteo@hsr.it	Iannacone, Matteo/I-8507-2018; Guidotti, Luca G./I-8542-2018	Iannacone, Matteo/0000-0002-9370-2671; Chakarov, Svetoslav/0000-0002-0665-5417; BLERIOT, Camille/0000-0002-4298-2888; Fumagalli, Valeria/0000-0003-2583-2498; Ficht, Xenia/0000-0002-4534-8225; rava', micol/0000-0001-7606-8368; Guidotti, Luca G./0000-0002-0205-2678; , Leonardo/0000-0003-3462-7891	A*STAR Biomedical Research Council [BMRC] Industry Alignment Fund [IAF] [311006]; BMRC transition funds [H16/99/b0/011]; European Research Council (ERC) Consolidator Grant [725038]; ERC Proof of Concept Grant [957502]; Italian Association for Cancer Research (AIRC) grants [19891, 22737]; Italian Ministry of Health (MoH) grant [RF-2018-12365801]; Lombardy Foundation for Biomedical Research (FRRB) grant [2015-0010]; European Molecular Biology Organization Young Investigator Program; Gilead Sciences; Fondazione Umberto Veronesi postdoctoral fellowship; iCARE fellowship from AIRC [23906]; SIgN; Singapore National Research Foundation Senior Investigatorship (NRFI) [NRF2016NRFNRFI001-02]	A*STAR Biomedical Research Council [BMRC] Industry Alignment Fund [IAF]; BMRC transition funds(Agency for Science Technology & Research (A*STAR)); European Research Council (ERC) Consolidator Grant(European Research Council (ERC)); ERC Proof of Concept Grant; Italian Association for Cancer Research (AIRC) grants(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health (MoH) grant; Lombardy Foundation for Biomedical Research (FRRB) grant; European Molecular Biology Organization Young Investigator Program(European Molecular Biology Organization (EMBO)); Gilead Sciences(Gilead Sciences); Fondazione Umberto Veronesi postdoctoral fellowship(Fondazione Umberto Veronesi); iCARE fellowship from AIRC; SIgN; Singapore National Research Foundation Senior Investigatorship (NRFI)(National Research Foundation, Singapore)	Wethank M. Freschi, M. Raso, and A. Fiocchi for technical support; M. Silva for secretarial assistance; D. Pinschewer for rLCMV; R. Ostuni for critical reading of the manuscript; and the members of the Iannacone laboratory for helpful discussions. Flow cytometry was carried out at FRACTAL, a flow cytometry resource and advanced cytometry technical applications laboratory established by the San Raffaele Scientific Institute. Confocal immunofluorescence histology was carried out at Alembic, an advanced microscopy laboratory established by the San Raffaele Scientific Institute and the Vita-Salute San Raffaele University. We thank the Singapore Immunology Network (SIgN) immunogenomics platform, part of the SIgN Immunomonitoring platform (supported by A*STAR Biomedical Research Council [BMRC] Industry Alignment Fund [IAF] grant 311006 and BMRC transition funds [H16/99/b0/011]). We would like to acknowledge the PhD program in basic and applied immunology and oncology at Vita-Salute San Raffaele University, as G.D.S., V.F., and C.L. conducted this study as partial fulfillment of their PhDs in molecular medicine within that program. M.I. is supported by European Research Council (ERC) Consolidator Grant 725038, ERC Proof of Concept Grant 957502, Italian Association for Cancer Research (AIRC) grants 19891 and 22737, Italian Ministry of Health (MoH) grant RF-2018-12365801, Lombardy Foundation for Biomedical Research (FRRB) grant 2015-0010, the European Molecular Biology Organization Young Investigator Program, and a Funded Research Agreement from Gilead Sciences. F.A. is the recipient of a Fondazione Umberto Veronesi postdoctoral fellowship. X.F. is the recipient of iCARE fellowship 23906 from AIRC. F.G. is supported by SIgN core funding, the Singapore National Research Foundation Senior Investigatorship (NRFI) (NRF2016NRFNRFI001-02), and the European Molecular Biology Organization Young Investigator Program.	Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2; Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Benechet AP, 2019, NATURE, V574, P200, DOI 10.1038/s41586-019-1620-6; Blattman JN, 2003, NAT MED, V9, P540, DOI 10.1038/nm866; Bleriot C, 2021, IMMUNITY, V54, P2101, DOI 10.1016/j.immuni.2021.08.006; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Bosco MC, 2000, J IMMUNOL, V164, P4575, DOI 10.4049/jimmunol.164.9.4575; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; De Giovanni M, 2020, NAT IMMUNOL, V21, P321, DOI 10.1038/s41590-020-0596-6; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ficht X, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba2351; Flatz L, 2010, NAT MED, V16, P339, DOI 10.1038/nm.2104; Fukao T, 2000, EUR J IMMUNOL, V30, P1453, DOI 10.1002/(SICI)1521-4141(200005)30:5<1453::AID-IMMU1453>3.0.CO;2-W; Fumagalli V, 2020, J EXP MED, V217, DOI 10.1084/jem.20200298; GUIDOTTI LG, 1994, J VIROL, V68, P5469, DOI 10.1128/JVI.68.9.5469-5475.1994; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Guidotti LG, 2015, CELL, V161, P486, DOI 10.1016/j.cell.2015.03.005; Herr F, 2014, J IMMUNOL, V192, P5660, DOI 10.4049/jimmunol.1300422; Horst AK, 2016, CELL MOL IMMUNOL, V13, P277, DOI 10.1038/cmi.2015.112; Huang RL, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00445; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Isogawa M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003490; Jenne CN, 2013, NAT IMMUNOL, V14, P996, DOI 10.1038/ni.2691; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kobayashi KS, 2012, NAT REV IMMUNOL, V12, P813, DOI 10.1038/nri3339; Kronin V, 1998, INT IMMUNOL, V10, P237, DOI 10.1093/intimm/10.2.237; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JH, 2016, NATURE, V533, P110, DOI 10.1038/nature17947; Liang DC, 2012, J IMMUNOL, V188, P5785, DOI 10.4049/jimmunol.1200109; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pol JG, 2020, J EXP MED, V217, DOI 10.1084/jem.20191247; Popov A, 2008, J IMMUNOL, V181, P4976, DOI 10.4049/jimmunol.181.7.4976; Raeber ME, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aba5464; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sitia G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002061; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Vollmar B, 2009, PHYSIOL REV, V89, P1269, DOI 10.1152/physrev.00027.2008; Warren A, 2006, HEPATOLOGY, V44, P1182, DOI 10.1002/hep.21378; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; Wong YC, 2015, J HEPATOL, V63, P1005, DOI 10.1016/j.jhep.2015.05.033; Wu X, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02108; Wuest SC, 2011, NAT MED, V17, P604, DOI 10.1038/nm.2365; Zordan P, 2018, J CLIN INVEST, V128, P1688, DOI 10.1172/JCI96342	53	27	27	5	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					2089	+		10.1016/j.immuni.2021.05.005	http://dx.doi.org/10.1016/j.immuni.2021.05.005		SEP 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34469774	Green Published, hybrid			2022-12-18	WOS:000695789800016
J	Gabriel, SS; Tsui, C; Chisanga, D; Weber, F; Llano-Leon, M; Gubser, PM; Bartholin, L; Souza-Fonseca-Guimaraes, F; Huntington, ND; Shi, W; Utzschneider, DT; Kallies, A				Gabriel, Sarah S.; Tsui, Carlson; Chisanga, David; Weber, Flora; Llano-Leon, Manuela; Gubser, Patrick M.; Bartholin, Laurent; Souza-Fonseca-Guimaraes, Fernando; Huntington, Nicholas D.; Shi, Wei; Utzschneider, Daniel T.; Kallies, Axel			Transforming growth factor-b-regulated mTOR activity preserves cellular metabolism to maintain long-term T cell responses in chronic infection	IMMUNITY			English	Article							INHIBITORY RECEPTOR PD-1; PERSISTENCE; EXHAUSTION; EXPRESSION; MICE; GENE; DIFFERENTIATION; COORDINATION; GENERATION; SUBSETS	Antigen-specific CD8(+) T cells in chronic viral infections and tumors functionally deteriorate, a process known as exhaustion. Exhausted T cells are sustained by precursors of exhausted (Tpex) cells that self-renew while continuously generating exhausted effector (Tex) cells. However, it remains unknown how Tpex cells maintain their functionality. Here, we demonstrate that Tpex cells sustained mitochondrial fitness, including high spare respiratory capacity, while Tex cells deteriorated metabolically over time. Tpex cells showed early suppression of mTOR kinase signaling but retained the ability to activate this pathway in response to antigen receptor signals. Early transient mTOR inhibition improved long-term T cell responses and checkpoint inhibition. Transforming growth factor-beta repressed mTOR signaling in exhausted T cells and was a critical determinant of Tpex cell metabolism and function. Overall, we demonstrate that the preservation of cellular metabolism allows Tpex cells to retain long-term functionality to sustain T cell responses during chronic infection.	[Gabriel, Sarah S.; Tsui, Carlson; Weber, Flora; Llano-Leon, Manuela; Gubser, Patrick M.; Utzschneider, Daniel T.; Kallies, Axel] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Chisanga, David; Shi, Wei] Olivia Newton John Canc Res Inst, Heidelberg, Vic, Australia; [Chisanga, David; Shi, Wei; Kallies, Axel] Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia; [Chisanga, David] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Chisanga, David; Shi, Wei] La Trobe Univ, Sch Canc Med, Heidelberg, Vic, Australia; [Bartholin, Laurent] Ctr Rech Cancerol Lyon, INSERM U1052, F-69000 Lyon, France; [Souza-Fonseca-Guimaraes, Fernando] Univ Queensland, Diamantina Inst, Woolloongabba, Qld, Australia; [Huntington, Nicholas D.] Monash Univ, Biomed Discovery Inst, Clayton, Vic, Australia; [Huntington, Nicholas D.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Shi, Wei] Univ Melbourne, Sch Comp & Informat Syst, Melbourne, Vic, Australia	University of Melbourne; La Trobe University; Olivia Newton-John Cancer Research Institute; Walter & Eliza Hall Institute; University of Melbourne; La Trobe University; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; University of Queensland; Monash University; Monash University; University of Melbourne	Utzschneider, DT; Kallies, A (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.; Kallies, A (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia.	daniel.utzschneider@unimelb.edu.au; axel.kallies@unimelb.edu.au	Utzschneider, Daniel/D-5855-2016; /H-4040-2014	Utzschneider, Daniel/0000-0003-2205-9057; Weber, Flora/0000-0001-6407-8542; Kallies, Axel/0000-0002-6312-6968; Gabriel, Sarah Sharon/0000-0002-6359-485X; /0000-0002-0421-3957	National Health and Medical Research Council (NHMRC) [1085151, 1139607, 2003942]; Swiss National Science Foundation; Novartis Foundation for Medical-Biological Research; University of Queensland, a NHMRC of Australia [1140406]; Cure Cancer Australia with the assistance of Cancer Australia [1158085]; Melanoma Research Alliance (USA), the Cancer Council of Victoria [1145730]; NHMRC [1124907, 1124784, 1124788]; Walter and Eliza Hall Institute Centenary Fellowship - CSL Ltd; National University of Colombia; Elite Network of Bavaria (Germany)	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Novartis Foundation for Medical-Biological Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Queensland, a NHMRC of Australia; Cure Cancer Australia with the assistance of Cancer Australia; Melanoma Research Alliance (USA), the Cancer Council of Victoria; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Walter and Eliza Hall Institute Centenary Fellowship - CSL Ltd; National University of Colombia; Elite Network of Bavaria (Germany)	We thank Teisha Mason for technical support and members of the Kallies lab and Sammy Bedoui for discussions. This work was funded by the National Health and Medical Research Council (NHMRC, project grant no. 1085151 and fellowship no. 1139607 [to A.K.] and ideas grant no. 2003942 [to S.G.]), the Swiss National Science Foundation (fellowships to S.S.G., P.M.G., and D.T.U.), and the Novartis Foundation for Medical-Biological Research (fellowship to S.S.G.). D.T.U. is a Special Fellow of The Leukemia & Lymphoma Society. F.S.-F.-G. is funded by the University of Queensland, a NHMRC of Australia grant (1140406), and a grant awarded through the Priority-driven Collaborative Cancer Research Scheme and funded by Cure Cancer Australia with the assistance of Cancer Australia (1158085). N.D.H. is funded by the Melanoma Research Alliance (USA), the Cancer Council of Victoria (1145730), and the NHMRC (1124907, 1124784, and 1124788). W.S. is funded by a Walter and Eliza Hall Institute Centenary Fellowship funded by a donation from CSL Ltd. The internship of M.L.-L. was funded by the National University of Colombia, and F.W. was supported by the Elite Network of Bavaria (Germany). We acknowledge the Melbourne Cytometry Platform for the provision of flow cytometry services and the NIH Tetramer Facility for providing tetramers.	Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Bartholin L, 2008, GENESIS, V46, P724, DOI 10.1002/dvg.20425; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Chapman NM, 2020, NAT REV IMMUNOL, V20, P55, DOI 10.1038/s41577-019-0203-y; Chen SQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08123-8; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Dimeloe S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav3334; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Galletti G, 2020, NAT IMMUNOL, V21, P1552, DOI 10.1038/s41590-020-0791-5; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; HOTCHIN J, 1962, VIROLOGY, V18, P71, DOI 10.1016/0042-6822(62)90178-2; Huang HL, 2020, IMMUNOL REV, V295, P15, DOI 10.1111/imr.12845; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Johnnidis JB, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe3702; Kallies A, 2020, NAT REV IMMUNOL, V20, P128, DOI 10.1038/s41577-019-0223-7; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Leveen P, 2002, BLOOD, V100, P560, DOI 10.1182/blood.V100.2.560; Lewis GM, 2016, J CLIN INVEST, V126, P3799, DOI 10.1172/JCI87041; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Maekawa Y, 2008, NAT IMMUNOL, V9, P1140, DOI 10.1038/ni.1649; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; McCarthy DJ, 2009, BIOINFORMATICS, V25, P765, DOI 10.1093/bioinformatics/btp053; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Miyazaki M, 2011, NAT IMMUNOL, V12, P992, DOI 10.1038/ni.2086; Nath AP, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210495; Phan AT, 2017, IMMUNITY, V46, P714, DOI 10.1016/j.immuni.2017.04.016; Phan AT, 2016, IMMUNITY, V45, P1024, DOI 10.1016/j.immuni.2016.10.017; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Rautela J, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aat7527; Regateiro FS, 2011, EUR J IMMUNOL, V41, P2955, DOI 10.1002/eji.201141512; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Scharping NE, 2021, NAT IMMUNOL, V22, P205, DOI 10.1038/s41590-020-00834-9; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Staron MM, 2014, IMMUNITY, V41, P802, DOI 10.1016/j.immuni.2014.10.013; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05854-6; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Utzschneider DT, 2020, NAT IMMUNOL, V21, P1256, DOI 10.1038/s41590-020-0760-z; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vardhana SA, 2020, NAT IMMUNOL, V21, P1022, DOI 10.1038/s41590-020-0725-2; Viel S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1884; Worthington JJ, 2015, IMMUNITY, V42, P903, DOI 10.1016/j.immuni.2015.04.012; Worthington JJ, 2011, TRENDS BIOCHEM SCI, V36, P47, DOI 10.1016/j.tibs.2010.08.002; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Yu YR, 2020, NAT IMMUNOL, V21, P1540, DOI 10.1038/s41590-020-0793-3; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zhang N, 2013, IMMUNITY, V39, P687, DOI 10.1016/j.immuni.2013.08.019	68	27	27	3	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1698	+		10.1016/j.immuni.2021.06.007	http://dx.doi.org/10.1016/j.immuni.2021.06.007		AUG 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34233154	Bronze			2022-12-18	WOS:000684589700010
J	Fang, R; Jiang, QF; Guan, YK; Gao, PF; Zhang, R; Zhao, Z; Jiang, ZF				Fang, Run; Jiang, Qifei; Guan, Yukun; Gao, Pengfei; Zhang, Rui; Zhao, Zhen; Jiang, Zhengfan			Golgi apparatus-synthesized sulfated glycosaminoglycans mediate polymerization and activation of the cGAMP sensor STING	IMMUNITY			English	Article							CYCLIC GMP-AMP; ENDOPLASMIC-RETICULUM; MOLECULAR-CLONING; KERATAN SULFATE; AMINO-ACIDS; DNA SENSOR; INNATE; BIOSYNTHESIS; ADAPTER; BINDING	Activation of the cyclic guanosine monophosphate (GMP)-AMP (cGAMP) sensor STING requires its translocation from the endoplasmic reticulum to the Golgi apparatus and subsequent polymerization. Using a genome-wide CRISPR-Cas9 screen to define factors critical for STING activation in cells, we identified proteins critical for biosynthesis of sulfated glycosaminoglycans (sGAGs) in the Golgi apparatus. Binding of sGAGs promoted STING polymerization through luminal, positively charged, polar residues. These residues are evolutionarily conserved, and selective mutation of specific residues inhibited STING activation. Purified or chemically synthesized sGAGs induced STING polymerization and activation of the kinase TBK1. The chain length and O-linked sulfation of sGAGs directly affected the level of STING polymerization and, therefore, its activation. Reducing the expression of Slc35b2 to inhibit GAG sulfation in mice impaired responses to vaccinia virus infection. Thus, sGAGs in the Golgi apparatus are necessary and sufficient to drive STING polymerization, providing a mechanistic understanding of the requirement for endoplasmic reticulum (ER)-toGolgi apparatus translocation for STING activation.	[Fang, Run; Jiang, Qifei; Guan, Yukun; Gao, Pengfei; Zhang, Rui; Zhao, Zhen; Jiang, Zhengfan] Peking Univ, Sch Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China; [Fang, Run; Jiang, Qifei; Guan, Yukun; Gao, Pengfei; Zhang, Rui; Zhao, Zhen; Jiang, Zhengfan] Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China; [Guan, Yukun] NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	Peking University; Peking University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Jiang, ZF (corresponding author), Peking Univ, Sch Life Sci, Key Lab Cell Proliferat & Differentiat, Minist Educ, Beijing 100871, Peoples R China.; Jiang, ZF (corresponding author), Peking Univ, Peking Tsinghua Ctr Life Sci, Beijing 100871, Peoples R China.	jiangzf@pku.edu.cn		Guan, Yukun/0000-0001-9312-0164	Chinese Ministry of Science and Technology [2019YFA0508500, 2020YFA 0707800]; National Natural Science Foundation of China [31830022, 81621001]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Drs. Xing Chen and Ling Gao for helpful discussions, Dr. Guangli Yu for keratan sulfate, Dr. Zhengli Shi for the bat STING expression vector, the staff of the BIOPIC High-Throughput Sequencing Center at Peking University for deep sequencing, and Dr. Zhiheng Liu for screen data analysis. We also thank the staff of the flow cytometry Core at the National Center for Protein Sciences at Peking University, in particular Liying Du and Dr. Jia Luo, for technical help with FACS and Drs. Chunyan Shan, Hongxia Lv, and Xiaochen Li for technical help with optical microscopy. This work was supported by the Chinese Ministry of Science and Technology (2019YFA0508500 and 2020YFA 0707800) and the National Natural Science Foundation of China (31830022 and 81621001). We thank Dr. Chenjian Li for critical reading of the manuscript.	Aquino RS, 2016, FRONT BIOSCI-LANDMRK, V21, P1260, DOI 10.2741/4455; Caldwell EEO, 1996, INT J BIOCHEM CELL B, V28, P203, DOI 10.1016/1357-2725(95)00123-9; Caterson B, 2018, GLYCOBIOLOGY, V28, P182, DOI 10.1093/glycob/cwy003; Chen HH, 2011, CELL, V147, P436, DOI 10.1016/j.cell.2011.09.022; da Costa DS, 2017, ANNU REV BIOMED ENG, V19, P1, DOI [10.1146/annurev-bioeng-071516044610, 10.1146/annurev-bioeng-071516-044610]; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Deng ZM, 2020, J EXP MED, V217, DOI 10.1084/jem.20201045; Dias IHK, 2019, CHEM PHYS LIPIDS, V221, P53, DOI 10.1016/j.chemphyslip.2019.03.009; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Ergun SL, 2019, CELL, V178, P290, DOI 10.1016/j.cell.2019.05.036; Fang R, 2017, J IMMUNOL, V199, P3222, DOI 10.4049/jimmunol.1700699; FROMM JR, 1995, ARCH BIOCHEM BIOPHYS, V323, P279, DOI 10.1006/abbi.1995.9963; Funderburgh JL, 2002, IUBMB LIFE, V54, P187, DOI 10.1080/15216540214932; Gaidt MM, 2017, CELL, V171, P1110, DOI 10.1016/j.cell.2017.09.039; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gordts PLSM, 2015, CYTOKINE, V72, P118, DOI 10.1016/j.cyto.2014.12.013; Gordts PLSM, 2014, CELL METAB, V20, P813, DOI 10.1016/j.cmet.2014.09.016; Gunal S, 2019, J BIOL CHEM, V294, P12293, DOI 10.1074/jbc.REV119.007422; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Hooy RM, 2020, NUCLEIC ACIDS RES, V48, P4435, DOI 10.1093/nar/gkaa084; Iozzo RV, 2015, MATRIX BIOL, V42, P11, DOI 10.1016/j.matbio.2015.02.003; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kamiyama S, 2006, J BIOL CHEM, V281, P10945, DOI 10.1074/jbc.M508991200; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Kolset SO, 2008, CELL MOL LIFE SCI, V65, P1073, DOI 10.1007/s00018-007-7455-6; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Konig N, 2017, ANN RHEUM DIS, V76, P468, DOI 10.1136/annrheumdis-2016-209841; Kusche-Gullberg M, 2003, CURR OPIN STRUC BIOL, V13, P605, DOI 10.1016/j.sbi.2003.08.002; Lepelley A, 2020, J EXP MED, V217, DOI 10.1084/jem.20200600; Li JP, 2016, INT REV CEL MOL BIO, V325, P215, DOI 10.1016/bs.ircmb.2016.02.009; Li Y, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.150275; Liu D, 2019, CELL DEATH DIFFER, V26, P1735, DOI 10.1038/s41418-018-0251-z; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Lv MZ, 2020, CELL RES, V30, P966, DOI 10.1038/s41422-020-00395-4; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Morre DM, 2000, J CHROMATOGR B, V743, P377, DOI 10.1016/S0378-4347(00)00058-X; Mukai K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20234-9; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Mulloy B, 2017, GLYCOCONJUGATE J, V34, P351, DOI 10.1007/s10719-016-9749-0; Munoz J, 2015, JAMA DERMATOL, V151, P872, DOI 10.1001/jamadermatol.2015.0251; Patel S, 2019, GENES IMMUN, V20, P82, DOI 10.1038/s41435-018-0029-9; Pomin VH, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11010027; Proudfoot AEI, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10030070; RAMSDEN L, 1992, EUR J IMMUNOL, V22, P3027, DOI 10.1002/eji.1830221139; Saitoh T, 2009, P NATL ACAD SCI USA, V106, P20842, DOI 10.1073/pnas.0911267106; Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5; Shang QS, 2016, MAR DRUGS, V14, DOI 10.3390/md14120224; Smock RG, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180026; Spillmann D, 1998, J BIOL CHEM, V273, P15487, DOI 10.1074/jbc.273.25.15487; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Sze A, 2013, CELL HOST MICROBE, V14, P422, DOI 10.1016/j.chom.2013.09.009; Venkatachalam KV, 2003, IUBMB LIFE, V55, P1, DOI 10.1080/1521654031000072148; Vigetti D, 2014, BBA-GEN SUBJECTS, V1840, P2452, DOI 10.1016/j.bbagen.2014.02.001; Wang CG, 2018, IMMUNITY, V48, P675, DOI 10.1016/j.immuni.2018.03.017; Wang F, 2012, GENE, V500, P59, DOI 10.1016/j.gene.2012.03.049; Woo SR, 2015, TRENDS IMMUNOL, V36, P250, DOI 10.1016/j.it.2015.02.003; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Wu JJ, 2019, J EXP MED, V216, P867, DOI 10.1084/jem.20182192; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Xu D, 2014, ANNU REV BIOCHEM, V83, P129, DOI 10.1146/annurev-biochem-060713-035314; You FP, 2009, NAT IMMUNOL, V10, P1300, DOI 10.1038/ni.1815; Zhang CG, 2019, NATURE, V567, P394, DOI 10.1038/s41586-019-1000-2; Zhang H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03615-z; Zhang XW, 2020, IMMUNITY, V53, P43, DOI 10.1016/j.immuni.2020.05.013; Zhao BY, 2019, NATURE, V569, P718, DOI 10.1038/s41586-019-1228-x; Zhao Z, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108053; Zheng CH, 2015, EUR CELLS MATER, V29, P224, DOI 10.22203/eCM.v029a17; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zierhut C, 2019, CELL, V178, P302, DOI 10.1016/j.cell.2019.05.035	77	27	27	9	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					962	+		10.1016/j.immuni.2021.03.011	http://dx.doi.org/10.1016/j.immuni.2021.03.011		MAY 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33857420	Bronze			2022-12-18	WOS:000652019500013
J	Liu, ZJ; Nailwal, H; Rector, J; Rahman, MM; Sam, R; McFadden, G; Chan, FKM				Liu, Zhijun; Nailwal, Himani; Rector, Jonah; Rahman, Masmudur M.; Sam, Richard; McFadden, Grant; Chan, Francis Ka-Ming			A class of viral inducer of degradation of the necroptosis adaptor RIPK3 regulates virus-induced inflammation	IMMUNITY			English	Article							NF-KAPPA-B; CELL-DEATH; PROGRAMMED NECROSIS; INHIBITION; EXPRESSION; PROTEIN; COMPLEXES; BINDING; TNF	The vaccine strain against smallpox, vaccinia virus (VACV), is highly immunogenic yet causes relatively benign disease. These attributes are believed to be caused by gene loss in VACV. Using a targeted small interfering RNA (siRNA) screen, we identified a viral inhibitor found in cowpox virus (CPXV) and other orthopoxviruses that bound to the host SKP1-Cullin1-F-box (SCF) machinery and the essential necroptosis kinase receptor interacting protein kinase 3 (RIPK3). This "viral inducer of RIPK3 degradation'' (vIRD) triggered ubiquitination and proteasome-mediated degradation of RIPK3 and inhibited necroptosis. In contrast to orthopoxviruses, the distantly related leporipoxvirus myxoma virus (MYXV), which infects RIPK3-deficient hosts, lacks a functional vIRD. Introduction of vIRD into VACV, which encodes a truncated and defective vIRD, enhanced viral replication in mice. Deletion of vIRD reduced CPXV-induced inflammation, viral replication, and mortality, which were reversed in RIPK3- and MLKL-deficient mice. Hence, vIRD-RIPK3 drives pathogen-host evolution and regulates virus-induced inflammation and pathogenesis.	[Liu, Zhijun; Rector, Jonah; Chan, Francis Ka-Ming] Duke Univ, Dept Immunol, Sch Med, DUMC 3010, Durham, NC 27710 USA; [Nailwal, Himani; Sam, Richard; Chan, Francis Ka-Ming] Univ Massachusetts, Dept Pathol, Immunol & Microbiol Program, Med Sch, Worcester, MA 01655 USA; [Rahman, Masmudur M.; McFadden, Grant] Arizona State Univ, Ctr Immunotherapy Vaccines & Virotherapy, Biodesign Inst, Tempe, AZ 85281 USA; [Nailwal, Himani] Innovate Calgary, Calgary, AB T2L 1Y8, Canada; [Sam, Richard] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA	Duke University; University of Massachusetts System; University of Massachusetts Worcester; Arizona State University; Arizona State University-Tempe; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Chan, FKM (corresponding author), Duke Univ, Dept Immunol, Sch Med, DUMC 3010, Durham, NC 27710 USA.; Chan, FKM (corresponding author), Univ Massachusetts, Dept Pathol, Immunol & Microbiol Program, Med Sch, Worcester, MA 01655 USA.	franciskaming.chan@duke.edu	Chan, Francis Ka-Ming/E-9647-2014; Chan, Francis/ABB-1895-2021	Chan, Francis Ka-Ming/0000-0002-4803-8353; Sam, Richard/0000-0002-2107-0329; McFadden, Grant/0000-0002-2556-3526; Liu, Zhijun/0000-0003-1006-7893	National Institute of Allergy and Infectious Diseases (United States) [AI 128197, AI148302, R01 AI080607]	National Institute of Allergy and Infectious Diseases (United States)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Chan lab for discussion. This work was supported by National Institute of Allergy and Infectious Diseases (United States) grants AI 128197, AI148302 (F.C.), and R01 AI080607 (G.M.). We thank the Duke University School of Medicine for the use of the Microbiome Core Facility for help with NanoString data acquisition.	BLASCO R, 1995, GENE, V158, P157, DOI 10.1016/0378-1119(95)00149-Z; Bratke KA, 2013, INFECT GENET EVOL, V14, P406, DOI 10.1016/j.meegid.2012.12.002; CARPENTER EA, 1994, J IMMUNOL, V152, P2652; Chan FKM, 2003, J BIOL CHEM, V278, P51613, DOI 10.1074/jbc.M305633200; Chan FKM, 2015, ANNU REV IMMUNOL, V33, P79, DOI 10.1146/annurev-immunol-032414-112248; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Daniels BP, 2017, CELL, V169, P301, DOI 10.1016/j.cell.2017.03.011; Dondelinger Y, 2016, TRENDS CELL BIOL, V26, P721, DOI 10.1016/j.tcb.2016.06.004; Enchev RI, 2015, NAT REV MOL CELL BIO, V16, P30, DOI 10.1038/nrm3919; Guo HY, 2015, CELL HOST MICROBE, V17, P243, DOI 10.1016/j.chom.2015.01.003; Harte MT, 2003, J EXP MED, V197, P343, DOI 10.1084/jem.20021652; Huang Z, 2015, CELL HOST MICROBE, V17, P229, DOI 10.1016/j.chom.2015.01.002; Koehler H, 2017, P NATL ACAD SCI USA, V114, P11506, DOI 10.1073/pnas.1700999114; Lee EK, 2014, ONCOGENE, V33, P2011, DOI 10.1038/onc.2013.144; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li M, 2000, J VIROL, V74, P7470, DOI 10.1128/JVI.74.16.7470-7477.2000; Mocarski ES, 2015, VIROLOGY, V479, P160, DOI 10.1016/j.virol.2015.03.016; Mohamed MR, 2009, J VIROL, V83, P9223, DOI 10.1128/JVI.00861-09; Moriwaki K, 2017, INT REV CEL MOL BIO, V328, P253, DOI 10.1016/bs.ircmb.2016.08.007; Moriwaki K, 2017, CELL REP, V18, P2441, DOI 10.1016/j.celrep.2017.02.015; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Myskiw C, 2009, J VIROL, V83, P6757, DOI 10.1128/JVI.02570-08; Nailwal H, 2019, CELL DEATH DIFFER, V26, P4, DOI 10.1038/s41418-018-0172-x; Najjar M, 2016, IMMUNITY, V45, P46, DOI 10.1016/j.immuni.2016.06.007; Petrie EJ, 2019, CELL REP, V28, P3309, DOI 10.1016/j.celrep.2019.08.055; Polykratis A, 2014, J IMMUNOL, V193, P1539, DOI 10.4049/jimmunol.1400590; Sanchez-Sampedro L, 2015, VIRUSES-BASEL, V7, P1726, DOI 10.3390/v7041726; Satheshkumar PS, 2009, J VIROL, V83, P2469, DOI 10.1128/JVI.01986-08; Sumner RP, 2014, J VIROL, V88, P3092, DOI 10.1128/JVI.02627-13; Teale A, 2009, J VIROL, V83, P2099, DOI 10.1128/JVI.01753-08; Upton JW, 2014, MOL CELL, V54, P273, DOI 10.1016/j.molcel.2014.01.027; Upton JW, 2012, CELL HOST MICROBE, V11, P290, DOI [10.1016/j.chom.2019.09.004, 10.1016/j.chom.2012.01.016]; Upton JW, 2010, CELL HOST MICROBE, V7, P302, DOI 10.1016/j.chom.2010.03.006; WEIR JP, 1984, J VIROL, V51, P662, DOI 10.1128/JVI.51.3.662-669.1984; Yamasaki L, 2004, CURR OPIN CELL BIOL, V16, P623, DOI 10.1016/j.ceb.2004.08.005; Yu XL, 2016, J VIROL, V90, P1088, DOI 10.1128/JVI.02446-15	36	27	27	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					247	+		10.1016/j.immuni.2020.11.020	http://dx.doi.org/10.1016/j.immuni.2020.11.020		FEB 2021	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33444549	Green Accepted			2022-12-18	WOS:000627407700010
J	Turner, JA; Stephen-Victor, E; Wang, S; Rivas, MN; Abdel-Gadir, A; Harb, H; Cui, Y; Fanny, M; Charbonnier, LM; Fong, JJH; Benamar, M; Wang, L; Burton, OT; Bansal, K; Bry, L; Zhu, C; Li, QZ; Clement, RL; Oettgen, HC; Crestani, E; Rachid, R; Sage, PT; Chatila, TA				Turner, Jacob A.; Stephen-Victor, Emmanuel; Wang, Sen; Rivas, Magali Noval; Abdel-Gadir, Azza; Harb, Hani; Cui, Ye; Fanny, Manoussa; Charbonnier, Louis-Marie; Fong, Jason Jun Hung; Benamar, Mehdi; Wang, Leighanne; Burton, Oliver T.; Bansal, Kushagra; Bry, Lynn; Zhu, Chengsong; Li, Quan-Zhen; Clement, Rachel L.; Oettgen, Hans C.; Crestani, Elena; Rachid, Rima; Sage, Peter T.; Chatila, Talal A.			Regulatory T Cell-Derived TGF-beta 1 Controls Multiple Checkpoints Governing Allergy and Autoimmunity	IMMUNITY			English	Article							TGF-BETA; REG-CELLS; DENDRITIC CELLS; ORAL TOLERANCE; FOOD ALLERGY; INDUCTION; LEADS; DISRUPTION; SUSCEPTIBILITY; ACTIVATION	The mechanisms by which regulatory T (Treg) cells differentially control allergic and autoimmune responses remain unclear. We show that Treg cells in food allergy (FA) had decreased expression of transforming growth factor beta 1 (TGF-beta 1) because of interleukin-4 (IL-4)- and signal transducer and activator of transciription-6 (STATE)-dependent inhibition of Tgfb1 transcription. These changes were modeled by Treg cell-specific Tgfb1 monoallelic inactivation, which induced allergic dysregulation by impairing microbiota-dependent retinoic acid receptor-related orphan receptor gamma t (ROR-gamma t)(+) Treg cell differentiation. This dysregulation was rescued by treatment with Clostridiales species, which upregulated Tgfb1 expression in Treg cells. Biallelic deficiency precipitated fatal autoimmunity with intense autoantibody production and dysregulated T follicular helper and B cell responses. These results identify a privileged role of Treg cell-derived TGF-beta 1 in regulating allergy and autoimmunity at distinct checkpoints in a Tgfb1 gene dose- and microbiota-dependent manner.	[Turner, Jacob A.; Stephen-Victor, Emmanuel; Wang, Sen; Abdel-Gadir, Azza; Harb, Hani; Cui, Ye; Fanny, Manoussa; Charbonnier, Louis-Marie; Fong, Jason Jun Hung; Benamar, Mehdi; Wang, Leighanne; Oettgen, Hans C.; Crestani, Elena; Rachid, Rima; Chatila, Talal A.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Turner, Jacob A.; Stephen-Victor, Emmanuel; Wang, Sen; Abdel-Gadir, Azza; Harb, Hani; Cui, Ye; Fanny, Manoussa; Charbonnier, Louis-Marie; Fong, Jason Jun Hung; Benamar, Mehdi; Wang, Leighanne; Oettgen, Hans C.; Crestani, Elena; Rachid, Rima; Chatila, Talal A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Rivas, Magali Noval] Cedars Sinai Med Ctr, Infect & Immunol Dis Res Ctr IIDRC, Dept Biomed Sci, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA; [Burton, Oliver T.] Babraham Inst, Lab Lymphocyte Signaling & Dev, Cambridge CB22 3AT, Cambs, England; [Bansal, Kushagra] Jawaharlal Nehru Ctr Adv Sci Res, Mol Biol & Genet Unit, Bangalore 560064, Karnataka, India; [Bry, Lynn] Harvard Med Sch, Brigham & Womens Hosp, Massachusetts Host Microbiome Ctr, Dept Pathol, Boston, MA 02115 USA; [Zhu, Chengsong; Li, Quan-Zhen] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol & Internal Med, Dallas, TX 75390 USA; [Clement, Rachel L.; Sage, Peter T.] Harvard Med Sch, Brigham & Womens Hosp, Transplantat Res Ctr, Renal Div, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Cedars Sinai Medical Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Chatila, TA (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.; Chatila, TA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	talal.chatila@childrens.harvard.edu	Harb, Hani/HGB-7333-2022; Harb, Hani/J-6517-2019; Stephen Victor, Emmanuel/HDN-0252-2022	Harb, Hani/0000-0001-8218-2538; Harb, Hani/0000-0001-8218-2538; Stephen Victor, Emmanuel/0000-0001-5049-7017; Charbonnier, Louis-Marie/0000-0002-4594-7893; Benamar, Mehdi/0000-0003-1532-8642; Fong, Jason/0000-0001-6164-6110; Bry, Lynn/0000-0002-8792-8527; Clement, Rachel/0000-0003-1422-9140	NIH NIAID [5R01AI1269151, 5R01AI085090, 5R01AI119918]; NIDDK [P30DK056338, T32 AI007512]; Rao Chakravorti Family Fund; Bunning Foundation; DBT/Wellcome Trust India Alliance Intermediate Fellowship [IA/I/19/1/504276]	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Rao Chakravorti Family Fund; Bunning Foundation; DBT/Wellcome Trust India Alliance Intermediate Fellowship	This work was supported by NIH NIAID grants 5R01AI1269151 and 5R01AI085090 (to T.A.C.) and 5R01AI119918 (to H.C.O), NIDDK grants P30DK056338 (to L.B.) and T32 AI007512 (O.T.B.), the Rao Chakravorti Family Fund (to H.C.O.), the Bunning Foundation (to H.C.O. and T.C.), and DBT/Wellcome Trust India Alliance Intermediate Fellowship IA/I/19/1/504276 (to K.B.).	Abdel-Gadir A, 2018, CLIN EXP ALLERGY, V48, P825, DOI 10.1111/cea.13161; Abdel-Gadir A, 2019, NAT MED, V25, P1164, DOI 10.1038/s41591-019-0461-z; Al Nabhani Z, 2019, IMMUNITY, V50, P1276, DOI 10.1016/j.immuni.2019.02.014; Apostolou I, 2004, J EXP MED, V199, P1401, DOI 10.1084/jem.20040249; Azhar M, 2009, GENESIS, V47, P423, DOI 10.1002/dvg.20516; Bach JF, 2018, NAT REV IMMUNOL, V18, P105, DOI 10.1038/nri.2017.111; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Burton OT, 2013, MUCOSAL IMMUNOL, V6, P740, DOI 10.1038/mi.2012.112; Burton OT, 2014, IMMUNITY, V41, P141, DOI 10.1016/j.immuni.2014.05.017; Charbonnier LM, 2019, NAT IMMUNOL, V20, P1208, DOI 10.1038/s41590-019-0442-x; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Cuende J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1983; Edwards JP, 2016, EUR J IMMUNOL, V46, P1480, DOI 10.1002/eji.201546204; Esterhazy D, 2016, NAT IMMUNOL, V17, P545, DOI 10.1038/ni.3408; Gomez G, 2005, J IMMUNOL, V174, P5987, DOI 10.4049/jimmunol.174.10.5987; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; Grant CR, 2015, AUTOIMMUN REV, V14, P105, DOI 10.1016/j.autrev.2014.10.012; Grutzkau A, 2004, CYTOM PART A, V61A, P62, DOI 10.1002/cyto.a.20068; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Hall BE, 2010, LAB INVEST, V90, P543, DOI 10.1038/labinvest.2010.5; Harb H, 2015, INT ARCH ALLERGY IMM, V168, P173, DOI 10.1159/000442158; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Konkel JE, 2017, IMMUNITY, V46, P660, DOI 10.1016/j.immuni.2017.03.015; Kotlarz D, 2018, NAT GENET, V50, P344, DOI 10.1038/s41588-018-0063-6; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Lienart S, 2018, SCIENCE, V362, P952, DOI 10.1126/science.aau2909; Lin W, 2005, J ALLERGY CLIN IMMUN, V116, P1106, DOI 10.1016/j.jaci.2005.08.046; Mani V, 2019, SCIENCE, V366, P202, DOI 10.1126/science.aav5728; Marie JC, 2005, J EXP MED, V201, P1061, DOI 10.1084/jem.20042276; McCarron MJ, 2014, J CLIN INVEST, V124, P4375, DOI 10.1172/JCI76179; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; MURPHY KM, 1990, SCIENCE, V250, P1720, DOI 10.1126/science.2125367; Nasrallah R, 2020, NATURE, V583, P447, DOI 10.1038/s41586-020-2296-7; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Platts-Mills TAE, 2015, J ALLERGY CLIN IMMUN, V136, P3, DOI 10.1016/j.jaci.2015.03.048; Ramalingam R, 2012, J IMMUNOL, V189, P3878, DOI 10.4049/jimmunol.1201029; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rivas MN, 2016, J ALLERGY CLIN IMMUN, V138, P639, DOI 10.1016/j.jaci.2016.06.003; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Rivas MN, 2013, J ALLERGY CLIN IMMUN, V131, P201, DOI 10.1016/j.jaci.2012.10.026; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stephen-Victor E, 2020, IMMUNITY, V53, P277, DOI 10.1016/j.immuni.2020.07.025; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Tachdjian R, 2010, J ALLERGY CLIN IMMUN, V125, P1128, DOI 10.1016/j.jaci.2010.01.054; Tran DQ, 2009, P NATL ACAD SCI USA, V106, P13445, DOI 10.1073/pnas.0901944106; Travis MA, 2014, ANNU REV IMMUNOL, V32, P51, DOI 10.1146/annurev-immunol-032713-120257; Voehringer D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-69; Wu D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15876; Yeh HW, 2018, NAT CELL BIOL, V20, P479, DOI 10.1038/s41556-018-0062-y; Zhou XY, 2008, J EXP MED, V205, P1983, DOI 10.1084/jem.20080707	61	27	28	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1202	+		10.1016/j.immuni.2020.10.002	http://dx.doi.org/10.1016/j.immuni.2020.10.002			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33086036	Green Accepted, Bronze			2022-12-18	WOS:000599363300010
J	Madsen, A; Dai, YN; McMahon, M; Schmitz, AJ; Turner, JS; Tan, J; Lei, T; Alsoussi, WB; Strohmeier, S; Amor, M; Mohammed, BM; Mudd, PA; Simon, V; Cox, RJ; Fremont, DH; Krammer, F; Ellebedy, AH				Madsen, Anders; Dai, Ya-Nan; McMahon, Meagan; Schmitz, Aaron J.; Turner, Jackson S.; Tan, Jessica; Lei, Tingting; Alsoussi, Wafaa B.; Strohmeier, Shirin; Amor, Mostafa; Mohammed, Bassem M.; Mudd, Philip A.; Simon, Viviana; Cox, Rebecca J.; Fremont, Daved H.; Krammer, Florian; Ellebedy, Ali H.			Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective	IMMUNITY			English	Article							MONOCLONAL-ANTIBODIES; INFECTION; VACCINE; OSELTAMIVIR; VISUALIZATION; THERAPEUTICS; SIALIDASE; INSIGHTS; ANTIGEN; SYSTEM	Influenza B virus (IBV) infections can cause severe disease in children and the elderly. Commonly used antivirals have lower clinical effectiveness against IBV compared to influenza A viruses (IAV). Neuraminidase (NA), the second major surface protein on the influenza virus, is emerging as a target of broadly protective antibodies that recognize the NA active site of lAVs. However, similarly broadly protective antibodies against IBV NA have not been identified. Here, we isolated and characterized human monoclonal antibodies (mAbs) that target IBV NA from an IBV-infected patient. Two mAbs displayed broad and potent capacity to inhibit IBV NA enzymatic activity, neutralize the virus in vitro, and protect against lethal IBV infection in mice in prophylactic and therapeutic settings. These mAbs inserted long CDR-H3 loops into the NA active site, engaging residues highly conserved among IBV NAs. These mAbs provide a blueprint for the development of improved vaccines and therapeutics against IBVs.	[Madsen, Anders; Cox, Rebecca J.] Univ Bergen, Dept Clin Sci, Influenza Ctr, N-5021 Bergen, Norway; [Dai, Ya-Nan; Schmitz, Aaron J.; Turner, Jackson S.; Lei, Tingting; Alsoussi, Wafaa B.; Amor, Mostafa; Mohammed, Bassem M.; Fremont, Daved H.; Ellebedy, Ali H.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [McMahon, Meagan; Tan, Jessica; Strohmeier, Shirin; Simon, Viviana; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Mudd, Philip A.] Washington Univ, Sch Med, Dept Internal Med, Div Emergency Med, St Louis, MO 63110 USA; [Cox, Rebecca J.] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway; [Fremont, Daved H.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Fremont, Daved H.; Ellebedy, Ali H.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Fremont, Daved H.; Ellebedy, Ali H.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA	University of Bergen; Washington University (WUSTL); Icahn School of Medicine at Mount Sinai; Washington University (WUSTL); University of Bergen; Haukeland University Hospital; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Fremont, DH; Ellebedy, AH (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.; Fremont, DH (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.; Fremont, DH; Ellebedy, AH (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Fremont, DH; Ellebedy, AH (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO 63110 USA.	fremont@wustl.edu; florian.krammer@mssm.edu; ellebedy@wustl.edu	simon, viviana/A-9131-2008; Krammer, Florian/H-3237-2019	simon, viviana/0000-0002-6416-5096; Krammer, Florian/0000-0003-4121-776X; Tan, Jessica/0000-0001-8269-5560; Dai, Yanan/0000-0003-1618-3043; Fremont, Daved/0000-0002-8544-2689; Madsen, Anders/0000-0002-0626-5443; Schmitz, Aaron/0000-0002-8077-6751	NIAID [R21 AI139813, U01 AI141990, R01 AI117287, 5T32CA009547]; NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS) [HHSN272201400006C]; NIAID CEIRS [HHSN272201400008C]; NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC) [75N93019C00051]; NIAID (CSGID) [HHSN272201700060C]; Ministry of Health and Care Services, Norway; Norwegian Research Council Globvac [284930]; National Graduate School in Infection Biology and Antimicrobials (IBA) [249062]; European Union [EU IMI115672]; K.G. Jebsen Centre for Influenza Vaccine Research; Washington University Institute of Clinical and Translational Sciences - NIH/National Center for Advancing Translational Sciences (NCATS, CTSA grant) [UL1TR002345]; Norway-America Association (NORAM); National Graduate School in Infection Biology and Antimicrobials (IBA); NIH Clinical and Translational Science Award [UL1 TR002345]; EU Nanomedicines Flunanoair (ERA-NETet EuroNanoMed2, JTC2016)	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS); NIAID CEIRS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC); NIAID (CSGID); Ministry of Health and Care Services, Norway; Norwegian Research Council Globvac(Research Council of Norway); National Graduate School in Infection Biology and Antimicrobials (IBA); European Union(European Commission); K.G. Jebsen Centre for Influenza Vaccine Research; Washington University Institute of Clinical and Translational Sciences - NIH/National Center for Advancing Translational Sciences (NCATS, CTSA grant); Norway-America Association (NORAM); National Graduate School in Infection Biology and Antimicrobials (IBA); NIH Clinical and Translational Science Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU Nanomedicines Flunanoair (ERA-NETet EuroNanoMed2, JTC2016)	We would like to thank S. House and the clinical sample collection team in the Washington University Emergency Care and Research Core. We thank J. Fitzpatrick and M. Rau of the Washington University Center for Cellular Imaging for assistance with cryo-EM data collection. The EDFLU study was reviewed and approved by the Washington University Institutional Review Board (approval no. 2017-10-220). Work in the Ellebedy laboratory was supported by NIAID R21 AI139813, U01 AI141990, and NIAID Centers of Excellence for Influenza Research and Surveillance (CEIRS, contract HHSN272201400006C). The Krammer laboratory was supported by NIAID (grant R01 AI117287), NIAID CEIRS (contract HHSN272201400008C), and NIAID Collaborative Influenza Vaccine Innovation Centers (CIVIC, contract 75N93019C00051). Work in the Fremont lab was supported by NIAID (CSGID, contract HHSN272201700060C). The Influenza Centre is funded by the Ministry of Health and Care Services, Norway, the Norwegian Research Council Globvac (284930), National Graduate School in Infection Biology and Antimicrobials (IBA, 249062), the European Union (EU IMI115672, FLUCOP), EU Nanomedicines Flunanoair (ERA-NETet EuroNanoMed2, JTC2016), and the K.G. Jebsen Centre for Influenza Vaccine Research. Human sample collection was supported by a grant from the Washington University Institute of Clinical and Translational Sciences to P.A.M., which is, in part, supported by the NIH/National Center for Advancing Translational Sciences (NCATS, CTSA grant UL1TR002345). A.M. received funding for this work from the Norway-America Association (NORAM) and the National Graduate School in Infection Biology and Antimicrobials (IBA). J.S.T. was supported by NIAID 5T32CA009547. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of NIAID or NIH. The manuscript was edited by the Scientific Editing Service of the Institute of Clinical and Translational Sciences at Washington University, which is supported by an NIH Clinical and Translational Science Award (UL1 TR002345).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; BURMEISTER WP, 1993, STRUCTURE, V1, P19, DOI 10.1016/0969-2126(93)90005-2; Burnham AJ, 2013, ANTIVIR RES, V100, P520, DOI 10.1016/j.antiviral.2013.08.023; Chen SX, 2013, ULTRAMICROSCOPY, V135, P24, DOI 10.1016/j.ultramic.2013.06.004; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YQ, 2018, CELL, V173, P417, DOI 10.1016/j.cell.2018.03.030; CHONG AKJ, 1992, EUR J BIOCHEM, V207, P335, DOI 10.1111/j.1432-1033.1992.tb17055.x; Crowe JE, 2017, CELL HOST MICROBE, V22, P193, DOI 10.1016/j.chom.2017.07.013; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Eichelberger MC, 2018, CURR OPIN IMMUNOL, V53, P38, DOI 10.1016/j.coi.2018.03.025; Ellebedy AH, 2009, VACCINE, V27, pD65, DOI 10.1016/j.vaccine.2009.08.038; Ellebedy AH, 2020, P NATL ACAD SCI USA, V117, P17957, DOI 10.1073/pnas.1906613117; Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533; Ellebedy AH, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00053; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erbelding EJ, 2018, J INFECT DIS, V218, P347, DOI 10.1093/infdis/jiy103; Gilchuk IM, 2019, CELL HOST MICROBE, V26, P715, DOI 10.1016/j.chom.2019.10.003; Giudicelli V., 2011, COLD SPRING HARB PRO, V2011, P695, DOI DOI 10.1101/PDB.PR0T5633; Glezen WP, 2013, AM J PUBLIC HEALTH, V103, pE43, DOI 10.2105/AJPH.2012.301137; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Govorkova EA, 2013, CURR TOP MICROBIOL, V370, P273, DOI 10.1007/82_2011_198; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Ho IY, 2016, J IMMUNOL METHODS, V438, P67, DOI 10.1016/j.jim.2016.09.001; Ison MG, 2006, J INFECT DIS, V193, P760, DOI 10.1086/500465; Kawai N, 2006, CLIN INFECT DIS, V43, P439, DOI 10.1086/505868; Krammer F, 2019, NAT REV IMMUNOL, V19, P383, DOI 10.1038/s41577-019-0143-6; Krammer F, 2018, MBIO, V9, DOI 10.1128/mBio.02332-17; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Langat Pinky, 2017, PLoS Pathog, V13, pe1006749, DOI 10.1371/journal.ppat.1006749; LENTZ MR, 1987, BIOCHEMISTRY-US, V26, P5351, DOI 10.1021/bi00391a020; Margine I, 2013, JOVE-J VIS EXP, DOI 10.3791/51112; McMahon M, 2019, MBIO, V10, DOI 10.1128/mBio.00560-19; Mishin VP, 2019, EMERG INFECT DIS, V25, P1969, DOI 10.3201/eid2510.190607; Murin CD, 2019, NAT MICROBIOL, V4, P734, DOI 10.1038/s41564-019-0392-y; Paules CI, 2018, NEW ENGL J MED, V378, P7, DOI 10.1056/NEJMp1714916; Paules CI, 2017, IMMUNITY, V47, P599, DOI 10.1016/j.immuni.2017.09.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piepenbrink MS, 2019, MBIO, V10, DOI 10.1128/mBio.00066-19; ROTA PA, 1990, VIROLOGY, V175, P59, DOI 10.1016/0042-6822(90)90186-U; Sato M, 2008, TOHOKU J EXP MED, V214, P113, DOI 10.1620/tjem.214.113; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Stadlbauer D, 2019, SCIENCE, V366, P499, DOI 10.1126/science.aay0678; Stadlbauer D, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0115-0; Sugaya N, 2007, CLIN INFECT DIS, V44, P197, DOI 10.1086/509925; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan J, 2018, CURR OPIN IMMUNOL, V53, P45, DOI 10.1016/j.coi.2018.04.002; TAYLOR NR, 1994, J MED CHEM, V37, P616, DOI 10.1021/jm00031a011; Virk RK, 2020, P NATL ACAD SCI USA, V117, P619, DOI 10.1073/pnas.1916585116; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Wilson PC, 2012, NAT REV IMMUNOL, V12, P709, DOI 10.1038/nri3285; Wohlbold TJ, 2017, NAT MICROBIOL, V2, P1415, DOI 10.1038/s41564-017-0011-8; Wohlbold TJ, 2015, MBIO, V6, DOI 10.1128/mBio.02556-14; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Wu NC, 2018, NAT STRUCT MOL BIOL, V25, P115, DOI 10.1038/s41594-018-0025-9; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhu XY, 2019, CELL HOST MICROBE, V26, P729, DOI 10.1016/j.chom.2019.10.002; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	62	27	27	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					852	+		10.1016/j.immuni.2020.08.015	http://dx.doi.org/10.1016/j.immuni.2020.08.015			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	32976769	Green Accepted, Bronze			2022-12-18	WOS:000581062800016
J	Beguier, F; Housset, M; Roubeix, C; Augustin, S; Zagar, Y; Nous, C; Mathis, T; Eandi, C; Benchaboune, M; Drame-Maigne, A; Carpentier, W; Chardonnet, S; Touhami, S; Blot, G; Conart, JB; Charles-Messance, H; Potey, A; Girmens, JF; Paques, M; Blond, F; Leveillard, T; Koertvely, E; Roger, JE; Sahel, JA; Sapieha, P; Delarasse, C; Guillonneau, X; Sennlaub, F				Beguier, Fanny; Housset, Michael; Roubeix, Christophe; Augustin, Sebastien; Zagar, Yvrick; Nous, Caroline; Mathis, Thibaud; Eandi, Chiara; Benchaboune, Mustapha; Drame-Maigne, Adele; Carpentier, Wassila; Chardonnet, Solenne; Touhami, Sara; Blot, Guillaume; Conart, Jean Baptiste; Charles-Messance, Hugo; Potey, Anais; Girmens, Jean-Francois; Paques, Michel; Blond, Frederic; Leveillard, Thierry; Koertvely, Elod; Roger, Jerome E.; Sahel, Jose-Alain; Sapieha, Przemyslaw; Delarasse, Cecile; Guillonneau, Xavier; Sennlaub, Florian			The 10q26 Risk Haplotype of Age-Related Macular Degeneration Aggravates Subretinal Inflammation by Impairing Monocyte Elimination	IMMUNITY			English	Article							SERINE-PROTEASE HTRA1; RETINAL-PIGMENT EPITHELIUM; COMPLEMENT FACTOR-H; CHOROIDAL NEOVASCULARIZATION; CHROMOSOME 10Q26; UP-REGULATION; EXPRESSION; GENE; THROMBOSPONDIN-1; OSTEOPONTIN	A minor haplotype of the 10q26 locus conveys the strongest genetic risk for age-related macular degeneration (AMD). Here, we examined the mechanisms underlying this susceptibility. We found that monocytes from homozygous carriers of the 10q26 AMD-risk haplotype expressed high amounts of the serine peptidase HTRA1, and HTRA1 located to mononuclear phagocytes (MPs) in eyes of non-carriers with AMD. HTRA1 induced the persistence of monocytes in the subretinal space and exacerbated pathogenic inflammation by hydrolyzing thrombospondin 1 (TSP1), which separated the two CD47-binding sites within TSP1 that are necessary for efficient CD47 activation. This HTRA1-induced inhibition of CD47 signaling induced the expression of pro-inflammatory osteopontin (OPN). OPN expression increased in early monocyte-derived macrophages in 10q26 risk carriers. In models of subretinal inflammation and AMD, OPN deletion or pharmacological inhibition reversed HTRA1-induced pathogenic MP persistence. Our findings argue for the therapeutic potential of CD47 agonists and OPN inhibitors for the treatment of AMD.	[Beguier, Fanny; Housset, Michael; Roubeix, Christophe; Augustin, Sebastien; Zagar, Yvrick; Nous, Caroline; Mathis, Thibaud; Drame-Maigne, Adele; Carpentier, Wassila; Touhami, Sara; Blot, Guillaume; Conart, Jean Baptiste; Charles-Messance, Hugo; Potey, Anais; Blond, Frederic; Leveillard, Thierry; Sahel, Jose-Alain; Delarasse, Cecile; Guillonneau, Xavier; Sennlaub, Florian] Sorbonne Univ, CNRS, Inst Vis, INSERM, 17 Rue Moreau, F-75012 Paris, France; [Chardonnet, Solenne] Sorbonne Univ, INSERM, Plateforme Postgen Pitie Salpetriere, P3S,UMS 37 PASS, F-75013 Paris, France; [Eandi, Chiara] Univ Torino, Dept Surg Sci, Turin, Italy; [Roger, Jerome E.] Univ Paris Saclay, CERTO Retina France, Univ Paris Sud, Paris Saclay Inst Neurosci,CNRS, F-91405 Orsay, France; [Benchaboune, Mustapha; Girmens, Jean-Francois; Paques, Michel; Sahel, Jose-Alain] INSERM, CHNO Quinze Vingts, DHU Sight Restore, DGOS,CIC 1423, 28 Rue Charenton, F-75012 Paris, France; [Koertvely, Elod] Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, 124 Grenzacherstr, CH-4070 Basel, Switzerland; [Sapieha, Przemyslaw] Univ Montreal, Dept Ophthalmol, Maisonneuve Rosemont Hosp, Res Ctr, Quebec City, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Turin; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Roche Holding; Universite de Montreal	Sennlaub, F (corresponding author), Sorbonne Univ, CNRS, Inst Vis, INSERM, 17 Rue Moreau, F-75012 Paris, France.	florian.sennlaub@inserm.fr	roger, jerome/P-3670-2019; Blot, Guillaume/AAK-5849-2021; Delarasse, Cecile/K-8234-2017; Mathis, Thibaud/AAK-5745-2021; Léveillard, Thierry/AAR-1804-2020; Sennlaub, Florian/F-2756-2017; guillonneau, xavier/AAF-9495-2021; Guillonneau, xavier/E-3995-2017; Beguier, Fanny/AAY-8581-2020; Touhami, Sara/AAF-7836-2021	roger, jerome/0000-0002-5061-230X; Blot, Guillaume/0000-0002-8955-6704; Delarasse, Cecile/0000-0001-9739-4306; Léveillard, Thierry/0000-0001-5692-8770; Sennlaub, Florian/0000-0003-4412-1341; guillonneau, xavier/0000-0001-7379-3935; Guillonneau, xavier/0000-0001-7379-3935; Beguier, Fanny/0000-0002-6123-2978; Blond, Frederic/0000-0002-2314-0570; Housset, Michael/0000-0002-3892-5696; CHARLES-MESSANCE, Hugo/0000-0002-6627-2098	Institut National de la Sante et de la Recherche Medicale (INSERM, France); Agence Nationale de la Recherche (ANR, France): ANR Geno 2009 [R09099DS]; ANR MA-CLEAR [ANR-15-CE14-0015-01]; Programme Investissements d'Avenir LABEX LIFESENSES [ANR-10-LABX-65]; Carnot Institute (France); IHU FOReSIGHT (France) [ANR-18-IAHU-0001]	Institut National de la Sante et de la Recherche Medicale (INSERM, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale de la Recherche (ANR, France): ANR Geno 2009(French National Research Agency (ANR)); ANR MA-CLEAR(French National Research Agency (ANR)); Programme Investissements d'Avenir LABEX LIFESENSES(French National Research Agency (ANR)); Carnot Institute (France); IHU FOReSIGHT (France)	This work was supported by grants from Institut National de la Sante et de la Recherche Medicale (INSERM, France) and grants from the Agence Nationale de la Recherche (ANR, France): ANR Geno 2009 (R09099DS) and ANR MACLEAR (ANR-15-CE14-0015-01). The work was supported by the Programme Investissements d'Avenir LABEX LIFESENSES [ANR-10-LABX-65] and IHU FOReSIGHT [ANR-18-IAHU-0001] (France), the Carnot Institute (France), and a generous donation by Doris and Michael Bunte.	An E, 2010, INVEST OPHTH VIS SCI, V51, P3379, DOI 10.1167/iovs.09-4853; Bruemmer D, 2003, J CLIN INVEST, V112, P1318, DOI 10.1172/JCI200318141; Calippe B, 2017, IMMUNITY, V46, P261, DOI 10.1016/j.immuni.2017.01.006; Chamberland A, 2009, J BIOL CHEM, V284, P27352, DOI 10.1074/jbc.M109.037051; Chen CY, 2018, MATRIX BIOL, V70, P84, DOI 10.1016/j.matbio.2018.03.013; Chen W, 2009, EXP EYE RES, V89, P292, DOI 10.1016/j.exer.2008.10.017; Chowers I, 2008, MOL VIS, V14, P2263; Clausen T, 2011, NAT REV MOL CELL BIO, V12, P152, DOI 10.1038/nrm3065; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eigenbrot C, 2012, STRUCTURE, V20, P1040, DOI 10.1016/j.str.2012.03.021; Fritsche LG, 2014, ANNU REV GENOM HUM G, V15, P151, DOI 10.1146/annurev-genom-090413-025610; Fritsche LG, 2013, NAT GENET, V45, P433, DOI 10.1038/ng.2578; Fujita N, 2011, INVEST OPHTH VIS SCI, V52, P9310, DOI 10.1167/iovs.10-7050; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Guillonneau X, 2017, PROG RETIN EYE RES, V61, P98, DOI 10.1016/j.preteyeres.2017.06.002; Hou YZ, 2014, J IMMUNOL, V193, P130, DOI 10.4049/jimmunol.1302700; Hu SJ, 2015, J NEUROSCI, V35, P6987, DOI 10.1523/JNEUROSCI.3955-14.2015; Hume DA, 2012, BLOOD, V119, P1810, DOI 10.1182/blood-2011-09-379214; Iejima Daisuke, 2015, J Stem Cells, V10, P193; Isenberg JS, 2009, J BIOL CHEM, V284, P1116, DOI 10.1074/jbc.M804860200; Jones A, 2011, P NATL ACAD SCI USA, V108, P14578, DOI 10.1073/pnas.1102853108; Kanda A, 2010, MOL VIS, V16, P1317; Lavalette S, 2011, AM J PATHOL, V178, P2416, DOI 10.1016/j.ajpath.2011.01.013; Lenzo JC, 2012, IMMUNOL CELL BIOL, V90, P429, DOI 10.1038/icb.2011.58; Levy O, 2015, EMBO MOL MED, V7, P211, DOI 10.15252/emmm.201404524; Liao SM, 2017, MOL VIS, V23, P318; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lin MK, 2018, AGING CELL, V17, DOI 10.1111/acel.12710; Liu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0050719, 10.1371/journal.pone.0064143, 10.1371/journal.pone.0057473]; Lorenzi M, 2016, EXP GERONTOL, V81, P8, DOI 10.1016/j.exger.2016.03.019; Luhmann UFO, 2009, INVEST OPHTH VIS SCI, V50, P5934, DOI 10.1167/iovs.09-3462; Lund SA, 2009, J CELL COMMUN SIGNAL, V3, P311, DOI 10.1007/s12079-009-0068-0; Manna PP, 2005, J BIOL CHEM, V280, P29637, DOI 10.1074/jbc.M500922200; Martinez-Torres AC, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001796; Mathis T, 2017, AGING CELL, V16, P173, DOI 10.1111/acel.12540; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McDonald JF, 2003, BIOCHEMISTRY-US, V42, P10001, DOI 10.1021/bi0341408; Micklisch S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0776-3; Milner JM, 2008, ARTHRITIS RHEUM-US, V58, P3644, DOI 10.1002/art.24046; Newman AM, 2012, GENOME MED, V4, DOI [10.1186/PREACCEPT-1418491035586234, 10.1186/gm315]; Ng TF, 2009, INVEST OPHTH VIS SCI, V50, P5472, DOI 10.1167/iovs.08-2877; O'Koren EG, 2019, IMMUNITY, V50, P723, DOI 10.1016/j.immuni.2019.02.007; Oura Y, 2018, AM J PATHOL, V188, P2729, DOI 10.1016/j.ajpath.2018.08.012; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Quesada AJ, 2005, CELL DEATH DIFFER, V12, P649, DOI 10.1038/sj.cdd.4401615; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Robbie SJ, 2016, NEUROBIOL AGING, V40, P110, DOI 10.1016/j.neurobiolaging.2015.12.019; Sakurai E, 2003, INVEST OPHTH VIS SCI, V44, P3578, DOI 10.1167/iovs.03-0097; SARKS SH, 1976, BRIT J OPHTHALMOL, V60, P324, DOI 10.1136/bjo.60.5.324; Sennlaub F, 2013, EMBO MOL MED, V5, P1775, DOI 10.1002/emmm.201302692; Shi YY, 2011, GRAEF ARCH CLIN EXP, V249, P1667, DOI 10.1007/s00417-011-1699-4; Spugnini EP, 2006, CLIN CANCER RES, V12, P6133, DOI 10.1158/1078-0432.CCR-06-1056; Streilein JW, 2002, VISION RES, V42, P487, DOI 10.1016/S0042-6989(01)00185-7; Tosi GM, 2017, INVEST OPHTH VIS SCI, V58, P162, DOI 10.1167/iovs.16-20922; Truebestein L, 2011, NAT STRUCT MOL BIOL, V18, P386, DOI 10.1038/nsmb.2013; Tsutsumi C, 2003, J LEUKOCYTE BIOL, V74, P25, DOI 10.1189/jlb.0902436; van de Garde MDB, 2014, J IMMUNOL, V192, P1196, DOI 10.4049/jimmunol.1302138; Wang SJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P615, DOI 10.1001/archopthalmol.2011.1892; Wang XL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10124-4; Wong WL, 2014, LANCET GLOB HEALTH, V2, pE106, DOI 10.1016/S2214-109X(13)70145-1; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yehualaeshet T, 1999, AM J PATHOL, V155, P841, DOI 10.1016/S0002-9440(10)65183-8	62	27	27	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					429	+		10.1016/j.immuni.2020.07.021	http://dx.doi.org/10.1016/j.immuni.2020.07.021			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32814029	Green Submitted, Bronze			2022-12-18	WOS:000561190600019
J	Jackson-Jones, LH; Smith, P; Portman, JR; Magalhaes, MS; Mylonas, KJ; Vermeren, MM; Nixon, M; Henderson, BEP; Dobie, R; Vermeren, S; Denby, L; Henderson, NC; Mole, DJ; Benezech, C				Jackson-Jones, Lucy Helen; Smith, Peter; Portman, Jordan Raymond; Magalhaes, Marlene Sophie; Mylonas, Katie Jude; Vermeren, Matthieu Marie; Nixon, Mark; Henderson, Beth Emily Pollot; Dobie, Ross; Vermeren, Sonja; Denby, Laura; Henderson, Neil Cowan; Mole, Damian James; Benezech, Cecile			Stromal Cells Covering Omental Fat-Associated Lymphoid Clusters Trigger Formation of Neutrophil Aggregates to Capture Peritoneal Contaminants	IMMUNITY			English	Article							MILKY SPOTS; MYELOPEROXIDASE; ELASTASE; PROTEIN	The omentum is a visceral adipose tissue rich in fat-associated lymphoid clusters (FALCs) that collects peritoneal contaminants and provides a first layer of immunological defense within the abdomen. Here, we investigated the mechanisms that mediate the capture of peritoneal contaminants during peritonitis. Single-cell RNA sequencing and spatial analysis of omental stromal cells revealed that the surface of FALCs were covered by CXCL1(+) mesothelial cells, which we termed FALC cover cells. Blockade of CXCL1 inhibited the recruitment and aggregation of neutrophils at FALCs during zymosan-induced peritonitis. Inhibition of protein arginine deiminase 4, an enzyme important for the release of neutrophil extracellular traps, abolished neutrophil aggregation and the capture of peritoneal contaminants by omental FALCs. Analysis of omental samples from patients with acute appendicitis confirmed neutrophil recruitment and bacterial capture at FALCs. Thus, specialized omental mesothelial cells coordinate the recruitment and aggregation of neutrophils to capture peritoneal contaminants.	[Jackson-Jones, Lucy Helen; Smith, Peter; Magalhaes, Marlene Sophie; Mylonas, Katie Jude; Nixon, Mark; Denby, Laura; Benezech, Cecile] Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland; [Jackson-Jones, Lucy Helen] Univ Lancaster, Div Biomed & Life Sci, Lancaster LA1 4YQ, England; [Portman, Jordan Raymond; Mylonas, Katie Jude; Henderson, Beth Emily Pollot; Dobie, Ross; Vermeren, Sonja; Henderson, Neil Cowan; Mole, Damian James] Univ Edinburgh, Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland; [Vermeren, Matthieu Marie] Univ Edinburgh, Ctr Regenerat Med, Edinburgh EH16 4TJ, Midlothian, Scotland; [Henderson, Neil Cowan] Univ Edinburgh, Inst Genet & Mol Med, MRC Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh; Lancaster University; University of Edinburgh; University of Edinburgh; University of Edinburgh	Jackson-Jones, LH; Benezech, C (corresponding author), Univ Edinburgh, Ctr Cardiovasc Sci, Edinburgh EH16 4TJ, Midlothian, Scotland.; Jackson-Jones, LH (corresponding author), Univ Lancaster, Div Biomed & Life Sci, Lancaster LA1 4YQ, England.	l.jackson-jones@lancaster.ac.uk; cbenezec@ed.ac.uk	Vermeren, Sonja/AAK-7442-2020; Denby, Laura/AAO-9765-2020; Nixon, Mark/R-3757-2018	Vermeren, Sonja/0000-0002-8460-0884; Denby, Laura/0000-0003-1277-708X; Nixon, Mark/0000-0001-5437-3724; Magalhaes Pinto, Marlene Sophie/0000-0002-1656-8747; Jackson-Jones, Lucy/0000-0003-0608-8966; Vermeren, Matthieu/0000-0003-3584-0387	QMRI flow-cytometry and cellsorting facility; CALM facility; CRM-Imaging, University of Edinburgh; Medical Research Council (MRC) UK grant [MR/M011542/1, MR/S008020/1]; British Heart Foundation Centre for Research Excellence award III [RE/18/5/34216]; Wellcome Trust Seed award in Science [213697/Z/18/Z]; MRC UK Senior Clinical Fellowship [MR/P008887/1]; Wellcome Trust Senior Research Fellowship in Clinical Science [103749]; MRC [MR/S008020/1, MR/P008887/1, MR/M011542/1] Funding Source: UKRI	QMRI flow-cytometry and cellsorting facility; CALM facility; CRM-Imaging, University of Edinburgh; Medical Research Council (MRC) UK grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation Centre for Research Excellence award III; Wellcome Trust Seed award in Science(Wellcome Trust); MRC UK Senior Clinical Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Senior Research Fellowship in Clinical Science(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to the Edinburgh Emergency Surgery Study Group, Royal Infirmary of Edinburgh, NHS Lothian: Graeme Couper, Christopher Deans, Gavin G.P. Browning, Anna M Paisley, Bruce Tulloh, Richard J.E. Skipworth, Simon Paterson-Brown, Rajan Ravindran, Andrew de Beaux, Stuart McKechnie, Andrew Healey, Dimitri Damaskos, Marina Garcia, and all Royal Infirmary surgical trainees for facilitating intraoperative sample collection. We thank the Wellcome Trust Clinical Research Facility, NHS Lothian, especially Beena Poulose, for clinical study support. Flow cytometry and confocal microscopy data were generated with support from the QMRI flow-cytometry and cellsorting facility, the CALM facility, and CRM-Imaging, University of Edinburgh. Stephen Mitchell provided assistance with SEM. Nadin Fathallah provided technical assistance. We thank Central Bioresearch Services, especially Gidona Goodman, Chris Flockhart, and Will Mungall for their technical support; and D. Leach (University of Edinburgh) for the RecA-mCherry E. coli. The graphical abstract was compiled using images from Servier Medical Art. This work was supported by a Medical Research Council (MRC) UK grant to C.B. (MR/M011542/1) and S.V. (MR/S008020/1), a British Heart Foundation Centre for Research Excellence award III (RE/18/5/34216), and a Wellcome Trust Seed award in Science to L.H.J.-J. (213697/Z/18/Z). D.J.M. was funded by an MRC UK Senior Clinical Fellowship (MR/P008887/1) and N.C.H. was supported by a Wellcome Trust Senior Research Fellowship in Clinical Science (ref. 103749).	Amarh V, 2018, J CELL BIOL, V217, P2299, DOI 10.1083/jcb.201803020; Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Belaaouaj A, 1998, NAT MED, V4, P615, DOI 10.1038/nm0598-615; Benezech C, 2015, NAT IMMUNOL, V16, P819, DOI 10.1038/ni.3215; Biondo C, 2014, INFECT IMMUN, V82, P4508, DOI 10.1128/IAI.02104-14; Blighe K., 2019, R PACKAGE VERSION 1; Boeltz S, 2019, CELL DEATH DIFFER, V26, P395, DOI 10.1038/s41418-018-0261-x; Buechler MB, 2019, IMMUNITY, V51, P119, DOI 10.1016/j.immuni.2019.05.010; Buscher K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10828; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Croft AP, 2019, NATURE, V570, P246, DOI 10.1038/s41586-019-1263-7; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Cruz-Migoni S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00612; Dickinson GK, 1906, ANN SURG, V44, P652, DOI 10.1097/00000658-190611000-00002; DOHERTY NS, 1995, INFLAMM RES, V44, P169, DOI 10.1007/BF01782815; Gray KS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043196; HODEL C, 1970, EUR SURG RES, V2, P435, DOI 10.1159/000127543; Huang HY, 2018, P NATL ACAD SCI USA, V115, pE6826, DOI 10.1073/pnas.1712628115; Jackson-Jones LH, 2018, CURR OPIN IMMUNOL, V50, P9, DOI 10.1016/j.coi.2017.10.006; Jackson-Jones LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12651; Jin LL, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006637; Kiselev VY, 2018, NAT METHODS, V15, P359, DOI 10.1038/nmeth.4644; Koga S, 2018, J EXP MED, V215, P1609, DOI 10.1084/jem.20172310; Konig MF, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00461; Lee W, 2019, J EXP MED, V216, P176, DOI 10.1084/jem.20181170; Leppkes M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10973; Lewis HD, 2015, NAT CHEM BIOL, V11, P189, DOI 10.1038/nchembio.1735; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Mahlakoiv T, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax0416; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Martinod K, 2015, BLOOD, V125, P1948, DOI 10.1182/blood-2014-07-587709; Metzler KD, 2011, BLOOD, V117, P953, DOI 10.1182/blood-2010-06-290171; Meza-Perez S, 2017, TRENDS IMMUNOL, V38, P526, DOI 10.1016/j.it.2017.03.002; MIRONOV VA, 1979, CELL TISSUE RES, V201, P327; Morison R, 1906, Br Med J, V1, P76; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Munoz LE, 2019, IMMUNITY, V51, P443, DOI 10.1016/j.immuni.2019.07.002; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Perez-Shibayama C, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar4539; Platell C, 2000, WORLD J GASTROENTERO, V6, P169; Preibisch S, 2009, BIOINFORMATICS, V25, P1463, DOI 10.1093/bioinformatics/btp184; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Schauer C, 2014, NAT MED, V20, P511, DOI 10.1038/nm.3547; Spallanzani RG, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw3658; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Zhang N, 2019, J EXP MED, V216, P1291, DOI 10.1084/jem.20182024; Zhu AQ, 2019, BIOINFORMATICS, V35, P2084, DOI 10.1093/bioinformatics/bty895	51	27	27	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 14	2020	52	4					700	+		10.1016/j.immuni.2020.03.011	http://dx.doi.org/10.1016/j.immuni.2020.03.011			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LE5TM	32294409	Green Published, hybrid, Green Accepted			2022-12-18	WOS:000526782600013
J	Maher, J; Wilkie, S; Davies, DM; Arif, S; Picco, G; Julien, S; Foster, J; Burchell, J; Taylor-Papadimitriou, J				Maher, John; Wilkie, Scott; Davies, David M.; Arif, Sefina; Picco, Gianfranco; Julien, Sylvain; Foster, Julie; Burchell, Joy; Taylor-Papadimitriou, Joyce			Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells	IMMUNITY			English	Letter							CHIMERIC ANTIGEN RECEPTOR; CANCER		[Maher, John; Wilkie, Scott; Davies, David M.; Picco, Gianfranco; Burchell, Joy; Taylor-Papadimitriou, Joyce] Kings Coll London, Guys Hosp, Div Canc Studies, London SE1 9RT, England; [Maher, John] Kings Coll Hosp NHS Fdn Trust, Dept Clin Immunol & Allergy, Denmark Hill, London SE5 9RS, England; [Maher, John] Eastbourne Hosp, Dept Immunol, Kings Dr, Eastbourne BN21 2UD, E Sussex, England; [Arif, Sefina] Kings Coll London, Dept Immunobiol, London SE1 9RT, England; [Julien, Sylvain] Univ Lille, F-59650 Villeneuve Dascq, France; [Foster, Julie] Queen Mary Univ London, Barts Canc Inst, London EC1M 6BQ, England	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; University of London; King's College London; Universite de Lille - ISITE; Universite de Lille; University of London; Queen Mary University London	Maher, J (corresponding author), Kings Coll London, Guys Hosp, Div Canc Studies, London SE1 9RT, England.; Maher, J (corresponding author), Kings Coll Hosp NHS Fdn Trust, Dept Clin Immunol & Allergy, Denmark Hill, London SE5 9RS, England.; Maher, J (corresponding author), Eastbourne Hosp, Dept Immunol, Kings Dr, Eastbourne BN21 2UD, E Sussex, England.	john.maher@kcl.ac.uk		Burchell, Joy/0000-0003-0413-3823; Maher, John/0000-0001-8275-8488				Blidner AG, 2016, IMMUNITY, V44, P1248, DOI 10.1016/j.immuni.2016.06.010; BURCHELL J, 1987, CANCER RES, V47, P5476; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; Posey AD, 2016, IMMUNITY, V44, P1444, DOI 10.1016/j.immuni.2016.05.014; van der Stegen SJC, 2013, J IMMUNOL, V191, P4589, DOI 10.4049/jimmunol.1301523; van Schalkwyk MCI, 2013, HUM GENE THER CL DEV, V24, P134, DOI 10.1089/humc.2013.144; Wilkie S, 2008, J IMMUNOL, V180, P4901, DOI 10.4049/jimmunol.180.7.4901	7	27	28	0	28	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					945	946		10.1016/j.immuni.2016.10.014	http://dx.doi.org/10.1016/j.immuni.2016.10.014			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851917	Bronze			2022-12-18	WOS:000389473500001
J	Chen, SS; Yang, MX; Du, J; Li, D; Li, ZH; Cai, CX; Ma, YW; Zhang, LF; Tian, ZG; Dong, ZJ				Chen, Shasha; Yang, Meixiang; Du, Juan; Li, Dan; Li, Zehua; Cai, Chenxu; Ma, Yuanwu; Zhang, Lianfeng; Tian, Zhigang; Dong, Zhongjun			The Self-Specific Activation Receptor SLAM Family Is Critical for NK Cell Education	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; HEMATOPOIETIC-CELLS; CENTRAL TOLERANCE; MARROW GRAFTS; MICE; RESPONSIVENESS; REJECTION; NKG2D; ENGAGEMENT; MOLECULES	NK cell education, a term describing a process for NK cell acquisition of functional competence, is primarily achieved by self-MHC-I-specific inhibitory receptors. In this study, we have demonstrated that SLAM family receptors (SFRs) redundantly expressed on hematopoietic cells function as self-specific activation receptors critical for NK cell education. To overcome gene redundancy, we generated mice simultaneously lacking seven SFRs, revealing that NK-cell-mediated rejection of semi-allogeneic hematopoietic cells largely depended on the presence of SFRs on target cells. This stimulatory effect was determined by the presence of SFR-coupled adaptors; however, SFR-deficient mice displayed enhanced reactivity to hematopoietic cells. These findings demonstrate that SFRs endow NK cells with an ability to kill hematopoietic cells during the effector phase; however, the sustained engagement of SFRs can desensitize NK cell responses during an education process. Therefore, self-specific activating ligands may be "tolerogens'' for NK cells, akin to self-antigens that induce T cell tolerance.	[Chen, Shasha; Du, Juan; Li, Dan; Li, Zehua; Cai, Chenxu; Dong, Zhongjun] Tsinghua Univ, Inst Immunol, Sch Med, Beijing 100084, Peoples R China; [Chen, Shasha; Du, Juan; Li, Dan; Li, Zehua; Cai, Chenxu; Dong, Zhongjun] Tsinghua Univ, Inst Immunol, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China; [Yang, Meixiang] Jinan Univ, Biomed Translat Res Inst, Guangzhou 510632, Guangdong, Peoples R China; [Ma, Yuanwu; Zhang, Lianfeng] Chinese Acad Med Sci, Inst Lab Anim Sci, Minist Hlth, Key Lab Human Dis Comparat Med, Beijing 100021, Peoples R China; [Ma, Yuanwu; Zhang, Lianfeng] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China; [Tian, Zhigang] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China	Tsinghua University; Tsinghua University; Jinan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Laboratory Animal Science - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Dong, ZJ (corresponding author), Tsinghua Univ, Inst Immunol, Sch Med, Beijing 100084, Peoples R China.; Dong, ZJ (corresponding author), Tsinghua Univ, Inst Immunol, Tsinghua Peking Ctr Life Sci, Beijing 100084, Peoples R China.; Tian, ZG (corresponding author), Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Peoples R China.	tzg@ustc.edu.cn; dongzj@biomed.tsinghua.edu.cn	Li, Zehua/ABG-8273-2021; Tian, Zhigang/J-3512-2013; Li, Ze-Hua/P-2281-2017	Li, Zehua/0000-0001-6342-3324; Li, Ze-Hua/0000-0001-6342-3324; Ma, Yuanwu/0000-0002-1882-1777	Natural Science Foundation of China [81322041, 81273198, 81361128016, 81471523]; Ministry of Science and Technology of China [2013CB944901, 91429303]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	We thank L. Yin for sharing the SAP-deficient mouse. Work in the Dong and Tian laboratory is supported by the Natural Science Foundation of China (81322041, 81273198, 81361128016, and 81471523) and the Ministry of Science and Technology of China (2013CB944901 and 91429303).	Beilke JN, 2010, BLOOD, V116, P5208, DOI 10.1182/blood-2010-05-285031; Belanger S, 2012, BLOOD, V120, P592, DOI 10.1182/blood-2012-02-408732; Bennett M, 1995, Semin Immunol, V7, P121, DOI 10.1006/smim.1995.0016; BIX M, 1991, NATURE, V349, P329, DOI 10.1038/349329a0; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Coudert JD, 2008, BLOOD, V111, P3571, DOI 10.1182/blood-2007-07-100057; Cruz-Munoz ME, 2009, NAT IMMUNOL, V10, P297, DOI 10.1038/ni.1693; DALEY JP, 1984, J EXP MED, V159, P1132, DOI 10.1084/jem.159.4.1132; Deng WW, 2015, SCIENCE, V348, P136, DOI 10.1126/science.1258867; Dong ZJ, 2012, IMMUNITY, V36, P974, DOI 10.1016/j.immuni.2012.03.023; Dong ZJ, 2010, TRENDS IMMUNOL, V31, P295, DOI 10.1016/j.it.2010.05.008; Dong ZJ, 2009, NAT IMMUNOL, V10, P973, DOI 10.1038/ni.1763; Elliott JM, 2011, TRENDS IMMUNOL, V32, P364, DOI 10.1016/j.it.2011.06.001; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Johnson LA, 2003, ANTICANCER RES, V23, P3651; Jordan MA, 2007, J IMMUNOL, V178, P1618, DOI 10.4049/jimmunol.178.3.1618; Kageyama R, 2012, IMMUNITY, V36, P986, DOI 10.1016/j.immuni.2012.05.016; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lee KM, 2004, J EXP MED, V199, P1245, DOI 10.1084/jem.20031989; LIAO NS, 1991, SCIENCE, V253, P199, DOI 10.1126/science.1853205; Narni-Mancinelli E, 2012, SCIENCE, V335, P344, DOI 10.1126/science.1215621; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; Proust R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043200; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Raulet DH, 2006, NAT REV IMMUNOL, V6, P520, DOI 10.1038/nri1863; Schwartzberg PL, 2009, NAT REV IMMUNOL, V9, P39, DOI 10.1038/nri2456; Shifrin N, 2014, SEMIN IMMUNOL, V26, P138, DOI 10.1016/j.smim.2014.02.007; Sun JC, 2008, J EXP MED, V205, P1819, DOI 10.1084/jem.20072448; Tripathy SK, 2008, J EXP MED, V205, P1829, DOI 10.1084/jem.20072446; Veillette A, 2007, IMMUNITY, V27, P698, DOI 10.1016/j.immuni.2007.11.005; Viant C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6108; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang MX, 2015, J EXP MED, V212, P253, DOI 10.1084/jem.20141703; Zafirova B, 2009, IMMUNITY, V31, P270, DOI 10.1016/j.immuni.2009.06.017; Zhao F, 2012, IMMUNITY, V36, P1003, DOI 10.1016/j.immuni.2012.05.017	38	27	28	3	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					292	304		10.1016/j.immuni.2016.07.013	http://dx.doi.org/10.1016/j.immuni.2016.07.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27521267	Bronze			2022-12-18	WOS:000382267300012
J	Erttmann, SF; Hartlova, A; Sloniecka, M; Raffi, FAM; Hosseinzadeh, A; Edgren, T; Rofougaran, R; Resch, U; Fallman, M; Ek, T; Gekara, NO				Erttmann, Saskia F.; Hartlova, Anetta; Sloniecka, Marta; Raffi, Faizal A. M.; Hosseinzadeh, Ava; Edgren, Tomas; Rofougaran, Reza; Resch, Ulrike; Fallman, Maria; Ek, Torben; Gekara, Nelson O.			Loss of the DNA Damage Repair Kinase ATM Impairs Inflammasome-Dependent Anti-Bacterial Innate Immunity	IMMUNITY			English	Article							NLRP3 INFLAMMASOME; ATAXIA-TELANGIECTASIA; NALP3 INFLAMMASOME; OXIDATIVE STRESS; HOST-DEFENSE; CELL-DEATH; ACTIVATION; CASPASE-1; ASC; SECRETION	The ATM kinase is a central component of the DNA damage repair machinery and redox balance. ATM dysfunction results in the multisystem disease ataxia-telangiectasia (AT). A major cause of mortality in AT is respiratory bacterial infections. Whether ATM deficiency causes innate immune defects that might contribute to bacterial infections is not known. Here we have shown that loss of ATM impairs inflammasome- dependent anti-bacterial innate immunity. Cells from AT patients or Atm(-/-) mice exhibited diminished interleukin-1 beta (IL-1 beta) production in response to bacteria. In vivo, Atm(-/-) mice were more susceptible to pulmonary S. pneumoniae infection in a manner consistent with inflammasome defects. Our data indicate that such defects were due to oxidative inhibition of inflammasome complex assembly. This study reveals an unanticipated function of reactive oxygen species (ROS) in negative regulation of inflammasomes and proposes a theory for the notable susceptibility of AT patients to pulmonary bacterial infection.	[Erttmann, Saskia F.; Hartlova, Anetta; Sloniecka, Marta; Raffi, Faizal A. M.; Hosseinzadeh, Ava; Resch, Ulrike; Fallman, Maria; Gekara, Nelson O.] Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden; [Erttmann, Saskia F.; Hartlova, Anetta; Sloniecka, Marta; Raffi, Faizal A. M.; Edgren, Tomas; Resch, Ulrike; Fallman, Maria; Gekara, Nelson O.] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Erttmann, Saskia F.; Hartlova, Anetta; Sloniecka, Marta; Raffi, Faizal A. M.; Hosseinzadeh, Ava; Edgren, Tomas; Resch, Ulrike; Fallman, Maria; Gekara, Nelson O.] Umea Univ, Umea Ctr Microbial Res UCMR, S-90187 Umea, Sweden; [Hosseinzadeh, Ava] Umea Univ, Dept Clin Microbiol, S-90187 Umea, Sweden; [Ek, Torben] Hosp Halland, Dept Paediat, S-30185 Halmstad, Sweden; [Rofougaran, Reza] Univ Tehran, Inst Biochem & Biophys, Dept Biochem, Tehran, Iran	Umea University; Umea University; Umea University; Umea University; University of Tehran	Gekara, NO (corresponding author), Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden.; Gekara, NO (corresponding author), Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden.; Gekara, NO (corresponding author), Umea Univ, Umea Ctr Microbial Res UCMR, S-90187 Umea, Sweden.	nelson.gekara@mims.umu.se	Ek, Torben/GWN-2839-2022; Gekara, Nelson/P-9208-2019; Gekara, Nelson/AAG-7944-2020	Hartlova, Anetta/0000-0002-8152-4361; Ek, Torben/0000-0002-0518-983X; Erttmann, Saskia Friederike/0000-0003-2398-8405; Resch, Ulrike/0000-0002-8380-9555; Gekara, Nelson O./0000-0002-1269-8288; hosseinzadeh, ava/0000-0003-3069-0295	Laboratory for Molecular Infection Medicine Sweden (MIMS); Umea University; Kempe Foundation; Swedish Research Council [2015-02857]	Laboratory for Molecular Infection Medicine Sweden (MIMS); Umea University; Kempe Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	We are grateful to Anders Johansson (Umea University) for S.pneumoniae-Xen10 strain A66.1 Serotype 3 and Siegfried Weiss (Helmholtz Centre for Infection Research, HZI) for L. monocytogenes EGDe and S. Typhimurium SL1344. We thank Vishva Dixit (Genentech) for anti-ASC and anti-Casp-1 p20 antibodies and Asc<SUP>-/-</SUP> mice. We are also grateful to Omid Aryani and Massoud Houshmand (Special Medical Center, Tehran) for valuable discussion about AT patients. This work was supported by funding from Laboratory for Molecular Infection Medicine Sweden (MIMS), Umea University, Kempe Foundation, and Swedish Research Council grant (2015-02857) to N.O.G.	AMMANN AJ, 1969, PEDIATRICS, V44, P672; Barlow C, 1999, P NATL ACAD SCI USA, V96, P9915, DOI 10.1073/pnas.96.17.9915; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Bredemeyer AL, 2006, NATURE, V442, P466, DOI 10.1038/nature04866; Broz P, 2010, CELL HOST MICROBE, V8, P471, DOI 10.1016/j.chom.2010.11.007; Broz P, 2010, J EXP MED, V207, P1745, DOI 10.1084/jem.20100257; Cai X, 2014, CELL, V156, P1207, DOI 10.1016/j.cell.2014.01.063; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; CAWLEY LP, 1970, AM J CLIN PATHOL, V54, P790; Cosentino C, 2011, EMBO J, V30, P546, DOI 10.1038/emboj.2010.330; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Fang RD, 2011, J IMMUNOL, V187, P4890, DOI 10.4049/jimmunol.1100381; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Grek CL, 2013, J BIOL CHEM, V288, P26497, DOI 10.1074/jbc.R113.461368; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Hernandez-Cuellar E, 2012, J IMMUNOL, V189, P5113, DOI 10.4049/jimmunol.1202479; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Lavin MF, 2008, NAT REV MOL CELL BIO, V9, P759, DOI 10.1038/nrm2514; Lavin MF, 2007, BRIT MED BULL, V81-82, P129, DOI 10.1093/bmb/ldm012; Lu A, 2014, CELL, V156, P1193, DOI 10.1016/j.cell.2014.02.008; Mao KR, 2013, CELL RES, V23, P201, DOI 10.1038/cr.2013.6; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; Martinon F, 2010, EUR J IMMUNOL, V40, P616, DOI 10.1002/eji.200940168; McKinnon PJ, 2012, ANNU REV PATHOL-MECH, V7, P303, DOI 10.1146/annurev-pathol-011811-132509; Meissner F, 2008, NAT IMMUNOL, V9, P866, DOI 10.1038/ni.1633; Meissner F, 2010, BLOOD, V116, P1570, DOI 10.1182/blood-2010-01-264218; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Miao EA, 2010, P NATL ACAD SCI USA, V107, P3076, DOI 10.1073/pnas.0913087107; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; Moin M, 2007, PEDIATR NEUROL, V37, P21, DOI 10.1016/j.pediatrneurol.2007.03.002; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Nowak-Wegrzyn A, 2004, J PEDIATR-US, V144, P505, DOI 10.1016/j.jpeds.2003.12.046; Perkins EJ, 2002, GENE DEV, V16, P159, DOI 10.1101/gad.956902; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Roberts TL, 2009, SCIENCE, V323, P1057, DOI 10.1126/science.1169841; Rotman G, 1997, BIOESSAYS, V19, P911, DOI 10.1002/bies.950191011; Rubartelli A, 2012, J LEUKOCYTE BIOL, V92, P951, DOI 10.1189/jlb.0512265; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; van de Veerdonk FL, 2010, P NATL ACAD SCI USA, V107, P3030, DOI 10.1073/pnas.0914795107; van Lieshout MH, 2014, AM J RESP CELL MOL, V50, P699, DOI 10.1165/rcmb.2013-0015OC; von Moltke J, 2013, ANNU REV IMMUNOL, V31, P73, DOI 10.1146/annurev-immunol-032712-095944; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Zhao Y, 2011, NATURE, V477, P596, DOI 10.1038/nature10510; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	57	27	29	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					106	118		10.1016/j.immuni.2016.06.018	http://dx.doi.org/10.1016/j.immuni.2016.06.018			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27421701	Bronze			2022-12-18	WOS:000380749000014
J	Miao, YX; Wu, JX; Abraham, SN				Miao, Yuxuan; Wu, Jianxuan; Abraham, Soman N.			Ubiquitination of Innate Immune Regulator TRAF3 Orchestrates Expulsion of Intracellular Bacteria by Exocyst Complex	IMMUNITY			English	Article							PROTEIN; ACTIVATION; TOLL-LIKE-RECEPTOR-4; INVOLVEMENT; ENDOCYTOSIS; MEMBRANE; TBK1	Although the intracellular trafficking system is integral to most physiologic activities, its role in mediating immune responses to infection has remained elusive. Here, we report that infected bladder epithelial cells (BECs) mobilized the exocyst complex, a powerful exporter of subcellular vesicles, to rapidly expel intracellular bacteria back for clearance. Toll-like receptor (TLR) 4 signals emanating from bacteria-containing vesicles (BCVs) were found to trigger K33-linked polyubiquitination of TRAF3 at Lys168, which was then detected by RalGDS, a guanine nucleotide exchange factor (GEF) that precipitated the assembly of the exocyst complex. Although this distinct modification of TRAF3 served to connect innate immune signaling to the cellular trafficking apparatus, it crucially ensured temporal and spatial accuracy in determining which among the many subcellular vesicles was recognized and selected for expulsion in response to innate immune signaling.	[Miao, Yuxuan; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Wu, Jianxuan; Abraham, Soman N.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Abraham, Soman N.] Duke Natl Univ Singapore, Program Emerging Infect Dis, Singapore 169857, Singapore; [Miao, Yuxuan] Rockefeller Univ, Howard Hughes Med Inst, Robin Neustein Lab Mammalian Dev & Cell Biol, New York, NY 10065 USA	Duke University; Duke University; Duke University; National University of Singapore; Howard Hughes Medical Institute; Rockefeller University	Miao, YX (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.; Miao, YX (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Robin Neustein Lab Mammalian Dev & Cell Biol, New York, NY 10065 USA.	ymiao@rockefeller.edu	Wu, Jianxuan/GON-3871-2022	Wu, Jianxuan/0000-0002-3461-2852	US NIH [R01 AI96305, R01 AI35678, R01 DK077159, R01 AI50021, R37 DK50814, R21 AI056101]; Duke-NUS Graduate Medical School, Singapore; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050021, R21AI056101, R01AI096305] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077159, R37DK050814] Funding Source: NIH RePORTER	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke-NUS Graduate Medical School, Singapore; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Duke Light Microscopy Core Facility (LMCF), especially Dr. Yasheng Gao, for expertise and advice in light microscopy imaging. We also appreciate the help of Duke Proteomics Center for their assistance with mass spectrometry analysis. The authors' work is supported by the US NIH grants R01 AI96305, R01 AI35678, R01 DK077159, R01 AI50021, R37 DK50814, and R21 AI056101 and a block grant from Duke-NUS Graduate Medical School, Singapore.	Abraham SN, 2015, NAT REV IMMUNOL, V15, P655, DOI 10.1038/nri3887; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Bishop BL, 2007, NAT MED, V13, P625, DOI 10.1038/nm1572; Bloom J, 2005, METHOD ENZYMOL, V399, P249, DOI 10.1016/S0076-6879(05)99017-4; Cheng C, 2012, CIRCULATION, V125, P3142, DOI 10.1161/CIRCULATIONAHA.111.064030; Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; Difeo A, 2009, CANCER RES, V69, P4733, DOI 10.1158/0008-5472.CAN-08-4282; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Friedrich GA, 1997, DEV BIOL, V192, P364, DOI 10.1006/dbio.1997.8727; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Guo W, 2004, TRENDS CELL BIOL, V14, P61, DOI 10.1016/j.tcb.2003.12.008; He B, 2009, CURR OPIN CELL BIOL, V21, P537, DOI 10.1016/j.ceb.2009.04.007; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Inoue M, 2003, NATURE, V422, P629, DOI 10.1038/nature01533; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lonnbro P, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-35; Miao YX, 2015, CELL, V161, P1306, DOI 10.1016/j.cell.2015.05.009; Moskalenko S, 2002, NAT CELL BIOL, V4, P66, DOI 10.1038/ncb728; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Neel Nicole F, 2011, Genes Cancer, V2, P275, DOI 10.1177/1947601911407329; Solis M, 2007, EUR J IMMUNOL, V37, P528, DOI 10.1002/eji.200636090; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wieser A, 2011, CELL MICROBIOL, V13, P742, DOI 10.1111/j.1462-5822.2011.01573.x; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022	29	27	29	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					94	105		10.1016/j.immuni.2016.06.023	http://dx.doi.org/10.1016/j.immuni.2016.06.023			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27438768	Green Accepted, Bronze			2022-12-18	WOS:000380749000013
J	Wang, S; Xia, PY; Chen, Y; Huang, GL; Xiong, Z; Liu, J; Li, C; Ye, BQ; Du, Y; Fan, ZS				Wang, Shuo; Xia, Pengyan; Chen, Yi; Huang, Guanling; Xiong, Zhen; Liu, Jing; Li, Chong; Ye, Buqing; Du, Ying; Fan, Zusen			Natural Killer-like B Cells Prime Innate Lymphocytes against Microbial Infection	IMMUNITY			English	Article							ROR-GAMMA-T; LYMPHOID-CELLS; MARGINAL ZONE; HEMATOPOIETIC STEM; TISSUE HOMEOSTASIS; IMMUNE-RESPONSES; TYPE-2 IMMUNITY; BONE-MARROW; NK CELLS; INFLAMMATION	Natural killer (NK) cells and non-cytotoxic interferon-gamma (IFN-gamma)-producing group I innate lymphoid cells (ILC1s) produce large amounts of IFN-gamma and cause activation of innate and adaptive immunity. However, how NKs and ILC1s are primed during infection remains elusive. Here we have shown that a lymphocyte subpopulation natural killer-like B (NKB) cells existed in spleen and mesenteric lymph nodes (MLNs). NKBs had unique features that differed from T and B cells, and produced interleukin-18 (IL-18) and IL-12 at an early phase of infection. NKB cells played a critical role in eradication of microbial infection via secretion of IL-18 and IL-12. Moreover, IL-18 deficiency abrogated the antibacterial effect of NKBs. Upon bacterial challenge, NKB precursors (NKBPs) rapidly differentiated to NKBs that activated NKs and ILC1s against microbial infection. Our findings suggest that NKBs might be exploited to develop effective therapies for treatment of infectious diseases.	[Wang, Shuo; Xia, Pengyan; Huang, Guanling; Xiong, Zhen; Liu, Jing; Li, Chong; Ye, Buqing; Du, Ying; Fan, Zusen] Chinese Acad Sci, Ctr Excellence Biomacromol, Inst Biophys, Key Lab Infect & Immun, Beijing 100101, Peoples R China; [Chen, Yi] Sichuan Univ, West China Hosp, Dept Gastrointestinal Surg, State Key Lab Biotherapy, Chengdu 610041, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Sichuan University	Fan, ZS (corresponding author), Chinese Acad Sci, Ctr Excellence Biomacromol, Inst Biophys, Key Lab Infect & Immun, Beijing 100101, Peoples R China.	fanz@moon.ibp.ac.cn	Huang, Guanling/AAE-3779-2020	Chen, Yi/0000-0002-5180-3490; Huang, Guanling/0000-0002-2597-6195	National Natural Science Foundation of China [91419308, 31530093, 31471386, 31300645, 81330047]; Strategic Priority Research Programs of the Chinese Academy of Sciences [XDA01010407]; Youth Innovation Promotion Association of CAS; China Postdoctoral Science Foundation [2015M571141]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Strategic Priority Research Programs of the Chinese Academy of Sciences; Youth Innovation Promotion Association of CAS; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	We thank Dr. Yong Tian, Junying Jia, Lei Sun, Yan Teng, Xiaoxiao Zhu, Shu Meng, and Zhonglin Fu for technical support. This work was supported by the National Natural Science Foundation of China (91419308, 31530093, 31471386, 31300645, and 81330047), the Strategic Priority Research Programs of the Chinese Academy of Sciences (XDA01010407), Youth Innovation Promotion Association of CAS to S.W., and the China Postdoctoral Science Foundation to P.X. (2015M571141).	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Becker-Herman S, 2002, J IMMUNOL, V168, P5507, DOI 10.4049/jimmunol.168.11.5507; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Berzins SP, 2011, NAT REV IMMUNOL, V11, P131, DOI 10.1038/nri2904; Boos MD, 2007, J EXP MED, V204, P1119, DOI 10.1084/jem.20061959; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Castagnaro L, 2013, IMMUNITY, V38, P782, DOI 10.1016/j.immuni.2012.12.005; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; Choi YS, 2012, EUR J IMMUNOL, V42, P120, DOI 10.1002/eji.201141890; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Cochrane SW, 2009, BLOOD, V113, P1016, DOI 10.1182/blood-2008-06-164996; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fan ZS, 2006, BLOOD, V107, P1342, DOI 10.1182/blood-2005-08-3485; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gasteiger G, 2014, NAT REV IMMUNOL, V14, P631, DOI 10.1038/nri3726; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; HOFFMANN MK, 1977, J EXP MED, V146, P1640, DOI 10.1084/jem.146.6.1640; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Kometani K, 2011, J EXP MED, V208, P1447, DOI 10.1084/jem.20102665; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Marquardt N, 2015, J IMMUNOL, V194, P2467, DOI 10.4049/jimmunol.1402756; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Martinet L, 2015, NAT REV IMMUNOL, V15, P243, DOI 10.1038/nri3799; Mchedlidze T, 2013, IMMUNITY, V39, P357, DOI 10.1016/j.immuni.2013.07.018; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Nombela-Arrieta C, 2013, NAT CELL BIOL, V15, P533, DOI 10.1038/ncb2730; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; OKAMURA H, 1995, NATURE, V378, P88, DOI 10.1038/378088a0; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; ROCK EP, 1994, J EXP MED, V179, P323, DOI 10.1084/jem.179.1.323; Roediger B, 2013, NAT IMMUNOL, V14, P564, DOI 10.1038/ni.2584; Rossjohn J, 2012, NAT REV IMMUNOL, V12, P845, DOI 10.1038/nri3328; Rothenberg EV, 2014, ANNU REV IMMUNOL, V32, P283, DOI 10.1146/annurev-immunol-032712-100024; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Takeda K, 1998, IMMUNITY, V8, P383, DOI 10.1016/S1074-7613(00)80543-9; Van Kaer L, 2013, TRENDS IMMUNOL, V34, P50, DOI 10.1016/j.it.2012.08.009; VanCott JL, 1998, NAT MED, V4, P1247, DOI 10.1038/3227; Wingender G, 2011, J EXP MED, V208, P1151, DOI 10.1084/jem.20102229; Xia PY, 2015, NAT IMMUNOL, V16, P366, DOI 10.1038/ni.3117; Xia PY, 2014, J EXP MED, V211, P2119, DOI 10.1084/jem.20140169; Yang Y, 2007, P NATL ACAD SCI USA, V104, P4542, DOI 10.1073/pnas.0700001104; Yu JH, 2013, TRENDS IMMUNOL, V34, P573, DOI 10.1016/j.it.2013.07.005	57	27	29	1	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					131	144		10.1016/j.immuni.2016.06.019	http://dx.doi.org/10.1016/j.immuni.2016.06.019			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27421702	Bronze			2022-12-18	WOS:000380749000016
J	Lutz, MB; Inaba, K; Schuler, G; Romani, N				Lutz, Manfred B.; Inaba, Kayo; Schuler, Gerold; Romani, Nikolaus			Still Alive and Kicking: In-Vitro-Generated GM-CSF Dendritic Cells!	IMMUNITY			English	Letter							MOUSE BONE-MARROW; MACROPHAGES; MONOCYTES		[Lutz, Manfred B.] Univ Wurzburg, Inst Virol & Immunobiol, D-97078 Wurzburg, Germany; [Inaba, Kayo] Kyoto Univ, Grad Sch Biostudies, Dept Anim Dev & Physiol, Lab Immunobiol, Kyoto 6068501, Japan; [Schuler, Gerold] Univ Hosp Erlangen, Dept Dermatol, D-91054 Erlangen, Germany; [Romani, Nikolaus] Med Univ Innsbruck, Dept Dermatol & Venereol, A-6020 Innsbruck, Austria	University of Wurzburg; Kyoto University; University of Erlangen Nuremberg; Medical University of Innsbruck	Lutz, MB (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, D-97078 Wurzburg, Germany.	m.lutz@vim.uni-wuerzburg.de		Lutz, Manfred B./0000-0001-9193-1772; Romani, Nikolaus/0000-0003-1614-9128				Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Guilliams M, 2015, IMMUNITY, V42, P988, DOI 10.1016/j.immuni.2015.05.020; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Menges M, 2005, J LEUKOCYTE BIOL, V77, P535, DOI 10.1189/jlb.0804473	7	27	27	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					1	2		10.1016/j.immuni.2015.12.013	http://dx.doi.org/10.1016/j.immuni.2015.12.013			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26789912	Bronze			2022-12-18	WOS:000368347000001
J	Malandro, N; Budhu, S; Kuhn, NF; Liu, CL; Murphy, JT; Cortez, C; Zhong, H; Yang, X; Rizzuto, G; Altan-Bonnet, G; Merghoub, T; Wolchok, JD				Malandro, Nicole; Budhu, Sadna; Kuhn, Nicholas F.; Liu, Cailian; Murphy, Judith T.; Cortez, Czrina; Zhong, Hong; Yang, Xia; Rizzuto, Gabrielle; Altan-Bonnet, Gregoire; Merghoub, Taha; Wolchok, Jedd D.			Clonal Abundance of Tumor-Specific CD4(+) T Cells Potentiates Efficacy and Alters Susceptibility to Exhaustion	IMMUNITY			English	Article							PRECURSOR FREQUENCY; IN-VIVO; ANTIGEN; COMPETITION; NAIVE; PROLIFERATION; DETERMINES; EXPRESSION; BLOCKADE; PD-1	Current approaches to cancer immunotherapy aim to engage the natural T cell response against tumors. One limitation is the elimination of self-antigen-specific T cells from the immune repertoire. Using a system in which precursor frequency can be manipulated in a murine melanoma model, we demonstrated that the clonal abundance of CD4(+) T cells specific for self-tumor antigen positively correlated with antitumor efficacy. At elevated precursor frequencies, intraclonal competition impaired initial activation and overall expansion of the tumor-specific CD4(+) T cell population. However, through clonally derived help, this population acquired a polyfunctional effector phenotype and antitumor immunity was enhanced. Conversely, development of effector function was attenuated at low precursor frequencies due to irreversible T cell exhaustion. Our findings assert that the differential effects of T cell clonal abundance on phenotypic outcome should be considered during the design of adoptive T cell therapies, including use of engineered T cells.	[Malandro, Nicole; Budhu, Sadna; Liu, Cailian; Murphy, Judith T.; Cortez, Czrina; Zhong, Hong; Yang, Xia; Rizzuto, Gabrielle; Merghoub, Taha; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Ludwig Collaborat Lab, New York, NY 10065 USA; [Malandro, Nicole; Liu, Cailian] Weill Cornell Grad Sch Med Sci, New York, NY 10065 USA; [Kuhn, Nicholas F.] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA; [Merghoub, Taha; Wolchok, Jedd D.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Rizzuto, Gabrielle; Wolchok, Jedd D.] Weill Cornell Med Coll, New York, NY 10065 USA; [Altan-Bonnet, Gregoire] Mem Sloan Kettering, Programs Computat Biol & Immunol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center	Merghoub, T (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Collaborat Lab, New York, NY 10065 USA.	merghout@mskcc.org; wolchokj@mskcc.org	Rizzuto, Gabrielle/GWR-2224-2022; Merghoub, Taha/ABD-8362-2021	Rizzuto, Gabrielle/0000-0003-3052-0253; Altan-Bonnet, Gregoire/0000-0002-7283-3162	NIH grants [R01CA56821, R01-AI116863, R01-AI083408]; NIH/NCI Cancer Center Support Grant [P30 CA008748]; Ludwig Collaborative Laboratory; Swim Across America; Lita Annenberg Hazen Foundation; Cancer Research Institute Pre-Doctoral Fellowship; NATIONAL CANCER INSTITUTE [P30CA008748, R25CA020449, ZIABC011728, R01CA056821] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083408] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI Cancer Center Support Grant; Ludwig Collaborative Laboratory; Swim Across America; Lita Annenberg Hazen Foundation; Cancer Research Institute Pre-Doctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was partially supported by NIH grants R01CA56821, R01-AI116863, R01-AI083408, the NIH/NCI Cancer Center Support Grant P30 CA008748, Ludwig Collaborative Laboratory, Swim Across America, and the Lita Annenberg Hazen Foundation. N.M. was supported by a Cancer Research Institute Pre-Doctoral Fellowship. We would like to thank Karen Tkach, Jen Oyler-Yaniv, and Alon Oyler-Yaniv for excellent discussion and insights.	Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Blair DA, 2007, P NATL ACAD SCI USA, V104, P15045, DOI 10.1073/pnas.0703767104; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Budhu S, 2010, J EXP MED, V207, P223, DOI 10.1084/jem.20091279; Buggert M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004251; BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Burnet FM., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Catron DM, 2006, J EXP MED, V203, P1045, DOI 10.1084/jem.20051954; Corbeau P., 2011, IMMUNE RECONSTITUTIO, V117; Crawford A, 2014, IMMUNITY, V40, P289, DOI 10.1016/j.immuni.2014.01.005; Creusot RJ, 2003, J IMMUNOL, V171, P240, DOI 10.4049/jimmunol.171.1.240; Foulds KE, 2006, J IMMUNOL, V176, P3037, DOI 10.4049/jimmunol.176.5.3037; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; Hirano F, 2005, CANCER RES, V65, P1089; HOUGHTON AN, 1994, J EXP MED, V180, P1, DOI 10.1084/jem.180.1.1; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Laouar Y, 2000, IMMUNITY, V13, P291, DOI 10.1016/S1074-7613(00)00029-7; Lazarevic V, 2013, NAT REV IMMUNOL, V13, P777, DOI 10.1038/nri3536; Marzo AL, 2005, NAT IMMUNOL, V6, P793, DOI 10.1038/ni1227; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; NABAVI N, 1992, NATURE, V360, P266, DOI 10.1038/360266a0; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Quezada SA, 2010, J EXP MED, V207, P637, DOI 10.1084/jem.20091918; Quiel J, 2011, P NATL ACAD SCI USA, V108, P3312, DOI 10.1073/pnas.1018525108; RANHEIM EA, 1993, J EXP MED, V177, P925, DOI 10.1084/jem.177.4.925; Rizzuto GA, 2009, J EXP MED, V206, P849, DOI 10.1084/jem.20081382; Smith A, 2000, IMMUNITY, V13, P783, DOI 10.1016/S1074-7613(00)00076-5; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Walsh KB, 2010, VIROLOGY, V397, P260, DOI 10.1016/j.virol.2009.08.043; Whitmire JK, 2006, J IMMUNOL, V176, P3028, DOI 10.4049/jimmunol.176.5.3028; Willis RA, 2006, P NATL ACAD SCI USA, V103, P12063, DOI 10.1073/pnas.0605130103; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Xie Y, 2010, J EXP MED, V207, P651, DOI 10.1084/jem.20091921; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	41	27	30	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					179	193		10.1016/j.immuni.2015.12.018	http://dx.doi.org/10.1016/j.immuni.2015.12.018			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26789923	Green Accepted, Bronze			2022-12-18	WOS:000368347000022
J	Hornung, V				Hornung, Veit			SnapShot: Nucleic Acid Immune Sensors, Part 1	IMMUNITY			English	Editorial Material							DNA; RECOGNITION		Univ Bonn, Inst Mol Med, Univ Hosp, Bonn, Germany	University of Bonn	Hornung, V (corresponding author), Univ Bonn, Inst Mol Med, Univ Hosp, Bonn, Germany.		Hornung, Veit/C-3565-2012	Hornung, Veit/0000-0002-4150-194X				Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Roth S, 2014, NAT IMMUNOL, V15, P538, DOI 10.1038/ni.2888	10	27	29	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					868	868E1		10.1016/j.immuni.2014.10.005	http://dx.doi.org/10.1016/j.immuni.2014.10.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25517618	Bronze			2022-12-18	WOS:000345504900023
J	Mantovani, A; Marchesi, F				Mantovani, Alberto; Marchesi, Federica			IL-10 and Macrophages Orchestrate Gut Homeostasis	IMMUNITY			English	Editorial Material							MONOCYTES		[Mantovani, Alberto; Marchesi, Federica] Humanitas Clin & Res Ctr, I-20089 Rozzano, Italy; [Mantovani, Alberto; Marchesi, Federica] Univ Milan, Dept Biotechnol & Translat Med, I-20122 Milan, Italy	IRCCS Humanitas Research Hospital; University of Milan	Mantovani, A (corresponding author), Humanitas Clin & Res Ctr, Via Manzoni 56, I-20089 Rozzano, Italy.	alberto.mantovani@humanitasresearch.it	Marchesi, Federica/E-5163-2017; Mantovani, Alberto/HCI-7449-2022	Marchesi, Federica/0000-0002-7212-5721; Mantovani, Alberto/0000-0001-5578-236X				Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Geissmann F, 2010, NAT REV IMMUNOL, V10, P453, DOI 10.1038/nri2784; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Shouval DS, 2014, IMMUNITY, V40, P706, DOI 10.1016/j.immuni.2014.03.011; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012; Zigmond E, 2013, TRENDS IMMUNOL, V34, P162, DOI 10.1016/j.it.2013.02.001; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	10	27	27	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					637	639		10.1016/j.immuni.2014.04.015	http://dx.doi.org/10.1016/j.immuni.2014.04.015			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24837099	Bronze			2022-12-18	WOS:000336026100003
J	Yoshimura, A; Yasukawa, H				Yoshimura, Akihiko; Yasukawa, Hideo			JAK's SOCS: A Mechanism of Inhibition	IMMUNITY			English	Editorial Material							JANUS TYROSINE KINASE; SH2 DOMAIN; CYTOKINE; SUPPRESSION; PROTEINS; BINDING	SOCS1 and SOCS3 are specific inhibitors for JAK tyrosine kinases. In this issue of Immunity, Babon et al. (2012) discovered the inhibition mechanism of SOCS3 by employing nuclear magnetic resonance and classical enzyme kinetics.	[Yoshimura, Akihiko] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Yoshimura, Akihiko] CREST, Japan Sci & Technol Agcy, Chiyoda Ku, Tokyo 1020075, Japan; [Yasukawa, Hideo] Kurume Univ, Sch Med, Div Cardiovasc Med, Kurume, Fukuoka 8300011, Japan	Keio University; Japan Science & Technology Agency (JST); Kurume University	Yoshimura, A (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	yoshimura@a6.keio.jp	Yoshimura, Akihiko/K-5515-2013					Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Babon JJ, 2012, IMMUNITY, V36, P239, DOI 10.1016/j.immuni.2011.12.015; Babon JJ, 2009, J MOL BIOL, V387, P162, DOI 10.1016/j.jmb.2009.01.024; Babon JJ, 2006, MOL CELL, V22, P205, DOI 10.1016/j.molcel.2006.03.024; Doti N, 2012, BIOCHEM J, V443, P231, DOI 10.1042/BJ20111647; Sasaki A, 1999, GENES CELLS, V4, P339, DOI 10.1046/j.1365-2443.1999.00263.x; Yasukawa H, 1999, EMBO J, V18, P1309, DOI 10.1093/emboj/18.5.1309; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938; Yoshida H, 2012, BIOCHEM BIOPH RES CO, V418, P234, DOI 10.1016/j.bbrc.2011.12.156; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	10	27	34	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB 24	2012	36	2					157	159		10.1016/j.immuni.2012.01.010	http://dx.doi.org/10.1016/j.immuni.2012.01.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	899JO	22365659	Bronze			2022-12-18	WOS:000300812400002
J	Green, DR				Green, Douglas R.			The End and After: How Dying Cells Impact the Living Organism	IMMUNITY			English	Editorial Material							AUTOPHAGY; APOPTOSIS; DEATH	All cells die, but the manner of death dictates interactions with living cells and consequences for the organism, especially with respect to the immune response. Here we discuss the different modes of cell death as they relate to this rapidly evolving field.	St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Green, DR (corresponding author), St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA.	douglas.green@stjude.org	Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417				Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Fan Y, 2008, TRENDS CELL BIOL, V18, P467, DOI 10.1016/j.tcb.2008.08.001; Green DR, 2011, MOL CELL, V44, P9, DOI 10.1016/j.molcel.2011.09.003; Green DR, 2011, MEANS END APOPTOSIS; Leung AWC, 2008, BBA-BIOENERGETICS, V1777, P946, DOI 10.1016/j.bbabio.2008.03.009; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Ryoo HD, 2010, CURR OPIN CELL BIOL, V22, P889, DOI 10.1016/j.ceb.2010.08.022; Singh R, 2011, CELL METAB, V13, P495, DOI 10.1016/j.cmet.2011.04.004; Ullrich E, 2008, CELL DEATH DIFFER, V15, P21, DOI 10.1038/sj.cdd.4402266	12	27	31	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					441	444		10.1016/j.immuni.2011.10.003	http://dx.doi.org/10.1016/j.immuni.2011.10.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	22035836	Bronze			2022-12-18	WOS:000296657700001
J	Collins, A; Hewitt, SL; Chaumeil, J; Sellars, M; Micsinai, M; Allinne, J; Parisi, F; Nora, EP; Bolland, DJ; Corcoran, AE; Kluger, Y; Bosselut, R; Ellmeier, W; Chong, MMW; Littman, DR; Skok, JA				Collins, Amelie; Hewitt, Susannah L.; Chaumeil, Julie; Sellars, MacLean; Micsinai, Mariann; Allinne, Jeanne; Parisi, Fabio; Nora, Elphege P.; Bolland, Dan J.; Corcoran, Anne E.; Kluger, Yuval; Bosselut, Remy; Ellmeier, Wilfried; Chong, Mark M. W.; Littman, Dan R.; Skok, Jane A.			RUNX Transcription Factor-Mediated Association of Cd4 and Cd8 Enables Coordinate Gene Regulation	IMMUNITY			English	Article							T-CELL LINEAGE; THYMOCYTE DIFFERENTIATION; LYMPHOCYTE DEVELOPMENT; IMMUNOGLOBULIN LOCI; X-INACTIVATION; B-CELLS; EXPRESSION; COMMITMENT; SILENCER; ENHANCER	T cell fate is associated with mutually exclusive expression of CD4 or CD8 in helper and cytotoxic T cells, respectively. How expression of one locus is temporally coordinated with repression of the other has been a long-standing enigma, though we know RUNX transcription factors activate the Cd8 locus, silence the Cd4 locus, and repress the Zbtb7b locus (encoding the transcription factor ThPOK), which is required for CD4 expression. Here we found that nuclear organization was altered by interplay among members of this transcription factor circuitry: RUNX binding mediated association of Cd4 and Cd8 whereas ThPOK binding kept the loci apart. Moreover, targeted deletions within Cd4 modulated CD8 expression and pericentromeric repositioning of Cd8. Communication between Cd4 and Cd8 thus appears to enable long-range epigenetic regulation to ensure that expression of one excludes the other in mature CD4 or CD8 single-positive (SP) cells.	[Hewitt, Susannah L.; Chaumeil, Julie; Micsinai, Mariann; Allinne, Jeanne; Parisi, Fabio; Kluger, Yuval; Skok, Jane A.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Collins, Amelie; Sellars, MacLean; Chong, Mark M. W.; Littman, Dan R.] NYU, Sch Med, Kimmel Ctr Biol & Med, Mol Pathogenesis Program,Skirball Inst, New York, NY 10016 USA; [Micsinai, Mariann] NYU, Sch Med, Ctr Hlth Informat & Bioinformat, New York, NY 10016 USA; [Micsinai, Mariann] NYU, Sch Med, Inst Canc, New York, NY 10016 USA; [Micsinai, Mariann; Parisi, Fabio; Kluger, Yuval] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06520 USA; [Nora, Elphege P.] Inst Curie, CNRS, INSERM, UMR3215,U934, F-75724 Paris 05, France; [Bolland, Dan J.; Corcoran, Anne E.] Babraham Inst, Cambridge CB22 3AT, England; [Bosselut, Remy] NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Ellmeier, Wilfried] Med Univ Vienna, Inst Immunol, Div Immunobiol, A-1090 Vienna, Austria; [Skok, Jane A.] UCL, Dept Immunol & Mol Pathol, Div Infect & Immun, London W1T 4JF, England; [Littman, Dan R.] UCL, Howard Hughes Med Inst, London W1T 4JF, England	New York University; New York University; New York University; New York University; Yale University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Medical University of Vienna; University of London; University College London; University of London; University College London	Skok, JA (corresponding author), NYU, Sch Med, Dept Pathol, 550 1st Ave, New York, NY 10016 USA.	jane.skok@med.nyu.edu	Chong, Mark/H-6684-2016; Nora, Elphège/AAW-9646-2021; Skok, Jane/ABF-7249-2020	Chong, Mark/0000-0002-3701-7397; Nora, Elphège/0000-0002-8347-4396; Skok, Jane/0000-0002-4145-1516; CHAUMEIL, Julie/0000-0002-8976-2890; Ellmeier, Wilfried/0000-0001-8192-8481	Leukemia and Lymphoma Scholar Award; NIH [1R01GM086852]; WT project [WT 085096]; Howard Hughes Medical Institute; Helen and Martin Kimmel Center for Biology and Medicine; American Society of Hematology; NSF [0333389]; Cancer Research Institute; Helen and Martin Kimmel Center for Stem Cell Biology; BBSRC (Biotechnology and Biological Sciences Research Council); Austrian Science Fund (FWF) [P19930]; National Cancer Institute, Center for Cancer Research, NIH; BBSRC [BB/F012217/1] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [ZIABC010671] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086852] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C163, BB/F012217/1] Funding Source: researchfish	Leukemia and Lymphoma Scholar Award(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); WT project; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Helen and Martin Kimmel Center for Biology and Medicine; American Society of Hematology; NSF(National Science Foundation (NSF)); Cancer Research Institute; Helen and Martin Kimmel Center for Stem Cell Biology; BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); National Cancer Institute, Center for Cancer Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We would like to thank J. de Nooij and T. Jessell for RUNX3 antibody (Kramer et al., 2006). We also thank members of the J.A.S. and D.R.L. labs for thoughtful discussions and critical comments on the manuscript. This work was supported by a Leukemia and Lymphoma Scholar Award, an NIH 1R01GM086852 grant, and a WT project grant (WT 085096) (J.A.S.). A.C. and D.R.L. were supported by funds from the Howard Hughes Medical Institute and from the Helen and Martin Kimmel Center for Biology and Medicine. S.L.H. is supported by a Fellow Scholar Award from the American Society of Hematology and M.M. is supported by NSF IGERT grant 0333389. M.M.W.C. was funded sequentially by a Postdoctoral Fellowship from the Cancer Research Institute and a Senior Fellowship from the Helen and Martin Kimmel Center for Stem Cell Biology. A.E.C. and D.J.B. are supported by a BBSRC project grant (Biotechnology and Biological Sciences Research Council). Work in the lab of W.E. is supported by the Austrian Science Fund (FWF; P19930). Work in the lab of R.B. is supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, NIH. M.S. is an Irvington Institute Fellow of the Cancer Research Institute.	Bacher CP, 2006, NAT CELL BIOL, V8, P293, DOI 10.1038/ncb1365; Bilic I, 2006, NAT IMMUNOL, V7, P392, DOI 10.1038/ni1311; Brown KE, 1999, MOL CELL, V3, P207, DOI 10.1016/S1097-2765(00)80311-1; Campbell R.C., 1989, STAT BIOL; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chong MMW, 2010, GENE DEV, V24, P659, DOI 10.1101/gad.1901610; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Dave VP, 1998, P NATL ACAD SCI USA, V95, P8187, DOI 10.1073/pnas.95.14.8187; Delaire S, 2004, J EXP MED, V200, P1427, DOI 10.1084/jem.20041041; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hewitt SL, 2008, NAT IMMUNOL, V9, P396, DOI 10.1038/ni1567; Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735; Hostert A, 1998, IMMUNITY, V9, P497, DOI 10.1016/S1074-7613(00)80633-0; Hostert A, 1997, IMMUNITY, V7, P525, DOI 10.1016/S1074-7613(00)80374-X; Iborra FJ, 1996, J CELL SCI, V109, P1427; Jenkinson SR, 2007, J EXP MED, V204, P267, DOI 10.1084/jem.20061982; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; LEWIS EB, 1985, COLD SPRING HARB SYM, V50, P155, DOI 10.1101/SQB.1985.050.01.021; Manel N, 2008, NAT IMMUNOL, V9, P641, DOI 10.1038/ni.1610; Massey F.J, 1951, J AM STAT ASSOC, V253, P1951; Merkenschlager M, 2004, J EXP MED, V200, P1437, DOI 10.1084/jem.20041127; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Sayegh C, 2005, GENE DEV, V19, P322, DOI 10.1101/gad.1254305; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Skok JA, 2007, NAT IMMUNOL, V8, P378, DOI 10.1038/ni1448; Spilianakis CG, 2005, NATURE, V435, P637, DOI 10.1038/nature03574; Stam M, 2009, MOL PLANT, V2, P578, DOI 10.1093/mp/ssp020; Stein GS, 2007, ADV ENZYME REGUL, V47, P242, DOI 10.1016/j.advenzreg.2006.12.014; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2002, MOL CELL, V10, P1083, DOI 10.1016/S1097-2765(02)00735-9; Wildt KF, 2007, J IMMUNOL, V179, P4405, DOI 10.4049/jimmunol.179.7.4405; Xu N, 2006, SCIENCE, V311, P1149, DOI 10.1126/science.1122984; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	48	27	28	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 25	2011	34	3					303	314		10.1016/j.immuni.2011.03.004	http://dx.doi.org/10.1016/j.immuni.2011.03.004			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21435585	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000289014500007
J	Sasawatari, S; Yoshizaki, M; Taya, C; Tazawa, A; Furuyama-Tanaka, K; Yonekawa, H; Dohi, T; Makrigiannis, AP; Sasazuki, T; Inaba, K; Toyama-Sorimachi, N				Sasawatari, Shigemi; Yoshizaki, Mariko; Taya, Choji; Tazawa, Aya; Furuyama-Tanaka, Kaori; Yonekawa, Hiromichi; Dohi, Taeko; Makrigiannis, Andrew P.; Sasazuki, Takehiko; Inaba, Kayo; Toyama-Sorimachi, Noriko			The Ly49Q Receptor Plays a Crucial Role in Neutrophil Polarization and Migration by Regulating Raft Trafficking	IMMUNITY			English	Article							DENDRITIC CELL-FUNCTION; INHIBITORY NK RECEPTOR; GROWTH-FACTOR; LIPID RAFTS; DOWN-REGULATION; IMMUNE-SYSTEM; C57BL/6 MICE; CHEMOTAXIS; FAMILY; SRC	Neutrophils rapidly undergo polarization and directional movement to infiltrate the sites of infection and inflammation. Here, we show that an inhibitory MHC I receptor, Ly49Q, was crucial for the swift polarization of and tissue infiltration by neutrophils. During the steady state, Ly49Q inhibited neutrophil adhesion by preventing focal-complex formation, likely by inhibiting Src and PI3 kinases. However, in the presence of inflammatory stimuli, Ly49Q mediated rapid neutrophil polarization and tissue infiltration in an ITIM-domain-dependent manner. These opposite functions appeared to be mediated by distinct use of effector phosphatase SHP-1 and SHP-2. Ly49Q-dependent polarization and migration were affected by Ly49Q regulation of membrane raft functions. We propose that Ly49Q is pivotal in switching neutrophils to their polarized morphology and rapid migration upon inflammation, through its spatiotemporal regulation of membrane rafts and raft-associated signaling molecules.	[Sasawatari, Shigemi; Yoshizaki, Mariko; Tazawa, Aya; Furuyama-Tanaka, Kaori; Dohi, Taeko; Toyama-Sorimachi, Noriko] Int Med Ctr Japan, Res Inst, Dept Gastroenterol, Shinjuku Ku, Tokyo 1628655, Japan; [Taya, Choji; Yonekawa, Hiromichi] Tokyo Metropolitan Inst Med Sci, Dept Lab Anim Sci, Setagaya Ku, Tokyo 1568506, Japan; [Makrigiannis, Andrew P.] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada; [Sasazuki, Takehiko] Int Med Ctr Japan, Shinjuku Ku, Tokyo 1628655, Japan; [Inaba, Kayo] Kyoto Univ, Grad Sch Biostudies, Dept Anim Dev & Physiol, Sakyo Ku, Kyoto 6068502, Japan	National Center for Global Health & Medicine - Japan; Tokyo Metropolitan Institute of Medical Science; University of Ottawa; National Center for Global Health & Medicine - Japan; Kyoto University	Toyama-Sorimachi, N (corresponding author), Int Med Ctr Japan, Res Inst, Dept Gastroenterol, Shinjuku Ku, Toyama1-21-1, Tokyo 1628655, Japan.	nsorima@ri.imcj.go.jp		Makrigiannis, Andrew/0000-0002-7258-9411	Ministry of Education, Science, Sports and Culture of Japan [17590445, 19590507, 1839012]; Ministry of Health and Labour Sciences research; Takeda Foundation; Naito Foundation	Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health and Labour Sciences research; Takeda Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation)	We thank T. Kitamura for providing the pMxs-IRES-GFP plasmid; J. Miyazaki for the pCAGGS plasmid; M. Miyasaka, T. Sado, L.A. Miglietta, and G.E. Gray for critical reading of this manuscript; T. Okamura, S. Takahashi, and other members of JAC Inc., Japan, for animal care; and M. Ookubo, N. Sato-Yamashiro and M. Nakasuji for technical support. We also thank H. Sorimachi, K. Nishikawa, and M. Watanabe-Takahashi for helpful discussion and raft preparation and Ms. K. Furuta for secretarial support. This work was supported by grants-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (17590445 and 19590507 for N.T-S., 1839012 for K.I.), grants-in-aid for Research on intractable diseases from the Ministry of Health and Labour Sciences research grants (N.T.-S.), and grants from the Takeda Foundation and the Naito Foundation. S.S., M.Y., A.T., and K.F.-T. performed experiments; C.T. and H.Y. established Tg mice; T.D. helped in doing experiments; A.P.M. generated KO mice; and N.T.-S. designed the research and wrote the manuscript with K. I. and T.S.	Affolter M, 2005, DEV CELL, V9, P19, DOI 10.1016/j.devcel.2005.06.003; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; BEGUINOT L, 1984, P NATL ACAD SCI-BIOL, V81, P2384, DOI 10.1073/pnas.81.8.2384; Ben-Neriah Y, 2002, NAT IMMUNOL, V3, P20, DOI 10.1038/ni0102-20; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; Dance M, 2008, CELL SIGNAL, V20, P453, DOI 10.1016/j.cellsig.2007.10.002; DELPOZO MA, 1995, J CELL BIOL, V131, P495, DOI 10.1083/jcb.131.2.495; DOWNEY GP, 1994, CURR OPIN IMMUNOL, V6, P113, DOI 10.1016/0952-7915(94)90042-6; Fincham VJ, 2000, MOL CELL BIOL, V20, P6518, DOI 10.1128/MCB.20.17.6518-6536.2000; Gomez-Mouton C, 2004, J CELL BIOL, V164, P759, DOI 10.1083/jcb.200309101; Grande-Garcia A, 2007, J CELL BIOL, V177, P683, DOI 10.1083/jcb.200701006; Lacalle RA, 2002, J CELL BIOL, V157, P277, DOI 10.1083/jcb.200109031; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Makrigiannis AP, 2002, GENOMICS, V79, P437, DOI 10.1006/geno.2002.6724; Manes S, 1999, EMBO J, V18, P6211, DOI 10.1093/emboj/18.22.6211; Manes S, 2001, SEMIN IMMUNOL, V13, P147, DOI 10.1006/smim.2000.0306; Omatsu Y, 2005, J IMMUNOL, V174, P6657, DOI 10.4049/jimmunol.174.11.6657; Parsons JT, 1997, CURR OPIN CELL BIOL, V9, P187, DOI 10.1016/S0955-0674(97)80062-2; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Pierini LM, 2003, J BIOL CHEM, V278, P10831, DOI 10.1074/jbc.M212386200; Polishchuk R, 2004, NAT CELL BIOL, V6, P297, DOI 10.1038/ncb1109; Poole AW, 2005, CELL SIGNAL, V17, P1323, DOI 10.1016/j.cellsig.2005.05.016; RALPH P, 1976, J EXP MED, V143, P1528, DOI 10.1084/jem.143.6.1528; Scarpellino L, 2007, J IMMUNOL, V178, P1277, DOI 10.4049/jimmunol.178.3.1277; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sitrin RG, 2006, J IMMUNOL, V177, P8177, DOI 10.4049/jimmunol.177.11.8177; STOSCHECK CM, 1984, J CELL BIOL, V98, P1048, DOI 10.1083/jcb.98.3.1048; Tai LH, 2007, MOL IMMUNOL, V44, P2638, DOI 10.1016/j.molimm.2006.12.010; Tai LH, 2008, J EXP MED, V205, P3187, DOI 10.1084/jem.20080718; Thelen M, 2001, NAT IMMUNOL, V2, P129, DOI 10.1038/84224; Toyama-Sorimachi N, 2005, J IMMUNOL, V174, P4621, DOI 10.4049/jimmunol.174.8.4621; Toyama-Sorimachi N, 2004, P NATL ACAD SCI USA, V101, P1016, DOI 10.1073/pnas.0305400101; TOYAMASORIMACHI N, 1995, J BIOL CHEM, V270, P7437, DOI 10.1074/jbc.270.13.7437; TSUI FWL, 1994, IMMUNOL REV, V138, P185, DOI 10.1111/j.1600-065X.1994.tb00852.x; Volz A, 2001, IMMUNOL REV, V181, P39, DOI 10.1034/j.1600-065X.2001.1810103.x; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wilhelm BT, 2002, GENOMICS, V80, P646, DOI 10.1006/geno.2002.7004; Wong K, 2006, P NATL ACAD SCI USA, V103, P3639, DOI 10.1073/pnas.0600092103; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Yoshizaki M, 2009, BLOOD, V114, P1518, DOI 10.1182/blood-2008-12-192344; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223; Zhang SQ, 2004, MOL CELL, V13, P341, DOI 10.1016/S1097-2765(04)00050-4; ZIGMOND SH, 1981, J CELL BIOL, V89, P585, DOI 10.1083/jcb.89.3.585	44	27	28	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 26	2010	32	2					200	213		10.1016/j.immuni.2010.01.012	http://dx.doi.org/10.1016/j.immuni.2010.01.012			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	566BX	20153219	Bronze			2022-12-18	WOS:000275346000010
J	Neurath, MF; Finotto, S				Neurath, Markus F.; Finotto, Susetta			Translating Inflammatory Bowel Disease Research into Clinical Medicine	IMMUNITY			English	Article							CHRONIC INTESTINAL INFLAMMATION; CROHNS-DISEASE; EXPERIMENTAL COLITIS; ULCERATIVE-COLITIS; CELLS; ACTIVATION; APOPTOSIS; PATHOGENESIS; IL-23; GAMMA	Recent studies have provided important insights into the pathogenesis of inflammatory bowel disease (IBD). The development of new therapeutic agents has been triggered by basic research and studies in mouse models of IBD. It is expected that improved translational research will lead to optimized therapy and new individualized treatment options.	[Neurath, Markus F.] Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany; [Finotto, Susetta] Johannes Gutenberg Univ Mainz, Inst Mol Med, D-55131 Mainz, Germany	University of Erlangen Nuremberg; Johannes Gutenberg University of Mainz	Neurath, MF (corresponding author), Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany.	markus.neurath@uk-erlangen.de	Finotto, Susetta/H-2753-2019					Abraham C, 2009, INFLAMM BOWEL DIS, V15, P1090, DOI 10.1002/ibd.20894; Atreya R, 2000, NAT MED, V6, P583, DOI 10.1038/75068; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JCI200317464; Duerkop BA, 2009, IMMUNITY, V31, P368, DOI 10.1016/j.immuni.2009.08.009; Fellermann K, 2006, AM J HUM GENET, V79, P439, DOI 10.1086/505915; Fina D, 2008, GASTROENTEROLOGY, V134, P1038, DOI 10.1053/j.gastro.2008.01.041; Heller F, 2005, GASTROENTEROLOGY, V129, P550, DOI 10.1053/j.gastro.2005.05.002; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kamada N, 2008, J CLIN INVEST, V118, P2269, DOI [10.1172/JCI34610, 10.1172/JC134610]; Kleinschek MA, 2009, J EXP MED, V206, P525, DOI 10.1084/jem.20081712; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Maynard CL, 2009, IMMUNITY, V31, P389, DOI 10.1016/j.immuni.2009.08.012; Neurath MF, 2002, J EXP MED, V195, P1129, DOI 10.1084/jem.20011956; Rousseaux C, 2005, J EXP MED, V201, P1205, DOI 10.1084/jem.20041948; SAKURABA A, 2009, GASTROENTER IN PRESS, DOI DOI 10.1053/J.GASTRO.2009.07.049; Sandborn WJ, 2008, GASTROENTEROLOGY, V135, P1130, DOI 10.1053/j.gastro.2008.07.014; Steidler L, 2003, NAT BIOTECHNOL, V21, P785, DOI 10.1038/nbt840; Strober W, 2009, IMMUNITY, V31, P377, DOI 10.1016/j.immuni.2009.09.001; Tiede I, 2003, J CLIN INVEST, V111, P1133, DOI 10.1172/JCI200316432; Van den Brande JMH, 2007, GUT, V56, P509, DOI 10.1136/gut.2006.105379; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Zenewicz LA, 2009, TRENDS MOL MED, V15, P199, DOI 10.1016/j.molmed.2009.03.002; Zhang H, 2008, BRIT MED BULL, V87, P17, DOI 10.1093/bmb/ldn031	26	27	28	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 18	2009	31	3					357	361		10.1016/j.immuni.2009.08.016	http://dx.doi.org/10.1016/j.immuni.2009.08.016			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19766078	Bronze			2022-12-18	WOS:000270525900001
J	Fujita, T				Fujita, Takashi			A Nonself RNA Pattern: Tri-p to Panhandle	IMMUNITY			English	Editorial Material							RIG-I; RECOGNITION; RESPONSES; DOMAIN	In this issue of Immunity, Schlee et al. (2009) defines key RNA structures recognized by a cellular viral sensor, RIG-I. This and another recent report by Schmidt et al. (2009) provide new insights into the mechanism of antiviral innate immunity.	Kyoto Univ, Inst Virus Res, Dept Mol Genet, Kyoto 6068507, Japan	Kyoto University	Fujita, T (corresponding author), Kyoto Univ, Inst Virus Res, Dept Mol Genet, Kyoto 6068507, Japan.	tfujita@virus.kyoto-u.ac.jp						Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	9	27	30	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 17	2009	31	1					4	5		10.1016/j.immuni.2009.06.014	http://dx.doi.org/10.1016/j.immuni.2009.06.014			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	473PN	19604485	Bronze			2022-12-18	WOS:000268219900003
J	Tram, DD; Edgar, CE; Heckman, KL; Sutor, SL; Huntoon, CJ; van Deursen, J; McKean, DL; Bram, RJ				Tram, DD; Edgar, CE; Heckman, KL; Sutor, SL; Huntoon, CJ; van Deursen, J; McKean, DL; Bram, RJ			CAML is a p56(Lck)-interacting protein that is required for thymocyte development	IMMUNITY			English	Article							T-CELL-RECEPTOR; POSITIVE THYMOCYTES; NEGATIVE SELECTION; CYCLOPHILIN LIGAND; TYROSINE 319; ZAP-70; LCK; PHOSPHORYLATION; ACTIVATION; BINDING	Calcium modulating cyclophilin ligand (CAML) is a ubiquitously expressed protein implicated in T cell signaling, although its mechanism and physiologic role in the immune system are unknown. We show here that CAML is essential for peripheral T cell development. Inactivation of CAML in mouse thymocytes lowered the numbers of double-positive and single-positive thymocytes, concomitant with reduced positive and enhanced negative selection. We found that CAML interacts with p56Lck and appears to regulate subcellular localization of the kinase in both resting and T cell receptor (TCR)-stimulated cells. CAML-deficient cells displayed enhanced p561ck and ZAP-70 phosphorylation and increased IL2 production and cell death after TCR stimulation, suggesting that CAML may act as a negative regulator of p561ck. Our data establish a novel role for CAML as an essential mediator of T cell survival during thymopoiesis and indicate that its loss deregulates p56Lck signaling.	Mayo Clin & Mayo Fdn, Coll Med, Dept Immunol, Rochester, MN 55905 USA; Mayo Clin & Mayo Fdn, Coll Med, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Bram, RJ (corresponding author), Mayo Clin & Mayo Fdn, Coll Med, Dept Immunol, 200 1st St SW, Rochester, MN 55905 USA.	bram.richard@mayo.edu			NATIONAL CANCER INSTITUTE [R01CA084195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044959] Funding Source: NIH RePORTER; NCI NIH HHS [CA84195] Funding Source: Medline; NIAID NIH HHS [AI44959] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alonso A, 2004, J BIOL CHEM, V279, P4922, DOI 10.1074/jbc.M308978200; BRAM RJ, 1994, NATURE, V371, P355, DOI 10.1038/371355a0; Cao YJ, 2002, EMBO J, V21, P4809, DOI 10.1093/emboj/cdf499; CHAN AC, 1995, EMBO J, V14, P2499, DOI 10.1002/j.1460-2075.1995.tb07247.x; Chi TH, 2003, IMMUNITY, V19, P169, DOI 10.1016/S1074-7613(03)00199-7; Di Bartolo V, 1999, J BIOL CHEM, V274, P6285, DOI 10.1074/jbc.274.10.6285; Doerfler P, 2000, J IMMUNOL, V164, P4071, DOI 10.4049/jimmunol.164.8.4071; Ehrlich LIR, 2002, IMMUNITY, V17, P809, DOI 10.1016/S1074-7613(02)00481-8; Gabor MJ, 1997, EUR J IMMUNOL, V27, P2010, DOI 10.1002/eji.1830270827; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; GonzalezGarcia A, 1997, J IMMUNOL, V158, P4104; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Holloway MP, 1998, J BIOL CHEM, V273, P16346, DOI 10.1074/jbc.273.26.16346; Holloway MP, 1996, J BIOL CHEM, V271, P8549, DOI 10.1074/jbc.271.15.8549; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; McKean DJ, 2001, J IMMUNOL, V166, P3468, DOI 10.4049/jimmunol.166.5.3468; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; NEUMEISTER EN, 1995, MOL CELL BIOL, V15, P3171; Pelosi M, 1999, J BIOL CHEM, V274, P14229, DOI 10.1074/jbc.274.20.14229; Penna D, 1999, J IMMUNOL, V163, P50; RUEGEMER JJ, 1990, J IMMUNOL, V144, P1767; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Sohn SJ, 2001, J IMMUNOL, V166, P2209, DOI 10.4049/jimmunol.166.4.2209; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stefanova I, 2003, NAT IMMUNOL, V4, P248, DOI 10.1038/ni895; Tran DD, 2003, DEV CELL, V5, P245, DOI 10.1016/S1534-5807(03)00207-7; Trobridge PA, 2001, J IMMUNOL, V166, P809, DOI 10.4049/jimmunol.166.2.809; Tuosto L, 2002, J IMMUNOL, V168, P6106, DOI 10.4049/jimmunol.168.12.6106; vonBulow GU, 1997, SCIENCE, V278, P138, DOI 10.1126/science.278.5335.138; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhao H, 1997, J BIOL CHEM, V272, P21625, DOI 10.1074/jbc.272.34.21625	34	27	31	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2005	23	2					139	152		10.1016/j.immuni.2005.06.006	http://dx.doi.org/10.1016/j.immuni.2005.06.006			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	962HM	16111633	Bronze			2022-12-18	WOS:000231721700005
J	Anderson, AO; Shaw, S				Anderson, AO; Shaw, S			Conduit for privileged communications in the lymph node	IMMUNITY			English	Editorial Material							CD4 T-CELLS; DENDRITIC CELLS; ANTIGEN; CORTEX; ENCOUNTER	A study by Sixt et al. in this issue of Immunity identifies conduit-associated dendritic cells whose privileged access to antigen arriving by the conduit enables uptake and processing of antigen within 90 min of antigen inoculation, long before the arrival of dendritic cells from skin.	USA, Med Res Inst Infect Dis, Dept Clin Pathol, Frederick, MD 21702 USA; NCI, Expt Immunol Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Anderson, AO (corresponding author), USA, Med Res Inst Infect Dis, Dept Clin Pathol, Frederick, MD 21702 USA.				NATIONAL CANCER INSTITUTE [Z01BC009257, ZIABC009257] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Anderson A O, 1993, Semin Immunol, V5, P271, DOI 10.1006/smim.1993.1031; Bajenoff M, 2003, J EXP MED, V198, P715, DOI 10.1084/jem.20030167; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Gretz JE, 1996, J IMMUNOL, V157, P495; HAYAKAWA M, 1988, ARCH HISTOL CYTOL, V51, P233, DOI 10.1679/aohc.51.233; Ingulli E, 2002, J IMMUNOL, V169, P2247, DOI 10.4049/jimmunol.169.5.2247; Itano AA, 2003, IMMUNITY, V19, P47, DOI 10.1016/S1074-7613(03)00175-4; Kaldjian EP, 2001, INT IMMUNOL, V13, P1243, DOI 10.1093/intimm/13.10.1243; Katakai T, 2004, INT IMMUNOL, V16, P1133, DOI 10.1093/intimm/dxh113; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Summers KL, 2001, AM J PATHOL, V159, P285, DOI 10.1016/S0002-9440(10)61694-X	11	27	28	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2005	22	1					3	5		10.1016/j.immuni.2005.01.003	http://dx.doi.org/10.1016/j.immuni.2005.01.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	892XI	15664153	Bronze			2022-12-18	WOS:000226682900001
J	Bhandoola, A; Cibotti, R; Punt, JA; Granger, L; Adams, AJ; Sharrow, SO; Singer, A				Bhandoola, A; Cibotti, R; Punt, JA; Granger, L; Adams, AJ; Sharrow, SO; Singer, A			Positive selection as a developmental progression initiated by alpha beta TCR signals that fix TCR specificity prior to lineage commitment	IMMUNITY			English	Article							T-CELL-RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; THYMOCYTE DEVELOPMENT; CD4(+)CD8(+) THYMOCYTES; NEGATIVE SELECTION; TRANSGENIC MICE; CD8 LINEAGE; EXPRESSION; THYMUS; PRECURSORS	During positive selection, immature thymocytes commit to either the CD4(+) or CD8(+) T cell lineage ("commitment") and convert from short-lived thymocytes into long-lived T cells ("rescue"). By formal precursor-progeny analysis, we now identify what is likely to be the initial positive selection step signaled by alpha beta TCR, which we have termed "induction". During induction, RAG mRNA expression is downregulated, but lineage commitment does not occur. Rather, lineage commitment (which depends upon the MHC class specificity of the alpha beta TCR) only occurs after downregulation of RAG expression and the consequent fixation of alpha beta TCR specificity. We propose that positive selection can be viewed as a sequence of increasingly selective developmental steps (induction-->commitment-->rescue) that are signaled by alpha beta TCR engagements of intrathymic ligands.	NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Singer, A (corresponding author), NCI, Expt Immunol Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.				NATIONAL CANCER INSTITUTE [ZIABC009273, Z01BC009273] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAHAM KM, 1991, J EXP MED, V173, P1421, DOI 10.1084/jem.173.6.1421; Akashi K, 1996, IMMUNITY, V5, P147, DOI 10.1016/S1074-7613(00)80491-4; Akashi K, 1998, P NATL ACAD SCI USA, V95, P2486, DOI 10.1073/pnas.95.5.2486; Anderson G, 1997, EUR J IMMUNOL, V27, P1838, DOI 10.1002/eji.1830270803; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; BORGULYA P, 1991, EMBO J, V10, P913, DOI 10.1002/j.1460-2075.1991.tb08024.x; BRANDLE D, 1994, EUR J IMMUNOL, V24, P145, DOI 10.1002/eji.1830240122; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; GOLDSCHNEIDER I, 1986, J EXP MED, V163, P1, DOI 10.1084/jem.163.1.1; GROETTRUP M, 1993, EUR J IMMUNOL, V23, P1393, DOI 10.1002/eji.1830230633; GROETTRUP M, 1993, CELL, V75, P283, DOI 10.1016/0092-8674(93)80070-U; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; GUIDOS CJ, 1990, J EXP MED, V172, P835, DOI 10.1084/jem.172.3.835; GUIDOS CJ, 1989, P NATL ACAD SCI USA, V86, P7542, DOI 10.1073/pnas.86.19.7542; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; JANEWAY CA, 1988, NATURE, V335, P208, DOI 10.1038/335208a0; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KEARSE KP, 1995, J EXP MED, V181, P193, DOI 10.1084/jem.181.1.193; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; Lever ABP, 1993, PHTHALOCYANINES PROP, V3, P1; LUCAS B, 1993, J IMMUNOL, V151, P4574; LUNDBERG K, 1994, J EXP MED, V179, P1475, DOI 10.1084/jem.179.5.1475; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MARODON G, 1994, EUR J IMMUNOL, V24, P196, DOI 10.1002/eji.1830240131; Marrack P, 1997, CURR OPIN IMMUNOL, V9, P250, DOI 10.1016/S0952-7915(97)80144-6; Merkenschlager M, 1997, J EXP MED, V186, P1149, DOI 10.1084/jem.186.7.1149; MOLINA TJ, 1992, NATURE, V357, P161, DOI 10.1038/357161a0; MOMBAERTS P, 1994, IMMUNITY, V1, P261, DOI 10.1016/1074-7613(94)90077-9; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; PETRIE HT, 1993, J EXP MED, V178, P615, DOI 10.1084/jem.178.2.615; Punt JA, 1996, J EXP MED, V184, P2091, DOI 10.1084/jem.184.6.2091; ROBEY E, 1994, ANNU REV IMMUNOL, V12, P675, DOI 10.1146/annurev.iy.12.040194.003331; ROBEY EA, 1991, CELL, V64, P99, DOI 10.1016/0092-8674(91)90212-H; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; SCOTT B, 1989, NATURE, V338, P591, DOI 10.1038/338591a0; Sheard M, 1996, SCAND J IMMUNOL, V43, P619, DOI 10.1046/j.1365-3083.1996.d01-263.x; SHORES EW, 1993, J IMMUNOL, V150, P1263; SHORTMAN K, 1991, J EXP MED, V173, P323, DOI 10.1084/jem.173.2.323; Shortman K, 1990, Semin Immunol, V2, P3; Singer A., 1986, PROG IMMUNOL, V6, P60; SUZUKI H, 1995, IMMUNITY, V2, P413, DOI 10.1016/1074-7613(95)90149-3; SWAT W, 1994, EUR J IMMUNOL, V24, P1010, DOI 10.1002/eji.1830240436; TAKAHAMA Y, 1992, SCIENCE, V258, P1456, DOI 10.1126/science.1439838; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; VONBOEHMER H, 1993, IMMUNOL REV, V135, P67; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139	54	27	27	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	1999	10	3					301	311		10.1016/S1074-7613(00)80030-8	http://dx.doi.org/10.1016/S1074-7613(00)80030-8			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	181RJ	10204486	Bronze			2022-12-18	WOS:000079455700003
J	Hezaveh, K; Shinde, RS; Klotgen, A; Halaby, MJ; Lamorte, S; Ciudad, MT; Quevedo, R; Neufeld, L; Liu, ZQ; Jin, R; Grunwald, BT; Foerster, EG; Chaharlangi, D; Guo, MD; Makhijani, P; Zhang, X; Pugh, TJ; Pinto, DM; Co, IL; McGuigan, AP; Jang, GH; Khokha, R; Ohashi, PS; O'Kane, GM; Gallinger, S; Navarre, WW; Maughan, H; Philpott, DJ; Brooks, DG; McGaha, TL				Hezaveh, Kebria; Shinde, Rahul S.; Kloetgen, Andreas; Halaby, Marie Jo; Lamorte, Sara; Ciudad, M. Teresa; Quevedo, Rene; Neufeld, Luke; Liu, Zhe Qi; Jin, Robbie; Grunwald, Barbara T.; Foerster, Elisabeth G.; Chaharlangi, Danica; Guo, Mengdi; Makhijani, Priya; Zhang, Xin; Pugh, Trevor J.; Pinto, Devanand M.; Co, Ileana L.; McGuigan, Alison P.; Jang, Gun Ho; Khokha, Rama; Ohashi, Pamela S.; O'Kane, Grainne M.; Gallinger, Steven; Navarre, William W.; Maughan, Heather; Philpott, Dana J.; Brooks, David G.; McGaha, Tracy L.			Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity	IMMUNITY			English	Article							T-CELL DIFFERENTIATION; AROMATIC-AMINO-ACIDS; TRANSCRIPTION FACTOR; CANCER; GUT; HOMEOSTASIS; RESPONSES; ALPHA	The aryl hydrocarbon receptor (AhR) is a sensor of products of tryptophan metabolism and a potent modulator of immunity. Here, we examined the impact of AhR in tumor-associated macrophage (TAM) function in pancreatic ductal adenocarcinoma (PDAC). TAMs exhibited high AhR activity and Ahr-deficient macrophages developed an inflammatory phenotype. Deletion of Ahr in myeloid cells or pharmacologic inhibition of AhR reduced PDAC growth, improved efficacy of immune checkpoint blockade, and increased intra-tumoral frequencies of IFN CD8(+) T cells. Macrophage tryptophan metabolism was not required for this effect. Rather, macrophage AhR activity was dependent on Lactobacillus metabolization of dietary tryptophan to indoles. Removal of dietary tryptophan reduced TAM AhR activity and promoted intra-tumoral accumulation of TNF alpha+IFN gamma(+)CD8(+) T cells; provision of dietary indoles blocked this effect. In patients with PDAC, high AHR expression associated with rapid disease progression and mortality, as well as with an immune-suppressive TAM phenotype, suggesting conservation of this regulatory axis in human disease.	[Hezaveh, Kebria; Shinde, Rahul S.; Halaby, Marie Jo; Lamorte, Sara; Ciudad, M. Teresa; Quevedo, Rene; Neufeld, Luke; Liu, Zhe Qi; Jin, Robbie; Guo, Mengdi; Makhijani, Priya; Zhang, Xin; Pugh, Trevor J.; Ohashi, Pamela S.; Brooks, David G.; McGaha, Tracy L.] Univ Hlth Network, Princess Margaret Canc Ctr, Tumor Immunotherapy Program, Toronto, ON M5G 2M9, Canada; [Kloetgen, Andreas] Helmholtz Ctr Infect Res, Dept Computat Biol Infect Res, D-38124 Braunschweig, Germany; [Neufeld, Luke; Liu, Zhe Qi; Jin, Robbie; Foerster, Elisabeth G.; Guo, Mengdi; Makhijani, Priya; Ohashi, Pamela S.; Philpott, Dana J.; Brooks, David G.; McGaha, Tracy L.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Grunwald, Barbara T.; Khokha, Rama] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 1L7, Canada; [Chaharlangi, Danica; Navarre, William W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Pugh, Trevor J.; Khokha, Rama] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Pugh, Trevor J.; Jang, Gun Ho; O'Kane, Grainne M.; Gallinger, Steven] Ontario Inst Canc Res, Toronto, ON M5G 0A3, Canada; [Pinto, Devanand M.] CNR, Human Hlth Therapeut, Halifax, NS B3H 3Z1, Canada; [Co, Ileana L.; McGuigan, Alison P.] Univ Toronto, Inst Biomed Engn, Toronto, ON M5S 3G9, Canada; [McGuigan, Alison P.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada; [O'Kane, Grainne M.] Univ Toronto, Dept Med, Div Med Oncol, Toronto, ON M5S 3H2, Canada; [Gallinger, Steven] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada; [Gallinger, Steven] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Maughan, Heather] Ronin Inst, Montclair, NJ 07043 USA; [Hezaveh, Kebria] Astra Zeneca, Translat Sci & Expt Med, Res & Early Dev, Resp & Immunol R&I,BioPharmaceut R&D, S-43150 Gothenburg, Sweden; [Shinde, Rahul S.] Wistar Inst Anat & Biol, Immunol Microenvironm & Metastasis Program, Philadelphia, PA 19104 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; Helmholtz Association; Helmholtz-Center for Infection Research; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; National Research Council Canada; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; AstraZeneca; The Wistar Institute	McGaha, TL (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Tumor Immunotherapy Program, Toronto, ON M5G 2M9, Canada.; McGaha, TL (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.	tmcgaha@uhnresearch.ca	Pugh, Trevor/Y-2535-2019; Shinde, Rahul/A-2940-2016	Pugh, Trevor/0000-0002-8073-5888; Foerster, Elisabeth/0000-0002-3271-0782; O'Kane, Grainne/0000-0002-8690-403X; Shinde, Rahul/0000-0001-8767-5032; Jin, Robbie/0000-0003-0761-2491	NIH [R01AR067763, R01CA190449, R01CA255670]; Terry Fox Research Institute New Frontiers Program; Medicine by Design-Canada First Research Excellence Fund; John R. Evans Leaders Fund; Canadian Institutes of Health Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Terry Fox Research Institute New Frontiers Program; Medicine by Design-Canada First Research Excellence Fund; John R. Evans Leaders Fund; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	We thank Kate Banks, Karen Parisien, and Amy Cao from the University of Tor-onto Germ Free Mouse Core for assistance in establishing the germ free ortho-topic PDAC mouse model. In addition, we thank Dr. Kieran Manion for assis-tance with graphical abstract images. We also thank Dr. Hal Berman for pathologic assessment of mouse PDAC tumors. This work was supported by NIH grants R01AR067763, R01CA190449, R01CA255670, the Terry Fox Research Institute New Frontiers Program, Medicine by Design-Canada First Research Excellence Fund, the John R. Evans Leaders Fund, and project grants from the Canadian Institutes of Health Research (T.L.M.) .	Afik R, 2016, J EXP MED, V213, P2315, DOI 10.1084/jem.20151193; Ambarus CA, 2012, J IMMUNOL METHODS, V375, P196, DOI 10.1016/j.jim.2011.10.013; ARAGOZZINI F, 1979, APPL ENVIRON MICROB, V38, P544, DOI 10.1128/AEM.38.3.544-546.1979; Boj SF, 2015, CELL, V160, P324, DOI 10.1016/j.cell.2014.12.021; Braumuller H, 2013, NATURE, V494, P361, DOI 10.1038/nature11824; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cao YH, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00490; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cervantes-Barragan L, 2017, SCIENCE, V357, P806, DOI 10.1126/science.aah5825; Chen X, 2015, FASEB J, V29, P443, DOI 10.1096/fj.14-259564; Chong J, 2020, NAT PROTOC, V15, P799, DOI 10.1038/s41596-019-0264-1; Cuadrado E, 2018, IMMUNITY, V48, P1046, DOI 10.1016/j.immuni.2018.04.008; D'Arcangelo E, 2020, BIOMATERIALS, V228, DOI 10.1016/j.biomaterials.2019.119572; Davar D, 2021, SCIENCE, V371, P595, DOI 10.1126/science.abf3363; de Vries J, 2020, PLANT J, V103, P1025, DOI 10.1111/tpj.14782; Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; DeNardo DG, 2019, NAT REV IMMUNOL, V19, P369, DOI 10.1038/s41577-019-0127-6; Dhariwal A, 2017, NUCLEIC ACIDS RES, V45, pW180, DOI 10.1093/nar/gkx295; Dias S, 2017, IMMUNITY, V46, P78, DOI 10.1016/j.immuni.2016.12.017; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; ELSDEN SR, 1976, ARCH MICROBIOL, V107, P283, DOI 10.1007/BF00425340; Flaveny Colin A, 2009, Mol Cell Pharmacol, V1, P119; Fragale A, 2008, J IMMUNOL, V181, P1673, DOI 10.4049/jimmunol.181.3.1673; Franchini Anthony M, 2019, Immunohorizons, V3, P219, DOI 10.4049/immunohorizons.1900004; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Goudot C, 2017, IMMUNITY, V47, P582, DOI 10.1016/j.immuni.2017.08.016; Halaby MJ, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax8189; Halbrook CJ, 2019, CELL METAB, V29, P1390, DOI 10.1016/j.cmet.2019.02.001; Hubbard TD, 2015, SCI REP-UK, V5, DOI 10.1038/srep12689; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lourenco AR, 2017, ONCOGENE, V36, P5221, DOI 10.1038/onc.2017.151; Maddipati R, 2015, CANCER DISCOV, V5, P1086, DOI 10.1158/2159-8290.CD-15-0120; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Murray IA, 2014, NAT REV CANCER, V14, P801, DOI 10.1038/nrc3846; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pino LK, 2020, MASS SPECTROM REV, V39, P229, DOI 10.1002/mas.21540; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Pushalkar S, 2018, CANCER DISCOV, V8, P403, DOI 10.1158/2159-8290.CD-17-1134; Ravishankar B, 2015, P NATL ACAD SCI USA, V112, P10774, DOI 10.1073/pnas.1504276112; Riquelme E, 2019, CELL, V178, P795, DOI 10.1016/j.cell.2019.07.008; Roager HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05470-4; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rothhammer V, 2018, NATURE, V557, P724, DOI 10.1038/s41586-018-0119-x; Rothhammer V, 2016, NAT MED, V22, P586, DOI 10.1038/nm.4106; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Russell WR, 2013, MOL NUTR FOOD RES, V57, P523, DOI 10.1002/mnfr.201200594; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Shinde R, 2018, TRENDS IMMUNOL, V39, P1005, DOI 10.1016/j.it.2018.10.010; Shinde R, 2018, NAT IMMUNOL, V19, P571, DOI 10.1038/s41590-018-0107-1; Smith EA, 1996, J APPL BACTERIOL, V81, P288, DOI 10.1111/j.1365-2672.1996.tb04331.x; St Paul M, 2020, TRENDS CELL BIOL, V30, P695, DOI 10.1016/j.tcb.2020.06.003; Steele NG, 2020, NAT CANCER, V1, P1097, DOI 10.1038/s43018-020-00121-4; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Takenaka MC, 2019, NAT NEUROSCI, V22, P729, DOI 10.1038/s41593-019-0370-y; Wang LM, 2020, INT J CANCER, V146, P3160, DOI 10.1002/ijc.32733; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Wilck N, 2017, NATURE, V551, P585, DOI 10.1038/nature24628; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Yamauchi T, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133920; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zhu M, 2015, CIRC RES, V117, P967, DOI 10.1161/CIRCRESAHA.115.306919; Zhu Y, 2017, IMMUNITY, V47, P597, DOI 10.1016/j.immuni.2017.08.018	68	26	27	65	121	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					324	+		10.1016/j.immuni.2022.01.006	http://dx.doi.org/10.1016/j.immuni.2022.01.006			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX8WB	35139353				2022-12-18	WOS:000754375200002
J	Orzalli, MH; Prochera, A; Payne, L; Smith, A; Garlick, JA; Kagan, JC				Orzalli, Megan H.; Prochera, Aleksandra; Payne, Laurellee; Smith, Avi; Garlick, Jonathan A.; Kagan, Jonathan C.			Virus-mediated inactivation of anti-apoptotic Bcl-2 family members promotes Gasdermin-E-dependent pyroptosis in barrier epithelial cells	IMMUNITY			English	Article							VESICULAR STOMATITIS-VIRUS; GREEN FLUORESCENT PROTEIN; GENE-EXPRESSION; MATRIX PROTEIN; NLRP1 INFLAMMASOME; BLOCKS APOPTOSIS; INHIBITION; KINASE; HOST; SURVIVAL	Two sets of innate immune proteins detect pathogens. Pattern recognition receptors (PRRs) bind microbial products, whereas guard proteins detect virulence factor activities by the surveillance of homeostatic processes within cells. While PRRs are well known for their roles in many types of infections, the role of guard proteins in most infectious contexts remains less understood. Here, we demonstrated that inhibition of protein synthesis during viral infection is sensed as a virulence strategy and initiates pyroptosis in human keratinocytes. We identified the BCL-2 family members MCL-1 and BCL-xL as sensors of translation shutdown. Virus- or chemical-induced translation inhibition resulted in MCL-1 depletion and inactivation of BCL-xL, leading to mitochondrial damage, caspase-3-dependent cleavage of gasdermin E, and release of interleukin-1 alpha (IL-1 alpha). Blocking this pathway enhanced virus replication in an organoid model of human skin. Thus, MCL-1 and BCL-xL can act as guard proteins within barrier epithelia and contribute to antiviral defense.	[Orzalli, Megan H.; Payne, Laurellee] Univ Massachusetts, Sch Med, Dept Med, Program Innate Immun,Div Infect Dis & Immunol, Worcester, MA 01655 USA; [Orzalli, Megan H.; Prochera, Aleksandra; Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA 01655 USA; [Orzalli, Megan H.; Prochera, Aleksandra; Kagan, Jonathan C.] Harvard Med Sch, Boston, MA 02115 USA; [Prochera, Aleksandra; Kagan, Jonathan C.] Harvard Med Sch, Program Immunol, Longwood Ave, Boston, MA 02115 USA; [Smith, Avi; Garlick, Jonathan A.] Tufts Univ, Sch Dent Med, Dept Diagnost Sci, Boston, MA 02111 USA; [Garlick, Jonathan A.] Tufts Univ, Sackler Grad Sch Biomed Sci, Boston, MA 02111 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Tufts University; Tufts University	Orzalli, MH (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Program Innate Immun,Div Infect Dis & Immunol, Worcester, MA 01655 USA.; Orzalli, MH; Kagan, JC (corresponding author), Boston Childrens Hosp, Div Gastroenterol, Boston, MA 01655 USA.; Orzalli, MH; Kagan, JC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Kagan, JC (corresponding author), Harvard Med Sch, Program Immunol, Longwood Ave, Boston, MA 02115 USA.	megan.orzalli@umassmed.edu; jonathan.kagan@childrens.harvard.edu		Orzalli, Megan/0000-0003-2177-1587	NIAMS Resource-Based Center [P30AR069625]; NIH [AI130258, AI133524, AI093589, AI116550, P30DK34854, 2R44AR072170, 1DP3DK108224]; Charles H. Hood Foundation Child Health Research Award	NIAMS Resource-Based Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charles H. Hood Foundation Child Health Research Award	We would like to thank the members of the Orzalli and Kagan labs for helpful discussions and Dr. Kate Fitzgerald and Dr. Neal Silverman for feedback on the manuscript. We thank the Human Skin Disease Resource Center of Brigham and Women's Hospital and Harvard Medical School for providing critical tissue samples. The Human Skin Disease Resource Center is supported in part by NIAMS Resource-Based Center grant P30AR069625. This work was supported by NIH grants AI130258 (M.H.O.); AI133524, AI093589, AI116550, and P30DK34854 (J.C.K.); and 2R44AR072170 and 1DP3DK108224 (J.A.G.). This work was also supported by a Charles H. Hood Foundation Child Health Research Award (M.H.O.).	Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Ahmed M, 2003, J VIROL, V77, P4646, DOI 10.1128/JVI.77.8.4646-4657.2003; Aizawa E, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101070; Alt-Holland A, 2008, CURR PROTOC CELL BIO; Aubert M, 1999, J VIROL, V73, P2803, DOI 10.1128/JVI.73.4.2803-2813.1999; Balachandran S, 2001, J VIROL, V75, P3474, DOI 10.1128/JVI.75.7.3474-3479.2001; Boyer L, 2011, IMMUNITY, V35, P536, DOI 10.1016/j.immuni.2011.08.015; Campbell S, 2010, J BIOL CHEM, V285, P4695, DOI 10.1074/jbc.M109.053769; Cartier A, 2003, EXP CELL RES, V291, P242, DOI 10.1016/S0014-4827(03)00375-6; Chen KW, 2019, EMBO J, V38, DOI 10.15252/embj.2019101638; Cheng ZX, 2013, CLIN CANCER RES, V19, P1748, DOI 10.1158/1078-0432.CCR-12-3066; Chui AJ, 2019, SCIENCE, V364, P82, DOI 10.1126/science.aau1208; Claerhout S, 2007, J INVEST DERMATOL, V127, P429, DOI 10.1038/sj.jid.5700533; Connor JH, 2005, J BIOL CHEM, V280, P13512, DOI 10.1074/jbc.M501156200; Connor JH, 2002, J VIROL, V76, P10177, DOI 10.1128/JVI.76.20.10177-10187.2002; Czabotar PE, 2014, NAT REV MOL CELL BIO, V15, P49, DOI 10.1038/nrm3722; Datta SR, 2000, MOL CELL, V6, P41, DOI 10.1016/S1097-2765(00)00006-X; Eckard SC, 2014, NAT IMMUNOL, V15, P839, DOI 10.1038/ni.2948; Elgendy M, 2017, J CLIN INVEST, V127, P153, DOI 10.1172/JCI84386; Evavold CL, 2019, IMMUNITY, V51, P609, DOI 10.1016/j.immuni.2019.08.005; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Farag NS, 2020, INT J BIOCHEM CELL B, V122, DOI 10.1016/j.biocel.2020.105738; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Fischer NL, 2020, NAT MICROBIOL, V5, P14, DOI 10.1038/s41564-019-0623-2; Fitzgerald KA, 2020, CELL, V180, P1044, DOI 10.1016/j.cell.2020.02.041; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Holler N, 2000, NAT IMMUNOL, V1, P489, DOI 10.1038/82732; Hong AL, 2019, MOL CANCER RES, V17, P1294, DOI 10.1158/1541-7786.MCR-18-0963; Howley P.M., 2013, PETER FIELDS VIROLOG, V6th; Humphries F, 2020, SCIENCE, V369, P1633, DOI 10.1126/science.abb9818; Ichinohe T, 2010, NAT IMMUNOL, V11, P404, DOI 10.1038/ni.1861; Iwasaki A, 2012, ANNU REV MICROBIOL, V66, P177, DOI 10.1146/annurev-micro-092611-150203; Johnson DC, 2018, NAT MED, V24, P1151, DOI 10.1038/s41591-018-0082-y; Johnson KE, 2008, VIROLOGY, V374, P487, DOI 10.1016/j.virol.2008.01.001; Jones JDG, 2016, SCIENCE, V354, DOI 10.1126/science.aaf6395; Kale J, 2018, CELL DEATH DIFFER, V25, P65, DOI 10.1038/cdd.2017.186; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kopecky SA, 2001, J VIROL, V75, P12169, DOI 10.1128/JVI.75.24.12169-12181.2001; Kovacs SB, 2017, TRENDS CELL BIOL, V27, P673, DOI 10.1016/j.tcb.2017.05.005; Kufer TA, 2019, TRENDS IMMUNOL, V40, P939, DOI 10.1016/j.it.2019.08.001; Lee ASY, 2014, J VIROL, V88, P8355, DOI 10.1128/JVI.00642-14; Mitchell PS, 2019, CURR OPIN IMMUNOL, V60, P37, DOI 10.1016/j.coi.2019.04.015; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Moore BB, 2019, J IMMUNOL, V202, P3, DOI 10.4049/jimmunol.1801485; Munger J, 2001, J VIROL, V75, P5491, DOI 10.1128/JVI.75.12.5491-5497.2001; Neidermyer WJ, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007875; Okondo MC, 2018, CELL CHEM BIOL, V25, P262, DOI 10.1016/j.chembiol.2017.12.013; Orning P, 2019, J EXP MED, V216, P2453, DOI 10.1084/jem.20190545; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Orzalli MH, 2018, MOL CELL, V71, P825, DOI 10.1016/j.molcel.2018.07.009; Palchaudhuri R, 2015, CELL REP, V13, P2027, DOI 10.1016/j.celrep.2015.10.042; Pearce AF, 2009, J VIROL, V83, P9102, DOI 10.1128/JVI.00436-09; Pradhan P, 2013, APOPTOSIS, V18, P160, DOI 10.1007/s10495-012-0773-7; Quan BL, 2014, P NATL ACAD SCI USA, V111, P9127, DOI 10.1073/pnas.1409076111; RICE SA, 1990, J VIROL, V64, P1704, DOI 10.1128/JVI.64.4.1704-1715.1990; Robinson KS, 2020, SCIENCE, V370, P1182, DOI 10.1126/science.aay2002; Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128; SAMANIEGO LA, 1995, J VIROL, V69, P5705, DOI 10.1128/JVI.69.9.5705-5715.1995; Sandstrom A, 2019, SCIENCE, V364, P42, DOI 10.1126/science.aau1330; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Singh R, 2019, NAT REV MOL CELL BIO, V20, P175, DOI 10.1038/s41580-018-0089-8; Steff AM, 2001, CYTOMETRY, V45, P237, DOI 10.1002/1097-0320(20011201)45:4<237::AID-CYTO10024>3.0.CO;2-J; Stern-Ginossar N, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033001; Strebel A, 2001, CYTOMETRY, V43, P126, DOI 10.1002/1097-0320(20010201)43:2<126::AID-CYTO1027>3.0.CO;2-J; Taabazuing CY, 2017, CELL CHEM BIOL, V24, P507, DOI 10.1016/j.chembiol.2017.03.009; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; WHELAN SPJ, 1995, P NATL ACAD SCI USA, V92, P8388, DOI 10.1073/pnas.92.18.8388; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Xu H, 2014, NATURE, V513, P237, DOI 10.1038/nature13449; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yousefzadeh MJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004654; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang ZB, 2020, NATURE, V579, P415, DOI 10.1038/s41586-020-2071-9; Zhong FL, 2018, J BIOL CHEM, V293, P18864, DOI 10.1074/jbc.RA118.004350; Zhou ZW, 2020, SCIENCE, V368, P965, DOI 10.1126/science.aaz7548	79	26	26	6	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1447	+		10.1016/j.immuni.2021.04.012	http://dx.doi.org/10.1016/j.immuni.2021.04.012		JUL 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	33979579	Bronze, Green Accepted			2022-12-18	WOS:000672812100011
J	Dikiy, S; Li, J; Bai, L; Jiang, ML; Janke, L; Zong, XY; Hao, XL; Hoyos, B; Wang, ZM; Xu, BS; Fan, YP; Rudensky, AY; Feng, YQ				Dikiy, Stanislav; Li, Jun; Bai, Lu; Jiang, Menglin; Janke, Laura; Zong, Xinying; Hao, Xiaolei; Hoyos, Beatrice; Wang, Zhong-Min; Xu, Beisi; Fan, Yiping; Rudensky, Alexander Y.; Feng, Yongqiang			A distal Foxp3 enhancer enables interleukin-2 dependent thymic Treg cell lineage commitment for robust immune tolerance	IMMUNITY			English	Article							REGULATORY T-CELLS; FOXP3 EXPRESSION; LETHAL AUTOIMMUNITY; DNA DEMETHYLATION; STAT5 ACTIVATION; SELF-TOLERANCE; IL-2 RECEPTOR; CIS-ELEMENT; TRANSCRIPTION; AIRE	Activation of the STAT5 transcription factor downstream of the Interleukin-2 receptor (IL-2R) induces expression of Foxp3, a critical step in the differentiation of regulatory T (Treg) cells. Due to the pleiotropic effects of IL-2R signaling, it is unclear how STAT5 acts directly on the Foxp3 locus to promote its expression. Here, we report that IL-2 - STAT5 signaling converged on an enhancer (CNS0) during Foxp3 induction. CNS0 facilitated the IL-2 dependent CD25(+)Foxp3(-) precursor to Treg cell transition in the thymus. Its deficiency resulted in impaired Treg cell generation in neonates, which was partially mitigated with age. While the thymic Treg cell paucity caused by CNS0 deficiency did not result in autoimmunity on its own, it exacerbated autoimmune manifestations caused by disruption of the Aire gene. Thus, CNS0 enhancer activity ensures robust Treg cell differentiation early in postnatal life and cooperatively with other tolerance mechanisms minimizes autoimmunity.	[Dikiy, Stanislav; Hoyos, Beatrice; Wang, Zhong-Min; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Dikiy, Stanislav; Hoyos, Beatrice; Wang, Zhong-Min; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, Immunol Program, New York, NY 10065 USA; [Wang, Zhong-Min] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA; [Dikiy, Stanislav] Weill Cornell Grad Sch Med Sci, Lmmunol & Microbial Pathogenesis Program, New York, NY 10021 USA; [Li, Jun; Bai, Lu; Jiang, Menglin; Zong, Xinying; Hao, Xiaolei; Feng, Yongqiang] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Janke, Laura] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Xu, Beisi; Fan, Yiping] St Jude Childrens Res Hosp, Ctr Appl Bioinformat, 332 N Lauderdale St, Memphis, TN 38105 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital	Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, Howard Hughes Med Inst, New York, NY 10065 USA.; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, Immunol Program, New York, NY 10065 USA.; Feng, YQ (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	rudenska@mskcc.org; Yong.Feng@stjude.org	Feng, Yongqiang/AAR-7719-2021; Wang, Zhongmin/GLU-9473-2022; Xu, Beisi/C-8560-2009; Dikiy, Stanislav/GWR-2104-2022	Feng, Yongqiang/0000-0002-2320-5063; Wang, Zhongmin/0000-0002-5538-1969; Xu, Beisi/0000-0003-0099-858X; Dikiy, Stanislav/0000-0002-8287-6561; Bai, Lu/0000-0002-8779-336X; Li, Jun/0000-0002-2611-8918; Hao, Xiaolei/0000-0003-3413-2338	NCI Cancer Center [P30 CA008748, P30 CA021765]; NIH [R37 AI034206, R01 AI153138]; Ludwig Center at the Memorial Sloan Kettering Cancer Center; American Lebanese Syrian Associated Charities; General Atlantic Fellowship	NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Center at the Memorial Sloan Kettering Cancer Center; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); General Atlantic Fellowship	We thank J. Verter and A. Bravo for help with animal husbandry, Y. Zhong for guidance on ATAC-seq analysis, and S. Schattgen for assistance with TCR sequencing. We thank S. Hemmers for generating the Il2<SUP>+/-</SUP> mice. We thank the Memorial Sloan Kettering Integrated Genomics Core facility for performing sequencing. We thank A. Mendoza and S. Hemmers for critical reading of the manuscript and all the members of the Rudensky laboratory for input. This work was supported by the NCI Cancer Center Support Grants P30 CA008748 (MSKCC) and P30 CA021765 (St. Jude), NIH grants R37 AI034206 (A.Y.R.) and R01 AI153138 (Y. Feng), the Ludwig Center at the Memorial Sloan Kettering Cancer Center (A.Y.R.), and the American Lebanese Syrian Associated Charities (Y. Feng). A.Y.R. is an investigator with the Howard Hughes Medical Institute. S.D. was supported by the General Atlantic Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Aschenbrenner K, 2007, NAT IMMUNOL, V8, P351, DOI 10.1038/ni1444; Bagadia P, 2019, NAT IMMUNOL, V20, P1174, DOI 10.1038/s41590-019-0449-3; Bending D, 2018, J CELL BIOL, V217, P2931, DOI 10.1083/jcb.201711048; Bjorses P, 1998, HUM MOL GENET, V7, P1547, DOI 10.1093/hmg/7.10.1547; Blaschke K, 2013, NATURE, V500, P222, DOI 10.1038/nature12362; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Campbell C, 2018, IMMUNITY, V48, P1245, DOI 10.1016/j.immuni.2018.04.013; Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chen ZB, 2005, P NATL ACAD SCI USA, V102, P14735, DOI 10.1073/pnas.0507014102; Chinen T, 2016, NAT IMMUNOL, V17, P1322, DOI 10.1038/ni.3540; Darce J, 2012, IMMUNITY, V36, P731, DOI 10.1016/j.immuni.2012.04.007; Dash P, 2015, METHODS MOL BIOL, V1343, P181, DOI 10.1007/978-1-4939-2963-4_15; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; Fan MY, 2018, CELL REP, V25, P1204, DOI 10.1016/j.celrep.2018.10.002; Feng YQ, 2015, NATURE, V528, P132, DOI 10.1038/nature16141; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Furtado GC, 2002, J EXP MED, V196, P851, DOI 10.1084/jem.20020190; Gaspar J.M., 2020, JSH58 GENRICH; Gaud G, 2018, NAT REV IMMUNOL, V18, P485, DOI 10.1038/s41577-018-0020-8; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Guerau-De-Arellano M, 2009, J EXP MED, V206, P1245, DOI 10.1084/jem.20090300; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hemmers S, 2019, J EXP MED, V216, P2466, DOI 10.1084/jem.20190993; Hernandez-Munain C, 1999, IMMUNITY, V10, P723, DOI 10.1016/S1074-7613(00)80071-0; Herppich S, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02382; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; KANG SM, 1992, MOL CELL BIOL, V12, P3149, DOI 10.1128/MCB.12.7.3149; Kawakami R, 2021, IMMUNITY, V54, P947, DOI 10.1016/j.immuni.2021.04.005; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Kurachi M, 2019, IMMUNITY, V51, P591, DOI 10.1016/j.immuni.2019.09.010; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Levine AG, 2017, J EXP MED, V214, P609, DOI 10.1084/jem.20161318; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Li YX, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-232; Lin W, 2007, NAT IMMUNOL, V8, P359, DOI 10.1038/ni1445; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Malek TR, 2002, IMMUNITY, V17, P167, DOI 10.1016/S1074-7613(02)00367-9; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Moore MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.33057; Nair VS, 2016, J IMMUNOL, V196, P2119, DOI 10.4049/jimmunol.1502352; Nikolouli E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00748; Owen DL, 2019, NAT IMMUNOL, V20, P195, DOI 10.1038/s41590-018-0289-6; Owen DL, 2018, J IMMUNOL, V200, P3926, DOI 10.4049/jimmunol.1800097; Pacholczyk R, 2002, J IMMUNOL, V168, P613, DOI 10.4049/jimmunol.168.2.613; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Perry JSA, 2014, IMMUNITY, V41, P414, DOI 10.1016/j.immuni.2014.08.007; Placek K, 2017, NAT IMMUNOL, V18, P1035, DOI 10.1038/ni.3812; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Popmihajlov Z, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00102; Proekt I, 2017, CURR OPIN IMMUNOL, V49, P71, DOI 10.1016/j.coi.2017.10.003; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team R, 2022, R LANG ENV STAT COMP; Romagnoli P, 2002, J IMMUNOL, V168, P1644, DOI 10.4049/jimmunol.168.4.1644; Rubtsov YP, 2010, SCIENCE, V329, P1667, DOI 10.1126/science.1191996; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2020, ANNU REV IMMUNOL, V38, P541, DOI 10.1146/annurev-immunol-042718-041717; SCHERER MT, 1993, ANNU REV CELL BIOL, V9, P101, DOI 10.1146/annurev.cb.09.110193.000533; Schuster M, 2017, J IMMUNOL, V199, P920, DOI 10.4049/jimmunol.1600877; Sharan SK, 2009, NAT PROTOC, V4, P206, DOI 10.1038/nprot.2008.227; SHEN FW, 1985, P NATL ACAD SCI USA, V82, P7360, DOI 10.1073/pnas.82.21.7360; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/nmeth.2960, 10.1038/NMETH.2960]; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Toomer KH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08960-1; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Yin RC, 2013, J AM CHEM SOC, V135, P10396, DOI 10.1021/ja4028346; Yue XJ, 2016, J EXP MED, V213, P377, DOI 10.1084/jem.20151438; Zemmour D, 2017, P NATL ACAD SCI USA, V114, pE3472, DOI 10.1073/pnas.1700946114; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zorn E, 2006, BLOOD, V108, P1571, DOI 10.1182/blood-2006-02-004747	98	26	27	7	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					931	+		10.1016/j.immuni.2021.03.020	http://dx.doi.org/10.1016/j.immuni.2021.03.020		MAY 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33838102	Green Accepted, Bronze			2022-12-18	WOS:000652019500011
J	Tello-Lafoz, M; Srpan, K; Sanchez, EE; Hu, J; Remsik, J; Romin, Y; Calo, A; Hoen, D; Bhanot, U; Morris, L; Boire, A; Hsu, KC; Massague, J; Huse, M; Er, EE				Tello-Lafoz, Maria; Srpan, Katja; Sanchez, Elisa E.; Hu, Jing; Remsik, Jan; Romin, Yevgeniy; Calo, Annalisa; Hoen, Douglas; Bhanot, Umeshkumar; Morris, Luc; Boire, Adrienne; Hsu, Katharine C.; Massague, Joan; Huse, Morgan; Er, Ekrem Emrah			Cytotoxic lymphocytes target characteristic biophysical vulnerabilities in cancer	IMMUNITY			English	Article							SERUM RESPONSE FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; ACTIN CYTOSKELETON; TUMOR-CELLS; CATCH BONDS; METASTASIS; ACTIVATION; INHIBITION; INTEGRIN; MUTATION	Immune cells identify and destroy tumors by recognizing cellular traits indicative of oncogenic transformation. In this study, we found that myocardin-related transcription factors (MRTFs), which promote migration and metastatic invasion, also sensitize cancer cells to the immune system. Melanoma and breast cancer cells with high MRTF expression were selectively eliminated by cytotoxic lymphocytes in mouse models of metastasis. This immunosurveillance phenotype was further enhanced by treatment with immune checkpoint blockade (ICB) antibodies. We also observed that high MRTF signaling in human melanoma is associated with ICB efficacy in patients. Using biophysical and functional assays, we showed that MRTF overexpression rigidified the filamentous actin cytoskeleton and that this mechanical change rendered mouse and human cancer cells more vulnerable to cytotoxic T lymphocytes and natural killer cells. Collectively, these results suggest that immunosurveillance has a mechanical dimension, which we call mechanosurveillance, that is particularly relevant for the targeting of metastatic disease.	[Tello-Lafoz, Maria; Huse, Morgan] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Srpan, Katja; Hsu, Katharine C.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Sanchez, Elisa E.] Weill Cornell Med Coll, Biochem & Mol Biol Program, New York, NY USA; [Hu, Jing; Massague, Joan; Er, Ekrem Emrah] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA; [Remsik, Jan; Hoen, Douglas; Morris, Luc; Boire, Adrienne] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA; [Romin, Yevgeniy; Calo, Annalisa] Mem Sloan Kettering Canc Ctr, Mol Cytol Core Facil, 1275 York Ave, New York, NY 10021 USA; [Bhanot, Umeshkumar] Mem Sloan Kettering Canc Ctr, Dept Pathol, Precis Pathol Ctr, 1275 York Ave, New York, NY 10021 USA; [Calo, Annalisa] Univ Barcelona, Dept Elect & Biomed Engn, Barcelona, Spain; [Er, Ekrem Emrah] Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Barcelona; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Huse, M (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; Er, EE (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, 1275 York Ave, New York, NY 10021 USA.; Er, EE (corresponding author), Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA.	husem@mskcc.org; eer@uic.edu	Boire, Adrienne/AAA-3578-2022; Boire, Adrienne/AAJ-9352-2021	Boire, Adrienne/0000-0002-9029-1248; Boire, Adrienne/0000-0002-9029-1248; Remsik, Jan/0000-0002-3228-2896; Tello-Lafoz, Maria/0000-0001-8909-6800; Bhanot, Umeshkumar/0000-0001-6656-1239; Sanchez, Elisa/0000-0002-0544-1302	NIH [R01-AI087644, R35-CA252978, R01-AI125651, P30-CA008748]; NSF [CMMI-1562905]; Parker Institute for Cancer Immunotherapy; Gerry Metastasis and Tumor Ecosystems Center; NCATS [UL1TR002003]; Cycle for Survival; Kravis Center for Molecular Oncology; Leukemia and Lymphoma Society; Ramon Areces Foundation; UIC (Department of Physiology and Biophysics funds)	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Parker Institute for Cancer Immunotherapy; Gerry Metastasis and Tumor Ecosystems Center; NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Cycle for Survival; Kravis Center for Molecular Oncology; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Ramon Areces Foundation; UIC (Department of Physiology and Biophysics funds)	We thank C. Firl, L. Stafford, C. Jeronimo, and X. Zheng for technical support; A. Barlas, B. Wang, E. Chan, and the MSKCC Molecular Cytology Core Facility for assistance with imaging and AFM; the MSKCC Animal Imaging Core for bioluminescence imaging; the Integrated Genomics Operation (IGO), Bioinformatics Core, Center for Molecular Oncology, and the Molecular Diagnostics Service at MSKCC for RNA sequencing and analysis; Z.A. Lei and the UIC Research Informatics Core for assistance with GSEA analysis; R.J. Deaton, P.L. Nguyen, and the UIC Department of Pathology Research Imaging Core for image analysis; K. Pham and A. Rudensky for critical reading of the manuscript; N. Biais, F. Paumet, D. Yuan, L.C. Kam, and members of the M.H., J.M., K.C.H., and J.C. Sun labs for advice and assistance. This work was supported in part by the NIH (R01-AI087644 to M.H., R35-CA252978 to J.M., R01AI125651 to K.C.H., and P30-CA008748 to MSKCC), the NSF (CMMI1562905 to M.H.), the Parker Institute for Cancer Immunotherapy (to M.H.), the Gerry Metastasis and Tumor Ecosystems Center (to J.M.), NCATS (UL1TR002003 to UIC and RIC), Cycle for Survival (to IGO), the Kravis Center for Molecular Oncology, the Leukemia and Lymphoma Society (to M.H.), the Ramon Areces Foundation (to M.T.-L.), and UIC (Department of Physiology and Biophysics funds to E.E.E.).	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; Alderton GK, 2013, NAT REV CANCER, V13, P3, DOI 10.1038/nrc3428; Bashour KT, 2014, P NATL ACAD SCI USA, V111, P2241, DOI 10.1073/pnas.1315606111; Basu R, 2016, CELL, V165, P100, DOI 10.1016/j.cell.2016.01.021; Behan FM, 2019, NATURE, V568, P511, DOI 10.1038/s41586-019-1103-9; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Blumenthal D, 2020, ELIFE, V9, DOI 10.7554/eLife.55995; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Bravo-Cordero JJ, 2012, CURR OPIN CELL BIOL, V24, P277, DOI 10.1016/j.ceb.2011.12.004; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Catalanotti F, 2017, JCO PRECIS ONCOL, V1, DOI 10.1200/PO.16.00054; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Comrie WA, 2015, J CELL BIOL, V208, P457, DOI 10.1083/jcb.201406120; David CJ, 2016, CELL, V164, P1015, DOI 10.1016/j.cell.2016.01.009; DeBerardinis RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600200; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; DYE ES, 1986, J IMMUNOL, V136, P1504; Ellrott K, 2018, CELL SYST, V6, P271, DOI 10.1016/j.cels.2018.03.002; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Er EE, 2018, NAT CELL BIOL, V20, P966, DOI 10.1038/s41556-018-0138-8; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Finn OJ, 2018, J IMMUNOL, V200, P385, DOI 10.4049/jimmunol.1701302; Friedland JC, 2009, SCIENCE, V323, P642, DOI 10.1126/science.1168441; Fu JX, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-0721-z; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao QS, 2018, CELL REP, V23, P227, DOI 10.1016/j.celrep.2018.03.050; Gau D, 2018, J CELL SCI, V131, DOI 10.1242/jcs.218222; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Gide TN, 2019, CANCER CELL, V35, P238, DOI 10.1016/j.ccell.2019.01.003; Gonzalez C, 2019, BIOPHYS J, V116, P1516, DOI 10.1016/j.bpj.2019.03.012; Gualdrini F, 2016, MOL CELL, V64, P1048, DOI 10.1016/j.molcel.2016.10.016; Guck J, 2005, BIOPHYS J, V88, P3689, DOI 10.1529/biophysj.104.045476; Hall A, 2009, CANCER METAST REV, V28, P5, DOI 10.1007/s10555-008-9166-3; Harterink M, 2017, NAT METHODS, V14, P479, DOI [10.1038/nmeth.4257, 10.1038/NMETH.4257]; Hernandez C, 2016, ONCOGENE, V35, P5931, DOI 10.1038/onc.2016.104; Hoadley KA, 2018, CELL, V173, P291, DOI 10.1016/j.cell.2018.03.022; Hou HW, 2009, BIOMED MICRODEVICES, V11, P557, DOI 10.1007/s10544-008-9262-8; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Huse M, 2017, NAT REV IMMUNOL, V17, P679, DOI 10.1038/nri.2017.74; Husson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019680; Jacobson K, 2019, CELL, V177, P806, DOI 10.1016/j.cell.2019.04.018; Jiang P, 2018, NAT MED, V24, P1550, DOI 10.1038/s41591-018-0136-1; Judokusumo E, 2012, BIOPHYS J, V102, pL5, DOI 10.1016/j.bpj.2011.12.011; Kai F, 2019, DEV CELL, V49, P332, DOI 10.1016/j.devcel.2019.03.026; Kasza KE, 2009, BIOPHYS J, V96, P4326, DOI 10.1016/j.bpj.2009.02.035; Kienast Y, 2010, NAT MED, V16, P116, DOI 10.1038/nm.2072; Kim T, 2017, EMBO J, V36, P520, DOI 10.15252/embj.201695137; Kong F, 2009, J CELL BIOL, V185, P1275, DOI 10.1083/jcb.200810002; Kong XJ, 2017, NATURE, V550, P270, DOI 10.1038/nature24037; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lawson DA, 2015, NATURE, V526, P131, DOI 10.1038/nature15260; Le Floc'h A, 2013, J EXP MED, V210, P2721, DOI 10.1084/jem.20131324; Lee MS, 2015, IMMUNITY, V43, P227, DOI 10.1016/j.immuni.2015.06.018; Lee SM, 2010, J BIOL CHEM, V285, P22036, DOI 10.1074/jbc.M110.108878; Lesokhin AM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010274; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Liang WS, 2017, GENOME RES, V27, P524, DOI 10.1101/gr.213348.116; Lionarons DA, 2019, CANCER CELL, V36, P68, DOI 10.1016/j.ccell.2019.05.015; Liu BY, 2014, CELL, V157, P357, DOI 10.1016/j.cell.2014.02.053; Liu D, 2019, NAT MED, V25, P1916, DOI 10.1038/s41591-019-0654-5; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Madera S, 2016, J EXP MED, V213, P225, DOI 10.1084/jem.20150712; Maldarelli F, 2014, SCIENCE, V345, P179, DOI 10.1126/science.1254194; Malladi S, 2016, CELL, V165, P45, DOI 10.1016/j.cell.2016.02.025; Medjkane S, 2009, NAT CELL BIOL, V11, P257, DOI 10.1038/ncb1833; Miao D, 2018, NAT GENET, V50, P1271, DOI 10.1038/s41588-018-0200-2; Muehlich S, 2008, MOL CELL BIOL, V28, P6302, DOI 10.1128/MCB.00427-08; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Northcott JM, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00017; Ocana OH, 2012, CANCER CELL, V22, P709, DOI 10.1016/j.ccr.2012.10.012; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Panciera T, 2020, NAT MATER, V19, P797, DOI 10.1038/s41563-020-0615-x; Pommier A, 2018, SCIENCE, V360, P1202, DOI 10.1126/science.aao4908; Ponomarev V, 2004, EUR J NUCL MED MOL I, V31, P740, DOI 10.1007/s00259-003-1441-5; Puram SV, 2018, MOL CELL ONCOL, V5, DOI 10.1080/23723556.2018.1448244; Riaz N, 2017, CELL, V171, P934, DOI 10.1016/j.cell.2017.09.028; Rotsch C, 2000, BIOPHYS J, V78, P520, DOI 10.1016/S0006-3495(00)76614-8; Saitakis M, 2017, ELIFE, V6, DOI 10.7554/eLife.23190; Samstein RM, 2019, NAT GENET, V51, P202, DOI 10.1038/s41588-018-0312-8; Sanchez-Vega F, 2018, CELL, V173, P321, DOI 10.1016/j.cell.2018.03.035; Schneider F, 2017, MOL BIOL CELL, V28, P1507, DOI 10.1091/mbc.E16-07-0536; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schumacher TN, 2019, ANNU REV IMMUNOL, V37, P173, DOI 10.1146/annurev-immunol-042617-053402; Selvaraj A, 2003, J BIOL CHEM, V278, P41977, DOI 10.1074/jbc.M305679200; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Shibue T, 2009, P NATL ACAD SCI USA, V106, P10290, DOI 10.1073/pnas.0904227106; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Suresh S, 2007, ACTA BIOMATER, V3, P413, DOI 10.1016/j.actbio.2007.04.002; Taylor AM, 2018, CANCER CELL, V33, P676, DOI 10.1016/j.ccell.2018.03.007; Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574; Tsai JH, 2012, CANCER CELL, V22, P725, DOI 10.1016/j.ccr.2012.09.022; Usmani SM, 2019, CELL HOST MICROBE, V25, P73, DOI 10.1016/j.chom.2018.12.008; Valiente M, 2014, CELL, V156, P1002, DOI 10.1016/j.cell.2014.01.040; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Van Allen EM, 2014, CANCER DISCOV, V4, P94, DOI 10.1158/2159-8290.CD-13-0617; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wan ZP, 2013, J IMMUNOL, V190, P4661, DOI 10.4049/jimmunol.1202976; Watson IR, 2014, CANCER RES, V74, P4845, DOI 10.1158/0008-5472.CAN-14-1232-T; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wesolowski Jordan, 2017, F1000Res, V6, P2058, DOI 10.12688/f1000research.12316.1; Xu WW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046609; Zhang N, 2011, IMMUNITY, V35, P161, DOI 10.1016/j.immuni.2011.07.010; Zhang Y, 2018, FRONT MED-PRC, V12, P361, DOI 10.1007/s11684-018-0656-6; Zhu C, 2019, NAT IMMUNOL, V20, P1269, DOI 10.1038/s41590-019-0491-1	112	26	26	3	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					1037	+		10.1016/j.immuni.2021.02.020	http://dx.doi.org/10.1016/j.immuni.2021.02.020		MAY 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33756102	Green Accepted, Bronze			2022-12-18	WOS:000652019500018
J	Tang, YT; Wang, XY; Li, ZZ; He, ZH; Yang, XY; Cheng, XY; Peng, Y; Xue, QQ; Bai, Y; Zhang, R; Zhao, K; Liang, F; Xiao, XZ; Andersson, U; Wang, HC; Billiar, TR; Lu, B				Tang, Yiting; Wang, Xiangyu; Li, Zhaozheng; He, Zhihui; Yang, Xinyu; Cheng, Xiaoye; Peng, Yue; Xue, Qianqian; Bai, Yang; Zhang, Rui; Zhao, Kai; Liang, Fang; Xiao, Xianzhong; Andersson, Ulf; Wang, Haichao; Billiar, Timothy R.; Lu, Ben			Heparin prevents caspase-11-dependent septic lethality independent of anticoagulant properties	IMMUNITY			English	Article							GASDERMIN D; INFLAMMASOME ACTIVATION; FACTOR XA; SEPSIS; ANTITHROMBIN; PYROPTOSIS; CASPASES; LOOP	Heparin, a mammalian polysaccharide, is a widely used anticoagulant medicine to treat thrombotic disorders. It is also known to improve outcomes in sepsis, a leading cause of mortality resulted from infection-induced immune dysfunction. Whereas it is relatively clear how heparin exerts its anticoagulant effect, the immunomodulatory mechanisms enabled by heparin remain enigmatic. Here, we show that heparin prevented caspase-11-dependent immune responses and lethality in sepsis independent of its anticoagulant properties. Heparin or a chemically modified form of heparin without anticoagulant function inhibited the alarmin HMGB1-lipopolysaccharide (LPS) interaction and prevented themacrophage glycocalyx degradation by heparanase. These events blocked the cytosolic delivery of LPS in macrophages and the activation of caspase-11, a cytosolic LPS receptor that mediates lethality in sepsis. Survival was higher in septic patients treated with heparin than those without heparin treatment. The identification of this previously unrecognized heparin function establishes a link between innate immune responses and coagulation.	[Tang, Yiting; Wang, Xiangyu; Li, Zhaozheng; He, Zhihui; Yang, Xinyu; Cheng, Xiaoye; Peng, Yue; Xue, Qianqian; Bai, Yang; Zhang, Rui; Zhao, Kai; Liang, Fang; Lu, Ben] Cent South Univ, Xiangya Hosp 3, Dept Crit Care Med & Hematol, Changsha 410000, Peoples R China; [Tang, Yiting] Cent South Univ, Sch Basic Med Sci, Dept Physiol, Changsha 410000, Hunan, Peoples R China; [Xiao, Xianzhong; Lu, Ben] Cent South Univ, Sch Basic Med Sci, Dept Pathophysiol, Changsha 410000, Hunan, Peoples R China; [Xiao, Xianzhong; Lu, Ben] Cent South Univ, Key Lab Sepsis Translat Med Hunan, Changsha 410000, Hunan, Peoples R China; [Andersson, Ulf] Karolinska Inst, Dept Womens & Childrens Hlth, S-17176 Stockholm, Sweden; [Wang, Haichao] Northwell Hlth, Feinstein Inst Med Res, 350 Community Dr, Manhasset, NY 11030 USA; [Billiar, Timothy R.] Univ Pittsburgh, Dept Surg, Med Ctr, Pittsburgh, PA 15213 USA	Central South University; Central South University; Central South University; Central South University; Karolinska Institutet; Northwell Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lu, B (corresponding author), Cent South Univ, Xiangya Hosp 3, Dept Crit Care Med & Hematol, Changsha 410000, Peoples R China.; Lu, B (corresponding author), Cent South Univ, Sch Basic Med Sci, Dept Pathophysiol, Changsha 410000, Hunan, Peoples R China.; Lu, B (corresponding author), Cent South Univ, Key Lab Sepsis Translat Med Hunan, Changsha 410000, Hunan, Peoples R China.	xybenlu@csu.edu.cn	Xiao, Xiao/GQP-7793-2022; Wang, Haichao/AAU-2237-2021; Andersson, Ulf/ABD-5162-2021; Lu, Ben/AAN-1068-2021; xiao, xiang/GWU-6035-2022	Wang, Haichao/0000-0002-0211-9000; Andersson, Ulf/0000-0003-0316-3860; Lu, Ben/0000-0002-8597-0406; 	National Natural Science Foundation of China [82025021, 81930059, 81971893]; Innovation-driven scientific project of CSU [2019CX013]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation-driven scientific project of CSU	The authors thank Professor Rongbin Zhou for sharing mouse strains (Nlrp3<SUP>-/-</SUP> mice), Dr. Kevin J. Tracey for providing recombinant HMGB1 protein, and Professor Feng Shao for providing recombinant caspase-11. We also thank Dr. Jianfeng Wu for in vitro fertilization of mice and Dr.Yanjun Zhong for sharing microbe strains. This work was supported by National Natural Science Foundation of China (No. 82025021 and No. 81930059 to B.L.; No. 81971893 to Y.T.), and was an Innovation-driven scientific project of CSU (No.2019CX013).	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Calis J, 2013, NEW ENGL J MED, V369, P2062, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Cheng KT, 2017, J CLIN INVEST, V127, P4124, DOI 10.1172/JCI94495; Chuang YJ, 2001, J BIOL CHEM, V276, P14961, DOI 10.1074/jbc.M011550200; Cornet AD, 2007, THROMB HAEMOSTASIS, V98, P579, DOI 10.1160/TH07-01-0006; Deng MH, 2018, IMMUNITY, V49, P740, DOI 10.1016/j.immuni.2018.08.016; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fan Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep25984; Gando S, 2013, CRIT CARE, V17, DOI 10.1186/cc13163; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; HIRSH J, 1992, BLOOD, V79, P1; Jaimes F, 2009, CRIT CARE MED, V37, P1185, DOI 10.1097/CCM.0b013e31819c06bc; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Kiyan Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50068-5; Koyama K, 2014, CRIT CARE, V18, DOI 10.1186/cc13190; Li X, 2018, J INTERF CYTOK RES, V38, P283, DOI 10.1089/jir.2018.0042; Li X, 2017, BRIT J HAEMATOL, V179, P389, DOI 10.1111/bjh.14885; Li Y, 2011, CRIT CARE MED, V39, P1104, DOI 10.1097/CCM.0b013e31820eb718; Liu Zhiyong, 2014, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V26, P135, DOI 10.3760/cma.j.issn.2095-4352.2014.03.003; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Popescu NI, 2018, BLOOD, V132, P849, DOI 10.1182/blood-2017-10-813618; Rezaie AR, 2004, BIOCHEMISTRY-US, V43, P2898, DOI 10.1021/bi036145a; Schmidt EP, 2012, NAT MED, V18, P1217, DOI 10.1038/nm.2843; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Vanaja SK, 2016, CELL, V165, P1106, DOI 10.1016/j.cell.2016.04.015; Wang CS, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0563-4; Wang HC, 1999, SCIENCE, V285, P248, DOI 10.1126/science.285.5425.248; Wildhagen KCAA, 2014, BLOOD, V123, P1098, DOI 10.1182/blood-2013-07-514984; Wu CQ, 2019, IMMUNITY, V50, P1401, DOI 10.1016/j.immuni.2019.04.003; Yang LK, 2004, BLOOD, V104, P1753, DOI 10.1182/blood-2004-03-1092; Yang XY, 2020, BLOOD, V135, P1087, DOI 10.1182/blood.2019002282; Yang XY, 2019, IMMUNITY, V51, P983, DOI 10.1016/j.immuni.2019.11.005; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036; Zarychanski R, 2015, CRIT CARE MED, V43, P511, DOI 10.1097/CCM.0000000000000763	40	26	26	5	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					454	+		10.1016/j.immuni.2021.01.007	http://dx.doi.org/10.1016/j.immuni.2021.01.007		MAR 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU		Bronze			2022-12-18	WOS:000627409300013
J	Yan, YQ; Ramanan, D; Rozenberg, M; McGovern, K; Rastelli, D; Vijaykumar, B; Yaghi, O; Voisin, T; Mosaheb, M; Chiu, I; Itzkovitz, S; Rao, M; Mathis, D; Benoist, C				Yan, Yiqing; Ramanan, Deepshika; Rozenberg, Milena; McGovern, Kelly; Rastelli, Daniella; Vijaykumar, Brinda; Yaghi, Omar; Voisin, Tiphaine; Mosaheb, Munir; Chiu, Isaac; Itzkovitz, Shalev; Rao, Meenakshi; Mathis, Diane; Benoist, Christophe			Interleukin-6 produced by enteric neurons regulates the number and phenotype of microbe-responsive regulatory T cells in the gut	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; GENE-RELATED PEPTIDE; NERVOUS-SYSTEM; IMMUNE INTERACTIONS; SENSORY NEURONS; C-MAF; DIFFERENTIATION; ROR-GAMMA-T(+); GENERATION; CULTURE	The immune and enteric nervous (ENS) systems monitor the frontier with commensal and pathogenic microbes in the colon. We investigated whether FoxP3(+) regulatory T (Treg) cells functionally interact with the ENS. Indeed, microbe-responsive ROR gamma(+) and Helios(+) subsets localized in close apposition to nitrergic and peptidergic nerve fibers in the colon lamina propria (LP). Enteric neurons inhibited in vitro Treg (iTreg) differentiation in a cell-contact-independent manner. A screen of neuron-secreted factors revealed a role for interleukin-6 (IL-6) in modulating iTreg formation and their ROR gamma(+) proportion. Colonization of germfree mice with commensals, especially ROR gamma(+) Treg inducers, broadly diminished colon neuronal density. Closing the triangle, conditional ablation of IL-6 in neurons increased total Treg cells but decreased the ROR gamma(+) subset, as did depletion of two ENS neurotransmitters. Our findings suggest a regulatory circuit wherein microbial signals condition neuronal density and activation, thus tuning Treg cell generation and immunological tolerance in the gut.	[Yan, Yiqing; Ramanan, Deepshika; Vijaykumar, Brinda; Yaghi, Omar; Voisin, Tiphaine; Mosaheb, Munir; Chiu, Isaac; Mathis, Diane; Benoist, Christophe] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Rozenberg, Milena; Itzkovitz, Shalev] Weizmann Inst Sci, Dept Mol Cell Biol, IL-7610001 Rehovot, Israel; [McGovern, Kelly; Rastelli, Daniella; Rao, Meenakshi] Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Weizmann Institute of Science; Harvard University; Boston Children's Hospital	Benoist, C (corresponding author), Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA.	cbdm@hms.harvard.edu		Rastelli, Daniella/0000-0002-9631-3401	NIH [AI125603, DK110532, AI30019, AT009499]; JPB Foundation; Broad-ISF exchange; SRAs from UCB; Damon Runyon Cancer Research Foundation [DRG 2300-17]; Evelo Biosciences	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JPB Foundation; Broad-ISF exchange; SRAs from UCB; Damon Runyon Cancer Research Foundation; Evelo Biosciences	We thank Drs. J. Wheaton, A. Munoz-Rojas, M. Ciofani, D. Kasper, and J. Huh, for insightful discussions and advice; L. Yang, A. Diallo, and C. Yapp (HMS IDAC facility) for help with computational analyses; and A. Jacobson, K. Hattori, N. Lai, A. Louis, and S. Soualhi for mice, advice, and assistance. This study benefited from data posted at mousebrain.org. This work was supported by grants AI125603 to C.B. and D.M., DK110532 to M.R., and AI30019 and AT009499 to I.C. from the NIH; by the JPB Foundation to C.B. and D.M.; by the Broad-ISF exchange to S.I. and C.B. and D.M.; and in part by SRAs from UCB and Evelo Biosciences. D.R. was supported by the Damon Runyon Cancer Research Foundation (DRG 2300-17, National Mah Jongg League Fellow).	Al Nabhani Z, 2019, IMMUNITY, V50, P1276, DOI 10.1016/j.immuni.2019.02.014; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; de Jong PR, 2015, MUCOSAL IMMUNOL, V8, P491, DOI 10.1038/mi.2014.82; De Schepper S, 2018, CELL, V175, P400, DOI 10.1016/j.cell.2018.07.048; Drokhlyansky E, 2020, CELL, V182, P1606, DOI 10.1016/j.cell.2020.08.003; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Engel MA, 2012, DIGEST LIVER DIS, V44, P24, DOI 10.1016/j.dld.2011.08.030; Furness JB, 2014, ADV EXP MED BIOL, V817, P39, DOI 10.1007/978-1-4939-0897-4_3; Furness JB, 2013, NAT REV GASTRO HEPAT, V10, P729, DOI 10.1038/nrgastro.2013.180; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Gadient RA, 1997, PROG NEUROBIOL, V52, P379, DOI 10.1016/S0301-0082(97)00021-X; Geva-Zatorsky N, 2017, CELL, V168, P928, DOI 10.1016/j.cell.2017.01.022; Gruol DL, 2015, NEUROPHARMACOLOGY, V96, P42, DOI 10.1016/j.neuropharm.2014.10.023; Hang SY, 2019, NATURE, V576, P143, DOI 10.1038/s41586-019-1785-z; He ZX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05716-z; Huh JR, 2020, NAT REV IMMUNOL, V20, P217, DOI 10.1038/s41577-019-0247-z; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Itzkovitz S, 2012, NAT CELL BIOL, V14, P106, DOI 10.1038/ncb2384; Jain S, 2006, J NEUROSCI, V26, P11230, DOI 10.1523/JNEUROSCI.1876-06.2006; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Joseph NM, 2011, J CLIN INVEST, V121, P3398, DOI 10.1172/JCI58186; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Kulkarni S, 2018, J NEUROSCI, V38, P9346, DOI 10.1523/JNEUROSCI.1663-18.2018; Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009; Lai NY, 2020, CELL, V180, P33, DOI 10.1016/j.cell.2019.11.014; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Liu YW, 2006, NAT MED, V12, P518, DOI 10.1038/nm1402; Margolis KG, 2016, TRENDS IMMUNOL, V37, P487, DOI 10.1016/j.it.2016.05.003; Marz P, 1998, P NATL ACAD SCI USA, V95, P3251, DOI 10.1073/pnas.95.6.3251; Meseguer V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4125; Molofsky AB, 2015, IMMUNITY, V42, P1005, DOI 10.1016/j.immuni.2015.06.006; MULDERRY PK, 1988, NEUROSCIENCE, V25, P195; Muller PA, 2014, CELL, V158, P300, DOI 10.1016/j.cell.2014.04.050; Neumann C, 2019, NAT IMMUNOL, V20, P471, DOI 10.1038/s41590-019-0316-2; Nutsch K, 2016, CELL REP, V17, P206, DOI 10.1016/j.celrep.2016.08.092; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Panduro M, 2016, ANNU REV IMMUNOL, V34, P609, DOI 10.1146/annurev-immunol-032712-095948; Peine M, 2016, TRENDS IMMUNOL, V37, P321, DOI 10.1016/j.it.2016.03.007; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pinho-Ribeiro FA, 2018, CELL, V173, P1083, DOI 10.1016/j.cell.2018.04.006; Pratama A, 2020, J EXP MED, V217, DOI 10.1084/jem.20190428; Quintana A, 2013, BRAIN BEHAV IMMUN, V27, P162, DOI 10.1016/j.bbi.2012.10.011; Ramanan D, 2020, CELL, V181, P1276, DOI 10.1016/j.cell.2020.04.030; Ringheim GE, 1995, J NEUROIMMUNOL, V63, P113, DOI 10.1016/0165-5728(95)00134-4; Sang Q, 1996, CELL TISSUE RES, V284, P39, DOI 10.1007/s004410050565; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Song XY, 2020, NATURE, V577, P410, DOI 10.1038/s41586-019-1865-0; Teratani T, 2020, NATURE, V585, P591, DOI 10.1038/s41586-020-2425-3; Thompson BJ, 2008, DIGEST DIS SCI, V53, P229, DOI 10.1007/s10620-007-9848-7; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Wallrapp A, 2019, IMMUNITY, V51, P709, DOI 10.1016/j.immuni.2019.09.005; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wheaton JD, 2017, J IMMUNOL, V199, P3931, DOI 10.4049/jimmunol.1701134; Wohlfert EA, 2011, J CLIN INVEST, V121, P4503, DOI 10.1172/JCI57456; Wu XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125225; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yadav AN, 2018, NEW AND FUTURE DEVELOPMENTS IN MICROBIAL BIOTECHNOLOGY AND BIOENGINEERING: PENICILLIUM SYSTEM PROPERTIES AND APPLICATIONS, P3, DOI 10.1016/B978-0-444-63501-3.00001-6; Yang BH, 2016, MUCOSAL IMMUNOL, V9, P444, DOI 10.1038/mi.2015.74; Yang NJ, 2017, J MOL BIOL, V429, P587, DOI 10.1016/j.jmb.2016.12.023; Ye J, 2017, CELL REP, V21, P2277, DOI 10.1016/j.celrep.2017.10.114; Yissachar N, 2017, CELL, V168, P1135, DOI 10.1016/j.cell.2017.02.009; Yoo BB, 2017, IMMUNITY, V46, P910, DOI 10.1016/j.immuni.2017.05.011; Zeisel A, 2018, CELL, V174, P999, DOI 10.1016/j.cell.2018.06.021; Zhang YG, 2013, METHODS MOL BIOL, V1078, P55, DOI 10.1007/978-1-62703-640-5_6; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	75	26	26	3	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					499	+		10.1016/j.immuni.2021.02.002	http://dx.doi.org/10.1016/j.immuni.2021.02.002		MAR 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33691135	Bronze, Green Accepted			2022-12-18	WOS:000627409300016
J	Wang, YT; Zolotarev, N; Yang, CY; Rambold, A; Mittler, G; Grosschedl, R				Wang, Yuanting; Zolotarev, Nikolay; Yang, Cheng-Yuan; Rambold, Angelika; Mittler, Gerhard; Grosschedl, Rudolf			A Prion-like Domain in Transcription Factor EBF1 Promotes Phase Separation and Enables B Cell Programming of Progenitor Chromatin	IMMUNITY			English	Article							ENHANCER REPERTOIRES; REGULATORY NETWORK; FATE COMMITMENT; READ ALIGNMENT; EARLY T; PROTEINS; IDENTITY; DIFFERENTIATION; ACTIVATION; OCCUPANCY	Establishment of B-lineage-specific gene expression requires the binding of transcription factors to inaccessible chromatin of progenitors. The transcription factor EBF1 can bind genomic regions prior to the detection of chromatin accessibility in a manner dependent on EBF1's C-terminal domain (CTD) and independent of cooperating transcription factors. Here, we studied the mechanism whereby the CTD enables this pioneering function. The CTD of EBF1 was dispensable for initial chromatin targeting but stabilized occupancy via recruitment of the chromatin remodeler Brg1. We found that the CTD harbors a prion-like domain (PLD) with an ability of liquid-liquid phase separation, which was enhanced by interaction of EBF1 with the RNA-binding protein FUS. Brg1 also partitioned into phase-separated FUS condensates and coincided with EBF1 and FUS foci in pro-B cells. Heterologous PLDs conferred pioneering function on EBF1 Delta CTD. Thus, the phase separation ability of EBF1 facilitates Brg1-mediated chromatin opening and the transition of naive progenitor chromatin to B-lineage-committed chromatin.	[Wang, Yuanting; Zolotarev, Nikolay; Yang, Cheng-Yuan; Rambold, Angelika; Mittler, Gerhard; Grosschedl, Rudolf] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany	Max Planck Society	Grosschedl, R (corresponding author), Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany.	grosschedl@ie-freiburg.mpg.de		Zolotarev, Nikolay/0000-0001-7917-2822	Max Planck Society, Germany	Max Planck Society, Germany(Max Planck Society)	We are grateful to Drs. Anthony Hyman and Jie Wang (Max Planck Institute of Molecular Cell Biology and Genetics, Dresden) for generously providing plasmids and purified FUS protein. We thank Herbert Holzer (Asifa Akhtar lab) for technical help with protein expression in insect cells, Ingrid Falk for technical assistance, and Marika Rott for help in the manuscript preparation. We are grateful to Drs. Simon Alberti, Ritwick Sawarkar, and Eirini Trompouki for discussions and critical reading of the manuscript. We also thank members of the Grosschedl lab for discussions. This work was supported by funds from the Max Planck Society, Germany.	Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Bailey TL, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks433; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Batista CR, 2017, J IMMUNOL, V198, P1565, DOI 10.4049/jimmunol.1601709; Bhardwaj V, 2019, BIOINFORMATICS, V35, P4757, DOI 10.1093/bioinformatics/btz436; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Boller S, 2016, IMMUNITY, V44, P527, DOI 10.1016/j.immuni.2016.02.021; Boller S, 2014, IMMUNOL REV, V261, P102, DOI 10.1111/imr.12206; Bossen C, 2015, NAT IMMUNOL, V16, P775, DOI 10.1038/ni.3170; Boulay G, 2017, CELL, V171, P163, DOI 10.1016/j.cell.2017.07.036; Carrero G, 2003, METHODS, V29, P14, DOI 10.1016/S1046-2023(02)00288-8; Cernilogar FM, 2019, NUCLEIC ACIDS RES, V47, P9069, DOI 10.1093/nar/gkz627; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Choi J, 2012, J IMMUNOL, V188, P3791, DOI 10.4049/jimmunol.1103390; Chong SS, 2018, SCIENCE, V361, DOI 10.1126/science.aar2555; Donaghey J, 2018, NAT GENET, V50, P250, DOI 10.1038/s41588-017-0034-3; Donath P, 2004, LASER SURG MED, P18; Gao H, 2009, P NATL ACAD SCI USA, V106, P11258, DOI 10.1073/pnas.0809485106; Garcia-Alonso L, 2019, GENOME RES, V29, P1363, DOI 10.1101/gr.240663.118; Georgopoulos K, 2002, NAT REV IMMUNOL, V2, P162, DOI 10.1038/nri747; Gibson BA, 2019, CELL, V179, P470, DOI 10.1016/j.cell.2019.08.037; HAGMAN J, 1995, EMBO J, V14, P2907, DOI 10.1002/j.1460-2075.1995.tb07290.x; HAGMAN JD, 1983, J EXP PSYCHOL LEARN, V9, P334, DOI 10.1037/0278-7393.9.2.334; Harrison AF, 2017, BIOCHEM J, V474, P1417, DOI 10.1042/BCJ20160499; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoffmann JA, 2018, ELIFE, V7, DOI 10.7554/eLife.35073; Hosokawa H, 2018, IMMUNITY, V48, P1119, DOI 10.1016/j.immuni.2018.04.024; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Iwafuchi-Doi M, 2016, DEVELOPMENT, V143, P1833, DOI 10.1242/dev.133900; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; King HW, 2017, ELIFE, V6, DOI 10.7554/eLife.22631; Lancaster AK, 2014, BIOINFORMATICS, V30, P2501, DOI 10.1093/bioinformatics/btu310; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Larson AG, 2017, NATURE, V547, P236, DOI 10.1038/nature22822; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li R, 2018, GENE DEV, V32, P96, DOI 10.1101/gad.309583.117; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lin YC, 2012, NAT IMMUNOL, V13, P1196, DOI 10.1038/ni.2432; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Linden M, 2019, EMBO REP, V20, DOI 10.15252/embr.201845766; Malinovska L, 2013, BBA-PROTEINS PROTEOM, V1834, P918, DOI 10.1016/j.bbapap.2013.01.003; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Meers MP, 2019, MOL CELL, V75, P562, DOI 10.1016/j.molcel.2019.05.025; Mercer EM, 2011, IMMUNITY, V35, P413, DOI 10.1016/j.immuni.2011.06.013; Minderjahn J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13960-2; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Morisaki T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5456; Nair SJ, 2019, NAT STRUCT MOL BIOL, V26, P193, DOI 10.1038/s41594-019-0190-5; Nechanitzky R, 2013, NAT IMMUNOL, V14, P867, DOI 10.1038/ni.2641; Nutt SL, 2007, IMMUNITY, V26, P715, DOI 10.1016/j.immuni.2007.05.010; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ranganath S, 2001, MOL CELL BIOL, V21, P2716, DOI 10.1128/MCB.21.8.2716-2725.2001; Revilla-i-Domingo R, 2012, EMBO J, V31, P3130, DOI 10.1038/emboj.2012.155; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Rothenberg EV, 2014, ANNU REV IMMUNOL, V32, P283, DOI 10.1146/annurev-immunol-032712-100024; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Sanulli S, 2019, NATURE, V575, P390, DOI 10.1038/s41586-019-1669-2; Schwartz JC, 2015, ANNU REV BIOCHEM, V84, P355, DOI 10.1146/annurev-biochem-060614-034325; Strom AR, 2017, NATURE, V547, P241, DOI 10.1038/nature22989; Swinstead EE, 2016, BIOESSAYS, V38, P1150, DOI 10.1002/bies.201600137; Swinstead EE, 2016, CELL, V165, P593, DOI 10.1016/j.cell.2016.02.067; Takaku M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0897-0; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Treiber N, 2010, GENE DEV, V24, P2270, DOI 10.1101/gad.1976610; Treiber T, 2010, IMMUNITY, V32, P714, DOI 10.1016/j.immuni.2010.04.013; Ungerback J, 2018, GENOME RES, V28, P1508, DOI 10.1101/gr.231423.117; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Zandi S, 2008, J IMMUNOL, V181, P3364, DOI 10.4049/jimmunol.181.5.3364; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu FJ, 2018, NATURE, V562, P76, DOI 10.1038/s41586-018-0549-5; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	77	26	26	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1151	+		10.1016/j.immuni.2020.10.009	http://dx.doi.org/10.1016/j.immuni.2020.10.009			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33159853	Bronze			2022-12-18	WOS:000599363300007
J	Kolev, M; West, EE; Kunz, N; Chauss, D; Moseman, EA; Rahman, J; Freiwald, T; Balmer, ML; Lotscher, J; Dimeloe, S; Rosser, EC; Wedderburn, LR; Mayer-Barber, KD; Bohrer, A; Lavender, P; Cope, A; Wang, L; Kaplan, MJ; Moutsopoulos, NM; McGavern, D; Holland, SM; Hess, C; Kazemian, M; Afzali, B; Kemper, C				Kolev, Martin; West, Erin E.; Kunz, Natalia; Chauss, Daniel; Moseman, E. Ashley; Rahman, Jubayer; Freiwald, Tilo; Balmer, Maria L.; Lotscher, Jonas; Dimeloe, Sarah; Rosser, Elizabeth C.; Wedderburn, Lucy R.; Mayer-Barber, Katrin D.; Bohrer, Andrea; Lavender, Paul; Cope, Andrew; Wang, Luopin; Kaplan, Mariana J.; Moutsopoulos, Niki M.; McGavern, Dorian; Holland, Steven M.; Hess, Christoph; Kazemian, Majid; Afzali, Behdad; Kemper, Claudia			Diapedesis-Induced Integrin Signaling via LFA-1 Facilitates Tissue Immunity by Inducing Intrinsic Complement C3 Expression in Immune Cells	IMMUNITY			English	Article							T-CELLS; IMMUNOLOGICAL SYNAPSES; MEMORY B; EFFECTOR; ACTIVATION; CD46; ADHESION; TH1; ICAM-1; DIFFERENTIATION	Intrinsic complement C3 activity is integral to human T helper type 1 (Th1) and cytotoxic T cell responses. Increased or decreased intracellular C3 results in autoimmunity and infections, respectively. The mechanisms regulating intracellular C3 expression remain undefined. We identified complement, including C3, as among the most significantly enriched biological pathway in tissue-occupying cells. We generated C3-reporter mice and confirmed that C3 expression was a defining feature of tissue-immune cells, including T cells and monocytes, occurred during transendothelial diapedesis, and depended on integrin lymphocyte-function-associated antigen 1 (LFA-1) signals. Immune cells from patients with leukocyte adhesion deficiency type 1 (LAD-1) had reduced C3 transcripts and diminished effector activities, which could be rescued propor-tionally by intracellular C3 provision. Conversely, increased C3 expression by T cells from arthritis patients correlated with disease severity. Our study defines integrins as key controllers of intracellular complement, demonstrates that perturbations in the LFA-1-C3-axis contribute to primary immunodeficiency, and identifies intracellular C3 as biomarker of severity in autoimmunity.	[Kolev, Martin; West, Erin E.; Kunz, Natalia; Kemper, Claudia] NHLBI, CIRS, NIH, Bldg 10, Bethesda, MD 20892 USA; [Chauss, Daniel; Freiwald, Tilo; Afzali, Behdad] NIDDK, Immunoregulat Sect, Kidney Dis Branch, NIH, Bethesda, MD 20892 USA; [Moseman, E. Ashley; Rahman, Jubayer; McGavern, Dorian] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Balmer, Maria L.; Lotscher, Jonas; Dimeloe, Sarah; Hess, Christoph] Univ Hosp, Dept Biomed, Immunobiol, CH-4031 Basel, Switzerland; [Balmer, Maria L.; Lotscher, Jonas; Dimeloe, Sarah; Hess, Christoph] Univ Basel, CH-4031 Basel, Switzerland; [Dimeloe, Sarah] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham B15 2TT, W Midlands, England; [Rosser, Elizabeth C.; Wedderburn, Lucy R.] UCL, Great Ormond St Inst Child Hlth, Inflammat Programme, Infect,Immun, London WC1N 1EH, England; [Rosser, Elizabeth C.; Wedderburn, Lucy R.] UCL, UCHL, Arthrit Res UK Ctr Adolescent Rheumatol, London WC1N 1EH, England; [Rosser, Elizabeth C.; Wedderburn, Lucy R.] GOSH, London WC1N 1EH, England; [Wedderburn, Lucy R.] Great Ormond St NHS Fdn Trust, Biomed Res Ctr, NIHR, London WC1N 1EH, England; [Mayer-Barber, Katrin D.; Bohrer, Andrea] NIAID, Inflammat & Innate Immun Unit, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lavender, Paul; Cope, Andrew; Kemper, Claudia] Kings Coll London, Fac Life Sci & Med, Sch Immunol & Microbial Sci, London SE1 9RT, England; [Wang, Luopin; Kazemian, Majid] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Wang, Luopin; Kazemian, Majid] Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA; [Kaplan, Mariana J.] Natl Inst Arthrit & Musculoskeletal & Skin Dis NI, Syst Autoimmun Branch, NIH, Bethesda, MD 20892 USA; [Moutsopoulos, Niki M.] NIDCR, Oral Immun & Inflammat Unit, NIH, Bethesda, MD 20892 USA; [Holland, Steven M.] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Hess, Christoph] Univ Cambridge, Dept Med, Cambridge CB2 0AW, England; [Kemper, Claudia] Univ Lubeck, Inst Syst Inflammat Res, D-23562 Lubeck, Germany	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); University of Basel; University of Birmingham; University of London; University College London; University of London; University College London; University of London; King's College London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of London; King's College London; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Cambridge; University of Lubeck	Kemper, C (corresponding author), NHLBI, CIRS, NIH, Bldg 10, Bethesda, MD 20892 USA.; Afzali, B (corresponding author), NIDDK, Immunoregulat Sect, Kidney Dis Branch, NIH, Bethesda, MD 20892 USA.; Kemper, C (corresponding author), Kings Coll London, Fac Life Sci & Med, Sch Immunol & Microbial Sci, London SE1 9RT, England.; Kazemian, M (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.; Kazemian, M (corresponding author), Purdue Univ, Dept Comp Sci, W Lafayette, IN 47907 USA.; Kemper, C (corresponding author), Univ Lubeck, Inst Syst Inflammat Res, D-23562 Lubeck, Germany.	kazemian@purdue.edu; behdad.afzali@nih.gov; claudia.kemper@nih.gov	McGavern, Dorian/HCH-3601-2022; Balmer, Maria Luisa/AAB-8993-2021; Afzali, Behdad/H-8565-2013	McGavern, Dorian/0000-0001-9568-545X; Balmer, Maria Luisa/0000-0003-0356-6352; Chauss, Daniel/0000-0002-8343-0860; Kolev, Martin/0000-0002-7208-3875; Rosser, Elizabeth/0000-0003-4800-4695; Wedderburn, Lucy/0000-0002-7495-1429; Afzali, Behdad/0000-0003-2968-1156; Freiwald, Tilo/0000-0002-4759-717X	MRC Centre [MR/J006742/1]; EU-funded Innovative Medicines Initiative BTCURE; Wellcome Trust [102932/Z/13/Z, 097261/Z/11/Z]; National Heart, Lung, and Blood Institute of the NIH [5K22HL125593]; Guy's and St Thomas' Charity; National Institute for Health Research (NIHR) Biomedical Research Centre at Great Ormond Street NHS Foundation Trust; King's College London BRC Genomics Facility; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; SNSF [31003A_172848]; Intramural Research Program of the NIH, the National Institute of Diabetes and Digestive and Kidney Diseases [ZIA/DK075149]; National Heart, Lung, and Blood Institute [zia/hl006223]	MRC Centre(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU-funded Innovative Medicines Initiative BTCURE; Wellcome Trust(Wellcome TrustEuropean Commission); National Heart, Lung, and Blood Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Guy's and St Thomas' Charity; National Institute for Health Research (NIHR) Biomedical Research Centre at Great Ormond Street NHS Foundation Trust; King's College London BRC Genomics Facility; NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; SNSF(Swiss National Science Foundation (SNSF)); Intramural Research Program of the NIH, the National Institute of Diabetes and Digestive and Kidney Diseases; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the patients and the healthy donors for their support. This work was financed by MRC Centre grant MR/J006742/1; an EU-funded Innovative Medicines Initiative BTCURE (C.K.); a Wellcome Trust Investigator Award (grant 102932/Z/13/Z to C.K); a Wellcome Trust Intermediate Clinical Fellowship (grant 097261/Z/11/Z to B.A.); the National Heart, Lung, and Blood Institute of the NIH (grant 5K22HL125593 to M. Kazemian); a grant from the Guy's and St Thomas' Charity (C.K. and B.A.); the National Institute for Health Research (NIHR) Biomedical Research Centre at Great Ormond Street NHS Foundation Trust (L.R.W. and L.R.); The King's College London BRC Genomics Facility; the NIHR Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; SNSF funding to C.H. (31003A_172848); and in part by the Intramural Research Program of the NIH, the National Institute of Diabetes and Digestive and Kidney Diseases (project number ZIA/DK075149 to B.A.), and the National Heart, Lung, and Blood Institute (project number zia/hl006223 to C.K.).	Abraham C, 1999, J IMMUNOL, V162, P4399; Alcaide P, 2012, J IMMUNOL, V188, P1421, DOI 10.4049/jimmunol.1101647; Novoa EA, 2018, J ALLER CL IMM-PRACT, V6, P1418, DOI 10.1016/j.jaip.2017.12.008; Arbore G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06706-z; Arbore G, 2016, EUR J IMMUNOL, V46, P1563, DOI 10.1002/eji.201546131; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Astier A, 2000, J IMMUNOL, V164, P6091, DOI 10.4049/jimmunol.164.12.6091; Atarashi K, 2005, J IMMUNOL, V174, P1424, DOI 10.4049/jimmunol.174.3.1424; Badell IR, 2010, J CLIN INVEST, V120, P4520, DOI 10.1172/JCI43895; Bianchi E, 2000, NATURE, V404, P617, DOI 10.1038/35007098; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Cassetta L, 2019, CANCER CELL, V35, P588, DOI 10.1016/j.ccell.2019.02.009; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chen ML, 2019, FISH SHELLFISH IMMUN, V86, P196, DOI 10.1016/j.fsi.2018.11.046; Chirathaworn C, 2002, J IMMUNOL, V168, P5530, DOI 10.4049/jimmunol.168.11.5530; Choi EY, 2008, SCIENCE, V322, P1101, DOI 10.1126/science.1165218; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Doh J, 2010, CURR TOP MICROBIOL, V340, P25, DOI 10.1007/978-3-642-03858-7_2; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Ellinghaus U, 2017, EUR J IMMUNOL, V47, P1200, DOI 10.1002/eji.201646822; Elvington M, 2017, J CLIN INVEST, V127, P970, DOI 10.1172/JCI89412; Feigelson SW, 2010, J IMMUNOL, V185, P7394, DOI 10.4049/jimmunol.1002246; Ghannam A, 2008, J IMMUNOL, V181, P5158, DOI 10.4049/jimmunol.181.7.5158; Ghannam A, 2014, MOL IMMUNOL, V58, P98, DOI 10.1016/j.molimm.2013.11.010; Heeger PS, 2012, IMMUNOBIOLOGY, V217, P216, DOI 10.1016/j.imbio.2011.06.004; Hess C, 2016, IMMUNITY, V45, P240, DOI 10.1016/j.immuni.2016.08.003; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hosokawa Y, 2006, CLIN EXP IMMUNOL, V144, P494, DOI 10.1111/j.1365-2249.2006.03064.x; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Jimenez-Reinoso A, 2018, J ALLERGY CLIN IMMUN, V141, P1151, DOI 10.1016/j.jaci.2017.09.037; Kemper C, 2007, NAT REV IMMUNOL, V7, P9, DOI 10.1038/nri1994; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD1284, DOI 10.1093/nar/gkx1188; King BC, 2019, CELL METAB, V29, P202, DOI 10.1016/j.cmet.2018.09.009; Kinoshita SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041725; Kolev M, 2015, IMMUNITY, V42, P1033, DOI 10.1016/j.immuni.2015.05.024; Kolev M, 2014, NAT REV IMMUNOL, V14, P811, DOI 10.1038/nri3761; Kolev M, 2013, SEMIN IMMUNOL, V25, P12, DOI 10.1016/j.smim.2013.04.012; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Laumonnier Y, 2017, MOL IMMUNOL, V89, P44, DOI 10.1016/j.molimm.2017.05.019; Le Friec G, 2012, NAT IMMUNOL, V13, P1213, DOI 10.1038/ni.2454; Liszewski MK, 2017, MOL IMMUNOL, V84, P2, DOI 10.1016/j.molimm.2017.01.004; Liszewski MK, 2013, IMMUNITY, V39, P1143, DOI 10.1016/j.immuni.2013.10.018; Lubbers R, 2017, CLIN EXP IMMUNOL, V188, P183, DOI 10.1111/cei.12952; McNamara HA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aaj1996; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Moutsopoulos NM, 2017, NEW ENGL J MED, V376, P1141, DOI 10.1056/NEJMoa1612197; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Parameswaran N, 2005, J IMMUNOL, V175, P2201, DOI 10.4049/jimmunol.175.4.2201; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tam JCH, 2014, SCIENCE, V345, P1134, DOI 10.1126/science.1256070; Thatte J, 2003, BLOOD, V101, P4916, DOI 10.1182/blood-2002-10-3159; Tsujimura A, 1998, BIOCHEM J, V330, P163, DOI 10.1042/bj3300163; van der Windt GJW, 2012, IMMUNOL REV, V249, P27, DOI 10.1111/j.1600-065X.2012.01150.x; Varga G, 2010, J INVEST DERMATOL, V130, P1005, DOI 10.1038/jid.2009.398; Verma NK, 2016, J IMMUNOL, V197, P108, DOI 10.4049/jimmunol.1501264; Wagner C, 2001, EUR J IMMUNOL, V31, P1173, DOI 10.1002/1521-4141(200104)31:4<1173::AID-IMMU1173>3.0.CO;2-9; Walling BL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00952; Wang GX, 2000, J IMMUNOL, V164, P1839, DOI 10.4049/jimmunol.164.4.1839; West EE, 2018, ANNU REV IMMUNOL, V36, P309, DOI 10.1146/annurev-immunol-042617-053245; Wolach B, 2019, EUR J CLIN INVEST, V49, DOI 10.1111/eci.13047; Yamamoto H, 2013, INT J BIOCHEM CELL B, V45, P2808, DOI 10.1016/j.biocel.2013.09.016; Zhang F, 2019, NAT IMMUNOL, V20, P928, DOI 10.1038/s41590-019-0378-1	70	26	26	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					513	+		10.1016/j.immuni.2020.02.006	http://dx.doi.org/10.1016/j.immuni.2020.02.006			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32187519	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000520600200013
J	Grassmann, S; Pachmayr, LO; Leube, J; Mihatsch, L; Andrae, I; Flommersfeld, S; Oduro, J; Cicin-Sain, L; Schiemann, M; Flossdorf, M; Buchholz, VR				Grassmann, Simon; Pachmayr, Ludwig O.; Leube, Justin; Mihatsch, Lorenz; Andrae, Immanuel; Flommersfeld, Sophie; Oduro, Jennifer; Cicin-Sain, Luka; Schiemann, Matthias; Flossdorf, Michael; Buchholz, Veit R.			Distinct Surface Expression of Activating Receptor Ly49H Drives Differential Expansion of NK Cell Clones upon Murine Cytomegalovirus Infection	IMMUNITY			English	Article							CD4(+) T-CELLS; MEMORY; EFFECTOR; SELECTION; REPERTOIRE; VIRUS; FATE; RECOGNITION; SUBSET	Natural killer (NK) cells show some features of adaptive immunity but have not been studied at the clonal level. Here, we used retrogenic color-barcoding and single-cell adoptive transfers to track clonal immune responses to murine cytomegalovirus (MCMV) infection, derived from individual NK cells expressing activating receptor Ly49H. Clonal expansion of single NK cells varied substantially, and this variation could not be attributed to the additional presence or absence of inhibitory Ly49 receptors. Instead, single-cell-derived variability correlated with distinct surface expression levels of Ly49H itself. Ly49H(hi) NK cell clones maintained higher Ly49H expression and expanded more than their Ly49H(lo) counterparts in response to MCMV. Thus, akin to adaptive processes shaping an antigen-specific T cell receptor (TCR) repertoire, the Ly49H(+) NK cell population adapts to MCMV infection. This process relies on the clonal maintenance of distinct Ly49H expression levels, generating a repertoire of individual NK cells outfitted with distinct reactivity to MCMV.	[Grassmann, Simon; Pachmayr, Ludwig O.; Leube, Justin; Mihatsch, Lorenz; Andrae, Immanuel; Flommersfeld, Sophie; Schiemann, Matthias; Flossdorf, Michael; Buchholz, Veit R.] TUM, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Oduro, Jennifer; Cicin-Sain, Luka] Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Hannover Braunschweig Site, D-38124 Braunschweig, Germany; [Cicin-Sain, Luka] Hannover Med Sch MHH, Cluster Excellence RESIST EXC 2155, Braunschweig, Germany	Technical University of Munich; Helmholtz Association; Helmholtz-Center for Infection Research	Buchholz, VR (corresponding author), TUM, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany.	veit.buchholz@tum.de	Buchholz, Veit R./AAF-6966-2021; Cicin-Sain, Luka/S-7504-2018	Buchholz, Veit R./0000-0003-0441-3913; Cicin-Sain, Luka/0000-0003-3978-778X; Andra, Immanuel/0000-0003-1543-9158; Mihatsch, Lorenz Leopold/0000-0003-3835-7964	TUM Seed Funds (SCIMAP); Helmholtz association [PIE-008];  [SFB 1054];  [272983813];  [TRR 179]	TUM Seed Funds (SCIMAP); Helmholtz association(Helmholtz Association); ; ; 	The authors thank I. Hensel for technical support and K. Schober, L. Kretschmer, D. Busch, M. Rapp, G. Wiedemann, and G. Gasteiger for helpful discussion and/or critically reading the manuscript. We thank N. Adams and J. Sun for sharing their manuscript with us before publication. The data presented in this work are tabulated in the main manuscript and in the supplementary materials. This work was supported by the SFB 1054 (TP-B09) and the TUM Seed Funds (SCIMAP). L.C.S. was supported by the Helmholtz association (PIE-008). M.S. was supported by TRR 179 (no. 272983813).	Adams NM, 2019, IMMUNITY, V50, P1381, DOI 10.1016/j.immuni.2019.04.009; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Bolanos FD, 2011, J IMMUNOL, V186, P2765, DOI 10.4049/jimmunol.1003046; Borkner L, 2017, J IMMUNOL, V199, P1737, DOI 10.4049/jimmunol.1602115; Buchholz VR, 2018, ADV IMMUNOL, V137, P1, DOI 10.1016/bs.ai.2017.12.001; Buchholz VR, 2016, ANNU REV IMMUNOL, V34, P65, DOI 10.1146/annurev-immunol-032414-112014; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Cho YL, 2017, CELL REP, V20, P806, DOI 10.1016/j.celrep.2017.07.005; Daniels KA, 2001, J EXP MED, V194, P29, DOI 10.1084/jem.194.1.29; Day EK, 2007, J IMMUNOL, V179, P3203, DOI 10.4049/jimmunol.179.5.3203; Dekhtiarenko I, 2013, J IMMUNOL, V190, P3399, DOI 10.4049/jimmunol.1203173; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Flossdorf M, 2015, NAT IMMUNOL, V16, P891, DOI 10.1038/ni.3235; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Gerlach C, 2010, J EXP MED, V207, P1235, DOI 10.1084/jem.20091175; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Hammer Q, 2018, NAT IMMUNOL, V19, P453, DOI 10.1038/s41590-018-0082-6; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Kamimura Y, 2015, CELL REP, V10, P280, DOI 10.1016/j.celrep.2014.12.025; Lanzavecchia A, 2002, NAT REV IMMUNOL, V2, P982, DOI 10.1038/nri959; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Nabekura T, 2016, IMMUNITY, V45, P74, DOI 10.1016/j.immuni.2016.06.024; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; Orr MT, 2010, NAT IMMUNOL, V11, P321, DOI 10.1038/ni.1849; Plumlee CR, 2013, IMMUNITY, V39, P347, DOI 10.1016/j.immuni.2013.07.014; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Schepers K, 2008, J EXP MED, V205, P2309, DOI 10.1084/jem.20072462; Schumacher TNM, 2010, NAT REV IMMUNOL, V10, P621, DOI 10.1038/nri2822; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Sun JC, 2011, NAT REV IMMUNOL, V11, P645, DOI 10.1038/nri3044; Sun JC, 2009, J IMMUNOL, V183, P2911, DOI 10.4049/jimmunol.0901872; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Taylor JJ, 2015, SCIENCE, V347, P784, DOI 10.1126/science.aaa1342; Trautmann L, 2005, J IMMUNOL, V175, P6123, DOI 10.4049/jimmunol.175.9.6123; Tubo NJ, 2016, SCIENCE, V351, P511, DOI 10.1126/science.aad0483; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Voigt V, 2003, P NATL ACAD SCI USA, V100, P13483, DOI 10.1073/pnas.2233572100; Weber K, 2011, NAT MED, V17, P504, DOI 10.1038/nm.2338; Williams MA, 2008, IMMUNITY, V28, P533, DOI 10.1016/j.immuni.2008.02.014; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	47	26	26	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1391	+		10.1016/j.immuni.2019.04.015	http://dx.doi.org/10.1016/j.immuni.2019.04.015			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31103380	Bronze			2022-12-18	WOS:000471876100011
J	Lindner, JM; Cornacchione, V; Sathe, A; Be, C; Srinivas, H; Riquet, E; Leber, XC; Hein, A; Wrobel, MB; Scharenberg, M; Pietzonka, T; Wiesmann, C; Abend, J; Traggiai, E				Lindner, John M.; Cornacchione, Vanessa; Sathe, Atul; Be, Celine; Srinivas, Honnappa; Riquet, Elodie; Leber, Xavier-Charles; Hein, Andreas; Wrobel, Matthias B.; Scharenberg, Meike; Pietzonka, Thomas; Wiesmann, Christian; Abend, Johanna; Traggiai, Elisabetta			Human Memory B Cells Harbor Diverse Cross-Neutralizing Antibodies against BK and JC Polyomaviruses	IMMUNITY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; RESPONSES; AFFINITY; EXPRESSION; GENERATION; CONSTANT; VIRUSES; DOMAIN	Human polyomaviruses cause a common childhood infection worldwide and typically elicit a neutralizing antibody and cellular immune response, while establishing a dormant infection in the kidney with minimal clinical manifestations. However, viral reactivation can cause severe pathology in immunocompromised individuals. We developed a high-throughput, functional antibody screen to examine the humoral response to BK polyomavirus. This approach enabled the isolation of antibodies from all peripheral B cell subsets and revealed the anti-BK virus antibody repertoire as clonally complex with respect to immunoglobulin sequences and isotypes (both IgM and IgG), including a high frequency of monoclonal antibodies that broadly neutralize BK virus subtypes and the related JC polyomavirus. Cryo-electron microscopy of a broadly neutralizing IgG single-chain variable fragment complexed with BK virus-like particles revealed the quaternary nature of a conserved viral epitope at the junction between capsid pentamers. These features unravel a potent modality for inhibiting polyomavirus infection in kidney transplant recipients and other immunocompromised patients.	[Lindner, John M.; Cornacchione, Vanessa; Sathe, Atul; Be, Celine; Srinivas, Honnappa; Riquet, Elodie; Leber, Xavier-Charles; Hein, Andreas; Wrobel, Matthias B.; Scharenberg, Meike; Pietzonka, Thomas; Wiesmann, Christian; Abend, Johanna; Traggiai, Elisabetta] Novartis Inst BioMed Res, Basel, Switzerland; [Lindner, John M.; Cornacchione, Vanessa; Sathe, Atul; Be, Celine; Srinivas, Honnappa; Riquet, Elodie; Leber, Xavier-Charles; Hein, Andreas; Wrobel, Matthias B.; Scharenberg, Meike; Pietzonka, Thomas; Wiesmann, Christian; Abend, Johanna; Traggiai, Elisabetta] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Lindner, John M.; Cornacchione, Vanessa; Sathe, Atul; Be, Celine; Srinivas, Honnappa; Riquet, Elodie; Leber, Xavier-Charles; Hein, Andreas; Wrobel, Matthias B.; Scharenberg, Meike; Pietzonka, Thomas; Wiesmann, Christian; Abend, Johanna; Traggiai, Elisabetta] Novartis Inst BioMed Res, Emeryville, CA 94608 USA	Novartis; Novartis; Novartis	Traggiai, E (corresponding author), Novartis Inst BioMed Res, Basel, Switzerland.; Traggiai, E (corresponding author), Novartis Inst BioMed Res, Cambridge, MA 02139 USA.; Traggiai, E (corresponding author), Novartis Inst BioMed Res, Emeryville, CA 94608 USA.	elisabetta.traggiai@novartis.com	lindner, john/ABD-7765-2020	Wrobel, Matthias B./0000-0003-0767-2160; Wiesmann, Christian/0000-0002-4092-9880				Abend JR, 2007, J VIROL, V81, P272, DOI 10.1128/JVI.01571-06; Abend JR, 2017, TRANSPLANTATION, V101, P1495, DOI [10.1097/tp.0000000000001261, 10.1097/TP.0000000000001261]; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banchereau J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00055; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Day PM, 2007, J VIROL, V81, P8784, DOI 10.1128/JVI.00552-07; Dugan AS, 2007, J VIROL, V81, P11798, DOI 10.1128/JVI.01316-07; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FLOWER AJE, 1977, BRIT MED J, V2, P220, DOI 10.1136/bmj.2.6081.220; FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4; GORNY MK, 1993, J IMMUNOL, V150, P635; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Grant T, 2015, ELIFE, V4, DOI 10.7554/eLife.06980; Haley SA, 2017, ANNU REV VIROL, V4, P349, DOI 10.1146/annurev-virology-101416-041439; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Hofmeister Y, 2011, J VIROL, V85, P1896, DOI 10.1128/JVI.02155-10; Huang JH, 2013, NAT PROTOC, V8, P1907, DOI 10.1038/nprot.2013.117; Hurdiss DL, 2016, STRUCTURE, V24, P528, DOI 10.1016/j.str.2016.02.008; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwakkenbos MJ, 2010, NAT MED, V16, P123, DOI 10.1038/nm.2071; Lamarche C, 2016, TRANSPLANTATION, V100, P2276, DOI 10.1097/TP.0000000000001333; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Liu W, 2016, CURR OPIN VIROL, V20, P20, DOI 10.1016/j.coviro.2016.07.011; McCarthy KR, 2018, IMMUNITY, V48, P174, DOI 10.1016/j.immuni.2017.12.009; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Pasare C, 2005, NATURE, V438, P364, DOI 10.1038/nature04267; Potzsch S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002172; Rathanaswami P, 2008, ANAL BIOCHEM, V373, P52, DOI 10.1016/j.ab.2007.08.014; Schena F, 2013, CELL REP, V3, P1824, DOI 10.1016/j.celrep.2013.05.022; Scheres SHW, 2014, ELIFE, V3, DOI 10.7554/eLife.03665; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sharma PM, 2006, J VIROL, V80, P8869, DOI 10.1128/JVI.00510-06; SITIA R, 1990, CELL, V60, P781, DOI 10.1016/0092-8674(90)90092-S; TEW JG, 1990, IMMUNOL REV, V117, P185, DOI 10.1111/j.1600-065X.1990.tb00573.x; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Torres M, 2008, TRENDS IMMUNOL, V29, P91, DOI 10.1016/j.it.2007.11.004; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Yogo Y, 2009, REV MED VIROL, V19, P185, DOI 10.1002/rmv.613	39	26	27	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					668	+		10.1016/j.immuni.2019.02.003	http://dx.doi.org/10.1016/j.immuni.2019.02.003			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30824324	Bronze			2022-12-18	WOS:000461660500017
J	Abe, T; Sitharam, ALR; Sitharam, R; Kesner, J; Rabadan, R; Shapira, SD				Abe, Takayuki; Lee, Albert; Sitharam, Ramaswami; Kesner, Jordan; Rabadan, Raul; Shapira, Sagi D.			Germ-Cell-Specific Inflammasome Component NLRP14 Negatively Regulates Cytosolic Nucleic Acid Sensing to Promote Fertilization	IMMUNITY			English	Article							NF-KAPPA-B; PATHOGEN RECOGNITION; ANTIVIRAL IMMUNITY; MOUSE OOCYTES; GENE; INFECTION; ACTIVATION; PATHWAYS; PROTEIN; NLRX1	Cytosolic sensing of nucleic acids initiates tightly regulated programs to limit infection. Oocyte fertilization represents a scenario wherein inappropriate responses to exogenous yet non-pathogen-derived nucleic acids would have negative consequences. We hypothesized that germ cells express negative regulators of nucleic acid sensing (NAS) in steady state and applied an integrated data-mining and functional genomics approach to identify a rheostat of DNA and RNA sensing-the inflammasome component NLRP14. We demonstrated that NLRP14 interacted physically with the nucleic acid sensing pathway and targeted TBK1 (TANK binding kinase 1) for ubiquitination and degradation. We further mapped domains in NLRP14 and TBK1 that mediated the inhibitory function. Finally, we identified a human nonsense germline variant associated with male sterility that results in loss of NLRP14 function and hyper-responsiveness to nucleic acids. The discovery points to a mechanism of nucleic acid sensing regulation that may be of particular importance in fertilization.	[Abe, Takayuki; Lee, Albert; Sitharam, Ramaswami; Kesner, Jordan; Rabadan, Raul; Shapira, Sagi D.] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Abe, Takayuki; Sitharam, Ramaswami; Kesner, Jordan; Shapira, Sagi D.] Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA; [Lee, Albert; Rabadan, Raul] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Abe, Takayuki] Kobe Univ, Grad Sch Med, Div Infect Dis Control Ctr Infect Dis, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan	Columbia University; Columbia University; Columbia University; Kobe University	Shapira, SD (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10032 USA.; Shapira, SD (corresponding author), Columbia Univ, Dept Microbiol & Immunol, New York, NY 10032 USA.	ss4197@columbia.edu	Rabadan, Raul/AAZ-7367-2020	Shapira, Sagi/0000-0002-5425-3682; Rabadan, Raul/0000-0001-7946-9255	NIH [GM109018-04, CA121852-07, GM117591-01, GM109018];  [HDTRA1-14-1-0016]; NATIONAL CANCER INSTITUTE [U54CA121852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109018, R01GM117591] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012351, S10OD021764] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	S.D.S. acknowledges funding from NIH R01 (GM109018-04) and NIH U54 (CA121852-07). R.R. acknowledges NIH R01 (GM117591-01), NIH R01 (GM109018), and HDTRA1-14-1-0016. Finally, we would like to thank Stephen P. Goff, Vincent Racaniello, and Saul Silverstein at Columbia University for discussions and critical reading of the manuscript.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Barber GN, 2015, NAT REV IMMUNOL, V15, P760, DOI 10.1038/nri3921; Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Chen GY, 2014, EUR J IMMUNOL, V44, P321, DOI 10.1002/eji.201344135; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Cui J, 2010, CELL, V141, P483, DOI 10.1016/j.cell.2010.03.040; de Almeida L, 2015, IMMUNITY, V43, P264, DOI 10.1016/j.immuni.2015.07.018; Fujisawa M, 1998, ARCH ANDROLOGY, V40, P211, DOI 10.3109/01485019808987944; Green RA, 2011, CELL, V145, P470, DOI 10.1016/j.cell.2011.03.037; Guo HT, 2016, CELL HOST MICROBE, V19, P515, DOI 10.1016/j.chom.2016.03.001; Hamatani T, 2004, HUM MOL GENET, V13, P2263, DOI 10.1093/hmg/ddh241; He Y, 2016, NATURE, V530, P354, DOI 10.1038/nature16959; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jia KL, 2009, P NATL ACAD SCI USA, V106, P14564, DOI 10.1073/pnas.0813319106; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kufer TA, 2011, NAT IMMUNOL, V12, P121, DOI 10.1038/ni.1985; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kumar H, 2011, J IMMUNOL, V186, P994, DOI 10.4049/jimmunol.1002094; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lupfer C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00285; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Satie AP, 2011, J BIOL CHEM, V286, P23280, DOI 10.1074/jbc.M111.229120; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; Shi HX, 2016, NAT IMMUNOL, V17, P250, DOI 10.1038/ni.3333; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Tian X, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-202; Ulusoy E, 2004, ARCH ANDROLOGY, V50, P379, DOI 10.1080/01485010490474823; Wang PH, 2015, SCIENCE, V350, P826, DOI 10.1126/science.aab3145; Wang SF, 2010, P NATL ACAD SCI USA, V107, P17639, DOI 10.1073/pnas.1013185107; Westerveld GH, 2006, HUM REPROD, V21, P3178, DOI 10.1093/humrep/del293; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Yan LY, 2013, NAT STRUCT MOL BIOL, V20, P1131, DOI 10.1038/nsmb.2660; Yurttas P, 2010, REPRODUCTION, V139, P809, DOI 10.1530/REP-09-0538; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010; Zhao W, 2013, FEBS LETT, V587, P542, DOI 10.1016/j.febslet.2013.01.052	43	26	27	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					621	634		10.1016/j.immuni.2017.03.020	http://dx.doi.org/10.1016/j.immuni.2017.03.020			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28423339	Green Accepted, Bronze			2022-12-18	WOS:000399451100015
J	Li, SY; Heller, JJ; Bostick, JW; Lee, A; Schjerven, H; Kastner, P; Chan, S; Chen, ZME; Zhou, L				Li, Shiyang; Heller, Jennifer J.; Bostick, John W.; Lee, Aileen; Schjerven, Hilde; Kastner, Philippe; Chan, Susan; Chen, Zongming E.; Zhou, Liang			Ikaros Inhibits Group 3 Innate Lymphoid Cell Development and Function by Suppressing the Aryl Hydrocarbon Receptor Pathway	IMMUNITY			English	Article							TISSUE INDUCER CELLS; INTESTINAL INFLAMMATION; GENE-EXPRESSION; IMMUNE-SYSTEM; T-CELLS; IDENTIFICATION; MICROBIOTA; MICE; DIFFERENTIATION; HOMEOSTASIS	Group 3 innate lymphoid cells (ILC3s) expressing the transcription factor (TF) ROR gamma t are important for the defense and homeostasis of host intestinal tissues. The zinc finger TF Ikaros, encoded by Ikzf1, is essential for the development of ROR gamma t(+) fetal lymphoid tissue inducer (LTi) cells and lymphoid organogenesis, but its role in postnatal ILC3s is unknown. Here, we show that small-intestinal ILC3s had lower Ikaros expression than ILC precursors and other ILC subsets. Ikaros inhibited ILC3s in a cell-intrinsic manner through zinc-finger-dependent inhibition of transcriptional activity of the aryl hydrocarbon receptor, a key regulator of ILC3 maintenance and function. Ablation of Ikzf1 in ROR gamma t(+) ILC3s resulted in increased expansion and cytokine production of intestinal ILC3s and protection against infection and colitis. Therefore, in contrast to being required for LTi development, Ikaros inhibits postnatal ILC3 development and function to regulate gut immune responses at steady state and in disease.	[Li, Shiyang; Heller, Jennifer J.; Bostick, John W.; Lee, Aileen; Zhou, Liang] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Li, Shiyang; Heller, Jennifer J.; Bostick, John W.; Lee, Aileen; Zhou, Liang] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Li, Shiyang; Zhou, Liang] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32608 USA; [Bostick, John W.] Northwestern Univ, McCormick Sch Engn, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Schjerven, Hilde] UCSF Sch Med, Dept Lab Med, San Francisco, CA 94143 USA; [Kastner, Philippe; Chan, Susan] Univ Strasbourg, Inst Genet & Biol Mol & Cellulaire, INSERM, U964,CNRS,UMR 7104, F-67404 Illkirch Graffenstaden, France; [Chen, Zongming E.] Geisinger Hlth Syst, Dept Lab Med, 100 N Acad Ave,MC 19-20, Danville, PA 17822 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; State University System of Florida; University of Florida; Northwestern University; University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Geisinger Health System	Zhou, L (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA.; Zhou, L (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA.; Zhou, L (corresponding author), Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL 32608 USA.	liangzhou497@ufl.edu	; Schjerven, Hilde/I-1437-2013	Bostick, John/0000-0001-8925-2447; Schjerven, Hilde/0000-0001-9287-3375	NIH [CA60553, AI089954, DK105562]; Cancer Research Institute; Burroughs Wellcome Fund; Pew Charitable Trusts; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089954] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105562] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Pew Charitable Trusts; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the entire L.Z. laboratory for help and suggestions and the Transgenic and Targeted Mutagenesis Laboratory (TTML) at Northwestern University (Dr. L. Doglio) for services and assistance. The TTML is partially supported by NIH grant CA60553 to the Robert H. Lurie Comprehensive Cancer Center at Northwestern University. We thank Drs. S. Swaminathan and C. Goolsby (Flow Cytometry Facility, Northwestern University) for assisting with cell sorting, Dr. M. Denison for providing pGudLuc6.1 luciferase plasmid, and Dr. D. Fang for supporting the luciferase assay. We also thank Drs. S.T. Smale and D. Avarm for advice and critical reading of the manuscript. The work was supported by the NIH (AI089954 and DK105562 to L.Z.) and by a Cancer Research Institute Investigator Award (to L.Z.). L.Z. is a Pew Biomedical Scholar (supported by the Pew Charitable Trusts) and an Investigator in the Pathogenesis of Infectious Disease (supported by the Burroughs Wellcome Fund).	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bando JK, 2015, NAT IMMUNOL, V16, P153, DOI 10.1038/ni.3057; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Collins JW, 2014, NAT REV MICROBIOL, V12, P612, DOI 10.1038/nrmicro3315; Dere E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-365; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; FERNANDEZSALGUERO P, 1995, SCIENCE, V268, P722, DOI 10.1126/science.7732381; FUKUNAGA BN, 1995, J BIOL CHEM, V270, P29270, DOI 10.1074/jbc.270.49.29270; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Guo XH, 2014, IMMUNITY, V40, P25, DOI 10.1016/j.immuni.2013.10.021; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; Heizmann B, 2013, J EXP MED, V210, P2823, DOI 10.1084/jem.20131735; Heller JJ, 2014, J IMMUNOL, V193, P3934, DOI 10.4049/jimmunol.1401234; Ilvanov II, 2006, CURR TOP MICROBIOL, V308, P59; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim MY, 2009, CLIN EXP IMMUNOL, V157, P20, DOI 10.1111/j.1365-2249.2009.03932.x; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koipally J, 2000, J BIOL CHEM, V275, P19594, DOI 10.1074/jbc.M000254200; Koipally J, 2002, J BIOL CHEM, V277, P27697, DOI 10.1074/jbc.M201694200; Lee JS, 2015, IMMUNITY, V43, P727, DOI 10.1016/j.immuni.2015.09.003; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Lugering A, 2010, CLIN EXP IMMUNOL, V160, P440, DOI 10.1111/j.1365-2249.2010.04103.x; McKenzie ANJ, 2014, IMMUNITY, V41, P366, DOI 10.1016/j.immuni.2014.09.006; Mimura J, 1999, GENE DEV, V13, P20, DOI 10.1101/gad.13.1.20; Naito T, 2007, IMMUNITY, V27, P723, DOI 10.1016/j.immuni.2007.09.008; Pavlick KP, 2006, INT IMMUNOL, V18, P389, DOI 10.1093/intimm/dxh378; Pearson C, 2012, TRENDS IMMUNOL, V33, P289, DOI 10.1016/j.it.2012.04.004; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Schjerven H, 2013, NAT IMMUNOL, V14, P1073, DOI 10.1038/ni.2707; Serafini N, 2015, NAT REV IMMUNOL, V15, P415, DOI 10.1038/nri3855; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Sridharan R, 2007, J BIOL CHEM, V282, P30227, DOI 10.1074/jbc.M702541200; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Wu DL, 2013, MOL CELL BIOL, V33, P4346, DOI 10.1128/MCB.00698-13; Wu L, 1997, IMMUNITY, V7, P483, DOI 10.1016/S1074-7613(00)80370-2; Yoshida T, 2010, CURR OPIN IMMUNOL, V22, P154, DOI 10.1016/j.coi.2010.02.011; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150	54	26	28	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					185	197		10.1016/j.immuni.2016.06.027	http://dx.doi.org/10.1016/j.immuni.2016.06.027			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27438771	Bronze, Green Accepted			2022-12-18	WOS:000380749000020
J	Matthews, SP; McMillan, SJ; Colbert, JD; Lawrence, RA; Watts, C				Matthews, Stephen P.; McMillan, Sarah J.; Colbert, Jeff D.; Lawrence, Rachel A.; Watts, Colin			Cystatin F Ensures Eosinophil Survival by Regulating Granule Biogenesis	IMMUNITY			English	Article							PROTEINS; DEGRANULATION; MEPOLIZUMAB; ACTIVATION; EXPRESSION; TOXICITY; HEALTH; ASTHMA; CELLS	Eosinophils are now recognized as multifunctional leukocytes that provide critical homeostatic signals to maintain other immune cells and aid tissue repair. Paradoxically, eosinophils also express an armory of granule-localized toxins and hydrolases believed to contribute to pathology in inflammatory disease. How eosinophils deliver their supporting functions while avoiding self-inflicted injury is poorly understood. We have demonstrated that cystatin F (CF) is a critical survival factor for eosinophils. Eosinophils from CF null mice had reduced lifespan, reduced granularity, and disturbed granule morphology. In vitro, cysteine protease inhibitors restored granularity, demonstrating that control of cysteine protease activity by CF is critical for normal eosinophil development. CF null mice showed reduced pulmonary pathology in a model of allergic lung inflammation but also reduced ability to combat infection by the nematode Brugia malayi. These data identify CF as a "cytoprotectant" that promotes eosinophil survival and function by ensuring granule integrity.	[Matthews, Stephen P.; McMillan, Sarah J.; Colbert, Jeff D.; Watts, Colin] Univ Dundee, Sch Life Sci, Div Cell Signaling & Immunol, Dundee DD1 5EH, Scotland; [Lawrence, Rachel A.] Univ London Royal Vet Coll, Dept Comparat Biomed Sci, Royal Coll St, London NW1 0TU, England; [Colbert, Jeff D.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01545 USA	University of Dundee; University of London; University of London Royal Veterinary College; University of Massachusetts System; University of Massachusetts Worcester	Watts, C (corresponding author), Univ Dundee, Sch Life Sci, Div Cell Signaling & Immunol, Dundee DD1 5EH, Scotland.	c.watts@dundee.ac.uk	Lawrence, Rachel/O-4641-2018	Lawrence, Rachel/0000-0001-9590-8940; Watts, Colin/0000-0001-6183-2087; Matthews, Stephen/0000-0003-3556-962X	Wellcome Trust; Biotechnology and Biological Sciences Research Council [BB/D013550/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Alan Prescott for help with tissue histology, Matthias Trost and Brian Dill for mass spectrometry, Rosie Clarke and Arlene Whigham for cell sorting, Monika Pawluk and Efrat Levy (Nathan S. Kline Institute, NY) for samples from cystatin C null mice, Elaine Shervill (RVC) for histological preparation of helminth infected lung samples, and Kris Clark for helpful discussions. This work was supported by a Wellcome Trust Programme grant to C. W.	Abrahamson M, 2003, BIOCHEM SOC SYMP, V70, P179, DOI 10.1042/bss0700179; Akuthota P, 2008, CLIN EXP ALLERGY, V38, P1254, DOI 10.1111/j.1365-2222.2008.03037.x; BARKER RL, 1991, J CLIN INVEST, V88, P798, DOI 10.1172/JCI115379; Berek C, 2016, CLIN EXP IMMUNOL, V183, P57, DOI 10.1111/cei.12695; Cadman ET, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003988; Cappello F, 2004, EXP CELL RES, V297, P607, DOI 10.1016/j.yexcr.2004.03.048; Clark K, 2004, J LEUKOCYTE BIOL, V75, P1001, DOI 10.1189/jlb.0803391; Colbert JD, 2009, TRAFFIC, V10, P425, DOI 10.1111/j.1600-0854.2009.00881.x; Denzler KL, 2000, J IMMUNOL, V165, P5509, DOI 10.4049/jimmunol.165.10.5509; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Doyle AD, 2013, BLOOD, V122, P781, DOI 10.1182/blood-2013-01-473405; Dyer KD, 2008, J IMMUNOL, V181, P4004, DOI 10.4049/jimmunol.181.6.4004; Furuta GT, 2005, AM J PHYSIOL-GASTR L, V289, pG890, DOI 10.1152/ajpgi.00015.2005; Griseri T, 2015, IMMUNITY, V43, P187, DOI 10.1016/j.immuni.2015.07.008; Haldar P, 2009, NEW ENGL J MED, V360, P973, DOI 10.1056/NEJMoa0808991; Hamilton G, 2008, EMBO J, V27, P499, DOI 10.1038/sj.emboj.7601979; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hogan SP, 2008, CLIN EXP ALLERGY, V38, P709, DOI 10.1111/j.1365-2222.2008.02958.x; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Liu N, 2004, NAT IMMUNOL, V5, P919, DOI 10.1038/ni1107; McMillan S, 2002, J EXP MED, V195, P51, DOI 10.1084/jem.20011732; Morita M, 1999, CANCER RES, V59, P151; Nair P, 2009, NEW ENGL J MED, V360, P985, DOI 10.1056/NEJMoa0805435; Nathanson CM, 2002, EUR J BIOCHEM, V269, P5502, DOI 10.1046/j.1432-1033.2002.03252.x; Persson T, 2002, BIOCHEM BIOPH RES CO, V291, P844, DOI 10.1006/bbrc.2002.6512; Petersen NHT, 2013, CANCER CELL, V24, P379, DOI 10.1016/j.ccr.2013.08.003; Popken-Harris P, 1998, BLOOD, V92, P623, DOI 10.1182/blood.V92.2.623.414k32_623_631; Rosenberg HF, 2013, NAT REV IMMUNOL, V13, P9, DOI 10.1038/nri3341; Schuttelkopf AW, 2006, J BIOL CHEM, V281, P16570, DOI 10.1074/jbc.M601033200; Simon D, 2010, J ALLERGY CLIN IMMUN, V126, P3, DOI 10.1016/j.jaci.2010.01.055; Simon HU, 1997, J IMMUNOL, V158, P3902; Soragni A, 2015, MOL CELL, V57, P1011, DOI 10.1016/j.molcel.2015.01.026; Spencer LA, 2010, IMMUNOL CELL BIOL, V88, P250, DOI 10.1038/icb.2009.115; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Zhang ML, 2006, IMMUNITY, V24, P451, DOI 10.1016/j.immuni.2006.02.002	38	26	28	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					795	806		10.1016/j.immuni.2016.03.003	http://dx.doi.org/10.1016/j.immuni.2016.03.003			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27067058	hybrid, Green Published			2022-12-18	WOS:000374444300012
J	Wang, HY; Zhang, X; Xue, L; Xing, J; Jouvin, MH; Putney, JW; Anderson, MP; Trebak, M; Kinet, JP				Wang, Huiyun; Zhang, Xuexin; Xue, Li; Xing, Juan; Jouvin, Marie-Helene; Putney, James W.; Anderson, Matthew P.; Trebak, Mohamed; Kinet, Jean-Pierre			Low-Voltage-Activated Ca(V)3.1 Calcium Channels Shape T Helper Cell Cytokine Profiles	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COLONY-STIMULATING FACTOR; GM-CSF; LYMPHOCYTE FUNCTION; CA2+ CHANNELS; EFFECTOR FUNCTIONS; CYCLOSPORINE-A; MICE LACKING; DIFFERENTIATION; NFAT	Activation of T cells is mediated by the engagement of T cell receptors (TCRs) followed by calcium entry via store-operated calcium channels. Here we have shown an additional route for calcium entry into T cells-through the low-voltage-activated T-type Ca(V)3.1 calcium channel. Ca(V)3.1 mediated a substantial current at resting membrane potentials, and its deficiency had no effect on TCR-initiated calcium entry. Mice deficient for Ca(V)3.1 were resistant to the induction of experimental autoimmune encephalomyelitis and had reduced productions of the granulocyte-macrophage colony-stimulating factor (GM-CSF) by central nervous system (CNS)-infiltrating T helper 1 (Th1) and Th17 cells. Ca(V)3.1 deficiency led to decreased secretion of GM-CSF from in vitro polarized Th1 and Th17 cells. Nuclear translocation of the nuclear factor of activated T cell (NFAT) was also reduced in Ca(V)3.1-deficient T cells. These data provide evidence for T-type channels in immune cells and their potential role in shaping the autoimmune response.	[Wang, Huiyun; Xue, Li; Jouvin, Marie-Helene; Anderson, Matthew P.; Kinet, Jean-Pierre] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Wang, Huiyun; Xue, Li; Jouvin, Marie-Helene; Anderson, Matthew P.; Kinet, Jean-Pierre] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Zhang, Xuexin; Trebak, Mohamed] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Xing, Juan; Putney, James W.] NIEHS, Lab Signal Transduct, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Anderson, Matthew P.] Beth Israel Deaconess Med Ctr, Dept Neurol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Harvard University; Beth Israel Deaconess Medical Center	Kinet, JP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA.; Kinet, JP (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	jkinet2@me.com	Putney, James W/F-7247-2019; 张学新, XUEXIN ZHANG/AAD-7645-2019	Putney, James W/0000-0002-3379-4789; 张学新, XUEXIN ZHANG/0000-0001-8276-3885; Anderson, Matthew/0000-0003-4602-1811	NIH [5T32HL789315, HL097111, 5R01NS081916, 5R37GM53950, 1R01AI095308]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123364, R01HL097111] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095308] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS081916] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded in part by NIH grants 5T32HL789315 to H.W., HL097111 to M.T., 5R01NS081916 to M.P.A., and 5R37GM53950 and 1R01AI095308 to J.-P.K.	Anderson MP, 2005, P NATL ACAD SCI USA, V102, P1743, DOI 10.1073/pnas.0409644102; Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Badou A, 2006, P NATL ACAD SCI USA, V103, P15529, DOI 10.1073/pnas.0607262103; Badou A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00243; Cabral MD, 2010, AM J RESP CRIT CARE, V181, P1310, DOI [10.1164/rccm.200907-1166oc, 10.1164/rccm.200907-1166OC]; Catterall WA, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003947; Christel C, 2012, BBA-GEN SUBJECTS, V1820, P1243, DOI 10.1016/j.bbagen.2011.12.012; Chu CQ, 2000, J EXP MED, V192, P123, DOI 10.1084/jem.192.1.123; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Coquet JM, 2008, J IMMUNOL, V180, P7097, DOI 10.4049/jimmunol.180.11.7097; Dietz L, 2015, EUR J IMMUNOL, V45, P1377, DOI 10.1002/eji.201444638; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Gomez-Ospina N, 2006, CELL, V127, P591, DOI 10.1016/j.cell.2006.10.017; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Harris TJ, 2007, J IMMUNOL, V179, P4313, DOI 10.4049/jimmunol.179.7.4313; HATFIELD SM, 1992, J PHARMACOL EXP THER, V260, P680; Hermann-Kleiter N, 2010, BLOOD, V115, P2989, DOI 10.1182/blood-2009-10-233585; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Huc S, 2009, BBA-MOL CELL RES, V1793, P947, DOI 10.1016/j.bbamcr.2008.11.003; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jha MK, 2009, NAT IMMUNOL, V10, P1275, DOI 10.1038/ni.1793; Johnson BV, 2004, MOL CELL BIOL, V24, P7914, DOI 10.1128/MCB.24.18.7914-7930.2004; Kim D, 2001, NEURON, V31, P35, DOI 10.1016/S0896-6273(01)00343-9; Klockner U, 1999, EUR J NEUROSCI, V11, P4171, DOI 10.1046/j.1460-9568.1999.00849.x; LEWIS RS, 1989, CELL REGUL, V1, P99, DOI 10.1091/mbc.1.1.99; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Lory P, 2006, CELL CALCIUM, V40, P135, DOI 10.1016/j.ceca.2006.04.017; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Martin RL, 2000, J PHARMACOL EXP THER, V295, P302; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; NILIUS B, 1985, NATURE, V316, P443, DOI 10.1038/316443a0; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Omilusik K, 2011, IMMUNITY, V35, P349, DOI 10.1016/j.immuni.2011.07.011; Omilusik KD, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00164; Parajuli B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-268; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Park JY, 2006, J PHYSIOL-LONDON, V577, P513, DOI 10.1113/jphysiol.2006.117440; Peng SL, 2001, IMMUNITY, V14, P13, DOI 10.1016/S1074-7613(01)00085-1; Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002; Perez-Reyes E, 1998, NATURE, V391, P896, DOI 10.1038/36110; Ponomarev ED, 2007, J IMMUNOL, V178, P39, DOI 10.4049/jimmunol.178.1.39; Reppert S, 2015, EUR J IMMUNOL, V45, P1426, DOI 10.1002/eji.201445150; RINK TJ, 1980, BIOCHIM BIOPHYS ACTA, V595, P15, DOI 10.1016/0005-2736(80)90243-6; Robert V, 2011, BIOCHIMIE, V93, P2087, DOI 10.1016/j.biochi.2011.06.016; Robert V, 2014, J ALLERGY CLIN IMMUN, V133, P1175, DOI 10.1016/j.jaci.2013.10.038; SCHREIBER SL, 1992, IMMUNOL TODAY, V13, P136, DOI 10.1016/0167-5699(92)90111-J; Shang C, 1999, INT IMMUNOL, V11, P1945, DOI 10.1093/intimm/11.12.1945; Shannon MF, 1997, CRIT REV IMMUNOL, V17, P301, DOI 10.1615/CritRevImmunol.v17.i3-4.30; Suzuki Y, 2010, MOL IMMUNOL, V47, P640, DOI 10.1016/j.molimm.2009.10.013; TSUBOI A, 1994, MOL BIOL CELL, V5, P119, DOI 10.1091/mbc.5.1.119; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Yunker AMR, 2003, J BIOENERG BIOMEMBR, V35, P533, DOI 10.1023/B:JOBB.0000008024.77488.48; Zamponi GW, 2009, BRAIN RES REV, V60, P84, DOI 10.1016/j.brainresrev.2008.12.021; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	57	26	26	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					782	794		10.1016/j.immuni.2016.01.015	http://dx.doi.org/10.1016/j.immuni.2016.01.015			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27037192	Green Accepted, Bronze			2022-12-18	WOS:000374444300011
J	Guilliams, M; Malissen, B				Guilliams, Martin; Malissen, Bernard			A Death Notice for In-Vitro-Generated GM-CSF Dendritic Cells?	IMMUNITY			English	Editorial Material							MACROPHAGES; MONOCYTES	Mouse bone marrow cells cultured with GM-CSF are often used to generate dendritic cells (DCs); in this issue of Immunity, Helft et al. (2015) show that this classical method produces heterogeneous populations of myeloid cells that are only distantly related to macrophages and DCs found in vivo.	[Guilliams, Martin] VIB Inflammat Res Ctr, Immunoregulat Lab, B-9000 Ghent, Belgium; [Malissen, Bernard] UM2 Aix Marseille Univ, INSERM, CNRS UMR7280, Ctr Immunol Marseille Luminy,U1104, F-13288 Marseille, France	Flanders Institute for Biotechnology (VIB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Guilliams, M (corresponding author), VIB Inflammat Res Ctr, Immunoregulat Lab, B-9000 Ghent, Belgium.	martin.guilliams@irc.ugent.be; bernardm@ciml.univ-mrs.fr	Guilliams, Martin/N-7803-2013; Malissen, Bernard/AAK-4659-2020	Guilliams, Martin/0000-0003-3525-7570; Malissen, Bernard/0000-0003-1340-9342				Bain CC, 2014, NAT IMMUNOL, V15, P929, DOI 10.1038/ni.2967; Breton G, 2015, J EXP MED, V212, P401, DOI 10.1084/jem.20141441; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Lee J, 2015, J EXP MED, V212, P385, DOI 10.1084/jem.20141442; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Varol C, 2015, ANNU REV IMMUNOL, V33, P643, DOI 10.1146/annurev-immunol-032414-112220; Wimmers F, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00165	10	26	26	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					988	990		10.1016/j.immuni.2015.05.020	http://dx.doi.org/10.1016/j.immuni.2015.05.020			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084019	Bronze			2022-12-18	WOS:000356362800006
J	Meisel, M; Hermann-Kleiter, N; Hinterleitner, R; Gruber, T; Wachowicz, K; Pfeifhofer-Obermair, C; Fresser, F; Leitges, M; Soldani, C; Viola, A; Kaminski, S; Baier, G				Meisel, Marlies; Hermann-Kleiter, Natascha; Hinterleitner, Reinhard; Gruber, Thomas; Wachowicz, Katarzyna; Pfeifhofer-Obermair, Christa; Fresser, Friedrich; Leitges, Michael; Soldani, Cristiana; Viola, Antonella; Kaminski, Sandra; Baier, Gottfried			The Kinase PKC alpha Selectively Upregulates Interleukin-17A during Th17 Cell Immune Responses	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; T-CELLS; MULTIPLE-SCLEROSIS; IN-VIVO; DIFFERENTIATION; CYTOKINE; IL-17; SUPPRESSION; PLASTICITY	Transforming growth-factor beta (TGF beta) has been implicated in T helper 17 (Th17) cell biology and in triggering expression of interleukin-17A (IL-17A), which is a key Th17 cell cytokine. Deregulated TGF beta receptor (TGF beta R) signaling has been implicated in Th17-cell-mediated autoimmune pathogenesis. Nevertheless, the full molecular mechanisms involved in the activation of the TGF beta R pathway in driving IL-17A expression remain unknown. Here, we identified protein kinase C alpha (PKC alpha) as a signaling intermediate specific to the Th17 cell subset in the activation of TGF beta RI. We have shown that PKCa physically interacts and functionally cooperates with TGF beta RI to promote robust SMAD2-3 activation. Furthermore, PKC alpha-deficient (Prkca(-/-)) cells demonstrated a defect in SMAD-dependent IL-2 suppression, as well as decreased STAT3 DNA binding within the II17a promoter. Consistently, Prkca(-/-) cells failed to mount appropriate IL-17A, but not IL-17F, responses in vitro and were resistant to induction of Th17-cell-dependent experimental autoimmune encephalomyelitis in vivo.	[Meisel, Marlies; Hermann-Kleiter, Natascha; Hinterleitner, Reinhard; Gruber, Thomas; Wachowicz, Katarzyna; Pfeifhofer-Obermair, Christa; Fresser, Friedrich; Kaminski, Sandra; Baier, Gottfried] Med Univ Innsbruck, Div Translat Cell Genet, Dept Pharmacol & Genet, A-6020 Innsbruck, Austria; [Leitges, Michael] Biotechnol Ctr Oslo, N-0317 Oslo, Norway; [Soldani, Cristiana; Viola, Antonella] Univ Milan, Inst Clin Humanitas, IRCCS, I-20089 Milan, Italy; [Soldani, Cristiana; Viola, Antonella] Univ Milan, Dept Translat Med, I-20089 Milan, Italy	Medical University of Innsbruck; University of Milan; University of Milan	Baier, G (corresponding author), Med Univ Innsbruck, Div Translat Cell Genet, Dept Pharmacol & Genet, A-6020 Innsbruck, Austria.	gottfried.baier@i-med.ac.at	soldani, cristiana/C-2401-2008; Kaminski, Sandra/AAM-6134-2021; Leitges, Michael/AAN-1953-2021; Hinterleitner, Reinhard/N-7091-2019; Kleiter, Natascha/I-5101-2018; Viola, Antonella/A-4321-2015	soldani, cristiana/0000-0001-5041-9588; Kleiter, Natascha/0000-0003-4389-9813; Gruber, Thomas/0000-0002-5796-7090; Viola, Antonella/0000-0002-0125-9271; Leitges, Michael/0000-0003-4203-6995; Baier, Gottfried/0000-0002-2085-8325; Pfeifhofer-Obermair, Christa/0000-0002-9942-6540	Austrian Science Fund (MCBO-DK) [SFB-021, T264-B13, P22207, P23537, P25044]; Austrian Ministry of Science and Research; European Community Program SYBILLA [HEALTH-F4-2008-201106]; Austrian Science Fund (FWF) [P 25044, T 264, P 23537] Funding Source: researchfish	Austrian Science Fund (MCBO-DK); Austrian Ministry of Science and Research; European Community Program SYBILLA; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to N. Haas and N. Krumbock for providing animal care and technical assistance. This work was supported by grants from the Austrian Science Fund (MCBO-DK, SFB-021, T264-B13, P22207, P23537, and P25044), funds from the Austrian Ministry of Science and Research, and European Community Program SYBILLA grant agreement HEALTH-F4-2008-201106.	Abromson-Leeman S, 2009, J NEUROIMMUNOL, V215, P10, DOI 10.1016/j.jneuroim.2009.07.007; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Baier G, 2009, CURR OPIN CELL BIOL, V21, P262, DOI 10.1016/j.ceb.2008.12.008; Barton A, 2004, BRAIN, V127, P1717, DOI 10.1093/brain/awh193; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Cejas PJ, 2010, BLOOD, V115, P4750, DOI 10.1182/blood-2009-09-242768; Chang X, 2011, IMMUNITY, V34, P201, DOI 10.1016/j.immuni.2011.01.017; Chen YG, 1997, EMBO J, V16, P3866, DOI 10.1093/emboj/16.13.3866; Chen Y, 2011, IMMUNITY, V34, P409, DOI 10.1016/j.immuni.2011.02.011; Chen Y, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-104; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Gao PJ, 2003, J MOL CELL CARDIOL, V35, P1105, DOI 10.1016/S0022-2828(03)00207-4; Gruber T, 2009, MOL IMMUNOL, V46, P2071, DOI 10.1016/j.molimm.2009.02.030; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Hermann-Kleiter N, 2008, IMMUNITY, V29, P205, DOI 10.1016/j.immuni.2008.06.008; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Hymowitz SG, 2001, EMBO J, V20, P5332, DOI 10.1093/emboj/20.19.5332; Ichiyama K, 2011, IMMUNITY, V34, P741, DOI 10.1016/j.immuni.2011.02.021; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kurschus FC, 2010, EUR J IMMUNOL, V40, P3336, DOI 10.1002/eji.201040755; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lock C, 2002, NAT MED, V8, P500, DOI 10.1038/nm0502-500; Malhotra N, 2010, J BIOL CHEM, V285, P29044, DOI 10.1074/jbc.C110.156745; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martinez GJ, 2009, J BIOL CHEM, V284, P35283, DOI 10.1074/jbc.C109.078238; Matusevicius D, 1999, MULT SCLER J, V5, P101, DOI 10.1177/135245859900500206; McKarns SC, 2004, J IMMUNOL, V172, P4275, DOI 10.4049/jimmunol.172.7.4275; McQualter JL, 2001, J EXP MED, V194, P873, DOI 10.1084/jem.194.7.873; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; O'Connor RA, 2008, J NEUROIMMUNOL, V193, P1, DOI 10.1016/j.jneuroim.2007.11.016; Pfeifhofer C, 2006, J IMMUNOL, V176, P6004, DOI 10.4049/jimmunol.176.10.6004; Saarela J, 2006, PLOS GENET, V2, P364, DOI 10.1371/journal.pgen.0020042; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Takimoto T, 2010, J IMMUNOL, V185, P842, DOI 10.4049/jimmunol.0904100; Thomas RM, 2012, J BIOL CHEM, V287, P25049, DOI 10.1074/jbc.M112.351916; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Uyttenhove C, 2006, EUR J IMMUNOL, V36, P2868, DOI 10.1002/eji.200636662; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; Yang XP, 2011, NAT IMMUNOL, V12, P247, DOI 10.1038/ni.1995; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhou HY, 2010, J VASC RES, V47, P9, DOI 10.1159/000231716; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	60	26	26	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 24	2013	38	1					41	52		10.1016/j.immuni.2012.09.021	http://dx.doi.org/10.1016/j.immuni.2012.09.021			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	079TQ	23290522	Green Published, hybrid			2022-12-18	WOS:000314195500008
J	Na, SY; Hermann, A; Sanchez-Ruiz, M; Storch, A; Deckert, M; Hunig, T				Na, Shin-Young; Hermann, Andreas; Sanchez-Ruiz, Monica; Storch, Alexander; Deckert, Martina; Huenig, Thomas			Oligodendrocytes Enforce Immune Tolerance of the Uninfected Brain by Purging the Peripheral Repertoire of Autoreactive CD8(+) T Cells	IMMUNITY			English	Article							MYELIN-BASIC-PROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS PATIENTS; MONOCLONAL-ANTIBODY; SELF-ANTIGENS; CROSS-PRESENTATION; VIRAL-INFECTION; MOUSE MODEL	Myelin-specific CD8(+) T cells are thought to contribute to the pathogenesis of multiple sclerosis. Here we modeled this contribution in mice with CD8(+) T cells recognizing ovalbumin (OVA) expressed in oligodendrocytes (ODCs). Surprisingly, even very high numbers of activated OVA-reactive CD8(+) T cells failed to induce disease and were cleared from the immune system after antigen encounter in the central nervous system (CNS). Peripheral infection with OVA-expressing Listeria (Lm-OVA) enabled CD8(+) T cells to enter the CNS, leading to the deletion of OVA-specific clones after OVA recognition on ODCs. In contrast, intracerebral infection allowed OVA-reactive CD8(+) T cells to cause demyelinating disease. Thus, in response to infection, CD8(+) T cells also patrol the CNS. If the CNS itself is infected, they destroy ODCs upon cognate antigen recognition in pursuit of pathogen eradication. In the sterile brain, however, antigen recognition on ODCs results in their deletion, thereby maintaining tolerance.	[Na, Shin-Young; Huenig, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, D-97078 Wurzburg, Germany; [Hermann, Andreas; Storch, Alexander] Tech Univ Dresden, Dept Neurol, D-01307 Dresden, Germany; [Hermann, Andreas; Storch, Alexander] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany; [Sanchez-Ruiz, Monica; Deckert, Martina] Univ Hosp Cologne, Dept Neuropathol, D-50924 Cologne, Germany	University of Wurzburg; Technische Universitat Dresden; Technische Universitat Dresden; University of Cologne	Hunig, T (corresponding author), Univ Wurzburg, Inst Virol & Immunobiol, D-97078 Wurzburg, Germany.	huenig@vim.uni-wuerzburg.de	Deckert, Martina/P-2842-2016; Hermann, Andreas/D-4213-2017	Hermann, Andreas/0000-0002-7364-7791	Deutsche Forschungsgemeinschaft (DFG), Wurzburg [SFB 581]; DFG-Research Center for Regenerative Therapies Dresden (CRTD)	Deutsche Forschungsgemeinschaft (DFG), Wurzburg; DFG-Research Center for Regenerative Therapies Dresden (CRTD)(German Research Foundation (DFG))	Supported by the Deutsche Forschungsgemeinschaft (DFG) through SFB 581, Wurzburg, and the DFG-Research Center for Regenerative Therapies Dresden (CRTD). We thank A. Waisman, A. Schimpl, and R. Gold for critical reading of the manuscript; P.J. Fink for providing V beta 5 mice; P. Zigan for typing mice; and Apogenix (Heidelberg) for Fas-Fc fusion protein.	Alferink J, 1998, SCIENCE, V282, P1338, DOI 10.1126/science.282.5392.1338; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; Bruck W, 2002, MULT SCLER, V8, P93, DOI 10.1191/1352458502ms785rr; Cao Y, 2006, EUR J IMMUNOL, V36, P207, DOI 10.1002/eji.200535211; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Crawford MP, 2004, BLOOD, V103, P4222, DOI 10.1182/blood-2003-11-4025; DILLON SR, 1994, J IMMUNOL, V152, P1790; Farhadi HF, 2003, J NEUROSCI, V23, P10214; FINK PJ, 1992, J EXP MED, V176, P1733, DOI 10.1084/jem.176.6.1733; Friese MA, 2008, NAT MED, V14, P1227, DOI 10.1038/nm.1881; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Habisch HJ, 2007, J NEURAL TRANSM, V114, P1395, DOI 10.1007/s00702-007-0748-y; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; Hohlfeld R, 2001, ANN NEUROL, V49, P281, DOI 10.1002/ana.61; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Ji QY, 2010, NAT IMMUNOL, V11, P628, DOI 10.1038/ni.1888; Jilek S, 2008, BRAIN, V131, P1712, DOI 10.1093/brain/awn108; Jurewicz A, 1998, J IMMUNOL, V160, P3056; KENT SJ, 1995, JMRI-J MAGN RESON IM, V5, P535, DOI 10.1002/jmri.1880050510; Kurts C, 1997, J EXP MED, V186, P2057, DOI 10.1084/jem.186.12.2057; Kurts C, 1997, J EXP MED, V186, P239, DOI 10.1084/jem.186.2.239; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lang HLE, 2002, NAT IMMUNOL, V3, P940, DOI 10.1038/ni835; Lee JW, 2007, NAT IMMUNOL, V8, P181, DOI 10.1038/ni1427; Leger Olivier J. P., 1997, Human Antibodies, V8, P3; MARTIN R, 1990, J IMMUNOL, V145, P540; Na SY, 2008, BRAIN, V131, P2353, DOI 10.1093/brain/awn148; Na SY, 2009, J IMMUNOL, V182, P6569, DOI 10.4049/jimmunol.0804200; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; PENDER MP, 1991, J NEUROL SCI, V104, P81, DOI 10.1016/0022-510X(91)90219-W; Perchellet A, 2004, NAT IMMUNOL, V5, P606, DOI 10.1038/ni1073; PETTE M, 1990, P NATL ACAD SCI USA, V87, P7968, DOI 10.1073/pnas.87.20.7968; Plunkett FJ, 2000, APOPTOSIS, V5, P431, DOI 10.1023/A:1009672331030; Pope C, 2001, J IMMUNOL, V166, P3402, DOI 10.4049/jimmunol.166.5.3402; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Sanchez-Ruiz M, 2008, J IMMUNOL, V180, P8421, DOI 10.4049/jimmunol.180.12.8421; Saxena A, 2008, J IMMUNOL, V181, P1617, DOI 10.4049/jimmunol.181.3.1617; SCHLUESENER HJ, 1985, J IMMUNOL, V135, P3128; SCHMIED M, 1993, AM J PATHOL, V143, P446; Serafini B, 2007, J EXP MED, V204, P2899, DOI 10.1084/jem.20071030; Stowe RP, 2007, EXP GERONTOL, V42, P563, DOI 10.1016/j.exger.2007.01.005; TSUCHIDA T, 1994, P NATL ACAD SCI USA, V91, P10859, DOI 10.1073/pnas.91.23.10859; TURNLEY AM, 1991, NEUROSCI LETT, V123, P45, DOI 10.1016/0304-3940(91)90154-L; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0; Young KG, 2011, J IMMUNOL, V187, P1192, DOI 10.4049/jimmunol.1100695; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0; Zehn D, 2006, IMMUNITY, V25, P261, DOI 10.1016/j.immuni.2006.06.009	49	26	27	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 27	2012	37	1					134	146		10.1016/j.immuni.2012.04.009	http://dx.doi.org/10.1016/j.immuni.2012.04.009			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22683122	Bronze			2022-12-18	WOS:000307133200016
J	Liu, X; Nguyen, P; Liu, W; Cheng, C; Steeves, M; Obenauer, JC; Ma, J; Geiger, TL				Liu, Xin; Nguyen, Phuong; Liu, Wei; Cheng, Cheng; Steeves, Meredith; Obenauer, John C.; Ma, Jing; Geiger, Terrence L.			T Cell Receptor CDR3 Sequence but Not Recognition Characteristics Distinguish Autoreactive Effector and Foxp3(+) Regulatory T Cells	IMMUNITY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; TRANSCRIPTION FACTOR FOXP3; CENTRAL-NERVOUS-SYSTEM; TGF-BETA; CUTTING EDGE; H-2(B) MICE; IN-VIVO; INFECTIOUS TOLERANCE; RETINOIC-ACID	The source, specificity, and plasticity of the forkhead box transcription factor 3 (Foxp3)(+) regulatory T (Treg) and conventional T (Tconv) cell populations active at sites of autoimmune pathology are not well characterized. To evaluate this, we combined global repertoire analyses and functional assessments of isolated T cell receptors (TCR) from TCR alpha retrogenic mice with autoimmune encephalomyelitis. Treg and Tconv cell TCR repertoires were distinct, and autoantigen-specific Treg and Tconv cells were enriched in diseased tissue. Autoantigen sensitivity and fine specificity of these cells intersected, implying that differences in responsiveness were not responsible for lineage specification. Notably, autoreactive Treg and Tconv cells could be fully distinguished by an acidic versus aliphatic variation at a single TCR CDR3 residue. Our results imply that ontogenically distinct Treg and Tconv cell repertoires with convergent specificities for autoantigen respond during autoimmunity and argue against more than limited plasticity between Treg and Tconv cells during autoimmune inflammation.	[Liu, Xin; Nguyen, Phuong; Steeves, Meredith; Geiger, Terrence L.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Liu, Wei; Cheng, Cheng] St Jude Childrens Hosp, Dept Biostat, Memphis, TN 38105 USA; [Obenauer, John C.; Ma, Jing] St Jude Childrens Hosp, Dept Informat Sci, Memphis, TN 38105 USA; [Liu, Xin] Univ Tennessee, Hlth Sci Ctr, Integrated Program Biomed Sci, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Geiger, TL (corresponding author), St Jude Childrens Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA.		Cheng, Cheng/N-8075-2018; Geiger, Terrence/M-4516-2018	Geiger, Terrence/0000-0001-8290-5732	National Institutes of Health [R01 A1056153]; American Lebanese Syrian Associated Charities (ALSAC)-St Jude Children's Research Hospital; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)-St Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank R Cross, Y He, and the Immunology Core Flow Cytometry facility for assistance with flow cytometric sorting and J S Geiger for assistance with CDR3 sequence analysis This work was supported by the National Institutes of Health Grant R01 A1056153 (to T L G) and by the American Lebanese Syrian Associated Charities (ALSAC)-St Jude Children's Research Hospital (to all authors)	Aifantis I, 2006, IMMUNOL REV, V209, P159, DOI 10.1111/j.0105-2896.2006.00343.x; Alli R, 2008, J IMMUNOL, V181, P136, DOI 10.4049/jimmunol.181.1.136; Andersson J, 2007, INT IMMUNOL, V19, P557, DOI 10.1093/intimm/dxm021; Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Ben-Nun A, 2006, EUR J IMMUNOL, V36, P478, DOI 10.1002/eji.200535363; Borowski C, 2004, J EXP MED, V199, P607, DOI 10.1084/jem.20031973; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Delarasse C, 2003, J CLIN INVEST, V112, P544, DOI 10.1172/JCI200315861; Fontenot JD, 2005, NAT IMMUNOL, V6, P331, DOI 10.1038/ni1179; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Grajewski RS, 2006, J EXP MED, V203, P851, DOI 10.1084/jem.20050429; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Hori S, 2002, P NATL ACAD SCI USA, V99, P8213, DOI 10.1073/pnas.122224799; Horwitz DA, 2008, TRENDS IMMUNOL, V29, P429, DOI 10.1016/j.it.2008.06.005; Hsieh CS, 2006, NAT IMMUNOL, V7, P401, DOI 10.1038/ni1318; Hsieh CS, 2004, IMMUNITY, V21, P267, DOI 10.1016/j.immuni.2004.07.009; Huang CY, 2004, EUR J IMMUNOL, V34, P1532, DOI 10.1002/eji.200424870; Huter EN, 2008, J IMMUNOL, V181, P8209, DOI 10.4049/jimmunol.181.12.8209; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; KAIGH WD, 1991, COMMUN STAT-THEOR M, V20, P977, DOI 10.1080/03610929108830543; Kohm AP, 2002, J IMMUNOL, V169, P4712, DOI 10.4049/jimmunol.169.9.4712; Korn T, 2007, NAT MED, V13, P423, DOI 10.1038/nm1564; Lathrop SK, 2008, J EXP MED, V205, P3105, DOI 10.1084/jem.20081359; Liang S, 2005, J EXP MED, V201, P127, DOI 10.1084/jem.20041201; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Mekala DJ, 2005, P NATL ACAD SCI USA, V102, P11817, DOI 10.1073/pnas.0505445102; Mendel I, 1996, EUR J IMMUNOL, V26, P2470, DOI 10.1002/eji.1830261030; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; O'Connor RA, 2008, CELL IMMUNOL, V251, P8, DOI 10.1016/j.cellimm.2008.02.001; Pacholczyk R, 2008, IMMUNOLOGY, V125, P450, DOI 10.1111/j.1365-2567.2008.02992.x; Pacholczyk R, 2007, IMMUNITY, V27, P493, DOI 10.1016/j.immuni.2007.07.019; Pacholczyk R, 2006, IMMUNITY, V25, P249, DOI 10.1016/j.immuni.2006.05.016; Persons DA, 1997, BLOOD, V90, P1777, DOI 10.1182/blood.V90.5.1777; Petersen TR, 2004, EUR J IMMUNOL, V34, P165, DOI 10.1002/eji.200324669; Picca CC, 2006, IMMUNOL REV, V212, P74, DOI 10.1111/j.0105-2896.2006.00416.x; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Reddy J, 2005, J IMMUNOL, V175, P5591, DOI 10.4049/jimmunol.175.9.5591; Reddy J, 2004, P NATL ACAD SCI USA, V101, P15434, DOI 10.1073/pnas.0404444101; Romagnoli P, 2002, J IMMUNOL, V168, P1644, DOI 10.4049/jimmunol.168.4.1644; Selvaraj RK, 2008, J IMMUNOL, V180, P2830, DOI 10.4049/jimmunol.180.5.2830; Selvaraj RK, 2007, J IMMUNOL, V178, P7667, DOI 10.4049/jimmunol.178.12.7667; Sugiyama H, 2005, J IMMUNOL, V174, P164, DOI 10.4049/jimmunol.174.1.164; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tang QZ, 2006, IMMUNOL REV, V212, P217, DOI 10.1111/j.0105-2896.2006.00421.x; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Wong J, 2007, J EXP MED, V204, P2039, DOI 10.1084/jem.20070822; Wong J, 2007, J IMMUNOL, V178, P7032, DOI 10.4049/jimmunol.178.11.7032; You S, 2007, P NATL ACAD SCI USA, V104, P6335, DOI 10.1073/pnas.0701171104; Yu P, 2005, J IMMUNOL, V174, P6772, DOI 10.4049/jimmunol.174.11.6772; Zhang XM, 2004, INT IMMUNOL, V16, P249, DOI 10.1093/intimm/dxh029; Zhang Y, 2009, IMMUNOL LETT, V122, P52, DOI 10.1016/j.imlet.2008.11.015	55	26	27	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 18	2009	31	6					909	920		10.1016/j.immuni.2009.09.023	http://dx.doi.org/10.1016/j.immuni.2009.09.023			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	20005134	Green Accepted, Bronze			2022-12-18	WOS:000273616400011
J	Kapsenberg, ML				Kapsenberg, Martien L.			gamma delta T Cell Receptors without a Job	IMMUNITY			English	Editorial Material							IL-17	In this issue of Immunity, the studies by Sutton et al. (2009) and Martin et al. (2009) indicate that gamma delta T cells are innate cells that rapidly produce interleukin (IL)-17 in response to cytokines or pathogens without the need for T cell receptor engagement.	Univ Amsterdam, Dept Cell Biol & Histol, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Kapsenberg, ML (corresponding author), Univ Amsterdam, Dept Cell Biol & Histol, Acad Med Ctr, Meibergdreef 15, NL-1105 AZ Amsterdam, Netherlands.	m.l.kapsenberg@amc.uva.nl						Awasthi A, 2009, J IMMUNOL, V182, P5904, DOI 10.4049/jimmunol.0900732; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; OBRIEN RL, 2008, EUR J IMMUNOL, V39, P634; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Shibata K, 2008, J IMMUNOL, V181, P5940, DOI 10.4049/jimmunol.181.9.5940; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001	10	26	26	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 21	2009	31	2					181	183		10.1016/j.immuni.2009.08.004	http://dx.doi.org/10.1016/j.immuni.2009.08.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19699169	Bronze			2022-12-18	WOS:000269338600005
J	Wang, E; Marincola, FM				Wang, Ena; Marincola, Francesco M.			Bottom up: A modular view of immunology	IMMUNITY			English	Editorial Material							RELEVANCE; CANCER		[Wang, Ena; Marincola, Francesco M.] NIH, Infect Dis & Immunogenet Sect, Dept Transfus Med, Ctr Clin, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Marincola, FM (corresponding author), NIH, Infect Dis & Immunogenet Sect, Dept Transfus Med, Ctr Clin, 9000 Rockville Pike, Bethesda, MD 20892 USA.	fmarincola@mail.cc.nih.gov			CLINICAL CENTER [ZIACL002118] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA CL002118-04] Funding Source: Medline	CLINICAL CENTER; Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Avila-Campillo I, 2007, BIOINFORMATICS, V23, P392, DOI 10.1093/bioinformatics/btl604; Basil CF, 2006, CANCER RES, V66, P2953, DOI 10.1158/0008-5472.CAN-05-3433; Benoist C, 2006, IMMUNOL REV, V210, P229, DOI 10.1111/j.0105-2896.2006.00374.x; Bialek W, 2004, SCIENCE, V303, P788, DOI 10.1126/science.1095480; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Critchley-Thorne RJ, 2007, PLOS MED, V4, P897, DOI 10.1371/journal.pmed.0040176; Dalgleish A, 1999, QJM-INT J MED, V92, P347, DOI 10.1093/qjmed/92.6.347; He XS, 2006, HEPATOLOGY, V44, P352, DOI 10.1002/hep.21267; Marincola FM, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-21	9	26	26	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 18	2008	29	1					9	11		10.1016/j.immuni.2008.07.002	http://dx.doi.org/10.1016/j.immuni.2008.07.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18631452	Green Accepted, Bronze			2022-12-18	WOS:000257905400005
J	Savill, J; Gregory, C				Savill, John; Gregory, Chris			Apoptotic PS to phagocyte TIM-4: Eat me	IMMUNITY			English	Editorial Material							PHOSPHATIDYLSERINE RECEPTOR; CELLS; CLEARANCE	Although cells dying by apoptosis expose the classical "eat me" signal phosphatidylserine (PS), a phagocytic transmembrane receptor for PS has proved elusive. Now cell and structural studies (Kobayashi et al. [2007] and Santiago et al. [2007] in this issue of Immunity) implicate the type I molecule TIM-4.	[Savill, John; Gregory, Chris] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, Edinburgh EH16 4TJ, Midlothian, Scotland	University of Edinburgh	Savill, J (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	headcmvm@miscorp.ed.ac.uk						Bose Jens, 2004, J Biol, V3, P15, DOI 10.1186/jbiol10; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; FADOK VA, 1992, J IMMUNOL, V148, P2207; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Lacy-Hulbert A, 2007, P NATL ACAD SCI USA, V104, P15823, DOI 10.1073/pnas.0707421104; Li MO, 2003, SCIENCE, V302, P1560, DOI 10.1126/science.1087621; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Santiago C, 2007, IMMUNITY, V27, P941, DOI 10.1016/j.immuni.2007.11.008; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL J, 1990, NATURE, V343, P170, DOI 10.1038/343170a0	12	26	29	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2007	27	6					830	832		10.1016/j.immuni.2007.12.002	http://dx.doi.org/10.1016/j.immuni.2007.12.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	245AS	18093535	Bronze			2022-12-18	WOS:000251907300003
J	Lowell, CA				Lowell, CA			Rewiring phagocytic signal transduction	IMMUNITY			English	Editorial Material							RECEPTOR-MEDIATED PHAGOCYTOSIS; GAMMA; NEUTROPHILS; MACROPHAGES; ACTIVATION; MECHANISMS	In this issue of Immunity, Hall et al. (2006) have examined primary macrophages from Vav1(-/-)/VaV3(-/-) and Rac1(-/-)/Rac2(-/-) mice to produce a new picture of Fc gamma receptor and complement receptor 3 intracellular signaling.	Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lowell, CA (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA.							Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Cougoule C, 2004, SEMIN CELL DEV BIOL, V15, P679, DOI 10.1016/j.semcdb.2004.09.001; Fitzer-Attas CJ, 2000, J EXP MED, V191, P669, DOI 10.1084/jem.191.4.669; Lofgren R, 1999, BBA-MOL CELL RES, V1452, P46, DOI 10.1016/S0167-4889(99)00112-3; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; Patel JC, 2002, MOL BIOL CELL, V13, P1215, DOI 10.1091/mbc.02-01-0002; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Zhang J, 2005, NAT IMMUNOL, V6, P911, DOI 10.1038/ni1232	9	26	27	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2006	24	3					243	245		10.1016/j.immuni.2006.03.002	http://dx.doi.org/10.1016/j.immuni.2006.03.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	028QY	16546092	Bronze			2022-12-18	WOS:000236504500004
J	Brodin, P				Brodin, Petter			SARS-CoV-2 infections in children: Understanding diverse outcomes	IMMUNITY			English	Review							MULTISYSTEM INFLAMMATORY SYNDROME; DISEASE; CORONAVIRUS; PERSISTENCE; RNA	SARS-CoV-2 infections mostly lead to mild or even asymptomatic infections in children, but the reasons for this are not fully understood. More efficient local tissue responses, better thymic function, and crossreactive immunity have all been proposed to explain this. In rare cases of children and young people, but very rarely in adults, post-infectious hyperinflammatory syndromes can develop and be serious. Here, I will discuss our current understanding of SARS-CoV-2 infections in children and hypothesize that a life history and energy allocation perspective might offer an additional explanation to mild infections, viral dynamics, and the higher incidence of rare multisystem inflammatory syndromes in children and young people.	[Brodin, Petter] Imperial Coll London, Dept Immunol & Inflammat, London, England; [Brodin, Petter] Karolinska Inst, Dept Womens & Childrens Hlth, Solna, Sweden	Imperial College London; Karolinska Institutet	Brodin, P (corresponding author), Imperial Coll London, Dept Immunol & Inflammat, London, England.; Brodin, P (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Solna, Sweden.	p.brodin@imperial.ac.uk	Brodin, Petter/C-3317-2011	Brodin, Petter/0000-0002-8103-0046	Garfield Weston foundation; Swedish Research council [2021-06529]; Karolinska Institutet; Bure Equity AB; Jonas & Christina af Jochnick Foundation	Garfield Weston foundation; Swedish Research council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); Bure Equity AB; Jonas & Christina af Jochnick Foundation	I thank Dr. Kim Vesto for assistance with figure preparations using BioRender. I am grateful to members of our laboratory as well as colleagues such as Dr. Carrie Lucas (Yale), Prof. Moshe Ardithi (UCLA), Prof. Michael Levin, Dr. Vanessa Sancho Shimitzu, Dr. Elizabeth Whittaker (Imperial College, London), Prof. Yenan Bryceson, and Anna Carin Horne (Karolinska Institutet). Finally, I am grateful to be a member of the COVID Human Genetic Effort consortium and to Prof. Jean-Laurent Casanova (Rockefeller University) and Prof. Helen Su (NIH) for initiating and leading this effort as well as all of the consortium's members for inspiring discussions and sharing of knowledge and data. I also thank the two reviewers for their constructive input. This work was funded by Garfield Weston foundation, The Swedish Research council (2021-06529), Karolinska Institutet, and donations from Bure Equity AB, and Jonas & Christina af Jochnick Foundation.	Abolhassani H, 2022, J CLIN IMMUNOL, V42, P1, DOI 10.1007/s10875-021-01151-y; Abrams JY, 2021, LANCET CHILD ADOLESC, V5, P323, DOI 10.1016/S2352-4642(21)00050-X; Addetia A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.02107-20; [Anonymous], 2020, MEDRXIV, DOI [10.1101/2020.05.10.20097394, DOI 10.1101/2020.05.10.20097394]; Arvin AM, 2020, NATURE, V584, P353, DOI 10.1038/s41586-020-2538-8; Asano T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4348; Avanzato VA, 2020, CELL, V183, P1901, DOI 10.1016/j.cell.2020.10.049; Bartsch YC, 2021, NAT MED, V27, P454, DOI 10.1038/s41591-021-01263-3; Bastard P, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4340; Bastard P, 2021, J EXP MED, V218, DOI 10.1084/jem.20210554; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Beccuti G, 2020, J ENDOCRINOL INVEST, V43, P1175, DOI 10.1007/s40618-020-01323-4; Behnood SA, 2022, J INFECTION, V84, P158, DOI 10.1016/j.jinf.2021.11.011; Belay ED, 2021, JAMA PEDIATR, V175, P837, DOI 10.1001/jamapediatrics.2021.0630; Brodin P, 2021, NAT MED, V27, P28, DOI 10.1038/s41591-020-01202-8; Brodin P, 2020, ACTA PAEDIATR, V109, P1082, DOI 10.1111/apa.15271; Bucciol G, 2021, CURR OPIN PEDIATR, V33, P648, DOI 10.1097/MOP.0000000000001062; CALLOW KA, 1990, EPIDEMIOL INFECT, V105, P435, DOI 10.1017/S0950268800048019; Carvalho T, 2021, NAT REV IMMUNOL, V21, P245, DOI 10.1038/s41577-021-00522-1; Ceulemans LJ, 2021, LANCET RESP MED, V9, pE78, DOI 10.1016/S2213-2600(21)00240-X; Cheng MH, 2020, P NATL ACAD SCI USA, V117, P25254, DOI 10.1073/pnas.2010722117; Consiglio CR, 2020, CELL, V183, P968, DOI 10.1016/j.cell.2020.09.016; Cotugno N, 2021, PEDIAT ALLERG IMM-UK, V32, P1833, DOI 10.1111/pai.13585; Delahoy MJ, 2021, MMWR-MORBID MORTAL W, V70, P1255, DOI 10.15585/mmwr.mm7036e2; Du WJ, 2020, J INFECT PUBLIC HEAL, V13, P926, DOI 10.1016/j.jiph.2020.05.025; Eastin Carly, 2020, NEW ENGL J MED, V58, P711, DOI [10.1016/j.ijcard.2021.09.058, DOI 10.1016/j.ijcard.2021.09.058, 10.1056/NEJMoa2002032, DOI 10.1056/NEJMOA2002032]; Fallerini C, 2021, ELIFE, V10, DOI 10.7554/eLife.67569; Feldstein L.R., JAMA-J AM MED ASSOC, V325, P1074; Ferre EMN, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.720205; Fukuda S, 2021, MOD RHEUMATOL CASE, V5, P442, DOI 10.1080/24725625.2021.1920140; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Gruber CN, 2020, CELL, V183, P982, DOI 10.1016/j.cell.2020.09.034; Hamady A, 2022, INFECTION, V50, P11, DOI 10.1007/s15010-021-01664-z; hang Q., 2021, J CLIN INVEST, V131; Hochberg Z, 2011, RAMBAM MAIMONIDES ME, V2, DOI 10.5041/RMMJ.10057; Hoste L, 2022, J EXP MED, V219, DOI [10.1084/jem.20211381, DOI 10.1084/JEM.20211381]; Israelow B, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl4509; Jayasooriya S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004746; Jones TC, 2021, SCIENCE, V373, P180, DOI 10.1126/science.abi5273; Kahn R, 2022, ACTA PAEDIATR, V111, P354, DOI 10.1111/apa.16191; Khanmohammadi S, 2022, J CLIN IMMUNOL, V42, P19, DOI 10.1007/s10875-021-01166-5; Kim Gi Beom, 2019, Korean J Pediatr, V62, P292, DOI 10.3345/kjp.2019.00157; Koch Clarissa M, 2021, medRxiv, DOI 10.1101/2021.01.26.21250269; Kosmicki JA, 2021, AM J HUM GENET, V108, P1350, DOI [10.1016/j.ajhg.2021.017, 10.1016/j.ajhg.2021.05.017]; Lei XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17665-9; Leidman E, 2021, MMWR-MORBID MORTAL W, V70, P88, DOI [10.15585/mmwr.mm7003e1, 10.15585/mmwr.mm7003e1externalicon]; Lemarquis A., 2021, J ALLERGY CLIN IMMUN; Loske J, 2022, NAT BIOTECHNOL, V40, P319, DOI 10.1038/s41587-021-01037-9; Mateus J, 2020, SCIENCE, V370, P89, DOI 10.1126/science.abd3871; McArdle AJ, 2021, NEW ENGL J MED, V385, P11, DOI 10.1056/NEJMoa2102968; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Meyts I, 2021, J ALLERGY CLIN IMMUN, V147, P520, DOI 10.1016/j.jaci.2020.09.010; Moreews M, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abh1516; Morone G, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00562; Morparia K, 2021, PEDIATR INFECT DIS J, V40, pE82, DOI 10.1097/INF.0000000000002967; Nakajima Y, 2021, J INFECT CHEMOTHER, V27, P387, DOI 10.1016/j.jiac.2020.12.001; Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z; Niessl J, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abk0894; Palmer S, 2021, J R SOC INTERFACE, V18, DOI 10.1098/rsif.2020.0982; Payne AB, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.16420; Pierce CA., 2021, JCI INSIGHT, V6, DOI [10.1172/jci.insight.148694, DOI 10.1172/JCI.INSIGHT.148694, DOI 10.1172/jci.insight.148694]; Porritt RA, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI146614; Pou C, 2019, NAT MED, V25, P591, DOI 10.1038/s41591-019-0392-8; Povysil G, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI147834; Preston LE, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.5298; Raja MA, 2021, TRANSPLANT REV-ORLAN, V35, DOI 10.1016/j.trre.2020.100588; Ramaswamy A, 2021, IMMUNITY, V54, P1083, DOI 10.1016/j.immuni.2021.04.003; Reyman M, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02755-1; Riphagen S, 2020, LANCET, V395, P1607, DOI [10.1016/50140-6736(20)31094-1, 10.1016/S0140-6736(20)31094-1]; Rodriguez L, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100078; Roltgen Katharina, 2021, medRxiv, DOI 10.1101/2021.04.05.21254952; Sagar M, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143380; Sancho-Shimizu V, 2021, J EXP MED, V218, DOI 10.1084/jem.20210446; Shulman ST, 2015, NAT REV RHEUMATOL, V11, P475, DOI 10.1038/nrrheum.2015.54; Smith C., 2021, NAT MED, DOI [10.1038/s41591-021-01578-1.-021-01578-1, DOI 10.1038/S41591-021-01578-1.-021-01578-1]; Stearns S.C., 1992, pi; Thabet F, 2015, SAUDI MED J, V36, P484, DOI 10.15537/smj.2015.4.10243; Thai KTD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001180; Torun B, 2005, PUBLIC HEALTH NUTR, V8, P968, DOI 10.1079/PHN2005791; Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09; van der Made CI, 2020, JAMA-J AM MED ASSOC, V324, P663, DOI 10.1001/jama.2020.13719; Verdoni L, 2020, LANCET, V395, P1771, DOI 10.1016/S0140-6736(20)31103-X; Wang EY, 2021, NATURE, V595, P283, DOI [10.1038/s41586-021-03631-y, 10.1101/2020.12.10.20247205]; Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369; Wolfel R, 2020, NATURE, V588, pE35, DOI 10.1038/s41586-020-2984-3; Xing YH, 2020, J MICROBIOL IMMUNOL, V53, P473, DOI 10.1016/j.jmii.2020.03.021; Yonker LM, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI149633; Zang RC, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc3582; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhang Q, 2020, MED-CAMBRIDGE, V1, P14, DOI 10.1016/j.medj.2020.12.001; Zhong Nan-Shan, 2004, Paediatr Respir Rev, V5, P270, DOI 10.1016/j.prrv.2004.07.011; Zimmermann P, 2021, ARCH DIS CHILD, V106, P429, DOI 10.1136/archdischild-2020-320338	92	25	25	6	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					201	209		10.1016/j.immuni.2022.01.014	http://dx.doi.org/10.1016/j.immuni.2022.01.014			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX7WH	35093190	hybrid, Green Published			2022-12-18	WOS:000754308000007
J	Wong, NR; Mohan, J; Kopecky, BJ; Guo, SC; Du, LX; Leid, J; Feng, GS; Lokshina, I; Dmytrenko, O; Luehmann, H; Bajpai, G; Ewald, L; Bell, L; Patel, N; Bredemeyer, A; Weinheimer, CJ; Nigro, JM; Kovacs, A; Morimoto, S; Bayguinov, PO; Fisher, MR; Stump, WT; Greenberg, M; Fitzpatrick, JAJ; Epelman, S; Kreisel, D; Sah, R; Liu, YJ; Hu, HZ; Lavine, KJ				Wong, Nicole R.; Mohan, Jay; Kopecky, Benjamin J.; Guo, Shuchi; Du, Lixia; Leid, Jamison; Feng, Guoshuai; Lokshina, Inessa; Dmytrenko, Oleksandr; Luehmann, Hannah; Bajpai, Geetika; Ewald, Laura; Bell, Lauren; Patel, Nikhil; Bredemeyer, Andrea; Weinheimer, Carla J.; Nigro, Jessica M.; Kovacs, Attila; Morimoto, Sachio; Bayguinov, Peter O.; Fisher, Max R.; Stump, W. Tom; Greenberg, Michael; Fitzpatrick, James A. J.; Epelman, Slava; Kreisel, Daniel; Sah, Rajan; Liu, Yongjian; Hu, Hongzhen; Lavine, Kory J.			Resident cardiac macrophages mediate adaptive myocardial remodeling	IMMUNITY			English	Article							TARGETED DELETION; FETAL MONOCYTES; MOUSE MODEL; CELLS; HOMEOSTASIS; MECHANISMS; SENESCENCE; CONTRIBUTE; IMMUNITY; DYNAMICS	Cardiac macrophages represent a heterogeneous cell population with distinct origins, dynamics, and functions. Recent studies have revealed that C-C Chemokine Receptor 2 positive (CCR2(+)) macrophages derived from infiltrating monocytes regulate myocardial inflammation and heart failure pathogenesis. Comparatively little is known about the functions of tissue resident (CCR2(-)) macrophages. Herein, we identified an essential role for CCR2(-) macrophages in the chronically failing heart. Depletion of CCR2(-) macrophages in mice with dilated cardiomyopathy accelerated mortality and impaired ventricular remodeling and coronary angiogenesis, adaptive changes necessary to maintain cardiac output in the setting of reduced cardiac contractility. Mechanistically, CCR2(-) macrophages interacted with neighboring cardiomyocytes via focal adhesion complexes and were activated in response to mechanical stretch through a transient receptor potential vanilloid 4 (TRPV4)-dependent pathway that controlled growth factor expression. These findings establish a role for tissue-resident macrophages in adaptive cardiac remodeling and implicate mechanical sensing in cardiac macrophage activation.	[Wong, Nicole R.; Mohan, Jay; Kopecky, Benjamin J.; Guo, Shuchi; Leid, Jamison; Feng, Guoshuai; Lokshina, Inessa; Dmytrenko, Oleksandr; Bajpai, Geetika; Ewald, Laura; Bell, Lauren; Bredemeyer, Andrea; Weinheimer, Carla J.; Nigro, Jessica M.; Kovacs, Attila; Sah, Rajan; Lavine, Kory J.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Du, Lixia; Hu, Hongzhen] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Luehmann, Hannah; Liu, Yongjian] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Patel, Nikhil] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA; [Morimoto, Sachio] Int Univ Hlth & Welf, Dept Phys Therapy, Otawara, Tochigi, Japan; [Bayguinov, Peter O.; Fisher, Max R.; Stump, W. Tom; Greenberg, Michael] Washington Univ, Sch Med, Dept Biochem, St Louis, MO 63110 USA; [Fitzpatrick, James A. J.] Washington Univ, Ctr Cellular Imaging, Sch Med, St Louis, MO 63110 USA; [Fitzpatrick, James A. J.] Washington Univ, Dept Neurosci, Sch Med, St Louis, MO 63110 USA; [Fitzpatrick, James A. J.] Washington Univ, Dept Cell Biol & Physiol, Sch Med, St Louis, MO 63110 USA; [Fitzpatrick, James A. J.] Washington Univ, Dept Biomed Engn, Sch Med, St Louis, MO 63110 USA; [Epelman, Slava] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Kreisel, Daniel; Lavine, Kory J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kreisel, Daniel] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Lavine, Kory J.] Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); International University of Health & Welfare; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Lavine, KJ (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Lavine, KJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Lavine, KJ (corresponding author), Washington Univ, Sch Med, Dept Dev Biol, St Louis, MO 63110 USA.	klavine@wustl.edu	Liu, Yong/GWQ-6163-2022; Epelman, Slava/AAO-1728-2020; Feng, Guoshuai/GPK-3366-2022	Epelman, Slava/0000-0003-3400-4475; Patel, Nikhil/0000-0001-6683-3329; Greenberg, Michael/0000-0003-1320-3547; Hu, Hongzhen/0000-0002-8967-7522	NHLBI [R01 HL138466, R01 HL139714, R01 HL151078]; Leducq Foundation Network [20CVD02]; Burroughs Welcome Fund [1014782]; Children's Discovery Institute of Washington University [CH-II-2015-462, CH-II2017-628, PM-LI-2019-829]; St. Louis Children's Hospital [CH-II-2015-462, CH-II2017-628, PM-LI-2019-829]; Foundation of Barnes-Jewish Hospital [8038-88]; NIH [P01AI116501, R01 HL094601, R01DK103901, R01AR077183, R01AA027065, R35HL145212, R01HL131908]; Veterans Administration Merit Review [1I01BX002730]; Foundation for Barnes-Jewish Hospital; Department of Anesthesiology at Washington University School of Medicine	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Leducq Foundation Network(Leducq Foundation); Burroughs Welcome Fund(Burroughs Wellcome Fund); Children's Discovery Institute of Washington University; St. Louis Children's Hospital; Foundation of Barnes-Jewish Hospital; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Administration Merit Review(US Department of Veterans Affairs); Foundation for Barnes-Jewish Hospital; Department of Anesthesiology at Washington University School of Medicine	K.L. is supported by funding provided from the NHLBI (R01 HL138466, R01 HL139714, R01 HL151078), Leducq Foundation Network (#20CVD02), Burroughs Welcome Fund (1014782), Children's Discovery Institute of Washington University and St. Louis Children's Hospital (CH-II-2015-462, CH-II2017-628, PM-LI-2019-829), and Foundation of Barnes-Jewish Hospital (8038-88). D.K. is supported by NIH (P01AI116501 and R01 HL094601), Veterans Administration Merit Review (1I01BX002730), and the Foundation for Barnes-Jewish Hospital. H.H. was supported by grants from the NIH (R01DK103901, R01AR077183, and R01AA027065) and the Department of Anesthesiology at Washington University School of Medicine. Y.L. is supported by the NIH (R35HL145212 and R01HL131908). We acknowledge the McDonnel Genome Institute, DDRCC histology core (P30 DK52574), and WUCCI (NIH OD021694,CDI-CORE-2015-505, CDI-CORE-2019-813; Foundation for Barnes-Jewish Hospital) for their valuable assistance.	Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI 10.1172/JCI72181; Bain CC, 2013, MUCOSAL IMMUNOL, V6, P498, DOI 10.1038/mi.2012.89; Bajpai G, 2019, CIRC RES, V124, P263, DOI 10.1161/CIRCRESAHA.118.314028; Bajpai G, 2018, NAT MED, V24, P1234, DOI 10.1038/s41591-018-0059-x; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Burchfield JS, 2013, CIRCULATION, V128, P388, DOI 10.1161/CIRCULATIONAHA.113.001878; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Clippinger SR, 2019, P NATL ACAD SCI USA, V116, P17831, DOI 10.1073/pnas.1910962116; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-018-0272-2, 10.1038/s41590-019-0363-8]; Du CK, 2007, CIRC RES, V101, P185, DOI 10.1161/CIRCRESAHA.106.146670; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Dutta B, 2020, LAB INVEST, V100, P178, DOI 10.1038/s41374-019-0334-6; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Godwin JW, 2017, NPJ REGEN MED, V2, DOI 10.1038/s41536-017-0027-y; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Hamanaka K, 2010, AM J PHYSIOL-LUNG C, V299, pL353, DOI 10.1152/ajplung.00315.2009; Han L, 2020, DEV CELL, V53, P42, DOI 10.1016/j.devcel.2020.01.030; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Heo GS, 2019, CIRC RES, V124, P881, DOI 10.1161/CIRCRESAHA.118.314030; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Hulsmans M, 2018, J EXP MED, V215, P423, DOI 10.1084/jem.20171274; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kanno S, 2002, J AM SOC ECHOCARDIOG, V15, P601, DOI 10.1067/mje.2002.117560; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Lavine KJ, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000343; Leid J, 2016, CIRC RES, V118, P1498, DOI 10.1161/CIRCRESAHA.115.308270; LI W, 2016, JCI INSIGHT, V1, DOI [10.1172/jci.insight.87315, DOI 10.1172/JCI.INSIGHT.87315]; Liu YJ, 2017, RADIOLOGY, V283, P757, DOI 10.1148/radiol.2016161409; Luehmann HP, 2014, J NUCL MED, V55, P629, DOI 10.2967/jnumed.113.132001; Luo JL, 2018, IMMUNITY, V49, P107, DOI 10.1016/j.immuni.2018.04.021; Madisen L, 2015, NEURON, V85, P942, DOI 10.1016/j.neuron.2015.02.022; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mannaa M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23165-0; McNally EM, 2017, CIRC RES, V121, P731, DOI 10.1161/CIRCRESAHA.116.309396; Merlo M, 2011, J AM COLL CARDIOL, V57, P1468, DOI 10.1016/j.jacc.2010.11.030; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Morimoto S, 2002, P NATL ACAD SCI USA, V99, P913, DOI 10.1073/pnas.022628899; Munoz-Espin D, 2013, CELL, V155, P1104, DOI 10.1016/j.cell.2013.10.019; Nakamura M, 2018, NAT REV CARDIOL, V15, P387, DOI 10.1038/s41569-018-0007-y; Nelson JW, 2017, BIOINFORMATICS, V33, P447, DOI 10.1093/bioinformatics/btw624; Nicolas-Avila JA, 2020, CELL, V183, P94, DOI 10.1016/j.cell.2020.08.031; Pairet N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196055; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Patel B, 2018, JACC-BASIC TRANSL SC, V3, P230, DOI 10.1016/j.jacbts.2017.12.006; Patel MD, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94382; Petrie TA, 2014, DEVELOPMENT, V141, P2581, DOI 10.1242/dev.098459; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Pinto AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036814; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Sager HB, 2016, CIRC RES, V119, P853, DOI 10.1161/CIRCRESAHA.116.309001; Samann Fars, 2019, Current Directions in Biomedical Engineering, V5, P385, DOI 10.1515/cdbme-2019-0097; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Scheraga RG, 2016, J IMMUNOL, V196, P428, DOI 10.4049/jimmunol.1501688; Soares MP, 2016, IMMUNITY, V44, P492, DOI 10.1016/j.immuni.2016.02.016; Storer M, 2013, CELL, V155, P1119, DOI 10.1016/j.cell.2013.10.041; Sugita J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22178-0; Swain SM, 2020, J CLIN INVEST, V130, P2527, DOI 10.1172/JCI134111; Theret M, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.156000; Uhl S, 2015, JOVE-J VIS EXP, DOI 10.3791/53076; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xie M, 2013, CIRCULATION, V128, P1021, DOI 10.1161/CIRCULATIONAHA.113.001879; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zaman Rysa, 2021, Immunity, V54, P2057, DOI 10.1016/j.immuni.2021.07.006	78	25	25	5	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					2072	+		10.1016/j.immuni.2021.07.003	http://dx.doi.org/10.1016/j.immuni.2021.07.003		SEP 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34320366	Green Accepted, Bronze, Green Submitted			2022-12-18	WOS:000695789800015
J	Huang, LJ; Mao, XT; Li, YY; Liu, DD; Fan, KQ; Liu, RB; Wu, TT; Wang, HL; Zhang, Y; Yang, B; Ye, CQ; Zhong, JY; Chai, RJ; Cao, Q; Jin, J				Huang, Ling-jie; Mao, Xin-tao; Li, Yi-yuan; Liu, Dan-dan; Fan, Ke-qi; Liu, Rong-bei; Wu, Ting-ting; Wang, Hao-li; Zhang, Yu; Yang, Bing; Ye, Cun-qi; Zhong, Jiang-yan; Chai, Ren-jie; Cao, Qian; Jin, Jin			Multiomics analyses reveal a critical role of selenium in controlling T cell differentiation in Crohn's disease	IMMUNITY			English	Article							KAPPA-B; METABOLISM; INFLAMMATION; ACTIVATION; RESPONSES; IMMUNITY; MITOCHONDRIA; CANCER; MODEL; TH2	Inflammatory bowel disease (IBD) mainly includes Crohn's disease (CD) and ulcerative colitis (UC). Immune disorders play an essential role in the pathogenesis of these two IBDs, but the differences in the immune microenvironment of the colon and their underlying mechanisms remain poorly investigated. Here we examined the immunological features and metabolic microenvironment of untreated individuals with IBD by multiomics analyses. Modulation of CD-specific metabolites, particularly reduced selenium, can obviously shape type 1 T helper (Th1) cell differentiation, which is specifically enriched in CD. Selenium supplementation suppressed the symptoms and onset of CD and Th1 cell differentiation via selenoprotein W (SELW)-mediated cellular reactive oxygen species scavenging. SELW promoted purine salvage pathways and inhibited one-carbon metabolism by recruiting an E3 ubiquitin ligase, tripartite motif-containing protein 21, which controlled the stability of serine hydroxymethyltransferase 2. Our work highlights selenium as an essential regulator of T cell responses and potential therapeutic targets in CD.	[Huang, Ling-jie; Liu, Rong-bei; Wu, Ting-ting; Zhang, Yu; Cao, Qian; Jin, Jin] Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Coll Med, Hangzhou 310016, Peoples R China; [Mao, Xin-tao; Liu, Dan-dan; Fan, Ke-qi; Wang, Hao-li; Yang, Bing; Ye, Cun-qi; Zhong, Jiang-yan; Jin, Jin] Zhejiang Univ, MOE Lab Biosyst Homeostasis & Protect, Hangzhou 310058, Peoples R China; [Mao, Xin-tao; Liu, Dan-dan; Fan, Ke-qi; Wang, Hao-li; Yang, Bing; Ye, Cun-qi; Zhong, Jiang-yan; Jin, Jin] Zhejiang Univ, Life Sci Inst, Hangzhou 310058, Peoples R China; [Li, Yi-yuan; Chai, Ren-jie] Southeast Univ, Inst Life Sci, Key Lab Dev Genes & Human Dis, Minist Educ,Jiangsu Prov High Tech Key Lab Biomed, Nanjing 210096, Peoples R China; [Chai, Ren-jie] Nantong Univ, Coinnovat Ctr Neuroregenerat, Nantong 226001, Peoples R China; [Chai, Ren-jie] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing 100101, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Southeast University - China; Nantong University; Chinese Academy of Sciences	Cao, Q; Jin, J (corresponding author), Zhejiang Univ, Sir Run Run Shaw Hosp, Dept Gastroenterol, Coll Med, Hangzhou 310016, Peoples R China.; Jin, J (corresponding author), Zhejiang Univ, MOE Lab Biosyst Homeostasis & Protect, Hangzhou 310058, Peoples R China.; Jin, J (corresponding author), Zhejiang Univ, Life Sci Inst, Hangzhou 310058, Peoples R China.	caoq@zju.edu.cn; jjin4@zju.edu.cn			National Key R&D Program of China [2018YFA0800503]; Excellent Young Scientist Fund of NSFC [31822017]; Zhejiang Provincial Natural Science Foundation of China [LR19C080001]; National Natural Science Foundation of China [81771675, 81970484]; Key R&D Program of Zhejiang Province [2020C03075]	National Key R&D Program of China; Excellent Young Scientist Fund of NSFC(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key R&D Program of Zhejiang Province	We thank the Life Sciences Institute core facilities, Zhejiang University, for technical assistance. This study was supported by the National Key R&D Program of China (2018YFA0800503), Excellent Young Scientist Fund of NSFC (31822017), Zhejiang Provincial Natural Science Foundation of China (LR19C080001), National Natural Science Foundation of China (81771675 and 81970484), and Key R&D Program of Zhejiang Province (2020C03075).	AMES BN, 1981, P NATL ACAD SCI-BIOL, V78, P6858, DOI 10.1073/pnas.78.11.6858; Barrett CW, 2015, J CLIN INVEST, V125, P2646, DOI 10.1172/JCI76099; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cao W, 2017, IMMUNITY, V47, P1182, DOI 10.1016/j.immuni.2017.11.012; Case AJ, 2011, FREE RADICAL BIO MED, V50, P448, DOI 10.1016/j.freeradbiomed.2010.11.025; Castellino F, 2006, NATURE, V440, P890, DOI 10.1038/nature04651; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Clare CE, 2019, ANNU REV ANIM BIOSCI, V7, P263, DOI 10.1146/annurev-animal-020518-115206; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Espinosa-Diez C, 2015, REDOX BIOL, V6, P183, DOI 10.1016/j.redox.2015.07.008; Franchina DG, 2018, TRENDS IMMUNOL, V39, P489, DOI 10.1016/j.it.2018.01.005; Frossi B, 2008, MOL IMMUNOL, V45, P58, DOI 10.1016/j.molimm.2007.05.008; Gambhir L, 2015, TOXICOL APPL PHARM, V289, P297, DOI 10.1016/j.taap.2015.09.014; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Gnanaprakasam JNR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01075; Guo L, 2018, CELL CHEM BIOL, V25, P1380, DOI 10.1016/j.chembiol.2018.08.006; Hang SY, 2019, NATURE, V576, P143, DOI 10.1038/s41586-019-1785-z; HINKS LJ, 1988, J CLIN PATHOL, V41, P198, DOI 10.1136/jcp.41.2.198; Jeong DW, 2002, FEBS LETT, V517, P225, DOI 10.1016/S0014-5793(02)02628-5; Korn SH, 2001, J BIOL CHEM, V276, P35693, DOI 10.1074/jbc.M104321200; Krehl S, 2012, CARCINOGENESIS, V33, P620, DOI 10.1093/carcin/bgr288; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kudva AK, 2015, AM J PHYSIOL-GASTR L, V309, pG71, DOI 10.1152/ajpgi.00379.2014; Lee DH, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.95; Lei XG, 2007, ANNU REV NUTR, V27, P41, DOI 10.1146/annurev.nutr.27.061406.093716; Linden J, 2019, ANNU REV IMMUNOL, V37, P325, DOI 10.1146/annurev-immunol-051116-052406; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma EH, 2017, CELL METAB, V25, P345, DOI 10.1016/j.cmet.2016.12.011; Matsushita M, 2015, J EXP MED, V212, P555, DOI 10.1084/jem.20140857; Mitsialis V, 2020, GASTROENTEROLOGY, V159, P591, DOI 10.1053/j.gastro.2020.04.074; Muri J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04274-w; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Nathan C, 2013, NAT REV IMMUNOL, V13, P349, DOI 10.1038/nri3423; Ng SC, 2017, LANCET, V390, P2769, DOI 10.1016/S0140-6736(17)32448-0; Nikolaus S, 2017, GASTROENTEROLOGY, V153, P1504, DOI 10.1053/j.gastro.2017.08.028; Ostanin DV, 2009, AM J PHYSIOL-GASTR L, V296, pG135, DOI 10.1152/ajpgi.90462.2008; Ostanin DV, 2006, AM J PHYSIOL-GASTR L, V290, pG109, DOI 10.1152/ajpgi.00214.2005; Ozay EI, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01284; Peng C, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/831841; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Ron-Harel N, 2018, P NATL ACAD SCI USA, V115, P13347, DOI 10.1073/pnas.1804149115; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Ruan HF, 2012, BIOL TRACE ELEM RES, V145, P59, DOI 10.1007/s12011-011-9166-y; Rubin SJS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10387-7; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shrimali RK, 2008, J BIOL CHEM, V283, P20181, DOI 10.1074/jbc.M802559200; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Song XY, 2020, NATURE, V577, P410, DOI 10.1038/s41586-019-1865-0; Strober W, 2011, GASTROENTEROLOGY, V140, P1756, DOI 10.1053/j.gastro.2011.02.016; Taylor CT, 2008, BIOCHEM J, V409, P19, DOI 10.1042/BJ20071249; Tokunaga R, 2018, CANCER TREAT REV, V63, P40, DOI 10.1016/j.ctrv.2017.11.007; Torres J, 2017, LANCET, V389, P1741, DOI 10.1016/S0140-6736(16)31711-1; Ungaro R, 2017, LANCET, V389, P1756, DOI 10.1016/S0140-6736(16)32126-2; Vento-Tormo R, 2018, NATURE, V563, P347, DOI 10.1038/s41586-018-0698-6; Won HY, 2010, ANTIOXID REDOX SIGN, V13, P575, DOI 10.1089/ars.2009.2989; Yang LL, 2019, INFLAMM BOWEL DIS, V25, P722, DOI 10.1093/ibd/izy359; Zuo T, 2018, NAT REV GASTRO HEPAT, V15, P440, DOI 10.1038/s41575-018-0003-z	60	25	25	20	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1728	+		10.1016/j.immuni.2021.07.004	http://dx.doi.org/10.1016/j.immuni.2021.07.004		AUG 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34343498	Bronze			2022-12-18	WOS:000684589700012
J	Jongsma, MLM; de Waard, AA; Raaben, M; Zhang, T; Cabukusta, B; Platzer, R; Blomen, VA; Xagara, A; Verkerk, T; Bliss, S; Kong, XR; Gerke, C; Janssen, L; Stickel, E; Holst, S; Plomp, R; Mulder, A; Ferrone, S; Claas, FHJ; Heemskerk, MHM; Griffioen, M; Halenius, A; Overkleeft, H; Huppa, JB; Wuhrer, M; Brummelkamp, TR; Neefjes, J; Spaapen, RM				Jongsma, Marlieke L. M.; de Waard, Antonius A.; Raaben, Matthijs; Zhang, Tao; Cabukusta, Birol; Platzer, Rene; Blomen, Vincent A.; Xagara, Anastasia; Verkerk, Tamara; Bliss, Sophie; Kong, Xiangrui; Gerke, Carolin; Janssen, Lennert; Stickel, Elmer; Holst, Stephanie; Plomp, Rosina; Mulder, Arend; Ferrone, Soldano; Claas, Frans H. J.; Heemskerk, Mirjam H. M.; Griffioen, Marieke; Halenius, Anne; Overkleeft, Hermen; Huppa, Johannes B.; Wuhrer, Manfred; Brummelkamp, Thijn R.; Neefjes, Jacques; Spaapen, Robbert M.			The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses	IMMUNITY			English	Article							MHC CLASS-I; SIGNAL PEPTIDE PEPTIDASE; MINOR HISTOCOMPATIBILITY ANTIGENS; HAPLOID GENETIC SCREENS; CRYSTAL-STRUCTURE; T-CELLS; INHIBITORY RECEPTOR; ACQUIRED-RESISTANCE; STRUCTURAL-ANALYSIS; COMPLEX	HLA class I (HLA-I) glycoproteins drive immune responses by presenting antigens to cognate CD8(+) T cells. This process is often hijacked by tumors and pathogens for immune evasion. Because options for restoring HLA-I antigen presentation are limited, we aimed to identify druggable HLA-I pathway targets. Using iterative genome-wide screens, we uncovered that the cell surface glycosphingolipid (GSL) repertoire determines effective HLA-I antigen presentation. We show that absence of the protease SPPL3 augmented B3GNT5 enzyme activity, resulting in upregulation of surface neolacto-series GSLs. These GSLs sterically impeded antibody and receptor interactions with HLA-I and diminished CDS+ T cell activation. Furthermore, a disturbed SPPL3-B3GNT5 pathway in glioma correlated with decreased patient survival. We show that the immunomodulatory effect could be reversed through GSL synthesis inhibition using clinically approved drugs. Overall, our study identifies a GSL signature that inhibits immune recognition and represents a potential therapeutic target in cancer, infection, and autoimmunity.	[Jongsma, Marlieke L. M.; de Waard, Antonius A.; Raaben, Matthijs; Xagara, Anastasia; Verkerk, Tamara; Bliss, Sophie; Kong, Xiangrui; Spaapen, Robbert M.] Sanquin Res, Dept Immunopathol, Amsterdam, Netherlands; [Jongsma, Marlieke L. M.; de Waard, Antonius A.; Xagara, Anastasia; Verkerk, Tamara; Bliss, Sophie; Kong, Xiangrui; Spaapen, Robbert M.] Univ Amsterdam, Landsteiner Lab, Amsterdam UMC, Amsterdam, Netherlands; [Jongsma, Marlieke L. M.; de Waard, Antonius A.; Xagara, Anastasia; Verkerk, Tamara; Bliss, Sophie; Kong, Xiangrui; Spaapen, Robbert M.] Canc Ctr Amsterdam, Amsterdam, Netherlands; [Jongsma, Marlieke L. M.; Cabukusta, Birol; Janssen, Lennert; Neefjes, Jacques] LUMC, Oncode Inst, Leiden, Netherlands; [Jongsma, Marlieke L. M.; Cabukusta, Birol; Janssen, Lennert; Neefjes, Jacques] LUMC, Dept Cell & Chem Biol, Leiden, Netherlands; [Raaben, Matthijs; Blomen, Vincent A.; Stickel, Elmer; Brummelkamp, Thijn R.] Netherlands Canc Inst, Oncode Inst, Div Biochem, Amsterdam, Netherlands; [Zhang, Tao; Holst, Stephanie; Plomp, Rosina; Wuhrer, Manfred] LUMC, Ctr Prote & Metabol, Leiden, Netherlands; [Platzer, Rene; Huppa, Johannes B.] Inst Hyg & Angew Immunol, Vienna, Austria; [Gerke, Carolin; Halenius, Anne] Univ Freiburg, Inst Virol, Med Ctr, Freiburg, Germany; [Gerke, Carolin; Halenius, Anne] Univ Freiburg, Fac Med, Freiburg, Germany; [Gerke, Carolin] Univ Freiburg, Spemann Grad Sch Biol & Med, Freiburg, Germany; [Gerke, Carolin] Univ Freiburg, Fac Biol, Freiburg, Germany; [Mulder, Arend; Claas, Frans H. J.] LUMC, Dept Immunol, Leiden, Netherlands; [Ferrone, Soldano] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Boston, MA 02115 USA; [Heemskerk, Mirjam H. M.; Griffioen, Marieke] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands; [Overkleeft, Hermen] Leiden Univ, Leiden Inst Chem, Leiden, Netherlands; [Brummelkamp, Thijn R.] Austrian Acad Sci, CeMM Res Ctr Mol Med, Vienna, Austria; [Brummelkamp, Thijn R.] Canc Genom Ctr, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC); Netherlands Cancer Institute; Leiden University; Leiden University Medical Center (LUMC); University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Leiden University; Leiden University Medical Center (LUMC); Harvard University; Harvard Medical School; Massachusetts General Hospital; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences	Spaapen, RM (corresponding author), Sanquin Res, Dept Immunopathol, Amsterdam, Netherlands.; Spaapen, RM (corresponding author), Univ Amsterdam, Landsteiner Lab, Amsterdam UMC, Amsterdam, Netherlands.; Spaapen, RM (corresponding author), Canc Ctr Amsterdam, Amsterdam, Netherlands.	r.spaapen@sanquin.nl	Heemskerk, Mirjam H.M./ABI-2336-2020; Wuhrer, Manfred/ABE-9168-2020; Spaapen, Robbert/AAF-9105-2021; Huppa, Johannes Bernhard/AAY-9471-2021; Neefjes, Jacques J.C./H-8780-2017	Heemskerk, Mirjam H.M./0000-0001-6320-9133; Wuhrer, Manfred/0000-0002-0814-4995; Huppa, Johannes Bernhard/0000-0003-2634-8198; Neefjes, Jacques J.C./0000-0001-6763-2211; de Waard, Antonius/0000-0002-3796-5178	Dutch Research Council [NWO-VENI 016.131.047, NWO-VIDI 91719369, ZonMw-ETH 435004024, NWO-Vici 016.Vici.170.033]; KWF (Alpe d'HuZes Bas Mulder Award) [2015-7982, NKI2015-7609]; Landsteiner Foundation for Blood Transfusion Research (LSBR fellowship) [1842F]; EMBO [ASTF 10-2016]; Cancer Genomics Center; Ammodo (KNAW Award 2015 for Biomedical Sciences); Boehringer Ingelheim Fonds; Vienna Science and Technolgy Fund [WWTF LS14-031]; DOD [W81XWMH-16-1-0500]; NIH [R01DE028172, R03CA216114, RO3CA223886, RO3CA231766]	Dutch Research Council; KWF (Alpe d'HuZes Bas Mulder Award); Landsteiner Foundation for Blood Transfusion Research (LSBR fellowship); EMBO(European Molecular Biology Organization (EMBO)); Cancer Genomics Center; Ammodo (KNAW Award 2015 for Biomedical Sciences); Boehringer Ingelheim Fonds(Boehringer Ingelheim); Vienna Science and Technolgy Fund; DOD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. R. Fluhrer (Ludwig Maximilians University, Germany) for providing SPPL3 plasmids; Dr. M. Griffioen (LUMC, the Netherlands) for providing T cell clones; Dr. O. Mandelboim (HebrewUniversity Hadassah Medical School, Israel) for providing LIR-1 Fc fusion protein; Dr. T. Rispens (Sanquin, the Netherlands) for expert advice for Fab generation and protein purification; E. Mul, S. Tol, and M. Hoogenboezem (Sanquin) for assistance with flow cytometry; Dr. D. Amsen (Sanquin) and Dr. I. Berlin (LUMC) for editorial help; Dr. Y. Rombouts (Universite ' de Toulouse, France) for contributing to MTBE extraction; and C.A.M. Koeleman and A.L. Hipgrave Ederveen (LUMC) for technical support with LC-MS. This work was supported by the Dutch Research Council (NWO-VENI 016.131.047, NWO-VIDI 91719369, and ZonMw-ETH 435004024 to R.M.S. and NWO-Vici 016.Vici.170.033 to T.R.B.), KWF (Alpe d'HuZes Bas Mulder Award 2015-7982 to R.M.S. and NKI2015-7609 to T.R.B.) the Landsteiner Foundation for Blood Transfusion Research (LSBR fellowship 1842F to R.M.S.), EMBO (ASTF 10-2016 to M.L.M.J.), the Cancer Genomics Center (to T.R.B.), Ammodo (KNAW Award 2015 for Biomedical Sciences to T.R.B.), the Boehringer Ingelheim Fonds (predoctoral fellowship to R.Platzer), the Vienna Science and Technolgy Fund (WWTF LS14-031 to J.B.H.), DOD (W81XWMH-16-1-0500 to S.F.), and NIH (R01DE028172, R03CA216114, RO3CA223886, and RO3CA231766 to S.F.).	Achdout H, 2008, J VIROL, V82, P8030, DOI 10.1128/JVI.00870-08; Allende ML, 2014, GLYCOCONJUGATE J, V31, P613, DOI 10.1007/s10719-014-9563-5; Amir AL, 2011, BLOOD, V118, P6733, DOI 10.1182/blood-2011-05-354787; Anaya J, 2016, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.67; ANDREWS PW, 1989, J EXP MED, V169, P1347, DOI 10.1084/jem.169.4.1347; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; BARBOSA JA, 1987, J EXP MED, V166, P1329, DOI 10.1084/jem.166.5.1329; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Blees A, 2017, NATURE, V551, P525, DOI 10.1038/nature24627; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Borges L, 1997, J IMMUNOL, V159, P5192; Brameshuber M, 2018, NAT IMMUNOL, V19, P487, DOI 10.1038/s41590-018-0092-4; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Brockmann M, 2017, NATURE, V546, P307, DOI 10.1038/nature22376; Caffaro CE, 2006, ACCOUNTS CHEM RES, V39, P805, DOI 10.1021/ar0400239; Carette JE, 2009, SCIENCE, V326, P1231, DOI 10.1126/science.1178955; Catalaa I, 2006, NMR BIOMED, V19, P463, DOI 10.1002/nbm.1059; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; Chowell D, 2018, SCIENCE, V359, P582, DOI 10.1126/science.aao4572; Colonna M, 1997, J EXP MED, V186, P1809, DOI 10.1084/jem.186.11.1809; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Cooper CA, 2001, PROTEOMICS, V1, P340, DOI 10.1002/1615-9861(200102)1:2<340::AID-PROT340>3.0.CO;2-B; Cosman D, 1997, IMMUNITY, V7, P273, DOI 10.1016/S1074-7613(00)80529-4; D'Angelo G, 2013, FEBS J, V280, P6338, DOI 10.1111/febs.12559; Davis EM, 2015, CELL REP, V11, P1727, DOI 10.1016/j.celrep.2015.05.026; de Groot NG, 2016, J IMMUNOL, V196, P750, DOI 10.4049/jimmunol.1500820; de Waard AA, 2021, EUR J IMMUNOL, V51, P734, DOI 10.1002/eji.202048599; Dersh D, 2021, IMMUNITY, V54, P116, DOI 10.1016/j.immuni.2020.11.002; Desai SA, 2000, J IMMUNOL, V165, P3275, DOI 10.4049/jimmunol.165.6.3275; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; DOMON B, 1988, BIOCHEMISTRY-US, V27, P1534, DOI 10.1021/bi00405a021; Duquesnoy RJ, 2013, HUM IMMUNOL, V74, P1271, DOI 10.1016/j.humimm.2013.05.016; Duquesnoy RJ, 2012, HUM IMMUNOL, V73, P267, DOI 10.1016/j.humimm.2011.11.011; Fantini J, 2000, GLYCOCONJUGATE J, V17, P199, DOI 10.1023/A:1026537122903; Fluhrer R, 2007, NEURODEGENER DIS, V4, P112, DOI 10.1159/000101835; Frohlich F, 2015, ELIFE, V4, DOI 10.7554/eLife.08712; Furukawa J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128300; Gao GF, 1997, NATURE, V387, P630, DOI 10.1038/42523; Gao YX, 2009, OPT EXPRESS, V17, P4685, DOI 10.1364/OE.17.004685; Garstka MA, 2015, P NATL ACAD SCI USA, V112, P1505, DOI 10.1073/pnas.1416543112; Gettinger S, 2017, CANCER DISCOV, V7, P1420, DOI 10.1158/2159-8290.CD-17-0593; Ghisaidoobe AT, 2014, J MED CHEM, V57, P9096, DOI 10.1021/jm501181z; Gonen-Gross T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008941; Griffioen M, 2012, HAEMATOL-HEMATOL J, V97, P1196, DOI 10.3324/haematol.2011.049478; Haehnel PS, 2008, CANCER RES, V68, P3899, DOI 10.1158/0008-5472.CAN-07-6286; HAKOMORI S, 1984, ANNU REV IMMUNOL, V2, P103, DOI 10.1146/annurev.iy.02.040184.000535; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Haworth KB, 2015, PEDIATR BLOOD CANCER, V62, P571, DOI 10.1002/pbc.25359; Heck D, 2014, NAT BIOTECHNOL, V32, P941, DOI 10.1038/nbt.2951; Hiby SE, 2010, J CLIN INVEST, V120, P4102, DOI 10.1172/JCI43998; HOGAN KT, 1992, HUM IMMUNOL, V33, P185, DOI 10.1016/0198-8859(92)90070-4; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Jensen PH, 2012, NAT PROTOC, V7, P1299, DOI 10.1038/nprot.2012.063; Jongsma MLM, 2019, MOL IMMUNOL, V113, P16, DOI 10.1016/j.molimm.2017.12.005; Karlsson NG, 2004, RAPID COMMUN MASS SP, V18, P2282, DOI 10.1002/rcm.1626; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KINGSLEY DM, 1986, J CELL BIOL, V102, P1576, DOI 10.1083/jcb.102.5.1576; Kuhn PH, 2015, MOL CELL PROTEOMICS, V14, P1584, DOI 10.1074/mcp.M115.048298; Lachmann Robin H, 2003, Curr Opin Investig Drugs, V4, P472; Ladasky JJ, 1999, IMMUNOGENETICS, V49, P312, DOI 10.1007/s002510050498; Li LN, 2012, NAT STRUCT MOL BIOL, V19, P1176, DOI 10.1038/nsmb.2396; Liu YY, 2013, ADV CANCER RES, V117, P59, DOI 10.1016/B978-0-12-394274-6.00003-0; Logtenberg MEW, 2019, NAT MED, V25, P612, DOI 10.1038/s41591-019-0356-z; Marrari M, 2010, TRANSPLANTATION, V90, P1468, DOI 10.1097/TP.0b013e3182007b74; Merrill AH, 2017, BBA-MOL CELL BIOL L, V1862, P774, DOI 10.1016/j.bbalip.2017.01.009; MillerPodraza H, 1997, GLYCOCONJUGATE J, V14, P231, DOI 10.1023/A:1018545922728; MILLERPODRAZA H, 1993, BIOCHIM BIOPHYS ACTA, V1168, P330, DOI 10.1016/0005-2760(93)90190-K; Mitra AK, 2004, CURR BIOL, V14, P718, DOI 10.1016/j.cub.2004.04.004; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Moore ML, 2008, VIRAL IMMUNOL, V21, P327, DOI 10.1089/vim.2008.0003; Mulder A, 2010, MOL IMMUNOL, V47, P809, DOI 10.1016/j.molimm.2009.10.004; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; NEEFJES JJ, 1990, J EXP MED, V171, P583, DOI 10.1084/jem.171.2.583; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Oostvogels R, 2014, HAEMATOLOGICA, V99, P1854, DOI 10.3324/haematol.2014.109801; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Pech M, 2019, ELIFE, V8, DOI 10.7554/eLife.47362; PLATT FM, 1994, J BIOL CHEM, V269, P8362; Plomp R, 2014, J PROTEOME RES, V13, P536, DOI 10.1021/pr400714w; Potapenko IO, 2015, MOL ONCOL, V9, P861, DOI 10.1016/j.molonc.2014.12.013; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; RADSAK K, 1984, VIROLOGY, V138, P300, DOI 10.1016/0042-6822(84)90353-2; Reiser JB, 2014, J IMMUNOL, V193, P5816, DOI 10.4049/jimmunol.1303084; Reits EA, 2006, J EXP MED, V203, P1259, DOI 10.1084/jem.20052494; Restifo NP, 1996, J NATL CANCER I, V88, P100, DOI 10.1093/jnci/88.2.100; Rigau M, 2020, SCIENCE, V367, P642, DOI 10.1126/science.aay5516; Righi V, 2009, NMR BIOMED, V22, P629, DOI 10.1002/nbm.1377; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Rock KL, 2016, TRENDS IMMUNOL, V37, P724, DOI 10.1016/j.it.2016.08.010; Roszkowski JJ, 2003, J IMMUNOL, V170, P2582, DOI 10.4049/jimmunol.170.5.2582; Ryan SO, 2012, SEMIN IMMUNOPATHOL, V34, P425, DOI 10.1007/s00281-012-0309-9; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Saverino D, 2000, J IMMUNOL, V165, P3742, DOI 10.4049/jimmunol.165.7.3742; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Schutz GJ, 1997, BIOPHYS J, V73, P1073, DOI 10.1016/S0006-3495(97)78139-6; Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16; Shayman JA, 2010, DRUG FUTURE, V35, P613, DOI 10.1358/dof.2010.035.08.1505566; Shi Y, 2011, MOL IMMUNOL, V48, P2198, DOI 10.1016/j.molimm.2011.05.009; Spaapen RM, 2008, J EXP MED, V205, P2863, DOI 10.1084/jem.20080713; Stirnemann J, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020441; Straten PT, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0127-z; TAKETANI S, 1983, J IMMUNOL, V131, P2935; Trymbulak WP, 1997, TRANSPLANTATION, V64, P640, DOI 10.1097/00007890-199708270-00016; UNANUE ER, 1989, FASEB J, V3, P2496, DOI 10.1096/fasebj.3.13.2572499; Valiante NM, 1997, IMMUNITY, V7, P739, DOI 10.1016/S1074-7613(00)80393-3; van Bergen CAM, 2007, BLOOD, V109, P4089, DOI 10.1182/blood-2006-08-043935; Van Bergen CAM, 2010, CANCER RES, V70, P9073, DOI 10.1158/0008-5472.CAN-10-1832; Voss M, 2014, EMBO J, V33, P2890, DOI 10.15252/embj.201488375; Voss M, 2013, BBA-BIOMEMBRANES, V1828, P2828, DOI 10.1016/j.bbamem.2013.03.033; Voss M, 2012, J BIOL CHEM, V287, P43401, DOI 10.1074/jbc.M112.371369; Wang Z, 2012, GLYCOBIOLOGY, V22, P930, DOI 10.1093/glycob/cws061; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; Wieser S, 2007, BIOPHYS J, V92, P3719, DOI 10.1529/biophysj.106.095398; WIKSTRAND CJ, 1991, J NEUROPATH EXP NEUR, V50, P756, DOI 10.1097/00005072-199111000-00007; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wraith James E, 2009, Ther Clin Risk Manag, V5, P877; Yewdell JW, 2002, NAT IMMUNOL, V3, P1019, DOI 10.1038/ni1102-1019; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang T, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00090; Zhang Y, 2020, BIORXIV, DOI [10.1101/2020.05.24.111823, DOI 10.1101/2020.05.24.111823]	124	25	25	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					132	+		10.1016/j.immuni.2020.11.003	http://dx.doi.org/10.1016/j.immuni.2020.11.003		JAN 2021	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33271119	Green Accepted, Green Submitted, Green Published, Bronze			2022-12-18	WOS:000607814000015
J	Li, XX; Rommelaere, S; Kondo, S; Lemaitre, B				Li, Xiaoxue; Rommelaere, Samuel; Kondo, Shu; Lemaitre, Bruno			Renal Purge of Hemolymphatic Lipids Prevents the Accumulation of ROS-Induced Inflammatory Oxidized Lipids and Protects Drosophila from Tissue Damage	IMMUNITY			English	Article							REACTIVE OXYGEN; MALPIGHIAN TUBULE; IMMUNE-RESPONSE; HOST-DEFENSE; OXIDATIVE STRESS; NOX ENZYMES; MELANOGASTER; SYSTEM; PEROXIDATION; GENE	Animals require complex metabolic and physiological adaptations to maintain the function of vital organs in response to environmental stresses and infection. Here, we found that infection or injury in Drosophila induced the excretion of hemolymphatic lipids by Malpighian tubules, the insect kidney. This lipid purge was mediated by a stress-induced lipid binding protein, Materazzi, which was enriched in Malpighian tubules. Flies lacking materazzi had higher hemolymph concentrations of reactive oxygen species (ROS) and increased lipid peroxidation. These flies also displayed Malpighian tubule dysfunction and were susceptible to infections and environmental stress. Feeding flies with antioxidants rescued the materazzi phenotype, indicating that the main role of Materazzi is to protect the organism from damage caused by stress-induced ROS. Our findings suggest that purging hemolymphatic lipids presents a physiological adaptation to protect host tissues from excessive ROS during immune and stress responses, a process that is likely to apply to other organisms.	[Li, Xiaoxue; Rommelaere, Samuel; Lemaitre, Bruno] Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Lausanne, Switzerland; [Kondo, Shu] Natl Inst Genet, Genet Strains Res Ctr, Invertebrate Genet Lab, Mishima, Shizuoka 4118540, Japan	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Li, XX; Lemaitre, B (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Global Hlth Inst, Lausanne, Switzerland.	xiaoxue.li@epfl.ch; bruno.lemaitre@epfl.ch		Kondo, Shu/0000-0002-4625-8379	SNSF [CRSII5_186397]	SNSF(Swiss National Science Foundation (SNSF))	We thank the Protein Production and Structure Core Facility in EPFL, especially Kelvin Lau and Marylin Aebi for the production of recombinant MatGFP protein and GFP control protein. We would also like to thank Giovanni D'Angelo for his kind help with TLC analysis. We would like to thank Hugo Stocker, Hui-Ying Lim, Won-Jae Lee, and Liming Wang for providing fly stocks. We thank the Bloomington Stock Center and the Vienna Drosophila Resource Center for fly stocks. We thank Mark Hanson, Claudia Melcarne, and Claudine Neyen for careful reading and comments on the manuscript. This project was supported by the SNSF grant CRSII5_186397.	Ayala A, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/360438; Bailey AP, 2015, CELL, V163, P340, DOI 10.1016/j.cell.2015.09.020; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763; Buchon N, 2013, NAT REV MICROBIOL, V11, P615, DOI 10.1038/nrmicro3074; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Cabrero P, 2002, J EXP BIOL, V205, P3799; Cannell E, 2016, PEPTIDES, V80, P96, DOI 10.1016/j.peptides.2016.02.004; Chakrabarti S, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004659; Chapman RF, 2013, J CHEM INF MODEL, V5th; Chen JM, 2010, P NATL ACAD SCI USA, V107, P20774, DOI 10.1073/pnas.1009223107; Chintapalli VR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032577; Conrad M, 2018, GENE DEV, V32, P602, DOI 10.1101/gad.314674.118; Craig CR, 2004, EMBO REP, V5, P1058, DOI 10.1038/sj.embor.7400282; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Daenen K, 2019, PEDIATR NEPHROL, V34, P975, DOI 10.1007/s00467-018-4005-4; Davies SA, 2012, J INSECT PHYSIOL, V58, P488, DOI 10.1016/j.jinsphys.2012.01.008; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dow JAT, 2001, ADV INSECT PHYSIOL, V28, P1, DOI 10.1016/S0065-2806(01)28008-4; DOW JAT, 1994, J EXP BIOL, V197, P421; Dow JAT, 2018, CURR OPIN INSECT SCI, V29, P7, DOI 10.1016/j.cois.2018.05.010; Dow JAT, 2009, J EXP BIOL, V212, P435, DOI 10.1242/jeb.024224; Ferro CJ, 2018, NAT REV NEPHROL, V14, P727, DOI 10.1038/s41581-018-0072-9; Franchet A, 2019, NAT MICROBIOL, V4, P645, DOI 10.1038/s41564-018-0344-y; Galenza A, 2019, DEV COMP IMMUNOL, V94, P22, DOI 10.1016/j.dci.2019.01.011; Ganeshan K, 2014, ANNU REV IMMUNOL, V32, P609, DOI 10.1146/annurev-immunol-032713-120236; Gonzalez EA, 2013, CURR BIOL, V23, P2319, DOI 10.1016/j.cub.2013.09.061; Gore JC, 2004, J MED ENTOMOL, V41, P953, DOI 10.1603/0022-2585-41.5.953; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Halberg KA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11266; Hildebrandt A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023796; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kashihara N, 2010, CURR MED CHEM, V17, P4256, DOI 10.2174/092986710793348581; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kolahi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153522; Kondo S, 2013, GENETICS, V195, P715, DOI 10.1534/genetics.113.156737; Lambeth JD, 2014, ANNU REV PATHOL-MECH, V9, P119, DOI 10.1146/annurev-pathol-012513-104651; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Leader DP, 2018, NUCLEIC ACIDS RES, V46, pD809, DOI 10.1093/nar/gkx976; Lee KZ, 2016, CELL HOST MICROBE, V20, P716, DOI 10.1016/j.chom.2016.10.010; Lee KA, 2018, CURR OPIN INSECT SCI, V29, P21, DOI 10.1016/j.cois.2018.05.014; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Lesch C, 2010, GENETICS, V186, P943, DOI 10.1534/genetics.110.121822; McGettigan J, 2005, INSECT BIOCHEM MOLEC, V35, P741, DOI 10.1016/j.ibmb.2005.02.017; Mittal M, 2014, ANTIOXID REDOX SIGN, V20, P1126, DOI 10.1089/ars.2012.5149; Moreira S, 2010, CURR BIOL, V20, P464, DOI 10.1016/j.cub.2010.01.047; Mueller GA, 2013, J ALLERGY CLIN IMMUN, V132, P1420, DOI 10.1016/j.jaci.2013.06.014; Myers AL, 2018, BIOCHEM BIOPH RES CO, V505, P726, DOI 10.1016/j.bbrc.2018.09.126; Nam HJ, 2012, EMBO J, V31, P1253, DOI 10.1038/emboj.2011.476; Nappi A, 2009, ADV PARASIT, V70, P99, DOI 10.1016/S0065-308X(09)70004-1; Negre-Salvayre A, 2008, BRIT J PHARMACOL, V153, P6, DOI 10.1038/sj.bjp.0707395; Neyen C, 2014, METHODS, V68, P116, DOI 10.1016/j.ymeth.2014.02.023; Nicolson SW, 1996, J INSECT PHYSIOL, V42, P1027, DOI 10.1016/S0022-1910(96)00067-4; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Palm W, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002828; Plekhanov AY, 1999, ANAL BIOCHEM, V271, P186, DOI 10.1006/abio.1999.4127; Pomes A, 1998, J BIOL CHEM, V273, P30801, DOI 10.1074/jbc.273.46.30801; Rambold AS, 2015, DEV CELL, V32, P678, DOI 10.1016/j.devcel.2015.01.029; Randall TA, 2013, GENOME BIOL EVOL, V5, P2344, DOI 10.1093/gbe/evt182; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Reczek CR, 2017, ANNU REV CANC BIOL, V1, P79, DOI 10.1146/annurev-cancerbio-041916-065808; Repetto M, 2012, LIPID PEROXIDATION, P3, DOI 10.5772/45943; Rommelaere S, 2019, CELL REP, V27, P886, DOI 10.1016/j.celrep.2019.03.074; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shao BH, 2010, J BIOL CHEM, V285, P18473, DOI 10.1074/jbc.M110.118182; Shao L, 2005, INSECT BIOCHEM MOLEC, V35, P947, DOI 10.1016/j.ibmb.2005.03.012; Suazo A, 2009, INSECT MOL BIOL, V18, P727, DOI 10.1111/j.1365-2583.2009.00912.x; Sureshbabu A, 2015, REDOX BIOL, V4, P208, DOI 10.1016/j.redox.2015.01.001; Xiong X, 2010, J CELL BIOL, V191, P211, DOI 10.1083/jcb.201006039; Yang J, 2007, PHYSIOL GENOMICS, V30, P223, DOI 10.1152/physiolgenomics.00018.2007; Yang Z, 2018, CELL RES, V28, P1013, DOI 10.1038/s41422-018-0084-9; Yin HY, 2011, CHEM REV, V111, P5944, DOI 10.1021/cr200084z; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257	77	25	26	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 18	2020	52	2					374	+		10.1016/j.immuni.2020.01.008	http://dx.doi.org/10.1016/j.immuni.2020.01.008			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN8FZ	32075729	Bronze			2022-12-18	WOS:000515082000017
J	Zenke, S; Palm, MM; Braun, J; Gavrilov, A; Meiser, P; Bottcher, JP; Beyersdorf, N; Ehl, S; Gerard, A; Lammermann, T; Schumacher, TN; Beltman, JB; Rohr, JC				Zenke, Simon; Palm, Margriet M.; Braun, Julia; Gavrilov, Alina; Meiser, Philippa; Boettcher, Jan P.; Beyersdorf, Niklas; Ehl, Stephan; Gerard, Audrey; Laemmermann, Tim; Schumacher, Ton N.; Beltman, Joost B.; Rohr, Jan C.			Quorum Regulation via Nested Antagonistic Feedback Circuits Mediated by the Receptors CD28 and CTLA-4 Confers Robustness to T Cell Population Dynamics	IMMUNITY			English	Article							DENDRITIC CELLS; CUTTING EDGE; ACTIVATION; DIFFERENTIATION; EXPRESSION; COMMUNICATION; MOLECULES; APOPTOSIS; MEMORY; DEATH	T cell responses upon infection display a remarkably reproducible pattern of expansion, contraction, and memory formation. If the robustness of this pattern builds entirely on signals derived from other cell types or if activated T cells themselves contribute to the orchestration of these population dynamics-akin to bacterial quorum regulation-is unclear. Here, we examined this question using time-lapse microscopy, genetic perturbation, bioinformatic predictions, and mathematical modeling. We found that ICAM-1-mediated cell clustering enabled CD8(+) T cells to collectively regulate the balance between proliferation and apoptosis. Mechanistically, T cell expressed CD80 and CD86 interacted with the receptors CD28 and CTLA-4 on neighboring T cells; these interactions fed two nested antagonistic feedback circuits that regulated interleukin 2 production in a manner dependent on T cell density as confirmed by in vivo modulation of this network. Thus, CD8(+) T cell-population-intrinsic mechanisms regulate cellular behavior, thereby promoting robustness of population dynamics.	[Zenke, Simon; Braun, Julia; Ehl, Stephan; Rohr, Jan C.] Albert Ludwigs Univ, Med Ctr, Inst Immunodeficiency, Freiburg, Germany; [Zenke, Simon; Braun, Julia; Ehl, Stephan; Rohr, Jan C.] Albert Ludwigs Univ, Fac Med, Freiburg, Germany; [Zenke, Simon; Braun, Julia] Albert Ludwigs Univ, Fac Biol, Freiburg, Germany; [Palm, Margriet M.; Beltman, Joost B.] Leiden Univ, Leiden Acad Ctr Drug Res, Div Drug Discovery & Safety, Leiden, Netherlands; [Gavrilov, Alina; Laemmermann, Tim] Max Planck Inst Immunobiol & Epigenet, Immune Cell Dynam Grp, Freiburg, Germany; [Meiser, Philippa; Boettcher, Jan P.] Tech Univ Munich, Klinikum Rechts Isar, Sch Med, Inst Mol Immunol & Expt Oncol, Munich, Germany; [Beyersdorf, Niklas] Univ Wurzburg, Inst Virol & Immunobiol, Wurzburg, Germany; [Gerard, Audrey] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Schumacher, Ton N.] Netherlands Canc Inst, Oncode Inst, Div Mol Oncol & Immunol, Amsterdam, Netherlands	University of Freiburg; University of Freiburg; University of Freiburg; Leiden University; Leiden University - Excl LUMC; Max Planck Society; Technical University of Munich; University of Wurzburg; University of Oxford; Netherlands Cancer Institute	Rohr, JC (corresponding author), Albert Ludwigs Univ, Med Ctr, Inst Immunodeficiency, Freiburg, Germany.; Rohr, JC (corresponding author), Albert Ludwigs Univ, Fac Med, Freiburg, Germany.	jan.rohr@uniklinik-freiburg.de	Schumacher, Ton/Y-2432-2019; Beyersdorf, Niklas/S-3845-2016; Lämmermann, Tim/AAD-7453-2022; Ehl, Stephan/AAM-6006-2020	Schumacher, Ton/0000-0003-0517-8804; Beyersdorf, Niklas/0000-0002-9236-5415; Ehl, Stephan/0000-0002-9265-2721; Beltman, Joost/0000-0001-9215-3087	Netherlands Organization for Scientific Research (NWO) [864.12.013]; Elite Network of Bavaria, Bavarian State Ministry of Science and the Arts [N-LW-2016-370]; Technical University of Munich; German Research Foundation (DFG) [RO 4120/2-1, SFB1160]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Elite Network of Bavaria, Bavarian State Ministry of Science and the Arts; Technical University of Munich; German Research Foundation (DFG)(German Research Foundation (DFG))	We acknowledge Susanne Kirschnek and Susanne Heinzel for providing plasmids, Jurgen Brandel for support on video compilation, and Clara Kamuller and Caro Schuler for mouse husbandry. We are grateful to Hanspeter Pircher and Peter Aichele for discussions, as well as Monika Wolkers, Susanne Heinzel, Carmen Gerlach, and Jannie Borst for critically reading the manuscript. Work in the authors' labs was supported by the Netherlands Organization for Scientific Research (NWO; grant 864.12.013 to J.B.B.), an International Junior Research Group grant (N-LW-2016-370) from the Elite Network of Bavaria, Bavarian State Ministry of Science and the Arts (to J.P.B.), and funding from Technical University of Munich (to J.P.B.) and the German Research Foundation (DFG) (to J.P.B. and J.C.R.: grant no. RO 4120/2-1) and the SFB1160 (project number 15 to J.C.R.).	AZUMA M, 1993, J EXP MED, V177, P845, DOI 10.1084/jem.177.3.845; Ben-Shlomo Izhar, 2003, Sci STKE, V2003, pRE9, DOI 10.1126/stke.2003.187.re9; Bosch AJT, 2017, CELL IMMUNOL, V316, P21, DOI 10.1016/j.cellimm.2017.03.002; Bretscher PA, 1999, P NATL ACAD SCI USA, V96, P185, DOI 10.1073/pnas.96.1.185; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Castello-Cros Remedios, 2009, V522, P275, DOI 10.1007/978-1-59745-413-1_19; Chen SS, 2013, CURR OPIN BIOTECH, V24, P790, DOI 10.1016/j.copbio.2013.02.025; Contardi E, 2005, INT J CANCER, V117, P538, DOI 10.1002/ijc.21155; DAS MRP, 1995, EUR J IMMUNOL, V25, P207, DOI 10.1002/eji.1830250134; Dennehy KM, 2006, J IMMUNOL, V176, P5725, DOI 10.4049/jimmunol.176.10.5725; Eberlein J, 2012, J VIROL, V86, P1955, DOI 10.1128/JVI.05949-11; FRITSCH FN, 1980, SIAM J NUMER ANAL, V17, P238, DOI 10.1137/0717021; Gerard A, 2013, NAT IMMUNOL, V14, P356, DOI 10.1038/ni.2547; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Graeber TG, 2001, NAT GENET, V29, P295, DOI 10.1038/ng755; GRIBBEN JG, 1995, P NATL ACAD SCI USA, V92, P811, DOI 10.1073/pnas.92.3.811; Heinzel S, 2017, NAT IMMUNOL, V18, P96, DOI 10.1038/ni.3598; Hommel M, 2003, J EXP MED, V197, P269, DOI 10.1084/jem.20021512; Huang JF, 1999, SCIENCE, V286, P952, DOI 10.1126/science.286.5441.952; Hudrisier D, 2001, J IMMUNOL, V166, P3645, DOI 10.4049/jimmunol.166.6.3645; Hugues S, 2007, NAT IMMUNOL, V8, P921, DOI 10.1038/ni1495; Hwang I, 2000, J EXP MED, V191, P1137, DOI 10.1084/jem.191.7.1137; Jones E., 2001, SCIPY OPEN SOURCE SC; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Klebanoff CA, 2016, J CLIN INVEST, V126, P318, DOI 10.1172/JCI81217; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; KYBURZ D, 1993, EUR J IMMUNOL, V23, P1956, DOI 10.1002/eji.1830230834; Li KP, 2017, IMMUNOL REV, V277, P21, DOI 10.1111/imr.12538; LINDSTEN T, 1989, SCIENCE, V244, P339, DOI 10.1126/science.2540528; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Pawson AJ, 2014, NUCLEIC ACIDS RES, V42, pD1098, DOI 10.1093/nar/gkt1143; PEACH RJ, 1995, J BIOL CHEM, V270, P21181, DOI 10.1074/jbc.270.36.21181; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Pletinckx K, 2015, EUR J IMMUNOL, V45, P480, DOI 10.1002/eji.201444991; Polonsky M, 2018, SCIENCE, V360, P1201, DOI 10.1126/science.aaj1853; Sabatos CA, 2008, IMMUNITY, V29, P238, DOI 10.1016/j.immuni.2008.05.017; Sanchez-Lockhart M, 2011, J IMMUNOL, V187, P5515, DOI 10.4049/jimmunol.1102497; Scheipers P, 1998, P NATL ACAD SCI USA, V95, P10083, DOI 10.1073/pnas.95.17.10083; THOMPSON CB, 1989, P NATL ACAD SCI USA, V86, P1333, DOI 10.1073/pnas.86.4.1333; Voisinne G, 2015, CELL REP, V11, P1208, DOI 10.1016/j.celrep.2015.04.051; Walunas TL, 1996, J EXP MED, V183, P2541, DOI 10.1084/jem.183.6.2541; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wu Y, 1997, J EXP MED, V185, P1327, DOI 10.1084/jem.185.7.1327; Yoon H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015423; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Youk H, 2014, SCIENCE, V343, P628, DOI 10.1126/science.1242782; Zumwalde NA, 2013, J IMMUNOL, V191, P3681, DOI 10.4049/jimmunol.1201954	50	25	24	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 18	2020	52	2					313	+		10.1016/j.immuni.2020.01.018	http://dx.doi.org/10.1016/j.immuni.2020.01.018			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN8FZ	32049052	Bronze, Green Published, Green Submitted			2022-12-18	WOS:000515082000013
J	Cildir, G; Toubia, J; Yip, KH; Zhou, MY; Pant, H; Hissaria, P; Zhang, JX; Hong, WJ; Robinson, N; Grimbaldeston, MA; Lopez, AF; Tergaonkar, V				Cildir, Gokhan; Toubia, John; Yip, Kwok Ho; Zhou, Mingyan; Pant, Harshita; Hissaria, Pravin; Zhang, Jingxian; Hong, Wanjin; Robinson, Nirmal; Grimbaldeston, Michele A.; Lopez, Angel F.; Tergaonkar, Vinay			Genome-wide Analyses of Chromatin State in Human Mast Cells Reveal Molecular Drivers and Mediators of Allergic and Inflammatory Diseases	IMMUNITY			English	Article							CARDIOTROPHIN-LIKE CYTOKINE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ENHANCERS; ASSOCIATION; DEGRANULATION; IDENTITY; H3K4ME3; IL-33; ACTIVATION	Mast cells (MCs) are versatile immune cells capable of rapidly responding to a diverse range of extracellular cues. Here, we mapped the genomic and transcriptomic changes in human MCs upon diverse stimuli. Our analyses revealed broad H3K4me3 domains and enhancers associated with activation. Notably, the rise of intracellular calcium concentration upon immunoglobulin E (IgE)-mediated crosslinking of the high-affinity IgE receptor (Fc epsilon RI) resulted in genome-wide reorganization of the chromatin landscape and was associated with a specific chromatin signature, which we term Ca2+dependent open chromatin (COC) domains. Examination of differentially expressed genes revealed potential effectors of MC function, and we provide evidence for fibrinogen-like protein 2 (FGL2) as an MC mediator with potential relevance in chronic spontaneous urticaria. Disease-associated singlenucleotide polymorphisms mapped onto cis-regulatory regions of human MCs suggest that MC function may impact a broad range of pathologies. The datasets presented here constitute a resource for the further study of MC function.	[Cildir, Gokhan; Toubia, John; Yip, Kwok Ho; Zhou, Mingyan; Robinson, Nirmal; Lopez, Angel F.; Tergaonkar, Vinay] Univ South Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Cildir, Gokhan; Toubia, John; Yip, Kwok Ho; Zhou, Mingyan; Robinson, Nirmal; Lopez, Angel F.; Tergaonkar, Vinay] SA Pathol, Adelaide, SA 5000, Australia; [Cildir, Gokhan; Tergaonkar, Vinay] IMCB, Lab NF KB Signaling, 61 Biopolis Dr, Singapore 138673, Singapore; [Toubia, John] Univ South Australia, Ctr Canc Biol, ACRF Canc Genom Facil, Adelaide, SA 5000, Australia; [Zhang, Jingxian; Hong, Wanjin] IMCB, 61 Biopolis Dr, Singapore 138673, Singapore; [Pant, Harshita] Univ Adelaide, Sch Med, Adelaide, SA, Australia; [Hissaria, Pravin] Royal Adelaide Hosp, Adelaide, SA 5000, Australia; [Grimbaldeston, Michele A.] Genentech Inc, OMNI Biomarker Dev, San Francisco, CA 94080 USA; [Tergaonkar, Vinay] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 119074, Singapore	Centre for Cancer Biology; University of South Australia; SA Pathology; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Centre for Cancer Biology; University of South Australia; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Adelaide; Royal Adelaide Hospital; Roche Holding; Genentech; National University of Singapore	Tergaonkar, V (corresponding author), Univ South Australia, Ctr Canc Biol, Adelaide, SA 5000, Australia.; Tergaonkar, V (corresponding author), SA Pathol, Adelaide, SA 5000, Australia.; Tergaonkar, V (corresponding author), IMCB, Lab NF KB Signaling, 61 Biopolis Dr, Singapore 138673, Singapore.; Tergaonkar, V (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pathol, Singapore 119074, Singapore.	vinayt@imcb.a-star.edu.sg	Zhang, Jing/GWZ-7332-2022; Cildir, Gökhan/AAC-6079-2019; Robinson, Nirmal/AAJ-1996-2020	CILDIR, GOKHAN/0000-0001-7457-9164; Lopez, Angel F/0000-0001-7430-0135; Yip, Kwok Ho/0000-0002-8453-0118; Toubia, John/0000-0002-5135-6504; Robinson, Nirmal/0000-0002-7361-9491	Agency for Science, Technology, and Research (A*STAR) of Singapore through Institute of Molecular and Cell Biology (IMCB) core fund [NFR-CRP17-2017-02]; National Health and Medical Research Council (NHMRC) of Australia [105253]; South Australian Government Department of State Development	Agency for Science, Technology, and Research (A*STAR) of Singapore through Institute of Molecular and Cell Biology (IMCB) core fund; National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); South Australian Government Department of State Development	We thank Tim Hercus and Frank Stomski for assistance and Zbigniew Adam Opala for the cover art. We gratefully acknowledge funding provided by the Agency for Science, Technology, and Research (A*STAR) of Singapore through Institute of Molecular and Cell Biology (IMCB) core fund NFR-CRP17-2017-02; the National Health and Medical Research Council (NHMRC) of Australia through program grant 105253; and the Premier's Research and Industry Fund grant provided by the South Australian Government Department of State Development.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Andrade MV, 2011, EUR J IMMUNOL, V41, P760, DOI 10.1002/eji.201040718; Ball DH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22716-9; Barbu EA, 2012, J IMMUNOL, V188, P6278, DOI 10.4049/jimmunol.1102660; Benayoun BA, 2014, CELL, V158, P673, DOI 10.1016/j.cell.2014.06.027; Beyaz S, 2017, NAT IMMUNOL, V18, P184, DOI 10.1038/ni.3644; Blank U, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00453; Brown MA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00147; Bunting KL, 2016, IMMUNITY, V45, P497, DOI 10.1016/j.immuni.2016.08.012; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Chen KF, 2015, NAT GENET, V47, P1149, DOI 10.1038/ng.3385; Cildir G, 2017, J EXP MED, V214, P2491, DOI 10.1084/jem.20170910; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; Davis C.A., 2017, NUCL ACIDS RES; de Kleer IM, 2016, IMMUNITY, V45, P1285, DOI 10.1016/j.immuni.2016.10.031; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; Demenais F, 2018, NAT GENET, V50, P42, DOI 10.1038/s41588-017-0014-7; Dhar SS, 2018, MOL CELL, V70, P825, DOI 10.1016/j.molcel.2018.04.028; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong XL, 2014, DIGEST DIS SCI, V59, P769, DOI 10.1007/s10620-013-2962-9; Dwyer DF, 2016, NAT IMMUNOL, V17, P878, DOI 10.1038/ni.3445; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Ferreira MA, 2017, NAT GENET, V49, P1752, DOI 10.1038/ng.3985; Finucane HK, 2015, NAT GENET, V47, P1228, DOI 10.1038/ng.3404; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Garcia-Rodriguez KM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01290; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; Gilchrist M, 2010, BLOOD, V115, P4734, DOI 10.1182/blood-2009-03-213512; Grootens J, 2018, BLOOD ADV, V2, P2273, DOI 10.1182/bloodadvances.2018019539; Hamilton MJ, 2014, INFLAMM BOWEL DIS, V20, P2364, DOI 10.1097/MIB.0000000000000142; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu JM, 2016, INT REV IMMUNOL, V35, P325, DOI 10.3109/08830185.2014.956360; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huynh JP, 2018, J EXP MED, V215, P1823, DOI 10.1084/jem.20171704; Janson C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049615; Johnson JL, 2018, IMMUNITY, V48, P243, DOI 10.1016/j.immuni.2018.01.012; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Joulia R, 2017, J ALLERGY CLIN IMMUN, V140, P497, DOI 10.1016/j.jaci.2016.09.049; Jung MY, 2013, J IMMUNOL, V190, P531, DOI 10.4049/jimmunol.1201576; Kang K, 2017, IMMUNITY, V47, P235, DOI 10.1016/j.immuni.2017.07.017; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee JC, 2017, NAT GENET, V49, P262, DOI 10.1038/ng.3755; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Lee YN, 2004, J IMMUNOL, V173, P2571, DOI 10.4049/jimmunol.173.4.2571; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZQ, 2018, IMMUNITY, V49, P640, DOI 10.1016/j.immuni.2018.09.023; LICHTIG C, 1981, DERMATOLOGICA, V162, P167, DOI 10.1159/000250265; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Lorentz A, 2015, METHODS MOL BIOL, V1220, P163, DOI 10.1007/978-1-4939-1568-2_11; Lun ATL, 2016, METHODS MOL BIOL, V1418, P391, DOI 10.1007/978-1-4939-3578-9_19; Lyons JJ, 2018, J EXP MED, V215, P1009, DOI 10.1084/jem.20172306; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McNeil BD, 2015, NATURE, V519, P237, DOI 10.1038/nature14022; Mizuno K, 2007, TRAFFIC, V8, P883, DOI 10.1111/j.1600-0854.2007.00571.x; Motakis E, 2014, BLOOD, V123, pE58, DOI 10.1182/blood-2013-02-483792; Nishida K, 2005, J CELL BIOL, V170, P115, DOI 10.1083/jcb.200501111; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Platts-Mills TAE, 2011, IMMUNOL REV, V242, P51, DOI 10.1111/j.1600-065X.2011.01021.x; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Redegeld FA, 2018, IMMUNOL REV, V282, P87, DOI 10.1111/imr.12629; Rickels R, 2018, TRENDS CELL BIOL, V28, P608, DOI 10.1016/j.tcb.2018.04.003; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rousseau F, 2006, P NATL ACAD SCI USA, V103, P10068, DOI 10.1073/pnas.0509598103; Schmiedel BJ, 2018, CELL, V175, P1701, DOI 10.1016/j.cell.2018.10.022; Selzner N, 2012, J HEPATOL, V56, P153, DOI 10.1016/j.jhep.2011.05.033; Shlyueva D, 2014, NAT REV GENET, V15, P272, DOI 10.1038/nrg3682; Shubin NJ, 2017, J ALLERGY CLIN IMMUN, V139, P323, DOI 10.1016/j.jaci.2016.03.051; Siebenhaar F, 2018, TRENDS IMMUNOL, V39, P151, DOI 10.1016/j.it.2017.10.005; Sims NA, 2015, CYTOKINE GROWTH F R, V26, P517, DOI 10.1016/j.cytogfr.2015.07.014; Smemo S, 2014, NATURE, V507, P371, DOI 10.1038/nature13138; St John AL, 2013, J IMMUNOL, V190, P4458, DOI 10.4049/jimmunol.1203420; Stunnenberg HG, 2016, CELL, V167, P1145, DOI 10.1016/j.cell.2016.11.007; Su S, 2017, BIOINFORMATICS, V33, P2050, DOI 10.1093/bioinformatics/btx094; Suzuki Y, 2012, ADV EXP MED BIOL, V740, P955, DOI 10.1007/978-94-007-2888-2_44; Tang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13149-x; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tordesillas L, 2017, IMMUNITY, V47, P32, DOI 10.1016/j.immuni.2017.07.004; Ubel C, 2014, J ALLERGY CLIN IMMUN, V133, P198, DOI 10.1016/j.jaci.2013.09.049; Vaeth M, 2017, IMMUNITY, V47, P664, DOI 10.1016/j.immuni.2017.09.003; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Yan J, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv137; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	89	25	25	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 19	2019	51	5					949	+		10.1016/j.immuni.2019.09.021	http://dx.doi.org/10.1016/j.immuni.2019.09.021			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JO8FW	31653482	Bronze			2022-12-18	WOS:000497811300016
J	Berrien-Elliott, MM; Sun, YP; Neal, C; Ireland, A; Trissal, MC; Sullivan, RP; Wagner, JA; Leong, JW; Wong, P; Mah-Som, AY; Wong, TN; Schappe, T; Keppel, CR; Cortez, VS; Stamatiades, EG; Li, MO; Colonna, M; Link, DC; French, AR; Cooper, MA; Wang, WL; Boldin, MP; Reddy, P; Fehniger, TA				Berrien-Elliott, Melissa M.; Sun, Yaping; Neal, Carly; Ireland, Aaron; Trissal, Maria C.; Sullivan, Ryan P.; Wagner, Julia A.; Leong, Jeffrey W.; Wong, Pamela; Mah-Som, Annelise Y.; Wong, Terrence N.; Schappe, Timothy; Keppel, Catherine R.; Cortez, Victor S.; Stamatiades, Efstathios G.; Li, Ming O.; Colonna, Marco; Link, Daniel C.; French, Anthony R.; Cooper, Megan A.; Wang, Wei-Le; Boldin, Mark P.; Reddy, Pavan; Fehniger, Todd A.			MicroRNA-142 Is Critical for the Homeostasis and Function of Type 1 Innate Lymphoid Cells	IMMUNITY			English	Article							NATURAL-KILLER; NK CELLS; VIRAL-INFECTION; DIFFERENTIATION; SURVIVAL; ALPHA(V)BETA(3); FIBRONECTIN; PROGENITOR; CONVERSION; RESPONSES	Natural killer (NK) cells are cytotoxic type 1 innate lymphoid cells (ILCs) that defend against viruses and mediate anti-tumor responses, yet mechanisms controlling their development and function remain incompletely understood. We hypothesized that the abundantly expressed microRNA-142 (miR-142) is a critical regulator of type 1 ILC biology. Interleukin-15 (IL-15) signaling induced miR-142 expression, whereas global and ILC-specific miR-142-deficient mice exhibited a cell-intrinsic loss of NK cells. Death of NK cells resulted from diminished IL-15 receptor signaling within miR-142-deficient mice, likely via reduced suppressor of cytokine signaling-1 (Socs1) regulation by miR-142-5p. ILCs persisting in Mir142(-/-) mice demonstrated increased expression of the miR-142-3p target alpha V integrin, which supported their survival. Global miR-142-deficient mice exhibited an expansion of ILC1-like cells concurrent with increased transforming growth factor-beta (TGF-beta) signaling. Further, miR-142-deficient mice had reduced NK-cell-dependent function and increased susceptibility to murine cytomegalovirus (MCMV) infection. Thus, miR-142 critically integrates environmental cues for proper type 1 ILC homeostasis and defense against viral infection.	[Berrien-Elliott, Melissa M.; Neal, Carly; Ireland, Aaron; Trissal, Maria C.; Sullivan, Ryan P.; Wagner, Julia A.; Leong, Jeffrey W.; Wong, Pamela; Wong, Terrence N.; Schappe, Timothy; Keppel, Catherine R.; Link, Daniel C.; Fehniger, Todd A.] Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA; [Sun, Yaping; Reddy, Pavan] Univ Michigan, Div Hematol & Oncol, Ann Arbor, MI 48109 USA; [Mah-Som, Annelise Y.; French, Anthony R.; Cooper, Megan A.] Washington Univ, Sch Med, Dept Pediat, Div Rheumatol, St Louis, MO 63110 USA; [Cortez, Victor S.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Stamatiades, Efstathios G.; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Wang, Wei-Le; Boldin, Mark P.] Beckman Res Inst City Hope, Dept Mol & Cellular Biol, Duarte, CA USA; [Sullivan, Ryan P.] Novartis Inst Biomed Res, 250 Massachusetts Ave, Cambridge, MA 02139 USA	Washington University (WUSTL); University of Michigan System; University of Michigan; Washington University (WUSTL); Washington University (WUSTL); Memorial Sloan Kettering Cancer Center; City of Hope; Beckman Research Institute of City of Hope; Novartis	Fehniger, TA (corresponding author), Washington Univ, Sch Med, Dept Med, Div Oncol, St Louis, MO 63110 USA.	tfehnige@wustl.edu		Wang, Wei-Le/0000-0002-6984-4514; Reddy, Pavan/0000-0001-7264-8429; Cooper, Megan/0000-0002-5696-172X; li, ming/0000-0002-1383-0535; Wong, Pamela/0000-0002-6856-2603; Stamatiades, Efstathios/0000-0002-2785-9005; Mah-Som, Annelise/0000-0003-4139-8206; Berrien-Elliott, Melissa/0000-0002-7319-9159	NIH/NCI [F32 CA200253, CA-143379]; NIH [T32HL007088, R01AI078994, U01AI095542, R01DE025884, R01DK103039, 5T32CA009547-30, CA-0173878, R01AI102924, R01CA205239]; Crohn's & Colitis Foundation of America [274415]; Howard Hughes Medical Institute Medical Fellow Award; Rheumatology Research Foundation, NIH [R01 AI127752]; American Association of Immunologists Fellowship; American Society of Hematology Foundation; Howard Hughes Medical Institute;  [F30AI129110];  [T32GM07200];  [NHLBI/HL-090775]; NATIONAL CANCER INSTITUTE [K08CA197369, P50CA171963, R01CA205239, R01CA173878, T32CA009547, F32CA200253] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007088, R01HL090775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078994, R01AI125615, F30AI129110, R01AI127752, U01AI095542, R01AI102924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK103039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007200] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's & Colitis Foundation of America; Howard Hughes Medical Institute Medical Fellow Award; Rheumatology Research Foundation, NIH; American Association of Immunologists Fellowship; American Society of Hematology Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Mark Sands for providing reagents, Dr. Marina Cella for providing human RNA samples, and Dr. Timothy O'Sullivan for useful discussions. This work was supported by NIH/NCI F32 CA200253 to M.M.B.-E.; NIH T32HL007088 to M.M.B-E., J.A.W., and R.P.S.; NIH R01AI078994 to A.R.F.; NIH U01AI095542, R01DE025884, and R01DK103039 to M.C.; NIH 5T32CA009547-30 to V.S.C.; Crohn's & Colitis Foundation of America 274415, to M. C.; Howard Hughes Medical Institute Medical Fellow Award to J.A.W.; Rheumatology Research Foundation, NIH R01 AI127752 to M.A.C.; F30AI129110, T32GM07200 to A.Y.M.; The American Association of Immunologists Fellowship A.Y.M. and M.A.C.; NIH CA-0173878, NIH/NCI CA-143379, and NHLBI/HL-090775 to P.R.; ASH Scholar Award from the American Society of Hematology Foundation, a Physician-Scientist Early Career Award from the Howard Hughes Medical Institute, and NIH R01AI102924 and R01CA205239 to T.A.F.	Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Chapnik E, 2014, ELIFE, V3, DOI 10.7554/eLife.01964; Collins PL, 2019, CELL, V176, P348, DOI 10.1016/j.cell.2018.11.045; Cooper MA, 2002, BLOOD, V100, P3633, DOI 10.1182/blood-2001-12-0293; Cortez VS, 2017, NAT IMMUNOL, V18, P995, DOI 10.1038/ni.3809; Cortez VS, 2016, IMMUNITY, V44, P1127, DOI 10.1016/j.immuni.2016.03.007; Cortez VS, 2014, J IMMUNOL, V192, P4487, DOI 10.4049/jimmunol.1303469; Daussy C, 2014, J EXP MED, V211, P563, DOI 10.1084/jem.20131560; Delconte RB, 2016, NAT IMMUNOL, V17, P816, DOI 10.1038/ni.3470; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Du F, 2016, CELL REP, V16, P1339, DOI 10.1016/j.celrep.2016.06.065; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Fehniger TA, 2007, IMMUNITY, V26, P798, DOI 10.1016/j.immuni.2007.04.010; Fehniger TA, 2010, GENOME RES, V20, P1590, DOI 10.1101/gr.107995.110; Fogel LA, 2013, J IMMUNOL, V190, P6269, DOI 10.4049/jimmunol.1202533; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Gasteiger G, 2015, SCIENCE, V350, P981, DOI 10.1126/science.aac9593; Hall BE, 2010, LAB INVEST, V90, P543, DOI 10.1038/labinvest.2010.5; IGNOTZ RA, 1986, J BIOL CHEM, V261, P4337; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Kramer NJ, 2015, BLOOD, V125, P3720, DOI 10.1182/blood-2014-10-603951; Lanier LL, 2008, NAT REV IMMUNOL, V8, P259, DOI 10.1038/nri2276; Lei Z, 2014, FASEB J, V28, P2696, DOI 10.1096/fj.13-247288; Leong JW, 2017, CLIN IMMUNOL, V177, P60, DOI 10.1016/j.clim.2016.03.003; Leong JW, 2015, P NATL ACAD SCI USA, V112, pE700, DOI 10.1073/pnas.1413886112; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu LF, 2015, IMMUNITY, V43, P52, DOI 10.1016/j.immuni.2015.04.022; Ma A, 2006, ANNU REV IMMUNOL, V24, P657, DOI 10.1146/annurev.immunol.24.021605.090727; Marcais A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00450; Matter ML, 2001, J BIOL CHEM, V276, P27757, DOI 10.1074/jbc.M102014200; Mildner A, 2013, BLOOD, V121, P1016, DOI 10.1182/blood-2012-07-445999; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Nilsson SK, 1998, J HISTOCHEM CYTOCHEM, V46, P371, DOI 10.1177/002215549804600311; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Rivkin N, 2017, HAEMATOLOGICA, V102, P476, DOI 10.3324/haematol.2017.171736; Roozendaal R, 2008, INT IMMUNOL, V20, P1483, DOI 10.1093/intimm/dxn110; Schuster IS, 2014, IMMUNITY, V41, P646, DOI 10.1016/j.immuni.2014.09.013; Singh PB, 2017, J EXP MED, V214, P3627, DOI 10.1084/jem.20170545; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Su SC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9523; Sullivan RP, 2015, J IMMUNOL, V195, P2806, DOI 10.4049/jimmunol.1500949; Sullivan RP, 2013, J IMMUNOL, V191, P5904, DOI 10.4049/jimmunol.1301950; Sullivan RP, 2012, J IMMUNOL, V188, P3019, DOI 10.4049/jimmunol.1102294; Sun YP, 2015, J CLIN INVEST, V125, P2825, DOI 10.1172/JCI78753; Viel S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aad1884; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Yamada Y, 2014, BIOCHEM BIOPH RES CO, V443, P980, DOI 10.1016/j.bbrc.2013.12.078; Yokoyama WM, 2004, ANNU REV IMMUNOL, V22, P405, DOI 10.1146/annurev.immunol.22.012703.104711; Yoshizawa K, 2011, J IMMUNOL, V187, P5162, DOI 10.4049/jimmunol.1101561; Zawislak CL, 2013, P NATL ACAD SCI USA, V110, P6967, DOI 10.1073/pnas.1304410110; ZHANG ZH, 1995, P NATL ACAD SCI USA, V92, P6161, DOI 10.1073/pnas.92.13.6161	55	25	26	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					479	+		10.1016/j.immuni.2019.06.016	http://dx.doi.org/10.1016/j.immuni.2019.06.016			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31402259	Green Accepted, Bronze			2022-12-18	WOS:000486184600011
J	Nakanishi, Y; Duran, A; L'Hermitte, A; Shelton, PM; Nakanishi, N; Reina-Campos, M; Huang, JF; Soldevila, F; Baaten, BJG; Tauriello, DVF; Castilla, EA; Bhangoo, MS; Bao, F; Sigal, D; Diaz-Meco, MT; Moscat, J				Nakanishi, Yuki; Duran, Angeles; L'Hermitte, Antoine; Shelton, Phillip M.; Nakanishi, Naoko; Reina-Campos, Miguel; Huang, Jianfeng; Soldevila, Ferran; Baaten, Bas J. G.; Tauriello, Daniele V. F.; Castilla, Elias A.; Bhangoo, Munveer S.; Bao, Fei; Sigal, Darren; Diaz-Meco, Maria T.; Moscat, Jorge			Simultaneous Loss of Both Atypical Protein Kinase C Genes in the Intestinal Epithelium Drives Serrated Intestinal Cancer by Impairing Immunosurveillance	IMMUNITY			English	Article							COLON-CANCER; TUMORIGENESIS; PROGRESSION; MODEL; YAP	Serrated adenocarcinoma, an alternative pathway for colorectal cancer (CRC) development, accounts for 15%-30% of all CRCs and is aggressive and treatment resistant. We show that the expression of atypical protein kinase C zeta (PKC zeta) and PKC lambda/iota was reduced in human serrated tumors. Simultaneous inactivation of the encoding genes in the mouse intestinal epithelium resulted in spontaneous serrated tumorigenesis that progressed to advanced cancer with a strongly reactive and immunosuppressive stroma. Whereas epithelial PKC lambda/iota deficiency led to immunogenic cell death and the infiltration of CD8(+) T cells, which repressed tumor initiation, PKC sigma loss impaired interferon and CD8(+) T cell responses, which resulted in tumorigenesis. Combined treatment with a TGF-beta receptor inhibitor plus anti-PD-L1 checkpoint blockade showed synergistic curative activity. Analysis of human samples supported the relevance of these kinases in the immunosurveillance defects of human serrated CRC. These findings provide insight into avenues for the detection and treatment of this poor-prognosis subtype of CRC.	[Nakanishi, Yuki; Duran, Angeles; L'Hermitte, Antoine; Shelton, Phillip M.; Nakanishi, Naoko; Reina-Campos, Miguel; Huang, Jianfeng; Castilla, Elias A.; Diaz-Meco, Maria T.; Moscat, Jorge] Sanford Burnham Prebys Med Discovery Inst, Canc Metab & Signaling Networks Program, La Jolla, CA 92037 USA; [Reina-Campos, Miguel] Sanford Burnham Prebys Med Discovery Inst, Sanford Burnham Prebys Grad Sch Biomed Sci, La Jolla, CA 92037 USA; [Soldevila, Ferran; Baaten, Bas J. G.] Sanford Burnham Prebys Med Discovery Inst, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Tauriello, Daniele V. F.] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Oncol Program, Barcelona 08028, Spain; [Bhangoo, Munveer S.; Sigal, Darren] Scripps Clin, Div Hematol Oncol, La Jolla, CA 92037 USA; [Bao, Fei] Scripps Clin, Dept Pathol, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Sanford Burnham Prebys Medical Discovery Institute; Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Scripps Research Institute; Scripps Research Institute	Moscat, J (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Canc Metab & Signaling Networks Program, La Jolla, CA 92037 USA.	jmoscat@sbpdiscovery.org	Tauriello, Daniele/H-4644-2018; Reina-Campos, Miguel/AAG-3644-2019; Huang, Jianfeng/AAM-4711-2021	Tauriello, Daniele/0000-0003-1522-3496; Huang, Jianfeng/0000-0003-0107-3482; Nakanishi, Naoko/0000-0003-0092-2593; Diaz-Meco, Maria/0000-0003-0147-0998; Soldevila, Ferran/0000-0001-9472-623X	NIH [R01CA207177, R01CA172025, R01CA192642, R01CA218254]; Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad; Crohn's & Colitis Foundation of America; NATIONAL CANCER INSTITUTE [R01CA218254, P30CA030199, R01CA172025, R01CA192642, R01CA207177] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Crohn's & Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by grants from the NIH (R01CA207177 and R01CA172025 to J.M.; R01CA192642, R01CA218254 to M.T.D.-M.). Y.N. was supported by the Japan Society for the Promotion of Science Postdoctoral Fellowship for Research Abroad and by the Crohn's & Colitis Foundation of America. We thank Eduard Batlle (Institute for Research in Biomedicine, IRB Barcelona, Spain) for critically reading the manuscript and for kindly providing galunisertib. We thank Naomi Ruff for editing this manuscript. We thank the personnel of the Histology, Cell Imaging, Genomics, Animal Facility, and Viral Vectors Shared Resources at the Sanford Burnham Prebys Medical Discovery Institute for technical assistance.	Beaugerie L, 2015, NEW ENGL J MED, V372, P1441, DOI 10.1056/NEJMra1403718; Bennecke M, 2010, CANCER CELL, V18, P135, DOI 10.1016/j.ccr.2010.06.013; Calon A, 2015, NAT GENET, V47, P320, DOI 10.1038/ng.3225; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; de la Chapelle A, 2010, J CLIN ONCOL, V28, P3380, DOI 10.1200/JCO.2009.27.0652; De Sousa E Melo F, 2013, NAT MED, V19, P614, DOI 10.1038/nm.3174; Delker DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088367; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fujii M, 2016, CELL STEM CELL, V18, P827, DOI 10.1016/j.stem.2016.04.003; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Gregorieff A, 2015, NATURE, V526, P715, DOI 10.1038/nature15382; IJspeert JEG, 2015, NAT REV GASTRO HEPAT, V12, P401, DOI 10.1038/nrgastro.2015.73; Isella C, 2015, NAT GENET, V47, P312, DOI 10.1038/ng.3224; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Leitges M, 2001, MOL CELL, V8, P771, DOI 10.1016/S1097-2765(01)00361-6; Llado V, 2015, CELL REP, V10, P740, DOI 10.1016/j.celrep.2015.01.007; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Parker BS, 2016, NAT REV CANCER, V16, P131, DOI 10.1038/nrc.2016.14; Rad R, 2013, CANCER CELL, V24, P15, DOI 10.1016/j.ccr.2013.05.014; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Tauriello DVF, 2018, NATURE, V554, P538, DOI 10.1038/nature25492	22	25	25	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					1132	+		10.1016/j.immuni.2018.09.013	http://dx.doi.org/10.1016/j.immuni.2018.09.013			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30552022	Bronze, Green Accepted			2022-12-18	WOS:000453556500017
J	Macal, M; Jo, Y; Dallari, S; Chang, AY; Dai, JH; Swaminathan, S; Wehrens, EJ; Fitzgerald-Bocarsly, P; Zuniga, EI				Macal, Monica; Jo, Yeara; Dallari, Simone; Chang, Aaron Y.; Dai, Jihong; Swaminathan, Shobha; Wehrens, Ellen J.; Fitzgerald-Bocarsly, Patricia; Zuniga, Elina I.			Self-Renewal and Toll-like Receptor Signaling Sustain Exhausted Plasmacytoid Dendritic Cells during Chronic Viral Infection	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MURINE CYTOMEGALOVIRUS-INFECTION; TRANSCRIPTION FACTOR E2-2; I INTERFERON RESPONSES; ALPHA PRODUCTION; HIV-INFECTION; HEPATITIS-B; INNATE; ACTIVATION; CONTRIBUTE	Although characterization of T cell exhaustion has unlocked powerful immunotherapies, the mechanisms sustaining adaptations of short-lived innate cells to chronic inflammatory settings remain unknown. During murine chronic viral infection, we found that concerted events in bone marrow and spleen mediated by type I interferon (IFN-I) and Toll-like receptor 7 (TLR7) maintained a pool of functionally exhausted plasmacytoid dendritic cells (pDCs). In the bone marrow, IFN-I compromised the number and the developmental capacity of pDC progenitors, which generated dysfunctional pDCs. Concurrently, exhausted pDCs in the periphery were maintained by self-renewal via IFN-I-and TLR7-induced proliferation of CD4(-) subsets. On the other hand, pDC functional loss was mediated by TLR7, leading to compromised IFN-I production and resistance to secondary infection. These findings unveil the mechanisms sustaining a self-perpetuating pool of functionally exhausted pDCs and provide a framework for deciphering long-term exhaustion of other short-lived innate cells during chronic inflammation.	[Macal, Monica; Jo, Yeara; Dallari, Simone; Chang, Aaron Y.; Wehrens, Ellen J.; Zuniga, Elina I.] Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA; [Dai, Jihong; Fitzgerald-Bocarsly, Patricia] Rutgers New Jersey Med Sch, Dept Pathol & Lab Med, Newark, NJ 07103 USA; [Swaminathan, Shobha] Rutgers New Jersey Med Sch, Dept Med, Newark, NJ 07103 USA	University of California System; University of California San Diego; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Zuniga, EI (corresponding author), Univ Calif San Diego, Div Biol Sci, San Diego, CA 92093 USA.	eizuniga@ucsd.edu	S, Swaminathan/AAC-4467-2020	Jo, Yeara/0000-0002-1340-1968	Lupus Research Institute; American Cancer Society; NIH [AI081923, AI113923, R01AI106125]; Ministero dell'Istruzione, dell'Universitae della Ricerca; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106125, R01AI081923, R01AI113923, P30AI036214] Funding Source: NIH RePORTER	Lupus Research Institute; American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministero dell'Istruzione, dell'Universitae della Ricerca(Ministry of Education, Universities and Research (MIUR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Christie Lyn Costanza and Marta Paez-Quinde for help with recruitment of human subjects. This study was supported by a scholar grant from Lupus Research Institute and a scholar research grant from American Cancer Society as well as NIH grants AI081923 and AI113923 (to E.I.Z.) and R01AI106125 (to P.F.B.). S.D. was a visiting graduate student from University of Milan, Italy and was supported by a scholarship from Ministero dell'Istruzione, dell'Universitae della Ricerca. E.I.Z. was a Leukemia and Lymphoma Society Scholar.	AHMED R, 1984, J EXP MED, V160, P521, DOI 10.1084/jem.160.2.521; Asselin-Paturel C, 2003, J IMMUNOL, V171, P6466, DOI 10.4049/jimmunol.171.12.6466; Attanasio J, 2016, IMMUNITY, V44, P1052, DOI 10.1016/j.immuni.2016.04.022; Biancotto A, 2007, BLOOD, V109, P4272, DOI 10.1182/blood-2006-11-055764; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Blasius AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002915; Borrow P, 2011, CURR OPIN HIV AIDS, V6, P353, DOI 10.1097/COH.0b013e3283495996; Brown KN, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000413; Bruel T, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003915; Cisse B, 2008, CELL, V135, P37, DOI 10.1016/j.cell.2008.09.016; Dajon M, 2015, ONCOIMMUNOLOGY, V4, DOI 10.4161/2162402X.2014.991615; Dalod M, 2003, J EXP MED, V197, P885, DOI 10.1084/jem.20021522; Dillon SM, 2008, JAIDS-J ACQ IMM DEF, V48, P1, DOI 10.1097/QAI.0b013e3181664b60; Duan XZ, 2004, J CLIN IMMUNOL, V24, P637, DOI 10.1007/s10875-004-6249-y; Feldman S, 2001, CLIN IMMUNOL, V101, P201, DOI 10.1006/clim.2001.5111; Foussat A, 2001, BLOOD, V98, P1678, DOI 10.1182/blood.V98.6.1678; Fuertes MB, 2013, TRENDS IMMUNOL, V34, P67, DOI 10.1016/j.it.2012.10.004; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Ghosh HS, 2010, IMMUNITY, V33, P905, DOI 10.1016/j.immuni.2010.11.023; Hahm B, 2005, IMMUNITY, V22, P247, DOI 10.1016/j.immuni.2005.01.005; Hartmann E, 2003, CANCER RES, V63, P6478; Ito T, 2006, BLOOD, V107, P2423, DOI 10.1182/blood-2005-07-2709; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jarrett RF, 2006, J PATHOL, V208, P176, DOI 10.1002/path.1905; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Kanto T, 2004, J INFECT DIS, V190, P1919, DOI 10.1086/425425; KOHLER M, 1990, CANCER IMMUNOL IMMUN, V32, P117, DOI 10.1007/BF01754208; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Labidi-Galy SI, 2011, CANCER RES, V71, P5423, DOI 10.1158/0008-5472.CAN-11-0367; Lee LN, 2009, J IMMUNOL, V182, P7178, DOI 10.4049/jimmunol.0802526; Li HS, 2011, BLOOD, V118, P3879, DOI 10.1182/blood-2011-04-349761; Li HY, 2015, J INFECT DIS, V211, P1717, DOI 10.1093/infdis/jiu671; Liu K, 2007, NAT IMMUNOL, V8, P578, DOI 10.1038/ni1462; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Macal M, 2016, J IMMUNOL, V196, P1900, DOI 10.4049/jimmunol.1501658; Macal M, 2012, CELL HOST MICROBE, V11, P617, DOI 10.1016/j.chom.2012.04.017; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Moir S, 2014, CURR OPIN HIV AIDS, V9, P472, DOI 10.1097/COH.0000000000000092; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Nascimbeni M, 2009, BLOOD, V113, P6112, DOI 10.1182/blood-2008-07-170803; Ng CT, 2016, CELL, V164, P349, DOI 10.1016/j.cell.2015.12.027; ORANGE JS, 1995, J EXP MED, V182, P1045, DOI 10.1084/jem.182.4.1045; Reizis B, 2011, ANNU REV IMMUNOL, V29, P163, DOI 10.1146/annurev-immunol-031210-101345; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Sasaki I, 2012, BLOOD, V120, P4733, DOI 10.1182/blood-2012-06-436527; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Schlitzer A, 2012, BLOOD, V119, P6063, DOI 10.1182/blood-2012-03-418400; Schlitzer A, 2011, BLOOD, V117, P6562, DOI 10.1182/blood-2010-12-326678; Schwartz JA, 2017, J IMMUNOL, V198, P3181, DOI 10.4049/jimmunol.1601298; Sevilla N, 2004, J CLIN INVEST, V113, P737, DOI 10.1172/JCI20243; Sisirak V, 2012, CANCER RES, V72, P5188, DOI 10.1158/0008-5472.CAN-11-3468; Snell LM, 2015, CURR OPIN IMMUNOL, V34, P91, DOI 10.1016/j.coi.2015.03.002; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Stelekati E, 2012, CELL HOST MICROBE, V12, P458, DOI 10.1016/j.chom.2012.10.001; Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865; Swiecki M, 2011, J EXP MED, V208, P2367, DOI 10.1084/jem.20110654; Swiecki M, 2010, IMMUNITY, V33, P955, DOI 10.1016/j.immuni.2010.11.020; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tilton JC, 2008, J VIROL, V82, P3997, DOI 10.1128/JVI.01545-07; Vanderford TH, 2012, BLOOD, V119, P5750, DOI 10.1182/blood-2012-02-411496; Vincent IE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026315; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang YM, 2012, CELL HOST MICROBE, V11, P631, DOI 10.1016/j.chom.2012.05.003; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Zhan YF, 2016, SCI REP-UK, V6, DOI 10.1038/srep25060; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016; Zuniga EI, 2015, ANNU REV VIROL, V2, P573, DOI 10.1146/annurev-virology-100114-055226	69	25	25	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					730	+		10.1016/j.immuni.2018.03.020	http://dx.doi.org/10.1016/j.immuni.2018.03.020			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669251	Bronze, Green Accepted			2022-12-18	WOS:000430198900019
J	Akbar, MA; Mandraju, R; Tracy, C; Hu, W; Pasare, C; Kramer, H				Akbar, Mohammed Ali; Mandraju, Rajakumar; Tracy, Charles; Hu, Wei; Pasare, Chandrashekhar; Kramer, Helmut			ARC Syndrome-Linked Vps33B Protein Is Required for Inflammatory Endosomal Maturation and Signal Termination	IMMUNITY			English	Article							TOLL-LIKE RECEPTORS; PHAGOSOME MATURATION; MACROPHAGE RESPONSE; ADAPTIVE IMMUNITY; RENAL DYSFUNCTION; MEMBRANE-FUSION; HOPS COMPLEX; SYNTAXIN 17; DROSOPHILA; MUTATIONS	Toll-like receptors (TLRs) and other pattern-recognition receptors (PRRs) sense microbial ligands and initiate signaling to induce inflammatory responses. Although the quality of inflammatory responses is influenced by internalization of TLRs, the role of endosomal maturation in clearing receptors and terminating inflammatory responses is not well understood. Here, we report that Drosophila and mammalian Vps33B proteins play critical roles in the maturation of phagosomes and endosomes following microbial recognition. Vps33B was necessary for clearance of endosomes containing internalized PRRs, failure of which resulted in enhanced signaling and expression of inflammatory mediators. Lack of Vps33B had no effect on trafficking of endosomes containing non-microbial cargo. These findings indicate that Vps33B function is critical for determining the fate of signaling endosomes formed following PRR activation. Exaggerated inflammatory responses dictated by persistence of receptors in aberrant endosomal compartments could therefore contribute to symptoms of ARC syndrome, a disease linked to loss of Vps33B.	[Akbar, Mohammed Ali; Tracy, Charles; Kramer, Helmut] Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Mandraju, Rajakumar; Hu, Wei; Pasare, Chandrashekhar] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Kramer, Helmut] Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kramer, H (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.; Pasare, C (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA.; Kramer, H (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	chandrashekhar.pasare@utsouthwestern.edu; helmut.kramer@utsouthwestern.edu	Hu, Wei/ABH-1470-2021	Hu, Wei/0000-0002-0392-6939; Kramer, Helmut/0000-0002-1167-2676	National Institutes of Health [EY010199, EY021922, AI082265, AI115420, AI113125]; core grant [EY020799]; NATIONAL EYE INSTITUTE [R01EY021922, R01EY010199, P30EY020799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082265, R01AI113125, R21AI115420] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); core grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Pasare and Kramer laboratories for helpful comments and the Bloomington Stock Center and Dr. Bruno Lemaitre for fly stocks, the Berkeley Drosophila Genome Project for producing DNA clones, the Drosophila Genomics Resource Center for their distribution, and Dr. Kate Fitzgerald for wild-type immortalized macrophages. FlyBase provided important information used in this work. This work was supported by grants from the National Institutes of Health (EY010199, EY021922) to H.K. and (AI082265, AI115420, and AI113125) to C.P. and core grant EY020799.	Akbar MA, 2009, MOL BIOL CELL, V20, P1705, DOI 10.1091/mbc.E08-03-0282; Akbar MA, 2011, J CELL BIOL, V192, P383, DOI 10.1083/jcb.201008119; Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008; Baker RW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067409; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Brandt KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080743; Chen C, 2012, J PROTEOMICS, V77, P251, DOI 10.1016/j.jprot.2012.08.024; Cullinane AR, 2010, NAT GENET, V42, P303, DOI 10.1038/ng.538; Decque A, 2016, NAT IMMUNOL, V17, P140, DOI 10.1038/ni.3342; Erdman LK, 2009, J IMMUNOL, V183, P6452, DOI 10.4049/jimmunol.0901374; Ewald SE, 2008, NATURE, V456, P658, DOI 10.1038/nature07405; Ewald SE, 2011, J EXP MED, V208, P643, DOI 10.1084/jem.20100682; FUKUDA S, 1986, VIRCHOWS ARCH B, V52, P1, DOI 10.1007/BF02889945; Gissen P, 2004, NAT GENET, V36, P400, DOI 10.1038/ng1325; Gissen P, 2006, HUM GENET, V120, P396, DOI 10.1007/s00439-006-0232-z; HAMPTON RY, 1991, NATURE, V352, P342, DOI 10.1038/352342a0; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Howes MT, 2010, CURR OPIN CELL BIOL, V22, P519, DOI 10.1016/j.ceb.2010.04.001; Hu W, 2011, IMMUNITY, V35, P1010, DOI 10.1016/j.immuni.2011.10.013; Husebye H, 2006, EMBO J, V25, P683, DOI 10.1038/sj.emboj.7600991; Husebye H, 2010, IMMUNITY, V33, P583, DOI 10.1016/j.immuni.2010.09.010; Ishii A, 2012, FEBS LETT, V586, P2245, DOI 10.1016/j.febslet.2012.05.051; Jang JY, 2009, J PEDIATR GASTR NUTR, V48, P348, DOI 10.1097/MPG.0b013e31817fcb3f; Jiang P, 2014, MOL BIOL CELL, V25, P1327, DOI 10.1091/mbc.E13-08-0447; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2012, TRAFFIC, V13, P1053, DOI 10.1111/j.1600-0854.2012.01377.x; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kinchen JM, 2008, NAT CELL BIOL, V10, P556, DOI 10.1038/ncb1718; Klein DCG, 2015, TRAFFIC, V16, P677, DOI 10.1111/tra.12274; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Lobingier BT, 2014, ELIFE, V3, DOI 10.7554/eLife.02272; Nagpal K, 2009, J BIOL CHEM, V284, P25742, DOI 10.1074/jbc.M109.014886; Nair-Gupta P, 2014, CELL, V158, P506, DOI 10.1016/j.cell.2014.04.054; Nandi N, 2014, J CELL BIOL, V207, P253, DOI 10.1083/jcb.201404028; Neyen C, 2012, J IMMUNOL, V189, P1886, DOI 10.4049/jimmunol.1201022; Peppelenbosch MP, 1999, BLOOD, V93, P4011, DOI 10.1182/blood.V93.11.4011.411a29_4011_4018; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Seo SH, 2015, CLIN GENET, V88, P80, DOI 10.1111/cge.12442; Shinzawa N, 2009, CELL HOST MICROBE, V6, P244, DOI 10.1016/j.chom.2009.07.010; Sjoelund V, 2014, J PROTEOME RES, V13, P5185, DOI 10.1021/pr5002466; Solinger JA, 2013, FEBS J, V280, P2743, DOI 10.1111/febs.12151; Suzuki T, 2003, P NATL ACAD SCI USA, V100, P1146, DOI 10.1073/pnas.0237292100; Takats S, 2014, MOL BIOL CELL, V25, P1338, DOI 10.1091/mbc.E13-08-0449; Tanimura N, 2008, BIOCHEM BIOPH RES CO, V368, P94, DOI 10.1016/j.bbrc.2008.01.061; Tornieri K, 2013, HUM MOL GENET, V22, P5215, DOI 10.1093/hmg/ddt378; Troutman TD, 2012, P NATL ACAD SCI USA, V109, P273, DOI 10.1073/pnas.1118579109; Underhill DM, 1999, NATURE, V401, P811, DOI 10.1038/44605; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; West MA, 2004, SCIENCE, V305, P1153, DOI 10.1126/science.1099153; Wickner W, 2010, ANNU REV CELL DEV BI, V26, P115, DOI 10.1146/annurev-cellbio-100109-104131; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yao M, 2009, J IMMUNOL, V183, P1751, DOI 10.4049/jimmunol.0900249; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	65	25	25	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					267	279		10.1016/j.immuni.2016.07.010	http://dx.doi.org/10.1016/j.immuni.2016.07.010			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27496733	Green Accepted, Bronze			2022-12-18	WOS:000382267300010
J	Nobs, SP; Schneider, C; Dietrich, MG; Brocker, T; Rolink, A; Hirsch, E; Kopf, M				Nobs, Samuel Philip; Schneider, Christoph; Dietrich, Maren Gil; Brocker, Thomas; Rolink, Antonius; Hirsch, Emilio; Kopf, Manfred			PI3-Kinase-gamma Has a Distinct and Essential Role in Lung-Specific Dendritic Cell Development	IMMUNITY			English	Article							STEADY-STATE; PI3K-GAMMA; HOMEOSTASIS; MACROPHAGES; FLT3-LIGAND; P110-GAMMA; ACTIVATION; EXPRESSION; KINASES; GAMMA	Development of dendritic cells (DCs) commences in the bone marrow, from where pre-DCs migrate to peripheral organs to differentiate into mature DCs in situ. However, the factors that regulate organ-specific differentiation to give rise to tissuespecific DC subsets remain unclear. Here we show that the Ras-PI3Kg-Akt-mTOR signaling axis acted downstream of FLT3L signaling and was required for development of lung CD103(+) DCs and, to a smaller extent, for lung CD11b(+) DCs, but not related DC populations in other non-lymphoid organs. Furthermore, we show that in lymphoid organs such as the spleen, DCs depended on a similar signaling network to respond to FLT3 ligand with overlapping and partially redundant roles for kinases PI3K gamma and PI3K delta. Thus we identified PI3K gamma as an essential organ-specific regulator of lung DC development and discovered a signaling network regulating tissue-specific DC development mediated by FLT3.	[Nobs, Samuel Philip; Schneider, Christoph; Kopf, Manfred] ETH, Dept Biol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland; [Dietrich, Maren Gil] Univ Zurich Hosp, Dept Endocrinol Diabet & Clin Nutr, CH-8091 Zurich, Switzerland; [Brocker, Thomas] Univ Munich, Inst Immunol, D-80336 Munich, Germany; [Rolink, Antonius; Hirsch, Emilio] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland; [Hirsch, Emilio] Univ Turin, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University Zurich Hospital; University of Munich; University of Basel; University of Turin	Kopf, M (corresponding author), ETH, Dept Biol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland.	manfred.kopf@ethz.ch	Kopf, Manfred/B-6907-2009; Hirsch, Emilio/F-4848-2013; Nobs, Samuel Philip/N-4819-2019	Kopf, Manfred/0000-0002-0628-7140; Hirsch, Emilio/0000-0002-9073-6024; Nobs, Samuel Philip/0000-0003-0627-892X; Schneider, Christoph/0000-0002-0452-2960; Brocker, Thomas/0000-0001-7060-5433	ETH Zurich [34/13-1]; SNF [310030B_141175]	ETH Zurich(ETH Zurich); SNF	We acknowledge the use of the Immgen database as an informative tool for the design of this study. We thank Len Stephens for providing the Pik3cg<SUP>DASAA/DASAA</SUP> mice and Sabine Suire for her assistance to analyze them. We thank Franziska Ampenberger for technical assistance. This work was supported by ETH Zurich (34/13-1) and SNF (310030B_141175).	Beer-Hammer S, 2010, J LEUKOCYTE BIOL, V87, P1083, DOI 10.1189/jlb.0809585; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Costa C, 2011, IUBMB LIFE, V63, P707, DOI 10.1002/iub.516; Cseh B, 2014, FEBS LETT, V588, P2398, DOI 10.1016/j.febslet.2014.06.025; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Guilliams M, 2013, MUCOSAL IMMUNOL, V6, P464, DOI 10.1038/mi.2013.14; Hackstein H, 2003, BLOOD, V101, P4457, DOI 10.1182/blood-2002-11-3370; Hashimoto D, 2011, IMMUNITY, V35, P323, DOI 10.1016/j.immuni.2011.09.007; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Kellersch B, 2013, BLOOD, V121, P298, DOI 10.1182/blood-2012-06-439786; Kingston D, 2009, BLOOD, V114, P835, DOI 10.1182/blood-2009-02-206318; Ladygina N, 2013, EUR J IMMUNOL, V43, P3183, DOI 10.1002/eji.201343812; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Malissen B, 2014, NAT REV IMMUNOL, V14, P417, DOI 10.1038/nri3683; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Miloud T, 2012, J IMMUNOL, V188, P1125, DOI 10.4049/jimmunol.1003920; Okkenhaug K, 2013, ANNU REV IMMUNOL, V31, P675, DOI 10.1146/annurev-immunol-032712-095946; Patrucco E, 2004, CELL, V118, P375, DOI 10.1016/j.cell.2004.07.017; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Saito Y, 2013, EUR J IMMUNOL, V43, P1651, DOI 10.1002/eji.201243163; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Sathaliyawala T, 2010, IMMUNITY, V33, P597, DOI 10.1016/j.immuni.2010.09.012; Scheffler JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6138; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schmid MC, 2011, CANCER CELL, V19, P715, DOI 10.1016/j.ccr.2011.04.016; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Suire S, 2006, NAT CELL BIOL, V8, P1303, DOI 10.1038/ncb1494; Sung SSJ, 2006, J IMMUNOL, V176, P2161, DOI 10.4049/jimmunol.176.4.2161; Waskow C, 2008, NAT IMMUNOL, V9, P676, DOI 10.1038/ni.1615; Weber JD, 2012, CELL CYCLE, V11, P236, DOI 10.4161/cc.11.2.19022; Zotes TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072674	38	25	25	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 20	2015	43	4					674	689		10.1016/j.immuni.2015.09.006	http://dx.doi.org/10.1016/j.immuni.2015.09.006			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CU4ED	26453378	Bronze			2022-12-18	WOS:000363478700011
J	van Bruggen, N; Ouyang, WJ				van Bruggen, Nicholas; Ouyang, Wenjun			Th17 Cells at the Crossroads of Autoimmunity, Inflammation, and Atherosclerosis	IMMUNITY			English	Editorial Material							MECHANISMS; DISEASE		[van Bruggen, Nicholas] Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA; [Ouyang, Wenjun] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	van Bruggen, N (corresponding author), Genentech Inc, Dept Biomed Imaging, San Francisco, CA 94080 USA.	vbruggen@gene.com; ouyang@gene.com	Ouyang, Wenjun/ABA-8763-2020	Ouyang, Wenjun/0000-0002-1811-5864				Eid RE, 2009, CIRCULATION, V119, P1424, DOI 10.1161/CIRCULATIONAHA.108.827618; Erbel C, 2009, J IMMUNOL, V183, P8167, DOI 10.4049/jimmunol.0901126; Gistera A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006133; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Kahlenberg JM, 2013, ANNU REV MED, V64, P249, DOI 10.1146/annurev-med-060911-090007; Li SJ, 2013, MOL METAB, V2, P256, DOI 10.1016/j.molmet.2013.06.001; Lim H, 2014, IMMUNITY, V40, P153, DOI 10.1016/j.immuni.2013.11.021; Powell-Braxton L, 1998, NAT MED, V4, P934, DOI 10.1038/nm0898-934; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Taleb S, 2009, J EXP MED, V206, P2067, DOI 10.1084/jem.20090545	10	25	26	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					10	12		10.1016/j.immuni.2013.12.006	http://dx.doi.org/10.1016/j.immuni.2013.12.006			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24439264	Bronze			2022-12-18	WOS:000331476900005
J	Callen, E; Faryabi, RB; Luckey, M; Hao, BT; Daniel, JA; Yang, WJ; Sun, HW; Dressler, G; Peng, WQ; Chi, HB; Ge, K; Krangel, MS; Park, JH; Nussenzweig, A				Callen, Elsa; Faryabi, Robert B.; Luckey, Megan; Hao, Bingtao; Daniel, Jeremy A.; Yang, Wenjing; Sun, Hong-Wei; Dressler, Greg; Peng, Weiqun; Chi, Hongbo; Ge, Kai; Krangel, Michael S.; Park, Jung-Hyun; Nussenzweig, Andre			The DNA Damage- and Transcription-Associated Protein Paxip1 Controls Thymocyte Development and Emigration	IMMUNITY			English	Article							LYSINE-4 METHYLTRANSFERASE COMPLEX; CLASS SWITCH RECOMBINATION; NAIVE T-CELLS; V(D)J RECOMBINATION; GENE SEGMENTS; BRCT-DOMAIN; RECEPTOR; PTIP; CHROMATIN; REARRANGEMENT	Histone 3 lysine 4 trimethylation (H3K4me3) is associated with promoters of active genes and found at hot spots for DNA recombination. Here we have shown that PAXIP1 (also known as PTIP), a protein associated with MLL3 and MLL4 methyltransferase and the DNA damage response, regulates RAG-mediated cleavage and repair during V(D)J recombination in CD4(+) CD8(+) DP thymocytes. Loss of PAXIP1 in developing thymocytes diminished J alpha H3K4me3 and germline transcription, suppressed double strand break formation at 3' J alpha segments, but resulted in accumulation of unresolved T cell receptor alpha-chain gene (Tcra) breaks. Moreover, PAXIP1 was essential for release of mature single positive (SP) alpha beta T cells from the thymus through transcriptional activation of sphingosine-1-phosphate receptor S1pr1 as well as for natural killer T cell development. Thus, in addition to maintaining genome integrity during Tcra rearrangements, PAXIP1 controls distinct transcriptional programs during DP differentiation necessary for Tcra locus accessibility, licensing mature thymocytes for trafficking and natural killer T cell development.	[Callen, Elsa; Faryabi, Robert B.; Daniel, Jeremy A.; Nussenzweig, Andre] NCI, Lab Genome Integr, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Luckey, Megan; Park, Jung-Hyun] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Hao, Bingtao; Krangel, Michael S.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA; [Yang, Wenjing; Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA; [Sun, Hong-Wei] NIH, Biodata Min & Discovery Sect, Off Sci & Technol, Bethesda, MD 20892 USA; [Dressler, Greg] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Ge, Kai] NIDDK, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Daniel, Jeremy A.] Univ Copenhagen, Fac Hlth Sci, Ctr Prot Res, Novo Nordisk Fdn, DK-2200 Copenhagen, Denmark	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Duke University; George Washington University; National Institutes of Health (NIH) - USA; University of Michigan System; University of Michigan; St Jude Children's Research Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Novo Nordisk Foundation; University of Copenhagen	Nussenzweig, A (corresponding author), NCI, Lab Genome Integr, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	andre_nussenzweig@nih.gov	/AAI-2516-2019; Park, Jung Hyun/B-5712-2015; Davis, Megan/F-5339-2015; Faryabi, Robert/AAN-5512-2020; Faryabi, Robert B/H-3544-2015; Chi, Hongbo/M-9397-2018; Ge, Kai/H-2810-2019; hao, Bingtao/G-6648-2011; Daniel, Jeremy/S-4729-2016	Park, Jung Hyun/0000-0002-9547-9055; Faryabi, Robert/0000-0002-7931-2175; Faryabi, Robert B/0000-0002-7931-2175; Chi, Hongbo/0000-0002-9997-2496; Ge, Kai/0000-0002-7442-5138; hao, Bingtao/0000-0003-1997-9338; Daniel, Jeremy/0000-0002-1981-5571; Davis, Megan/0000-0002-9674-0753; Peng, Weiqun/0000-0001-5521-9091	NIH [R37 GM41052]; National Cancer Institute; Center for Cancer Research; Ellison Medical Foundation; NATIONAL CANCER INSTITUTE [ZIABC010959, Z01BC010283, ZIABC011215, ZIABC011214, ZIABC010283] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIHAR041173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK075003, R01DK073722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM041052] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Gustavo Gutierrez-Cruz for technical assistance, Susan Sharrow, Larry Granger, and Tony Adams for flow cytometry, and Remy Bosselut, Albert Bendelac, and Rebecca Mathew for helpful discussions. This work was supported by the Intramural Research Program of the NIH, National Cancer Institute, and Center for Cancer Research to A.N. and J.-H.P., and a Senior Scholar award from the Ellison Medical Foundation to A.N. M.S.K. was supported by NIH grant R37 GM41052.	Abarrategui I, 2006, NAT IMMUNOL, V7, P1109, DOI 10.1038/ni1379; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Callen E, 2007, CELL, V130, P63, DOI 10.1016/j.cell.2007.06.016; Chen HT, 2000, SCIENCE, V290, P1962, DOI 10.1126/science.290.5498.1962; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Cho YW, 2012, METHODS MOL BIOL, V809, P465, DOI 10.1007/978-1-61779-376-9_30; Daniel JA, 2010, SCIENCE, V329, P917, DOI 10.1126/science.1187942; Difilippantonio S, 2008, NATURE, V456, P529, DOI 10.1038/nature07476; Freitas AA, 2009, NAT IMMUNOL, V10, P133, DOI 10.1038/ni0209-133; Gapin L, 2001, NAT IMMUNOL, V2, P971, DOI 10.1038/ni710; Gellert M, 2002, ANNU REV BIOCHEM, V71, P101, DOI 10.1146/annurev.biochem.71.090501.150203; Godfrey DI, 2007, NAT REV IMMUNOL, V7, P505, DOI 10.1038/nri2116; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Grundy GJ, 2010, P NATL ACAD SCI USA, V107, P22487, DOI 10.1073/pnas.1014958107; Guo J, 2002, NAT IMMUNOL, V3, P469, DOI 10.1038/ni791; Hawwari A, 2005, NAT IMMUNOL, V6, P481, DOI 10.1038/ni1189; Hawwari A, 2007, P NATL ACAD SCI USA, V104, P903, DOI 10.1073/pnas.0608248104; He X, 2010, ANNU REV IMMUNOL, V28, P295, DOI 10.1146/annurev.immunol.25.022106.141715; Hennet T, 1995, P NATL ACAD SCI USA, V92, P12070, DOI 10.1073/pnas.92.26.12070; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Ji YH, 2010, CELL, V141, P419, DOI 10.1016/j.cell.2010.03.010; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kim D, 2007, J AM SOC NEPHROL, V18, P1458, DOI 10.1681/ASN.2006060625; Krangel MS, 2007, NAT IMMUNOL, V8, P686, DOI 10.1038/ni1484; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Liu Y, 2007, IMMUNITY, V27, P561, DOI 10.1016/j.immuni.2007.09.005; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; McMurry MT, 1997, MOL CELL BIOL, V17, P4553, DOI 10.1128/MCB.17.8.4553; Odumade OA, 2010, J IMMUNOL, V184, P6060, DOI 10.4049/jimmunol.1000511; Osipovich O, 2010, SEMIN IMMUNOL, V22, P313, DOI 10.1016/j.smim.2010.07.001; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Portales-Casamar E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r207; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schatz DG, 2011, ANNU REV GENET, V45, P167, DOI 10.1146/annurev-genet-110410-132552; Schwab KR, 2011, MOL CELL BIOL, V31, P1503, DOI 10.1128/MCB.00990-10; Seitan VC, 2011, NATURE, V476, P467, DOI 10.1038/nature10312; Shimazaki N, 2009, MOL CELL, V34, P535, DOI 10.1016/j.molcel.2009.05.011; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; Stavnezer J, 2008, ANNU REV IMMUNOL, V26, P261, DOI 10.1146/annurev.immunol.26.021607.090248; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Wang L, 2010, SEMIN IMMUNOL, V22, P294, DOI 10.1016/j.smim.2010.04.013; Wang X., 2010, PTIP PROMOTES DNA DO; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Yannoutsos N, 2001, J EXP MED, V194, P471, DOI 10.1084/jem.194.4.471	49	25	26	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2012	37	6					971	985		10.1016/j.immuni.2012.10.007	http://dx.doi.org/10.1016/j.immuni.2012.10.007			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23159437	Green Accepted, Bronze			2022-12-18	WOS:000312575000007
J	Zhou, L				Zhou, Liang			Striking Similarity: GATA-3 Regulates ILC2 and Th2 Cells	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; TRANSCRIPTION FACTOR GATA3; TYPE-2 IMMUNITY; ALPHA	Innate lymphoid cells (ILCs) and T helper (Th) cells share similar effector functions. In this issue of Immunity, Hoyler et al. (2012) and Mjosberg et al. (2012) demonstrate that GATA-3, a Th2 regulator, controls ILC2 differentiation, maintenance, and function.	[Zhou, Liang] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Zhou, Liang] Northwestern Univ, Dept Microbiol Immunol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Zhou, L (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA.	l-zhou@northwestern.edu			NIAID NIH HHS [R21 AI091962, R01 AI089954] Funding Source: Medline; NIDDK NIH HHS [R01 DK105562] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089954, R21AI091962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK105562] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Halim TYF, 2012, IMMUNITY, V37, P463, DOI 10.1016/j.immuni.2012.06.012; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Monticelli LA, 2011, NAT IMMUNOL, V12, P1045, DOI [10.1031/ni.2131, 10.1038/ni.2131]; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Price AE, 2010, P NATL ACAD SCI USA, V107, P11489, DOI 10.1073/pnas.1003988107; Saenz SA, 2010, NATURE, V464, P1362, DOI 10.1038/nature08901; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208	11	25	26	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 19	2012	37	4					589	591		10.1016/j.immuni.2012.10.002	http://dx.doi.org/10.1016/j.immuni.2012.10.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	025JQ	23084352	Green Accepted, Bronze			2022-12-18	WOS:000310185400001
J	McAleer, JP; Kolls, JK				McAleer, Jeremy P.; Kolls, Jay K.			Maintaining Poise: Commensal Microbiota Calibrate Interferon Responses	IMMUNITY			English	Editorial Material							TRACT		[McAleer, Jeremy P.; Kolls, Jay K.] UPMC, Childrens Hosp Pittsburgh, Richard King Mellon Fdn, Pediat Res Inst, Pittsburgh, PA 15224 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kolls, JK (corresponding author), UPMC, Childrens Hosp Pittsburgh, Richard King Mellon Fdn, Pediat Res Inst, Pittsburgh, PA 15224 USA.	jay.kolls@chp.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304				Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Brenchley JM, 2012, ANNU REV IMMUNOL, V30, P149, DOI 10.1146/annurev-immunol-020711-075001; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	8	25	26	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 27	2012	37	1					10	12		10.1016/j.immuni.2012.07.001	http://dx.doi.org/10.1016/j.immuni.2012.07.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	983QG	22840839	Bronze			2022-12-18	WOS:000307133200005
J	Xiao, WB; Kashiwakura, J; Hong, H; Yasudo, H; Ando, T; Maeda-Yamamoto, M; Wu, DQ; Kawakami, Y; Kawakami, T				Xiao, Wenbin; Kashiwakura, Jun-ichi; Hong, Hong; Yasudo, Hiroki; Ando, Tomoaki; Maeda-Yamamoto, Mari; Wu, Dianqing; Kawakami, Yuko; Kawakami, Toshiaki			Phospholipase C-beta 3 Regulates Fc epsilon RI-Mediated Mast Cell Activation by Recruiting the Protein Phosphatase SHP-1	IMMUNITY			English	Article							LYN TYROSINE KINASE; NEGATIVE REGULATION; INOSITOL PHOSPHATASE; CYTOKINE PRODUCTION; B-CELL; IGE; PHOSPHORYLATION; RECEPTOR; SHIP; DEGRANULATION	Mast cells are major effectors in high-affinity IgE receptor (Fc epsilon RI)-dependent allergic reactions. Here we show that phospholipase C (PLC)-beta 3 is crucial for Fc epsilon RI-mediated mast cell activation. Plcb3(-/-) mice showed blunted Fc epsilon RI-dependent late-phase, but not acute, anaphylactic responses and airway inflammation. Accordingly, Fc epsilon RI stimulation of Plcb3(-/-) mast cells exhibited reduced cytokine production but normal degranulation. Reduced cytokine production in Plcb3(-/-) cells could be accounted for by increased activity of the negative regulatory Src family kinase Lyn and reduced activities of the positive regulatory protein kinases MAPKs. Mechanistically, PLC-beta 3 constitutively interacts with Fc epsilon RI, Lyn, and SHP-1 (protein phosphatase). SHP-1 probably recognizes its substrates Lyn and MAPKs via the recently described kinase tyrosine-based inhibitory motif, KTIM. Consistent with PLC-beta 3- and SHP-1-mediated repression of Lyn activity by dephosphorylation at Tyr396, Fc epsilon RI-mediated phenotypes were similar in Plcb3(-/-) and SHP-1 mutant mast cells. Thus, we have defined a PLC-beta 3- and SHP-1-mediated signaling pathway for Fc epsilon RI-mediated cytokine production.	[Xiao, Wenbin; Kashiwakura, Jun-ichi; Hong, Hong; Yasudo, Hiroki; Ando, Tomoaki; Kawakami, Yuko; Kawakami, Toshiaki] La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA; [Maeda-Yamamoto, Mari] Natl Agr Res Org, Natl Inst Vegetables & Tea Sci, Shizuoka 4288501, Japan; [Wu, Dianqing] Yale Univ, Sch Med, Program Vasc Biol & Therapeut, New Haven, CT 06520 USA; [Wu, Dianqing] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA	La Jolla Institute for Immunology; National Agriculture & Food Research Organization - Japan; Yale University; Yale University	Kawakami, T (corresponding author), La Jolla Inst Allergy & Immunol, Div Cell Biol, La Jolla, CA 92037 USA.	toshi@liai.org	Kawakami, Toshiaki/O-1616-2015	Maeda-Yamamoto, Mari/0000-0002-4494-7509; Xiao, Wenbin/0000-0001-8586-8500; Hong, Hong/0000-0002-1009-3621	National Institutes of Health [AI50209]; Diabetes and Immune Disease National Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108430, P01HL070694, R01HL080706] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050209] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054597] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes and Immune Disease National Research Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to C.A. Lowell for providing us with lyn<SUP>-/-</SUP> mice. We thank S.G. Ward for providing the rat CD2-SHIP-1 construct and A. Rao and S. Trifari for helping with the lentiviral transduction experiments. This study was supported in part by grants from the National Institutes of Health AI50209 (T.K.) and the Diabetes and Immune Disease National Research Institute (W.X.). This is Publication 1286 from the La Jolla Institute for Allergy and Immunology.	Abramson J, 2003, EUR J IMMUNOL, V33, P85, DOI 10.1002/immu.200390011; Abu-Dayyeh I, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000305; Abu-Dayyeh I, 2010, DEV COMP IMMUNOL, V34, P481, DOI 10.1016/j.dci.2009.12.012; Edmunds C, 1999, EUR J IMMUNOL, V29, P3507, DOI 10.1002/(SICI)1521-4141(199911)29:11<3507::AID-IMMU3507>3.0.CO;2-9; EISEMAN E, 1992, NATURE, V355, P78; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Freeburn RW, 2002, J IMMUNOL, V169, P5441, DOI 10.4049/jimmunol.169.10.5441; Furumoto Y, 2004, J BIOL CHEM, V279, P49177, DOI 10.1074/jbc.M404730200; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Gilfillan AM, 2006, NAT REV IMMUNOL, V6, P218, DOI 10.1038/nri1782; Gimborn K, 2005, J IMMUNOL, V174, P507, DOI 10.4049/jimmunol.174.1.507; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hernandez-Hansen V, 2004, J IMMUNOL, V173, P100, DOI 10.4049/jimmunol.173.1.100; Hibbs ML, 2002, J EXP MED, V196, P1593, DOI 10.1084/jem.20020515; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; INAGAKI N, 1986, INT ARCH ALLER A IMM, V80, P285, DOI 10.1159/000234067; JOUVIN MHE, 1994, J BIOL CHEM, V269, P5918; Kalesnikoff J, 2002, J IMMUNOL, V168, P4737, DOI 10.4049/jimmunol.168.9.4737; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Kawakami Y, 2000, J IMMUNOL, V165, P1210, DOI 10.4049/jimmunol.165.3.1210; Kimura T, 1997, J IMMUNOL, V159, P4426; Kimura T, 1997, J BIOL CHEM, V272, P13991, DOI 10.1074/jbc.272.21.13991; Kinet JP, 1999, ANNU REV IMMUNOL, V17, P931, DOI 10.1146/annurev.immunol.17.1.931; Kitaura J, 2000, J EXP MED, V192, P729, DOI 10.1084/jem.192.5.729; Kitaura J, 2003, P NATL ACAD SCI USA, V100, P12911, DOI 10.1073/pnas.1735525100; Klemm S, 2006, J EXP MED, V203, P337, DOI 10.1084/jem.20051982; Leung WH, 2007, J IMMUNOL, V179, P95, DOI 10.4049/jimmunol.179.1.95; Liang XQ, 2002, J BIOL CHEM, V277, P13732, DOI 10.1074/jbc.M200277200; Mashima R, 2009, IMMUNOL REV, V232, P273, DOI 10.1111/j.1600-065X.2009.00844.x; Nakata K, 2008, J IMMUNOL, V181, P5414, DOI 10.4049/jimmunol.181.8.5414; Nishida K, 2005, J CELL BIOL, V170, P115, DOI 10.1083/jcb.200501111; Nishida K, 2009, J EXP MED, V206, P1351, DOI 10.1084/jem.20082533; Odom S, 2004, J EXP MED, V199, P1491, DOI 10.1084/jem.20040382; Ott VL, 2000, J ALLERGY CLIN IMMUN, V106, P429, DOI 10.1067/mai.2000.109428; OZAWA K, 1993, J BIOL CHEM, V268, P1749; Parravicini V, 2002, NAT IMMUNOL, V3, P741, DOI 10.1038/ni817; Phee H, 2000, J BIOL CHEM, V275, P19090, DOI 10.1074/jbc.M001093200; Poderycki M, 2010, J IMMUNOL, V184, P84, DOI 10.4049/jimmunol.0901590; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rivera J, 2006, J ALLERGY CLIN IMMUN, V117, P1214, DOI 10.1016/j.jaci.2006.04.015; Saitoh S, 2000, IMMUNITY, V12, P525, DOI 10.1016/S1074-7613(00)80204-6; Somani AK, 2001, J BIOL CHEM, V276, P1938, DOI 10.1074/jbc.M006820200; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Taube C, 2004, J IMMUNOL, V172, P6398, DOI 10.4049/jimmunol.172.10.6398; Tolar P, 2004, EUR J IMMUNOL, V34, P1136, DOI 10.1002/eji.200324505; Turner H, 1999, NATURE, V402, pB24, DOI 10.1038/35037021; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; WERSHIL BK, 1991, J CLIN INVEST, V87, P446, DOI 10.1172/JCI115016; Williams CMM, 2000, J EXP MED, V192, P455, DOI 10.1084/jem.192.3.455; Wilson BS, 2000, J CELL BIOL, V149, P1131, DOI 10.1083/jcb.149.5.1131; Wilson BS, 2004, MOL BIOL CELL, V15, P2580, DOI 10.1091/mbc.E03-08-0574; Xiao WB, 2005, J IMMUNOL, V175, P6885, DOI 10.4049/jimmunol.175.10.6885; Xiao WB, 2010, BLOOD, V116, P6003, DOI 10.1182/blood-2010-05-283937; Xiao WB, 2009, CANCER CELL, V16, P161, DOI 10.1016/j.ccr.2009.05.018; Xie ZH, 2000, J IMMUNOL, V164, P1521, DOI 10.4049/jimmunol.164.3.1521; Yamashita Y, 2007, J IMMUNOL, V179, P740, DOI 10.4049/jimmunol.179.2.740; Yang WT, 1998, EXP HEMATOL, V26, P1126; Yoshida K, 1999, J BIOL CHEM, V274, P34663, DOI 10.1074/jbc.274.49.34663	61	25	27	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 24	2011	34	6					893	904		10.1016/j.immuni.2011.04.010	http://dx.doi.org/10.1016/j.immuni.2011.04.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21683628	Bronze, Green Accepted			2022-12-18	WOS:000292349700010
J	O'Neill, LAJ				O'Neill, Luke A. J.			Boosting the Brain's Ability to Block Inflammation via MicroRNA-132	IMMUNITY			English	Editorial Material								The brain-immune axis continues to fascinate. In this issue of Immunity, Shaked et al. (2009) describe how miR-132 mediates an anti-inflammatory effect via the targeting of acetylcholinesterase , leading to an increase in the neurotransmitter acetylcholine.	Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	Trinity College Dublin	O'Neill, LAJ (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland.	laoneill@tcd.ie		O'Neill, Luke/0000-0002-4333-2748				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Sheedy FJ, 2008, ANN RHEUM DIS, V67, P50, DOI 10.1136/ard.2008.100289; Sternberg EM, 2006, NAT REV IMMUNOL, V6, P318, DOI 10.1038/nri1810; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103	6	25	27	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2009	31	6					854	855		10.1016/j.immuni.2009.11.004	http://dx.doi.org/10.1016/j.immuni.2009.11.004			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	543YE	20064444	Bronze			2022-12-18	WOS:000273616400005
J	Rowell, E; Wilson, CB				Rowell, Emily; Wilson, Christopher B.			Programming Perpetual T Helper Cell Plasticity	IMMUNITY			English	Editorial Material							HUMAN TH17 CELLS; EXPRESSION; LONG; VIVO	In this issue of Immunity, Lee et al. (2009) and Wei et al. (2009) each investigate the stability of T helper cell lineages and find that commitment to these fates is more plastic than previously appreciated.	[Rowell, Emily; Wilson, Christopher B.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Wilson, CB (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	cbwilson@u.washington.edu						Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Lexberg MH, 2008, EUR J IMMUNOL, V38, P2654, DOI 10.1002/eji.200838541; McGeachy MJ, 2008, IMMUNITY, V28, P445, DOI 10.1016/j.immuni.2008.03.001; Streeck H, 2008, J IMMUNOL METHODS, V333, P115, DOI 10.1016/j.jim.2008.01.018; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yang XO, 2008, IMMUNITY, V29, P44, DOI 10.1016/j.immuni.2008.05.007	9	25	26	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					7	9		10.1016/j.immuni.2008.12.012	http://dx.doi.org/10.1016/j.immuni.2008.12.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19144312	Bronze			2022-12-18	WOS:000262769900004
J	Green, DR				Green, Douglas R.			Fas bim boom!	IMMUNITY			English	Editorial Material							LYMPHOCYTE APOPTOSIS; CELL-DEATH; BCL-2; PATHWAYS; MICE	New findings by Hughes et al. (2008), Hutcheson et al. (2008), and Weant et al. (2008) highlight the roles of apoptosis regulators Bim and Fas in the contraction phase of T cell responses and reveal consequences of failure of this process.	[Green, Douglas R.] St Jude Childrens Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Green, DR (corresponding author), St Jude Childrens Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	douglas.green@stjude.org	Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417				Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Hildeman DA, 2002, IMMUNITY, V16, P759, DOI 10.1016/S1074-7613(02)00322-9; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Pellegrini M, 2005, BLOOD, V106, P1581, DOI 10.1182/blood-2005-01-0284; RAZVI ES, 1995, AM J PATHOL, V147, P79; REAP EA, 1995, J IMMUNOL, V155, P5455; Rieux-Laucat F, 2003, CELL DEATH DIFFER, V10, P124, DOI 10.1038/sj.cdd.4401190; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; Weant AE, 2008, IMMUNITY, V28, P218, DOI 10.1016/j.immuni.2007.12.014	12	25	26	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB	2008	28	2					141	143		10.1016/j.immuni.2008.01.004	http://dx.doi.org/10.1016/j.immuni.2008.01.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18275825	Bronze			2022-12-18	WOS:000253275000003
J	Menendez-Benito, V; Neefjes, J				Menendez-Benito, Victoria; Neefjes, Jacques			Autophagy in MHC class II presentation: Sampling from within	IMMUNITY			English	Editorial Material							DEFENSE-MECHANISM; ANTIGEN	MHC class II molecules usually present exogenous antigens, but peptidome analyses have also identified many antigens from cytosolic or nuclear sources. In this issue of Immunity, Schmid et al. (2007) show that MHC class II molecules can present these through autophagosomes.	Netherlands Canc Inst, Div Tumor Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	Neefjes, J (corresponding author), Netherlands Canc Inst, Div Tumor Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	j.neefjes@nki.nl	Neefjes, Jacques J.C./H-8780-2017	Neefjes, Jacques J.C./0000-0001-6763-2211; Menendez-Benito, Victoria/0000-0001-5312-3037				ALBERTS B, 2003, ESSENTIAL CELL BIOL, P50; Dengjel J, 2005, P NATL ACAD SCI USA, V102, P7922, DOI 10.1073/pnas.0501190102; Deretic V, 2006, CURR OPIN IMMUNOL, V18, P375, DOI 10.1016/j.coi.2006.05.019; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Li P, 2005, IMMUNOL REV, V207, P206, DOI 10.1111/j.0105-2896.2005.00297.x; Ossendorp F, 1998, J EXP MED, V187, P693, DOI 10.1084/jem.187.5.693; Paludan C, 2005, SCIENCE, V307, P593, DOI 10.1126/science.1104904; Schmid D, 2007, IMMUNITY, V26, P79, DOI 10.1016/j.immuni.2006.10.018; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765; Zhou DL, 2005, IMMUNITY, V22, P571, DOI 10.1016/j.immuni.2005.03.009	10	25	50	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JAN	2007	26	1					1	3		10.1016/j.immuni.2007.01.005	http://dx.doi.org/10.1016/j.immuni.2007.01.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	132RD	17241953	Bronze			2022-12-18	WOS:000243959000001
J	Takahashi, Y; Inamine, A; Hashimoto, S; Haraguchi, S; Yoshioka, E; Kojima, N; Abe, R; Takemori, T				Takahashi, Y; Inamine, A; Hashimoto, S; Haraguchi, S; Yoshioka, E; Kojima, N; Abe, R; Takemori, T			Novel role of the Ras cascade in memory B cell response	IMMUNITY			English	Article							XID-LIKE IMMUNODEFICIENCY; PRIMARY IMMUNE-RESPONSE; ANTIBODY-FORMING-CELLS; CLONAL SELECTION; GERMINAL-CENTERS; PHOSPHOINOSITIDE 3-KINASE; RAS/RAF/MEK/ERK PATHWAY; SOMATIC HYPERMUTATION; AFFINITY MATURATION; SIGNAL-TRANSDUCTION	Engagement of the B cell antigen receptor (BCR) triggers the Ras cascade, but the biological role of the latter in B cell response is unknown. Here, we report that in T cell-dependent response, the role of the Ras cascade is confined to memory B cells and possibly marginal zone B cells. When Ras-dependent BCR signaling was impaired, the generation of IgG germinal center B cells was unaffected but the recruitment of high-affinity cells into the memory compartment and terminal differentiation were inhibited. Furthermore, inhibition of MEK activity consistently impaired antibody production by lgG memory B cells (but not naive B cells) in vitro. Notably, this impairment was countered by overexpression of Bcl-2. Thus, our data suggest that upon antigen stimulation, memory B cells are susceptible to apoptosis but can be rescued via an antiapoptotic effect mediated through the Ras cascade.	Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, Tokyo 1628640, Japan; Tokyo Univ Sci, Res Inst Biol Sci, Div Immunobiol, Noda, Chiba 2780022, Japan; Tokyo Univ Sci, Genome & Drug Res Ctr, Noda, Chiba 2780022, Japan; Tokai Univ, Inst Glycotechnol, Hiratsuka, Kanagawa 2591292, Japan; Tokai Univ, Dept Appl Biochem, Hiratsuka, Kanagawa 2591292, Japan	National Institute of Infectious Diseases (NIID); Tokyo University of Science; Tokyo University of Science; Tokai University; Tokai University	Takemori, T (corresponding author), Natl Inst Infect Dis, Dept Immunol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628640, Japan.	ttoshi@nih.go.jp	Takemori, Toshitada/A-5909-2016	Hashimoto, Shu-ichi/0000-0002-2968-5846; Takahashi, Yoshimasa/0000-0001-6342-4087				Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Arpin C, 1997, J EXP MED, V186, P931, DOI 10.1084/jem.186.6.931; Berard R, 1999, J IMMUNOL, V163, P4655; Calame KL, 2001, NAT IMMUNOL, V2, P1103, DOI 10.1038/ni1201-1103; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Doody GM, 2001, NAT IMMUNOL, V2, P542, DOI 10.1038/88748; Enders A, 2003, J EXP MED, V198, P1119, DOI 10.1084/jem.20030411; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Feldhahn N, 2002, J EXP MED, V196, P1291, DOI 10.1084/jem.20020881; Fruman DA, 1999, SCIENCE, V283, P393, DOI 10.1126/science.283.5400.393; Harmer SL, 1997, MOL CELL BIOL, V17, P4087, DOI 10.1128/MCB.17.7.4087; Inamine A, 2005, INT IMMUNOL, V17, P581, DOI 10.1093/intimm/dxh241; Iritani BM, 1997, EMBO J, V16, P7019, DOI 10.1093/emboj/16.23.7019; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kolch W, 2000, BIOCHEM J, V351, P289, DOI 10.1042/0264-6021:3510289; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; LIU YJ, 1995, IMMUNITY, V2, P239, DOI 10.1016/1074-7613(95)90048-9; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; MAIZELS N, 1985, CELL, V43, P715, DOI 10.1016/0092-8674(85)90244-2; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1111/j.1600-065X.2000.imr017515.x; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Matallanas D, 2003, J BIOL CHEM, V278, P4572, DOI 10.1074/jbc.M209807200; MCHEYZERWILLIAMS MG, 1991, NATURE, V350, P502, DOI 10.1038/350502a0; Nagaoka H, 2000, J EXP MED, V192, P171, DOI 10.1084/jem.192.2.171; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Richards JD, 2001, J IMMUNOL, V166, P3855, DOI 10.4049/jimmunol.166.6.3855; Ridderstad A, 1996, J IMMUNOL, V157, P3357; Ridderstad A, 1998, J IMMUNOL, V160, P4688; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; SMITH KGC, 1994, IMMUNITY, V1, P803, DOI 10.1016/S1074-7613(94)80022-7; Smith KGC, 2000, J EXP MED, V191, P475, DOI 10.1084/jem.191.3.475; Song HF, 2003, J EXP MED, V198, P1923, DOI 10.1084/jem.20031498; Suzuki H, 1999, SCIENCE, V283, P390, DOI 10.1126/science.283.5400.390; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Tangye SG, 1998, J EXP MED, V188, P1691, DOI 10.1084/jem.188.9.1691; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Xu SL, 2000, INT IMMUNOL, V12, P397, DOI 10.1093/intimm/12.3.397	46	25	26	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2005	23	2					127	138		10.1016/j.immuni.2005.06.010	http://dx.doi.org/10.1016/j.immuni.2005.06.010			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	962HM	16111632	Bronze			2022-12-18	WOS:000231721700004
J	Cheng, Y; Gunasegaran, B; Singh, HD; Dutertre, CA; Loh, CY; Lim, JQ; Crawford, JC; Lee, HK; Zhang, XM; Lee, B; Becht, E; Lim, WJ; Yeong, J; Chan, CY; Chung, A; Goh, BKP; Chow, PKH; Chan, JKY; Ginhoux, F; Tai, D; Chen, JM; Lim, SG; Zhai, W; Choo, SP; Newell, EW				Cheng, Yang; Gunasegaran, Bavani; Singh, Harsimran D.; Dutertre, Charles-Antoine; Loh, Chiew Yee; Lim, Jia Qi; Crawford, Jeremy Chase; Lee, Hong Kai; Zhang, Xiaomeng; Lee, Bernett; Becht, Etienne; Lim, Wan Jun; Yeong, Joe; Chan, Chung Yip; Chung, Alexander; Goh, Brian K. P.; Chow, Pierce K. H.; Chan, Jerry K. Y.; Ginhoux, Florent; Tai, David; Chen, Jinmiao; Lim, Seng Gee; Zhai, Weiwei; Choo, Su Pin; Newell, Evan W.			Non-terminally exhausted tumor-resident memory HBV-specific T cell responses correlate with relapse-free survival in hepatocellular carcinoma	IMMUNITY			English	Article							RNA-SEQ; EXPRESSION; SIGNATURES; MUTATIONS	Hepatocellular carcinoma (HCC) often develops following chronic hepatitis B virus (HBV) infection and responds poorly to immune checkpoint blockade. Here, we examined the antigen specificities of HCC-infiltrating T cells and their relevance to tumor control. Using highly multiplexed peptide-MHC tetramer staining of unexpanded cells from blood, liver, and tumor tissues from 46 HCC patients, we detected 91 different antigen-specific CD8(+) T cell populations targeting HBV, neoantigen, tumor-associated, and disease-unrelated antigens. Parallel high-dimensional analysis delineated five distinct antigen-specific tissue-resident memory T (Trm) cell populations. Intratumoral and intrahepatic HBV-specific T cells were enriched for two Trm cell subsets that were PD-1 loTOXlo, despite being clonally expanded. High frequencies of intratumoral terminally exhausted T cells were uncommon. Patients with tumor-infiltrating HBV-specific CD8(+) Trm cells exhibited longer-term relapse-free survival. Thus, non-terminally exhausted HBV-specific CD8(+) Trm cells show hallmarks of active involvement and effective antitumor response, implying that these cells could be harnessed for therapeutic purposes.	[Cheng, Yang; Gunasegaran, Bavani; Singh, Harsimran D.; Dutertre, Charles-Antoine; Loh, Chiew Yee; Lee, Hong Kai; Zhang, Xiaomeng; Lee, Bernett; Becht, Etienne; Yeong, Joe; Ginhoux, Florent; Chen, Jinmiao; Newell, Evan W.] ASTAR, Singapore Immunol Network, 8A Biomed Grove, Singapore 138648, Singapore; [Dutertre, Charles-Antoine] Duke NUS Med Sch, Emerging Infect Dis Program, 8 Coll Rd, Singapore 169857, Singapore; [Dutertre, Charles-Antoine] Inst Gustave Roussy, Inserm U1015, 114 Rue Edouard Vaillant, F-94800 Villejuif, France; [Lim, Jia Qi; Zhai, Weiwei] ASTAR, Genome Inst Singapore, 60 Biopolis St, Singapore 138672, Singapore; [Crawford, Jeremy Chase] St Jude Childrens Res Hosp, Dept Immunol, 262 Danny Thomas Pl, Memphis, TN 38105 USA; [Lim, Wan Jun; Tai, David; Choo, Su Pin] Natl Canc Ctr Singapore, Div Med Oncol, 11 Hosp Dr, Singapore 169610, Singapore; [Yeong, Joe] Singapore Gen Hosp, Div Pathol, 20 Coll Rd, Singapore 169856, Singapore; [Chan, Chung Yip; Chung, Alexander; Goh, Brian K. P.; Chow, Pierce K. H.] Singapore Gen Hosp, Dept Hepatopancreatobiliary & Transplant Surg, 20 Coll Rd, Singapore 169856, Singapore; [Chan, Chung Yip; Chung, Alexander; Goh, Brian K. P.; Chow, Pierce K. H.; Tai, David] Duke NUS Med Sch, 8 Coll Rd, Singapore 169857, Singapore; [Chow, Pierce K. H.] Natl Canc Ctr Singapore, Div Surg & Surg Oncol, 11 Hosp Dr, Singapore 169610, Singapore; [Chan, Jerry K. Y.] KK Womens & Childrens Hosp, Dept Reprod Med, 100 Bukit Timah Rd, Singapore 229899, Singapore; [Chan, Jerry K. Y.] Duke NUS Med Sch, Obstet & Gynaecol Acad Clin Program, 8 Coll Rd, Singapore 169857, Singapore; [Lim, Seng Gee] Natl Univ Hlth Syst, Div Gastroenterol & Hepatol, 1E Kent Ridge Rd, Singapore 119228, Singapore; [Zhai, Weiwei] Chinese Acad Sci, Inst Zool, Key Lab Zool Systemat & Evolut, Beijing, Peoples R China; [Zhai, Weiwei] Chinese Acad Sci, Ctr Excellence Anim Evolut & Genet, Kunming, Yunnan, Peoples R China; [Becht, Etienne; Newell, Evan W.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1100 Fairview Ave N, Seattle, WA 98109 USA; [Cheng, Yang] Harvard Med Sch, Ctr Syst Biol, Massachusetts Gen Hosp, 55 Fruit St, Boston, MA 02114 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); St Jude Children's Research Hospital; National Cancer Centre Singapore (NCCS); Singapore General Hospital; Singapore General Hospital; National University of Singapore; National Cancer Centre Singapore (NCCS); KK Women's & Children's Hospital; National University of Singapore; National University of Singapore; Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Fred Hutchinson Cancer Center; Harvard University; Harvard Medical School; Massachusetts General Hospital	Newell, EW (corresponding author), ASTAR, Singapore Immunol Network, 8A Biomed Grove, Singapore 138648, Singapore.; Newell, EW (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1100 Fairview Ave N, Seattle, WA 98109 USA.	enewell@fredhutch.org	Chen, Jinmiao/ABE-5601-2021; Crawford, Jeremy Chase/G-5711-2013; Cheng, Yang/I-7107-2016	Crawford, Jeremy Chase/0000-0003-4096-6048; Gunasegaran, Bavani/0000-0002-4783-8404; Cheng, Yang/0000-0002-5906-7694; Becht, Etienne/0000-0003-1859-9202; Chow, Pierce/0000-0003-0584-2584	Clinician-Scientist Individual Research Grant (CS-IRG); Translational & Clinical Research Flagship program [NMRC/TCR/014-NUHS/2015]; National Medical Research Council of Singapore, Singapore Immunology Network core fund; A*STAR; Andy Hill Endowment Distinguished Researcher CARE fund; A*STAR Singapore International Graduate Award (SINGA)	Clinician-Scientist Individual Research Grant (CS-IRG); Translational & Clinical Research Flagship program; National Medical Research Council of Singapore, Singapore Immunology Network core fund; A*STAR(Agency for Science Technology & Research (A*STAR)); Andy Hill Endowment Distinguished Researcher CARE fund; A*STAR Singapore International Graduate Award (SINGA)(Agency for Science Technology & Research (A*STAR))	The authors are thankful to Antonio Bertoletti from Duke-NUS Medical School for his invaluable comments and review of this manuscript. We also thank Laura Mackay from The Peter Doherty Institute for her critical inputs during the preparation of this study. We are grateful to Amy Yuh Ling Tay for her support and coordination of patient samples. We also thank Karen Teng, Ivy Low, and Josephine Lum, as well as all the members of Newell laboratory, Flow Cytometry core facility and Immunogenomic platform in Singapore Immunology Network. This study was funded by a Clinician-Scientist Individual Research Grant (CS-IRG) (S.P.C., D.T., and E.W.N.) and Translational & Clinical Research Flagship program (NMRC/TCR/014-NUHS/2015) (S.G.L., E.W.N., and Y.C.) from the National Medical Research Council of Singapore, Singapore Immunology Network core funding (E.W.N.); Immunomonitoring platform funding (E.W.N.) of A*STAR; the Andy Hill Endowment Distinguished Researcher CARE fund (E.W.N.); and the A*STAR Singapore International Graduate Award (SINGA) (Y.C.).	Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Becht E, 2019, BIOINFORMATICS, V35, P301, DOI 10.1093/bioinformatics/bty491; Benechet AP, 2019, NATURE, V574, P200, DOI 10.1038/s41586-019-1620-6; Bertoletti A, 2019, GUT, V68, P770, DOI 10.1136/gutjnl-2018-317959; Bertoletti A, 2016, J HEPATOL, V64, pS71, DOI 10.1016/j.jhep.2016.01.026; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Boddupalli CS, 2016, J CLIN INVEST, V126, P3905, DOI 10.1172/JCI85329; Bricard G, 2005, J IMMUNOL, V174, P1709, DOI 10.4049/jimmunol.174.3.1709; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Cheng Y, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6905; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Dash P, 2017, NATURE, V547, P89, DOI 10.1038/nature22383; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Flecken T, 2014, HEPATOLOGY, V59, P1415, DOI 10.1002/hep.26731; Gehring AJ, 2011, J HEPATOL, V55, P103, DOI 10.1016/j.jhep.2010.10.025; Gehring AJ, 2009, GASTROENTEROLOGY, V137, P682, DOI 10.1053/j.gastro.2009.04.045; Graber-Stiehl I, 2018, NATURE, V564, P24, DOI 10.1038/d41586-018-07592-7; Guidotti LG, 1999, SCIENCE, V284, P825, DOI 10.1126/science.284.5415.825; Gupta PK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005177; Hamaoka M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217586; Hoogeveen RC, 2019, GUT, V68, P893, DOI 10.1136/gutjnl-2018-316644; Hundal J, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0264-5; Kallies A, 2020, NAT REV IMMUNOL, V20, P128, DOI 10.1038/s41577-019-0223-7; Kared H, 2016, CANCER IMMUNOL IMMUN, V65, P441, DOI 10.1007/s00262-016-1803-z; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Levrero M, 2016, J HEPATOL, V64, pS84, DOI 10.1016/j.jhep.2016.02.021; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, J IMMUNOL, V194, P2059, DOI 10.4049/jimmunol.1402256; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; McInnes L., 2018, ARXIV180203426; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mueller SN, 2016, NAT REV IMMUNOL, V16, P79, DOI 10.1038/nri.2015.3; Nault JC, 2019, NAT REV GASTRO HEPAT, V16, P544, DOI 10.1038/s41575-019-0165-3; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Pallett LJ, 2017, J EXP MED, V214, P1567, DOI 10.1084/jem.20162115; Park SL, 2019, NATURE, V565, P366, DOI 10.1038/s41586-018-0812-9; Park SL, 2018, NAT IMMUNOL, V19, P183, DOI 10.1038/s41590-017-0027-5; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Rosato PC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08534-1; Saunders CT, 2012, BIOINFORMATICS, V28, P1811, DOI 10.1093/bioinformatics/bts271; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Schenkel JM, 2014, SCIENCE, V346, P98, DOI 10.1126/science.1254536; Schuch A, 2019, GUT, V68, P905, DOI 10.1136/gutjnl-2018-316641; Shukla SA, 2015, NAT BIOTECHNOL, V33, P1152, DOI 10.1038/nbt.3344; Sideras K, 2015, BRIT J CANCER, V112, P1911, DOI 10.1038/bjc.2015.92; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sung WK, 2012, NAT GENET, V44, P765, DOI 10.1038/ng.2295; Tan AT, 2019, GASTROENTEROLOGY, V156, P1862, DOI 10.1053/j.gastro.2019.01.251; Tang KW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3513; Turato C, 2009, DIGEST LIVER DIS, V41, P212, DOI 10.1016/j.dld.2008.06.001; Villanueva A, 2019, NEW ENGL J MED, V380, P1450, DOI 10.1056/NEJMra1713263; Ward JP, 2016, ADV IMMUNOL, V130, P25, DOI 10.1016/bs.ai.2016.01.001; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wong MT, 2016, IMMUNITY, V45, P442, DOI 10.1016/j.immuni.2016.07.007; Yang JD, 2019, NAT REV GASTRO HEPAT, V16, P589, DOI 10.1038/s41575-019-0186-y; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Zhai WW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14565; Zhang XN, 2016, J CLIN INVEST, V126, P1079, DOI 10.1172/JCI83339	71	24	25	11	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1825	+		10.1016/j.immuni.2021.06.013	http://dx.doi.org/10.1016/j.immuni.2021.06.013		AUG 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34270940	Bronze			2022-12-18	WOS:000684589700018
J	Loembe, MM; Nkengasong, JN				Loembe, Marguerite Massinga; Nkengasong, John N.			COVID-19 vaccine access in Africa: Global distribution, vaccine platforms, and challenges ahead	IMMUNITY			English	Editorial Material								Development COVID-19 vaccines in a record time has been an unprecedented global scientific achievement. However, the world has failed to ensure equitable access to what should have been a global public good. What options remain available to African countries to ensure immunization of their populations and ultimately overcome the pandemic?	[Loembe, Marguerite Massinga; Nkengasong, John N.] Africa Ctr Dis Control & Prevent, POB 3243, Addis Ababa, Ethiopia		Nkengasong, JN (corresponding author), Africa Ctr Dis Control & Prevent, POB 3243, Addis Ababa, Ethiopia.	NkengasongJ@africa-union.org		Massinga Loembe, Marguerite/0000-0002-7822-566X				Abiodun T, 2021, VACCINE MANUFACTURIN; Algeria Press Services, 2021, SPUTNIK V VACC PROD; Bridge Consulting, 2021, CHIN COVID 19 VACC T; Callaway E, 2020, NATURE, V584, P506, DOI 10.1038/d41586-020-02450-x; Irwin Aisling, 2021, Nature, DOI 10.1038/d41586-021-01048-1; Kreier Freda, 2021, Nature, DOI 10.1038/d41586-021-01136-2; Kuppalli K, 2021, LANCET, V397, P2132, DOI 10.1016/S0140-6736(21)01121-1; Lee J.K., LANCET COVID 19 COMM; Maxmen A, 2021, NATURE, V593, P21, DOI 10.1038/d41586-021-01069-w; Ncube BM, 2021, J PHARM POLICY PRACT, V14, DOI 10.1186/s40545-020-00281-9; Nkengasong JN, 2020, NATURE, V586, P197, DOI 10.1038/d41586-020-02774-8; Samarasekera U, 2021, LANCET INFECT DIS, V21, P324, DOI 10.1016/S1473-3099(21)00082-7; The World Bank, 2021, ASS COUNTR READ COVI, DOI [10.1596/35281.http://documents1.worldbank.org/curated/en/467291615997445437/pdf/AssessingCountry-Readiness-for-COVID-19-Vaccines-FirstInsights-from-the-Assessment-Rollout.pdf, DOI 10.1596/35281.HTTP://DOCUMENTS1.WORLDBANK.ORG/CURATED/EN/467291615997445437/PDF/ASSESSINGCOUNTRY-READINESS-FOR-COVID-19-VACCINES-FIRSTINSIGHTS-FROM-THE-ASSESSMENT-ROLLOUT.PDF]; TheGlobal Fund, 2021, IMP COVID 19 HIV TB; Yunus M, 2020, LANCET HEALTH LONGEV, V1, pE6, DOI 10.1016/S2666-7568(20)30003-9; Zimmer Carl, 2021, CORONAVIRUS VACCINE	16	24	24	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1353	1362		10.1016/j.immuni.2021.06.017	http://dx.doi.org/10.1016/j.immuni.2021.06.017		JUL 2021	10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34260880	Green Published, Bronze			2022-12-18	WOS:000672812100001
J	Zhong, C; Zheng, MZ; Cui, KR; Martins, AJ; Hu, GQ; Li, D; Tessarollo, L; Kozlov, S; Keller, JR; Tsang, JS; Zhao, KJ; Zhu, JF				Zhong, Chao; Zheng, Mingzhu; Cui, Kairong; Martins, Andrew J.; Hu, Gangqing; Li, Dan; Tessarollo, Lino; Kozlov, Serguei; Keller, Jonathan R.; Tsang, John S.; Zhao, Keji; Zhu, Jinfang			Differential Expression of the Transcription Factor GATA3 Specifies Lineage and Functions of Innate Lymphoid Cells	IMMUNITY			English	Article							T-CELL; FACTOR BCL11B; RNA-SEQ; PROGENITOR; REPRESSION; GENERATION; DEFINES; THPOK; IL-4	Lymphoid tissue inducer (LTi) cells are regarded as a subset of innate lymphoid cells (ILCs). However, these cells are not derived from the ILC common progenitor, which generates other ILC subsets and is defined by the expression of the transcription factor PLZF. Here, we examined transcription factor(s) determining the fate of LTi progenitors versus non-LTi ILC progenitors. Conditional deletion of Gata3 resulted in the loss of PLZF(+) non-LTi progenitors but not the LTi progenitors that expressed the transcription factor ROR gamma t. Consistently, PLZF(+) non-LTi progenitors expressed high amounts of GATA3, whereas GATA3 expression was low in ROR gamma t(+) LTi progenitors. The generation of both progenitors required the transcriptional regulator Id2, which defines the common helper-like innate lymphoid progenitor (ChILP), but not cytokine signaling. Nevertheless, low GATA3 expression was necessary for the generation of functionally mature LTi cells. Thus, differential expression of GATA3 determines the fates and functions of distinct ILC progenitors.	[Zhong, Chao; Zheng, Mingzhu; Martins, Andrew J.; Li, Dan; Tsang, John S.; Zhu, Jinfang] NIAID, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Zhong, Chao] Peking Univ, Inst Syst Biomed, Dept Immunol, Beijing Key Lab Tumor Syst Biol,Hlth Sci Ctr, Beijing 100191, Peoples R China; [Cui, Kairong; Hu, Gangqing; Zhao, Keji] NHLBI, Lab Epigenome Biol, Syst Biol Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA; [Hu, Gangqing] West Virginia Univ, Sch Med, Dept Microbiol Immunol & Cell Biol, Morgantown, WV 26506 USA; [Li, Dan] Zhejiang Univ, Inst Immunol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Li, Dan] Soochow Univ, Dept Clin Lab, Affiliated Hosp 2, Suzhou 215004, Jiangsu, Peoples R China; [Tessarollo, Lino; Keller, Jonathan R.] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21702 USA; [Kozlov, Serguei] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Ctr Adv Preclin Res, Frederick, MD 21702 USA; [Keller, Jonathan R.] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Basic Sci Program, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Peking University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); West Virginia University; Zhejiang University; Soochow University - China; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Zhong, C; Zhu, JF (corresponding author), NIAID, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Zhong, C (corresponding author), Peking Univ, Inst Syst Biomed, Dept Immunol, Beijing Key Lab Tumor Syst Biol,Hlth Sci Ctr, Beijing 100191, Peoples R China.	zhongc@hsc.pku.edu.cn; jfzhu@niaid.nih.gov	Keller, Jonathan R./O-6677-2018; Martins, Andrew/AAU-7039-2021; Zheng, Mingzhu/AAC-7818-2022; Zhu, Jinfang/B-7574-2012; Hu, Gangqing/ABA-3507-2020; Hu, Gangqing/K-5849-2012	Martins, Andrew/0000-0002-1832-1924; Zheng, Mingzhu/0000-0002-9399-9225; Zhu, Jinfang/0000-0002-0117-4745; Hu, Gangqing/0000-0001-5453-6888	Division of Intramural Research of the NIAID; NHLBI (US National Institutes of Health) [1ZIAAI001169, 1ZIAHL006031]; Frederick National Laboratory for Cancer Research, NIH [HHSN261200800001E]; National Natural Science Foundation of China [31770957, 91842102]; Natural Science Foundation of Beijing [18G10645]	Division of Intramural Research of the NIAID; NHLBI (US National Institutes of Health); Frederick National Laboratory for Cancer Research, NIH; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation)	We thank Drs. Remy Bosselut of NCI and Kairui Mao of Xiamen University for their critical reading of the manuscript. We also thank Dr. Remy Bosselut for providing the TghCD2-Gata3 transgenic mouse strain. This work is supported by the Division of Intramural Research of the NIAID and the NHLBI (US National Institutes of Health, 1ZIAAI001169 and 1ZIAHL006031). The generation of Id2-YFP mice has been funded in part with Federal funds from the Frederick National Laboratory for Cancer Research, NIH, under contract HHSN261200800001E. C.Z. is also supported by the National Natural Science Foundation of China (31770957 and 91842102) and the Natural Science Foundation of Beijing (18G10645).	Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bernink JH, 2019, NAT IMMUNOL, V20, P992, DOI 10.1038/s41590-019-0423-0; Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fang DF, 2017, J EXP MED, V214, P1861, DOI 10.1084/jem.20170494; Furusawa J, 2013, J IMMUNOL, V191, P1818, DOI 10.4049/jimmunol.1300379; Harly C, 2018, J EXP MED, V215, P249, DOI 10.1084/jem.20170832; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Hu GQ, 2018, IMMUNITY, V48, P227, DOI 10.1016/j.immuni.2018.01.013; Ishizuka IE, 2016, NAT IMMUNOL, V17, P269, DOI 10.1038/ni.3344; Kim W, 2014, BLOOD, V124, P1586, DOI 10.1182/blood-2014-02-556522; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lesourne R, 2009, NAT IMMUNOL, V10, P840, DOI 10.1038/ni.1768; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Okubo Y, 2019, INT IMMUNOL, V31, P489, DOI 10.1093/intimm/dxz019; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Rankin LC, 2016, NAT IMMUNOL, V17, P179, DOI 10.1038/ni.3332; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Seehus CR, 2015, NAT IMMUNOL, V16, P599, DOI 10.1038/ni.3168; Seillet C, 2016, CELL REP, V17, P436, DOI 10.1016/j.celrep.2016.09.025; Serafini N, 2014, J EXP MED, V211, P199, DOI 10.1084/jem.20131038; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Song C, 2015, J EXP MED, V212, P1869, DOI 10.1084/jem.20151403; Walker JA, 2019, IMMUNITY, V51, P104, DOI 10.1016/j.immuni.2019.05.002; Walker JA, 2015, J EXP MED, V212, P875, DOI 10.1084/jem.20142224; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wolterink RGJK, 2013, P NATL ACAD SCI USA, V110, P10240, DOI 10.1073/pnas.1217158110; Xiong YM, 2013, EUR J IMMUNOL, V43, P918, DOI 10.1002/eji.201242944; Xu W, 2019, IMMUNITY, V50, P1054, DOI 10.1016/j.immuni.2019.02.022; Yagi RJ, 2014, IMMUNITY, V40, P378, DOI 10.1016/j.immuni.2014.01.012; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yu Y, 2016, NATURE, V539, P102, DOI 10.1038/nature20105; Yu Y, 2015, J EXP MED, V212, P865, DOI 10.1084/jem.20142318; Zhong C, 2018, CYTOKINE GROWTH F R, V42, P5, DOI 10.1016/j.cytogfr.2018.02.004; Zhong C, 2017, PROTEIN CELL, V8, P242, DOI 10.1007/s13238-017-0369-7; Zhong C, 2016, NAT IMMUNOL, V17, P169, DOI 10.1038/ni.3318; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128; Zook EC, 2016, NAT IMMUNOL, V17, P775, DOI 10.1038/ni.3481	52	24	24	3	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					83	+		10.1016/j.immuni.2019.12.001	http://dx.doi.org/10.1016/j.immuni.2019.12.001			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31882362	Green Accepted, Bronze			2022-12-18	WOS:000507384600010
J	Humblin, E; Kamphorst, AO				Humblin, Etienne; Kamphorst, Alice O.			CXCR3-CXCL9: It's All in the Tumor	IMMUNITY			English	Editorial Material							T-CELL TRAFFICKING; RESPONSES	In this issue of Immunity, Chow et al. (2019) show that the CXCR3-CXCL9 axis is required for reinvigoration of intratumoral CD8(+) T cell responses in response to PD-1 blockade and demonstrate that local guidance to dendritic cells, rather than recruitment of T cells into the tumor, underlies the importance of this chemokine axis.	[Humblin, Etienne] Icahn Sch Med Mt Sinai, Precis Immunol Inst, New York, NY 10029 USA; [Kamphorst, Alice O.] Icahn Sch Med Mt Sinai, Tisch Canc Inst, Precis Immunol Inst, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Kamphorst, AO (corresponding author), Icahn Sch Med Mt Sinai, Tisch Canc Inst, Precis Immunol Inst, Dept Oncol Sci, New York, NY 10029 USA.	alice.kamphorst@mssm.edu		Humblin, Etienne/0000-0002-4559-6106; Kamphorst, Alice/0000-0002-9230-9501				Chow MT, 2019, IMMUNITY, V50, P1498, DOI 10.1016/j.immuni.2019.04.010; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Mikucki ME, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8458; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Sade-Feldman M, 2019, CELL, V176, P404, DOI 10.1016/j.cell.2018.12.034; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003	10	24	25	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1347	1349		10.1016/j.immuni.2019.05.013	http://dx.doi.org/10.1016/j.immuni.2019.05.013			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31216458	Bronze			2022-12-18	WOS:000471876100006
J	Kuriakose, T; Kanneganti, TD				Kuriakose, Teneema; Kanneganti, Thirumala-Devi			Gasdermin D Flashes an Exit Signal for IL-1	IMMUNITY			English	Editorial Material							INFLAMMASOME ACTIVATION		[Kuriakose, Teneema; Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Kanneganti, TD (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA.	thirumala-devi.kanneganti@stjude.org	Kanneganti, Thirumala-Devi/Y-2503-2019; Kanneganti, Thirumala-Devi/M-9435-2018	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kuriakose, Teneema/0000-0003-4032-1290	US National Institutes of Health; American Lebanese Syrian Associated Charities	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	Research studies from our laboratory are supported by the US National Institutes of Health and the American Lebanese Syrian Associated Charities to T.D.K.	Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Fink SL, 2006, CELL MICROBIOL, V8, P1812, DOI 10.1111/j.1462-5822.2006.00751.x; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Sharma D, 2016, J CELL BIOL, V213, P617, DOI 10.1083/jcb.201602089; Shi JJ, 2017, TRENDS BIOCHEM SCI, V42, P245, DOI 10.1016/j.tibs.2016.10.004; Shimada T, 2010, CELL HOST MICROBE, V7, P38, DOI 10.1016/j.chom.2009.12.008; Swanson KV, 2017, J EXP MED, V214, P3611, DOI 10.1084/jem.20171749; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036	10	24	24	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					1	3		10.1016/j.immuni.2018.01.003	http://dx.doi.org/10.1016/j.immuni.2018.01.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29343431	Bronze			2022-12-18	WOS:000422751600001
J	Hellmann, MD; Snyder, A				Hellmann, Matthew D.; Snyder, Alexandra			Making It Personal: Neoantigen Vaccines in Metastatic Melanoma	IMMUNITY			English	Editorial Material							PD-1 BLOCKADE; CANCER; IMMUNITY	Somatic mutations in cancer can be translated into peptides, termed neoantigens, which can be recognized by the immune system as "foreign'' epitopes. Two recent studies in Nature (Sahin et al., 2017; Ott et al., 2017) examine the effects of neoantigen vaccines on patients with stage III or IV melanoma and demonstrate immunogenicity and intriguing clinical safety and efficacy data in phase I studies.	[Hellmann, Matthew D.; Snyder, Alexandra] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10028 USA; [Snyder, Alexandra] Adapt Biotechnol, 1551 Eastlake Ave E,Ste 200, Seattle, WA 98102 USA	Memorial Sloan Kettering Cancer Center	Hellmann, MD; Snyder, A (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10028 USA.; Snyder, A (corresponding author), Adapt Biotechnol, 1551 Eastlake Ave E,Ste 200, Seattle, WA 98102 USA.	hellmanm@mskcc.org; snyderca@mskcc.org						Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; PREHN RT, 1957, J NATL CANCER I, V18, P769; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Snyder A, 2014, NEW ENGL J MED, V371, P2189, DOI 10.1056/NEJMoa1406498; Stronen E, 2016, SCIENCE, V352, P1337, DOI 10.1126/science.aaf2288; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; van Rooij N, 2013, J CLIN ONCOL, V31, pE439, DOI 10.1200/JCO.2012.47.7521; Verdegaal EME, 2016, NATURE, V536, P91, DOI 10.1038/nature18945	11	24	25	2	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					221	223		10.1016/j.immuni.2017.08.001	http://dx.doi.org/10.1016/j.immuni.2017.08.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28813655	Bronze			2022-12-18	WOS:000407788300009
J	Rescigno, M				Rescigno, Maria			Before They Were Gut Dendritic Cells	IMMUNITY			English	Editorial Material							RETINOIC-ACID; DIFFERENTIATION	Gut lamina propria dendritic cell (DC) subsets have specialized functions. In this issue of Immunity, Varol et al. (2009) and Bogunovic et al. (2009) describe the different blood precursors for CD103(+) and CD103(-) DC subsets.	European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy	IRCCS European Institute of Oncology (IEO)	Rescigno, M (corresponding author), European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy.	maria.rescigno@ifom-ieo-campus.it	Rescigno, Maria/J-9704-2012	Rescigno, Maria/0000-0002-6464-509X				Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Monteleone I, 2008, EUR J IMMUNOL, V38, P1533, DOI 10.1002/eji.200737909; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Sun CM, 2007, J EXP MED, V204, P1775, DOI 10.1084/jem.20070602; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025	11	24	24	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP 18	2009	31	3					454	456		10.1016/j.immuni.2009.08.015	http://dx.doi.org/10.1016/j.immuni.2009.08.015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19766089	Bronze			2022-12-18	WOS:000270525900012
J	Welsh, RM				Welsh, Raymond M.			Blimp Hovers over T Cell Immunity	IMMUNITY			English	Editorial Material							MEMORY; DIFFERENTIATION	The functions of T lymphocytes are regulated by transcription factors controlling gene expression. Three studies in this issue of Immunity (Kallies et al., 2009; Rutishauser et al., 2009; Shin et al., 2009) indicate that the transcriptional repressor Blimp-1 promotes the development of short-lived effector cells and regulates clonal exhaustion.	Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Welsh, RM (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01655 USA.	raymond.welsh@umassmed.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI017672, R01AI081675, R01AI017672] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI017672-20, R01 AI081675-25, R01 AI017672, R37 AI017672, R01 AI081675] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; John SA, 2009, EXP CELL RES, V315, P1077, DOI 10.1016/j.yexcr.2008.11.015; Kallies A, 2006, NAT IMMUNOL, V7, P466, DOI 10.1038/ni1321; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Martins GA, 2008, J EXP MED, V205, P1959, DOI 10.1084/jem.20080526; Parish IA, 2009, CURR OPIN IMMUNOL, V21, P291, DOI 10.1016/j.coi.2009.05.008; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019	12	24	24	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 21	2009	31	2					178	180		10.1016/j.immuni.2009.08.005	http://dx.doi.org/10.1016/j.immuni.2009.08.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	488GY	19699168	Green Accepted, Bronze			2022-12-18	WOS:000269338600004
J	Colonna, M; Cella, M				Colonna, Marco; Cella, Marina			Crosspresentation: Plasmacytoid dendritic cells are in the business	IMMUNITY			English	Editorial Material							T-CELLS; RECEPTOR; PROTEIN; CD8(+)	Crosspriming and crosspresentation are performed by specialized subsets of dendritic cells. In this issue, Hoeffel et al. (2007) show that human plasmacytoid dendritic cells can crosspresent HIV-derived peptides conjugated to a lipopeptide or HIV-infected cells undergoing apoptosis.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@pathology.wustl.edu	Cella, Marina/G-8850-2011; Cella, Marina/ABA-8564-2020	Cella, Marina/0000-0003-1230-1313; Colonna, Marco/0000-0001-5222-4987				Ackerman AL, 2006, IMMUNITY, V25, P607, DOI 10.1016/j.immuni.2006.08.017; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; Bozzacco L, 2007, P NATL ACAD SCI USA, V104, P1289, DOI 10.1073/pnas.0610383104; Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971; Hoeffel G, 2007, IMMUNITY, V27, P481, DOI 10.1016/j.immuni.2007.07.021; Sapoznikov A, 2007, J EXP MED, V204, P1923, DOI 10.1084/jem.20062373; Schnurr M, 2005, BLOOD, V105, P2465, DOI 10.1182/blood-2004-08-3105; Shinohara ML, 2006, NAT IMMUNOL, V7, P498, DOI 10.1038/ni1327; Zhang JQ, 2006, BLOOD, V107, P3600, DOI 10.1182/blood-2005-09-3842	9	24	24	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	SEP	2007	27	3					419	421		10.1016/j.immuni.2007.08.006	http://dx.doi.org/10.1016/j.immuni.2007.08.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	215XX	17892851	Bronze			2022-12-18	WOS:000249843400008
J	Clynes, R				Clynes, Raphael			IVIG therapy: Interfering with interferon-gamma	IMMUNITY			English	Editorial Material							INTRAVENOUS IMMUNOGLOBULIN; ANTIINFLAMMATORY ACTIVITY; AUTOIMMUNE-DISEASE; RECEPTOR	The immunosuppressive mechanism of action of intravenous immune globulin (IVIG) has remained enigmatic despite the many years of clinical experience in the treatment of autoimmunity. In this issue of Immunity, Park-Min et al. (2007) demonstrate that IVIG engagement of Fc gamma RIII receptor on monocytes inhibits the cellular response to interferon-gamma.	Columbia Univ, Dept Med & Microbiol, New York, NY 10032 USA	Columbia University	Clynes, R (corresponding author), Columbia Univ, Dept Med & Microbiol, New York, NY 10032 USA.	rc645@columbia.edu						Bruhns P, 2003, IMMUNITY, V18, P573, DOI 10.1016/S1074-7613(03)00080-3; HAMERMAN JA, 2006, SCI STKE, pRE1, DOI DOI 10.1126/STKE.3202006RE1; Hansen RJ, 2002, BLOOD, V100, P2087, DOI 10.1182/blood.V100.6.2087.h81802002087_2087_2093; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Park-Min KH, 2007, IMMUNITY, V26, P67, DOI 10.1016/j.immuni.2006.11.010; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Samuelsson A, 2001, SCIENCE, V291, P484, DOI 10.1126/science.291.5503.484; Siragam V, 2005, J CLIN INVEST, V115, P155, DOI 10.1172/JCI200522753; Siragam V, 2006, NAT MED, V12, P688, DOI 10.1038/nm1416; SOUBRANE C, 1993, BLOOD, V81, P15; Sutterwala FS, 1998, J EXP MED, V188, P217, DOI 10.1084/jem.188.1.217	11	24	24	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2007	26	1					4	6		10.1016/j.immuni.2007.01.006	http://dx.doi.org/10.1016/j.immuni.2007.01.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	132RD	17241954	Bronze			2022-12-18	WOS:000243959000002
J	Beutler, B				Beutler, B			Not "molecular patterns" but molecules	IMMUNITY			English	Editorial Material							LIPOPOLYSACCHARIDE; RECEPTOR; RECOGNITION; TLR4; LPS	In this issue of Immunity, Weber et al. show that LBP is multifunctional: able to sense not only LPS but peptidoglycan as well. The study helps to demystify the physical interactions that occur between host sensors and microbial inducers, and hints at one mechanism by which a limited number of receptors may engage a larger number of target molecules.	Scripps Res Inst, Dept Immunol, IMM 31, La Jolla, CA 92037 USA	Scripps Research Institute	Beutler, B (corresponding author), Scripps Res Inst, Dept Immunol, IMM 31, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.							Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Correia JD, 2001, J BIOL CHEM, V276, P21129, DOI 10.1074/jbc.M009164200; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; SCHUMANN RR, 1990, SCIENCE, V249, P1429, DOI 10.1126/science.2402637; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	13	24	26	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2003	19	2					155	156		10.1016/S1074-7613(03)00212-7	http://dx.doi.org/10.1016/S1074-7613(03)00212-7			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	714TF	12932347	Bronze			2022-12-18	WOS:000184929000001
J	Katayama, Y; Frenette, PS				Katayama, Y; Frenette, PS			Galactocerebrosides are required postnatally for stromal-dependent bone marrow lymphopoiesis	IMMUNITY			English	Article							GALACTOSE-CERAMIDE GALACTOSYLTRANSFERASE; HEMATOPOIETIC STEM-CELLS; UDP-GALACTOSE; DEFICIENT MICE; FIBRONECTIN; EXPRESSION; SULFOGLYCOLIPIDS; PROGENITORS; SULFATIDES; GANGLIOSIDES	Galactocerebrosides (GCs) represent a major class of glycolipids in the nervous system. Here, we show that mice lacking the key enzyme to generate GCs, UDPgalactose:ceramide galactosyltransferase (CGT(-/-)), exhibit severe postnatal atrophy of all lymphoid organs, owing to a maturational arrest before the pro-B/T cell stage. This lineage-specific defect originates from the bone marrow (BM) stroma since it is not transplantable to irradiated wild-type recipients. Remarkably, CGT-/- long-term B lymphoid BM cultures displayed severe deficits in the number of CD45(neg)VCAM-1(pos) stromal cells and fibronectin matrix assembly, and produced floating macrophages rather than B lymphocytes. The fibronectin network was also altered in the CGT-deficient BM parenchyma. These results point to an essential role for galactolipids in the formation of fibronectin-enriched lymphoid-specific stromal niches in the BM.	CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai	Frenette, PS (corresponding author), CUNY Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.	paul.frenette@mssm.edu	Frenette, Paul S/J-8272-2012	Frenette, Paul S/0000-0003-0862-9922	NCI NIH HHS [CA-095823] Funding Source: Medline; NCRR NIH HHS [1S10 RR0 9145] Funding Source: Medline; NHLBI NIH HHS [HL 69438] Funding Source: Medline; NIDDK NIH HHS [DK 56638] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056638] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alfsen A, 2002, J BIOL CHEM, V277, P25649, DOI 10.1074/jbc.M200554200; ALLEN TD, 1984, EXP HEMATOL, V12, P517; Arroyo AG, 1996, CELL, V85, P997, DOI 10.1016/S0092-8674(00)81301-X; ARUFFO A, 1991, CELL, V67, P35, DOI 10.1016/0092-8674(91)90570-O; BENNETT JH, 1991, J CELL SCI, V99, P131; Bianco P, 2000, J CLIN INVEST, V105, P1663, DOI 10.1172/JCI10413; Bosio A, 1996, P NATL ACAD SCI USA, V93, P13280, DOI 10.1073/pnas.93.23.13280; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; DERYUGINA EI, 1993, CRIT REV IMMUNOL, V13, P115; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; DORSHKIND K, 1990, ANNU REV IMMUNOL, V8, P111, DOI 10.1146/annurev.iy.08.040190.000551; Frenette PS, 2000, BLOOD, V96, P2460, DOI 10.1182/blood.V96.7.2460.h8002460_2460_2468; Friedenstein A J, 1980, Haematol Blood Transfus, V25, P19; Friedrich C, 1996, EUR J IMMUNOL, V26, P2773, DOI 10.1002/eji.1830261133; Fujimoto H, 2000, J BIOL CHEM, V275, P22623, DOI 10.1074/jbc.C000200200; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Hardy RR, 2001, ANNU REV IMMUNOL, V19, P595, DOI 10.1146/annurev.immunol.19.1.595; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; HAROUSE JM, 1991, SCIENCE, V253, P320, DOI 10.1126/science.1857969; HARRISON DE, 1993, EXP HEMATOL, V21, P206; Honke K, 1997, J BIOL CHEM, V272, P4864, DOI 10.1074/jbc.272.8.4864; Honke K, 2002, P NATL ACAD SCI USA, V99, P4227, DOI 10.1073/pnas.032068299; Hynes RO, 1990, FIBRONECTINS; Ishizuka I, 1997, PROG LIPID RES, V36, P245, DOI 10.1016/S0163-7827(97)00011-8; JACOBSEN K, 1990, EUR J IMMUNOL, V20, P2395, DOI 10.1002/eji.1830201106; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; KIERNEY PC, 1987, BLOOD, V70, P1418; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; LAUDANNA C, 1994, J BIOL CHEM, V269, P4021; Leuker CE, 2001, J EXP MED, V193, P755, DOI 10.1084/jem.193.6.755; Merten M, 2001, CIRCULATION, V104, P2955, DOI 10.1161/hc4901.100383; MIYAKE K, 1991, J EXP MED, V173, P599, DOI 10.1084/jem.173.3.599; Montecino-Rodriguez E, 2001, NAT IMMUNOL, V2, P83, DOI 10.1038/83210; OWEN M, 1988, J CELL SCI, P63; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Sakai T, 2001, NAT MED, V7, P324, DOI 10.1038/85471; Shamshiev A, 2002, J EXP MED, V195, P1013, DOI 10.1084/jem.20011963; Sidobre S, 2002, J IMMUNOL METHODS, V268, P107, DOI 10.1016/S0022-1759(02)00204-1; SPIEGEL S, 1984, J CELL BIOL, V99, P699, DOI 10.1083/jcb.99.2.699; Sprong H, 1998, J BIOL CHEM, V273, P25880, DOI 10.1074/jbc.273.40.25880; STAHL N, 1994, J NEUROSCI RES, V38, P234, DOI 10.1002/jnr.490380214; Tadano-Aritomi K, 2000, J LIPID RES, V41, P1237; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; Vogelezang MG, 2001, J NEUROSCI, V21, P6732, DOI 10.1523/JNEUROSCI.21-17-06732.2001; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; WEISSMAN IL, 1994, CELL, V76, P207, DOI 10.1016/0092-8674(94)90329-8; WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608; YAMADA KM, 1983, EXP CELL RES, V143, P295, DOI 10.1016/0014-4827(83)90054-X	50	24	24	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2003	18	6					789	800		10.1016/S1074-7613(03)00150-X	http://dx.doi.org/10.1016/S1074-7613(03)00150-X			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	694HB	12818160	Bronze			2022-12-18	WOS:000183767700009
J	WAYNE, J; SUH, H; MISULOVIN, Z; SOKOL, KA; INABA, K; NUSSENZWEIG, MC				WAYNE, J; SUH, H; MISULOVIN, Z; SOKOL, KA; INABA, K; NUSSENZWEIG, MC			A REGULATORY ROLE FOR RECOMBINASE ACTIVATING GENES, RAG-1 AND RAG-2, IN T-CELL DEVELOPMENT	IMMUNITY			English	Article							ANTIGEN RECEPTOR GENES; V(D)J RECOMBINATION; THYMOCYTE DEVELOPMENT; MONOCLONAL-ANTIBODY; LYMPHOCYTES-T; B-CELLS; NEGATIVE SELECTION; TRANSGENIC MICE; DEFICIENT MICE; LYMPH-NODE	RAG-1 and RAG-2 are developmentally regulated genes that are essential for the assembly of antigen receptors in lymphoid cells. Here we describe transgenic mice that carry RAG-1 and RAG-2 under the control of the proximal Ick promoter. Persistent expression of RAG-1 and RAG-2 was associated with incomplete thymopoiesis and profoundly compromised cellular immunity. In addition, RAG transgenic mice rapidly developed lymphadenopathy, splenomegaly, and lymphocytic perivascular infiltrates. These effects required both RAG-1 and RAG-2, since mice that carried either gene exclusively were indistinguishable from wild-type controls. We propose that in addition to a previously documented role in V(D)J recombination, RAG-1 and RAG-2 expression must be properly regulated for completion of normal T cell development.	ROCKEFELLER UNIV,LAB ANIM RES CTR,NEW YORK,NY 10021; KYOTO UNIV,FAC SCI,DEPT ZOOL,SAKYO KU,KYOTO 606,JAPAN	Rockefeller University; Kyoto University	WAYNE, J (corresponding author), ROCKEFELLER UNIV,HOWARD HUGHES MED INST,NEW YORK,NY 10021, USA.		Nussenzweig, Michel/AAE-7292-2019		NCRR NIH HHS [RR07044] Funding Source: Medline; NIGMS NIH HHS [GM07982] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALT FW, 1992, IMMUNOL TODAY, V13, P306, DOI 10.1016/0167-5699(92)90043-7; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; BELITSOS PC, 1990, J IMMUNOL, V144, P1661; BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; BIRKELAND ML, 1988, J MOL CELL IMMUNOL, V4, P71; BORGULYA P, 1992, CELL, V69, P529, DOI 10.1016/0092-8674(92)90453-J; BORGULYA P, 1991, EMBO J, V10, P913, DOI 10.1002/j.1460-2075.1991.tb08024.x; BRANDLE D, 1992, P NATL ACAD SCI USA, V89, P9529, DOI 10.1073/pnas.89.20.9529; BRUCE J, 1981, J IMMUNOL, V127, P2496; BUDD RC, 1987, J IMMUNOL, V138, P3120; CAMP RL, 1993, J EXP MED, V178, P497, DOI 10.1084/jem.178.2.497; CHAFFIN KE, 1990, EMBO J, V9, P3821, DOI 10.1002/j.1460-2075.1990.tb07600.x; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; CULTY M, 1990, J CELL BIOL, V111, P2765, DOI 10.1083/jcb.111.6.2765; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; FLAHERTY L, 1976, IMMUNOGENETICS, V3, P533, DOI 10.1007/BF01576983; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; GARVIN AM, 1990, INT IMMUNOL, V2, P173, DOI 10.1093/intimm/2.2.173; GARVIN AM, 1988, MOL CELL BIOL, V8, P3058, DOI 10.1128/MCB.8.8.3058; GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999; HAPNER KD, 1968, J BIOL CHEM, V243, P683; HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3; HUET S, 1989, J IMMUNOL, V143, P798; INABA K, 1983, P NATL ACAD SCI-BIOL, V80, P6041, DOI 10.1073/pnas.80.19.6041; JALKANEN S, 1987, J CELL BIOL, V105, P983, DOI 10.1083/jcb.105.2.983; JALKANEN S, 1992, J CELL BIOL, V116, P817, DOI 10.1083/jcb.116.3.817; JULIUS MH, 1973, EUR J IMMUNOL, V3, P645, DOI 10.1002/eji.1830031011; KELLY KA, 1990, INT IMMUNOL, V2, P419, DOI 10.1093/intimm/2.5.419; KINCADE PW, 1980, J IMMUNOL, V124, P2879; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LEWIS DB, 1991, J EXP MED, V173, P89, DOI 10.1084/jem.173.1.89; LIN WC, 1993, SCIENCE, V260, P953, DOI 10.1126/science.8493533; LYNCH F, 1987, EUR J IMMUNOL, V17, P137, DOI 10.1002/eji.1830170123; LYNCH F, 1989, EUR J IMMUNOL, V19, P223, DOI 10.1002/eji.1830190202; MA A, 1992, EMBO J, V11, P2727, DOI 10.1002/j.1460-2075.1992.tb05338.x; MATSUMOTO K, 1991, J EXP MED, V173, P127, DOI 10.1084/jem.173.1.127; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MIYAKE K, 1990, J EXP MED, V171, P477, DOI 10.1084/jem.171.2.477; MIYAKE K, 1990, J EXP MED, V172, P69, DOI 10.1084/jem.172.1.69; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; NAUJOKAS MF, 1993, CELL, V74, P257, DOI 10.1016/0092-8674(93)90417-O; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NIKOLICZUGIC J, 1990, INT IMMUNOL, V2, P135, DOI 10.1093/intimm/2.2.135; NUSSENZWEIG MC, 1987, SCIENCE, V236, P816, DOI 10.1126/science.3107126; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; OETTINGER MA, 1992, TRENDS GENET, V8, P413, DOI 10.1016/0168-9525(92)90323-V; OKAMOTO M, 1992, J EXP MED, V175, P71, DOI 10.1084/jem.175.1.71; PALMITER RD, 1986, ANNU REV GENET, V20, P465, DOI 10.1146/annurev.ge.20.120186.002341; RAMSDELL F, 1991, J IMMUNOL, V147, P1779; SCHATZ DG, 1992, ANNU REV IMMUNOL, V10, P359, DOI 10.1146/annurev.iy.10.040192.002043; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHATZ DG, 1988, CELL, V53, P107, DOI 10.1016/0092-8674(88)90492-8; SEIDL C, 1992, J IMMUNOL, V148, P1576; SHIMIZU Y, 1989, J IMMUNOL, V143, P2457; SHINKAI Y, 1993, SCIENCE, V259, P822, DOI 10.1126/science.8430336; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; SHULTZ LD, 1987, ANNU REV IMMUNOL, V5, P367, DOI 10.1146/annurev.iy.05.040187.002055; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SILVER DP, 1993, P NATL ACAD SCI USA, V90, P6100, DOI 10.1073/pnas.90.13.6100; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STAMENKOVIC I, 1991, EMBO J, V10, P343, DOI 10.1002/j.1460-2075.1991.tb07955.x; STROYNOWSKI I, 1987, CELL, V50, P759, DOI 10.1016/0092-8674(87)90334-5; SWIGGARD WJ, 1992, CURRENTPROTOCOLS I S, V3; TACCIOLI GE, 1993, SCIENCE, V260, P207, DOI 10.1126/science.8469973; TAKAHAMA Y, 1992, SCIENCE, V258, P1456, DOI 10.1126/science.1439838; TAKEI F, 1985, J IMMUNOL, V134, P1403; TAKETO M, 1991, P NATL ACAD SCI USA, V88, P2065, DOI 10.1073/pnas.88.6.2065; TIEGS SL, 1993, J EXP MED, V177, P1009, DOI 10.1084/jem.177.4.1009; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VASICEK TJ, 1992, J EXP MED, V175, P1169, DOI 10.1084/jem.175.5.1169; VERNACHIO J, 1989, J IMMUNOL, V142, P48; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WILDIN RS, 1991, J EXP MED, V173, P383, DOI 10.1084/jem.173.2.383; WILSON A, 1988, J IMMUNOL, V140, P1461; WYSOCKI LJ, 1978, P NATL ACAD SCI USA, V75, P2844, DOI 10.1073/pnas.75.6.2844; ZHOU T, 1991, J IMMUNOL, V147, P466	82	24	24	2	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	MAY	1994	1	2					95	107		10.1016/1074-7613(94)90103-1	http://dx.doi.org/10.1016/1074-7613(94)90103-1			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK162	7534201				2022-12-18	WOS:A1994PK16200002
J	Barkaway, A; Rolas, L; Joulia, R; Bodkin, J; Lenn, T; Owen-Woods, C; Reglero-Real, N; Stein, M; Vazquez-Martinez, L; Girbl, T; Poston, RN; Golding, M; Saleeb, RS; Thiriot, A; von Andrian, UH; Duchene, J; Voisin, MB; Bishop, CL; Voehringer, D; Roers, A; Rot, A; Lammermann, T; Nourshargh, S				Barkaway, Anna; Rolas, Loic; Joulia, Regis; Bodkin, Jennifer; Lenn, Tchern; Owen-Woods, Charlotte; Reglero-Real, Natalia; Stein, Monja; Vazquez-Martinez, Laura; Girbl, Tamara; Poston, Robin N.; Golding, Matthew; Saleeb, Rebecca S.; Thiriot, Aude; von Andrian, Ulrich H.; Duchene, Johan; Voisin, Mathieu-Benoit; Bishop, Cleo L.; Voehringer, David; Roers, Axel; Rot, Antal; Laemmermann, Tim; Nourshargh, Sussan			Age-related changes in the local milieu of inflamed tissues cause aberrant neutrophil trafficking and subsequent remote organ damage	IMMUNITY			English	Article							MAST-CELLS; LEUKOCYTE MIGRATION; INFLAMMATION; ADHESION; RECEPTOR; CHEMOKINES; PROTEIN; CXCR2; DYSREGULATION; RECRUITMENT	Aging is associated with dysregulated immune functions. Here, we investigated the impact of age on neutrophil diapedesis. Using confocal intravital microscopy, we found that in aged mice, neutrophils adhered to vascular endothelium in inflamed tissues but exhibited a high frequency of reverse transendothelial migration (rTEM). This retrograde breaching of the endothelium by neutrophils was governed by enhanced production of the chemokine CXCL1 from mast cells that localized at endothelial cell (EC) junctions. Increased EC expression of the atypical chemokine receptor 1 (ACKR1) supported this pro-inflammatory milieu in aged venules. Accumulation of CXCL1 caused desensitization of the chemokine receptor CXCR2 on neutrophils and loss of neutrophil directional motility within EC junctions. Fluorescent tracking revealed that in aged mice, neutrophils undergoing rTEM re-entered the circulation and disseminated to the lungs where they caused vascular leakage. Thus, neutrophils stemming from a local inflammatory site contribute to remote organ damage, with implication to the dysregulated systemic inflammation associated with aging.	[Barkaway, Anna; Rolas, Loic; Joulia, Regis; Bodkin, Jennifer; Lenn, Tchern; Owen-Woods, Charlotte; Reglero-Real, Natalia; Stein, Monja; Vazquez-Martinez, Laura; Girbl, Tamara; Poston, Robin N.; Golding, Matthew; Saleeb, Rebecca S.; Voisin, Mathieu-Benoit; Rot, Antal; Nourshargh, Sussan] Queen Mary Univ London, Ctr Microvasc Res, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Thiriot, Aude; von Andrian, Ulrich H.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA; [Thiriot, Aude; von Andrian, Ulrich H.] Harvard Med Sch, HMS Ctr Immune Imaging, Boston, MA 02115 USA; [Thiriot, Aude; von Andrian, Ulrich H.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Duchene, Johan] Ludwig Maximillians Univ LMU Munchen, Inst Cardiovasc Prevent IPEK, D-80336 Munich, Germany; [Bishop, Cleo L.] Queen Mary Univ London, Ctr Cell Biol & Cutaneous Res, Barts & London Sch Med & Dent, Blizard Inst, London E1 2AT, England; [Voehringer, David] Univ Hosp Erlangen, Dept Infect Biol, D-91054 Erlangen, Germany; [Voehringer, David] Friedrich Alexander Univ Erlangen Nuremberg FAU, D-91054 Erlangen, Germany; [Roers, Axel] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, D-01069 Dresden, Germany; [Rot, Antal; Nourshargh, Sussan] Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, Barts & London Sch Med & Dent, London EC1M 6BQ, England; [Laemmermann, Tim] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany	University of London; Queen Mary University London; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Munich; University of London; Queen Mary University London; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Technische Universitat Dresden; Carl Gustav Carus University Hospital; University of London; Queen Mary University London; Max Planck Society	Nourshargh, S (corresponding author), Queen Mary Univ London, Ctr Microvasc Res, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England.; Nourshargh, S (corresponding author), Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, Barts & London Sch Med & Dent, London EC1M 6BQ, England.	s.nourshargh@qmul.ac.uk	Reglero, Natalia/AAU-2845-2021; Lämmermann, Tim/AAD-7453-2022; Duchene, Johan/AAY-7297-2021; Joulia, Régis/AAX-9773-2021; Rolas, Loic/AAA-6717-2022	Duchene, Johan/0000-0002-3973-0022; Lenn, Yueng Tchern/0000-0002-5827-4616; Barkaway, Anna/0000-0003-4366-0378; , Mathieu-Benoit/0000-0003-3001-0894; Bishop, Cleo/0000-0002-6189-8163; Rolas, Loic/0000-0001-7617-0768; Reglero Real, Natalia/0000-0002-3916-119X; Joulia, Regis/0000-0002-7908-5670	Wellcome Trust [098291/Z/12/Z]; British Heart Foundation [PG/17/85/33395]; People Programme (Marie Curie Actions) of the EU's 7th Framework Programme (FP7/2007-2013) under REA [608765]; Deutsche Forschungsgemeinschaft [SFB1123-A10]	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); People Programme (Marie Curie Actions) of the EU's 7th Framework Programme (FP7/2007-2013) under REA; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by the Wellcome Trust (098291/Z/12/Z to S.N.). Additionally, the study was supported by funds from the British Heart Foundation (PG/17/85/33395 to S.N. R.J. and M.-B.V.), the People Programme (Marie Curie Actions) of the EU's 7th Framework Programme (FP7/2007-2013) under REA grant agreement (n<SUP>o</SUP> 608765) (to L.R., R.J., and S.N.) and the Deutsche Forschungsgemeinschaft SFB1123-A10 (to J.D.). We thank Dr T.J. Williams for critical assessment.	Akbar AN, 2020, SCIENCE, V369, P256, DOI 10.1126/science.abb0762; Aragay AM, 1998, FEBS LETT, V430, P37, DOI 10.1016/S0014-5793(98)00495-5; Asai K, 2001, IMMUNITY, V14, P791, DOI 10.1016/S1074-7613(01)00157-1; Beyrau M, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120134; Brandt EB, 2003, J CLIN INVEST, V112, P1666, DOI 10.1172/JCI19785; Buckley CD, 2006, J LEUKOCYTE BIOL, V79, P303, DOI 10.1189/jlb.0905496; Choudhury SR, 2019, CELL, V178, P1205, DOI 10.1016/j.cell.2019.07.017; Colom B, 2015, IMMUNITY, V42, P1075, DOI 10.1016/j.immuni.2015.05.010; Dawson TC, 2000, BLOOD, V96, P1681, DOI 10.1182/blood.V96.5.1681.h8001681a_1681_1684; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; de Oliveira S, 2016, NAT REV IMMUNOL, V16, P378, DOI 10.1038/nri.2016.49; Duchene J, 2017, NAT IMMUNOL, V18, P753, DOI 10.1038/ni.3763; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Eskan MA, 2012, NAT IMMUNOL, V13, P465, DOI 10.1038/ni.2260; Faust N, 2000, BLOOD, V96, P719; Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Fulop T, 2004, AGING CELL, V3, P217, DOI 10.1111/j.1474-9728.2004.00110.x; Galli SJ, 2020, ANNU REV IMMUNOL, V38, P49, DOI 10.1146/annurev-immunol-071719-094903; Germain RN, 2012, SCIENCE, V336, P1676, DOI 10.1126/science.1221063; Girbl T, 2018, IMMUNITY, V49, P1062, DOI 10.1016/j.immuni.2018.09.018; Gomez CR, 2007, CRIT CARE MED, V35, P246, DOI 10.1097/01.CCM.0000251639.05135.E0; Granton E, 2018, TRENDS IMMUNOL, V39, P890, DOI 10.1016/j.it.2018.09.002; Gunin AG, 2011, J GERONTOL A-BIOL, V66, P385, DOI 10.1093/gerona/glq205; Kalucka J, 2020, CELL, V180, P764, DOI 10.1016/j.cell.2020.01.015; Kienle K, 2016, IMMUNOL REV, V273, P76, DOI 10.1111/imr.12458; Kruger-Krasagakes S, 1999, IMMUNOLOGY, V98, P253; Kular JK, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414557112; Kulkarni U, 2019, MUCOSAL IMMUNOL, V12, P545, DOI 10.1038/s41385-018-0115-3; Labat-Robert J, 2004, AGEING RES REV, V3, P233, DOI 10.1016/j.arr.2003.10.002; Lammermann T, 2019, IMMUNOL REV, V289, P205, DOI 10.1111/imr.12752; Ng LG, 2019, NAT REV IMMUNOL, V19, P255, DOI 10.1038/s41577-019-0141-8; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Minten C, 2014, BRAIN, V137, P1454, DOI 10.1093/brain/awu045; Nemeth T, 2020, NAT REV DRUG DISCOV, V19, P253, DOI 10.1038/s41573-019-0054-z; Nikolich-Zugich J, 2018, NAT IMMUNOL, V19, P10, DOI 10.1038/s41590-017-0006-x; Nomellini V, 2008, J LEUKOCYTE BIOL, V83, P1493, DOI 10.1189/jlb.1007672; Nomellini V, 2012, AGING DIS, V3, P234; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Novitzky-Basso I, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00266; Oki T, 2006, J IMMUNOL, V176, P52, DOI 10.4049/jimmunol.176.1.52; Owen-Woods C, 2020, J CLIN INVEST, V130, P2301, DOI 10.1172/JCI133661; Pilkington SM, 2019, BRIT J DERMATOL, V180, P849, DOI 10.1111/bjd.17268; Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675; Raghuwanshi SK, 2012, J IMMUNOL, V189, P2824, DOI 10.4049/jimmunol.1201114; Robba C, 2020, EXPERT REV RESP MED, V14, P865, DOI 10.1080/17476348.2020.1778470; Sapey E, 2014, BLOOD, V123, P239, DOI 10.1182/blood-2013-08-519520; Scapini P, 2016, IMMUNOL REV, V273, P48, DOI 10.1111/imr.12448; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Siebenhaar F, 2018, TRENDS IMMUNOL, V39, P151, DOI 10.1016/j.it.2017.10.005; Thiriot A, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0381-7; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Wang J, 2017, SCIENCE, V358, P111, DOI 10.1126/science.aam9690; Weninger W, 2014, NAT REV IMMUNOL, V14, P232, DOI 10.1038/nri3641; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Wulfert FM, 2012, ANESTHESIOLOGY, V117, P126, DOI 10.1097/ALN.0b013e31825b57c9	60	23	23	4	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1494	+		10.1016/j.immuni.2021.04.025	http://dx.doi.org/10.1016/j.immuni.2021.04.025		JUL 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34033752	hybrid, Green Submitted, Green Published			2022-12-18	WOS:000672812100014
J	Devi, S; Alexandre, YO; Loi, JK; Gillis, R; Ghazanfari, N; Creed, SJ; Holz, LE; Shackleford, D; Mackay, LK; Heath, WR; Sloan, EK; Mueller, SN				Devi, Sapna; Alexandre, Yannick O.; Loi, Joon Keit; Gillis, Ryan; Ghazanfari, Nazanin; Creed, Sarah J.; Holz, Lauren E.; Shackleford, David; Mackay, Laura K.; Heath, William R.; Sloan, Erica K.; Mueller, Scott N.			Adrenergic regulation of the vasculature impairs leukocyte interstitial migration and suppresses immune responses	IMMUNITY			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; LYMPH-NODES; CHRONIC STRESS; CELL SUBSETS; INNERVATION; MOUSE; REFLEX; PATTERNS; RECEPTOR; MALARIA	The sympathetic nervous system (SNS) controls various physiological functions via the neurotransmitter noradrenaline. Activation of the SNS in response to psychological or physical stress is frequently associated with weakened immunity. Here, we investigated how adrenoceptor signaling influences leukocyte behavior. Intravital two-photon imaging after injection of noradrenaline revealed transient inhibition of CD8(+) and CD4(+) T cell locomotion in tissues. Expression of beta-adrenergic receptor in hematopoietic cells was not required for NA-mediated inhibition of motility. Rather, chemogenetic activation of the SNS or treatment with adrenergic receptor agonists induced vasoconstriction and decreased local blood flow, resulting in abrupt hypoxia that triggered rapid calciumsignaling in leukocytes and halted cellmotility. Oxygen supplementation reversed these effects. Treatmentwith adrenergic receptor agonists impaired T cell responses induced in response to viral and parasitic infections, as well as anti-tumor responses. Thus, stimulation of the SNS impairs leukocyte mobility, providing a mechanistic understanding of the link between adrenergic receptors and compromised immunity.	[Devi, Sapna; Alexandre, Yannick O.; Loi, Joon Keit; Ghazanfari, Nazanin; Holz, Lauren E.; Mackay, Laura K.; Heath, William R.; Mueller, Scott N.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia; [Devi, Sapna; Holz, Lauren E.; Heath, William R.; Mueller, Scott N.] Univ Melbourne, Australian Res Council, Ctr Excellence Adv Mol Imaging, Melbourne, Vic 3000, Australia; [Gillis, Ryan; Creed, Sarah J.; Sloan, Erica K.] Monash Univ, Monash Inst Pharmaceut Sci, Drug Discovery Biol Theme, Parkville, Vic 3052, Australia; [Shackleford, David] Monash Univ, Ctr Drug Candidate Optimisat, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia; [Sloan, Erica K.] Peter MacCallum Canc Ctr, Div Surg, Melbourne, Vic 3000, Australia; [Creed, Sarah J.] Hudson Inst Med Res, Clayton, Vic 3168, Australia	University of Melbourne; University of Melbourne; Monash University; Monash University; Peter Maccallum Cancer Center; Hudson Institute of Medical Research	Mueller, SN (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic 3000, Australia.; Mueller, SN (corresponding author), Univ Melbourne, Australian Res Council, Ctr Excellence Adv Mol Imaging, Melbourne, Vic 3000, Australia.	smue@unimelb.edu.au	Mackay, Laura K/HGC-6580-2022; Mueller, Scott/B-1918-2012	Mackay, Laura K/0000-0002-8496-6632; Heath, William/0000-0001-9670-259X; Mueller, Scott/0000-0002-3838-3989; Creed, Sarah/0000-0003-4744-9924; Loi, Joon Keit/0000-0003-2058-7817; Alexandre, Yannick/0000-0002-6634-4098; Devi, Sapna/0000-0003-4714-6018	National Health and Medical Research Council of Australia [1082450, 1161734, 1154457, 1147498]; Australian Research Council [CE140100011]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	We thank Tsuneyasu Kaisho for the XCR1venus mice; Dorian McGavern, Pamela Schwartzberg, and Tuoqi Wu for the GCaMP6s mice; Virginia Sanders for BALB/c-Adrb2 ~/~ mice; and Francis Carbone, Robin McAllen, John Furness, Roger Summers, Christopher Langmead, Daniel Poole, Michelle Halls, John Haynes, Connie Wong, Aeson Chang, Gavin Lambert, and Stephen Kent for help, advice, and discussions. This work was supported by the National Health and Medical Research Council of Australia (1082450 to S.N.M. and E.K.S., 1161734 to S.N.M., 1154457 to W.R.H., and 1147498 to E.K.S.) and the Australian Research Council (CE140100011 to W.R.H. and S.N.M.).	Abe C, 2017, NAT NEUROSCI, V20, P700, DOI 10.1038/nn.4526; Aley PK, 2005, J BIOL CHEM, V280, P13349, DOI 10.1074/jbc.M413674200; Benschop RJ, 1996, BRAIN BEHAV IMMUN, V10, P77, DOI 10.1006/brbi.1996.0009; Coles RM, 2002, J IMMUNOL, V168, P834, DOI 10.4049/jimmunol.168.2.834; ECKSTEIN JW, 1959, J CLIN INVEST, V38, P342, DOI 10.1172/JCI103807; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; FELTEN DL, 1984, BRAIN RES BULL, V13, P693, DOI 10.1016/0361-9230(84)90230-2; FELTEN DL, 1987, IMMUNOL REV, V100, P225, DOI 10.1111/j.1600-065X.1987.tb00534.x; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Ghazanfari N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02016; Grebe KM, 2009, P NATL ACAD SCI USA, V106, P5300, DOI 10.1073/pnas.0808851106; Hatfield SM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa1260; Hiller JG, 2020, CLIN CANCER RES, V26, P1803, DOI 10.1158/1078-0432.CCR-19-2641; Hor JL, 2015, IMMUNITY, V43, P554, DOI 10.1016/j.immuni.2015.07.020; Huang JH, 2007, J IMMUNOL, V178, P7747, DOI 10.4049/jimmunol.178.12.7747; JAMERSON KA, 1994, HYPERTENSION, V23, P1006, DOI 10.1161/01.HYP.23.6.1006; Jayaprakash P, 2018, J CLIN INVEST, V128, P5137, DOI 10.1172/JCI96268; Kamiya A, 2019, NAT NEUROSCI, V22, P1289, DOI 10.1038/s41593-019-0430-3; Kim JH, 2019, CIRC RES, V125, P874, DOI 10.1161/CIRCRESAHA.119.315005; KIM S, 1989, ARCH ORAL BIOL, V34, P707, DOI 10.1016/0003-9969(89)90077-0; Lammermann T, 2009, CURR OPIN CELL BIOL, V21, P636, DOI 10.1016/j.ceb.2009.05.003; Lau LS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004135; Le CP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10634; Marelli-Berg FM, 2018, J LEUKOCYTE BIOL, V104, P285, DOI 10.1002/JLB.1MR1117-472R; Martelli D, 2014, J PHYSIOL-LONDON, V592, P1677, DOI 10.1113/jphysiol.2013.268573; Michiels C, 2000, BBA-MOL CELL RES, V1497, P1, DOI 10.1016/S0167-4889(00)00041-0; Moriyama S, 2018, SCIENCE, V359, P1056, DOI 10.1126/science.aan4829; Moseman EA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3565; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Mueller SN, 2002, IMMUNOL CELL BIOL, V80, P156, DOI 10.1046/j.1440-1711.2002.01071.x; Negulescu PA, 1996, IMMUNITY, V4, P421, DOI 10.1016/S1074-7613(00)80409-4; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Park SL, 2019, NATURE, V565, P366, DOI 10.1038/s41586-018-0812-9; Pavlov VA, 2018, ANNU REV IMMUNOL, V36, P783, DOI 10.1146/annurev-immunol-042617-053158; Petrova V, 2018, ONCOGENESIS, V7, DOI 10.1038/s41389-017-0011-9; Rios AC, 2019, CANCER CELL, V35, P618, DOI 10.1016/j.ccell.2019.02.010; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Rytelewski M, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0543-y; Savitt JM, 2005, J NEUROSCI, V25, P6721, DOI 10.1523/JNEUROSCI.0760-05.2005; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Segerstrom SC, 2007, CURR DIR PSYCHOL SCI, V16, P326, DOI 10.1111/j.1467-8721.2007.00522.x; Sloan EK, 2007, J NEUROSCI, V27, P8857, DOI 10.1523/JNEUROSCI.1247-07.2007; Stolk RF, 2016, AM J RESP CRIT CARE, V194, P550, DOI 10.1164/rccm.201604-0862CP; Suzuki K, 2016, J EXP MED, V213, P2567, DOI 10.1084/jem.20160723; Triposkiadis F, 2009, J AM COLL CARDIOL, V54, P1747, DOI 10.1016/j.jacc.2009.05.015; VILLARO AC, 1987, AM J ANAT, V179, P175, DOI 10.1002/aja.1001790210; Walker AK, 2019, PSYCHONEUROENDOCRINO, V99, P191, DOI 10.1016/j.psyneuen.2018.09.012; Wang Yarong, 2016, Intravital, V5; WILLIAMS JM, 1981, BRAIN RES BULL, V6, P83, DOI 10.1016/S0361-9230(81)80072-X; Yamazaki C, 2013, J IMMUNOL, V190, P6071, DOI 10.4049/jimmunol.1202798; Zhu H, 2016, GENESIS, V54, P439, DOI 10.1002/dvg.22949	54	23	23	2	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1219	+		10.1016/j.immuni.2021.03.025	http://dx.doi.org/10.1016/j.immuni.2021.03.025		JUN 2021	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	33915109	Bronze			2022-12-18	WOS:000659882900013
J	Delacher, M; Simon, M; Sanderink, L; Hotz-Wagenblatt, A; Wuttke, M; Schambeck, K; Schmidleithner, L; Bittner, S; Pant, A; Ritter, U; Hehlgans, T; Riegel, D; Schneider, V; Groeber-Becker, FK; Eigenberger, A; Gebhard, C; Strieder, N; Fischer, A; Rehli, M; Hoffmann, P; Edinger, M; Strowig, T; Huehn, J; Schmidl, C; Werner, JM; Prantl, L; Brors, B; Imbusch, CD; Feuerer, M				Delacher, Michael; Simon, Malte; Sanderink, Lieke; Hotz-Wagenblatt, Agnes; Wuttke, Marina; Schambeck, Kathrin; Schmidleithner, Lisa; Bittner, Sebastian; Pant, Asmita; Ritter, Uwe; Hehlgans, Thomas; Riegel, Dania; Schneider, Verena; Groeber-Becker, Florian Kai; Eigenberger, Andreas; Gebhard, Claudia; Strieder, Nicholas; Fischer, Alexander; Rehli, Michael; Hoffmann, Petra; Edinger, Matthias; Strowig, Till; Huehn, Jochen; Schmidl, Christian; Werner, Jens M.; Prantl, Lukas; Brors, Benedikt; Imbusch, Charles D.; Feuerer, Markus			Single-cell chromatin accessibility landscape identifies tissue repair program in human regulatory T cells	IMMUNITY			English	Article							GENOME BROWSER; POPULATION; ALIGNMENT; LINEAGE; BATF	Murine regulatory T (Treg) cells in tissues promote tissue homeostasis and regeneration. We sought to identify features that characterize human Treg cells with these functions in healthy tissues. Single-cell chromatin accessibility profiles of murine and human tissue Treg cells defined a conserved, microbiota-independent tissue-repair Treg signature with a prevailing footprint of the transcription factor BATF. This signature, combined with gene expression profiling and TCR fate mapping, identified a population of tissue-like Treg cells in human peripheral blood that expressed BATF, chemokine receptor CCR8 and HLA-DR. Human BATF(+) CCR8(+) Treg cells from normal skin and adipose tissue shared features with nonlymphoid T follicular helper-like (Tfh-like) cells, and induction of a Tfh-like differentiation program in naive human Treg cells partially recapitulated tissue Treg regenerative characteristics, including wound healing potential. Human BATF(+) CCR8(+) Treg cells from healthy tissue share features with tumor-resident Treg cells, highlighting the importance of understanding the context-specific functions of these cells.	[Delacher, Michael; Sanderink, Lieke; Wuttke, Marina; Schambeck, Kathrin; Schmidleithner, Lisa; Bittner, Sebastian; Pant, Asmita; Ritter, Uwe; Hehlgans, Thomas; Riegel, Dania; Gebhard, Claudia; Strieder, Nicholas; Fischer, Alexander; Rehli, Michael; Hoffmann, Petra; Edinger, Matthias; Schmidl, Christian; Feuerer, Markus] Regensburg Ctr Intervent Immunol RCI, Regensburg, Germany; [Delacher, Michael; Sanderink, Lieke; Wuttke, Marina; Schambeck, Kathrin; Schmidleithner, Lisa; Bittner, Sebastian; Pant, Asmita; Ritter, Uwe; Hehlgans, Thomas; Feuerer, Markus] Univ Regensburg, Chair Immunol, D-93053 Regensburg, Germany; [Delacher, Michael] Univ Med Ctr Mainz, Inst Immunol, D-55131 Mainz, Germany; [Delacher, Michael] Univ Med Ctr Mainz, Res Ctr Immunotherapy, D-55131 Mainz, Germany; [Simon, Malte] Heidelberg Univ, Fac Biosci, D-69120 Heidelberg, Germany; [Simon, Malte; Brors, Benedikt; Imbusch, Charles D.] German Canc Res Ctr, Div Appl Bioinformat, D-69120 Heidelberg, Germany; [Hotz-Wagenblatt, Agnes] German Canc Res Ctr, Core Facil Omics IT & Data Management ODCF, D-69120 Heidelberg, Germany; [Schneider, Verena; Groeber-Becker, Florian Kai] Univ Hosp Wurzburg, Dept Tissue Engn & Regenerat Med TERM, D-97070 Wurzburg, Germany; [Schneider, Verena; Groeber-Becker, Florian Kai] Translat Ctr Regenerat Therapies TLZ RT, Fraunhofer Inst Silicate Res ISC, D-97082 Wurzburg, Germany; [Eigenberger, Andreas; Prantl, Lukas] Univ Hosp Regensburg, Dept Plast Hand & Reconstruct Surg, D-93053 Regensburg, Germany; [Fischer, Alexander; Rehli, Michael; Hoffmann, Petra; Edinger, Matthias] Univ Hosp Regensburg, Dept Internal Med 3, D-93053 Regensburg, Germany; [Strowig, Till] Helmholtz Ctr Infect Res, Dept Microbial Immune Regulat, D-38124 Braunschweig, Germany; [Huehn, Jochen] Helmholtz Ctr Infect Res, Dept Expt Immunol, D-38124 Braunschweig, Germany; [Strowig, Till] Hannover Med Sch, D-30625 Hannover, Germany; [Strowig, Till; Huehn, Jochen] Hannover Med Sch, Cluster Excellence 2155, RESIST, D-30625 Hannover, Germany; [Werner, Jens M.] Univ Hosp Regensburg, Dept Surg, D-93053 Regensburg, Germany; [Brors, Benedikt] Natl Ctr Tumor Dis NCT, D-69120 Heidelberg, Germany; [Brors, Benedikt] German Canc Res Ctr, German Canc Consortium DKTK, D-69120 Heidelberg, Germany	University of Regensburg; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Wurzburg; Fraunhofer Gesellschaft; University of Regensburg; University of Regensburg; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Hannover Medical School; University of Regensburg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Feuerer, M (corresponding author), Regensburg Ctr Intervent Immunol RCI, Regensburg, Germany.; Feuerer, M (corresponding author), Univ Regensburg, Chair Immunol, D-93053 Regensburg, Germany.	markus.feuerer@ukr.de	Schmidl, Christian/HDO-6299-2022; Brors, Benedikt/E-5620-2013; Prantl, Lukas/AAM-1848-2021	Schmidl, Christian/0000-0002-0522-202X; Brors, Benedikt/0000-0001-5940-3101; Prantl, Lukas/0000-0003-2454-2499; Simon, Malte/0000-0003-3959-7978; Sanderink, Lieke/0000-0001-9801-343X	European Research Council (ERC-CoG) [648145 REGiREG]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [324392634 -TRR 221, 390874280]	European Research Council (ERC-CoG); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	We thank the RCI NGS core facility and the RCI flow cytometry core for technical support. We thank B. Ruhland, V. Hofmann, H. Stanewsky, J. Raitel, L. Schwarzfischer, U. Ackermann, R. Eder, and I. Fink for technical support and G. K_ublbeck (DKFZ) for help with the BAC construct. We thank C. Klein and C. Mulas for providing BALB-NeuT transgenic mice and S. Hori for Foxp3(huCD2) mice. We thank C. Albert and K.K. Tiltmann (TLZ-RT) for technical support. This work was supported by grants from the European Research Council (ERC-CoG, #648145 REGiREG) to M.F. and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) -Projektnummer 324392634 -TRR 221 to M.F., and under Germany's Excellence Strategy EXC 2155 -Projektnummer 390874280 -to T.S. and J.H.	Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Alvisi G, 2020, J CLIN INVEST, V130, P3137, DOI 10.1172/JCI130426; Arpaia N, 2015, CELL, V162, P1078, DOI 10.1016/j.cell.2015.08.021; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bateman A, 2018, METHODS MOL BIOL, V1806, P3, DOI 10.1007/978-1-4939-8559-3_1; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burzyn D, 2013, CELL, V155, P1282, DOI 10.1016/j.cell.2013.10.054; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Cossarizza A, 2017, EUR J IMMUNOL, V47, P1584, DOI 10.1002/eji.201646632; De Simone M, 2016, IMMUNITY, V45, P1135, DOI 10.1016/j.immuni.2016.10.021; Delacher M, 2020, IMMUNITY, V52, P295, DOI 10.1016/j.immuni.2019.12.002; Delacher M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09276-w; Delacher M, 2017, NAT IMMUNOL, V18, P1160, DOI 10.1038/ni.3799; DiSpirito JR, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat5861; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dombrowski Y, 2017, NAT NEUROSCI, V20, P674, DOI 10.1038/nn.4528; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Dvorak HF, 2015, CANCER IMMUNOL RES, V3, P1, DOI 10.1158/2326-6066.CIR-14-0209; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Groeber F, 2016, TOXICOL IN VITRO, V36, P254, DOI 10.1016/j.tiv.2016.07.008; Groeber F, 2015, PHARM RES-DORDR, V32, P1845, DOI 10.1007/s11095-014-1580-3; Hasan Z, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15628; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Henriksson J, 2019, CELL, V176, P882, DOI 10.1016/j.cell.2018.11.044; Hosseini H, 2016, NATURE, V540, P552, DOI 10.1038/nature20785; Hui SP, 2017, DEV CELL, V43, P659, DOI 10.1016/j.devcel.2017.11.010; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Ito M, 2019, NATURE, V565, P246, DOI 10.1038/s41586-018-0824-5; James KR, 2020, NAT IMMUNOL, V21, P343, DOI 10.1038/s41590-020-0602-z; Jiang HS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-182; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kiesewetter L, 2019, BIOSENS BIOELECTRON, V142, DOI 10.1016/j.bios.2019.111555; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kuhn RM, 2013, BRIEF BIOINFORM, V14, P144, DOI 10.1093/bib/bbs038; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li CR, 2018, CELL, V174, P285, DOI 10.1016/j.cell.2018.05.004; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Pliner HA, 2018, MOL CELL, V71, P858, DOI 10.1016/j.molcel.2018.06.044; Plitas G, 2016, IMMUNITY, V45, P1122, DOI 10.1016/j.immuni.2016.10.032; Pope BD, 2014, NATURE, V515, P402, DOI 10.1038/nature13986; Povoleri GAM, 2018, NAT IMMUNOL, V19, P1403, DOI 10.1038/s41590-018-0230-z; Qin L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01884; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sakaguchi S, 2020, ANNU REV IMMUNOL, V38, P541, DOI 10.1146/annurev-immunol-042718-041717; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Schiering C, 2014, NATURE, V513, P564, DOI 10.1038/nature13577; Schmid M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139866; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Sheffield NC, 2016, BIOINFORMATICS, V32, P587, DOI 10.1093/bioinformatics/btv612; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sundaram GM, 2018, FEBS J, V285, P4516, DOI 10.1111/febs.14586; Szabo PA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12464-3; Tanaka A, 2017, CELL RES, V27, P109, DOI 10.1038/cr.2016.151; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Vasanthakumar A, 2015, NAT IMMUNOL, V16, P276, DOI 10.1038/ni.3085; Wang L, 2019, NAT IMMUNOL, V20, P1220, DOI 10.1038/s41590-019-0429-7; Wu D, 2019, EUR J IMMUNOL, V49, P336, DOI 10.1002/eji.201847570	72	23	23	7	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					702	+		10.1016/j.immuni.2021.03.007	http://dx.doi.org/10.1016/j.immuni.2021.03.007		APR 2021	36	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33789089	Green Published, hybrid			2022-12-18	WOS:000640102800012
J	Ehx, G; Larouche, JD; Durette, C; Laverdure, JP; Hesnard, L; Vincent, K; Hardy, MP; Theriault, C; Rulleau, C; Lanoix, J; Bonneil, E; Feghaly, A; Apavaloaei, A; Noronha, N; Laumont, CM; Delisle, JS; Vago, L; Hebert, J; Sauvageau, G; Lemieux, S; Thibault, P; Perreault, C				Ehx, Gregory; Larouche, Jean-David; Durette, Chantal; Laverdure, Jean-Philippe; Hesnard, Leslie; Vincent, Krystel; Hardy, Marie-Pierre; Theriault, Catherine; Rulleau, Caroline; Lanoix, Joel; Bonneil, Eric; Feghaly, Albert; Apavaloaei, Anca; Noronha, Nandita; Laumont, Celine M.; Delisle, Jean-Sebastien; Vago, Luca; Hebert, Josee; Sauvageau, Guy; Lemieux, Sebastien; Thibault, Pierre; Perreault, Claude			Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes	IMMUNITY			English	Article							COSTIMULATORY MOLECULES; T-CELLS; EXPRESSION; MUTATIONS; PREDICTION; CLASSIFICATION; IMMUNOTHERAPY; INTERROGATION; HETEROGENEITY; METHYLATION	Acute myeloid leukemia (AML) has not benefited from innovative immunotherapies, mainly because of the lack of actionable immune targets. Using an original proteogenomic approach, we analyzed the major histocompatibility complex class I (MHC class I)-associated immunopeptidome of 19 primary AML samples and identified 58 tumor-specific antigens (TSAs). These TSAs bore no mutations and derived mainly (86%) from supposedly non-coding genomic regions. Two AML-specific aberrations were instrumental in the biogenesis of TSAs, intron retention, and epigenetic changes. Indeed, 48% of TSAs resulted from intron retention and translation, and their RNA expression correlated with mutations of epigenetic modifiers (e.g., DNMT3A). AML TSA-coding transcripts were highly shared among patients and were expressed in both blasts and leukemic stem cells. In AML patients, the predicted number of TSAs correlated with spontaneous expansion of cognate T cell receptor clonotypes, accumulation of activated cytotoxic T cells, immunoediting, and improved survival. These TSAs represent attractive targets for AML immunotherapy.	[Ehx, Gregory; Larouche, Jean-David; Durette, Chantal; Laverdure, Jean-Philippe; Hesnard, Leslie; Vincent, Krystel; Hardy, Marie-Pierre; Theriault, Catherine; Lanoix, Joel; Bonneil, Eric; Feghaly, Albert; Apavaloaei, Anca; Noronha, Nandita; Laumont, Celine M.; Hebert, Josee; Sauvageau, Guy; Lemieux, Sebastien; Thibault, Pierre; Perreault, Claude] Univ Montreal, Inst Res Immunol & Canc IRIC, Montreal, PQ H3C 3J7, Canada; [Ehx, Gregory; Larouche, Jean-David; Hesnard, Leslie; Vincent, Krystel; Apavaloaei, Anca; Noronha, Nandita; Laumont, Celine M.; Delisle, Jean-Sebastien; Hebert, Josee; Sauvageau, Guy; Perreault, Claude] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; [Rulleau, Caroline; Delisle, Jean-Sebastien] Ctr Rech Hop Maisonneuve Rosemt, Montreal, PQ, Canada; [Delisle, Jean-Sebastien; Hebert, Josee; Sauvageau, Guy] Maisonneuve Rosemont Hosp, Div Hematol, Montreal, PQ H1T 2M4, Canada; [Vago, Luca] IRCCS San Raffaele Sci Inst, Unit Immunogenet, Leukemia Genom & Immunobiol, Milan, Italy; [Lemieux, Sebastien] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ H3C 3J7, Canada; [Thibault, Pierre] Univ Montreal, Dept Chem, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universite de Montreal; Universite de Montreal	Thibault, P; Perreault, C (corresponding author), Univ Montreal, Inst Res Immunol & Canc IRIC, Montreal, PQ H3C 3J7, Canada.; Perreault, C (corresponding author), Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada.	pierre.thibault@umontreal.ca; claude.perreault@umontreal.ca	Perreault, Claude/A-7220-2008; Ehx, Gregory/AAH-1706-2021	Perreault, Claude/0000-0001-9453-7383; Vincent, Krystel/0000-0001-6180-5345; Hesnard, Leslie/0000-0002-4623-7703; Laverdure, Jean-Philippe/0000-0002-9245-6413; Delisle, Jean-Sebastien/0000-0003-1460-7287; Ehx, Gregory/0000-0002-7018-1770; Apavaloaei, Anca/0000-0001-6896-1199; Hardy, Marie-Pierre/0000-0003-1316-6483; Larouche, Jean-David/0000-0003-3056-0714; Sauvageau, Guy/0000-0002-4333-7266; Feghaly, Albert/0000-0001-7929-415X	Canadian Cancer Society [705604]; AbbVie; Leukemia and Lymphoma Society of Canada; Oncopole; IRIC; FRQS; Cole Foundation; Canadian Government through Genome Canada; Cancer Research Network of the Fonds de Recherche du Quebec -Sante (FRQS); Common Fund of the Office of the Director of the National Institutes of Health; NCI; NHGRI; NHLBI; NIDA; NIMH; NINDS	Canadian Cancer Society(Canadian Cancer Society (CCS)); AbbVie(AbbVie); Leukemia and Lymphoma Society of Canada; Oncopole; IRIC; FRQS; Cole Foundation; Canadian Government through Genome Canada; Cancer Research Network of the Fonds de Recherche du Quebec -Sante (FRQS); Common Fund of the Office of the Director of the National Institutes of Health; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from the Canadian Cancer Society (705604) and AbbVie to C.P. and P.T.; a grant from the Leukemia and Lymphoma Society of Canada to C.P.; and a grant from The Oncopole to C.P., P.T., J.-S.D., and S.L. G.E. is supported by postdoctoral fellowships from the IRIC, the FRQS, and the Cole Foundation. We thank Raphaelle Lambert, Jennifer Huber, and the IRIC genomics facility for RNA-seq and Pascal Benoit for administrative support. We thank Patrick Gendron, Eric Audemard, and Genevieve Boucher of the IRIC bioinformatic platform for assistance with RNA-seq analysis. We also thank Adeline Deward (GIGA, University of Liege) for the design of our graphical abstract. The IRIC proteomics facility is a Genomics Technology platform funded in part by the Canadian Government through Genome Canada. We acknowledge the work of Claude Rondeau and all members of the Banque de Cellules Leucemiques du Quebec (BCLQ). The BCLQ is supported by grants from the Cancer Research Network of the Fonds de Recherche du Quebec -Sante (FRQS) to J.H. We also thank Amina Dahmani and Cedric Carli for T cell cultures. We thank the GenotypeTissue Expression (GTEx) Project for providing RNA-seq data. The GTEx Project was supported by the Common Fund of the Office of the Director of the National Institutes of Health and by the NCI, NHGRI, NHLBI, NIDA, NIMH, and NINDS.	Adamopoulou E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3039; Audemard EO, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900336; Audoux J, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1372-2; Avigan D, 2018, BLOOD, V131, P2640, DOI 10.1182/blood-2017-11-785873; Bamezai S, 2012, STEM CELLS, V30, P2603, DOI 10.1002/stem.1237; Berlin C, 2015, LEUKEMIA, V29, P647, DOI 10.1038/leu.2014.233; Boegel S, 2018, BMC MED GENOMICS, V11, DOI 10.1186/s12920-018-0354-x; Bouwmeester R, 2020, BIORXIV; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Chapuis AG, 2019, NAT MED, V25, P1064, DOI 10.1038/s41591-019-0472-9; Charni S, 2010, J IMMUNOL, V185, P3498, DOI 10.4049/jimmunol.1001250; Chen J, 2020, SCIENCE, V367, P1140, DOI 10.1126/science.aay0262; Chong CE, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14968-9; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cosma GL, 2019, MOL IMMUNOL, V113, P120, DOI 10.1016/j.molimm.2019.03.010; Coulie PG, 2014, NAT REV CANCER, V14, P135, DOI 10.1038/nrc3670; Courcelles M, 2020, J PROTEOME RES, V19, P1873, DOI 10.1021/acs.jproteome.9b00859; Danilova L, 2018, CANCER IMMUNOL RES, V6, P888, DOI 10.1158/2326-6066.CIR-18-0129; Daouda Tariq, 2016, F1000Res, V5, P381; Di Stasi A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00036; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dutoit V, 2002, J EXP MED, V196, P207, DOI 10.1084/jem.20020242; Dvinge H, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0168-9; Efremova M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01679; Egen JG, 2020, IMMUNITY, V52, P36, DOI 10.1016/j.immuni.2019.12.010; Ehx G, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0642-x; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Eng JK, 2015, J AM SOC MASS SPECTR, V26, P1865, DOI 10.1007/s13361-015-1179-x; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fennell KA, 2019, BLOOD, V134, P1891, DOI 10.1182/blood.2019003262; Fergusson JR, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02902; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Figueroa ME, 2010, CANCER CELL, V17, P13, DOI 10.1016/j.ccr.2009.11.020; Garrison E., 2012, HAPLOTYPE BASED VARI; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Greiner J, 2017, HAEMATOLOGICA, V102, P499, DOI 10.3324/haematol.2017.176461; Gu MX, 2020, HAEMATOLOGICA, V105, pE290, DOI 10.3324/haematol.2019.230821; Gutierrez SE, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-57; Hardy MP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02934; He H, 2020, LEUKEMIA, V34, P1626, DOI 10.1038/s41375-019-0698-z; Hesnard L, 2016, EUR J IMMUNOL, V46, P560, DOI 10.1002/eji.201545951; Janelle V, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0495-z; Jung N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9489; Knaus HA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.120974; Krokhin OV, 2006, ANAL CHEM, V78, P7785, DOI 10.1021/ac060777w; Lagus H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53874-z; Lamoliatte F, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14109; Larouche JD, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00740-7; Laumont CM, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau5516; Laumont CM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10238; Lavallee VP, 2016, BLOOD, V127, P3054, DOI 10.1182/blood-2016-03-705053; Lavallee VP, 2016, BLOOD, V127, P2498, DOI 10.1182/blood-2016-03-703868; Lavallee VP, 2015, NAT GENET, V47, P1030, DOI 10.1038/ng.3371; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Legat A, 2016, CLIN CANCER RES, V22, P1330, DOI 10.1158/1078-0432.CCR-15-1212; Lewinsky H, 2018, J CLIN INVEST, V128, P5465, DOI 10.1172/JCI96610; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li B, 2017, NAT GENET, V49, P482, DOI 10.1038/ng.3820; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li S, 2016, NAT MED, V22, P792, DOI 10.1038/nm.4125; Liu L, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.526; Loffler MW, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0636-8; Logtenberg MEW, 2020, IMMUNITY, V52, P742, DOI 10.1016/j.immuni.2020.04.011; Luo KT, 2006, GENE, V367, P89, DOI 10.1016/j.gene.2005.09.023; Araujo GDM, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00036; MacRae T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072884; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Maiga A, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.36; Maiga A., 2016, BIOINFORMATICS; Marcais G, 2011, BIOINFORMATICS, V27, P764, DOI 10.1093/bioinformatics/btr011; Maslak PG, 2018, BLOOD ADV, V2, P224, DOI 10.1182/bloodadvances.2017014175; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Middleton R, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1184-4; Noronha N, 2020, INT J CANCER, V147, P2000, DOI 10.1002/ijc.32967; Ntziachristos P, 2016, NAT IMMUNOL, V17, P1016, DOI 10.1038/ni.3517; Ogishi M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00827; Pabst C, 2016, BLOOD, V127, P2018, DOI 10.1182/blood-2015-11-683649; Papaemmanuil E, 2016, NEW ENGL J MED, V374, P2209, DOI 10.1056/NEJMoa1516192; Pearson H, 2016, J CLIN INVEST, V126, P4690, DOI 10.1172/JCI88590; Qazilbash MH, 2017, LEUKEMIA, V31, P697, DOI 10.1038/leu.2016.254; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rashidi A, 2016, EXPERT REV HEMATOL, V9, P335, DOI 10.1586/17474086.2016.1142868; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rogers MF, 2018, BIOINFORMATICS, V34, P511, DOI 10.1093/bioinformatics/btx536; Sarkizova S, 2020, NAT BIOTECHNOL, V38, P199, DOI 10.1038/s41587-019-0322-9; Schulz WA, 2006, CURR TOP MICROBIOL, V310, P211; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shao WG, 2018, NUCLEIC ACIDS RES, V46, pD1237, DOI 10.1093/nar/gkx664; Shlush LI, 2017, NATURE, V547, P104, DOI 10.1038/nature22993; Smart AC, 2018, NAT BIOTECHNOL, V36, P1056, DOI 10.1038/nbt.4239; Smith CC, 2019, NAT REV CANCER, V19, P465, DOI 10.1038/s41568-019-0162-4; Springer I, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01803; Szolek A, 2014, BIOINFORMATICS, V30, P3310, DOI 10.1093/bioinformatics/btu548; Takahashi N, 2019, GENE DEV, V33, P49, DOI 10.1101/gad.320069.118; Tamura H, 2005, CLIN CANCER RES, V11, P5708, DOI 10.1158/1078-0432.CCR-04-2672; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; Thomsen M, 2013, IMMUNOGENETICS, V65, P655, DOI 10.1007/s00251-013-0714-9; Toffalori C, 2019, NAT MED, V25, P603, DOI 10.1038/s41591-019-0400-z; Tripathi SC, 2016, P NATL ACAD SCI USA, V113, pE1555, DOI 10.1073/pnas.1521812113; van der Lee DI, 2019, J CLIN INVEST, V129, P774, DOI 10.1172/JCI97482; Vasu S, 2018, BLOOD ADV, V2, P1645, DOI 10.1182/bloodadvances.2017015222; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang E, 2019, CANCER CELL, V35, P369, DOI 10.1016/j.ccell.2019.01.010; Wang Q, 2019, CANCER LETT, V444, P9, DOI 10.1016/j.canlet.2018.11.024; Whiteway A, 2003, BRIT J HAEMATOL, V120, P442, DOI 10.1046/j.1365-2141.2003.04085.x; Wilson CS, 2006, BLOOD, V108, P685, DOI 10.1182/blood-2004-12-4633; Wolfl M, 2014, NAT PROTOC, V9, P950, DOI 10.1038/nprot.2014.064; Wong JJL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15134; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yang LB, 2015, NAT REV CANCER, V15, P152, DOI 10.1038/nrc3895; Yang XJ, 2018, LEUKEMIA, V32, P1587, DOI 10.1038/s41375-018-0010-7; Zhang J, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0681-3; Zhang X, 2015, IUBMB LIFE, V67, P77, DOI 10.1002/iub.1351; Zhao QC, 2020, CANCER IMMUNOL RES, V8, P544, DOI 10.1158/2326-6066.CIR-19-0541; Zhi H, 2014, NUCLEIC ACIDS RES, V42, P8258, DOI 10.1093/nar/gku575; Zhou Jianbiao, 2017, Stem Cell Investig, V4, P6, DOI 10.21037/sci.2017.01.06; Zhou YP, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-123	120	23	23	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					737	+		10.1016/j.immuni.2021.03.001	http://dx.doi.org/10.1016/j.immuni.2021.03.001		APR 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33740418	Bronze			2022-12-18	WOS:000640102800014
J	Roth, S; Cao, JY; Singh, V; Tiedt, S; Hundeshagen, G; Li, T; Boehme, JD; Chauhan, D; Zhu, J; Ricci, A; Gorka, O; Asare, Y; Yang, J; Lopez, MS; Rehberg, M; Bruder, D; Zhang, SX; Gross, O; Dichgans, M; Hornung, V; Liesz, A				Roth, Stefan; Cao, Jiayu; Singh, Vikramjeet; Tiedt, Steffen; Hundeshagen, Gabriel; Li, Ting; Boehme, Julia D.; Chauhan, Dhruv; Zhu, Jie; Ricci, Alessio; Gorka, Oliver; Asare, Yaw; Yang, Jun; Lopez, Mary S.; Rehberg, Markus; Bruder, Dunja; Zhang, Shengxiang; Gross, Olaf; Dichgans, Martin; Hornung, Veit; Liesz, Arthur			Post-injury immunosuppression and secondary infections are caused by an AIM2 inflammasome-driven signaling cascade	IMMUNITY			English	Article							TYROSINE KINASE-3 LIGAND; INDUCED IMMUNODEFICIENCY; IMMUNE-RESPONSE; NERVOUS-SYSTEM; BURN INJURY; ACTIVATION; DEATH; ASC; IMMUNODEPRESSION; EXPRESSION	Loss of lymphocytes, particularly T cell apoptosis, is a central pathological event after severe tissue injury that is associated with increased susceptibility for life-threatening infections. The precise immunological mechanisms leading to T cell death after acute injury are largely unknown. Here, we identified a monocyte-T cell interaction driving bystander cell death of T cells in ischemic stroke and burn injury. Specifically, we found that stroke induced a FasL-expressing monocyte population, which led to extrinsic T cell apoptosis. This phenomenon was driven by AIM2 inflammasome-dependent interleukin-1 beta (IL-1 beta) secretion after sensing cell-free DNA. Pharmacological inhibition of this pathway improved T cell survival and reduced post-stroke bacterial infections. As such, this study describes inflammasome-dependent monocyte activation as a previously unstudied cause of T cell death after injury and challenges the current paradigms of post-injury lymphopenia.	[Roth, Stefan; Cao, Jiayu; Singh, Vikramjeet; Tiedt, Steffen; Zhu, Jie; Ricci, Alessio; Asare, Yaw; Yang, Jun; Lopez, Mary S.; Rehberg, Markus; Dichgans, Martin; Liesz, Arthur] Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Stroke & Dementia Res ISD, Munich, Germany; [Tiedt, Steffen; Dichgans, Martin; Liesz, Arthur] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Hundeshagen, Gabriel] Heidelberg Univ, Burn Ctr, BG Trauma Ctr Ludwigshafen, Dept Hand Plast & Reconstruct Surg, Ludwigshafen, Germany; [Li, Ting; Zhang, Shengxiang] Lanzhou Univ, Sch Life Sci, Gansu Key Lab Biomonitoring & Bioremediat Environ, Lanzhou, Peoples R China; [Boehme, Julia D.; Bruder, Dunja] Helmholtz Ctr Infect Res, Immune Regulat, Braunschweig, Germany; [Boehme, Julia D.; Bruder, Dunja] Otto von Guericke Univ, Infect Immunol, Inst Med Microbiol Infect Control & Prevent, Hlth Campus Immunol Infectiol & Inflammat, Magdeburg, Germany; [Chauhan, Dhruv; Hornung, Veit] Ludwig Maximilians Univ Munchen, Gene Ctr, Munich, Germany; [Chauhan, Dhruv; Hornung, Veit] Ludwig Maximilians Univ Munchen, Dept Biochem, Munich, Germany; [Gorka, Oliver; Gross, Olaf] Univ Freiburg, Med Ctr, Inst Neuropathol, Freiburg, Germany; [Gross, Olaf] Signalling Res Ctr BIOSS & CIBSS, Freiburg, Germany; [Gross, Olaf] Ctr Basics NeuroModulat NeuroModulBasics, Freiburg, Germany	University of Munich; University of Munich; Ruprecht Karls University Heidelberg; Lanzhou University; Helmholtz Association; Helmholtz-Center for Infection Research; Otto von Guericke University; University of Munich; University of Munich; University of Freiburg	Liesz, A (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp, Inst Stroke & Dementia Res ISD, Munich, Germany.; Liesz, A (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.	arthur.liesz@med.uni-muenchen.de	Liesz, Arthur/AAT-7147-2021; Boehme, Julia/AAP-1197-2021; Dichgans, Martin/HCH-3247-2022; Asare, Yaw/AAY-1626-2021; Singh, Vikramjeet/E-4397-2013; Gross, Olaf/E-4570-2010	Liesz, Arthur/0000-0002-9069-2594; Boehme, Julia/0000-0002-6257-0952; Dichgans, Martin/0000-0002-0654-387X; Asare, Yaw/0000-0002-8946-5650; Singh, Vikramjeet/0000-0003-0287-7554; Gross, Olaf/0000-0001-8660-3619; Rehberg, Markus/0000-0001-7314-6332; Gorka, Oliver/0000-0002-8245-3008; Singh, Vikramjeet/0000-0002-7361-8317	Vascular Dementia Research Foundation; European Research Council [ERC-StGs 802305, 337689, ERC-CoG 647858]; National Natural Science Foundation of China [31600831, 81771324]; German Research Foundation (DFG) [EXC 2145, 390857198, EXC 390939984, 390939984, SFB 1160, SFB/TRR 167, SFB 1425, GRK 2606, FOR 2879, SFB TRR 274, LI-2534/2-1, LI-2534/5-1, HO-2783/9-1]	Vascular Dementia Research Foundation; European Research Council(European Research Council (ERC)European Commission); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); German Research Foundation (DFG)(German Research Foundation (DFG))	The authors thank Kerstin Thu beta-Silczak for technical support and Daniela Maurer for help in immunoblotting. The authors are grateful to Eicke Latz (Institute of Innate Immunity, University Bonn, Germany) for providing Aim2-/-mice. We acknowledge the Core Facility Flow Cytometry at the Biomedical Center, Ludwig-Maximilians-Universitat Munchen, for providing equipment, services, and expertise. This work was funded by the Vascular Dementia Research Foundation, the European Research Council (ERC-StGs 802305 to A.L., 337689 to O.G., and ERC-CoG 647858 to V.H.), the National Natural Science Foundation of China (31600831 and 81771324), and the German Research Foundation (DFG) under Germany's Excellence Strategy (EXC 2145, SyNergy ID 390857198, and EXC 390939984, CIBSS ID 390939984) through SFB 1160, SFB/TRR 167, SFB 1425, GRK 2606, FOR 2879, and SFB TRR 274 and under grants LI-2534/2-1, LI-2534/5-1, and HO-2783/9-1.	Ayasoufi K, 2020, BRAIN, V143, P3629, DOI 10.1093/brain/awaa343; BARLOW Y, 1994, BURNS, V20, P487, DOI 10.1016/0305-4179(94)90002-7; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bohannon J, 2008, J IMMUNOL, V180, P3038, DOI 10.4049/jimmunol.180.5.3038; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Brinkman W, 2014, JAMA INTERN MED, V174, P1320, DOI 10.1001/jamainternmed.2014.2356; Chamorro A, 2012, NAT REV NEUROL, V8, P401, DOI 10.1038/nrneurol.2012.98; D'Avignon LC, 2010, BURNS, V36, P773, DOI 10.1016/j.burns.2009.11.007; Denes A, 2015, P NATL ACAD SCI USA, V112, P4050, DOI 10.1073/pnas.1419090112; Dockrell DH, 1998, J CLIN INVEST, V101, P2394, DOI 10.1172/JCI1171; Drexler SK, 2012, P NATL ACAD SCI USA, V109, P18384, DOI 10.1073/pnas.1209171109; Fas SC, 2006, CURR DIRECT AUTOIMMU, V9, P1; Finnerty CC, 2006, SHOCK, V26, P13, DOI 10.1097/01.shk.0000223120.26394.7d; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Girardot T, 2017, APOPTOSIS, V22, P295, DOI 10.1007/s10495-016-1325-3; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Huang HW, 2013, NEUROIMMUNOMODULAT, V20, P1, DOI 10.1159/000343099; Hundeshagen G, 2018, SHOCK, V49, P721, DOI 10.1097/SHK.0000000000000964; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kimmelman J, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001863; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; KRAMMER PH, 1994, CURR OPIN IMMUNOL, V6, P279, DOI 10.1016/0952-7915(94)90102-3; Kroemer G, 2013, ANNU REV IMMUNOL, V31, P51, DOI 10.1146/annurev-immunol-032712-100008; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Li T, 2013, BRAIN, V136, P3578, DOI 10.1093/brain/awt287; Li-Weber M, 2003, SEMIN IMMUNOL, V15, P145, DOI 10.1016/S1044-5323(03)00030-7; Liesz A, 2015, J NEUROSCI, V35, P583, DOI 10.1523/JNEUROSCI.2439-14.2015; Liesz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074839; Liesz A, 2009, STROKE, V40, P2849, DOI 10.1161/STROKEAHA.109.549618; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Llovera G, 2016, J NEUROCHEM, V139, P271, DOI 10.1111/jnc.13516; Llovera G, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa9853; Loftus TJ, 2016, SHOCK, V46, P341, DOI 10.1097/SHK.0000000000000636; Lord JM, 2014, LANCET, V384, P1455, DOI 10.1016/S0140-6736(14)60687-5; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meisel C, 2011, NEW ENGL J MED, V365, P2134, DOI 10.1056/NEJMcibr1112454; Mracsko E, 2014, BRAIN BEHAV IMMUN, V41, P200, DOI 10.1016/j.bbi.2014.05.015; Norbury WB, 2008, J CLIN ENDOCR METAB, V93, P1270, DOI 10.1210/jc.2006-2158; Ormstad H, 2011, J NEUROL, V258, P677, DOI 10.1007/s00415-011-6006-0; Panahi M, 2018, CARDIOVASC RES, V114, P1445, DOI 10.1093/cvr/cvy145; Poh L, 2019, BRAIN BEHAV IMMUN, V75, P34, DOI 10.1016/j.bbi.2018.09.001; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Pruss H, 2017, NAT NEUROSCI, V20, P1549, DOI 10.1038/nn.4643; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rubio I, 2019, LANCET INFECT DIS, V19, pE422, DOI 10.1016/S1473-3099(19)30567-5; Singh V, 2018, J CEREBR BLOOD F MET, V38, P1293, DOI 10.1177/0271678X18780130; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Toliver-Kinsky TE, 2005, J IMMUNOL, V174, P404, DOI 10.4049/jimmunol.174.1.404; Tzeng TC, 2016, CELL REP, V16, P571, DOI 10.1016/j.celrep.2016.06.011; VanderWeele TJ, 2010, AM J EPIDEMIOL, V172, P1339, DOI 10.1093/aje/kwq332; Westendorp WF, 2016, CEREBROVASC DIS, V42, P506, DOI 10.1159/000450926; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Wu T, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01331	58	23	23	3	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					648	+		10.1016/j.immuni.2021.02.004	http://dx.doi.org/10.1016/j.immuni.2021.02.004		APR 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33667383	Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000640102800008
J	Chopp, LB; Gopalan, V; Ciucci, T; Ruchinskas, A; Rae, Z; Lagarde, M; Gao, YY; Li, CY; Bosticardo, M; Pala, F; Livak, F; Kelly, MC; Hannenhalli, S; Bosselut, R				Chopp, Laura B.; Gopalan, Vishaka; Ciucci, Thomas; Ruchinskas, Allison; Rae, Zachary; Lagarde, Manon; Gao, Yayi; Li, Caiyi; Bosticardo, Marita; Pala, Francesca; Livak, Ferenc; Kelly, Michael C.; Hannenhalli, Sridhar; Bosselut, Remy			An Integrated Epigenomic and Transcriptomic Map of Mouse and Human alpha beta T Cell Development	IMMUNITY			English	Article							NEGATIVE SELECTION; LINEAGE FATE; HELPER T; SIGNAL STRENGTH; READ ALIGNMENT; RUNX PROTEINS; TCR SIGNALS; CD4; DIFFERENTIATION; EXPRESSION	alpha beta lineage T cells, most of which are CD4(+) or CD8(+) and recognize MHC I- or MHC II-presented antigens, are essential for immune responses and develop from CD4(+) CD8(+) thymocytes. The absence of in vitro models and the heterogeneity of alpha beta thymocytes have hampered analyses of their intrathymic differentiation. Here, combining single-cell RNA and ATAC (chromatin accessibility) sequencing, we identified mouse and human cep thymocyte developmental trajectories, We demonstrated asymmetric emergence of CD4(+) and CD8(+) lineages, matched differentiation programs of agonist-signaled cells to their MHC specificity, and identified correspondences between mouse and human transcriptomic and epigenomic patterns. Through computational analysis of single-cell data and binding sites for the CD4(+) -lineage transcription factor Thpok, we inferred transcriptional networks associated with CD4(+) - or CD8(+) -lineage differentiation, and with expression of Thpok or of the CD8(+)-lineage factor Runx3. Our findings provide insight into the mechanisms of CD4(+) and CD8(+) T cell differentiation and a foundation for mechanistic investigations of ocI T cell development.	[Chopp, Laura B.; Ciucci, Thomas; Lagarde, Manon; Gao, Yayi; Bosselut, Remy] NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Chopp, Laura B.] Univ Penn, Sch Med, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Gopalan, Vishaka; Hannenhalli, Sridhar] NCI, Canc Data Sci Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Ruchinskas, Allison; Rae, Zachary; Kelly, Michael C.] Frederick Natl Lab Canc Res, Canc Res Technol Program, Single Cell Anal Facil, Bethesda, MD USA; [Li, Caiyi; Livak, Ferenc] NCI, Lab Genom Integr, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Bosticardo, Marita; Pala, Francesca] NIAID, Lab Clin Immunol & Microbiol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bosselut, R (corresponding author), NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	bosselur@nih.gov	Bosticardo, Marita/ABA-2688-2021	Bosticardo, Marita/0000-0002-1771-4523; Chopp, Laura/0000-0001-6494-4439; Ruchinskas, Allison/0000-0002-8412-1082; Datta, Vishaka/0000-0002-5582-3130; Pala, Francesca/0000-0003-4537-9061	CCR Single Cell Analysis Facility - Frederick National Laboratory for Cancer Research (FNLCR) [HHSN261200800001E]; National Cancer Institute,Center for Cancer Research, NIH; National Science Foundation (NSF) fellowship	CCR Single Cell Analysis Facility - Frederick National Laboratory for Cancer Research (FNLCR); National Cancer Institute,Center for Cancer Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Science Foundation (NSF) fellowship(National Science Foundation (NSF))	We thank J. Paiano, A. Stanlie, and A. Nussenzweig for assistance with ChIPseq experiments; Q. Xiao, M. Balmaceno-Criss, and H. Kwak for expert animal care and genotyping; L. Notarangelo for guidance with patient samples; A. Bhandoola, B. Larsen, J. O'Shea, H.-Y. Shih, T. Stuart, and M. Taves for useful discussions; Y. Zhao, the CCR Flow Cytometry Core, and the NIH high-performance computing cluster staff for assistance; J. Ashwell, M. BalmacenoCriss, A. Bhandoola, V. Lazarevic, P. Love, L. Notarangelo, H.-Y. Shih, and M. Vacchio for reading the manuscript; and D. Goldstein, M. Malik, and the NCI Office of Science and Technology Resources for their support. Support from the CCR Single Cell Analysis Facility was funded by Frederick National Laboratory for Cancer Research (FNLCR) contract HHSN261200800001E. Sequencing was performed with the CCR Genomics Core or FNLCR CCR Sequencing Facility. This work used the NIH high-performance computing cluster. This work was supported by the Intramural Research Program of the National Cancer Institute,Center for Cancer Research, NIH, and by a National Science Foundation (NSF) fellowship to L.B.C.	Adoro S, 2012, EMBO J, V31, P366, DOI 10.1038/emboj.2011.388; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Au-Yeung BB, 2014, NAT IMMUNOL, V15, P687, DOI 10.1038/ni.2918; Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Canela A, 2019, MOL CELL, V75, P252, DOI 10.1016/j.molcel.2019.04.030; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Carpenter AC, 2012, IMMUNITY, V37, P622, DOI 10.1016/j.immuni.2012.06.019; Carpenter AC, 2010, NAT IMMUNOL, V11, P666, DOI 10.1038/ni.1887; Chung W, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15081; Ciucci T, 2019, IMMUNITY, V50, P91, DOI 10.1016/j.immuni.2018.12.019; Collins A, 2009, NAT REV IMMUNOL, V9, P106, DOI 10.1038/nri2489; Costello PS, 2004, NAT IMMUNOL, V5, P289, DOI 10.1038/ni1038; Cowan JE, 2013, J EXP MED, V210, P675, DOI 10.1084/jem.20122070; Daley SR, 2013, J EXP MED, V210, P269, DOI 10.1084/jem.20121458; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Driegen S, 2005, TRANSGENIC RES, V14, P477, DOI 10.1007/s11248-005-7220-2; Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hemmers S, 2019, J EXP MED, V216, P2466, DOI 10.1084/jem.20190993; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Hojo MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10525-1; Jones-Mason ME, 2012, IMMUNITY, V36, P348, DOI 10.1016/j.immuni.2012.02.010; Kakugawa K, 2017, CELL REP, V19, P1176, DOI 10.1016/j.celrep.2017.04.038; Kamimoto K., 2020, BIORXIV, DOI [10. 1101/2020.02.17.947416, DOI 10.1101/2020.02.17.947416, 10.1101/2020.02.17.947416]; Kee BL, 2009, NAT REV IMMUNOL, V9, P175, DOI 10.1038/nri2507; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kernfeld EM, 2018, IMMUNITY, V48, P1258, DOI 10.1016/j.immuni.2018.04.015; Kojo S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00768-1; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kwan J, 2004, J IMMUNOL, V172, P3999, DOI 10.4049/jimmunol.172.7.3999; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lavaert M, 2020, IMMUNITY, V52, P1088, DOI 10.1016/j.immuni.2020.03.019; Le J, 2020, IMMUNITY, V52, P1105, DOI 10.1016/j.immuni.2020.05.010; Lee HM, 2009, J IMMUNOL, V183, P2261, DOI 10.4049/jimmunol.0901304; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Liu XL, 2005, J IMMUNOL, V175, P4465, DOI 10.4049/jimmunol.175.7.4465; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Luckey MA, 2014, NAT IMMUNOL, V15, P638, DOI 10.1038/ni.2917; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Marsden VS, 2003, ANNU REV IMMUNOL, V21, P71, DOI 10.1146/annurev.immunol.21.120601.141029; McDonald BD, 2018, NAT REV IMMUNOL, V18, P514, DOI 10.1038/s41577-018-0013-7; McGargill MA, 2009, J IMMUNOL, V183, P4838, DOI 10.4049/jimmunol.0902208; Melichar HJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004400; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Mudge JM, 2015, MAMM GENOME, V26, P366, DOI 10.1007/s00335-015-9583-x; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Pai SY, 2003, IMMUNITY, V19, P863, DOI 10.1016/S1074-7613(03)00328-5; Palmer E, 2003, NAT REV IMMUNOL, V3, P383, DOI 10.1038/nri1085; Papalexi E, 2018, NAT REV IMMUNOL, V18, P35, DOI 10.1038/nri.2017.76; Park JE, 2020, SCIENCE, V367, P868, DOI 10.1126/science.aay3224; Pliner HA, 2018, MOL CELL, V71, P858, DOI 10.1016/j.molcel.2018.06.044; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Rahimpour A, 2015, J EXP MED, V212, P1095, DOI 10.1084/jem.20142110; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Rothenberg EV, 2019, GENE DEV, V33, P1117, DOI 10.1101/gad.327163.119; Ruscher R, 2019, CURR OPIN IMMUNOL, V58, P83, DOI 10.1016/j.coi.2019.04.010; Sakaguchi S, 2010, NAT IMMUNOL, V11, P442, DOI 10.1038/ni.1860; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Sekkali B, 2005, J IMMUNOL, V175, P5203, DOI 10.4049/jimmunol.175.8.5203; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Shao H, 1997, J EXP MED, V185, P731, DOI 10.1084/jem.185.4.731; Shih HY, 2014, IMMUNOL REV, V261, P23, DOI 10.1111/imr.12208; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Stritesky GL, 2013, P NATL ACAD SCI USA, V110, P4679, DOI 10.1073/pnas.1217532110; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Taniuchi I, 2018, ANNU REV IMMUNOL, V36, P579, DOI 10.1146/annurev-immunol-042617-053411; Tenno M, 2018, J EXP MED, V215, P595, DOI 10.1084/jem.20171221; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; TURKA LA, 1991, SCIENCE, V253, P778, DOI 10.1126/science.1831564; Ueno T, 2004, J EXP MED, V200, P493, DOI 10.1084/jem.20040643; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Wood CD, 2016, ELIFE, V5, DOI 10.7554/eLife.18270; Woolf E, 2003, P NATL ACAD SCI USA, V100, P7731, DOI 10.1073/pnas.1232420100; Xing Y, 2016, NAT IMMUNOL, V17, P565, DOI 10.1038/ni.3419; Xiong YM, 2012, CURR OPIN IMMUNOL, V24, P139, DOI 10.1016/j.coi.2012.02.002; Yin XY, 2007, J IMMUNOL, V179, P7358, DOI 10.4049/jimmunol.179.11.7358; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Zamisch M, 2009, J EXP MED, V206, P2685, DOI 10.1084/jem.20092024; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	113	23	24	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1182	+		10.1016/j.immuni.2020.10.024	http://dx.doi.org/10.1016/j.immuni.2020.10.024			28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33242395	Bronze, Green Accepted			2022-12-18	WOS:000599363300009
J	Le, J; Park, JE; Ha, VL; Luong, A; Branciamore, S; Rodin, AS; Gogoshin, G; Li, F; Loh, YHE; Camacho, V; Patel, SB; Welner, RS; Parekh, C				Le, Justin; Park, Jeong Eun; Ha, Vi Luan; Luong, Annie; Branciamore, Sergio; Rodin, Andrei S.; Gogoshin, Grigoriy; Li, Fan; Loh, Yong-Hwee Eddie; Camacho, Virginia; Patel, Sweta B.; Welner, Robert S.; Parekh, Chintan			Single-Cell RNA-Seq Mapping of Human Thymopoiesis Reveals Lineage Specification Trajectories and a Commitment Spectrum in T Cell Development	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; DENDRITIC CELL; PROGENITOR CELLS; B-CELL; EXPRESSION; IDENTIFICATION; CHECKPOINT; PRECURSORS; IDENTITY; NETWORKS	The challenges in recapitulating in vivo human T cell development in laboratory models have posed a barrier to understanding human thymopoiesis. Here, we used single-cell RNA sequencing (sRNA-seq) to interrogate the rare CD34(+) progenitor and the more differentiated CD34(-) fractions in the human postnatal thymus. CD34(+) thymic progenitors were comprised of a spectrum of specification and commitment states characterized by multilineage priming followed by gradual T cell commitment. The earliest progenitors in the differentiation trajectory were CD7(-) and expressed a stem-cell-like transcriptional profile, but had also initiated T cell priming. Clustering analysis identified a CD34(+) subpopulation primed for the plasmacytoid dendritic lineage, suggesting an intrathymic dendritic specification pathway. CD2 expression defined T cell commitment stages where loss of B cell potential preceded that of myeloid potential. These datasets delineate gene expression profiles spanning key differentiation events in human thymopoiesis and provide a resource for the further study of human T cell development.	[Le, Justin; Park, Jeong Eun; Ha, Vi Luan; Luong, Annie; Li, Fan; Parekh, Chintan] Childrens Hosp Los Angeles, Canc & Blood Dis Inst, Los Angeles, CA 90027 USA; [Branciamore, Sergio; Rodin, Andrei S.; Gogoshin, Grigoriy] City Hope Natl Med Ctr, Dept Computat & Quantitat Med, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Branciamore, Sergio; Rodin, Andrei S.; Gogoshin, Grigoriy] City Hope Natl Med Ctr, Diabet & Metab Res Inst, 1500 E Duarte Rd, Duarte, CA 91010 USA; [Loh, Yong-Hwee Eddie] USC Lib Bioinformat Serv, Los Angeles, CA USA; [Camacho, Virginia; Patel, Sweta B.; Welner, Robert S.] Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL USA; [Parekh, Chintan] Univ Southern Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90007 USA	Children's Hospital Los Angeles; City of Hope; City of Hope; University of Alabama System; University of Alabama Birmingham; University of Southern California	Parekh, C (corresponding author), Childrens Hosp Los Angeles, Canc & Blood Dis Inst, Los Angeles, CA 90027 USA.; Parekh, C (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Pediat, Los Angeles, CA 90007 USA.	cparekh@chla.usc.edu	Patel, Sweta/ABA-5585-2021	Patel, Sweta/0000-0001-7082-7204; Le, Justin/0000-0003-4275-7725; Camacho, Virginia/0000-0002-6970-0932	St. Baldrick's foundation; Nautica foundation; Shirley Mckernan foundation; Couples Against Leukemia foundation; Hyundai Hope On Wheels foundation; SHARE, Inc. foundation; Susumu Ohno Chair in Theoretical and Computational Biology; Susumu Ohno Distinguished Investigator Fellowship; NCI Cancer Systems Biology Consortium [1U01CA23221601A1]	St. Baldrick's foundation; Nautica foundation; Shirley Mckernan foundation; Couples Against Leukemia foundation; Hyundai Hope On Wheels foundation; SHARE, Inc. foundation; Susumu Ohno Chair in Theoretical and Computational Biology; Susumu Ohno Distinguished Investigator Fellowship; NCI Cancer Systems Biology Consortium	We thank F. Codrea, J. Scholes, C. Daly, and H. Long for technical assistance; A. Hartley, Dr. W. Wells, and Dr. R. Subramanyan from the Cardiothoracic Surgery Department at the Children's Hospital Los Angeles (CHLA) for collecting thymuses; the CHLA and Harvard University Bauer next generation sequencing cores; the CHLA, University of Alabama, and Broad Stem Cell Research Center flow cytometry facilities; the University of Southern California Libraries Bioinformatics Services; and Dr. G. Crooks (University of California Los Angeles) for the MS5 and MS5-DLL1 cell lines. This work was supported by the St. Baldrick's (C.P.), the Nautica (C.P.), the Shirley Mckernan, the Couples Against Leukemia (C.P.), Hyundai Hope On Wheels (C.P.), and the SHARE, Inc. (C.P.) foundations; the Susumu Ohno Chair in Theoretical and Computational Biology (A.S.R.); the Susumu Ohno Distinguished Investigator Fellowship (G.G.); and NCI Cancer Systems Biology Consortium 1U01CA23221601A1 (A.S.R., S.B., and G.G.).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Balan S, 2014, J IMMUNOL, V193, P1622, DOI 10.4049/jimmunol.1401243; Bhandoola A, 2007, IMMUNITY, V26, P678, DOI 10.1016/j.immuni.2007.05.009; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cante-Barrett K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00032; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Casero D, 2015, NAT IMMUNOL, V16, P1282, DOI 10.1038/ni.3299; Charoensawan V, 2010, NUCLEIC ACIDS RES, V38, P7364, DOI 10.1093/nar/gkq617; Collin M, 2018, IMMUNOLOGY, V154, P3, DOI 10.1111/imm.12888; Collins A, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.90063; Crinier A, 2018, IMMUNITY, V49, P971, DOI 10.1016/j.immuni.2018.09.009; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Fulton DL, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r29; Gogoshin Grigoriy, 2017, J Comput Biol, V24, P340, DOI 10.1089/cmb.2016.0100; Ha VL, 2017, LEUKEMIA, V31, P2503, DOI 10.1038/leu.2017.70; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Hao QL, 2008, BLOOD, V111, P1318, DOI 10.1182/blood-2007-08-106294; Ho IC, 2009, NAT REV IMMUNOL, V9, P125, DOI 10.1038/nri2476; Holyoake TL, 1999, EXP HEMATOL, V27, P1418, DOI 10.1016/S0301-472X(99)00078-8; Hosokawa H, 2018, NAT IMMUNOL, V19, P1427, DOI 10.1038/s41590-018-0238-4; Hu F, 2010, ONCOGENE, V29, P5464, DOI 10.1038/onc.2010.275; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jackson JT, 2017, STEM CELLS, V35, P1948, DOI 10.1002/stem.2648; Johnson JL, 2018, IMMUNITY, V48, P243, DOI 10.1016/j.immuni.2018.01.012; Kernfeld EM, 2018, IMMUNITY, V48, P1258, DOI 10.1016/j.immuni.2018.04.015; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim YW, 2011, NUCLEIC ACIDS RES, V39, P6944, DOI 10.1093/nar/gkr253; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kueh HY, 2016, NAT IMMUNOL, V17, P956, DOI 10.1038/ni.3514; Lee J, 2017, NAT IMMUNOL, V18, P877, DOI 10.1038/ni.3789; Li FZ, 1998, NATURE, V396, P580, DOI 10.1038/25141; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luecken MD, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188746; Marafioti T, 2008, BLOOD, V111, P3778, DOI 10.1182/blood-2007-10-117531; Marquez C, 1998, BLOOD, V91, P2760, DOI 10.1182/blood.V91.8.2760.2760_2760_2771; Martin-Gayo E, 2017, J EXP MED, V214, P3361, DOI 10.1084/jem.20161564; Medvedovic J, 2011, ADV IMMUNOL, V111, P179, DOI 10.1016/B978-0-12-385991-4.00005-2; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Moore AJ, 2012, DEVELOPMENT, V139, P373, DOI 10.1242/dev.069344; Parekh C, 2013, J CLIN IMMUNOL, V33, P711, DOI 10.1007/s10875-012-9844-3; Park JE, 2020, SCIENCE, V367, P868, DOI 10.1126/science.aay3224; Pellin D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10291-0; Plum J, 2008, SEMIN IMMUNOPATHOL, V30, P411, DOI 10.1007/s00281-008-0135-2; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rothenberg EV, 2019, GENE DEV, V33, P1117, DOI 10.1101/gad.327163.119; Rothenberg EV, 2016, ADV IMMUNOL, V129, P109, DOI 10.1016/bs.ai.2015.09.002; Schmitt N, 2007, IMMUNOBIOLOGY, V212, P167, DOI 10.1016/j.imbio.2007.01.008; Scripture-Adams DD, 2014, J IMMUNOL, V193, P3470, DOI 10.4049/jimmunol.1301663; Seet CS, 2017, NAT METHODS, V14, P521, DOI [10.1038/NMETH.4237, 10.1038/nmeth.4237]; Shafer MER, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00175; Sontag S, 2017, STEM CELLS, V35, P898, DOI 10.1002/stem.2565; Stehling-Sun S, 2009, NAT IMMUNOL, V10, P289, DOI 10.1038/ni.1694; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Taghon T, 2009, BLOOD, V113, P3254, DOI 10.1182/blood-2008-07-168906; Tomasello E, 2005, EUR J IMMUNOL, V35, P1670, DOI 10.1002/eji.200425932; Unnisa Z, 2012, BLOOD, V120, P4973, DOI 10.1182/blood-2012-06-435800; Van de Walle I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11171; Van den Berge K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14766-3; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Weerkamp F, 2006, BLOOD, V107, P3131, DOI 10.1182/blood-2005-08-3412; Wolock SL, 2019, CELL REP, V28, P302, DOI 10.1016/j.celrep.2019.06.031; Wolock SL, 2019, CELL SYST, V8, P281, DOI 10.1016/j.cels.2018.11.005; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0; Zeng Y, 2019, IMMUNITY, V51, P930, DOI 10.1016/j.immuni.2019.09.008; Zheng SW, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178041; Zhou W, 2019, CELL SYST, V9, P321, DOI 10.1016/j.cels.2019.09.008; Zilionis R, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.154; Zlotoff DA, 2010, BLOOD, V115, P1897, DOI 10.1182/blood-2009-08-237784	74	23	24	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					1105	+		10.1016/j.immuni.2020.05.010	http://dx.doi.org/10.1016/j.immuni.2020.05.010			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32553173	Bronze, Green Accepted			2022-12-18	WOS:000541890000021
J	Troha, K; Nagy, P; Pivovar, A; Lazzaro, BP; Hartley, PS; Buchon, N				Troha, Katia; Nagy, Peter; Pivovar, Andrew; Lazzaro, Brian P.; Hartley, Paul S.; Buchon, Nicolas			Nephrocytes Remove Microbiota-Derived Peptidoglycan from Systemic Circulation to Maintain Immune Homeostasis	IMMUNITY			English	Article							BACTERIAL-CELL-WALLS; DROSOPHILA-MELANOGASTER; FUNCTIONAL-ANALYSIS; PERICARDIAL CELLS; PGRP-LC; RECOGNITION; TOLL; ACTIVATION; IMD; ULTRASTRUCTURE	Preventing aberrant immune responses against the microbiota is essential for the health of the host. Microbiota-shed pathogen-associated molecular patterns translocate from the gut lumen into systemic circulation. Here, we examined the role of hemolymph (insect blood) filtration in regulating systemic responses to microbiota-derived peptidoglycan. Drosophila deficient for the transcription factor Klf15 (Klf15(NN)) are viable but lack nephrocytes-cells structurally and functionally homologous to the glomerular podocytes of the kidney. We found that Klf15(NN) flies were more resistant to infection than wild-type (WT) counterparts but exhibited a shortened lifespan. This was associated with constitutive Toll pathway activation triggered by excess peptidoglycan circulating in Klf15(NN) flies. In WT flies, peptidoglycan was removed from systemic circulation by nephrocytes through endocytosis and subsequent lysosomal degradation. Thus, renal filtration of microbiota-derived peptidoglycan maintains immune homeostasis in Drosophila, a function likely conserved in mammals and potentially relevant to the chronic immune activation seen in settings of impaired blood filtration.	[Troha, Katia; Nagy, Peter; Pivovar, Andrew; Lazzaro, Brian P.; Buchon, Nicolas] Cornell Univ, Dept Entomol, Cornell Inst Host Microbe Interact & Dis, Ithaca, NY 14853 USA; [Hartley, Paul S.] Univ Bournemouth, Dept Life & Environm Sci, Talbot Campus, Poole BH12 5BB, Dorset, England	Cornell University; Bournemouth University	Buchon, N (corresponding author), Cornell Univ, Dept Entomol, Cornell Inst Host Microbe Interact & Dis, Ithaca, NY 14853 USA.	nicolas.buchon@cornell.edu	Nagy, Peter/AFT-0238-2022; Buchon, Nicolas/AAE-9323-2019	Nagy, Peter/0000-0002-5053-0646; Buchon, Nicolas/0000-0003-3636-8387; Hartley, Paul/0000-0003-2782-0490; Troha, Katia/0000-0001-9389-4952	NSF [IOS1653021, IOS1656118]	NSF(National Science Foundation (NSF))	We thank J. Rossi for assistance with manuscript editing. We also thank all members of the Buchon lab for helpful comments on the manuscript. Finally, we thank Gabor Juhasz for providing the dLamp-3xmCherry transgenic flies. The graphical abstract was created with BioRender. This work was supported by NSF IOS1656118 and NSF IOS1653021 to N.B.	Aggarwal K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000120; AGGARWAL SK, 1967, PROTOPLASMA, V63, P343, DOI 10.1007/BF01252944; Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Basbous N, 2011, EMBO REP, V12, P327, DOI 10.1038/embor.2011.19; Binggeli O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004067; Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Broderick SR, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0307-2; Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763; Buchon N, 2009, P NATL ACAD SCI USA, V106, P12442, DOI 10.1073/pnas.0901924106; Cao Y, 2013, P NATL ACAD SCI USA, V110, pE1752, DOI 10.1073/pnas.1306220110; Capo F, 2017, J INNATE IMMUN, V9, P483, DOI 10.1159/000475771; Cecconi M, 2018, LANCET, V392, P75, DOI 10.1016/S0140-6736(18)30696-2; Charroux B, 2018, CELL HOST MICROBE, V23, P215, DOI 10.1016/j.chom.2017.12.007; Chintapalli VR, 2007, NAT GENET, V39, P715, DOI 10.1038/ng2049; Clarke TB, 2010, NAT MED, V16, P228, DOI 10.1038/nm.2087; Corbitt N, 2013, AM J PATHOL, V182, P180, DOI 10.1016/j.ajpath.2012.09.010; CROSSLEY AC, 1972, TISSUE CELL, V4, P529, DOI 10.1016/S0040-8166(72)80029-6; De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698; De Gregorio E, 2002, DEV CELL, V3, P581, DOI 10.1016/S1534-5807(02)00267-8; Denholm B, 2009, CURR OPIN GENET DEV, V19, P526, DOI 10.1016/j.gde.2009.08.006; Dudzic JP, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0193-6; Duneau D, 2017, ELIFE, V6, DOI 10.7554/eLife.28298; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Soukup SF, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000532; Fu YL, 2017, CELL TISSUE RES, V368, P615, DOI 10.1007/s00441-017-2575-2; Gendrin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000694; Ghosh AC, 2014, P NATL ACAD SCI USA, V111, P5729, DOI 10.1073/pnas.1319116111; Glorieux G, 2015, NEPHROL DIAL TRANSPL, V30, P1842, DOI 10.1093/ndt/gfv254; Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432; Gordon MD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000111; Gottar M, 2006, CELL, V127, P1425, DOI 10.1016/j.cell.2006.10.046; Guillou A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005961; Guo LL, 2014, CELL, V156, P109, DOI 10.1016/j.cell.2013.12.018; Hartley PS, 2016, CIRC-CARDIOVASC GENE, V9, P119, DOI 10.1161/CIRCGENETICS.115.001254; Hegedus K, 2016, MOL BIOL CELL, V27, P3132, DOI 10.1091/mbc.E16-03-0205; Jang IH, 2006, DEV CELL, V10, P45, DOI 10.1016/j.devcel.2005.11.013; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; KAWASAKI A, 1987, MICROBIOL IMMUNOL, V31, P551, DOI 10.1111/j.1348-0421.1987.tb03117.x; Kleino A, 2008, J IMMUNOL, V180, P5413, DOI 10.4049/jimmunol.180.8.5413; KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Levashina EA, 1999, SCIENCE, V285, P1917, DOI 10.1126/science.285.5435.1917; Lhocine N, 2008, CELL HOST MICROBE, V4, P147, DOI 10.1016/j.chom.2008.07.004; Liu X, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006277; Maillet F, 2008, CELL HOST MICROBE, V3, P293, DOI 10.1016/j.chom.2008.04.002; Mallipattu SK, 2012, J BIOL CHEM, V287, P19122, DOI 10.1074/jbc.M112.345983; Mauvezin C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8007; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Ming M, 2014, J BIOL CHEM, V289, P7558, DOI 10.1074/jbc.M113.543884; Na JB, 2013, J AM SOC NEPHROL, V24, P161, DOI 10.1681/ASN.2012121227; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Paredes JC, 2011, IMMUNITY, V35, P770, DOI 10.1016/j.immuni.2011.09.018; Park JW, 2007, P NATL ACAD SCI USA, V104, P6602, DOI 10.1073/pnas.0610924104; Psathaki OE, 2018, MECH AGEING DEV, V173, P9, DOI 10.1016/j.mad.2018.04.006; Regel R, 1998, INSECT BIOCHEM MOLEC, V28, P309, DOI 10.1016/S0965-1748(97)00108-2; Reiser J., 2016, F1000RESEARCH, V5, P5, DOI [10.12688/f1000research.7255.1, DOI 10.12688/F1000RESEARCH.7255.1]; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Salvetti E, 2012, PROBIOTICS ANTIMICRO, V4, P217, DOI 10.1007/s12602-012-9117-8; Scherfer C, 2008, DEV BIOL, V323, P189, DOI 10.1016/j.ydbio.2008.08.030; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Sorensen KK, 2012, AM J PHYSIOL-REG I, V303, pR1217, DOI 10.1152/ajpregu.00686.2011; Stewart L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135176; Thevenon D, 2009, CELL HOST MICROBE, V6, P309, DOI 10.1016/j.chom.2009.09.007; Troha K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006847; Weavers H, 2009, NATURE, V457, P322, DOI 10.1038/nature07526; WIGGLESWORTH VB, 1970, J RETICULOENDOTH SOC, V7, P208; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zhang FJ, 2013, J AM SOC NEPHROL, V24, P191, DOI 10.1681/ASN.2012080769; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	71	23	23	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					625	+		10.1016/j.immuni.2019.08.020	http://dx.doi.org/10.1016/j.immuni.2019.08.020			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31564469	Bronze, Green Accepted			2022-12-18	WOS:000490141700010
J	Helmink, BA; Gaudreau, PO; Wargo, JA				Helmink, Beth A.; Gaudreau, Pierre-Olivier; Wargo, Jennifer A.			Immune Checkpoint Blockade across the Cancer Care Continuum	IMMUNITY			English	Editorial Material							CELL LUNG-CANCER; CHEMOTHERAPY; IMMUNOTHERAPY; MELANOMA; THERAPY	Four studies recently reported in the New England Journal of Medicine highlight advances in treatment with immune checkpoint blockade across the cancer care continuum. These findings demonstrate efficacy of these agents in the treatment of early and late-stage disease, as monotherapy or in combination, and in addition to-or in place of-standard front-line therapy.	[Helmink, Beth A.; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Gaudreau, Pierre-Olivier; Wargo, Jennifer A.] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, 1515 Holcombe Blvd, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Wargo, JA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.; Wargo, JA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genom Med, 1515 Holcombe Blvd, Houston, TX 77030 USA.	jwargo@mdanderson.org		Helmink, Beth/0000-0002-8206-0351	NCI NIH HHS [T32 CA009599] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA009599] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Cyriac G, 2018, SEMIN CANCER BIOL, V52, P269, DOI 10.1016/j.semcancer.2018.05.006; Eggermont AMM, 2016, NEW ENGL J MED, V375, P1845, DOI 10.1056/NEJMoa1611299; Eggermont AMM, 2018, NEW ENGL J MED, V378, P1789, DOI 10.1056/NEJMoa1802357; Forde PM, 2018, NEW ENGL J MED, V378, P1976, DOI 10.1056/NEJMoa1716078; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Gettinger S, 2018, J CLIN ONCOL, V36, P1675, DOI 10.1200/JCO.2017.77.0412; Hellmann MD, 2018, NEW ENGL J MED, V378, P2093, DOI 10.1056/NEJMoa1801946; Liu J, 2016, CANCER DISCOV, V6, P1382, DOI 10.1158/2159-8290.CD-16-0577; Peng J, 2015, CANCER RES, V75, P5034, DOI 10.1158/0008-5472.CAN-14-3098; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Sheng J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20090; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8	14	23	23	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1077	1080		10.1016/j.immuni.2018.06.003	http://dx.doi.org/10.1016/j.immuni.2018.06.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29924973	Bronze			2022-12-18	WOS:000436456900008
J	Chang, YH; Wang, KC; Chu, KL; Clouthier, DL; Tran, AT; Perez, MST; Zhou, AC; Abdul-Sater, AA; Watts, TH				Chang, Yu-Han; Wang, Kuan Chung; Chu, Kuan-Lun; Clouthier, Derek L.; Tran, Anh T.; Perez, Miguel S. Torres; Zhou, Angela C.; Abdul-Sater, Ali A.; Watts, Tania H.			Dichotomous Expression of TNF Superfamily Ligands on Antigen-Presenting Cells Controls Post-priming Anti-viral CD4(+) T Cell Immunity	IMMUNITY			English	Article							PLASMACYTOID DENDRITIC CELLS; I INTERFERON; LYMPHOCYTE ATTENUATOR; LCMV INFECTION; CO-STIMULATION; B-LYMPHOCYTE; GITR LIGAND; SUBSETS; RESPONSES; SURVIVAL	T cell antigen-presenting cell (APC) interactions early during chronic viral infection are crucial for determining viral set point and disease outcome, but how and when different APC subtypes contribute to these outcomes is unclear. The TNF receptor superfamily (TNFRSF) member GITR is important for CD4(+) T cell accumulation and control of chronic lymphocytic choriomeningitis virus (LCMV). We found that type I interferon (IFN-I) induced TNFSF ligands GITRL, 4-1BBL, OX40L, and CD70 predominantly on monocyte-derived APCs and CD80 and CD86 predominantly on classical dendritic cells (cDCs). Mice with hypofunctional GITRL in Lyz2(+) cells had decreased LCMV-specific CD4(+) T cell accumulation and increased viral load. GITR signals in CD4(+) T cells occurred after priming to upregulate OX40, CD25, and chemokine receptor CX3CR1. Thus IFN-I (signal 3) induced a post-priming checkpoint (signal 4) for CD4(+) T cell accumulation, revealing a division of labor between cDCs and monocyte-derived APCs in regulating T cell expansion.	[Chang, Yu-Han; Wang, Kuan Chung; Chu, Kuan-Lun; Clouthier, Derek L.; Tran, Anh T.; Perez, Miguel S. Torres; Zhou, Angela C.; Abdul-Sater, Ali A.; Watts, Tania H.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Clouthier, Derek L.] Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Abdul-Sater, Ali A.] York Univ, Sch Kinesiol & Hlth Sci, Toronto, ON M3J 1P3, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; York University - Canada	Watts, TH (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.	tania.watts@utoronto.ca	Tran, Anh T/L-5968-2016	Tran, Anh T/0000-0003-0644-6014	Canadian Institutes of Health (CIHR) [MOP-123480, FDN-143250]; CIHR [GSD-134854]; CIHR/Canadian Association for HIV Research doctoral award [DOB128604]; Ontario Graduate scholarship	Canadian Institutes of Health (CIHR)(Canadian Institutes of Health Research (CIHR)); CIHR(Canadian Institutes of Health Research (CIHR)); CIHR/Canadian Association for HIV Research doctoral award(Canadian Institutes of Health Research (CIHR)); Ontario Graduate scholarship(Ontario Graduate Scholarship)	We thank Ethan Shevach for provision of Tnfsf<SUP>18exon2fl/fl</SUP> mice, Simon Eng for help with volcano plots, Dionne White and Joanna Warzyszynska for assistance with flow cytometry/cell sorting, Birinder Ghumman for technical assistance, Arthur Mortha and Jen Gommerman for helpful discussion and critical reading of the manuscript, and Savanna Jackson at www.biorender.io for preparing the graphical abstract. This research was funded by Canadian Institutes of Health (CIHR) Research Grants MOP-123480 and FDN-143250 to T.H.W. Y.-H.C. and A.C.Z. were funded by CIHR studentship awards (GSD-134854 to A.C.Z.), D.L.C. by a CIHR/Canadian Association for HIV Research doctoral award (DOB128604), and K.-L.C. by an Ontario Graduate scholarship. T.H.W. holds the Sanofi Pasteur Chair in Human Immunology at the University of Toronto.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bottcher JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9306; Boettler T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002913; Brewitz A, 2017, IMMUNITY, V46, P205, DOI 10.1016/j.immuni.2017.01.003; Chattopadhyay K, 2009, ACTA CRYSTALLOGR D, V65, P434, DOI 10.1107/S0907444909005721; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Clouthier DL, 2015, TRENDS IMMUNOL, V36, P697, DOI 10.1016/j.it.2015.09.005; Clouthier DL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004517; Clouthier DL, 2014, J IMMUNOL, V193, P5033, DOI 10.4049/jimmunol.1401002; Clouthier DL, 2014, CYTOKINE GROWTH F R, V25, P91, DOI 10.1016/j.cytogfr.2013.12.003; Cottey R., 2001, CURRENT PROTOCOLS IM; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Cunningham CR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005356; Curtsinger JM, 2010, CURR OPIN IMMUNOL, V22, P333, DOI 10.1016/j.coi.2010.02.013; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Emonet SF, 2009, P NATL ACAD SCI USA, V106, P3473, DOI 10.1073/pnas.0900088106; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Gautier EL, 2009, ARTERIOSCL THROM VAS, V29, P1412, DOI 10.1161/ATVBAHA.108.180505; Gerlach C, 2016, IMMUNITY, V45, P1270, DOI 10.1016/j.immuni.2016.10.018; Gonzalez LC, 2005, P NATL ACAD SCI USA, V102, P1116, DOI 10.1073/pnas.0409071102; Gordon S, 2014, IMMUNOL REV, V262, P36, DOI 10.1111/imr.12223; Granger SW, 2003, CYTOKINE GROWTH F R, V14, P289, DOI 10.1016/S1359-6101(03)00031-5; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kim TS, 2014, IMMUNITY, V40, P400, DOI 10.1016/j.immuni.2014.02.004; Langlet C, 2012, J IMMUNOL, V188, P1751, DOI 10.4049/jimmunol.1102744; Li QS, 2009, SCIENCE, V323, P1726, DOI 10.1126/science.1168676; Macal M, 2012, CELL HOST MICROBE, V11, P617, DOI 10.1016/j.chom.2012.04.017; Merad M, 2013, ANNU REV IMMUNOL, V31, P563, DOI 10.1146/annurev-immunol-020711-074950; Mionnet C, 2010, NAT MED, V16, P1305, DOI 10.1038/nm.2253; Murphy KM, 2006, NAT REV IMMUNOL, V6, P671, DOI 10.1038/nri1917; Murphy TL, 2016, ANNU REV IMMUNOL, V34, P93, DOI 10.1146/annurev-immunol-032713-120204; Nanjappa SG, 2011, BLOOD, V117, P5123, DOI 10.1182/blood-2010-12-323154; ODERMATT B, 1991, P NATL ACAD SCI USA, V88, P8252, DOI 10.1073/pnas.88.18.8252; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pascutti MF, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004675; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Peters NC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004538; Plantinga M, 2013, IMMUNITY, V38, P322, DOI 10.1016/j.immuni.2012.10.016; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schaer DA, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-7; Schluns KS, 2003, NAT REV IMMUNOL, V3, P269, DOI 10.1038/nri1052; SCHWARTZ RH, 1992, CELL, V71, P1065, DOI 10.1016/S0092-8674(05)80055-8; Sedy JR, 2005, NAT IMMUNOL, V6, P90, DOI 10.1038/ni1144; Segura E, 2013, TRENDS IMMUNOL, V34, P440, DOI 10.1016/j.it.2013.06.001; Snell LM, 2015, CURR OPIN IMMUNOL, V34, P91, DOI 10.1016/j.coi.2015.03.002; Snell LM, 2010, J IMMUNOL, V185, P7223, DOI 10.4049/jimmunol.1001912; Teijaro JR, 2013, SCIENCE, V340, P207, DOI 10.1126/science.1235214; Wang C, 2012, J EXP MED, V209, P77, DOI 10.1084/jem.20110675; Wang Y, 2005, J CLIN INVEST, V115, P711, DOI 10.1172/JCI200522982; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; White GE, 2012, ARTERIOSCL THROM VAS, V32, P589, DOI 10.1161/ATVBAHA.111.237412; Wilson EB, 2013, SCIENCE, V340, P202, DOI 10.1126/science.1235208; Wilson EB, 2012, CELL HOST MICROBE, V11, P481, DOI 10.1016/j.chom.2012.03.009; Wu C, 2007, BIOTECHNIQUES, V42, P290, DOI 10.2144/000112428; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhou ZC, 2008, P NATL ACAD SCI USA, V105, P641, DOI 10.1073/pnas.0711206105; Zuniga EI, 2008, CELL HOST MICROBE, V4, P374, DOI 10.1016/j.chom.2008.08.016	61	23	23	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					943	+		10.1016/j.immuni.2017.10.014	http://dx.doi.org/10.1016/j.immuni.2017.10.014			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29150240	Bronze			2022-12-18	WOS:000416483700017
J	Brandsma, AM; Hogarth, PM; Nimmerjahn, F; Leusen, JHW				Brandsma, Arianne M.; Hogarth, P. Mark; Nimmerjahn, Falk; Leusen, Jeanette H. W.			Clarifying the Confusion between Cytokine and Fc Receptor "Common Gamma Chain''	IMMUNITY			English	Letter							FUNCTIONAL COMPONENT; GENE		[Brandsma, Arianne M.; Leusen, Jeanette H. W.] Univ Med Ctr Utrecht, Immunotherapy Lab, Lab Translat Immunol, NL-3584 Utrecht, Netherlands; [Hogarth, P. Mark] Burnet Inst, Ctr Biomed Res, Melbourne, Vic 3004, Australia; [Nimmerjahn, Falk] Univ Erlangen Nurnberg, Inst Genet, Dept Biol, D-91058 Erlangen, Germany	Utrecht University; Utrecht University Medical Center; Burnet Institute; University of Erlangen Nuremberg	Leusen, JHW (corresponding author), Univ Med Ctr Utrecht, Immunotherapy Lab, Lab Translat Immunol, NL-3584 Utrecht, Netherlands.	jleusen@umcutrecht.nl	, Jeanette/AAG-3736-2019	Hogarth, Mark/0000-0002-0360-7890; Brandsma, Arianne/0000-0002-7969-4046; Leusen, Jeanette/0000-0003-4982-6914				Clynes R, 1998, P NATL ACAD SCI USA, V95, P652, DOI 10.1073/pnas.95.2.652; de Haij S, 2010, CANCER RES, V70, P3209, DOI 10.1158/0008-5472.CAN-09-4109; Hida S, 2009, NAT IMMUNOL, V10, P214, DOI 10.1038/ni.1686; KUSTER H, 1990, J BIOL CHEM, V265, P6448; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; NOGUCHI M, 1993, SCIENCE, V262, P1877, DOI 10.1126/science.8266077; OHNO H, 1994, J EXP MED, V179, P365, DOI 10.1084/jem.179.1.365; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; RUSSELL SM, 1993, SCIENCE, V262, P1880, DOI 10.1126/science.8266078; TAKESHITA T, 1992, SCIENCE, V257, P379, DOI 10.1126/science.1631559	10	23	24	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 16	2016	45	2					225	226		10.1016/j.immuni.2016.07.006	http://dx.doi.org/10.1016/j.immuni.2016.07.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DU5QV	27533005	Bronze			2022-12-18	WOS:000382267300001
J	Poffenberger, MC; Jones, RG				Poffenberger, Maya C.; Jones, Russell G.			Amino Acids Fuel T Cell-Mediated Inflammation	IMMUNITY			English	Editorial Material							GLUTAMINE UPTAKE; MTOR; TRANSPORT		[Poffenberger, Maya C.; Jones, Russell G.] McGill Univ, Goodman Canc Res Ctr, Dept Physiol, Montreal, PQ H3G 1Y6, Canada	McGill University	Jones, RG (corresponding author), McGill Univ, Goodman Canc Res Ctr, Dept Physiol, Montreal, PQ H3G 1Y6, Canada.	russell.jones@mcgill.ca	Jones, Russell/AAC-2861-2022; Jones, Russell Graham/ABD-5261-2021	Jones, Russell Graham/0000-0003-2250-4675				Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Zeng H, 2013, CURR OPIN IMMUNOL, V25, P347, DOI 10.1016/j.coi.2013.05.002	10	23	24	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					635	637		10.1016/j.immuni.2014.04.017	http://dx.doi.org/10.1016/j.immuni.2014.04.017			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24837098	Bronze			2022-12-18	WOS:000336026100002
J	Forni, D; Cagliani, R; Pozzoli, U; Colleoni, M; Riva, S; Biasin, M; Filippi, G; De Gioia, L; Gnudi, F; Comi, GP; Bresolin, N; Clerici, M; Sironi, M				Forni, Diego; Cagliani, Rachele; Pozzoli, Uberto; Colleoni, Marta; Riva, Stefania; Biasin, Mara; Filippi, Giulia; De Gioia, Luca; Gnudi, Federica; Comi, Giacomo P.; Bresolin, Nereo; Clerici, Mario; Sironi, Manuela			A 175 Million Year History of T Cell Regulatory Molecules Reveals Widespread Selection, with Adaptive Evolution of Disease Alleles	IMMUNITY			English	Article							LIGAND-BINDING SITE; AMINO-ACID SITES; CRYSTAL-STRUCTURE; POSITIVE SELECTION; HUMAN-POPULATIONS; IMMUNE-RESPONSES; LIPID RAFTS; FAS CD95; CD40; GENOME	T cell activation plays a central role in immune response and in the maintenance of self-tolerance. We analyzed the evolutionary history of T cell regulatory molecules. Nine genes involved in triggering T cell activation or in regulating the ensuing response evolved adaptively in mammals. Several positively selected sites overlap with positions interacting with the binding partner or with cellular components. Population genetic analysis in humans revealed a complex scenario of local (FASLG, CD40LG, HAVCR2) and worldwide (FAS, ICOSLG) adaptation and H. sapiens-to-Neandertal gene flow (gene transfer between populations). Disease variants in these genes are preferential targets of pathogen-driven selection, and a Crohn's disease risk polymorphism targeted by bacterial-driven selection modulates the expression of ICOSLG in response to a bacterial superantigen. Therefore, we used evolutionary information to generate experimentally testable hypotheses concerning the function of specific genetic variants and indicate that adaptation to infection underlies the maintenance of autoimmune risk alleles.	[Forni, Diego; Cagliani, Rachele; Pozzoli, Uberto; Colleoni, Marta; Riva, Stefania; Bresolin, Nereo; Sironi, Manuela] Sci Inst IRCCS E Medea, I-23842 Bosisio Parini, LC, Italy; [Biasin, Mara; Gnudi, Federica] Univ Milan, Dept Biomed & Clin Sci, I-20157 Milan, Italy; [Filippi, Giulia; De Gioia, Luca] Univ Milano Bicocca, Dept Biosci & Biotechnol, I-20126 Milan, Italy; [Comi, Giacomo P.; Bresolin, Nereo] Univ Milan, Fdn Ca Granda IRCCS Osped Maggiore Policlin, Dept Physiopathol & Transplantat, Dino Ferrari Ctr, I-20122 Milan, Italy; [Clerici, Mario] Univ Milan, Dept Physiopathol & Transplantat, Chair Immunol, I-20090 Milan, Italy; [Clerici, Mario] Don C Gnocchi Fdn ONLUS, IRCCS, I-20148 Milan, Italy	IRCCS Eugenio Medea; University of Milan; University of Milano-Bicocca; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; IRCCS Fondazione Don Carlo Gnocchi Onlus	Sironi, M (corresponding author), Sci Inst IRCCS E Medea, I-23842 Bosisio Parini, LC, Italy.	manuela.sironi@bp.lnf.it	Cagliani, Rachele/K-4545-2016; Pozzoli, Uberto/K-6587-2016; biasin, mara/G-7426-2012; Comi, Giacomo P/K-5702-2016; De Gioia, Luca/K-6439-2016; Gnudi, Federica/Y-3811-2019; Colleoni, Marta/R-3548-2019; Sironi, manuela/K-5633-2016; Forni, Diego/K-5643-2016; Pozzoli, Uberto/AAH-5492-2019	Cagliani, Rachele/0000-0003-2670-3532; Pozzoli, Uberto/0000-0003-0670-7106; biasin, mara/0000-0003-3671-4235; Comi, Giacomo P/0000-0002-1383-5248; Gnudi, Federica/0000-0002-4591-5699; Sironi, manuela/0000-0002-2267-5266; Forni, Diego/0000-0001-9291-5352; Pozzoli, Uberto/0000-0003-0670-7106; Colleoni, Marta/0000-0002-7214-9088; Bresolin, Nereo/0000-0001-6694-3595; Clerici, Mario/0000-0001-5920-6191	Broad Medical Research Program of The Broad Foundation [IBD-0294]; Doctorate School of Molecular Medicine, University of Milan	Broad Medical Research Program of The Broad Foundation; Doctorate School of Molecular Medicine, University of Milan	This work was supported by the Broad Medical Research Program of The Broad Foundation (grant IBD-0294). D.F. is supported by a fellowship of the Doctorate School of Molecular Medicine, University of Milan.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; Anisimova M, 2003, GENETICS, V164, P1229; Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152; Anisimova M, 2012, CODON EVOLUTION: MECHANISMS AND MODELS, P73; Bajorath J, 1999, PROTEINS, V35, P475, DOI 10.1002/(SICI)1097-0134(19990601)35:4<475::AID-PROT11>3.3.CO;2-S; Barreiro LB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000562; Bignami F, 2012, BLOOD, V119, P6259, DOI 10.1182/blood-2011-09-379503; Bock J, 2003, FEBS LETT, V534, P169, DOI 10.1016/S0014-5793(02)03784-5; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chiba S, 2012, NAT IMMUNOL, V13, P832, DOI 10.1038/ni.2376; DeKruyff RH, 2010, J IMMUNOL, V184, P1918, DOI 10.4049/jimmunol.0903059; Dermody TS, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000481; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Farre L, 2008, J LEUKOCYTE BIOL, V83, P220, DOI 10.1189/jlb.0407198; Fay JC, 2000, GENETICS, V155, P1405; FU YX, 1993, GENETICS, V133, P693; Fumagalli M, 2009, J EXP MED, V206, P1395, DOI 10.1084/jem.20082779; Garcia-Garcia E, 2007, J IMMUNOL, V178, P3048, DOI 10.4049/jimmunol.178.5.3048; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; HUDSON RR, 1987, GENETICS, V116, P153; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; Kajikawa M, 2012, J VIROL, V86, P5288, DOI 10.1128/JVI.00219-12; Kanemitsu S, 2002, J RHEUMATOL, V29, P1183; Khan N, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002676; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Lappalainen T, 2010, HUM MOL GENET, V19, pR197, DOI 10.1093/hmg/ddq406; Lazar-Molnar E, 2008, P NATL ACAD SCI USA, V105, P10483, DOI 10.1073/pnas.0804453105; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lin DYW, 2008, P NATL ACAD SCI USA, V105, P3011, DOI 10.1073/pnas.0712278105; Lu LF, 2003, J BIOL CHEM, V278, P45414, DOI 10.1074/jbc.M309601200; Manry J, 2011, J EXP MED, V208, P2747, DOI 10.1084/jem.20111680; Mansouri M, 2003, J VIROL, V77, P1427, DOI 10.1128/JVI.77.2.1427-1440.2003; Morio T, 1999, IMMUNITY, V11, P339, DOI 10.1016/S1074-7613(00)80109-0; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Nagae M, 2006, J BIOL CHEM, V281, P35884, DOI 10.1074/jbc.M606648200; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Nurieva RI, 2009, IMMUNOL REV, V229, P88, DOI 10.1111/j.1600-065X.2009.00769.x; Pullen SS, 1999, J BIOL CHEM, V274, P14246, DOI 10.1074/jbc.274.20.14246; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Richter C, 2012, MOL CELL BIOL, V32, P2515, DOI 10.1128/MCB.06458-11; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sakuishi K, 2011, TRENDS IMMUNOL, V32, P345, DOI 10.1016/j.it.2011.05.003; Sankararaman S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002947; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Stamper CC, 2001, NATURE, V410, P608, DOI 10.1038/35069118; Starling GC, 1998, BIOCHEMISTRY-US, V37, P3723, DOI 10.1021/bi972959d; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; TAJIMA F, 1989, GENETICS, V123, P585; Voight BF, 2006, PLOS BIOL, V4, P659, DOI 10.1371/journal.pbio.0040072; Wanderley JLM, 2010, CELL MOL LIFE SCI, V67, P1653, DOI 10.1007/s00018-010-0291-0; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Yel L, 2010, J CLIN IMMUNOL, V30, P10, DOI 10.1007/s10875-009-9357-x; Zhernakova A, 2010, AM J HUM GENET, V86, P970, DOI 10.1016/j.ajhg.2010.05.004	60	23	25	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1129	1141		10.1016/j.immuni.2013.04.008	http://dx.doi.org/10.1016/j.immuni.2013.04.008			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23707475	Bronze			2022-12-18	WOS:000330947500009
J	Galli, SJ; Franco, CB				Galli, Stephen J.; Franco, Christopher B.			Basophils are back!	IMMUNITY			English	Editorial Material							ANAPHYLAXIS; MOUSE	In this issue of Immunity, Tsujimura et al. (2008) report that the release of platelet-activating factor by basophils stimulated with immunoglobulin G1 (IgG1)-antigen immune complexes contributes substantially to the expression of an IgG1-dependent alternative pathway of systemic anaphylaxis in mice.	[Galli, Stephen J.; Franco, Christopher B.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University	Galli, SJ (corresponding author), Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.	sgalli@stanford.edu			NIAID NIH HHS [T32 AI007290] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BOCHNER BS, 1991, NEW ENGL J MED, V324, P1785, DOI 10.1056/NEJM199106203242506; DVORAK AM, 1982, BLOOD, V59, P1279; Finkelman FD, 2007, J ALLERGY CLIN IMMUN, V120, P506, DOI 10.1016/j.jaci.2007.07.033; Galli SJ, 2005, J ALLERGY CLIN IMMUN, V115, P571, DOI 10.1016/j.jaci.2004.12.1133; Galli SJ, 2005, WILLIAMS HEMATOLOGY, P879; Marone Gianni, 2002, Trends in Immunology, V23, P425, DOI 10.1016/S1471-4906(02)02274-3; Miyajima I, 1997, J CLIN INVEST, V99, P901, DOI 10.1172/JCI119255; Obata K, 2007, BLOOD, V110, P913, DOI 10.1182/blood-2007-01-068718; Tsujimura Y, 2008, IMMUNITY, V28, P581, DOI 10.1016/j.immuni.2008.02.008; URBINA C, 1981, INT ARCH ALLER A IMM, V66, P158, DOI 10.1159/000232814	10	23	24	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR	2008	28	4					495	497		10.1016/j.immuni.2008.03.010	http://dx.doi.org/10.1016/j.immuni.2008.03.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18400194	Bronze			2022-12-18	WOS:000254939400010
J	Mizui, M; Kikutani, H				Mizui, Masayuki; Kikutani, Hitoshi			Neuropilin-1: The glue between regulatory T cells and dendritic cells?	IMMUNITY			English	Editorial Material							RECEPTOR		[Mizui, Masayuki; Kikutani, Hitoshi] Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, Suita, Osaka 5650871, Japan; [Mizui, Masayuki; Kikutani, Hitoshi] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan	Osaka University; Osaka University	Kikutani, H (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Mol Immunol, 3-1 Yamada Oka, Suita, Osaka 5650871, Japan.	kikutani@ragtime.biken.osaka-u.ac.jp	Kikutani, Hitoshi/C-9525-2009; Mizui, Masayuki/AAD-1432-2019	Mizui, Masayuki/0000-0003-2543-8108				Hill JA, 2007, IMMUNITY, V27, P786, DOI 10.1016/j.immuni.2007.09.010; Hubert P, 2007, J LEUKOCYTE BIOL, V82, P781, DOI 10.1189/jlb.1106694; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Lepelletier Y, 2006, EUR J IMMUNOL, V36, P1782, DOI 10.1002/eji.200535601; Sarris M, 2008, IMMUNITY, V28, P402, DOI 10.1016/j.immuni.2008.01.012; Schneider H, 2005, P NATL ACAD SCI USA, V102, P12861, DOI 10.1073/pnas.0505802102; Suzuki K, 2008, NAT IMMUNOL, V9, P17, DOI 10.1038/ni1553; Tadokoro CE, 2006, J EXP MED, V203, P505, DOI 10.1084/jem.20050783; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789	10	23	25	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR	2008	28	3					302	303		10.1016/j.immuni.2008.02.012	http://dx.doi.org/10.1016/j.immuni.2008.02.012			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18342004	Bronze			2022-12-18	WOS:000254142500007
J	Knight, SC				Knight, Stella C.			Specialized perinodal fat fuels and fashions immunity	IMMUNITY			English	Editorial Material							ADIPOSE-TISSUE; DENDRITIC CELLS; INSULIN-RESISTANCE; CROHNS-DISEASE; OBESITY; ACID; INFLAMMATION; MACROPHAGE; EXPRESSION; LIPIDS	Adipose tissue around lymph nodes is usually removed prior to the study of immune activity-but is it time to reconsider this practice? Perinodal adipose tissue may provide not only a specific lipid resource but also fatty acids, dendritic cells, and soluble mediators that modulate local immunity.	[Knight, Stella C.] Univ London Imperial Coll Sci & Technol, Antigen Presentation Res Grp, Harrow HA1 3UJ, Middx, England	Imperial College London	Knight, SC (corresponding author), Univ London Imperial Coll Sci & Technol, Antigen Presentation Res Grp, Northwick Pk & St Mark Campus, Watford Rd, Harrow HA1 3UJ, Middx, England.	s.knight@imperial.ac.uk			Medical Research Council [G0500677] Funding Source: Medline; MRC [G0500677] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Bedford PA, 2006, J LEUKOCYTE BIOL, V80, P546, DOI 10.1189/jlb.0905501; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Charriere G, 2003, J BIOL CHEM, V278, P9850, DOI 10.1074/jbc.M210811200; GABRILOVICH DI, 1994, IMMUNOLOGY, V82, P82; Hasenkrug KJ, 2007, IMMUNITY, V26, P143, DOI 10.1016/j.immuni.2007.02.002; Lee JY, 2001, J BIOL CHEM, V276, P16683, DOI 10.1074/jbc.M011695200; Maroof A, 2005, IMMUNOLOGY, V115, P473, DOI 10.1111/j.1365-2567.2005.02181.x; Martensson UEA, 2006, VIROLOGY, V355, P6, DOI 10.1016/j.virol.2006.07.010; Mattacks CA, 2004, BRIT J NUTR, V91, P883, DOI 10.1079/BJN20041147; Pond CM, 2003, TRENDS IMMUNOL, V24, P13, DOI 10.1016/S1471-4906(02)00004-2; Rabkin SW, 2007, OBES REV, V8, P253, DOI 10.1111/j.1467-789X.2006.00293.x; Schaffler A, 2007, NAT CLIN PRACT ENDOC, V3, P345, DOI 10.1038/ncpendmet0456; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sijben JWC, 2007, P NUTR SOC, V66, P237, DOI 10.1017/S0029665107005472; THUMHER M, 2007, J LEUKOCYTE BIOL, V81, P154; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Tsukumo DML, 2007, DIABETES, V56, P1986, DOI 10.2337/db06-1595; Voight BF, 2006, PLOS BIOL, V4, P659, DOI 10.1371/journal.pbio.0040072; Weatherill AR, 2005, J IMMUNOL, V174, P5390, DOI 10.4049/jimmunol.174.9.5390; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Westcott E, 2005, INFLAMM BOWEL DIS, V11, P820, DOI 10.1097/01.mib.0000179213.80778.9a; Whigham LD, 2006, AM J PHYSIOL-REG I, V290, pR190, DOI 10.1152/ajpregu.00479.2005; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244	25	23	25	1	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB	2008	28	2					135	138		10.1016/j.immuni.2008.01.003	http://dx.doi.org/10.1016/j.immuni.2008.01.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18275823	Bronze			2022-12-18	WOS:000253275000001
J	Huang, F; Kitaura, Y; Jang, IK; Naramura, M; Kole, HH; Liu, LP; Qin, HY; Schlissel, MS; Gu, H				Huang, Fang; Kitaura, Yasuyuki; Jang, IhnKyung; Naramura, Mayumi; Kole, Hemanta H.; Liu, Liping; Qin, Haiyan; Schlissel, Mark S.; Gu, Hua			Establishment of the major compatibility complex-dependent development of CD4(+) and CD8(+) T cells by the Cbl family proteins	IMMUNITY			English	Article							NF-KAPPA-B; CLASS-II MOLECULES; C-CBL; ANTIGEN RECEPTOR; THYMOCYTE DEVELOPMENT; SIGNAL-TRANSDUCTION; NEGATIVE REGULATION; POSITIVE SELECTION; UBIQUITIN LIGASES; TRANSGENIC MICE	Casitas B cell lymphoma (Cbl) proteins are negative regulators for T cell antigen receptor (TCR) signaling. Their role in thymocyte development remains unclear. Here we show that simultaneous inactivation of c-Cbl and Cbl-b in thymocytes enhanced thymic negative selection and altered the ratio of CD4(+) and CD8(+) T cells. Strikingly, the mutant thymocytes developed into CD4(+)- and CD8(+)-Iineage T cells independent of the major histocompatibility complex (MHC), indicating that the CD4(+)- and CD8+-Iineage development programs are constitutively active in the absence of c-Cbl and Cbl-b. The mutant double-positive (DP) thymocytes exhibited spontaneous hyperactivation of nuclear factor-kappa B (NF-kappa B). Additionally, they failed to downregulate the pre-TCR and pre-TCR signaling. Thus, our data indicate that Cbl proteins play a critical role in establishing the MHC-dependent CD4(+) and CD8(+) T cell development programs. They likely do so by suppressing MHC-independent NF-kappa B activation, possibly through downmodulating pre-TCR signaling in DP thymocytes.	Columbia Univ Coll Phys & Surg, Dept Microbiol, New York, NY 10032 USA; NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of California System; University of California Berkeley	Gu, H (corresponding author), Columbia Univ Coll Phys & Surg, Dept Microbiol, 701 W 168th St, New York, NY 10032 USA.	hg2065@columbia.edu		Naramura, Mayumi/0000-0003-3658-0767	Intramural NIH HHS Funding Source: Medline; NHLBI NIH HHS [R01 HL48702] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048702] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aifantis I, 2001, NAT IMMUNOL, V2, P403, DOI 10.1038/87704; Bachmaier K, 2000, NATURE, V403, P211, DOI 10.1038/35003228; Baker JE, 2001, MOL CELL BIOL, V21, P2393, DOI 10.1128/MCB.21.7.2393-2403.2001; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Choi EY, 2005, IMMUNITY, V23, P387, DOI 10.1016/j.immuni.2005.09.005; COSGROVE D, 1991, CELL, V66, P1051, DOI 10.1016/0092-8674(91)90448-8; Dikic Ivan, 1999, Cell Biochemistry and Biophysics, V30, P369, DOI 10.1007/BF02738120; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; FINK PJ, 1978, J EXP MED, V148, P766, DOI 10.1084/jem.148.3.766; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; GODFREY DI, 1993, J IMMUNOL, V150, P4244; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; Hayday AC, 1999, SEMIN IMMUNOL, V11, P239, DOI 10.1006/smim.1999.0180; Jehn BM, 2002, J BIOL CHEM, V277, P8033, DOI 10.1074/jbc.M108552200; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Kane LP, 2002, TRENDS IMMUNOL, V23, P413, DOI 10.1016/S1471-4906(02)02264-0; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269; Koretzky GA, 2001, NAT REV IMMUNOL, V1, P95, DOI 10.1038/35100523; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Li WL, 2005, MICROSYST TECHNOL, V11, P23, DOI 10.1007/s00542-004-0462-8; Liu YC, 2004, ANNU REV IMMUNOL, V22, P81, DOI 10.1146/annurev.immunol.22.012703.104813; Love PE, 2003, CURR OPIN IMMUNOL, V15, P199, DOI 10.1016/S0952-7915(03)00002-5; Lucas JA, 2003, IMMUNOL REV, V191, P119, DOI 10.1034/j.1600-065X.2003.00029.x; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; NAKAYAMA T, 1991, P NATL ACAD SCI USA, V88, P9949, DOI 10.1073/pnas.88.22.9949; Naramura M, 2002, NAT IMMUNOL, V3, P1192, DOI 10.1038/ni855; Naramura M, 1998, P NATL ACAD SCI USA, V95, P15547, DOI 10.1073/pnas.95.26.15547; Panigada M, 2002, J EXP MED, V195, P1585, DOI 10.1084/jem.20020047; Rao N, 2002, J LEUKOCYTE BIOL, V71, P753; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Sanchez-Martin L, 2004, J BIOL CHEM, V279, P16194, DOI 10.1074/jbc.M400905200; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Takahama Y, 1998, EUR J IMMUNOL, V28, P2159, DOI 10.1002/(SICI)1521-4141(199807)28:07<2159::AID-IMMU2159>3.0.CO;2-B; Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9; Tanchot C, 1997, SCIENCE, V276, P2057, DOI 10.1126/science.276.5321.2057; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; Thien CBF, 2001, MOL CELL, V7, P355, DOI 10.1016/S1097-2765(01)00183-6; Thome M, 2003, TRENDS IMMUNOL, V24, P419, DOI 10.1016/S1471-4906(03)00177-7; Viret C, 1999, IMMUNITY, V10, P559, DOI 10.1016/S1074-7613(00)80055-2; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; VONBOEHMER H, 1988, ANNU REV IMMUNOL, V6, P309, DOI 10.1146/annurev.iy.06.040188.001521; vonBoehmer H, 1997, ANNU REV IMMUNOL, V15, P433, DOI 10.1146/annurev.immunol.15.1.433; Wang DH, 2004, MOL CELL BIOL, V24, P164, DOI 10.1128/MCB.24.1.164-171.2003; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Witherden D, 2000, J EXP MED, V191, P355, DOI 10.1084/jem.191.2.355; Yamasaki S, 2006, NAT IMMUNOL, V7, P67, DOI 10.1038/ni1290; Zell T, 1999, IMMUNOL RES, V20, P127; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	53	23	23	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2006	25	4					571	581		10.1016/j.immuni.2006.08.021	http://dx.doi.org/10.1016/j.immuni.2006.08.021			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17045823	Bronze			2022-12-18	WOS:000241481500009
J	Montecino-Rodriguez, E; Dorshkind, K				Montecino-Rodriguez, Encarnacion; Dorshkind, Kenneth			Evolving patterns of lymphopoiesis from embryogenesis through senescence	IMMUNITY			English	Editorial Material							B-CELL; T-CELL; AGED MICE; PROGENITORS; IDENTIFICATION; INSIGHTS; ABILITY; DECLINE	Lymphopoiesis occurs throughout adult life, but the number of lymphocytes produced is substantially reduced in old individuals. This commentary will highlight observations suggesting that common mechanisms underlie declines in both B and T cell production and that reductions in lymphopoiesis are initiated much earlier than has generally been appreciated.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Dorshkind, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.	kdorshki@mednet.ucla.edu		Montecino Rodriguez, Encarnacion/0000-0002-2826-7503				Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Aspinall R, 2001, CELL IMMUNOL, V212, P150, DOI 10.1006/cimm.2001.1848; Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Bhandoola A, 2003, J IMMUNOL, V171, P5653, DOI 10.4049/jimmunol.171.11.5653; Blackburn CC, 2004, NAT REV IMMUNOL, V4, P278, DOI 10.1038/nri1331; Heng TSP, 2005, J IMMUNOL, V175, P2982, DOI 10.4049/jimmunol.175.5.2982; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; IKUTA K, 1990, CELL, V62, P863, DOI 10.1016/0092-8674(90)90262-D; Johnson KM, 2002, INT IMMUNOL, V14, P1313, DOI 10.1093/intimm/dxf092; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Labrie JE, 2004, J EXP MED, V200, P411, DOI 10.1084/jem.20040845; Miller JP, 2005, SEMIN IMMUNOL, V17, P321, DOI 10.1016/j.smim.2005.05.003; Miller JP, 2003, J IMMUNOL, V171, P2326, DOI 10.4049/jimmunol.171.5.2326; Min HY, 2006, J IMMUNOL, V176, P1007, DOI 10.4049/jimmunol.176.2.1007; Min HY, 2005, IMMUNOL REV, V205, P7, DOI 10.1111/j.0105-2896.2005.00263.x; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Rothenberg EV, 2005, ANNU REV IMMUNOL, V23, P601, DOI 10.1146/annurev.immunol.23.021704.115737; Solana R, 2006, IMMUNITY, V24, P491, DOI 10.1016/j.immuni.2006.05.003; Steinmann G G, 1986, Curr Top Pathol, V75, P43; Stephan RP, 1998, BLOOD, V91, P75, DOI 10.1182/blood.V91.1.75.75_75_88; Stephan RP, 1997, J IMMUNOL, V158, P1598; Taub DD, 2005, IMMUNOL REV, V205, P72, DOI 10.1111/j.0105-2896.2005.00275.x; Thoman ML, 1997, CELL IMMUNOL, V178, P117, DOI 10.1006/cimm.1997.1133; Van der Put E, 2004, J IMMUNOL, V173, P818, DOI 10.4049/jimmunol.173.2.818; Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001	28	23	23	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2006	24	6					659	662		10.1016/j.immuni.2006.06.001	http://dx.doi.org/10.1016/j.immuni.2006.06.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057JN	16782019	Bronze			2022-12-18	WOS:000238592200001
J	MacLennan, ICM				MacLennan, ICM			Germinal centers still hold secrets	IMMUNITY			English	Editorial Material							ACTIVATION	There has been recent progress in understanding the mechanism of somatic hypermutation in germinal centers. By contrast, there is more theory than certainty about the way those cells that acquire heightened affinity for antigen are subsequently selected. Wang and Carter (2005) highlight this in the current issue of Immunity in a study of germinal center development in mice with impaired CD19 signaling.	Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England	University of Birmingham	MacLennan, ICM (corresponding author), Univ Birmingham, MRC, Ctr Immune Regulat, Birmingham B15 2TT, W Midlands, England.							de Vinuesa CG, 2000, J EXP MED, V191, P485, DOI 10.1084/jem.191.3.485; Dempsey PW, 1996, SCIENCE, V271, P348, DOI 10.1126/science.271.5247.348; HANNA MG, 1964, LAB INVEST, V13, P95; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x; LIU YJ, 1991, EUR J IMMUNOL, V21, P2951, DOI 10.1002/eji.1830211209; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; PEZZUTTO A, 1986, WHITE CELL DIFFERENT, P358; Tedder TF, 1997, IMMUNITY, V6, P107, DOI 10.1016/S1074-7613(00)80418-5; Wang Y, 2005, IMMUNITY, V22, P749, DOI 10.1016/j.immuni.2005.04.012	11	23	23	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN	2005	22	6					656	657		10.1016/j.immuni.2005.06.002	http://dx.doi.org/10.1016/j.immuni.2005.06.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	940XX	15963779	Bronze			2022-12-18	WOS:000230180300002
J	Banta, KL; Xu, XZ; Chitre, AS; Au-Yeung, A; Takahashi, C; O'Gorman, WE; Wu, TD; Mittman, S; Cubas, R; Comps-Agrar, L; Fulzele, A; Bennett, EJ; Grogan, JL; Hui, EF; Chiang, EY; Mellman, I				Banta, Karl L.; Xu, Xiaozheng; Chitre, Avantika S.; Au-Yeung, Amelia; Takahashi, Chikara; O'Gorman, William E.; Wu, Thomas D.; Mittman, Stephanie; Cubas, Rafael; Comps-Agrar, Laetitia; Fulzele, Amit; Bennett, Eric J.; Grogan, Jane L.; Hui, Enfu; Chiang, Eugene Y.; Mellman, Ira			Mechanistic convergence of the TIGIT and PD-1 inhibitory pathways necessitates co-blockade to optimize anti-tumor CD8(+) T cell responses	IMMUNITY			English	Article							IMMUNE-RESPONSE; OPEN-LABEL; PHASE-II; ATEZOLIZUMAB; DNAM-1; CD226; CYTOTOXICITY; MULTICENTER; RECRUITMENT; EXHAUSTION	Dual blockade of the PD-1 and TIGIT coinhibitory receptors on T cells shows promising early results in cancer patients. Here, we studied the mechanisms whereby PD-1 and/or TIGIT blockade modulate anti-tumor CD8(+) T cells. Although PD-1 and TIGIT are thought to regulate different costimulatory receptors (CD28 and CD226), effectiveness of PD-1 or TIGIT inhibition in preclinical tumor models was reduced in the absence of CD226. CD226 expression associated with clinical benefit in patients with non-small cell lung carcinoma (NSCLC) treated with anti-PD-L1 antibody atezolizumab. CD226 and CD28 were co-expressed on NSCLC infiltrating CD8(+) T cells poised for expansion. Mechanistically, PD-1 inhibited phosphorylation of both CD226 and CD28 via its ITIM-containing intracellular domain (ICD); TIGIT's ICD was dispensable, with TIGIT restricting CD226 co-stimulation by blocking interaction with their common ligand PVR (CD155). Thus, full restoration of CD226 signaling, and optimal anti-tumor CD8(+) T cell responses, requires blockade of TIGIT and PD-1, providing a mechanistic rationale for combinatorial targeting in the clinic.	[Banta, Karl L.; Chitre, Avantika S.; Au-Yeung, Amelia; Takahashi, Chikara; O'Gorman, William E.; Wu, Thomas D.; Mittman, Stephanie; Cubas, Rafael; Comps-Agrar, Laetitia; Grogan, Jane L.; Chiang, Eugene Y.; Mellman, Ira] Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA; [Xu, Xiaozheng; Fulzele, Amit; Bennett, Eric J.; Hui, Enfu] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Cubas, Rafael] Lovance, 3802 Spectrum Blvd, Tampa, FL 33612 USA; [Grogan, Jane L.] Graphite Bio, 279 E Grand Ave, San Francisco, CA 94080 USA	Roche Holding; Genentech; University of California System; University of California San Diego	Chiang, EY; Mellman, I (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	chiang.eugene@gene.com; mellman.ira@gene.com		Xu, Xiaozheng/0000-0001-6888-4285; Comps-Agrar, Laetitia/0000-0002-5260-6536; Cubas, Rafael/0000-0002-3450-9054				Amsen D, 2018, NAT IMMUNOL, V19, P538, DOI 10.1038/s41590-018-0114-2; Balanca CC, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.142513; Banchereau R, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2020-002231; Beziat V, 2021, CELL, V184, P3812, DOI 10.1016/j.cell.2021.06.004; Braun M., 2020, IMMUNITY, V53; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Chauvin JM, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000957; Chen DS, 2013, IMMUNITY, V39, P1, DOI 10.1016/j.immuni.2013.07.012; Chiang EY, 2020, EUR J IMMUNOL, V50, P891, DOI 10.1002/eji.201948405; Corgnac S, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100127; Craig DJ, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8040562; Dixon KO, 2018, J IMMUNOL, V200, P3000, DOI 10.4049/jimmunol.1700407; Du XN, 2018, P NATL ACAD SCI USA, V115, pE11731, DOI 10.1073/pnas.1814052115; Edelstein Arthur D, 2014, J Biol Methods, V1; Fehrenbacher L, 2016, LANCET, V387, P1837, DOI 10.1016/S0140-6736(16)00587-0; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gilfillan S, 2008, J EXP MED, V205, P2965, DOI 10.1084/jem.20081752; Han JC, 2020, SEMIN IMMUNOL, V49, DOI 10.1016/j.smim.2020.101435; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Hui EF, 2014, NAT STRUCT MOL BIOL, V21, P133, DOI 10.1038/nsmb.2762; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Jansen CS, 2019, NATURE, V576, P465, DOI 10.1038/s41586-019-1836-5; Jin HS, 2020, CANCER IMMUNOL RES, V8, P912, DOI 10.1158/2326-6066.CIR-19-0877; Johnston RJ, 2014, CANCER CELL, V26, P923, DOI 10.1016/j.ccell.2014.10.018; Joller N, 2014, IMMUNITY, V40, P569, DOI 10.1016/j.immuni.2014.02.012; Joller N, 2011, J IMMUNOL, V186, P1338, DOI 10.4049/jimmunol.1003081; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Konduri V, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.613204; Kurtulus S, 2015, J CLIN INVEST, V125, P4053, DOI 10.1172/JCI81187; Li M, 2014, J BIOL CHEM, V289, P17647, DOI 10.1074/jbc.M114.572420; Liu S, 2013, CELL DEATH DIFFER, V20, P456, DOI 10.1038/cdd.2012.141; Lozano E, 2012, J IMMUNOL, V188, P3869, DOI 10.4049/jimmunol.1103627; Lucca LE, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124427; Manes TD, 2011, J IMMUNOL, V186, P1763, DOI 10.4049/jimmunol.1002835; Manieri NA, 2017, TRENDS IMMUNOL, V38, P20, DOI 10.1016/j.it.2016.10.002; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Oh SA, 2020, NAT CANCER, V1, P681, DOI 10.1038/s43018-020-0075-x; Park SL, 2019, TRENDS IMMUNOL, V40, P735, DOI 10.1016/j.it.2019.06.002; Peters S, 2017, J CLIN ONCOL, V35, P2781, DOI 10.1200/JCO.2016.71.9476; Qin S, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1091-2; Ralston KJ, 2004, J BIOL CHEM, V279, P33816, DOI 10.1074/jbc.M401040200; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Rodriguez-Abreu D, 2020, J CLIN ONCOL, V38; Sansom DM, 2006, IMMUNOL REV, V212, P131, DOI 10.1111/j.0105-2896.2006.00419.x; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shah NH, 2018, ELIFE, V7, DOI 10.7554/eLife.35190; Shibuya K, 1999, IMMUNITY, V11, P615, DOI 10.1016/S1074-7613(00)80136-3; Shibuya K, 2003, J EXP MED, V198, P1829, DOI 10.1084/jem.20030958; Shirakawa J, 2005, INT IMMUNOL, V17, P217, DOI 10.1093/intimm/dxh199; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Stanietsky N, 2013, EUR J IMMUNOL, V43, P2138, DOI 10.1002/eji.201243072; Stengel KF, 2012, P NATL ACAD SCI USA, V109, P5399, DOI 10.1073/pnas.1120606109; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Waight JD, 2018, CANCER CELL, V33, P1033, DOI 10.1016/j.ccell.2018.05.005; Wang B, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat7061; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Weulersse M, 2020, IMMUNITY, V53, P824, DOI 10.1016/j.immuni.2020.09.006; Wu TD, 2020, NATURE, V579, P274, DOI 10.1038/s41586-020-2056-8; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Xu X., 2021, MOLECULAR FEATURES U; Yang F, 2020, J IMMUNOL, V205, P2156, DOI 10.4049/jimmunol.1901413; Yost KE, 2021, SCIENCE, V372, P130, DOI 10.1126/science.abd1329; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Yu X, 2009, NAT IMMUNOL, V10, P48, DOI 10.1038/ni.1674; Zarour HM, 2016, CLIN CANCER RES, V22, P1856, DOI 10.1158/1078-0432.CCR-15-1849; Zhang Q, 2018, NAT IMMUNOL, V19, P723, DOI 10.1038/s41590-018-0132-0	68	22	22	18	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					512	+		10.1016/j.immuni.2022.02.005	http://dx.doi.org/10.1016/j.immuni.2022.02.005			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ5WU	35263569	hybrid, Green Accepted			2022-12-18	WOS:000767175700002
J	Levine, LS; Hiam-Galvez, KJ; Marquez, DM; Tenvooren, I; Madden, MZ; Contreras, DC; Dahunsi, DO; Irish, JM; Oluwole, OO; Rathmell, JC; Spitzer, MH				Levine, Lauren S.; Hiam-Galvez, Kamir J.; Marquez, Diana M.; Tenvooren, Iliana; Madden, Matthew Z.; Contreras, Diana C.; Dahunsi, Debolanle O.; Irish, Jonathan M.; Oluwole, Olalekan O.; Rathmell, Jeffrey C.; Spitzer, Matthew H.			Single-cell analysis by mass cytometry reveals metabolic states of early-activated CD8(+) T cells during the primary immune response	IMMUNITY			English	Article							MITOCHONDRIAL BIOGENESIS; MEMORY; ACID; REGULATOR; CANCER; DIFFERENTIATION; LYMPHOCYTE; INFLAMMATION; PROGRESSION; TRANSPORTER	Memory T cells are thought to rely on oxidative phosphorylation and short-lived effector T cells on glycolysis. Here, we investigated how T cells arrive at these states during an immune response. To understand the metabolic state of rare, early-activated T cells, we adapted mass cytometry to quantify metabolic regulators at single-cell resolution in parallel with cell signaling, proliferation, and effector function. We interrogated CD8(+) T cell activation in vitro and in response to Listeria monocytogenes infection in vivo. This approach revealed a distinct metabolic state in early-activated T cells characterized by maximal expression of glycolytic and oxidative metabolic proteins. Cells in this transient state were most abundant 5 days post-infection before rapidly decreasing metabolic protein expression. Analogous findings were observed in chimeric antigen receptor (CAR) T cells interrogated longitudinally in advanced lymphoma patients. Our study demonstrates the utility of single-cell metabolic analysis by mass cytometry to identify metabolic adaptations of immune cell populations in vivo and provides a resource for investigations of metabolic regulation of immune responses across a variety of applications.	[Levine, Lauren S.; Hiam-Galvez, Kamir J.; Marquez, Diana M.; Tenvooren, Iliana; Spitzer, Matthew H.] Univ Calif San Francisco, Dept Otolaryngol Head & Neck Canc, San Francisco, CA 94143 USA; [Levine, Lauren S.; Hiam-Galvez, Kamir J.; Marquez, Diana M.; Tenvooren, Iliana; Spitzer, Matthew H.] Univ Calif San Francisco, GW Hooper Res Fdn, Dept Immunol & Microbiol, San Francisco, CA 94143 USA; [Levine, Lauren S.; Hiam-Galvez, Kamir J.; Marquez, Diana M.; Tenvooren, Iliana; Spitzer, Matthew H.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA; [Levine, Lauren S.; Hiam-Galvez, Kamir J.; Marquez, Diana M.; Tenvooren, Iliana; Spitzer, Matthew H.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Levine, Lauren S.; Hiam-Galvez, Kamir J.; Marquez, Diana M.; Tenvooren, Iliana; Spitzer, Matthew H.] Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA; [Levine, Lauren S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Madden, Matthew Z.; Contreras, Diana C.; Dahunsi, Debolanle O.; Irish, Jonathan M.; Rathmell, Jeffrey C.] Vanderbilt Univ, Med Ctr, Vanderbilt Ctr Immunobiol, Dept Pathol Microbiol & Immunol, Nashville, TN 37232 USA; [Oluwole, Olalekan O.] Vanderbilt Univ, Med Ctr, Dept Med, Div Hematol Oncol, Nashville, TN 37232 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; Vanderbilt University; Vanderbilt University	Spitzer, MH (corresponding author), Univ Calif San Francisco, Dept Otolaryngol Head & Neck Canc, San Francisco, CA 94143 USA.; Spitzer, MH (corresponding author), Univ Calif San Francisco, GW Hooper Res Fdn, Dept Immunol & Microbiol, San Francisco, CA 94143 USA.; Spitzer, MH (corresponding author), Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA.; Spitzer, MH (corresponding author), Chan Zuckerberg Biohub, San Francisco, CA 94158 USA.; Spitzer, MH (corresponding author), Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA.	matthew.spitzer@ucsf.edu		Dahunsi, Debolanle/0000-0002-5230-022X; Madden, Matthew/0000-0003-4062-4427; Levine, Lauren/0000-0001-5504-7736; Hiam, Kamir/0000-0002-1956-0257	NIH [P30DK063720, S10OD018040, S10OD021822, DP5OD023056, R01DK105550, R01HL136664, F30CA239367]; Conquer Cancer Foundation Young Investigator Award [CA-0122026]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Conquer Cancer Foundation Young Investigator Award	We would like to thank the members of the Spitzer lab, Vinh Ngyuen, Stanley Tamaki, Sagar Bapat, Adil Daud, Lawrence Fong, Andrei Goga, and Rushika Perera for their experimental contributions and helpful discussions. Listeria monocytogenes strain 10403s expressing OVA (Lm-OVA) was kindly provided by Shomyseh Sanjabi (UCSF). We acknowledge the Parnassus Flow Cytometry Core Facility, which is supported in part by NIH grants P30DK063720, S10OD018040, S10OD018040, and S10OD021822. Recombinant human IL2 (IL-2, TECIN, Teceleukin) was provided by the National Cancer Institute. This work was supported by NIH grant DP5OD023056 to M.H.S. and grants R01DK105550 and R01HL136664 to J.C.R. M.Z.M was supported by NIH grant F30CA239367. L.S.L. was supported by Conquer Cancer Foundation Young Investigator Award grant CA-0122026. M.H.S. is a Chan Zuckerberg Biohub investigator and a Parker Institute for Cancer Immunotherapy investigator.	Ahl PJ, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-1027-9; Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Andrejeva G, 2017, CELL METAB, V26, P49, DOI 10.1016/j.cmet.2017.06.004; Araki K., 2010, HHS PUBLIC ACCESS, V460, P108; Artyomov MN, 2020, CELL METAB, V32, P710, DOI 10.1016/j.cmet.2020.09.013; Badovinac VP, 2007, IMMUNITY, V26, P827, DOI 10.1016/j.immuni.2007.04.013; Bandura DR, 2009, ANAL CHEM, V81, P6813, DOI 10.1021/ac901049w; Bastian M., 2009, 3 INT AAAI C WEBLOGS; Bendall SC, 2014, CELL, V157, P714, DOI 10.1016/j.cell.2014.04.005; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bodenmiller B, 2012, NAT BIOTECHNOL, V30, P858, DOI 10.1038/nbt.2317; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Callahan MK, 2016, IMMUNITY, V44, P1069, DOI 10.1016/j.immuni.2016.04.023; Cantor JR, 2017, CELL, V169, P258, DOI 10.1016/j.cell.2017.03.023; CARPENTER K, 1992, BIOCHEM BIOPH RES CO, V183, P443, DOI 10.1016/0006-291X(92)90501-B; Carrio R, 2004, J IMMUNOL, V172, P7315, DOI 10.4049/jimmunol.172.12.7315; Cheung P, 2018, CELL, V173, P1385, DOI 10.1016/j.cell.2018.03.079; Chisolm DA, 2017, IMMUNITY, V47, P251, DOI 10.1016/j.immuni.2017.07.015; Chu T, 2013, CELL REP, V3, P701, DOI 10.1016/j.celrep.2013.02.020; Cunningham CA, 2018, J IMMUNOL, V201, P1627, DOI 10.4049/jimmunol.1800705; D'Souza AD, 2007, MITOCHONDRION, V7, P374, DOI 10.1016/j.mito.2007.08.001; da Silva HB, 2018, NATURE, V559, P264, DOI 10.1038/s41586-018-0282-0; Dennis M.K., 2012, CELL, V127, P358; Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Fracchia KM, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00324; Geltink RIK, 2017, CELL, V171, P385, DOI 10.1016/j.cell.2017.08.018; Good Z, 2019, NAT BIOTECHNOL, V37, P259, DOI 10.1038/s41587-019-0033-2; Gray SM, 2017, IMMUNITY, V46, P596, DOI 10.1016/j.immuni.2017.03.012; Hartmann FJ, 2021, NAT BIOTECHNOL, V39, DOI 10.1038/s41587-020-0651-8; Harty JT, 2002, CURR OPIN IMMUNOL, V14, P360, DOI 10.1016/S0952-7915(02)00333-3; Hayashi K, 2013, J IMMUNOL, V191, P4080, DOI 10.4049/jimmunol.1300923; Howie D, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01949; Jiang J, 2003, J IMMUNOL, V171, P4352, DOI 10.4049/jimmunol.171.8.4352; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2001, NAT IMMUNOL, V2, P415, DOI 10.1038/87720; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Krishnaswamy S, 2014, SCIENCE, V346, P1079, DOI 10.1126/science.1250689; Laforge M, 2016, CELL DEATH DIFFER, V23, P89, DOI 10.1038/cdd.2015.42; Lee J, 2014, J IMMUNOL, V192, P3190, DOI 10.4049/jimmunol.1302985; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Ma EH, 2019, IMMUNITY, V51, P856, DOI 10.1016/j.immuni.2019.09.003; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; MCGREGOR DD, 1970, NATURE, V228, P855, DOI 10.1038/228855a0; Menk AV, 2018, J EXP MED, V215, P1091, DOI 10.1084/jem.20171068; Menk AV, 2018, CELL REP, V22, P1509, DOI 10.1016/j.celrep.2018.01.040; Mingueneau M, 2014, P NATL ACAD SCI USA, V111, P16466, DOI 10.1073/pnas.1419337111; Nii T, 2001, BIOCHEM J, V358, P693, DOI 10.1042/0264-6021:3580693; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Obar JJ, 2010, J IMMUNOL, V185, P263, DOI 10.4049/jimmunol.1000492; Olenchock BA, 2017, IMMUNITY, V46, P703, DOI 10.1016/j.immuni.2017.04.013; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pollizzi KN, 2015, J CLIN INVEST, V125, P2090, DOI 10.1172/JCI77746; Raud B, 2018, CELL METAB, V28, P504, DOI 10.1016/j.cmet.2018.06.002; Ren W, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.222; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Shen H, 1998, CELL, V92, P535, DOI 10.1016/S0092-8674(00)80946-0; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Spitzer MH, 2016, CELL, V165, P780, DOI 10.1016/j.cell.2016.04.019; Spitzer MH, 2015, SCIENCE, V349, DOI 10.1126/science.1259425; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Teijeira A, 2018, CANCER IMMUNOL RES, V6, P798, DOI 10.1158/2326-6066.CIR-17-0767; van der Windt Gerritje J W, 2016, Curr Protoc Immunol, V113, DOI 10.1002/0471142735.im0316bs113; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wherry EJ, 2004, J VIROL, V78, P5535, DOI 10.1128/JVI.78.11.5535-5545.2004; WIEGAND G, 1986, ANNU REV BIOPHYS BIO, V15, P97; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017; Zhang LJ, 2018, TRENDS MOL MED, V24, P30, DOI 10.1016/j.molmed.2017.11.005; Zunder ER, 2015, CELL STEM CELL, V16, P323, DOI 10.1016/j.stem.2015.01.015	76	22	23	3	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					829	+		10.1016/j.immuni.2021.02.018	http://dx.doi.org/10.1016/j.immuni.2021.02.018		APR 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33705706	Green Accepted, Bronze			2022-12-18	WOS:000640102800020
J	Kim, S; Bagadia, P; Anderson, DA; Liu, TT; Huang, X; Theisen, DJ; O'Connor, KW; Ohara, RA; Iwata, A; Murphy, TL; Murphy, KM				Kim, Sunkyung; Bagadia, Prachi; Anderson, David A., III; Liu, Tian-Tian; Huang, Xiao; Theisen, Derek J.; O'Connor, Kevin W.; Ohara, Ray A.; Iwata, Arifumi; Murphy, Theresa L.; Murphy, Kenneth M.			High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity	IMMUNITY			English	Article							IFN REGULATORY FACTOR-4; GENE-EXPRESSION; FACTOR PU.1; PROTEIN INTERACTIONS; ACTIVATION; DIFFERENTIATION; MACROPHAGES; INVOLVEMENT; PROGENITORS; ORCHESTRATE	Development and function of conventional dendritic cell (cDC) subsets, cDC1 and cDC2, depend on transcription factors (TFs) IRF8 and IRF4, respectively. Since IRF8 and IRF4 can each interact with TF BATF3 at AP1-IRF composite elements (AICEs) and with TF PU.1 at Ets-IRF composite elements (EICEs), it is unclear how these factors exert divergent actions. Here, we determined the basis for distinct effects of IRF8 and IRF4 in cDC development. Genes expressed commonly by cDC1 and cDC2 used EICE-dependent enhancers that were redundantly activated by low amounts of either IRF4 or IRF8. By contrast, cDC1 -specific genes relied on AICE-dependent enhancers, which required high IRF concentrations, but were activated by either IRF4 or IRF8. IRF8 was specifically required only by a minority of cDC1 -specific genes, such as Xcr1, which could distinguish between IRF8 and IRF4 DNA-binding domains. Thus, these results explain how BATF3-dependent Irf8 autoactivation underlies emergence of the cDC1-specific transcriptional program.	[Kim, Sunkyung; Bagadia, Prachi; Anderson, David A., III; Liu, Tian-Tian; Huang, Xiao; Theisen, Derek J.; O'Connor, Kevin W.; Ohara, Ray A.; Iwata, Arifumi; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Murphy, Kenneth M.] Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA; [Bagadia, Prachi] Amgen Inc, Dept Oncol, 1120 Vet Blvd, San Francisco, CA 94080 USA; [Iwata, Arifumi] Chiba Univ, Grad Sch Med, Dept Allergy & Clin Immunol, Chiba 2608670, Japan	Washington University (WUSTL); Howard Hughes Medical Institute; Washington University (WUSTL); Amgen; Chiba University	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Murphy, KM (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, St Louis, MO 63110 USA.	kmurphy@wustl.edu	Huang, Xiao/GPF-9961-2022	Huang, Xiao/0000-0002-2754-5225; Ohara, Ray/0000-0001-7897-3169; Iwata, Arifumi/0000-0002-8771-481X; Theisen, Derek/0000-0002-2204-8676; O&apos;Connor, Kevin/0000-0002-5542-405X	National Cancer Institute's Cancer Center Support grant [P30 CA91842]; Institute of Clinical and Translational Sciences/Clinical and Trans-lational Science Award from National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1TR000448]; NIH Roadmap for Medical Research; Howard Hughes Medical Institute; NIH [R01AI150297]; National Science Foundation [DGE-1745038, DGE-1143954]; National Cancer Institute of NIH [F31 CA228240]	National Cancer Institute's Cancer Center Support grant; Institute of Clinical and Translational Sciences/Clinical and Trans-lational Science Award from National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Cancer Institute of NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the Genome Technology Access Center in the Department of Genetics at Washington University School of Medicine for help with genomic analysis. The center is partially supported by the National Cancer Institute's Cancer Center Support grant no. P30 CA91842 to the Siteman Cancer Center and by the Institute of Clinical and Translational Sciences/Clinical and Trans-lational Science Award grant no. UL1TR000448 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) and NIH Roadmap for Medical Research. This publication is solely the responsibility of the authors and does not necessarily represent the official view of the NCRR or NIH. This work benefitted from data assembled by the ImmGen consortium (Heng et al., 2008). This work was supported by the Howard Hughes Medical Institute and NIH (grant no. R01AI150297 to K.M.M.), the National Science Foundation (grant no. DGE-1745038 to P.B. and DGE-1143954 to D.A.A.), and National Cancer Institute of NIH (grant no. F31 CA228240 to D.A.A.).	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Alexeyev MF, 2010, MOL BIOL REP, V37, P1987, DOI 10.1007/s11033-009-9647-7; Anderson DA, 2017, EUR J IMMUNOL, V47, P1317, DOI 10.1002/eji.201747050; Bajana S, 2016, J IMMUNOL, V196, P1666, DOI 10.4049/jimmunol.1501870; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; BOVOLENTA C, 1994, P NATL ACAD SCI USA, V91, P5046, DOI 10.1073/pnas.91.11.5046; Brahler S, 2018, J AM SOC NEPHROL, V29, P138, DOI 10.1681/ASN.2017030270; Briseno CG, 2016, CELL REP, V15, P2462, DOI 10.1016/j.celrep.2016.05.025; Carotta S, 2010, IMMUNITY, V32, P628, DOI 10.1016/j.immuni.2010.05.005; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; Chopin M, 2019, IMMUNITY, V50, P77, DOI 10.1016/j.immuni.2018.11.010; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Collin M, 2018, IMMUNOLOGY, V154, P3, DOI 10.1111/imm.12888; Crozat K, 2011, J IMMUNOL, V187, P4411, DOI 10.4049/jimmunol.1101717; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Durai V, 2019, NAT IMMUNOL, V20, P1161, DOI 10.1038/s41590-019-0450-x; Durai V, 2018, J EXP MED, V215, P1417, DOI 10.1084/jem.20171784; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; EISENBEIS CF, 1995, GENE DEV, V9, P1377, DOI 10.1101/gad.9.11.1377; Ginhoux F, 2009, J EXP MED, V206, P3115, DOI 10.1084/jem.20091756; Glasmacher E, 2012, SCIENCE, V338, P975, DOI 10.1126/science.1228309; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Hambleton S, 2011, NEW ENGL J MED, V365, P127, DOI 10.1056/NEJMoa1100066; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; HESS JL, 1989, J VIROL, V63, P3001, DOI 10.1128/JVI.63.7.3001-3015.1989; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Honda K, 2004, P NATL ACAD SCI USA, V101, P2416, DOI 10.1073/pnas.0307336101; Humblin E, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01070-w; Ichikawa E, 2004, P NATL ACAD SCI USA, V101, P3909, DOI 10.1073/pnas.0400610101; Iwata A, 2017, NAT IMMUNOL, V18, P563, DOI 10.1038/ni.3714; Kanno Y, 2005, J INTERF CYTOK RES, V25, P770, DOI 10.1089/jir.2005.25.770; KLEMSZ MJ, 1990, CELL, V61, P113, DOI 10.1016/0092-8674(90)90219-5; Koblansky AA, 2013, IMMUNITY, V38, P119, DOI 10.1016/j.immuni.2012.09.016; Kretzer NM, 2016, J EXP MED, V213, P2871, DOI 10.1084/jem.20160597; Krishnamoorthy V, 2017, IMMUNITY, V47, P481, DOI 10.1016/j.immuni.2017.09.001; Kuwata T, 2002, MOL CELL BIOL, V22, P7439, DOI 10.1128/MCB.22.21.7439-7448.2002; Lau CM, 2018, J EXP MED, V215, P2265, DOI 10.1084/jem.20172323; Lee J, 2017, NAT IMMUNOL, V18, P877, DOI 10.1038/ni.3789; Li P, 2012, NATURE, V490, P543, DOI 10.1038/nature11530; Lin Q, 2015, NUCLEIC ACIDS RES, V43, P9680, DOI 10.1093/nar/gkv1056; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; Lu RQ, 2003, GENE DEV, V17, P1703, DOI 10.1101/gad.1104803; Lugt BV, 2014, NAT IMMUNOL, V15, P161, DOI 10.1038/ni.2795; Ma SB, 2006, J IMMUNOL, V177, P7898, DOI 10.4049/jimmunol.177.11.7898; Mashayekhi M, 2011, IMMUNITY, V35, P249, DOI 10.1016/j.immuni.2011.08.008; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Meraro D, 1999, J IMMUNOL, V163, P6468; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nayar R, 2014, J IMMUNOL, V192, P5881, DOI 10.4049/jimmunol.1303187; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Raetz M, 2013, J IMMUNOL, V191, P4818, DOI 10.4049/jimmunol.1301301; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; SHIH DS, 1992, VIROLOGY, V190, P84, DOI 10.1016/0042-6822(92)91194-Y; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Tamura T, 2005, J IMMUNOL, V174, P2573, DOI 10.4049/jimmunol.174.5.2573; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Theisen DJ, 2019, CANCER IMMUNOL RES, V7, P29, DOI 10.1158/2326-6066.CIR-18-0138; Theisen DJ, 2018, SCIENCE, V362, P694, DOI 10.1126/science.aat5030; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; VEALS SA, 1993, MOL CELL BIOL, V13, P196, DOI 10.1128/MCB.13.1.196; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025812	72	22	22	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					759	+		10.1016/j.immuni.2020.07.018	http://dx.doi.org/10.1016/j.immuni.2020.07.018			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	32795402	Bronze, Green Accepted			2022-12-18	WOS:000581062800010
J	Sciume, G; Mikami, Y; Jankovic, D; Nagashima, H; Villarino, AV; Morrison, T; Yao, C; Signorella, S; Sun, HW; Brooks, SR; Fang, DF; Sartorelli, V; Nakayamada, S; Hirahara, K; Zitti, B; Davis, FP; Kanno, Y; O'Shea, JJ; Shih, HY				Sciume, Giuseppe; Mikami, Yohei; Jankovic, Dragana; Nagashima, Hiroyuki; Villarino, Alejandro V.; Morrison, Tasha; Yao, Chen; Signorella, Sadie; Sun, Hong-Wei; Brooks, Stephen R.; Fang, Difeng; Sartorelli, Vittorio; Nakayamada, Shingo; Hirahara, Kiyoshi; Zitti, Beatrice; Davis, Fred P.; Kanno, Yuka; O'Shea, John J.; Shih, Han-Yu			Rapid Enhancer Remodeling and Transcription Factor Repurposing Enable High Magnitude Gene Induction upon Acute Activation of NK Cells	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; NATURAL-KILLER-CELLS; SUPER-ENHANCERS; T-CELL; OPEN CHROMATIN; CUTTING EDGE; HELPER T; EXPRESSION; MACROPHAGE; LANDSCAPE	Innate immune responses rely on rapid and precise gene regulation mediated by accessibility of regulatory regions to transcription factors (TFs). In natural killer (NK) cells and other innate lymphoid cells, competent enhancers are primed during lineage acquisition, and formation of de novo enhancers characterizes the acquisition of innate memory in activated NK cells and macrophages. Here, we investigated how primed and de novo enhancers coordinate to facilitate high-magnitude gene induction during acute activation. Epigenomic and transcriptomic analyses of regions near highly induced genes (HIGs) in NK cells both in vitro and in a model of Toxoplasma gondii infection revealed de novo chromatin accessibility and enhancer remodeling controlled by signal-regulated TFs STATs. Acute NK cell activation redeployed the lineage-determining TF T-bet to de novo enhancers, independent of DNA-sequence-specific motif recognition. Thus, acute stimulation reshapes enhancer function through the combinatorial usage and repurposing of both lineage-determining and signal-regulated TFs to ensure an effective response.	[Sciume, Giuseppe; Mikami, Yohei; Nagashima, Hiroyuki; Villarino, Alejandro V.; Morrison, Tasha; Yao, Chen; Signorella, Sadie; Nakayamada, Shingo; Hirahara, Kiyoshi; Zitti, Beatrice; Davis, Fred P.; Kanno, Yuka; O'Shea, John J.; Shih, Han-Yu] NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Sciume, Giuseppe] Sapienza Univ Rome, Dept Mol Med, Lab Affiliated Ist Pasteur Italia Fdn Cenci Bolog, I-00185 Rome, Italy; [Jankovic, Dragana] NIAID, Immunol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Sun, Hong-Wei; Brooks, Stephen R.] NIAMSD, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Fang, Difeng] NIAID, Mol & Cellular Immunoregulat Sect, Lab Immune Syst Biol, NIH, Bethesda, MD 20892 USA; [Sartorelli, Vittorio] NIAMSD, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA; [Shih, Han-Yu] NEI, Neuroimmune Regulome Unit, NIH, Bethesda, MD 20892 USA; [Shih, Han-Yu] NINDS, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Sapienza University Rome; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Shih, HY (corresponding author), NIAMSD, Lymphocyte Cell Biol Sect, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.; Shih, HY (corresponding author), NEI, Neuroimmune Regulome Unit, NIH, Bethesda, MD 20892 USA.; Shih, HY (corresponding author), NINDS, NIH, Bethesda, MD 20892 USA.	han-yu.shih@nih.gov	Nagashima, Hiroyuki/AAL-3128-2021; MIKAMI, YOHEI/GRJ-8133-2022; FANG, DIFENG/G-7796-2018; Kanno, Yuka/B-5802-2013; Sciume, Giuseppe/K-8985-2016; Hirahara, Kiyoshi/E-2460-2017	MIKAMI, YOHEI/0000-0001-5104-4415; FANG, DIFENG/0000-0003-2105-6743; Kanno, Yuka/0000-0001-5668-9319; Sciume, Giuseppe/0000-0003-0131-512X; Villarino, Alejandro/0000-0001-8068-2176; Nagashima, Hiroyuki/0000-0001-8405-6746; Hirahara, Kiyoshi/0000-0002-9128-9449; Yao, Chen/0000-0001-6852-5661; Shih, Han-Yu/0000-0002-7525-5433	NIAMS; NIAID; Italian Association for Cancer Research (AIRC) (MFAG 2018) [21311]; NEI	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Italian Association for Cancer Research (AIRC) (MFAG 2018); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank S. Dell'Orso, G. Gutierrez-Cruz (Genomic Technology Section, NIAMS), J. Simone, J. Lay, and K. Tinsley (Flow Cytometry Section, NIAMS) for their excellent technical support. We thank Dr. Nilisha Fernando for proofreading this manuscript. This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the NIH. This work was supported by the Intramural Research Programs of the NEI, NIAMS, and NIAID and the Italian Association for Cancer Research (AIRC) (MFAG 2018; project code 21311).	Barton K, 1998, IMMUNITY, V9, P555, DOI 10.1016/S1074-7613(00)80638-X; Bezman NA, 2012, NAT IMMUNOL, V13, P1000, DOI 10.1038/ni.2395; Bonelli M, 2014, CURR TOP MICROBIOL, V381, P279, DOI 10.1007/82_2014_371; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Choi HJ, 2011, BLOOD, V117, P1880, DOI 10.1182/blood-2010-09-309468; Collins PL, 2019, CELL, V176, P348, DOI 10.1016/j.cell.2018.11.045; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Ebihara T, 2015, NAT IMMUNOL, V16, P1124, DOI 10.1038/ni.3272; Eckelhart E, 2011, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Furlong EEM, 2018, SCIENCE, V361, P1341, DOI 10.1126/science.aau0320; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Glass CK, 2016, NAT IMMUNOL, V17, P26, DOI 10.1038/ni.3306; Goldszmid RS, 2012, IMMUNITY, V36, P1047, DOI 10.1016/j.immuni.2012.03.026; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Heinz S, 2012, CURR TOP MICROBIOL, V356, P1, DOI 10.1007/82_2011_142; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hnisz D, 2016, CELL, V167, P1188, DOI 10.1016/j.cell.2016.10.024; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Huntington ND, 2007, NAT IMMUNOL, V8, P856, DOI 10.1038/ni1487; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Koues OI, 2016, CELL, V165, P1134, DOI 10.1016/j.cell.2016.04.014; Kugler DG, 2013, J EXP MED, V210, P1919, DOI 10.1084/jem.20122300; Lacorazza HD, 2002, IMMUNITY, V17, P437, DOI 10.1016/S1074-7613(02)00422-3; Langmead B., 2012, GENOME BIOL, V10, pR25; Lau CM, 2018, NAT IMMUNOL, V19, P963, DOI 10.1038/s41590-018-0176-1; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Loven J, 2013, CELL, V153, P320, DOI 10.1016/j.cell.2013.03.036; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Madera S, 2018, J IMMUNOL, V200, P1977, DOI 10.4049/jimmunol.1700416; Mao YM, 2016, BLOOD, V128, P1475, DOI 10.1182/blood-2016-02-698027; Marais A, 2014, NAT IMMUNOL, V15, P749, DOI 10.1038/ni.2936; Marcais A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00450; Mikami Y, 2018, EUR J IMMUNOL, V48, P1174, DOI 10.1002/eji.201847480; Miyagi T, 2007, J EXP MED, V204, P2383, DOI 10.1084/jem.20070401; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Phan AT, 2017, IMMUNITY, V46, P714, DOI 10.1016/j.immuni.2017.04.016; Pope SD, 2018, MOL CELL, V71, P389, DOI 10.1016/j.molcel.2018.07.017; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rapp M, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan3796; Sciume G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01579; Sher A, 2003, IMMUNOL RES, V27, P521, DOI 10.1385/IR:27:2-3:521; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Shih HY, 2014, IMMUNOL REV, V261, P23, DOI 10.1111/imr.12208; Smale ST, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016261; Smale ST, 2014, ANNU REV IMMUNOL, V32, P489, DOI 10.1146/annurev-immunol-031210-101303; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stabile H, 2018, IMMUNOL REV, V286, P148, DOI 10.1111/imr.12705; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Tarrio ML, 2014, J IMMUNOL, V193, P354, DOI 10.4049/jimmunol.1302999; Tato C, 2004, J IMMUNOL, V173, P1514, DOI 10.4049/jimmunol.173.3.1514; Tong AJ, 2016, CELL, V165, P165, DOI 10.1016/j.cell.2016.01.020; Townsend MJ, 2004, IMMUNITY, V20, P477, DOI 10.1016/S1074-7613(04)00076-7; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Villarino AV, 2017, J EXP MED, V214, P2999, DOI 10.1084/jem.20150907; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035; Winter DR, 2014, IMMUNOL REV, V261, P9, DOI 10.1111/imr.12200; Witte S, 2015, TRENDS IMMUNOL, V36, P519, DOI 10.1016/j.it.2015.07.005; Xu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052209; Yao ZJ, 2006, P NATL ACAD SCI USA, V103, P1000, DOI 10.1073/pnas.0507350103; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zaret KS, 2011, GENE DEV, V25, P2227, DOI 10.1101/gad.176826.111; Zhang J, 2018, EUR J IMMUNOL, V48, P738, DOI 10.1002/eji.201747299; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	71	22	22	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					745	+		10.1016/j.immuni.2020.09.008	http://dx.doi.org/10.1016/j.immuni.2020.09.008			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	33010223	Green Submitted, Bronze, Green Accepted			2022-12-18	WOS:000581062800009
J	Chauveau, A; Pirgova, G; Cheng, HW; De Martin, A; Zhou, FY; Wideman, S; Rittscher, J; Ludewig, B; Arnon, TI				Chauveau, Anne; Pirgova, Gabriela; Cheng, Hung-Wei; De Martin, Angelina; Zhou, Felix Y.; Wideman, Sarah; Rittscher, Jens; Ludewig, Burkhard; Arnon, Tal, I			Visualization of T Cell Migration in the Spleen Reveals a Network of Perivascular Pathways that Guide Entry into T Zones	IMMUNITY			English	Article							SPLENIC WHITE PULP; BLOOD-VESSELS; LYMPHOCYTE MIGRATION; BRIDGING CHANNELS; TRAFFICKING; CHEMOKINES; MOLECULES; SELECTION; ANTIGEN	Lymphocyte homeostasis and immune surveillance require that T and B cells continuously recirculate between secondary lymphoid organs. Here, we used intravital microscopy to define lymphocyte trafficking routes within the spleen, an environment of open blood circulation and shear forces unlike other lymphoid organs. Upon release from arterioles into the red pulp sinuses, T cells latched onto perivascular stromal cells in a manner that was independent of the chemokine receptor CCR7 but sensitive to Gi protein-coupled receptor inhibitors. This latching sheltered T cells from blood flow and enabled unidirectional migration to the bridging channels and then to T zones, entry into which required CCR7. Inflammatory responses modified the chemotactic cues along the perivascular homing paths, leading to rapid block of entry. Our findings reveal a role for vascular structures in lymphocyte recirculation through the spleen, indicating the existence of separate entry and exit routes and that of a checkpoint located at the gate to the T zone.	[Chauveau, Anne; Pirgova, Gabriela; Wideman, Sarah; Arnon, Tal, I] Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England; [Cheng, Hung-Wei; De Martin, Angelina; Ludewig, Burkhard] Kantonsspital St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland; [Zhou, Felix Y.; Rittscher, Jens] Univ Oxford, Ludwig Inst Canc Res, Oxford OX3 7DQ, England; [Rittscher, Jens] Univ Oxford, Inst Biomed Engn, Oxford OX3 7DQ, England; [Rittscher, Jens] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Oxford OX3 7XP, England	University of Oxford; Kantonsspital St. Gallen; Ludwig Institute for Cancer Research; University of Oxford; University of Oxford; University of Oxford	Arnon, TI (corresponding author), Univ Oxford, Kennedy Inst Rheumatol, Oxford OX3 7FY, England.	tal.arnon@kennedy.ox.ac.uk	joy, shone/AAR-3728-2020	Wideman, Sarah Karin/0000-0001-7803-9894; Zhou, Felix/0000-0003-4463-1165; De Martin, Angelina/0000-0002-9056-8075; Pirgova, Gabriela/0000-0003-1033-5755	Wellcome Trust, United Kingdom, through an Investigator Award [106245/Z/14/Z]; Kennedy Trust, United Kingdom, through a Senior Fellowship	Wellcome Trust, United Kingdom, through an Investigator Award; Kennedy Trust, United Kingdom, through a Senior Fellowship	We thank Bostjan Markelc for the VE-cadherin tdTomato mice; Tri Phan, Oliver Bannard, Elizabeth Thompson, Irina Grigorova, and Jason Cyster for critical reading of the manuscript, and Audrey Gerard and Enas Abu-Shah for helpful discussion. This work was supported by the Wellcome Trust, United Kingdom, through an Investigator Award (T.I.A., 106245/Z/14/Z) and the Kennedy Trust, United Kingdom, through a Senior Fellowship.	Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Arnon TI, 2013, NATURE, V493, P684, DOI 10.1038/nature11738; Bajenoff M, 2008, J IMMUNOL, V181, P3947, DOI 10.4049/jimmunol.181.6.3947; Benedict CA, 2006, PLOS PATHOG, V2, P164, DOI 10.1371/journal.ppat.0020016; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Bovetti S, 2007, J NEUROSCI, V27, P5976, DOI 10.1523/JNEUROSCI.0678-07.2007; BRELINSKA R, 1984, CELL TISSUE RES, V236, P661, DOI 10.1007/BF00217236; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Calderon L, 2011, P NATL ACAD SCI USA, V108, P7517, DOI 10.1073/pnas.1016428108; Cheng HW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09728-3; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; CYSTER JG, 1995, J EXP MED, V182, P581, DOI 10.1084/jem.182.2.581; Cyster JG, 1999, SCIENCE, V286, P2098, DOI 10.1126/science.286.5447.2098; Dupre L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00586; FORD WL, 1969, SEMIN HEMATOL, V6, P67; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; Hons M, 2018, NAT IMMUNOL, V19, P606, DOI 10.1038/s41590-018-0109-z; Hu JK, 2011, P NATL ACAD SCI USA, V108, pE118, DOI 10.1073/pnas.1101881108; Kaneider NC, 2006, FEBS J, V273, P4416, DOI 10.1111/j.1742-4658.2006.05441.x; Khanna KM, 2007, SCIENCE, V318, P116, DOI 10.1126/science.1146291; KOTANI M, 1986, ACTA ANAT, V126, P193; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; Lewis SM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6085; Lo CG, 2003, J EXP MED, V197, P353, DOI 10.1084/jem.20021569; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Luster AD, 2005, NAT IMMUNOL, V6, P1182, DOI 10.1038/ni1275; Manevich-Mendelson E, 2010, BLOOD, V116, P5907, DOI 10.1182/blood-2010-06-293506; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mebius RE, 2005, NAT REV IMMUNOL, V5, P606, DOI 10.1038/nri1669; Mempel TR, 2004, CURR OPIN IMMUNOL, V16, P406, DOI 10.1016/j.coi.2004.05.018; MITCHELL J, 1973, IMMUNOLOGY, V24, P93; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; NIEUWENHUIS P, 1976, CELL IMMUNOL, V23, P254, DOI 10.1016/0008-8749(76)90191-X; Nolte MA, 2003, J EXP MED, V198, P505, DOI 10.1084/jem.20021801; Nolte MA, 2002, IMMUNOLOGY, V106, P299, DOI 10.1046/j.1365-2567.2002.01443.x; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Ozerlat Iley, 2011, Nat Rev Neurol, V7, P246, DOI 10.1038/nrneurol.2011.52; Saghatelyan A, 2009, SEMIN CELL DEV BIOL, V20, P744, DOI 10.1016/j.semcdb.2009.04.006; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Segarra M, 2015, MECH DEVELOP, V138, P17, DOI 10.1016/j.mod.2015.07.004; Shah S, 2015, ELIFE, V4, DOI 10.7554/eLife.09017; Sixt M, 2006, CURR OPIN CELL BIOL, V18, P482, DOI 10.1016/j.ceb.2006.08.007; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; SPANGRUDE GJ, 1985, J IMMUNOL, V135, P4135; Sparwasser T, 2007, IMMUNOLOGY, V121, P308, DOI 10.1111/j.1365-2567.2007.02605.x; Tadayon S, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aat0297; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Zhou FY, 2019, ELIFE, V8, DOI 10.7554/eLife.40162	52	22	22	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					794	+		10.1016/j.immuni.2020.03.010	http://dx.doi.org/10.1016/j.immuni.2020.03.010			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32298648	hybrid, Green Published			2022-12-18	WOS:000535371100013
J	Fukushima, K; Satoh, T; Sugihara, F; Sato, Y; Okamoto, T; Mitsui, Y; Yoshio, S; Li, SL; Nojima, S; Motooka, D; Nakamura, S; Kida, H; Standley, DM; Morii, E; Kanto, T; Yanagita, M; Matsuura, Y; Nagasawa, T; Kumanogoh, A; Akira, S				Fukushima, Kiyoharu; Satoh, Takashi; Sugihara, Fuminori; Sato, Yuki; Okamoto, Toru; Mitsui, Yuichi; Yoshio, Sachiyo; Li, Songling; Nojima, Satoshi; Motooka, Daisuke; Nakamura, Shota; Kida, Hiroshi; Standley, Daron M.; Morii, Eiichi; Kanto, Tatsuya; Yanagita, Motoko; Matsuura, Yoshiharu; Nagasawa, Takashi; Kumanogoh, Atsushi; Akira, Shizuo			Dysregulated Expression of the Nuclear Exosome Targeting Complex Component Rbm7 in Nonhematopoietic Cells Licenses the Development of Fibrosis	IMMUNITY			English	Article							HOST RESPONSES; TISSUE-REPAIR; BONE-MARROW; STEM-CELLS; IDENTIFICATION; ANGIOGENESIS; LOCALIZATION; POLARIZATION; REPLICATION; MACROPHAGES	Fibrosis is an incurable disorder of unknown etiology. Segregated-nucleus-containing atypical monocytes (SatMs) are critical for the development of fibrosis. Here we examined the mechanisms that recruit SatMs to pre-fibrotic areas. A screen based on cytokine expression in the fibrotic lung revealed that the chemokine Cxcl12, which is produced by apoptotic nonhematopoietic cells, was essential for SatM recruitment. Analyses of lung tissues at fibrosis onset showed increased expression of Rbm7, a component of the nuclear exosome targeting complex. Rbm7 deletion suppressed bleomycin-induced fibrosis and at a cellular level, suppressed apoptosis of nonhematopoietic cells. Mechanistically, Rbm7 bound to noncoding (nc)RNAs that form subnuclear bodies, including Neat1 speckles. Dysregulated expression of Rbm7 resulted in the nuclear degradation of Neat1 speckles, the dispersion of the DNA repair protein BRCA1, and the triggering of apoptosis. Thus, Rbm7 in epithelial cells plays a critical role in the development of fibrosis by regulating ncRNA decay and thereby the production of chemokines that recruit SatMs.	[Fukushima, Kiyoharu; Satoh, Takashi; Mitsui, Yuichi; Akira, Shizuo] Osaka Univ, RIMD, Dept Host Def, Osaka 5650871, Japan; [Fukushima, Kiyoharu; Satoh, Takashi; Mitsui, Yuichi; Akira, Shizuo] Osaka Univ, World Premier Inst, Immunol Frontier Res Ctr IFReC, Lab Host Def, Osaka 5650871, Japan; [Fukushima, Kiyoharu; Mitsui, Yuichi; Kida, Hiroshi; Kumanogoh, Atsushi] Osaka Univ, Grad Sch Med, Dept Resp Med & Clin Immunol, Osaka 5650871, Japan; [Satoh, Takashi] Japan Agcy Med Res & Dev AMED, Precursory Res Innovat Med Care PRIME, Tokyo 1000004, Japan; [Sugihara, Fuminori] Osaka Univ, Lab Biofunct Imaging, WPI IFReC, Osaka 5650871, Japan; [Sato, Yuki; Yanagita, Motoko] Kyoto Univ, Dept Nephrol, Grad Sch Med, Kyoto 6068507, Japan; [Sato, Yuki] Kyoto Univ, Dept Nephrol, Med Innovat Ctr TMK Project, Grad Sch Med, Kyoto 6068507, Japan; [Okamoto, Toru; Matsuura, Yoshiharu] Osaka Univ, Dept Mol Virol, RIMD, Osaka 5650871, Japan; [Yoshio, Sachiyo; Kanto, Tatsuya] Natl Ctr Global Hlth & Med, Res Ctr Hepatitis & Immunol, Chiba 2728516, Japan; [Li, Songling; Standley, Daron M.] Osaka Univ, Res Inst Microbial Dis, Genome Informat Res Ctr, Dept Genome Informat, Osaka 5650871, Japan; [Nojima, Satoshi; Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Osaka 5650871, Japan; [Motooka, Daisuke; Nakamura, Shota] Osaka Univ, Genome Informat Res Ctr, RIMD, Osaka 5650871, Japan; [Nagasawa, Takashi] Osaka Univ, WPI IFReC, Grad Sch Frontier Biosci, Lab Stem Cell Biol & Dev Immunol, Osaka 5650871, Japan; [Nagasawa, Takashi] Osaka Univ, WPI IFReC, Grad Sch Med, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Kyoto University; Kyoto University; Osaka University; National Center for Global Health & Medicine - Japan; Osaka University; Osaka University; Osaka University; Osaka University; Osaka University	Satoh, T; Akira, S (corresponding author), Osaka Univ, RIMD, Dept Host Def, Osaka 5650871, Japan.; Satoh, T; Akira, S (corresponding author), Osaka Univ, World Premier Inst, Immunol Frontier Res Ctr IFReC, Lab Host Def, Osaka 5650871, Japan.; Satoh, T (corresponding author), Japan Agcy Med Res & Dev AMED, Precursory Res Innovat Med Care PRIME, Tokyo 1000004, Japan.	sohsatoh@biken.osaka-u.ac.jp; sakira@biken.osaka-u.ac.jp	Yanagita, Motoko/AAJ-7731-2021; Yoshio, Sachiyo/K-8791-2019	Yoshio, Sachiyo/0000-0001-7860-6916; Li, Songling/0000-0001-9554-2248; Fukushima, Kiyoharu/0000-0002-9767-7899; Yanagita, Motoko/0000-0002-0339-9008; Sato, Yuki/0000-0002-8417-6083; Nagasawa, Takashi/0000-0002-1085-0960	Japan Science and Technology Agency (JST) [15H05704, 16H06234, T17K195570, 18H05032]; Visionary Research Fund from Takeda Science Foundation; PRIME [17 gm6110002h0001]; ACT-M [17im0210108h0001]; Japan Agency for Medical Research and Development, AMED [18fk0310106h0002, 18fk0210041h0001]	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Visionary Research Fund from Takeda Science Foundation; PRIME; ACT-M; Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED))	We thank K. Nakagawa, N. Miyamoto, R. Takenaka, T. Hongo, and K. Yamada for assistance with the experiments and T. Machida, T. Matsuki, T. Kawasaki, H. Nabeshima, and Drs. H. Tanaka and K. Kuniyoshi for helpful discussions. We thank T. Kitamura for kindly providing PlatE cells. We also thank Y. Kinehara and Y. Mano for preparing human clinical samples. We are also grateful to E. Kamada for secretarial assistance and C. Funamoto, K. Yokoyama, and R. Kawaguchi for technical assistance. This work was supported by the Japan Science and Technology Agency (JST) through funding for Specially Promoted Research (15H05704), a Grant-inAid for Young Scientists (A) (16H06234), a Grant-in-Aid for Challenging Exploratory Research (T17K195570), Grant-in-Aid for Scientific Research on Innovative Areas (18H05032), and the Visionary Research Fund from Takeda Science Foundation. This work was also supported by PRIME (17 gm6110002h0001), ACT-M (17im0210108h0001), and the Research Program on Hepatitis (18fk0310106h0002 and 18fk0210041h0001) from the Japan Agency for Medical Research and Development, AMED.	Aceves SS, 2008, CURR MOL MED, V8, P350, DOI 10.2174/156652408785161023; Adriaens C, 2016, NAT MED, V22, P861, DOI 10.1038/nm.4135; Aizawa S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11379; Ara T, 2003, IMMUNITY, V19, P257, DOI 10.1016/S1074-7613(03)00201-2; Arakawa H, 2016, EUR RADIOL, V26, P1485, DOI 10.1007/s00330-015-3973-z; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Borthwick LA, 2016, MUCOSAL IMMUNOL, V9, P38, DOI 10.1038/mi.2015.34; Chang Jing, 2016, Transl Perioper Pain Med, V1, P24; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Ealey KN, 2017, IMMUNOL REV, V278, P207, DOI 10.1111/imr.12547; Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Kerpedjiev P, 2015, BIOINFORMATICS, V31, P3374, DOI 10.1093/bioinformatics/btv372; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Kisseleva T, 2012, J HEPATOL, V56, P965, DOI 10.1016/j.jhep.2011.09.021; Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005; Kotzin JJ, 2016, NATURE, V537, P239, DOI 10.1038/nature19346; Kouwaki T, 2016, J VIROL, V90, P3530, DOI 10.1128/JVI.02776-15; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li RH, 2017, RNA, V23, P872, DOI 10.1261/rna.059477.116; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Lubas M, 2015, CELL REP, V10, P178, DOI 10.1016/j.celrep.2014.12.026; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; Martin M., 2011, EMBNET J, V17, P5, DOI 10.14806/ej.17.1.200; Naganuma T, 2013, RNA BIOL, V10, P456, DOI 10.4161/rna.23547; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Orthwein A, 2015, NATURE, V528, P422, DOI 10.1038/nature16142; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Satoh T, 2017, NATURE, V541, P96, DOI 10.1038/nature20611; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Symington LS, 2011, ANNU REV GENET, V45, P247, DOI 10.1146/annurev-genet-110410-132435; Takaori K, 2016, J AM SOC NEPHROL, V27, P2393, DOI 10.1681/ASN.2015060647; Takemura N, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan0333; Tiedje C, 2015, RNA, V21, P262, DOI 10.1261/rna.048090.114; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vucic D, 2011, NAT REV MOL CELL BIO, V12, P439, DOI 10.1038/nrm3143; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Williams E C, 1923, Proc R Soc Med, V16, P79; Wu XW, 2002, FRONT BIOSCI, V7, pD151, DOI 10.2741/wu1; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhang YZ, 2012, CURR OPIN PULM MED, V18, P441, DOI 10.1097/MCP.0b013e328356d03c	54	22	23	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2020	52	3					542	+		10.1016/j.immuni.2020.02.007	http://dx.doi.org/10.1016/j.immuni.2020.02.007			29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KV6NX	32187520	Bronze			2022-12-18	WOS:000520600200015
J	Adrover, JM; del Fresno, C; Crainiciuc, G; Cuartero, MI; Casanova-Acebes, M; Weiss, LA; Huerga-Encabo, H; Silvestre-Roig, C; Rossaint, J; Cossio, I; Lechuga-Vieco, AV; Garcia-Prieto, J; Gomez-Parrizas, M; Quintana, JA; Ballesteros, I; Martin-Salamanca, S; Aroca-Crevillen, A; Chong, SZ; Evrard, M; Balabanian, K; Lopez, J; Bidzhekov, K; Bachelerie, F; Abad-Santos, F; Munoz-Calleja, C; Zarbock, A; Soehnlein, O; Weber, C; Ng, LG; Lopez-Rodriguez, C; Sancho, D; Moro, MA; Ibanez, B; Hidalgo, A				Adrover, Jose M.; del Fresno, Carlos; Crainiciuc, Georgiana; Cuartero, Maria Isabel; Casanova-Acebes, Maria; Weiss, Linnea A.; Huerga-Encabo, Hector; Silvestre-Roig, Carlos; Rossaint, Jan; Cossio, Itziar; Lechuga-Vieco, Ana V.; Garcia-Prieto, Jaime; Gomez-Parrizas, Monica; Quintana, Juan A.; Ballesteros, Ivan; Martin-Salamanca, Sandra; Aroca-Crevillen, Alejandra; Chong, Shu Zhen; Evrard, Maximilien; Balabanian, Karl; Lopez, Jorge; Bidzhekov, Kiril; Bachelerie, Francoise; Abad-Santos, Francisco; Munoz-Calleja, Cecilia; Zarbock, Alexander; Soehnlein, Oliver; Weber, Christian; Lai Guan Ng; Lopez-Rodriguez, Cristina; Sancho, David; Moro, Maria A.; Ibanez, Borja; Hidalgo, Andres			A Neutrophil Timer Coordinates Immune Defense and Vascular Protection (vol 50, pg 390, 2019)	IMMUNITY			English	Correction												ahidalgo@cnic.es	Del Fresno, Carlos/ABD-7766-2020; Adrover, Jose M/G-9741-2017; Cuartero, Maria Isabel/E-8103-2012; Balabanian, Karl/S-6250-2019; Moro, María Ángeles/K-6396-2014; Abad-Santos, Francisco/J-7115-2013; Del Fresno Sánchez, CArlos/AAY-1525-2021; Weber, Christian/AAW-2153-2020	Del Fresno, Carlos/0000-0003-1771-7254; Adrover, Jose M/0000-0002-1395-5477; Cuartero, Maria Isabel/0000-0003-4728-068X; Balabanian, Karl/0000-0002-0534-3198; Moro, María Ángeles/0000-0003-1010-8237; Abad-Santos, Francisco/0000-0002-6519-8885; Weber, Christian/0000-0003-4610-8714; Crainiciuc, Georgiana/0000-0002-0912-7425				Adrover JM, 2019, IMMUNITY, V50, P390, DOI 10.1016/j.immuni.2019.01.002	1	22	22	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 19	2019	51	5					966	967		10.1016/j.immuni.2019.11.001	http://dx.doi.org/10.1016/j.immuni.2019.11.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JO8FW	31747583	Bronze, Green Accepted			2022-12-18	WOS:000497811300017
J	Huang, C; Niethammer, P				Huang, Cong; Niethammer, Philipp			Tissue Damage Signaling Is a Prerequisite for Protective Neutrophil Recruitment to Microbial Infection in Zebrafish	IMMUNITY			English	Article							PSEUDOMONAS-AERUGINOSA; PHOSPHOLIPASE A(2); WOUND CLOSURE; CELL; ACTIVATION; REVEALS; SYSTEM; INFLAMMATION; MACROPHAGES; ONCOSIS	Tissue damage and infection are deemed likewise triggers of innate immune responses. But whereas neutrophil responses to microbes are generally protective, neutrophil recruitment into damaged tissues without infection is deleterious. Why neutrophils respond to tissue damage and not just to microbes is unknown. Is it a flaw of the innate immune system that persists because evolution did not select against it, or does it provide a selective advantage? Here we dissect the contribution of tissue damage signaling to antimicrobial immune responses in a live vertebrate. By intravital imaging of zebrafish larvae, a powerful model for innate immunity, we show that prevention of tissue damage signaling upon microbial ear infection abrogates leukocyte chemotaxis and reduces animal survival, at least in part, through suppression of cytosolic phospholipase A(2) (cPla(2)), which integrates tissue damage- and microbederived cues. Thus, microbial cues are insufficient, and damage signaling is essential for antimicrobial neutrophil responses in zebrafish.	[Huang, Cong; Niethammer, Philipp] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Huang, Cong] Weill Cornell Med Coll, BCMB Allied Program, 1300 York Ave, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Niethammer, P (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA.	niethamp@mskcc.org			NIH/NIGMS grant [R01GM099970]; American Asthma Foundation Scholar award; MSKCC Functional Genome Initiative; NIH/NCI Cancer Center Support grant [P30CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099970] Funding Source: NIH RePORTER	NIH/NIGMS grant; American Asthma Foundation Scholar award; MSKCC Functional Genome Initiative; NIH/NCI Cancer Center Support grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Alexander Rudensky, Michael Glickman, Timothy Mitchison, and Martin Wuehr, as well as Weili Tian, and Xiaojing Mu for comments on the manuscript or study. The authors thank Shan Ba for discussion of data analysis, and Joao Xavier and Cole Haynes for the kind gift of PA strains. Research was supported by the NIH/NIGMS grant R01GM099970, an American Asthma Foundation Scholar award to P.N., the MSKCC Functional Genome Initiative, and in part through the NIH/NCI Cancer Center Support grant P30CA008748. Specifically, the authors thank the Integrated Genomics Operation Core and Bioinformatics Core at MSKCC for their assistance. The content of this study is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bloes DA, 2015, NAT REV MICROBIOL, V13, P95, DOI 10.1038/nrmicro3390; Brand M., 2002, ZEBRAFISH PRACTICAL; Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873; Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x; Deng Q, 2012, CELL MICROBIOL, V14, P517, DOI 10.1111/j.1462-5822.2011.01738.x; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dovi JV, 2004, THROMB HAEMOSTASIS, V92, P275, DOI 10.1160/TH03-11-0720; Dovi JV, 2003, J LEUKOCYTE BIOL, V73, P448, DOI 10.1189/jlb.0802406; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Engstrom PG, 2013, NAT METHODS, V10, P1185, DOI [10.1038/NMETH.2722, 10.1038/nmeth.2722]; Enyedi B, 2016, CELL, V165, P1160, DOI 10.1016/j.cell.2016.04.016; Enyedi B, 2013, NAT CELL BIOL, V15, P1123, DOI 10.1038/ncb2818; Feinbaum RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002813; FinckBarbancon V, 1997, MOL MICROBIOL, V25, P547, DOI 10.1046/j.1365-2958.1997.4891851.x; Fitsialos G, 2007, J BIOL CHEM, V282, P15090, DOI 10.1074/jbc.M606094200; Forn-Cuni G, 2017, SCI REP-UK, V7, DOI 10.1038/srep41905; Gault WJ, 2014, J CELL BIOL, V207, P767, DOI 10.1083/jcb.201408049; Gerlach GF, 2014, DEV BIOL, V396, P183, DOI 10.1016/j.ydbio.2014.08.038; Hall C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-42; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Hurley BP, 2006, AM J PHYSIOL-LUNG C, V290, pL703, DOI 10.1152/ajplung.00390.2005; Hurley BP, 2011, AM J PHYSIOL-LUNG C, V300, pL286, DOI 10.1152/ajplung.00147.2010; Kawahara T, 2005, AM J PHYSIOL-CELL PH, V288, pC450, DOI 10.1152/ajpcell.00319.2004; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kono H, 2008, NAT REV IMMUNOL, V8, P279, DOI 10.1038/nri2215; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Land WG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00349; Liang Danny, 2007, Neurosurg Focus, V22, pE2, DOI 10.3171/foc.2007.22.5.3; Lindner SC, 2009, J LEUKOCYTE BIOL, V86, P389, DOI 10.1189/jlb.1008591; Liu T, 2014, CELL REP, V8, P974, DOI 10.1016/j.celrep.2014.07.012; MAJNO G, 1995, AM J PATHOL, V146, P3; Matsumoto T, 1998, J MED MICROBIOL, V47, P295, DOI 10.1099/00222615-47-4-295; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McDonald B, 2010, SCIENCE, V330, P362, DOI 10.1126/science.1195491; Mclachlan G., 2000, WILEY SER PROB STAT; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Ng LG, 2011, J INVEST DERMATOL, V131, P2058, DOI 10.1038/jid.2011.179; Niethammer P, 2016, CURR OPIN GENET DEV, V40, P17, DOI 10.1016/j.gde.2016.05.001; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nuzzi Paul A, 2007, Methods Mol Biol, V370, P23; Picoli T, 2017, MICROB PATHOGENESIS, V112, P57, DOI 10.1016/j.micpath.2017.09.046; Progatzky F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6864; Qi HY, 2005, J BIOL CHEM, V280, P38969, DOI 10.1074/jbc.M509352200; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Ruiperez V, 2009, J IMMUNOL, V182, P3877, DOI 10.4049/jimmunol.0804003; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; SCHIFFMANN E, 1975, P NATL ACAD SCI USA, V72, P1059, DOI 10.1073/pnas.72.3.1059; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schofield ZV, 2013, SHOCK, V40, P463, DOI 10.1097/SHK.0000000000000044; SIMPSON DM, 1972, J CLIN INVEST, V51, P2009, DOI 10.1172/JCI107007; Trede NS, 2004, IMMUNITY, V20, P367, DOI 10.1016/S1074-7613(04)00084-6; Tucker DE, 2009, J BIOL CHEM, V284, P9596, DOI 10.1074/jbc.M807299200; van der Sar AM, 2006, INFECT IMMUN, V74, P2436, DOI 10.1128/IAI.74.4.2436-2441.2006; van der Vaart M, 2013, DIS MODEL MECH, V6, P841, DOI 10.1242/dmm.010843; Vance RE, 2000, J IMMUNOL, V165, P1725, DOI 10.4049/jimmunol.165.4.1725; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036	64	22	22	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					1006	+		10.1016/j.immuni.2018.04.020	http://dx.doi.org/10.1016/j.immuni.2018.04.020			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768163	Green Accepted, Bronze			2022-12-18	WOS:000432488600019
J	Hussen, KA; Manh, TPV; Guimiot, F; Nelson, E; Chabaane, E; Delord, M; Barbier, M; Berthault, C; Dulphy, N; Alberdi, AJ; Burlen-Defranoux, O; Socie, G; Bories, JC; Larghero, J; Vanneaux, V; Verhoeyen, E; Wirth, T; Dalod, M; Gluckman, JC; Cumano, A; Canque, B				Hussen, Kutaiba Alhaj; Thien-Phong Vu Manh; Guimiot, Fabien; Nelson, Elisabeth; Chabaane, Emna; Delord, Marc; Barbier, Maxime; Berthault, Claire; Dulphy, Nicolas; Alberdi, Antonio Jose; Burlen-Defranoux, Odile; Socie, Gerard; Bories, Jean Christophe; Larghero, Jerome; Vanneaux, Valerie; Verhoeyen, Els; Wirth, Thierry; Dalod, Marc; Gluckman, Jean Claude; Cumano, Ana; Canque, Bruno			Molecular and Functional Characterization of Lymphoid Progenitor Subsets Reveals a Bipartite Architecture of Human Lymphopoiesis	IMMUNITY			English	Article							SET ENRICHMENT ANALYSIS; NATURAL-KILLER; BONE-MARROW; CORD BLOOD; STEM-CELLS; MULTIPOTENT PROGENITORS; MYELOID PROGENITORS; DENDRITIC CELLS; T-CELL; IDENTIFICATION	The classical model of hematopoiesis established in the mouse postulates that lymphoid cells originate from a founder population of common lymphoid progenitors. Here, using a modeling approach in humanized mice, we showed that human lymphoid development stemmed from distinct populations of CD127(-) and CD127(+) early lymphoid progenitors (ELPs). Combining molecular analyses with in vitro and in vivo functional assays, we demonstrated that CD127(-) and CD127+ ELPs emerged independently from lympho-mono-dendritic progenitors, responded differently to Notch1 signals, underwent divergent modes of lineage restriction, and displayed both common and specific differentiation potentials. Whereas CD127(-) ELPs comprised precursors of T cells, marginal zone B cells, and natural killer (NK) and innate lymphoid cells (ILCs), CD127(+) ELPs supported production of all NK cell, ILC, and B cell populations but lacked T potential. On the basis of these results, we propose a "two-family'' model of human lymphoid development that differs from the prevailing model of hematopoiesis.	[Hussen, Kutaiba Alhaj; Nelson, Elisabeth; Chabaane, Emna; Bories, Jean Christophe; Gluckman, Jean Claude; Canque, Bruno] PSL Res Univ, Inst Univ Hematol, Hop Saint Louis,Ecole Pratique Hautes Etud, Univ Paris Diderot,INSERM,U1126, Paris, France; [Thien-Phong Vu Manh; Dalod, Marc] Aix Marseille Univ, CNRS, INSERM, Ctr Immunol Marseille Luminy,CIML, Marseille, France; [Guimiot, Fabien] Univ Paris Diderot, Hop Robert Debre, AP HP, Serv Biol Dev,INSERM,UMR 1141, Paris, France; [Delord, Marc] Univ Paris Diderot, Inst Univ Hematol, Bioinformat, Paris, France; [Barbier, Maxime] Sorbonne Univ, Inst Systemat Evolut Biodiversite ISYEB, UMR 7205, CNRS,MNHN,Univ Pierre & Marie Curie, Paris, France; [Barbier, Maxime] Sorbonne Univ, EPHE, Paris, France; [Dulphy, Nicolas; Burlen-Defranoux, Odile; Cumano, Ana] Inst Pasteur, Dept Immunol, Unite Lymphopoiese, Paris, France; [Berthault, Claire; Burlen-Defranoux, Odile; Cumano, Ana] Univ Paris Diderot, Cellule Pasteur, Sorbonne Paris Cite, Paris, France; [Berthault, Claire; Burlen-Defranoux, Odile; Cumano, Ana] INSERM, U1223, Paris, France; [Dulphy, Nicolas; Socie, Gerard] Univ Paris Diderot, Inst Univ Hematol, INSERM, UMRS 1160, F-75010 Paris, France; [Dulphy, Nicolas; Socie, Gerard] Hop St Louis, AP HP, Lab Immunol & Histocompatibilite, F-75010 Paris, France; [Alberdi, Antonio Jose] Hop St Louis, Inst Univ Hematol, Plateforme Imagerie & Tri Cellulaire, Paris, France; [Larghero, Jerome; Vanneaux, Valerie] Hop Saint Louis, AP HP, Unite Therapie Cellulaire, F-75475 Paris, France; [Larghero, Jerome; Vanneaux, Valerie] INSERM, Univ Paris Diderot, CIC Biotherapies, Sorbonne Paris Cite, F-75475 Paris, France; [Verhoeyen, Els] Univ Lyon, INSERM,U1111, Int Ctr Infectiol Res, CIRI,EVIR Team, Lyon, France; [Verhoeyen, Els] INSERM, U1065, Team Controle Metabol Morts Cellulaires, Ctr Mediterrane Med Mol C3M, F-06204 Nice, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Ecole Normale Superieure de Lyon (ENS de LYON); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Canque, B (corresponding author), PSL Res Univ, Inst Univ Hematol, Hop Saint Louis,Ecole Pratique Hautes Etud, Univ Paris Diderot,INSERM,U1126, Paris, France.	bruno.canque@ephe.sorbonne.fr	Bories, Jean-Christophe/L-6952-2017; Dalod, Marc/AAK-6163-2020; Verhoeyen, Els/H-6360-2016; Dulphy, Nicolas/J-5960-2017; Wirth, Thierry/B-4915-2008; Verhoeyen, Els/AAW-4853-2021; Vanneaux, Valérie/D-7853-2017; canque, Bruno/F-2743-2019	Dalod, Marc/0000-0002-6436-7966; Dulphy, Nicolas/0000-0002-1243-6456; Wirth, Thierry/0000-0002-7371-0172; Verhoeyen, Els/0000-0001-9224-5491; Vanneaux, Valérie/0000-0003-0813-2318; Alhaj Hussen, Kutaiba/0000-0003-4834-1229; Vu Manh, Thien-Phong/0000-0002-0294-342X; Delord, Marc/0000-0002-0455-6749; Berthault, Claire/0000-0001-6848-0993; canque, Bruno/0000-0003-0892-2811; Cumano, Ana/0000-0002-4578-959X	Agence de la Biomedecine; Universite Paris-Diderot; Comite de Paris de la Ligue contre le Cancer; Institut National du Cancer; Fondation Ramsay Generale de Sante; Fondation pour la Recherche Medicale	Agence de la Biomedecine; Universite Paris-Diderot; Comite de Paris de la Ligue contre le Cancer; Institut National du Cancer(Institut National du Cancer (INCA) France); Fondation Ramsay Generale de Sante; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	This work was supported by the Agence de la Biomedecine, Universite Paris-Diderot, the Comite de Paris de la Ligue contre le Cancer, the Institut National du Cancer, the Fondation Ramsay Generale de Sante, and the Fondation pour la Recherche Medicale.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Berthault C, 2017, NAT IMMUNOL, V18, P1139, DOI 10.1038/ni.3820; Canque B, 2000, BLOOD, V96, P3748, DOI 10.1182/blood.V96.12.3748.h8003748_3748_3756; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; Delaney C, 2005, BLOOD, V106, P2693, DOI 10.1182/blood-2005-03-1131; Descatoire M, 2014, J EXP MED, V211, P986, DOI 10.1084/jem.20132203; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; FRITSCH G, 1993, BLOOD, V81, P2301; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Haddad R, 2006, IMMUNITY, V24, P217, DOI 10.1016/j.immuni.2006.01.008; Hao QL, 2001, BLOOD, V97, P3683, DOI 10.1182/blood.V97.12.3683; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kohn LA, 2012, NAT IMMUNOL, V13, P963, DOI 10.1038/ni.2405; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Luis TC, 2016, NAT IMMUNOL, V17, P1424, DOI 10.1038/ni.3576; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Notta F., 2015, SCIENCE, V351; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Parietti V, 2012, J IMMUNOL, V189, P1648, DOI 10.4049/jimmunol.1201251; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Ramond C, 2014, NAT IMMUNOL, V15, P27, DOI 10.1038/ni.2782; Renoux VM, 2015, IMMUNITY, V43, P394, DOI 10.1016/j.immuni.2015.07.011; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Spinelli L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2012-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369	31	22	22	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					680	+		10.1016/j.immuni.2017.09.009	http://dx.doi.org/10.1016/j.immuni.2017.09.009			25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045900	Bronze			2022-12-18	WOS:000413091600013
J	Cheallaigh, CN; Sheedy, FJ; Harris, J; Munoz-Wolf, N; Lee, J; West, K; McDermott, EP; Smyth, A; Gleeson, LE; Coleman, M; Martinez, N; Hearnden, CHA; Tynan, GA; Carroll, EC; Jones, SA; Corr, SC; Bernard, NJ; Hughes, MM; Corcoran, SE; O'Sullivan, M; Fallon, CM; Kornfeld, H; Golenbock, D; Gordon, SV; O'Neill, LAJ; Lavelle, EC; Keane, J				Cheallaigh, Cliona Ni; Sheedy, Frederick J.; Harris, James; Munoz-Wolf, Natalia; Lee, Jinhee; West, Kim; McDermott, Eva Palsson; Smyth, Alicia; Gleeson, Laura E.; Coleman, Michelle; Martinez, Nuria; Hearnden, Claire H. A.; Tynan, Graham A.; Carroll, Elizabeth C.; Jones, Sarah A.; Corr, Sinead C.; Bernard, Nicholas J.; Hughes, Mark M.; Corcoran, Sarah E.; O'Sullivan, Mary; Fallon, Ciara M.; Kornfeld, Hardy; Golenbock, Douglas; Gordon, Stephen V.; O'Neill, Luke A. J.; Lavelle, Ed C.; Keane, Joseph			A Common Variant in the Adaptor Mal Regulates Interferon Gamma Signaling	IMMUNITY			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; MYCOBACTERIUM-TUBERCULOSIS INFECTION; TOLL-LIKE RECEPTORS; CD8(+) T-CELLS; IFN-GAMMA; DEFENSE-MECHANISM; MACROPHAGES; TIRAP; AUTOPHAGY; IMMUNITY	Humans that are heterozygous for the common S180L polymorphism in the Toll-like receptor (TLR) adaptor Mal (encoded by TIRAP) are protected from a number of infectious diseases, including tuberculosis (TB), whereas those homozygous for the allele are at increased risk. The reason for this difference in susceptibility is not clear. We report that Mal has a TLR-independent role in interferon-gamma (IFN-gamma) receptor signaling. Mal-dependent IFN-gamma receptor (IFNGR) signaling led to mitogen-activated protein kinase (MAPK) p38 phosphorylation and autophagy. IFN-g signaling via Mal was required for phagosome maturation and killing of intracellular Mycobacterium tuberculosis (Mtb). The S180L polymorphism, and its murine equivalent S200L, reduced the affinity of Mal for the IFNGR, thereby compromising IFNGR signaling in macrophages and impairing responses to TB. Our findings highlight a role for Mal outside the TLR system and imply that genetic variation in TIRAP may be linked to other IFN-gamma-related diseases including autoimmunity and cancer.	[Cheallaigh, Cliona Ni; Sheedy, Frederick J.; Gleeson, Laura E.; Coleman, Michelle; O'Sullivan, Mary; Fallon, Ciara M.; Keane, Joseph] Univ Dublin Trinity Coll, Dept Clin Med, Inst Mol Med, D08 W9RT, Dublin 2, Ireland; [Cheallaigh, Cliona Ni; Sheedy, Frederick J.; Gleeson, Laura E.; Coleman, Michelle; O'Sullivan, Mary; Fallon, Ciara M.; Keane, Joseph] St James Hosp, D08 W9RT, Dublin 8, Ireland; [Cheallaigh, Cliona Ni; Munoz-Wolf, Natalia; Hearnden, Claire H. A.; Tynan, Graham A.; Carroll, Elizabeth C.; Lavelle, Ed C.] Univ Dublin Trinity Coll, Adjuvant Res Grp, Sch Biochem & Immunol, Trinity Biomed Sci Inst, D02 PN40, Dublin 2, Ireland; [Harris, James; Jones, Sarah A.] Monash Univ, Fac Med Nursing & Hlth Sci, Southern Clin Sch, Ctr Inflammatory Dis, Clayton, Vic 3168, Australia; [Lee, Jinhee; West, Kim; Martinez, Nuria; Kornfeld, Hardy; Golenbock, Douglas] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01655 USA; [McDermott, Eva Palsson; Corr, Sinead C.; Bernard, Nicholas J.; Hughes, Mark M.; Corcoran, Sarah E.; O'Neill, Luke A. J.] Univ Dublin Trinity Coll, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Inflammat Res Grp, D02 PN40, Dublin 2, Ireland; [Smyth, Alicia; Gordon, Stephen V.] Univ Coll Dublin, UCD Sch Vet Med, Dublin 4, Ireland; [Smyth, Alicia; Gordon, Stephen V.] Univ Coll Dublin, UCD Sch Med & Med Sci, Dublin 4, Ireland; [Smyth, Alicia; Gordon, Stephen V.] Univ Coll Dublin, UCD Sch Biomol & Biomol Sci, Dublin 4, Ireland; [Smyth, Alicia; Gordon, Stephen V.] Univ Coll Dublin, UCD Conway Inst, Dublin 4, Ireland; [Lavelle, Ed C.] Univ Dublin Trinity Coll, Adv Mat & BioEngn Res AMBER, CRANN, D02 PN40, Dublin, Ireland	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Monash University; University of Massachusetts System; University of Massachusetts Worcester; Trinity College Dublin; University College Dublin; University College Dublin; University College Dublin; University College Dublin; Trinity College Dublin	Cheallaigh, CN (corresponding author), Univ Dublin Trinity Coll, Dept Clin Med, Inst Mol Med, D08 W9RT, Dublin 2, Ireland.; Cheallaigh, CN (corresponding author), St James Hosp, D08 W9RT, Dublin 8, Ireland.; Cheallaigh, CN; Lavelle, EC (corresponding author), Univ Dublin Trinity Coll, Adjuvant Res Grp, Sch Biochem & Immunol, Trinity Biomed Sci Inst, D02 PN40, Dublin 2, Ireland.	nicheacm@tcd.ie; lavellee@tcd.ie	Cheallaigh, Cliona Ni/C-5482-2017; Kornfeld, Hardy/AAS-2903-2021; Muñoz-Wolf, Natalia/AAQ-1677-2021; Keane, Joseph/AAX-6658-2021; Lavelle, Ed/A-1716-2008; O'Sullivan, Mary P/C-9413-2012; Jones, Sarah/I-1458-2013	Cheallaigh, Cliona Ni/0000-0002-0842-425X; Muñoz-Wolf, Natalia/0000-0002-5173-4026; Keane, Joseph/0000-0001-5313-385X; Lavelle, Ed/0000-0002-3167-1080; O'Sullivan, Mary P/0000-0002-6104-8943; Gordon, Stephen/0000-0002-4833-5542; Harris, James/0000-0002-5634-9637; Sheedy, Frederick/0000-0002-4722-3135; Hughes, Mark/0000-0003-0851-9563; O'Neill, Luke/0000-0002-4333-2748; Bernard, Nicholas/0000-0002-9483-7922; Jones, Sarah/0000-0001-9571-3289; Coleman, Michelle/0000-0002-6752-3266; Smyth, Alicia/0000-0002-4752-1562; Sheedy, Frederick/0000-0003-2645-8493; Corr, Sinead/0000-0001-9930-5039	Health Research Board Ireland [NSAFP 2009/2, CSA/2004/7, CSA/2012/16]; Royal City of Dublin Hospital Trust; NIH [HL081149]; Wellcome Trust [102395/Z/13/Z]; Science Foundation Ireland [08/IN.1/B2038, 12/IA/1421]; Science Foundation Ireland Strategic Research Cluster [07/SRC/B1144]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081149] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM054060] Funding Source: NIH RePORTER	Health Research Board Ireland; Royal City of Dublin Hospital Trust; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Science Foundation Ireland Strategic Research Cluster(Science Foundation Ireland); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported in part by Health Research Board Ireland by grant NSAFP 2009/2 (C.N.C.), CSA/2004/7 and CSA/2012/16 (J.K.), The Royal City of Dublin Hospital Trust (J.K.), NIH grant HL081149 (H.K.), Wellcome Trust PhD award 102395/Z/13/Z (A.S.), Science Foundation Ireland Investigator Awards 08/IN.1/B2038 (S.G.) and 12/IA/1421 (E.C.L.), and the Science Foundation Ireland Strategic Research Cluster 07/SRC/B1144 (E.C.L.).	Bogunovic D, 2012, SCIENCE, V337, P1684, DOI 10.1126/science.1224026; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Capparelli R, 2013, GENES IMMUN, V14, P504, DOI 10.1038/gene.2013.48; Castiblanco J, 2008, INFECT GENET EVOL, V8, P541, DOI 10.1016/j.meegid.2008.03.001; Cheallaigh CN, 2011, CLIN EXP IMMUNOL, V164, P291, DOI 10.1111/j.1365-2249.2011.04381.x; COOPER AM, 1993, J EXP MED, V178, P2243, DOI 10.1084/jem.178.6.2243; Darwich L, 2009, IMMUNOLOGY, V126, P386, DOI 10.1111/j.1365-2567.2008.02905.x; de Castro CP, 2012, J IMMUNOL, V189, P4144, DOI 10.4049/jimmunol.1201946; Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x; DIMARZIO P, 1994, J EXP MED, V179, P1731, DOI 10.1084/jem.179.5.1731; Dissanayeke SR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006698; Feingold KR, 2014, J INVEST DERMATOL, V134, P597, DOI 10.1038/jid.2013.440; Fenton MJ, 1997, INFECT IMMUN, V65, P5149, DOI 10.1128/IAI.65.12.5149-5156.1997; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Filipe-Santos O, 2006, SEMIN IMMUNOL, V18, P347, DOI 10.1016/j.smim.2006.07.010; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; FLESCH IEA, 1991, INFECT IMMUN, V59, P3213, DOI 10.1128/IAI.59.9.3213-3218.1991; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; FULTZ MJ, 1993, INT IMMUNOL, V5, P1383, DOI 10.1093/intimm/5.11.1383; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harris J, 2009, TRANSBOUND EMERG DIS, V56, P248, DOI 10.1111/j.1865-1682.2009.01069.x; Harris J, 2007, IMMUNITY, V27, P505, DOI 10.1016/j.immuni.2007.07.022; Holscher C, 2008, EUR J IMMUNOL, V38, P680, DOI 10.1002/eji.200736458; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Ikeda H, 2002, CYTOKINE GROWTH F R, V13, P95, DOI 10.1016/S1359-6101(01)00038-7; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kenny EF, 2009, J IMMUNOL, V183, P3642, DOI 10.4049/jimmunol.0901140; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kim WU, 2009, AUTOIMMUN REV, V8, P204, DOI 10.1016/j.autrev.2008.07.046; Ladhani SN, 2010, CLIN INFECT DIS, V51, P761, DOI 10.1086/656236; Liu Q., 2014, INFECT GENET EVOL; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Martens GW, 2012, J LEUKOCYTE BIOL, V91, P849, DOI 10.1189/jlb.0311164; Martinez FO, 2014, F1000PRIME REP, V6, P13, DOI DOI 10.12703/P6-13; Matsuzawa T, 2014, IMMUNOLOGY, V141, P61, DOI 10.1111/imm.12168; Mishra BB, 2013, NAT IMMUNOL, V14, P52, DOI 10.1038/ni.2474; MOSMANN TR, 1989, ANNU REV IMMUNOL, V7, P145, DOI 10.1146/annurev.immunol.7.1.145; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Nejentsev S, 2008, NAT GENET, V40, P261, DOI 10.1038/ng0308-261; O'Carroll C, 2014, J IMMUNOL, V192, P427, DOI 10.4049/jimmunol.1301722; PERUSSIA B, 1991, CURR OPIN IMMUNOL, V3, P49, DOI 10.1016/0952-7915(91)90076-D; Pollard KM, 2013, DISCOV MED, V16, P123; Roca FJ, 2013, CELL, V153, P521, DOI 10.1016/j.cell.2013.03.022; SAD S, 1995, IMMUNITY, V2, P271, DOI 10.1016/1074-7613(95)90051-9; Schleicher U, 2005, BLOOD, V105, P1319, DOI 10.1182/blood-2004-05-1749; Schroecksnadel Katharina, 2006, Current Vascular Pharmacology, V4, P205, DOI 10.2174/157016106777698379; Selvaraj P, 2010, TUBERCULOSIS, V90, P306, DOI 10.1016/j.tube.2010.08.001; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yamamoto M, 2002, NATURE, V420, P324, DOI 10.1038/nature01182; Yang ZX, 2012, CYTOKINE, V57, P282, DOI 10.1016/j.cyto.2011.11.017	54	22	23	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					368	379		10.1016/j.immuni.2016.01.019	http://dx.doi.org/10.1016/j.immuni.2016.01.019			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26885859	Green Published, hybrid			2022-12-18	WOS:000370294000018
J	Lee, SY; Coffey, F; Fahl, SP; Peri, S; Rhodes, M; Cai, KQ; Carleton, M; Hedrick, SM; Fehling, HJ; Zuniga-Pflucker, JC; Kappes, DJ; Wiest, DL				Lee, Sang-Yun; Coffey, Francis; Fahl, Shawn P.; Peri, Suraj; Rhodes, Michele; Cai, Kathy Q.; Carleton, Michael; Hedrick, Stephen M.; Fehling, Hans Joerg; Zuniga-Pfluecker, Juan Carlos; Kappes, Dietmar J.; Wiest, David L.			Noncanonical Mode of ERK Action Controls Alternative alpha beta and gamma delta T Cell Lineage Fates	IMMUNITY			English	Article							B-RAF; TCR; EXPRESSION; SIGNAL; STRENGTH; CONTRIBUTES; DETERMINES; COMMITMENT; THYMOCYTES; MECHANISM	Gradations in extracellular regulated kinase (ERK) signaling have been implicated in essentially every developmental checkpoint or differentiation process encountered by lymphocytes. Yet, despite intensive effort, the molecular basis by which differences in ERK activation specify alternative cell fates remains poorly understood. We report here that differential ERK signaling controls lymphoid-fate specification through an alternative mode of action. While ERK phosphorylates most substrates, such as RSK, by targeting them through its D-domain, this well-studied mode of ERK action was dispensable for development of gamma delta T cells. Instead, development of gamma delta T cells was dependent upon an alternative mode of action mediated by the DEF-binding pocket (DBP) of ERK. This domain enabled ERK to bind a distinct and select set of proteins required for specification of the gd fate. These data provide the first in vivo demonstration for the role of DBP-mediated interactions in orchestrating alternate ERK-dependent developmental outcomes.	[Lee, Sang-Yun; Coffey, Francis; Fahl, Shawn P.; Rhodes, Michele; Kappes, Dietmar J.; Wiest, David L.] Fox Chase Canc Ctr, Immune Cell Dev & Host Def Program, Philadelphia, PA 19111 USA; [Peri, Suraj] Fox Chase Canc Ctr, Dept Biostat & Bioinformat, Philadelphia, PA 19111 USA; [Cai, Kathy Q.] Fox Chase Canc Ctr, Canc Biol Program, Philadelphia, PA 19111 USA; [Carleton, Michael] Rosetta Inpharmat LLC, Seattle, WA 98034 USA; [Hedrick, Stephen M.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Hedrick, Stephen M.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Fehling, Hans Joerg] Univ Clin Ulm, Inst Immunol, D-89081 Ulm, Germany; [Zuniga-Pfluecker, Juan Carlos] Univ Toronto, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada; [Zuniga-Pfluecker, Juan Carlos] Univ Toronto, Dept Immunol, Toronto, ON M4N 3M5, Canada	Fox Chase Cancer Center; Fox Chase Cancer Center; Fox Chase Cancer Center; Merck & Company; University of California System; University of California San Diego; University of California System; University of California San Diego; Ulm University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto	Wiest, DL (corresponding author), Fox Chase Canc Ctr, Immune Cell Dev & Host Def Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	david.wiest@fccc.edu	Fahl, Shawn/ABC-9986-2021; Hedrick, Stephen M/E-9171-2010; Zuniga-Pflucker, Juan C/H-1295-2012	Hedrick, Stephen/0000-0002-6345-8751; Zuniga-Pflucker, Juan Carlos/0000-0003-2538-3178; Wiest, David/0000-0002-0792-3188	NIH [R01AI081314, R01AI073920, P01AI102853, P01CA06927, P30-DK-50306]; Reggie and Betty Bishop Research Fund; Greenwald Fellowship; CIHR [MOP-42387]; Krembil Foundation; DFG [FE 578/3-1]; Plain & Fancy Fellowship;  [T32CA903536];  [F32AI098241]; NATIONAL CANCER INSTITUTE [P30CA006927, T32CA009035, P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI098241, P01AI102853, R01AI081314, R01AI037988, R01AI073920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Reggie and Betty Bishop Research Fund; Greenwald Fellowship; CIHR(Canadian Institutes of Health Research (CIHR)); Krembil Foundation; DFG(German Research Foundation (DFG)); Plain & Fancy Fellowship; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank A. Singer for critical review of the manuscript and gratefully acknowledge the assistance of the following core facilities of the Fox Chase Cancer Center: Cell Culture, DNA Sequencing, Flow Cytometry, Genomics, Histopathology, and Laboratory Animal and Transgenic Mouse. D.L.W. was supported by NIH grants R01AI081314, R01AI073920, P01AI102853, NIH core grant P01CA06927, Center grant #P30-DK-50306, by the Reggie and Betty Bishop Research Fund, and by an appropriation from the Commonwealth of Pennsylvania. F.C. was supported by T32CA903536 and F32AI098241. S.-Y.L. was supported by the Greenwald and Plain & Fancy Fellowships. J.C.Z.-P. is a Canada Research Chair in Developmental Immunology, and supported by the CIHR (MOP-42387) and Krembil Foundation. H.J.F. was supported by DFG-FE 578/3-1. S.P.F. was supported by the Greenwald Fellowship and T32CA903536.	Andreadi C, 2012, BIOCHEM SOC T, V40, P67, DOI 10.1042/BST20110621; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Bosselut R, 2004, NAT REV IMMUNOL, V4, P529, DOI 10.1038/nri1392; Carlson SM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002568; Catalanotti F, 2009, NAT STRUCT MOL BIOL, V16, P294, DOI 10.1038/nsmb.1564; Coffey F, 2014, J EXP MED, V211, P329, DOI 10.1084/jem.20131540; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Deswal S, 2013, J IMMUNOL, V190, P1927, DOI 10.4049/jimmunol.1200653; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Formstecher E, 2001, DEV CELL, V1, P239, DOI 10.1016/S1534-5807(01)00035-1; Frascoli M, 2012, J IMMUNOL, V189, P174, DOI 10.4049/jimmunol.1101582; Haas J, 2009, NATION, V289, P6; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Hayes SM, 2006, IMMUNOL REV, V209, P170, DOI 10.1111/j.0105-2896.2006.00356.x; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Hernandez-Hoyos G, 2000, IMMUNITY, V12, P313, DOI 10.1016/S1074-7613(00)80184-3; Hu TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019890; Ingram DA, 2002, BLOOD, V100, P3656, DOI 10.1182/blood-2002-03-0734; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Lauritsen JPH, 2009, IMMUNITY, V31, P565, DOI 10.1016/j.immuni.2009.07.010; Lee SY, 2010, SEMIN IMMUNOL, V22, P237, DOI 10.1016/j.smim.2010.04.008; Liu HP, 2013, EUR J IMMUNOL, V43, P1716, DOI 10.1002/eji.201242889; Luche H, 2013, J EXP MED, V210, P699, DOI 10.1084/jem.20122609; McNeil LK, 2005, P NATL ACAD SCI USA, V102, P13574, DOI 10.1073/pnas.0505110102; Melichar HJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004400; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Pastorino S, 2010, FASEB J, V24, P2818, DOI 10.1096/fj.09-144295; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Tsukamoto H, 2004, J BIOL CHEM, V279, P48457, DOI 10.1074/jbc.M403087200; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; von Kriegsheim A, 2009, NAT CELL BIOL, V11, P1458, DOI 10.1038/ncb1994; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; YAMASHITA I, 1993, INT IMMUNOL, V5, P1139, DOI 10.1093/intimm/5.9.1139	37	22	23	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					934	946		10.1016/j.immuni.2014.10.021	http://dx.doi.org/10.1016/j.immuni.2014.10.021			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526308	Green Accepted, Bronze			2022-12-18	WOS:000346654100012
J	Mauri, C; Blair, PA				Mauri, Claudia; Blair, Paul A.			The Incognito Journey of a Regulatory B Cell	IMMUNITY			English	Editorial Material							B10 CELLS; AUTOIMMUNE; EXPRESSION		[Mauri, Claudia; Blair, Paul A.] UCL, Div Med, Ctr Rheumatol, London WC1E 6JF, England	University of London; University College London	Mauri, C (corresponding author), UCL, Div Med, Ctr Rheumatol, London WC1E 6JF, England.	c.mauri@ucl.ac.uk; p.blair@ucl.ac.uk	Mauri, Chiara/GXN-0766-2022	Mauri, Claudia/0000-0001-9761-2625	Arthritis Research UK [17707, 19314] Funding Source: Medline; Versus Arthritis [17707, 19314] Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Versus Arthritis(Versus Arthritis)		Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Ding Q, 2011, J CLIN INVEST, V121, P3645, DOI 10.1172/JCI46274; Kalampokis I, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar3907; Maseda D, 2012, J IMMUNOL, V188, P1036, DOI 10.4049/jimmunol.1102500; Matsumoto M, 2014, IMMUNITY, V41, P1040, DOI 10.1016/j.immuni.2014.10.016; Mauri C, 2012, ANNU REV IMMUNOL, V30, P221, DOI 10.1146/annurev-immunol-020711-074934; Rosser EC, 2014, NAT MED, V20, P1334, DOI 10.1038/nm.3680; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Wei B, 2005, P NATL ACAD SCI USA, V102, P2010, DOI 10.1073/pnas.0409449102	10	22	22	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					878	880		10.1016/j.immuni.2014.12.003	http://dx.doi.org/10.1016/j.immuni.2014.12.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526301	Bronze			2022-12-18	WOS:000346654100005
J	Topalian, SL; Sharpe, AH				Topalian, Suzanne L.; Sharpe, Arlene H.			Balance and Imbalance in the Immune System: Life on the Edge	IMMUNITY			English	Editorial Material							T-CELL FUNCTION; CTLA-4	CTLA-4 is a key immune checkpoint in maintaining self-tolerance, which can be co-opted by cancer to evade immune attack. In Science, Kuehn et al. (2014) describe clinical manifestations from inherited heterozygous CTLA4 mutations, and some are reminiscent of immune-related consequences from anti-CTLA-4 cancer therapy.	[Topalian, Suzanne L.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21287 USA; [Sharpe, Arlene H.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Johns Hopkins University; Harvard University; Harvard Medical School	Topalian, SL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21287 USA.	stopali1@jhmi.edu; arlene_sharpe@hms.harvard.edu			NCI NIH HHS [P30 CA006973] Funding Source: Medline; NIAID NIH HHS [P01 AI039671, P01 AI39671] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI039671] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Attia P, 2005, J CLIN ONCOL, V23, P6043, DOI 10.1200/JCO.2005.06.205; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Kong KF, 2014, NAT IMMUNOL, V15, P465, DOI 10.1038/ni.2866; Kuehn HS, 2014, SCIENCE, V345, P1623, DOI 10.1126/science.1255904; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Schubert D., 2014, NAT MED; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Steinman L., 2014, EUR J IMMUNOL; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	10	22	22	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					682	684		10.1016/j.immuni.2014.11.005	http://dx.doi.org/10.1016/j.immuni.2014.11.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25517610	Green Accepted, Bronze			2022-12-18	WOS:000345504900006
J	Pabst, O; Hornef, M				Pabst, Oliver; Hornef, Mathias			Gut Microbiota: A Natural Adjuvant for Vaccination	IMMUNITY			English	Editorial Material							IMMUNITY; TOLL-LIKE-RECEPTOR-5	In this issue of Immunity, Oh et al. (2014) reveal an unappreciated facet of how the microbiota influences immune responses. Immunity to nonadjuvanted vaccines depends on Toll-like-receptor-5-mediated sensing of the microbiota.	[Pabst, Oliver] RWTH Univ, Inst Mol Med, D-52074 Aachen, Germany; [Hornef, Mathias] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, D-30625 Hannover, Germany; [Hornef, Mathias] RWTH Univ, Inst Med Microbiol, D-52074 Aachen, Germany	RWTH Aachen University; Hannover Medical School; RWTH Aachen University	Pabst, O (corresponding author), RWTH Univ, Inst Mol Med, D-52074 Aachen, Germany.	opabst@ukaachen.de	Pabst, Oliver/H-5014-2016	Pabst, Oliver/0000-0002-5533-883X; Hornef, Mathias/0000-0001-6096-9110				Andersen-Nissen E, 2005, P NATL ACAD SCI USA, V102, P9247, DOI 10.1073/pnas.0502040102; Cullender TC, 2013, CELL HOST MICROBE, V14, P571, DOI 10.1016/j.chom.2013.10.009; DUPONT A, 2014, GUT; Gewirtz AT, 2001, J CLIN INVEST, V107, P99, DOI 10.1172/JCI10501; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Lozupone C, 2012, GENOME RES, V22, P1974, DOI 10.1101/gr.138198.112; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Uematsu S, 2008, NAT IMMUNOL, V9, P769, DOI 10.1038/ni.1622; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721	10	22	23	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2014	41	3					349	351		10.1016/j.immuni.2014.09.002	http://dx.doi.org/10.1016/j.immuni.2014.09.002			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ2ON	25238091	Bronze			2022-12-18	WOS:000342626500005
J	King, C				King, Cecile			A Fine Romance: T Follicular Helper Cells and B Cells	IMMUNITY			English	Editorial Material							ANTIGEN	T follicular helper (Tfh) cells help B cells to generate affinity-matured antibodies. Three papers in this issue of Immunity (Choi et al., 2011; Kerfoot et al., 2011; Kitano et al., 2011) provide information about the reciprocal relationship between B cells and Tfh cells.	[King, Cecile] Garvan Inst Med Res, Dept Immunol, Darlinghurst, NSW 2010, Australia; [King, Cecile] Univ New S Wales, St Vincents Clin Sch, Sydney, NSW 2010, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney	King, C (corresponding author), Garvan Inst Med Res, Dept Immunol, 384 Victoria St, Darlinghurst, NSW 2010, Australia.	c.king@garvan.org.au	King, Cecile/Q-9794-2019	King, Cecile/0000-0003-2193-2563				Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Cyster JG, 2010, NAT IMMUNOL, V11, P989, DOI 10.1038/ni.1946; Deenick EK, 2010, IMMUNITY, V33, P241, DOI 10.1016/j.immuni.2010.07.015; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; RON Y, 1987, J IMMUNOL, V138, P2848	10	22	22	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 24	2011	34	6					827	829		10.1016/j.immuni.2011.06.007	http://dx.doi.org/10.1016/j.immuni.2011.06.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	787AT	21703537	Bronze			2022-12-18	WOS:000292349700004
J	McKitrick, TR; Muscat, CC; Pierce, JD; Bhattacharya, D; De Tomaso, AW				McKitrick, Tanya R.; Muscat, Christina C.; Pierce, James D.; Bhattacharya, Deepta; De Tomaso, Anthony W.			Allorecognition in a Basal Chordate Consists of Independent Activating and Inhibitory Pathways	IMMUNITY			English	Article							PROTOCHORDATE HISTOCOMPATIBILITY LOCUS; ASCIDIAN BOTRYLLUS-SCHLOSSERI; NATURAL-KILLER-CELLS; CLASS-I MOLECULES; MHC CLASS-I; IMMUNE-SYSTEM; MORULA CELLS; UROCHORDATE; RECEPTORS; TOLERANCE	Histocompatibility in the basal chordate Bottyllus schlosseri is controlled by the polymorphisms of a single gene: the fuhc. A polymorphic candidate receptor (fester) appeared to play roles in both initiating the reaction and discriminating between fuhc alleles. Here we report the characterization of a related protein, uncle fester. uncle fester is not polymorphic, and although coexpressed with fester, has different functional properties. Loss-of-function studies demonstrate that uncle fester was required for incompatible reactions but has no role in interactions between compatible individuals. Furthermore, stimulation with monoclonal antibodies could initiate a rejection phenotype on a single colony, and in both assays the severity of the rejection could be manipulated. These findings suggest that allorecognition in Botryllus consists of independent pathways that control compatible and incompatible outcomes that are integrated within the interacting cells, and may provide insight into basal processes conserved in allorecognition responses throughout the metazoa.	[McKitrick, Tanya R.; Pierce, James D.; De Tomaso, Anthony W.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [McKitrick, Tanya R.; Muscat, Christina C.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [McKitrick, Tanya R.; Muscat, Christina C.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Bhattacharya, Deepta] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	University of California System; University of California Santa Barbara; Stanford University; Stanford University; Washington University (WUSTL)	De Tomaso, AW (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	detomaso@lifesci.ucsb.edu		McKitrick, Tanya/0000-0002-1312-6089	NIH [AI041588, DK045762, 1F31A1075606-01A2]; EPA [91631401-0]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041588, F31AI075606] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPA(United States Environmental Protection Agency); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank K. Palmeri, K. Ishizuka, and M. Caun for help with animal rearing; L. Jerabek, M. Inlay, T. Serwold, and I. Weissman for help with antibody production; and J. Carlyle and N. Netuschil for critical reading of the manuscript and helpful discussions. This research was supported by NIH grants AI041588 and DK045762 to A.W.D. and EPA STAR fellowship 91631401-0 and NIH grant 1F31A1075606-01A2 to T.R.M.	Azumi K, 2003, IMMUNOGENETICS, V55, P570, DOI 10.1007/s00251-003-0606-5; Ballarin L, 1995, ZOOL SCI, V12, P757, DOI 10.2108/zsj.12.757; Boehm T, 2006, CELL, V125, P845, DOI 10.1016/j.cell.2006.05.017; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; Cima F, 2004, DEV COMP IMMUNOL, V28, P881, DOI 10.1016/j.dci.2004.02.001; De Tomaso AW, 2009, DIS MODEL MECH, V2, P440, DOI 10.1242/dmm.001156; De Tomaso AW, 2005, NATURE, V438, P454, DOI 10.1038/nature04150; De Tomaso AW, 2003, IMMUNOGENETICS, V55, P480, DOI 10.1007/s00251-003-0612-7; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; Hoglund P, 2010, NAT REV IMMUNOL, V10, P724, DOI 10.1038/nri2835; Joncker NT, 2009, J IMMUNOL, V182, P4572, DOI 10.4049/jimmunol.0803900; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Laird DJ, 2005, CELL, V123, P1351, DOI 10.1016/j.cell.2005.10.026; Lanier LL, 2001, CURR OPIN IMMUNOL, V13, P326, DOI 10.1016/S0952-7915(00)00222-3; Litman GW, 2010, NAT REV IMMUNOL, V10, P543, DOI 10.1038/nri2807; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mueller DL, 2003, NAT IMMUNOL, V4, P210, DOI 10.1038/ni0303-210; NAGASHIMA L, 1981, AM ZOOL, V21, P984; Nyholm SV, 2006, IMMUNITY, V25, P163, DOI 10.1016/j.immuni.2006.04.011; Rinkevich B, 1998, MAR BIOL, V131, P227, DOI 10.1007/s002270050315; RINKEVICH B, 1995, P ROY SOC B-BIOL SCI, V259, P319, DOI 10.1098/rspb.1995.0047; SCOFIELD VL, 1983, BIOL BULL, V165, P733, DOI 10.2307/1541475; SCOFIELD VL, 1982, NATURE, V295, P499, DOI 10.1038/295499a0	27	22	23	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 22	2011	34	4					616	626		10.1016/j.immuni.2011.01.019	http://dx.doi.org/10.1016/j.immuni.2011.01.019			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21497115	Bronze			2022-12-18	WOS:000290367300019
J	Finberg, RW; Kurt-Jones, EA				Finberg, RW; Kurt-Jones, EA			CD14: Chaperone or matchmaker?	IMMUNITY			English	Editorial Material							GOLGI-APPARATUS; RECEPTORS; LIPOPOLYSACCHARIDE; CYTOKINE; VIRUS	In this issue of Immunity, Lee et al. (2006) describe a physical and functional relationship between Toll-like receptor 3 (TLR3) and the pattern recognition protein CD14. In the presence of CD14, TLR3-mediated signal transduction events are amplified.	Univ Massachusetts, Sch Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Finberg, RW (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01605 USA.							Compton T, 2003, J VIROL, V77, P4588, DOI 10.1128/JVI.77.8.4588-4596.2003; Kurt-Jones EA, 2000, NAT IMMUNOL, V1, P398, DOI 10.1038/80833; Latz E, 2002, J BIOL CHEM, V277, P47834, DOI 10.1074/jbc.M207873200; Lentschat A, 2005, J IMMUNOL, V174, P4252, DOI 10.4049/jimmunol.174.7.4252; Pauligk C, 2004, IMMUNOBIOLOGY, V209, P3, DOI 10.1016/j.imbio.2004.04.002; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Pugin J, 1998, INFECT IMMUN, V66, P1174, DOI 10.1128/IAI.66.3.1174-1180.1998; Schmitz G, 2002, CURR OPIN LIPIDOL, V13, P513, DOI 10.1097/00041433-200210000-00007; Thieblemont N, 1999, J EXP MED, V190, P523, DOI 10.1084/jem.190.4.523; Underhill DM, 2003, EUR J IMMUNOL, V33, P1767, DOI 10.1002/eji.200324037; ZIEGLERHEITBROCK HWL, 1993, IMMUNOL TODAY, V14, P121, DOI 10.1016/0167-5699(93)90212-4	11	22	22	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2006	24	2					127	129		10.1016/j.immuni.2006.01.010	http://dx.doi.org/10.1016/j.immuni.2006.01.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	014KN	16473824	Bronze			2022-12-18	WOS:000235479000003
J	Meyer-Wentrup, F; Cambi, A; Adema, GJ; Figdor, CG				Meyer-Wentrup, F; Cambi, A; Adema, GJ; Figdor, CG			"Sweet talk": Closing in on C type lectin signaling	IMMUNITY			English	Editorial Material							DENDRITIC CELLS; DECTIN-1; YEAST		Radboud Univ, Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Meyer-Wentrup, F (corresponding author), Radboud Univ, Nijmegen Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, POB 9101, NL-6500 HB Nijmegen, Netherlands.		Figdor, Carl G/A-4232-2010; Adema, G.J./H-8007-2014; Cambi, Alessandra/L-4242-2015	Figdor, Carl G/0000-0002-2366-9212; Cambi, Alessandra/0000-0003-1597-1582				Billadeau DD, 2002, J CLIN INVEST, V109, P161, DOI 10.1172/JCI14843; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; Drickamer K, 1999, CURR OPIN STRUC BIOL, V9, P585, DOI 10.1016/S0959-440X(99)00009-3; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Kiely JM, 2003, J IMMUNOL, V171, P3216, DOI 10.4049/jimmunol.171.6.3216; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004	10	22	23	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2005	22	4					399	400		10.1016/j.immuni.2005.04.001	http://dx.doi.org/10.1016/j.immuni.2005.04.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	923KU	15845444	Bronze			2022-12-18	WOS:000228909600001
J	Apostolopoulos, J; McKenzie, IFC; Sandrin, MS				Apostolopoulos, J; McKenzie, IFC; Sandrin, MS			Ly6d-L, a cell surface ligand for mouse Ly6d	IMMUNITY			English	Article							LYMPHOCYTES-T; ANTIGEN THB; CDNA CLONES; EXPRESSION; ADHESION; NOTCH; RECEPTOR; FAMILY; IDENTIFICATION; ACTIVATION	The mouse Ly6 gene family encodes proteins found in lymphocytes and other cells. Some are involved in cell activation; no ligands have been found. A ligand for Ly6d (ThB) was identified on lymphocytes using microspheres loaded with Ly6d and the cDNA isolated from a spleen/thymus library by panning on Ly6d. The Ly6d ligand (Ly6d-L) is a nonglycosylated protein of 9 kDa of broad distribution, rich in cysteine, with no discernable transmembrane sequence. Its N and C termini are on the cell surface, where it associates with a 30 kDa protein. Ly6d-L is homologous with an EGF repeat of Notch.	Austin & Repatriat Med Ctr, Austin Res Inst, Mol Immunogenet & Transplantat Lab, Heidelberg, Vic 3084, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health	Apostolopoulos, J (corresponding author), Austin & Repatriat Med Ctr, Austin Res Inst, Mol Immunogenet & Transplantat Lab, Kronheimer Bldg, Heidelberg, Vic 3084, Australia.							Adermann K, 1999, PROTEIN SCI, V8, P810, DOI 10.1110/ps.8.4.810; APELLA E, 1994, FEBS LETT, V231, P1; Apostolopoulos J, 1999, IMMUNOGENETICS, V49, P987, DOI 10.1007/s002510050583; Apostolopoulos J, 1996, J IMMUNOL METHODS, V199, P27, DOI 10.1016/S0022-1759(96)00145-7; BAMEZAI A, 1995, P NATL ACAD SCI USA, V92, P4294, DOI 10.1073/pnas.92.10.4294; BAMEZAI A, 1995, J IMMUNOL, V154, P4233; BARCLAY AN, 1997, LEUCOCYTE ANTIGEN FA, P2; BRAKENHOFF RH, 1995, J CELL BIOL, V129, P1677, DOI 10.1083/jcb.129.6.1677; Campbell ID, 1998, IMMUNOL REV, V163, P11; ECHHARDT LA, 1980, IMMUNOGENETICS, V11, P275; FLOOD PM, 1990, J EXP MED, V172, P115, DOI 10.1084/jem.172.1.115; GUMLEY TP, 1995, IMMUNOL CELL BIOL, V73, P277, DOI 10.1038/icb.1995.45; GUMLEY TP, 1992, J IMMUNOL, V149, P2615; GUMLEY TP, 1994, IMMUNOGENETICS, V39, P390, DOI 10.1007/BF00176155; Hanninen A, 1997, P NATL ACAD SCI USA, V94, P6898, DOI 10.1073/pnas.94.13.6898; HOGARTH PM, 1984, IMMUNOGENETICS, V20, P57, DOI 10.1007/BF00373447; Horie M, 1998, GENOMICS, V53, P365, DOI 10.1006/geno.1998.5462; Izon DJ, 1996, J IMMUNOL, V156, P2391; KIMURA S, 1984, IMMUNOGENETICS, V20, P47, DOI 10.1007/BF00373446; LARDELLI M, 1993, EXP CELL RES, V204, P364, DOI 10.1006/excr.1993.1044; LEE SK, 1994, EMBO J, V13, P2167, DOI 10.1002/j.1460-2075.1994.tb06493.x; Lendahl U, 1998, BIOESSAYS, V20, P103, DOI 10.1002/(SICI)1521-1878(199802)20:2<103::AID-BIES1>3.0.CO;2-U; MALEK TR, 1989, J IMMUNOL, V143, P439; MCKENZIE IFC, 1977, IMMUNOGENETICS, V5, P25, DOI 10.1007/BF01570460; ROCK KL, 1986, J EXP MED, V163, P315, DOI 10.1084/jem.163.2.315; SEED B, 1987, P NATL ACAD SCI USA, V84, P3365, DOI 10.1073/pnas.84.10.3365; STERN LJ, 1994, STRUCTURE, V2, P245, DOI 10.1016/S0969-2126(00)00026-5; SUTTON VR, 1985, IMMUNOGENETICS, V21, P539, DOI 10.1007/BF00395878; VANDERMERWE PA, 1994, TRENDS BIOCHEM SCI, V19, P354; VAUGHAN HA, 1991, IMMUNOGENETICS, V33, P113; vonBoehmer H, 1997, CURR BIOL, V7, pR308, DOI 10.1016/S0960-9822(06)00145-X; Weinmaster G, 1997, MOL CELL NEUROSCI, V9, P91, DOI 10.1006/mcne.1997.0612	32	22	23	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2000	12	2					223	232		10.1016/S1074-7613(00)80175-2	http://dx.doi.org/10.1016/S1074-7613(00)80175-2			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	289LA	10714688	Bronze			2022-12-18	WOS:000085621400012
J	WEISSMAN, IL				WEISSMAN, IL			STEM-CELLS, CLONAL PROGENITORS, AND COMMITMENT TO THE 3 LYMPHOCYTE LINEAGES - T-CELLS, B-CELLS, AND NK-CELLS	IMMUNITY			English	Review							SEVERE COMBINED IMMUNODEFICIENCY; CAENORHABDITIS-ELEGANS; MOUSE; DIFFERENTIATION; POPULATION; MUTATION; NEMATODE; THYMUS		STANFORD UNIV,SCH MED,DEPT DEV BIOL,STANFORD,CA 94305	Stanford University	WEISSMAN, IL (corresponding author), STANFORD UNIV,SCH MED,DEPT PATHOL,STANFORD,CA 94305, USA.							ARDAVIN C, 1993, NATURE, V362, P761, DOI 10.1038/362761a0; BAUM CM, 1992, P NATL ACAD SCI USA, V89, P2804, DOI 10.1073/pnas.89.7.2804; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; GEORGOPOULOS K, 1994, IN PRESS CELL, V79; GUIDOS CJ, 1990, J EXP MED, V172, P835, DOI 10.1084/jem.172.3.835; LIEBER MR, 1988, CELL, V55, P7, DOI 10.1016/0092-8674(88)90004-9; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; MORRISON SJ, 1994, IN PRESS IMMUNITY, V1; NOGUCHI M, 1993, CELL, V73, P147, DOI 10.1016/0092-8674(93)90167-O; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; WONG PMC, 1994, IMMUNITY, V1, P571, DOI 10.1016/1074-7613(94)90047-7; WU L, 1991, J EXP MED, V174, P1617, DOI 10.1084/jem.174.6.1617	16	22	22	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1994	1	7					529	531		10.1016/1074-7613(94)90042-6	http://dx.doi.org/10.1016/1074-7613(94)90042-6			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PN127	7600281				2022-12-18	WOS:A1994PN12700001
J	Shmuel-Galia, L; Humphries, F; Lei, XQ; Ceglia, S; Wilson, R; Jiang, ZZ; Ketelut-Carneiro, N; Foley, SE; Pechhold, S; Houghton, J; Muneeruddin, K; Shaffer, SA; McCormick, BA; Reboldi, A; Ward, D; Marshak-Rothstein, A; Fitzgerald, KA				Shmuel-Galia, Liraz; Humphries, Fiachra; Lei, Xuqiu; Ceglia, Simona; Wilson, Ruth; Jiang, Zhaozhao; Ketelut-Carneiro, Natalia; Foley, Sage E.; Pechhold, Susanne; Houghton, JeanMarie; Muneeruddin, Khaja; Shaffer, Scott A.; McCormick, Beth A.; Reboldi, Andrea; Ward, Doyle; Marshak-Rothstein, Ann; Fitzgerald, Katherine A.			Dysbiosis exacerbates colitis by promoting ubiquitination and accumulation of the innate immune adaptor STING in myeloid cells	IMMUNITY			English	Article							INTESTINAL MICROBIOTA; ULCERATIVE-COLITIS; HELICOBACTER-TYPHLONIUS; INFLAMMATION; ACTIVATION; DISEASE; INTERFERON; INDUCTION; UNDERLIES; EXPANSION	Alterations in the cGAS-STING DNA-sensing pathway affect intestinal homeostasis. We sought to delineate the functional role of STING in intestinal inflammation. Increased STING expression was a feature of intestinal inflammation in mice with colitis and in humans afflicted with inflammatory bowel disease. Mice bearing an allele rendering STING constitutively active exhibited spontaneous colitis and dysbiosis, as well as progressive chronic intestinal inflammation and fibrosis. Bone marrow chimera experiments revealed STING accumulation in intestinal macrophages and monocytes as the initial driver of inflammation. Depletion of Gram-negative bacteria prevented STING accumulation in these cells and alleviated intestinal inflammation. STING accumulation occurred at the protein rather than transcript level, suggesting post-translational stabilization. We found that STING was ubiquitinated in myeloid cells, and this K63-linked ubiquitination could be elicited by bacterial products, including cyclic di-GMP. Our findings suggest a positive feedback loop wherein dysbiosis foments the accumulation of STING in intestinal myeloid cells, driving intestinal inflammation.	[Shmuel-Galia, Liraz; Humphries, Fiachra; Lei, Xuqiu; Wilson, Ruth; Jiang, Zhaozhao; Ketelut-Carneiro, Natalia; Marshak-Rothstein, Ann; Fitzgerald, Katherine A.] Univ Massachusetts, Program Innate Immun, Dept Med, Med Sch, Worcester, MA 01605 USA; [Foley, Sage E.; McCormick, Beth A.; Ward, Doyle] Univ Massachusetts, Dept Microbiol & Physiol Syst, Med Sch, Worcester, MA 01605 USA; [Foley, Sage E.; McCormick, Beth A.; Ward, Doyle] Univ Massachusetts, Ctr Microbiome Res, Med Sch, Worcester, MA 01605 USA; [Ceglia, Simona; Reboldi, Andrea] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA; [Pechhold, Susanne] Univ Massachusetts, Flow Cytometry Core Facil, Med Sch, Worcester, MA 01605 USA; [Houghton, JeanMarie] Univ Massachusetts, Div Gastroenterol, Dept Med, Med Sch, Worcester, MA 01605 USA; [Muneeruddin, Khaja; Shaffer, Scott A.] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Med Sch, Worcester, MA 01605 USA; [Muneeruddin, Khaja; Shaffer, Scott A.] Univ Massachusetts, Mass Spectrometry Facil, Med Sch, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Shmuel-Galia, L; Fitzgerald, KA (corresponding author), Univ Massachusetts, Program Innate Immun, Dept Med, Med Sch, Worcester, MA 01605 USA.	liraz.galia@umassmed.edu; kate.fitzgerald@umassmed.edu	Muneeruddin, Khaja/AAU-9383-2021	Ketelut-Carneiro, Natalia/0000-0003-0940-3415; Humphries, Fiachra/0000-0003-0216-5776; Wilson, Ruth/0000-0002-2477-2027	Lupus Research Alliance; NIH [AI128358]; EMBO long term postdoctoral fellowship [ALTF 534-2017]; Crohn's and Colitis Foundation [708946]; GSK postdoctoral fellowship; Cancer Research Institute	Lupus Research Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EMBO long term postdoctoral fellowship(European Molecular Biology Organization (EMBO)); Crohn's and Colitis Foundation; GSK postdoctoral fellowship; Cancer Research Institute	We thank all the members of the Fitzgerald laboratory for helpful discussion. We further thank the staff of the UMass Medical School Animal Facility and the Flow Cytometry Core for expert advice and technical assistance. We also thank professor Joonsoo Kang, Dr. Mor Gross-Vered, and professor Pranoti Mandrekar for helpful suggestions and insightful discussions. This study was funded by a Target Identification in Lupus grant from the Lupus Research Alliance and by grants from the NIH (AI128358) awarded to K.A.F. L.S.-G. is a recipient of the EMBO long term postdoctoral fellowship (ALTF 534-2017) and is funded by the Crohn's and Colitis Foundation, award number 708946 (title: SAVI mutations in STING lead to intestinal inflammation and fibrosis in mice). F.H. is a recipient of a GSK postdoctoral fellowship, and N.K.-C. is a Cancer Research Irvington fellow supported by the Cancer Research Institute.	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Aden K, 2018, J EXP MED, V215, P2868, DOI 10.1084/jem.20171029; Ahn J, 2017, CELL REP, V21, P3873, DOI 10.1016/j.celrep.2017.11.101; Alam MT, 2020, GUT PATHOG, V12, DOI 10.1186/s13099-019-0341-6; Bennion BG, 2019, J VIROL, V93, DOI 10.1128/JVI.01806-18; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolyen E, 2019, NAT BIOTECHNOL, V37, P1091, DOI 10.1038/s41587-019-0252-6; Canesso MCC, 2018, MUCOSAL IMMUNOL, V11, P820, DOI 10.1038/mi.2017.88; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Chen ZJJ, 2012, IMMUNOL REV, V246, P95, DOI 10.1111/j.1600-065X.2012.01108.x; Chia J, 2016, J AM ACAD DERMATOL, V74, P186, DOI 10.1016/j.jaad.2015.10.007; Chichlowski M, 2008, COMPARATIVE MED, V58, P534; Drewes JL, 2017, NPJ BIOFILMS MICROBI, V3, DOI 10.1038/s41522-017-0040-3; Dziarski R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146162; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; Fischer JC, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2513; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Franklin CL, 2001, J CLIN MICROBIOL, V39, P3920, DOI 10.1128/JCM.39.11.3920-3926.2001; Graspeuntner S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27757-8; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Guarner F, 2008, INFLAMM BOWEL DIS, V14, pS83, DOI 10.1002/ibd.20548; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hold GL, 2014, WORLD J GASTROENTERO, V20, P1192, DOI 10.3748/wjg.v20.i5.1192; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hu QY, 2019, EBIOMEDICINE, V41, P497, DOI 10.1016/j.ebiom.2019.02.055; Imam T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01212; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jeremiah N, 2014, J CLIN INVEST, V124, P5516, DOI 10.1172/JCI79100; Jiang Y, 2017, PROTEIN CELL, V8, P72, DOI 10.1007/s13238-016-0351-9; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kullberg MC, 2003, P NATL ACAD SCI USA, V100, P15830, DOI 10.1073/pnas.2534546100; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lavelle A, 2015, GUT, V64, P1553, DOI 10.1136/gutjnl-2014-307873; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Ma CM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6717; Ma F, 2015, EMBO REP, V16, P202, DOI 10.15252/embr.201439366; Man SM, 2008, HELICOBACTER, V13, P234, DOI 10.1111/j.1523-5378.2008.00607.x; Marinho FV, 2017, TRENDS MICROBIOL, V25, P906, DOI 10.1016/j.tim.2017.05.008; Martin GR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50656-5; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Motwani M, 2019, P NATL ACAD SCI USA, V116, P7941, DOI 10.1073/pnas.1818281116; Nahar S, 2019, POL ARCH INTERN MED, V129, P620, DOI 10.20452/pamw.14835; Picard C, 2016, CHEST, V150, pE65, DOI 10.1016/j.chest.2016.02.682; Picard C, 2015, AUTOIMMUN REV, V14, P1147, DOI 10.1016/j.autrev.2015.08.002; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Schunter MO, 2007, J CROHNS COLITIS, V1, P41, DOI 10.1016/j.crohns.2007.06.004; Shang GJ, 2019, NATURE, V567, P389, DOI 10.1038/s41586-019-0998-5; Sharp JM, 2008, COMPARATIVE MED, V58, P447; Shen ZH, 2018, WORLD J GASTROENTERO, V24, P5, DOI 10.3748/wjg.v24.i1.5; Shmuel-Galia L, 2016, EMBO J, V35, P685, DOI 10.15252/embj.201592649; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Truong DT, 2015, NAT METHODS, V12, P902, DOI 10.1038/nmeth.3589; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Warner JD, 2017, J EXP MED, V214, P3279, DOI 10.1084/jem.20171351; Wu JJ, 2019, J EXP MED, V216, P867, DOI 10.1084/jem.20182192; Yang S, 2014, IMMUNITY, V41, P973, DOI 10.1016/j.immuni.2014.11.013; Zhang CG, 2019, NATURE, V567, P394, DOI 10.1038/s41586-019-1000-2; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zheng DP, 2020, CELL RES, V30, P492, DOI 10.1038/s41422-020-0332-7; Zhu QF, 2014, J IMMUNOL, V193, P4779, DOI 10.4049/jimmunol.1402051	66	21	21	12	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1137	+		10.1016/j.immuni.2021.05.008	http://dx.doi.org/10.1016/j.immuni.2021.05.008		JUN 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	34051146	Bronze, Green Accepted			2022-12-18	WOS:000659882900008
J	Zhu, BB; Wu, Y; Huang, S; Zhang, RX; Son, YM; Li, CF; Cheon, IS; Gao, XC; Wang, M; Chen, Y; Zhou, X; Nguyen, Q; Phan, AT; Behl, S; Taketo, MM; Mack, M; Shapiro, VS; Zeng, H; Ebihara, H; Mullon, JJ; Edell, ES; Reisenauer, JS; Demirel, N; Kern, RM; Chakraborty, R; Cui, WG; Kaplan, MH; Zhou, XB; Goldrath, AW; Sun, J				Zhu, Bibo; Wu, Yue; Huang, Su; Zhang, Ruixuan; Son, Young Min; Li, Chaofan; Cheon, In Su; Gao, Xiaochen; Wang, Min; Chen, Yao; Zhou, Xian; Quynh Nguyen; Phan, Anthony T.; Behl, Supriya; Taketo, M. Mark; Mack, Matthias; Shapiro, Virginia S.; Zeng, Hu; Ebihara, Hideki; Mullon, John J.; Edell, Eric S.; Reisenauer, Janani S.; Demirel, Nadir; Kern, Ryan M.; Chakraborty, Rana; Cui, Weiguo; Kaplan, Mark H.; Zhou, Xiaobo; Goldrath, Ananda W.; Sun, Jie			Uncoupling of macrophage inflammation from self-renewal modulates host recovery from respiratory viral infection	IMMUNITY			English	Article							INFLUENZA-VIRUS INFECTION; ALVEOLAR MACROPHAGES; BETA-CATENIN; IMMUNE-RESPONSE; STEM-CELLS; PATHWAY; INTERFERON; PROLIFERATION; HIF-1-ALPHA; ACTIVATION	Tissue macrophages self-renew during homeostasis and produce inflammatory mediators upon microbial infection. We examined the relationship between proliferative and inflammatory properties of tissue macrophages by defining the impact of the Wnt/beta-catenin pathway, a central regulator of self-renewal, in alveolar macrophages (AMs). Activation of beta-catenin by Wnt ligand inhibited AM proliferation and stemness, but promoted inflammatory activity. In a murine influenza viral pneumonia model, beta-catenin-mediated AM inflammatory activity promoted acute host morbidity; in contrast, AM proliferation enabled repopulation of reparative AMs and tissue recovery following viral clearance. Mechanistically, Wnt treatment promoted beta-catenin-HIF-1 alpha interaction and glycolysis-dependent inflammation while suppressing mitochondrial metabolism and thereby, AM proliferation. Differential HIF-1 alpha activities distinguished proliferative and inflammatory AMs in vivo. This beta-catenin-HIF-1 alpha axis was conserved in human AMs and enhanced HIF-1 alpha expression associated with macrophage inflammation in COVID-19 patients. Thus, inflammatory and reparative activities of lung macrophages are regulated by beta-catenin-HIF-1 alpha signaling, with implications for the treatment of severe respiratory diseases.	[Zhu, Bibo; Wu, Yue; Huang, Su; Zhang, Ruixuan; Son, Young Min; Li, Chaofan; Cheon, In Su; Gao, Xiaochen; Wang, Min; Mullon, John J.; Edell, Eric S.; Reisenauer, Janani S.; Kern, Ryan M.; Sun, Jie] Mayo Clin, Div Pulm & Crit Care Med, Dept Med, Coll Med & Sci, Rochester, MN 55905 USA; [Zhu, Bibo; Wu, Yue; Huang, Su; Zhang, Ruixuan; Son, Young Min; Li, Chaofan; Cheon, In Su; Gao, Xiaochen; Wang, Min; Zhou, Xian; Shapiro, Virginia S.; Zeng, Hu; Sun, Jie] Mayo Clin, Dept Immunol, Coll Med & Sci, Rochester, MN 55905 USA; [Chen, Yao; Cui, Weiguo] Versiti Blood Res Inst, Milwaukee, WI 53226 USA; [Chen, Yao; Cui, Weiguo] Med Coll Wisconsin, Dept Microbiol & Immunol, Wauwatosa, WI 53226 USA; [Zhou, Xian; Zeng, Hu] Mayo Clin, Div Rheumatol, Dept Med, Coll Med & Sci, Rochester, MN 55905 USA; [Quynh Nguyen; Phan, Anthony T.; Goldrath, Ananda W.] Univ Calif San Diego, Div Biol Sci, Sect Mol Biol, La Jolla, CA 92093 USA; [Behl, Supriya; Demirel, Nadir; Chakraborty, Rana] Mayo Clin, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA; [Taketo, M. Mark] Kyoto Univ, Grad Sch Med, Div Expt Therapeut, Kyoto, Japan; [Mack, Matthias] Univ Hosp Regensburg, Dept Nephrol, D-93053 Regensburg, Germany; [Ebihara, Hideki] Mayo Clin, Dept Mol Med, Coll Med & Sci, Rochester, MN 55905 USA; [Kaplan, Mark H.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Zhou, Xiaobo] Brigham & Womens Hosp, Channing Div Network Med, Dept Med, Boston, MA 02115 USA	Mayo Clinic; Mayo Clinic; Medical College of Wisconsin; Mayo Clinic; University of California System; University of California San Diego; Mayo Clinic; Kyoto University; University of Regensburg; Mayo Clinic; Indiana University System; Indiana University Bloomington; Harvard University; Brigham & Women's Hospital	Sun, J (corresponding author), Mayo Clin, Div Pulm & Crit Care Med, Dept Med, Coll Med & Sci, Rochester, MN 55905 USA.; Sun, J (corresponding author), Mayo Clin, Dept Immunol, Coll Med & Sci, Rochester, MN 55905 USA.	sun.jie@mayo.edu	Li, Chaofan/GMX-4943-2022	Li, Chaofan/0000-0002-5426-1498; ZHU, BIBO/0000-0002-1187-4526; Behl, Supriya/0000-0002-6672-4824	NIH [AI112844, AI147394, AG069264, AG047156, AI129241, AI067545]; Mayo Clinic Kogod Aging Center and Center for Biomedical Discovery funds	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Clinic Kogod Aging Center and Center for Biomedical Discovery funds	We thank the NIH Tetramer Core, the Mayo Flow Cytometry and Genomic cores, and Drs. M. Tanaka, K. Khanna, and A. Robling for assistance. This study was funded by NIH grants AI112844, AI147394, AG069264, and AG047156 and Mayo Clinic Kogod Aging Center and Center for Biomedical Discovery funds to J.S., as well as NIH grants AI129241 to M.H.K and AI067545 to A.W.G.	Aegerter H, 2020, NAT IMMUNOL, V21, P145, DOI 10.1038/s41590-019-0568-x; Caputa G, 2019, NAT IMMUNOL, V20, P793, DOI 10.1038/s41590-019-0407-0; Cardani A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006140; Channappanavar R, 2017, SEMIN IMMUNOPATHOL, V39, P529, DOI 10.1007/s00281-017-0629-x; Channappanavar R, 2016, CELL HOST MICROBE, V19, P181, DOI 10.1016/j.chom.2016.01.007; Chapman HA, 2011, J CLIN INVEST, V121, P2855, DOI 10.1172/JCI57673; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; del Peso L, 2003, J BIOL CHEM, V278, P48690, DOI 10.1074/jbc.M308862200; Desai TJ, 2014, NATURE, V507, P190, DOI 10.1038/nature12930; Desch AN, 2016, AM J RESP CRIT CARE, V193, P614, DOI 10.1164/rccm.201507-1376OC; Findlay EG, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/140937; Ghoneim HE, 2013, J IMMUNOL, V191, P1250, DOI 10.4049/jimmunol.1300014; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Huang S, 2019, J VIROL, V93, DOI 10.1128/JVI.00030-19; HUPRIKAR J, 1980, J VIROL METHODS, V1, P117, DOI 10.1016/0166-0934(80)90020-8; Hussell T, 2014, NAT REV IMMUNOL, V14, P81, DOI 10.1038/nri3600; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Izquierdo HM, 2018, CELL REP, V24, P1738, DOI 10.1016/j.celrep.2018.07.034; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556; Klochendler A, 2012, DEV CELL, V23, P681, DOI 10.1016/j.devcel.2012.08.009; Kumagai Y, 2007, IMMUNITY, V27, P240, DOI 10.1016/j.immuni.2007.07.013; Lee JH, 2017, CELL, V170, P1149, DOI 10.1016/j.cell.2017.07.028; Lee K, 2010, BIOCHEM PHARMACOL, V80, P982, DOI 10.1016/j.bcp.2010.06.018; Li CF, 2019, IMMUNITY, V51, P491, DOI 10.1016/j.immuni.2019.08.013; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Londrigan SL, 2015, J VIROL, V89, P12319, DOI 10.1128/JVI.01455-15; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Manoharan I, 2014, J IMMUNOL, V193, P4203, DOI 10.4049/jimmunol.1400614; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Mei J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22020-6; Merad M, 2020, NAT REV IMMUNOL, V20, P355, DOI 10.1038/s41577-020-0331-4; Minutti CM, 2017, SEMIN CELL DEV BIOL, V61, P3, DOI 10.1016/j.semcdb.2016.08.006; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Morris SAL, 2016, GENES DIS, V3, P41, DOI 10.1016/j.gendis.2015.12.003; Nabhan AN, 2018, SCIENCE, V359, P1118, DOI 10.1126/science.aam6603; Newton AH, 2016, SEMIN IMMUNOPATHOL, V38, P471, DOI 10.1007/s00281-016-0558-0; Pernet E, 2019, NAT MICROBIOL, V4, P1389, DOI 10.1038/s41564-019-0444-3; Purnama C, 2014, EUR J IMMUNOL, V44, P2003, DOI 10.1002/eji.201344359; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rubins JB, 2003, AM J RESP CRIT CARE, V167, P103, DOI 10.1164/rccm.2210007; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schneider C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004053; Short KR, 2014, LANCET INFECT DIS, V14, P57, DOI 10.1016/S1473-3099(13)70286-X; Sieweke MH, 2013, SCIENCE, V342, P946, DOI 10.1126/science.1242974; Sohn YS, 2013, P NATL ACAD SCI USA, V110, P14676, DOI 10.1073/pnas.1313198110; Soucie EL, 2016, SCIENCE, V351, DOI 10.1126/science.aad5510; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun J, 2011, NAT IMMUNOL, V12, P327, DOI 10.1038/ni.1996; Sun J, 2009, NAT MED, V15, P277, DOI 10.1038/nm.1929; Suryawanshi A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00460; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tate MD, 2010, J VIROL, V84, P7569, DOI 10.1128/JVI.00291-10; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Ural BB, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax8756; Wang JR, 2011, AM J RESP CELL MOL, V45, P582, DOI 10.1165/rcmb.2010-0108OC; Wang Z, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw1217; Wellenstein MD, 2019, NATURE, V572, P538, DOI 10.1038/s41586-019-1450-6; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Xi Y, 2017, NAT CELL BIOL, V19, P904, DOI 10.1038/ncb3580; Yao SY, 2013, IMMUNITY, V39, P833, DOI 10.1016/j.immuni.2013.10.007; Yao YS, 2018, CELL, V175, P1634, DOI 10.1016/j.cell.2018.09.042; Zhang L, 2020, J MED VIROL, V92, P479, DOI 10.1002/jmv.25707; Zhu BB, 2019, P NATL ACAD SCI USA, V116, P11888, DOI 10.1073/pnas.1902310116	76	21	21	1	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1200	+	e9	10.1016/j.immuni.2021.04.001	http://dx.doi.org/10.1016/j.immuni.2021.04.001		JUN 2021	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	33951416	Bronze, Green Published			2022-12-18	WOS:000659882900012
J	Huang, JL; Lee, HY; Zhao, XH; Han, JY; Su, Y; Sun, QL; Shao, J; Ge, JW; Zhao, YX; Bai, X; He, Y; Wang, XQ; Wang, XH; Dong, C				Huang, Jinling; Lee, Hae-youn; Zhao, Xiaohong; Han, Jinyi; Su, Yang; Sun, Qinli; Shao, Jing; Ge, Jiwan; Zhao, Yuxi; Bai, Xue; He, Yi; Wang, Xinquan; Wang, Xiaohu; Dong, Chen			Interleukin-17D regulates group 3 innate lymphoid cell function through its receptor CD93	IMMUNITY			English	Article							ROR-GAMMA-T; CUTTING EDGE; DIFFERENTIATION; IMMUNITY; PROMOTES; INFLAMMATION; IL-17C; GUT; COLONIZATION; MICROBIOTA	The interleukin (IL)-17 family, consisting of six members, promotes host defense but can in some context promote the development of autoimmune disease. Here, we examined the role of IL-17D, a poorly understood member in the IL-17 family. IL-17D was expressed primarily by colonic epithelial cells. Il17d(-/-) mice were more susceptible to acute colitis, bacterial infection and experimentally induced colon cancer than their wild-type counterparts. Il17d deficiency impaired IL-22 production by group 3 innate lymphoid cells (ILC3s) and reduced expression of IL-22-dependent antimicrobial peptides, RegIII beta and RegIII gamma, in colon tissue at steady state and in colitis; this was associated with changes in microbial composition and dysbiosis. Protein purification studies revealed that IL-17D bound not canonical IL-17 receptors, but rather CD93, a glycoprotein expressed on mature ILC3s. Mice lacking Cd93 in ILC3s exhibited impaired IL-22 production and aggravated colonic inflammation in experimental colitis. Thus, an IL-17D-CD93 axis regulates ILC3 function to preserve intestinal homeostasis.	[Huang, Jinling; Lee, Hae-youn; Zhao, Xiaohong; Han, Jinyi; Su, Yang; Sun, Qinli; Shao, Jing; Zhao, Yuxi; Bai, Xue; He, Yi; Wang, Xiaohu; Dong, Chen] Tsinghua Univ, Inst Immunol & Sch Med, Beijing 100084, Peoples R China; [Huang, Jinling] Tsinghua Univ, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China; [Ge, Jiwan; Wang, Xinquan] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Beijing Frontier Res Ctr Biol Struct,Key Lab Prot, Collaborat Innovat Centerfor Biotherapy,Minist Ed, Beijing 100084, Peoples R China; [Dong, Chen] Shanghai Jiao Tong Univ, Sch Med, Affiliated Renji Hosp, Shanghai 200127, Peoples R China; [Lee, Hae-youn] LG Chem Ltd, Life Sci R&D, Drug Discovery Ctr, Seoul, South Korea	Tsinghua University; Tsinghua University; Tsinghua University; Shanghai Jiao Tong University; LG Chem	Dong, C (corresponding author), Tsinghua Univ, Inst Immunol & Sch Med, Beijing 100084, Peoples R China.; Dong, C (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Affiliated Renji Hosp, Shanghai 200127, Peoples R China.	chendong@tsinghua.edu.cn	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130	National Key Research and Development Program of China [2016YFC0906200]; Beijing Municipal Science and Technology [Z181100001318007]; National Natural Science Foundation of China [31630022, 31821003, 31991170, 32070889]	National Key Research and Development Program of China; Beijing Municipal Science and Technology; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank the Animal Facility at Tsinghua University for providing germ-free mice and their assistance in generation of Cd93-deficient mice. We also thank the Centre for Protein Technology at Tsinghua University for help with mass spectrometry. This study was supported by grants from the National Key Research and Development Program of China (2016YFC0906200 to C.D.), Beijing Municipal Science and Technology (Z181100001318007 to C.D.), and the National Natural Science Foundation of China (31630022, 31821003, 31991170 to C.D. and 32070889 to X.W.).	Angkasekwinai P, 2007, J EXP MED, V204, P1509, DOI 10.1084/jem.20061675; Behnsen J, 2014, IMMUNITY, V40, P262, DOI 10.1016/j.immuni.2014.01.003; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chang SH, 2011, IMMUNITY, V35, P611, DOI 10.1016/j.immuni.2011.09.010; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Diefenbach A, 2014, IMMUNITY, V41, P354, DOI 10.1016/j.immuni.2014.09.005; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Eberl G, 2003, IMMUNOL REV, V195, P81, DOI 10.1034/j.1600-065X.2003.00074.x; Greenlee-Wacker MC, 2011, J IMMUNOL, V187, P3353, DOI 10.4049/jimmunol.1100803; Guo XH, 2015, IMMUNITY, V42, P731, DOI 10.1016/j.immuni.2015.03.012; Guo XH, 2014, IMMUNITY, V40, P25, DOI 10.1016/j.immuni.2013.10.021; Guo YH, 2018, J IMMUNOL, V201, P2427, DOI 10.4049/jimmunol.1800620; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Huang JL, 2016, CELL MOL IMMUNOL, V13, P474, DOI 10.1038/cmi.2015.56; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Johansen C, 2009, BRIT J DERMATOL, V160, P319, DOI 10.1111/j.1365-2133.2008.08902.x; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Luci C, 2009, NAT IMMUNOL, V10, P75, DOI 10.1038/ni.1681; Moriwaki K, 2014, IMMUNITY, V41, P567, DOI 10.1016/j.immuni.2014.09.016; Nepomuceno RR, 1999, J IMMUNOL, V162, P3583; Norsworthy PJ, 2004, J IMMUNOL, V172, P3406, DOI 10.4049/jimmunol.172.6.3406; O'Sullivan T, 2014, CELL REP, V7, P989, DOI 10.1016/j.celrep.2014.03.073; Orlandini M, 2014, ONCOTARGET, V5, P2750, DOI 10.18632/oncotarget.1887; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Ramirez-Carrozzi V, 2011, NAT IMMUNOL, V12, P1159, DOI 10.1038/ni.2156; Reynolds JM, 2015, IMMUNITY, V42, P692, DOI 10.1016/j.immuni.2015.03.008; Reynolds JM, 2012, J IMMUNOL, V189, P4226, DOI 10.4049/jimmunol.1103014; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Saddawi-Konefka R, 2016, CELL REP, V16, P2348, DOI 10.1016/j.celrep.2016.07.075; Satoh-Takayama N, 2008, IMMUNITY, V29, P958, DOI 10.1016/j.immuni.2008.11.001; Satoh-Takayama N, 2014, IMMUNITY, V41, P776, DOI 10.1016/j.immuni.2014.10.007; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Scoville SD, 2019, CURR OPIN IMMUNOL, V56, P100, DOI 10.1016/j.coi.2018.11.003; Song XY, 2015, IMMUNITY, V43, P488, DOI 10.1016/j.immuni.2015.06.024; Song XY, 2011, NAT IMMUNOL, V12, P1151, DOI 10.1038/ni.2155; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Starnes T, 2002, J IMMUNOL, V169, P642, DOI 10.4049/jimmunol.169.2.642; Su Y, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau9657; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zenewicz LA, 2013, J IMMUNOL, V190, P5306, DOI 10.4049/jimmunol.1300016; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	52	21	21	6	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					673	+		10.1016/j.immuni.2021.03.018	http://dx.doi.org/10.1016/j.immuni.2021.03.018		APR 2021	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33852831	Bronze			2022-12-18	WOS:000640102800010
J	Wang, YJ; Wang, P; Zhang, YK; Xu, JF; Li, ZQ; Li, ZM; Zhou, ZC; Liu, L; Cao, XT				Wang, Yujia; Wang, Pin; Zhang, Yunkai; Xu, Junfang; Li, Zhiqing; Li, Zemeng; Zhou, Zhongcheng; Liu, Lin; Cao, Xuetao			Decreased Expression of the Host Long-Noncoding RNA-GM Facilitates Viral Escape by Inhibiting the Kinase activity TBK1 via S-glutathionylation	IMMUNITY			English	Article							NF-KAPPA-B; TRANSFERASE-PI; I INTERFERON; RESPONSES; VIRUS; RECOGNITION; DEFENSE; CELLS; SUPPRESSION; METABOLISM	Viruses have evolved multiple strategies to evade elimination by the immune system. Here we examined the contribution of host long noncoding RNAs (lncRNAs) in viral immune evasion. By functional screening of lncRNAs whose expression decreased upon viral infection of macrophages, we identified a lncRNA (lncRNA-GM, Gene Symbol: AK189470.1) that promoted type 1 interferon (IFN-I) production and inhibited viral replication. Deficiency of lncRNA-GM in mice increased susceptibility to viral infection and impaired IFN-1 production. Mechanistically, lncRNA-GM bound to glutathione S-transferase M1 (GSTM1) and blocked GSTM1 interaction with the kinase TBK1, reducing GSTM1-mediated S-glutathionylation of TBK1. Decreased S-glutathionylation enhanced TBK1 activity and downstream production of antiviral mediators, Viral infection reprogrammed intracellular glutathione metabolism and furthermore, an oxidized glutathione mimetic could inhibit TBK1 activity and promote viral replication. Our findings reveal regulation of TBK1 by S-glutathionylation and provide insight into the viral mediated metabolic changes that impact innate immunity and viral evasion.	[Wang, Yujia; Cao, Xuetao] Zhejiang Univ, Inst Immunol, Sch Med, Hangzhou 310058, Peoples R China; [Wang, Yujia; Wang, Pin; Zhang, Yunkai; Xu, Junfang; Li, Zhiqing; Li, Zemeng; Cao, Xuetao] Navy Med Univ, Inst Immunol, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Xu, Junfang; Cao, Xuetao] Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China; [Zhou, Zhongcheng; Liu, Lin; Cao, Xuetao] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China	Zhejiang University; Naval Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Nankai University	Cao, XT (corresponding author), Zhejiang Univ, Inst Immunol, Sch Med, Hangzhou 310058, Peoples R China.; Cao, XT (corresponding author), Navy Med Univ, Inst Immunol, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China.; Cao, XT (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing 100005, Peoples R China.; Cao, XT (corresponding author), Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China.	caoxt@immunol.org			National Natural Science Foundation of China [81788101, 81671566, 81922032]; National Key Research and Development Program of China [2018YFA0507403]; CAMS Innovation Fund for Medical Sciences [2016-12M-1-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; CAMS Innovation Fund for Medical Sciences	We thank Dr. Qian Zhang for helpful discussion. This work is supported by grants from the National Natural Science Foundation of China(81788101, 81671566, 81922032), the National Key Research and Development Program of China (2018YFA0507403), and CAMS Innovation Fund for Medical Sciences (2016-12M-1-003).	Alegre-Cebollada J, 2014, CELL, V156, P1235, DOI 10.1016/j.cell.2014.01.056; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075; Bajwa G, 2016, J IMMUNOL, V196, P2004, DOI 10.4049/jimmunol.1501557; Bradley KC, 2019, CELL REP, V28, P245, DOI 10.1016/j.celrep.2019.05.105; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Butturini E, 2014, ACS CHEM BIOL, V9, P1885, DOI 10.1021/cb500407d; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; Chan YK, 2016, NAT IMMUNOL, V17, P523, DOI 10.1038/ni.3393; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Cho SG, 2001, J BIOL CHEM, V276, P12749, DOI 10.1074/jbc.M005561200; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Cui J, 2012, NAT IMMUNOL, V13, P387, DOI 10.1038/ni.2239; Dai JP, 2017, MOLECULES, V22, DOI 10.3390/molecules22101754; Dai J, 2019, CELL, V176, P1447, DOI 10.1016/j.cell.2019.01.016; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Esfandiar A, 2017, SCIENCE, V358, P511, DOI 10.1126/science.aan5275; Feng Q, 2018, J IMMUNOL, V201, P675, DOI 10.4049/jimmunol.1800285; Galvan-Pena S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08187-6; Gate L, 2004, J BIOL CHEM, V279, P8608, DOI 10.1074/jbc.M308613200; Grek CL, 2012, CANCER RES, V72, P2383, DOI 10.1158/0008-5472.CAN-11-4088; Hoetzenecker W, 2012, NAT MED, V18, P128, DOI 10.1038/nm.2557; Hosono Y, 2017, CELL, V171, P1559, DOI 10.1016/j.cell.2017.11.040; Hsu CH, 2002, ONCOLOGY-BASEL, V62, P305, DOI 10.1159/000065061; Hughes MM, 2017, P NATL ACAD SCI USA, V114, pE6480, DOI 10.1073/pnas.1701868114; Imamura K, 2014, MOL CELL, V53, P393, DOI 10.1016/j.molcel.2014.01.009; Jiang MH, 2018, CELL, V173, P906, DOI 10.1016/j.cell.2018.03.064; Kano S, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aar2124; Katoh T, 2015, NUCLEIC ACIDS RES, V43, P7521, DOI 10.1093/nar/gkv669; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kell AM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008483; Kishore N, 2002, J BIOL CHEM, V277, P13840, DOI 10.1074/jbc.M110474200; Kyle JE, 2019, P NATL ACAD SCI USA, V116, P3919, DOI 10.1073/pnas.1815356116; Kyogoku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083776; Levy G, 2016, NAT CHEM BIOL, V12, P1037, DOI [10.1038/NCHEMBIO.2193, 10.1038/nchembio.2193]; Li SL, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0792-3; Li TL, 2018, CELL HOST MICROBE, V24, P791, DOI 10.1016/j.chom.2018.11.001; Li X, 2017, ENERGIES, V10, P1, DOI DOI 10.1063/1.4998611; Liang YS, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007075; Lien EC, 2016, NAT CELL BIOL, V18, P572, DOI 10.1038/ncb3341; Lin HY, 2019, NAT IMMUNOL, V20, P812, DOI 10.1038/s41590-019-0379-0; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Liu Y, 2019, SCIENCE, V365, P1171, DOI 10.1126/science.aax4468; Mayer AK, 2007, J IMMUNOL, V178, P3134, DOI 10.4049/jimmunol.178.5.3134; Melero I, 2015, CANCER RES, V75, P497, DOI 10.1158/0008-5472.CAN-13-3356; Menon D, 2015, J CELL SCI, V128, P1982, DOI 10.1242/jcs.167858; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Nolin JD, 2014, FREE RADICAL BIO MED, V73, P143, DOI 10.1016/j.freeradbiomed.2014.04.028; Ouyang J, 2014, CELL HOST MICROBE, V16, P616, DOI 10.1016/j.chom.2014.10.001; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Queiroga CSF, 2010, J BIOL CHEM, V285, P17077, DOI 10.1074/jbc.M109.065052; Reynaert NL, 2006, P NATL ACAD SCI USA, V103, P13086, DOI 10.1073/pnas.0603290103; ROSS VL, 1993, BIOCHEM J, V294, P373, DOI 10.1042/bj2940373; Song GH, 2016, NAT IMMUNOL, V17, P1342, DOI 10.1038/ni.3588; Takata MA, 2017, NATURE, V550, P124, DOI 10.1038/nature24039; Townsend DM, 2009, J BIOL CHEM, V284, P436, DOI 10.1074/jbc.M805586200; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Wang CG, 2018, IMMUNITY, V48, P675, DOI 10.1016/j.immuni.2018.03.017; Wang D, 2011, J VIROL, V85, P3758, DOI 10.1128/JVI.02589-10; Wang P, 2014, SCIENCE, V344, P310, DOI 10.1126/science.1251456; Wang WM, 2019, NATURE, V569, P270, DOI 10.1038/s41586-019-1170-y; Winterbourn CC, 2008, FREE RADICAL BIO MED, V45, P549, DOI 10.1016/j.freeradbiomed.2008.05.004; Xie Y, 2009, ENDOCRINOLOGY, V150, P1122, DOI 10.1210/en.2008-1241; Xu N, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0270-5; Yamada T, 2016, NAT IMMUNOL, V17, P687, DOI 10.1038/ni.3422; Yao H, 2019, NAT BIOMED ENG, V3, P306, DOI 10.1038/s41551-019-0375-6; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Zhang WN, 2019, CELL, V178, P176, DOI 10.1016/j.cell.2019.05.003	71	21	21	3	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2020	53	6					1168	+		10.1016/j.immuni.2020.11.010	http://dx.doi.org/10.1016/j.immuni.2020.11.010			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9JT	33326766	Bronze			2022-12-18	WOS:000599363300008
J	Bilate, AM; London, M; Castro, TBR; Mesin, L; Bortolatto, J; Kongthong, S; Harnagel, A; Victora, GD; Mucida, D				Bilate, Angelina M.; London, Mariya; Castro, Tiago B. R.; Mesin, Luka; Bortolatto, Juliana; Kongthong, Suppawat; Harnagel, Audrey; Victora, Gabriel D.; Mucida, Daniel			T Cell Receptor Is Required for Differentiation, but Not Maintenance, of Intestinal CD4(+) Intraepithelial Lymphocytes	IMMUNITY			English	Article							TISSUE ADAPTATION; SELF-REACTIVITY; TCR; LINEAGE; ALPHA; CD8-ALPHA-ALPHA; REPERTOIRE; EXPRESSION; INDUCTION; TOLERANCE	The gut epithelium is populated by intraepithelial lymphocytes (IELs), a heterogeneous T cell population with cytotoxic and regulatory properties, which can be acquired at the epithelial layer. However, the role of T cell receptor (TCR) in this process remains unclear. Single-cell transcriptomic analyses revealed distinct clonal expansions between cell states, with CD4 (+)CD8 alpha alpha (+) IELs being one of the least diverse populations. Conditional deletion of TCR on differentiating CD4 (+) T cells or of major histocompatibility complex (MHC) class II on intestinal epithelial cells prevented CD4 (+)CD8 alpha alpha (+) IEL differentiation. However, TCR ablation on differentiated CD4 (+)CD8 alpha alpha (+) IELs or long-term cognate antigen withdraw did not affect their maintenance. TCR re-engagement of antigen-specific CD4 (+)CD8 alpha alpha (+) IELs by Listeria monocytogenes did not alter their state but correlated with reduced bacterial invasion. Thus, local antigen recognition is an essential signal for differentiation of CD4 (+) T cells at the epithelium, yet differentiated IELs are able to preserve an effector program in the absence of TCR signaling.	[Bilate, Angelina M.; London, Mariya; Castro, Tiago B. R.; Bortolatto, Juliana; Kongthong, Suppawat; Harnagel, Audrey; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA; [Castro, Tiago B. R.; Mesin, Luka; Bortolatto, Juliana; Victora, Gabriel D.] Rockefeller Univ, Lab Lymphocyte Dynam, New York, NY 10065 USA	Rockefeller University; Rockefeller University	Bilate, AM; Mucida, D (corresponding author), Rockefeller Univ, Lab Mucosal Immunol, New York, NY 10065 USA.	abilate@rockefeller.edu; mucida@rockefeller.edu	TBR, Castro/K-4014-2018	TBR, Castro/0000-0002-0359-0611	NIH [R01DK093674, R01DK113375, R21A144827]; Mathers Foundation; Pershing Square Foundation; Black Family Metastasis Center; FASI/FARE Consortium	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mathers Foundation; Pershing Square Foundation(Pershing Square Foundation); Black Family Metastasis Center; FASI/FARE Consortium	This work was supported by NIH grants R01DK093674, R01DK113375, and R21A144827. D.M. is also supported by the Mathers Foundation, the Pershing Square Foundation, the Black Family Metastasis Center, and the FASI/FARE Consortium.	Alexa A., 2019, GENE SET ENRICHMENT; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Beura LK, 2019, J EXP MED, V216, P1214, DOI 10.1084/jem.20181365; Bilate AM, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf7471; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Bousbaine D., 2020, ANTIGEN SPECIFIC IND; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Carlson M, 2019, GO DB SET ANNOTATION; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Cervantes-Barragan L, 2017, SCIENCE, V357, P806, DOI 10.1126/science.aah5825; Cheroutre H, 2008, IMMUNITY, V28, P149, DOI 10.1016/j.immuni.2008.01.005; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Cortez VS, 2014, J EXP MED, V211, P623, DOI 10.1084/jem.20130904; Dash P, 2011, J CLIN INVEST, V121, P288, DOI 10.1172/JCI44752; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Ellmeier W, 1997, IMMUNITY, V7, P537, DOI 10.1016/S1074-7613(00)80375-1; Faria AMC, 2017, J EXP MED, V214, P1211, DOI 10.1084/jem.20162014; Guehler SR, 1998, J IMMUNOL, V160, P5341; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Koyama M, 2019, IMMUNITY, V51, P885, DOI 10.1016/j.immuni.2019.08.011; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Ladinsky MS, 2019, SCIENCE, V363, P1058, DOI 10.1126/science.aat4042; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Levine AG, 2014, NAT IMMUNOL, V15, P1070, DOI 10.1038/ni.3004; London M., 2020, STEPWISE CHROMATIN T; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; Mayans S, 2014, IMMUNITY, V41, P207, DOI 10.1016/j.immuni.2014.07.010; McDonald BD, 2018, NAT REV IMMUNOL, V18, P514, DOI 10.1038/s41577-018-0013-7; McDonald BD, 2014, IMMUNITY, V41, P219, DOI 10.1016/j.immuni.2014.07.008; Melandri D, 2018, NAT IMMUNOL, V19, P1352, DOI 10.1038/s41590-018-0253-5; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Panja A, 1998, J IMMUNOL, V161, P3675; Pimentel H, 2017, NAT METHODS, V14, P687, DOI 10.1038/nmeth.4324; REGNAULT A, 1994, J EXP MED, V180, P1345, DOI 10.1084/jem.180.4.1345; Reis BS, 2014, IMMUNITY, V41, P244, DOI 10.1016/j.immuni.2014.06.017; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Rempala GA, 2013, J MATH BIOL, V67, P1339, DOI 10.1007/s00285-012-0589-7; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; Romagnoli PA, 2017, MUCOSAL IMMUNOL, V10, P520, DOI 10.1038/mi.2016.66; Sergushichev A., 2016, ALGORITHM FAST PRERA, DOI [10.1101/060012, DOI 10.1101/060012]; Sheridan BS, 2014, IMMUNITY, V40, P747, DOI 10.1016/j.immuni.2014.03.007; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sujino T, 2016, SCIENCE, V352, P1581, DOI 10.1126/science.aaf3892; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trombetta John J, 2014, Curr Protoc Mol Biol, V107, DOI 10.1002/0471142727.mb0422s107; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555, DOI 10.1111/j.1348-0421.1995.tb02242.x; Wojciech L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29073-7; Yamagata T, 2004, NAT IMMUNOL, V5, P597, DOI 10.1038/ni1070; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	62	21	21	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					1001	+		10.1016/j.immuni.2020.09.003	http://dx.doi.org/10.1016/j.immuni.2020.09.003			34	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33022229	Green Accepted, Bronze			2022-12-18	WOS:000599348200012
J	Tortola, L; Jacobs, A; Pohlmeier, L; Obermair, FJ; Ampenberger, F; Bodenmiller, B; Kopf, M				Tortola, Luigi; Jacobs, Andrea; Pohlmeier, Lea; Obermair, Franz-Josef; Ampenberger, Franziska; Bodenmiller, Bernd; Kopf, Manfred			High-Dimensional T Helper Cell Profiling Reveals a Broad Diversity of Stably Committed Effector States and Uncovers Interlineage Relationships	IMMUNITY			English	Article							MESSENGER-RNA; TH17 CELLS; AIRWAY INFLAMMATION; EPIGENETIC CONTROL; REGULATORY CELLS; TYPE-2 IMMUNITY; MASS CYTOMETRY; INTERLEUKIN 22; DIFFERENTIATION; EXPRESSION	CD4(+) T helper (Th) cells are fundamental players in immunity. Based on the expression of signature cytokines and transcription factors, several Th subsets have been defined, Th cells are thought to be far more heterogeneous and multifunctional than originally believed, but characterization of the full diversity has been hindered by technical limitations. Here, we employ mass cytometry to analyze the diversity of Th cell responses generated in vitro and in animal disease models, revealing a vast heterogeneity of effector states with distinct cytokine footprints. The diversities of cytokine responses established during primary antigen encounters in Th1- and Th2-cell-polarizing conditions are largely maintained after secondary challenge, regardless of the new inflammatory environment, highlighting many of the identified states as stable Th cell sublineages. We also find that Th17 cells tend to upregulate Th2-cell-associated cytokines upon challenge, indicating a closer developmental connection between Th17 and Th2 cells than previously anticipated.	[Tortola, Luigi; Pohlmeier, Lea; Obermair, Franz-Josef; Ampenberger, Franziska; Kopf, Manfred] Swiss Fed Inst Technol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland; [Jacobs, Andrea; Bodenmiller, Bernd] Univ Zurich, Dept Quantitat Biomed, CH-8057 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Tortola, L; Kopf, M (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, CH-8093 Zurich, Switzerland.	luigi.tortola@biol.ethz.ch; manfred.kopf@ethz.ch	Kopf, Manfred/B-6907-2009	Kopf, Manfred/0000-0002-0628-7140; Pohlmeier, Lea/0000-0001-5066-6941; Tortola, Luigi/0000-0002-8480-2080	SNF [310030B_182829]	SNF	This work was supported with grants from SNF (310030B_182829). We thank the ETH Flow Cytometry Core Facility for cell sorting. We also thank Christoph Schneider from the Univeor support with the N. brsity of California, San Francisco frasiliensis-infection experiments and Peter Nielsen for useful discussions and for proofreading the manuscript. We also thank Judith Allen and Jesuthas Ajendra for useful discussions and Salome ' Leibundgut for the IL-17ACre mice.	Al-Ramli W, 2009, J ALLERGY CLIN IMMUN, V123, P1185, DOI 10.1016/j.jaci.2009.02.024; Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Becher B, 2014, NAT IMMUNOL, V15, P1181, DOI 10.1038/ni.3006; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Behbehani GK, 2015, CANCER DISCOV, V5, P988, DOI 10.1158/2159-8290.CD-15-0298; Behbehani GK, 2014, CYTOM PART A, V85A, P1011, DOI 10.1002/cyto.a.22573; Bendall SC, 2011, SCIENCE, V332, P687, DOI 10.1126/science.1198704; Bending D, 2009, J CLIN INVEST, V119, P565, DOI 10.1172/JCI37865; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; Brown DM, 2012, J VIROL, V86, P6792, DOI 10.1128/JVI.07172-11; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chevrier S, 2018, CELL SYST, V6, P612, DOI 10.1016/j.cels.2018.02.010; Chevrier S, 2017, CELL, V169, P736, DOI 10.1016/j.cell.2017.04.016; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Darrah PA, 2007, NAT MED, V13, P843, DOI 10.1038/nm1592; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Fienberg HG, 2012, CYTOM PART A, V81A, P467, DOI 10.1002/cyto.a.22067; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Geginat J, 2013, SEMIN IMMUNOL, V25, P252, DOI 10.1016/j.smim.2013.10.012; Geginat J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00630; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Harbour SN, 2015, P NATL ACAD SCI USA, V112, P7061, DOI 10.1073/pnas.1415675112; He R, 2007, P NATL ACAD SCI USA, V104, P15817, DOI 10.1073/pnas.0706942104; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Iezzi G, 2009, P NATL ACAD SCI USA, V106, P876, DOI 10.1073/pnas.0810769106; Irvin C, 2014, J ALLERGY CLIN IMMUN, V134, P1175, DOI 10.1016/j.jaci.2014.05.038; Jankovic D, 2010, MUCOSAL IMMUNOL, V3, P239, DOI 10.1038/mi.2010.8; Kara EE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003905; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Kudo M, 2012, NAT MED, V18, P547, DOI 10.1038/nm.2684; Kunicki MA, 2018, J IMMUNOL, V200, P336, DOI 10.4049/jimmunol.1701025; Lal G, 2009, J IMMUNOL, V182, P259, DOI 10.4049/jimmunol.182.1.259; Lancioni C, 2012, AM J RESP CRIT CARE, V185, P206, DOI 10.1164/rccm.201107-1355OC; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee YK, 2009, IMMUNITY, V30, P92, DOI 10.1016/j.immuni.2008.11.005; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Lexberg MH, 2008, EUR J IMMUNOL, V38, P2654, DOI 10.1002/eji.200838541; Liu YS, 2016, CELL, V165, P535, DOI 10.1016/j.cell.2016.03.014; Luche H, 2007, EUR J IMMUNOL, V37, P43, DOI 10.1002/eji.200636745; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Messi M, 2003, NAT IMMUNOL, V4, P78, DOI 10.1038/ni872; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Murphy E, 1996, J EXP MED, V183, P901, DOI 10.1084/jem.183.3.901; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Newell EW, 2012, IMMUNITY, V36, P142, DOI 10.1016/j.immuni.2012.01.002; Nicolet BP, 2017, J IMMUNOL, V198, P962, DOI 10.4049/jimmunol.1601531; O'Garra A, 2011, NAT IMMUNOL, V12, P288, DOI 10.1038/ni.2003; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Oboki Keisuke, 2008, Allergol Int, V57, P121, DOI 10.2332/allergolint.R-07-160; Oestreich KJ, 2012, NAT REV IMMUNOL, V12, P799, DOI 10.1038/nri3321; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Peine M, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001633; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; POWRIE F, 1994, IMMUNITY, V1, P553, DOI 10.1016/1074-7613(94)90045-0; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Reiner SL, 2009, NAT REV IMMUNOL, V9, P81, DOI 10.1038/nri2490; Ruedl C, 2000, EUR J IMMUNOL, V30, P2056, DOI 10.1002/1521-4141(200007)30:7<2056::AID-IMMU2056>3.0.CO;2-S; Sandberg R, 2014, NAT METHODS, V11, P22, DOI 10.1038/nmeth.2764; Saravia J, 2019, CELL MOL IMMUNOL, V16, P634, DOI 10.1038/s41423-019-0220-6; Schmitt N, 2015, CURR OPIN IMMUNOL, V34, P130, DOI 10.1016/j.coi.2015.03.007; Seder RA, 2008, NAT REV IMMUNOL, V8, P247, DOI 10.1038/nri2274; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Shebl FM, 2010, CANCER EPIDEM BIOMAR, V19, P978, DOI 10.1158/1055-9965.EPI-10-0064; SZABO SJ, 1995, IMMUNITY, V2, P665, DOI 10.1016/1074-7613(95)90011-X; Thomas PG, 2013, P NATL ACAD SCI USA, V110, P1839, DOI 10.1073/pnas.1222149110; Trifari S, 2009, NAT IMMUNOL, V10, P864, DOI 10.1038/ni.1770; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Villarino AV, 2011, IMMUNITY, V34, P50, DOI 10.1016/j.immuni.2010.12.014; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wakashin H, 2008, AM J RESP CRIT CARE, V178, P1023, DOI 10.1164/rccm.200801-086OC; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wong MT, 2016, IMMUNITY, V45, P442, DOI 10.1016/j.immuni.2016.07.007; Yu F, 2015, NAT IMMUNOL, V16, P197, DOI 10.1038/ni.3053; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zunder ER, 2015, NAT PROTOC, V10, P316, DOI 10.1038/nprot.2015.020	90	21	21	3	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					597	+		10.1016/j.immuni.2020.07.001	http://dx.doi.org/10.1016/j.immuni.2020.07.001			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32735846	Bronze			2022-12-18	WOS:000569806100016
J	Brodin, P; Duffy, D; Quintana-Murci, L				Brodin, Petter; Duffy, Darragh; Quintana-Murci, Lluis			A Call for Blood-In Human Immunology	IMMUNITY			English	Letter							WHOLE-BLOOD; IMMUNE-SYSTEM		[Brodin, Petter] Karolinska Inst, Sci Life Lab, Dept Womens & Childrens Hlth, S-17121 Solna, Sweden; [Brodin, Petter] Karolinska Univ Hosp, Dept Newborn Med, S-17176 Stockholm, Sweden; [Duffy, Darragh] Inst Pasteur, INSERM, U1223, Immunobiol Dendrit Cells Unit, F-75015 Paris, France; [Quintana-Murci, Lluis] Inst Pasteur, CNRS, UMR 2000, Human Evolutionary Genet Unit, F-75015 Paris, France	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite	Brodin, P (corresponding author), Karolinska Inst, Sci Life Lab, Dept Womens & Childrens Hlth, S-17121 Solna, Sweden.; Brodin, P (corresponding author), Karolinska Univ Hosp, Dept Newborn Med, S-17176 Stockholm, Sweden.	petter.brodin@ki.se	Quintana-Murci, Lluis/AAB-7468-2022; Brodin, Petter/C-3317-2011	Brodin, Petter/0000-0002-8103-0046				Appay V, 2006, J IMMUNOL METHODS, V309, P192, DOI 10.1016/j.jim.2005.11.007; Davis MM, 2018, ANNU REV IMMUNOL, V36, P843, DOI 10.1146/annurev-immunol-042617-053206; Duffy D, 2017, CLIN IMMUNOL, V183, P325, DOI 10.1016/j.clim.2017.09.019; Duffy D, 2014, IMMUNITY, V40, P436, DOI 10.1016/j.immuni.2014.03.002; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Jahr H, 1999, J MOL MED, V77, P118, DOI 10.1007/s001090050316; Kagina BM, 2015, J IMMUNOL METHODS, V417, P22, DOI 10.1016/j.jim.2014.12.003; Olin A, 2018, CELL, V174, P1277, DOI 10.1016/j.cell.2018.06.045; Piasecka B, 2018, P NATL ACAD SCI USA, V115, pE488, DOI 10.1073/pnas.1714765115; Quach H, 2016, CELL, V167, P643, DOI 10.1016/j.cell.2016.09.024	10	21	21	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1335	1336		10.1016/j.immuni.2019.05.012	http://dx.doi.org/10.1016/j.immuni.2019.05.012			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31216453	Bronze			2022-12-18	WOS:000471876100001
J	Davis, MM				Davis, Mark M.			Not-So-Negative Selection	IMMUNITY			English	Editorial Material							T-CELLS; ANTIGEN; TOLERANCE; PHENOTYPE		[Davis, Mark M.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Davis, Mark M.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Davis, MM (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	mmdavis@stanford.edu		Davis, Mark/0000-0001-6868-657X	NIAID NIH HHS [U19 AI057229] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057229] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BURNET F. M., 1957, AUSTRALIAN JOUR SCI, V20, P67; Goodnow C. C., 2013, FUNDAMENTAL IMMUNOLO, P765; GOODNOW CC, 1989, NATURE, V342, P385, DOI 10.1038/342385a0; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Legoux FP, 2015, IMMUNITY, V43, P896, DOI 10.1016/j.immuni.2015.10.011; Maeda Y, 2014, SCIENCE, V346, P1536, DOI 10.1126/science.aaa1292; NOSSAL GJV, 1980, P NATL ACAD SCI-BIOL, V77, P1602, DOI 10.1073/pnas.77.3.1602; Silverstein AM, 2001, NAT IMMUNOL, V2, P279, DOI 10.1038/86280; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001	10	21	21	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2015	43	5					833	835		10.1016/j.immuni.2015.11.002	http://dx.doi.org/10.1016/j.immuni.2015.11.002			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DM	26588773	Bronze			2022-12-18	WOS:000366846000002
J	Hornung, V				Hornung, Veit			SnapShot: Nucleic Acid Immune Sensors, Part 2	IMMUNITY			English	Editorial Material							DNA; RECOGNITION		Univ Bonn, Univ Hosp, Inst Mol Med, Bonn, Germany	University of Bonn	Hornung, V (corresponding author), Univ Bonn, Univ Hosp, Inst Mol Med, Bonn, Germany.		Hornung, Veit/C-3565-2012	Hornung, Veit/0000-0002-4150-194X				Barbalat R, 2011, ANNU REV IMMUNOL, V29, P185, DOI 10.1146/annurev-immunol-031210-101340; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; Hornung V, 2010, NAT REV IMMUNOL, V10, P123, DOI 10.1038/nri2690; Jiang XM, 2012, NAT REV IMMUNOL, V12, P35, DOI 10.1038/nri3111; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Paludan SR, 2013, IMMUNITY, V38, P870, DOI 10.1016/j.immuni.2013.05.004; Schattgen SA, 2011, IMMUNOL REV, V243, P109, DOI 10.1111/j.1600-065X.2011.01053.x	10	21	23	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					1066	U407		10.1016/j.immuni.2014.10.006	http://dx.doi.org/10.1016/j.immuni.2014.10.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526315	Bronze			2022-12-18	WOS:000346654100024
J	Noy, R; Pollard, JW				Noy, Roy; Pollard, Jeffrey W.			Tumor-Associated Macrophages: From Mechanisms to Therapy (vol 41, pg 49, 2014)	IMMUNITY			English	Correction												jeff.pollard@ed.ac.uk						Noy R, 2014, IMMUNITY, V41, P49, DOI 10.1016/j.immuni.2014.06.010	1	21	21	1	48	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					866	866		10.1016/j.immuni.2014.09.021	http://dx.doi.org/10.1016/j.immuni.2014.09.021			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID		Bronze			2022-12-18	WOS:000345504900021
J	Natoli, G; Monticelli, S				Natoli, Gioacchino; Monticelli, Silvia			Macrophage Activation: Glancing into Diversity	IMMUNITY			English	Editorial Material							CELLS	Macrophage activation is a crucial process for innate immunity as well as for tissue and metabolic homeostasis. In this issue of Immunity, Xue et al. (2014) extend our knowledge on macrophage activation and identify unique functional states, thus expanding the M1-M2 paradigm.	[Natoli, Gioacchino] IEO, Dept Expt Oncol, I-20141 Milan, Italy; [Monticelli, Silvia] IRB, CH-6500 Bellinzona, Switzerland	IRCCS European Institute of Oncology (IEO); Universita della Svizzera Italiana	Natoli, G (corresponding author), IEO, Dept Expt Oncol, I-20141 Milan, Italy.	gioacchino.natoli@ieo.eu; silvia.monticelli@irb.usi.ch	Natoli, gioacchino/ABB-8679-2020; Monticelli, Silvia/ABE-7054-2020; Natoli, gioacchino/J-2100-2018	Natoli, Gioacchino/0000-0003-0711-2411; Monticelli, Silvia/0000-0002-5909-8802				Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kasowski M, 2013, SCIENCE, V342, P750, DOI 10.1126/science.1242510; Monticelli S, 2013, NAT IMMUNOL, V14, P777, DOI 10.1038/ni.2636; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006	10	21	21	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2014	40	2					175	177		10.1016/j.immuni.2014.01.004	http://dx.doi.org/10.1016/j.immuni.2014.01.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB2QQ	24560195	Bronze			2022-12-18	WOS:000331637600005
J	Katagiri, K; Ueda, Y; Tomiyama, T; Yasuda, K; Toda, Y; Ikehara, S; Nakayama, KI; Kinashi, T				Katagiri, Koko; Ueda, Yoshihiro; Tomiyama, Takashi; Yasuda, Kaneki; Toda, Yoshinobu; Ikehara, Susumu; Nakayama, Keiichi I.; Kinashi, Tatsuo			Deficiency of Rap1-Binding Protein RAPL Causes Lymphoproliferative Disorders through Mislocalization of p27kip1	IMMUNITY			English	Article							CELL-CYCLE PROGRESSION; DEPENDENT KINASE INHIBITOR; TUMOR-SUPPRESSOR; LYMPH-NODES; P27(KIP1); PHOSPHORYLATION; P27; PROLIFERATION; MIGRATION; EXPANSION	RAPL (an alternative spliced form of Rassf5) is a critical Ras-related protein1 (Rap1) effector that regulates lymphocyte adhesion. Here, we have shown that in addition to this previously described function, RAPL also negatively controls lymphocyte proliferation and prevents autoimmunity and lymphoma. RAPL-deficient mice experienced age-related lupus-like glomerulonephritis and developed B cell lymphomas. RAPL-deficient lymphocytes showed hyperproliferation by enhanced S phase entry after antigen receptor ligation. Compared to wild-type cells, RAPL-deficient naive lymphocytes had a 2- to 3-fold increase in Cdk2 kinase activity with a cytoplasmic mislocalization of the cyclin-dependent kinase inhibitor p27(kip1). RAPL was found to suppress the phosphorylation of p27(kip1) on serine 10 (S10) and promoted p27(kip1) nuclear translocation. An S10A mutation in p27(kip1) corrected its cytoplasmic accumulation, reduced hyperproliferation in RAPL-deficient lymphocytes, and suppressed glomerulonephritis and development of B cell lymphoma. Thus, RAPL serves as a checkpoint for S phase entry to prevent lymphoproliferative disorders through the spatial regulation of p27(kip1).	[Katagiri, Koko; Ueda, Yoshihiro; Kinashi, Tatsuo] Kansai Med Univ, Inst Biomed Sci, Dept Mol Genet, Osaka 5708506, Japan; [Katagiri, Koko; Ueda, Yoshihiro; Kinashi, Tatsuo] Kansai Med Univ, JST, CREST, Osaka 5708506, Japan; [Katagiri, Koko] Kwanseigakuen Univ, Sch Sci & Technol, Dept Life Sci, Sanda, Hyogo 6691337, Japan; [Katagiri, Koko] JST, CREST, Sanda, Hyogo 6691337, Japan; [Tomiyama, Takashi] Kansai Med Univ, Dept Internal Med 3, Div Gastroenterol & Hepatol, Osaka 5708506, Japan; [Yasuda, Kaneki] Kansai Med Univ, Dept Urol & Androl, Osaka 5708506, Japan; [Ikehara, Susumu] Kansai Med Univ, Dept Stem Cell Disorders, Osaka 5708506, Japan; [Toda, Yoshinobu] Kyoto Univ, Grad Sch Med, Ctr Anat Studies, Sakyo Ku, Kyoto 6068507, Japan; [Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan	Kansai Medical University; Japan Science & Technology Agency (JST); Kansai Medical University; Japan Science & Technology Agency (JST); Kansai Medical University; Kansai Medical University; Kansai Medical University; Kyoto University; Kyushu University	Kinashi, T (corresponding author), Kansai Med Univ, Inst Biomed Sci, Dept Mol Genet, 10-15 Fumizono Cho, Osaka 5708506, Japan.	kinashi@takii.kmu.ac.jp	Tomiyama, Takashi/AAZ-9910-2020		Ministry of Education, Culture, Sports, Science and Technology of Japan; Ministry of Health, Labor and Welfare; CREST Japan Science and Technology Agency; Takeda Science Foundation; Yasuda Medical foundation; Japan Leukemia Research Fund; Astellas Foundation for Research on Metabolic Disorders	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); CREST Japan Science and Technology Agency(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Yasuda Medical foundation; Japan Leukemia Research Fund(Japan Leukemia Research Fund (JLRF)); Astellas Foundation for Research on Metabolic Disorders	We would like to thank S. Matsuda (Kansai Medical University, Japan) for critical reading of the manuscript and S. Ohishi, K. Maebara, and R. Hamaguchi for technical assistance. This research was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Ministry of Health, Labor and Welfare, and from CREST Japan Science and Technology Agency, and research grants from Takeda Science Foundation, Yasuda Medical foundation, Japan Leukemia Research Fund, and Astellas Foundation for Research on Metabolic Disorders.	Aleem E, 2005, NAT CELL BIOL, V7, P831, DOI 10.1038/ncb1284; Appleman LJ, 2000, J IMMUNOL, V164, P144, DOI 10.4049/jimmunol.164.1.144; Avruch J, 2009, J BIOL CHEM, V284, P11001, DOI 10.1074/jbc.R800073200; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Balomenos D, 2000, IMMUNOL TODAY, V21, P551, DOI 10.1016/S0167-5699(00)01748-5; Barnouin K, 1999, ONCOGENE, V18, P6388, DOI 10.1038/sj.onc.1203162; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Besson A, 2006, GENE DEV, V20, P47, DOI 10.1101/gad.1384406; Besson A, 2007, GENE DEV, V21, P1731, DOI 10.1101/gad.1556607; Bhattacharjee RN, 2001, MOL CELL BIOL, V21, P5417, DOI 10.1128/MCB.21.16.5417-5425.2001; Boehm M, 2002, EMBO J, V21, P3390, DOI 10.1093/emboj/cdf343; Boussiotis VA, 2000, NAT MED, V6, P290, DOI 10.1038/73144; Ebisuno Y, 2010, BLOOD, V115, P804, DOI 10.1182/blood-2009-03-211979; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Fero ML, 1996, CELL, V85, P733, DOI 10.1016/S0092-8674(00)81239-8; Hara T, 2001, J BIOL CHEM, V276, P48937, DOI 10.1074/jbc.M107274200; Ishida N, 2002, J BIOL CHEM, V277, P14355, DOI 10.1074/jbc.C100762200; Ishida N, 2000, J BIOL CHEM, V275, P25146, DOI 10.1074/jbc.M001144200; Jacobs SR, 2010, J IMMUNOL, V184, P3461, DOI 10.4049/jimmunol.0902593; Katagiri K, 2004, NAT IMMUNOL, V5, P1045, DOI 10.1038/ni1111; Katagiri K, 2006, NAT IMMUNOL, V7, P919, DOI 10.1038/ni1374; Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82; Kawauchi T, 2006, NAT CELL BIOL, V8, P17, DOI 10.1038/ncb1338; Kotake Y, 2005, J BIOL CHEM, V280, P1095, DOI 10.1074/jbc.M406117200; Lawson BR, 2001, J IMMUNOL, V167, P2354, DOI 10.4049/jimmunol.167.4.2354; Lee JG, 2007, J BIOL CHEM, V282, P6444, DOI 10.1074/jbc.M607808200; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Li WQ, 2006, J EXP MED, V203, P573, DOI 10.1084/jem.20051520; Macheiner D, 2006, J HEPATOL, V45, P81, DOI 10.1016/j.jhep.2005.12.017; Nakamura S, 2008, LEUKEMIA RES, V32, P1358, DOI 10.1016/j.leukres.2008.02.012; Nakayama K, 1996, CELL, V85, P707, DOI 10.1016/S0092-8674(00)81237-4; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; Qi CF, 2006, LEUKEMIA RES, V30, P153, DOI 10.1016/j.leukres.2005.06.025; Raab M, 2010, IMMUNITY, V32, P541, DOI 10.1016/j.immuni.2010.03.007; Reynisdottir I, 1997, GENE DEV, V11, P492, DOI 10.1101/gad.11.4.492; Rodier G, 2001, EMBO J, V20, P6672, DOI 10.1093/emboj/20.23.6672; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Stork PJS, 2005, BLOOD, V106, P2952, DOI 10.1182/blood-2005-03-1062; Vos MD, 2003, J BIOL CHEM, V278, P21938, DOI 10.1074/jbc.M211019200	40	21	23	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 28	2011	34	1					24	38		10.1016/j.immuni.2010.12.010	http://dx.doi.org/10.1016/j.immuni.2010.12.010			15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO	21194982	Bronze			2022-12-18	WOS:000287336600007
J	Dubin, PJ; Kolis, JK				Dubin, Patricia J.; Kolis, Jay K.			Interleukin-17A and Interleukin-17F: A Tale of Two Cytokines	IMMUNITY			English	Editorial Material							IL-17 RECEPTOR; HOST-DEFENSE; CELLS	In this issue of Immunity, Ishigame et al. (2009) show that interleukin-17A (IL-17A) mediates autoimmunity whereas both IL-17A and IL-17F are required for mucosal immunity. IL-17A may be more pathologic by inducing proinflammatory cytokines.	[Kolis, Jay K.] LSU Hlth Sci Ctr, Dept Genet, New Orleans, LA 70112 USA; [Dubin, Patricia J.] Childrens Hosp Pittsburgh, Rangos Res Ctr, Pittsburgh, PA 15201 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kolis, JK (corresponding author), LSU Hlth Sci Ctr, Dept Genet, CSRB Room 657, New Orleans, LA 70112 USA.	jay.kolls@chp.edu	Dubin, Patricia/AAB-9951-2020					Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Lubberts E, 2005, J IMMUNOL, V175, P3360, DOI 10.4049/jimmunol.175.5.3360; McAllister F, 2005, J IMMUNOL, V175, P404, DOI 10.4049/jimmunol.175.1.404; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Schwarzenberger P, 2002, J CELL BIOCHEM, P88, DOI 10.1002/jcb.10054; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Yang XXO, 2008, J EXP MED, V205, P1063, DOI 10.1084/jem.20071978; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	10	21	25	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2009	30	1					9	11		10.1016/j.immuni.2008.12.010	http://dx.doi.org/10.1016/j.immuni.2008.12.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	398ZJ	19144313	Bronze			2022-12-18	WOS:000262769900005
J	Prisco, A; Vanes, L; Ruf, S; Trigueros, C; Tybulewicz, VLJ				Prisco, A; Vanes, L; Ruf, S; Trigueros, C; Tybulewicz, VLJ			Lineage-specific requirement for the PH domain of Vav1 in the activation of CD4(+) but not CD8(+) T cells	IMMUNITY			English	Article							PLECKSTRIN HOMOLOGY DOMAINS; EXCHANGE FACTOR VAV; RHO-FAMILY; TYROSINE PHOSPHORYLATION; NEGATIVE SELECTION; RECEPTOR SIGNALS; STRUCTURAL BASIS; PROTOONCOGENE PRODUCT; BIOLOGICAL-ACTIVITY; ANTIGEN RECEPTOR	Vav1 is a guanine nucleotide exchange factor (GEF) for Rho-family GTPases, which is activated by tyrosine phosphorylation following TCR stimulation. Vav1-deficient mice have defects in positive and negative selection of thymocytes as well as TCR-induced proliferation in mature T cells, demonstrating a critical role for Vav1 in transducing TCR signals. Binding of phospholipids to the PH domain of Vav1 has been proposed to regulate its GEF activity in vitro. To test this model in vivo, we have generated mice carrying a point mutation in the PH domain of Vav1, and we show that they have defects in T cell development and activation. We demonstrate that the mutation affects the function of Vav1 as a GEF and perturbs PI3K-dependent pathways downstream of Vav1. Unexpectedly, the mutation selectively affects TCR-induced proliferation of CD4(+) but not CD8(+) T cells, demonstrating differences in the wiring of TCR signaling pathways between the two lineages.	Natl Inst Med Res, Div Immune Cell Biol, London NW7 1AA, England	MRC National Institute for Medical Research	Tybulewicz, VLJ (corresponding author), Natl Inst Med Res, Div Immune Cell Biol, Ridgeway,Mill Hill, London NW7 1AA, England.	vtybule@nimr.mrc.ac.uk	Prisco, Antonella/X-5749-2019	Tybulewicz, Victor/0000-0003-2439-0798; Prisco, Antonella/0000-0001-8061-0068				Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Billadeau DD, 2000, J IMMUNOL, V164, P3971, DOI 10.4049/jimmunol.164.8.3971; Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; BUSTELO XR, 1992, NATURE, V356, P68, DOI 10.1038/356068a0; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Das B, 2000, J BIOL CHEM, V275, P15074, DOI 10.1074/jbc.M907269199; Ebinu JO, 2000, BLOOD, V95, P3199; Ferguson KM, 2000, MOL CELL, V6, P373, DOI 10.1016/S1097-2765(00)00037-X; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; FISCHER KD, 1995, NATURE, V374, P474, DOI 10.1038/374474a0; Gomez M, 2000, NAT IMMUNOL, V1, P348, DOI 10.1038/79808; Han JW, 1997, MOL CELL BIOL, V17, P1346, DOI 10.1128/MCB.17.3.1346; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Hoffman GR, 2002, FEBS LETT, V513, P85, DOI 10.1016/S0014-5793(01)03310-5; Holsinger LJ, 1998, CURR BIOL, V8, P563, DOI 10.1016/S0960-9822(98)70225-8; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kong YY, 1998, J EXP MED, V188, P2099, DOI 10.1084/jem.188.11.2099; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; MAMALAKI C, 1993, DEV IMMUNOL, V3, P159, DOI 10.1155/1993/98015; MARGOLIS B, 1992, NATURE, V356, P71, DOI 10.1038/356071a0; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Palmby TR, 2002, J BIOL CHEM, V277, P39350, DOI 10.1074/jbc.M202641200; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Reynolds LF, 2002, J EXP MED, V195, P1103, DOI 10.1084/jem.20011663; Schuebel KE, 1998, EMBO J, V17, P6608, DOI 10.1093/emboj/17.22.6608; SIMPSON E, 1993, IMMUNOL REV, V131, P93, DOI 10.1111/j.1600-065X.1993.tb01532.x; SPANOPOULOU E, 1994, GENE DEV, V8, P1030, DOI 10.1101/gad.8.9.1030; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; TARAKHOVSKY A, 1995, NATURE, V374, P467, DOI 10.1038/374467a0; TOLIAS KF, 1995, J BIOL CHEM, V270, P17656, DOI 10.1074/jbc.270.30.17656; Turner M, 1997, IMMUNITY, V7, P451, DOI 10.1016/S1074-7613(00)80367-2; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; ZHANG R, 1995, NATURE, V374, P470, DOI 10.1038/374470a0; ZHENG Y, 1994, J BIOL CHEM, V269, P18727; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	39	21	21	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2005	23	3					263	274		10.1016/j.immuni.2005.07.007	http://dx.doi.org/10.1016/j.immuni.2005.07.007			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	971KJ	16169499	Bronze			2022-12-18	WOS:000232382500005
J	Wilson, N; Fremont, D; Marrack, P; Kappler, J				Wilson, N; Fremont, D; Marrack, P; Kappler, J			Mutations changing the kinetics of class II MHC peptide exchange	IMMUNITY			English	Article							HLA-DR MOLECULES; T-CELL-RECEPTOR; HYDROGEN-BOND; ANTIGEN; BINDING; COMPLEX; SINGLE; PH; CONSEQUENCES; DISSOCIATION	IE/DR MHC class II molecules have an extensive H-bonding network under the bound peptide. In IEk, two or chain acidic amino acids in the core of this network were mutated to amides. At low pH, the mutant molecule exchanged peptide much more rapidly than the wild-type. The crystal structure of the mutant IEk revealed the loss of a single buried water molecule and a reorganization of the predicted H-bonding network. We suggest that these mutations enhance the transition of MHC class II to an open conformation at low pH allowing the bound peptide to escape. In wildtype IEk, the need to protonate these amino acids also may be a bottleneck in the return to a closed conformation after peptide binding.	Natl Jewish Med & Res Ctr, Zuckerman Family Canyon Ranch Crystallog Lab, Howard Hughes Med Inst, Integrated Dept Immunol, Denver, CO 80206 USA; Univ Colorado, Sch Med, Integrated Dept Immunol, Denver, CO 80262 USA; Univ Colorado, Sch Med, Dept Med, Denver, CO 80262 USA; Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80262 USA; Univ Colorado, Sch Med, Dept Pharmacol, Denver, CO 80262 USA; Univ Colorado, Sch Med, Program Biomol Struct, Denver, CO 80262 USA	Howard Hughes Medical Institute; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Wilson, N (corresponding author), Natl Jewish Med & Res Ctr, Zuckerman Family Canyon Ranch Crystallog Lab, Howard Hughes Med Inst, Integrated Dept Immunol, Denver, CO 80206 USA.		Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687; Fremont, Daved/0000-0002-8544-2689; Wilson, Nancy/0000-0002-9472-6026				AVVA RR, 1994, IMMUNITY, V1, P763, DOI 10.1016/S1074-7613(94)80018-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Boniface JJ, 1996, J EXP MED, V183, P119, DOI 10.1084/jem.183.1.119; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254; Bryant PW, 1999, EUR J IMMUNOL, V29, P2729, DOI 10.1002/(SICI)1521-4141(199909)29:09<2729::AID-IMMU2729>3.0.CO;2-A; Busch R, 2000, CURR OPIN IMMUNOL, V12, P99, DOI 10.1016/S0952-7915(99)00057-6; Busch R, 1996, CURR OPIN IMMUNOL, V8, P51, DOI 10.1016/S0952-7915(96)80105-1; Ceman S, 1998, J EXP MED, V188, P2139, DOI 10.1084/jem.188.11.2139; Crawford F, 1998, IMMUNITY, V8, P675, DOI 10.1016/S1074-7613(00)80572-5; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; JENSEN PE, 1991, J EXP MED, V174, P1111, DOI 10.1084/jem.174.5.1111; JENSEN PE, 1990, J EXP MED, V171, P1779, DOI 10.1084/jem.171.5.1779; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; JORGENSEN JL, 1992, ANNU REV IMMUNOL, V10, P835, DOI 10.1146/annurev.iy.10.040192.004155; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; Kleywegt G. J., 2001, INT TABLES CRYSTALLO; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; KOZONO H, 1994, NATURE, V369, P151, DOI 10.1038/369151a0; KOZONO H, 1995, IMMUNITY, V3, P187, DOI 10.1016/1074-7613(95)90088-8; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; LANGSETMO K, 1991, BIOCHEMISTRY-US, V30, P7603, DOI 10.1021/bi00244a032; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LERNER EA, 1980, J EXP MED, V152, P1085, DOI 10.1084/jem.152.4.1085; LORENZ RG, 1988, P NATL ACAD SCI USA, V85, P5220, DOI 10.1073/pnas.85.14.5220; MARRACK P, 1993, J EXP MED, V178, P2173, DOI 10.1084/jem.178.6.2173; McFarland BJ, 1999, J IMMUNOL, V163, P3567; MCGRATH ME, 1992, BIOCHEMISTRY-US, V31, P3059, DOI 10.1021/bi00127a005; MOURITSEN S, 1992, J IMMUNOL, V148, P1438; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; OZATO K, 1980, J IMMUNOL, V124, P533; Reich Z, 1997, P NATL ACAD SCI USA, V94, P2495, DOI 10.1073/pnas.94.6.2495; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; RIBERDY JM, 1992, NATURE, V360, P474, DOI 10.1038/360474a0; Runnels HA, 1996, J EXP MED, V183, P127, DOI 10.1084/jem.183.1.127; Sant AJ, 1999, IMMUNOL REV, V172, P239, DOI 10.1111/j.1600-065X.1999.tb01369.x; SETTE A, 1992, J IMMUNOL, V148, P844; SETTE A, 1992, SCIENCE, V258, P1801, DOI 10.1126/science.1465617; SHERMAN MA, 1995, IMMUNITY, V3, P197, DOI 10.1016/1074-7613(95)90089-6; vanHam SM, 1996, J EXP MED, V184, P2019, DOI 10.1084/jem.184.5.2019; Vogt AB, 1996, P NATL ACAD SCI USA, V93, P9724, DOI 10.1073/pnas.93.18.9724	43	21	22	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2001	14	5					513	522		10.1016/S1074-7613(01)00140-6	http://dx.doi.org/10.1016/S1074-7613(01)00140-6			10	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	435KP	11371354	Bronze			2022-12-18	WOS:000168880900004
J	Bleriot, C; Barreby, E; Dunsmore, G; Ballaire, R; Chakarov, S; Ficht, X; De Simone, G; Andreata, F; Fumagalli, V; Guo, W; Wan, GC; Gessain, G; Khalilnezhad, A; Zhang, XM; Ang, N; Chen, P; Morgantini, C; Azzimato, V; Kong, WT; Liu, ZY; Pai, R; Lum, J; Shihui, F; Low, I; Xu, C; Malleret, B; Kairi, MFM; Balachander, A; Cexus, O; Larbi, A; Lee, B; Newell, EW; Ng, LG; Phoo, WW; Sobota, RM; Sharma, A; Howland, SW; Chen, JM; Bajenoff, M; Yvan-Charvet, L; Venteclef, N; Iannacone, M; Aouadi, M; Ginhoux, F				Bleriot, Camille; Barreby, Emelie; Dunsmore, Garett; Ballaire, Raphaelle; Chakarov, Svetoslav; Ficht, Xenia; De Simone, Giorgia; Andreata, Francesco; Fumagalli, Valeria; Guo, Wei; Wan, Guochen; Gessain, Gregoire; Khalilnezhad, Ahad; Zhang, Xiao Meng; Ang, Nicholas; Chen, Ping; Morgantini, Cecilia; Azzimato, Valerio; Kong, Wan Ting; Liu, Zhaoyuan; Pai, Rhea; Lum, Josephine; Shihui, Foo; Low, Ivy; Xu, Connie; Malleret, Benoit; Kairi, Muhammad Faris Mohd; Balachander, Akhila; Cexus, Olivier; Larbi, Anis; Lee, Bernett; Newell, Evan W.; Ng, Lai Guan; Phoo, Wint Wint; Sobota, Radoslaw M.; Sharma, Ankur; Howland, Shanshan W.; Chen, Jinmiao; Bajenoff, Marc; Yvan-Charvet, Laurent; Venteclef, Nicolas; Iannacone, Matteo; Aouadi, Myriam; Ginhoux, Florent			A subset of Kupffer cells regulates metabolism through the expression of CD36	IMMUNITY			English	Article							LIVER MACROPHAGES; GLOBAL EPIDEMIOLOGY; INSULIN SENSITIVITY; MYELOID CELLS; RNA-SEQ; HETEROGENEITY; MONOCYTES; PREVALENCE; LANDSCAPE; NETWORK	Tissue macrophages are immune cells whose phenotypes and functions are dictated by origin and niches. However, tissues are complex environments, and macrophage heterogeneity within the same organ has been overlooked so far. Here, we used high-dimensional approaches to characterize macrophage populations in the murine liver. We identified two distinct populations among embryonically derived Kupffer cells (KCs) sharing a core signature while differentially expressing numerous genes and proteins: a major CD206(lo)ESAM(-) population (KC1) and a minor CD206(hi)ESAM(+) population (KC2). KC2 expressed genes involved in metabolic processes, including fatty acid metabolism both in steady-state and in diet-induced obesity and hepatic steatosis. Functional characterization by depletion of KC2 or targeted silencing of the fatty acid transporter Cd36 highlighted a crucial contribution of KC2 in the liver oxidative stress associated with obesity. In summary, our study reveals that KCs are more heterogeneous than anticipated, notably describing a subpopulation wired with metabolic functions.	[Bleriot, Camille; Chakarov, Svetoslav; Wan, Guochen; Gessain, Gregoire; Khalilnezhad, Ahad; Zhang, Xiao Meng; Ang, Nicholas; Kong, Wan Ting; Lum, Josephine; Shihui, Foo; Low, Ivy; Malleret, Benoit; Kairi, Muhammad Faris Mohd; Balachander, Akhila; Larbi, Anis; Lee, Bernett; Newell, Evan W.; Ng, Lai Guan; Howland, Shanshan W.; Chen, Jinmiao; Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Bleriot, Camille; Dunsmore, Garett] Gustave Roussy, INSERM, U1015, F-94800 Villejuif, France; [Barreby, Emelie; Chen, Ping; Morgantini, Cecilia; Azzimato, Valerio; Xu, Connie; Aouadi, Myriam] Karolinska Inst, Ctr Infect Med, Dept Med, S-14157 Huddinge, Sweden; [Ballaire, Raphaelle] Inovarion, F-75005 Paris, France; [Ficht, Xenia; De Simone, Giorgia; Andreata, Francesco; Fumagalli, Valeria; Iannacone, Matteo] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, I-20132 Milan, Italy; [De Simone, Giorgia; Fumagalli, Valeria; Iannacone, Matteo] Univ Vita Salute San Raffaele, I-20132 Milan, Italy; [Chakarov, Svetoslav; Guo, Wei; Liu, Zhaoyuan; Ginhoux, Florent] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai 200025, Peoples R China; [Khalilnezhad, Ahad; Malleret, Benoit; Ng, Lai Guan; Ginhoux, Florent] Natl Univ Singapore, Yong Loo Lin Sch Med, Life Sci Inst,Immunol Program, Dept Microbiol & Immunol,Immunol Translat Res Pro, Singapore 117543, Singapore; [Pai, Rhea; Sharma, Ankur] ASTAR, Genome Inst Singapore, Singapore 138672, Singapore; [Cexus, Olivier] Univ Surrey, Fac Hlth & Med Sci, Biosci & Med, Guildford GU2 7XH, Surrey, England; [Phoo, Wint Wint; Sobota, Radoslaw M.] ASTAR, Inst Mol & Cell Biol, SingMass Natl Lab, Funct Prote Lab, Singapore 138673, Singapore; [Bajenoff, Marc] Aix Marseille Univ, CIML, INSERM, CNRS, F-13288 Marseille, France; [Yvan-Charvet, Laurent] UMR INSERM U1065 UNS, C3M, F-06204 Nice, France; [Venteclef, Nicolas] Univ Paris, Sorbonne Univ, Ctr Rech Cordeliers, INSERM,IMMEDIAB Lab, F-75006 Paris, France; [Iannacone, Matteo] IRCCS San Raffaele Sci Inst, Expt Imaging Ctr, I-20132 Milan, Italy; [Ginhoux, Florent] SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore 169856, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Karolinska Institutet; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; Chinese Academy of Sciences; Shanghai Jiao Tong University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); University of Surrey; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Bleriot, C; Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore.; Bleriot, C (corresponding author), Gustave Roussy, INSERM, U1015, F-94800 Villejuif, France.; Ginhoux, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai 200025, Peoples R China.; Ginhoux, F (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Life Sci Inst,Immunol Program, Dept Microbiol & Immunol,Immunol Translat Res Pro, Singapore 117543, Singapore.; Ginhoux, F (corresponding author), SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore 169856, Singapore.	camille.bleriot@gustaveroussy.fr; florent_ginhoux@immunol.a-star.edu.sg	Howland, Shanshan W/I-2245-2014; Sharma, Ankur/GQZ-7151-2022; Chen, Ping/AAL-8264-2020; Larbi, Anis/ABE-5868-2020; Azzimato, Valerio/AAX-2711-2021; Iannacone, Matteo/I-8507-2018; Ng, Lai Guan/E-5673-2011; Chen, Jinmiao/ABE-5601-2021; Malleret, Benoit/E-9159-2011	Howland, Shanshan W/0000-0003-4794-1564; Chen, Ping/0000-0002-8068-1891; Azzimato, Valerio/0000-0003-4141-961X; Iannacone, Matteo/0000-0002-9370-2671; Ng, Lai Guan/0000-0003-1905-3586; Kong, Wan Ting/0000-0002-9271-841X; BLERIOT, Camille/0000-0002-4298-2888; Sharma, Ankur/0000-0002-6862-136X; Chakarov, Svetoslav/0000-0002-0665-5417; Cexus, Olivier.N.F./0000-0003-3773-3323; Ficht, Xenia/0000-0002-4534-8225; Fumagalli, Valeria/0000-0003-2583-2498; Yvan-Charvet, Laurent/0000-0002-7748-4942; Malleret, Benoit/0000-0001-9658-7528	BMRC [IAF311006, H16/99/b0/011]; European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme [864788]; EMBO YIP; Singapore Immunology Network core funding (A*STAR); Singapore NRF Senior Investigatorship [NRFI2017-02]; A*STAR; Singapore NRF under its NRF-SIS "SingMass'' scheme; NUHS [NUHSRO/2018/006/SU/01]; ARC; FRM; European Union [ERC-EpiFAT 725790]	BMRC(Agency for Science Technology & Research (A*STAR)); European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme(European Research Council (ERC)); EMBO YIP(European Molecular Biology Organization (EMBO)); Singapore Immunology Network core funding (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore NRF Senior Investigatorship(National Research Foundation, Singapore); A*STAR(Agency for Science Technology & Research (A*STAR)); Singapore NRF under its NRF-SIS "SingMass'' scheme; NUHS; ARC(Australian Research Council); FRM(Fondation pour la Recherche Medicale); European Union(European Commission)	We thank all the members of the Ginhoux laboratory for helpful discussions. Flow cytometry and cell sorting, CyTOF, microscopy, and RNA library preparation were carried out on SIgN platforms established by the Agency of Science, Technolog,y and Research (A*STAR) Singapore. We would like to acknowledge C. Phua and the staff from the Biological Resource Center for their invaluable help for the animal-based experiments and the Electron Microscopy Unit, National University of Singapore, particularly Professor Ong Wei Yi, Miss Tan Suat Hoon, and Mister Lu Thong Beng. We would like to thank L. Robinson of Insight Editing London for editing the manuscript. SIgN platforms are supported by a BMRC IAF311006 grant and BMRC transition funds #H16/99/b0/011. This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement no. 864788). This work was supported by EMBO YIP, Singapore Immunology Network core funding (A*STAR), and Singapore NRF Senior Investigatorship (NRFI2017-02) to F.G.; A*STAR core funding and Singapore NRF under its NRF-SIS ``SingMass'' scheme to R.M.S.; NUHS start-up funding (NUHSRO/2018/006/SU/01) to B.M.; and ARC and FRM programs to C.B. N.V. was supported by the European Union Horizon 20202 (H2020) framework (ERC-EpiFAT 725790).	A-Gonzalez N, 2017, J EXP MED, V214, P1281, DOI 10.1084/jem.20161375; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Aizarani N, 2019, NATURE, V572, P199, DOI 10.1038/s41586-019-1373-2; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Aparicio-Vergara M, 2017, METHODS MOL BIOL, V1639, P161, DOI 10.1007/978-1-4939-7163-3_16; Azzimato V, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw9709; Barreby E, 2019, METHODS MOL BIOL, V1951, P49, DOI 10.1007/978-1-4939-9130-3_4; Beattie L, 2016, J HEPATOL, V65, P758, DOI 10.1016/j.jhep.2016.05.037; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bleriot C, 2020, METHODS MOL BIOL, V2164, P87, DOI 10.1007/978-1-0716-0704-6_10; Bleriot C, 2020, IMMUNITY, V52, P957, DOI 10.1016/j.immuni.2020.05.014; Bleriot C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02694; Bleriot C, 2015, IMMUNITY, V42, P145, DOI 10.1016/j.immuni.2014.12.020; Bonnardel J, 2019, IMMUNITY, V51, P638, DOI 10.1016/j.immuni.2019.08.017; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Cheng Y, 2016, J IMMUNOL, V196, P924, DOI 10.4049/jimmunol.1501928; David BA, 2016, GASTROENTEROLOGY, V151, P1176, DOI 10.1053/j.gastro.2016.08.024; De Simone G, 2021, IMMUNITY, V54, P2089, DOI 10.1016/j.immuni.2021.05.005; Devisscher L, 2017, CELL IMMUNOL, V322, P74, DOI 10.1016/j.cellimm.2017.10.006; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; GEBHARDT R, 1992, PHARMACOL THERAPEUT, V53, P275, DOI 10.1016/0163-7258(92)90055-5; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; Guilliams M, 2017, NAT REV IMMUNOL, V17, P451, DOI 10.1038/nri.2017.42; Haimon Z, 2018, NAT IMMUNOL, V19, P636, DOI 10.1038/s41590-018-0110-6; Halpern KB, 2018, NAT BIOTECHNOL, V36, P962, DOI 10.1038/nbt.4231; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Han YH, 2017, CELL REP, V20, P124, DOI 10.1016/j.celrep.2017.06.017; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Hebbard L, 2011, NAT REV GASTRO HEPAT, V8, P34, DOI 10.1038/nrgastro.2010.191; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Jourdan T, 2017, MOL METAB, V6, P1517, DOI 10.1016/j.molmet.2017.08.011; JUNGERMANN K, 1978, TRENDS BIOCHEM SCI, V3, P198, DOI 10.1016/S0968-0004(78)91764-4; Kim K, 2018, CIRC RES, V123, P1127, DOI 10.1161/CIRCRESAHA.118.312804; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Kolodziejczyk AA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-1102-2; Krenkel O, 2017, NAT REV IMMUNOL, V17, P306, DOI 10.1038/nri.2017.11; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lim HY, 2018, IMMUNITY, V49, P326, DOI [10.1016/j.immuni.2018.12.009, 10.1016/j.immuni.2018.06.008]; Liu ZY, 2019, CELL, V178, P1509, DOI 10.1016/j.cell.2019.08.009; Lonardo A, 2016, HEPATOLOGY, V64, P1388, DOI 10.1002/hep.28584; Lynch RW, 2018, J LEUKOCYTE BIOL, V104, P579, DOI 10.1002/JLB.1TA0517-169R; MacParland SA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06318-7; Mair F, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.063; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; Morgantini C, 2019, NAT METAB, V1, P445, DOI 10.1038/s42255-019-0044-9; Mulder K, 2021, IMMUNITY, V54, P1883, DOI 10.1016/j.immuni.2021.07.007; Okada T, 2016, SCAND J IMMUNOL, V83, P139, DOI 10.1111/sji.12402; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Rada P, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03003-w; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Remmerie A, 2020, IMMUNITY, V53, P641, DOI 10.1016/j.immuni.2020.08.004; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakai M, 2019, IMMUNITY, V51, P655, DOI 10.1016/j.immuni.2019.09.002; Sanz E, 2009, P NATL ACAD SCI USA, V106, P13939, DOI 10.1073/pnas.0907143106; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott CL, 2018, IMMUNITY, V49, P312, DOI 10.1016/j.immuni.2018.07.004; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Seidman JS, 2020, IMMUNITY, V52, P1057, DOI 10.1016/j.immuni.2020.04.001; Sharma A, 2020, CELL, V183, P377, DOI 10.1016/j.cell.2020.08.040; Sierro F, 2017, IMMUNITY, V47, P374, DOI 10.1016/j.immuni.2017.07.018; Silverstein RL, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.272re3; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tencerova M, 2015, FASEB J, V29, P2959, DOI 10.1096/fj.15-270496; Tesz GJ, 2011, BIOCHEM J, V436, P351, DOI 10.1042/BJ20110352; Tran S, 2020, IMMUNITY, V53, P627, DOI 10.1016/j.immuni.2020.06.003; van Rooijen N, 2010, METHODS MOL BIOL, V605, P189, DOI 10.1007/978-1-60327-360-2_13; Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607; Wang CY, 2012, METHODS MOL BIOL, V821, P421, DOI 10.1007/978-1-61779-430-8_27; Wang J, 2016, CELL, V165, P668, DOI 10.1016/j.cell.2016.03.009; Wang MH, 2017, GENETICS, V207, P883, DOI 10.1534/genetics.117.300257; Wu X, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02108; Xiong XL, 2019, MOL CELL, V75, P644, DOI 10.1016/j.molcel.2019.07.028; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	84	20	20	3	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					2101	+		10.1016/j.immuni.2021.08.006	http://dx.doi.org/10.1016/j.immuni.2021.08.006		SEP 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34469775	Bronze			2022-12-18	WOS:000695789800017
J	Wang, XQ; Cai, J; Lin, BL; Ma, M; Tao, Y; Zhou, YB; Li, B; Jiang, W; Zhou, RB				Wang, Xiaqiong; Cai, Juan; Lin, Bolong; Ma, Ming; Tao, Ye; Zhou, Yubo; Li Bai; Jiang, Wei; Zhou, Rongbin			GPR34-mediated sensing of lysophosphatidylserine released by apoptotic neutrophils activates type 3 innate lymphoid cells to mediate tissue repair	IMMUNITY			English	Article							ARYL-HYDROCARBON RECEPTOR; ULCERATIVE-COLITIS; INTESTINAL-MUCOSA; STEM-CELLS; RESOLUTION; IDENTIFICATION; INFLAMMATION; RECOGNITION; RECRUITMENT; HOMEOSTASIS	Neutrophils migrate rapidly to damaged tissue and play critical roles in host defense and tissue homeostasis. Here we investigated the mechanisms whereby neutrophils participate in tissue repair. In an intestinal epithelia injury model, neutrophil depletion exacerbated colitis and associated with reduced interleukin (IL)-22 and limited activation of type 3 innate lymphoid cells (ILC3s). Co-culture with neutrophils activated ILC3s in a manner dependent on neutrophil apoptosis. Metabolomic analyses revealed that lysophosphatidylserine (LysoPS) from apoptotic neutrophils directly stimulated ILC3 activation. ILC3-specific deletion of Gpr34, encoding the LysoPS receptor GPR34, or inhibition of downstream PI3K-AKT or ERK suppressed IL-22 production in response to apoptotic neutrophils. Gpr34(-/-) mice exhibited compromised ILC3 activation and tissue repair during colon injury, and neutrophil depletion abrogated these defects. GPR34 deficiency in ILC3s limited IL-22 production and tissue repair in vivo in settings of colon and skin injury. Thus, GPR34 is an ILC3-expressed damage-sensing receptor that triggers tissue repair upon recognition of dying neutrophils.	[Wang, Xiaqiong; Zhou, Rongbin] Univ Sci & Technol China, Affiliated Hosp 1, Div Life Sci & Med, Dept Geriatr, Hefei 230036, Peoples R China; [Wang, Xiaqiong; Cai, Juan; Lin, Bolong; Ma, Ming; Tao, Ye; Zhou, Yubo; Li Bai; Jiang, Wei; Zhou, Rongbin] Univ Sci & Technol China, Sch Basic Med Sci, Div Life Sci & Med, Hefei Natl Lab Phys Sci Microscale,CAS Key Lab In, Hefei 230027, Peoples R China; [Zhou, Rongbin] Univ Sci & Technol China, CAS Ctr Excellence Cell & Mol Biol, Hefei 230027, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Zhou, RB (corresponding author), Univ Sci & Technol China, Affiliated Hosp 1, Div Life Sci & Med, Dept Geriatr, Hefei 230036, Peoples R China.; Jiang, W; Zhou, RB (corresponding author), Univ Sci & Technol China, Sch Basic Med Sci, Div Life Sci & Med, Hefei Natl Lab Phys Sci Microscale,CAS Key Lab In, Hefei 230027, Peoples R China.; Zhou, RB (corresponding author), Univ Sci & Technol China, CAS Ctr Excellence Cell & Mol Biol, Hefei 230027, Peoples R China.	ustcjw@ustc.edu.cn; zrb1980@ustc.edu.cn			National Key Research and Development Program of China [2019YFA0508503, 2020YFA0509101]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDB29030102]; National Natural Science Foundation of China [U20A20359, 81821001, 31770991, 91742202]; Fundamental Research Funds for the Central Universities; University Synergy Innovation Program of Anhui Province [GXXT-2019-026]	National Key Research and Development Program of China; Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); University Synergy Innovation Program of Anhui Province	This research was supported by the National Key Research and Development Program of China (2019YFA0508503 and 2020YFA0509101), the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB29030102), the National Natural Science Foundation of China (U20A20359, 81821001, 31770991, and 91742202), the Fundamental Research Funds for the Central Universities, and the University Synergy Innovation Program of Anhui Province (GXXT-2019-026).	Amulic B, 2012, ANNU REV IMMUNOL, V30, P459, DOI 10.1146/annurev-immunol-020711-074942; Aparicio-Domingo P, 2015, J EXP MED, V212, P1783, DOI 10.1084/jem.20150318; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Bouchery T, 2019, IMMUNOL CELL BIOL, V97, P289, DOI 10.1111/imcb.12241; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Castellanos JG, 2018, IMMUNITY, V49, P1077, DOI 10.1016/j.immuni.2018.10.014; Chu C, 2018, CELL REP, V23, P3750, DOI 10.1016/j.celrep.2018.05.099; Chun E, 2019, IMMUNITY, V51, P871, DOI 10.1016/j.immuni.2019.09.014; Conway KL, 2012, J IMMUNOL, V189, P3631, DOI 10.4049/jimmunol.1103746; Diefenbach A, 2017, IMMUNITY, V46, P327, DOI 10.1016/j.immuni.2017.03.008; Dieleman LA, 1998, CLIN EXP IMMUNOL, V114, P385; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Duffin R, 2016, SCIENCE, V351, P1333, DOI 10.1126/science.aad9903; Dunn L, 2013, JOVE-J VIS EXP, DOI 10.3791/50265; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Eken A, 2014, MUCOSAL IMMUNOL, V7, P143, DOI 10.1038/mi.2013.33; Emgard J, 2018, IMMUNITY, V48, P120, DOI 10.1016/j.immuni.2017.11.020; Eming SA, 2017, SCIENCE, V356, P1026, DOI 10.1126/science.aam7928; Forkel M, 2019, J CROHNS COLITIS, V13, P67, DOI 10.1093/ecco-jcc/jjy119; Fox S, 2010, J INNATE IMMUN, V2, P216, DOI 10.1159/000284367; Frasch SC, 2012, PROG LIPID RES, V51, P199, DOI 10.1016/j.plipres.2012.03.001; Frasch SC, 2008, J BIOL CHEM, V283, P33736, DOI 10.1074/jbc.M807047200; Gong T, 2020, NAT REV IMMUNOL, V20, P95, DOI 10.1038/s41577-019-0215-7; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Gronke K, 2019, NATURE, V566, P249, DOI 10.1038/s41586-019-0899-7; Hall LM, 1998, J AM SOC MASS SPECTR, V9, P527, DOI 10.1016/S1044-0305(98)00013-0; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Ibeakanma C, 2010, GUT, V59, P612, DOI 10.1136/gut.2009.190439; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Inoue A, 2012, NAT METHODS, V9, P1021, DOI [10.1038/NMETH.2172, 10.1038/nmeth.2172]; Jiang W, 2013, J EXP MED, V210, P2465, DOI 10.1084/jem.20122490; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Kitamura H, 2012, J BIOCHEM, V151, P511, DOI 10.1093/jb/mvs011; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Li J, 2017, CLIN EXP IMMUNOL, V190, P143, DOI 10.1111/cei.12996; Li Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11394; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Liu L, 2019, NAT IMMUNOL, V20, P1681, DOI 10.1038/s41590-019-0513-z; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Moniruzzaman M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143468; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Naganuma M, 2018, GASTROENTEROLOGY, V154, P935, DOI 10.1053/j.gastro.2017.11.024; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Rutz S, 2014, NAT REV IMMUNOL, V14, P783, DOI 10.1038/nri3766; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Sawa S, 2011, NAT IMMUNOL, V12, P320, DOI 10.1038/ni.2002; Schoneberg T, 2018, PHARMACOL THERAPEUT, V189, P71, DOI 10.1016/j.pharmthera.2018.04.008; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Sugimoto S, 2016, DIGESTION, V93, P193, DOI 10.1159/000444217; Sugo T, 2006, BIOCHEM BIOPH RES CO, V341, P1078, DOI 10.1016/j.bbrc.2006.01.069; Suratt BT, 2001, AM J PHYSIOL-LUNG C, V281, pL913, DOI 10.1152/ajplung.2001.281.4.L913; Takayama T, 2010, GASTROENTEROLOGY, V139, P882, DOI 10.1053/j.gastro.2010.05.040; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wardle DJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015768; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zhao ZW, 2010, J LIPID RES, V51, P652, DOI 10.1194/jlr.D001503; Zhou J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10176-2	65	20	20	8	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1123	+	e8	10.1016/j.immuni.2021.05.007	http://dx.doi.org/10.1016/j.immuni.2021.05.007		JUN 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	34107271	Bronze			2022-12-18	WOS:000659882900007
J	Wu, B; Zhang, S; Guo, ZL; Bi, YM; Zhou, MX; Li, P; Seyedsadr, M; Xu, XJ; Li, JL; Markovic-Plese, S; Wan, YSY				Wu, Bing; Zhang, Song; Guo, Zengli; Bi, Yanmin; Zhou, Mingxia; Li, Ping; Seyedsadr, Maryamsadat; Xu, Xiaojiang; Li, Jian-liang; Markovic-Plese, Silva; Wan, Yisong Y.			The TGF-beta superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; T-CELLS; BINDING-PROTEIN; T(H)17 CELLS; GENERATION; IL-17; INFLAMMATION; FOLLISTATIN; EXPRESSION; PROMOTES	Th17 cells are known to exert pathogenic and non-pathogenic functions. Although the cytokine transforming growth factor beta 1 (TGF-beta 1) is instrumental for Th17 cell differentiation, it is dispensable for generation of pathogenic Th17 cells. Here, we examined the T cell-intrinsic role of Activin-A, a TGF-beta superfamily member closely related to TGF-beta 1, in pathogenic Th17 cell differentiation. Activin-A expression was increased in individuals with relapsing-remitting multiple sclerosis and in mice with experimental autoimmune encephalomyelitis. Stimulation with interleukin-6 and Activin-A induced a molecular program that mirrored that of pathogenic Th17 cells and was inhibited by blocking Activin-A signaling. Genetic disruption of Activin-A and its receptor ALK4 in T cells impaired pathogenic Th17 cell differentiation in vitro and in vivo. Mechanistically, extracellular-signal-regulated kinase (ERK) phosphorylation, which was essential for pathogenic Th17 cell differentiation, was suppressed by TGF-beta 1-ALK5 but not Activin-A-ALK4 signaling. Thus, Activin-A drives pathogenic Th17 cell differentiation, implicating the Activin-A-ALK4-ERK axis as a therapeutic target for Th17 cell-related diseases.	[Wu, Bing; Zhang, Song; Guo, Zengli; Zhou, Mingxia; Li, Ping; Wan, Yisong Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA; [Wu, Bing; Zhang, Song; Guo, Zengli; Zhou, Mingxia; Li, Ping; Wan, Yisong Y.] Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27599 USA; [Bi, Yanmin] Univ N Carolina, Gene Therapy Ctr, Chapel Hill, NC 27599 USA; [Seyedsadr, Maryamsadat; Markovic-Plese, Silva] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA; [Xu, Xiaojiang; Li, Jian-liang] NIEHS, Integrat Bioinformat, Res Triangle Pk, NC 27709 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Jefferson University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Wan, YSY (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Sch Med, Chapel Hill, NC 27599 USA.; Wan, YSY (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27599 USA.	wany@email.unc.edu	Li, Jian-Liang/AAE-9315-2019; Guo, Zengli/F-5743-2019; Guo, Zengli/AAE-4706-2021; Wan, Yisong/ABE-1200-2021	Li, Jian-Liang/0000-0002-6487-081X; Guo, Zengli/0000-0003-2950-4790; Guo, Zengli/0000-0003-2950-4790; Wan, Yisong/0000-0003-4346-9717; Zhang, Song/0000-0003-1492-8988	Intramural Research Program of the NIEHS, United States; NIH/NIAID, United States [AI131238, AI123193]; PA State Tobacco Award, United States [4100083100]; United States, National Multiple Sclerosis Society, United States [RG-1802-30483]; Yang Family Biomedical Scholars Award, United States	Intramural Research Program of the NIEHS, United States; NIH/NIAID, United States; PA State Tobacco Award, United States; United States, National Multiple Sclerosis Society, United States; Yang Family Biomedical Scholars Award, United States	We thank F. Zhang for Cre-dependent Cas9-expressing mice and J. McGuire for clinical data. We also thank the supports from the Intramural Research Program of the NIEHS, United States, to J.-l.L, from NIH/NIAID (AI131238), United States, and PA State Tobacco Award (SAP#4100083100), United States, to S.M.-P, and from NIH/NIAID (AI123193), United States, National Multiple Sclerosis Society (RG-1802-30483), United States, and Yang Family Biomedical Scholars Award, United States, to Y.Y.W.	Aschenbrenner D, 2018, NAT IMMUNOL, V19, P1126, DOI 10.1038/s41590-018-0200-5; Batlle E, 2019, IMMUNITY, V50, P924, DOI 10.1016/j.immuni.2019.03.024; Bauer J, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0456-4; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brereton CF, 2009, J IMMUNOL, V183, P1715, DOI 10.4049/jimmunol.0803851; Chen WJ, 2016, NAT REV IMMUNOL, V16, P723, DOI 10.1038/nri.2016.112; David CJ, 2018, NAT REV MOL CELL BIO, V19, P419, DOI 10.1038/s41580-018-0007-0; de Kretser DM, 2012, MOL CELL ENDOCRINOL, V359, P101, DOI 10.1016/j.mce.2011.10.009; Derynck R, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav5183; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Gawa K, 2006, J IMMUNOL, V177, P6787, DOI 10.4049/jimmunol.177.10.6787; Ghoreschi K, 2011, TRENDS IMMUNOL, V32, P395, DOI 10.1016/j.it.2011.06.007; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Green EA, 2003, P NATL ACAD SCI USA, V100, P10878, DOI 10.1073/pnas.1834400100; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; Hedger MP, 2013, CYTOKINE GROWTH F R, V24, P285, DOI 10.1016/j.cytogfr.2013.03.003; Heldin CH, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a022053; Huber S, 2009, J IMMUNOL, V182, P4633, DOI 10.4049/jimmunol.0803143; Jones CP, 2012, J ALLERGY CLIN IMMUN, V129, P1000, DOI 10.1016/j.jaci.2011.12.965; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Lee JY, 2020, CELL, V180, P79, DOI 10.1016/j.cell.2019.11.026; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li MO, 2007, IMMUNITY, V26, P579, DOI 10.1016/j.immuni.2007.03.014; Liu HP, 2013, EUR J IMMUNOL, V43, P1716, DOI 10.1002/eji.201242889; Locci M, 2016, NAT IMMUNOL, V17, P976, DOI 10.1038/ni.3494; Luisi S, 2001, EUR J ENDOCRINOL, V145, P225, DOI 10.1530/eje.0.1450225; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martinez GJ, 2010, J BIOL CHEM, V285, P29039, DOI 10.1074/jbc.C110.155820; McGeachy MJ, 2007, NAT IMMUNOL, V8, P1390, DOI 10.1038/ni1539; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Moren A, 2005, J BIOL CHEM, V280, P22115, DOI 10.1074/jbc.M414027200; Morianos I, 2020, P NATL ACAD SCI USA, V117, P12269, DOI [10.1073/pnas.1918196117/-/DCSupplemental, 10.1073/pnas.1918196117]; Morianos I, 2019, J AUTOIMMUN, V104, DOI 10.1016/j.jaut.2019.102314; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; Nakamura K, 2001, J EXP MED, V194, P629, DOI 10.1084/jem.194.5.629; Naviaux RK, 1996, J VIROL, V70, P5701, DOI 10.1128/JVI.70.8.5701-5705.1996; Omenetti S, 2019, IMMUNITY, V51, P77, DOI 10.1016/j.immuni.2019.05.004; Phillips DJ, 2009, CYTOKINE GROWTH F R, V20, P153, DOI 10.1016/j.cytogfr.2009.02.007; Platt RJ, 2014, CELL, V159, P440, DOI 10.1016/j.cell.2014.09.014; Revu S, 2018, CELL REP, V22, P2642, DOI 10.1016/j.celrep.2018.02.044; Rubtsov YP, 2007, NAT REV IMMUNOL, V7, P443, DOI 10.1038/nri2095; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sideras P, 2013, SEMIN IMMUNOPATHOL, V35, P481, DOI 10.1007/s00281-013-0365-9; Stockinger B, 2017, NAT REV IMMUNOL, V17, P535, DOI 10.1038/nri.2017.50; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; Thompson AJ, 2018, LANCET NEUROL, V17, P162, DOI 10.1016/S1474-4422(17)30470-2; Tsuchida K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-15; Tu E, 2018, IMMUNITY, V48, P745, DOI 10.1016/j.immuni.2018.03.025; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wang XH, 2020, IMMUNITY, V52, P328, DOI 10.1016/j.immuni.2020.01.006; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Weiss A, 2013, WIRES DEV BIOL, V2, P47, DOI 10.1002/wdev.86; Werner S, 2006, CYTOKINE GROWTH F R, V17, P157, DOI 10.1016/j.cytogfr.2006.01.001; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Zhang S, 2017, NATURE, V551, P105, DOI 10.1038/nature24283	59	20	22	3	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					308	+		10.1016/j.immuni.2020.12.010	http://dx.doi.org/10.1016/j.immuni.2020.12.010		FEB 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33421362	Bronze, Green Accepted			2022-12-18	WOS:000627407700014
J	van der Veeken, J; Glasner, A; Zhong, Y; Hu, W; Wang, ZM; Bou-Puerto, R; Charbonnier, LM; Chatila, TA; Leslie, CS; Rudensky, AY				van der Veeken, Joris; Glasner, Ariella; Zhong, Yi; Hu, Wei; Wang, Zhong-Min; Bou-Puerto, Regina; Charbonnier, Louis-Marie; Chatila, Talal A.; Leslie, Christina S.; Rudensky, Alexander Y.			The Transcription Factor Foxp3 Shapes Regulatory T Cell Identity by Tuning the Activity of trans-Acting Intermediaries	IMMUNITY			English	Article							NATURAL GENETIC-VARIATION; CHROMATIN; EXPRESSION; PROTEIN; DIFFERENTIATION; AUTOIMMUNITY; REPRESSION; LANDSCAPE; TCF-1	Regulatory T (Treg) cell identity is defined by the lineage-specifying transcription factor (TF) Foxp3. Here we examined mechanisms of Foxp3 function by leveraging naturally occurring genetic variation in wild-derived inbred mice, which enables the identification of DNA sequence motifs driving epigenetic features. Chromatin accessibility, TF binding, and gene expression patterns in resting and activated subsets of Treg cells, conventional CD4 T cells, and cells expressing a Foxp3 reporter null allele revealed that the majority of Foxp3-dependent changes occurred at sites not bound by Foxp3. Chromatin accessibility of these indirect Foxp3 targets depended on the presence of DNA binding motifs for other TFs, including TCF1 Foxp3 expression correlated with decreased TCF1 and reduced accessibility of TCF1-bound chromatin regions. Deleting one copy of the Tcf7 gene recapitulated Foxp3-dependent negative regulation of chromatin accessibility. Thus, Foxp3 defines Treg cell identity in a largely indirect manner by fine-tuning the activity of other major chromatin remodeling TFs such as TCF1.	[van der Veeken, Joris; Glasner, Ariella; Zhong, Yi; Hu, Wei; Wang, Zhong-Min; Bou-Puerto, Regina; Rudensky, Alexander Y.] Howard Hughes Med Inst, New York, NY 10032 USA; [van der Veeken, Joris; Glasner, Ariella; Zhong, Yi; Hu, Wei; Wang, Zhong-Min; Bou-Puerto, Regina; Rudensky, Alexander Y.] Sloan Kettering Inst, Immunol Program, New York, NY 10065 USA; [van der Veeken, Joris; Glasner, Ariella; Zhong, Yi; Hu, Wei; Wang, Zhong-Min; Bou-Puerto, Regina; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA; [Zhong, Yi; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat & Syst Biol Program, 1275 York Ave, New York, NY 10021 USA; [Wang, Zhong-Min] Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, 1275 York Ave, New York, NY 10021 USA; [Bou-Puerto, Regina] Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY USA; [Charbonnier, Louis-Marie; Chatila, Talal A.] Boston Childrens Hosp, Div Immunol, Boston, MA USA; [Charbonnier, Louis-Marie; Chatila, Talal A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	van der Veeken, J; Rudensky, AY (corresponding author), Howard Hughes Med Inst, New York, NY 10032 USA.; van der Veeken, J; Rudensky, AY (corresponding author), Sloan Kettering Inst, Immunol Program, New York, NY 10065 USA.; van der Veeken, J; Rudensky, AY (corresponding author), Mem Sloan Kettering Canc Ctr, Ludwig Ctr, 1275 York Ave, New York, NY 10021 USA.	vandervj@mskcc.org; rudenska@mskcc.org	Glasner, Ari/HHC-5411-2022; Hu, Wei/ABH-1470-2021; Wang, Zhongmin/GLU-9473-2022	Hu, Wei/0000-0002-0392-6939; Wang, Zhongmin/0000-0002-5538-1969; Charbonnier, Louis-Marie/0000-0002-4594-7893; Bou Puerto, Regina/0000-0002-7546-3312; van der Veeken, Joris/0000-0001-7299-2174	NIH [R01AI034206, U54 CA209975]; NIH/NCI Cancer Center Support Grant [P30 CA008748]; Ludwig Center at Memorial Sloan Kettering Cancer Center; Parker Institute for Cancer Immunotherapy; Irvington fellowship of the Cancer Research Institute; "la Caixa'' fellowship from the "la Caixa'' Foundation [LCF/BQ/AA17/11610016]; NIH/NCI Cancer Center Support Grant, Cycle for Survival [P30 CA008748]; Marie-Josee and Henry R. Kravis Center for Molecular Oncology	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI Cancer Center Support Grant; Ludwig Center at Memorial Sloan Kettering Cancer Center; Parker Institute for Cancer Immunotherapy; Irvington fellowship of the Cancer Research Institute; "la Caixa'' fellowship from the "la Caixa'' Foundation; NIH/NCI Cancer Center Support Grant, Cycle for Survival; Marie-Josee and Henry R. Kravis Center for Molecular Oncology	Wethank all members of the Rudensky lab for discussions and technical assistance. We thank Stephen Henikoff for providing the protein A/G-MNase plasmid. This study was supported by NIH grants R01AI034206 and U54 CA209975, NIH/NCI Cancer Center Support Grant P30 CA008748, The Ludwig Center at Memorial Sloan Kettering Cancer Center, and the Parker Institute for Cancer Immunotherapy. A.G. was supported by an Irvington fellowship of the Cancer Research Institute. R.B.P. was supported by a "la Caixa'' fellowship from the "la Caixa'' Foundation (LCF/BQ/AA17/11610016). A.Y.R. is an investigator with the Howard Hughes Medical Institute. We acknowledge the use of the MSKCC Integrated Genomics Operation Core, funded by NIH/NCI Cancer Center Support Grant P30 CA008748, Cycle for Survival, and the Marie-Josee and Henry R. Kravis Center for Molecular Oncology.	Arvey A, 2015, ELIFE, V4, DOI 10.7554/eLife.07571; Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Boller S, 2016, IMMUNITY, V44, P527, DOI 10.1016/j.immuni.2016.02.021; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Campbell C, 2020, CELL METAB, V31, P18, DOI 10.1016/j.cmet.2019.09.010; Charbonnier LM, 2019, NAT IMMUNOL, V20, P1208, DOI 10.1038/s41590-019-0442-x; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11101; Crowley JJ, 2015, NAT GENET, V47, P353, DOI 10.1038/ng.3222; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Farley EK, 2015, COLD SH Q B, V80, P27, DOI 10.1101/sqb.2015.80.027227; Farley EK, 2015, SCIENCE, V350, P325, DOI 10.1126/science.aac6948; Fasolino M, 2020, IMMUNITY, V52, P257, DOI 10.1016/j.immuni.2020.01.003; Fontenot JD, 2005, J EXP MED, V202, P901, DOI 10.1084/jem.20050784; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Heinz S, 2013, NATURE, V503, P487, DOI 10.1038/nature12615; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Huang SP, 2014, DATABASE-OXFORD, DOI 10.1093/database/bau057; Johnson JL, 2018, IMMUNITY, V48, P243, DOI 10.1016/j.immuni.2018.01.012; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Keerthivasan S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007607; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kwon HK, 2017, NAT IMMUNOL, V18, P1238, DOI 10.1038/ni.3835; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Li R, 2018, GENE DEV, V32, P96, DOI 10.1101/gad.309583.117; Link VM, 2018, CELL, V173, P1796, DOI 10.1016/j.cell.2018.04.018; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liu N, 2018, CELL, V173, P430, DOI 10.1016/j.cell.2018.03.016; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Meers MP, 2019, ELIFE, V8, DOI 10.7554/eLife.46314; Okamura RM, 1998, IMMUNITY, V8, P11, DOI 10.1016/S1074-7613(00)80454-9; Owen DL, 2019, NAT IMMUNOL, V20, P195, DOI 10.1038/s41590-018-0289-6; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Soccio RE, 2015, CELL, V162, P33, DOI 10.1016/j.cell.2015.06.025; van der Veeken J, 2019, IMMUNITY, V50, P1202, DOI 10.1016/j.immuni.2019.03.031; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Vierbuchen T, 2017, MOL CELL, V68, P1067, DOI 10.1016/j.molcel.2017.11.026; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Xing SJ, 2019, J EXP MED, V216, P847, DOI 10.1084/jem.20182010; Yang BH, 2019, CELL REP, V27, P3629, DOI 10.1016/j.celrep.2019.05.061; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	51	20	20	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					971	+		10.1016/j.immuni.2020.10.010	http://dx.doi.org/10.1016/j.immuni.2020.10.010			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33176163	Bronze, Green Accepted			2022-12-18	WOS:000599348200010
J	Starkl, P; Watzenboeck, ML; Popov, LM; Zahalka, S; Hladik, A; Lakovits, K; Radhouani, M; Haschemi, A; Marichal, T; Reber, LL; Gaudenzio, N; Sibilano, R; Stulik, L; Fontaine, F; Mueller, AC; Amieva, MR; Galli, SJ; Knapp, S				Starkl, Philipp; Watzenboeck, Martin L.; Popov, Lauren M.; Zahalka, Sophie; Hladik, Anastasiya; Lakovits, Karin; Radhouani, Mariem; Haschemi, Arvand; Marichal, Thomas; Reber, Laurent L.; Gaudenzio, Nicolas; Sibilano, Riccardo; Stulik, Lukas; Fontaine, Frederic; Mueller, Andre C.; Amieva, Manuel R.; Galli, Stephen J.; Knapp, Sylvia			IgE Effector Mechanisms, in Concert with Mast Cells, Contribute to Acquired Host Defense against Staphylococcus aureus	IMMUNITY			English	Article							IMMUNOGLOBULIN-E; INFECTION; IMMUNITY; VENOM; ANAPHYLAXIS; ANTIBODY; SNAKE	Allergies are considered to represent mal-directed type 2 immune responses against mostly innocuous exogenous compounds. Immunoglobulin E (IgE) antibodies are a characteristic feature of allergies and mediate hypersensitivity against allergens through activation of effector cells, particularly mast cells (MCs). Although the physiological functions of this dangerous branch of immunity have remained enigmatic, recent evidence shows that allergic immune reactions can help to protect against the toxicity of venoms. Because bacteria are a potent alternative source of toxins, we assessed the possible role of allergy-like type 2 immunity in antibacterial host defense. We discovered that the adaptive immune response against Staphylococcus aureus (SA) skin infection substantially improved systemic host defense against secondary SA infections in mice. Moreover, this acquired protection depended on IgE effector mechanisms and MCs. Importantly, our results reveal a previously unknown physiological function of allergic immune responses, IgE antibodies, and MCs in host defense against a pathogenic bacterium.	[Starkl, Philipp; Watzenboeck, Martin L.; Zahalka, Sophie; Hladik, Anastasiya; Lakovits, Karin; Radhouani, Mariem; Knapp, Sylvia] Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria; [Starkl, Philipp; Watzenboeck, Martin L.; Zahalka, Sophie; Hladik, Anastasiya; Lakovits, Karin; Radhouani, Mariem; Fontaine, Frederic; Mueller, Andre C.; Knapp, Sylvia] Med Univ Vienna, Dept Med 1, Lab Infect Biol, A-1090 Vienna, Austria; [Starkl, Philipp; Marichal, Thomas; Reber, Laurent L.; Gaudenzio, Nicolas; Sibilano, Riccardo; Galli, Stephen J.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Popov, Lauren M.; Amieva, Manuel R.; Galli, Stephen J.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Popov, Lauren M.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Haschemi, Arvand] Med Univ Vienna, Dept Lab Med, A-1090 Vienna, Austria; [Marichal, Thomas] Univ Liege, GIGA Res, B-4000 Liege, Belgium; [Marichal, Thomas] Univ Liege, Fac Vet Med, B-4000 Liege, Belgium; [Reber, Laurent L.] Univ Toulouse, CNRS, Ctr Physiopathol Toulouse Purpan CPTP, INSERM,UMR 1043, F-31024 Toulouse, France; [Gaudenzio, Nicolas] Univ Toulouse, INSERM, UMR 1056, Unite Differenciat Epitheliale & Autoimmun Rhumat, F-31059 Toulouse, France; [Sibilano, Riccardo; Galli, Stephen J.] Stanford Univ, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA; [Stulik, Lukas] X4 Pharmaceut Austria GmbH, A-1030 Vienna, Austria; [Amieva, Manuel R.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA	Austrian Academy of Sciences; CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences; Medical University of Vienna; Stanford University; Stanford University; University of California System; University of California Berkeley; Medical University of Vienna; University of Liege; University of Liege; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Stanford University; Stanford University	Starkl, P; Knapp, S (corresponding author), Austrian Acad Sci, CeMM Res Ctr Mol Med, A-1090 Vienna, Austria.; Starkl, P; Knapp, S (corresponding author), Med Univ Vienna, Dept Med 1, Lab Infect Biol, A-1090 Vienna, Austria.; Starkl, P; Galli, SJ (corresponding author), Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA.; Galli, SJ (corresponding author), Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA.; Galli, SJ (corresponding author), Stanford Univ, Sean N Parker Ctr Allergy & Asthma Res, Stanford, CA 94305 USA.	philipp.starkl@meduniwien.ac.at; sgalli@stanford.edu; sylvia.knapp@meduniwien.ac.at	Knapp, Sylvia/J-3973-2013; Reber, Laurent L/K-4148-2014; Amieva, Manuel/U-2581-2017	Knapp, Sylvia/0000-0001-9016-5244; Reber, Laurent L/0000-0003-3384-6769; Mueller, Andre/0000-0002-0608-8176; Amieva, Manuel/0000-0002-5601-4490; FONTAINE, FREDERIC/0000-0002-5044-1029; Watzenboeck, Martin/0000-0001-9445-3331; Haschemi, Arvand/0000-0001-9532-3205	Marie Sk1odowska-Curie Individual Fellowship H2020-MSCA-IF-2016 [749629]; European Research Council [802041]; INSERM ATIP-Avenir program; Marie Sk1odowska-Curie Individual Fellowship [H2020-MSCA-IF-2014 655153]; Austrian Science Fund (FWF) [P31113-B30]; Schroedinger Fellowship of the FWF [J3399-B21]; NIH [R01 AI23990, R01 AI070813, R01 AR067145, R01 AI132494]; French ANR [ANR-18-CE18-0023]	Marie Sk1odowska-Curie Individual Fellowship H2020-MSCA-IF-2016; European Research Council(European Research Council (ERC)European Commission); INSERM ATIP-Avenir program; Marie Sk1odowska-Curie Individual Fellowship; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Schroedinger Fellowship of the FWF; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); French ANR(French National Research Agency (ANR))	We thank members of the Knapp and Galli labs for helpful discussions and Dr. Mindy Tsai for organizational support. We thank Axel Roers for providing Mcpt5 Cre mice and Hans Oettgen for providing Igh-7<SUP>-/-</SUP> (IgE-deficient) mice. This work was supported by Marie Sk1odowska-Curie Individual Fellowship H2020-MSCA-IF-2016 #749629, the European Research Council (ERC2018-StG #802041), and the INSERM ATIP-Avenir program (to N.G.); Marie Sk1odowska-Curie Individual Fellowship H2020-MSCA-IF-2014 655153, the Austrian Science Fund (FWF; P31113-B30), and the Schroedinger Fellowship of the FWF (J3399-B21) (to P.S.); and NIH grants R01 AI23990, R01 AI070813, R01 AR067145, and R01 AI132494 (to S.J.G.). L.L.R. is supported by the INSERM ATIP-Avenir program and the French ANR (ANR-18-CE18-0023).	Akahoshi M, 2011, J CLIN INVEST, V121, P4180, DOI 10.1172/JCI46139; Anderson E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01532; Arifuzzaman M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav0216; Badarau A, 2016, MABS-AUSTIN, V8, P1347, DOI 10.1080/19420862.2016.1215791; Balbino B, 2018, PHARMACOL THERAPEUT, V191, P50, DOI 10.1016/j.pharmthera.2018.05.015; Bankhead P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17204-5; Bruhns P, 2015, IMMUNOL REV, V268, P25, DOI 10.1111/imr.12350; Cassini A, 2019, LANCET INFECT DIS, V19, P56, DOI 10.1016/S1473-3099(18)30605-4; Cosmi L, 2019, EUR J IMMUNOL, V49, P1334, DOI 10.1002/eji.201948156; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; DOMBROWICZ D, 1993, CELL, V75, P969, DOI 10.1016/0092-8674(93)90540-7; Eberl G, 2016, NAT REV IMMUNOL, V16, P524, DOI 10.1038/nri.2016.75; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gause WC, 2020, NAT REV IMMUNOL, V20, P603, DOI 10.1038/s41577-020-0301-x; Gowthaman U, 2019, SCIENCE, V365, P883, DOI 10.1126/science.aaw6433; Hahn BL, 2013, MICROB PATHOGENESIS, V63, P24, DOI 10.1016/j.micpath.2013.05.012; Hammad H, 2015, IMMUNITY, V43, P29, DOI 10.1016/j.immuni.2015.07.007; Harris NL, 2018, IMMUNITY, V48, P396, DOI 10.1016/j.immuni.2018.02.011; Hughes CS, 2014, MOL SYST BIOL, V10, DOI 10.15252/msb.20145625; Inoshima I, 2011, NAT MED, V17, P1310, DOI 10.1038/nm.2451; Kim J, 2019, ALLERGY ASTHMA IMMUN, V11, P593, DOI 10.4168/aair.2019.11.5.593; Kobayashi T, 2019, IMMUNITY, V50, P552, DOI 10.1016/j.immuni.2019.02.023; Langen U, 2013, BUNDESGESUNDHEITSBLA, V56, P698, DOI 10.1007/s00103-012-1652-7; LIU FT, 1980, J IMMUNOL, V124, P2728; Lloyd CM, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1604; Marichal T, 2016, J CLIN INVEST, V126, P4497, DOI 10.1172/JCI86359; Marichal T, 2013, IMMUNITY, V39, P963, DOI 10.1016/j.immuni.2013.10.005; Meindl S, 2006, J LEUKOCYTE BIOL, V80, P816, DOI 10.1189/jlb.0106015; Metz M, 2006, SCIENCE, V313, P526, DOI 10.1126/science.1128877; Miller LS, 2018, P NATL ACAD SCI USA, V115, P2272, DOI 10.1073/pnas.1800448115; Mukai K, 2018, IMMUNOL REV, V282, P121, DOI 10.1111/imr.12634; Mukai K, 2016, SEMIN IMMUNOPATHOL, V38, P581, DOI 10.1007/s00281-016-0565-1; Musher DM, 2014, NEW ENGL J MED, V371, P1619, DOI 10.1056/NEJMra1312885; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Oettgen HC, 2016, J ALLERGY CLIN IMMUN, V137, P1631, DOI 10.1016/j.jaci.2016.04.009; OETTGEN HC, 1994, NATURE, V370, P367, DOI 10.1038/370367a0; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Otto M, 2014, CURR OPIN MICROBIOL, V17, P32, DOI 10.1016/j.mib.2013.11.004; Palm NW, 2013, IMMUNITY, V39, P976, DOI 10.1016/j.immuni.2013.10.006; Palm NW, 2012, NATURE, V484, P465, DOI 10.1038/nature11047; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Piliponsky AM, 2018, IMMUNOL REV, V282, P188, DOI 10.1111/imr.12623; Popov LM, 2015, P NATL ACAD SCI USA, V112, P14337, DOI 10.1073/pnas.1510265112; Prabhakara R, 2013, INFECT IMMUN, V81, P1306, DOI 10.1128/IAI.01304-12; PROFET M, 1991, Q REV BIOL, V66, P23, DOI 10.1086/417049; Pundir P, 2019, CELL HOST MICROBE, V26, P114, DOI 10.1016/j.chom.2019.06.003; Reber LL, 2017, J ALLERGY CLIN IMMUN, V140, P335, DOI 10.1016/j.jaci.2017.06.003; Redegeld FA, 2018, IMMUNOL REV, V282, P87, DOI 10.1111/imr.12629; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rouha H, 2018, VIRULENCE, V9, P231, DOI 10.1080/21505594.2017.1391447; Rudkin JK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006452; Schneider LA, 2007, J EXP MED, V204, P2629, DOI 10.1084/jem.20071262; Scholten J, 2008, TRANSGENIC RES, V17, P307, DOI 10.1007/s11248-007-9153-4; Sintobin I, 2019, EUR RESPIR J, V54, DOI 10.1183/13993003.00198-2019; Starkl P, 2016, J ALLERGY CLIN IMMUN, V137, P246, DOI 10.1016/j.jaci.2015.08.005; Stemeseder T, 2017, ALLERGY, V72, P754, DOI 10.1111/all.13071; Stentzel S, 2017, J ALLERGY CLIN IMMUN, V139, P492, DOI 10.1016/j.jaci.2016.03.045; Stryjewski ME, 2008, CLIN INFECT DIS, V46, pS368, DOI 10.1086/533593; Sullivan BM, 2011, NAT IMMUNOL, V12, P527, DOI 10.1038/ni.2036; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Torres A, 2010, AM J RESP CRIT CARE, V181, P782, DOI 10.1164/rccm.201001-0030UP; Untersmayr E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014210; Van Zele T, 2004, J ALLERGY CLIN IMMUN, V114, P981, DOI 10.1016/j.jaci.2004.07.013; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; Voehringer D, 2013, NAT REV IMMUNOL, V13, P362, DOI 10.1038/nri3427; Walch M, 2014, CELL, V157, P1309, DOI 10.1016/j.cell.2014.03.062; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Zhang XF, 2018, NAT PROTOC, V13, P530, DOI 10.1038/nprot.2017.147	69	20	20	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 13	2020	53	4					793	+		10.1016/j.immuni.2020.08.002	http://dx.doi.org/10.1016/j.immuni.2020.08.002			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OF2RX	32910906	Bronze, Green Accepted			2022-12-18	WOS:000581062800012
J	Stephen-Victor, E; Crestani, E; Chatila, TA				Stephen-Victor, Emmanuel; Crestani, Elena; Chatila, Talal A.			Dietary and Microbial Determinants in Food Allergy	IMMUNITY			English	Review							REGULATORY T-CELLS; GUT MICROBIOTA; EARLY-LIFE; ORAL TOLERANCE; DENDRITIC CELLS; EPICUTANEOUS IMMUNOTHERAPY; IMMUNE-RESPONSES; NATURAL-HISTORY; PEANUT ALLERGY; LYMPH-NODES	The steep rise in food allergy (FA) has evoked environmental factors involved in disease pathogenesis, including the gut microbiota, diet, and their metabolites. Early introduction of solid foods synchronizes with the "weaning reaction,'' a time during which the microbiota imprints durable oral tolerance. Recent work has shown that children with FA manifest an early onset dysbiosis with the loss of Clostridiales species, which promotes the differentiation of ROR-gamma t(+) regulatory T cells to suppress FA. This process can be reversed in pre-clinical mouse models by targeted bacteriotherapy. Here, we review the dominant tolerance mechanisms enforced by the microbiota to suppress FA and discuss therapeutic intervention strategies that act to recapitulate the early life window of opportunity in stemming the FA epidemic.	[Stephen-Victor, Emmanuel; Crestani, Elena; Chatila, Talal A.] Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Stephen-Victor, Emmanuel; Crestani, Elena; Chatila, Talal A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Chatila, TA (corresponding author), Boston Childrens Hosp, Div Immunol, Boston, MA 02115 USA.; Chatila, TA (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.	Talal.chatila@childrens.harvard.edu	Stephen Victor, Emmanuel/HDN-0252-2022	Stephen Victor, Emmanuel/0000-0001-5049-7017; Crestani, Elena/0000-0001-7718-0431	National Institutes of Health [R01 AI126915, R21 AI132843]; Bunning Food Allergy Fund; Jasmine and Paul Mashikian Fund	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bunning Food Allergy Fund; Jasmine and Paul Mashikian Fund	This work was supported by the National Institutes of Health grants R01 AI126915 and R21 AI132843 to T.A.C., and by the Bunning Food Allergy Fund and the Jasmine and Paul Mashikian Fund.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Abdel-Gadir A, 2018, CLIN EXP ALLERGY, V48, P825, DOI 10.1111/cea.13161; Abdel-Gadir A, 2019, NAT MED, V25, P1164, DOI 10.1038/s41591-019-0461-z; Abdel-Gadir Azza, 2018, F1000Res, V7, P38, DOI 10.12688/f1000research.12650.1; Agus A, 2018, CELL HOST MICROBE, V23, P716, DOI 10.1016/j.chom.2018.05.003; Al Nabhani Z, 2019, IMMUNITY, V50, P1276, DOI 10.1016/j.immuni.2019.02.014; Albuhairi S, 2020, IMMUNOL ALLERGY CLIN, V40, P175, DOI 10.1016/j.iac.2019.09.007; An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Anvari S, 2017, JAMA PEDIATR, V171, P77, DOI 10.1001/jamapediatrics.2016.2552; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Azad MB, 2015, CLIN EXP ALLERGY, V45, P632, DOI 10.1111/cea.12487; Baker SS, 2000, PEDIATRICS, V106, P346; Bansal T, 2010, P NATL ACAD SCI USA, V107, P228, DOI 10.1073/pnas.0906112107; Bock SA, 2001, J ALLERGY CLIN IMMUN, V107, P191, DOI 10.1067/mai.2001.112031; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Braun-Fahrlander C, 2002, NEW ENGL J MED, V347, P869, DOI 10.1056/NEJMoa020057; Britton GJ, 2019, IMMUNITY, V50, P212, DOI 10.1016/j.immuni.2018.12.015; Brown JM, 2018, NAT REV MICROBIOL, V16, P171, DOI 10.1038/nrmicro.2017.149; Bunyavanich S, 2019, J ALLERGY CLIN IMMUN, V144, P1468, DOI 10.1016/j.jaci.2019.10.019; Bunyavanich S, 2016, J ALLERGY CLIN IMMUN, V138, P1122, DOI 10.1016/j.jaci.2016.03.041; Burton OT, 2014, J ALLERGY CLIN IMMUN, V134, P1310, DOI 10.1016/j.jaci.2014.05.042; Buyuktiryaki B, 2016, ALLERGY, V71, P258, DOI 10.1111/all.12785; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Cammarota G, 2019, NAT REV GASTRO HEPAT, V16, P266, DOI 10.1038/s41575-019-0131-0; Campbell C, 2020, NATURE, V581, P475, DOI 10.1038/s41586-020-2193-0; Canani RB, 2016, ISME J, V10, P742, DOI 10.1038/ismej.2015.151; Cantarel BL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028742; Chu DK, 2019, LANCET, V393, P2222, DOI 10.1016/S0140-6736(19)30420-9; Chun E, 2019, IMMUNITY, V51, P871, DOI 10.1016/j.immuni.2019.09.014; Crestani E, 2020, J ALLERGY CLIN IMMUN, V145, P897, DOI 10.1016/j.jaci.2019.10.014; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; de Goffau MC, 2019, NATURE, V572, P329, DOI 10.1038/s41586-019-1451-5; DeFilipp Z, 2019, NEW ENGL J MED, V381, P2043, DOI 10.1056/NEJMoa1910437; Dodd D, 2017, NATURE, V551, P648, DOI 10.1038/nature24661; Dowds CM, 2015, CLIN IMMUNOL, V159, P128, DOI 10.1016/j.clim.2015.05.008; Downing NS, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.2044; Du Toit G, 2008, J ALLERGY CLIN IMMUN, V122, P984, DOI 10.1016/j.jaci.2008.08.039; du Toit G, 2018, J ALLERGY CLIN IMMUN, V141, P1343, DOI 10.1016/j.jaci.2017.09.034; Du Toit G, 2016, NEW ENGL J MED, V374, P1435, DOI 10.1056/NEJMoa1514209; Du Toit G, 2015, NEW ENGL J MED, V372, P803, DOI 10.1056/NEJMoa1414850; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Esterhazy D, 2019, NATURE, V569, P126, DOI 10.1038/s41586-019-1125-3; Esterhazy D, 2016, NAT IMMUNOL, V17, P545, DOI 10.1038/ni.3408; Feehley T, 2019, NAT MED, V25, P448, DOI 10.1038/s41591-018-0324-z; Fleischer DM, 2019, JAMA-J AM MED ASSOC, V321, P946, DOI 10.1001/jama.2019.1113; Fujimura KE, 2016, NAT MED, V22, P1187, DOI 10.1038/nm.4176; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Ganal-Vonarburg SC, 2020, SCIENCE, V368, P604, DOI 10.1126/science.aba0478; Garron ML, 2019, CURR OPIN CHEM BIOL, V53, P82, DOI 10.1016/j.cbpa.2019.08.004; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Gowthaman U., 2019, SCIENCE, V365; Greer FR, 2008, PEDIATRICS, V121, P183, DOI 10.1542/peds.2007-3022; Gupta RS, 2011, PEDIATRICS, V128, pE9, DOI 10.1542/peds.2011-0204; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Hang SY, 2019, NATURE, V576, P143, DOI 10.1038/s41586-019-1785-z; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; Hornef MW, 2020, IMMUNOLOGY, V159, P15, DOI 10.1111/imm.13149; Host A, 1999, ARCH DIS CHILD, V81, P80, DOI 10.1136/adc.81.1.80; Imdad A, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012774.pub2; James LK, 2011, J ALLERGY CLIN IMMUN, V127, P509, DOI 10.1016/j.jaci.2010.12.1080; Jones SM, 2017, J ALLERGY CLIN IMMUN, V139, P1242, DOI 10.1016/j.jaci.2016.08.017; Katz Y, 2010, J ALLERGY CLIN IMMUN, V126, P77, DOI 10.1016/j.jaci.2010.04.020; Kepert I, 2017, J ALLERGY CLIN IMMUN, V139, P1525, DOI 10.1016/j.jaci.2016.09.003; Kim EH, 2020, ALLERGY, V75, P1337, DOI 10.1111/all.14220; Kim KS, 2016, SCIENCE, V351, P858, DOI 10.1126/science.aac5560; Knoop KA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aao1314; Koenig JE, 2011, P NATL ACAD SCI USA, V108, P4578, DOI 10.1073/pnas.1000081107; Koplin JJ, 2010, J ALLERGY CLIN IMMUN, V126, P807, DOI 10.1016/j.jaci.2010.07.028; Kulis MD, 2018, J ALLERGY CLIN IMMUN, V141, P491, DOI 10.1016/j.jaci.2017.12.979; Kulkarni DH, 2020, MUCOSAL IMMUNOL, V13, P271, DOI 10.1038/s41385-019-0240-7; Lamas B, 2016, NAT MED, V22, P598, DOI 10.1038/nm.4102; Le Doare K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00361; Lee-Sarwar K, 2018, J ALLERGY CLIN IMMUN, V142, P335, DOI 10.1016/j.jaci.2018.04.016; Leiby JS, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0575-4; Macpherson AJ, 2018, ANNU REV IMMUNOL, V36, P359, DOI 10.1146/annurev-immunol-042617-053238; McDole JR, 2012, NATURE, V483, P345, DOI 10.1038/nature10863; Mold JE, 2010, SCIENCE, V330, P1695, DOI 10.1126/science.1196509; Neu J, 2011, NEW ENGL J MED, V364, P255, DOI 10.1056/NEJMra1005408; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Porter NT, 2017, ANNU REV MICROBIOL, V71, P349, DOI 10.1146/annurev-micro-102215-095316; Postler TS, 2017, CELL METAB, V26, P110, DOI 10.1016/j.cmet.2017.05.008; Rachid R, 2016, CURR OPIN PEDIATR, V28, P748, DOI 10.1097/MOP.0000000000000427; Ramanan D, 2020, CELL, V181, P1276, DOI 10.1016/j.cell.2020.04.030; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Rivas MN, 2015, IMMUNITY, V42, P512, DOI 10.1016/j.immuni.2015.02.004; Rivas MN, 2013, J ALLERGY CLIN IMMUN, V131, P201, DOI 10.1016/j.jaci.2012.10.026; Rolland J, 1998, CURR OPIN IMMUNOL, V10, P640, DOI 10.1016/S0952-7915(98)80082-4; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Savage J, 2016, J ALLER CL IMM-PRACT, V4, P196, DOI 10.1016/j.jaip.2015.11.024; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Shane AL, 2017, LANCET, V390, P1770, DOI 10.1016/S0140-6736(17)31002-4; Shimada Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070995; Sicherer SH, 2018, J ALLERGY CLIN IMMUN, V141, P41, DOI 10.1016/j.jaci.2017.11.003; Sicherer SH, 2010, J ALLERGY CLIN IMMUN, V125, P1322, DOI 10.1016/j.jaci.2010.03.029; Skripak JM, 2007, J ALLERGY CLIN IMMUN, V120, P1172, DOI 10.1016/j.jaci.2007.08.023; Song XY, 2020, NATURE, V577, P410, DOI 10.1038/s41586-019-1865-0; Spahn TW, 2002, EUR J IMMUNOL, V32, P1109, DOI 10.1002/1521-4141(200204)32:4<1109::AID-IMMU1109>3.3.CO;2-B; Spahn TW, 2001, EUR J IMMUNOL, V31, P1278, DOI 10.1002/1521-4141(200104)31:4<1278::AID-IMMU1278>3.0.CO;2-A; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Stefka AT, 2014, P NATL ACAD SCI USA, V111, P13145, DOI 10.1073/pnas.1412008111; Stephen-Victor E, 2019, CURR OPIN IMMUNOL, V60, P141, DOI 10.1016/j.coi.2019.06.001; Stewart CJ, 2018, NATURE, V562, P583, DOI 10.1038/s41586-018-0617-x; Stockinger B, 2014, ANNU REV IMMUNOL, V32, P403, DOI 10.1146/annurev-immunol-032713-120245; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Syed A, 2014, J ALLERGY CLIN IMMUN, V133, P500, DOI 10.1016/j.jaci.2013.12.1037; Tamburini S, 2016, NAT MED, V22, P713, DOI 10.1038/nm.4142; Tan J, 2016, CELL REP, V15, P2809, DOI 10.1016/j.celrep.2016.05.047; Tanoue T, 2016, NAT REV IMMUNOL, V16, P295, DOI 10.1038/nri.2016.36; Theriot CM, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00045-15; Tordesillas L, 2017, IMMUNITY, V47, P32, DOI 10.1016/j.immuni.2017.07.004; Tordesillas L, 2017, J ALLERGY CLIN IMMUN, V139, P189, DOI 10.1016/j.jaci.2016.03.057; Tsai M, 2020, J ALLERGY CLIN IMMUN, V145, P885, DOI 10.1016/j.jaci.2019.10.038; van Nood E, 2013, NEW ENGL J MED, V368, P407, DOI 10.1056/NEJMoa1205037; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Veenbergen S, 2016, MUCOSAL IMMUNOL, V9, P894, DOI 10.1038/mi.2015.118; Venkatesh M, 2014, IMMUNITY, V41, P296, DOI 10.1016/j.immuni.2014.06.014; Vickery BP, 2018, NEW ENGL J MED, V379, P1991, DOI 10.1056/NEJMoa1812856; Vickery BP, 2014, J ALLERGY CLIN IMMUN, V133, P468, DOI 10.1016/j.jaci.2013.11.007; von Mutius E, 2000, CLIN EXP ALLERGY, V30, P1230; Vonk MM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01230; Wahlstrom A, 2016, CELL METAB, V24, P41, DOI 10.1016/j.cmet.2016.05.005; Wambre E, 2014, J ALLERGY CLIN IMMUN, V133, P872, DOI 10.1016/j.jaci.2013.10.054; Wang S, 2015, IMMUNITY, V43, P289, DOI 10.1016/j.immuni.2015.06.014; Willemsen LEM, 2003, GUT, V52, P1442, DOI 10.1136/gut.52.10.1442; Wold AE, 1998, ALLERGY, V53, P20, DOI 10.1111/j.1398-9995.1998.tb04953.x; Wrzosek L, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-61; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017	137	20	20	3	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 18	2020	53	2					277	289		10.1016/j.immuni.2020.07.025	http://dx.doi.org/10.1016/j.immuni.2020.07.025			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NC4NX	32814026	Green Accepted, Bronze			2022-12-18	WOS:000561190600009
J	Gaylo-Moynihan, A; Prizant, H; Popovic, M; Fernandes, NRJ; Anderson, CS; Chiou, KK; Bell, H; Schrock, DC; Schumacher, J; Capece, T; Walling, BL; Topham, DJ; Miller, J; Smrcka, AV; Kim, M; Hughson, A; Fowell, DJ				Gaylo-Moynihan, Alison; Prizant, Hen; Popovic, Milan; Fernandes, Ninoshka R. J.; Anderson, Christopher S.; Chiou, Kevin K.; Bell, Hannah; Schrock, Dillon C.; Schumacher, Justin; Capece, Tara; Walling, Brandon L.; Topham, David J.; Miller, Jim; Smrcka, Alan, V; Kim, Minsoo; Hughson, Angela; Fowell, Deborah J.			Programming of Distinct Chemokine-Dependent and -Independent Search Strategies for Th1 and Th2 Cells Optimizes Function at Inflamed Sites	IMMUNITY			English	Article							REGULATORY T-CELLS; LEISHMANIA-MAJOR; NEUTROPHIL CHEMOTAXIS; ANTIGEN PRESENTATION; LYMPHOCYTE MOTILITY; IMMUNE-RESPONSES; CUTTING EDGE; IN-VIVO; MIGRATION; EFFECTOR	T-helper (Th) cell differentiation drives specialized gene programs that dictate effector T cell function at sites of infection. Here, we have shown Th cell differentiation also imposes discrete motility gene programs that shape Th1 and Th2 cell navigation of the inflamed dermis. Th1 cells scanned a smaller tissue area in a G protein-coupled receptor (GPCR) and chemokine-dependent fashion, while Th2 cells scanned a larger tissue area independent of GPCR signals. Differential chemokine reliance for interstitial migration was linked to STAT6 transcription-factor-dependent programming of integrin alpha(v)beta(3) expression: Th2 cell differentiation led to high alpha(v)beta(3) expression relative to Th1 cells. Th1 and Th2 cell modes of motility could be switched simply by manipulating the amount of alpha(v)beta(3) on the cell surface. Deviating motility modes from those established during differentiation impaired effector function. Thus, programmed expression of alpha(v)beta(3) tunes effector T cell reliance on environmental cues for optimal exploration of inflamed tissues.	[Gaylo-Moynihan, Alison; Prizant, Hen; Popovic, Milan; Fernandes, Ninoshka R. J.; Anderson, Christopher S.; Bell, Hannah; Schrock, Dillon C.; Capece, Tara; Walling, Brandon L.; Topham, David J.; Miller, Jim; Kim, Minsoo; Hughson, Angela; Fowell, Deborah J.] Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Aab Inst Biomed Sci, Dept Microbiol & Immunol,Med Ctr, Rochester, NY 14642 USA; [Fernandes, Ninoshka R. J.; Schumacher, Justin] Univ Rochester, Dept Biomed Engn, Rochester, NY 14642 USA; [Smrcka, Alan, V] Univ Rochester, Med Ctr, Dept Pharmacol & Physiol, Rochester, NY 14642 USA; [Chiou, Kevin K.] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA	University of Rochester; University of Rochester; University of Rochester; University of Pennsylvania	Fowell, DJ (corresponding author), Univ Rochester, David H Smith Ctr Vaccine Biol & Immunol, Aab Inst Biomed Sci, Dept Microbiol & Immunol,Med Ctr, Rochester, NY 14642 USA.	deborah_fowell@urmc.rochester.edu	FERNANDES, NINOSHKA/AAC-1341-2022	FERNANDES, NINOSHKA/0000-0003-1386-0635; Capece, Tara/0000-0001-9282-0273; Schumacher, Justin/0000-0003-0395-7580	NIH/National Institute of Allergy and Infectious Diseases [P01 AI102851, R01 AI072690, F30 AI114036-03, F32 AI138415, T32 AI007285-28]; Charles E. Kaufman Foundation [KA2015-79179]; NSF [DMR-1506625]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI138415, P01AI102851, F30AI114036, R01AI072690, T32AI007285] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM127303] Funding Source: NIH RePORTER	NIH/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Charles E. Kaufman Foundation; NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Fowell lab for helpful discussions on the studies and Valeria Alberti for generation of retroviruses. Ronen Alon, Michael Elliott, and Tim Mosmann provided insightful comments on the manuscript. We thank S. Priore and D. Palframan for custom Perl scripts for image analysis. We gratefully acknowledge support from NIH/National Institute of Allergy and Infectious Diseases (P01 AI102851 and R01 AI072690 to D.J.F.; F30 AI114036-03 to A.G.; F32 AI138415 to H.P.; and T32 AI007285-28 to D.C.S.), Charles E. Kaufman Foundation (KA2015-79179 to K.K.C.), and NSF (DMR-1506625).	Aronin CEP, 2017, IMMUNITY, V47, P862, DOI 10.1016/j.immuni.2017.10.020; Bonacci TM, 2006, SCIENCE, V312, P443, DOI 10.1126/science.1120378; Bromley SK, 2008, NAT IMMUNOL, V9, P970, DOI 10.1038/ni.f.213; Bromley SK, 2000, J IMMUNOL, V165, P15, DOI 10.4049/jimmunol.165.1.15; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Christen U, 2003, J IMMUNOL, V171, P6838, DOI 10.4049/jimmunol.171.12.6838; Du F, 2016, CELL REP, V16, P1339, DOI 10.1016/j.celrep.2016.06.065; Egen JG, 2011, IMMUNITY, V34, P807, DOI 10.1016/j.immuni.2011.03.022; Filipe-Santos O, 2009, CELL HOST MICROBE, V6, P23, DOI 10.1016/j.chom.2009.04.014; Fowell DJ, 1997, IMMUNITY, V6, P559, DOI 10.1016/S1074-7613(00)80344-1; Gaylo A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00428; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gerard A, 2014, CELL, V158, P492, DOI 10.1016/j.cell.2014.05.044; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Hallmann R, 2015, CURR OPIN CELL BIOL, V36, P54, DOI 10.1016/j.ceb.2015.06.006; Harris TH, 2012, NATURE, V486, P545, DOI 10.1038/nature11098; Heit B, 2002, J CELL BIOL, V159, P91, DOI 10.1083/jcb.200202114; Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Horiuchi S, 2011, J IMMUNOL, V186, P6378, DOI 10.4049/jimmunol.1100179; Hu P, 2013, J CELL PHYSIOL, V228, P306, DOI 10.1002/jcp.24154; Islam SA, 2012, NAT MED, V18, P705, DOI 10.1038/nm.2760; Kanhere A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2260; Katakai T, 2002, J BIOL CHEM, V277, P50948, DOI 10.1074/jbc.M204133200; Khan IA, 2000, IMMUNITY, V12, P483, DOI 10.1016/S1074-7613(00)80200-9; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kim D, 2012, ANAL CHEM, V84, P6070, DOI 10.1021/ac3009548; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Krummel MF, 2016, NAT REV IMMUNOL, V16, P193, DOI 10.1038/nri.2015.16; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Lammermann T, 2014, SEMIN IMMUNOPATHOL, V36, P227, DOI 10.1007/s00281-014-0418-8; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Leithner A, 2016, NAT CELL BIOL, V18, P1253, DOI 10.1038/ncb3426; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Masopust D, 2013, NAT REV IMMUNOL, V13, P309, DOI 10.1038/nri3442; Mathew A, 2002, J IMMUNOL, V169, P651, DOI 10.4049/jimmunol.169.2.651; McLachlan JB, 2009, IMMUNITY, V30, P277, DOI 10.1016/j.immuni.2008.11.013; Mikucki ME, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8458; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Muller AJ, 2012, IMMUNITY, V37, P147, DOI 10.1016/j.immuni.2012.05.015; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Overstreet MG, 2013, NAT IMMUNOL, V14, P949, DOI 10.1038/ni.2682; Paul WE, 2010, NAT REV IMMUNOL, V10, P225, DOI 10.1038/nri2735; Pease JE, 2011, BIOCHEM J, V434, P11, DOI 10.1042/BJ20101132; Rajagopal S, 2013, J BIOL CHEM, V288, P35039, DOI 10.1074/jbc.M113.479113; Rangel-Moreno J, 2016, ARTHRITIS RHEUMATOL, V68, P2244, DOI 10.1002/art.39673; Rosas LE, 2005, EUR J IMMUNOL, V35, P515, DOI 10.1002/eji.200425422; Sacks D, 2002, NAT REV IMMUNOL, V2, P845, DOI 10.1038/nri933; Sarris M, 2015, CURR OPIN CELL BIOL, V36, P93, DOI 10.1016/j.ceb.2015.08.001; Sarris M, 2012, CURR BIOL, V22, P2375, DOI 10.1016/j.cub.2012.11.018; Satoh JI, 2013, GENE REGUL SYST BIO, V7, P41, DOI 10.4137/GRSB.S11433; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Schulz O, 2016, ANNU REV IMMUNOL, V34, P203, DOI 10.1146/annurev-immunol-041015-055649; Scott P, 2016, NAT REV IMMUNOL, V16, P581, DOI 10.1038/nri.2016.72; Shakhar G, 2005, NAT IMMUNOL, V6, P707, DOI 10.1038/ni1210; Shulman Z, 2012, NAT IMMUNOL, V13, P67, DOI 10.1038/ni.2173; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Sojka DK, 2011, P NATL ACAD SCI USA, V108, P18336, DOI 10.1073/pnas.1110566108; Stetson DB, 2003, J EXP MED, V198, P1069, DOI 10.1084/jem.20030630; Stubbington MJT, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0045-x; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; te Boekhorst V, 2016, ANNU REV CELL DEV BI, V32, P491, DOI 10.1146/annurev-cellbio-111315-125201; Walch JM, 2013, J CLIN INVEST, V123, P2663, DOI 10.1172/JCI66722; Wang Q, 2001, J IMMUNOL, V167, P4311, DOI 10.4049/jimmunol.167.8.4311; Wei G, 2011, IMMUNITY, V35, P299, DOI 10.1016/j.immuni.2011.08.007; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Wynn TA, 2015, NAT REV IMMUNOL, V15, P271, DOI 10.1038/nri3831	71	20	21	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					298	+		10.1016/j.immuni.2019.06.026	http://dx.doi.org/10.1016/j.immuni.2019.06.026			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31399281	Bronze, Green Accepted			2022-12-18	WOS:000482088500013
J	Boulais, PE; Mizoguchi, T; Zimmerman, S; Nakahara, F; Vivie, J; Mar, JC; van Oudenaarden, A; Frenette, PS				Boulais, Philip E.; Mizoguchi, Toshihide; Zimmerman, Samuel; Nakahara, Fumio; Vivie, Judith; Mar, Jessica C.; van Oudenaarden, Alexander; Frenette, Paul S.			The Majority of CD45(-) Ter119(-) CD31(-) Bone Marrow Cell Fraction Is of Hematopoietic Origin and Contains Erythroid and Lymphoid Progenitors	IMMUNITY			English	Article							MESENCHYMAL STEM-CELLS; B-CELL; TRANSCRIPTOME ANALYSES; MOUSE MODEL; DIFFERENTIATION; NICHES; MARKS; MICE; ERYTHROPOIESIS; SPECIFICATION	The non-hematopoietic cell fraction of the bone marrow (BM) is classically identified as CD45(-) Ter119(-) CD31(-) (herein referred to as triple-negative cells or TNCs). Although TNCs are believed to contain heterogeneous stromal cell populations, they remain poorly defined. Here we showed that the vast majority of TNCs (-85%) have a hematopoietic rather than mesenchymal origin. Single cell RNA-sequencing revealed erythroid and lymphoid progenitor signatures among CD51(-) TNCs. Ly6D(+) CD44(+) CD51(-) TNCs phenotypically and functionally resembled CD45(+) pro-B lymphoid cells, whereas Ly6D(-) CD44(+) CD51(-) TNCs were enriched in previously unappreciated stromal-dependent erythroid progenitors hierarchically situated between preCFU-E and proery-throblasts. Upon adoptive transfer, CD44(+) CD51(-) TNCs contributed to repopulate the B-lymphoid and erythroid compartments. CD44(+) CD51(-) TNCs also expanded during phenylhydrazine-induced acute hemolysis or in a model of sickle cell anemia. These findings thus uncover physiologically relevant new classes of stromal-associated functional CD45(-) hematopoietic progenitors.	[Boulais, Philip E.; Nakahara, Fumio; Frenette, Paul S.] Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA; [Frenette, Paul S.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Boulais, Philip E.; Zimmerman, Samuel; Nakahara, Fumio; Mar, Jessica C.; Frenette, Paul S.] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA; [Mizoguchi, Toshihide] Matsumoto Dent Univ, Inst Oral Sci, Nagano 3990781, Japan; [Zimmerman, Samuel; Mar, Jessica C.] Albert Einstein Coll Med, Dept Syst & Computat Biol, Bronx, NY 10461 USA; [Vivie, Judith; van Oudenaarden, Alexander] KNAW Royal Netherlands Acad Arts & Sci, Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Vivie, Judith; van Oudenaarden, Alexander] Univ Med Ctr Utrecht, Canc Genom Netherlands, NL-3584 CT Utrecht, Netherlands; [Mar, Jessica C.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Mar, Jessica C.] Univ Queensland, Australian Inst Bioengn & Nanotechnol, Brisbane, Qld 4072, Australia; [Mizoguchi, Toshihide] Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo 1010061, Japan	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Matsumoto Dental University; Yeshiva University; Albert Einstein College of Medicine; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Queensland; Tokyo Dental College	Frenette, PS (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, Bronx, NY 10461 USA.; Frenette, PS (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA.; Frenette, PS (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell & Regen, Bronx, NY 10461 USA.	paul.frenette@einstein.yu.edu	van Oudenaarden, Alexander/AAA-1705-2019; Frenette, Paul S/J-8272-2012	Frenette, Paul S/0000-0003-0862-9922; Nakahara, Fumio/0000-0003-1515-8284; Mar, Jessica/0000-0002-5147-9299	NIH [DK056638, HL069438, DK112976, DK116312, HL097819]; New York State Department of Health (NYSTEM Program) [N13G-262]; Leukemia and Lymphoma Society's Translational Research Program [LLS-TRP 6475-15]; NCI cancer center [P30CA013330]; Fonds de recherche du Quebec-Sante (FRQS); Japan Society for the Promotion of Science; NYSTEM [C029154]; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097819, R01HL069438] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK112976, U01DK116312, R01DK056638] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New York State Department of Health (NYSTEM Program); Leukemia and Lymphoma Society's Translational Research Program(Leukemia and Lymphoma Society); NCI cancer center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Fonds de recherche du Quebec-Sante (FRQS); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NYSTEM; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are grateful to C. Prophete, P. Ciero, C. Cruz, and L. Tesfa from the Flow Cytometry Core Facility and P. Guo from the Analytical Imaging Facility for their technical assistance; S. Pinho and Q. Wei for helpful scientific discussions; and D. Sun from Human Stem Cell FACS and Xenotransplantation Facility for cell sorting assistance. This work was supported by grants from the NIH (DK056638, HL069438, DK112976, DK116312, and HL097819 to P.S.F.). We are also grateful to the New York State Department of Health (NYSTEM Program) for shared facility (C029154) and research support (N13G-262) and the Leukemia and Lymphoma Society's Translational Research Program (LLS-TRP 6475-15). The Analytical Imaging Facility is supported by a grant from NCI cancer center (P30CA013330). P.E.B is supported by a postdoctoral fellowship from Fonds de recherche du Quebec-Sante (FRQS). F.N. is supported by a Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science. J.C.M and S.Z are supported by NYSTEM C029154.	An XL, 2014, BLOOD, V123, P3466, DOI 10.1182/blood-2014-01-548305; Asada N, 2017, NAT CELL BIOL, V19, P214, DOI 10.1038/ncb3475; Chan CKF, 2015, CELL, V160, P285, DOI 10.1016/j.cell.2014.12.002; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Chen K, 2009, P NATL ACAD SCI USA, V106, P17413, DOI 10.1073/pnas.0909296106; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Ding L, 2012, NATURE, V481, P457, DOI 10.1038/nature10783; Gomes AC, 2016, IMMUNITY, V45, P1219, DOI 10.1016/j.immuni.2016.11.004; Grun D, 2016, CELL STEM CELL, V19, P266, DOI 10.1016/j.stem.2016.05.010; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Hashimshony T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0938-8; Hattangadi SM, 2011, BLOOD, V118, P6258, DOI 10.1182/blood-2011-07-356006; Heinrich AC, 2004, BLOOD, V104, P659, DOI 10.1182/blood-2003-05-1442; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Joshi I, 2014, NAT IMMUNOL, V15, P294, DOI 10.1038/ni.2821; Kina T, 2000, BRIT J HAEMATOL, V109, P280, DOI 10.1046/j.1365-2141.2000.02037.x; Kunisaki Y, 2013, NATURE, V502, P637, DOI 10.1038/nature12612; Li J, 2014, BLOOD, V124, P3636, DOI 10.1182/blood-2014-07-588806; Liu J, 2013, BLOOD, V121, pE43, DOI 10.1182/blood-2012-09-456079; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mizoguchi T, 2014, DEV CELL, V29, P340, DOI 10.1016/j.devcel.2014.03.013; Montecino-Rodriguez E, 2006, NAT PROTOC, V1, P1140, DOI 10.1038/nprot.2006.163; Morikawa S, 2009, J EXP MED, V206, P2483, DOI 10.1084/jem.20091046; Muraro MJ, 2016, CELL SYST, V3, P385, DOI 10.1016/j.cels.2016.09.002; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Paszty C, 1997, SCIENCE, V278, P876, DOI 10.1126/science.278.5339.876; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Rolink AG, 2000, J EXP MED, V191, P23, DOI 10.1084/jem.191.1.23; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Schaefer BC, 2001, CELL IMMUNOL, V214, P110, DOI 10.1006/cimm.2001.1895; Schepers K, 2012, BLOOD, V120, P3425, DOI 10.1182/blood-2011-11-395418; Shivtiel S, 2008, J EXP MED, V205, P2381, DOI 10.1084/jem.20080072; Shivtiel S, 2011, EXP HEMATOL, V39, P1161, DOI 10.1016/j.exphem.2011.08.012; Short Brenton J., 2009, V482, P259, DOI 10.1007/978-1-59745-060-7_16; SIMMONS PJ, 1987, NATURE, V328, P429, DOI 10.1038/328429a0; Socolovsky M, 2001, BLOOD, V98, P3261, DOI 10.1182/blood.V98.12.3261; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; TROWBRIDGE IS, 1994, ANNU REV IMMUNOL, V12, P85, DOI 10.1146/annurev.iy.12.040194.000505; Worthley DL, 2015, CELL, V160, P269, DOI 10.1016/j.cell.2014.11.042; Zhou BO, 2014, CELL STEM CELL, V15, P154, DOI 10.1016/j.stem.2014.06.008	49	20	20	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 16	2018	49	4					627	+		10.1016/j.immuni.2018.08.019	http://dx.doi.org/10.1016/j.immuni.2018.08.019			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX0FW	30314756	Bronze, Green Accepted			2022-12-18	WOS:000447386700010
J	Ols, ML; Cullen, JL; Turqueti-Neves, A; Giles, J; Shlomchik, MJ				Ols, Michelle L.; Cullen, Jaime L.; Turqueti-Neves, Adriana; Giles, Josephine; Shlomchik, Mark J.			Dendritic Cells Regulate Extrafollicular Autoreactive B Cells via T Cells Expressing Fas and Fas Ligand	IMMUNITY			English	Article							SHORT-LIVED PLASMABLASTS; GERMINAL-CENTERS; SOMATIC HYPERMUTATION; ANTIBODY-RESPONSE; ANTIGEN; ACTIVATION; AUTOANTIBODY; LUPUS; MOUSE; HELPER	The extrafollicular (EF) plasmablast response to self-antigens that contain Toll-like receptor (TLR) ligands is prominent in murine lupus models and some bacterial infections, but the inhibitors and activators involved have not been fully delineated. Here, we used two conventional dendritic cell (cDC) depletion systems to investigate the role of cDCs on a classical TLR-dependent autoreactive EF response elicited in rheumatoid-factor B cells by DNA-containing immune complexes. Contrary to our hypothesis, cDC depletion amplified rather than dampened the EF response in Fas-intact but not Fas-deficient mice. Further, we demonstrated that cDC-dependent regulation requires Fas and Fas ligand (FasL) expression by T cells, but not Fas expression by B cells. Thus, cDCs activate FasL-expressing T cells that regulate Fas-expressing extrafollicular helper T (Tefh) cells. These studies reveal a regulatory role for cDCs in B cell plasmablast responses and provide a mechanistic explanation for the excess autoantibody production observed in Fas deficiency.	[Ols, Michelle L.; Cullen, Jaime L.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06519 USA; [Giles, Josephine] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06519 USA; [Turqueti-Neves, Adriana; Giles, Josephine; Shlomchik, Mark J.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA	Yale University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shlomchik, MJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA.	mshlomch@pitt.edu	Shlomchik, Mark J./AAN-6189-2020	Shlomchik, Mark J./0000-0002-2152-0959	NIH [AI073722, AR044077]; Ruth L. Kirschstein National Research Service Award NIH [T32 AI07019-30]; Arthritis Foundation Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR023431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073722, T32AI007019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR053495, R01AR044077] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service Award NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Dr. Juan Martinez-Barbera and Boris Reizis for Rosa26-eGFP-flox-stop-DTA and Itgax-cre mice, respectively. We thank Dr. Thomas Ferguson for providing BALB/c.Faslpr mice. Cuiling Zhang, Yuqi Zhang, and Colin Smith provided outstanding technical assistance. Kevin Nickerson assisted in our experimental response to the reviewers. We thank the Yale Animal Resources Center and the Yale Cell Sorter Facility for their excellent services. This work was supported by NIH grants AI073722 and AR044077 (to M.J.S.), a Ruth L. Kirschstein National Research Service Award NIH T32 AI07019-30 (to M.L.O.), and an Arthritis Foundation Postdoctoral Fellowship (to M.L.O.).	Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Birnberg T, 2008, IMMUNITY, V29, P986, DOI 10.1016/j.immuni.2008.10.012; Boule MW, 2004, J EXP MED, V199, P1631, DOI 10.1084/jem.20031942; Butt D, 2015, IMMUNITY, V42, P890, DOI 10.1016/j.immuni.2015.04.010; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; Daridon C, 2012, BLOOD, V120, P5021, DOI 10.1182/blood-2012-04-424648; Di Niro R, 2015, IMMUNITY, V43, P120, DOI 10.1016/j.immuni.2015.06.013; Do RKG, 2000, J EXP MED, V192, P953, DOI 10.1084/jem.192.7.953; Eckl-Dorna J, 2009, BLOOD, V113, P3969, DOI 10.1182/blood-2008-10-185421; Gilbert MR, 2007, J IMMUNOL, V178, P4803, DOI 10.4049/jimmunol.178.8.4803; Giltiay NV, 2013, J IMMUNOL, V191, P2155, DOI 10.4049/jimmunol.1300152; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Gregory MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017659; Hannum LG, 1996, J EXP MED, V184, P1269, DOI 10.1084/jem.184.4.1269; Hao ZY, 2008, IMMUNITY, V29, P615, DOI 10.1016/j.immuni.2008.07.016; Hebel K, 2006, EUR J IMMUNOL, V36, P2912, DOI 10.1002/eji.200636356; Herlands RA, 2008, IMMUNITY, V29, P249, DOI 10.1016/j.immuni.2008.06.009; Herlands RA, 2007, EUR J IMMUNOL, V37, P3339, DOI 10.1002/eji.200737752; Hoyer BF, 2004, J EXP MED, V199, P1577, DOI 10.1084/jem.20040168; Ivanova A, 2005, GENESIS, V43, P129, DOI 10.1002/gene.20162; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; LOSMAN MJ, 1992, J IMMUNOL, V148, P1561; Lu LN, 1997, J IMMUNOL, V158, P5676; Mabrouk I, 2008, IMMUNITY, V29, P922, DOI 10.1016/j.immuni.2008.10.007; MacLennan ICM, 2003, IMMUNOL REV, V194, P8, DOI 10.1034/j.1600-065X.2003.00058.x; Mohr E, 2009, J IMMUNOL, V182, P2113, DOI 10.4049/jimmunol.0802771; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Rasheed AU, 2006, EUR J IMMUNOL, V36, P1892, DOI 10.1002/eji.200636136; RATHMELL JC, 1995, NATURE, V376, P181, DOI 10.1038/376181a0; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; ROTHSTEIN TL, 1995, NATURE, V374, P163, DOI 10.1038/374163a0; Sage PT, 2015, TRENDS IMMUNOL, V36, P410, DOI 10.1016/j.it.2015.05.005; Sang A, 2014, J IMMUNOL, V193, P1609, DOI 10.4049/jimmunol.1303000; Santos L, 2008, J IMMUNOL, V180, P4561, DOI 10.4049/jimmunol.180.7.4561; Seo SJ, 2002, IMMUNITY, V16, P535, DOI 10.1016/S1074-7613(02)00298-4; Shlomchik MJ, 2009, CURR OPIN IMMUNOL, V21, P626, DOI 10.1016/j.coi.2009.08.005; Sindhava VJ, 2012, J IMMUNOL, V189, P3355, DOI 10.4049/jimmunol.1101352; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Suss G, 1996, J EXP MED, V183, P1789, DOI 10.1084/jem.183.4.1789; Sweet RA, 2011, P NATL ACAD SCI USA, V108, P7932, DOI 10.1073/pnas.1018571108; Sweet RA, 2010, AUTOIMMUNITY, V43, P607, DOI 10.3109/08916930903567500; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Teichmann LL, 2015, IMMUNITY, V42, P552, DOI 10.1016/j.immuni.2015.02.015; Teichmann LL, 2010, IMMUNITY, V33, P967, DOI 10.1016/j.immuni.2010.11.025; Tipton CM, 2015, NAT IMMUNOL, V16, P755, DOI 10.1038/ni.3175; Ursini-Siegel J, 2002, J IMMUNOL, V169, P5505, DOI 10.4049/jimmunol.169.10.5505; vanParijs L, 1996, CURR OPIN IMMUNOL, V8, P355, DOI 10.1016/S0952-7915(96)80125-7; Wang HW, 1999, J EXP MED, V190, P639, DOI 10.1084/jem.190.5.639; William J, 2005, J IMMUNOL, V174, P6879, DOI 10.4049/jimmunol.174.11.6879; William J, 2005, J IMMUNOL, V174, P6872, DOI 10.4049/jimmunol.174.11.6872; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Zelenay S, 2012, J CLIN INVEST, V122, P1615, DOI 10.1172/JCI60644	60	20	21	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					1052	1065		10.1016/j.immuni.2016.10.005	http://dx.doi.org/10.1016/j.immuni.2016.10.005			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27793595	Green Accepted, Bronze			2022-12-18	WOS:000389473500016
J	Knudsen, NH; Lee, CH				Knudsen, Nelson H.; Lee, Chih-Hao			Identity Crisis: CD301b(+) Mononuclear Phagocytes Blur the M1-M2 Macrophage Line	IMMUNITY			English	Editorial Material							ADIPOSE-TISSUE MACROPHAGES; INSULIN-RESISTANCE; OBESITY; INFLAMMATION; HOMEOSTASIS; MICE	Obesity shifts the immune phenotype from M2 macrophage polarization to M1, which causes metabolic dysfunction. In this issue of Immunity, Kumamoto et al. (2016) identify a tissue-resident mononuclear phagocyte population that promotes weight gain and glucose intolerance but are defined by the M2 marker CD301b.	[Knudsen, Nelson H.; Lee, Chih-Hao] Harvard TH Chan Sch Publ Hlth, Div Biol Sci, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Lee, CH (corresponding author), Harvard TH Chan Sch Publ Hlth, Div Biol Sci, Dept Genet & Complex Dis, 665 Huntington Ave, Boston, MA 02115 USA.	clee@hsph.harvard.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES016645] Funding Source: NIH RePORTER; NIEHS NIH HHS [T32 ES016645] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Cho KW, 2014, CELL REP, V9, P605, DOI 10.1016/j.celrep.2014.09.004; Kuipers F, 2014, NAT REV ENDOCRINOL, V10, P488, DOI 10.1038/nrendo.2014.60; Kumamoto Y, 2016, IMMUNITY, V45, P583, DOI 10.1016/j.immuni.2016.08.002; Lee MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5410; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Shaul ME, 2010, DIABETES, V59, P1171, DOI 10.2337/db09-1402; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Westcott DJ, 2009, J EXP MED, V206, P3143, DOI 10.1084/jem.20091333; Zeyda M, 2007, INT J OBESITY, V31, P1420, DOI 10.1038/sj.ijo.0803632	10	20	20	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 20	2016	45	3					461	463		10.1016/j.immuni.2016.09.004	http://dx.doi.org/10.1016/j.immuni.2016.09.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC9HD	27653596	Bronze			2022-12-18	WOS:000388454300003
J	Nabekura, T; Lanier, LL				Nabekura, Tsukasa; Lanier, Lewis L.			Activating Receptors for Self-MHC Class I Enhance Effector Functions and Memory Differentiation of NK Cells during Mouse Cytomegalovirus Infection	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; RECOGNITION; EDUCATION; TOLERANCE; MOLECULES; RESPONSES; ANTIGEN; LIGAND; TRANSPLANTATION; STIMULATION	Natural killer (NK) cells are important in host defense against pathogens, and they can subsequently differentiate into memory NK cells. The Ly49 and KIR gene families in rodents and humans encode both inhibitory and activating receptors for MHC class I. The physiological role of activating KIR or Ly49 receptors that recognize self-MHC class I during immune response to viral infections is unknown. Here, we address how the activating Ly49D receptor impacts the NK cell response to mouse cytomegalovirus (MCMV) infection by comparing the activation and differentiation of Ly49D-bearing NK cells in mice lacking or expressing H-2D(d), the cognate MHC class I ligand of Ly49D. After MCMV infection, Ly49D augmented IFN-gamma production by MCMV-specific Ly49H(+) NK cells and preferentially promoted the generation of memory Ly49H(+) NK cells. Thus, activating receptors for self-MHC class I modulate the differentiation of MCMV-specific NK cells and are beneficial for host defense against MCMV infection.	[Nabekura, Tsukasa; Lanier, Lewis L.] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Nabekura, Tsukasa; Lanier, Lewis L.] Univ Calif San Francisco, Parker Inst Canc Immunotherapy, San Francisco, CA 94143 USA; [Nabekura, Tsukasa] Univ Tsukuba, Tsukuba Adv Res Alliance, Life Sci Ctr, Ibaraki 3058577, Japan	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Tsukuba	Lanier, LL (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.; Lanier, LL (corresponding author), Univ Calif San Francisco, Parker Inst Canc Immunotherapy, San Francisco, CA 94143 USA.	lewis.lanier@ucsf.edu	Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952	NIH [AI068129]; Leukemia Research Fund; Nakajima Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia Research Fund; Nakajima Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the L.L.L. laboratory for comments and discussions. The work was supported by NIH grant AI068129. L.L.L. is an American Cancer Society Professor, and the Friends of Leukemia Research Fund and the Nakajima Foundation support T.N.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Barao I, 2011, BLOOD, V117, P7032, DOI 10.1182/blood-2010-11-316653; Behrendt CE, 2009, BIOL BLOOD MARROW TR, V15, P54, DOI 10.1016/j.bbmt.2008.10.023; Bessoles S, 2013, J IMMUNOL, V191, P5044, DOI 10.4049/jimmunol.1301971; Beziat V, 2013, BLOOD, V121, P2678, DOI 10.1182/blood-2012-10-459545; Brune W, 2001, CURRENT PROTOCOLS IM; Chalifour A, 2009, IMMUNITY, V30, P337, DOI 10.1016/j.immuni.2008.12.019; Chewning JH, 2007, J IMMUNOL, V179, P854, DOI 10.4049/jimmunol.179.2.854; COLONNA M, 1993, SCIENCE, V260, P1121, DOI 10.1126/science.8493555; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Elmaagacli AH, 2011, BLOOD, V118, P1402, DOI 10.1182/blood-2010-08-304121; Fauriat C, 2010, BLOOD, V115, P1166, DOI 10.1182/blood-2009-09-245746; Fodil-Cornu N, 2008, J IMMUNOL, V181, P6394, DOI 10.4049/jimmunol.181.9.6394; Foley B, 2012, J IMMUNOL, V189, P5082, DOI 10.4049/jimmunol.1201964; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; George TC, 1999, J IMMUNOL, V163, P1859; George TC, 1999, J IMMUNOL, V162, P2035; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Kamimura Y, 2014, J VIROL METHODS, V205, P53, DOI 10.1016/j.jviromet.2014.03.029; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; Krug A, 2004, IMMUNITY, V21, P107, DOI 10.1016/j.immuni.2004.06.007; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Min-Oo G, 2013, TRENDS IMMUNOL, V34, P251, DOI 10.1016/j.it.2013.02.005; Nabekura T, 2014, J EXP MED, V211, P2455, DOI 10.1084/jem.20140798; Nabekura T, 2014, IMMUNITY, V40, P225, DOI 10.1016/j.immuni.2013.12.011; O'Leary JG, 2006, NAT IMMUNOL, V7, P507, DOI 10.1038/ni1332; Orr MT, 2010, NAT IMMUNOL, V11, P321, DOI 10.1038/ni.1849; Parham P, 2013, NAT REV IMMUNOL, V13, P133, DOI 10.1038/nri3370; Paust S, 2010, NAT IMMUNOL, V11, P1127, DOI 10.1038/ni.1953; Pittari G, 2013, J IMMUNOL, V190, P4650, DOI 10.4049/jimmunol.1202120; Schenkel AR, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00090; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Sun JC, 2010, IMMUNOL REV, V236, P83, DOI 10.1111/j.1600-065X.2010.00900.x; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Sun JC, 2008, J IMMUNOL, V181, P7453, DOI 10.4049/jimmunol.181.11.7453; TAY CH, 1995, J IMMUNOL, V154, P780; Xiong S, 2013, J CLIN INVEST, V123, P4264, DOI 10.1172/JCI68991	39	20	23	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 19	2016	45	1					74	82		10.1016/j.immuni.2016.06.024	http://dx.doi.org/10.1016/j.immuni.2016.06.024			9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS4KC	27438766	Green Published, Green Accepted, Bronze			2022-12-18	WOS:000380749000011
J	Chatila, TA; Williams, CB				Chatila, Talal A.; Williams, Calvin B.			Regulatory T Cells: Exosomes Deliver Tolerance	IMMUNITY			English	Editorial Material							EXTRACELLULAR VESICLES; RESPONSES	T regulatory (Treg) cells enforce peripheral tolerance through regulation of diverse immune responses in a context-specific manner. Okoye et al. show one way that Treg cells suppress Th1 cell responses is through nonautonomous gene silencing mediated by microRNA-containing exosomes.	[Chatila, Talal A.] Childrens Hosp, Div Immunol, Boston, MA 02115 USA; [Chatila, Talal A.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Williams, Calvin B.] Med Coll Wisconsin, Rheumatol Sect, Dept Pediat, Milwaukee, WI 53226 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Medical College of Wisconsin	Chatila, TA (corresponding author), Childrens Hosp, Div Immunol, 300 Longwood Ave, Boston, MA 02115 USA.	talal.chatila@childrens.harvard.edu		Chatila, Talal/0000-0001-7439-2762; Williams, Calvin/0000-0002-5492-8475	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI085090] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI085090, R01AI085090] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Koch MA, 2012, IMMUNITY, V37, P501, DOI 10.1016/j.immuni.2012.05.031; Liston A, 2008, J EXP MED, V205, P1993, DOI 10.1084/jem.20081062; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Okoye IS, 2014, IMMUNITY, V41, P89, DOI [10.1016/j.immuni.2014.05.019, 10.1016/j.immuni.2014.08.008]; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Robbins PD, 2014, NAT REV IMMUNOL, V14, P195, DOI 10.1038/nri3622; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	10	20	24	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					3	5		10.1016/j.immuni.2014.07.001	http://dx.doi.org/10.1016/j.immuni.2014.07.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25035945	Bronze, Green Accepted			2022-12-18	WOS:000341444200002
J	Lee, JS; Cua, DJ				Lee, Jacob S.; Cua, Daniel J.			The Emerging Landscape of ROR gamma t Biology	IMMUNITY			English	Editorial Material							DIFFERENTIATION; CELLS	The transcription factor retinoid-related orphan receptor gamma t (ROR gamma t) has emerged as an exciting target for inflammatory diseases. Xiao et al. (2014) show that a new class of ROR gamma t antagonists can inhibit the inflammatory function of T helper 17 cells without altering ROR gamma t occupancy on its target genes.	[Lee, Jacob S.; Cua, Daniel J.] Merck Res Labs, Palo Alto, CA 94304 USA	Merck & Company	Cua, DJ (corresponding author), Merck Res Labs, Palo Alto, CA 94304 USA.	daniel.cua@merck.com						Huh JR, 2012, EUR J IMMUNOL, V42, P2232, DOI 10.1002/eji.201242740; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Patel DD, 2013, ANN RHEUM DIS, V72, P116, DOI 10.1136/annrheumdis-2012-202371; Sandborn WJ, 2012, NEW ENGL J MED, V367, P1519, DOI 10.1056/NEJMoa1203572; Skepner J, 2014, J IMMUNOL, V192, P2564, DOI 10.4049/jimmunol.1302190; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Xu T, 2011, J BIOL CHEM, V286, P22707, DOI 10.1074/jbc.C111.250407	9	20	23	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					451	452		10.1016/j.immuni.2014.04.005	http://dx.doi.org/10.1016/j.immuni.2014.04.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24745326	Bronze			2022-12-18	WOS:000334849400001
J	Jobin, C				Jobin, Christian			GPR109a: The Missing Link between Microbiome and Good Health?	IMMUNITY			English	Editorial Material							CHAIN FATTY-ACIDS; INFLAMMATORY RESPONSES; GUT MICROBIOTA; COMMENSAL; METABOLITES; BUTYRATE; RECEPTOR		Univ Florida, Dept Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Jobin, C (corresponding author), Univ Florida, Dept Med, Dept Infect Dis & Pathol, Gainesville, FL 32611 USA.	christian.jobin@medicine.ufl.edu			NIDDK NIH HHS [R01 DK073338, R01 DK047700] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047700, R01DK073338] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Guzman JR, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/425146; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kim MH, 2013, GASTROENTEROLOGY, V145, P396, DOI 10.1053/j.gastro.2013.04.056; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165	11	20	21	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					8	10		10.1016/j.immuni.2013.12.009	http://dx.doi.org/10.1016/j.immuni.2013.12.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24439263	Bronze, Green Accepted			2022-12-18	WOS:000331476900004
J	Serbina, NV; Pamer, EG				Serbina, Natalya V.; Pamer, Eric G.			Coordinating Innate Immune Cells to Optimize Microbial Killing	IMMUNITY			English	Editorial Material							LISTERIA-MONOCYTOGENES INFECTION; DENDRITIC CELLS; ACTIVATION; RESPONSES; SPLEEN; ENTRY	The mechanisms underlying innate immune cell trafficking and activation during infection remain incompletely defined. In this issue of Immunity, Kang et al. (2008) begin to reveal the cytokine and chemokine cascades that coordinate cellular responses induced by microbial pathogens.	[Serbina, Natalya V.; Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, Program Immunol,Sloan Kattering Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Pamer, EG (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, Infect Dis Serv, Program Immunol,Sloan Kattering Inst, 1275 York Ave, New York, NY 10021 USA.	pamere@mskcc.org			NATIONAL CANCER INSTITUTE [P01CA023766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080619, R37AI039031] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA023766, P01 CA023766-320044] Funding Source: Medline; NIAID NIH HHS [R01 AI080619, R37 AI039031, R37 AI039031-16] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Conlan JW, 1996, J MED MICROBIOL, V44, P295, DOI 10.1099/00222615-44-4-295; Gerard C, 2001, NAT IMMUNOL, V2, P108, DOI 10.1038/84209; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Lowes MA, 2005, P NATL ACAD SCI USA, V102, P19057, DOI 10.1073/pnas.0509736102; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Serbina NV, 2003, IMMUNITY, V19, P891, DOI 10.1016/S1074-7613(03)00330-3	10	20	20	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2008	29	5					672	674		10.1016/j.immuni.2008.10.003	http://dx.doi.org/10.1016/j.immuni.2008.10.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	19006691	Green Accepted, Bronze			2022-12-18	WOS:000261036000005
J	Niiro, H; Clark, EA				Niiro, H; Clark, EA			Branches of the B cell antigen receptor pathway are directed by protein conduits Bam32 and Carma1	IMMUNITY			English	Review							NF-KAPPA-B; ADAPTER PROTEIN; INDUCED ACTIVATION; LYMPHOCYTE; PROLIFERATION; SURVIVAL; MEKK1; REGULATOR; RESPONSES; CARD11	Adaptor proteins act as conduits to channel upstream signals into downstream effector branches. Two. B cell-associated adaptors, Bam32 and Carma1, regulate the ERK, JNK, and NF-kappaB branches of the BCR signaling pathway. Recent studies of Bam32(-/-) and Carma1(-/-) mice suggest that each adaptor controls a distinct conduit regulating either only proliferation (Bam32) or both the proliferation and survival of B cells (Carma1).	Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Clark, EA (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98195 USA.		Clark, Edward/K-3462-2012	Clark, Edward A/0000-0001-8061-5475	NIAID NIH HHS [AI45088, AI44250] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044250, R01AI045088] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abbas AK, 2003, IMMUNITY, V18, P721, DOI 10.1016/S1074-7613(03)00143-2; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Brummer T, 2002, EMBO J, V21, P5611, DOI 10.1093/emboj/cdf588; Cuevas BD, 2003, EMBO J, V22, P3346, DOI 10.1093/emboj/cdg322; Dowler S, 1999, BIOCHEM J, V342, P7, DOI 10.1042/0264-6021:3420007; Egawa T, 2003, CURR BIOL, V13, P1252, DOI 10.1016/S0960-9822(03)00491-3; Fournier E, 2003, CURR BIOL, V13, P1858, DOI 10.1016/j.cub.2003.09.034; GRAVES JD, 2003, IN PRESS IMMUNOL REV; Han A, 2003, IMMUNITY, V19, P621, DOI 10.1016/S1074-7613(03)00275-9; Hara H, 2003, IMMUNITY, V18, P763, DOI 10.1016/S1074-7613(03)00148-1; Jumaa H, 1999, IMMUNITY, V11, P547, DOI 10.1016/S1074-7613(00)80130-2; Jun JE, 2003, IMMUNITY, V18, P751, DOI 10.1016/S1074-7613(03)00141-9; Kwan R, 2001, MOL CELL BIOL, V21, P7183, DOI 10.1128/MCB.21.21.7183-7190.2001; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Liou J, 2000, IMMUNITY, V12, P399, DOI 10.1016/S1074-7613(00)80192-2; Marshall AJ, 2000, J EXP MED, V191, P1319, DOI 10.1084/jem.191.8.1319; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Newton K, 2003, CURR BIOL, V13, P1247, DOI 10.1016/S0960-9822(03)00458-5; Niiro H, 2002, J EXP MED, V195, P143, DOI 10.1084/jem.20011524; Niiro H, 2002, NAT REV IMMUNOL, V2, P945, DOI 10.1038/nri955; Rao VR, 1999, J BIOL CHEM, V274, P37893, DOI 10.1074/jbc.274.53.37893; Ruland J, 2001, CELL, V104, P33, DOI 10.1016/S0092-8674(01)00189-1; Solvason N, 2000, INT IMMUNOL, V12, P631, DOI 10.1093/intimm/12.5.631; Tan JEL, 2001, J BIOL CHEM, V276, P20055, DOI 10.1074/jbc.M010800200; Tsuji S, 2001, J EXP MED, V194, P529, DOI 10.1084/jem.194.4.529; Yujiri T, 1998, SCIENCE, V282, P1911, DOI 10.1126/science.282.5395.1911	27	20	23	0	2	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2003	19	5					637	640		10.1016/S1074-7613(03)00303-0	http://dx.doi.org/10.1016/S1074-7613(03)00303-0			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	745CY	14614850	Bronze			2022-12-18	WOS:000186672200003
J	Maillard, I; He, YP; Pear, WS				Maillard, I; He, YP; Pear, WS			From the yolk sac to the spleen: New roles for notch in regulating hematopoiesis	IMMUNITY			English	Review							MARGINAL ZONE; LINEAGE; CELLS; MICE	Although Notch receptors are widely expressed during hematopoiesis, their roles outside of the T cell lineage are not well characterized. Two reports in this issue of Immunity show that Notch1 and Notch2, respectively, are required to generate the earliest embryonic hematopoietic stem cells and splenic marginal zone B cells. Thus, different Notch receptors have specific and nonoverlapping functions that influence multiple hematopoietic lineages at various stages of development.	Univ Penn, Div Hematol Oncol, Philadelphia, PA 19104 USA; Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; Univ Penn, Inst Med & Engn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Pear, WS (corresponding author), Univ Penn, Div Hematol Oncol, 611 BRB 2-3,421 Curie Blvd, Philadelphia, PA 19104 USA.			Maillard, Ivan/0000-0003-1312-6748				Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Allman D, 2002, IMMUNOL REV, V187, P75, DOI 10.1034/j.1600-065X.2002.18707.x; Bash J, 1999, EMBO J, V18, P2803, DOI 10.1093/emboj/18.10.2803; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Izon DJ, 2002, IMMUNITY, V16, P231, DOI 10.1016/S1074-7613(02)00271-6; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kumano K, 2003, IMMUNITY, V18, P699, DOI 10.1016/S1074-7613(03)00117-1; Kunisato A, 2003, BLOOD, V101, P1777, DOI 10.1182/blood-2002-07-2051; Kuroda K, 2003, IMMUNITY, V18, P301, DOI 10.1016/S1074-7613(03)00029-3; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Ohishi K, 2003, SEMIN CELL DEV BIOL, V14, P143, DOI 10.1016/S1084-9521(02)00183-0; Orkin SH, 2002, NAT IMMUNOL, V3, P323, DOI 10.1038/ni0402-323; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; REYA T, 2003, IN PRESS NATURE; Saito T, 2003, IMMUNITY, V18, P675, DOI 10.1016/S1074-7613(03)00111-0; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Vinuesa CG, 2003, EUR J IMMUNOL, V33, P297, DOI 10.1002/immu.200310003	24	20	24	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2003	18	5					587	589		10.1016/S1074-7613(03)00119-5	http://dx.doi.org/10.1016/S1074-7613(03)00119-5			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680DZ	12753735	Bronze			2022-12-18	WOS:000182962200003
J	POIRIER, G; LO, D; REILLY, CR; KAYE, J				POIRIER, G; LO, D; REILLY, CR; KAYE, J			DISCRIMINATION BETWEEN THYMIC EPITHELIAL-CELLS AND PERIPHERAL ANTIGEN-PRESENTING CELLS IN THE INDUCTION OF IMMATURE T-CELL DIFFERENTIATION	IMMUNITY			English	Article							THYMOCYTE POSITIVE SELECTION; NEGATIVE SELECTION; IN-VIVO; RECEPTOR; ACTIVATION; EXPRESSION; LINE; SPECIFICITY; FIBROBLASTS; POPULATIONS	During their intrathymic migration, immature CD4(+) CD8(+) thymocytes that express a TCR able to recognize the expressed MHC molecules are positively selected, i.e., complete their differentiation program and become mature T cells. Using the immature CD4(+)CD8(+) T cell line DPK, which can be induced to differentiate in culture, we show here that a subset of isolated thymic epithelial cells, but not peripheral antigen-presenting cells, can induce differentiation, suggesting a unique function of these cells in T cell development. In addition, analysis of activation markers induced by thymic epithelial cells versus specific antigen gives the first direct evidence that positive selection is associated with low level cell activation. In contrast with strict affinity-avidity models of thymic selection, we propose that a specialized antigen-presenting cell environment is an essential contributor to TCR-mediated differentiation in the thymus.			POIRIER, G (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA.			Kaye, Jonathan/0000-0002-1634-9069	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI031231, R01AI031231, R01AI033219, R21AI031583, R01AI031583] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-33219, AI-31231, AI-31583] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADKINS B, 1988, IMMUNOGENETICS, V27, P180, DOI 10.1007/BF00346584; ASHTONRICKARDT PG, 1994, CELL, V76, P651, DOI 10.1016/0092-8674(94)90505-3; BENDELAC A, 1992, J EXP MED, V175, P731, DOI 10.1084/jem.175.3.731; BENOIST C, 1989, CELL, V58, P1027, DOI 10.1016/0092-8674(89)90501-1; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BEVAN MJ, 1978, IMMUNOL REV, V42, P3, DOI 10.1111/j.1600-065X.1978.tb00256.x; BIX M, 1992, NATURE, V359, P330, DOI 10.1038/359330a0; BONOMO A, 1993, J EXP MED, V177, P1153, DOI 10.1084/jem.177.4.1153; BOYER PD, 1988, J IMMUNOL, V140, P2886; BURKLY LC, 1993, J IMMUNOL, V151, P3954; CHAN SH, 1993, CELL, V73, P225, DOI 10.1016/0092-8674(93)90225-F; CRISPE IN, 1987, J IMMUNOL, V138, P2013; DEGERMANN S, 1994, J IMMUNOL, V152, P3254; FREEMAN GJ, 1993, SCIENCE, V262, P909, DOI 10.1126/science.7694363; FREEMAN GJ, 1991, J EXP MED, V174, P625, DOI 10.1084/jem.174.3.625; HATHCOCK KS, 1993, SCIENCE, V262, P905, DOI 10.1126/science.7694361; HAVRAN WL, 1987, NATURE, V330, P6144; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; HUGO P, 1993, P NATL ACAD SCI USA, V90, P10335, DOI 10.1073/pnas.90.21.10335; HUGO P, 1992, NATURE, V360, P679, DOI 10.1038/360679a0; JANEWAY C, 1980, SCAND J IMMUNOL, V12, P83, DOI 10.1111/j.1365-3083.1980.tb00044.x; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; KAYE J, 1992, CELL, V71, P423, DOI 10.1016/0092-8674(92)90512-B; KAYE J, 1992, J IMMUNOL, V148, P3342; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KUHLMAN P, 1991, J IMMUNOL, V146, P1773; LO D, 1986, NATURE, V319, P672, DOI 10.1038/319672a0; MULLER KP, 1993, EUR J IMMUNOL, V23, P1661, DOI 10.1002/eji.1830230740; NELSON AJ, 1993, J IMMUNOL, V151, P2453; PAWLOWSKI T, 1993, NATURE, V364, P642, DOI 10.1038/364642a0; SCHONRICH G, 1993, J IMMUNOL, V151, P4098; SEBZDA E, 1994, SCIENCE, V263, P1615, DOI 10.1126/science.8128249; SPEISER DE, 1989, J EXP MED, V170, P2165, DOI 10.1084/jem.170.6.2165; SPRENT J, 1989, FUNDAMENTAL IMMUNOLO, P69; SWAT W, 1993, EUR J IMMUNOL, V23, P739, DOI 10.1002/eji.1830230326; VUKMANOVIC S, 1992, NATURE, V359, P729, DOI 10.1038/359729a0; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	37	20	20	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	AUG	1994	1	5					385	391		10.1016/1074-7613(94)90069-8	http://dx.doi.org/10.1016/1074-7613(94)90069-8			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PK168	7882169				2022-12-18	WOS:A1994PK16800007
J	Overacre-Delgoffe, AE; Bumgarner, HJ; Cillo, AR; Burr, AHP; Tometich, JT; Bhattacharjee, A; Bruno, TC; Vignali, DAA; Hand, TW				Overacre-Delgoffe, Abigail E.; Bumgarner, Hannah J.; Cillo, Anthony R.; Burr, Ansen H. P.; Tometich, Justin T.; Bhattacharjee, Amrita; Bruno, Tullia C.; Vignali, Dario A. A.; Hand, Timothy W.			Microbiota-specific T follicular helper cells drive tertiary lymphoid structures and anti-tumor immunity against colorectal cancer	IMMUNITY			English	Article							B-CELLS; LYMPHATIC VESSELS; COLON TUMORIGENESIS; IMMUNOTHERAPY; SURVIVAL; COLITIS; INFLAMMATION; INDUCTION; INFECTION; RESPONSES	The composition of the intestinal microbiota is associated with both the development of tumors and the efficacy of anti-tumor immunity. Here, we examined the impact of microbiota-specific T cells in anti-colorectal cancer (CRC) immunity. Introduction of Helicobacter hepaticus (Hhep) in a mouse model of CRC did not alter the microbial landscape but increased tumor infiltration by cytotoxic lymphocytes and inhibited tumor growth. Anti-tumor immunity was independent of CD8(+) T cells but dependent upon CD4(+) T cells, B cells, and natural killer (NK) cells. Hhep colonization induced Hhep-specific T follicular helper (Tfh) cells, increased the number of colon Tfh cells, and supported the maturation of Hhep+ tumor-adjacent tertiary lymphoid structures. Tfh cells were necessary for Hhep-mediated tumor control and immune infiltration, and adoptive transfer of Hhep-specific CD4(+) T cells to Tfh cell-deficient Bcl6(fl/fl) Cd4(Cre) mice restored anti-tumor immunity. Thus, introduction of immunogenic intestinal bacteria can promote Tfh-associated anti-tumor immunity in the colon, suggesting therapeutic approaches for the treatment of CRC.	[Overacre-Delgoffe, Abigail E.; Bumgarner, Hannah J.; Burr, Ansen H. P.; Tometich, Justin T.; Bhattacharjee, Amrita; Hand, Timothy W.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Infect Dis Sect, RK Mellon Inst Pediat Res,Pediat Dept, Pittsburgh, PA 15224 USA; [Overacre-Delgoffe, Abigail E.; Bumgarner, Hannah J.; Cillo, Anthony R.; Burr, Ansen H. P.; Bhattacharjee, Amrita; Bruno, Tullia C.; Vignali, Dario A. A.; Hand, Timothy W.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA; [Cillo, Anthony R.; Bruno, Tullia C.; Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA; [Bumgarner, Hannah J.; Burr, Ansen H. P.] Univ Pittsburgh, Sch Med, Grad Program Microbiol & Immunol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hand, TW (corresponding author), Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Infect Dis Sect, RK Mellon Inst Pediat Res,Pediat Dept, Pittsburgh, PA 15224 USA.; Hand, TW (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15261 USA.	timothy.hand@chp.edu		Vignali, Dario/0000-0002-2771-5992	UPMC Children's Hospital of Pittsburgh/R.K. Mellon Institute for Pediatric Research; NIH [R21 CA249074, T32 5T32CA082084-18, T32AI089443, R01 CA203689, P01 AI108545]; Damon Runyon Cancer Research Foundation (DRCRF postdoctoral fellowship); Eden Hall Foundation; Hillman Cancer Cen-ter (Hillman Postdoctoral Fellowship for Innovative Cancer Research)	UPMC Children's Hospital of Pittsburgh/R.K. Mellon Institute for Pediatric Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation (DRCRF postdoctoral fellowship); Eden Hall Foundation; Hillman Cancer Cen-ter (Hillman Postdoctoral Fellowship for Innovative Cancer Research)	The authors thank A. Poholek for Bcl6fl/flCd4Cre mice; J. Michel and A. Styche from the Children's Hospital of Pittsburgh Flow Core for cell sorting; T. Tabib, R. Lafyatis, and the UPMC Genome Center for preparation and sequencing of scRNA-seq samples; the NIH tetramer core for MHC class II tetramers containing sequences from Hhep; the staff of the Division of Laboratory Animal Services for the animal husbandry; and the Children's Hospital of Pittsburgh Histology Core, the Center for Biological Imaging, the Center for Research Computing, the RK Mellon Institute, and the Depart-ment of Pediatrics and the Department of Immunology at the University of Pittsburgh/UPMC as well as Nikhil Joshi, Grace Chen, Semir Beyaz, and the Hand lab for helpful discussions. This work was supported by the UPMC Children's Hospital of Pittsburgh/R.K. Mellon Institute for Pediatric Research (including a RAC post-doctoral fellowship to A.B.) , the NIH (R21 CA249074 to T.W.H., T32 5T32CA082084-18 to A.E.O.-D., T32AI089443 to A.H.P.B., and R01 CA203689 and P01 AI108545 to D.A.A.V.) , the Damon Runyon Cancer Research Foundation (DRCRF postdoctoral fellowship to A.E.O.-D.) , the Eden Hall Foundation (T.W.H.) , and the Hillman Cancer Cen-ter (Hillman Postdoctoral Fellowship for Innovative Cancer Research to A.R.C.) .	Amaya E, 2007, AQUACULTURE, V262, P419, DOI 10.1016/j.aquaculture.2006.11.001; Ansaldo E, 2019, SCIENCE, V364, P1179, DOI 10.1126/science.aaw7479; Arnold M, 2017, GUT, V66, P683, DOI 10.1136/gutjnl-2015-310912; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Becht E, 2016, CLIN CANCER RES, V22, P4057, DOI 10.1158/1078-0432.CCR-15-2879; Bihl F, 2010, J IMMUNOL, V185, P2174, DOI 10.4049/jimmunol.1001486; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; Cao YJ, 2019, P NATL ACAD SCI USA, V116, P6286, DOI 10.1073/pnas.1818164116; Chai JN, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5068; Chen BB, 2018, METHODS MOL BIOL, V1711, P243, DOI 10.1007/978-1-4939-7493-1_12; Chen WS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11302; Chiaranunt P, 2018, J IMMUNOL, V201, P243, DOI 10.4049/jimmunol.1800236; Cillo AR, 2020, IMMUNITY, V52, P183, DOI 10.1016/j.immuni.2019.11.014; Coppola D, 2011, AM J PATHOL, V179, P37, DOI 10.1016/j.ajpath.2011.03.007; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Danne C, 2018, MICROB CELL, V5, P208, DOI 10.15698/mic2018.04.626; Danne C, 2017, CELL HOST MICROBE, V22, P733, DOI 10.1016/j.chom.2017.11.002; DeFalco J, 2018, CLIN IMMUNOL, V187, P37, DOI 10.1016/j.clim.2017.10.002; Dejea CM, 2018, SCIENCE, V359, P592, DOI 10.1126/science.aah3648; Deng M, 2017, DATABASE-OXFORD, DOI 10.1093/database/baw160; Di Caro G, 2014, CLIN CANCER RES, V20, P2147, DOI 10.1158/1078-0432.CCR-13-2590; Dieu-Nosjean MC, 2016, IMMUNOL REV, V271, P260, DOI 10.1111/imr.12405; Doorduijn EM, 2017, CANCER IMMUNOL RES, V5, P642, DOI 10.1158/2326-6066.CIR-16-0334; Erdman SE, 2009, P NATL ACAD SCI USA, V106, P1027, DOI 10.1073/pnas.0812347106; Erdman SE, 2003, AM J PATHOL, V162, P691, DOI 10.1016/S0002-9440(10)63863-1; Farnsworth RH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00518; Favoriti P, 2016, UPDATES SURG, V68, P7, DOI 10.1007/s13304-016-0359-y; FOX JG, 1994, J CLIN MICROBIOL, V32, P1238, DOI 10.1128/JCM.32.5.1238-1245.1994; Galon J, 2020, Q J NUCL MED MOL IM, V64, P152, DOI 10.23736/S1824-4785.20.03249-5; Ge ZM, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12728; Gilbert JA, 2018, NAT MED, V24, P392, DOI 10.1038/nm.4517; Gopalakrishnan V, 2018, SCIENCE, V359, P97, DOI 10.1126/science.aan4236; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hand TW, 2016, TRENDS IMMUNOL, V37, P647, DOI 10.1016/j.it.2016.08.007; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Hollern DP, 2019, CELL, V179, P1191, DOI 10.1016/j.cell.2019.10.028; Hollister K, 2013, J IMMUNOL, V191, P3705, DOI 10.4049/jimmunol.1300378; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Hunter MC, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00613; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Joshi NS, 2015, IMMUNITY, V43, P579, DOI 10.1016/j.immuni.2015.08.006; Jost S, 2014, J VIROL, V88, P8349, DOI 10.1128/JVI.00924-14; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Koscso B, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aax0062; Kostic AD, 2013, CELL HOST MICROBE, V14, P207, DOI 10.1016/j.chom.2013.07.007; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Kullberg MC, 2003, P NATL ACAD SCI USA, V100, P15830, DOI 10.1073/pnas.2534546100; Kullberg MC, 2001, INFECT IMMUN, V69, P4232, DOI 10.1128/IAI.69.7.4232-4241.2001; Kullberg MC, 1998, INFECT IMMUN, V66, P5157, DOI 10.1128/IAI.66.11.5157-5166.1998; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Le DT, 2017, SCIENCE, V357, P409, DOI 10.1126/science.aan6733; Li H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9292; Liu JF, 2018, CELL, V173, P400, DOI 10.1016/j.cell.2018.02.052; Lund AW, 2016, TRENDS CANCER, V2, P548, DOI 10.1016/j.trecan.2016.09.005; Lund AW, 2016, J CLIN INVEST, V126, P3389, DOI 10.1172/JCI79434; Ma C, 2018, SCIENCE, V360, DOI 10.1126/science.aan5931; Maggio-Price L, 2006, CANCER RES, V66, P828, DOI 10.1158/0008-5472.CAN-05-2448; Maloy KJ, 2005, IMMUNOL LETT, V97, P189, DOI 10.1016/j.imlet.2005.01.004; Martens R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14921-w; Matson V, 2018, SCIENCE, V359, P104, DOI 10.1126/science.aao3290; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Mlecnik B, 2016, IMMUNITY, V44, P698, DOI 10.1016/j.immuni.2016.02.025; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Nagamine CM, 2008, INFECT IMMUN, V76, P2758, DOI 10.1128/IAI.01604-07; Nagamine CM, 2008, INT J CANCER, V122, P832, DOI 10.1002/ijc.23175; Nolte MA, 2004, J IMMUNOL, V172, P3620, DOI 10.4049/jimmunol.172.6.3620; Oldenhove G, 2009, IMMUNITY, V31, P772, DOI 10.1016/j.immuni.2009.10.001; Pepper M, 2011, IMMUNITY, V35, P583, DOI 10.1016/j.immuni.2011.09.009; Petitprez F, 2020, NATURE, V577, P556, DOI 10.1038/s41586-019-1906-8; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Randall TD, 2014, MUCOSAL IMMUNOL, V7, P455, DOI 10.1038/mi.2014.11; Randall TD, 2014, AM J RESP CRIT CARE, V189, P767, DOI 10.1164/rccm.201402-0317ED; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Rawla P, 2019, GASTROENTEROL REV, V14, P89, DOI 10.5114/pg.2018.81072; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Routy B, 2018, SCIENCE, V359, P91, DOI 10.1126/science.aan3706; Ruddle NH, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00491; Ruddle NH, 2014, J CLIN INVEST, V124, P953, DOI 10.1172/JCI71611; Schurch CM, 2020, CELL, V182, P1341, DOI 10.1016/j.cell.2020.07.005; Schwabe RF, 2013, NAT REV CANCER, V13, P800, DOI 10.1038/nrc3610; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tauriello DVF, 2017, MOL ONCOL, V11, P97, DOI 10.1002/1878-0261.12018; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Twyman-Saint Victor C, 2015, NATURE, V520, P373, DOI 10.1038/nature14292; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Wegorzewska MM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau9079; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yu AI, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.03.035; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zackular JP, 2013, MBIO, V4, DOI 10.1128/mBio.00692-13	103	19	20	12	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2812	+		10.1016/j.immuni.2021.11.003	http://dx.doi.org/10.1016/j.immuni.2021.11.003		DEC 2021	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6LX	34861182	Bronze, Green Accepted			2022-12-18	WOS:000731658800002
J	Shreeve, N; Depierreux, D; Hawkes, D; Traherne, JA; Sovio, U; Huhn, O; Jayaraman, J; Horowitz, A; Ghadially, H; Perry, JRB; Moffett, A; Sled, JG; Sharkey, AM; Colucci, F				Shreeve, Norman; Depierreux, Delphine; Hawkes, Delia; Traherne, James A.; Sovio, Ulla; Huhn, Oisin; Jayaraman, Jyothi; Horowitz, Amir; Ghadially, Hormas; Perry, John R. B.; Moffett, Ashley; Sled, John G.; Sharkey, Andrew M.; Colucci, Francesco			The CD94/NKG2A inhibitory receptor educates uterine NK cells to optimize pregnancy outcomes in humans and mice	IMMUNITY			English	Article							ENDOPLASMIC-RETICULUM STRESS; NATURAL-KILLER-CELLS; RNA-SEQ DATA; HLA-E; FETAL-GROWTH; SPIRAL ARTERIES; MATERNAL KIR; EXPRESSION; PREECLAMPSIA; RESTRICTION	The conserved CD94/NKG2A inhibitory receptor is expressed by nearly all human and similar to 50% of mouse uterine natural killer (uNK) cells. Binding human HLA-E and mouse Qa-1, NKG2A drives NK cell education, a process of unknown physiological importance influenced by HLA-B alleles. Here, we show that NKG2A genetic ablation in dams mated with wild-type males caused suboptimal maternal vascular responses in pregnancy, accompanied by perturbed placental gene expression, reduced fetal weight, greater rates of smaller fetuses with asymmetric growth, and abnormal brain development. These are features of the human syndrome preeclampsia. In a genome-wide association study of 7,219 pre-eclampsia cases, we found a 7% greater relative risk associated with the maternal HLA-B allele that does not favor NKG2A education. These results show that the maternal HLA-B -> HLA-E -> NKG2A pathway contributes to healthy pregnancy and may have repercussions on offspring health, thus establishing the physiological relevance for NK cell education.	[Shreeve, Norman; Depierreux, Delphine; Hawkes, Delia; Sovio, Ulla; Huhn, Oisin; Colucci, Francesco] Univ Cambridge, Dept Obstet & Gynaecol, Natl Inst Hlth Res Cambridge Biomed Res Ctr, Cambridge CB2 0SW, England; [Shreeve, Norman; Depierreux, Delphine; Sovio, Ulla; Huhn, Oisin; Jayaraman, Jyothi; Moffett, Ashley; Sharkey, Andrew M.; Colucci, Francesco] Univ Cambridge, Ctr Trophoblast Res, Cambridge, England; [Traherne, James A.; Huhn, Oisin; Jayaraman, Jyothi; Moffett, Ashley; Sharkey, Andrew M.] Univ Cambridge, Dept Pathol, Cambridge, England; [Huhn, Oisin; Ghadially, Hormas] AstraZeneca, Granta Pk, Cambridge CB21 6GH, England; [Jayaraman, Jyothi] Univ Cambridge, Dept Physiol Dev & Neurobiol, Cambridge, England; [Horowitz, Amir] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Precis Immunol Inst, New York, NY USA; [Horowitz, Amir] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY USA; [Perry, John R. B.] Univ Cambridge, MRC Epidemiol Unit, Cambridge, England; [Sled, John G.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Sled, John G.] Hosp Sick Children, Translat Med, Toronto, ON, Canada	University of Cambridge; University of Cambridge; University of Cambridge; AstraZeneca; University of Cambridge; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; University of Cambridge; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Colucci, F (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Natl Inst Hlth Res Cambridge Biomed Res Ctr, Cambridge CB2 0SW, England.	fc287@medschl.cam.ac.uk			Wellcome Trust [200841/Z/16/Z, RG86992]; Medical Research Council [MR/P001092/1]; European Research Council under the European Union's Horizon 2020 research and innovation program [695551]; MedImmune-Cambridge PhD fellowship; Centre for Trophoblast Research PhD fellowship	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council under the European Union's Horizon 2020 research and innovation program; MedImmune-Cambridge PhD fellowship(AstraZenecaMedimmune); Centre for Trophoblast Research PhD fellowship	This project was funded by the Wellcome Trust (awards 200841/Z/16/Z to F.C. and A.M. and RG86992 to N.S. and F.C.), the Medical Research Council (grant MR/P001092/1 to A.M.S., F.C., and A.M.). J.A.T. received funding from the European Research Council under the European Union's Horizon 2020 research and innovation program (grant agreement 695551). O.H. was supported by a MedImmune-Cambridge PhD fellowship. J.J. was supported by a Centre for Trophoblast Research PhD fellowship. We thank Jens Kieckbusch for suggesting study of CD94/NKG2A; John Trowsdale for critically reading the manuscript; Lydia Farrell, Olympe Chazara, Elisa Balmas, and Iva Filipovic for helpful discussions; Lindsay Cahill and Xinwen Lisa Yu for teaching microultrasound and micro-CT techniques; and Gao Xiaojiang and Mary Carrington for sharing their HLA-B exon 1 primer sequences and helpful discussion. We also thank Luka Cicin-Sain for providing us with Klrc1~/~ mice and Ralph McGinnis for advice regarding accessing the human pre-eclampsia GWAS meta-analysis.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andre P, 2018, CELL, V175, P1731, DOI 10.1016/j.cell.2018.10.014; Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; ARBEILLE P, 1983, Journal de Gynecologie Obstetrique et biologie de la Reproduction, V12, P851; Ashkar AA, 2003, J IMMUNOL, V171, P2937, DOI 10.4049/jimmunol.171.6.2937; Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259; Barber EM, 2003, J IMMUNOL, V171, P37, DOI 10.4049/jimmunol.171.1.37; Bjorkstrom NK, 2016, NAT REV IMMUNOL, V16, P310, DOI 10.1038/nri.2016.34; Bjorkstrom NK, 2010, BLOOD, V116, P3853, DOI 10.1182/blood-2010-04-281675; Boudreau JE, 2018, CURR OPIN IMMUNOL, V50, P102, DOI 10.1016/j.coi.2017.11.003; Boulenouar S, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00043; Braud VM, 1998, CURR BIOL, V8, P1, DOI 10.1016/S0960-9822(98)70014-4; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Brodin P, 2009, BLOOD, V113, P2434, DOI 10.1182/blood-2008-05-156836; Burton GJ, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l2381; Burton GJ, 2018, AM J OBSTET GYNECOL, V218, pS745, DOI 10.1016/j.ajog.2017.11.577; Cahill LS, 2014, J CEREBR BLOOD F MET, V34, P1082, DOI 10.1038/jcbfm.2014.62; Chu A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37627-y; Chu A, 2016, NUTR RES, V36, P1055, DOI 10.1016/j.nutres.2016.08.001; Collins MK, 2009, J CLIN INVEST, V119, P2062, DOI 10.1172/JCI38714; Colucci F, 2019, SCIENCE, V365, P862, DOI 10.1126/science.aaw1300; Day FR, 2016, NAT GENET, V48, P617, DOI 10.1038/ng.3551; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doisne JM, 2015, J IMMUNOL, V195, P3937, DOI 10.4049/jimmunol.1500689; Duzkale H, 2011, BLOOD, V117, P4076, DOI 10.1182/blood-2010-09-304881; Eixarch E, 2008, ULTRASOUND OBST GYN, V32, P894, DOI 10.1002/uog.6249; Fernandez NC, 2005, BLOOD, V105, P4416, DOI 10.1182/blood-2004-08-3156; Filipovic I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06918-3; Goodridge JP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08384-x; Greco A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077205; Guleria I, 2005, J EXP MED, V202, P231, DOI 10.1084/jem.20050019; Hallner A, 2019, BLOOD, V133, P1479, DOI 10.1182/blood-2018-09-874990; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Hansen KD, 2012, BIOSTATISTICS, V13, P204, DOI 10.1093/biostatistics/kxr054; Hernandez-Andrade E, 2014, ULTRASOUND MED BIOL, V40, P351, DOI 10.1016/j.ultrasmedbio.2013.09.026; Hiby SE, 2004, J EXP MED, V200, P957, DOI 10.1084/jem.20041214; Hiby SE, 2014, J IMMUNOL, V192, P5069, DOI 10.4049/jimmunol.1400577; Hiby SE, 2010, J CLIN INVEST, V120, P4102, DOI 10.1172/JCI43998; Highton AJ, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.559576; Hoglund P, 2010, NAT REV IMMUNOL, V10, P724, DOI 10.1038/nri2835; Horowitz A, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aag1672; Hung TH, 2002, CIRC RES, V90, P1274, DOI 10.1161/01.RES.0000024411.22110.AA; Johnson MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033666; Juarez SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061734; Kennedy PR, 2016, J IMMUNOL, V197, P4292, DOI 10.4049/jimmunol.1601279; Kieckbusch J, 2015, JOVE-J VIS EXP, DOI 10.3791/53534; Kieckbusch J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4359; Kim S, 2005, NATURE, V436, P709, DOI 10.1038/nature03847; KING A, 1989, CELL IMMUNOL, V118, P337, DOI 10.1016/0008-8749(89)90382-1; King A, 2000, EUR J IMMUNOL, V30, P1623, DOI 10.1002/1521-4141(200006)30:6<1623::AID-IMMU1623>3.0.CO;2-M; Knop MR, 2018, J AM HEART ASSOC, V7, DOI [10.1161/JAHA.118.008870, 10.1161/jaha.118.008870]; Le Luduec JB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00734; Lee N, 1998, J IMMUNOL, V160, P4951; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Lopez D, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4167-7; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McGinnis R, 2017, NAT GENET, V49, P1255, DOI 10.1038/ng.3895; Moffett A, 2015, IMMUNOL REV, V267, P283, DOI 10.1111/imr.12323; Moffett A, 2015, HUM REPROD, V30, P1519, DOI 10.1093/humrep/dev098; Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107; Mol BJ, 2016, LANCET, V387, P999, DOI 10.1016/S0140-6736(15)00070-7; Morgan Linda, 2014, Nor Epidemiol, V24, P141; Mouse Genomics Informatics International Mouse Phenotyping Consortium, 2014, OBT LOAD PHEN ANN IN; Nagasaki K, 2003, INT J CANCER, V105, P454, DOI 10.1002/ijc.11122; Nakimuli A, 2015, P NATL ACAD SCI USA, V112, P845, DOI 10.1073/pnas.1413453112; Olahova M, 2015, EUR J HUM GENET, V23, P935, DOI 10.1038/ejhg.2014.214; OLOFSSON P, 1993, EUR J OBSTET GYN R B, V49, P161, DOI 10.1016/0028-2243(93)90265-E; Oros D, 2010, ULTRASOUND OBST GYN, V35, P456, DOI 10.1002/uog.7588; Orr MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015184; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; Petersdorf EW, 2020, LANCET HAEMATOL, V7, pE50, DOI 10.1016/S2352-3026(19)30208-X; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; Ramsuran V, 2018, SCIENCE, V359, P86, DOI 10.1126/science.aam8825; Rapaport AS, 2015, IMMUNITY, V43, P1112, DOI 10.1016/j.immuni.2015.11.005; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; Rennie MY, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140681; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Robson S., 2013, GREEN TOP GUIDELINE; Sagol S, 1999, AUST NZ J OBSTET GYN, V39, P324, DOI 10.1111/j.1479-828X.1999.tb03407.x; Sharkey AM, 2015, J IMMUNOL, V195, P3026, DOI 10.4049/jimmunol.1501229; Sharma D, 2016, CLIN MED INSIGHTS-PE, V10, P67, DOI 10.4137/CMPed.S40070; Sim MJW, 2016, EUR J IMMUNOL, V46, P185, DOI 10.1002/eji.201545757; Skjaerven R, 2005, BRIT MED J, V331, P877, DOI 10.1136/bmj.38555.462685.8F; Solano ME, 2016, PLACENTA, V39, P7, DOI 10.1016/j.placenta.2015.12.017; Steinthorsdottir V, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19733-6; Tolsa CB, 2004, PEDIATR RES, V56, P132, DOI 10.1203/01.PDR.0000128983.54614.7E; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; Vance RE, 1999, J EXP MED, V190, P1801, DOI 10.1084/jem.190.12.1801; Wagner AK, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15627; Wong MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084321; Wong MD, 2012, DEVELOPMENT, V139, P3248, DOI 10.1242/dev.082016; Xu YY, 2017, J REPROD DEVELOP, V63, P289, DOI 10.1262/jrd.2016-177; Yawata M, 2008, BLOOD, V112, P2369, DOI 10.1182/blood-2008-03-143727; Yung HW, 2012, FASEB J, V26, P1970, DOI 10.1096/fj.11-190082; Yung HW, 2008, AM J PATHOL, V173, P451, DOI 10.2353/ajpath.2008.071193; Yunis Edmond J, 2007, J Stem Cells, V2, P237; Zhang JH, 2009, COMPARATIVE MED, V59, P527; Zhang XQ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13032-5; Zhao LL, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-61; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	100	19	20	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 8	2021	54	6					1231	+	e4	10.1016/j.immuni.2021.03.021	http://dx.doi.org/10.1016/j.immuni.2021.03.021		JUN 2021	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SP7ZL	33887202	Green Published, hybrid, Green Submitted			2022-12-18	WOS:000659882900014
J	Zheng, H; Rao, AM; Dermadi, D; Toh, J; Jones, LM; Donato, M; Liu, YR; Su, YP; Dai, CL; Kornilov, SA; Karagiannis, M; Marantos, T; Hasin-Brumshtein, Y; He, YD; Giamarellos-Bourboulis, EJ; Heath, JR; Khatri, P				Zheng, Hong; Rao, Aditya M.; Dermadi, Denis; Toh, Jiaying; Jones, Lara Murphy; Donato, Michele; Liu, Yiran; Su, Yapeng; Dai, Cheng L.; Kornilov, Sergey A.; Karagiannis, Minas; Marantos, Theodoros; Hasin-Brumshtein, Yehudit; He, Yudong D.; Giamarellos-Bourboulis, Evangelos J.; Heath, James R.; Khatri, Purvesh			Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses	IMMUNITY			English	Article							TRANSCRIPTIONAL SIGNATURES; PULMONARY TUBERCULOSIS; EXPRESSION; INFECTION; THIOREDOXIN; HOMEOSTASIS; MONOCYTES; PROTEINS; PATTERNS; CHILDREN	Viral infections induce a conserved host response distinct from bacterial infections. We hypothesized that the conserved response is associated with disease severity and is distinct between patients with different outcomes. To test this, we integrated 4,780 blood transcriptome profiles from patients aged 0 to 90 years infected with one of 16 viruses, including SARS-CoV-2, Ebola, chikungunya, and influenza, across 34 cohorts from 18 countries, and single-cell RNA sequencing profiles of 702,970 immune cells from 289 samples across three cohorts. Severe viral infection was associated with increased hematopoiesis, myelopoiesis, and myeloid-derived suppressor cells. We identified protective and detrimental gene modules that defined distinct trajectories associated with mild versus severe outcomes. The interferon response was decoupled from the protective host response in patients with severe outcomes. These findings were consistent, irrespective of age and virus, and provide insights to accelerate the development of diagnostics and host-directed therapies to improve global pandemic preparedness.	[Zheng, Hong; Rao, Aditya M.; Dermadi, Denis; Toh, Jiaying; Jones, Lara Murphy; Donato, Michele; Liu, Yiran; Khatri, Purvesh] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Zheng, Hong; Dermadi, Denis; Jones, Lara Murphy; Donato, Michele; Khatri, Purvesh] Stanford Univ, Sch Med, Ctr Biomed Informat Res, Dept Med, Stanford, CA 94305 USA; [Rao, Aditya M.; Toh, Jiaying] Stanford Univ, Immunol Program, Stanford, CA 94305 USA; [Jones, Lara Murphy] Stanford Univ, Sch Med, Dept Pediat, Div Crit Care Med, Stanford, CA 94305 USA; [Liu, Yiran] Stanford Univ, Canc Biol Program, Stanford, CA 94305 USA; [Su, Yapeng; Dai, Cheng L.; Kornilov, Sergey A.; Heath, James R.] Inst Syst Biol, Seattle, WA USA; [Karagiannis, Minas; Marantos, Theodoros; Giamarellos-Bourboulis, Evangelos J.] Natl & Kapodistrian Univ Athens, Med Sch, Dept Internal Med 4, Athens 12462, Greece; [Hasin-Brumshtein, Yehudit; He, Yudong D.] Inflammatix Inc, Burlingame, CA USA; [Heath, James R.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Institute for Systems Biology (ISB); National & Kapodistrian University of Athens; University of Washington; University of Washington Seattle	Khatri, P (corresponding author), Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.; Khatri, P (corresponding author), Stanford Univ, Sch Med, Ctr Biomed Informat Res, Dept Med, Stanford, CA 94305 USA.	pkhatri@stanford.edu	Rao, Aditya M/AAM-1449-2021; Kornilov, Sergey/F-1234-2010	Rao, Aditya M/0000-0001-9400-7155; Kornilov, Sergey/0000-0002-8378-110X; Su, Yapeng/0000-0002-6305-8467; Dermadi Bebek, Denis/0000-0001-6268-4178; Liu, Yiran/0000-0001-7964-712X; Khatri, Purvesh/0000-0002-4143-4708; Zheng, Hong/0000-0002-8884-8211; Dai, Chengzhen/0000-0002-3073-211X; Hasin-Brumshtein, Yehudit/0000-0001-7528-603X	Bill and Melinda Gates Foundation [OPP1113682]; National Institute of Allergy and Infectious Diseases (NIAID) [1U19AI109662, U19AI057229, 5R01AI125197]; Department of Defense [W81XWH-18-1-0253, W81XWH1910235]; Ralph & Marian Falk Medical Research Trust; National Science Foundation Graduate Research Fellowship; Stanford Graduate Fellowship; Knight-Hennessy Scholars Program; Agency of Science, Technology, and Research (A*STAR), Singapore	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Department of Defense(United States Department of Defense); Ralph & Marian Falk Medical Research Trust; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); Knight-Hennessy Scholars Program; Agency of Science, Technology, and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	P.K. is funded in part by the Bill and Melinda Gates Foundation (OPP1113682); the National Institute of Allergy and Infectious Diseases (NIAID) grants 1U19AI109662, U19AI057229, and 5R01AI125197; Department of Defense contracts W81XWH-18-1-0253 and W81XWH1910235; and the Ralph & Marian Falk Medical Research Trust. A.M.R. is funded by National Science Foundation Graduate Research Fellowship and Stanford Graduate Fellowship. Y.L. is funded by the Knight-Hennessy Scholars Program and National Science Foundation Graduate Research Fellowship. J.T. is funded by National Science Scholarship (PhD) from the Agency of Science, Technology, and Research (A*STAR), Singapore.	Andres-Terre M, 2015, IMMUNITY, V43, P1199, DOI 10.1016/j.immuni.2015.11.003; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261; Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537; Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778; Berdal JE, 2011, J INFECTION, V63, P308, DOI 10.1016/j.jinf.2011.07.004; Bermejo-Martin JF, 2010, CRIT CARE, V14, DOI 10.1186/cc9259; Bertini R, 1999, J EXP MED, V189, P1783, DOI 10.1084/jem.189.11.1783; Bongen E, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0554-1; Bruns H, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3230; Choi JW, 2019, CLIN LAB, V65, P1063, DOI 10.7754/Clin.Lab.2019.181235; Chowdhury RR, 2018, NATURE, V560, P644, DOI 10.1038/s41586-018-0439-x; Christiansen J., 2018, SCI AM, V318, P48; Davenport EE, 2015, J MOL MED, V93, P105, DOI 10.1007/s00109-014-1212-8; Dermadi D, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100842; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dunning J, 2018, NAT IMMUNOL, V19, P625, DOI 10.1038/s41590-018-0111-5; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Eriksson J, 2017, FREE RADICAL BIO MED, V104, P138, DOI 10.1016/j.freeradbiomed.2017.01.016; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Gatti A, 2020, CYTOM PART A, V97, P887, DOI 10.1002/cyto.a.24188; Giamarellos-Bourboulis EJ, 2020, CELL HOST MICROBE, V27, P992, DOI 10.1016/j.chom.2020.04.009; Gupta RK, 2020, LANCET RESP MED, V8, P395, DOI 10.1016/S2213-2600(19)30282-6; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Haynes WA, 2017, BIOCOMPUTING, P144, DOI 10.1142/9789813207813_0015; Heinonen S, 2016, AM J RESP CRIT CARE, V193, P772, DOI 10.1164/rccm.201504-0749OC; Hoffmann S, 2017, J CEREBR BLOOD F MET, V37, P3671, DOI 10.1177/0271678X16671964; Jaggi P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197858; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jong VL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36603; Liao Y, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01097; Liu TY, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0889-9; Liu X, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1137-3; Hoang LT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111640; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mace EM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00445; Martin M., 2011, EMBNET J, V17, P5, DOI 10.14806/ej.17.1.200; Mayhew MB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14975-w; McInnes L., 2018, J OPEN SOURCE SOFTW, DOI [DOI 10.21105/JOSS.00861, 10.21105/joss.00861]; Mejias A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001549; Michlmayr D., 2018, MOL SYSTEMS BIOL, V14, P491; Monneret G, 2006, INTENS CARE MED, V32, P1175, DOI 10.1007/s00134-006-0204-8; Morens DM, 2020, CELL, V182, P1077, DOI 10.1016/j.cell.2020.08.021; Nakamura K, 2015, CYTOKINE, V73, P8, DOI 10.1016/j.cyto.2015.01.017; Papathanassiu AE, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16040; Parnell G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017186, 10.1371/journal.pone.0023162]; Parnell GP, 2012, CRIT CARE, V16, DOI 10.1186/cc11477; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Piters WAAD, 2016, AM J RESP CRIT CARE, V194, P1104, DOI 10.1164/rccm.201602-0220OC; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Ramos-Martinez E, 2018, CYTOKINE, V108, P239, DOI 10.1016/j.cyto.2018.01.001; Rodriguez-Fernandez R, 2018, J INFECT DIS, V217, P24, DOI 10.1093/infdis/jix543; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schrijver IT, 2019, FRONT IMMUNOL, V10, DOI [10.3389/fimmu.2019.00327, 10.1155/2014/598654]; Schulte-Schrepping J, 2020, CELL, V182, P1419, DOI 10.1016/j.cell.2020.08.001; Scott M.K. D., 2019, LANCET RESP MED, P1; Silvin A, 2020, CELL, V182, P1401, DOI 10.1016/j.cell.2020.08.002; Smith CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5649; Soares-Schanoski A, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007880; Soneson C., 2018, BIAS ROBUSTNESS SCAL, P1; Srivastava A, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1670-y; Stone JH, 2020, NEW ENGL J MED, V383, P2333, DOI 10.1056/NEJMoa2028836; Su Y, 2020, BIORXIV; Sweeney TE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7165; Sweeney TE, 2016, LANCET RESP MED, V4, P213, DOI 10.1016/S2213-2600(16)00048-5; Sweeney TE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5993; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Thair SA, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2020.101947; Turner CT, 2020, LANCET RESP MED, V8, P407, DOI 10.1016/S2213-2600(19)30469-2; Vallania F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07242-6; Venet F, 2021, ANN NY ACAD SCI, V1499, P3, DOI 10.1111/nyas.14333; Wang YH, 2007, J VIROL, V81, P3904, DOI 10.1128/JVI.01887-06; Warsinske HC, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.3779; Wei FH, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008062; Wilk AJ, 2020, NAT MED, V26, P1070, DOI [10.1038/s41591-020-0944-y, 10.1101/2020.04.17.20069930]; Wong HR, 2008, AM J RESP CRIT CARE, V178, P276, DOI 10.1164/rccm.200801-131OC; Wong HR, 2007, PHYSIOL GENOMICS, V30, P146, DOI 10.1152/physiolgenomics.00024.2007; Wong HR, 2012, CRIT CARE, V16, DOI 10.1186/cc11847; Wu J., 2020, GCRMA BACKGROUND ADJ; Wu T., 2016, SCI IMMUNOLOGY, V1; Yu JS, 2019, J INFECT DIS, V219, P1151, DOI 10.1093/infdis/jiy608; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; Zhai YJ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004869; Zhao XS, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03228; Zhou Z, 2020, CELL HOST MICROBE, V27, P883, DOI 10.1016/j.chom.2020.04.017	86	19	19	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					753	+		10.1016/j.immuni.2021.03.002	http://dx.doi.org/10.1016/j.immuni.2021.03.002		APR 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33765435	Green Published, hybrid			2022-12-18	WOS:000640102800015
J	Dudeck, J; Kotrba, J; Immler, R; Hoffmann, A; Voss, M; Alexaki, VI; Morton, L; Jahn, SR; Katsoulis-Dimitriou, K; Winzer, S; Kollias, G; Fischer, T; Nedospasov, SA; Dunay, IR; Chavakis, T; Muller, AJ; Schraven, B; Sperandio, M; Dudeck, A				Dudeck, Jan; Kotrba, Johanna; Immler, Roland; Hoffmann, Aaron; Voss, Martin; Alexaki, Vasileia Ismini; Morton, Lorena; Jahn, Stephan Rene; Katsoulis-Dimitriou, Konstantinos; Winzer, Simon; Kollias, Georg; Fischer, Thomas; Nedospasov, Sergei A.; Dunay, Ildiko Rita; Chavakis, Triantafyllos; Mueller, Andreas J.; Schraven, Burkhart; Sperandio, Markus; Dudeck, Anne			Directional mast cell degranulation of tumor necrosis factor into blood vessels primes neutrophil extravasation	IMMUNITY			English	Article							LEUKOCYTE RECRUITMENT; T-CELLS; IN-VIVO; TNF; TRYPTASE; ADHESION; INFLAMMATION; MODULATION; ACTIVATION; MODEL	Tissue resident mast cells (MCs) rapidly initiate neutrophil infiltration upon inflammatory insult, yet the molecular mechanism is still unknown. Here, we demonstrated that MC-derived tumor necrosis factor (TNF) was crucial for neutrophil extravasation to sites of contact hypersensitivity-induced skin inflammation by promoting intraluminal crawling. MC-derived TNF directly primed circulating neutrophils via TNF receptor-1 (TNFR1) while being dispensable for endothelial cell activation. The MC-derived TNF was infused into the bloodstream by directional degranulation of perivascular MCs that were part of the vascular unit with access to the vessel lumen. Consistently, intravenous administration of MC granules boosted neutrophil extravasation. Pronounced and rapid intravascular MC degranulation was also observed upon IgE crosslinking or LPs challenge indicating a universal MC potential. Consequently, the directional MC degranulation of pro-inflammatory mediators into the bloodstream may represent an important target for therapeutic approaches aimed at dampening cytokine storm syndromes or shock symptoms, or intentionally pushing immune defense.	[Dudeck, Jan; Kotrba, Johanna; Hoffmann, Aaron; Voss, Martin; Katsoulis-Dimitriou, Konstantinos; Mueller, Andreas J.; Schraven, Burkhart; Dudeck, Anne] Otto von Guericke Univ, Med Fac, Inst Mol & Clin Immunol, Magdeburg, Germany; [Dudeck, Jan; Fischer, Thomas; Mueller, Andreas J.; Schraven, Burkhart; Dudeck, Anne] Otto von Guericke Univ, Hlth Campus Immunol Infectiol & Inflammat, Magdeburg, Germany; [Immler, Roland; Sperandio, Markus] Ludwig Maximilians Univ Munchen, Walter Brendel Ctr Expt Med, Inst Cardiovasc Physiol & Pathophysiol, Planegg Martinsried, Germany; [Alexaki, Vasileia Ismini; Chavakis, Triantafyllos] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Clin Chem & Lab Med, Dresden, Germany; [Morton, Lorena; Dunay, Ildiko Rita] Otto von Guericke Univ, Med Fac, Inst Inflammat & Neurodegenerat, Magdeburg, Germany; [Jahn, Stephan Rene; Winzer, Simon] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Immunol, Dresden, Germany; [Winzer, Simon] Tech Univ Dresden, Univ Clin Carl Gustav Carus, Dept Neurol, Dresden, Germany; [Kollias, Georg] Biomed Sci Res Ctr Alexander Fleming, Vari, Greece; [Fischer, Thomas] Otto von Guericke Univ, Med Fac, Dept Hematol & Oncol, Magdeburg, Germany; [Nedospasov, Sergei A.] Russian Acad Sci, Ctr Precis Genome Editing & Genet Technol Biomed, Engelhardt Inst Mol Biol, Moscow 119991, Russia; [Nedospasov, Sergei A.] Lomonosov Moscow State Univ, Moscow 119991, Russia; [Mueller, Andreas J.] Helmholtz Ctr Infect Res, Braunschweig, Germany	Otto von Guericke University; Otto von Guericke University; University of Munich; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Otto von Guericke University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Alexander Fleming Biomedical Sciences Research Center; Otto von Guericke University; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Lomonosov Moscow State University; Helmholtz Association; Helmholtz-Center for Infection Research	Dudeck, A (corresponding author), Otto von Guericke Univ, Med Fac, Inst Mol & Clin Immunol, Magdeburg, Germany.; Dudeck, A (corresponding author), Otto von Guericke Univ, Hlth Campus Immunol Infectiol & Inflammat, Magdeburg, Germany.	anne.dudeck@med.ovgu.de	Immler, Roland/GRF-6232-2022	Immler, Roland/0000-0002-4086-7528; Kotrba, Johanna/0000-0002-2113-5284; Dudeck, Anne/0000-0002-1311-9620; Sperandio, Markus/0000-0002-7689-3613; Morton, Lorena/0000-0002-3957-3848; Alexaki, Vasileia Ismini/0000-0003-3935-8985	Deutsche Forschungsgemeinschaft (DFG, Germany) [97850925/SFB854/A28N, DU1172/3, 1394, 361210922/RTG2408/TP4, SFB854/Z01, SFB914]	Deutsche Forschungsgemeinschaft (DFG, Germany)(German Research Foundation (DFG))	We cordially thank all members of the Dudeck and Sperandio laboratories for discussions and support. Expert technical assistance by K. Baumgart and N. Riemann and support by J. Frobel is gratefully acknowledged. We thank A. Roers (Dresden, Germany) and D. Voehringer (Erlangen, Germany) for providing Mcpt5-cre and R-DTA mice, respectively, for breedings. This work was funded by the Deutsche Forschungsgemeinschaft (DFG, Germany): Project-ID 97850925/SFB854/A28N, DU1172/3 (Priority Program 1394), and grant 361210922/RTG2408/TP4 to A.D., SFB854/Z01 to A.J.M., and SFB914 Project B01 to M.S.	Silveira AAA, 2018, J LEUKOCYTE BIOL, V103, P87, DOI 10.1189/jlb.3A0916-388RR; Biedermann T, 2000, J EXP MED, V192, P1441, DOI 10.1084/jem.192.10.1441; Bonneville M, 2007, J INVEST DERMATOL, V127, P1430, DOI 10.1038/sj.jid.5700726; Bose O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118513; Butterfield JH, 2018, IMMUNOL ALLERGY CLIN, V38, P397, DOI 10.1016/j.iac.2018.04.011; Cheng LE, 2013, IMMUNITY, V38, P166, DOI 10.1016/j.immuni.2012.09.022; Christy AL, 2013, J AUTOIMMUN, V42, P50, DOI 10.1016/j.jaut.2012.11.003; Condliffe AM, 1996, IMMUNOLOGY, V89, P105, DOI 10.1046/j.1365-2567.1996.d01-711.x; Cunin P, 2019, BLOOD ADV, V3, P256, DOI 10.1182/bloodadvances.2018026732; De Filippo K, 2013, BLOOD, V121, P4930, DOI 10.1182/blood-2013-02-486217; Drube S, 2016, J IMMUNOL, V197, P3662, DOI 10.4049/jimmunol.1600658; Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Dudeck J, 2019, J ALLERGY CLIN IMMUN, V143, P1849, DOI 10.1016/j.jaci.2018.08.052; Dudeck J, 2015, CELL REP, V13, P399, DOI 10.1016/j.celrep.2015.08.078; Echtenacher B, 1996, NATURE, V381, P75, DOI 10.1038/381075a0; Faust N, 2000, BLOOD, V96, P719; Ferrer M, 2010, CLIN EXP ALLERGY, V40, P1760, DOI 10.1111/j.1365-2222.2010.03582.x; Frasca L, 2018, FRONT IMMUNOL, V9, DOI [10.3389/fimmu.2018.01936, 10.3389/fimmu.2018.02363]; Frieri M, 2018, CLIN REV ALLERG IMMU, V54, P353, DOI 10.1007/s12016-015-8487-6; Gaudenzio N, 2016, J CLIN INVEST, V126, P3981, DOI 10.1172/JCI85538; Gorina R, 2014, J IMMUNOL, V192, P324, DOI 10.4049/jimmunol.1300858; Granger D.N., 2005, ENDOTHELIAL CELLS HL; Granger DN, 2010, INFLAMMATION MICROCI, DOI DOI 10.4199/C00013ED1V01Y201006ISP008; Grivennikov SI, 2005, IMMUNITY, V22, P93, DOI 10.1016/j.immuni.2004.11.016; Guo YY, 2014, IMMUNOLOGY, V142, P67, DOI 10.1111/imm.12197; Hasenberg A, 2015, NAT METHODS, V12, P445, DOI [10.1038/NMETH.3322, 10.1038/nmeth.3322]; Hoppe A, 2020, J ALLERGY CLIN IMMUN, V145, P1476, DOI 10.1016/j.jaci.2020.01.036; Hyun YM, 2019, EXP MOL MED, V51, DOI 10.1038/s12276-019-0227-1; Joulia R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7174; Katsoulis-Dimitriou K., 2020, CELLS, V9, pE2538; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kneilling M, 2009, BLOOD, V114, P1696, DOI 10.1182/blood-2008-11-187682; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kourtzelis I, 2017, J LEUKOCYTE BIOL, V102, P677, DOI 10.1189/jlb.3MR0117-024R; Kunder CA, 2011, BLOOD, V118, P5383, DOI 10.1182/blood-2011-07-358432; Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805; LEY K, 1991, CIRC RES, V69, P1034, DOI 10.1161/01.RES.69.4.1034; Li N, 2018, MOL BIOL CELL, V29, P408, DOI 10.1091/mbc.E16-12-0827; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Malaviya R, 1996, NATURE, V381, P77, DOI 10.1038/381077a0; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; McGettrick HM, 2006, J LEUKOCYTE BIOL, V79, P779, DOI 10.1189/jlb.0605350; Miralda I, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00217; Montecucco F, 2008, CELL SIGNAL, V20, P557, DOI 10.1016/j.cellsig.2007.11.008; Motoike T, 2000, GENESIS, V28, P75, DOI 10.1002/1526-968X(200010)28:2<75::AID-GENE50>3.0.CO;2-S; Nemeth T, 2020, NAT REV DRUG DISCOV, V19, P253, DOI 10.1038/s41573-019-0054-z; Passia E, 2020, CLIN REV ALLERG IMMU, V58, P366, DOI 10.1007/s12016-020-08777-7; Paulsson JM, 2010, J IMMUNOL METHODS, V361, P82, DOI 10.1016/j.jim.2010.07.015; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; SCHWARTZ LB, 1981, J IMMUNOL, V126, P2071; Sperandio M, 2001, J IMMUNOL, V167, P2268, DOI 10.4049/jimmunol.167.4.2268; Sperandio M, 2013, BLOOD, V121, pE118, DOI 10.1182/blood-2012-07-447144; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Taira M, 2002, J ASTHMA, V39, P315, DOI 10.1081/JAS-120002288; Van Hauwermeiren F, 2013, J CLIN INVEST, V123, P2590, DOI 10.1172/JCI65624; Vestweber D, 2013, TISSUE BARRIERS, V1, DOI [10.1084/jem.20101920, 10.4161/tisb.23862]; Vitte J, 2015, MOL IMMUNOL, V63, P18, DOI 10.1016/j.molimm.2014.04.001; Vocanson M, 2009, ALLERGY, V64, P1699, DOI 10.1111/j.1398-9995.2009.02082.x; Voehringer D, 2008, J IMMUNOL, V180, P4742, DOI 10.4049/jimmunol.180.7.4742; von Stebut E, 2003, BLOOD, V101, P210, DOI 10.1182/blood-2002-03-0921; Wang JX, 2012, BLOOD, V120, P1489, DOI 10.1182/blood-2012-01-404046; Weber FC, 2015, J EXP MED, V212, P15, DOI 10.1084/jem.20130062; Wernersson S, 2014, NAT REV IMMUNOL, V14, P478, DOI 10.1038/nri3690; Wezel A, 2015, ATHEROSCLEROSIS, V241, P289, DOI 10.1016/j.atherosclerosis.2015.05.028; Zeng M, 2002, AM J PHYSIOL-HEART C, V283, pH2420, DOI 10.1152/ajpheart.00787.2001; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367	66	19	19	5	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					468	+		10.1016/j.immuni.2020.12.017	http://dx.doi.org/10.1016/j.immuni.2020.12.017		MAR 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33484643	Bronze			2022-12-18	WOS:000627409300014
J	Yousif, AS; Ronsard, L; Shah, P; Omatsu, T; Sangesland, M; Moreno, TB; Lam, EC; Vrbanac, VD; Balazs, AB; Reinecker, HC; Lingwood, D				Yousif, Ashraf S.; Ronsard, Larance; Shah, Pankaj; Omatsu, Tatsushi; Sangesland, Maya; Moreno, Thalia Bracamonte; Lam, Evan C.; Vrbanac, Vladimir D.; Balazs, Alejandro B.; Reinecker, Hans-Christian; Lingwood, Daniel			The persistence of interleukin-6 is regulated by a blood buffer system derived from dendritic cells	IMMUNITY			English	Article							CORONARY-HEART-DISEASE; ZONE B-CELLS; IL-6 RECEPTOR; CYTOKINE STORM; SOLUBLE IL-6; CLASS-II; T-CELLS; INFLUENZA; ACTIVATION; RESPONSES	The interleukin-6 (IL-6) membrane receptor and its circulating soluble form, sIL-6R, can be targeted by antibody therapy to reduce deleterious immune signaling caused by chronic overexpression of the pro inflammatory cytokine IL-6. This strategy may also hold promise for treating acute hyperinflammation, such as observed in coronavirus disease 2019 (COVID-19), highlighting a need to define regulators of IL-6 homeostasis. We found that conventional dendritic cells (cDCs), defined in mice via expression of the transcription factor Zbtb46, were a major source of circulating sIL-6R and, thus, systemically regulated IL-6 signaling. This was uncovered through identification of a cDC-dependent but T cell-independent modality that naturally adjuvants plasma cell differentiation and antibody responses to protein antigens. This pathway was then revealed as part of a broader biological buffer system in which cDC-derived sIL-6R set the in-solution persistence of IL-6. This control axis may further inform the development of therapeutic agents to modulate pro-inflammatory immune reactions.	[Yousif, Ashraf S.; Ronsard, Larance; Sangesland, Maya; Moreno, Thalia Bracamonte; Lam, Evan C.; Vrbanac, Vladimir D.; Balazs, Alejandro B.; Lingwood, Daniel] MIT, Massachusetts Gen Hosp, Ragon Inst, 400 Technol Sq, Cambridge, MA 02139 USA; [Yousif, Ashraf S.; Ronsard, Larance; Sangesland, Maya; Moreno, Thalia Bracamonte; Lam, Evan C.; Vrbanac, Vladimir D.; Balazs, Alejandro B.; Lingwood, Daniel] Harvard Univ, 400 Technol Sq, Cambridge, MA 02139 USA; [Shah, Pankaj; Omatsu, Tatsushi; Reinecker, Hans-Christian] Massachusetts Gen Hosp, Ctr Study Inflammatory Bowel Dis, Ctr Computat & Integrat Biol, 185 Cambridge St, Boston, MA 02114 USA; [Reinecker, Hans-Christian] Univ Texas Southwestern Med Ctr Dallas, Ctr Genet Host Def, 5323 Harry Hines Blvd, Dallas, TX 75390 USA	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lingwood, D (corresponding author), MIT, Massachusetts Gen Hosp, Ragon Inst, 400 Technol Sq, Cambridge, MA 02139 USA.; Lingwood, D (corresponding author), Harvard Univ, 400 Technol Sq, Cambridge, MA 02139 USA.	dlingwood@mgh.harvard.edu	Yousif, Ashraf Siddig/U-2876-2019	Yousif, Ashraf Siddig/0000-0001-9215-3853; Sangesland, Maya/0000-0001-8316-039X; Balazs, Alejandro/0000-0002-1767-3944; Lam, Evan/0000-0002-5556-2559; Ronsard, Larance/0000-0002-5307-1940	NIH [R01AI137057, DP2DA042422, R01AI124378, R01AI153098, DK068181, AI113333, DK043351, GM138599]; Harvard University Milton Award; Gilead Research Scholars Program	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University Milton Award; Gilead Research Scholars Program	D.L. was supported by NIH grants (R01AI137057, DP2DA042422, R01AI124378, and R01AI153098), the Harvard University Milton Award, and the Gilead Research Scholars Program. H.C.R. was supported by the NIH (DK068181, AI113333, DK043351, and GM138599). We thank Lingwood lab technicians past and present for generating the recombinant protein antigens used in this study (Grant Weaver, Rina Villar, Celina Keating, Matthew Smoot, Julia Bals, and Vintus Okonkwo). The authors also thank Masaru Kanekiyo, Jose Ordovas-Montanes, Shiv Pillai, Facundo Batista, Ulrich von Andrian, and Lingwood lab members for helpful discussions. We gratefully acknowledge Michal Grzybek for assistance with figure graphics and Thomas Diefenbach for help with microscopy and imaging analyses.	Adler LN, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00319; Altman MO, 2018, VIRAL IMMUNOL, V31, P142, DOI 10.1089/vim.2017.0129; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Amitai A., 2020, CELL SYST, DOI [10.2139/ssrn.3586996, DOI 10.2139/SSRN.3586996]; Andersen TK, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0101-0; Angeletti D, 2017, NAT IMMUNOL, V18, P456, DOI 10.1038/ni.3680; Balazs AB, 2013, NAT BIOTECHNOL, V31, P647, DOI 10.1038/nbt.2618; Balazs AB, 2012, NATURE, V481, P81, DOI 10.1038/nature10660; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Baran P, 2018, J BIOL CHEM, V293, P6762, DOI 10.1074/jbc.RA117.001163; Bergtold A, 2005, IMMUNITY, V23, P503, DOI 10.1016/j.immuni.2005.09.013; Biran N, 2020, LANCET RHEUMATOL, V2, pE603, DOI 10.1016/S2665-9913(20)30277-0; Chalaris A, 2007, BLOOD, V110, P1748, DOI 10.1182/blood-2007-01-067918; Chappell CP, 2012, J EXP MED, V209, P1825, DOI 10.1084/jem.20120774; Diao J, 2018, J IMMUNOL, V201, P1306, DOI 10.4049/jimmunol.1701514; Doganci A, 2005, J CLIN INVEST, V115, P313, DOI 10.1172/JCI200522433; Dubois B, 1998, J IMMUNOL, V161, P2223; Durai V, 2016, IMMUNITY, V45, P719, DOI 10.1016/j.immuni.2016.10.010; Dutta A, 2013, J IMMUNOL, V190, P4205, DOI 10.4049/jimmunol.1202434; Ferreira RC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003444; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; GALANOS C, 1979, P NATL ACAD SCI USA, V76, P5939, DOI 10.1073/pnas.76.11.5939; Garbers C, 2014, BBA-MOL BASIS DIS, V1842, P1485, DOI 10.1016/j.bbadis.2014.05.018; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Glaser L, 2007, VIRUS RES, V126, P9, DOI 10.1016/j.virusres.2007.01.011; Gonzalez SF, 2010, NAT IMMUNOL, V11, P427, DOI 10.1038/ni.1856; Heink S, 2017, NAT IMMUNOL, V18, P74, DOI 10.1038/ni.3632; Henrickson SE, 2013, IMMUNITY, V39, P496, DOI 10.1016/j.immuni.2013.08.034; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kanekiyo M, 2013, NATURE, V499, P102, DOI 10.1038/nature12202; Karnowski A, 2012, J EXP MED, V209, P2049, DOI 10.1084/jem.20111504; Kim SJ, 2008, J EXP MED, V205, P2437, DOI 10.1084/jem.20070731; Kishimoto T, 2010, INT IMMUNOL, V22, P347, DOI 10.1093/intimm/dxq030; Larousserie F, 2006, J IMMUNOL, V176, P5890, DOI 10.4049/jimmunol.176.10.5890; Loschko J, 2016, J IMMUNOL METHODS, V434, P32, DOI 10.1016/j.jim.2016.04.004; Loschko J, 2016, J EXP MED, V213, P517, DOI 10.1084/jem.20160062; Lu E, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal5237; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Macdougall CE, 2018, CELL METAB, V27, P588, DOI 10.1016/j.cmet.2018.02.007; MacLennan ICM, 2002, IMMUNITY, V17, P235, DOI 10.1016/S1074-7613(02)00398-9; Matsuura M, 1999, INFECT IMMUN, V67, P6286; Matthews V, 2003, J BIOL CHEM, V278, P38829, DOI 10.1074/jbc.M210584200; McElvaney OJ, 2020, EBIOMEDICINE, V61, DOI 10.1016/j.ebiom.2020.103026; McFarland-Mancini MM, 2010, J IMMUNOL, V184, P7219, DOI 10.4049/jimmunol.0901929; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Meredith MM, 2012, J EXP MED, V209, P1153, DOI 10.1084/jem.20112675; Modares NF, 2019, HEPATOLOGY, V70, P2075, DOI 10.1002/hep.30774; MULLBERG J, 1994, J IMMUNOL, V152, P4958; MULLBERG J, 1995, J IMMUNOL, V155, P5198; Narazaki M, 2017, EXPERT REV CLIN IMMU, V13, P535, DOI 10.1080/1744666X.2017.1295850; Nowell MA, 2003, J IMMUNOL, V171, P3202, DOI 10.4049/jimmunol.171.6.3202; Eunju OJ, 2014, J VIROL, V88, P7764, DOI 10.1128/JVI.00748-14; Park SM, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0701-2; Qi H, 2006, SCIENCE, V312, P1672, DOI 10.1126/science.1125703; Riethmueller S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25550; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; Rombouts M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169608; Rose-John S, 2017, CLIN PHARMACOL THER, V102, P591, DOI 10.1002/cpt.782; Rose-John S, 2012, INT J BIOL SCI, V8, P1237, DOI 10.7150/ijbs.4989; Rubtsov A, 2005, IMMUNITY, V23, P527, DOI 10.1016/j.immuni.2005.09.018; Sangesland M, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108065; Sangesland M, 2019, IMMUNITY, V51, P735, DOI 10.1016/j.immuni.2019.09.001; Sarwar N, 2012, LANCET, V379, P1205, DOI 10.1016/S0140-6736(11)61931-4; Satpathy AT, 2012, NAT IMMUNOL, V13, P1145, DOI 10.1038/ni.2467; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Scheller J, 2006, SCAND J IMMUNOL, V63, P321, DOI 10.1111/j.1365-3083.2006.01750.x; Scheller J, 2012, LANCET, V380, P338, DOI 10.1016/S0140-6736(12)61246-X; Schuett H, 2012, ARTERIOSCL THROM VAS, V32, P281, DOI 10.1161/ATVBAHA.111.229435; Schumacher N, 2016, J IMMUNOL, V197, P3705, DOI 10.4049/jimmunol.1600909; Schumacher N, 2015, J BIOL CHEM, V290, P26059, DOI 10.1074/jbc.M115.649509; Shi JY, 2018, METHODS MOL BIOL, V1784, P263, DOI 10.1007/978-1-4939-7837-3_24; Somers EC, 2021, CLIN INFECT DIS, V73, pE445, DOI [10.1093/cid/ciaa954, 10.1101/2020.05.29.20117358]; Song HF, 2003, J EXP MED, V198, P1923, DOI 10.1084/jem.20031498; Spencer S, 2019, J EXP MED, V216, P1986, DOI 10.1084/jem.20190344; Stebegg M, 2020, ELIFE, V9, DOI 10.7554/eLife.52473; Sun T, 2017, MUCOSAL IMMUNOL, V10, P775, DOI 10.1038/mi.2016.79; Swerdlow DI, 2012, LANCET, V379, P1214, DOI 10.1016/S0140-6736(12)60110-X; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Tanaka T, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028456; Tanaka T, 2016, IMMUNOTHERAPY-UK, V8, P959, DOI 10.2217/imt-2016-0020; Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295; Tenhumberg S, 2008, J BIOL CHEM, V283, P27200, DOI 10.1074/jbc.M803694200; Tesfaye DY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01529; Vogel AJ, 2014, VIRAL IMMUNOL, V27, P214, DOI 10.1089/vim.2013.0095; Vollmer P, 1996, INFECT IMMUN, V64, P3646, DOI 10.1128/IAI.64.9.3646-3651.1996; WANG MH, 1991, INFECT IMMUN, V59, P4655, DOI 10.1128/IAI.59.12.4655-4664.1991; Weaver GC, 2016, NAT PROTOC, V11, P193, DOI 10.1038/nprot.2016.009; Weisend CM, 2009, GENESIS, V47, P789, DOI 10.1002/dvg.20568; Wolf J, 2014, CYTOKINE, V70, P11, DOI 10.1016/j.cyto.2014.05.024; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xu E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14803; Xu XL, 2020, P NATL ACAD SCI USA, V117, P10970, DOI 10.1073/pnas.2005615117; Yassine HM, 2015, NAT MED, V21, P1065, DOI 10.1038/nm.3927; Zhang JZ, 2019, J CLIN INVEST, V129, P2920, DOI 10.1172/JCI124829; Zhao Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09283-x	96	19	19	5	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					235	+		10.1016/j.immuni.2020.12.001	http://dx.doi.org/10.1016/j.immuni.2020.12.001		FEB 2021	17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33357409	Green Published, Bronze			2022-12-18	WOS:000627407700009
J	Lefkopoulos, S; Polyzou, A; Derecka, M; Bergo, V; Clapes, T; Cauchy, P; Jerez-Longres, C; Onishi-Seebacher, M; Yin, N; Martagon-Calderon, NA; Potts, KS; Klaeyle, L; Liu, F; Bowman, TV; Jenuwein, T; Mione, MC; Trompouki, E				Lefkopoulos, Stylianos; Polyzou, Aikaterini; Derecka, Marta; Bergo, Veronica; Clapes, Thomas; Cauchy, Pierre; Jerez-Longres, Carolina; Onishi-Seebacher, Megumi; Yin, Na; Martagon-Calderoen, Natalia-Adriana; Potts, Kathryn S.; Klaeyle, Lheanna; Liu, Feng; Bowman, Teresa, V; Jenuwein, Thomas; Mione, Maria Caterina; Trompouki, Eirini			Repetitive Elements Trigger RIG-I-like Receptor Signaling that Regulates the Emergence of Hematopoietic Stem and Progenitor Cells	IMMUNITY			English	Article							NF-KAPPA-B; DIFFERENTIAL EXPRESSION ANALYSIS; PATTERN-RECOGNITION RECEPTORS; READ ALIGNMENT; STRUCTURAL BASIS; CANCER CELLS; SELF-RENEWAL; RNA; ZEBRAFISH; ACTIVATION	Inflammatory signaling is required for hematopoietic stem and progenitor cell (HSPC) development. Here, we studied the involvement of RIG-I-like receptors (RLRs) in HSPC formation. Rig-I or Mda5 deficiency impaired, while Lgp2 deficiency enhanced, HSPC emergence in zebrafish embryos. Rig-I or Mda5 deficiency reduced HSPC numbers by inhibiting inflammatory signals that were in turn enhanced in Lgp2 deficient embryos. Simultaneous reduction of Lgp2 and either Rig-I or Mda5 rescued inflammatory signals and HSPC numbers. Modulating the expression of the signaling mediator Traf6 in RLR deficient embryos restored HSPC numbers. Repetitive element transcripts could be detected in hemogenic endothelial cells and HSPCs, suggesting a role as RLR ligands. Indeed, ectopic expression of repetitive elements enhanced HSPC formation in wild-type, but not in Rig-I or Mda5 deficient embryos. Manipulation of RLR expression in mouse fetal liver HSPCs indicated functional conservation among species. Thus, repetitive elements transcribed during development drive RLR-mediated inflammatory signals that regulate HSPC formation.	[Lefkopoulos, Stylianos; Polyzou, Aikaterini; Derecka, Marta; Bergo, Veronica; Clapes, Thomas; Cauchy, Pierre; Jerez-Longres, Carolina; Yin, Na; Martagon-Calderoen, Natalia-Adriana; Klaeyle, Lheanna; Trompouki, Eirini] Max Planck Inst Immunobiol & Epigenet, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany; [Lefkopoulos, Stylianos; Polyzou, Aikaterini] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Lefkopoulos, Stylianos] Int Max Planck Res Sch Mol & Cellular Biol IMPRS, D-79108 Freiburg, Germany; [Bergo, Veronica; Mione, Maria Caterina] Univ Trento, Dept Cellular Computat & Integrat Biol, Via Sommar 9, I-38123 Trento, Italy; [Onishi-Seebacher, Megumi; Jenuwein, Thomas] Max Planck Inst Immunobiol & Epigenet, Dept Epigenet, D-79108 Freiburg, Germany; [Potts, Kathryn S.; Bowman, Teresa, V] Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10467 USA; [Liu, Feng] Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing 100101, Peoples R China; [Trompouki, Eirini] Univ Freiburg, CIBSS Ctr Integrat Biol Signaling Studies, Freiburg, Germany; [Jerez-Longres, Carolina] Univ Freiburg, Fac Biol, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany; [Jerez-Longres, Carolina] BIOSS Ctr Biol Signalling Studies, CIBSS Ctr Integrat Biol Signaling Studies, Freiburg, Germany	Max Planck Society; University of Freiburg; University of Trento; Max Planck Society; Yeshiva University; Albert Einstein College of Medicine; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Freiburg; University of Freiburg	Trompouki, E (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany.; Trompouki, E (corresponding author), Univ Freiburg, CIBSS Ctr Integrat Biol Signaling Studies, Freiburg, Germany.	trompouki@ie-freiburg.mpg.de	Trompouki, Eirini/AAX-9539-2020; Mione, Maria Caterina/ABG-9926-2021; Liu, Feng/B-9985-2015	Trompouki, Eirini/0000-0002-7242-8810; Liu, Feng/0000-0003-3228-0943; Cauchy, Pierre/0000-0002-0659-0799; Derecka, Marta/0000-0001-6265-9781; Potts, Kathryn/0000-0002-3246-9597	Max Planck Society; Marie Curie Career Integration Grant [631432]; Fritz Thyssen Stiftung [Az 10.17.1.026MN]; Deutsche Forschungsgemeinschaft, Research Training Group [GRK2344]; Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy [390939984]; American Cancer Society [RSG-129527-DDC]; EvansMDS Foundation; American Australian Association Sir Rupert Murdoch Postdoctoral Fellowship; Einstein Training Program in Stem Cell Research by the Empire State Stem Cell Fund through New York State Department of Health Contract [C30292GG]; National Key Research and Development Program of China [2018YFA0800200]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Marie Curie Career Integration Grant; Fritz Thyssen Stiftung; Deutsche Forschungsgemeinschaft, Research Training Group(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy(German Research Foundation (DFG)); American Cancer Society(American Cancer Society); EvansMDS Foundation; American Australian Association Sir Rupert Murdoch Postdoctoral Fellowship; Einstein Training Program in Stem Cell Research by the Empire State Stem Cell Fund through New York State Department of Health Contract; National Key Research and Development Program of China	We would like to thank Thomas Boehm (MPI-IE) for useful discussions and advice, George Mosialos (Aristotle University of Thessaloniki) for the Traf6 construct, Mary Goll (Georgia University) for the mavs<SUP>mk28/mk28</SUP> zebrafish line, George Pyrowolakis and Adam Karoutas for critically reading our manuscript, as well as all facilities of the MPI-IE. E.T. was supported by the Max Planck Society, a Marie Curie Career Integration Grant (631432 Bloody Signals), and The Fritz Thyssen Stiftung (Az 10.17.1.026MN). E.T. and A.P. are members and get funds from the Deutsche Forschungsgemeinschaft, Research Training Group GRK2344 "MeInBio -BioInMe.'' This study was supported by the Deutsche Forschungsgemeinschaft under Germany's Excellence Strategy (CIBSS-EXC-2189-Project ID 390939984). T.V.B. was funded by American Cancer Society RSG-129527-DDC and the EvansMDS Foundation. K.S.P. was funded by the American Australian Association Sir Rupert Murdoch Postdoctoral Fellowship and The Einstein Training Program in Stem Cell Research funded by the Empire State Stem Cell Fund through New York State Department of Health Contract C30292GG. F.L. was funded by the National Key Research and Development Program of China (2018YFA0800200).	Ahmad S, 2018, CELL, V172, P797, DOI 10.1016/j.cell.2017.12.016; Aktas T, 2017, NATURE, V544, P115, DOI 10.1038/nature21715; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Arulmozhivarman G., 2017, SCI REP, V7, P1; Bao WD, 2015, MOBILE DNA-UK, V6, DOI 10.1186/s13100-015-0041-9; Barbieri D, 2018, J EXP MED, V215, P1463, DOI 10.1084/jem.20170997; Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Berghmans S, 2005, P NATL ACAD SCI USA, V102, P407, DOI 10.1073/pnas.0406252102; Boelens MC, 2014, CELL, V159, P499, DOI 10.1016/j.cell.2014.09.051; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolli N, 2011, BLOOD, V117, P3996, DOI 10.1182/blood-2010-08-304030; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Bruns AM, 2012, CRIT REV BIOCHEM MOL, V47, P194, DOI 10.3109/10409238.2011.630974; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burns CE, 2002, EXP HEMATOL, V30, P1381, DOI 10.1016/S0301-472X(02)00955-4; Cauchy P, 2016, NUCLEIC ACIDS RES, V44, P3567, DOI 10.1093/nar/gkv1475; Chaurasia P, 2014, J CLIN INVEST, V124, P2378, DOI 10.1172/JCI70313; Chiappinelli KB, 2015, CELL, V162, P974, DOI 10.1016/j.cell.2015.07.011; Choudhuri A, 2017, STEM CELL REP, V8, P1465, DOI 10.1016/j.stemcr.2017.05.018; Chow KT, 2018, ANNU REV IMMUNOL, V36, P667, DOI 10.1146/annurev-immunol-042617-053309; Ciau-Uitz A, 2014, EXP HEMATOL, V42, P669, DOI 10.1016/j.exphem.2014.06.001; Clapes T, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00487; Dale RK, 2011, BIOINFORMATICS, V27, P3423, DOI 10.1093/bioinformatics/btr539; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dhir A, 2018, NATURE, V560, P238, DOI 10.1038/s41586-018-0363-0; Ding Y., 2020, BLOOD; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dzierzak E, 2018, CELL STEM CELL, V22, P639, DOI 10.1016/j.stem.2018.04.015; Ellett F, 2011, BLOOD, V117, pE49, DOI 10.1182/blood-2010-10-314120; Espin-Palazon R, 2016, EXP HEMATOL, V44, P519, DOI 10.1016/j.exphem.2016.03.010; Espin-Palazon R, 2014, CELL, V159, P1070, DOI 10.1016/j.cell.2014.10.031; Fang J, 2018, CELL REP, V22, P1250, DOI 10.1016/j.celrep.2018.01.013; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gagnon JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098186; Gao YM, 2020, IMMUNITY, V52, P1007, DOI 10.1016/j.immuni.2020.05.003; Hall C, 2016, MOL IMMUNOL, V69, P113, DOI 10.1016/j.molimm.2015.10.020; He QP, 2015, BLOOD, V125, P1098, DOI 10.1182/blood-2014-09-601542; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herman JS, 2018, NAT METHODS, V15, P379, DOI 10.1038/nmeth.4662; Hess I, 2012, IMMUNITY, V36, P298, DOI 10.1016/j.immuni.2011.12.016; Hu ZB, 2010, MOL CANCER THER, V9, P1536, DOI 10.1158/1535-7163.MCT-10-0191; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Ji YX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11267; Jin Y, 2015, BIOINFORMATICS, V31, P3593, DOI 10.1093/bioinformatics/btv422; Kanther M, 2011, GASTROENTEROLOGY, V141, P197, DOI 10.1053/j.gastro.2011.03.042; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kato H, 2015, CURR OPIN IMMUNOL, V37, P40, DOI 10.1016/j.coi.2015.10.002; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klaus A, 2017, DEV BIOL, V428, P318, DOI 10.1016/j.ydbio.2017.03.008; Koh FM, 2015, P NATL ACAD SCI USA, V112, pE1734, DOI 10.1073/pnas.1424850112; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Kowalinski E, 2011, CELL, V147, P423, DOI 10.1016/j.cell.2011.09.039; Lassig C, 2017, J BIOL CHEM, V292, P9000, DOI 10.1074/jbc.R117.788398; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lawson ND, 2001, DEVELOPMENT, V128, P3675; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li K, 2005, J BIOL CHEM, V280, P16739, DOI 10.1074/jbc.M414139200; Li XY, 2014, MOL CELL, V53, P407, DOI 10.1016/j.molcel.2013.12.008; Li Y, 2014, GENE DEV, V28, P2597, DOI 10.1101/gad.253302.114; Lieschke GJ, 2001, BLOOD, V98, P3087, DOI 10.1182/blood.V98.10.3087; Liu GQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05745-w; Long QM, 1997, DEVELOPMENT, V124, P4105; Mathias JR, 2006, J LEUKOCYTE BIOL, V80, P1281, DOI 10.1189/jlb.0506346; Milhem M, 2004, BLOOD, V103, P4102, DOI 10.1182/blood-2003-07-2431; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mu X, 2016, ADV IMMUNOL, V132, P47, DOI 10.1016/bs.ai.2016.07.001; Muto T, 2020, NAT IMMUNOL, V21, P535, DOI 10.1038/s41590-020-0663-z; Paik EJ, 2010, INT J DEV BIOL, V54, P1127, DOI 10.1387/ijdb.093042ep; Palchetti S, 2015, J BIOL CHEM, V290, P5470, DOI 10.1074/jbc.M114.601625; Papa L, 2018, BLOOD ADV, V2, P2766, DOI 10.1182/bloodadvances.2018024273; Parisien JP, 2018, EMBO REP, V19, DOI 10.15252/embr.201745176; Percharde M, 2017, DEV CELL, V40, P9, DOI 10.1016/j.devcel.2016.11.010; Piper J, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt850; Piragyte I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05311-4; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajshekar S, 2018, ELIFE, V7, DOI 10.7554/eLife.39658; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ranoa DRE, 2016, ONCOTARGET, V7, P26496, DOI 10.18632/oncotarget.8420; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez KR, 2014, J VIROL, V88, P8194, DOI 10.1128/JVI.00640-14; Roehr JT, 2017, BIOINFORMATICS, V33, P2941, DOI 10.1093/bioinformatics/btx330; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Roulois D, 2015, CELL, V162, P961, DOI 10.1016/j.cell.2015.07.056; Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Salminen A, 2009, PROG NEUROBIOL, V87, P181, DOI 10.1016/j.pneurobio.2009.01.001; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Sawamiphak S, 2014, DEV CELL, V31, P640, DOI 10.1016/j.devcel.2014.11.007; Schorpp M, 2006, J IMMUNOL, V177, P2463, DOI 10.4049/jimmunol.177.4.2463; Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116; Stockhammer OW, 2010, MOL IMMUNOL, V48, P179, DOI 10.1016/j.molimm.2010.08.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Suthar MS, 2012, IMMUNITY, V37, P235, DOI 10.1016/j.immuni.2012.07.004; Suzuki M, 2004, AM J HEMATOL, V77, P313, DOI 10.1002/ajh.20178; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tamplin OJ, 2015, CELL, V160, P241, DOI 10.1016/j.cell.2014.12.032; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thompson GL, 1998, SOUTHEAST SYMP SYSTE, P3; Thompson MA, 1998, DEV BIOL, V197, P248, DOI 10.1006/dbio.1998.8887; Tripathi S, 2015, CELL HOST MICROBE, V18, P723, DOI 10.1016/j.chom.2015.11.002; van der Vaart M, 2014, CELL HOST MICROBE, V15, P753, DOI 10.1016/j.chom.2014.05.005; van der Veen AG, 2018, EMBO J, V37, DOI 10.15252/embj.201797479; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Watanabe Y, 2013, NUTRIENTS, V5, P3757, DOI 10.3390/nu5093757; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willemsen J, 2017, MOL CELL, V65, P403, DOI 10.1016/j.molcel.2016.12.021; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Xu XX, 2018, PROTEIN CELL, V9, P246, DOI 10.1007/s13238-017-0431-5; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Yu LL, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/5271295; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029; Zhang NN, 2008, P NATL ACAD SCI USA, V105, P10553, DOI 10.1073/pnas.0804895105; Zhang PP, 2015, CELL RES, V25, P1093, DOI 10.1038/cr.2015.109; Zhang QM, 2018, J IMMUNOL, V200, P688, DOI 10.4049/jimmunol.1701388; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao LZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14991	128	19	19	2	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					934	+		10.1016/j.immuni.2020.10.007	http://dx.doi.org/10.1016/j.immuni.2020.10.007			27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33159854	Bronze			2022-12-18	WOS:000599348200008
J	Effern, M; Glodde, N; Braun, M; Liebing, J; Boll, HN; Yong, M; Bawden, E; Hinze, D; Van den Boorn-Konijnenberg, D; Daoud, M; Aymans, P; Landsberg, J; Smyth, MJ; Flatz, L; Tuting, T; Bald, T; Gebhardt, T; Holzel, M				Effern, Maike; Glodde, Nicole; Braun, Matthias; Liebing, Jana; Boll, Helena N.; Yong, Michelle; Bawden, Emma; Hinze, Daniel; Van den Boorn-Konijnenberg, Debby; Daoud, Mila; Aymans, Pia; Landsberg, Jennifer; Smyth, Mark J.; Flatz, Lukas; Tueting, Thomas; Bald, Tobias; Gebhardt, Thomas; Hoelzel, Michael			Adoptive T Cell Therapy Targeting Different Gene Products Reveals Diverse and Context-Dependent Immune Evasion in Melanoma	IMMUNITY			English	Article							PD-1 BLOCKADE; ANTIGEN; IDENTIFICATION; LYMPHOCYTES; CANCER; RESISTANCE; ERADICATION; MUTATIONS; INDUCTION; RESPONSES	Tumor immune escape limits durable responses to T cell therapy. Here, we examined how regulation and function of gene products that provide the target epitopes for CD8(+) T cell anti-tumor immunity influence therapeutic efficacy and resistance. We used a CRISPR-Cas9-based method (CRISPitope) in syngeneic melanoma models to fuse the same model CD8(+) T cell epitope to the C-termini of different endogenous gene products. Targeting melanosomal proteins or oncogenic CDK4(R24C )(Cyclin-dependent kinase 4) by adoptive cell transfer (ACT) of the same epitope-specific CD8(+) T cells revealed diverse genetic and non-genetic immune escape mechanisms. ACT directed against melanosomal proteins, but not CDK4(R24C), promoted melanoma dedifferentiation, and increased myeloid cell infiltration. CDK4(R24C) antigen persistence was associated with an interferon-high and T-cell-rich tumor microenvironment, allowing for immune checkpoint inhibition as salvage therapy. Thus, the choice of target antigen determines the phenotype and immune contexture of recurrent melanomas, with implications to the design of cancer immunotherapies.	[Effern, Maike; Glodde, Nicole; Liebing, Jana; Boll, Helena N.; Yong, Michelle; Bawden, Emma; Hinze, Daniel; Van den Boorn-Konijnenberg, Debby; Daoud, Mila; Hoelzel, Michael] Univ Bonn, Univ Hosp Bonn, Med Fac, Inst Expt Oncol IEO, D-53105 Bonn, Germany; [Effern, Maike; Bawden, Emma; Gebhardt, Thomas] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Braun, Matthias; Bald, Tobias] QIMR Berghofer Med Res Inst, Oncol & Cellular Immunol Lab, Herston, Qld 4006, Australia; [Braun, Matthias; Smyth, Mark J.] QIMR Berghofer Med Res Inst, Immunol Canc & Infect Lab, Herston, Qld 4006, Australia; [Aymans, Pia; Landsberg, Jennifer] Univ Bonn, Dept Dermatol & Allergy, Lab Expt Dermatol, D-53105 Bonn, Germany; [Smyth, Mark J.] Univ Queensland, Sch Med, Herston, Qld 4006, Australia; [Flatz, Lukas] Kantonsspital St Gallen, Inst Immunobiol, CH-9007 St Gallen, Switzerland; [Flatz, Lukas] Kantonsspital St Gallen, Dept Dermatol Allergol & Venerol, CH-9007 St Gallen, Switzerland; [Tueting, Thomas] Univ Magdeburg, Dept Dermatol, Lab Expt Dermatol, Magdeburg, Germany; [Daoud, Mila] Univ Cologne, Inst Med Microbiol Immunol & Hyg, Ctr Mol Med Cologne, Cologne, Germany; [Daoud, Mila] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, Cologne, Germany	University of Bonn; University of Melbourne; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; University of Bonn; University of Queensland; Kantonsspital St. Gallen; Kantonsspital St. Gallen; Otto von Guericke University; University of Cologne; University of Cologne	Holzel, M (corresponding author), Univ Bonn, Univ Hosp Bonn, Med Fac, Inst Expt Oncol IEO, D-53105 Bonn, Germany.	michael.hoelzel@ukbonn.de	Tüting, Thomas/AAJ-3610-2021; Landsberg, Jenny/AGI-0216-2022	Tüting, Thomas/0000-0001-7146-0934; Landsberg, Jenny/0000-0001-8029-3883; Daoud, Mila/0000-0002-8705-5869; Effern, Maike/0000-0002-1766-9881; Bawden, Emma/0000-0002-4772-7675	NHMRC Early Career fellowship [1124690]; EMBO Long Term Fellowship ALTF [945-2015]; Deutsche Krebshilfe (German Cancer Aid) through a junior research group grant within the Mildred Scheel School of Oncology (MSSO) Cologne-Bonn [70113307]; Mildred Scheel Stiftung f_ur Krebsforschung; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [GRK 2168]; University of Melbourne; DFG [EXC2151-390873048]; NHMRC [1173958, 1132519]	NHMRC Early Career fellowship(National Health and Medical Research Council (NHMRC) of Australia); EMBO Long Term Fellowship ALTF; Deutsche Krebshilfe (German Cancer Aid) through a junior research group grant within the Mildred Scheel School of Oncology (MSSO) Cologne-Bonn; Mildred Scheel Stiftung f_ur Krebsforschung(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); University of Melbourne(University of Melbourne); DFG(German Research Foundation (DFG)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We thank P. Wurst and An. Dolf for help with flow cytometry. We thank the UKB core facilities (flow cytometry and NGS). This work was supported by an NHMRC Early Career fellowship (grant number 1124690) and an EMBO Long Term Fellowship ALTF (grant number 945-2015) to T.B., the Deutsche Krebshilfe (German Cancer Aid) through a junior research group grant within the Mildred Scheel School of Oncology (MSSO) Cologne-Bonn (70113307) to N.G., a scholarship within the ``Mildred Scheel Stiftung f_ur Krebsforschung'' to M.B., the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) within GRK 2168 to M.H., scholarships by the University of Melbourne to M.E. and E.B., a scholarship to M.E. within GRK 2168, and the DFG under Germany's Excellence Strategy-EXC2151-390873048. M.J.S. was supported by NHMRC Investigator (1173958) and Program (1132519) grants. T.G. and M.H. are supervisors in the GRK 2168 international graduate school, Bonn-Melbourne. M.H. is a member of the DFG Excellence Cluster ImmunoSensation2 (EXC 2151).	Anders K, 2011, CANCER CELL, V20, P755, DOI 10.1016/j.ccr.2011.10.019; Ayers M, 2017, J CLIN INVEST, V127, P2930, DOI 10.1172/JCI91190; Balachandran VP, 2017, NATURE, V551, P512, DOI 10.1038/nature24462; Bald T, 2014, CANCER DISCOV, V4, P674, DOI 10.1158/2159-8290.CD-13-0458; Bald T, 2014, NATURE, V507, P109, DOI 10.1038/nature13111; Bassani-Sternberg M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13404; Benci JL, 2016, CELL, V167, P1540, DOI 10.1016/j.cell.2016.11.022; Blankenstein T, 2015, CURR OPIN IMMUNOL, V33, P112, DOI 10.1016/j.coi.2015.02.005; BRICHARD V, 1993, J EXP MED, V178, P489, DOI 10.1084/jem.178.2.489; Bulik-Sullivan B, 2019, NAT BIOTECHNOL, V37, P55, DOI 10.1038/nbt.4313; Chandran SS, 2015, CLIN CANCER RES, V21, P534, DOI 10.1158/1078-0432.CCR-14-2208; Chodon T, 2014, CLIN CANCER RES, V20, P2457, DOI 10.1158/1078-0432.CCR-13-3017; Cristescu R, 2018, SCIENCE, V362, P197, DOI 10.1126/science.aar3593; Engels B, 2013, CANCER CELL, V23, P516, DOI 10.1016/j.ccr.2013.03.018; Gajewski TF, 2017, ADV EXP MED BIOL, V1036, P19, DOI 10.1007/978-3-319-67577-0_2; Glodde N, 2017, IMMUNITY, V47, P789, DOI 10.1016/j.immuni.2017.09.012; Goding CR, 2019, GENE DEV, V33, P983, DOI 10.1101/gad.324657.119; Hanada KI, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124405; Hinrichs CS, 2013, NAT BIOTECHNOL, V31, P999, DOI 10.1038/nbt.2725; Hoek KS, 2008, CANCER RES, V68, P650, DOI 10.1158/0008-5472.CAN-07-2491; Jacquelot N, 2019, CELL RES, V29, P846, DOI 10.1038/s41422-019-0224-x; Jurtz V, 2017, J IMMUNOL, V199, P3360, DOI 10.4049/jimmunol.1700893; KAWAKAMI Y, 1994, P NATL ACAD SCI USA, V91, P6458, DOI 10.1073/pnas.91.14.6458; Konieczkowski DJ, 2014, CANCER DISCOV, V4, P816, DOI 10.1158/2159-8290.CD-13-0424; Landsberg J, 2012, NATURE, V490, P412, DOI 10.1038/nature11538; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leisegang M, 2016, CLIN CANCER RES, V22, P2734, DOI 10.1158/1078-0432.CCR-15-2361; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Luksza M, 2017, NATURE, V551, P517, DOI 10.1038/nature24473; Macleod BL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004303; Mehta A, 2018, CANCER DISCOV, V8, P935, DOI 10.1158/2159-8290.CD-17-1178; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Nowicki TS, 2019, CLIN CANCER RES, V25, P2096, DOI 10.1158/1078-0432.CCR-18-3496; O'Donnell TJ, 2018, CELL SYST, V7, P129, DOI 10.1016/j.cels.2018.05.014; Ott PA, 2017, NATURE, V547, P217, DOI 10.1038/nature22991; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Pai CCS, 2019, IMMUNITY, V50, P477, DOI 10.1016/j.immuni.2019.01.006; Reinhardt J, 2017, CANCER RES, V77, P4697, DOI 10.1158/0008-5472.CAN-17-0395; Reinius B, 2016, NAT GENET, V48, P1430, DOI 10.1038/ng.3678; Riesenberg S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9755; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodig SJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3342; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Schmid-Burgk JL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12338; Schmid-Burgk JL, 2014, GENOME RES, V24, P1719, DOI 10.1101/gr.176701.114; Schumacher T, 2014, NATURE, V512, P324, DOI 10.1038/nature13387; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeda K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14607; Tran E, 2016, NEW ENGL J MED, V375, P2255, DOI 10.1056/NEJMoa1609279; Verdegaal EME, 2016, NATURE, V536, P91, DOI 10.1038/nature18945; Verfaillie A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7683; Walton SM, 2006, J IMMUNOL, V177, P8212, DOI 10.4049/jimmunol.177.11.8212; WANG RF, 1995, J EXP MED, V181, P799, DOI 10.1084/jem.181.2.799; WOLFEL T, 1995, SCIENCE, V269, P1281, DOI 10.1126/science.7652577; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhao F, 2016, CANCER RES, V76, P4347, DOI 10.1158/0008-5472.CAN-16-0008	59	19	20	3	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					564	+		10.1016/j.immuni.2020.07.007	http://dx.doi.org/10.1016/j.immuni.2020.07.007			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32750334	Bronze			2022-12-18	WOS:000569806100014
J	Vacchio, MS; Ciucci, T; Gao, YY; Watanabe, M; Balmaceno-Criss, M; McGinty, MT; Huang, A; Xiao, Q; McConkey, C; Zhao, YM; Shetty, J; Tran, B; Pepper, M; Vahedi, G; Jenkins, MK; McGavern, DB; Bosselut, R				Vacchio, Melanie S.; Ciucci, Thomas; Gao, Yayi; Watanabe, Masashi; Balmaceno-Criss, Mariah; McGinty, Mitchell T.; Huang, Allan; Xiao, Qi; McConkey, Cameron; Zhao, Yongmei; Shetty, Jyoti; Tran, Bao; Pepper, Marion; Vahedi, Golnaz; Jenkins, Marc K.; McGavern, Dorian B.; Bosselut, Remy			A Thpok-Directed Transcriptional Circuitry Promotes Bcl6 and Maf Expression to Orchestrate T Follicular Helper Differentiation	IMMUNITY			English	Article							CELL DIFFERENTIATION; LINEAGE DIFFERENTIATION; GENE-EXPRESSION; C-MAF; CD4; PD-1; BATF; BLIMP-1; ANTIGEN; REGULATORS	The generation of high-affinity neutralizing antibodies, the objective of most vaccine strategies, occurs in B cells within germinal centers (GCs) and requires rate-limiting "help" from follicular helper CD4(+) T (Tfh) cells. Although Tfh differentiation is an attribute of MHC II-restricted CD4(+) T cells, the transcription factors driving Tfh differentiation, notably Bcl6, are not restricted to CD4(+) T cells. Here, we identified a requirement for the CD4(+)-specific transcription factor Thpok during Tfh cell differentiation, GC formation, and antibody maturation. Thpok promoted Bcl6 expression and bound to a Thpok-responsive region in the first intron of Bcl6. Thpok also promoted the expression of Bcl6-independent genes, including the transcription factor Maf, which cooperated with Bcl6 to mediate the effect of Thpok on Tfh cell differentiation. Our findings identify a transcriptional program that links the CD4(+) lineage with Tfh differentiation, a limiting factor for efficient B cell responses, and suggest avenues to optimize vaccine generation.	[Vacchio, Melanie S.; Ciucci, Thomas; Gao, Yayi; Balmaceno-Criss, Mariah; McGinty, Mitchell T.; Huang, Allan; Xiao, Qi; McConkey, Cameron; Bosselut, Remy] NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Watanabe, Masashi] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Zhao, Yongmei; Shetty, Jyoti; Tran, Bao] NCI, Ctr Canc Res, Sequencing Facil, Adv Technol Res Facil,NIH, Bethesda, MD 20892 USA; [Pepper, Marion] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Vahedi, Golnaz] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Jenkins, Marc K.] Univ Minnesota, Dept Microbiol & Immunol, Ctr Immunol, Minneapolis, MN USA; [McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Washington; University of Washington Seattle; University of Pennsylvania; University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Bosselut, R (corresponding author), NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	bosselur@nih.gov	McGavern, Dorian/HCH-3601-2022; Jenkins, Marc/G-1063-2012	McGavern, Dorian/0000-0001-9568-545X; Jenkins, Marc/0000-0001-8009-7655; Ciucci, Thomas/0000-0002-5828-0207; Balmaceno-Criss, Mariah/0000-0002-5065-6062; Watanabe, Masashi/0000-0003-1741-8748	Intramural Research Program of the National Cancer Institute, Center for Cancer Research, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL145754] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003112] Funding Source: NIH RePORTER	Intramural Research Program of the National Cancer Institute, Center for Cancer Research, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T.-A. Lewis, E. Castro, and H. Kwak for expert animal care and genotyping; Y. Belkaid, J. Zhu, J. O'Shea, Ming Li, R. Ahmed, and the NIH tetramer facility for mice and reagents; Maggie Cam (CCR Bioinformatics Core), the CCR Flow Cytometry Core, the CCR Confocal Microscopy Core Facility, and the NIH high-performance computing cluster for assistance; and J. Ashwell, Y. Belkaid, R. Hodes, P. Love, and J. Zhu for reading the manuscript. This work benefited from data assembled by the Immgen Consortium. Supported by the Intramural Research Program of the National Cancer Institute, Center for Cancer Research, NIH.	Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andris F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00480; Austin JW, 2014, J IMMUNOL, V192, P4876, DOI 10.4049/jimmunol.1302750; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Carpenter AC, 2017, J IMMUNOL, V199, P1716, DOI 10.4049/jimmunol.1700181; Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Choi YS, 2015, METHODS MOL BIOL, V1291, P49, DOI 10.1007/978-1-4939-2498-1_5; Ciucci T, 2019, IMMUNITY, V50, P91, DOI 10.1016/j.immuni.2018.12.019; Ciucci T, 2017, P NATL ACAD SCI USA, V114, P13236, DOI 10.1073/pnas.1711160114; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; D'Cruz LM, 2009, SEMIN IMMUNOL, V21, P92, DOI 10.1016/j.smim.2009.02.002; DiToro D, 2018, SCIENCE, V361, P1086, DOI 10.1126/science.aao2933; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong ZJ, 2010, TRENDS IMMUNOL, V31, P295, DOI 10.1016/j.it.2010.05.008; Driegen S, 2005, TRANSGENIC RES, V14, P477, DOI 10.1007/s11248-005-7220-2; Elgueta R, 2009, IMMUNOL REV, V229, P152, DOI 10.1111/j.1600-065X.2009.00782.x; Ellebrecht CT, 2016, SCIENCE, V353, P179, DOI 10.1126/science.aaf6756; Grusdat M, 2014, CELL DEATH DIFFER, V21, P1050, DOI 10.1038/cdd.2014.19; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Ise W, 2011, NAT IMMUNOL, V12, P536, DOI 10.1038/ni.2037; Iwata A, 2017, NAT IMMUNOL, V18, P563, DOI 10.1038/ni.3714; Jenkinson SR, 2007, J EXP MED, V204, P267, DOI 10.1084/jem.20061982; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Klinger M, 2009, J IMMUNOL, V182, P4581, DOI 10.4049/jimmunol.0900010; Koguchi Y, 2011, J IMMUNOL, V187, P626, DOI 10.4049/jimmunol.1004083; Kroenke MA, 2012, J IMMUNOL, V188, P3734, DOI 10.4049/jimmunol.1103246; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Kusam S, 2009, INT J CANCER, V125, P977, DOI 10.1002/ijc.24450; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Leek JT, 2012, BIOINFORMATICS, V28, P882, DOI 10.1093/bioinformatics/bts034; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Liu XD, 2016, CELL REP, V14, P1735, DOI 10.1016/j.celrep.2016.01.038; Liu XD, 2014, NATURE, V507, P513, DOI 10.1038/nature12910; Liu XD, 2013, IMMUNOL REV, V252, P139, DOI 10.1111/imr.12040; Liu XD, 2012, J EXP MED, V209, P1841, DOI 10.1084/jem.20120219; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mudge JM, 2015, MAMM GENOME, V26, P366, DOI 10.1007/s00335-015-9583-x; Naoe Y, 2007, J EXP MED, V204, P1749, DOI 10.1084/jem.20062456; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Oldstone MBA, 2002, CURR TOP MICROBIOL, V263, P83; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Sadanand S, 2016, ANNU REV MED, V67, P185, DOI 10.1146/annurev-med-091014-090749; Saitoh T, 2002, FEBS LETT, V532, P45, DOI 10.1016/S0014-5793(02)03622-0; Scott DW, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01576; Shan Q, 2017, NAT IMMUNOL, V18, P931, DOI 10.1038/ni.3773; Shapiro-Shelef M, 2003, IMMUNITY, V19, P607, DOI 10.1016/S1074-7613(03)00267-X; Shaw LA, 2016, NAT IMMUNOL, V17, P834, DOI 10.1038/ni.3461; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Toney LM, 2000, NAT IMMUNOL, V1, P214, DOI 10.1038/79749; Vacchio MS, 2016, J IMMUNOL, V196, P4848, DOI 10.4049/jimmunol.1600415; Vacchio MS, 2014, NAT IMMUNOL, V15, P947, DOI 10.1038/ni.2960; Victora GD, 2015, CELL, V163, P545, DOI 10.1016/j.cell.2015.10.004; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wang L, 2009, J IMMUNOL, V183, P2903, DOI 10.4049/jimmunol.0901041; Wang L, 2008, IMMUNITY, V29, P876, DOI 10.1016/j.immuni.2008.09.019; Watanabe M, 2017, J EXP MED, V214, P2795, DOI 10.1084/jem.20161955; Wildt KF, 2007, J IMMUNOL, V179, P4405, DOI 10.4049/jimmunol.179.7.4405; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Wu TQ, 2015, CELL REP, V12, P2099, DOI 10.1016/j.celrep.2015.08.049; Xie MM, 2017, EUR J IMMUNOL, V47, P1136, DOI 10.1002/eji.201747034; Xin G, 2015, CELL REP, V13, P1118, DOI 10.1016/j.celrep.2015.09.069; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Yagi R, 2010, IMMUNITY, V32, P507, DOI 10.1016/j.immuni.2010.04.004; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhu JF, 2004, NAT IMMUNOL, V5, P1157, DOI 10.1038/ni1128	83	19	20	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 17	2019	51	3					465	+		10.1016/j.immuni.2019.06.023	http://dx.doi.org/10.1016/j.immuni.2019.06.023			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY1XI	31422869	Green Accepted, Bronze			2022-12-18	WOS:000486184600010
J	Chisolm, DA; Cheng, WN; Colburn, SA; Silva-Sanchez, A; Meza-Perez, S; Randall, TD; Weinmann, AS				Chisolm, Danielle A.; Cheng, Wayne; Colburn, Shelby A.; Silva-Sanchez, Aaron; Meza-Perez, Selene; Randall, Troy D.; Weinmann, Amy S.			Defining Genetic Variation in Widely Used Congenic and Backcrossed Mouse Models Reveals Varied Regulation of Genes Important for Immune Responses	IMMUNITY			English	Article							T-CELLS; TRANSPOSABLE ELEMENTS; MICE; MUTATION; INFLAMMATION; GENERATION; SELECTIN; PROGRAM; CD4	Genetic variation influences how the genome is interpreted in individuals and in mouse strains used to modelimmune responses. Wedevelopedapproaches to utilize next-generation sequencing datasets to identify sequence variation in genes and enhancer elements in congenic and backcross mouse models. We defined genetic variation in the widely used B6-CD45.2 and B6.SJL-CD45.1 congenic model, identifying substantial differences inSJL geneticcontent retained in B6.SJL-CD45.1 strains on the basis of the vendor source of the mice. Genes encoding PD-1, CD62L, Bcl-2, cathepsin E, and Cxcr4 were within SJL genetic content in at least one vendor source of B6.SJL-CD45.1 mice. SJL genetic content affected enhancer elements, gene regulation, protein expression, and amino acid content in CD4(+) T helper 1 cells, and mice infected with influenza showed reduced expression of Cxcr4 on B6.SJL-CD45.1 T follicular helper cells. These findings provide information on experimental variables and aid in creating approaches that account for genetic variables.	[Chisolm, Danielle A.; Cheng, Wayne; Colburn, Shelby A.; Weinmann, Amy S.] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Silva-Sanchez, Aaron; Meza-Perez, Selene; Randall, Troy D.] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA; [Chisolm, Danielle A.] NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Weinmann, AS (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	weinmann@uab.edu	Silva-Sanchez, Aaron/AAI-8572-2021; Meza-Perez, Selene/AAX-2300-2021	Silva-Sanchez, Aaron/0000-0002-1882-2534; Meza-Perez, Selene/0000-0001-7881-6964	National Institutes of Health [AI061061, CA216234, AI109962]; National Cancer Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI061061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Weinmann lab for discussions, the Gnotobiotic Core Facility at University of Alabama at Birmingham for providing germ-free mice, the National Institutes of Health for funding (AI061061 to A.S.W. and CA216234 and AI109962 to T.D.R.), and the National Cancer Institute preclinical repository for IL-2.	Basu S, 2013, J IMMUNOL METHODS, V396, P163, DOI 10.1016/j.jim.2013.07.008; Chisolm DA, 2018, ANNU REV IMMUNOL, V36, P221, DOI 10.1146/annurev-immunol-042617-053127; Chisolm DA, 2017, IMMUNITY, V47, P251, DOI 10.1016/j.immuni.2017.07.015; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dwir O, 2000, J BIOL CHEM, V275, P18682, DOI 10.1074/jbc.M001103200; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Estes JD, 2004, J IMMUNOL, V173, P6169, DOI 10.4049/jimmunol.173.10.6169; Gezsi A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2050-y; Gray EE, 2013, NAT IMMUNOL, V14, P584, DOI 10.1038/ni.2585; Hwang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep17875; Jafri S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03784-9; Jang Y, 2018, J IMMUNOL, V200, P1982, DOI 10.4049/jimmunol.1701676; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levine AG, 2017, NATURE, V546, P421, DOI 10.1038/nature22360; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Link VM, 2018, CELL, V173, P1796, DOI 10.1016/j.cell.2018.04.018; Lippert E, 2003, J IMMUNOL, V171, P1542, DOI 10.4049/jimmunol.171.3.1542; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mercier FE, 2016, STEM CELL REP, V6, P985, DOI 10.1016/j.stemcr.2016.04.010; Oestreich KJ, 2014, NAT IMMUNOL, V15, P957, DOI 10.1038/ni.2985; Phan UT, 2006, NAT IMMUNOL, V7, P883, DOI 10.1038/ni1366; Purtha WE, 2012, P NATL ACAD SCI USA, V109, pE898, DOI 10.1073/pnas.1118155109; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; SHEN FW, 1985, P NATL ACAD SCI USA, V82, P7360, DOI 10.1073/pnas.82.21.7360; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Tacchini-Cottier F, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00032; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Timpson NJ, 2018, NAT REV GENET, V19, P110, DOI 10.1038/nrg.2017.101; Vahedi G, 2015, NATURE, V520, P558, DOI 10.1038/nature14154; Vanden Berghe T, 2015, IMMUNITY, V43, P200, DOI 10.1016/j.immuni.2015.06.011; Waterstrat A, 2010, BLOOD, V115, P408, DOI 10.1182/blood-2008-03-143370; Wong SY, 2018, J IMMUNOL, V201, P1442, DOI 10.4049/jimmunol.1800014; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yalcin B, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r18; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	44	19	19	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					155	+		10.1016/j.immuni.2019.05.006	http://dx.doi.org/10.1016/j.immuni.2019.05.006			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31248780	Bronze, Green Accepted			2022-12-18	WOS:000475561000018
J	O'Sullivan, D; van der Windt, GJW; Huang, SCC; Curtis, JD; Chang, CH; Buck, MD; Qiu, J; Smith, AM; Lam, WY; DiPlato, LM; Hsu, FF; Birnbaum, MJ; Pearce, EJ; Pearce, EL				O'Sullivan, David; van der Windt, Gerritje J. W.; Huang, Stanley Ching-Cheng; Curtis, Jonathan D.; Chang, Chih-Hao; Buck, Michael D.; Qiu, Jing; Smith, Amber M.; Lam, Wing Y.; DiPlato, Lisa M.; Hsu, Fong-Fu; Birnbaum, Morris J.; Pearce, Edward J.; Pearce, Erika L.			Memory CD8(+) T Cells Use Cell-Intrinsic Lipolysis to Support the Metabolic Programming Necessary for Development (vol 41, pg 75, 2014)	IMMUNITY			English	Correction												erikapearce@path.wustl.edu	Huang, Stanley Ching-Cheng/AAE-7866-2019	Huang, Stanley Ching-Cheng/0000-0002-6557-3737	NATIONAL CANCER INSTITUTE [R01CA181125] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI091965] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA181125] Funding Source: Medline; NIAID NIH HHS [R01 AI091965] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005	1	19	19	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2018	49	2					375	376		10.1016/j.immuni.2018.07.018	http://dx.doi.org/10.1016/j.immuni.2018.07.018			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR1YX	30134202	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000442354500021
J	Schultze, JL; Rosenstiel, P				Schultze, Joachim L.; Rosenstiel, Philip		SYSCID Consortium	Systems Medicine in Chronic Inflammatory Diseases	IMMUNITY			English	Editorial Material							LINKS	Chronic inflammatory diseases represent an increasing medical burden, yet neither tools to predict the individual disease course nor causal cures are at hand. We discuss opportunities for systems medicine to derive precise, individualized disease models and outline the European consortium SYSCID as part of the roadmap to clinical practice.	[Schultze, Joachim L.] Univ Bonn, Life & Med Sci LIMES Inst, Genom & Immunoregulat, D-53115 Bonn, Germany; [Schultze, Joachim L.] German Ctr Neurodegenerat Dis DZNE, Mol Immunol Neurodegenerat, D-53127 Bonn, Germany; [Rosenstiel, Philip] Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Campus Kiel, D-24105 Kiel, Germany; [Rosenstiel, Philip] Univ Hosp Schleswig Holstein, Campus Kiel, D-24105 Kiel, Germany; [Rosenstiel, Philip] Univ Kiel, Dept Med, D-24105 Kiel, Germany	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Kiel; University of Kiel; Schleswig Holstein University Hospital; University of Kiel	Schultze, JL (corresponding author), Univ Bonn, Life & Med Sci LIMES Inst, Genom & Immunoregulat, D-53115 Bonn, Germany.; Schultze, JL (corresponding author), German Ctr Neurodegenerat Dis DZNE, Mol Immunol Neurodegenerat, D-53127 Bonn, Germany.; Rosenstiel, P (corresponding author), Christian Albrechts Univ Kiel, Inst Clin Mol Biol, Campus Kiel, D-24105 Kiel, Germany.; Rosenstiel, P (corresponding author), Univ Hosp Schleswig Holstein, Campus Kiel, D-24105 Kiel, Germany.; Rosenstiel, P (corresponding author), Univ Kiel, Dept Med, D-24105 Kiel, Germany.	j.schultze@uni-bonn.de; p.rosenstiel@mucosa.de	Andersen, Vibeke/I-7932-2012; Schultze, Joachim L./ABA-8176-2020; Rosenstiel, Philip/A-5137-2009	Andersen, Vibeke/0000-0002-0127-2863; Schultze, Joachim L./0000-0003-2812-9853; Rosenstiel, Philip/0000-0002-9692-8828; Jawhara, Mohamad/0000-0002-0338-2548	European Union [733100]; e:Med program SYSINFLAME; DFG EXC Immunosensation; EXC Inflammation at Interfaces	European Union(European Commission); e:Med program SYSINFLAME; DFG EXC Immunosensation(German Research Foundation (DFG)); EXC Inflammation at Interfaces	We thank Renate Nikolaus for her help with graphic design. The work of the authors receives funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 733100 (SYSCID), the e:Med program SYSINFLAME, the DFG EXC Immunosensation, and the EXC Inflammation at Interfaces.	Aronson SJ, 2015, NATURE, V526, P336, DOI 10.1038/nature15816; Astle WJ, 2016, CELL, V167, P1415, DOI 10.1016/j.cell.2016.10.042; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Davis MM, 2008, IMMUNITY, V29, P835, DOI 10.1016/j.immuni.2008.12.003; Durek P, 2016, IMMUNITY, V45, P1148, DOI 10.1016/j.immuni.2016.10.022; Ellinghaus D, 2016, NAT GENET, V48, P510, DOI 10.1038/ng.3528; Fairfax BP, 2014, SCIENCE, V343, P1118, DOI 10.1126/science.1246949; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Lappalainen T, 2013, NATURE, V501, P506, DOI 10.1038/nature12531; Lee JC, 2013, CELL, V155, P57, DOI 10.1016/j.cell.2013.08.034; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Wolkenhauer O, 2013, FEBS J, V280, P5938, DOI 10.1111/febs.12311; Zhernakova A, 2009, NAT REV GENET, V10, P43, DOI 10.1038/nrg2489	15	19	21	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					608	613		10.1016/j.immuni.2018.03.022	http://dx.doi.org/10.1016/j.immuni.2018.03.022			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669240	Bronze			2022-12-18	WOS:000430198900004
J	Dai, HS; Griffin, N; Bolyard, C; Mao, HC; Zhang, JY; Cripe, TP; Suenaga, T; Arase, H; Nakano, I; Chiocca, EA; Kaur, B; Yu, JH; Caligiuri, MA				Dai, Hong-Sheng; Griffin, Nathaniel; Bolyard, Chelsea; Mao, Hsiaoyin Charlene; Zhang, Jianying; Cripe, Timothy P.; Suenaga, Tadahiro; Arase, Hisashi; Nakano, Ichiro; Chiocca, E. A.; Kaur, Balveen; Yu, Jianhua; Caligiuri, Michael A.			The Fc Domain of Immunoglobulin Is Sufficient to Bridge NK Cells with Virally Infected Cells	IMMUNITY			English	Article							NATURAL-KILLER-CELLS; DEPENDENT CELLULAR CYTOTOXICITY; SIMPLEX-VIRUS-GE; PROTEIN-A; STAPHYLOCOCCUS-AUREUS; CRYSTAL-STRUCTURE; HUMAN-LYMPHOCYTES; TYROSINE PHOSPHORYLATION; HERPESVIRUS INFECTIONS; HUMAN IGG1	Clearance of pathogens or tumor cells by antibodies traditionally requires both Fab and Fc domains of IgG. Here, we show the Fc domain of IgG alone mediates recognition and clearance of herpes simplex virus (HSV1)-infected cells. The human natural killer (NK) cell surface is naturally coated with IgG bound by its Fc domain to the Fc gamma receptor CD16a. NK cells utilize the Fc domain of bound IgG to recognize gE, an HSV1-encoded glycoprotein that also binds the Fc domain of IgG but at a site distinct from CD16a. The bridge formed by the Fc domain between the HSV1-infected cell and the NK cell results in NK cell activation and lysis of the HSV1-infected cell in the absence of HSV1-specific antibody in vitro and prevents fatal HSV1 infection in vivo. This mechanism also explains how bacterial IgG-binding proteins regulate NK cell function and may be broadly applicable to Fc gamma-receptor-bearing cells.	[Dai, Hong-Sheng; Griffin, Nathaniel; Mao, Hsiaoyin Charlene; Yu, Jianhua; Caligiuri, Michael A.] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA; [Dai, Hong-Sheng; Griffin, Nathaniel; Mao, Hsiaoyin Charlene; Yu, Jianhua; Caligiuri, Michael A.] Solove Res Inst, Columbus, OH 43210 USA; [Dai, Hong-Sheng; Griffin, Nathaniel; Mao, Hsiaoyin Charlene; Yu, Jianhua; Caligiuri, Michael A.] Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43205 USA; [Bolyard, Chelsea; Kaur, Balveen] Ohio State Univ, Dept Neurol Surg, Columbus, OH 43205 USA; [Zhang, Jianying] Ohio State Univ, Ctr Biostat, Columbus, OH 43205 USA; [Cripe, Timothy P.] Ohio State Univ, Nationwide Childrens Hosp, Ctr Childhood Canc & Blood Dis, Columbus, OH 43205 USA; [Cripe, Timothy P.] Ohio State Univ, Nationwide Childrens Hosp, Div Hematol Oncol Blood & Marrow Transplantat, Columbus, OH 43205 USA; [Suenaga, Tadahiro; Arase, Hisashi] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immunochem, Suita, Osaka 5650871, Japan; [Suenaga, Tadahiro; Arase, Hisashi] Osaka Univ, Microbial Dis Res Inst, Dept Immunochem, Suita, Osaka 5650871, Japan; [Nakano, Ichiro] Univ Alabama Birmingham, Neurosurg, Birmingham, AL 35294 USA; [Chiocca, E. A.] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurosurg, Boston, MA 02115 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Osaka University; Osaka University; University of Alabama System; University of Alabama Birmingham; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Dai, HS; Caligiuri, MA (corresponding author), Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA.; Dai, HS; Caligiuri, MA (corresponding author), Solove Res Inst, Columbus, OH 43210 USA.; Dai, HS; Caligiuri, MA (corresponding author), Ohio State Univ, Coll Med, Dept Internal Med, Div Hematol, Columbus, OH 43205 USA.	daihsh@gmail.com; michael.caligiuri@osumc.edu	Nakano, Ichiro/AAR-9562-2020; Arase, Hisashi/C-8442-2009	Nakano, Ichiro/0000-0002-0916-3207; Arase, Hisashi/0000-0002-1153-3166	NIH [P01CA163205, P01CA095426]; NCI [CA155521, CA210087, CA068458]; Grants-in-Aid for Scientific Research [17H05793, 15H02545] Funding Source: KAKEN; NATIONAL CANCER INSTITUTE [R01CA150153, R01CA155521, P01CA163205, P30CA016058, P01CA095426, R37CA068458, R35CA210087] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like thank Roselyn J. Eisenberg, Gary Cohen, Harvey Friedman, Timothy Frost, Bernard Roizman, and Lewis Lanier for sharing reagents. Thanks to Clark Anderson, Susheela Tridandapani, Jon Butchar, and Ansel Nalin for critically reading the manuscript. Thanks to Kathleen McConnell and Victoria Sellers for help with mouse experiments. H.S.D. is a Pelotonia fellow. This research has been supported by NIH grant P01CA163205 awarded to E.A.C., I.N., T.P.C., B.K., J.Y., and M.A.C., NIH grant P01CA095426 awarded to J.Y. and M.A.C., NCI grant CA155521 awarded to J.Y., and NCI grants CA210087, and CA068458 awarded to M.A.C.	Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Alvarez-Breckenridge CA, 2012, NAT MED, V18, P1827, DOI 10.1038/nm.3013; ANDERSON P, 1990, P NATL ACAD SCI USA, V87, P2274, DOI 10.1073/pnas.87.6.2274; BIRON CA, 1989, NEW ENGL J MED, V320, P1731, DOI 10.1056/NEJM198906293202605; BISHOP GA, 1983, J EXP MED, V157, P1544, DOI 10.1084/jem.157.5.1544; CATALONA WJ, 1981, NATURE, V291, P77, DOI 10.1038/291077a0; Chapman TL, 1999, J BIOL CHEM, V274, P6911, DOI 10.1074/jbc.274.11.6911; Chisholm SE, 2007, J INFECT DIS, V195, P1160, DOI 10.1086/512862; Collins WJ, 2003, J VIROL, V77, P2686, DOI 10.1128/JVI.77.4.2686-2695.2003; Corrales-Aguilar E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004131; Deis LN, 2015, P NATL ACAD SCI USA, V112, P9028, DOI 10.1073/pnas.1424724112; DEMIRANDASANTOS IKF, 1981, J EXP MED, V154, P1732, DOI 10.1084/jem.154.6.1732; DUBIN G, 1991, J VIROL, V65, P7046, DOI 10.1128/JVI.65.12.7046-7050.1991; Edwards JCW, 2004, NEW ENGL J MED, V350, P2572, DOI 10.1056/NEJMoa032534; FITZGERALDBOCARSLY P, 1991, J VIROL, V65, P3151, DOI 10.1128/JVI.65.6.3151-3160.1991; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; FRANK I, 1989, J VIROL, V63, P4479, DOI 10.1128/JVI.63.11.4479-4488.1989; Furman D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa2293; Gilden DH, 2007, NAT CLIN PRACT NEURO, V3, P82, DOI 10.1038/ncpneuro0401; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Huard B, 2000, EUR J IMMUNOL, V30, P509, DOI 10.1002/1521-4141(200002)30:2<509::AID-IMMU509>3.0.CO;2-H; Imai T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072050; JOHNSON DC, 1988, J VIROL, V62, P1347, DOI 10.1128/JVI.62.4.1347-1354.1988; Kalina U, 2000, J IMMUNOL, V165, P1307, DOI 10.4049/jimmunol.165.3.1307; Karaba AH, 2012, P NATL ACAD SCI USA, V109, P20649, DOI 10.1073/pnas.1216967109; KASAHARA T, 1981, IMMUNOLOGY, V42, P175; KASAHARA T, 1982, IMMUNOLOGY, V45, P687; KASAI M, 1981, NATURE, V291, P334, DOI 10.1038/291334a0; KAY HD, 1977, J IMMUNOL, V118, P2058; Kiyoshi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7866; LANIER LL, 1989, NATURE, V342, P803, DOI 10.1038/342803a0; LITWIN V, 1992, J VIROL, V66, P3643, DOI 10.1128/JVI.66.6.3643-3651.1992; Liu C, 2014, ONCOL LETT, V8, P2747, DOI 10.3892/ol.2014.2575; LOPEZGUERRERO JA, 1988, J GEN VIROL, V69, P2859, DOI 10.1099/0022-1317-69-11-2859; Loukas A, 2001, INFECT IMMUN, V69, P3646, DOI 10.1128/IAI.69.6.3646-3651.2001; LOZZIO BB, 1979, LEUKEMIA RES, V3, P363, DOI 10.1016/0145-2126(79)90033-X; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; METZGER H, 1992, J IMMUNOL, V149, P1477; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; OLINESCU A, 1983, IMMUNOL LETT, V6, P231, DOI 10.1016/0165-2478(83)90010-X; Olson JK, 1997, J VIROL, V71, P110, DOI 10.1128/JVI.71.1.110-119.1997; Orr MT, 2010, CELL, V142, P847, DOI 10.1016/j.cell.2010.08.031; OSHEA JJ, 1991, P NATL ACAD SCI USA, V88, P350, DOI 10.1073/pnas.88.2.350; Palmqvist N, 2002, MICROB PATHOGENESIS, V33, P239, DOI 10.1006/mpat.2002.0533; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; PATEL PC, 1981, INT J CANCER, V28, P277, DOI 10.1002/ijc.2910280305; PERUSSIA B, 1984, J IMMUNOL, V133, P180; Pierce BG, 2014, BIOINFORMATICS, V30, P1771, DOI 10.1093/bioinformatics/btu097; Polcicova K, 2005, J VIROL, V79, P11990, DOI 10.1128/JVI.79.18.11990-12001.2005; RATLIFF TL, 1981, CELL IMMUNOL, V57, P1, DOI 10.1016/0008-8749(81)90114-3; Romee R, 2013, BLOOD, V121, P3599, DOI 10.1182/blood-2012-04-425397; SAUERERIKSSON AE, 1995, STRUCTURE, V3, P265, DOI 10.1016/S0969-2126(01)00157-5; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Sprague ER, 2008, J VIROL, V82, P3490, DOI 10.1128/JVI.01476-07; Sprague ER, 2006, PLOS BIOL, V4, P975, DOI 10.1371/journal.pbio.0040148; Suenaga T, 2014, MICROBIOL IMMUNOL, V58, P513, DOI 10.1111/1348-0421.12180; Szpara ML, 2010, J VIROL, V84, P5303, DOI 10.1128/JVI.00312-10; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; Watford WT, 2004, IMMUNOL REV, V202, P139, DOI 10.1111/j.0105-2896.2004.00211.x; Zerboni L, 2013, J VIROL, V87, P2791, DOI 10.1128/JVI.01375-12	62	19	20	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2017	47	1					159	+		10.1016/j.immuni.2017.06.019	http://dx.doi.org/10.1016/j.immuni.2017.06.019			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FA8RG	28723548	Green Accepted, Bronze			2022-12-18	WOS:000405712800017
J	Helft, J; Bottcher, JP; Chakravarty, P; Zelenay, S; Huotari, J; Schraml, BU; Goubau, D; Sousa, CRE				Helft, Julie; Boettcher, Jan P.; Chakravarty, Probir; Zelenay, Santiago; Huotari, Jatta; Schraml, Barbara U.; Goubau, Delphine; Reis e Sousa, Caetano			Alive but Confused: Heterogeneity of CD11c(+) MHC Class II+ Cells in GM-CSF Mouse Bone Marrow Cultures	IMMUNITY			English	Letter							DENDRITIC CELLS; MACROPHAGES		[Helft, Julie; Boettcher, Jan P.; Zelenay, Santiago; Huotari, Jatta; Schraml, Barbara U.; Goubau, Delphine; Reis e Sousa, Caetano] Lincolns Inn Fields Lab, Francis Crick Inst, Immunobiol Lab, London WC2A 3LY, England; [Chakravarty, Probir] Lincolns Inn Fields Lab, Francis Crick Inst, Bioinformat Lab, London WC2A 3LY, England	Francis Crick Institute; Francis Crick Institute	Sousa, CRE (corresponding author), Lincolns Inn Fields Lab, Francis Crick Inst, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3LY, England.	caetano@crick.ac.uk	Helft, Julie/ABE-6179-2020; Reis e Sousa, Caetano/O-1657-2014; Reis e Sousa, Caetano/ABD-7322-2021	Helft, Julie/0000-0002-2733-1972; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Zelenay, Santiago/0000-0002-6865-3978; Bottcher, Jan/0000-0002-8163-8107; Schraml, Barbara/0000-0002-5801-0151	Cancer Research UK [15689] Funding Source: researchfish; The Francis Crick Institute [10138, 10002, 10136, 10334] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); The Francis Crick Institute		Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Greter M, 2012, IMMUNITY, V36, P1031, DOI 10.1016/j.immuni.2012.03.027; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Lutz MB, 2016, IMMUNITY, V44, P1, DOI 10.1016/j.immuni.2015.12.013; Menges M, 2005, J LEUKOCYTE BIOL, V77, P535, DOI 10.1189/jlb.0804473; Schraml BU, 2013, CELL, V154, P843, DOI 10.1016/j.cell.2013.07.014	6	19	20	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 19	2016	44	1					3	4		10.1016/j.immuni.2015.12.014	http://dx.doi.org/10.1016/j.immuni.2015.12.014			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB2NU	26789913	Bronze			2022-12-18	WOS:000368347000002
J	Ohkura, N; Sakaguchi, S				Ohkura, Naganari; Sakaguchi, Shimon			Foxo1 and Foxo3 help Foxp3	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; EXPRESSION; DIFFERENTIATION; RECEPTOR; MTOR; AKT	In this issue of Immunity, Kerdiles et al. (2010) report that Foxo transcription factors are essential for the development and function of Foxp3-expressing regulatory T (Treg) cells via controlling the expression of genes associated with Treg cell function.	[Ohkura, Naganari; Sakaguchi, Shimon] Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Dept Expt Immunol, Suita, Osaka 5650871, Japan; [Ohkura, Naganari; Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan	Osaka University; Kyoto University	Ohkura, N (corresponding author), Osaka Univ, World Premier Int Immunol Frontier Res Ctr, Dept Expt Immunol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	nohkura@frontier.kyoto-u.ac.jp	Sakaguchi, Shimon/C-9535-2009					Dejean AS, 2009, NAT IMMUNOL, V10, P504, DOI 10.1038/ni.1729; Harada Y, 2010, J EXP MED, V207, P1381, DOI 10.1084/jem.20100004; Haxhinasto S, 2008, J EXP MED, V205, P565, DOI 10.1084/jem.20071477; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549	10	19	19	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 22	2010	33	6					835	837		10.1016/j.immuni.2010.12.004	http://dx.doi.org/10.1016/j.immuni.2010.12.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	707NS	21168774	Bronze			2022-12-18	WOS:000286293900003
J	Belkaid, Y; Tarbell, KV				Belkaid, Yasmine; Tarbell, Kristin V.			Arming Treg Cells at the Inflammatory Site	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; MICE	In this issue of Immunity, Zhang et al. (2009) propose that Treg cells, in order to efficiently control alloimmune response, need to be educated first in the target tissue before entering the draining lymph node.	[Belkaid, Yasmine] NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Tarbell, Kristin V.] NIDDK, Immune Tolerance Sect, Diabet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Belkaid, Y (corresponding author), NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Tarbell, Kristin/E-6458-2016	Tarbell, Kristin/0000-0003-3738-379X; Belkaid, Yasmine/0000-0001-9962-3571	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000955, ZIAAI000955] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK069016, Z01DK069016] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Chen ZB, 2005, J EXP MED, V202, P1387, DOI 10.1084/jem.20051409; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Mottet C, 2003, J IMMUNOL, V170, P3939, DOI 10.4049/jimmunol.170.8.3939; Onishi Y, 2008, P NATL ACAD SCI USA, V105, P10113, DOI 10.1073/pnas.0711106105; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tarbell KV, 2007, J EXP MED, V204, P191, DOI 10.1084/jem.20061631; Wei S, 2006, BLOOD, V108, P426, DOI 10.1182/blood-2006-01-0177; Zhang N, 2009, IMMUNITY, V30, P458, DOI 10.1016/j.immuni.2008.12.022	10	19	19	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 20	2009	30	3					322	323		10.1016/j.immuni.2009.03.004	http://dx.doi.org/10.1016/j.immuni.2009.03.004			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	422CU	19303386	Bronze			2022-12-18	WOS:000264405500005
J	Haynes, BF; Alann, SM				Haynes, Barton F.; Alann, S. Munir			HIV-1 hides an Achilles' heel in virion lipids	IMMUNITY			English	Editorial Material							ANTIBODY; GP41; 4E10; 2F5; RECOGNIZES; EPITOPE; FUSION	In this issue, Sun et al. (2008) model the interface between a neutralizing antibody and HIV-1 glycoprotein 41 (gp41) envelope peptide in lipids. This model could help overcome a roadblock in HIV-1 vaccine development.	[Haynes, Barton F.; Alann, S. Munir] Duke Univ, Sch Med, Dept Med, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Haynes, Barton F.; Alann, S. Munir] Duke Univ, Sch Med, Dept Pathol, Duke Human Vaccine Inst, Durham, NC 27710 USA; [Haynes, Barton F.; Alann, S. Munir] Duke Univ, Sch Med, Dept Immunol, Duke Human Vaccine Inst, Durham, NC 27710 USA	Duke University; Duke University; Duke University	Haynes, BF (corresponding author), Duke Univ, Sch Med, Dept Med, Duke Human Vaccine Inst, Durham, NC 27710 USA.	hayne002@mc.duke.edu			NIAID NIH HHS [U19 AI067854-03, U19 AI067854] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; HAYNES BF, 2006, VACCINES, V5, P579; Meffre E, 2001, J CLIN INVEST, V108, P879, DOI 10.1172/JCI13051; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0	10	19	21	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN	2008	28	1					10	12		10.1016/j.immuni.2007.12.005	http://dx.doi.org/10.1016/j.immuni.2007.12.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18199412	Bronze, Green Accepted			2022-12-18	WOS:000252627300004
J	Unanue, ER				Unanue, Emil R.			Ito cells, stellate cells, and myofibroblasts: New actors in antigen presentation	IMMUNITY			English	Editorial Material							PRESENTING CELLS; ORIGIN	Winau et al. (2007) provide convincing evidence that liver stellate cells can be antigen-presenting cells. This paper raises the following question: what are the roles and importance of diverse antigen-presenting cells in different organs?	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Unanue, ER (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	unanue@pathbox.wustl.edu						BOTTAZZO GF, 1983, LANCET, V2, P1115; Geerts A, 2004, J HEPATOL, V40, P331, DOI 10.1016/j.jhep.2003.12.006; Geerts A, 2001, SEMIN LIVER DIS, V21, P311, DOI 10.1055/s-2001-17550; Ogawa M, 2006, BLOOD, V108, P2893, DOI 10.1182/blood-2006-04-016600; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Sousa CR, 2006, NAT REV IMMUNOL, V6, P476, DOI 10.1038/nri1845; Schmieg J, 2005, P NATL ACAD SCI USA, V102, P1127, DOI 10.1073/pnas.0408288102; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011	10	19	19	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN	2007	26	1					9	10		10.1016/j.immuni.2007.01.001	http://dx.doi.org/10.1016/j.immuni.2007.01.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	132RD	17241956	Bronze			2022-12-18	WOS:000243959000004
J	Neurath, MF; Finotto, S				Neurath, M. F.; Finotto, S.			The many roads to inflammatory bowel diseases	IMMUNITY			English	Editorial Material							TOLL; COLITIS		Univ Mainz, Immunol Lab, Med Clin 1, D-55131 Mainz, Germany	Johannes Gutenberg University of Mainz	Neurath, MF (corresponding author), Univ Mainz, Immunol Lab, Med Clin 1, D-55131 Mainz, Germany.		Finotto, Susetta/H-2753-2019					Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Neurath MF, 2002, NAT MED, V8, P567, DOI 10.1038/nm0602-567; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Wagner H, 2006, J EXP MED, V203, P265, DOI 10.1084/jem.20052191; Wirtz S, 2006, J EXP MED, V203, P1875, DOI 10.1084/jem.20060471; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404	11	19	19	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2006	25	2					189	191		10.1016/j.immuni.2006.08.005	http://dx.doi.org/10.1016/j.immuni.2006.08.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16920636	Bronze			2022-12-18	WOS:000240047500004
J	Prabhakaran, K; Sheridan, BS; Kinchington, PR; Khanna, KM; Decman, V; Lathrop, K; Hendricks, RL				Prabhakaran, K; Sheridan, BS; Kinchington, PR; Khanna, KM; Decman, V; Lathrop, K; Hendricks, RL			RETRACTED: Sensory neurons regulate the effector functions of CD8(+) T cells in controlling HSV-1 latency ex vivo (Retracted Article. See vol 24, pg 657, 2006)	IMMUNITY			English	Article; Retracted Publication							HERPES-SIMPLEX-VIRUS; CHRONIC VIRAL-INFECTION; IMMUNE CONTROL; EXPRESSION; REACTIVATION; GANGLIA; GRANZYME; MICE; GAMMAHERPESVIRUS; IMMUNODOMINANCE	We provide evidence that sensory neurons regulate the effector functions and phenotype of CD8(+) T cells during active immunosurveillance of HSV-1 latency. Low-level viral gene expression in latently infected sensory ganglia gives rise to a unique, functionally active CD8(+) T cell population. Surprisingly, distinct neuronal subsets require different CD8 effector mechanisms to maintain viral latency, with some requiring IFN-gamma and others requiring lytic granules (LG). This nonredundant efficacy of CD8(+) T cell effector mechanisms in maintaining viral latency is explained as follows: (1) a subset of neurons that expresses IFN-gamma receptors (IFN-gamma R+) and Qa1 responds to IFN-gamma, but Qa1 engagement of CD94/NKG2a blocks LG exocytosis by CD8(+) T cells; (2) another neuronal subset is responsive to LG because it lacks Gal and is refractory to IFN-gamma because it also lacks IFN-gamma R. In the latter subset, LG appear to provide a nonlethal block of viral reactivation.	Univ Pittsburgh, Sch Med, Grad Program Immunol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Mol Genet & Biochem, Pittsburgh, PA 15213 USA; Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Hendricks, RL (corresponding author), Univ Pittsburgh, Sch Med, Grad Program Immunol, 203 Lothrop St, Pittsburgh, PA 15213 USA.	hendricksrr@upmc.edu			NEI NIH HHS [P30EY08098, EY05945, EY015291] Funding Source: Medline; NINDS NIH HHS [F30 NS50905-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R01EY005945, P30EY008098, R01EY015291] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS050905] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Betts MR, 2004, J IMMUNOL, V172, P6407, DOI 10.4049/jimmunol.172.10.6407; BONNEAU RH, 1993, VIROLOGY, V195, P62, DOI 10.1006/viro.1993.1346; Browne KA, 1999, MOL CELL BIOL, V19, P8604; Chen SH, 2002, J VIROL, V76, P4764, DOI 10.1128/JVI.76.10.4764-4772.2002; Decman V, 2005, J VIROL, V79, P10339, DOI 10.1128/JVI.79.16.10339-10347.2005; Edwards KM, 1999, IMMUNOL CELL BIOL, V77, P76, DOI 10.1046/j.1440-1711.1999.00799.x; Feldman LT, 2002, P NATL ACAD SCI USA, V99, P978, DOI 10.1073/pnas.022301899; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Khanna KM, 2004, CURR OPIN IMMUNOL, V16, P463, DOI 10.1016/j.coi.2004.05.003; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Kramer J, 1995, Eur Spine J, V4, P69, DOI 10.1007/BF00278914; Kubota A, 1999, J IMMUNOL, V163, P6488; Lang KS, 2005, EUR J IMMUNOL, V35, P738, DOI 10.1002/eji.200425828; Liu HsuanLiang, 2001, Recent Research Developments in Protein Engineering, V1, P75; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Loh J, 2004, J VIROL, V78, P12519, DOI 10.1128/JVI.78.22.12519-12528.2004; Miller JD, 2002, J IMMUNOL, V169, P693, DOI 10.4049/jimmunol.169.2.693; Mullbacher A, 1996, P NATL ACAD SCI USA, V93, P5783, DOI 10.1073/pnas.93.12.5783; Pereira RA, 2000, J VIROL, V74, P1029, DOI 10.1128/JVI.74.2.1029-1032.2000; Perng GC, 2000, SCIENCE, V287, P1500, DOI 10.1126/science.287.5457.1500; Sawtell NA, 2004, J VIROL, V78, P7784, DOI 10.1128/JVI.78.14.7784-7794.2004; Slifka MK, 1999, NATURE, V401, P76, DOI 10.1038/43454; Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4; Tibbetts SA, 2002, J VIROL, V76, P7125, DOI 10.1128/JVI.76.14.7125-7132.2002; van der Most RG, 2003, VIROLOGY, V315, P93, DOI 10.1016/j.virol.2003.07.001; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wojtasiak M, 2004, INT IMMUNOL, V16, P1333, DOI 10.1093/intimm/dxh136; Wolint P, 2004, J EXP MED, V199, P925, DOI 10.1084/jem.20031799; Zhang D, 2003, BLOOD, V101, P226, DOI 10.1182/blood-2002-03-0791	31	19	20	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV	2005	23	5					515	525		10.1016/j.immuni.2005.09.017	http://dx.doi.org/10.1016/j.immuni.2005.09.017			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	989GK	16286019	Bronze			2022-12-18	WOS:000233660700008
J	Zediak, VP; Maillard, I; Bhandoola, A				Zediak, VP; Maillard, I; Bhandoola, A			Closer to the source: Notch and the nature of thymus-settling cells	IMMUNITY			English	Review							T-CELL; PROGENITORS; DIFFERENTIATION; IDENTIFICATION; SPECIFICATION; REQUIREMENT; THYMOCYTES; EXPRESSION	Questions regarding T cell development have recently received much attention, but the earliest intrathymic differentiation steps in adult mice have remained controversial. Three new papers together show that for at least some thymus-settling precursors, the loss of B lineage potential occurs in the thymus, and Notch acts on multipotent progenitors early after thymic entry.	Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Div Hematol & Oncol, Philadelphia, PA 19104 USA; Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Bhandoola, A (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	bhandooa@mail.med.upenn.edu		Maillard, Ivan/0000-0003-1312-6748	NATIONAL CANCER INSTITUTE [T32CA009140] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Balciunaite G, 2005, BLOOD, V105, P1930, DOI 10.1182/blood-2004-08-3087; Benz C, 2005, J EXP MED, V202, P21, DOI 10.1084/jem.20050146; Carlyle JR, 1998, IMMUNITY, V9, P187, DOI 10.1016/S1074-7613(00)80601-9; Harman BC, 2005, BLOOD, V106, P886, DOI 10.1182/blood-2004-12-4881; Igarashi H, 2002, IMMUNITY, V17, P117, DOI 10.1016/S1074-7613(02)00366-7; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Masuda K, 2005, J IMMUNOL, V174, P2525, DOI 10.4049/jimmunol.174.5.2525; Perry SS, 2004, BLOOD, V103, P2990, DOI 10.1182/blood-2003-09-3030; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; RODEWALD HR, 1994, EMBO J, V13, P4229, DOI 10.1002/j.1460-2075.1994.tb06743.x; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Shortman K, 1996, ANNU REV IMMUNOL, V14, P29, DOI 10.1146/annurev.immunol.14.1.29; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217	20	19	20	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2005	23	3					245	248		10.1016/j.immuni.2005.08.008	http://dx.doi.org/10.1016/j.immuni.2005.08.008			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	971KJ	16169497	Bronze			2022-12-18	WOS:000232382500003
J	Janeway, CA				Janeway, CA			A tale of two T cells	IMMUNITY			English	Article							CHAIN GENE REARRANGEMENT; DEVELOPMENT IN-VIVO; POSITIVE SELECTION; BETA-CHAIN; THYMOCYTE DEVELOPMENT; ALPHA-BETA; RECEPTOR; PEPTIDE; ANTIGEN; MICE		Yale Univ, Sch Med, Howard Hughes Med Inst, Immunol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Janeway, CA (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Immunol Sect, New Haven, CT 06520 USA.							ASHTONRICKARDT PG, 1993, CELL, V73, P1041, DOI 10.1016/0092-8674(93)90281-T; BROKER T, 1997, J EXP MED, V186, P1223; BUSCH DH, 1998, IN PRESS J IMMUNOL; Ding YH, 1998, IMMUNITY, V8, P403, DOI 10.1016/S1074-7613(00)80546-4; DUDLEY EC, 1994, IMMUNITY, V1, P83, DOI 10.1016/1074-7613(94)90102-3; EVAVOLD BD, 1995, IMMUNITY, V2, P655, DOI 10.1016/1074-7613(95)90010-1; FEHLING HJ, 1995, NATURE, V375, P795, DOI 10.1038/375795a0; FORD WL, 1971, NATURE-NEW BIOL, V234, P178, DOI 10.1038/newbio234178a0; FungLeung WP, 1996, SCIENCE, V271, P1278, DOI 10.1126/science.271.5253.1278; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Grubin CE, 1997, IMMUNITY, V7, P197, DOI 10.1016/S1074-7613(00)80523-3; Hoffman ES, 1996, GENE DEV, V10, P948, DOI 10.1101/gad.10.8.948; Hogquist KA, 1997, IMMUNITY, V6, P389, DOI 10.1016/S1074-7613(00)80282-4; HOGQUIST KA, 1993, J EXP MED, V177, P1469, DOI 10.1084/jem.177.5.1469; Hu QH, 1997, IMMUNITY, V7, P221, DOI 10.1016/S1074-7613(00)80525-7; Ignatowicz L, 1996, CELL, V84, P521, DOI 10.1016/S0092-8674(00)81028-4; JACOBS H, 1994, EUR J IMMUNOL, V24, P934, DOI 10.1002/eji.1830240423; JAMESON SC, 1994, NATURE, V369, P750, DOI 10.1038/369750a0; JORGENSEN JL, 1992, NATURE, V355, P224, DOI 10.1038/355224a0; Laufer TM, 1996, NATURE, V383, P81, DOI 10.1038/383081a0; MALLICK CA, 1993, CELL, V73, P513, DOI 10.1016/0092-8674(93)90138-G; Martin WD, 1996, CELL, V84, P543, DOI 10.1016/S0092-8674(00)81030-2; MASON D, 1998, IN PRESS IMMUNOL TOD; MCHEYZERWILLIAMS MG, 1995, SCIENCE, V268, P106, DOI 10.1126/science.7535476; Miyazaki T, 1996, CELL, V84, P531, DOI 10.1016/S0092-8674(00)81029-6; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; SantAngelo DB, 1997, IMMUNITY, V7, P517, DOI 10.1016/S1074-7613(00)80373-8; SantAngelo DB, 1996, IMMUNITY, V4, P367, DOI 10.1016/S1074-7613(00)80250-2; Surh CD, 1997, IMMUNITY, V7, P209, DOI 10.1016/S1074-7613(00)80524-5; WILSON DB, 1978, J EXP MED, V129, P1157; WUCHERPFENNIG KW, 1995, CELL, V80, P695, DOI 10.1016/0092-8674(95)90348-8; ZERHANN J, 1997, CELL, V188, P627	34	19	19	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1998	8	4					391	394		10.1016/S1074-7613(00)80544-0	http://dx.doi.org/10.1016/S1074-7613(00)80544-0			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZK664	9586629	Bronze			2022-12-18	WOS:000073348000001
J	Young, C; Brink, R				Young, Clara; Brink, Robert			The unique biology of germinal center B cells	IMMUNITY			English	Review							NEUTRALIZING ANTIBODY-RESPONSES; FOLLICULAR DENDRITIC CELLS; AFFINITY MATURATION; PLASMA-CELL; TRANSCRIPTION FACTOR; DARK ZONE; T-CELLS; VIRAL-INFECTION; CENTER LIGHT; C-MYC	Germinal center (GC) B cells are the source of the high-affinity, class-switched antibodies required for protective immunity. The unique biology of GC B cells involves iterative rounds of antibody gene somatic hypermutation coupled to multiple selection and differentiation pathways. Recent advances in areas such as single cell and gene editing technologies have shed new light upon these complex and dynamic processes. We review these findings here and integrate them into the current understanding of GC B cell replication and death, the retention of high-affinity and class-switched B cells in the GC, and differentiation into plasma and memory cell effectors. We also discuss how the biology of GC responses relates to vaccine effectiveness and outline current and future challenges in the field.	[Young, Clara; Brink, Robert] Garvan Inst Med Res, Immunol Div, Darlinghurst, NSW 2010, Australia; [Young, Clara; Brink, Robert] UNSW Sydney, St Vincents Clin Sch, Sydney, NSW 2010, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney	Young, C (corresponding author), Garvan Inst Med Res, Immunol Div, Darlinghurst, NSW 2010, Australia.; Young, C (corresponding author), UNSW Sydney, St Vincents Clin Sch, Sydney, NSW 2010, Australia.							Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Afshar-Sterle S, 2014, NAT MED, V20, P283, DOI 10.1038/nm.3442; Akkaya M, 2020, NAT REV IMMUNOL, V20, P229, DOI 10.1038/s41577-019-0244-2; Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Amitai A, 2020, CELL SYST, V11, P573, DOI 10.1016/j.cels.2020.09.005; Andersen TK, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0101-0; Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Bannard O, 2016, J EXP MED, V213, P993, DOI 10.1084/jem.20151682; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Beguelin W, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01029-x; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Briney B, 2016, CELL, V166, P1459, DOI 10.1016/j.cell.2016.08.005; Brink R, 2018, ANNU REV IMMUNOL, V36, P339, DOI 10.1146/annurev-immunol-051116-052510; Bunting KL, 2016, IMMUNITY, V45, P497, DOI 10.1016/j.immuni.2016.08.012; Burnett DL, 2019, IMMUNOL REV, V292, P61, DOI 10.1111/imr.12808; Butt D, 2015, IMMUNITY, V42, P890, DOI 10.1016/j.immuni.2015.04.010; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Chen H, 2020, NATURE, V582, P421, DOI 10.1038/s41586-020-2262-4; Chou C, 2016, IMMUNITY, V45, P570, DOI 10.1016/j.immuni.2016.07.023; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Cirelli KM, 2019, CELL, V177, P1153, DOI 10.1016/j.cell.2019.04.012; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dominguez D, 2016, CELL RES, V26, P946, DOI 10.1038/cr.2016.84; Dominguez PM, 2018, CANCER DISCOV, V8, P1632, DOI 10.1158/2159-8290.CD-18-0657; Dominguez PM, 2015, CELL REP, V12, P2086, DOI 10.1016/j.celrep.2015.08.036; Dominguez-Sola D, 2015, IMMUNITY, V43, P1064, DOI 10.1016/j.immuni.2015.10.015; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Fang YF, 1998, J IMMUNOL, V160, P5273; Finkin S, 2019, IMMUNITY, V51, P324, DOI 10.1016/j.immuni.2019.06.013; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Gaebler C, 2020, NATURE, V586, DOI 10.1038/d41586-020-02926-w; Gitlin AD, 2016, IMMUNITY, V44, P769, DOI 10.1016/j.immuni.2016.01.011; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hashwah H, 2017, P NATL ACAD SCI USA, V114, P9701, DOI 10.1073/pnas.1619555114; Hatzi K, 2019, NAT IMMUNOL, V20, P86, DOI 10.1038/s41590-018-0273-1; Hatzi K, 2015, J EXP MED, V212, P539, DOI 10.1084/jem.20141380; Havenar-Daughton C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0381; Holmes AB, 2020, J EXP MED, V217, DOI 10.1084/jem.20200483; Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106; Hraber P, 2014, AIDS, V28, P163, DOI 10.1097/QAD.0000000000000106; Huang CX, 2014, CELL REP, V8, P1497, DOI 10.1016/j.celrep.2014.07.059; Hwang JK, 2017, P NATL ACAD SCI USA, V114, P8614, DOI 10.1073/pnas.1709203114; Inoue T, 2021, J EXP MED, V218, DOI 10.1084/jem.20200866; Inoue T, 2018, IMMUNOL REV, V283, P138, DOI 10.1111/imr.12640; Ise W, 2018, IMMUNITY, V48, P702, DOI 10.1016/j.immuni.2018.03.027; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jiang YW, 2017, CANCER DISCOV, V7, P38, DOI 10.1158/2159-8290.CD-16-0975; Kato Y, 2020, IMMUNITY, V53, P548, DOI 10.1016/j.immuni.2020.08.001; Kennedy DE, 2020, NAT IMMUNOL, V21, P660, DOI 10.1038/s41590-020-0660-2; King HW, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe6291; Krautler NJ, 2017, J EXP MED, V214, P1259, DOI 10.1084/jem.20161533; Kulis M, 2015, NAT GENET, V47, P746, DOI 10.1038/ng.3291; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Kwak K, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6598; Kwong PD, 2018, IMMUNITY, V48, P855, DOI 10.1016/j.immuni.2018.04.029; Laidlaw BJ, 2021, NAT REV IMMUNOL, V21, P209, DOI 10.1038/s41577-020-00446-2; Laidlaw BJ, 2020, NAT IMMUNOL, V21, P1082, DOI 10.1038/s41590-020-0713-6; Laidlaw BJ, 2017, J EXP MED, V214, P639, DOI 10.1084/jem.20161461; Lau AWY, 2021, J EXP MED, V218, DOI 10.1084/jem.20191167; Lau AWY, 2020, CURR OPIN IMMUNOL, V63, P29, DOI 10.1016/j.coi.2019.11.001; Le Q, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005411; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Li X, 2018, IMMUNITY, V48, P530, DOI 10.1016/j.immuni.2018.03.006; Lio CWJ, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau7523; Liu B, 2021, NATURE, V592, DOI 10.1038/s41586-021-03239-2; Lu PW, 2017, SCIENCE, V356, DOI 10.1126/science.aai9264; Lu YS, 2021, J EXP MED, V218, DOI 10.1084/jem.20200547; Luo W, 2019, NAT IMMUNOL, V20, P736, DOI 10.1038/s41590-019-0376-3; Luo W, 2018, IMMUNITY, V48, P313, DOI 10.1016/j.immuni.2018.01.008; Magnuson B, 2012, BIOCHEM J, V441, P1, DOI 10.1042/BJ20110892; Mayer CT, 2017, SCIENCE, V358, DOI 10.1126/science.aao2602; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Meyer SN, 2019, IMMUNITY, V51, P535, DOI 10.1016/j.immuni.2019.08.006; Milpied P, 2018, NAT IMMUNOL, V19, P1013, DOI 10.1038/s41590-018-0181-4; Nakagawa R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016425118; NIEUWENHUIS P, 1984, AM J ANAT, V170, P421, DOI 10.1002/aja.1001700315; Nowosad CR, 2020, NATURE, V588, DOI 10.1038/s41586-020-2865-9; Nowosad CR, 2016, NAT IMMUNOL, V17, P870, DOI 10.1038/ni.3458; Ochiai K, 2013, IMMUNITY, V38, P918, DOI 10.1016/j.immuni.2013.04.009; Okada T, 2005, PLOS BIOL, V3, P1047, DOI 10.1371/journal.pbio.0030150; Pae J, 2021, J EXP MED, V218, DOI 10.1084/jem.20201699; Pape KA, 2003, J EXP MED, V197, P1677, DOI 10.1084/jem.20012065; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Petrovas C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2285; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Pikor NB, 2020, NAT IMMUNOL, V21, P649, DOI 10.1038/s41590-020-0672-y; Pilzecker B, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00438; Ramezani-Rad P, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108403; Rathanaswami P, 2005, BIOCHEM BIOPH RES CO, V334, P1004, DOI 10.1016/j.bbrc.2005.07.002; Razzaghi R, 2021, J EXP MED, V218, DOI 10.1084/jem.20201173; Reddy A, 2017, CELL, V171, P481, DOI 10.1016/j.cell.2017.09.027; Roco JA, 2019, IMMUNITY, V51, P337, DOI 10.1016/j.immuni.2019.07.001; Rosikiewicz W, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay5872; Sage PT, 2020, CURR OPIN IMMUNOL, V67, P68, DOI 10.1016/j.coi.2020.10.009; Sander S, 2015, IMMUNITY, V43, P1075, DOI 10.1016/j.immuni.2015.10.021; Sautto GA, 2018, VIROL J, V15, DOI 10.1186/s12985-017-0918-y; Schoeler K, 2019, FEBS J, V286, P3566, DOI 10.1111/febs.14934; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Schwickert TA, 2009, J EXP MED, V206, P2907, DOI 10.1084/jem.20091225; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Shlomchik MJ, 2019, IMMUNOL REV, V288, P49, DOI 10.1111/imr.12744; Silva-Cayetano A, 2020, CURR OPIN IMMUNOL, V64, P26, DOI 10.1016/j.coi.2020.03.007; Sokal A, 2021, CELL, V184, P1201, DOI 10.1016/j.cell.2021.01.050; Stewart I, 2018, IMMUNITY, V49, P477, DOI 10.1016/j.immuni.2018.08.025; Suan D, 2017, IMMUNITY, V47, P1142, DOI 10.1016/j.immuni.2017.11.022; Suan D, 2017, CURR OPIN IMMUNOL, V45, P97, DOI 10.1016/j.coi.2017.03.006; Sundling C, 2021, IMMUNITY, V54, P988, DOI 10.1016/j.immuni.2021.03.013; Tanaka S, 2020, NAT IMMUNOL, V21, P950, DOI 10.1038/s41590-020-0700-y; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Thaunat O, 2012, SCIENCE, V335, P475, DOI 10.1126/science.1214100; Toboso-Navasa A, 2020, J EXP MED, V217, DOI 10.1084/jem.20191933; Toellner KM, 1996, J EXP MED, V183, P2303, DOI 10.1084/jem.183.5.2303; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Turner JS, 2017, J IMMUNOL, V199, P1301, DOI 10.4049/jimmunol.1700267; van der Poel CE, 2019, CELL REP, V29, P2745, DOI 10.1016/j.celrep.2019.10.086; Viant C, 2020, CELL, V183, P1298, DOI 10.1016/j.cell.2020.09.063; Victora GD, 2012, BLOOD, V120, P2240, DOI 10.1182/blood-2012-03-415380; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Wang Q, 2017, J EXP MED, V214, P49, DOI 10.1084/jem.20161649; Wing JB, 2020, IMMUNOL REV, V296, P104, DOI 10.1111/imr.12888; Yeh CH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03382-x; Yi CY, 2021, CELL MOL IMMUNOL, V18, P675, DOI 10.1038/s41423-020-0403-1; Yusufova N, 2021, NATURE, V589, P299, DOI 10.1038/s41586-020-3017-y; Zhang JY, 2017, CANCER DISCOV, V7, P322, DOI 10.1158/2159-8290.CD-16-1417; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940; Zhang Y, 2018, J EXP MED, V215, P1227, DOI 10.1084/jem.20160832	135	18	18	3	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1652	1664						13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34380063	Bronze			2022-12-18	WOS:000684589700007
J	Sharif, H; Hollingsworth, LR; Griswold, AR; Hsiao, JC; Wang, QH; Bachovchin, DA; Wu, H				Sharif, Humayun; Hollingsworth, L. Robert; Griswold, Andrew R.; Hsiao, Jeffrey C.; Wang, Qinghui; Bachovchin, Daniel A.; Wu, Hao			Dipeptidyl peptidase 9 sets a threshold for CARD8 inflammasome formation by sequestering its active C-terminal fragment	IMMUNITY			English	Article							CRYO-EM; NLRP1 INFLAMMASOME; INHIBITION; MECHANISM; VITILIGO; FEATURES; CORNEAL; FIIND	CARD8 detects intracellular danger signals and forms a caspase-1 activating inflammasome. Like the related inflammasome sensor NLRP1, CARD8 autoprocesses into noncovalently associated N-terminal (NT) and C-terminal (CT) fragments and binds the cellular dipeptidyl peptidases DPP8 and 9 (DPP8/9). Certain danger-associated signals, including the DPP8/9 inhibitor Val-boroPro (VbP) and HIV protease, induce proteasome-mediated NT degradation and thereby liberate the inflammasome-forming CT. Here, we report cryo-electron microscopy (cryo-EM) structures of CARD8 bound to DPP9, revealing a repressive ternary complex consisting of DPP9, full-length CARD8, and CARD8-CT. Unlike NLRP1-CT, CARD8-CT does not interact with the DPP8/9 active site and is not directly displaced by VbP. However, larger DPP8/9 active-site probes can directly weaken this complex in vitro, and VbP itself nevertheless appears to disrupt this complex, perhaps indirectly, in cells. Thus, DPP8/9 inhibitors can activate the CARD8 inflammasome by promoting CARD8 NT degradation and by weakening ternary complex stability.	[Sharif, Humayun; Hollingsworth, L. Robert; Wu, Hao] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Sharif, Humayun; Hollingsworth, L. Robert; Wu, Hao] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Hollingsworth, L. Robert] Harvard Med Sch, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Griswold, Andrew R.] Weill Cornell Rockefeller Sloan Kettering Triinst, New York, NY USA; [Griswold, Andrew R.; Hsiao, Jeffrey C.; Bachovchin, Daniel A.] Mem Sloan Kettering Canc Ctr, Weill Cornell Grad Sch Med Sci, Pharmacol Program, New York, NY 10065 USA; [Wang, Qinghui; Bachovchin, Daniel A.] Mem Sloan Kettering Canc Ctr, Chem Biol Program, 1275 York Ave, New York, NY 10021 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; Cornell University; Memorial Sloan Kettering Cancer Center; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center	Wu, H (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Wu, H (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Bachovchin, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Weill Cornell Grad Sch Med Sci, Pharmacol Program, New York, NY 10065 USA.; Bachovchin, DA (corresponding author), Mem Sloan Kettering Canc Ctr, Chem Biol Program, 1275 York Ave, New York, NY 10021 USA.	bachovcd@mskcc.org; wu@crystal.harvard.edu	wang, qinghui/AAU-6164-2021	wang, qinghui/0000-0002-1223-8193; Sharif, Humayun/0000-0003-1308-3442; Griswold, Andrew/0000-0003-2957-2355; Hollingsworth, Louis/0000-0002-4130-3580	NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy program [U24 GM129539]; Simons Foundation [SF349247]; NY State; NIH [U24GM129547]; Office of Biological and Environmental Research; National Institutes of Health [DP1 HD087988, R01 AI124491, T32-GM007726, F31-AI152267-01A1, T32 GM007739, F30 CA243444]; Memorial Sloan Kettering Cancer Center Core Grants [P30 CA008748, R01 AI137168]	NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NY State; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Biological and Environmental Research(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Memorial Sloan Kettering Cancer Center Core Grants	We thank T.-M. Fu of the laboratory of H.W. for initiating a CARD8 alone project, all members of the laboratories of H.W. and D.A.B. for helpful discussions, Dr. Maria Ericsson at the HMS EM facility for advice and training, and Drs. Richard Walsh, Sarah Sterling, and Shaun Rawson at the Harvard Cryo-EM Center for Structural Biology for cryo-EM training and productive consultation. We thank Drs. Kangkang Song and Kyounghwan Lee for data collection at UMass Medical School. We thank Daija Bobe and Dr. Ed Eng for data collection at the National Center for CryoEM Access and Training (NCCAT) and the Simons Electron Microscopy Center located at the New York Structural Biology Center, supported by the NIH Common Fund Transformative High Resolution Cryo-Electron Microscopy program (U24 GM129539) and by grants from the Simons Foundation (SF349247) and NY State. We thank Theo Humphreys and the Pacific Northwest Center for Cryo-EM (PNCC) at Oregon Health & Science University for screening and preliminary dataset collection, under the NIH grant U24GM129547 and accessed through EMSL (grid.436923.9), a DOE Office of Science User Facility sponsored by the Office of Biological and Environmental Research. We also thank Drs. Irina Novikova, Harry Scott, and Craig Yoshioka at PNCC for cryo-EM data processing training. pInducer20 was a gift from Stephen Elledge (Addgene plasmid no. 44012). pLEX_307 was a gift from David Root (Addgene plasmid no. 41392). pcDNA3.1 LIC 6A and pcDNA 3.1 LIC 6D were gifts from Scott Gradia (Addgene plasmid nos. 30124 and 30127). pLEX_305-N-dTAG was a gift from James Bradner and BehnamNabet (Addgene plasmid no. 91797) This work was supported by National Institutes of Health grants DP1 HD087988 and R01 AI124491 to H.W., T32-GM007726 and F31-AI152267-01A1 to L.R.H., and T32 GM007739-Andersen and F30 CA243444 to A.R.G. and the Memorial Sloan Kettering Cancer Center Core Grants P30 CA008748 and R01 AI137168 to D.A.B. We thank BioRender for figure design and SBGrid for computing support.	Bagnall RD, 2008, EUR J HUM GENET, V16, P619, DOI 10.1038/sj.ejhg.5201996; Ball DP, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000664; Bauernfried S, 2021, SCIENCE, V371, P482, DOI 10.1126/science.abd0811; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Chui AJ, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108264; Chui AJ, 2019, SCIENCE, V364, P82, DOI 10.1126/science.aau1208; D'Osualdo A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027396; Diaz B.H.R, 2018, THESIS U HAMBURG THESIS U HAMBURG; Drutman SB, 2019, P NATL ACAD SCI USA, V116, P19055, DOI 10.1073/pnas.1906184116; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finger JN, 2012, J BIOL CHEM, V287, P25030, DOI 10.1074/jbc.M112.378323; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Grandemange S, 2017, ANN RHEUM DIS, V76, P1191, DOI 10.1136/annrheumdis-2016-210021; Griswold AR, 2019, ACS CHEM BIOL, V14, P2424, DOI 10.1021/acschembio.9b00462; Griswold AR, 2019, CELL CHEM BIOL, V26, P901, DOI 10.1016/j.chembiol.2019.03.007; Herlin T, 2020, RHEUMATOLOGY, V59, P2334, DOI 10.1093/rheumatology/kez612; Hollingsworth LR, 2021, NATURE, V592, P778, DOI 10.1038/s41586-021-03350-4; Hollingsworth LR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20320-y; Holm L, 2019, BIOINFORMATICS, V35, P5326, DOI 10.1093/bioinformatics/btz536; Huang MH, 2021, NATURE, V592, P773, DOI 10.1038/s41586-021-03320-w; Jacobson MP, 2002, J MOL BIOL, V320, P597, DOI 10.1016/S0022-2836(02)00470-9; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Johnson DC, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02865-4; Johnson DC, 2018, NAT MED, V24, P1151, DOI 10.1038/s41591-018-0082-y; Klaholz BP, 2019, ACTA CRYSTALLOGR D, V75, P878, DOI 10.1107/S2059798319013391; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Levandowski CB, 2013, P NATL ACAD SCI USA, V110, P2952, DOI 10.1073/pnas.1222808110; Linder A, 2020, EMBO J, V39, DOI 10.15252/embj.2020105071; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Nabet B, 2018, NAT CHEM BIOL, V14, P431, DOI 10.1038/s41589-018-0021-8; Naydenova K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00782-3; Okondo MC, 2017, NAT CHEM BIOL, V13, P46, DOI [10.1038/NCHEMBIO.2229, 10.1038/nchembio.2229]; Punjani A, 2020, NAT METHODS, V17, P1214, DOI 10.1038/s41592-020-00990-8; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]; Qin G., 2021, NAT COMMUN, V12; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Robertson MJ, 2020, STRUCTURE, V28, P707, DOI 10.1016/j.str.2020.04.018; Robinson KS, 2020, SCIENCE, V370, P1182, DOI 10.1126/science.aay2002; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Roppongi S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21056-y; Ross B, 2018, P NATL ACAD SCI USA, V115, pE1437, DOI 10.1073/pnas.1717565115; Sandstrom A, 2019, SCIENCE, V364, P42, DOI 10.1126/science.aau1330; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schrodinger, 2020, SCHRODINGER RELEASE; Shen C, 2019, CURR OPIN STRUC BIOL, V58, P18, DOI 10.1016/j.sbi.2019.03.033; Soler VJ, 2013, J MED GENET, V50, P246, DOI 10.1136/jmedgenet-2012-101325; Spagnuolo PA, 2013, LEUKEMIA, V27, P1236, DOI 10.1038/leu.2013.9; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Tsu BV, 2021, ELIFE, V10, DOI 10.7554/eLife.60609; Van Goethem S, 2008, BIOORG MED CHEM LETT, V18, P4159, DOI 10.1016/j.bmcl.2008.05.079; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Wang C, 2012, P NATL ACAD SCI USA, V109, P4822, DOI 10.1073/pnas.1200613109; Wang QK, 2021, SCIENCE, V371, P1224, DOI 10.1126/science.abe1707; Wang R, 2009, MOL CELL, V33, P692, DOI 10.1016/j.molcel.2009.02.016; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhong FL, 2018, J BIOL CHEM, V293, P18864, DOI 10.1074/jbc.RA118.004350; Zhong FL, 2016, CELL, V167, P187, DOI 10.1016/j.cell.2016.09.001; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	65	18	18	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1392	+		10.1016/j.immuni.2021.04.024	http://dx.doi.org/10.1016/j.immuni.2021.04.024		JUL 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34019797	Bronze, Green Accepted			2022-12-18	WOS:000672812100007
J	Adelaja, A; Taylor, B; Sheu, KM; Liu, Y; Luecke, S; Hoffmann, A				Adelaja, Adewunmi; Taylor, Brooks; Sheu, Katherine M.; Liu, Yi; Luecke, Stefanie; Hoffmann, Alexander			Six distinct NF kappa B signaling codons convey discrete information to distinguish stimuli and enable appropriate macrophage responses	IMMUNITY			English	Article							TUMOR-NECROSIS-FACTOR; SJOGRENS-SYNDROME; TRANSCRIPTIONAL CONTROL; TEMPORAL CONTROL; NEGATIVE FEEDBACK; GENE-EXPRESSION; I INTERFERON; DYNAMICS; ALPHA; ACTIVATION	Macrophages initiate inflammatory responses via the transcription factor NF kappa B. The temporal pattern of NF kappa B activity determines which genes are expressed and thus, the type of response that ensues. Here, we examined how information about the stimulus is encoded in the dynamics of NF kappa B activity. We generated an mVenus-RelA reporter mouse line to enable high-throughput live-cell analysis of primary macrophages responding to host- and pathogen-derived stimuli. An information-theoretic workflow identified six dynamical features-termed signaling codons-that convey stimulus information to the nucleus. In particular, oscillatory trajectories were a hallmark of responses to cytokine but not pathogen-derived stimuli. Single-cell imaging and RNA sequencing of macrophages from a mouse model of Sjogren's syndrome revealed inappropriate responses to stimuli, suggestive of confusion of two NF kappa B signaling codons. Thus, the dynamics of NF kappa B signaling classify immune threats through six signaling codons, and signal confusion based on defective codon deployment may underlie the etiology of some inflammatory diseases.	[Adelaja, Adewunmi; Taylor, Brooks; Sheu, Katherine M.; Liu, Yi; Luecke, Stefanie; Hoffmann, Alexander] Univ Calif Los Angeles, Inst Quantitat & Computat Biosci QCBio, Mol Biol Inst MBI, 611 Charles E Young Dr S, Los Angeles, CA 90093 USA; [Adelaja, Adewunmi; Taylor, Brooks; Sheu, Katherine M.; Liu, Yi; Luecke, Stefanie; Hoffmann, Alexander] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet MIMG, 611 Charles E Young Dr S, Los Angeles, CA 90093 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Hoffmann, A (corresponding author), Univ Calif Los Angeles, Inst Quantitat & Computat Biosci QCBio, Mol Biol Inst MBI, 611 Charles E Young Dr S, Los Angeles, CA 90093 USA.; Hoffmann, A (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet MIMG, 611 Charles E Young Dr S, Los Angeles, CA 90093 USA.	ahoffmann@ucla.edu		Luecke, Stefanie/0000-0001-5320-8110	NIH [R01GM117134, R01AI127864, T32GM008042, T32HL69766, T32GM008185]; NIH NRSA Predoctoral Fellowship [F31AI138450]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [419234150]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NRSA Predoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	We thank laboratory members, especially Quen Cheng and Ying Tang, as well as Roy Wollman (UCLA) and Eric Deeds (UCLA), for critical discussion and reading of the manuscript. The work was supported by NIH training grants for MSTPs (T32GM008042 to A.A. and K.M.S.),Vascular Biology (T32HL69766 to A.A.), and Systems Biology (T32GM008185 to K.M.S.), an NIH NRSA Predoctoral Fellowship to A.A. (F31AI138450), a postdoctoral fellowship from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation, 419234150) to S.L., and NIH grants to A.H. (R01GM117134 and R01AI127864).	Akosa J.S., 2017, SAS GLOB FORUM, V942, P1; Alpaydin E, 2014, ADAPT COMPUT MACH LE, P1; Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Barken Derren, 2005, Science, V308, P52; Basak S, 2012, IMMUNOL REV, V246, P221, DOI 10.1111/j.1600-065X.2011.01092.x; Bauer J, 2001, J INVEST DERMATOL, V116, P313, DOI 10.1046/j.1523-1747.2001.01247.x; Becker V, 2010, SCIENCE, V328, P1404, DOI 10.1126/science.1184913; Behar M, 2013, CELL, V155, P448, DOI 10.1016/j.cell.2013.09.018; Behar M, 2010, CURR OPIN GENET DEV, V20, P684, DOI 10.1016/j.gde.2010.09.007; Bromberg Y, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S8; Burbelo PD, 2014, AUTOIMMUN REV, V13, P756, DOI 10.1016/j.autrev.2014.02.002; Caldwell AB, 2014, GENE DEV, V28, P2120, DOI 10.1101/gad.244749.114; Caruana R., 2006, P 23 INT C MACH LEAR, P161; Cheng CS, 2017, CELL SYST, V4, P330, DOI 10.1016/j.cels.2017.01.012; Cheng Z, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa5208; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Cheong R, 2011, SCIENCE, V334, P354, DOI 10.1126/science.1204553; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; De Lorenzi R, 2009, GENESIS, V47, P323, DOI 10.1002/dvg.20468; Fagerlund R, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0262; Gutschow MV, 2019, MOL BIOL CELL, V30, P282, DOI 10.1091/mbc.E18-07-0423; HASTIE T., 2001, MATH INTELL, V27, P83, DOI [10.1198/jasa.2004.s339., DOI 10.1198/JASA.2004.S339]; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hughey JJ, 2015, MOL BIOL CELL, V26, P583, DOI 10.1091/mbc.E14-08-1267; James G, 2017, INTRO STAT LEARNING; Jetka T, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007132; Kearns JD, 2006, J CELL BIOL, V173, P659, DOI 10.1083/jcb.200510155; Kellogg RA, 2015, ELIFE, V4, DOI 10.7554/eLife.08931; Kellogg RA, 2015, CELL, V160, P381, DOI 10.1016/j.cell.2015.01.013; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Lane K, 2017, CELL SYST, V4, P458, DOI 10.1016/j.cels.2017.03.010; Lee REC, 2014, MOL CELL, V53, P867, DOI 10.1016/j.molcel.2014.01.026; Lee S, 2014, J IMMUNOL, V193, P3726, DOI 10.4049/jimmunol.1400210; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Lisi S, 2012, PATHOLOGY, V44, P557, DOI 10.1097/PAT.0b013e3283580388; Longo DM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003112; MacKay D. J. C., 2003, INFORM THEORY INFERE, P269; Marketos N, 2019, CLIN EXP RHEUMATOL, V37, pS185; Marshak-Rothstein A, 2006, NAT REV IMMUNOL, V6, P823, DOI 10.1038/nri1957; Martin EW, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aax7195; Mathworks, 2017, STAT MACH LEARN TOOL; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mor A, 2010, NAT CELL BIOL, V12, P543, DOI 10.1038/ncb2056; MOSSELMANS R, 1988, J IMMUNOL, V141, P3096; Muskardin TLW, 2018, NAT REV RHEUMATOL, V14, P214, DOI 10.1038/nrrheum.2018.31; Nakata T, 2006, CELL MICROBIOL, V8, P1899, DOI 10.1111/j.1462-5822.2006.00756.x; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Nordmark G, 2013, SCAND J IMMUNOL, V78, P447, DOI 10.1111/sji.12101; O'Mahony D Shane, 2008, Int J Med Sci, V5, P1; Ou TT, 2008, J CLIN IMMUNOL, V28, P440, DOI 10.1007/s10875-008-9212-5; Peng BL, 2010, P NATL ACAD SCI USA, V107, P15193, DOI 10.1073/pnas.1005533107; Powers D.M.W., 2007, EVALUATION PRECISION; Purvis JE, 2013, CELL, V152, P945, DOI 10.1016/j.cell.2013.02.005; Rutz M, 2004, EUR J IMMUNOL, V34, P2541, DOI 10.1002/eji.200425218; Selimkhanov J, 2014, SCIENCE, V346, P1370, DOI 10.1126/science.1254933; Sen S, 2020, CELL SYST, V10, P169, DOI 10.1016/j.cels.2019.12.004; Sergushichev AA., 2016, BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012]; Shiha VFS, 2009, P NATL ACAD SCI USA, V106, P9619, DOI 10.1073/pnas.0812367106; Sisto M, 2013, J MOL HISTOL, V44, P447, DOI 10.1007/s10735-013-9487-6; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sung MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007163; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Tay S, 2010, NATURE, V466, P267, DOI 10.1038/nature09145; Taylor KE, 2017, ARTHRITIS RHEUMATOL, V69, P1294, DOI 10.1002/art.40040; THOMPSON JE, 1995, CELL, V80, P573, DOI 10.1016/0092-8674(95)90511-1; WATANABE N, 1988, J BIOL CHEM, V263, P10262; Werner SL, 2008, GENE DEV, V22, P2093, DOI 10.1101/gad.1680708; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zambrano S, 2016, ELIFE, V5, DOI 10.7554/eLife.09100; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	74	18	18	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					916	+		10.1016/j.immuni.2021.04.011	http://dx.doi.org/10.1016/j.immuni.2021.04.011		MAY 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33979588	Green Accepted, Green Published, hybrid			2022-12-18	WOS:000652019500010
J	Kawakami, R; Kitagawa, Y; Chen, KY; Arai, M; Ohara, D; Nakamura, Y; Yasuda, K; Osaki, M; Mikami, N; Lareau, CA; Watanabe, H; Kondoh, G; Hirota, K; Ohkura, N; Sakaguchi, S				Kawakami, Ryoji; Kitagawa, Yohko; Chen, Kelvin Y.; Arai, Masaya; Ohara, Daiya; Nakamura, Yamami; Yasuda, Keiko; Osaki, Motonao; Mikami, Norihisa; Lareau, Caleb A.; Watanabe, Hitomi; Kondoh, Gen; Hirota, Keiji; Ohkura, Naganari; Sakaguchi, Shimon			Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells	IMMUNITY			English	Article							EPIGENETIC CHANGES; SIGNAL STRENGTH; READ ALIGNMENT; CIS-ELEMENT; CHIP-SEQ; RECEPTOR; EXPRESSION; LINEAGE; DISEASE; GENE	The transcription factor Foxp3 plays crucial roles for Treg cell development and function. Conserved non-coding sequences (CNSs) at the Foxp3 locus control Foxp3 transcription, but how they developmentally contribute to Treg cell lineage specification remains obscure. Here, we show that among Foxp3 CNSs, the promoter-upstream CNS0 and the intergenic CNS3, which bind distinct transcription factors, were activated at early stages of thymocyte differentiation prior to Foxp3 promoter activation, with sequential genomic looping bridging these regions and the promoter. While deletion of either CNS0 or CNS3 partially compromised thymic Treg cell generation, deletion of both completely abrogated the generation and impaired the stability of Foxp3 expression in residual Treg cells. As a result, CNS0 and CNS3 double-deleted mice succumbed to lethal systemic autoimmunity and inflammation. Thus, hierarchical and coordinated activation of Foxp3 CNS0 and CNS3 initiates and stabilizes Foxp3 gene expression, thereby crucially controlling Treg cell development, maintenance, and consequently immunological self-tolerance.	[Kawakami, Ryoji; Kitagawa, Yohko; Chen, Kelvin Y.; Arai, Masaya; Nakamura, Yamami; Yasuda, Keiko; Osaki, Motonao; Mikami, Norihisa; Ohkura, Naganari; Sakaguchi, Shimon] Osaka Univ, Immunol Frontier Res Ctr, Dept Expt Immunol, Suita, Osaka 5650871, Japan; [Kawakami, Ryoji; Kitagawa, Yohko; Yasuda, Keiko; Osaki, Motonao; Mikami, Norihisa; Sakaguchi, Shimon] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan; [Ohara, Daiya; Watanabe, Hitomi; Kondoh, Gen; Hirota, Keiji] Kyoto Univ, Inst Frontier Life & Med Sci, Lab Integrat Biol Sci, Kyoto 6068507, Japan; [Lareau, Caleb A.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Lareau, Caleb A.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	Osaka University; Kyoto University; Kyoto University; Stanford University; Stanford University	Sakaguchi, S (corresponding author), Osaka Univ, Immunol Frontier Res Ctr, Dept Expt Immunol, Suita, Osaka 5650871, Japan.; Sakaguchi, S (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Dept Expt Pathol, Kyoto 6068507, Japan.	shimon@ifrec.osaka-u.ac.jp	Sakaguchi, Shimon/C-9535-2009	Kawakami, Ryoji/0000-0003-2253-4559; Lareau, Caleb/0000-0003-4179-4807; Arai, Masaya/0000-0002-0876-7842	Japan Society for the Promotion of Science (JSPS) [16J03628, 20K16279]; JSPS [16H06295]; Core Research for Evolutional Science and Technology (CREST); Agency for Medical Research and Development (AMED) [JP 19gm0010005]; Leading Advanced Projects for Medical Innovation (LEAP)	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Leading Advanced Projects for Medical Innovation (LEAP)	We thank M. Matsuura, S. Akahori, H. Yasutomi, Y. Li, R. Takeda, T. Nagai, M. Zaizen, Z. Ci, and R. Ishii for their technical assistance. We would like to thank S. Hori for providing Foxp3-hCD2/CD52 mice. The bioinformatics analyses were conducted using the facility at the Genome Information Research Center of the Research Institute for Microbial Diseases, Osaka University, and the core facility of Graduate School of BioStudies, Kyoto University. This work was supported by a Japan Society for the Promotion of Science (JSPS) grant-in-aid for JSPS Fellows (16J03628 to R.K.), a Grant-in-Aid for Young Scientists (20K16279 to R.K.), a JSPS Grant-in-Aid for Specially Promoted Research (16H06295 to S.S.), Core Research for Evolutional Science and Technology (CREST; to S.S.), the Agency for Medical Research and Development (AMED) (JP 19gm0010005 to S.S.), and Leading Advanced Projects for Medical Innovation (LEAP; to S.S.).	Akamatsu M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw2707; Burchill MA, 2008, IMMUNITY, V28, P112, DOI 10.1016/j.immuni.2007.11.022; Chen WJ, 2015, EUR J IMMUNOL, V45, P958, DOI 10.1002/eji.201444999; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Dikiy S, 2021, IMMUNITY, V54, P931, DOI 10.1016/j.immuni.2021.03.020; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Feng YQ, 2015, NATURE, V528, P132, DOI 10.1038/nature16141; Feng YQ, 2014, CELL, V158, P749, DOI 10.1016/j.cell.2014.07.031; Floess S, 2007, PLOS BIOL, V5, P169, DOI 10.1371/journal.pbio.0050038; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; GODFREY VL, 1991, AM J PATHOL, V138, P1379; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Komatsu N, 2009, P NATL ACAD SCI USA, V106, P1903, DOI 10.1073/pnas.0811556106; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lareau CA, 2018, NAT METHODS, V15, P155, DOI 10.1038/nmeth.4583; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li XD, 2014, CELL, V158, P734, DOI 10.1016/j.cell.2014.07.030; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Loo CS, 2020, IMMUNITY, V53, P143, DOI 10.1016/j.immuni.2020.06.011; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Mikami N, 2020, P NATL ACAD SCI USA, V117, P12258, DOI [10.1073/pnas.1922600117/-/DCSupplemental, 10.1073/pnas.1922600117]; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Morikawa H, 2014, P NATL ACAD SCI USA, V111, P5289, DOI 10.1073/pnas.1312717110; Mumbach MR, 2017, NAT GENET, V49, P1602, DOI 10.1038/ng.3963; Mumbach MR, 2016, NAT METHODS, V13, P919, DOI 10.1038/nmeth.3999; Ohkura N, 2020, CELL RES, V30, P465, DOI 10.1038/s41422-020-0324-7; Ohkura N, 2012, IMMUNITY, V37, P785, DOI 10.1016/j.immuni.2012.09.010; Placek K, 2017, NAT IMMUNOL, V18, P1035, DOI 10.1038/ni.3812; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruan QG, 2009, IMMUNITY, V31, P932, DOI 10.1016/j.immuni.2009.10.006; SAKAGUCHI S, 1989, J IMMUNOL, V142, P471; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Savage PA, 2020, ANNU REV IMMUNOL, V38, P421, DOI 10.1146/annurev-immunol-100219-020937; Schmidt C, 2015, NAT METHODS, V12, P963, DOI [10.1038/NMETH.3542, 10.1038/nmeth.3542]; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou X, 2013, NAT METHODS, V10, P375, DOI 10.1038/nmeth.2440	50	18	19	3	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					947	+		10.1016/j.immuni.2021.04.005	http://dx.doi.org/10.1016/j.immuni.2021.04.005		MAY 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33930308	Bronze			2022-12-18	WOS:000652019500012
J	Litvak, Y; Baumler, AJ				Litvak, Yael; Baumler, Andreas J.			Microbiota-Nourishing Immunity: A Guide to Understanding Our Microbial Self	IMMUNITY			English	Review							INTESTINAL BACTERIAL OVERGROWTH; ENTERICA SEROVAR TYPHIMURIUM; ACTIVATED RECEPTOR-GAMMA; CHAIN FATTY-ACIDS; GUT MICROBIOTA; HISTORICAL CONTINGENCY; KLEBSIELLA-PNEUMONIAE; VIRULENCE FACTORS; ESCHERICHIA-COLI; BARRIER FUNCTION	In ecological terms, the microbiome is defined as the microbiota and its environment, a definition that encompasses the human host. The size, species composition, and biogeography of microbial communities is shaped by host interactions, and, in turn, the microbiota influences many aspects of human health. Here we discuss the concept of microbiota-nourishing immunity, a host-microbe chimera composed of the microbiota and host factors that shape the microbial ecosystem, which functions in conferring colonization resistance against pathogens. We propose that dysbiosis is a biomarker of a weakening in microbiota-nourishing immunity and that homeostasis can be defined as a state of immune competence. Microbiota-nourishing immunity thus provides a conceptual framework to further examine the mechanisms that preserve a healthy microbiome and the drivers and consequences of dysbiosis.	[Litvak, Yael; Baumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA	University of California System; University of California Davis	Baumler, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu	Litvak, Yael/AAK-9203-2021; Baumler, Andreas J/H-2301-2011	Litvak, Yael/0000-0002-0183-2816; Baumler, Andreas J/0000-0001-9152-7809	Vaadia-BARD Postdoctoral Fellowship [FI-505-2014]; USDA/NIFA [2015-67015-22930]; Public Health Service [AI044170, AI096528, AI112445, AI112949]	Vaadia-BARD Postdoctoral Fellowship; USDA/NIFA(United States Department of Agriculture (USDA)); Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service)	Y.L. was supported by Vaadia-BARD Postdoctoral Fellowship FI-505-2014. Work in A.J.B.'s lab is supported by USDA/NIFA award 2015-67015-22930 and by Public Health Service Grants AI044170, AI096528, AI112445, and AI112949.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Altura MA, 2013, ENVIRON MICROBIOL, V15, P2937, DOI 10.1111/1462-2920.12179; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Arthur JC, 2012, SCIENCE, V338, P120, DOI 10.1126/science.1224820; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Bakken JS, 2011, CLIN GASTROENTEROL H, V9, P1044, DOI 10.1016/j.cgh.2011.08.014; BOHNHOFF M, 1964, J EXP MED, V120, P817, DOI 10.1084/jem.120.5.817; Brugiroux S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.215; Buffie CG, 2015, NATURE, V517, P205, DOI 10.1038/nature13828; Buler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049863; Bures J, 2010, WORLD J GASTROENTERO, V16, P2978, DOI 10.3748/wjg.v16.i24.2978; Byndloss MX, 2019, INFLAMM BOWEL DIS, V25, P811, DOI 10.1093/ibd/izz004; Byndloss MX, 2018, MUCOSAL IMMUNOL, V11, P1299, DOI 10.1038/s41385-018-0010-y; Byndloss MX, 2017, SCIENCE, V357, P570, DOI 10.1126/science.aam9949; Campbell EL, 2014, IMMUNITY, V40, P66, DOI 10.1016/j.immuni.2013.11.020; Cani PD, 2017, NAT REV GASTRO HEPAT, V14, P321, DOI 10.1038/nrgastro.2017.54; Daikos GL, 2010, J ANTIMICROB CHEMOTH, V65, P784, DOI 10.1093/jac/dkq005; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Deriu E, 2013, CELL HOST MICROBE, V14, P26, DOI 10.1016/j.chom.2013.06.007; Devkota S, 2012, NATURE, V487, P104, DOI 10.1038/nature11225; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Dubinkina VB, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0359-2; Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3; Ejtahed HS, 2019, EUR J ENDOCRINOL, V180, P165, DOI [10.1530/EJE-18-0826, 10.1530/eje-18-0826]; El Kaoutari A, 2013, NAT REV MICROBIOL, V11, P497, DOI 10.1038/nrmicro3050; Fan X, 2009, ALIMENT PHARM THER, V29, P1069, DOI 10.1111/j.1365-2036.2009.03970.x; Finley LWS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023295; Foster KR, 2017, NATURE, V548, P43, DOI 10.1038/nature23292; FRETER R, 1983, INFECT IMMUN, V39, P686, DOI 10.1128/IAI.39.2.686-703.1983; Fukami T, 2015, ANNU REV ECOL EVOL S, V46, P1, DOI 10.1146/annurev-ecolsys-110411-160340; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gill N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049646; Gillis CC, 2019, INFECT IMMUN, V87, DOI 10.1128/IAI.00773-18; Gillis CC, 2018, CELL HOST MICROBE, V23, P54, DOI 10.1016/j.chom.2017.11.006; Giralt A, 2011, J BIOL CHEM, V286, P16958, DOI 10.1074/jbc.M110.202390; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hooper LV, 2001, SCIENCE, V292, P1115, DOI 10.1126/science.1058709; Hughes ER, 2017, CELL HOST MICROBE, V21, P208, DOI 10.1016/j.chom.2017.01.005; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kamdar K, 2016, CELL HOST MICROBE, V19, P21, DOI 10.1016/j.chom.2015.12.006; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kongara KR, 2000, J CLIN GASTROENTEROL, V30, P84, DOI 10.1097/00004836-200001000-00017; Kremer N, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0504; Kremer N, 2013, CELL HOST MICROBE, V14, P183, DOI 10.1016/j.chom.2013.07.006; Kuijper EJ, 2006, CLIN MICROBIOL INFEC, V12, P2, DOI 10.1111/j.1469-0691.2006.01580.x; Libertucci J, 2019, NAT MICROBIOL, V4, P35, DOI 10.1038/s41564-018-0278-4; Litvak Y, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007563; Litvak Y, 2019, CELL HOST MICROBE, V25, P128, DOI 10.1016/j.chom.2018.12.003; Litvak Y, 2018, SCIENCE, V362, P1017, DOI 10.1126/science.aat9076; Litvak Y, 2017, CURR OPIN MICROBIOL, V39, P1, DOI 10.1016/j.mib.2017.07.003; Lopez CA, 2016, SCIENCE, V353, P1249, DOI 10.1126/science.aag3042; Lopez CA, 2015, INFECT IMMUN, V83, P3470, DOI 10.1128/IAI.00351-15; Lopez CA, 2012, MBIO, V3, DOI 10.1128/mBio.00143-12; Louis P, 2009, FEMS MICROBIOL LETT, V294, P1, DOI 10.1111/j.1574-6968.2009.01514.x; Lowe CF, 2013, INFECT CONT HOSP EP, V34, P49, DOI 10.1086/668778; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Martinez-Medina M, 2014, GUT, V63, P116, DOI 10.1136/gutjnl-2012-304119; Mazzocchi F, 2015, EMBO REP, V16, P1250, DOI 10.15252/embr.201541001; McLaughlin PA, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007847; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Nedialkova LP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003844; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Olesen SW, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.228, 10.1038/nmicrobiol.2016.228]; PIGNATA C, 1990, GUT, V31, P879, DOI 10.1136/gut.31.8.879; Proctor L, 2019, NATURE, V569, P623, DOI 10.1038/d41586-019-01654-0; Putze J, 2009, INFECT IMMUN, V77, P4696, DOI 10.1128/IAI.00522-09; QUIE PG, 1986, J PEDIATR-US, V108, P813, DOI 10.1016/S0022-3476(86)80750-8; Razazi K, 2012, INTENS CARE MED, V38, P1769, DOI 10.1007/s00134-012-2675-0; Rigottier-Gois L, 2013, ISME J, V7, P1256, DOI 10.1038/ismej.2013.80; Rivera-Chavez F, 2016, CELL HOST MICROBE, V19, P443, DOI 10.1016/j.chom.2016.03.004; ROEDIGER WEW, 1980, LANCET, V2, P712; Rohmer L, 2011, TRENDS MICROBIOL, V19, P341, DOI 10.1016/j.tim.2011.04.003; Rousseaux C, 2013, CARCINOGENESIS, V34, P2580, DOI 10.1093/carcin/bgt245; Ruby EG, 1996, ANNU REV MICROBIOL, V50, P591, DOI 10.1146/annurev.micro.50.1.591; Rustgi AK, 2007, GENE DEV, V21, P2525, DOI 10.1101/gad.1593107; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sana TG, 2016, P NATL ACAD SCI USA, V113, pE5044, DOI 10.1073/pnas.1608858113; Sarker SA, 2017, MICROB BIOTECHNOL, V10, P1025, DOI 10.1111/1751-7915.12780; Sassone-Corsi M, 2016, NATURE, V540, P280, DOI 10.1038/nature20557; Sears CL, 2014, CELL HOST MICROBE, V15, P317, DOI 10.1016/j.chom.2014.02.007; Sears CL, 2011, J INFECT DIS, V203, P306, DOI 10.1093/jinfdis/jiq061; Sekirov I, 2010, GUT MICROBES, V1, P30, DOI 10.4161/gmic.1.1.10950; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Shanthi M, 2010, J Assoc Physicians India, V58 Suppl, P41; Shepherd ES, 2018, NATURE, V557, P434, DOI 10.1038/s41586-018-0092-4; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sommer F, 2017, NAT REV MICROBIOL, V15, P630, DOI 10.1038/nrmicro.2017.58; Sommer F, 2016, BIOESSAYS, V38, P455, DOI 10.1002/bies.201500151; Sonnenburg ED, 2016, NATURE, V529, P212, DOI 10.1038/nature16504; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Spear GT, 2014, J INFECT DIS, V210, P1019, DOI 10.1093/infdis/jiu231; Spees AM, 2013, MBIO, V4, DOI 10.1128/mBio.00430-13; Spiga L, 2019, TRENDS MICROBIOL, V27, P243, DOI 10.1016/j.tim.2018.11.007; Sprockett D, 2018, NAT REV GASTRO HEPAT, V15, P197, DOI 10.1038/nrgastro.2017.173; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; Theriot CM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4114; Tjalsma H, 2012, NAT REV MICROBIOL, V10, P575, DOI 10.1038/nrmicro2819; Trespi E, 1999, CURR MED RES OPIN, V15, P47, DOI 10.1185/03007999909115173; Tripathi A, 2018, CURR OPIN MICROBIOL, V44, P61, DOI 10.1016/j.mib.2018.07.002; Troll JV, 2010, ENVIRON MICROBIOL, V12, P2190, DOI 10.1111/j.1462-2920.2009.02121.x; Tsolis RM, 1999, INFECT IMMUN, V67, P4879, DOI 10.1128/IAI.67.9.4879-4885.1999; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Vannette RL, 2014, ECOL LETT, V17, P115, DOI 10.1111/ele.12204; Velazquez EM, 2019, NAT MICROBIOL, V4, P1057, DOI 10.1038/s41564-019-0407-8; Velazquez OC, 1997, ADV EXP MED BIOL, V427, P123; Vital M, 2014, MBIO, V5, DOI 10.1128/mBio.00889-14; Weingarden AR, 2014, AM J PHYSIOL-GASTR L, V306, pG310, DOI 10.1152/ajpgi.00282.2013; Wells JE, 2000, APPL ENVIRON MICROB, V66, P1107, DOI 10.1128/AEM.66.3.1107-1113.2000; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Xu J, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01274; Zhao SY, 2016, EPIDEMIOL INFECT, V144, P695, DOI 10.1017/S0950268815001879; Zheng L, 2015, AM J PHYSIOL-CELL PH, V309, pC350, DOI 10.1152/ajpcell.00191.2015; Zhou SY, 1999, DRUG METAB DISPOS, V27, P479; Zhu WH, 2018, NATURE, V553, P208, DOI 10.1038/nature25172; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	121	18	19	4	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					214	224		10.1016/j.immuni.2019.08.003	http://dx.doi.org/10.1016/j.immuni.2019.08.003			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31433969	Bronze			2022-12-18	WOS:000482088500007
J	Wu, JX; Ma, SC; Sandhoff, R; Ming, YA; Hotz-Wagenblatt, A; Timmerman, V; Bonello-Palot, N; Schlotter-Weigel, B; Auer-Grumbach, M; Seeman, P; Loscher, WN; Reindl, M; Weiss, F; Mah, E; Weisshaar, N; Madi, A; Mohr, K; Schlimbach, T; Cardenas, RMHV; Koeppel, J; Grunschlager, F; Muller, L; Baumeister, M; Brugger, B; Schmitt, M; Wabnitz, G; Samstag, Y; Cui, GL				Wu, Jingxia; Ma, Sicong; Sandhoff, Roger; Ming, Yanan; Hotz-Wagenblatt, Agnes; Timmerman, Vincent; Bonello-Palot, Nathalie; Schlotter-Weigel, Beate; Auer-Grumbach, Michaela; Seeman, Pavel; Loescher, Wolfgang N.; Reindl, Markus; Weiss, Florian; Mah, Eric; Weisshaar, Nina; Madi, Alaa; Mohr, Kerstin; Schlimbach, Tilo; Cardenas, Rubi M. -H. Velasco; Koeppel, Jonas; Gruenschlaeger, Florian; Mueller, Lisann; Baumeister, Maren; Bruegger, Britta; Schmitt, Michael; Wabnitz, Guido; Samstag, Yvonne; Cui, Guoliang			Loss of Neurological Disease HSAN-I-Associated Gene SPTLC2 Impairs CD8(+) T Cell Responses to Infection by Inhibiting T Cell Metabolic Fitness	IMMUNITY			English	Article							HEREDITARY SENSORY NEUROPATHY; SERINE PALMITOYLTRANSFERASE; SPHINGOSINE 1-PHOSPHATE; MITOCHONDRIAL-FUNCTION; POTENT INHIBITOR; CERAMIDE; CHAIN; MTOR; HELP; SPHINGOSINE-1-PHOSPHATE	Patients with the neurological disorder HSAN-I suffer frequent infections, attributed to a lack of pain sensation and failure to seek care for minor injuries. Whether protective CD8(+) T cells are affected in HSAN-I patients remains unknown. Here, we report that HSAN-I-associated mutations in serine palmitoyltransferase subunit SPTLC2 dampened human T cell responses. Antigen stimulation and inflammation induced SPTLC2 expression, and murine T-cell-specific ablation of Sptlc2 impaired antiviralT-cell expansion and effector function. Sptlc2 deficiency reduced sphingolipid biosynthetic flux and led to prolonged activation of the mechanistic target of rapamycin complex 1 (mTORC1), endoplasmic reticulum (ER) stress, and CD8(+) T cell death. Protective CD8(+) T cell responses in HSAN-I patient PBMCs and Sptlc2-deficient mice were restored by supplementing with sphingolipids and pharmacologically inhibiting ER stress-induced cell death. Therefore, SPTLC2 underpins protective immunity by translating extracellular stimuli into intracellular anabolic signals and antagonizes ER stress to promote T cell metabolic fitness.	[Wu, Jingxia; Ma, Sicong; Weisshaar, Nina; Madi, Alaa; Mohr, Kerstin; Schlimbach, Tilo; Cardenas, Rubi M. -H. Velasco; Koeppel, Jonas; Gruenschlaeger, Florian; Mueller, Lisann; Baumeister, Maren; Cui, Guoliang] German Canc Res Ctr, T Cell Metab Grp D140, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Sandhoff, Roger] German Canc Res Ctr, Lipid Pathobiochem Grp G131, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Ming, Yanan] Univ Heidelberg Hosp, Internal Med 4, Neuenheimer Feld 345, D-69120 Heidelberg, Germany; [Hotz-Wagenblatt, Agnes] German Canc Res Ctr, Core Facil Om IT & Data Management, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Timmerman, Vincent] Univ Antwerp, Inst Born Bunge, Dept Biomed Sci, Peripheral Neuropathy Res Grp, B-2610 Antwerp, Belgium; [Bonello-Palot, Nathalie] Children Timone Hosp, Dept Med Genet, 264 Rue St Pierre, F-13385 Marseille, France; [Bonello-Palot, Nathalie] Aix Marseille Univ, INSERM, MMG, U1251, F-13385 Marseille, France; [Schlotter-Weigel, Beate] Ludwig Maximilians Univ Munchen, Neurol Klin & Poliklin, Friedrich Baur Inst, D-80336 Munich, Germany; [Auer-Grumbach, Michaela] Med Univ Vienna, Dept Orthopaed & Trauma Surg, Vienna, Austria; [Seeman, Pavel] Charles Univ Prague, Univ Hosp Motol, Med Sch 2, Dept Child Neurol,DNA Lab, Prague, Czech Republic; [Loescher, Wolfgang N.; Reindl, Markus] Med Univ Innsbruck, Dept Clin Neurol, Anichstr 35, A-6020 Innsbruck, Austria; [Weiss, Florian] Univ Hosp Psychiat, Dept Psychiat & Psychotherapy, Bolligenstr 111, D-3000 Bern, Germany; [Mah, Eric] Univ Calif San Diego, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Bruegger, Britta] Heidelberg Univ, Biochem Ctr BZH, Neuenheimer Feld 328, Heidelberg, Germany; [Schmitt, Michael] Univ Heidelberg Hosp, Internal Med 5, Neuenheimer Feld 410, D-69120 Heidelberg, Germany; [Wabnitz, Guido; Samstag, Yvonne] Heidelberg Univ, Inst Immunol, Sect Mol Immunol, Neuenheimer Feld 305, D-69120 Heidelberg, Germany; [Ma, Sicong] Heidelberg Univ, Med Fac Heidelberg, D-69120 Heidelberg, Germany; [Cui, Guoliang] Heidelberg Univ, Fac Biosci, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of Antwerp; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Medical University of Vienna; Charles University Prague; Motol University Hospital; Medical University of Innsbruck; University of California System; University of California San Diego; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Cui, GL (corresponding author), German Canc Res Ctr, T Cell Metab Grp D140, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.; Cui, GL (corresponding author), Heidelberg Univ, Fac Biosci, D-69120 Heidelberg, Germany.	g.cui@dkfz.de	Palot, Nathalie Bonello/M-7134-2016; wu, Jingxia/AFR-6587-2022; Reindl, Markus/ABE-5880-2020	Palot, Nathalie Bonello/0000-0002-8657-1271; Grunschlager, Florian/0000-0003-0021-6912; Wabnitz, Guido/0000-0001-5101-9885; Velasco Cardenas, Rubi M.-H./0000-0002-1764-115X; Cui, Guoliang/0000-0001-5559-7957; Ma, Sicong/0000-0001-7569-2177; Loscher, Wolfgang/0000-0002-7593-3222; Reindl, Markus/0000-0003-2817-1402	Helmholtz Young Investigator Award [VH-NG-1113]; German Research Foundation (DFG) [CU375/5-1]; German Cancer Aid Foundation (DKH) [70113343]; Helmholtz AMPro; Rare Disease Foundation; BC Children's Hospital Foundation [2286, 2604]; Chinese Scholar Council fellowship; Fund for Scientific Research (FWO-Flanders); Medical Foundation Queen Elisabeth (GSKE); Association Belge contre les Maladies Neuromusculaires (ABMM); H2020 grant Solve-RD, 'Solving the unsolved rare diseases' [2017-779257]; Ministry of Health of the Czech Republic [AZV 16-30206A, DRO 00064203]; Austrian Science Fund (FWF) [P27634FW]; ONB [16880]; US National Institutes of Health (NIH) [UL1TR001442]; German Research Foundation [278001972 TRR 186]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001442] Funding Source: NIH RePORTER	Helmholtz Young Investigator Award; German Research Foundation (DFG)(German Research Foundation (DFG)); German Cancer Aid Foundation (DKH); Helmholtz AMPro; Rare Disease Foundation; BC Children's Hospital Foundation; Chinese Scholar Council fellowship; Fund for Scientific Research (FWO-Flanders)(FWO); Medical Foundation Queen Elisabeth (GSKE); Association Belge contre les Maladies Neuromusculaires (ABMM); H2020 grant Solve-RD, 'Solving the unsolved rare diseases'; Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ONB; US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	We thank the DKFZ core facilities (mouse work, flow cytometry, biosafety, monoclonal antibody, and genomics) for the assistance. We thank Drs. Karsten Richter and Michelle Nessling for their help with the EM imaging. We thank Drs. Carla Grosmann, David Boyle, and Andre A. Matti for helping with the human sample collection. We thank Drs. Hermann-Josef Grone, Walee Chamulitrat, and Hongying Gan-Schreier for discussions. We thank Dr. Xian-cheng Jiang (SUNY Downstate Medical Center, New York) for providing the Sptlc2 Flox/Flox mice. LCMV was provided by Dr. Susan Kaech (Yale University, New Haven, Connecticut). We also thank NIH core facility for kindly providing the LCMV tetramers. G.C. is supported by a Helmholtz Young Investigator Award (VH-NG-1113) and the German Research Foundation (DFG, CU375/5-1), German Cancer Aid Foundation (DKH, 70113343), Helmholtz AMPro, Rare Disease Foundation, and BC Children's Hospital Foundation (#2286 and #2604). S.M. is supported by a Chinese Scholar Council fellowship. V.T. is supported by the Fund for Scientific Research (FWO-Flanders), Medical Foundation Queen Elisabeth (GSKE), Association Belge contre les Maladies Neuromusculaires (ABMM), and H2020 grant Solve-RD, 'Solving the unsolved rare diseases' under grant agreement 2017-779257. P.S. is supported by the Ministry of Health of the Czech Republic grants AZV 16-30206A and DRO 00064203. This work was supported by the Austrian Science Fund (FWF, P27634FW, to M.A.-G.) and ONB (Nr. 16880, to M.A.-G.). E.M. is supported by the US National Institutes of Health (NIH) grant UL1TR001442 awarded to UC San Diego Altman Clinical & Translational Research Institute (ACTRI). B.B. is supported by the German Research Foundation (278001972 TRR 186).	Albert V, 2015, CURR OPIN CELL BIOL, V33, P55, DOI 10.1016/j.ceb.2014.12.001; Alecu I, 2017, J LIPID RES, V58, P42, DOI 10.1194/jlr.M068676; Apostolidis SA, 2016, NAT IMMUNOL, V17, P556, DOI 10.1038/ni.3390; Arora AS, 1997, HEPATOLOGY, V25, P958, DOI 10.1002/hep.510250428; Bejaoui K, 2001, NAT GENET, V27, P261, DOI 10.1038/85817; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bennett SRM, 1997, J EXP MED, V186, P65, DOI 10.1084/jem.186.1.65; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Chakraborty M, 2013, J CLIN INVEST, V123, P1784, DOI 10.1172/JCI60415; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chung TW, 1997, J BIOL CHEM, V272, P3064, DOI 10.1074/jbc.272.5.3064; Cremesti A, 2001, J BIOL CHEM, V276, P23954, DOI 10.1074/jbc.M101866200; Cuvillier O, 1996, NATURE, V381, P800, DOI 10.1038/381800a0; Cyster JG, 2012, ANNU REV IMMUNOL, V30, P69, DOI 10.1146/annurev-immunol-020711-075011; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; Di Nardo A, 2009, J NEUROSCI, V29, P5926, DOI 10.1523/JNEUROSCI.0778-09.2009; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; DUTKO FJ, 1983, J GEN VIROL, V64, P1689, DOI 10.1099/0022-1317-64-8-1689; Finlay DK, 2012, J EXP MED, V209, P2441, DOI 10.1084/jem.20112607; Garofalo K, 2011, J CLIN INVEST, V121, P4735, DOI 10.1172/JCI57549; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Grey A, 2002, ENDOCRINOLOGY, V143, P4755, DOI 10.1210/en.2002-220347; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herz J, 2009, NAT IMMUNOL, V10, P761, DOI 10.1038/ni.1757; Jin YX, 2003, BLOOD, V101, P4909, DOI 10.1182/blood-2002-09-2962; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kluk MJ, 2001, CIRC RES, V89, P496, DOI 10.1161/hh1801.096338; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee SY, 2017, DIABETES, V66, P2596, DOI 10.2337/db16-1232; Lee SY, 2012, J BIOL CHEM, V287, P18429, DOI 10.1074/jbc.M111.296947; Leonard WJ, 1996, ANNU REV MED, V47, P229; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Li ZQ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0214-1; Li ZQ, 2009, J BIOL CHEM, V284, P27010, DOI 10.1074/jbc.M109.042028; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu GW, 2009, NAT IMMUNOL, V10, P769, DOI 10.1038/ni.1743; Liu GX, 2010, PROCEEDINGS OF THE 7TH INTERNATIONAL CONFERENCE ON INNOVATION AND MANAGEMENT, VOLS I AND II, P1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mendoza A, 2017, NATURE, V546, P158, DOI 10.1038/nature22352; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Murphy SM, 2013, NEUROLOGY, V80, P2106, DOI 10.1212/WNL.0b013e318295d789; Nickels JT, 1996, GENE DEV, V10, P382, DOI 10.1101/gad.10.4.382; Novgorodov SA, 2008, J BIOL CHEM, V283, P24707, DOI 10.1074/jbc.M801810200; Oh S, 2008, P NATL ACAD SCI USA, V105, P5201, DOI 10.1073/pnas.0801003105; Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Romero P, 2007, J IMMUNOL, V178, P4112, DOI 10.4049/jimmunol.178.7.4112; Rotthier A, 2010, AM J HUM GENET, V87, P513, DOI 10.1016/j.ajhg.2010.09.010; Sallusto F, 1996, J EXP MED, V184, P2411, DOI 10.1084/jem.184.6.2411; Sandhoff K., 1993, JPN J CANC RES, V84; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Scheffel MJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15791-x; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Seki A, 2018, J EXP MED, V215, P985, DOI 10.1084/jem.20171626; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Sofi MH, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91701; Tettamanti G, 2003, BIOCHIMIE, V85, P423, DOI 10.1016/S0300-9084(03)00047-6; Umeshappa CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047004; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wilson EB, 2008, J IMMUNOL, V181, P7445, DOI 10.4049/jimmunol.181.11.7445; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; 2004, IMMUNOL REV, V202, P67; 2001, J BIOL CHEM, V276, P2058	74	18	18	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 21	2019	50	5					1218	+		10.1016/j.immuni.2019.03.005	http://dx.doi.org/10.1016/j.immuni.2019.03.005			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HY8ZR	30952607	Green Accepted, Bronze			2022-12-18	WOS:000468429500013
J	Li, XH; Gong, W; Wang, H; Li, TL; Attri, KS; Lewis, RE; Kalil, AC; Bhinderwala, F; Powers, R; Yin, GW; Herring, LE; Asara, JM; Lei, YL; Yang, XY; Rodriguez, DA; Yang, M; Green, DR; Singh, PK; Wen, HT				Li, Xinghui; Gong, Wei; Wang, Hao; Li, Tianliang; Attri, Kuldeep S.; Lewis, Robert E.; Kalil, Andre C.; Bhinderwala, Fatema; Powers, Robert; Yin, Guowei; Herring, Laura E.; Asara, John M.; Lei, Yu L.; Yang, Xiaoyong; Rodriguez, Diego A.; Yang, Mao; Green, Douglas R.; Singh, Pankaj K.; Wen, Haitao			O-GlcNAc Transferase Suppresses Inflammation and Necroptosis by Targeting Receptor-Interacting Serine/Threonine-Protein Kinase 3 (vol 50, pg 576, 2019)	IMMUNITY			English	Correction												haitao.wen@osumc.edu	Attri, Kuldeep S/S-9840-2019; Powers, Robert/AAK-3431-2020; Wen, Haitao/AAJ-7621-2020; Lei, Yu Leo/ABF-1293-2020	Powers, Robert/0000-0001-9948-6837; Lei, Yu Leo/0000-0002-9868-9824	NATIONAL CANCER INSTITUTE [P01CA120964, R01CA163649, R01CA216853, R01CA210439] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI044828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE026728, R00DE024173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102648] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM120496] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA216853, R35 CA231620, R01 CA163649, R01 CA210439] Funding Source: Medline; NIAID NIH HHS [R01 AI044828, R37 AI044828] Funding Source: Medline; NIDCR NIH HHS [R01 DE026728, R00 DE024173] Funding Source: Medline; NIDDK NIH HHS [R01 DK102648] Funding Source: Medline; NIGMS NIH HHS [R01 GM120496] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Li XH, 2019, IMMUNITY, V50, P576, DOI 10.1016/j.immuni.2019.01.007	1	18	18	2	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 16	2019	50	4					1115	1115		10.1016/j.immuni.2019.03.008	http://dx.doi.org/10.1016/j.immuni.2019.03.008			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HT6FY	30995496	Bronze, Green Accepted			2022-12-18	WOS:000464660800026
J	Kishore, M; Cheung, KCP; Fu, HM; Bonacina, F; Wang, GS; Coe, D; Ward, EJ; Colamatteo, A; Jangani, M; Baragetti, A; Matarese, G; Smith, DM; Haas, R; Mauro, C; Wraith, DC; Okkenhaug, K; Catapano, AL; De Rosa, V; Norata, GD; Marelli-Berg, FM				Kishore, Madhav; Cheung, Kenneth C. P.; Fu, Hongmei; Bonacina, Fabrizia; Wang, Guosu; Coe, David; Ward, Eleanor J.; Colamatteo, Alessandra; Jangani, Maryam; Baragetti, Andrea; Matarese, Giuseppe; Smith, David M.; Haas, Robert; Mauro, Claudio; Wraith, David C.; Okkenhaug, Klaus; Catapano, Alberico L.; De Rosa, Veronica; Norata, Giuseppe D.; Marelli-Berg, Federica M.			Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis (vol 47, pg 875, 2017)	IMMUNITY			English	Correction												f.marelli-berg@qmul.ac.uk	Okkenhaug, Klaus/H-3154-2019; Catapano, alberico/AAC-2827-2019; Bonacina, Fabrizia/AAC-3359-2022	Okkenhaug, Klaus/0000-0002-9432-4051; Catapano, alberico/0000-0002-7593-2094; Bonacina, Fabrizia/0000-0002-2611-1177; Haas, Robert/0000-0003-4826-2379; Coe, David/0000-0001-8167-600X; Smith, David/0000-0001-6831-280X; Norata, Giuseppe Danilo/0000-0002-6081-1257	BBSRC [BBS/E/B/000C0407, BBS/E/B/000C0427] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Kishore M, 2017, IMMUNITY, V47, P875, DOI 10.1016/j.immuni.2017.10.017	1	18	20	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					831	832		10.1016/j.immuni.2018.03.034	http://dx.doi.org/10.1016/j.immuni.2018.03.034			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669254	Green Published, hybrid			2022-12-18	WOS:000430198900026
J	Seo, YJ; Jothikumar, P; Suthar, MS; Zhu, C; Grakoui, A				Seo, Young-Jin; Jothikumar, Prithiviraj; Suthar, Mehul S.; Zhu, Cheng; Grakoui, Arash			Local Cellular and Cytokine Cues in the Spleen Regulate In Situ T Cell Receptor Affinity, Function, and Fate of CD8(+) T Cells	IMMUNITY			English	Article							LYMPHOCYTIC CHORIOMENINGITIS VIRUS; TGF-BETA; TRANSCRIPTIONAL CONTROL; VIRAL-INFECTION; EFFECTOR; KINETICS; TCR; DIFFERENTIATION; ACTIVATION; SELECTION	T cells rapidly undergo contraction upon viral clearance, but how T cell function and fate are determined during this phase is unclear. During the contraction phase of an acute infection with lymphocytic choriomeningitis virus, we found that virus-specific CD8(+) T cells within the splenic red pulp (RP) had higher two-dimensional (2D) effective affinity than those within the white pulp (WP). This increased antigen recognition of RP-derived CD8(+) T cells correlated with more efficient target cell killing and improved control of viremia. FoxP3(+) regulatory T cells and cytokine TGF-beta limited the 2D-affinity in the WP during the contraction phase. Anatomical location drove gene expression patterns in CD8(+) T cells that led to preferential differentiation of memory precursor WP T cells into long-term memory cells. These results highlight that intricate regulation of T cell function and fate is determined by anatomic compartmentalization during the early immune contraction phase.	[Seo, Young-Jin; Grakoui, Arash] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30329 USA; [Seo, Young-Jin; Suthar, Mehul S.; Grakoui, Arash] Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA; [Jothikumar, Prithiviraj; Zhu, Cheng] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Suthar, Mehul S.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30329 USA; [Suthar, Mehul S.] Emory Univ, Sch Med, Childrens Healthcare Atlanta, Atlanta, GA 30329 USA	Emory University; Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; Children's Healthcare of Atlanta (CHOA); Emory University	Grakoui, A (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30329 USA.; Grakoui, A (corresponding author), Emory Vaccine Ctr, Yerkes Natl Primate Res Ctr, Atlanta, GA 30329 USA.; Zhu, C (corresponding author), Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA.	cheng.zhu@bme.gatech.edu; arash.grakoui@emory.edu		Zhu, Cheng/0000-0002-1718-565X	NIH Tetramer Core Facility [HHSN272201300006C]; NIH [U19AI083019, R56AI110516, R01AI070101, R01AI124680, R01AI126890]; ORIP-OD [P51OD011132]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI110516, R01AI038282, R01AI126890, R01AI070101, R21AI118337, R29AI038282, P30AI050409, R01AI124680, U19AI083019, R56AI038282] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011132] Funding Source: NIH RePORTER	NIH Tetramer Core Facility(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ORIP-OD; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Drs. Rafi Ahmed, David Weiss, Brian Evavold, and Christopher Walker for helpful discussions and Dr. Holly Hanson for critical reading of the manuscript. We would like to thank Drs. David Masopust and Jacob Kohlmeier for helping us to establish and adapt the intravascular staining procedure and Larissa Doudy for technical support. We acknowledge the NIH Tetramer Core Facility (contract HHSN272201300006C) for provision of tetramers. We also would like to thank Yerkes Nonhuman Primate Genomics Core and the Immunology and Flow Cytometry Core of the Center for AIDS Research at Emory University (P30AI050409). This project was supported by NIH grants U19AI083019 and R56AI110516 to M.S.S., NIH grant R01AI124680 to C.Z., ORIP-OD P51OD011132 (formerly NCRR P51RR000165) to the Yerkes National Primate Research Center, and NIH grants R01AI070101, R01AI124680, and R01AI126890 to A.G. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Beemiller P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002444; Blake JA, 2015, NUCLEIC ACIDS RES, V43, pD1049, DOI 10.1093/nar/gku1179; Campi G, 2005, J EXP MED, V202, P1031, DOI 10.1084/jem.20051182; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Chesla SE, 1998, BIOPHYS J, V75, P1553, DOI 10.1016/S0006-3495(98)74074-3; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Ernst J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100115; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Goulder PJR, 2004, NAT REV IMMUNOL, V4, P630, DOI 10.1038/nri1417; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang J, 2007, J IMMUNOL, V179, P7653, DOI 10.4049/jimmunol.179.11.7653; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Jung YW, 2010, J IMMUNOL, V185, P5315, DOI 10.4049/jimmunol.1001948; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Li MO, 2008, CELL, V134, P392, DOI 10.1016/j.cell.2008.07.025; Liblau RS, 2002, IMMUNITY, V17, P1, DOI 10.1016/S1074-7613(02)00338-2; Liu BY, 2014, EUR J IMMUNOL, V44, P239, DOI 10.1002/eji.201343774; Man K, 2015, NAT REV IMMUNOL, V15, P574, DOI 10.1038/nri3874; Manning TC, 1999, IMMUNOL TODAY, V20, P417, DOI 10.1016/S0167-5699(99)01508-X; Miceli MC, 2001, SEMIN IMMUNOL, V13, P115, DOI 10.1006/smim.2000.0303; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Penaloza-MacMaster P, 2014, J EXP MED, V211, P1905, DOI 10.1084/jem.20132577; Puglielli MT, 2001, J VIROL, V75, P5099, DOI 10.1128/JVI.75.11.5099-5107.2001; Richer MJ, 2013, IMMUNITY, V38, P140, DOI 10.1016/j.immuni.2012.09.017; Sabatino JJ, 2011, J EXP MED, V208, P81, DOI 10.1084/jem.20101574; Slifka MK, 2001, NAT IMMUNOL, V2, P711, DOI 10.1038/90650; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	44	18	18	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					988	998		10.1016/j.immuni.2016.10.024	http://dx.doi.org/10.1016/j.immuni.2016.10.024			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851926	Bronze, Green Accepted			2022-12-18	WOS:000389473500011
J	Murray, PJ; Allen, JE; Biswas, SK; Fisher, EA; Gilroy, DW; Goerdt, S; Gordon, S; Hamilton, JA; Ivashkiv, LB; Lawrence, T; Locati, M; Mantovani, A; Martinez, FO; Mege, JL; Mosser, DM; Natoli, G; Saeij, JP; Schultze, JL; Shirey, KA; Sica, A; Suttles, J; Udalova, I; van Ginderachter, JA; Vogel, SN; Wynn, TA				Murray, Peter J.; Allen, Judith E.; Biswas, Subhra K.; Fisher, Edward A.; Gilroy, Derek W.; Goerdt, Sergij; Gordon, Siamon; Hamilton, John A.; Ivashkiv, Lionel B.; Lawrence, Toby; Locati, Massimo; Mantovani, Alberto; Martinez, Fernando O.; Mege, Jean-Louis; Mosser, David M.; Natoli, Gioacchino; Saeij, Jeroen P.; Schultze, Joachim L.; Shirey, Kari Ann; Sica, Antonio; Suttles, Jill; Udalova, Irina; van Ginderachter, Jo A.; Vogel, Stefanie N.; Wynn, Thomas A.			Macrophage Activation and Polarization: Nomenclature and Experimental Guidelines (vol 41, pg 14, 2014)	IMMUNITY			English	Correction												peter.murray@stjude.org	Lawrence, Toby/GLU-3895-2022; Murray, Peter J/K-4725-2018; Wynn, Thomas A/AAO-3523-2021; Natoli, gioacchino/ABB-8679-2020; Mantovani, Alberto/HCI-7449-2022; Natoli, gioacchino/J-2100-2018; Schultze, Joachim L/D-7794-2011; Sica, Antonio/AAB-9546-2020; Schultze, Joachim L./ABA-8176-2020; Fisher, Edward/ABE-7469-2020; Van Ginderachter, Jo A/H-5473-2013; Gilroy, Derek/AAP-7227-2020; Martinez Estrada, Fernando O/AAW-9409-2021; Allen, Judith E/C-9198-2011; Gilroy, Derek W/C-2588-2009; Locati, Massimo/ABF-6807-2021	Lawrence, Toby/0000-0003-0967-6122; Murray, Peter J/0000-0001-6329-9802; Wynn, Thomas A/0000-0002-7244-8731; Mantovani, Alberto/0000-0001-5578-236X; Schultze, Joachim L/0000-0003-2812-9853; Schultze, Joachim L./0000-0003-2812-9853; Van Ginderachter, Jo A/0000-0002-4442-7474; Gilroy, Derek/0000-0003-3476-0844; Martinez Estrada, Fernando O/0000-0003-0908-9366; Allen, Judith E/0000-0002-3829-066X; 				Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008	1	18	18	1	76	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 21	2014	41	2					339	340		10.1016/j.immuni.2014.07.009	http://dx.doi.org/10.1016/j.immuni.2014.07.009			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6JA		Bronze, Green Published			2022-12-18	WOS:000341455300019
J	Colonna, M				Colonna, Marco			AHR: Making the Keratinocytes Thick Skinned	IMMUNITY			English	Editorial Material							ARYL-HYDROCARBON RECEPTOR; PSORIASIS; RESPONSES	Dysregulated signals from the external environment and/or the internal milieu of the skin can lead to pathological conditions such as psoriasis. Di Meglio et al. (2014) show that the environment-responsive transcription factor AhR acts in keratinocytes to suppress psoriatic lesions.	Washington Univ, Sch Med, St Louis, MO 63130 USA	Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, St Louis, MO 63130 USA.	mcolonna@pathology.wustl.edu		Colonna, Marco/0000-0001-5222-4987				Di Meglio P, 2014, IMMUNITY, V40, P989, DOI 10.1016/j.immuni.2014.04.019; Fallarino F, 2012, EUR J IMMUNOL, V42, P1932, DOI 10.1002/eji.201242572; Fritsche E, 2007, P NATL ACAD SCI USA, V104, P8851, DOI 10.1073/pnas.0701764104; Lowes MA, 2013, TRENDS IMMUNOL, V34, P174, DOI 10.1016/j.it.2012.11.005; Nguyen NT, 2013, INT IMMUNOL, V25, P335, DOI 10.1093/intimm/dxt011; Nguyen LP, 2008, CHEM RES TOXICOL, V21, P102, DOI 10.1021/tx7001965; Quintana FJ, 2013, PHARMACOL REV, V65, P1148, DOI 10.1124/pr.113.007823; Roberson EDO, 2010, TRENDS GENET, V26, P415, DOI 10.1016/j.tig.2010.06.006; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003; Zenz R, 2005, NATURE, V437, P369, DOI 10.1038/nature03963	10	18	18	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2014	40	6					863	864		10.1016/j.immuni.2014.06.001	http://dx.doi.org/10.1016/j.immuni.2014.06.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6DT	24950209	Bronze			2022-12-18	WOS:000341440200009
J	Garcia, KC; Gapin, L; Adams, JJ; Birnbaum, ME; Scott-Browne, JP; Kappler, JW; Marrack, P				Garcia, K. Christopher; Gapin, Laurent; Adams, Jarrett J.; Birnbaum, Michael E.; Scott-Browne, James P.; Kappler, John W.; Marrack, Philippa			A Closer Look at TCR Germline Recognition	IMMUNITY			English	Letter							T-CELL-RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; AMINO-ACIDS; MHC; PEPTIDE		[Garcia, K. Christopher; Kappler, John W.; Marrack, Philippa] Howard Hughes Med Inst, Chevy Chase, MD USA; [Garcia, K. Christopher; Adams, Jarrett J.; Birnbaum, Michael E.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Dept Biol Struct, Stanford, CA 94305 USA; [Gapin, Laurent; Scott-Browne, James P.; Kappler, John W.; Marrack, Philippa] Natl Jewish Hlth & Univ Colorado, Sch Med, Integrated Dept Immunol, Denver, CO 80206 USA; [Kappler, John W.; Marrack, Philippa] Univ Colorado, Sch Med, Dept Med, Denver, CO 80220 USA; [Kappler, John W.] Univ Colorado, Sch Med, Dept Pharmacol, Denver, CO 80220 USA; [Kappler, John W.] Univ Colorado, Sch Med, Program Biomol Struct, Denver, CO 80220 USA; [Kappler, John W.; Marrack, Philippa] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Denver, CO 80220 USA	Howard Hughes Medical Institute; Stanford University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Garcia, KC (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD USA.	kcgarcia@stanford.edu	Marrack, Philippa/AHE-6316-2022	Birnbaum, Michael/0000-0002-2281-3518; Marrack, Philippa/0000-0003-1883-3687	NIAID NIH HHS [R01 AI048540] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048540] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Burrows SR, 2010, P NATL ACAD SCI USA, V107, P10608, DOI 10.1073/pnas.1004926107; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Feng D, 2007, NAT IMMUNOL, V8, P975, DOI 10.1038/ni1502; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Stadinski BD, 2011, IMMUNITY, V35, P694, DOI 10.1016/j.immuni.2011.10.012; Turner SJ, 2011, IMMUNITY, V35, P660, DOI 10.1016/j.immuni.2011.11.002	11	18	18	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 29	2012	36	6					887	888		10.1016/j.immuni.2012.05.018	http://dx.doi.org/10.1016/j.immuni.2012.05.018			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22705103	Bronze, Green Accepted			2022-12-18	WOS:000306097100001
J	Jiang, X; Chen, ZJJ				Jiang, Xiaomo; Chen, Zhijian J.			Viperin Links Lipid Bodies to Immune Defense	IMMUNITY			English	Editorial Material							ANTIVIRAL PROTEIN; VIRUS	Viperin is an interferon-stimulated gene that exerts antiviral effects. In this issue of Immunity, Saitoh et al. (2011) uncovered an unexpected function of Viperin and lipid bodies in interferon induction by Toll-like receptors, specifically in plasmacytoid dendritic cells.	[Jiang, Xiaomo; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Chen, Zhijian/C-6039-2012	Chen, Zhijian/0000-0002-8475-8251	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093967] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI093967, R01 AI093967-01] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Blasius AL, 2010, P NATL ACAD SCI USA, V107, P19973, DOI 10.1073/pnas.1014051107; Fitzgerald KA, 2011, J INTERF CYTOK RES, V31, P131, DOI 10.1089/jir.2010.0127; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Honda K, 2005, NATURE, V434, P1035, DOI 10.1038/nature03547; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Rehwinkel J, 2010, SCIENCE, V327, P284, DOI 10.1126/science.1185068; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012	10	18	18	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 25	2011	34	3					285	287		10.1016/j.immuni.2011.03.012	http://dx.doi.org/10.1016/j.immuni.2011.03.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21435581	Bronze, Green Accepted			2022-12-18	WOS:000289014500003
J	Gajewski, TF				Gajewski, Thomas F.			The expanding universe of regulatory T cell subsets in cancer	IMMUNITY			English	Editorial Material							IMMUNITY	Evidence has indicated that failed antitumor immunity is dominated by immunosuppressive mechanisms within the tumor microenvironment. In this issue of Immunity, Peng et al. (2007) add to this list by describing tumor-infiltrating gamma delta T cells that have regulatory function.	Univ Chicago, Chicago, IL 60637 USA	University of Chicago	Gajewski, TF (corresponding author), Univ Chicago, Chicago, IL 60637 USA.	tgajewsk@medicine.bsd.uchicago.edu						Dannull J, 2005, J CLIN INVEST, V115, P3623, DOI 10.1172/JCI25947; Girardi M, 2001, SCIENCE, V294, P605, DOI 10.1126/science.1063916; Groh V, 1999, P NATL ACAD SCI USA, V96, P6879, DOI 10.1073/pnas.96.12.6879; Ke Y, 2003, CELL IMMUNOL, V221, P107, DOI 10.1016/S0008-8749(03)00066-2; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Peng G, 2007, IMMUNITY, V27, P334, DOI 10.1016/j.immuni.2007.05.020; Peng GY, 2005, SCIENCE, V309, P1380, DOI 10.1126/science.1113401; Qin ZH, 1998, NAT MED, V4, P627, DOI 10.1038/nm0598-627; Shevach EM, 2006, IMMUNITY, V25, P195, DOI 10.1016/j.immuni.2006.08.003; von Lilienfeld-Toal M, 2006, CLIN EXP IMMUNOL, V144, P528, DOI 10.1111/j.1365-2249.2006.03078.x	10	18	19	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2007	27	2					185	187		10.1016/j.immuni.2007.08.001	http://dx.doi.org/10.1016/j.immuni.2007.08.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17723212	Bronze			2022-12-18	WOS:000249056300005
J	Bangham, J; Jiggins, F; Lemaitre, B				Bangham, Jenny; Jiggins, Frank; Lemaitre, Bruno			Insect immunity: The post-genomic era	IMMUNITY			English	News Item							DROSOPHILA-MELANOGASTER; POLYDNAVIRUS; PHAGOCYTOSIS; ACTIVATION; COMPONENTS; DEFENSE; PATHWAY; OXIDASE; PROTEIN; GLAND	Insects have a complex and effective immune system, many components of which are conserved in mammals. But only in the last decade have the molecular mechanisms that regulate the insect immune response-and their relevance to general biology and human immunology-become fully appreciated. A meeting supported by the Centre National de la Recherche Scientifique (France) was held to bring together the whole spectrum of researchers working on insect immunity. The meeting addressed diverse aspects of insect immunity and brought together geneticists working on Drosophila melanogaster with those working on other insects.	Univ Edinburgh, Inst Evolutionary Biol, Ashworth Labs, Edinburgh EH9 3JT, Midlothian, Scotland; CNRS, Ctr Genet Mol, F-91198 Gif Sur Yvette, France	University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Bangham, J (corresponding author), Univ Edinburgh, Inst Evolutionary Biol, Ashworth Labs, Kings Bldg,W Mains Rd, Edinburgh EH9 3JT, Midlothian, Scotland.	jenny.bangham@ed.ac.uk	Lemaitre, Bruno/T-8146-2019	Lemaitre, Bruno/0000-0001-7970-1667; Jiggins, Francis Michael/0000-0001-7470-8157; Bangham, Jenny/0000-0001-8781-571X	Biotechnology and Biological Sciences Research Council [BB/C514623/1] Funding Source: Medline; Wellcome Trust [070535] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abraham EG, 2005, P NATL ACAD SCI USA, V102, P16327, DOI 10.1073/pnas.0508335102; Beck M, 2005, J VIROL, V79, P1861, DOI 10.1128/JVI.79.3.1861-1870.2005; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Espagne E, 2005, J VIROL, V79, P9765, DOI 10.1128/JVI.79.15.9765-9776.2005; Espagne E, 2004, SCIENCE, V306, P286, DOI 10.1126/science.1103066; Filipe SR, 2005, EMBO REP, V6, P327, DOI 10.1038/sj.embor.7400371; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Heddi A, 2005, CELL MICROBIOL, V7, P293, DOI 10.1111/j.1462-5822.2004.00461.x; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Labrosse C, 2005, J INSECT PHYSIOL, V51, P161, DOI 10.1016/j.jinsphys.2004.10.004; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Michel K, 2005, EMBO REP, V6, P891, DOI 10.1038/sj.embor.7400478; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Shin SW, 2005, J BIOL CHEM, V280, P16499, DOI 10.1074/jbc.M500711200; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Tong YR, 2005, J BIOL CHEM, V280, P14932, DOI 10.1074/jbc.M500532200; Wood W, 2006, J CELL BIOL, V173, P405, DOI 10.1083/jcb.200508161; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	24	18	25	3	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2006	25	1					1	5		10.1016/j.immuni.2006.07.002	http://dx.doi.org/10.1016/j.immuni.2006.07.002			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16892501	Green Submitted, Bronze			2022-12-18	WOS:000239713000001
J	Halin, C; Detmar, M				Halin, C; Detmar, M			An unexpected connection: Lymph node lymphangiogenesis and dendritic cell migration	IMMUNITY			English	Editorial Material							TRAFFICKING	Migration of antigen-presenting dendritic cells (DCs) through lymphatics to draining lymph nodes (LNs) represents a key step in the initiation of an adaptive immune response. In this issue of Immunity, Angeli et al. (2006) provide the first evidence that remodeling of the lymphatic network within LNs and in peripheral tissues enhances DC migration after immunization and that this process depends on the presence of B cells within the LN.	ETH, Swiss Fed Inst Technol, Inst Pharmaceut Sci, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Halin, C (corresponding author), ETH, Swiss Fed Inst Technol, Inst Pharmaceut Sci, Wolfgang Pauli Str,10, CH-8093 Zurich, Switzerland.			Halin, Cornelia/0000-0002-7899-2850				Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Berger TG, 2003, CURR TOP MICROBIOL, V276, P163; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Halin C, 2005, ANNU REV CELL DEV BI, V21, P581, DOI 10.1146/annurev.cellbio.21.122303.133159; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Kerjaschki D, 2004, J AM SOC NEPHROL, V15, P603, DOI 10.1097/01.ASN.0000113316.52371.2E; Kunstfeld R, 2004, BLOOD, V104, P1048, DOI 10.1182/blood-2003-08-2964; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; Oliver G, 2002, GENE DEV, V16, P773, DOI 10.1101/gad.975002; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670	10	18	19	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2006	24	2					129	131		10.1016/j.immuni.2006.01.011	http://dx.doi.org/10.1016/j.immuni.2006.01.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	014KN	16473825	Bronze			2022-12-18	WOS:000235479000004
J	Labrecque, N; Madsen, L; Fugger, L; Benoist, C; Mathis, D				Labrecque, N; Madsen, L; Fugger, L; Benoist, C; Mathis, D			Toxic MHC class II beta chains	IMMUNITY			English	Article							INVARIANT CHAIN; EXPRESSION		ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, F-67404 Illkirch, CU Strasbourg, France; Aarhus Univ Hosp, Skejby Sygehus, Dept Clin Immunol, DK-2200 Aarhus, Denmark	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Aarhus University	Labrecque, N (corresponding author), ULP, INSERM, CNRS, Inst Genet & Biol Mol & Cellulaire, BP 163, F-67404 Illkirch, CU Strasbourg, France.							BONNEROT C, 1994, EMBO J, V13, P934, DOI 10.1002/j.1460-2075.1994.tb06338.x; GERMAIN RN, 1993, ANNU REV IMMUNOL, V11, P403, DOI 10.1146/annurev.immunol.11.1.403; GILFILLAN S, 1990, P NATL ACAD SCI USA, V87, P7319, DOI 10.1073/pnas.87.18.7319; Kenty G, 1998, J IMMUNOL, V160, P606; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; MARKOWITZ JS, 1993, J IMMUNOL, V150, P1223; PARHAM P, 1988, NATURE, V333, P500, DOI 10.1038/333500a0; Rolink AG, 1999, IMMUNITY, V10, P619, DOI 10.1016/S1074-7613(00)80061-8; Shachar I, 1996, SCIENCE, V274, P106, DOI 10.1126/science.274.5284.106; Singer SM, 1996, P NATL ACAD SCI USA, V93, P2947, DOI 10.1073/pnas.93.7.2947	10	18	18	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	1999	11	5					515	516		10.1016/S1074-7613(00)80126-0	http://dx.doi.org/10.1016/S1074-7613(00)80126-0			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	260LM	10591176	Bronze			2022-12-18	WOS:000083952200002
J	MOTTERSHEAD, DG; HSU, PN; URBAN, RG; STROMINGER, JL; HUBER, BT				MOTTERSHEAD, DG; HSU, PN; URBAN, RG; STROMINGER, JL; HUBER, BT			DIRECT BINDING OF THE MTV7 SUPERANTIGEN (MIS-1) TO SOLUBLE MHC CLASS-II MOLECULES	IMMUNITY			English	Article							STAPHYLOCOCCAL ENTEROTOXIN-A; T-CELL RECEPTOR; MAJOR HISTOCOMPATIBILITY COMPLEX; HIGH-AFFINITY BINDING; MAMMARY-TUMOR VIRUS; HLA-DR; MONOCLONAL-ANTIBODY; ANTIGENS; MLS-1; REACTIVITY	The superantigen encoded by the mouse mammary tumor Virus (MMTV) is a potent stimulator of T cells when bound to MHC class II molecules. Recent data from this laboratory have shown that the Mtv7 superantigen, Mls-1, elicits a strong T cell response when presented by HLA-DR. To expand these observations further, we have produced the 28 kDa extracellular domain and the 18 kDa carboxy-terminal subfragment of the Mls-1 protein in E. coli and studied their interaction with human MHC class II molecules in vitro. In this report, we demonstrate direct binding of these recombinant forms of the Mls-1 protein to soluble HLA-DR1 and HLA-DR4, but not to HLA-A2. Our data imply a unique class II interaction site of retroviral superantigens that is not shared with bacterial superantigens.	HARVARD UNIV,DEPT BIOCHEM & MOLEC BIOL,CAMBRIDGE,MA 02138	Harvard University	MOTTERSHEAD, DG (corresponding author), TUFTS UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02111, USA.		Mottershead, David G/B-7749-2013	Mottershead, David G/0000-0003-2593-0725; HSU, PING-NING/0000-0003-4479-3391	NCI NIH HHS [R35-CA47554] Funding Source: Medline; NIAID NIH HHS [R01 AI-14910] Funding Source: Medline; NIDDK NIH HHS [1 P30 DK39428] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R35CA047554] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI014910] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ACHAORBEA H, 1991, NATURE, V350, P207, DOI 10.1038/350207a0; BEUTNER U, 1992, P NATL ACAD SCI USA, V89, P5432, DOI 10.1073/pnas.89.12.5432; CARLSSON R, 1988, J IMMUNOL, V140, P2484; CHOI YW, 1992, J EXP MED, V175, P847, DOI 10.1084/jem.175.3.847; DELLABONA P, 1990, CELL, V62, P1115, DOI 10.1016/0092-8674(90)90388-U; FISCHER H, 1989, J IMMUNOL, V142, P3151; FLEISCHER B, 1988, J EXP MED, V167, P1697, DOI 10.1084/jem.167.5.1697; FRASER JD, 1989, NATURE, V339, P221, DOI 10.1038/339221a0; FU XT, 1994, HUM IMMUNOL, V39, P253, DOI 10.1016/0198-8859(94)90268-2; GORGA JC, 1991, RES IMMUNOL, V142, P401, DOI 10.1016/0923-2494(91)90038-K; GORGA JC, 1987, J BIOL CHEM, V262, P16087; GORGA JC, 1992, PROTEINS, V12, P87, DOI 10.1002/prot.340120110; GRIGGS ND, 1992, J IMMUNOL, V148, P2516; HAPP MP, 1989, P NATL ACAD SCI USA, V86, P6293, DOI 10.1073/pnas.86.16.6293; HERMAN A, 1991, P NATL ACAD SCI USA, V88, P9954, DOI 10.1073/pnas.88.22.9954; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; JOHNSON HM, 1991, FASEB J, V5, P2706, DOI 10.1096/fasebj.5.12.1916093; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KARP DR, 1990, NATURE, V346, P474, DOI 10.1038/346474a0; KARP DR, 1992, J EXP MED, V176, P415; LABRECQUE N, 1993, J EXP MED, V177, P1735, DOI 10.1084/jem.177.6.1735; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MELLINS E, 1994, J EXP MED, V179, P541, DOI 10.1084/jem.179.2.541; MOHAN N, 1993, J EXP MED, V177, P351, DOI 10.1084/jem.177.2.351; MOLLICK JA, 1989, SCIENCE, V244, P817, DOI 10.1126/science.2658055; MORRIS P, 1994, NATURE, V368, P551, DOI 10.1038/368551a0; OKADA CY, 1990, J IMMUNOL, V144, P3473; PARHAM P, 1978, NATURE, V276, P397, DOI 10.1038/276397a0; QUARATINO S, 1993, IMMUNOLOGY, V78, P600; RUSSELL JK, 1992, BIOPHYS RES COMMUN, V152, P1016; SETH A, 1994, NATURE, V369, P324, DOI 10.1038/369324a0; SMEEKENS SP, 1993, BIO-TECHNOL, V11, P182, DOI 10.1038/nbt0293-182; SMITH HP, 1992, J IMMUNOL, V149, P887; SUBRAMANYAM M, 1993, J IMMUNOL, V151, P2538; THIBODEAU J, 1994, J EXP MED, V179, P1029, DOI 10.1084/jem.179.3.1029; TORRES BA, 1993, NATURE, V364, P152, DOI 10.1038/364152a0; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; VACCHIO MS, 1992, J EXP MED, V175, P1405, DOI 10.1084/jem.175.5.1405; WINSLOW GM, 1992, CELL, V71, P719, DOI 10.1016/0092-8674(92)90549-R; WINSLOW GM, 1994, IMMUNITY, V1, P23, DOI 10.1016/1074-7613(94)90006-X; WOODLAND DL, 1993, J EXP MED, V177, P433, DOI 10.1084/jem.177.2.433	41	18	18	0	0	CELL PRESS	CAMBRIDGE	50 CHURCH ST CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	FEB	1995	2	2					149	154		10.1016/S1074-7613(95)80027-1	http://dx.doi.org/10.1016/S1074-7613(95)80027-1			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QH132	7895171	Bronze			2022-12-18	WOS:A1995QH13200003
J	WONG, PMC; HAN, XD; RUSCETTI, FW; CHUNG, SW				WONG, PMC; HAN, XD; RUSCETTI, FW; CHUNG, SW			IMMORTALIZED HEMATOPOIETIC-CELLS WITH STEM-CELL PROPERTIES	IMMUNITY			English	Article							GROWTH-FACTOR-BETA; CFU-S CELL; HEMATOPOIETIC STEM; BONE-MARROW; W/WV MICE; TERATOCARCINOMA CELLS; TRANSCRIPTION FACTOR; INTERLEUKIN-3 GENE; SELF-RENEWAL; V-ABL	We have established a hemopoietic cell line, BL3, that possesses a rearranged retroviral genome, which we used as a genetic tag for their engraftment into lethally irradiated mice. Analysis of recipients up to 7 months after engraftment indicates that the marker was present in differentiated cells of various hemopoietic organs, in colony-forming cells, pre-CFU-S-forming cells, and in organs of secondary recipients from bone marrow cells of primary recipients. BL3 cells are Thy-1(+), Sca-1(+), B220(-), Mac-1(-), and Gr1(-). They express GATA-1 and are able to develop ''cobblestones'' with stromal cells. They do not express and respond to several hemopoietic growth factors known to facilitate marrow recovery. However, they are negatively regulated by TGF beta and can be stimulated by mitogenstimulated spleen cell-conditioned medium. We conclude that BL3 cells possess properties of hemopoietic stem cells, including their capability to contribute to long-term repopulation.	TEMPLE UNIV,FELS INST CANC RES & MOLEC BIOL,DEPT MICROBIOL,PHILADELPHIA,PA 19140; TEMPLE UNIV,FELS INST CANC RES & MOLEC BIOL,DEPT IMMUNOL,PHILADELPHIA,PA 19140; SUNY,MORSE INST MOLEC GENET,DEPT MICROBIOL & IMMUNOL,BROOKLYN,NY 11203; NCI,LEUKOCYTE BIOL LAB,BIOL RESPONSE MODIFIERS PROGRAM,FREDERICK,MD 21702	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University of New York (SUNY) System; SUNY Maritime College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	WONG, PMC (corresponding author), TEMPLE UNIV,FELS INST CANC RES & MOLEC BIOL,DEPT BIOCHEM,3307 N BROAD ST,PHILADELPHIA,PA 19140, USA.				NCI NIH HHS [5P30CA12227] Funding Source: Medline; NHLBI NIH HHS [HL46547] Funding Source: Medline; NIDDK NIH HHS [DK41298] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA012227] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R29DK041298] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567; BERTONCELLO I, 1988, EXP HEMATOL, V16, P245; BOGGS DR, 1982, J CLIN INVEST, V70, P242, DOI 10.1172/JCI110611; BRECHER G, 1988, EXP HEMATOL, V16, P627; BRINSTER RL, 1974, J EXP MED, V140, P1049, DOI 10.1084/jem.140.4.1049; CAPEL B, 1989, P NATL ACAD SCI USA, V86, P4564, DOI 10.1073/pnas.86.12.4564; CHUNG SW, 1991, P NATL ACAD SCI USA, V88, P1585, DOI 10.1073/pnas.88.4.1585; CHUNG SW, 1994, IN PRESS ONCOGENE; COULOMBEL L, 1983, BLOOD, V62, P291; DEXTER TM, 1987, ANNU REV CELL BIOL, V3, P423; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; GRANT S, 1994, BLOOD, V83, P663; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; HAN XD, 1991, P NATL ACAD SCI USA, V88, P10129, DOI 10.1073/pnas.88.22.10129; HERMINE O, 1991, BLOOD, V78, P2253; HODGSON GS, 1979, NATURE, V281, P381, DOI 10.1038/281381a0; JOHNSON GR, 1977, P NATL ACAD SCI USA, V74, P3879, DOI 10.1073/pnas.74.9.3879; JONES RJ, 1989, BLOOD, V73, P397; JONES RJ, 1990, NATURE, V347, P188, DOI 10.1038/347188a0; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; KELLIHER MA, 1990, P NATL ACAD SCI USA, V87, P6649, DOI 10.1073/pnas.87.17.6649; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; LENFANT M, 1989, P NATL ACAD SCI USA, V86, P779, DOI 10.1073/pnas.86.3.779; LERNER C, 1990, EXP HEMATOL, V18, P114; MAGLI MC, 1982, NATURE, V295, P527, DOI 10.1038/295527a0; MALTMAN J, 1993, J EXP MED, V178, P925, DOI 10.1084/jem.178.3.925; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; MATTHEWS W, 1991, CELL, V65, P1143, DOI 10.1016/0092-8674(91)90010-V; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MICKLEM HS, 1966, TISSUE GRAFTING RAD; MINTZ B, 1984, P NATL ACAD SCI-BIOL, V81, P7835, DOI 10.1073/pnas.81.24.7835; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; NAKAHATA T, 1982, P NATL ACAD SCI-BIOL, V79, P3843, DOI 10.1073/pnas.79.12.3843; OHTA M, 1987, NATURE, V329, P539, DOI 10.1038/329539a0; OPPENHEIM JJ, 1982, IMMUNOL TODAY, V3, P113, DOI 10.1016/S0167-5699(82)80027-3; PAPAIOANNOU VE, 1975, NATURE, V258, P70, DOI 10.1038/258070a0; PLOEMACHER RE, 1989, EXP HEMATOL, V17, P263; RAMBALDI A, 1987, BLOOD, V69, P1409; RUSCETTI FW, 1992, BAILLIERE CLIN HAEM, V5, P703, DOI 10.1016/S0950-3536(11)80013-2; Sambrook J., 1989, MOL CLONING LAB MANU; SEIFERT RA, 1984, NATURE, V311, P669, DOI 10.1038/311669a0; SIMINOVITCH L, 1963, J CELL COMPAR PHYSL, V62, P327, DOI 10.1002/jcp.1030620313; SING GK, 1988, BLOOD, V72, P1504; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SNODGRASS R, 1987, EMBO J, V6, P3955, DOI 10.1002/j.1460-2075.1987.tb02737.x; SPANGRUDE GJ, 1990, P NATL ACAD SCI USA, V87, P7433, DOI 10.1073/pnas.87.19.7433; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPANGRUDE GJ, 1991, BLOOD, V78, P1395; SPOONCER E, 1986, DIFFERENTIATION, V31, P111, DOI 10.1111/j.1432-0436.1986.tb00391.x; SPOSI NM, 1992, P NATL ACAD SCI USA, V89, P6353, DOI 10.1073/pnas.89.14.6353; SUDA T, 1984, P NATL ACAD SCI-BIOL, V81, P2520, DOI 10.1073/pnas.81.8.2520; SZILVASSY SJ, 1989, P NATL ACAD SCI USA, V86, P8798, DOI 10.1073/pnas.86.22.8798; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; TILL JE, 1980, BIOCHIM BIOPHYS ACTA, V605, P431, DOI 10.1016/0304-419X(80)90009-8; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; VANZANT G, 1984, J EXP MED, V159, P679, DOI 10.1084/jem.159.3.679; WADDICK KG, 1991, BLOOD, V77, P2364; WHITLOCK CA, 1982, P NATL ACAD SCI-BIOL, V79, P3608, DOI 10.1073/pnas.79.11.3608; WILLIAMS DA, 1984, NATURE, V310, P476, DOI 10.1038/310476a0; WONG BY, 1994, J VIROL, V68, P5523, DOI 10.1128/JVI.68.9.5523-5531.1994; WONG PMC, 1989, MOL CELL BIOL, V9, P798, DOI 10.1128/MCB.9.2.798; WONG PMC, 1986, P NATL ACAD SCI USA, V83, P3851, DOI 10.1073/pnas.83.11.3851; WONG PMC, 1987, GENE DEV, V1, P358, DOI 10.1101/gad.1.4.358; WONG PMC, 1983, BLOOD, V62, P1280; ZON LI, 1991, P NATL ACAD SCI USA, V88, P10638, DOI 10.1073/pnas.88.23.10638	67	18	20	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	OCT	1994	1	7					571	583		10.1016/1074-7613(94)90047-7	http://dx.doi.org/10.1016/1074-7613(94)90047-7			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PN127	7600286				2022-12-18	WOS:A1994PN12700006
J	Wang, Y; Chen, DY; Xu, D; Huang, C; Xing, RX; He, DY; Xu, HP				Wang, Yan; Chen, Dianyu; Xu, Di; Huang, Chao; Xing, Ruxiao; He, Danyang; Xu, Heping			Early developing B cells undergo negative selection by central nervous system-specific antigens in the meninges	IMMUNITY			English	Article								Self-reactive B cell progenitors are eliminated through central tolerance checkpoints, a process thought to be restricted to the bone marrow in mammals. Here, we identified a consecutive trajectory of B cell development in the meninges of mice and non-human primates. The meningeal B cells were located predominantly at the dural sinuses, where endothelial cells expressed essential niche factors to support B cell development. Parabiosis experiments together with lineage tracing showed that meningeal developing B cells were replenished continuously from hematopoietic stem cell (HSC)-derived progenitors via a circulation-independent route. Autoreactive immature B cells that recognized myelin oligodendrocyte glycoprotein (MOG), a central nervous system-specific antigen, were eliminated specifically from the meninges. Furthermore, genetic deletion of the Mog gene restored the self-reactive B cell population in the meninges. These findings identify the meninges as a distinct reservoir for B cell development, allowing in situ negative selection to ensure a locally non-self reactive immune repertoire.	[Wang, Yan; Chen, Dianyu; Xu, Di; Huang, Chao; Xing, Ruxiao; He, Danyang; Xu, Heping] Westlake Univ, Sch Life Sci, Key Lab Growth Regulat & Translat Res Zhejiang Pr, Hangzhou 310024, Zhejiang, Peoples R China; [Wang, Yan; Chen, Dianyu; Xu, Di; Huang, Chao; Xing, Ruxiao; He, Danyang; Xu, Heping] Westlake Lab Life Sci & Biomed, Hangzhou 310024, Zhejiang, Peoples R China; [Wang, Yan; Chen, Dianyu; Huang, Chao; Xu, Heping] Westlake Inst Adv Study, Inst Basic Med Sci, Lab Syst Immunol, Hangzhou 310024, Zhejiang, Peoples R China; [Xu, Di; Xing, Ruxiao; He, Danyang] Westlake Inst Adv Study, Inst Basic Med Sci, Lab Neuroimmunol, Hangzhou 310024, Zhejiang, Peoples R China	Westlake University; Westlake University; Westlake University	He, DY; Xu, HP (corresponding author), Westlake Univ, Sch Life Sci, Key Lab Growth Regulat & Translat Res Zhejiang Pr, Hangzhou 310024, Zhejiang, Peoples R China.; He, DY; Xu, HP (corresponding author), Westlake Lab Life Sci & Biomed, Hangzhou 310024, Zhejiang, Peoples R China.; Xu, HP (corresponding author), Westlake Inst Adv Study, Inst Basic Med Sci, Lab Syst Immunol, Hangzhou 310024, Zhejiang, Peoples R China.; He, DY (corresponding author), Westlake Inst Adv Study, Inst Basic Med Sci, Lab Neuroimmunol, Hangzhou 310024, Zhejiang, Peoples R China.	hedanyang@westlake.edu.cn; xuheping@westlake.edu.cn		Chen, Dianyu/0000-0002-4217-2279; Xu, Heping/0000-0003-2149-7004; He, Danyang/0000-0002-3613-4188	Labo-ratory Animal Resources Center, High-Performance Computing Center, Flow Cytometry Core, and Genomic Core of Westlake University; National Key R&D Program of China [2020YFA0804200, 2019YFA0802900]; National Natural Science Founda-tion of China [U20A20346, 31970842, 32070953]; Educa-tion Foundation of Westlake University	Labo-ratory Animal Resources Center, High-Performance Computing Center, Flow Cytometry Core, and Genomic Core of Westlake University; National Key R&D Program of China; National Natural Science Founda-tion of China(National Natural Science Foundation of China (NSFC)); Educa-tion Foundation of Westlake University	We thank H. Wekerle and G. Krishnamoorthy for providing Th mice, J. Zheng for providing Scl-creERT mice, S.M. Kerfoot for sharing the mMOGtag plasmid, P. Lu for MOG protein expression and purification, Y. Li and Y. Zang for technical support, W. Zhu for mouse genotyping, all the members of the Xu and He laboratories for discussions and suggestions, and the Labo-ratory Animal Resources Center, High-Performance Computing Center, Flow Cytometry Core, and Genomic Core of Westlake University for support. This work was supported by the National Key R&D Program of China (grants 2020YFA0804200 and 2019YFA0802900) , National Natural Science Founda-tion of China (grants U20A20346, 31970842, and 32070953) , and the Educa-tion Foundation of Westlake University.	Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290; Brioschi S, 2021, SCIENCE, V373, P408, DOI 10.1126/science.abf9277; Cai RY, 2019, NAT NEUROSCI, V22, P317, DOI 10.1038/s41593-018-0301-3; Cencioni MT, 2021, NAT REV NEUROL, V17, P399, DOI 10.1038/s41582-021-00498-5; Chen DY, 2021, NAT IMMUNOL, V22, P904, DOI 10.1038/s41590-021-00936-y; Cugurra A, 2021, SCIENCE, V373, P409, DOI 10.1126/science.abf7844; de Lima KA, 2020, ANNU REV IMMUNOL, V38, P597, DOI 10.1146/annurev-immunol-102319-103410; Fitzpatrick Z, 2020, NATURE, V587, P472, DOI 10.1038/s41586-020-2886-4; Gothert JR, 2005, BLOOD, V105, P2724, DOI 10.1182/blood-2004-08-3037; Herisson F, 2018, NAT NEUROSCI, V21, P1209, DOI 10.1038/s41593-018-0213-2; Jain RW, 2016, JOVE-J VIS EXP, DOI 10.3791/54727; Jankovic M, 2004, ANNU REV IMMUNOL, V22, P485, DOI 10.1146/annurev.immunol.22.012703.104707; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Li WZ, 2017, P NATL ACAD SCI USA, V114, pE7321, DOI 10.1073/pnas.1708981114; Li XN, 2018, P NATL ACAD SCI USA, V115, P415, DOI 10.1073/pnas.1703601115; Litzenburger T, 1998, J EXP MED, V188, P169, DOI 10.1084/jem.188.1.169; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; Meffre E, 2019, IMMUNOL REV, V292, P90, DOI 10.1111/imr.12821; Melchers F, 2015, J CLIN INVEST, V125, P2203, DOI 10.1172/JCI78083; Mrdjen D, 2018, IMMUNITY, V48, P380, DOI 10.1016/j.immuni.2018.01.011; Mundt S, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau8380; Nagaoka H, 2000, J EXP MED, V191, P2113, DOI 10.1084/jem.191.12.2113; Nemazee D, 2017, NAT REV IMMUNOL, V17, P281, DOI 10.1038/nri.2017.19; Rubin SJS, 2019, NAT REV RHEUMATOL, V15, P303, DOI 10.1038/s41584-019-0211-0; RUSSELL DM, 1991, NATURE, V354, P308, DOI 10.1038/354308a0; Rustenhoven J, 2021, CELL, V184, P1000, DOI 10.1016/j.cell.2020.12.040; Schafflick D, 2021, NAT NEUROSCI, V24, P1225, DOI 10.1038/s41593-021-00880-y; Shechter R, 2013, NAT REV IMMUNOL, V13, P206, DOI 10.1038/nri3391; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Van Hove H, 2019, NAT NEUROSCI, V22, P1021, DOI 10.1038/s41593-019-0393-4; van Zelm MC, 2007, J EXP MED, V204, P645, DOI 10.1084/jem.20060964; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496; Yao H, 2018, NATURE, V560, P55, DOI 10.1038/s41586-018-0342-5; Zehentmeier S, 2019, IMMUNOL REV, V289, P142, DOI 10.1111/imr.12749	37	17	17	7	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2784	+		10.1016/j.immuni.2021.09.016	http://dx.doi.org/10.1016/j.immuni.2021.09.016		DEC 2021	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34626548				2022-12-18	WOS:000731645300016
J	Glaros, V; Rauschmeier, R; Artemov, AV; Reinhardt, A; Ols, S; Emmanouilidi, A; Gustafsson, C; You, YY; Mirabello, C; Bjorklund, AK; Perez, L; King, NP; Mansson, R; Angeletti, D; Lore, K; Adameyko, I; Busslinger, M; Kreslavsky, T				Glaros, Vassilis; Rauschmeier, Rene; Artemov, Artem, V; Reinhardt, Annika; Ols, Sebastian; Emmanouilidi, Aikaterini; Gustafsson, Charlotte; You, Yuanyuan; Mirabello, Claudio; Bjorklund, Asa K.; Perez, Laurent; King, Neil P.; Mansson, Robert; Angeletti, Davide; Lore, Karin; Adameyko, Igor; Busslinger, Meinrad; Kreslavsky, Taras			Limited access to antigen drives generation of early B cell memory while restraining the plasmablast response	IMMUNITY			English	Article							GERMINAL-CENTER; ANTIBODY-RESPONSES; NANOPARTICLE VACCINE; AFFINITY; DIFFERENTIATION; EXPRESSION; MOUSE; DYNAMICS; CENTERS; NAIVE	Cell fate decisions during early B cell activation determine the outcome of responses to pathogens and vaccines. We examined the early B cell response to T-dependent antigen in mice by single-cell RNA sequencing. Early after immunization, a homogeneous population of activated precursors (APs) gave rise to a transient wave of plasmablasts (PBs), followed a day later by the emergence of germinal center B cells (GCBCs). Most APs rapidly exited the cell cycle, giving rise to non-GC-derived early memory B cells (eMBCs) that retained an AP-like transcriptional profile. Rapid decline of antigen availability controlled these events; provision of excess antigen precluded cell cycle exit and induced a new wave of PBs. Fate mapping revealed a prominent contribution of eMBCs to the MBC pool. Quiescent cells with an MBC phenotype dominated the early response to immunization in primates. A reservoir of APs/eMBCs may enable rapid readjustment of the immune response when failure to contain a threat is manifested by increased antigen availability.	[Glaros, Vassilis; Reinhardt, Annika; Ols, Sebastian; You, Yuanyuan; Lore, Karin; Kreslavsky, Taras] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Div Immunol & Allergy, Stockholm, Sweden; [Glaros, Vassilis; Reinhardt, Annika; Ols, Sebastian; You, Yuanyuan; Lore, Karin; Kreslavsky, Taras] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden; [Rauschmeier, Rene; Busslinger, Meinrad] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Vienna, Austria; [Artemov, Artem, V; Adameyko, Igor] Med Univ Vienna, Dept Neuroimmunol, Vienna, Austria; [Artemov, Artem, V] Endocrinol Res Ctr, Moscow, Russia; [Emmanouilidi, Aikaterini; Angeletti, Davide] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Gustafsson, Charlotte; Mansson, Robert] Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Lab Med, Stockholm, Sweden; [Mirabello, Claudio] Linkoping Univ, Dept Phys Chem & Biol, Sci Life Lab, Natl Bioinformat Infrastruct Sweden, Linkoping, Sweden; [Bjorklund, Asa K.] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Natl Bioinformat Infrastruct Sweden, Uppsala, Sweden; [Perez, Laurent] Lausanne Univ Hosp, Dept Med, Serv Immunol & Allergy, Lausanne, Switzerland; [Perez, Laurent] Univ Lausanne, Lausanne, Switzerland; [King, Neil P.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [King, Neil P.] Univ Washington, Inst Prot Design, Seattle, WA 98195 USA; [Mansson, Robert] Karolinska Univ Hosp, Hematol Ctr, Stockholm, Sweden; [Adameyko, Igor] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Medical University of Vienna; Russian Academy of Medical Sciences; Endocrinology Research Centre; University of Gothenburg; Karolinska Institutet; Linkoping University; Uppsala University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Kreslavsky, T (corresponding author), Karolinska Univ Hosp, Karolinska Inst, Dept Med, Div Immunol & Allergy, Stockholm, Sweden.; Kreslavsky, T (corresponding author), Karolinska Inst, Ctr Mol Med, Stockholm, Sweden.	taras.kreslayskiy@ki.se	Angeletti, Davide/H-7350-2019; Artemov, Artem/I-9119-2014; Busslinger, Meinrad/J-1249-2016	Angeletti, Davide/0000-0002-5256-1972; Ols, Sebastian/0000-0001-9784-7176; Adameyko, Igor/0000-0001-5471-0356; Glaros, Vassilis/0000-0001-6211-9515; Perez, Laurent/0000-0002-8860-7928; Artemov, Artem/0000-0002-0056-4549; Busslinger, Meinrad/0000-0002-9111-9351	Swedish Research Council [2018-05973, SNIC 2019/8-289, 2020/16-34, 2017-01118, 2017-01439]; Cancerfonden [CAN 2018/710]; Ake Wibergs Stiftelse [M18-0094]; German Research Foundation (DFG) [RE 4264/1-1]; Boehringer Ingelheim; European Research Council (ERC) [740349, 850638]; Bill & Melinda Gates Foundation [OPP1156262]; Ministry of Science and Higher Education of the Russian Federation [075-15-2020784]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Cancerfonden(Swedish Cancer Society); Ake Wibergs Stiftelse; German Research Foundation (DFG)(German Research Foundation (DFG)); Boehringer Ingelheim(Boehringer Ingelheim); European Research Council (ERC)(European Research Council (ERC)European Commission); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Ministry of Science and Higher Education of the Russian Federation	We thank T. Kurosaki and R. Shinnakasu for S1pr2-ERT2cre mice, G. Victora for gene sets for GSEA, A. Sommer's team at the Vienna Biocenter Support Facilities GmbH (VBCF) for library preparation and Illumina sequencing, I. Mantas for help with preparation of the graphical abstract, and C. Sundling for helpful discussions and critical reading of the manuscript. We acknowledge resources provided by the Swedish National Infrastructure for Computing (SNIC) at UPPMAX, partially funded by the Swedish Research Council through grant agreement no. 2018-05973 (projects SNIC 2019/8-289 and 2020/16-34). This study was supported by the Swedish Research Council (grants 2017-01118 to T.K. and 2017-01439 to D.A.), Cancerfonden (CAN 2018/710 to T.K.), long-term bioinformatics support from SciLifeLab and the Knut and Alice Wallenberg Foundation, Ake Wibergs Stiftelse (M18-0094 to T.K.), a stipend from the Wenner-Gren Foundations (to T.K.), a stipend from the German Research Foundation (DFG) (RE 4264/1-1 to A.R.), Boehringer Ingelheim (M.B. and R.R.), the European Research Council (ERC) grants (grants 740349-PlasmaCellControl to M.B. and 850638 to D.A.), and a grant from the Bill & Melinda Gates Foundation (OPP1156262 to N.P.K. and K.L.). A.V.A. was supported by Ministry of Science and Higher Education of the Russian Federation (agreement no. 075-15-2020784). We thank the NIH tetramer core facility for preparation of MHC tetramers, the Mammalian Protein Expression core facility at the University of Gothenburg for recombinant HA production, and the Mammalian Protein and Nanoparticle Core Labs at the Institute for Protein Design for assistance with RSV F protein and nanoparticle production.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Angeletti D, 2019, P NATL ACAD SCI USA, V116, P13474, DOI 10.1073/pnas.1816300116; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Brescia P, 2018, CANCER CELL, V34, P453, DOI 10.1016/j.ccell.2018.08.006; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Chen JG, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1578-4; Cirelli KM, 2019, CELL, V177, P1153, DOI 10.1016/j.cell.2019.04.012; Coffey F, 2009, IMMUNITY, V30, P599, DOI 10.1016/j.immuni.2009.01.011; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; De Silva NS, 2015, NAT REV IMMUNOL, V15, P137, DOI 10.1038/nri3804; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dosenovic P, 2018, P NATL ACAD SCI USA, V115, P4743, DOI 10.1073/pnas.1803457115; Elgueta R, 2015, J IMMUNOL, V194, P505, DOI 10.4049/jimmunol.1401553; Gertz J, 2012, GENOME RES, V22, P134, DOI 10.1101/gr.127373.111; GINSBERG HS, 1952, J EXP MED, V95, P135, DOI 10.1084/jem.95.2.135; Havenar-Daughton C, 2019, CELL REP, V29, P1756, DOI 10.1016/j.celrep.2019.10.008; He JS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00723-0; Hwang IY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060139; Jash A, 2016, J IMMUNOL, V197, P1159, DOI 10.4049/jimmunol.1600882; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kitano M, 2011, IMMUNITY, V34, P961, DOI 10.1016/j.immuni.2011.03.025; Kuhrt D, 2011, J IMMUNOL METHODS, V363, P166, DOI 10.1016/j.jim.2010.09.017; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Laidlaw BJ, 2020, NAT IMMUNOL, V21, P1082, DOI 10.1038/s41590-020-0713-6; Laidlaw BJ, 2017, J EXP MED, V214, P639, DOI 10.1084/jem.20161461; Lau AWY, 2021, J EXP MED, V218, DOI 10.1084/jem.20191167; Liang F, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2094; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mabbott NA, 2014, IMMUNOLOGY, V141, P79, DOI 10.1111/imm.12171; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Marcandalli J, 2019, CELL, V176, P1420, DOI 10.1016/j.cell.2019.01.046; Mesin L, 2020, CELL, V180, P92, DOI 10.1016/j.cell.2019.11.032; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Moon JJ, 2012, P NATL ACAD SCI USA, V109, P1080, DOI 10.1073/pnas.1112648109; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Moyer TJ, 2020, NAT MED, V26, P430, DOI 10.1038/s41591-020-0753-3; Muller-Winkler J, 2021, J EXP MED, V218, DOI 10.1084/jem.20191393; Muto A, 2004, NATURE, V429, P566, DOI 10.1038/nature02596; O'Connor BP, 2006, J IMMUNOL, V177, P7723, DOI 10.4049/jimmunol.177.11.7723; Ols S, 2020, CELL REP, V30, P3964, DOI 10.1016/j.celrep.2020.02.111; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Pape KA, 2018, IMMUNITY, V48, P1135, DOI 10.1016/j.immuni.2018.04.019; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Rauschmeier R., 2021, CELL INTRINSIC FUNCT; Roco JA, 2019, IMMUNITY, V51, P337, DOI 10.1016/j.immuni.2019.07.001; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Schenten D, 2006, BLOOD, V107, P4849, DOI 10.1182/blood-2005-10-4154; Schwickert TA, 2011, J EXP MED, V208, P1243, DOI 10.1084/jem.20102477; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suan D, 2017, IMMUNITY, V47, P1142, DOI 10.1016/j.immuni.2017.11.022; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sundling C, 2021, IMMUNITY, V54, P988, DOI 10.1016/j.immuni.2021.03.013; Tam HH, 2016, P NATL ACAD SCI USA, V113, pE6639, DOI 10.1073/pnas.1606050113; Tan C, 2020, NAT IMMUNOL, V21, P1267, DOI 10.1038/s41590-020-0765-7; Taylor JJ, 2015, SCIENCE, V347, P784, DOI 10.1126/science.aaa1342; Taylor JJ, 2012, TRENDS IMMUNOL, V33, P590, DOI 10.1016/j.it.2012.07.005; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tokatlian T, 2019, SCIENCE, V363, P649, DOI 10.1126/science.aat9120; Toyama H, 2002, IMMUNITY, V17, P329, DOI 10.1016/S1074-7613(02)00387-4; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Vijay R, 2020, NAT IMMUNOL, V21, P790, DOI 10.1038/s41590-020-0678-5; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Whittle JRR, 2014, J VIROL, V88, P4047, DOI 10.1128/JVI.03422-13; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Zhang TT, 2017, ELIFE, V6, DOI 10.7554/eLife.19552; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zikherman J, 2012, NATURE, V489, P160, DOI 10.1038/nature11311; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	84	17	17	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					2005	+		10.1016/j.immuni.2021.08.017	http://dx.doi.org/10.1016/j.immuni.2021.08.017		SEP 2021	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34525339	hybrid, Green Published, Green Accepted			2022-12-18	WOS:000695789800011
J	Hofbauer, D; Mougiakakos, D; Broggini, L; Zaiss, M; Buttner-Herold, M; Bach, C; Spriewald, B; Neumann, F; Bisht, S; Nolting, J; Zeiser, R; Hamarsheh, S; Eberhardt, M; Vera, J; Visentin, C; De Luca, CMG; Moda, F; Haskamp, S; Flamann, C; Bottcher, M; Bitterer, K; Volkl, S; Mackensen, A; Ricagno, S; Bruns, H				Hofbauer, Daniel; Mougiakakos, Dimitrios; Broggini, Luca; Zaiss, Mario; Buettner-Herold, Maike; Bach, Christian; Spriewald, Bernd; Neumann, Frank; Bisht, Savita; Nolting, Jens; Zeiser, Robert; Hamarsheh, Shaima'a; Eberhardt, Martin; Vera, Julio; Visentin, Cristina; De Luca, Chiara Maria Giulia; Moda, Fabio; Haskamp, Stefan; Flamann, Cindy; Boettcher, Martin; Bitterer, Katrin; Voelkl, Simon; Mackensen, Andreas; Ricagno, Stefano; Bruns, Heiko			beta(2)-microglobulin triggers NLRP3 inflammasome activation in tumor-associated macrophages to promote multiple myeloma progression	IMMUNITY			English	Article							INTERNATIONAL STAGING SYSTEM; NECROSIS-FACTOR-ALPHA; NALP3 INFLAMMASOME; SERUM-LEVELS; BETA-2-MICROGLOBULIN; DISEASE; PROTEIN; CELLS; ANGIOGENESIS; HEMODIALYSIS	As substantial constituents of the multiple myeloma (MM) microenvironment, pro-inflammatory macrophages have emerged as key promoters of disease progression, bone destruction, and immune impairment. We identify beta-2-microglobulin (beta 2m) as a driver in initiating inflammation in myeloma-associated macrophages (MAMs). Lysosomal accumulation of phagocytosed beta 2m promotes beta 2m amyloid aggregation in MAMs, resulting in lysosomal rupture and ultimately production of active interleukin-1 beta (IL-1 beta) and IL-18. This process depends on activation of the NLRP3 inflammasome after beta 2m accumulation, as macrophages from NLRP3-deficient mice lack efficient beta 2m-induced IL-1 beta production. Moreover, depletion or silencing of beta 2m in MM cells abrogates inflammasome activation in a murine MM model. Finally, we demonstrate that disruption of NLRP3 or IL-18 diminishes tumor growth and osteolytic bone destruction normally promoted by beta 2m-induced inflammasome signaling. Our results provide mechanistic evidence for beta 2m's role as an NLRP3 inflammasome activator during MM pathogenesis. Moreover, inhibition of NLRP3 represents a potential therapeutic approach in MM.	[Hofbauer, Daniel; Mougiakakos, Dimitrios; Bach, Christian; Spriewald, Bernd; Flamann, Cindy; Boettcher, Martin; Bitterer, Katrin; Voelkl, Simon; Mackensen, Andreas; Bruns, Heiko] Univ Hosp Erlangen, Dept Internal Med 5, Erlangen, Germany; [Broggini, Luca; Visentin, Cristina; Ricagno, Stefano] Univ Milan, Dept Biosci, Milan, Italy; [Zaiss, Mario] Univ Hosp Erlangen, Dept Internal Med 3, Erlangen, Germany; [Buettner-Herold, Maike] Univ Hosp Erlangen, Dept Nephropathol, Erlangen, Germany; [Neumann, Frank] Saarland Univ, Dept Internal Med 1, Med Sch, Homburg, Germany; [Bisht, Savita; Nolting, Jens] Univ Hosp Bonn, Dept Oncol Hematol & Rheumatol, Bonn, Germany; [Zeiser, Robert; Hamarsheh, Shaima'a] Univ Freiburg, Dept Med 1, Freiburg, Germany; [Eberhardt, Martin; Vera, Julio] Univ Hosp Erlangen, Dept Dermatol, Erlangen, Germany; [De Luca, Chiara Maria Giulia; Moda, Fabio] Fdn IRCCS Ist Neurol Carlo Besta, Div Neurol Neuropatol 5, Milan, Italy; [Haskamp, Stefan] Friedrich Alexander Univ Erlangen Nurnberg, Univ Klinikum Erlangen, Inst Human Genet, D-91054 Erlangen, Germany; [Broggini, Luca] IRCCS Policlin San Donato, Inst Mol & Translat Cardiol, Milan, Italy	University of Erlangen Nuremberg; University of Milan; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Universitatsklinikum des Saarlandes; University of Bonn; University of Freiburg; University of Erlangen Nuremberg; IRCCS Istituto Neurologico Besta; University of Erlangen Nuremberg; IRCCS Policlinico San Donato	Bruns, H (corresponding author), Univ Hosp Erlangen, Dept Internal Med 5, Erlangen, Germany.	heiko.bruns@uk-erlangen.de	Böttcher, Martin/AFQ-7409-2022; De Luca, Chiara/AAK-2127-2021; Vera, Julio/O-4134-2015; Moda, Fabio/J-6445-2018	Böttcher, Martin/0000-0003-2911-8830; De Luca, Chiara/0000-0002-6233-8272; Vera, Julio/0000-0002-3076-5122; Volkl, Simon/0000-0003-2193-3048; Zeiser, Robert/0000-0001-6565-3393; Haskamp, Stefan/0000-0003-3760-9074; broggini, luca/0000-0001-9472-6854; Moda, Fabio/0000-0002-2820-9880	Wilhelm-Sander Foundation; German Research Foundation (DFG) [BR 4775/2-1]; Research Foundation Medicine at the University Clinic Erlangen, Germany; Fondazione ARISLA [TDP43-STRUCT]; Fondazione Telethon [GGP17036]; Core Unit Cell Sorting and Immunomonitoring Erlangen	Wilhelm-Sander Foundation; German Research Foundation (DFG)(German Research Foundation (DFG)); Research Foundation Medicine at the University Clinic Erlangen, Germany; Fondazione ARISLA(Fondazione AriSLA); Fondazione Telethon(Fondazione TelethonEuropean Commission); Core Unit Cell Sorting and Immunomonitoring Erlangen	H.B. was supported by the Wilhelm-Sander Foundation and the German Research Foundation (DFG BR 4775/2-1). S.V. was supported by the Research Foundation Medicine at the University Clinic Erlangen, Germany. Martina Maritan is kindly acknowledged for technical help. We thank Monika Klewer for her help with the electron microscopy. The graphical abstract was created with the help of Designs that Cell (https://www.designsthatcell.ca/).This work was partially supported by Fondazione ARISLA (project TDP43-STRUCT) and Fondazione Telethon (GGP17036) (S.R.). We thank the Core Unit Cell Sorting and Immunomonitoring Erlangen for supporting the work.	Alexandrakis MG, 2004, LEUKEMIA RES, V28, P259, DOI 10.1016/S0145-2126(03)00261-3; ALEXANIAN R, 1986, ANN INTERN MED, V105, P8, DOI 10.7326/0003-4819-105-1-8; Ami D, 2012, BIOPHYS J, V102, P1676, DOI 10.1016/j.bpj.2012.02.045; Ayto Robert, 2013, Critical Reviews in Oncogenesis, V18, P247; BATAILLE R, 1984, BLOOD, V63, P468; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; Camilloni C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25559; Chevriaux A, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00167; Chu J, 2009, J LEUKOCYTE BIOL, V86, P1227, DOI 10.1189/jlb.0309164; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dai SM, 2004, ANN RHEUM DIS, V63, P1379, DOI 10.1136/ard.2003.018481; De Veirman K, 2017, CANCER IMMUNOL RES, V5, P839, DOI 10.1158/2326-6066.CIR-17-0192; DESCOS L, 1979, NEW ENGL J MED, V301, P440; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; DURIE BGM, 1990, CURR TOP MICROBIOL, V166, P33; Enoksson SL, 2011, P NATL ACAD SCI USA, V108, pE1399, DOI 10.1073/pnas.1107830108; Esposito G, 2008, J MOL BIOL, V378, P887, DOI 10.1016/j.jmb.2008.03.002; GEJYO F, 1985, BIOCHEM BIOPH RES CO, V129, P701, DOI 10.1016/0006-291X(85)91948-5; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Guo C, 2018, CLIN EXP IMMUNOL, V194, P231, DOI 10.1111/cei.13167; Halabelian L, 2014, J BIOL CHEM, V289, P3318, DOI 10.1074/jbc.M113.524157; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hamarsheh S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01444; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Hebron E, 2013, BRIT J HAEMATOL, V160, P779, DOI 10.1111/bjh.12175; Hideshima T, 2001, ONCOGENE, V20, P4519, DOI 10.1038/sj.onc.1204623; Hope C, 2014, BLOOD, V123, P3305, DOI 10.1182/blood-2014-02-554071; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Karki R, 2019, NAT REV CANCER, V19, P197, DOI 10.1038/s41568-019-0123-y; Kawano Y, 2015, IMMUNOL REV, V263, P160, DOI 10.1111/imr.12233; Keller M, 2009, J IMMUNOL, V183, P5593, DOI 10.4049/jimmunol.0900476; Kim J, 2012, BRIT J HAEMATOL, V158, P336, DOI 10.1111/j.1365-2141.2012.09154.x; Klingstedt T, 2012, BIOCHEM SOC T, V40, P704, DOI 10.1042/BST20120009; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lightfield KL, 2008, NAT IMMUNOL, V9, P1171, DOI 10.1038/ni.1646; Lust JA, 1999, HEMATOL ONCOL CLIN N, V13, P1117, DOI 10.1016/S0889-8588(05)70115-5; Lust JA, 2009, MAYO CLIN PROC, V84, P114, DOI 10.4065/84.2.114; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mbalaviele G, 2017, J CLIN INVEST, V127, P2030, DOI 10.1172/JCI93356; McParland VJ, 2000, BIOCHEMISTRY-US, V39, P8735, DOI 10.1021/bi000276j; Minnie SA, 2020, J CLIN INVEST, V130, P1565, DOI 10.1172/JCI129205; MIYATA T, 1994, J CLIN INVEST, V93, P521, DOI 10.1172/JCI117002; Nakamura K, 2018, CANCER CELL, V33, P634, DOI 10.1016/j.ccell.2018.02.007; Palumbo A, 2015, J CLIN ONCOL, V33, P2863, DOI 10.1200/JCO.2015.61.2267; Palumbo A, 2011, NEW ENGL J MED, V364, P1046, DOI 10.1056/NEJMra1011442; Platt GW, 2009, FEBS LETT, V583, P2623, DOI 10.1016/j.febslet.2009.05.005; Prabhala RH, 2010, BLOOD, V115, P5385, DOI 10.1182/blood-2009-10-246660; Qu C, 2015, FASEB J, V29, P1269, DOI 10.1096/fj.14-264804; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Roussou M, 2009, LEUKEMIA, V23, P2177, DOI 10.1038/leu.2009.130; Rutella S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/196063; Santambrogio C, 2010, PROTEIN SCI, V19, P1386, DOI 10.1002/pro.419; SJOBLOM KG, 1980, ANN RHEUM DIS, V39, P333, DOI 10.1136/ard.39.4.333; Sutterwala FS, 2007, J LEUKOCYTE BIOL, V82, P259, DOI 10.1189/jlb.1206755; Suyani E, 2013, ANN HEMATOL, V92, P669, DOI 10.1007/s00277-012-1652-6; Terpos E, 2013, J CLIN ONCOL, V31, P2347, DOI 10.1200/JCO.2012.47.7901; Valleix S, 2012, NEW ENGL J MED, V366, P2276, DOI 10.1056/NEJMoa1201356; Yang Y, 2007, BLOOD, V110, P2041, DOI 10.1182/blood-2007-04-082495; Zhen Y, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00276; Zheng YH, 2009, BLOOD, V114, P3625, DOI 10.1182/blood-2009-05-220285; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	66	17	17	4	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1772	+		10.1016/j.immuni.2021.07.002	http://dx.doi.org/10.1016/j.immuni.2021.07.002		AUG 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34289378	Bronze, Green Submitted			2022-12-18	WOS:000684589700015
J	Saxton, RA; Henneberg, LT; Calafiore, M; Su, L; Jude, KM; Hanash, AM; Garcia, KC				Saxton, Robert A.; Henneberg, Lukas T.; Calafiore, Marco; Su, Leon; Jude, Kevin M.; Hanash, Alan M.; Garcia, K. Christopher			The tissue protective functions of interleukin-22 can be decoupled from pro-inflammatory actions through structure-based design	IMMUNITY			English	Article							TH22 CELLS; IL-22; CYTOKINE; INTERFERON; MICE; ACTIVATION; IMMUNITY; FEATURES; SIGNALS; INNATE	Interleukin-22 (IL-22) acts on epithelial cells to promote tissue protection and regeneration, but can also elicit pro-inflammatory effects, contributing to disease pathology. Here, we engineered a high-affinity IL-22 superagonist that enabled the structure determination of the IL-22-IL-22Ra-IL-10Rb ternary complex to a resolution of 2.6 A degrees. Using structure-based design, we systematically destabilized the IL-22-IL-10Rb binding interface to create partial agonist analogs that decoupled downstream STAT1 and STAT3 signaling. The extent of STAT bias elicited by a single ligand varied across tissues, ranging from full STAT3-biased agonism to STAT1/3 antagonism, correlating with IL-10Rb expression levels. In vivo, this tissue-selective signaling drove tissue protection in the pancreas and gastrointestinal tract without inducing local or systemic inflammation, thereby uncoupling these opposing effects of IL-22 signaling. Our findings provide insight into the mechanisms underlying the cytokine pleiotropy and illustrate how differential receptor expression levels and STAT response thresholds can be synthetically exploited to endow pleiotropic cytokines with enhanced functional specificity.	[Saxton, Robert A.; Henneberg, Lukas T.; Su, Leon; Jude, Kevin M.; Garcia, K. Christopher] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, 279 Campus Dr, Stanford, CA 94305 USA; [Saxton, Robert A.; Jude, Kevin M.; Garcia, K. Christopher] Stanford Univ, Howard Hughes Med Inst, Sch Med, 279 Campus Dr, Stanford, CA 94305 USA; [Calafiore, Marco; Hanash, Alan M.] Mem Sloan Kettering Canc Ctr, Dept Med, Human Oncol & Pathogenesis Program, New York, NY 10065 USA; [Calafiore, Marco; Hanash, Alan M.] Mem Sloan Kettering Canc Ctr, Immunol & Microbial Pathogenesis Program, New York, NY 10065 USA; [Calafiore, Marco; Hanash, Alan M.] Weill Cornell Med Coll, New York, NY 10065 USA; [Garcia, K. Christopher] Stanford Univ, Dept Struct Biol, Sch Med, 299 Campus Dr, Stanford, CA 94305 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Stanford University	Garcia, KC (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, 279 Campus Dr, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, 279 Campus Dr, Stanford, CA 94305 USA.; Garcia, KC (corresponding author), Stanford Univ, Dept Struct Biol, Sch Med, 299 Campus Dr, Stanford, CA 94305 USA.	kcgarcia@stanford.edu		Saxton, Robert/0000-0001-9777-8270; Henneberg, Lukas/0000-0003-3477-4541; Jude, Kevin/0000-0002-3675-5136; Su, Leon/0000-0001-7654-9997	NIH [5R01CA177684, R37AI51321, U54CA244711, R01-HL125571, R01HL146338, R01-HL145631, P30-CA008748]; Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank Caleb Glassman, Monther Abu-Remaileh, and Nouf Laqtoum for helpful advice and discussions. We thank the Stanford PAN facility for technical assistance with real-time PCR analysis, the Stanford Veterinary Service Center for serum amylase/lipase measurements, and Novogene for performing RNA-seq. K.C.G. is an investigator with the Howard Hughes Medical Institute (HHMI). R.A.S. is an HHMI Fellow of the Helen Hay Whitney Foundation. This work was supported by NIH grants 5R01CA177684 (K.C.G), R37AI51321 (K.C.G.), U54CA244711 (K.C.G.), R01-HL125571 (A.M.H.), R01HL146338 (A.M.H), R01-HL145631 (A.M.H.), and P30-CA008748 (MSKCC Core Grant). Use of the Advanced Photon Source was supported by the Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akdis M, 2016, J ALLERGY CLIN IMMUN, V138, P984, DOI 10.1016/j.jaci.2016.06.033; Alonzi T, 2001, MOL CELL BIOL, V21, P1621, DOI 10.1128/MCB.21.5.1621-1632.2001; Angelini A, 2015, METHODS MOL BIOL, V1319, P3, DOI 10.1007/978-1-4939-2748-7_1; Bachmann M, 2013, BIOCHEM PHARMACOL, V85, P396, DOI 10.1016/j.bcp.2012.11.004; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Bernshtein B, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6571; Boniface K, 2005, J IMMUNOL, V174, P3695, DOI 10.4049/jimmunol.174.6.3695; Bricogne G., 2016, BUSTER VERSION X Y Z; Cao ZW, 2011, CANCER RES, V71, P2286, DOI 10.1158/0008-5472.CAN-10-3367; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chao G, 2006, NAT PROTOC, V1, P755, DOI 10.1038/nprot.2006.94; Delgoffe GM, 2011, CURR OPIN IMMUNOL, V23, P632, DOI 10.1016/j.coi.2011.07.013; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dudakov JA, 2015, ANNU REV IMMUNOL, V33, P747, DOI 10.1146/annurev-immunol-032414-112123; Dudakov JA, 2012, SCIENCE, V336, P91, DOI 10.1126/science.1218004; Dumoutier L, 2009, J BIOL CHEM, V284, P26377, DOI 10.1074/jbc.M109.007955; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Feng DC, 2012, INT J BIOL SCI, V8, P249, DOI 10.7150/ijbs.3967; Fujita H, 2013, J DERMATOL SCI, V72, P3, DOI 10.1016/j.jdermsci.2013.04.028; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gronke K, 2019, NATURE, V566, P249, DOI 10.1038/s41586-019-0899-7; Gunasekera DC, 2020, MUCOSAL IMMUNOL, V13, P493, DOI 10.1038/s41385-019-0252-3; Hanash AM, 2012, IMMUNITY, V37, P339, DOI 10.1016/j.immuni.2012.05.028; Hayer A, 2016, NAT CELL BIOL, V18, P1311, DOI 10.1038/ncb3438; Hernandez PP, 2015, NAT IMMUNOL, V16, P698, DOI 10.1038/ni.3180; Jones BC, 2008, STRUCTURE, V16, P1333, DOI 10.1016/j.str.2008.06.005; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Kim AR, 2017, CELL, V168, P1053, DOI 10.1016/j.cell.2017.02.026; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee JY, 2020, CELL, V180, P79, DOI 10.1016/j.cell.2019.11.026; Liang SC, 2010, J IMMUNOL, V185, P5531, DOI 10.4049/jimmunol.0904091; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lin JX, 2019, ANNU REV IMMUNOL, V37, P295, DOI 10.1146/annurev-immunol-042718-041447; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mendoza JL, 2017, IMMUNITY, V46, P379, DOI 10.1016/j.immuni.2017.02.017; Midelfort KS, 2004, J MOL BIOL, V343, P685, DOI 10.1016/j.jmb.2004.08.019; Mohan K, 2019, SCIENCE, V364, P750, DOI 10.1126/science.aav7532; Moraga I, 2015, CELL, V160, P1196, DOI 10.1016/j.cell.2015.02.011; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Morris R, 2018, PROTEIN SCI, V27, P1984, DOI 10.1002/pro.3519; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muhl H, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00018; O'Shea JJ, 2008, IMMUNITY, V28, P477, DOI 10.1016/j.immuni.2008.03.002; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Ouyang WJ, 2019, IMMUNITY, V50, P871, DOI 10.1016/j.immuni.2019.03.020; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004; Riggs BL, 2003, NEW ENGL J MED, V348, P618, DOI 10.1056/NEJMra022219; Rothenberg ME, 2019, CLIN PHARMACOL THER, V105, P177, DOI 10.1002/cpt.1164; Sabat R, 2014, NAT REV DRUG DISCOV, V13, P21, DOI 10.1038/nrd4176; Sano T, 2016, CELL, V164, P324, DOI 10.1016/j.cell.2015.12.047; Sonnenberg GF, 2011, NAT IMMUNOL, V12, P383, DOI 10.1038/ni.2025; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Tang KY, 2019, CELL MOL IMMUNOL, V16, P473, DOI 10.1038/s41423-018-0029-8; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Wang XQ, 2009, ANNU REV IMMUNOL, V27, P29, DOI 10.1146/annurev.immunol.24.021605.090616; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Wootten D, 2018, NAT REV MOL CELL BIO, V19, P638, DOI 10.1038/s41580-018-0049-3; Xie MH, 2000, J BIOL CHEM, V275, P31335, DOI 10.1074/jbc.M005304200; Xue J, 2012, GASTROENTEROLOGY, V143, P1670, DOI 10.1053/j.gastro.2012.08.051; Yoon SI, 2010, STRUCTURE, V18, P638, DOI 10.1016/j.str.2010.02.009; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zenewicz LA, 2008, IMMUNITY, V29, P947, DOI 10.1016/j.immuni.2008.11.003; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505	72	17	17	4	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					660	+		10.1016/j.immuni.2021.03.008	http://dx.doi.org/10.1016/j.immuni.2021.03.008		APR 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33852830	Bronze, Green Accepted			2022-12-18	WOS:000640102800009
J	New, JS; Dizon, BLP; Fucile, CF; Rosenberg, AF; Kearney, JF; King, RG				New, J. Stewart; Dizon, Brian L. P.; Fucile, Christopher F.; Rosenberg, Alexander F.; Kearney, John F.; King, R. Glenn			Neonatal Exposure to Commensal-Bacteria-Derived Antigens Directs Polysaccharide-Specific B-1 B Cell Repertoire Development	IMMUNITY			English	Article							GROUP-A CARBOHYDRATE; SELECTIVE IGM DEFICIENCY; GERM-FREE MICE; NATURAL ANTIBODY; ADAPTIVE IMMUNITY; MARGINAL ZONE; PLASMA-CELLS; BALB/C MICE; MONOCLONAL-ANTIBODIES; POSITIVE SELECTION	B-1 B cells derive from a developmental program distinct from that of conventional B cells, through B cell receptor (BCR)-dependent positive selection of fetally derived precursors. Here, we used direct labeling of B cells reactive with the N-acetyl-D-glucosamine (GlcNAc)-containing Lancefield group A carbohydrate of Streptococcus pyogenes to study the effects of bacterial antigens on the emergent B-1 B cell clonal repertoire. The number, phenotype, and BCR clonotypes of GlcNAc-reactive B-1 B cells were modulated by neonatal exposure to heat-killed S. pyogenes bacteria. GlcNAc-reactive B-1 clonotypes and serum antibodies were reduced in germ-free mice compared with conventionally raised mice. Colonization of germ-free mice with a conventional microbiota promoted GlcNAc-reactive B-1 B cell development and concomitantly elicited clonally related IgA(+) plasma cells in the small intestine. Thus, exposure to microbial antigens in early life determines the clonality of the mature B-1 B cell repertoire and ensuing antibody responses, with implications for vaccination approaches and schedules.	[New, J. Stewart; Dizon, Brian L. P.; Rosenberg, Alexander F.; Kearney, John F.; King, R. Glenn] Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA; [Dizon, Brian L. P.] NIAMSD, NIH, Bethesda, MD 20892 USA; [Fucile, Christopher F.; Rosenberg, Alexander F.] Univ Alabama Birmingham, Informat Inst, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Alabama System; University of Alabama Birmingham	Kearney, JF; King, RG (corresponding author), Univ Alabama Birmingham, Dept Microbiol, Birmingham, AL 35294 USA.	jfk@uab.edu; rgking@uab.edu	Kearney, John/GOV-3123-2022		US National Institutes of Health [NIH] [P30 AR048311, P30 AI027767]; UAB School of Medicine; O'Neal Comprehensive Cancer Center at UAB [P30 CA013148]; Center for Clinical and Translational Science at UAB [UL1TR001417]; NIH [G20OD016623, R01 AI14782, U01 AI100005, F31 AI120500, T32 A1007051, F30 DK082277, T32 GM008861]	US National Institutes of Health [NIH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB School of Medicine; O'Neal Comprehensive Cancer Center at UAB; Center for Clinical and Translational Science at UAB; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge Enid Keyser, V. Sagar Hanumanthu, and the University of Alabama at Birmingham (UAB) Comprehensive Flow Cytometry Center (CFCC, supported by US National Institutes of Health [NIH] grants P30 AR048311 and P30 AI027767) for assistance in single-cell sorting; the UAB Heflin Center for Genomics Studies Core Laboratory for DNA sequencing; Dr. Casey Morrow and the UAB Microbiome Resource (supported by the UAB School of Medicine, the O'Neal Comprehensive Cancer Center at UAB [P30 CA013148], and the Center for Clinical and Translational Science at UAB [UL1TR001417]) for assistance in 16S rDNA microbiome profiling; and Dr. Trenton Schoeb and the Gnotobiotic and Genetically Engineered Mouse Core (supported by NIH grant G20OD016623) for gnotobiotic animal resource support. We thank Lisa Jia and Jeffrey Sides for assisting with mouse husbandry and hybridoma maintenance and Drs. Denise Kaminski and David Woodland for their support in editing this manuscript. This work was supported by NIH grants R01 AI14782 and U01 AI100005 (J.F.K.), F31 AI120500 and T32 A1007051 (J.S.N.), and F30 DK082277 and T32 GM008861 (B.L.P. D).	Alugupalli KR, 2004, IMMUNITY, V21, P379, DOI 10.1016/j.immuni.2004.06.019; Antar M, 2008, CLIN EXP NEPHROL, V12, P300, DOI 10.1007/s10157-008-0049-2; Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Binder CJ, 2003, NAT MED, V9, P736, DOI 10.1038/nm876; BLOCH R, 1974, FEBS LETT, V44, P286, DOI 10.1016/0014-5793(74)81159-2; BOS NA, 1987, CELL IMMUNOL, V105, P235, DOI 10.1016/0008-8749(87)90071-2; BOS NA, 1989, EUR J IMMUNOL, V19, P2335, DOI 10.1002/eji.1830191223; Brandlein S, 2003, CANCER RES, V63, P7995; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; BRILES DE, 1982, J IMMUNOL, V128, P2032; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Choi YS, 2012, EUR J IMMUNOL, V42, P120, DOI 10.1002/eji.201141890; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; Cole LE, 2009, P NATL ACAD SCI USA, V106, P4343, DOI 10.1073/pnas.0813411106; Cywes-Bentley C, 2013, P NATL ACAD SCI USA, V110, pE2209, DOI 10.1073/pnas.1303573110; Dotan I, 2006, GASTROENTEROLOGY, V131, P366, DOI 10.1053/j.gastro.2006.04.030; EMMRICH F, 1983, EUR J IMMUNOL, V13, P273, DOI 10.1002/eji.1830130402; Engelbertsen D, 2015, J IMMUNOL, V195, P3020, DOI 10.4049/jimmunol.1402869; ETLINGER HM, 1986, J IMMUNOL, V136, P1988; Felsenstein J., 2005, CLADISTICS; Fransen F, 2015, IMMUNITY, V43, P527, DOI 10.1016/j.immuni.2015.08.011; Friedrich C, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006357; Ghosn EEB, 2011, P NATL ACAD SCI USA, V108, P2879, DOI 10.1073/pnas.1019764108; Golby S, 2002, J LEUKOCYTE BIOL, V72, P279; GREENSPAN NS, 1985, J IMMUNOL, V134, P1065; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; HAMILTON AM, 1994, INT IMMUNOL, V6, P355, DOI 10.1093/intimm/6.3.355; Hardy RR, 2004, IMMUNOL REV, V197, P60, DOI 10.1111/j.0105-2896.2004.0100.x; Haury M, 1997, EUR J IMMUNOL, V27, P1557, DOI 10.1002/eji.1830270635; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; Hayakawa K, 2017, J EXP MED, V214, P3067, DOI 10.1084/jem.20170497; HILL MO, 1973, ECOLOGY, V54, P427, DOI 10.2307/1934352; HOOIJKAAS H, 1984, EUR J IMMUNOL, V14, P1127, DOI 10.1002/eji.1830141212; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Hou B, 2008, IMMUNITY, V29, P272, DOI 10.1016/j.immuni.2008.05.016; Jayasekera JP, 2007, J VIROL, V81, P3487, DOI 10.1128/JVI.02128-06; Kabanova A, 2010, VACCINE, V29, P104, DOI 10.1016/j.vaccine.2010.09.018; Kaminski DA, 2006, J IMMUNOL, V177, P6025, DOI 10.4049/jimmunol.177.9.6025; KANTOR AB, 1993, ANNU REV IMMUNOL, V11, P501, DOI 10.1146/annurev.iy.11.040193.002441; Kawahara T, 2003, J IMMUNOL, V171, P5406, DOI 10.4049/jimmunol.171.10.5406; KEARNEY JF, 1985, J IMMUNOL, V135, P3468; Kearney JF, 2015, ANNU REV IMMUNOL, V33, P475, DOI 10.1146/annurev-immunol-032713-120140; Kin NW, 2012, J IMMUNOL, V189, P2246, DOI 10.4049/jimmunol.1200702; Kirvan CA, 2003, NAT MED, V9, P914, DOI 10.1038/nm892; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Komai-Koma M, 2011, J IMMUNOL, V186, P2584, DOI 10.4049/jimmunol.1002103; Kroese FGM, 1989, INT IMMUNOL, V1, P75, DOI 10.1093/intimm/1.1.75; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kumar Ranjit, 2014, Curr Protoc Hum Genet, V82, DOI 10.1002/0471142905.hg1808s82; Louis AG, 2014, CLIN REV ALLERG IMMU, V46, P104, DOI 10.1007/s12016-013-8375-x; LUTZ CT, 1987, J EXP MED, V165, P531, DOI 10.1084/jem.165.2.531; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Magri G, 2017, IMMUNITY, V47, P118, DOI 10.1016/j.immuni.2017.06.013; MCCARTY M, 1956, J EXP MED, V104, P629, DOI 10.1084/jem.104.5.629; MCCARTY M, 1952, J EXP MED, V96, P569, DOI 10.1084/jem.96.6.569; MCCARTY M, 1955, J EXP MED, V102, P11, DOI 10.1084/jem.102.1.11; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Morisita M., 1959, MEM FAC SCI KYUSHU E, V2, P215; NAHM MH, 1982, J IMMUNOL, V129, P1513; New JS, 2016, IMMUNOL REV, V270, P32, DOI 10.1111/imr.12397; Nogales A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22307-8; Ochsenbein AF, 1999, SCIENCE, V286, P2156, DOI 10.1126/science.286.5447.2156; Ohdan H, 2000, J IMMUNOL, V165, P5518, DOI 10.4049/jimmunol.165.10.5518; Oliver AM, 1999, HYBRIDOMA, V18, P113, DOI 10.1089/hyb.1999.18.113; PHILLIPS NJ, 1990, J IMMUNOL, V145, P915; Rapaka RR, 2010, J EXP MED, V207, P2907, DOI 10.1084/jem.20100034; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Sabharwal H, 2006, J INFECT DIS, V193, P129, DOI 10.1086/498618; SCHAEDLER RW, 1965, J EXP MED, V122, P77, DOI 10.1084/jem.122.1.77; Schwarz M, 2006, J NEUROL SCI, V244, P59, DOI 10.1016/j.jns.2005.12.006; Seidl KJ, 1997, INT IMMUNOL, V9, P689, DOI 10.1093/intimm/9.5.689; Seo SJ, 2001, J IMMUNOL, V166, P3710, DOI 10.4049/jimmunol.166.6.3710; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi B, 2014, THEOR BIOL MED MODEL, V11, DOI 10.1186/1742-4682-11-30; SIGAL NH, 1975, J IMMUNOL, V114, P1354; Silver K, 2006, EUR J IMMUNOL, V36, P1404, DOI 10.1002/eji.200636019; Stoehr AD, 2011, J IMMUNOL, V187, P2953, DOI 10.4049/jimmunol.1003340; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Takeuchi T, 2001, AUTOIMMUNITY, V34, P115, DOI 10.3109/08916930109001959; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Tipton CM, 2015, NAT IMMUNOL, V16, P755, DOI 10.1038/ni.3175; Townsend SE, 2001, J IMMUNOL METHODS, V249, P137, DOI 10.1016/S0022-1759(00)00352-5; TURNER JR, 1990, P NATL ACAD SCI USA, V87, P5608, DOI 10.1073/pnas.87.15.5608; Vakil M, 1991, Dev Immunol, V1, P213, DOI 10.1155/1991/91729; Vas J, 2012, ARTHRITIS RHEUM-US, V64, P3388, DOI 10.1002/art.34537; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Wesemann DR, 2013, NATURE, V501, DOI 10.1038/nature12496; Won WJ, 2002, J IMMUNOL, V168, P5605, DOI 10.4049/jimmunol.168.11.5605; Won WJ, 2008, J IMMUNOL, V180, P230, DOI 10.4049/jimmunol.180.1.230; Won WJ, 2006, J IMMUNOL, V177, P6815, DOI 10.4049/jimmunol.177.10.6815; Yang Y, 2015, ELIFE, V4, DOI 10.7554/eLife.09083; Yilmaz B, 2014, CELL, V159, P1277, DOI 10.1016/j.cell.2014.10.053; Yoshimoto M, 2011, P NATL ACAD SCI USA, V108, P1468, DOI 10.1073/pnas.1015841108; ZENKE G, 1984, EUR J IMMUNOL, V14, P164, DOI 10.1002/eji.1830140211	101	17	17	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					172	+		10.1016/j.immuni.2020.06.006	http://dx.doi.org/10.1016/j.immuni.2020.06.006			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32610078	Green Accepted, Bronze			2022-12-18	WOS:000551116800018
J	Trivedi, N; Weisel, F; Smita, S; Joachim, S; Kader, M; Radhakrishnan, A; Clouser, C; Rosenfeld, AM; Chikina, M; Vigneault, F; Hershberg, U; Ismail, N; Shlomchik, MJ				Trivedi, Nikita; Weisel, Florian; Smita, Shuchi; Joachim, Stephen; Kader, Muhamuda; Radhakrishnan, Aditya; Clouser, Chris; Rosenfeld, Aaron M.; Chikina, Maria; Vigneault, Francois; Hershberg, Uri; Ismail, Nahed; Shlomchik, Mark Jay			Liver Is a Generative Site for the B Cell Response to Ehrlichia muris	IMMUNITY			English	Article							FACTOR T-BET; MARGINAL ZONE; CLONAL EXPANSIONS; GERMINAL CENTER; ANIMAL-MODEL; IFN-GAMMA; CHAFFEENSIS; INFECTION; HEPATITIS; ANTIGEN	The B cell response to Ehrlichia muris is dominated by plasmablasts (PBs), with few-if any-germinal centers (GCs), yet it generates protective immunoglobulin M (IgM) memory B cells (MBCs) that express the transcription factor T-bet and harbor V-region mutations. Because Ehrlichia prominently infects the liver, we investigated the nature of liver B cell response and that of the spleen. B cells within infected livers proliferated and underwent somatic hypermutation (SHM). Vh-region sequencing revealed trafficking of clones between the spleen and liver and often subsequent local clonal expansion and intraparenchymal localization of T-bet(+) MBCs. T-bet(+) MBCs expressed MBC subset markers CD80 and PD-L2. Many T-ber MBCs lacked CD11b or CD11c expression but had marginal zone (MZ) B cell phenotypes and colonized the splenic MZ, revealing T-bet(+) MBC plasticity. Hence, liver and spleen are generative sites of B cell responses, and they include V-region mutation and result in liver MBC localization.	[Trivedi, Nikita; Weisel, Florian; Smita, Shuchi; Joachim, Stephen; Shlomchik, Mark Jay] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA; [Trivedi, Nikita] Univ Pittsburgh, Grad Program Microbiol & Immunol, Pittsburgh, PA 15261 USA; [Kader, Muhamuda; Ismail, Nahed] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Radhakrishnan, Aditya; Clouser, Chris; Vigneault, Francois] Juno Therapeut, Seattle, WA 98109 USA; [Rosenfeld, Aaron M.; Hershberg, Uri] Drexel Univ, Philadelphia, PA 19104 USA; [Smita, Shuchi; Chikina, Maria] Univ Pittsburgh, Dept Computat & Syst Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Shlomchik, MJ (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15261 USA.	mshlomch@pitt.edu	Hershberg, Uri/AAQ-6255-2020; Shlomchik, Mark J./AAN-6189-2020; Rosenfeld, Aaron/ABB-9927-2020	Hershberg, Uri/0000-0002-6425-5980; Shlomchik, Mark J./0000-0002-2152-0959; Radhakrishnan, Aditya/0000-0001-9119-0679	NIH [NIH-1R01AI105018, NIH-2R01AI043603, P01-AI106697]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043603, P01AI106697, R01AI105018] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Dr. David Walker at the University of Texas Medical Branch for providing E. muris Ags Omp12 and Omp19. We thank the Histology Core at Magee Research Institute for laser micro-dissections. We are thankful to Laura Conter and Rachel Green for helping with the experiments. This work was funded by NIH grants NIH-1R01AI105018 and NIH-2R01AI043603. A.M.R. was supported by NIH grant P01-AI106697.	ANDERSON BE, 1991, J CLIN MICROBIOL, V29, P2838, DOI 10.1128/JCM.29.12.2838-2842.1991; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Bankoti R, 2012, J IMMUNOL, V188, P3961, DOI 10.4049/jimmunol.1102880; Barnett BE, 2016, J IMMUNOL, V197, P1017, DOI 10.4049/jimmunol.1500368; Barry WT, 2008, ANN APPL STAT, V2, P286, DOI 10.1214/07-AOAS146; Bemark M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12698; Coro ES, 2006, J IMMUNOL, V176, P4343, DOI 10.4049/jimmunol.176.7.4343; Crocquet-Valdes PA, 2011, CLIN VACCINE IMMUNOL, V18, P2018, DOI 10.1128/CVI.05292-11; Cunningham AF, 2007, J IMMUNOL, V178, P6200, DOI 10.4049/jimmunol.178.10.6200; DAWSON JE, 1991, J CLIN MICROBIOL, V29, P2741, DOI 10.1128/JCM.29.12.2741-2745.1991; Di Niro R, 2015, IMMUNITY, V43, P120, DOI 10.1016/j.immuni.2015.06.013; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DUMLER JS, 1993, CLIN INFECT DIS, V17, P903, DOI 10.1093/clinids/17.5.903; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]; Habib S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153223; Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530; Hastey CJ, 2012, J IMMUNOL, V188, P5612, DOI 10.4049/jimmunol.1103735; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Intlekofer AM, 2008, SCIENCE, V321, P408, DOI 10.1126/science.1159806; Ismail N, 2004, J IMMUNOL, V172, P1786, DOI 10.4049/jimmunol.172.3.1786; Ismail N, 2017, CLIN LAB MED, V37, P317, DOI 10.1016/j.cll.2017.01.006; Ismail N, 2010, CLIN LAB MED, V30, P261, DOI 10.1016/j.cll.2009.10.004; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Jegerlehner A, 2007, J IMMUNOL, V178, P2415, DOI 10.4049/jimmunol.178.4.2415; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kenderes KJ, 2018, CELL REP, V24, P824, DOI 10.1016/j.celrep.2018.06.074; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; Kunisawa J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2718; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lindner C, 2012, J EXP MED, V209, P365, DOI 10.1084/jem.20111980; Magri G, 2017, IMMUNITY, V47, P118, DOI 10.1016/j.immuni.2017.06.013; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Meng WZ, 2017, NAT BIOTECHNOL, V35, P879, DOI 10.1038/nbt.3942; Miura K, 2009, INFECT IMMUN, V77, P245, DOI 10.1128/IAI.00979-08; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Muller S, 2002, J VIROL, V76, P2375, DOI 10.1128/JVI.76.5.2375-2383.2002; Murakami J, 1999, HEPATOLOGY, V30, P143, DOI 10.1002/hep.510300107; Naradikian MS, 2016, IMMUNOL REV, V269, P118, DOI 10.1111/imr.12380; Olano JP, 2004, AM J PATHOL, V165, P997, DOI 10.1016/S0002-9440(10)63361-5; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Papillion AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178853; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Racanelli V, 2001, J IMMUNOL, V167, P21, DOI 10.4049/jimmunol.167.1.21; Racine R, 2008, J IMMUNOL, V181, P1375, DOI 10.4049/jimmunol.181.2.1375; Racine R, 2010, J IMMUNOL, V184, P5085, DOI 10.4049/jimmunol.0902710; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rosche KL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130092; Rosenfeld AM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02107; Rubtsov AV, 2013, IMMUNOL RES, V55, P210, DOI 10.1007/s12026-012-8365-8; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Rubtsova K, 2017, J CLIN INVEST, V127, P1392, DOI 10.1172/JCI91250; Rubtsova K, 2015, J IMMUNOL, V195, P1933, DOI 10.4049/jimmunol.1501209; Rubtsova K, 2013, P NATL ACAD SCI USA, V110, pE3216, DOI 10.1073/pnas.1312348110; Sansonno D, 2004, EUR J IMMUNOL, V34, P126, DOI 10.1002/eji.200324328; Sathaliyawala T, 2013, IMMUNITY, V38, P187, DOI 10.1016/j.immuni.2012.09.020; Sehdev AES, 2003, AM J CLIN PATHOL, V119, P859, DOI 10.1309/F7EAB5P7321716LJ; Sheneman L, 2006, BIOINFORMATICS, V22, P2823, DOI 10.1093/bioinformatics/btl478; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8; Standaert SM, 2000, J INFECT DIS, V181, P1082, DOI 10.1086/315346; Stephens R, 2009, PARASITE IMMUNOL, V31, P20, DOI 10.1111/j.1365-3024.2008.01066.x; Stevenson HL, 2006, INFECT IMMUN, V74, P4856, DOI 10.1128/IAI.00246-06; Stone SL, 2019, IMMUNITY, V50, P1172, DOI 10.1016/j.immuni.2019.04.004; Thirumalapura NR, 2008, INFECT IMMUN, V76, P1920, DOI 10.1128/IAI.01293-07; Thirumalapura NR, 2009, INFECT IMMUN, V77, P5682, DOI 10.1128/IAI.00720-09; Tsioris K, 2015, INTEGR BIOL-UK, V7, P1587, DOI [10.1039/c5ib00169b, 10.1039/C5IB00169B]; Urban BC, 2005, INFECT IMMUN, V73, P1986, DOI 10.1128/IAI.73.4.1986-1994.2005; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Winslow GM, 2017, CELL IMMUNOL, V321, P8, DOI 10.1016/j.cellimm.2017.07.006; Winslow GM, 2000, INFECT IMMUN, V68, P2187, DOI 10.1128/IAI.68.4.2187-2195.2000; Yates JL, 2013, J IMMUNOL, V191, P1240, DOI 10.4049/jimmunol.1300062	78	17	17	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 17	2019	51	6					1088	+		10.1016/j.immuni.2019.10.004	http://dx.doi.org/10.1016/j.immuni.2019.10.004			19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JW6ME	31732168	Bronze, Green Accepted			2022-12-18	WOS:000503162900014
J	Wallach, D; Kang, TB				Wallach, David; Kang, Tae-Bong			Programmed Cell Death in Immune Defense: Knowledge and Presumptions	IMMUNITY			English	Review							TUMOR-NECROSIS-FACTOR; RECEPTOR TRANSGENIC MICE; KAPPA-B ACTIVATION; LPR-LPR MICE; T-CELLS; FAS-LIGAND; AUTOIMMUNE-DISEASE; NEGATIVE SELECTION; NLRP3 INFLAMMASOME; IN-VIVO	Cell-culture studies are our main source of knowledge of the various forms of programmed cell death. Yet genetic perturbations of death-protein function in animal models are almost the only source of our knowledge of the physiological roles of these programs. Shortcomings in the state of knowledge acquired by these two experimental approaches are exemplified in this Perspective by reference to research on the contribution of apoptosis to lymphocyte development, a subject on which there is already much knowledge, and on the role of necroptosis in inflammation, about which information is just beginning to emerge. To address these shortcomings, there is need to find ways to verify the notions obtained through the current experimental approaches by directly monitoring death programs within specific cells in vivo.	[Wallach, David] Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel; [Kang, Tae-Bong] Konkuk Univ, Coll Biomed & Hlth Sci, Dept Biotechnol, Chungju 27478, South Korea	Weizmann Institute of Science; Konkuk University	Wallach, D (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, IL-76100 Rehovot, Israel.	d.wallach@weizmann.ac.il	kang, Tae-bong/AAD-7950-2022	kang, Tae-bong/0000-0003-1441-9470				ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Alvarez-Diaz S, 2016, IMMUNITY, V45, P513, DOI 10.1016/j.immuni.2016.07.016; Balomenos D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00237; Ben Moshe T, 2007, HEPATOLOGY, V45, P1014, DOI 10.1002/hep.21495; Bonneau B, 2013, BBA-MOL CELL RES, V1833, P1755, DOI 10.1016/j.bbamcr.2013.01.021; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Brouckaert G, 2004, MOL BIOL CELL, V15, P1089, DOI 10.1091/mbc.E03-09-0668; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Butt D, 2015, IMMUNITY, V42, P890, DOI 10.1016/j.immuni.2015.04.010; Cai ZY, 2016, CELL RES, V26, P886, DOI 10.1038/cr.2016.87; Carrington EM, 2017, IMMUNOL CELL BIOL, V95, P870, DOI 10.1038/icb.2017.72; Christofferson DE, 2014, ANNU REV PHYSIOL, V76, P129, DOI 10.1146/annurev-physiol-021113-170259; Clarke PGH, 1996, ANAT EMBRYOL, V193, P81; COHEN PL, 1991, ANNU REV IMMUNOL, V9, P243, DOI 10.1146/annurev.iy.09.040191.001331; Conos SA, 2017, P NATL ACAD SCI USA, V114, pE961, DOI 10.1073/pnas.1613305114; Corriden R, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3104re1; Cruz AC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13895; Daley SR, 2017, IMMUNOL REV, V277, P9, DOI 10.1111/imr.12532; Dannappel M, 2014, NATURE, V513, P90, DOI 10.1038/nature13608; de Vasconcelos NM, 2019, CELL DEATH DIFFER, V26, P146, DOI 10.1038/s41418-018-0106-7; Defrance T, 2002, ADV CANCER RES, V86, P195, DOI 10.1016/S0065-230X(02)86006-7; DHEIN J, 1995, NATURE, V373, P438, DOI 10.1038/373438a0; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Dovey CM, 2018, MOL CELL, V70, P936, DOI 10.1016/j.molcel.2018.05.010; Ekert PG, 2004, J CELL BIOL, V165, P835, DOI 10.1083/jcb.200312031; ERICKSON SL, 1994, NATURE, V372, P560, DOI 10.1038/372560a0; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; FISHER GH, 1995, CELL, V81, P935, DOI 10.1016/0092-8674(95)90013-6; Flemming W., 1885, Archiv fuer Anatomie und Physiologie (Anat), P221; Fukuyama H, 1998, J IMMUNOL, V160, P3805; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Gerlach B, 2011, NATURE, V471, P591, DOI 10.1038/nature09816; GIROIR BP, 1992, P NATL ACAD SCI USA, V89, P4864, DOI 10.1073/pnas.89.11.4864; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Gross A, 2017, CELL DEATH DIFFER, V24, P1348, DOI 10.1038/cdd.2017.22; Guegan JP, 2018, FEBS J, V285, P809, DOI 10.1111/febs.14292; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Gutierrez KD, 2017, J IMMUNOL, V198, P2156, DOI 10.4049/jimmunol.1601757; Hahne M, 1996, EUR J IMMUNOL, V26, P721, DOI 10.1002/eji.1830260332; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Hao ZY, 2004, J EXP MED, V199, P1355, DOI 10.1084/jem.20032196; Hara H, 2002, J IMMUNOL, V168, P2288, DOI 10.4049/jimmunol.168.5.2288; Haraguchi M, 2000, J EXP MED, V191, P1709, DOI 10.1084/jem.191.10.1709; Heilig R, 2018, EUR J IMMUNOL, V48, P584, DOI 10.1002/eji.201747404; Henry CM, 2017, MOL CELL, V65, P715, DOI 10.1016/j.molcel.2017.01.022; Hernandez JB, 2010, CURR OPIN CELL BIOL, V22, P865, DOI 10.1016/j.ceb.2010.08.003; Horn S, 2017, CELL REP, V19, P785, DOI 10.1016/j.celrep.2017.04.010; HUANG L, 1994, INT IMMUNOL, V6, P533, DOI 10.1093/intimm/6.4.533; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Imamura R, 2004, J BIOL CHEM, V279, P46415, DOI 10.1074/jbc.M403226200; Izquierdo M, 1999, EMBO J, V18, P156, DOI 10.1093/emboj/18.1.156; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8515; Kang T.B., 2018, CELL DEATH DIFFERENT; Kang TB, 2013, IMMUNITY, V38, P27, DOI 10.1016/j.immuni.2012.09.015; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kishimoto H, 1998, J EXP MED, V187, P1427, DOI 10.1084/jem.187.9.1427; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; KLAS C, 1993, INT IMMUNOL, V5, P625, DOI 10.1093/intimm/5.6.625; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Kumari S, 2014, ELIFE, V3, DOI 10.7554/eLife.03422; Lamhamedi-Cherradi SE, 2003, NAT IMMUNOL, V4, P255, DOI 10.1038/ni894; Lee P, 2009, NATURE, V458, P519, DOI 10.1038/nature07687; Lockshin RA, 2001, NAT REV MOL CELL BIO, V2, P545, DOI 10.1038/35080097; Marsden VS, 2002, NATURE, V419, P634, DOI 10.1038/nature01101; Marsden VS, 2004, J CELL BIOL, V165, P775, DOI 10.1083/jcb.200312030; Martina MN, 2015, IMMUNOL CELL BIOL, V93, P305, DOI 10.1038/icb.2014.99; Matsuki Y, 2002, SCAND J IMMUNOL, V56, P174, DOI 10.1046/j.1365-3083.2002.01120.x; Mocarski ES, 2015, VIROLOGY, V479, P160, DOI 10.1016/j.virol.2015.03.016; Mohamood AS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003465; Moriwaki K, 2016, CELL MOL LIFE SCI, V73, P2325, DOI 10.1007/s00018-016-2203-4; NAGATA S, 1995, IMMUNOL TODAY, V16, P39, DOI 10.1016/0167-5699(95)80069-7; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; OHTEKI T, 1990, J EXP MED, V172, P7, DOI 10.1084/jem.172.1.7; OWENSCHAUB LB, 1992, CELL IMMUNOL, V140, P197, DOI 10.1016/0008-8749(92)90187-T; Pearson JS, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12750; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; Renno T, 1996, J EXP MED, V183, P431, DOI 10.1084/jem.183.2.431; Rickard JA, 2014, ELIFE, V3, DOI 10.7554/eLife.03464; RIEUXLAUCAT F, 1995, SCIENCE, V268, P1347, DOI 10.1126/science.7539157; Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; SHLOMCHIK MJ, 1994, J EXP MED, V180, P1295, DOI 10.1084/jem.180.4.1295; SHOKAT KM, 1995, NATURE, V375, P334, DOI 10.1038/375334a0; SIDMAN CL, 1992, EUR J IMMUNOL, V22, P499, DOI 10.1002/eji.1830220231; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Smith KGC, 1996, EMBO J, V15, P5167, DOI 10.1002/j.1460-2075.1996.tb00901.x; STEINBERG AD, 1980, J IMMUNOL, V125, P871; Stranges PB, 2007, IMMUNITY, V26, P629, DOI 10.1016/j.immuni.2007.03.016; Strasser A, 1995, EMBO J, V14, P6136, DOI 10.1002/j.1460-2075.1995.tb00304.x; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Sytwu HK, 1996, IMMUNITY, V5, P17, DOI 10.1016/S1074-7613(00)80306-4; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Wallach D, 2008, CELL DEATH DIFFER, V15, P1533, DOI 10.1038/cdd.2008.41; Wallach D, 2014, NAT REV IMMUNOL, V14, P51, DOI 10.1038/nri3561; Wallach D, 2011, TRENDS IMMUNOL, V32, P505, DOI 10.1016/j.it.2011.07.004; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; WATANABEFUKUNAGA R, 1992, J IMMUNOL, V148, P1274; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; Weant AE, 2008, IMMUNITY, V28, P218, DOI 10.1016/j.immuni.2007.12.014; Weber K, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-017-0007-1; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; WU JG, 1994, P NATL ACAD SCI USA, V91, P2344, DOI 10.1073/pnas.91.6.2344; Yamagiwa S, 1998, J IMMUNOL, V160, P2665; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; YANG YL, 1995, J EXP MED, V181, P1673, DOI 10.1084/jem.181.5.1673; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Yoon S, 2016, CELL DEATH DIFFER, V23, P253, DOI 10.1038/cdd.2015.92; Yoon S, 2017, IMMUNITY, V47, P51, DOI 10.1016/j.immuni.2017.06.001; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zargarian S, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2002711; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zhang XX, 2016, CELL REP, V16, P3247, DOI 10.1016/j.celrep.2016.06.103; Zhou T, 1996, J IMMUNOL, V156, P2661; Zhu KZ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0524-y	124	17	19	2	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2018	49	1					19	32		10.1016/j.immuni.2018.06.019	http://dx.doi.org/10.1016/j.immuni.2018.06.019			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN3YN	30021143	Bronze			2022-12-18	WOS:000438949100008
J	Elinav, E; Henao-Mejia, J; Strowig, T; Flavell, R				Elinav, Eran; Henao-Mejia, Jorge; Strowig, Till; Flavell, Richard			NLRP6 and Dysbiosis: Avoiding the Luring Attraction of Over-Simplification	IMMUNITY			English	Letter							GUT MICROBIOTA COMPOSITION; SHAPE; MICE		[Elinav, Eran] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Henao-Mejia, Jorge] Univ Penn, Philadelphia, PA 19104 USA; [Strowig, Till] Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany; [Flavell, Richard] Yale Univ, New Haven, CT 06520 USA	Weizmann Institute of Science; University of Pennsylvania; Helmholtz Association; Helmholtz-Center for Infection Research; Yale University	Elinav, E (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.; Henao-Mejia, J (corresponding author), Univ Penn, Philadelphia, PA 19104 USA.; Strowig, T (corresponding author), Helmholtz Ctr Infect Res, D-38124 Braunschweig, Germany.; Flavell, R (corresponding author), Yale Univ, New Haven, CT 06520 USA.	eran.elinav@weizmann.ac.il; jhena@pennmedicine.upenn.edu; till.strowig@helmholtz-hzi.de; richard.flavell@yale.edu	Elinav, Eran/ABE-8881-2020	Elinav, Eran/0000-0002-5775-2110; Strowig, Till/0000-0003-0185-1459				Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Galvez EJC, 2017, CELL REP, V21, P3914, DOI 10.1016/j.celrep.2017.12.027; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Lemire P, 2017, CELL REP, V21, P3653, DOI 10.1016/j.celrep.2017.12.026; Levy M, 2017, TRENDS IMMUNOL, V38, P248, DOI 10.1016/j.it.2017.01.001; Levy M, 2015, CELL, V163, P1428, DOI 10.1016/j.cell.2015.10.048; Mamantopoulos M, 2017, IMMUNITY, V47, P339, DOI 10.1016/j.immuni.2017.07.011; Radulovic K, 2018, MUCOSAL IMMUNOL, V11, P811, DOI 10.1038/mi.2017.87; Robertson SJ, 2013, GUT MICROBES, V4, P222, DOI 10.4161/gmic.24373; Seregin SS, 2017, CELL REP, V19, P733, DOI 10.1016/j.celrep.2017.03.080	10	17	17	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					603	604		10.1016/j.immuni.2018.04.002	http://dx.doi.org/10.1016/j.immuni.2018.04.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669238	Bronze			2022-12-18	WOS:000430198900002
J	Simoni, Y; Newell, EW				Simoni, Yannick; Newell, Evan W.			Toward Meaningful Definitions of Innate-Lymphoid-Cell Subsets	IMMUNITY			English	Letter							HETEROGENEITY		[Simoni, Yannick; Newell, Evan W.] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Simoni, Y; Newell, EW (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore.	yannick_simoni@immunol.a-star.edu.sg; evan_newell@immunol.a-star.edu.sg	Newell, Evan W/F-9711-2012	Newell, Evan W/0000-0002-2889-243X; SIMONI, Yannick/0000-0002-9086-3680				Bekiaris V, 2013, J IMMUNOL, V191, P4611, DOI 10.4049/jimmunol.1301672; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Burkhard S. H., 2014, J IMMUNOL, V9; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005	5	17	17	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					760	761		10.1016/j.immuni.2017.04.026	http://dx.doi.org/10.1016/j.immuni.2017.04.026			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514678	Bronze			2022-12-18	WOS:000401316300007
J	Krueger, J; Rudd, CE				Krueger, Janna; Rudd, Christopher E.			Two Strings in One Bow: PD-1 Negatively Regulates via Co-receptor CD28 on T Cells	IMMUNITY			English	Editorial Material							MOTIF; IMMUNOTHERAPY; CANCER	The identity of PD-1 dependency on other receptors and signaling has been unclear. In a recent issue of Science, Hui et al. (2017) and Kamphorst et al. (2017) now show that CD28 expression is a target of PD-1-associated phosphatases and is needed for T cell expansion in anti-PD-1 immunotherapy.	[Krueger, Janna; Rudd, Christopher E.] Hop Maison Neuve Rosemont, Res Ctr, Div Immunol Oncol, Montreal, PQ H1T 2M4, Canada; [Rudd, Christopher E.] Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Rudd, CE (corresponding author), Hop Maison Neuve Rosemont, Res Ctr, Div Immunol Oncol, Montreal, PQ H1T 2M4, Canada.; Rudd, CE (corresponding author), Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada.	cerudd@outlook.com	Rudd, Christopher E/GOH-2021-2022; Rudd, Christopher E/ABF-7259-2021	Rudd, Christopher E/0000-0001-5295-9019; 				Baumeister SH, 2016, ANNU REV IMMUNOL, V34, P539, DOI 10.1146/annurev-immunol-032414-112049; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Kamphorst AO, 2017, SCIENCE, V355, P1423, DOI 10.1126/science.aaf0683; Kong KF, 2011, NAT IMMUNOL, V12, P1105, DOI 10.1038/ni.2120; Okazaki T, 2013, NAT IMMUNOL, V14, P1212, DOI 10.1038/ni.2762; Rudd CE, 2003, NAT REV IMMUNOL, V3, P544, DOI 10.1038/nri1131; Rudd CE, 2008, NAT REV IMMUNOL, V8, P153, DOI 10.1038/nri2253; Sharma P, 2011, NAT REV CANCER, V11, P805, DOI 10.1038/nrc3153; Tai XG, 2007, P NATL ACAD SCI USA, V104, P13756, DOI 10.1073/pnas.0706509104; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036	11	17	20	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					529	531		10.1016/j.immuni.2017.04.003	http://dx.doi.org/10.1016/j.immuni.2017.04.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28423334	Bronze			2022-12-18	WOS:000399451100007
J	Gattinoni, L				Gattinoni, Luca			Memory T Cells Officially Join the Stem Cell Club	IMMUNITY			English	Editorial Material								In this issue of Immunity, Graef et al. (2014) demonstrate self-renewal and multipotency of a single CD62L(+) memory T cell across serial adoptive transfers and infection-driven re-expansions, providing evidence of true stemness within the T cell memory compartment.	NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gattinoni, L (corresponding author), NCI, Expt Transplantat & Immunol Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	gattinol@mail.nih.gov	Gattinoni, Luca/A-2281-2008	Gattinoni, Luca/0000-0003-2239-3282	NATIONAL CANCER INSTITUTE [ZIABC011480] Funding Source: NIH RePORTER; Intramural NIH HHS [ZIA BC011480-02] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Cartwright EK, 2014, J IMMUNOL, V192, P4666, DOI 10.4049/jimmunol.1303193; Fearon DT, 2001, SCIENCE, V293, P248, DOI 10.1126/science.1062589; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Lugli E, 2013, J CLIN INVEST, V123, P594, DOI 10.1172/JCI66327; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889	10	17	17	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 17	2014	41	1					7	9		10.1016/j.immuni.2014.07.003	http://dx.doi.org/10.1016/j.immuni.2014.07.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AO6FC	25035947	Green Accepted, Bronze			2022-12-18	WOS:000341444200004
J	Medzhitov, R				Medzhitov, Ruslan			Septic Shock: On the Importance of Being Tolerant	IMMUNITY			English	Editorial Material							ANTHRACYCLINES		[Medzhitov, Ruslan] Howard Hughes Med Inst, New Haven, CT 06510 USA; [Medzhitov, Ruslan] Yale Univ, Sch Med, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University	Medzhitov, R (corresponding author), Howard Hughes Med Inst, New Haven, CT 06510 USA.	ruslan.medzhitov@yale.edu						Ayres JS, 2012, ANNU REV IMMUNOL, V30, P271, DOI 10.1146/annurev-immunol-020711-075030; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Figueiredo N, 2013, IMMUNITY, V39, P874, DOI 10.1016/j.immuni.2013.08.039; Iskander KN, 2013, PHYSIOL REV, V93, P1247, DOI 10.1152/physrev.00037.2012; Kaiser J, 2003, SCIENCE, V302, P376, DOI 10.1126/science.302.5644.376; Larsen R, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001118; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402	9	17	17	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 14	2013	39	5					799	800		10.1016/j.immuni.2013.10.012	http://dx.doi.org/10.1016/j.immuni.2013.10.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UV	24238335	Bronze			2022-12-18	WOS:000330950600002
J	Restifo, NP				Restifo, Nicholas P.			A "Big Data" View of the Tumor "Immunome"	IMMUNITY			English	Editorial Material							ADOPTIVE IMMUNOTHERAPY; T-CELLS; CANCER	Tumors are complex masses containing not just neoplastic cells but also stromal cells, neovasculature, and a gamut of immune cells. In this issue, Bindea et al. (2013) identify a surprising new "immune landscape" associated with prolonged disease-free survival.	[Restifo, Nicholas P.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Restifo, Nicholas P.] NIH, Ctr Regenerat Med, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA	Restifo, NP (corresponding author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	restifo@nih.gov	Restifo, Nicholas Phillip/Z-1614-2019; Restifo, Nicholas Phillip/M-6549-2019	Restifo, Nicholas P./0000-0003-4229-4580	Intramural NIH HHS [ZIA BC010763-07] Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Fridman WH, 2012, NAT REV CANCER, V12, P298, DOI 10.1038/nrc3245; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Hinrichs CS, 2008, BLOOD, V111, P5326, DOI 10.1182/blood-2007-09-113050; Khong HT, 2002, NAT IMMUNOL, V3, P999, DOI 10.1038/ni1102-999; Mlecnik B, 2011, J CLIN ONCOL, V29, P610, DOI 10.1200/JCO.2010.30.5425; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Restifo NP, 2012, NAT REV IMMUNOL, V12, P269, DOI 10.1038/nri3191; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; van Elsas A, 2001, J EXP MED, V194, P481, DOI 10.1084/jem.194.4.481	10	17	17	1	25	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					631	632		10.1016/j.immuni.2013.10.002	http://dx.doi.org/10.1016/j.immuni.2013.10.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24138879	Green Accepted, Bronze			2022-12-18	WOS:000330950000005
J	Yona, S; Kim, KW; Wolf, Y; Mildner, A; Varol, D; Breker, M; Strauss-Ayali, D; Viukov, S; Guilliams, M; Misharin, A; Hume, DA; Perlman, H; Malissen, B; Zelzer, E; Jung, S				Yona, Simon; Kim, Ki-Wook; Wolf, Yochai; Mildner, Alexander; Varol, Diana; Breker, Michal; Strauss-Ayali, Dalit; Viukov, Sergey; Guilliams, Martin; Misharin, Alexander; Hume, David A.; Perlman, Harris; Malissen, Bernard; Zelzer, Elazar; Jung, Steffen			Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis (vol 38, pg 79, 2013)	IMMUNITY			English	Correction												s.jung@weizmann.ac.il	Misharin, Alexander/AAD-6456-2019; Breker-Dekel, Michal/ABS-5753-2022; Jung, Steffen/K-1409-2012; Yona, Simon/ABE-6572-2020; Mildner, Alexander/ABG-6122-2020; mildner, alexander/GQA-3761-2022; Malissen, Bernard/AAK-4659-2020	Jung, Steffen/0000-0003-4290-5716; mildner, alexander/0000-0002-2019-8427; Hume, David/0000-0002-2615-1478; Malissen, Bernard/0000-0003-1340-9342; Yona, Simon/0000-0002-3984-2008				Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001	1	17	17	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 23	2013	38	5					1073	1079		10.1016/j.immuni.2013.05.008	http://dx.doi.org/10.1016/j.immuni.2013.05.008			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RT		Bronze, Green Accepted			2022-12-18	WOS:000330942500023
J	Hedrick, SM				Hedrick, Stephen M.			Thymus lineage commitment: A single switch	IMMUNITY			English	Editorial Material							T-CELL DEVELOPMENT; POSITIVE SELECTION; CD4; TRANSCRIPTION; DIFFERENTIATION; REPRESSION; POK		Univ Calif San Diego, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hedrick, SM (corresponding author), Univ Calif San Diego, La Jolla, CA 92093 USA.	shedrick@ucsd.edu	Hedrick, Stephen M/E-9171-2010	Hedrick, Stephen/0000-0002-6345-8751				Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Hedrick SM, 2002, IMMUNITY, V16, P619, DOI 10.1016/S1074-7613(02)00316-3; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; Sarafova SD, 2005, IMMUNITY, V23, P75, DOI 10.1016/j.immuni.2005.05.011; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007	10	17	17	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR	2008	28	3					297	299		10.1016/j.immuni.2008.02.011	http://dx.doi.org/10.1016/j.immuni.2008.02.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18342002	Bronze			2022-12-18	WOS:000254142500005
J	Villadangos, JA				Villadangos, Jose A.			Hold on, the monocytes are coming!	IMMUNITY			English	Editorial Material							NODE DENDRITIC CELLS; LYMPH-NODE; IN-VIVO; DIFFERENTIATION; MACROPHAGES	The role that monocyte-derived dendritic cells play in vivo remains enigmatic. Leon et al. (2007) now show that these cells develop "on demand" at a site of Leishmania infection to promote a life-saving T helper 1 immune response.	Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3050, Australia	Walter & Eliza Hall Institute	Villadangos, JA (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, 1G Royal Parade Parkville, Melbourne, Vic 3050, Australia.	villadangos@wehi.edu.au	Villadangos, Jose A/AAU-1404-2020	Villadangos, Jose A/0000-0001-6771-8891				Granelli-Piperno A, 2005, J IMMUNOL, V175, P4265, DOI 10.4049/jimmunol.175.7.4265; Krutzik SR, 2005, NAT MED, V11, P653, DOI 10.1038/nm1246; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; Randolph GJ, 1999, IMMUNITY, V11, P753, DOI 10.1016/S1074-7613(00)80149-1; Robben PM, 2005, J EXP MED, V201, P1761, DOI 10.1084/jem.20050054; Rotta G, 2003, J EXP MED, V198, P1253, DOI 10.1084/jem.20030335; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Tacke F, 2006, IMMUNOBIOLOGY, V211, P609, DOI 10.1016/j.imbio.2006.05.025; Villadangos JA, 2005, SEMIN IMMUNOL, V17, P262, DOI 10.1016/j.smim.2005.05.015; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3	10	17	19	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2007	26	4					390	392		10.1016/j.immuni.2007.04.006	http://dx.doi.org/10.1016/j.immuni.2007.04.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	162YW	17459807	Bronze			2022-12-18	WOS:000246126400004
J	Singh, NJ; Schwartz, RH				Singh, Nevil J.; Schwartz, Ronald H.			The lymphopenic mouse in immunology: From patron to pariah	IMMUNITY			English	Editorial Material							T-CELL SURVIVAL; HOMEOSTATIC PROLIFERATION; CUTTING EDGE; IN-VIVO; NAIVE; LYMPHOCYTES; INDUCTION; TOLERANCE; EXPANSION; LIGANDS	A recent surge of interest in the behavior of T and B cells in lymphopenic model systems has resurrected a certain cynicism about the validity of using such models to answer important immunological questions. Here we discuss this skepticism in a broader historical context.	NIAID, Lab Cellular & Mol Immunol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Schwartz, RH (corresponding author), NIAID, Lab Cellular & Mol Immunol, NIH, 4-111 Ctr Dr,MSC-0420, Bethesda, MD 20892 USA.	rs34r@nih.gov		Singh, Nevil/0000-0002-8384-9290	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000485, Z01AI000485] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		BELL EB, 1987, J IMMUNOL, V139, P1379; Bruno L, 1996, EUR J IMMUNOL, V26, P3179, DOI 10.1002/eji.1830261251; Cho BK, 2000, J EXP MED, V192, P549, DOI 10.1084/jem.192.4.549; CLAMAN HN, 1966, P SOC EXP BIOL MED, V122, P1167; Clarke SRM, 2000, J IMMUNOL, V165, P2458, DOI 10.4049/jimmunol.165.5.2458; DEUTSCH L, 1899, ANN I PASTEUR, V13, P689; Dorfman JR, 2000, NAT IMMUNOL, V1, P329, DOI 10.1038/79783; Ernst B, 1999, IMMUNITY, V11, P173, DOI 10.1016/S1074-7613(00)80092-8; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Goldrath AW, 1999, IMMUNITY, V11, P183, DOI 10.1016/S1074-7613(00)80093-X; Goldrath AW, 2004, P NATL ACAD SCI USA, V101, P16885, DOI 10.1073/pnas.0407417101; Grandjean I, 2003, J EXP MED, V198, P1089, DOI 10.1084/jem.20030963; HARRIS TN, 1954, J EXP MED, V100, P289, DOI 10.1084/jem.100.3.289; Hataye J, 2006, SCIENCE, V312, P114, DOI 10.1126/science.1124228; HERZENBERG LA, 1983, ANNU REV IMMUNOL, V1, P609, DOI 10.1146/annurev.iy.01.040183.003141; Jelley-Gibbs DM, 2000, J IMMUNOL, V165, P5017, DOI 10.4049/jimmunol.165.9.5017; Judge AD, 2002, J EXP MED, V196, P935, DOI 10.1084/jem.20020772; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Le Campion A, 2002, P NATL ACAD SCI USA, V99, P4538, DOI 10.1073/pnas.062621699; McHugh RS, 2002, J IMMUNOL, V168, P5979, DOI 10.4049/jimmunol.168.12.5979; Min BK, 2003, IMMUNITY, V18, P131, DOI 10.1016/S1074-7613(02)00508-3; MITCHISON N A, 1971, European Journal of Immunology, V1, P18, DOI 10.1002/eji.1830010104; MITCHISON NA, 1957, J CELL COMPAR PHYSL, V50, P247, DOI 10.1002/jcp.1030500416; MITCHISON NA, 1955, J EXP MED, V102, P157, DOI 10.1084/jem.102.2.157; Patke A, 2004, CURR OPIN IMMUNOL, V16, P251, DOI 10.1016/j.coi.2004.01.007; SAKAGUCHI N, 1994, J IMMUNOL, V152, P2586; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Singh NJ, 2006, PLOS BIOL, V4, P1957, DOI 10.1371/journal.pbio.0040340; Sojka DK, 2004, J IMMUNOL, V172, P6136, DOI 10.4049/jimmunol.172.10.6136; Surh CD, 2005, SEMIN IMMUNOL, V17, P183, DOI 10.1016/j.smim.2005.02.007; Tanchot C, 2001, J IMMUNOL, V167, P2030, DOI 10.4049/jimmunol.167.4.2030; Wu ZH, 2004, NAT MED, V10, P87, DOI 10.1038/nm965	33	17	18	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2006	25	6					851	855		10.1016/j.immuni.2006.12.002	http://dx.doi.org/10.1016/j.immuni.2006.12.002			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17174925	Bronze			2022-12-18	WOS:000243087500001
J	Gamero, AM; Oppenheim, JJ				Gamero, AM; Oppenheim, JJ			IL-1 can act as number one	IMMUNITY			English	Editorial Material							STAPHYLOCOCCUS-AUREUS; INTERLEUKIN-1; EXPRESSION		NCI, FCRF, Expt Immunol Lab, Ft Detrick, MD 21702 USA; NCI, FCRF, Mol Immunoregulat Lab, Canc Res Ctr, Ft Detrick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gamero, AM (corresponding author), NCI, FCRF, Expt Immunol Lab, Ft Detrick, MD 21702 USA.							Armstrong DA, 2004, J LEUKOCYTE BIOL, V75, P641, DOI 10.1189/jlb.0803370; Horng T, 2002, NATURE, V420, P329, DOI 10.1038/nature01180; Kopydlowski KM, 1999, J IMMUNOL, V163, P1537; Medvedev AE, 2005, J IMMUNOL, V174, P6587, DOI 10.4049/jimmunol.174.11.6587; Miller LS, 2006, IMMUNITY, V24, P79, DOI 10.1016/j.immuni.2005.11.011; Nakata S, 2003, INT CONGR SER, V1257, P95, DOI 10.1016/S0531-5131(03)01167-1; Nicklin M. J. H., 2003, CYTOKINE KNOCKOUTS, P111; OPPENHEIM JJ, 1993, IMMUNOL TODAY, V14, P232, DOI 10.1016/0167-5699(93)90169-L; OPPENHEIM JJ, 1982, IMMUNOL TODAY, V3, P113, DOI 10.1016/S0167-5699(82)80027-3; Su SB, 2005, J IMMUNOL, V175, P6303, DOI 10.4049/jimmunol.175.10.6303; Verdrengh M, 2004, MICROBES INFECT, V6, P1268, DOI 10.1016/j.micinf.2004.08.009	11	17	19	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN	2006	24	1					16	17		10.1016/j.immuni.2005.12.007	http://dx.doi.org/10.1016/j.immuni.2005.12.007			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005UT	16413919	Bronze			2022-12-18	WOS:000234850200006
J	Underhill, DM				Underhill, DM			Phagosome maturation: Steady as she goes	IMMUNITY			English	Editorial Material							MACROPHAGES; PHAGOCYTOSIS; RECEPTOR	Toll-like receptors (TLRs) trigger inflammatory signaling in macrophages and enrich on phagosomes, suggesting that TLRs may directly influence phagosome formation and maturation. However, in this issue of Immunity, Yates and Russell use carefully defined particles and quantitative methodology to measure phagosome maturation and find no effect of TLR Signaling on the process.	Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center	Underhill, DM (corresponding author), Cedars Sinai Med Ctr, Immunobiol Res Inst, Los Angeles, CA 90048 USA.		UNDERHILL, DAVID/ABE-2185-2021	Underhill, David/0000-0002-2989-658X				Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Brumell JH, 2004, CURR OPIN MICROBIOL, V7, P78, DOI 10.1016/j.mib.2003.12.005; Griffiths G, 2004, TRENDS CELL BIOL, V14, P343, DOI 10.1016/j.tcb.2004.05.010; Henry RM, 2004, J CELL BIOL, V164, P185, DOI 10.1083/jcb.200307080; Shi SAP, 2003, J EXP MED, V198, P987, DOI 10.1084/jem.20030603; Shiratsuchi A, 2004, J IMMUNOL, V172, P2039, DOI 10.4049/jimmunol.172.4.2039; Stuart LM, 2005, IMMUNITY, V22, P539, DOI 10.1016/j.immuni.2005.05.002; Underhill DM, 2004, MICROBES INFECT, V6, P1368, DOI 10.1016/j.micinf.2004.08.016; Yates RM, 2005, IMMUNITY, V23, P409, DOI 10.1016/j.immuni.2005.09.007	10	17	17	0	6	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2005	23	4					343	344		10.1016/j.immuni.2005.09.011	http://dx.doi.org/10.1016/j.immuni.2005.09.011			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	980EC	16226498	Bronze			2022-12-18	WOS:000232995800001
J	Schwartzberg, PL				Schwartzberg, PL			Amplifying Btk's signal	IMMUNITY			English	Editorial Material							BRUTONS TYROSINE KINASE; CELL ANTIGEN RECEPTOR; TEC FAMILY KINASES; ACTIVATION		NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Schwartzberg, PL (corresponding author), NHGRI, NIH, Bethesda, MD 20892 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000123, Z01HG000123] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Bourne HR, 2002, NATURE, V419, P21, DOI 10.1038/419021a; Fluckiger AC, 1998, EMBO J, V17, P1973, DOI 10.1093/emboj/17.7.1973; Gilbert C, 2003, J IMMUNOL, V170, P5235, DOI 10.4049/jimmunol.170.10.5235; Grasis JA, 2003, J IMMUNOL, V170, P3971, DOI 10.4049/jimmunol.170.8.3971; Honda A, 1999, CELL, V99, P521, DOI 10.1016/S0092-8674(00)81540-8; Labno CM, 2003, CURR BIOL, V13, P1619, DOI 10.1016/j.cub.2003.08.005; Nore BF, 2000, EUR J IMMUNOL, V30, P145, DOI 10.1002/1521-4141(200001)30:1<145::AID-IMMU145>3.0.CO;2-0; Saito K, 2003, IMMUNITY, V19, P669, DOI 10.1016/S1074-7613(03)00297-8; Schaeffer EM, 2000, CURR OPIN IMMUNOL, V12, P282, DOI 10.1016/S0952-7915(00)00088-1; Scharenberg AM, 1998, EMBO J, V17, P1961, DOI 10.1093/emboj/17.7.1961; Takata M, 1996, J EXP MED, V184, P31, DOI 10.1084/jem.184.1.31; Takenawa T, 2001, BBA-MOL CELL BIOL L, V1533, P190, DOI 10.1016/S1388-1981(01)00165-2; Tomlinson M G, 2001, BMC Immunol, V2, P4, DOI 10.1186/1471-2172-2-4	13	17	17	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	NOV	2003	19	5					634	636		10.1016/S1074-7613(03)00304-2	http://dx.doi.org/10.1016/S1074-7613(03)00304-2			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	745CY	14614849	Bronze			2022-12-18	WOS:000186672200002
J	Posnett, DN; Yarilina, AA				Posnett, DN; Yarilina, AA			Sleeping with the enemy - Endogenous superantigens in humans	IMMUNITY			English	Article							MAMMARY-TUMOR VIRUS; T-CELLS; DIABETES-MELLITUS; RETROVIRUS; EXPRESSION; INFECTION; REPERTOIRE; GENE; PATHOGENESIS; STIMULATION	We usually think of superantigens (SAg) as dangerous toxins that may cause toxic shock syndrome and death (Marrack and Kappier, 1990). Now, based on two papers in this issue of Immunity, it seems that we all have SAg genes within us, lying dormant and waiting to be activated under special circumstances (Sutkowski et al., 2001; Stauffer et al., 2001).	Cornell Univ, Weill Med Coll, Dept Med, New York, NY 10021 USA	Cornell University	Posnett, DN (corresponding author), Cornell Univ, Weill Med Coll, Dept Med, 1300 York Ave, New York, NY 10021 USA.			Yarilina, Anna/0000-0002-7925-856X				ACHAORBEA H, 1995, ANNU REV IMMUNOL, V13, P459, DOI 10.1146/annurev.iy.13.040195.002331; Belardelli F, 1996, IMMUNOL TODAY, V17, P369, DOI 10.1016/0167-5699(96)10027-X; COFFIN JM, 1995, FIELDS VIROLOGY, P1825; Conrad B, 1997, CELL, V90, P303, DOI 10.1016/S0092-8674(00)80338-4; de Parseval N, 1998, J VIROL, V72, P3442, DOI 10.1128/JVI.72.4.3442-3445.1998; DOBRESCU D, 1995, P NATL ACAD SCI USA, V92, P5563, DOI 10.1073/pnas.92.12.5563; DOBRESCU D, 1995, CELL, V82, P753, DOI 10.1016/0092-8674(95)90472-7; DOHERTY PJ, 1991, MOL IMMUNOL, V28, P607, DOI 10.1016/0161-5890(91)90129-8; FRIEDMAN SM, 1991, ARTHRITIS RHEUM-US, V34, P468, DOI 10.1002/art.1780340412; Garderet L, 1998, BLOOD, V91, P340, DOI 10.1182/blood.V91.1.340.340_340_346; GOLOVKINA TV, 1995, P NATL ACAD SCI USA, V92, P4828, DOI 10.1073/pnas.92.11.4828; GOLOVKINA TV, 1992, CELL, V69, P637, DOI 10.1016/0092-8674(92)90227-4; Hasuike S, 1999, J HUM GENET, V44, P343, DOI 10.1007/s100380050173; HELD W, 1993, CELL, V74, P529, DOI 10.1016/0092-8674(93)80054-I; HELD W, 1994, J EXP MED, V180, P2347, DOI 10.1084/jem.180.6.2347; KAWAMURA T, 1993, J IMMUNOL, V151, P4362; Lan MS, 1998, CELL, V95, P14, DOI 10.1016/S0092-8674(00)81777-8; Lapatschek M, 2000, J VIROL, V74, P6386, DOI 10.1128/JVI.74.14.6386-6393.2000; Larsson E, 1996, INT J CANCER, V67, P451, DOI 10.1002/(SICI)1097-0215(19960729)67:3<451::AID-IJC23>3.0.CO;2-9; Liao L, 1996, J EXP MED, V184, P1471, DOI 10.1084/jem.184.4.1471; Lower R, 1996, P NATL ACAD SCI USA, V93, P5177, DOI 10.1073/pnas.93.11.5177; Lower R, 1998, CELL, V95, P11, DOI 10.1016/S0092-8674(00)81776-6; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Murphy VJ, 1998, CELL, V95, P9, DOI 10.1016/S0092-8674(00)81775-4; Schelonka RL, 1998, PEDIATR RES, V43, P396, DOI 10.1203/00006450-199803000-00015; Schiffenbauer J, 1998, IMMUNOL TODAY, V19, P117, DOI 10.1016/S0167-5699(97)01199-7; Stauffer Y, 2001, IMMUNITY, V15, P591, DOI 10.1016/S1074-7613(01)00212-6; Sugimoto J, 2001, GENOMICS, V72, P137, DOI 10.1006/geno.2001.6473; Sutkowski N, 2001, IMMUNITY, V15, P579, DOI 10.1016/S1074-7613(01)00210-2; Sutkowski N, 1996, J EXP MED, V184, P971, DOI 10.1084/jem.184.3.971; TSIAGBE VK, 1993, EMBO J, V12, P2313, DOI 10.1002/j.1460-2075.1993.tb05885.x	32	17	17	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2001	15	4					503	506		10.1016/S1074-7613(01)00211-4	http://dx.doi.org/10.1016/S1074-7613(01)00211-4			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485MH	11672533	Bronze			2022-12-18	WOS:000171757800002
J	KURUCZ, I; BRINKMANN, U; LEE, B; SEGAL, DM; REITER, Y; JUNG, SH; PASTAN, I				KURUCZ, I; BRINKMANN, U; LEE, B; SEGAL, DM; REITER, Y; JUNG, SH; PASTAN, I			CONSTRUCTION OF A FUNCTIONAL DISULFIDE-STABILIZED TCR FV INDICATES THAT ANTIBODY AND TCR FV FRAMEWORKS ARE VERY SIMILAR IN STRUCTURE	IMMUNITY			English	Article							T-CELL RECEPTOR; ANTIGEN RECEPTOR; ESCHERICHIA-COLI; FUSION PROTEINS; HETERODIMERS; RECOGNITION; EXPRESSION; SECRETION; FRAGMENTS; CHAINS	Disulfide-stabilized Fvs (dsFv) are recombinant Fv fragments of antibodies in which the inherently unstable V-H-V-L heterodimer is stabilized by an interchain disulfide bond engineered between structurally conserved framework positions. We now design and produce a disulfide-stabilized Fv of a T cell receptor. It is composed of V alpha and V beta variable domains of the 2B4 TCR stabilized by a disulfide bond between framework residues of the TCR Fv at a site corresponding to that used for disulfide stabilization of antibody Fvs. For ease of production and detection, the TCRdsFv was fused to a truncated form of Pseudomonas exotoxin (PE38). The TCR(dsFv) retains its native conformation and is much more stable than a TcR scFv. Moreover, it is functional in biological assays. Because successful disulfide stabilization of the TCR Fv by the positions used for antibody Fv stabilization would not occur unless the mutated residues in TCR Fv are at positions closely similar to those in antibody Fvs, most likely within less than 1.5 Angstrom, these results provide very strong experimental evidence for the structural similarity between immunoglobulin and TCR antigen-binding variable domains.	NCI, DIV CANC BIOL DIAG & CTR, EXPTL IMMUNOL BRANCH, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	KURUCZ, I (corresponding author), NCI, DIV CANC BIOL DIAG & CTR, MOLEC BIOL LAB, BETHESDA, MD 20892 USA.		Brinkmann, Ulrich/AAF-8216-2019; Lee, Byungkook/E-4564-2011; pastan, ira/P-9319-2019	Brinkmann, Ulrich/0000-0002-5558-0212; Lee, Byungkook/0000-0002-3339-4582; pastan, ira/0000-0002-9223-0270				BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; BRINKMANN U, 1993, P NATL ACAD SCI USA, V90, P7538, DOI 10.1073/pnas.90.16.7538; BUCHNER J, 1992, ANAL BIOCHEM, V205, P263, DOI 10.1016/0003-2697(92)90433-8; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; CLAVERIE JM, 1989, IMMUNOL TODAY, V10, P10, DOI 10.1016/0167-5699(89)90058-3; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; ENGEL I, 1992, SCIENCE, V256, P1318, DOI 10.1126/science.1598575; GASCOIGNE NRJ, 1990, J BIOL CHEM, V265, P9296; GLOCKSHUBER R, 1990, BIOCHEMISTRY-US, V29, P1362, DOI 10.1021/bi00458a002; GREGOIRE C, 1991, P NATL ACAD SCI USA, V88, P8077, DOI 10.1073/pnas.88.18.8077; HEDRICK SM, 1984, NATURE, V308, P153, DOI 10.1038/308153a0; HOO WFS, 1992, P NATL ACAD SCI USA, V89, P4759, DOI 10.1073/pnas.89.10.4759; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; HUSTON JS, 1991, METHOD ENZYMOL, V203, P46; JORES R, 1990, P NATL ACAD SCI USA, V87, P9138, DOI 10.1073/pnas.87.23.9138; JUNG SH, 1994, PROTEINS, V19, P35, DOI 10.1002/prot.340190106; Kabat E.A., 1991, SEQUENCES IMMUNOLOGI; KATZ BA, 1986, J BIOL CHEM, V261, P5480; KRONENBERG M, 1986, ANNU REV IMMUNOL, V4, P529, DOI 10.1146/annurev.iy.04.040186.002525; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; KURUCZ I, 1993, P NATL ACAD SCI USA, V90, p3P830; LIN AY, 1990, SCIENCE, V249, P677, DOI 10.1126/science.1696397; NOVOTNY J, 1991, P NATL ACAD SCI USA, V88, P8646, DOI 10.1073/pnas.88.19.8646; NOVOTNY J, 1986, P NATL ACAD SCI USA, V83, P742, DOI 10.1073/pnas.83.3.742; OZATO K, 1980, J IMMUNOL, V124, P533; REITER Y, 1994, PROTEIN ENG, V7, P697, DOI 10.1093/protein/7.5.697; REITER Y, 1994, CANCER RES, V54, P2714; REITER Y, 1994, BIOCHEMISTRY-US, V33, P5451, DOI 10.1021/bi00184a014; WARD ES, 1992, J MOL BIOL, V224, P885, DOI 10.1016/0022-2836(92)90455-S; WEBER S, 1992, NATURE, V356, P793, DOI 10.1038/356793a0	31	17	46	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR	1995	2	3					281	287		10.1016/1074-7613(95)90052-7	http://dx.doi.org/10.1016/1074-7613(95)90052-7			7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QP276	7697545	Bronze			2022-12-18	WOS:A1995QP27600007
J	Vijayakumar, B; Boustani, K; Ogger, PP; Papadaki, A; Tonkin, J; Orton, CM; Ghai, P; Suveizdyte, K; Hewitt, RJ; Desai, SR; Devaraj, A; Snelgrove, RJ; Molyneaux, PL; Garner, JL; Peters, JE; Shah, PL; Lloyd, CM; Harker, JA				Vijayakumar, Bavithra; Boustani, Karim; Ogger, Patricia P.; Papadaki, Artemis; Tonkin, James; Orton, Christopher M.; Ghai, Poonam; Suveizdyte, Kornelija; Hewitt, Richard J.; Desai, Sujal R.; Devaraj, Anand; Snelgrove, Robert J.; Molyneaux, Philip L.; Garner, Justin L.; Peters, James E.; Shah, Pallav L.; Lloyd, Clare M.; Harker, James A.			Graphical abstract	IMMUNITY			English	Article							T-CELLS; MEMORY; INFECTION; RESPONSES; IMMUNITY	Some patients hospitalized with acute COVID-19 suffer respiratory symptoms that persist for many months. We delineated the immune-proteomic landscape in the airways and peripheral blood of healthy controls and post-COVID-19 patients 3 to 6 months after hospital discharge. Post-COVID-19 patients showed abnormal airway (but not plasma) proteomes, with an elevated concentration of proteins associated with apoptosis, tissue repair, and epithelial injury versus healthy individuals. Increased numbers of cytotoxic lymphocytes were observed in individuals with greater airway dysfunction, while increased B cell numbers and altered monocyte subsets were associated with more widespread lung abnormalities. A one-year follow-up of some post-COVID-19 patients indicated that these abnormalities resolved over time. In summary, COVID-19 causes a prolonged change to the airway immune landscape in those with persistent lung disease, with evidence of cell death and tissue repair linked to the ongoing activation of cytotoxic T cells.	[Vijayakumar, Bavithra; Boustani, Karim; Ogger, Patricia P.; Tonkin, James; Orton, Christopher M.; Ghai, Poonam; Suveizdyte, Kornelija; Hewitt, Richard J.; Desai, Sujal R.; Devaraj, Anand; Snelgrove, Robert J.; Molyneaux, Philip L.; Shah, Pallav L.; Lloyd, Clare M.; Harker, James A.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Vijayakumar, Bavithra; Garner, Justin L.; Shah, Pallav L.] Chelsea & Westminster Hosp, London, England; [Vijayakumar, Bavithra; Tonkin, James; Orton, Christopher M.; Hewitt, Richard J.; Desai, Sujal R.; Devaraj, Anand; Molyneaux, Philip L.; Garner, Justin L.; Shah, Pallav L.] Guys & St Thomas NHS Fdn Trust, Royal Brompton & Harefield Hosp, London, England; [Boustani, Karim; Snelgrove, Robert J.; Lloyd, Clare M.; Harker, James A.] Asthma UK Ctr Allerg Mech Asthma, London, England; [Papadaki, Artemis; Peters, James E.] Imperial Coll London, Ctr Inflammatory Dis, Dept Immunol & Inflammat, London, England; [Desai, Sujal R.] Margaret Turner Warwick Ctr Fibrosing Lung Dis, London, England	Imperial College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; Royal Brompton Hospital; University of London; King's College London; Imperial College London	Harker, JA (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, London, England.; Harker, JA (corresponding author), Asthma UK Ctr Allerg Mech Asthma, London, England.	j.harker@imperial.ac.uk	Papadaki, Artemis/GPX-1948-2022	Papadaki, Artemis/0000-0002-2295-3713; Boustani, Karim/0000-0001-9344-5890; Lloyd, Clare/0000-0001-8977-6726; Shah, Pallav/0000-0002-9052-4638; Ogger, Patricia/0000-0002-2698-3565	Wellcome Trust [107059/Z/15/Z, 209458/Z/17/Z]; Rosetrees Seed Fund [A2172]; Imperial College Healthcare NHS Trust BRC award [RDF04]; Joint Research Committee on behalf of CW+; Westminster Medical School Research Trust; Asthma UK PhD Studentship as part of the Asthma UK centre in allergic mechanisms of asthma [AUK-BC2015-01]; UKRI COVID-19 Rapid Response Rolling Call [MR/V027638/1]; Imperial College London Community Jameel; Imperial President's Excellence Fund; UKRI Innovation Fellowship at Health Data Research UK [MR/S004068/2]	Wellcome Trust(Wellcome TrustEuropean Commission); Rosetrees Seed Fund; Imperial College Healthcare NHS Trust BRC award; Joint Research Committee on behalf of CW+; Westminster Medical School Research Trust; Asthma UK PhD Studentship as part of the Asthma UK centre in allergic mechanisms of asthma; UKRI COVID-19 Rapid Response Rolling Call; Imperial College London Community Jameel; Imperial President's Excellence Fund; UKRI Innovation Fellowship at Health Data Research UK(UK Research & Innovation (UKRI))	This work was supported by a Wellcome Trust Senior fellowship 107059/Z/15/Z to C.M.L. J.A.H. is supported by a Rosetrees Seed Fund (A2172) and an Imperial College Healthcare NHS Trust BRC award (RDF04). P.L.M. is an action for pulmonary fibrosis mike Bray Fellowship. B.V. is funded by the Joint Research Committee on behalf of CW+ and Westminster Medical School Research Trust. K.B. is funded by an Asthma UK PhD Studentship as part of the Asthma UK centre in allergic mechanisms of asthma (AUK-BC2015-01). R.J.S. is supported by a Wellcome Trust Senior Fellowship (209458/Z/17/Z). J.E.P. is supported by a UKRI COVID-19 Rapid Response Rolling Call (MR/V027638/1), the Imperial College London Community Jameel and the Imperial President's Excellence Fund, and a UKRI Innovation Fellowship at Health Data Research UK (MR/S004068/2).	Ali MF, 2021, AM J RESP CELL MOL, V64, P722, DOI 10.1165/rcmb.2020-0387OC; Allden SJ, 2019, AM J RESP CRIT CARE, V200, P209, DOI 10.1164/rccm.201809-1775OC; Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261; Asai Y, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1216-6; Boyd DF, 2020, NATURE, V587, P466, DOI 10.1038/s41586-020-2877-5; Byrneee AJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20191236; Chen ZY, 2020, NAT REV IMMUNOL, V20, P529, DOI 10.1038/s41577-020-0402-6; Cheon IS, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abk1741; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Desai O, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00043; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Drake TM, 2021, LANCET, V398, P223, DOI 10.1016/S0140-6736(21)00799-6; Duan S, 2016, FRONT IMMUNOL, V7, P1, DOI 10.3389/fimmu.2016.00025; Evren E, 2021, IMMUNITY, V54, P259, DOI 10.1016/j.immuni.2020.12.003; Fabbri L., 2021, MEDRXIV2021200320152; Filbin MR, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100287; Gisby J, 2021, ELIFE, V10, DOI 10.7554/eLife.64827; Guler SA, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03690-2020; Han XY, 2021, RADIOLOGY, V299, pE177, DOI 10.1148/radiol.2021203153; Harker JA, 2021, IMMUNITY, V54, P617, DOI 10.1016/j.immuni.2021.03.010; Invernizzi R, 2021, AM J RESP CRIT CARE, V203, P339, DOI 10.1164/rccm.202002-0460OC; Israelow B., 2020, MEDRXIV2020201220102; Jozwik A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10224; Kim TS, 2010, J EXP MED, V207, P1161, DOI 10.1084/jem.20092017; Kory P, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000724; Laing AG, 2020, NAT MED, V26, P1623, DOI 10.1038/s41591-020-1038-6; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li Y, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101160; Liao MF, 2020, NAT MED, V26, P842, DOI 10.1038/s41591-020-0901-9; Lucas C, 2020, NATURE, V584, P463, DOI 10.1038/s41586-020-2588-y; Mandal S, 2021, THORAX, V76, P396, DOI 10.1136/thoraxjnl-2020-215818; Mann ER, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd6197; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Morimoto Y, 2018, IMMUNITY, V49, P134, DOI 10.1016/j.immuni.2018.04.023; Myall KJ, 2021, ANN AM THORAC SOC, V18, P799, DOI 10.1513/AnnalsATS.202008-1002OC; Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z; Polverino F, 2016, AM J PHYSIOL-LUNG C, V311, pL687, DOI 10.1152/ajplung.00304.2016; Poon MML, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl9105; Pribul PK, 2008, J VIROL, V82, P4441, DOI 10.1128/JVI.02541-07; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Rodriguez L, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100078; Saris A, 2021, THORAX, V76, P1010, DOI 10.1136/thoraxjnl-2020-216256; Schmidt ME, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00678; Scott N.A., 2020, MEDRXIV2020201020207; Sigfrid L., 2021, MEDRXIV2021200320182; Slutter B, 2013, IMMUNITY, V39, P939, DOI 10.1016/j.immuni.2013.09.013; Slutter B, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2031; Szabo PA, 2021, IMMUNITY, V54, P797, DOI 10.1016/j.immuni.2021.03.005; Szabo PA, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aas9673; Thwaites RS, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg9873; Vijayakumar B, 2022, RADIOLOGY, V303, DOI 10.1148/radiol.2021211746; Wu T, 2014, J LEUKOCYTE BIOL, V95, P215, DOI 10.1189/jlb.0313180; Yamashita CM, 2011, AM J PATHOL, V179, P1733, DOI 10.1016/j.ajpath.2011.06.041; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	55	16	16	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					542	+		10.1016/j.immuni.2022.01.017	http://dx.doi.org/10.1016/j.immuni.2022.01.017			21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZQ5WU	35151371	Green Published, hybrid			2022-12-18	WOS:000767175700004
J	Maurano, M; Snyder, JM; Connelly, C; Henao-Mejia, J; Sidrauski, C; Stetson, DB				Maurano, Megan; Snyder, Jessica M.; Connelly, Caitlin; Henao-Mejia, Jorge; Sidrauski, Carmela; Stetson, Daniel B.			Protein kinase R and the integrated stress response drive immunopathology caused by mutations in the RNA deaminase ADAR1	IMMUNITY			English	Article							INITIATION-FACTOR EIF2B; TRANSLATION INITIATION; ADENOSINE-DEAMINASE; AUTOIMMUNE-DISEASE; ACID; EXPRESSION; SUBUNITS; IFIH1; TREX1; LGP2	The RNA deaminase ADAR1 is an essential negative regulator of the RNA sensor MDA5, and loss of ADAR1 function triggers inappropriate activation of MDA5 by self-RNAs. Mutations in ADAR, the gene that encodes ADAR1, cause human immune diseases, including Aicardi-Goutieres syndrome (AGS). However, the mechanisms of MDA5-dependent disease pathogenesis in vivo remain unknown. Here we generated mice with a single amino acid change in ADAR1 that models the most common human ADAR AGS mutation. These Adar mutant mice developed lethal disease that required MDA5, the RIG-I-like receptor LGP2, type I interferons, and the eIF2 alpha kinase PKR. A small-molecule inhibitor of the integrated stress response (ISR) that acts downstream of eIF2 alpha phosphorylation prevented immunopathology and rescued the mice from mortality. These findings place PKR and the ISR as central components of immunopathology in vivo and identify therapeutic targets for treatment of human diseases associated with the ADAR1-MDA5 axis.	[Maurano, Megan; Stetson, Daniel B.] Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA; [Maurano, Megan] Univ Washington, Med Scientist Training Program, Sch Med, Seattle, WA 98195 USA; [Maurano, Megan] Univ Washington, Mol & Cellular Biol Grad Program, Sch Med, Seattle, WA 98195 USA; [Snyder, Jessica M.] Univ Washington, Dept Comparat Med, Sch Med, Seattle, WA 98195 USA; [Connelly, Caitlin; Sidrauski, Carmela] Cal Life Sci LLC, San Francisco, CA 94080 USA; [Henao-Mejia, Jorge] Univ Penn, Perelman Sch Med, Inst Immunol, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Henao-Mejia, Jorge] Childrens Hosp Philadelphia, Dept Pathol & Lab Med, Div Protect Immun, Philadelphia, PA 19104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Stetson, DB (corresponding author), Univ Washington, Dept Immunol, Sch Med, Seattle, WA 98195 USA.	stetson@uw.edu			NIH [R01 AI084914, T32 AI106677, F31 AI40432]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Stuart Orkin, Michael Oldstone, Michael Gale, Jr., Gokhan Hotamiscomma ligil, and Robert Silverman for providing mice used in this study. We are grateful to the University of Washington Histology and Imaging Core and B. Johnson for histology preparation and Vivian Gersuk and the Benaroya Research Institute Genomics Core for mRNA-seq. We are grateful to Leonel Joannas for expertise regarding generation of Adar P195A mice, Sarah Miller for expert mouse colony management, and all members of the Stetson lab for insightful discussions. This work was supported by NIH R01 AI084914 (to D.B.S.) and T32 AI106677 and F31 AI40432 (to M.M.). D.B.S. is a Faculty Scholar of the Howard Hughes Medical Institute.	Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Ahmad S, 2018, CELL, V172, P797, DOI 10.1016/j.cell.2017.12.016; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Bruns AM, 2014, MOL CELL, V55, P771, DOI 10.1016/j.molcel.2014.07.003; Chung HC, 2018, CELL, V172, P811, DOI 10.1016/j.cell.2017.12.038; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Costa-Mattioli M, 2020, SCIENCE, V368, P384, DOI 10.1126/science.aat5314; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Crowl JT, 2017, ANNU REV IMMUNOL, V35, P313, DOI 10.1146/annurev-immunol-051116-052331; Daou S, 2020, P NATL ACAD SCI USA, V117, P24802, DOI 10.1073/pnas.2006883117; De Reuver R., 2020, ADAR1 INTERACTION WI, DOI [10.1101/2020.12.04.411702, DOI 10.1101/2020.12.04.411702]; Deddouche S, 2014, ELIFE, V3, DOI 10.7554/eLife.01535; Duic I, 2020, NUCLEIC ACIDS RES, V48, P11664, DOI 10.1093/nar/gkaa935; Elde NC, 2009, NATURE, V457, P485, DOI 10.1038/nature07529; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gannon HS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07824-4; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; George CX, 2016, J BIOL CHEM, V291, P6158, DOI 10.1074/jbc.M115.709014; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gorman JA, 2017, NAT IMMUNOL, V18, P744, DOI 10.1038/ni.3766; Goubau D, 2013, IMMUNITY, V38, P855, DOI 10.1016/j.immuni.2013.05.007; Gray EE, 2016, IMMUNITY, V45, P255, DOI 10.1016/j.immuni.2016.06.015; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Hayashi M, 2013, J DERMATOL, V40, P336, DOI 10.1111/j.1346-8138.2012.01661.x; Henao-Mejia Jorge, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.prot090704; Hinnebusch AG, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011544; Hornung V, 2014, NAT REV IMMUNOL, V14, P521, DOI 10.1038/nri3719; Ishizuka JJ, 2019, NATURE, V565, P43, DOI 10.1038/s41586-018-0768-9; Kolumam GA, 2005, J EXP MED, V202, P637, DOI 10.1084/jem.20050821; Koretkevich G, 2019, FAST GENE SET ENRICH; Krishnamoorthy T, 2001, MOL CELL BIOL, V21, P5018, DOI 10.1128/MCB.21.15.5018-5030.2001; Kristiansen H, 2011, J INTERF CYTOK RES, V31, P41, DOI 10.1089/jir.2010.0107; Leegwater PAJ, 2001, NAT GENET, V29, P383, DOI 10.1038/ng764; Li YZ, 2017, ELIFE, V6, DOI 10.7554/eLife.25687; Li ZQ, 2010, VIROLOGY, V396, P316, DOI 10.1016/j.virol.2009.10.026; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Livingston JH, 2014, J MED GENET, V51, P76, DOI 10.1136/jmedgenet-2013-102038; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nakahama T., 2020, DISRUPTION Z RNA BIN, DOI [10.1101/2020.12.16.422984, DOI 10.1101/2020.12.16.422984]; Nakamura T, 2015, CELL REP, V11, P295, DOI 10.1016/j.celrep.2015.03.021; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Osenberg S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011173; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pham AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005489; Rice GI, 2013, LANCET NEUROL, V12, P1159, DOI 10.1016/S1474-4422(13)70258-8; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Robinson T, 2011, J IMMUNOL, V187, P1298, DOI 10.4049/jimmunol.1100857; Sachs AB, 1997, CELL, V89, P831, DOI 10.1016/S0092-8674(00)80268-8; Satoh T, 2010, P NATL ACAD SCI USA, V107, P1512, DOI 10.1073/pnas.0912986107; Schulz O, 2010, CELL HOST MICROBE, V7, P354, DOI 10.1016/j.chom.2010.04.007; Sekine Y, 2015, SCIENCE, V348, P1027, DOI 10.1126/science.aaa6986; Sidrauski C, 2015, ELIFE, V4, DOI 10.7554/eLife.05033; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Suthar MS, 2012, IMMUNITY, V37, P235, DOI 10.1016/j.immuni.2012.07.004; Tang Q., 2020, RECOGNITION Z RNA AD, DOI [10.1101/2020.12.04.411793, DOI 10.1101/2020.12.04.411793, 10.1101/ 2020.12.04.411793]; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Tsai JC, 2018, SCIENCE, V359, P1483, DOI 10.1126/science.aaq0939; van der Knaap MS, 2002, ANN NEUROL, V51, P264, DOI 10.1002/ana.10112; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Way SW, 2016, LANCET NEUROL, V15, P434, DOI 10.1016/S1474-4422(15)00381-6; Wong YL, 2019, ELIFE, V8, DOI 10.7554/eLife.42940; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355; Zyryanova AF, 2018, SCIENCE, V359, P1533, DOI 10.1126/science.aar5129	74	16	16	3	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					1948	+		10.1016/j.immuni.2021.07.001	http://dx.doi.org/10.1016/j.immuni.2021.07.001		SEP 2021	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB		Bronze, Green Accepted			2022-12-18	WOS:000695789800007
J	Colaco, HG; Barros, A; Neves-Costa, A; Seixas, E; Pedroso, D; Velho, T; Willmann, KL; Faisca, P; Grabmann, G; Yi, HS; Shong, M; Benes, V; Weis, S; Kocher, T; Moita, LF				Colaco, Henrique G.; Barros, Andre; Neves-Costa, Ana; Seixas, Elsa; Pedroso, Dora; Velho, Tiago; Willmann, Katharina L.; Faisca, Pedro; Grabmann, Gerlinde; Yi, Hyon-Seung; Shong, Minho; Benes, Vladimir; Weis, Sebastian; Koecher, Thomas; Moita, Luis F.			Tetracycline Antibiotics Induce Host-Dependent Disease Tolerance to Infection	IMMUNITY			English	Article							ELECTRON-TRANSPORT CHAIN; INNATE IMMUNE-RESPONSES; OXIDATIVE-PHOSPHORYLATION; MITOCHONDRIAL-FUNCTION; CELLS; PROTEIN; STRESS; SEPSIS; EXPRESSION; GENERATION	Several classes of antibiotics have long been known to have beneficial effects that cannot be explained strictly on the basis of their capacity to control the infectious agent. Here, we report that tetracycline antibiotics, which target the mitoribosome, protected against sepsis without affecting the pathogen load. Mechanistically, we found that mitochondrial inhibition of protein synthesis perturbed the electron transport chain (ETC) decreasing tissue damage in the lung and increasing fatty acid oxidation and glucocorticoid sensitivity in the liver. Using a liver-specific partial and acute deletion of Crif1, a critical mitoribosomal component for protein synthesis, we found that mice were protected against sepsis, an observation that was phenocopied by the transient inhibition of complex I of the ETC by phenformin. Together, we demonstrate that mitoribosome-targeting antibiotics are beneficial beyond their antibacterial activity and that mitochondrial protein synthesis inhibition leading to ETC perturbation is a mechanism for the induction of disease tolerance.	[Colaco, Henrique G.; Barros, Andre; Neves-Costa, Ana; Seixas, Elsa; Pedroso, Dora; Velho, Tiago; Willmann, Katharina L.; Faisca, Pedro; Moita, Luis F.] Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal; [Grabmann, Gerlinde; Koecher, Thomas] Vienna BioCtr Core Facil GmbH, A-1030 Vienna, Austria; [Yi, Hyon-Seung; Shong, Minho] Chungnam Natl Univ, Res Ctr Endocrine & Metab Dis, Sch Med, Daejeon 35015, South Korea; [Benes, Vladimir] EMBL Genom Core Facil, D-69117 Heidelberg, Germany; [Weis, Sebastian] Jena Univ Hosp, Inst Infect Dis & Infect Control, D-07747 Jena, Germany; [Weis, Sebastian] Jena Univ Hosp, Dept Anesthesiol & Intens Care Med, D-07747 Jena, Germany; [Weis, Sebastian] Jena Univ Hosp, Ctr Sepsis Control & Care, D-07747 Jena, Germany; [Moita, Luis F.] Univ Lisbon, Fac Med, Inst Histol & Biol Desenvolvimento, Lisbon, Portugal	Instituto Gulbenkian de Ciencia; Chungnam National University; European Molecular Biology Laboratory (EMBL); Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Universidade de Lisboa	Moita, LF (corresponding author), Inst Gulbenkian Ciencias, Rua Quinta Grande 6, P-2780156 Oeiras, Portugal.; Moita, LF (corresponding author), Univ Lisbon, Fac Med, Inst Histol & Biol Desenvolvimento, Lisbon, Portugal.	lmoita@igc.gulbenkian.pt	Willmann, Katharina/AGX-5847-2022; Moita, Luis F./L-1296-2013; Moita, Luis/HCI-2793-2022; Yi, Hyon-Seung/ABA-2729-2022; Neves-Costa, Ana/AAJ-7066-2021; Weis, Sebastian/P-9016-2014; Colaco, Henrique/M-5790-2014	Willmann, Katharina/0000-0002-7714-5801; Moita, Luis F./0000-0003-0707-315X; Moita, Luis/0000-0003-0707-315X; Neves-Costa, Ana/0000-0001-6506-7829; Seixas, Elsa/0000-0003-2819-2051; Pedroso, Dora/0000-0002-5735-5094; Velho, Tiago/0000-0002-0455-8189; Faisca, Pedro/0000-0002-3922-3602; Weis, Sebastian/0000-0003-3201-2375; Colaco, Henrique/0000-0002-2026-0163	European Commission [ERC-2014-CoG 647888iPROTECTION]; Fundacao para a Ciencia e Tecnologia [FCT: PTDC/BIM-MEC/4665/2014]; Congento [LISBOA-01-0145-FEDER-022170]; FCT; Lisboa2020, under the PORTUGAL2020 agreement (European Regional Development Fund); FCT [PD/BD/105998/2014]; city of Vienna through the Vienna Business Agency	European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Congento; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Lisboa2020, under the PORTUGAL2020 agreement (European Regional Development Fund); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); city of Vienna through the Vienna Business Agency	We thank R.B. Soria and I. Gordo (IGC) for the TetR phage lysate, Z. Vaz da Silva and M.J. Amorim (IGC) for flu infections, M.P. Soares and S. Ramos (IGC) for Plasmodium infection, S. LeibundGut-Landmann (U. Zurich) for the C. albicans infection, and W. Xian and F. McKeon (HMS, Boston, USA) for KRT6-DTR mice. We thank M. Alenquer, M.J. Amorim, L. Bergman, and J. Demengeot (IGC) for refinement of the methods section, K. Jesus (IGC) for drafting the graphical abstract, and D.M. Sabatini (WI, Boston, USA) for the critical reading of the manuscript. We are grateful to the Animal House, Histopathology, Electron Microscopy, and Genomics Units at IGC. This work was supported by the European Commission Horizon 2020 (ERC-2014-CoG 647888iPROTECTION), Fundacao para a Ciencia e Tecnologia (FCT: PTDC/BIM-MEC/4665/2014), and Congento LISBOA-01-0145-FEDER-022170, cofinanced by FCT and Lisboa2020, under the PORTUGAL2020 agreement (European Regional Development Fund). H.G.C. was funded by FCT (PD/BD/105998/2014). The VBCF Metabolomics Facility is funded by the city of Vienna through the Vienna Business Agency.	Aksoy MO, 2002, J ALLERGY CLIN IMMUN, V109, P491, DOI 10.1067/mai.2002.122154; Borghesani PR, 2000, P NATL ACAD SCI USA, V97, P3336, DOI 10.1073/pnas.050584897; Bouazza B, 2012, AM J RESP CELL MOL, V47, P464, DOI 10.1165/rcmb.2011-0364OC; Cecconi M, 2018, LANCET, V392, P75, DOI 10.1016/S0140-6736(18)30696-2; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; Choy KR, 2018, DEV DYNAM, V247, P33, DOI 10.1002/dvdy.24522; Chung HK, 2017, J CELL BIOL, V216, P149, DOI 10.1083/jcb.201607110; Cohen J, 2015, LANCET INFECT DIS, V15, P581, DOI 10.1016/S1473-3099(15)70112-X; Colaco HG, 2016, FEBS J, V283, P2448, DOI 10.1111/febs.13730; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; Dendoncker K, 2019, P NATL ACAD SCI USA, V116, P12942, DOI 10.1073/pnas.1821565116; Dendoncker K, 2017, CYTOKINE GROWTH F R, V35, P85, DOI 10.1016/j.cytogfr.2017.04.002; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Divakaruni AS, 2018, CELL METAB, V28, P490, DOI 10.1016/j.cmet.2018.06.001; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Dykens JA, 2008, TOXICOL APPL PHARM, V233, P203, DOI 10.1016/j.taap.2008.08.013; Elkholi R, 2019, MOL CELL, V74, P452, DOI 10.1016/j.molcel.2019.02.012; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Figueiredo N, 2013, IMMUNITY, V39, P874, DOI 10.1016/j.immuni.2013.08.039; Gaddnas F, 2009, CRIT CARE, V13, DOI 10.1186/cc7780; Ganeshan K, 2019, CELL, V177, P399, DOI 10.1016/j.cell.2019.01.050; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Haak BW, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02042; Hackett NR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018378; Houtkooper RH, 2013, NATURE, V497, P451, DOI 10.1038/nature12188; Hu XW, 2018, FUTURE ONCOL, V14, P2599, DOI 10.2217/fon-2018-0043; Kim SJ, 2012, CELL METAB, V16, P274, DOI 10.1016/j.cmet.2012.06.012; Kwon MC, 2008, EMBO J, V27, P642, DOI 10.1038/sj.emboj.7601986; Lei Y, 2013, AUTOPHAGY, V9, P432, DOI 10.4161/auto.23026; Lin JZ, 2018, ANNU REV BIOCHEM, V87, P451, DOI 10.1146/annurev-biochem-062917-011942; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luan H., 2019, CELL; Masand R, 2018, CELL METAB, V27, P616, DOI 10.1016/j.cmet.2018.01.018; Michel S, 2015, MITOCHONDRION, V21, P58, DOI 10.1016/j.mito.2015.01.005; Moullan N, 2015, CELL REP, V10, P1681, DOI 10.1016/j.celrep.2015.02.034; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Paumelle R, 2019, J HEPATOL, V70, P963, DOI 10.1016/j.jhep.2018.12.037; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Rajan A, 2011, DEV CELL, V21, P29, DOI 10.1016/j.devcel.2011.06.034; SAKAUE M, 1991, J CLIN INVEST, V88, P385, DOI 10.1172/JCI115315; Sawa T, 2016, SHOCK, V46, P113, DOI 10.1097/SHK.0000000000000603; Shore DE, 2013, TRENDS CELL BIOL, V23, P409, DOI 10.1016/j.tcb.2013.04.007; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Soares MP, 2017, NAT REV IMMUNOL, V17, P83, DOI 10.1038/nri.2016.136; Spinazzi M, 2012, NAT PROTOC, V7, P1235, DOI 10.1038/nprot.2012.058; Stephens M, 2017, BIOSTATISTICS, V18, P275, DOI 10.1093/biostatistics/kxw041; Tauber S C, 2008, Curr Mol Pharmacol, V1, P68; Van Wyngene L, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708712; Wang A, 2019, SCIENCE, V363, P140, DOI 10.1126/science.aar3932; Wang A, 2016, CELL, V166, P1512, DOI 10.1016/j.cell.2016.07.026; Weis S, 2017, CELL, V169, P1263, DOI 10.1016/j.cell.2017.05.031; Wiersinga WJ, 2014, VIRULENCE, V5, P36, DOI 10.4161/viru.25436; Yun J, 2014, CELL METAB, V19, P757, DOI 10.1016/j.cmet.2014.01.011; Zhao RZ, 2019, INT J MOL MED, V44, P3, DOI 10.3892/ijmm.2019.4188; Zuckerbraun BS, 2007, FASEB J, V21, P1099, DOI 10.1096/fj.06-6644com; Zuo W, 2015, NATURE, V517, P616, DOI 10.1038/nature13903	57	16	16	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 12	2021	54	1					53	+		10.1016/j.immuni.2020.09.011	http://dx.doi.org/10.1016/j.immuni.2020.09.011		JAN 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PS3GL	33058782	Green Published, hybrid			2022-12-18	WOS:000607814000010
J	McWhirter, SM; Jefferies, CA				McWhirter, Sarah M.; Jefferies, Caroline A.			Nucleic Acid Sensors as Therapeutic Targets for Human Disease	IMMUNITY			English	Review							TOLL-LIKE RECEPTORS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; T-CELL RESPONSES; CYCLIC GMP-AMP; DEPENDENT ANTITUMOR IMMUNITY; BLOOD MONONUCLEAR-CELLS; RECOMBINANT HUMAN DNASE; I INTERFERON RESPONSE; HEPATITIS-C VIRUS; ACTIVATE B-CELLS	Innate immune sensors that detect nucleic acids are attractive targets for therapeutic intervention because of their diverse roles in many disease processes. In detecting RNA and DNA from either self or non-self, nucleic acid sensors mediate the pathogenesis of many autoimmune and inflammatory conditions. Despite promising pre-clinical data and investigational use in the clinic, relatively few drugs targeting nucleic acid sensors are approved for therapeutic use. Nevertheless, there is growing appreciation for the untapped potential of nucleic acid sensors as therapeutic targets, driven by the need for better therapies for cancer, infectious diseases, and autoimmune disorders. This review highlights the diverse mechanisms by which nucleic acid sensors are activated and exert their biological effects in the context of various disease settings. We discuss current therapeutic strategies utilizing agonists and antagonists targeting nucleic acid sensors to treat infectious disease, cancer, and autoimmune and inflammatory disorders.	[McWhirter, Sarah M.] Aduro Biotech Inc, Berkeley, CA 94710 USA; [Jefferies, Caroline A.] Cedars Sinai Med Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Jefferies, Caroline A.] Cedars Sinai Med Ctr, Dept Med, Div Rheumatol, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center	McWhirter, SM (corresponding author), Aduro Biotech Inc, Berkeley, CA 94710 USA.	smcwhirter@aduro.com	Jefferies, Caroline/AAI-1543-2021	Jefferies, Caroline/0000-0002-8879-6722	Arthritis Foundation [AF2017-433570]	Arthritis Foundation	The authors would like to thank Leticia Corrales for creating and conceptualizing the original artwork. We also thank Russell Vance and Erin Benanti for helpful suggestions and edits on the manuscript and Greg Barton for valuable discussions. This work is supported by funding from the Arthritis Foundation (grant AF2017-433570) to C.A.J.	Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657; Ablasser A, 2013, NATURE, V503, P530, DOI 10.1038/nature12640; Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Adamus Tomasz, 2018, Contemp Oncol (Pozn), V22, P56, DOI 10.5114/wo.2018.73887; Agarwal SK, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3221; Ager CR, 2017, CANCER IMMUNOL RES, V5, P676, DOI 10.1158/2326-6066.CIR-17-0049; Ahmad L, 2016, TRENDS MOL MED, V22, P511, DOI 10.1016/j.molmed.2016.04.006; Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4723; AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109; Al-Mayouf SM, 2011, NAT GENET, V43, P1186, DOI 10.1038/ng.975; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Ammi R, 2015, PHARMACOL THERAPEUT, V146, P120, DOI 10.1016/j.pharmthera.2014.09.010; An J, 2018, ARTHRITIS RHEUMATOL, V70, P1807, DOI 10.1002/art.40559; An J, 2017, ARTHRITIS RHEUMATOL, V69, P800, DOI 10.1002/art.40002; Aznar MA, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0568-2; Assassi S, 2010, ARTHRITIS RHEUM-US, V62, P589, DOI 10.1002/art.27224; Baird JR, 2016, CANCER RES, V76, P50, DOI 10.1158/0008-5472.CAN-14-3619; Bakhoum SF, 2018, NATURE, V553, P467, DOI 10.1038/nature25432; Bald T, 2014, CANCER DISCOV, V4, P674, DOI 10.1158/2159-8290.CD-13-0458; Barnett KC, 2019, CELL, V176, P1432, DOI 10.1016/j.cell.2019.01.049; Barrat FJ, 2016, ANNU REV MED, V67, P323, DOI 10.1146/annurev-med-052814-023338; Barry KC, 2018, NAT MED, V24, P1178, DOI 10.1038/s41591-018-0085-8; Barsoum J, 2017, CANCER IMMUNOL RES, V5, DOI 10.1158/2326-6074.TUMIMM16-B44; Berger M, 2012, J BIOL CHEM, V287, P19409, DOI 10.1074/jbc.M112.353557; Berghofer B, 2006, J IMMUNOL, V177, P2088, DOI 10.4049/jimmunol.177.4.2088; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; Blum A, 2019, AUTOIMMUN REV, V18, P679, DOI 10.1016/j.autrev.2019.05.005; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Brody JD, 2010, J CLIN ONCOL, V28, P4324, DOI 10.1200/JCO.2010.28.9793; BRUNO TC, 2020, NATURE, V577, P476, DOI DOI 10.1038/d41586-020-00093-6; Bu Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165681; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Burleigh K, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba4219; Campbell JD, 2014, THORAX, V69, P565, DOI 10.1136/thoraxjnl-2013-204605; Capolunghi F, 2010, RHEUMATOLOGY, V49, P2281, DOI 10.1093/rheumatology/keq226; Cervantes JL, 2012, CELL MOL IMMUNOL, V9, P434, DOI 10.1038/cmi.2012.38; Chandra D, 2014, CANCER IMMUNOL RES, V2, P901, DOI 10.1158/2326-6066.CIR-13-0123; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Chiang JJ, 2018, NAT IMMUNOL, V19, P53, DOI 10.1038/s41590-017-0005-y; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Ciechomska M, 2016, ARTHRITIS RHEUMATOL, V68, P1493, DOI 10.1002/art.39602; Ciechomska M, 2013, ANN RHEUM DIS, V72, P1382, DOI 10.1136/annrheumdis-2012-201958; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Crow MK, 2019, ANNU REV PATHOL-MECH, V14, P369, DOI 10.1146/annurev-pathol-020117-043952; Crow Y.J., 2019, DEV MED CHILD NEUROL, V5, P1; Danto SI, 2019, ARTHRITIS RES THER, V21, DOI 10.1186/s13075-019-2008-6; Davis JC, 1999, LUPUS, V8, P68, DOI 10.1191/096120399678847380; de Jesus AA, 2015, CURR OPIN RHEUMATOL, V27, P511, DOI 10.1097/BOR.0000000000000207; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Demaria O, 2015, P NATL ACAD SCI USA, V112, P15408, DOI 10.1073/pnas.1512832112; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Desnues B, 2014, P NATL ACAD SCI USA, V111, P1497, DOI 10.1073/pnas.1314121111; Dhodapkar MV, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008068; Diab A, 2018, ANN ONCOL, V29, P442, DOI DOI 10.1093/annonc/mdy289.001; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Diner BA, 2015, J BIOL CHEM, V290, P26412, DOI 10.1074/jbc.R115.652289; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Ding LY, 2018, CELL REP, V25, P2972, DOI 10.1016/j.celrep.2018.11.054; Doener F, 2019, VACCINE, V37, P1819, DOI 10.1016/j.vaccine.2019.02.024; Dowling David J, 2018, Immunohorizons, V2, P185, DOI 10.4049/immunohorizons.1700063; Downey CM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099988; Dubensky Thomas W Jr, 2013, Ther Adv Vaccines, V1, P131, DOI 10.1177/2051013613501988; Ebensen T, 2007, CLIN VACCINE IMMUNOL, V14, P952, DOI 10.1128/CVI.00119-07; Ellermeier J, 2013, CANCER RES, V73, P1709, DOI 10.1158/0008-5472.CAN-11-3850; Espinosa DA, 2019, J IMMUNOL, V202, P1153, DOI 10.4049/jimmunol.1801323; Fang F, 2016, ARTHRITIS RHEUMATOL, V68, P1989, DOI 10.1002/art.39655; Farina GA, 2010, J INVEST DERMATOL, V130, P2583, DOI 10.1038/jid.2010.200; Fazzi E, 2013, AUTOIMMUN REV, V12, P506, DOI 10.1016/j.autrev.2012.08.012; Foote JB, 2017, CANCER IMMUNOL RES, V5, P468, DOI 10.1158/2326-6066.CIR-16-0284; Fox CB, 2016, J CONTROL RELEASE, V244, P98, DOI 10.1016/j.jconrel.2016.11.011; Francica BJ, 2018, CANCER IMMUNOL RES, V6, P422, DOI 10.1158/2326-6066.CIR-17-0263; Frank MJ, 2018, CANCER DISCOV, V8, P1258, DOI 10.1158/2159-8290.CD-18-0743; Fu J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4306; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Fuertes MB, 2011, J EXP MED, V208, P2005, DOI 10.1084/jem.20101159; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gallotta M, 2018, CANCER RES, V78, P4943, DOI 10.1158/0008-5472.CAN-18-0729; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Garcia-Ortiz H, 2010, ANN RHEUM DIS, V69, P1861, DOI 10.1136/ard.2009.124313; Gekara NO, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aax3521; Gentili M, 2019, CELL REP, V26, P2377, DOI 10.1016/j.celrep.2019.01.105; Giannelou M, 2017, J AUTOIMMUN, V82, P1, DOI 10.1016/j.jaut.2017.05.008; Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Griffiths EA, 2018, CLIN CANCER RES, V24, P1019, DOI 10.1158/1078-0432.CCR-17-1792; Gutowski NJ, 2019, EUR J NEUROL, V26, P717; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Hammerich L, 2019, NAT MED, V25, P814, DOI 10.1038/s41591-019-0410-x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Harrington K., 2018, ANN ONCOL, V29, DOI DOI 10.1093/ANNONC/MDY424.015; Hartmann G, 1999, P NATL ACAD SCI USA, V96, P9305, DOI 10.1073/pnas.96.16.9305; Hayashi T, 2011, MELANOMA RES, V21, P66, DOI 10.1097/CMR.0b013e328340ce6c; Heidegger S, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau8943; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Hilf N, 2019, NATURE, V565, P240, DOI 10.1038/s41586-018-0810-y; Hirsh V, 2011, J CLIN ONCOL, V29, P2667, DOI 10.1200/JCO.2010.32.8971; Ho SSW, 2016, IMMUNITY, V44, P1177, DOI 10.1016/j.immuni.2016.04.010; Jackson S, 2018, CLIN PHARMACOL THER, V104, P335, DOI 10.1002/cpt.938; Jahrsdorfer B, 2005, J LEUKOCYTE BIOL, V77, P378, DOI 10.1189/jlb.0604373; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jiang H, 2019, EMBO J, V38, DOI 10.15252/embj.2019102718; Jiang W, 2012, J IMMUNOL S, V188; Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kato Y, 2018, ANN RHEUM DIS, V77, P1507, DOI 10.1136/annrheumdis-2018-212988; Ke CY, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav7666; Kell SA, 2019, INT IMMUNOPHARMACOL, V66, P296, DOI 10.1016/j.intimp.2018.11.019; Kelley J, 2007, ARTHRITIS RHEUM, V56, P3375, DOI 10.1002/art.22916; Kim GT, 2010, CLIN RHEUMATOL, V29, P273, DOI 10.1007/s10067-009-1316-7; Kim Y, 2018, CELL HOST MICROBE, V23, P14, DOI 10.1016/j.chom.2017.12.004; Kioon MDA, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam8458; Kitapma S, 2019, CANCER DISCOV, V9, P34, DOI 10.1158/2159-8290.CD-18-0689; Klarquist J, 2014, J IMMUNOL, V193, P6124, DOI 10.4049/jimmunol.1401869; Klein JC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14600; Komatsuda A, 2008, CLIN EXP IMMUNOL, V152, P482, DOI 10.1111/j.1365-2249.2008.03646.x; Korolowicz KE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161313; Krieg AM, 2008, ONCOGENE, V27, P161, DOI 10.1038/sj.onc.1210911; Kuznik A, 2011, J IMMUNOL, V186, P4794, DOI 10.4049/jimmunol.1000702; Kyi C, 2018, CLIN CANCER RES, V24, P4937, DOI 10.1158/1078-0432.CCR-17-1866; Lachmann PJ, 2003, LUPUS, V12, P202, DOI 10.1191/0961203303lu357xx; Lafyatis R, 2006, ARTHRITIS RHEUM, V54, P3068, DOI 10.1002/art.22157; Lama L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08620-4; Lau CM, 2005, J EXP MED, V202, P1171, DOI 10.1084/jem.20050630; Leadbetter EA, 2002, NATURE, V416, P603, DOI 10.1038/416603a; Lee KL, 2017, J MED CHEM, V60, P5521, DOI 10.1021/acs.jmedchem.7b00231; Lee-Kirsch MA, 2017, ANNU REV MED, V68, P297, DOI 10.1146/annurev-med-050715-104506; Lemos H, 2016, CANCER RES, V76, P2076, DOI 10.1158/0008-5472.CAN-15-1456; Li DZ, 2017, LEUKEMIA RES, V58, P23, DOI 10.1016/j.leukres.2017.03.010; Li LY, 2014, NAT CHEM BIOL, V10, P1043, DOI [10.1038/NChemBio.1661, 10.1038/nchembio.1661]; Lim SY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao4521; Liu HP, 2018, NATURE, V563, P131, DOI 10.1038/s41586-018-0629-6; Liu X, 2016, IMMUNOLOGY, V147, P285, DOI 10.1111/imm.12561; Liu Y, 2014, NEW ENGL J MED, V371, P507, DOI 10.1056/NEJMoa1312625; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lou YY, 2011, J IMMUNOTHER, V34, P279, DOI 10.1097/CJI.0b013e31820d2a05; Lugrin J, 2018, IMMUNOL REV, V281, P99, DOI 10.1111/imr.12618; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Lynn GM, 2019, CANCER LETT, V459, P192, DOI 10.1016/j.canlet.2019.114427; Macanovic M, 1996, CLIN EXP IMMUNOL, V106, P243, DOI 10.1046/j.1365-2249.1996.d01-839.x; Macedo AB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02450; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Marabelle A, 2014, CLIN CANCER RES, V20, P1747, DOI 10.1158/1078-0432.CCR-13-2116; Marcus A, 2018, IMMUNITY, V49, P754, DOI 10.1016/j.immuni.2018.09.016; Martins KA, 2015, EXPERT REV VACCINES, V14, P447, DOI 10.1586/14760584.2015.966085; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; MERICBERNSTAM F, 2019, J CLIN ONCOL S, V37; Miettinen M, 2001, GENES IMMUN, V2, P349, DOI 10.1038/sj.gene.6363791; Milhem M, 2018, CANCER RES, V78, DOI 10.1158/1538-7445.AM2018-CT144; Monlish DA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00390; Moore E, 2016, CANCER IMMUNOL RES, V4, P1061, DOI 10.1158/2326-6066.CIR-16-0104; Mukai K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11932; Mustelin T, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01028; Muzio M, 2000, J IMMUNOL, V164, P5998, DOI 10.4049/jimmunol.164.11.5998; Nagato T, 2014, CLIN CANCER RES, V20, P1223, DOI 10.1158/1078-0432.CCR-13-2781; Namjou B, 2011, GENES IMMUN, V12, P270, DOI 10.1038/gene.2010.73; Navabi H, 2009, VACCINE, V27, P107, DOI 10.1016/j.vaccine.2008.10.024; Nazmi A, 2019, GLIA, V67, P1254, DOI 10.1002/glia.23592; Tran NL, 2015, IMMUNOLOGY, V145, P60, DOI 10.1111/imm.12426; Nicolai CJ, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaz2738; Nishimura M, 2005, BIOL PHARM BULL, V28, P886, DOI 10.1248/bpb.28.886; Nozawa K, 2017, AUTOIMMUNITY, V50, P241, DOI 10.1080/08916934.2017.1329422; O'Driscoll M, 2008, DNA REPAIR, V7, P997, DOI 10.1016/j.dnarep.2008.02.010; O'Reilly S, 2018, IMMUNOL LETT, V195, P2, DOI 10.1016/j.imlet.2017.09.001; Oakes JA, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0287-x; Ohkuri T, 2014, CANCER IMMUNOL RES, V2, P1199, DOI 10.1158/2326-6066.CIR-14-0099; Onyedibe KI, 2019, MOLECULES, V24, DOI 10.3390/molecules24224192; Orzalli MH, 2015, P NATL ACAD SCI USA, V112, pE1773, DOI 10.1073/pnas.1424637112; Park CG, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar1916; Paulsen D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144383; Pendergraft WF, 2015, J CLIN INVEST, V125, P102, DOI 10.1172/JCI78533; Pepin G, 2020, MBIO, V11, DOI 10.1128/mBio.03187-19; Planas O, 2020, SCIENCE, V367, DOI 10.1126/science.abb2416; Poeck H, 2008, NAT MED, V14, P1256, DOI 10.1038/nm.1887; Ramanjulu JM, 2018, NATURE, V564, P439, DOI 10.1038/s41586-018-0705-y; Ranoa DRE, 2016, ONCOTARGET, V7, P26496, DOI 10.18632/oncotarget.8420; Ribas A, 2018, CANCER DISCOV, V8, P1250, DOI 10.1158/2159-8290.CD-18-0280; Ridnour LA, 2013, CLIN CANCER RES, V19, P1340, DOI 10.1158/1078-0432.CCR-12-0408; Ritchie C, 2019, MOL CELL, V75, P372, DOI 10.1016/j.molcel.2019.05.006; Rodero MP, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01932-3; Rodero MP, 2016, J EXP MED, V213, P2527, DOI 10.1084/jem.20161596; Roers A, 2016, IMMUNITY, V44, P739, DOI 10.1016/j.immuni.2016.04.002; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Rozenblit M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42784-9; Ruiz-Irastorza G, 2010, ANN RHEUM DIS, V69, P20, DOI 10.1136/ard.2008.101766; Sabado RL, 2015, CANCER IMMUNOL RES, V3, P278, DOI 10.1158/2326-6066.CIR-14-0202; Sagiv-Barfi I, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan4488; Santiago-Raber ML, 2009, J AUTOIMMUN, V33, P231, DOI 10.1016/j.jaut.2009.10.001; Saxena M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00725; Schadt L, 2019, CELL REP, V29, P1236, DOI 10.1016/j.celrep.2019.09.065; Sharma MD, 2010, IMMUNITY, V33, P942, DOI 10.1016/j.immuni.2010.11.022; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Singh M, 2014, J IMMUNOL, V193, P4722, DOI 10.4049/jimmunol.1401160; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Sitia S, 2009, AUTOIMMUN REV, V8, P281, DOI 10.1016/j.autrev.2008.08.004; Sivick KE, 2018, CELL REP, V25, P3074, DOI 10.1016/j.celrep.2018.11.047; Song SS, 2017, SCI REP-UK, V7, DOI 10.1038/srep39858; Souyris M, 2019, SEMIN IMMUNOPATHOL, V41, P153, DOI 10.1007/s00281-018-0712-y; Spinetti T, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1230578; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Suarez-Farinas M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084634; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun XZ, 2013, J IMMUNOL, V190, P2536, DOI 10.4049/jimmunol.1202689; Takeshita F, 2001, J IMMUNOL, V167, P3555, DOI 10.4049/jimmunol.167.7.3555; Tan XJ, 2018, ANNU REV MICROBIOL, V72, P447, DOI 10.1146/annurev-micro-102215-095605; Tang CHA, 2016, CANCER RES, V76, P2137, DOI 10.1158/0008-5472.CAN-15-1885; Thompson MR, 2011, VIRUSES-BASEL, V3, P920, DOI 10.3390/v3060920; Tournadre A, 2010, ARTHRITIS RHEUM-US, V62, P2144, DOI 10.1002/art.27465; Tsukumo SI, 2004, CLIN IMMUNOL, V113, P14, DOI 10.1016/j.clim.2004.05.009; Ulloa-Montoya F, 2013, J CLIN ONCOL, V31, P2388, DOI 10.1200/JCO.2012.44.3762; Van Dis E, 2018, CELL REP, V23, P1435, DOI 10.1016/j.celrep.2018.04.003; Vanpouille-Box C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15618; Vibholm LK, 2019, AIDS, V33, P1315, DOI 10.1097/QAD.0000000000002213; Volkman HE, 2019, ELIFE, V8, DOI 10.7554/eLife.47491; Vreca M, 2018, J APPL GENET, V59, P59, DOI 10.1007/s13353-017-0415-4; Wagstaff AJ, 2007, DRUGS, V67, P2187, DOI 10.2165/00003495-200767150-00006; Wang H, 2017, P NATL ACAD SCI USA, V114, P1637, DOI 10.1073/pnas.1621363114; Wang N, 2009, J VIROL, V83, P9824, DOI 10.1128/JVI.01125-09; Wang Q, 2009, J IMMUNOL, V183, P6989, DOI 10.4049/jimmunol.0901386; Wang S, 2016, P NATL ACAD SCI USA, V113, pE7240, DOI 10.1073/pnas.1608555113; Wilson LE, 2002, SEMIN ARTHRITIS RHEU, V32, P163, DOI 10.1053/sarh.2002.37277; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu YW, 2016, CELL MOL IMMUNOL, V13, P379, DOI 10.1038/cmi.2015.13; Xia TL, 2016, CELL REP, V14, P282, DOI 10.1016/j.celrep.2015.12.029; Xu RH, 2015, IMMUNITY, V43, P1148, DOI 10.1016/j.immuni.2015.11.015; Young A, 2018, CANCER IMMUNOL RES, V6, P1445, DOI 10.1158/2326-6066.CIR-18-0487; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554; Zhang ZJ, 2018, J EXP MED, V215, P3019, DOI 10.1084/jem.20180800; Zhang ZK, 2016, IMMUNITY, V45, P737, DOI 10.1016/j.immuni.2016.09.011; Zhu M, 2012, J IMMUNOL, V188; Zhu QF, 2014, J IMMUNOL, V193, P4779, DOI 10.4049/jimmunol.1402051; Zitvogel L, 2015, NAT REV IMMUNOL, V15, P405, DOI 10.1038/nri3845; Zoglmeier C, 2011, CLIN CANCER RES, V17, P1765, DOI 10.1158/1078-0432.CCR-10-2672	239	16	18	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 14	2020	53	1					78	97		10.1016/j.immuni.2020.04.004	http://dx.doi.org/10.1016/j.immuni.2020.04.004			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MN8UK	32668230	Bronze			2022-12-18	WOS:000551116800011
J	LeBleu, VS; Kalluri, R				LeBleu, Valerie S.; Kalluri, Raghu			Exosomes Exercise Inhibition of Anti-Tumor Immunity during Chemotherapy	IMMUNITY			English	Editorial Material							ADENOSINE	Exosomes are nano-sized extracellular vesicles that contain DNA, RNA, proteins, and lipids. Exosomes likely participate in facilitating intercellular communication and tumor growth. In this issue of Immunity, Zhang et al. (2019) report on the metabolic activity of B cell-derived exosomes in facilitating the suppression of cytotoxic T cells.	[LeBleu, Valerie S.; Kalluri, Raghu] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Metastasis Res Ctr, Houston, TX 77054 USA; [LeBleu, Valerie S.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA	University of Texas System; UTMD Anderson Cancer Center; Northwestern University; Feinberg School of Medicine	Kalluri, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Metastasis Res Ctr, Houston, TX 77054 USA.	rkalluri@mdanderson.org	Kalluri, Raghu/E-2677-2015	Kalluri, Raghu/0000-0002-2190-547X				Allard B, 2016, CURR OPIN PHARMACOL, V29, P7, DOI 10.1016/j.coph.2016.04.001; Clayton A, 2011, J IMMUNOL, V187, P676, DOI 10.4049/jimmunol.1003884; Kalluri R, 2016, J CLIN INVEST, V126, P1208, DOI 10.1172/JCI81135; Kowal J, 2014, CURR OPIN CELL BIOL, V29, P116, DOI 10.1016/j.ceb.2014.05.004; Liu YF, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1027472; Michaud M, 2012, ONCOIMMUNOLOGY, V1, P392, DOI 10.4161/onci.19070; Ohta A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00304; Zhang FH, 2019, IMMUNITY, V50, P738, DOI 10.1016/j.immuni.2019.01.010; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	9	16	18	6	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					547	549		10.1016/j.immuni.2019.02.019	http://dx.doi.org/10.1016/j.immuni.2019.02.019			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH	30893584	Bronze			2022-12-18	WOS:000461660500006
J	Webb, LV; Barbarulo, A; Huysentruyt, J; Vanden Berghe, T; Takahashi, N; Ley, S; Vandenabeele, P; Seddon, B				Webb, Louise, V; Barbarulo, Alessandro; Huysentruyt, Jelle; Vanden Berghe, Tom; Takahashi, Nozomi; Ley, Steven; Vandenabeele, Peter; Seddon, Benedict			Survival of Single Positive Thymocytes Depends upon Developmental Control of RIPK1 Kinase Signaling by the IKK Complex Independent of NF-kappa B	IMMUNITY			English	Article							T-CELLS; DEATH; NECROPTOSIS; ACTIVATION; APOPTOSIS; SELECTION; INNATE; TAK1; DIFFERENTIATION; MECHANISMS	NF-kappa B(nuclear factor kappa B) signaling is considered critical for single positive (SP) thymocyte development because loss of upstream activators of NF-kappa B, such as the IKK complex, arrests their development. We found that the compound ablation of RelA, cRel, and p50, required for canonical NF-kappa B transcription, had no impact upon thymocyte development. While IKK-deficient thymocytes were acutely sensitive to tumor necrosis factor (TNF)-induced cell death, Rel-deficient cells remained resistant, calling into question the importance of NF-kappa B as the IKK target required for thymocyte survival. Instead, we found that IKK controlled thymocyte survival by repressing cell-death-inducing activity of the serine/threonine kinase RIPK1. We observed that RIPK1 expression was induced during development of SP thymocytes and that IKK was required to prevent RIPK1-kinase-dependent death of SPs in vivo. Finally, we showed that IKK was required to protect Rel-deficient thymocytes from RIPK1-dependent cell death, underscoring the NF-kappa B-independent function of IKK during thymic development.	[Barbarulo, Alessandro; Seddon, Benedict] Royal Free Hosp, UCL Inst Immun & Transplantat, Div Infect & Immun, Rowland Hill St, London NW3 2PF, England; [Webb, Louise, V] Francis Crick Inst, Mill Hill Labs, London NW7 1AA, England; [Huysentruyt, Jelle; Vanden Berghe, Tom; Takahashi, Nozomi; Vandenabeele, Peter] VIB UGent Ctr Inflammat Res, VIB UGent Res Bldg FSVM,Technol Pk 927, B-9052 Ghent, Belgium; [Huysentruyt, Jelle; Vanden Berghe, Tom; Takahashi, Nozomi; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Ley, Steven] Imperial Coll, Div Mol Immunol, London, England	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; Francis Crick Institute; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Imperial College London	Seddon, B (corresponding author), Royal Free Hosp, UCL Inst Immun & Transplantat, Div Infect & Immun, Rowland Hill St, London NW3 2PF, England.	benedict.seddon@ucl.ac.uk	Vanden Berghe, Tom/C-4916-2009; Vandenabeele, Peter/AAD-5793-2022; Berghe, Tom Vanden/N-2902-2019	Vanden Berghe, Tom/0000-0002-1633-0974; Vandenabeele, Peter/0000-0002-6669-8822; Berghe, Tom Vanden/0000-0002-1633-0974; Seddon, Benedict/0000-0003-4352-3373; Takahashi, Nozomi/0000-0002-3751-4203	Belgian (Interuniversity Attraction Poles) [IAP 7/32, EOS 30826052 MODEL-IDI]; Flemish (Research Foundation Flanders) [FWO G.0875.11, G.0973.11, G.0A45.12N, G.0787.13N, G.0C31.14N, G.0C37.14N, G.0E04.16N, G.0C76.18N, G.0B71.18N]; Methusalem grant [BOF16/MET_V/007]; Ghent University (MRP, GROUP-ID consortium); Foundation against Cancer [2012-188, FAF-F/2016/865]; VIB; Medical Research Council UK [MC_PC_13055, MR/P011225/1]; MRC [MR/P011225/1, MC_PC_13055] Funding Source: UKRI	Belgian (Interuniversity Attraction Poles)(Belgian Federal Science Policy Office); Flemish (Research Foundation Flanders); Methusalem grant; Ghent University (MRP, GROUP-ID consortium); Foundation against Cancer; VIB; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank UCL Comparative Biology Unit staff for assistance with mouse breeding and maintenance, Janani Sivakumaran-Nguyen from the UCL Institute of Immunity and Transplantation Flow Cytometry Facility for help performing cell sorting, and Paola Niola from UCL Genomics for performing RNA sequencing and analysis. We thank Dr. Joe Grove, Dr. Alessandro Annibaldi, and Professor Pascal Meier for technical assistance and generous sharing of reagents. We thank the following for generous sharing of their mouse strains: Professor Manolis Pasparakis for the Chuk conditional strain, Professor Michael Karin for the Ikbkb conditional strain, Professor Vishva Dixit for the RIPK1<SUP>D138N</SUP> strain, Professor Albert Baldwin for the Rela conditional strain, and Steve Gerondakis for Rel<SUP>-/-</SUP> mice. Grant support in the Vandenabeele group included: Belgian (Interuniversity Attraction Poles: IAP 7/32, EOS 30826052 MODEL-IDI), Flemish (Research Foundation Flanders: FWO G.0875.11, G.0973.11, G.0A45.12N, G.0787.13N, G.0C31.14N, G.0C37.14N, G.0E04.16N, G.0C76.18N, and G.0B71.18N), a Methusalem grant (BOF16/MET_V/007, for N.T.), Ghent University (MRP, GROUP-ID consortium), the Foundation against Cancer (2012-188 and FAF-F/2016/865) and grants from VIB. J.H. has a FWO-SB PhD fellowship, and P.V. is senior full professor at UGent and PI at VIB. The work in the Seddon lab is supported by the Medical Research Council UK under program codes MC_PC_13055 and MR/P011225/1.	Annibaldi A, 2018, TRENDS MOL MED, V24, P49, DOI 10.1016/j.molmed.2017.11.002; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Ch'en IL, 2011, J EXP MED, V208, P633, DOI 10.1084/jem.20110251; Chen X, 2015, FASEB J, V29, P443, DOI 10.1096/fj.14-259564; Clark K, 2011, BIOCHEM J, V434, P93, DOI 10.1042/BJ20101701; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dillon CP, 2014, CELL, V157, P1189, DOI 10.1016/j.cell.2014.04.018; Dondelinger Y, 2013, CELL DEATH DIFFER, V20, P1381, DOI 10.1038/cdd.2013.94; Dondelinger Y, 2016, CELL CYCLE, V15, P5, DOI 10.1080/15384101.2015.1112688; Dondelinger Y, 2015, MOL CELL, V60, P63, DOI 10.1016/j.molcel.2015.07.032; Gareus R, 2007, NAT CELL BIOL, V9, P461, DOI 10.1038/ncb1560; Geng JF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00406-w; Gugasyan R, 2012, EMBO J, V31, P692, DOI 10.1038/emboj.2011.435; Hettmann T, 2000, J IMMUNOL, V165, P5004, DOI 10.4049/jimmunol.165.9.5004; Isomura I, 2009, J EXP MED, V206, P3001, DOI 10.1084/jem.20091411; Jimi E, 2008, IMMUNITY, V29, P523, DOI 10.1016/j.immuni.2008.08.010; Kaiser WJ, 2014, P NATL ACAD SCI USA, V111, P7753, DOI 10.1073/pnas.1401857111; Kelliher MA, 1998, IMMUNITY, V8, P297, DOI 10.1016/S1074-7613(00)80535-X; Legarda-Addison D, 2009, CELL DEATH DIFFER, V16, P1279, DOI 10.1038/cdd.2009.41; Li ZW, 2003, J IMMUNOL, V170, P4630, DOI 10.4049/jimmunol.170.9.4630; Liu HH, 2006, P NATL ACAD SCI USA, V103, P11677, DOI 10.1073/pnas.0603089103; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Miller ML, 2014, P NATL ACAD SCI USA, V111, P7397, DOI 10.1073/pnas.1315398111; Mocarski ES, 2012, NAT REV IMMUNOL, V12, P79, DOI 10.1038/nri3131; Mora AL, 1999, EUR J IMMUNOL, V29, P2968, DOI 10.1002/(SICI)1521-4141(199909)29:09<2968::AID-IMMU2968>3.3.CO;2-O; Newton K, 2014, SCIENCE, V343, P1357, DOI 10.1126/science.1249361; Pasparakis M, 2015, NATURE, V517, P311, DOI 10.1038/nature14191; Rickard JA, 2014, CELL, V157, P1175, DOI 10.1016/j.cell.2014.04.019; Schmidt-Supprian M, 2004, P NATL ACAD SCI USA, V101, P4566, DOI 10.1073/pnas.0400885101; Schmidt-Supprian M, 2003, IMMUNITY, V19, P377, DOI 10.1016/S1074-7613(03)00237-1; Silva A, 2014, P NATL ACAD SCI USA, V111, pE846, DOI 10.1073/pnas.1319397111; Sinclair C, 2015, IMMUNOL CELL BIOL, V93, P406, DOI 10.1038/icb.2014.107; Sinclair C, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002246; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Teh CE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13353; Ting AT, 2016, TRENDS IMMUNOL, V37, P535, DOI 10.1016/j.it.2016.06.002; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Waelchli R, 2006, BIOORG MED CHEM LETT, V16, P108, DOI 10.1016/j.bmcl.2005.09.035; Wan YSY, 2006, NAT IMMUNOL, V7, P851, DOI 10.1038/ni1355; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Webb LV, 2016, J EXP MED, V213, P1399, DOI 10.1084/jem.20151604; Xing Y, 2016, NAT IMMUNOL, V17, P565, DOI 10.1038/ni.3419; Xu CX, 2018, J IMMUNOL, V200, P271, DOI 10.4049/jimmunol.1700859; Zheng Y, 2003, J EXP MED, V197, P861, DOI 10.1084/jem.20021610	46	16	16	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 19	2019	50	2					348	+		10.1016/j.immuni.2019.01.004	http://dx.doi.org/10.1016/j.immuni.2019.01.004			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL8QC	30737145	Green Published, hybrid			2022-12-18	WOS:000459006700011
J	Jayachandran, R; Gumienny, A; Bolinger, B; Ruehl, S; Lang, MJ; Fucile, G; Mazumder, S; Tchang, V; Woischnig, AK; Stiess, M; Kun, G; Claudi, B; Schmaler, M; Siegmund, K; Li, JP; Dertschnig, S; Hollander, G; Medina, E; Karrer, U; Moshous, D; Bumann, D; Khanna, N; Rossi, SW; Pieters, J				Jayachandran, Rajesh; Gumienny, Aleksandra; Bolinger, Beatrice; Ruehl, Sebastian; Lang, Mathias Jakob; Fucile, Geoffrey; Mazumder, Saumyabrata; Tchang, Vincent; Woischnig, Anne-Kathrin; Stiess, Michael; Kun, Gabriele; Claudi, Beatrice; Schmaler, Mathias; Siegmund, Kerstin; Li, Jianping; Dertschnig, Simone; Hollaender, George; Medina, Eva; Karrer, Urs; Moshous, Despina; Bumann, Dirk; Khanna, Nina; Rossi, Simona W.; Pieters, Jean			Disruption of Coronin 1 Signaling in T Cells Promotes Allograft Tolerance while Maintaining Anti-Pathogen Immunity	IMMUNITY			English	Article							VERSUS-HOST-DISEASE; COMBINED IMMUNODEFICIENCY; PROTEIN; KINASE; MICE; ACTIVATION; DYNAMICS; SURVIVAL; TYPHIMURIUM; INFECTIONS	The ability of the immune system to discriminate self from non-self is essential for eradicating microbial pathogens but is also responsible for allograft rejection. Whether it is possible to selectively suppress alloresponses while maintaining anti-pathogen immunity remains unknown. We found that mice deficient in coronin 1, a regulator of naive T cell homeostasis, fully retained allografts while maintaining T cell-specific responses against microbial pathogens. Mechanistically, coronin 1-deficiency increased cyclic adenosine monophosphate (cAMP) concentrations to suppress allo-specific T cell responses. Costimulation induced on microbe-infected antigen presenting cells was able to overcome cAMP-mediated immunosuppression to maintain anti-pathogen immunity. In vivo pharmacological modulation of this pathway or a prior transfer of coronin 1-deficient T cells actively suppressed allograft rejection. These results define a coronin 1-dependent regulatory axis in T cells important for allograft rejection and suggest that modulation of this pathway may be a promising approach to achieve long-term acceptance of mismatched allografts.	[Jayachandran, Rajesh; Gumienny, Aleksandra; Bolinger, Beatrice; Ruehl, Sebastian; Lang, Mathias Jakob; Mazumder, Saumyabrata; Tchang, Vincent; Stiess, Michael; Kun, Gabriele; Claudi, Beatrice; Siegmund, Kerstin; Bumann, Dirk; Pieters, Jean] Univ Basel, Biozentrum, Basel, Switzerland; [Woischnig, Anne-Kathrin; Schmaler, Mathias; Dertschnig, Simone; Hollaender, George; Khanna, Nina; Rossi, Simona W.] Univ Basel, Dept Biomed, Basel, Switzerland; [Woischnig, Anne-Kathrin; Schmaler, Mathias; Dertschnig, Simone; Hollaender, George; Khanna, Nina; Rossi, Simona W.] Univ Hosp Basel, Basel, Switzerland; [Khanna, Nina] Univ Basel, Div Infect Dis, Basel, Switzerland; [Fucile, Geoffrey] Univ Basel, Swiss Inst Bioinformat, SciCORE Comp Ctr, Basel, Switzerland; [Li, Jianping] Novartis, Basel, Switzerland; [Hollaender, George] Univ Oxford, Dept Paediat, Oxford, England; [Medina, Eva] Helmholtz Ctr Infect Res, Braunschweig, Germany; [Karrer, Urs] Cantonal Hosp Winterthur, Div Infect Dis, Winterthur, Switzerland; [Karrer, Urs] Cantonal Hosp Winterthur, Dept Med, Winterthur, Switzerland; [Moshous, Despina] Univ Paris 05, Sorbonne Paris Cite, Inst Imagine, Paris, France; [Moshous, Despina] Hop Univ Necker Enfants Malad, AP HP, Unite Immunol Hematol & Rhumatol Pediat, Paris, France; [Siegmund, Kerstin] Med Univ Innsbruck, Dept Pharmacol & Genet, Innsbruck, Austria	University of Basel; University of Basel; University of Basel; University of Basel; Swiss Institute of Bioinformatics; University of Basel; University of Oxford; Helmholtz Association; Helmholtz-Center for Infection Research; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Medical University of Innsbruck	Jayachandran, R; Pieters, J (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.	rajesh.jayachandran@unibas.ch; jean.pieters@unibas.ch	LI, JIAN/GRY-2197-2022; Bellaire-Siegmund, Kerstin/AAA-9702-2021; Li, Jin/GYQ-5363-2022; Khanna, Nina/AAL-7648-2021; Moshous, Despina/B-7507-2017; Stiess, Michael/ABF-9835-2020; Ruehl, Sebastian/AAJ-7903-2020; li, jian/GSE-0245-2022; Li, Jing/GYU-5036-2022	Bellaire-Siegmund, Kerstin/0000-0002-3654-1170; Moshous, Despina/0000-0001-6719-3693; Stiess, Michael/0000-0001-5363-0389; Pieters, Jean/0000-0002-5284-9757; Dertschnig, Simone/0000-0002-3410-5121; Rossi, Simona W/0000-0002-8212-0502; Hollander, Georg/0000-0002-8790-0874; Khanna, Nina/0000-0002-2642-419X	Cloetta foundation; Swiss Life fellowship; HSFP fellowship; Marie Vogt Heim Fellowship; Lise Meitner position of the FWF Austrian Science Fund; Swiss National Science Foundation; Gebert Ruef Foundation; Swiss MS Society; Canton of Basel; SIB Swiss Institute of Bioinformatics	Cloetta foundation; Swiss Life fellowship; HSFP fellowship; Marie Vogt Heim Fellowship; Lise Meitner position of the FWF Austrian Science Fund; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gebert Ruef Foundation; Swiss MS Society; Canton of Basel; SIB Swiss Institute of Bioinformatics	We thank Helene Rossez, Julie Ruer-Laventie, Lotte Kuhn, Janine Zankl, Stella Stefanova, Jiagui Li, and Philippe Demougin for excellent support and assistance. We thank Bettina Oswald, Renato Zedi, Mattias Thimm, Frederic Schmitt, Dominique Grosshenny, David Ueberschlag, and members of the Animal Unit, Biozentrum, and DBM. We are indebted to Ed Palmer and the late Ton Rolink for fruitful discussions. R.J. was supported by a Cloetta foundation and Swiss Life fellowship. M.S., B.B., and K.S. were supported by an HSFP fellowship, Marie Vogt Heim Fellowship, and Lise Meitner position of the FWF Austrian Science Fund, respectively. This work was further supported by the Swiss National Science Foundation, the Gebert Ruef Foundation, the Swiss MS Society, and the Canton of Basel. RNA sequencing was conducted at the Genomics Facility Basel (by Christian Beisel), ETH Zurich Department of Biosystems Science and Engineering), and analyses were performed at sciCORE (http://scicore.unibas.ch/) scientific computing core facility at University of Basel, with support by the SIB Swiss Institute of Bioinformatics.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson KA, 2002, MOL CELL BIOL, V22, P23, DOI 10.1128/MCB.22.1.23-29.2002; Anderson KA, 1997, MOL ENDOCRINOL, V11, P725, DOI 10.1210/me.11.6.725; Arandjelovic S, 2010, J LEUKOCYTE BIOL, V88, P737, DOI 10.1189/jlb.0310131; Arumugham VB, 2017, J LEUKOCYTE BIOL, V101, P1301, DOI 10.1189/jlb.2RU1116-474R; Avery RK, 2013, CURR OPIN ORGAN TRAN, V18, P659, DOI 10.1097/MOT.0000000000000023; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Birkeland SA, 2000, LANCET, V355, P1886, DOI 10.1016/S0140-6736(00)02298-4; Bodor J, 2012, EUR J IMMUNOL, V42, P1375, DOI 10.1002/eji.201141578; Bopp T, 2007, J EXP MED, V204, P1303, DOI 10.1084/jem.20062129; BOURNE HR, 1974, SCIENCE, V184, P19, DOI 10.1126/science.184.4132.19; Bubic I, 2004, J VIROL, V78, P7536, DOI 10.1128/JVI.78.14.7536-7544.2004; Bumann D, 2001, INFECT IMMUN, V69, P7493, DOI 10.1128/IAI.69.12.7493-7500.2001; Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DOHERTY PC, 1975, LANCET, V1, P1406, DOI 10.1016/S0140-6736(75)92610-0; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; Erdogan S, 1997, BIOCHEM J, V321, P165, DOI 10.1042/bj3210165; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Ford ML, 2016, IMMUNITY, V44, P1020, DOI 10.1016/j.immuni.2016.04.012; Fulton LM, 2014, EUR J IMMUNOL, V44, P1662, DOI 10.1002/eji.201344155; Giembycz MA, 1996, BRIT J PHARMACOL, V118, P1945, DOI 10.1111/j.1476-5381.1996.tb15629.x; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Goulmy E, 1996, NEW ENGL J MED, V334, P281, DOI 10.1056/NEJM199602013340501; Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023; HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Jayachandran R, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001820; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Krenger W, 2000, BLOOD, V96, P347, DOI 10.1182/blood.V96.1.347.013k26_347_354; Krenger W, 2000, TRANSPLANTATION, V69, P2190, DOI 10.1097/00007890-200005270-00040; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Kupz A, 2014, INFECT IMMUN, V82, P4997, DOI 10.1128/IAI.02192-14; Lang MJ, 2017, J IMMUNOL, V199, P2421, DOI 10.4049/jimmunol.1700438; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; MCKENZIE IFC, 1979, J EXP MED, V150, P1323, DOI 10.1084/jem.150.6.1323; Mosenden R, 2011, CELL SIGNAL, V23, P1009, DOI 10.1016/j.cellsig.2010.11.018; Moshous D, 2013, J ALLERGY CLIN IMMUN, V131, P1594, DOI 10.1016/j.jaci.2013.01.042; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Mueller P, 2011, J IMMUNOL, V186, P4039, DOI 10.4049/jimmunol.1003352; Niimi M, 2001, J HEART LUNG TRANSPL, V20, P1123, DOI 10.1016/S1053-2498(01)00309-6; Nowakowska J, 2014, ANTIBIOTICS-BASEL, V3, P378, DOI 10.3390/antibiotics3030378; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Pick R, 2017, BLOOD, V130, P847, DOI 10.1182/blood-2016-11-749622; Pieters J, 2013, NAT REV IMMUNOL, V13, P510, DOI 10.1038/nri3465; Punwani D, 2015, J CLIN IMMUNOL, V35, P135, DOI 10.1007/s10875-014-0125-1; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ravindran R, 2005, IMMUNOLOGY, V114, P450, DOI 10.1111/j.1365-2567.2005.02140.x; Richters CD, 2005, CLIN DERMATOL, V23, P338, DOI 10.1016/j.clindermatol.2004.07.022; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Schmaler  M., 2014, JOVE-J VIS EXP, V89; Schmidt EM, 2009, J IMMUNOL, V182, P274, DOI 10.4049/jimmunol.182.1.274; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Shiow LR, 2009, CLIN IMMUNOL, V131, P24, DOI 10.1016/j.clim.2008.11.002; Siegmund K, 2013, IMMUNOL LETT, V153, P62, DOI 10.1016/j.imlet.2013.06.005; Siegmund K, 2011, J IMMUNOL, V186, P3452, DOI 10.4049/jimmunol.1003491; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Sojka DK, 2009, EUR J IMMUNOL, V39, P1544, DOI 10.1002/eji.200838603; Stray-Pedersen A, 2014, J CLIN IMMUNOL, V34, P871, DOI 10.1007/s10875-014-0074-8; Suo D, 2014, NAT NEUROSCI, V17, P36, DOI 10.1038/nn.3593; Surh CD, 2008, IMMUNITY, V29, P848, DOI 10.1016/j.immuni.2008.11.002; Tang QZ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015552; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Tchang VSY, 2017, IMMUNOBIOLOGY, V222, P291, DOI 10.1016/j.imbio.2016.09.011; Vang T, 2001, J EXP MED, V193, P497, DOI 10.1084/jem.193.4.497; Verma S, 2016, J VIROL, V90, P650, DOI 10.1128/JVI.02123-15; Vinet AF, 2014, MOL BIOL CELL, V25, P688, DOI 10.1091/mbc.E13-04-0219; Walton SM, 2008, J IMMUNOL, V181, P1128, DOI 10.4049/jimmunol.181.2.1128; Wayman GA, 1997, J BIOL CHEM, V272, P16073, DOI 10.1074/jbc.272.26.16073; Wehbi VL, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00222; Westritschnig K, 2013, MOL IMMUNOL, V53, P379, DOI 10.1016/j.molimm.2012.09.002; Yee CS, 2016, J ALLERGY CLIN IMMUN, V137, P879, DOI 10.1016/j.jaci.2015.08.020; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Ziegler C, 2011, EMBO MOL MED, V3, P652, DOI 10.1002/emmm.201100173	78	16	16	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					152	+		10.1016/j.immuni.2018.12.011	http://dx.doi.org/10.1016/j.immuni.2018.12.011			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30611611	Bronze, Green Accepted, Green Submitted			2022-12-18	WOS:000455661600017
J	Wullaert, A; Lamkanfi, M; McCoy, KD				Wullaert, Andy; Lamkanfi, Mohamed; McCoy, Kathy D.			Defining the Impact of Host Genotypes on Microbiota Composition Requires Meticulous Control of Experimental Variables	IMMUNITY			English	Letter							NLRP6; MICE		[Wullaert, Andy] Univ Ghent, Dept Internal Med, Ghent, Belgium; [Wullaert, Andy] VIB, VIB UGent Ctr Inflammat Res, Ghent, Belgium; [Wullaert, Andy] Univ Ghent, GGIG, Ghent, Belgium; [Lamkanfi, Mohamed] Pharmaceut Co Johnson & Johnson, Janssen Res & Dev, Turnhoutseweg 30, B-2340 Beerse, Belgium; [McCoy, Kathy D.] Univ Calgary, Snyder Inst Chron Dis, Cumming Sch Med, Dept Physiol, Calgary, AB T2N 4N1, Canada; [McCoy, Kathy D.] Univ Calgary, Snyder Inst Chron Dis, Cumming Sch Med, Pharmacol & Gastrointestinal Res Grp, Calgary, AB T2N 4N1, Canada	Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Johnson & Johnson; Janssen Pharmaceuticals; University of Calgary; University of Calgary	McCoy, KD (corresponding author), Univ Calgary, Snyder Inst Chron Dis, Cumming Sch Med, Dept Physiol, Calgary, AB T2N 4N1, Canada.; McCoy, KD (corresponding author), Univ Calgary, Snyder Inst Chron Dis, Cumming Sch Med, Pharmacol & Gastrointestinal Res Grp, Calgary, AB T2N 4N1, Canada.	kathy.mccoy@ucalgary.ca	McCoy, Kathy/ABD-5814-2021; Wullaert, Andy/R-1924-2019	Wullaert, Andy/0000-0001-5012-654X				Birchenough GMH, 2016, SCIENCE, V352, P1535, DOI 10.1126/science.aaf7419; Blazejewski AJ, 2017, CELL REP, V19, P2319, DOI 10.1016/j.celrep.2017.05.058; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Galvez EJC, 2017, CELL REP, V21, P3914, DOI 10.1016/j.celrep.2017.12.027; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Lemire P, 2017, CELL REP, V21, P3653, DOI 10.1016/j.celrep.2017.12.026; Levy M, 2017, TRENDS IMMUNOL, V38, P248, DOI 10.1016/j.it.2017.01.001; Mamantopoulos M, 2017, IMMUNITY, V47, P339, DOI 10.1016/j.immuni.2017.07.011; Seregin SS, 2017, CELL REP, V19, P733, DOI 10.1016/j.celrep.2017.03.080; Stappenbeck TS, 2016, NATURE, V534, P191, DOI 10.1038/nature18285	10	16	16	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					605	607		10.1016/j.immuni.2018.04.001	http://dx.doi.org/10.1016/j.immuni.2018.04.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669239	Bronze			2022-12-18	WOS:000430198900003
J	Van Braeckel-Budimir, N; Gras, S; Ladell, K; Josephs, TM; Pewe, L; Urban, SL; Miners, KL; Farenc, C; Price, DA; Rossjohn, J; Harty, JT				Van Braeckel-Budimir, Natalija; Gras, Stephanie; Ladell, Kristin; Josephs, Tracy M.; Pewe, Lecia; Urban, Stina L.; Miners, Kelly L.; Farenc, Carine; Price, David A.; Rossjohn, Jamie; Harty, John T.			A T Cell Receptor Locus Harbors a Malaria-Specific Immune Response Gene	IMMUNITY			English	Article							PRECURSOR FREQUENCY; STRUCTURAL BASIS; REPERTOIRE; SELECTION; MEMORY; MICE; PATHOGENESIS; DIVERSITY; BIAS; MAINTENANCE	Immune response (Ir) genes, originally proposed by Baruj Benacerraf to explain differential antigen-specific responses in animal models, have become synonymous with the major histocompatibility complex (MHC). We discovered a non-MHC-linked Ir gene in a T cell receptor (TCR) locus that was required for CD8(+) T cell responses to the Plasmodium berghei GAP50(40-48) epitope in mice expressing the MHC class I allele H-2D(b). GAP50(40-48)-specific CD8(+) T cell responses emerged from a very large pool of naive V beta 8.1(+) precursors, which dictated susceptibility to cerebral malaria and conferred protection against recombinant Listeria monocytogenes infection. Structural analysis of a prototypical V beta 8.1(+) TCR-H-2D(b)-GAP50(40-48) ternary complex revealed that germline- encoded complementarity-determining region 1 beta residues present exclusively in the V beta 8.1 segment mediated essential interactions with the GAP50(40-48) peptide. Collectively, these findings demonstrated that V beta 8.1 functioned as an Ir gene that was indispensable for immune reactivity against the malaria GAP50(40-48) epitope.	[Van Braeckel-Budimir, Natalija; Pewe, Lecia; Urban, Stina L.; Harty, John T.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Gras, Stephanie; Josephs, Tracy M.; Rossjohn, Jamie] Monash Univ, Ctr Excellence Adv Mol Imaging, Australian Res Council, Clayton, Vic 3800, Australia; [Gras, Stephanie; Josephs, Tracy M.; Farenc, Carine; Rossjohn, Jamie] Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia; [Gras, Stephanie; Josephs, Tracy M.; Farenc, Carine; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic 3800, Australia; [Ladell, Kristin; Miners, Kelly L.; Price, David A.; Rossjohn, Jamie] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff CF14 4XN, S Glam, Wales; [Price, David A.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Harty, John T.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA; [Harty, John T.] Univ Iowa, Interdisciplinary Program Immunol, Iowa City, IA 52242 USA	University of Iowa; Monash University; Monash University; Monash University; Cardiff University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA.; Rossjohn, J (corresponding author), Monash Univ, Ctr Excellence Adv Mol Imaging, Australian Res Council, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Monash Univ, Infect & Immun Program, Clayton, Vic 3800, Australia.; Rossjohn, J (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic 3800, Australia.; Price, DA; Rossjohn, J (corresponding author), Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff CF14 4XN, S Glam, Wales.; Price, DA (corresponding author), NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.; Harty, JT (corresponding author), Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA.; Harty, JT (corresponding author), Univ Iowa, Interdisciplinary Program Immunol, Iowa City, IA 52242 USA.	priced6@cardiff.ac.uk; jamie.rossjohn@monash.edu; john-harty@uiowa.edu	Rossjohn, Jamie/F-9032-2013; Miners, Kelly/AAC-6903-2020; Ladell, Kristin/C-8301-2013; Price, David A/C-7876-2013	Rossjohn, Jamie/0000-0002-2020-7522; Ladell, Kristin/0000-0002-9856-2938; Price, David A/0000-0001-9416-2737; gras, stephanie/0000-0001-7416-038X; Farenc, Carine/0000-0001-6383-3032; Harty, John/0000-0001-7266-2802	National Institutes of Health (NIH) [AI42767, AI85515, AI95178, AI100527, T32 AI007511, T32 AI007343]; Australian Research Council (ARC); Australian National Health and Medical Research Council (NHMRC); Wellcome Trust [100326/Z/12/Z]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042767, T32AI007260, R21AI042767, R01AI085515, T32AI007343, R01AI095178, R01AI100527, T32AI007511, R01AI042767] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council (ARC)(Australian Research Council); Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Marc Jenkins for helpful discussions, Vladimir Badovinac and Stanley Perlman for constructive comments on the manuscript, Lisa Hancox and Steven Moieffer for excellent technical support, and staff at the New York University Insectary Core and the University of Iowa Flow Cytometry Core. This work was supported by grants from the National Institutes of Health (NIH) (AI42767, AI85515, AI95178, and AI100527 to J.T.H., T32 AI007511 to N.V.B.B., and T32 AI007343 to S.L.U.), the Australian Research Council (ARC) and the Australian National Health and Medical Research Council (NHMRC) to J.R., and the Wellcome Trust to D.A.P. (100326/Z/12/Z). S.G. is a Monash Senior Research Fellow, D.A.P. is a Wellcome Trust Senior Investigator, and J.R. is an ARC Australian Laureate Fellow.	Akue AD, 2012, J IMMUNOL, V188, P2516, DOI 10.4049/jimmunol.1102213; Amani V, 2000, EUR J IMMUNOL, V30, P1646, DOI 10.1002/1521-4141(200006)30:6&lt;1646::AID-IMMU1646&gt;3.0.CO;2-0; Badovinac VP, 2000, J IMMUNOL, V164, P6444, DOI 10.4049/jimmunol.164.12.6444; Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; BEHLKE MA, 1986, P NATL ACAD SCI USA, V83, P767, DOI 10.1073/pnas.83.3.767; BENACERR.B, 1972, SCIENCE, V175, P273, DOI 10.1126/science.175.4019.273; BENACERRAF B, 1978, IMMUNOL REV, V38, P70, DOI 10.1111/j.1600-065X.1978.tb00385.x; BENACERRAF B, 1974, SCAND J IMMUNOL, V3, P381, DOI 10.1111/j.1365-3083.1974.tb01269.x; Bendelac A, 1997, ANNU REV IMMUNOL, V15, P535, DOI 10.1146/annurev.immunol.15.1.535; Bettini ML, 2013, NAT PROTOC, V8, P1837, DOI 10.1038/nprot.2013.111; Blattman JN, 2002, J EXP MED, V195, P657, DOI 10.1084/jem.20001021; Boubou MI, 1999, INT IMMUNOL, V11, P1553, DOI 10.1093/intimm/11.9.1553; BREWSTER DR, 1990, LANCET, V336, P1039, DOI 10.1016/0140-6736(90)92498-7; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Busch DH, 1998, J EXP MED, V188, P61, DOI 10.1084/jem.188.1.61; Cabaniols JP, 2001, J EXP MED, V194, P1385, DOI 10.1084/jem.194.9.1385; CHOTHIA C, 1988, EMBO J, V7, P3745, DOI 10.1002/j.1460-2075.1988.tb03258.x; Davis MM, 2003, ANNU REV BIOCHEM, V72, P717, DOI 10.1146/annurev.biochem.72.121801.161625; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Day EB, 2011, P NATL ACAD SCI USA, V108, P9536, DOI 10.1073/pnas.1106851108; DELANO WL, 2002, PYMOL MOL GRAPHICS S, DOI DOI 10.1073/PNAS.1106851108; Doll KL, 2016, J IMMUNOL, V196, P4253, DOI 10.4049/jimmunol.1600155; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engwerda C, 2005, CURR TOP MICROBIOL, V297, P103; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fulton RB, 2015, NAT IMMUNOL, V16, P107, DOI 10.1038/ni.3043; Garcia KC, 2009, NAT IMMUNOL, V10, P143, DOI 10.1038/ni.f.219; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Gordon EB, 2015, P NATL ACAD SCI USA, V112, P13075, DOI 10.1073/pnas.1516544112; Gras S, 2009, IMMUNITY, V30, P193, DOI 10.1016/j.immuni.2008.11.011; Hafalla JCR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003303; Haluszczak C, 2009, J EXP MED, V206, P435, DOI 10.1084/jem.20081829; Haque A, 2011, J IMMUNOL, V186, P6148, DOI 10.4049/jimmunol.1003955; Holst J, 2006, NAT PROTOC, V1, P406, DOI 10.1038/nprot.2006.61; Horne-Debets JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26210; Howland SW, 2013, EMBO MOL MED, V5, P984, DOI 10.1002/emmm.201202273; Imai T, 2010, EUR J IMMUNOL, V40, P1053, DOI 10.1002/eji.200939525; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kjer-Nielsen L, 2002, STRUCTURE, V10, P1521, DOI 10.1016/S0969-2126(02)00878-X; Lefranc MP, 2003, LEUKEMIA, V17, P260, DOI 10.1038/sj.leu.2402637; Mach N, 2000, CANCER RES, V60, P3239; Malherbe L, 2004, IMMUNITY, V21, P669, DOI 10.1016/j.immuni.2004.09.008; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Mariotti-Ferrandiz E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147871; MARSHAK A, 1977, J EXP MED, V146, P1773, DOI 10.1084/jem.146.6.1773; MCDEVITT HO, 1969, SCIENCE, V163, P1207, DOI 10.1126/science.163.3872.1207; Miles JJ, 2011, IMMUNOL CELL BIOL, V89, P375, DOI 10.1038/icb.2010.139; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Neller MA, 2015, IMMUNOL CELL BIOL, V93, P625, DOI 10.1038/icb.2015.17; OWENS T, 1989, BIOCHEM CELL BIOL, V67, P481, DOI 10.1139/o89-078; Pham NLL, 2009, J IMMUNOL, V183, P2337, DOI 10.4049/jimmunol.0901203; Price DA, 2005, J EXP MED, V202, P1349, DOI 10.1084/jem.20051357; Quigley Maire F, 2011, Curr Protoc Immunol, VChapter 10, DOI 10.1002/0471142735.im1033s94; Quigley MF, 2010, P NATL ACAD SCI USA, V107, P19414, DOI 10.1073/pnas.1010586107; Rai D, 2009, J IMMUNOL, V183, P7672, DOI 10.4049/jimmunol.0902874; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Savage PA, 1999, IMMUNITY, V10, P485, DOI 10.1016/S1074-7613(00)80048-5; Scott-Browne JP, 2009, NATURE, V458, P1043, DOI 10.1038/nature07812; Struik SS, 2004, IMMUNOL REV, V201, P268, DOI 10.1111/j.0105-2896.2004.00181.x; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; Turner SJ, 2006, NAT REV IMMUNOL, V6, P883, DOI 10.1038/nri1977; VALKENBURG SA, 2013, NAT COMMUN, V4, DOI DOI 10.1038/NRI1977; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Van Rhijn I, 2015, NAT REV IMMUNOL, V15, P643, DOI 10.1038/nri3889; VANDERHEYDE HC, 1993, J IMMUNOL, V151, P3187; VINETZ JM, 1990, J IMMUNOL, V144, P1069; Wilson A, 2001, J IMMUNOL, V166, P51, DOI 10.4049/jimmunol.166.1.51; Yanez DM, 1996, J IMMUNOL, V157, P1620; YOUNG ACM, 1994, CELL, V76, P39, DOI 10.1016/0092-8674(94)90171-6; Zhao JX, 2009, J IMMUNOL, V183, P5163, DOI 10.4049/jimmunol.0902164; ZINKERNAGEL RM, 1978, IMMUNOL REV, V42, P224, DOI 10.1111/j.1600-065X.1978.tb00264.x	78	16	16	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 21	2017	47	5					835	+		10.1016/j.immuni.2017.10.013	http://dx.doi.org/10.1016/j.immuni.2017.10.013			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FO0YZ	29150238	Green Accepted, Bronze			2022-12-18	WOS:000416483700009
J	Geltink, RIK; O'Sullivan, D; Pearce, EL				Geltink, Ramon I. Klein; O'Sullivan, David; Pearce, Erika L.			Caught in the cROSsfire: GSH Controls T Cell Metabolic Reprogramming	IMMUNITY			English	Editorial Material							ACTIVATION; MTOR; MYC	T cell activation and proliferation critical for protective immunity depend on appropriate rewiring of cellular metabolism. In this issue of Immunity, Mak et al. (2017) show that the antioxidant gluthathione (GSH) controls reactive oxygen species (ROS)-dependent engagement of metabolic signaling pathways that lead to protective T cell responses.	[Geltink, Ramon I. Klein; O'Sullivan, David; Pearce, Erika L.] Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany	Max Planck Society	Pearce, EL (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Immunometab, D-79108 Freiburg, Germany.	pearce@ie-freiburg.mpg.de		Klein Geltink, Ramon/0000-0003-4610-3059	NCI NIH HHS [R01 CA181125] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA181125] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Chen Y, 2005, J BIOL CHEM, V280, P33766, DOI 10.1074/jbc.M504604200; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Mak TW, 2017, IMMUNITY, V46, P675, DOI 10.1016/j.immuni.2017.03.019; Powell JD, 2012, ANNU REV IMMUNOL, V30, P39, DOI 10.1146/annurev-immunol-020711-075024; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Sabharwal SS, 2014, NAT REV CANCER, V14, P709, DOI 10.1038/nrc3803; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.02.004, 10.1016/j.cell.2017.03.035]; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021	10	16	16	3	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2017	46	4					525	527		10.1016/j.immuni.2017.03.022	http://dx.doi.org/10.1016/j.immuni.2017.03.022			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES3TD	28423332	Green Accepted, Bronze			2022-12-18	WOS:000399451100005
J	Posey, AD; Clausen, H; June, CH				Posey, Avery D., Jr.; Clausen, Henrik; June, Carl H.			Distinguishing Truncated and Normal MUC1 Glycoform Targeting from Tn-MUC1-Specific CAR T Cells: Specificity Is the Key to Safety	IMMUNITY			English	Letter							CHIMERIC ANTIGEN RECEPTOR; PROTEIN		[Posey, Avery D., Jr.; June, Carl H.] Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA; [Posey, Avery D., Jr.; June, Carl H.] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Cellular & Mol Med, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark; [Clausen, Henrik] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Odontol, Blegdamsvej 3, DK-2200 Copenhagen N, Denmark	University of Pennsylvania; University of Pennsylvania; University of Copenhagen; University of Copenhagen	Posey, AD; June, CH (corresponding author), Univ Penn, Ctr Cellular Immunotherapies, Philadelphia, PA 19104 USA.; Posey, AD; June, CH (corresponding author), Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.	aposey@mail.med.upenn.edu; cjune@exchange.upenn.edu	Posey, Avery D./P-4890-2019; clausen, henrik/AAD-8016-2021	Posey, Avery D./0000-0001-8711-629X; Clausen, Henrik/0000-0002-0915-5055				BURCHELL J, 1987, CANCER RES, V47, P5476; Dalziel M, 2001, J BIOL CHEM, V276, P11007, DOI 10.1074/jbc.M006523200; Demichelis SO, 2010, APPL IMMUNOHISTO M M, V18, P41, DOI 10.1097/PAI.0b013e3181ac1c20; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Posey AD, 2016, IMMUNITY, V44, P1444, DOI 10.1016/j.immuni.2016.05.014; Schietinger A, 2006, SCIENCE, V314, P304, DOI 10.1126/science.1129200; Stone JD, 2012, ONCOIMMUNOLOGY, V1, P863, DOI 10.4161/onci.20592; Tarp MA, 2008, BBA-GEN SUBJECTS, V1780, P546, DOI 10.1016/j.bbagen.2007.09.010; Wilkie S, 2008, J IMMUNOL, V180, P4901, DOI 10.4049/jimmunol.180.7.4901	9	16	17	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					947	948		10.1016/j.immuni.2016.10.015	http://dx.doi.org/10.1016/j.immuni.2016.10.015			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851918	Bronze			2022-12-18	WOS:000389473500002
J	Garcia-Vallejo, JJ; van Kooyk, Y				Garcia-Vallejo, Juan J.; van Kooyk, Yvette			DC-SIGN: The Strange Case of Dr. Jekyll and Mr. Hyde	IMMUNITY			English	Editorial Material							T-CELL RESPONSES; DENDRITIC CELLS	In this issue of Immunity, Conde et al. (2015) showed that a costimulatory blockade favors the accumulation of CD209a(+) macrophages which, upon interaction with fucosylated tissue ligands, promotes the expansion of CD4(+) Foxp3(+) Treg cell number.	[Garcia-Vallejo, Juan J.; van Kooyk, Yvette] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Garcia-Vallejo, JJ (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam MF-B242, NL-1081 BT Amsterdam, Netherlands.	jj.garciavallejo@vumc.nl; y.vankooyk@vumc.nl	Vallejo, Juan Garcia/AAA-3765-2020; Garcia-Vallejo, Juan/H-4162-2012	Garcia-Vallejo, Juan/0000-0001-6238-7069; Van Kooyk, Yvette/0000-0001-5997-3665				Cheong C, 2010, CELL, V143, P416, DOI 10.1016/j.cell.2010.09.039; Conde P, 2015, IMMUNITY, V42, P1143, DOI 10.1016/j.immuni.2015.05.009; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Garcia-Vallejo JJ, 2013, TRENDS IMMUNOL, V34, P482, DOI 10.1016/j.it.2013.03.001; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Tacken PJ, 2005, BLOOD, V106, P1278, DOI 10.1182/blood-2005-01-0318; Unger WWJ, 2012, J CONTROL RELEASE, V160, P88, DOI 10.1016/j.jconrel.2012.02.007; Walsh KP, 2013, TRENDS IMMUNOL, V34, P521, DOI 10.1016/j.it.2013.07.006; Zuidwijk K, 2012, KIDNEY INT, V81, P64, DOI 10.1038/ki.2011.289	10	16	16	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2015	42	6					983	985		10.1016/j.immuni.2015.05.021	http://dx.doi.org/10.1016/j.immuni.2015.05.021			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK6UC	26084017	Bronze			2022-12-18	WOS:000356362800004
J	Cadwell, K; Philips, JA				Cadwell, Ken; Philips, Jennifer A.			Autophagy Meets Phagocytosis	IMMUNITY			English	Editorial Material							TUBERCULOSIS; MECHANISM; BCG		[Cadwell, Ken] NYU, Sch Med, Kimmel Ctr Biol & Med, New York, NY 10016 USA; [Cadwell, Ken] NYU, Sch Med, Skirball Inst, New York, NY 10016 USA; [Cadwell, Ken; Philips, Jennifer A.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA; [Philips, Jennifer A.] NYU, Sch Med, Dept Med, Div Infect Dis, New York, NY 10016 USA; [Philips, Jennifer A.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University; New York University; New York University; New York University	Cadwell, K (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, New York, NY 10016 USA.	ken.cadwell@med.nyu.edu		Cadwell, Ken/0000-0002-5860-0661				Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104; Bonilla DL, 2013, IMMUNITY, V39, P537, DOI 10.1016/j.immuni.2013.08.026; Castillo EF, 2012, P NATL ACAD SCI USA, V109, pE3168, DOI 10.1073/pnas.1210500109; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Harvey CJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002042; Jagannath C, 2009, NAT MED, V15, P267, DOI 10.1038/nm.1928; Lau A, 2010, MOL CELL BIOL, V30, P3275, DOI 10.1128/MCB.00248-10; Ponpuak M, 2010, IMMUNITY, V32, P329, DOI 10.1016/j.immuni.2010.02.009; Watson RO, 2012, CELL, V150, P803, DOI 10.1016/j.cell.2012.06.040	9	16	19	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					425	427		10.1016/j.immuni.2013.08.027	http://dx.doi.org/10.1016/j.immuni.2013.08.027			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24054324	Bronze			2022-12-18	WOS:000330949600005
J	Brown, MA; Hatfield, JK; Walker, ME; Sayed, BA				Brown, Melissa A.; Hatfield, Julianne K.; Walker, Maggie E.; Sayed, Blayne A.			A Game of Kit and Mouse: The Kit Is Still in the Bag	IMMUNITY			English	Letter							MAST-CELLS; AUTOIMMUNITY; MICE		[Brown, Melissa A.; Hatfield, Julianne K.; Walker, Maggie E.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Sayed, Blayne A.] Emory Univ, Sch Med, Dept Surg, Atlanta, GA 30322 USA	Northwestern University; Feinberg School of Medicine; Emory University	Brown, MA (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol & Immunol, Chicago, IL 60611 USA.	mastcells@gmail.com	Sayed, Blayne Amir/AAF-9501-2019	Sayed, Blayne Amir/0000-0003-3224-8871				Dudeck A, 2011, IMMUNITY, V34, P973, DOI 10.1016/j.immuni.2011.03.028; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Katz HR, 2011, IMMUNITY, V35, P668, DOI 10.1016/j.immuni.2011.11.004; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Lilla JN, 2011, BLOOD, V118, P6930, DOI 10.1182/blood-2011-03-343962; Otsuka A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025538; Piconese S, 2011, LAB INVEST, V91, P627, DOI 10.1038/labinvest.2011.3; Rao KN, 2008, ANN NY ACAD SCI, V1143, P83, DOI 10.1196/annals.1443.023; Sayed BA, 2011, J IMMUNOL, V186, P3294, DOI 10.4049/jimmunol.1003574; Walker ME, 2012, BBA-MOL BASIS DIS, V1822, P57, DOI 10.1016/j.bbadis.2011.02.009	10	16	16	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 29	2012	36	6					891	892		10.1016/j.immuni.2012.05.004	http://dx.doi.org/10.1016/j.immuni.2012.05.004			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	969ZE	22749345	Bronze			2022-12-18	WOS:000306097100003
J	Villanueva, CJ; Tontonoz, P				Villanueva, Claudio J.; Tontonoz, Peter			Licensing PPAR gamma to Work in Macrophages	IMMUNITY			English	Editorial Material							CELLS	The mechanisms that direct cell-type-specific peroxisome proliferator-activated receptor (PPAR) gene programs are poorly understood. In this issue of Immunity, Szanto et al. (2010) identify signal transducer and activator of transcription 6 as a transcriptional switch that licenses PPAR gamma-dependent gene expression in macrophages and dendritic cells.	[Villanueva, Claudio J.; Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Villanueva, Claudio J.; Tontonoz, Peter] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Tontonoz, P (corresponding author), Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA.	ptontonoz@mednet.ucla.edu		Villanueva, Claudio/0000-0002-9731-7463	Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL066088, R01 HL066088-12] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL066088] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Lefterova MI, 2010, MOL CELL BIOL, V30, P2078, DOI 10.1128/MCB.01651-09; Marathe C, 2009, J LIPID RES, V50, P214, DOI 10.1194/jlr.M800189-JLR200; Mukundan L, 2009, NAT MED, V15, P1266, DOI 10.1038/nm.2048; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224	8	16	16	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 24	2010	33	5					647	649		10.1016/j.immuni.2010.11.017	http://dx.doi.org/10.1016/j.immuni.2010.11.017			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	704VB	21094459	Green Accepted, Bronze			2022-12-18	WOS:000286082600002
J	Belz, GT; Masson, F				Belz, Gabrielle T.; Masson, Frederick			Interleukin-2 Tickles T Cell Memory	IMMUNITY			English	Editorial Material							EFFECTOR; EXPRESSION; BET		[Belz, Gabrielle T.; Masson, Frederick] Walter & Eliza Hall Inst Med Res, Div Immunol, Melbourne, Vic 3052, Australia	Walter & Eliza Hall Institute	Belz, GT (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, 1G Royal Parade, Melbourne, Vic 3052, Australia.	belz@wehi.edu.au	Belz, Gabrielle T/C-9350-2013	Belz, Gabrielle T/0000-0002-9660-9587; Masson, Frederic/0000-0001-9909-2985				Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kallies A, 2009, IMMUNITY, V31, P283, DOI 10.1016/j.immuni.2009.06.021; Kedzierska K, 2007, P NATL ACAD SCI USA, V104, P9782, DOI 10.1073/pnas.0703699104; Obar JJ, 2010, P NATL ACAD SCI USA, V107, P193, DOI 10.1073/pnas.0909945107; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Rutishauser RL, 2009, IMMUNITY, V31, P296, DOI 10.1016/j.immuni.2009.05.014; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790	11	16	21	2	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 29	2010	32	1					7	9		10.1016/j.immuni.2010.01.009	http://dx.doi.org/10.1016/j.immuni.2010.01.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	550HW	20152165	Bronze			2022-12-18	WOS:000274119900005
J	Sarafova, SD; Van Laethem, F; Adoro, S; Guinter, T; Sharrow, SO; Feigenbaum, L; Singer, A				Sarafova, Sophia D.; Van Laethem, Francois; Adoro, Stanley; Guinter, Terry; Sharrow, Susan O.; Feigenbaum, Lionel; Singer, Alfred			Upregulation of CD4 Expression during MHC Class II-Specific Positive Selection Is Essential for Error-free Lineage Choice	IMMUNITY			English	Article							FACTOR TH-POK; GENE-EXPRESSION; CORECEPTOR EXPRESSION; TRANSCRIPTION FACTORS; STOCHASTIC MECHANISM; SILENCER ELEMENT; RUNX PROTEINS; THYMOCYTES; COMMITMENT; DIFFERENTIATION	The lineage fate of developing thymocytes is determined by the persistence or cessation of T cell receptor (TCR) signaling during positive selection, with persistent TCR signaling required for CD4 lineage choice. We show here that transcriptional upregulation of CD4 expression is essential for error-free lineage choice during major histocompatibility complex class II (MHC II)-specific positive selection and is critical for error-free lineage choice in TCR-transgenic mice whose thymocytes compete for the identical selecting ligand. CD4 upregulation occurred for endogenously encoded CD4 coreceptors, but CD4 transgenes were downregulated during positive selection, disrupting MHC II-specific TCR signaling and causing lineage errors regardless of the absolute number or signaling strength of transgenic CD4 proteins. Thus, the kinetics of CD4 coreceptor expression during MIHC II-specific positive selection determines the integrity of CD4 lineage choice, revealing an elegant symmetry between coreceptor kinetics and lineage choice.	[Sarafova, Sophia D.; Van Laethem, Francois; Adoro, Stanley; Guinter, Terry; Sharrow, Susan O.; Singer, Alfred] NCI, Expt Immunol Branch, Bethesda, MD 20892 USA; [Feigenbaum, Lionel] NCI, SAIC Frederick, Frederick Canc Res & Dev Ctr, Frederick, MD 21702 USA; [Sarafova, Sophia D.] Davidson Coll, Dept Biol, Davidson, NC 28036 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Davidson College	Singer, A (corresponding author), NCI, Expt Immunol Branch, Bldg 10, Bethesda, MD 20892 USA.	singera@nih.gov			Intramural Research Program of the NIH; National Cancer Institute; enter for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC009273, ZIABC011106, ZICBC009255] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); enter for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank N. Taylor, R. Bosselut, H. Park, and R. Hodes for helpful discussions and critical readings of the manuscript; R. Bosselut for the original construction of re-engineered CD4<SUP>hCD2</SUP> transgenes; L. Granger and A. Adams for expert flow cytometry; D. Plugge for data analysis support; and K. Tsaneva-Atanasova for help with statistical analyses. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, and enter for Cancer Research.	Adoro S, 2008, J IMMUNOL, V181, P6975, DOI 10.4049/jimmunol.181.10.6975; Aliahmad P, 2008, J EXP MED, V205, P245, DOI 10.1084/jem.20071944; Bosselut R, 2003, J EXP MED, V197, P1709, DOI 10.1084/jem.20030170; Brugnera E, 2000, IMMUNITY, V13, P59, DOI 10.1016/S1074-7613(00)00008-X; Cibotti R, 2000, MOL CELL BIOL, V20, P3852, DOI 10.1128/MCB.20.11.3852-3859.2000; Dave VP, 1998, P NATL ACAD SCI USA, V95, P8187, DOI 10.1073/pnas.95.14.8187; DAVIS CB, 1993, CELL, V73, P237, DOI 10.1016/0092-8674(93)90226-G; Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; Ellmeier W, 1998, IMMUNITY, V9, P485, DOI 10.1016/S1074-7613(00)80632-9; He X, 2006, CURR OPIN IMMUNOL, V18, P135, DOI 10.1016/j.coi.2006.02.003; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Hedrick SM, 2008, IMMUNITY, V28, P297, DOI 10.1016/j.immuni.2008.02.011; Hernandez-Hoyos G, 2003, IMMUNITY, V19, P83, DOI 10.1016/S1074-7613(03)00176-6; HUESMANN M, 1991, CELL, V66, P533, DOI 10.1016/0092-8674(81)90016-7; Itano A, 2000, IMMUNITY, V12, P383, DOI 10.1016/S1074-7613(00)80190-9; Itano A, 1996, J EXP MED, V183, P731, DOI 10.1084/jem.183.3.731; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; Kioussis D, 2002, NAT REV IMMUNOL, V2, P909, DOI 10.1038/nri952; LEE NA, 1992, J EXP MED, V175, P1013, DOI 10.1084/jem.175.4.1013; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; Lucas B, 1996, IMMUNITY, V5, P461, DOI 10.1016/S1074-7613(00)80502-6; Matechak EO, 1996, IMMUNITY, V4, P337, DOI 10.1016/S1074-7613(00)80247-2; Sant'Angelo DB, 1998, IMMUNITY, V9, P179, DOI 10.1016/S1074-7613(00)80600-7; Sarafova SD, 2005, IMMUNITY, V23, P75, DOI 10.1016/j.immuni.2005.05.011; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Singer A, 2004, ADV IMMUNOL, V83, P91; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2004, ADV IMMUNOL, V83, P55; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007; Wang L, 2008, NAT IMMUNOL, V9, P1122, DOI 10.1038/ni.1647; Wilkinson B, 2002, NAT IMMUNOL, V3, P272, DOI 10.1038/ni767; Wong P, 2000, J IMMUNOL, V164, P6252, DOI 10.4049/jimmunol.164.12.6252; Yasutomo K, 2000, NATURE, V404, P506, DOI 10.1038/35006664	42	16	16	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2009	31	3					480	490		10.1016/j.immuni.2009.07.006	http://dx.doi.org/10.1016/j.immuni.2009.07.006			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19747858	Green Accepted, Bronze			2022-12-18	WOS:000270525900015
J	Trapani, JA; Bird, PI				Trapani, Joseph A.; Bird, Phillip I.			A Renaissance in Understanding the Multiple and Diverse Functions of Granzymes?	IMMUNITY			English	Editorial Material							TARGET-CELL DEATH; PERFORIN; INDUCE	In this issue of Immunity, Metkar et al. (2008) present evidence that granzyme A plays a role in inflammatory signaling and that contrary to previous studies, it is incapable of inducing target cell death. The work challenges us to reconsider the broader biological roles of all the granzymes.	[Trapani, Joseph A.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic 3002, Australia; [Bird, Phillip I.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia	Peter Maccallum Cancer Center; Monash University	Trapani, JA (corresponding author), Peter MacCallum Canc Ctr, Canc Immunol Program, St Andrews Pl, Melbourne, Vic 3002, Australia.	joe.trapani@petermac.org; phil.bird@med.monash.edu.au		Trapani, Joseph/0000-0003-0983-1532; Bird, Phillip/0000-0002-6695-606X				Andrade F, 2007, EMBO J, V26, P2148, DOI 10.1038/sj.emboj.7601650; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; KRAMER MD, 1987, IMMUNOL TODAY, V8, P140, DOI 10.1016/0167-5699(87)90141-1; Martinvalet D, 2008, CELL, V133, P681, DOI 10.1016/j.cell.2008.03.032; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; NAKAJIMA H, 1995, J EXP MED, V181, P1037, DOI 10.1084/jem.181.3.1037; SHI LF, 1992, J EXP MED, V176, P1521, DOI 10.1084/jem.176.6.1521; Van Damme P, 2009, MOL CELL PROTEOMICS, V8, P258, DOI 10.1074/mcp.M800060-MCP200; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983	9	16	16	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 14	2008	29	5					665	667		10.1016/j.immuni.2008.10.002	http://dx.doi.org/10.1016/j.immuni.2008.10.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	19006688	Bronze			2022-12-18	WOS:000261036000002
J	Miller, EA; Ernst, JD				Miller, Elizabeth A.; Ernst, Joel D.			Illuminating the black box of TNF action in tuberculous granulomas	IMMUNITY			English	Editorial Material							TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSE; FACTOR-ALPHA; INFECTION; MACROPHAGE	TNF clearly contributes to immunity to intracellular pathogens, but how it does so is incompletely understood. In this issue of Immunity, Clay et al. (2008) provide unique insights, using intravital microscopy and the zebrafish-embryo model of tuberculosis.	[Miller, Elizabeth A.; Ernst, Joel D.] NYU, Sch Med, Dept Med, Div Infect Dis, New York, NY 10016 USA; [Miller, Elizabeth A.] NYU, Sch Med, Inst Canc, New York, NY 10016 USA; [Ernst, Joel D.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Ernst, Joel D.] NYU, Sch Med, Dept Microbiol, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Ernst, JD (corresponding author), NYU, Sch Med, Dept Med, Div Infect Dis, New York, NY 10016 USA.	joel.ernst@med.nyu.edu		Ernst, Joel/0000-0001-9951-6207				Algood HMS, 2004, J IMMUNOL, V172, P6846, DOI 10.4049/jimmunol.172.11.6846; Chakravarty SD, 2008, INFECT IMMUN, V76, P916, DOI 10.1128/IAI.01011-07; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Keane J, 2002, TUBERCULOSIS, V82, P55, DOI 10.1054/tube.2002.0322; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Mohan VP, 2001, INFECT IMMUN, V69, P1847, DOI 10.1128/IAI.69.3.1847-1855.2001; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Zganiacz A, 2004, J CLIN INVEST, V113, P401, DOI 10.1172/JCI200418991	10	16	17	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	AUG 15	2008	29	2					175	177		10.1016/j.immuni.2008.07.003	http://dx.doi.org/10.1016/j.immuni.2008.07.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	339XO	18701080	Bronze			2022-12-18	WOS:000258610800005
J	Onai, N; Manz, MG				Onai, Nobuyuki; Manz, Markus G.			The STATs on dendritic cell development	IMMUNITY			English	Editorial Material								Dendritic cells are a heterogeneous group of antigen presenting cells. In this issue of Immunity, Esashi et al. (2008) demonstrate how cytokine-receptor-regulated downstream transcription factors direct dendritic cell subpopulation differentiation from hematopoietic progenitor cells.	[Onai, Nobuyuki] Akita Univ, Grad Sch Med, Dept Immunol, Akita 0108543, Japan; [Manz, Markus G.] Biomed Res Inst, CH-6500 Bellinzona, Switzerland; [Manz, Markus G.] Osped San Giovanni Bellinzona, Dept Hematol, Oncol Inst So Switzerland, CH-6500 Bellinzona, Switzerland	Akita University; Universita della Svizzera Italiana; Institute of Oncology Research (IOR); Regional Hospital of Bellinzona & Valleys, San Giovanni	Onai, N (corresponding author), Akita Univ, Grad Sch Med, Dept Immunol, 1-1-1 Hondo, Akita 0108543, Japan.	nobuonai@med.akita-u.ac.jp; manz@irb.unisi.ch	Manz, Markus G/C-7588-2011	Manz, Markus/0000-0002-4676-7931; Onai, Nobuyuki/0000-0003-2246-4917				Esashi E, 2008, IMMUNITY, V28, P509, DOI 10.1016/j.immuni.2008.02.013; Fancke B, 2008, BLOOD, V111, P150, DOI 10.1182/blood-2007-05-089292; Gilliet M, 2002, J EXP MED, V195, P953, DOI 10.1084/jem.20020045; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Onai N, 2006, J EXP MED, V203, P227, DOI 10.1084/jem.20051645; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Schiavoni G, 2002, J EXP MED, V196, P1415, DOI 10.1084/jem.20021263; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Zenke M, 2006, TRENDS IMMUNOL, V27, P140, DOI 10.1016/j.it.2005.12.007	10	16	18	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR	2008	28	4					490	492		10.1016/j.immuni.2008.03.006	http://dx.doi.org/10.1016/j.immuni.2008.03.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18400192	Bronze			2022-12-18	WOS:000254939400008
J	Davis, JM; Ramakrishnan, L				Davis, J. Muse; Ramakrishnan, Lalita			"The very pulse of the machine": The tuberculous granuloma in motion	IMMUNITY			English	Editorial Material							MACROPHAGE; ZEBRAFISH	What is happening inside the tuberculous granuloma? In this issue of Immunity, Egen et al. (2008) present live images of tuberculous granulomas of the mouse, demonstrating the influx and incessant wandering of T lymphocytes.	[Ramakrishnan, Lalita] Univ Washington, Dept Microbiol Immunol & Med, Seattle, WA 98195 USA; [Davis, J. Muse] Emory Univ, Immunol & Mol Pathogenesis Grad Program, Atlanta, GA 30322 USA	University of Washington; University of Washington Seattle; Emory University	Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol Immunol & Med, Seattle, WA 98195 USA.	lalitar@u.washington.edu		Ramakrishnan, Lalita/0000-0003-0692-5533; Davis, J. Muse/0000-0001-9959-6921				ADAMS DO, 1976, AM J PATHOL, V84, P164; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Cosma CL, 2004, NAT IMMUNOL, V5, P828, DOI 10.1038/ni1091; DANNENBERG AM, 1993, HOSP PRACT, V28, P51, DOI 10.1080/21548331.1993.11442738; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Egen JG, 2008, IMMUNITY, V28, P271, DOI 10.1016/j.immuni.2007.12.010; Flynn JL, 2006, MICROBES INFECT, V8, P1179, DOI 10.1016/j.micinf.2005.10.033; Ulrichs T, 2004, J PATHOL, V204, P217, DOI 10.1002/path.1628; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367	9	16	16	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	FEB	2008	28	2					146	148		10.1016/j.immuni.2008.01.002	http://dx.doi.org/10.1016/j.immuni.2008.01.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	264GH	18275827	Bronze			2022-12-18	WOS:000253275000005
J	Rescigno, M				Rescigno, M			CCR6(+) dendritic cells: The gut tactical-response unit	IMMUNITY			English	Editorial Material							DOME	How an immune response to pathogens is initiated in the gut is still an open question. In this issue of Immunity, Salazar-Gonzales et al., 2006 find that a distinct subset of CCR6-expressing dendritic cells are absolutely required to activate anti-Salmonella-specific T cells.	European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy	IRCCS European Institute of Oncology (IEO)	Rescigno, M (corresponding author), European Inst Oncol, Dept Expt Oncol, Via Ripamonti 435, I-20141 Milan, Italy.		Rescigno, Maria/J-9704-2012	Rescigno, Maria/0000-0002-6464-509X				Hopkins SA, 1997, ADV EXP MED BIOL, V417, P105; Iwasaki A, 2000, J EXP MED, V191, P1381, DOI 10.1084/jem.191.8.1381; Jepson MA, 2001, MICROBES INFECT, V3, P1183, DOI 10.1016/S1286-4579(01)01478-2; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192; Salazar-Gonzalez RM, 2006, IMMUNITY, V24, P623, DOI 10.1016/j.immuni.2006.02.015; Zhao XY, 2003, J IMMUNOL, V171, P2797, DOI 10.4049/jimmunol.171.6.2797	8	16	16	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2006	24	5					508	510		10.1016/j.immuni.2006.05.005	http://dx.doi.org/10.1016/j.immuni.2006.05.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713968	Bronze			2022-12-18	WOS:000237970100007
J	Young, HA				Young, HA			Unraveling the pros and cons of interferon-gamma gene regulation	IMMUNITY			English	Editorial Material							T-BET; IL-12; BINDING; CELLS	Although transforming growth factor-beta (TGF-beta) inhibition of interferon-gamma (IFN-gamma) expression has been known for some time, in this issue of Immunity, Yu et al. (2006) are the first to detail the crosstalk between proinflammatory cytokine and TGF-beta signaling that regulates IFN-gamma expression.	NCI, Canc Res Ctr, Frederick, MD 21702 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Young, HA (corresponding author), NCI, Canc Res Ctr, Frederick, MD 21702 USA.		Young, Howard/A-6350-2008; Young, Howard/R-5140-2019	Young, Howard/0000-0002-3118-5111; 	NATIONAL CANCER INSTITUTE [Z01BC009283, ZIABC009283] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BELLONE G, 1995, J IMMUNOL, V155, P1066; HUNTER CA, 1995, EUR J IMMUNOL, V25, P994, DOI 10.1002/eji.1830250420; Kaminuma O, 2004, FEBS LETT, V570, P63, DOI 10.1016/j.febslet.2004.06.026; Nakahira M, 2002, J IMMUNOL, V168, P1146, DOI 10.4049/jimmunol.168.3.1146; Okamura H, 1998, CURR OPIN IMMUNOL, V10, P259, DOI 10.1016/S0952-7915(98)80163-5; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Szabo SJ, 2002, SCIENCE, V295, P338, DOI 10.1126/science.1065543; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; YE JP, 1995, J LEUKOCYTE BIOL, V58, P225, DOI 10.1002/jlb.58.2.225; Yu JH, 2006, IMMUNITY, V24, P575, DOI 10.1016/j.immuni.2006.03.016	10	16	20	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2006	24	5					506	507		10.1016/j.immuni.2006.05.004	http://dx.doi.org/10.1016/j.immuni.2006.05.004			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713967	Bronze			2022-12-18	WOS:000237970100006
J	Ward, ES				Ward, ES			Acquiring maternal immunoglobulin: Different receptors, similar functions	IMMUNITY			English	Editorial Material							I-RELATED RECEPTOR; FCRN; TRANSPORT	The isolation of a novel Fc receptor (FcRY) from chicken yolk sac provides insight at the mechanistic level as to how avian maternal immunoglobulin (IgY) is transferred to offspring. This receptor is distinct from its mammalian counterpart and is a phospholipase A(2) receptor homolog. Biophysical analyses indicate that FcRY achieves pH-dependent binding to IgY through a conformational change.	Univ Texas, SW Med Ctr, Ctr Immunol, Dallas, TX 75390 USA	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas	Ward, ES (corresponding author), Univ Texas, SW Med Ctr, Ctr Immunol, 6000 Harry Hines Blvd, Dallas, TX 75390 USA.							Brambell FWR., 1970, N HOLL RES MONOGR FR, V18; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Ghetie V, 2000, ANNU REV IMMUNOL, V18, P739, DOI 10.1146/annurev.immunol.18.1.739; Medesan C, 1997, J IMMUNOL, V158, P2211; Morrison SL, 2002, MOL IMMUNOL, V38, P619, DOI 10.1016/S0161-5890(01)00095-5; Ober RJ, 2004, J IMMUNOL, V172, P2021, DOI 10.4049/jimmunol.172.4.2021; Spiekermann GM, 2002, J EXP MED, V196, P303, DOI 10.1084/jem.20020400; WARR GW, 1995, IMMUNOL TODAY, V16, P392, DOI 10.1016/0167-5699(95)80008-5; West AP, 2004, IMMUNITY, V20, P601, DOI 10.1016/S1074-7613(04)00113-X; Wu Z, 2001, J BIOL CHEM, V276, P5240, DOI 10.1074/jbc.M006684200	10	16	17	0	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2004	20	5					507	508		10.1016/S1074-7613(04)00117-7	http://dx.doi.org/10.1016/S1074-7613(04)00117-7			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	823RX	15142519	Bronze			2022-12-18	WOS:000221631900001
J	Roche, PA				Roche, PA			Intracellular protein traffic in lymphocytes: "How do I get THERE from HERE?"	IMMUNITY			English	Review							TRANS-GOLGI NETWORK; ENDOPLASMIC-RETICULUM; CELL-SURFACE; ANTIGEN PRESENTATION; MEMBRANE-PROTEIN; DENDRITIC CELLS; MOLECULES; COMPLEXES; INTERNALIZATION; ASSOCIATION		NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Roche, PA (corresponding author), NCI, Expt Immunol Branch, NIH, Bethesda, MD 20892 USA.			Roche, Paul/0000-0002-8949-9172	NATIONAL CANCER INSTITUTE [Z01BC009404, ZIABC009404] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Avery J, 1999, ANNU REV PHYSIOL, V61, P777, DOI 10.1146/annurev.physiol.61.1.777; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Baram D, 1999, J EXP MED, V189, P1649, DOI 10.1084/jem.189.10.1649; BENAROCH P, 1995, EMBO J, V14, P37, DOI 10.1002/j.1460-2075.1995.tb06973.x; Bonfanti L, 1998, CELL, V95, P993, DOI 10.1016/S0092-8674(00)81723-7; Cole NB, 1998, J CELL BIOL, V140, P1, DOI 10.1083/jcb.140.1.1; Farquhar MG, 1998, TRENDS CELL BIOL, V8, P2, DOI 10.1016/S0962-8924(97)01187-2; Geuze HJ, 1998, IMMUNOL TODAY, V19, P282, DOI 10.1016/S0167-5699(98)01269-9; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; Guo ZH, 1998, CELL, V94, P537, DOI 10.1016/S0092-8674(00)81594-9; Hegde RS, 1997, CELL, V91, P575, DOI 10.1016/S0092-8674(00)80445-6; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Kutay Ulrike, 1993, Trends in Cell Biology, V3, P72, DOI 10.1016/0962-8924(93)90066-A; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Mellman I, 1998, TRENDS CELL BIOL, V8, P231, DOI 10.1016/S0962-8924(98)01276-8; PELCHENMATTHEWS A, 1993, J EXP MED, V178, P1209, DOI 10.1084/jem.178.4.1209; Pelham HRB, 1998, TRENDS CELL BIOL, V8, P45, DOI 10.1016/S0962-8924(97)01185-9; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Pierre P, 1998, CELL, V93, P1135, DOI 10.1016/S0092-8674(00)81458-0; Piguet V, 1999, CELL, V97, P63, DOI 10.1016/S0092-8674(00)80715-1; PINET V, 1995, NATURE, V375, P603, DOI 10.1038/375603a0; Rapoport TA, 1996, ANNU REV BIOCHEM, V65, P271; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; ROCHE PA, 1993, P NATL ACAD SCI USA, V90, P8581, DOI 10.1073/pnas.90.18.8581; Roth MG, 1999, TRENDS CELL BIOL, V9, P174, DOI 10.1016/S0962-8924(99)01535-4; Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227; ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0; Saudrais C, 1998, J IMMUNOL, V160, P2597; SCHELLER RH, 1995, NEURON, V14, P893; Schimmoller F, 1998, J BIOL CHEM, V273, P22161, DOI 10.1074/jbc.273.35.22161; Shiratori T, 1997, IMMUNITY, V6, P583, DOI 10.1016/S1074-7613(00)80346-5; SOGAARD M, 1994, CELL, V78, P937, DOI 10.1016/0092-8674(94)90270-4; Tooze SA, 1998, BBA-MOL CELL RES, V1404, P231, DOI 10.1016/S0167-4889(98)00059-7; Traub LM, 1997, CURR OPIN CELL BIOL, V9, P527, DOI 10.1016/S0955-0674(97)80029-4; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; Watts C, 1997, ANNU REV IMMUNOL, V15, P821, DOI 10.1146/annurev.immunol.15.1.821; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; WIEST DL, 1995, EMBO J, V14, P3425, DOI 10.1002/j.1460-2075.1995.tb07348.x; Wubbolts R, 1996, J CELL BIOL, V135, P611, DOI 10.1083/jcb.135.3.611; ZIEGLER HK, 1982, P NATL ACAD SCI-BIOL, V79, P175, DOI 10.1073/pnas.79.1.175	41	16	16	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	1999	11	4					391	398		10.1016/S1074-7613(00)80114-4	http://dx.doi.org/10.1016/S1074-7613(00)80114-4			8	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	249QE	10549621	Bronze			2022-12-18	WOS:000083343100001
J	Erttmann, SF; Swacha, P; Aung, KM; Brindefalk, B; Jiang, H; Hartova, A; Uhlin, BE; Wai, SN; Gekara, NO				Erttmann, Saskia F.; Swacha, Patrycja; Aung, Kyaw Min; Brindefalk, Bjorn; Jiang, Hui; Hartova, Anetta; Uhlin, Bernt Eric; Wai, Sun N.; Gekara, Nelson O.			The gut microbiota prime systemic antiviral immunity via the cGAS-STING-IFN-I axis	IMMUNITY			English	Article							CYTOSOLIC DNA SENSOR; TOLL-LIKE RECEPTORS; COMMENSAL MICROBIOTA; INNATE; INFLUENZA; INFECTION; RESPONSES; BACTERIA; GENES; LIPOPOLYSACCHARIDE	The microbiota are vital for immune homeostasis and provide a competitive barrier to bacterial and fungal pathogens. Here, we investigated how gut commensals modulate systemic immunity and response to viral infection. Antibiotic suppression of the gut microbiota reduced systemic tonic type I interferon (IFN-I) and antiviral priming. The microbiota-driven tonic IFN-I-response was dependent on cGAS-STING but not on TLR signaling or direct host-bacteria interactions. Instead, membrane vesicles (MVs) from extracellular bacteria activated the cGAS-STING-IFN-I axis by delivering bacterial DNA into distal host cells. DNA-containing MVs from the gut microbiota were found in circulation and promoted the clearance of both DNA (herpes simplex virus type 1) and RNA (vesicular stomatitis virus) viruses in a cGAS-dependent manner. In summary, this study establishes an important role for the microbiota in peripheral cGAS-STING activation, which promotes host resistance to systemic viral infections. Moreover, it uncovers an underappreciated risk of antibiotic use during viral infections.	[Erttmann, Saskia F.; Uhlin, Bernt Eric; Wai, Sun N.; Gekara, Nelson O.] Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res UCMR, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden; [Swacha, Patrycja; Aung, Kyaw Min; Jiang, Hui; Gekara, Nelson O.] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden; [Brindefalk, Bjorn] Swedish Def Res Agcy, CBRN Def & Secur, Umea, Sweden; [Hartova, Anetta] Univ Gothenburg, Sahlgrenska Acad Fac Sci, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Hartova, Anetta] Univ Gothenburg, Wallenberg Ctr Mol & Translat Med, Gothenburg, Sweden	Umea University; Stockholm University; Saab Group; University of Gothenburg; University of Gothenburg	Gekara, NO (corresponding author), Umea Univ, Dept Mol Biol, Umea Ctr Microbial Res UCMR, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden.; Gekara, NO (corresponding author), Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, S-10691 Stockholm, Sweden.	nelson.gekara@su.se		Erttmann, Saskia Friederike/0000-0003-2398-8405; Uhlin, Bernt Eric/0000-0002-2991-8072	Stockholm University; Laboratory for Molecular Infection Medicine Sweden (MIMS); Swedish Research Council [2015-02857, 2016-00890, 2018-02914, 2015-03007, 2015-06824, 2019-01720, 2016-06598]; Ume University (Faculty of Science and Technology); Kempestiftelserna [SMK-1858.2]; Ake Wibergs stiftelse [M19-0314]; Knut and Alice Wallenberg Foundation; University of Gothenburg; Swedish Cancer Foundation [CAN 2017/421, 2017/419]	Stockholm University; Laboratory for Molecular Infection Medicine Sweden (MIMS); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ume University (Faculty of Science and Technology); Kempestiftelserna; Ake Wibergs stiftelse; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); University of Gothenburg; Swedish Cancer Foundation	We are grateful to Monica Persson for helping with the atomic force micro-scopy (AFM) and Paulina Pastuszek for mouse pellet DNA extraction and 16S qPCR. We are grateful to Drs. S. Lienenklaus and S. Weiss (HZI-Germany) for the Ifnb+/Db-luc mice. Funding: This work was funded by Stockholm Univer-sity, the Laboratory for Molecular Infection Medicine Sweden (MIMS) , the Swedish Research Council (grants 2015-02857 and 2016-00890 to N.O.G.; 2018-02914 to S.N.W.; 2015-03007, 2015-06824, and 2019-01720 to B. E.U.; and 2016-06598 to MIMS) , Ume University (Faculty of Science and Technology starting grant to S.F.E.) , Kempestiftelserna (SMK-1858.2 to S.F.E.) , Ake Wibergs stiftelse (M19-0314 to S.F.E.) , Knut and Alice Wallenberg Foundation, University of Gothenburg (to A.H.) , and the Swedish Cancer Foundation (grants CAN 2017/421 to N.O.G. and 2017/419 to S.N.W.) .	Abreu MT, 2010, NAT REV IMMUNOL, V10, P131, DOI 10.1038/nri2707; Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Albers J, 2015, J CLIN INVEST, V125, P1603, DOI 10.1172/JCI79743; Auta A, 2019, J INFECTION, V78, P8, DOI 10.1016/j.jinf.2018.07.001; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Blander JM, 2017, NAT IMMUNOL, V18, P851, DOI 10.1038/ni.3780; Bradley KC, 2019, CELL REP, V28, P245, DOI 10.1016/j.celrep.2019.05.105; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; CASADABAN MJ, 1980, J BACTERIOL, V143, P971, DOI 10.1128/JB.143.2.971-980.1980; Chou HH, 2015, P NATL ACAD SCI USA, V112, P2175, DOI 10.1073/pnas.1424775112; d'Hennezel E, 2017, MSYSTEMS, V2, DOI 10.1128/mSystems.00046-17; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dietrich N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010250; DOLOWY WC, 1964, P SOC EXP BIOL MED, V116, P365, DOI 10.3181/00379727-116-29249; DUNNY GM, 1978, P NATL ACAD SCI USA, V75, P3479, DOI 10.1073/pnas.75.7.3479; Ganal SC, 2012, IMMUNITY, V37, P171, DOI 10.1016/j.immuni.2012.05.020; Gough DJ, 2012, IMMUNITY, V36, P166, DOI 10.1016/j.immuni.2012.01.011; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Howell DPG, 2003, MOL THER, V8, P957, DOI 10.1016/j.ymthe.2003.09.011; Ichinohe T, 2011, P NATL ACAD SCI USA, V108, P5354, DOI 10.1073/pnas.1019378108; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; ITO Y, 1976, INFECT IMMUN, V13, P332, DOI 10.1128/IAI.13.2.332-336.1976; Jones MK, 2014, SCIENCE, V346, P755, DOI 10.1126/science.1257147; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Khosravi A, 2013, CURR OPIN MICROBIOL, V16, P221, DOI 10.1016/j.mib.2013.03.009; Kolling GL, 1999, APPL ENVIRON MICROB, V65, P1843; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Lienenklaus S, 2009, J IMMUNOL, V183, P3229, DOI 10.4049/jimmunol.0804277; Lima DS, 2021, CELL, V184, P3794, DOI 10.1016/j.cell.2021.05.020; Littman DR, 2011, CELL HOST MICROBE, V10, P311, DOI 10.1016/j.chom.2011.10.004; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Mashburn-Warren LM, 2006, MOL MICROBIOL, V61, P839, DOI 10.1111/j.1365-2958.2006.05272.x; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Nair S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003999; Nandakumar R, 2019, NAT MICROBIOL, V4, P701, DOI 10.1038/s41564-019-0367-z; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Robinson CM, 2014, CELL HOST MICROBE, V15, P36, DOI 10.1016/j.chom.2013.12.004; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Shibolet O, 2007, AM J PHYSIOL-GASTR L, V292, pG1469, DOI 10.1152/ajpgi.00531.2006; Shmuel-Galia L, 2021, IMMUNITY, V54, P1137, DOI 10.1016/j.immuni.2021.05.008; Sisquella X, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02083-1; Somerville JE, 1996, J CLIN INVEST, V97, P359, DOI 10.1172/JCI118423; Steed AL, 2017, SCIENCE, V357, P498, DOI 10.1126/science.aam5336; Stefan KL, 2020, CELL, V183, P1312, DOI 10.1016/j.cell.2020.10.047; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Summers BC, 2002, J VIROL, V76, P7020, DOI 10.1128/JVI.76.14.7020-7029.2002; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Taniguchi T, 2001, NAT REV MOL CELL BIO, V2, P378, DOI 10.1038/35073080; Thackray LB, 2018, CELL REP, V22, P3440, DOI 10.1016/j.celrep.2018.03.001; Tsuneyoshi N, 2006, CELL IMMUNOL, V244, P57, DOI 10.1016/j.cellimm.2007.02.010; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; Wilks J, 2013, IMMUNOL REV, V255, P222, DOI 10.1111/imr.12097; Winkler ES, 2020, CELL, V182, P901, DOI 10.1016/j.cell.2020.06.029	67	15	15	30	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 10	2022	55	5					847	+		10.1016/j.immuni.2022.04.006	http://dx.doi.org/10.1016/j.immuni.2022.04.006			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1P7FS	35545033	hybrid, Green Published			2022-12-18	WOS:000802171100010
J	Chaurio, RA; Anadon, CM; Costich, TL; Payne, KK; Biswas, S; Harro, CM; Moran, C; Ortiz, AC; Cortina, C; Rigolizzo, KE; Sprenger, KB; Mine, JA; Innamarato, P; Mandal, G; Powers, JJ; Martin, A; Wang, ZT; Mehta, S; Perez, BA; Li, R; Robinson, J; Kroeger, JL; Curiel, TJ; Yu, XQ; Rodriguez, PC; Conejo-Garcia, JR				Chaurio, Ricardo A.; Anadon, Carmen M.; Costich, Tara Lee; Payne, Kyle K.; Biswas, Subir; Harro, Carly M.; Moran, Carlos; Ortiz, Antonio C.; Cortina, Carla; Rigolizzo, Kristen E.; Sprenger, Kimberly B.; Mine, Jessica A.; Innamarato, Patrick; Mandal, Gunjan; Powers, John J.; Martin, Alexandra; Wang, Zhitao; Mehta, Sumit; Perez, Bradford A.; Li, Roger; Robinson, John; Kroeger, Jodi L.; Curiel, Tyler J.; Yu, Xiaoqing; Rodriguez, Paulo C.; Conejo-Garcia, Jose R.			TGF-beta-mediated silencing of genomic organizer SATB1 promotes Tfh cell differentiation and formation of intra-tumoral tertiary lymphoid structures	IMMUNITY			English	Article							FOLLICULAR HELPER-CELLS; T-CELLS; INFILTRATION; EXPRESSION; BREAST; SUPPRESSION; PROGRESSION; INDUCTION; PROGNOSIS; RESPONSES	The immune checkpoint receptor PD-1 on T follicular helper (Tfh) cells promotes Tfh:B cell interactions and appropriate positioning within tissues. Here, we examined the impact of regulation of PD-1 expression by the genomic organizer SATB1 on Tfh cell differentiation. Vaccination of CD4(Cre)Satb1(f/f) mice enriched for antigen-specific Tfh cells, and TGF-beta-mediated repression of SATB1 enhanced Tfh differentiation of human T cells. Mechanistically, high Icos expression in Satb1(-/-) CD4(+) T cells promoted Tfh cell differentiation by preventing T follicular regulatory cell skewing and resulted in increased isotype-switched B cell responses in vivo. Ovarian tumors in CD4(Cre)Satb1(f/f) mice accumulated tumor antigen-specific, LIGHT(+)CXCL13(+)IL-21(+) Tfh cells and tertiary lymphoid structures (TLS). TLS formation decreased tumor growth in a CD4(+) T cell and CXCL13-dependent manner. The transfer of Tfh cells, but not naive CD4(+) T cells, induced TLS at tumor beds and decreased tumor growth. Thus, TGF-beta-mediated silencing of Satb1 licenses Tfh cell differentiation, providing insight into the genesis of TLS within tumors.	[Chaurio, Ricardo A.; Anadon, Carmen M.; Costich, Tara Lee; Payne, Kyle K.; Biswas, Subir; Harro, Carly M.; Cortina, Carla; Rigolizzo, Kristen E.; Sprenger, Kimberly B.; Mine, Jessica A.; Innamarato, Patrick; Mandal, Gunjan; Powers, John J.; Wang, Zhitao; Rodriguez, Paulo C.; Conejo-Garcia, Jose R.] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA; [Moran, Carlos] H Lee Moffitt Canc Ctr & Res Inst, Dept Pathol, Tampa, FL 33612 USA; [Ortiz, Antonio C.] H Lee Moffitt Canc Ctr & Res Inst, Dept Analyt Microscopy, Tampa, FL 33612 USA; [Martin, Alexandra; Mehta, Sumit; Conejo-Garcia, Jose R.] H Lee Moffitt Canc Ctr & Res Inst, Dept Gynecol Oncol, Tampa, FL 33612 USA; [Perez, Bradford A.] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Therapy, Tampa, FL 33612 USA; [Li, Roger] H Lee Moffitt Canc Ctr & Res Inst, Dept Genitourinary Oncol, Tampa, FL 33612 USA; [Robinson, John; Kroeger, Jodi L.] H Lee Moffitt Canc Ctr & Res Inst, Dept Flow Cytometry Core, Tampa, FL 33612 USA; [Curiel, Tyler J.] Univ Texas Hlth, Mays Canc Ctr, San Antonio, TX 78229 USA; [Yu, Xiaoqing] H Lee Moffitt Canc Ctr & Res Inst, Dept Biostat, Tampa, FL 33612 USA; [Yu, Xiaoqing] H Lee Moffitt Canc Ctr & Res Inst, Dept Bioinformat, Tampa, FL 33612 USA; [Conejo-Garcia, Jose R.] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of Texas System; University of Texas Health San Antonio; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute	Conejo-Garcia, JR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA.; Conejo-Garcia, JR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Gynecol Oncol, Tampa, FL 33612 USA.; Conejo-Garcia, JR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL 33612 USA.	jose.conejo-garcia@moffitt.org	Rodríguez, Paulo/HDM-9539-2022; Powers, John/AGY-0294-2022	Powers, John/0000-0003-3800-2645; BISWAS, SUBIR/0000-0003-2428-6288; Innamarato, Patrick/0000-0001-7601-1134; Conejo-Garcia, Jose/0000-0001-6431-4074; Cortina Martin, Carla/0000-0002-4353-4008; Costich, Tara Lee/0000-0003-2074-6275; Moran-Segura, Carlos/0000-0001-8702-0554; Anadon Galindo, Carmen Maria/0000-0002-8851-4545; Rodriguez, Paulo/0000-0001-7480-6566	Cancer Center Support Grant (CCSG) [CA076292]; American Cancer Society Postdoctoral Fellowship;  [R01CA157664];  [R01CA124515];  [R01CA178687];  [R01CA211913];  [U01CA232758];  [R01CA184185];  [T32CA009140]	Cancer Center Support Grant (CCSG); American Cancer Society Postdoctoral Fellowship(American Cancer Society); ; ; ; ; ; ; 	Support for Shared Resources was provided by Cancer Center Support Grant (CCSG) CA076292 to H. Lee Moffitt Cancer Center. This study was supported by R01CA157664, R01CA124515, R01CA178687, R01CA211913, and U01CA232758 to J.R.C.-G. and R01CA184185 to P.C.R. K.K.P. was sup-ported by T32CA009140 and The American Cancer Society Postdoctoral Fellowship. We are especially grateful to the Advanced Analytical and Digital Pathology (J. Nguyen) , Flow Cytometry and Tissue Core Shared Resources at Moffitt Cancer Center, for exceptional support. We would like to thank the staff members of Comparative Medicine in the Stabile Research Building Vi-varium for their husbandry and technical assistance. We also thanks to Johana Melendez, Jonathan Semidey-Hurtado, Mary Jane Perkins, Noel D. Clark, Neelkamal Chaudhary, and Haley E. Bruns for technical support.	Allegrezza MJ, 2016, CANCER RES, V76, P6253, DOI 10.1158/0008-5472.CAN-16-1308; Biswas S, 2021, NATURE, V591, P464, DOI 10.1038/s41586-020-03144-0; Buckley CD, 2015, ANNU REV IMMUNOL, V33, P715, DOI 10.1146/annurev-immunol-032713-120252; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cillo AR, 2020, IMMUNITY, V52, P183, DOI 10.1016/j.immuni.2019.11.014; Conejo-Garcia JR, 2020, SEMIN IMMUNOL, V49, DOI 10.1016/j.smim.2020.101419; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Di Caro G, 2014, CLIN CANCER RES, V20, P2147, DOI 10.1158/1078-0432.CCR-13-2590; Engelhard VH, 2018, J IMMUNOL, V200, P432, DOI 10.4049/jimmunol.1701269; Georgiev H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00714; Germain C, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00067; Gonzalez-Figueroa P, 2021, CELL, V184, P1775, DOI 10.1016/j.cell.2021.02.027; Gu-Trantien C, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91487; Gu-Trantien C, 2013, J CLIN INVEST, V123, P2873, DOI 10.1172/JCI67428; Havenar-Daughton C, 2016, P NATL ACAD SCI USA, V113, P2702, DOI 10.1073/pnas.1520112113; Hiraoka N, 2015, BRIT J CANCER, V112, P1782, DOI 10.1038/bjc.2015.145; Hollern DP, 2019, CELL, V179, P1191, DOI 10.1016/j.cell.2019.10.028; Iglesia MD, 2014, CLIN CANCER RES, V20, P3818, DOI 10.1158/1078-0432.CCR-13-3368; Johansson-Percival A, 2017, NAT IMMUNOL, V18, P1207, DOI 10.1038/ni.3836; Kakugawa K, 2017, CELL REP, V19, P1176, DOI 10.1016/j.celrep.2017.04.038; Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646; Kroeger DR, 2016, CLIN CANCER RES, V22, P3005, DOI 10.1158/1078-0432.CCR-15-2762; Marinkovic T, 2006, J CLIN INVEST, V116, P2622, DOI 10.1172/JCI28993; Marshall HD, 2015, ELIFE, V4, DOI 10.7554/eLife.04851; Messina JL, 2012, SCI REP-UK, V2, DOI 10.1038/srep00765; Montfort A, 2017, CLIN CANCER RES, V23, P250, DOI 10.1158/1078-0432.CCR-16-0081; Naik R, 2019, ONCOGENE, V38, P1989, DOI 10.1038/s41388-018-0541-4; Nayar S, 2019, P NATL ACAD SCI USA, V116, P13490, DOI 10.1073/pnas.1905301116; Park BV, 2016, CANCER DISCOV, V6, P1366, DOI 10.1158/2159-8290.CD-15-1347; Payne KK, 2020, SCIENCE, V369, P942, DOI 10.1126/science.aay2767; Peske JD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8114; Pfannstiel C, 2019, CANCER IMMUNOL RES, V7, P923, DOI 10.1158/2326-6066.CIR-18-0758; Rodriguez AB, 2018, METHODS MOL BIOL, V1845, P241, DOI 10.1007/978-1-4939-8709-2_14; Rutkowski MR, 2015, CANCER CELL, V27, P27, DOI 10.1016/j.ccell.2014.11.009; Sage PT, 2016, NAT IMMUNOL, V17, P1436, DOI 10.1038/ni.3578; Sage PT, 2013, NAT IMMUNOL, V14, P152, DOI 10.1038/ni.2496; Sautes-Fridman C, 2019, NAT REV CANCER, V19, P307, DOI 10.1038/s41568-019-0144-6; Scarlett UK, 2012, J EXP MED, V209, P495, DOI 10.1084/jem.20111413; Schmitt N, 2014, NAT IMMUNOL, V15, P856, DOI 10.1038/ni.2947; Shi JW, 2018, IMMUNITY, V49, P264, DOI 10.1016/j.immuni.2018.06.012; Silina K, 2018, CANCER RES, V78, P1308, DOI 10.1158/0008-5472.CAN-17-1987; Stephen TL, 2017, IMMUNITY, V46, P51, DOI 10.1016/j.immuni.2016.12.015; Stephen TL, 2014, IMMUNITY, V41, P427, DOI 10.1016/j.immuni.2014.08.012; Tesone AJ, 2016, CELL REP, V14, P1774, DOI 10.1016/j.celrep.2016.01.056; Walters GD, 2016, TRANSPLANTATION, V100, P1650, DOI 10.1097/TP.0000000000001217; Wang HK, 2014, NAT IMMUNOL, V15, P667, DOI 10.1038/ni.2890; Weinstein AM, 2015, ADV CANCER RES, V128, P197, DOI 10.1016/bs.acr.2015.04.003; Williams JM, 2015, J IMMUNOL, V195, P853, DOI 10.4049/jimmunol.1403114; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhu GY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01609	52	15	15	10	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					115	+		10.1016/j.immuni.2021.12.007	http://dx.doi.org/10.1016/j.immuni.2021.12.007			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI5DT	35021053	hybrid			2022-12-18	WOS:000743868800001
J	Wu, JN; Ma, ZY; Raman, A; Beckerman, P; Dhillon, P; Mukhi, D; Palmer, M; Chen, HC; Cohen, CR; Dunn, T; Reilly, J; Meyer, N; Shahaty, M; Arany, Z; Hasko, G; Laudanski, K; Hung, AA; Susztak, K				Wu, Junnan; Ma, Ziyuan; Raman, Archana; Beckerman, Pazit; Dhillon, Poonam; Mukhi, Dhanunjay; Palmer, Matthew; Chen, Hua Chang; Cohen, Cassiane Robinson; Dunn, Thomas; Reilly, John; Meyer, Nuala; Shahaty, Michael; Arany, Zoltan; Hasko, Gyorgy; Laudanski, Krzysztof; Hung, Adriana; Susztak, Katalin			APOL1 risk variants in individuals of African genetic ancestry drive endothelial cell defects that exacerbate sepsis	IMMUNITY			English	Article							KIDNEY-DISEASE; COVID-19; EXPRESSION; STORY	The incidence and severity of sepsis is higher among individuals of African versus European ancestry. We found that genetic risk variants (RVs) in the trypanolytic factor apolipoprotein L1 (APOL1), present only in individuals of African ancestry, were associated with increased sepsis incidence and severity. Serum APOL1 levels correlated with sepsis and COVID-19 severity, and single-cell sequencing in human kidneys revealed high expression of APOL1 in endothelial cells. Analysis of mice with endothelial-specific expression of RV APOL1 and in vitro studies demonstrated that RV APOL1 interfered with mitophagy, leading to cytosolic release of mitochondrial DNA and activation of the inflammasome (NLRP3) and the cytosolic nucleotide sensing pathways (STING). Genetic deletion or pharmacological inhibition of NLRP3 and STING protected mice from RV APOL1-induced permeability defects and proinflammatory endothelial changes in sepsis. Our studies identify the inflammasome and STING pathways as potential targets to reduce APOL1-associ	[Wu, Junnan; Ma, Ziyuan; Raman, Archana; Beckerman, Pazit; Dhillon, Poonam; Mukhi, Dhanunjay; Susztak, Katalin] Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA; [Wu, Junnan; Ma, Ziyuan; Raman, Archana; Beckerman, Pazit; Dhillon, Poonam; Mukhi, Dhanunjay; Susztak, Katalin] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Wu, Junnan] Shanghai Jiao Tong Univ Affiliated Peoples Hosp 6, Dept Nephrol, Shanghai, Peoples R China; [Palmer, Matthew] Univ Penn, Perelman Sch Med, Dept Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Chen, Hua Chang; Cohen, Cassiane Robinson; Hung, Adriana] Tennessee Valley Healthcare Syst, Div Nephrol & Hypertens, Nashville Campus, Nashville, TN USA; [Chen, Hua Chang; Cohen, Cassiane Robinson; Hung, Adriana] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Chen, Hua Chang] Vanderbilt Univ, Med Ctr, Div Biostat, Nashville, TN USA; [Cohen, Cassiane Robinson; Hung, Adriana] Vanderbilt Univ, Med Ctr, Div Nephrol & Hypertens, Vanderbilt Precis Nephrol Program, Nashville, TN USA; [Dunn, Thomas; Reilly, John; Meyer, Nuala; Shahaty, Michael] Univ Penn, Perelman Sch Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Dunn, Thomas; Reilly, John; Meyer, Nuala; Shahaty, Michael] Univ Penn, Ctr Translat Lung Biol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Shahaty, Michael] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Arany, Zoltan] Univ Penn, Perelman Sch Med, Cardiovasc Inst, Philadelphia, PA 19104 USA; [Hasko, Gyorgy] Columbia Univ, Dept Anesthesiol, New York, NY 10032 USA; [Laudanski, Krzysztof] Univ Penn, Perelman Sch Med, Dept Anesthesiol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Shanghai Jiao Tong University; University of Pennsylvania; Pennsylvania Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Columbia University; University of Pennsylvania; Pennsylvania Medicine	Susztak, K (corresponding author), Univ Penn, Perelman Sch Med, Dept Med, Renal Electrolyte & Hypertens Div, Philadelphia, PA 19104 USA.; Susztak, K (corresponding author), Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA.	ksusztak@pennmedicine.upenn.edu	Mukhi, Dhanunjay/AAV-7589-2020; Dhillon, Poonam/GNP-5678-2022	Mukhi, Dhanunjay/0000-0001-6179-5220; CHEN, HUA-CHANG/0000-0003-0497-2483; Ma, Ziyuan/0000-0002-1512-8993; Beckerman, Pazit/0000-0003-3061-6757	NIH NIDDK [R01DK076077, R01 DK087635, R01 DK105821]; National Natural Sci-ence Foundation of China [81870487]; VA CSRD MVP grant [CX001897]	NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Natural Sci-ence Foundation of China(National Natural Science Foundation of China (NSFC)); VA CSRD MVP grant	Work in the Susztak lab is supported by the NIH NIDDK R01DK076077, R01 DK087635, and R01 DK105821. J.W. was supported by National Natural Sci-ence Foundation of China (81870487) . A.H. and H.C.C. were supported by VA CSR&D MVP grant CX001897. This research is based on data from the MVP, Office of Research and Development, Veterans Health Administration. This publication does not represent the views of the Department of Veteran Affairs or the United States government. Acknowledgment of the MVP leadership and staff contributions can be found in Data S1.	Aarreberg LD, 2019, MOL CELL, V74, P801, DOI 10.1016/j.molcel.2019.02.038; Alsan M, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.12403; Bajaj A, 2017, ARTERIOSCL THROM VAS, V37, P1587, DOI 10.1161/ATVBAHA.117.309756; Beckerman P, 2017, NAT MED, V23, P429, DOI 10.1038/nm.4287; Bick AG, 2019, CIRCULATION, V140, P1031, DOI 10.1161/CIRCULATIONAHA.118.036589; Cates J, 2020, MMWR-MORBID MORTAL W, V69, P1528, DOI 10.15585/mmwr.mm6942e3; Couturier A, 2020, CLIN KIDNEY J, V13, P347, DOI 10.1093/ckj/sfaa088; Datta S, 2020, J AM SOC NEPHROL, V31, P2083, DOI 10.1681/ASN.2020010079; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; Estrella MM, 2013, KIDNEY INT, V84, P834, DOI 10.1038/ki.2013.203; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Fine DM, 2012, J AM SOC NEPHROL, V23, P343, DOI 10.1681/ASN.2011060562; Freedman BI, 2021, KIDNEY INT, V99, P1296, DOI 10.1016/j.kint.2021.03.013; Friedman DJ, 2011, J AM SOC NEPHROL, V22, P2098, DOI 10.1681/ASN.2011050519; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Giovinazzo JA, 2020, ELIFE, V9, DOI 10.7554/eLife.51185; Granado D, 2017, J AM SOC NEPHROL, V28, P3226, DOI 10.1681/ASN.2016111220; Hunter-Zinck H, 2020, AM J HUM GENET, V106, P535, DOI 10.1016/j.ajhg.2020.03.004; Ilboudo H, 2012, INFECT GENET EVOL, V12, P1519, DOI 10.1016/j.meegid.2012.05.010; Kellum JA, 2020, KIDNEY INT, V98, P1370, DOI 10.1016/j.kint.2020.08.009; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Kruzel-Davila E, 2017, J AM SOC NEPHROL, V28, P1117, DOI 10.1681/ASN.2016050546; Kudose S, 2020, J AM SOC NEPHROL, V31, P1959, DOI 10.1681/ASN.2020060802; Lazareth H, 2020, AM J KIDNEY DIS, V76, P590, DOI 10.1053/j.ajkd.2020.06.009; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lukasz A, 2008, CRIT CARE, V12, DOI 10.1186/cc6966; Luo W, 2020, CIRCULATION, V141, P42, DOI 10.1161/CIRCULATIONAHA.119.041460; Ma LJ, 2017, J AM SOC NEPHROL, V28, P1093, DOI 10.1681/ASN.2016050567; May RM, 2021, KIDNEY INT, V100, P1303, DOI 10.1016/j.kint.2021.07.015; Molina-Portela MD, 2005, MOL BIOCHEM PARASIT, V144, P218, DOI 10.1016/j.molbiopara.2005.08.018; Nichols B, 2015, KIDNEY INT, V87, P332, DOI 10.1038/ki.2014.270; Oniszczuk J, 2021, TRANSPLANTATION, V105, P206, DOI 10.1097/TP.0000000000003432; Osuchowski MF, 2021, LANCET RESP MED, V9, P622, DOI 10.1016/S2213-2600(21)00218-6; Papeta N, 2011, J AM SOC NEPHROL, V22, P1991, DOI 10.1681/ASN.2011040434; Park J, 2018, SCIENCE, V360, P758, DOI 10.1126/science.aar2131; Pays E, 2020, KIDNEY INT, V98, P1373, DOI 10.1016/j.kint.2020.07.034; Reidy KJ, 2018, AM J HUM GENET, V103, P367, DOI 10.1016/j.ajhg.2018.08.002; Reilly JP, 2018, INTENS CARE MED, V44, P1849, DOI 10.1007/s00134-018-5328-0; Reilly JP, 2015, CLIN J AM SOC NEPHRO, V10, P1911, DOI 10.2215/CJN.12201214; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Scales SJ, 2020, J AM SOC NEPHROL, V31, P2044, DOI 10.1681/ASN.2019080829; Shah SS, 2019, J AM SOC NEPHROL, V30, P2355, DOI 10.1681/ASN.2019020114; Sharma Y, 2020, KIDNEY MED, V2, P493, DOI 10.1016/j.xkme.2020.05.005; Shimada K, 2012, IMMUNITY, V36, P401, DOI 10.1016/j.immuni.2012.01.009; Shukha K, 2017, J AM SOC NEPHROL, V28, P1079, DOI 10.1681/ASN.2016040441; De La Rica AS, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.08.59; Szulcek R, 2014, JOVE-J VIS EXP, DOI 10.3791/51300; Thomson R, 2015, P NATL ACAD SCI USA, V112, P2894, DOI 10.1073/pnas.1421953112; Thomson R, 2014, P NATL ACAD SCI USA, V111, pE2130, DOI 10.1073/pnas.1400699111; Tiberti N, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-1; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; van Beijnum JR, 2008, NAT PROTOC, V3, P1085, DOI 10.1038/nprot.2008.71; Vanwalleghem G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9078; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Ward C, 2016, BBA-MOL CELL BIOL L, V1861, P269, DOI 10.1016/j.bbalip.2016.01.006; Wasser WG, 2012, J NEPHROL, V25, P603, DOI 10.5301/jn.5000179; Yang Anderncn B.J., CRIT CARE, V23, P735	58	15	15	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2632	+		10.1016/j.immuni.2021.10.004	http://dx.doi.org/10.1016/j.immuni.2021.10.004		NOV 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LN	34715018	Green Accepted, Bronze			2022-12-18	WOS:000718365500005
J	Onodera, T; Kita, S; Adachi, Y; Moriyama, S; Sato, A; Nomura, T; Sakakibara, S; Inoue, T; Tadokoro, T; Anraku, Y; Yumoto, K; Tian, C; Fukuhara, H; Sasaki, M; Orba, Y; Shiwa, N; Iwata, N; Nagata, N; Suzuki, T; Sasaki, J; Sekizuka, T; Tonouchi, K; Sun, L; Fukushi, S; Satofuka, H; Kazuki, Y; Oshimura, M; Kurosaki, T; Kuroda, M; Matsuura, Y; Suzuki, T; Sawa, H; Hashiguchi, T; Maenaka, K; Takahashi, Y				Onodera, Taishi; Kita, Shunsuke; Adachi, Yu; Moriyama, Saya; Sato, Akihiko; Nomura, Takao; Sakakibara, Shuhei; Inoue, Takeshi; Tadokoro, Takashi; Anraku, Yuki; Yumoto, Kohei; Tian, Cong; Fukuhara, Hideo; Sasaki, Michihito; Orba, Yasuko; Shiwa, Nozomi; Iwata, Naoko; Nagata, Noriyo; Suzuki, Tateki; Sasaki, Jiei; Sekizuka, Tsuyoshi; Tonouchi, Keisuke; Sun, Lin; Fukushi, Shuetsu; Satofuka, Hiroyuki; Kazuki, Yasuhiro; Oshimura, Mitsuo; Kurosaki, Tomohiro; Kuroda, Makoto; Matsuura, Yoshiharu; Suzuki, Tadaki; Sawa, Hirofumi; Hashiguchi, Takao; Maenaka, Katsumi; Takahashi, Yoshimasa			A SARS-CoV-2 antibody broadly neutralizes SARS-related coronaviruses and variants by coordinated recognition of a virus-vulnerable site	IMMUNITY			English	Article							HUMAN B-CELLS; MONOCLONAL-ANTIBODIES; SPIKE; MUTATIONS; INFECTION; SELECTION; EVASION	Potent neutralizing SARS-CoV-2 antibodies often target the spike protein receptor-binding site (RBS), but the variability of RBS epitopes hampers broad neutralization of multiple sarbecoviruses and drifted viruses. Here, using humanized mice, we identified an RBS antibody with a germline V-H gene that potently neutralized SARS-related coronaviruses, including SARS-CoV and SARS-CoV-2 variants. X-ray crystallography revealed coordinated recognition by the heavy chain of non-RBS conserved sites and the light chain of RBS with a binding angle mimicking the angiotensin-converting enzyme 2 (ACE2) receptor. The minimum footprints in the hypervariable region of RBS contributed to the breadth of neutralization, which was enhanced by immunoglobulin G3 (IgG3) class switching. The coordinated binding resulted in broad neutralization of SARS-CoV and emerging SARS-CoV-2 variants of concern. Low-dose therapeutic antibody treatment in hamsters reduced the virus titers and morbidity during SARS-CoV-2 challenge. The structural basis for broad neutralizing activity may inform the design of a broad spectrum of therapeutics and vaccines.	[Onodera, Taishi; Adachi, Yu; Moriyama, Saya; Tonouchi, Keisuke; Sun, Lin; Takahashi, Yoshimasa] Natl Inst Infect Dis, Res Ctr Drug & Vaccine Dev, Tokyo 1628640, Japan; [Kita, Shunsuke; Nomura, Takao; Tadokoro, Takashi; Anraku, Yuki; Yumoto, Kohei; Tian, Cong; Fukuhara, Hideo; Maenaka, Katsumi] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomol Sci, Sapporo, Hokkaido 0600812, Japan; [Kita, Shunsuke; Nomura, Takao; Tadokoro, Takashi; Anraku, Yuki; Yumoto, Kohei; Tian, Cong; Fukuhara, Hideo; Maenaka, Katsumi] Hokkaido Univ, Fac Pharmaceut Sci, Ctr Res & Educ Drug Discovery, Sapporo, Hokkaido 0600812, Japan; [Sato, Akihiko; Sasaki, Michihito; Orba, Yasuko; Sawa, Hirofumi] Hokkaido Univ, Res Ctr Zoonosis Control, Div Mol Pathobiol, Sapporo, Hokkaido 0010020, Japan; [Sato, Akihiko] Shion & Co Ltd, Drug Discovery & Dis Res Lab, Osaka 5610825, Japan; [Sakakibara, Shuhei] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Immune Regulat, Osaka 5650871, Japan; [Inoue, Takeshi; Kurosaki, Tomohiro] Osaka Univ, WPI Immunol Frontier Res Ctr, Lab Lymphocyte Differentiat, Osaka 5650871, Japan; [Fukuhara, Hideo; Maenaka, Katsumi] Hokkaido Univ, Global Stn Biosurfaces & Drug Discovery, Sapporo, Hokkaido 0600812, Japan; [Shiwa, Nozomi; Iwata, Naoko; Nagata, Noriyo; Suzuki, Tadaki] Natl Inst Infect Dis, Dept Pathol, Tokyo 2080011, Japan; [Suzuki, Tateki; Sasaki, Jiei; Hashiguchi, Takao] Kyushu Univ, Fac Med, Dept Virol, Fukuoka 8128582, Japan; [Sekizuka, Tsuyoshi; Kuroda, Makoto] Natl Inst Infect Dis, Pathogen Genom Ctr, Tokyo 1628640, Japan; [Tonouchi, Keisuke] Waseda Univ, Dept Life Sci & Med Biosci, Tokyo 1628480, Japan; [Fukushi, Shuetsu] Natl Inst Infect Dis, Dept Virol 1, Tokyo 1628640, Japan; [Satofuka, Hiroyuki; Kazuki, Yasuhiro] Tottori Univ, Chromosome Engn Res Ctr, Tottori 6838503, Japan; [Kazuki, Yasuhiro] Tottori Univ, Fac Med, Sch Life Sci, Div Genome & Cellular Funct,Dept Mol & Cellular B, Tottori 6838503, Japan; [Oshimura, Mitsuo] Trans Chromos Inc, Tottori 6838503, Japan; [Matsuura, Yoshiharu] Osaka Univ, Ctr Infect Dis Educ & Res, Lab Virus Control, Osaka 5650871, Japan; [Hashiguchi, Takao] Kyoto Univ, Inst Frontier Life & Med Sci, Lab Med Virol, Kyoto 6068507, Japan	National Institute of Infectious Diseases (NIID); Hokkaido University; Hokkaido University; Hokkaido University; Osaka University; Osaka University; Hokkaido University; National Institute of Infectious Diseases (NIID); Kyushu University; National Institute of Infectious Diseases (NIID); Waseda University; National Institute of Infectious Diseases (NIID); Tottori University; Tottori University; Osaka University; Kyoto University	Takahashi, Y (corresponding author), Natl Inst Infect Dis, Res Ctr Drug & Vaccine Dev, Tokyo 1628640, Japan.; Maenaka, K (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomol Sci, Sapporo, Hokkaido 0600812, Japan.; Maenaka, K (corresponding author), Hokkaido Univ, Fac Pharmaceut Sci, Ctr Res & Educ Drug Discovery, Sapporo, Hokkaido 0600812, Japan.; Maenaka, K (corresponding author), Hokkaido Univ, Global Stn Biosurfaces & Drug Discovery, Sapporo, Hokkaido 0600812, Japan.	maenaka@pharm.hokudai.ac.jp; ytakahas@niid.go.jp	Suzuki, Tadaki/ABH-2661-2020; Sawa, Hirofumi/F-6954-2012	Sawa, Hirofumi/0000-0003-2569-2755; Kita, Shunsuke/0000-0003-3969-302X; Yumoto, Kohei/0000-0002-7282-0150; Anraku, Yuki/0000-0002-5731-0902; Takahashi, Yoshimasa/0000-0001-6342-4087; Satofuka, Hiroyuki/0000-0002-8524-7322; sasaki, Jiei/0000-0002-5129-2336; Sakakibara, Shuhei/0000-0003-3157-5870; Inoue, Takeshi/0000-0002-9972-6105	Japan Agency for Medical Research and Development [JP19fk0108111, JP20fk0108298, JP20am0101093, JP20ae0101047, JP20fk0108251, JP20am0101124]; Ministry of Education, Culture, Sports, Science and Technology [JPMXS0420100119, 20H05773]; Naito Foundation; Takeda Foundation; Joint Usage/Research Center program of the Institute for Frontier Life and Medical Sciences, Kyoto University	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Takeda Foundation(Takeda Science Foundation (TSF)); Joint Usage/Research Center program of the Institute for Frontier Life and Medical Sciences, Kyoto University	We thank Akira Dosaka, Eriko Izumiyama, and Ryoko Itami at NIID for technical support. We also thank the beamline staff at Photon Factory and Swiss Light Source for supporting data collection. This work was supported by Japan Agency for Medical Research and Development grants JP19fk0108111 (to T.H. and Y.T.), JP20fk0108298 (to T.H., K.M., and Y.T.), JP20am0101093 (to K.M.), JP20ae0101047 (to K.M.), JP20fk0108251 (to H. Sawa), and JP20am0101124 (to Y.K.); by Ministry of Education, Culture, Sports, Science and Technology grants JPMXS0420100119 (to K.M.) and 20H05773 (to T.H.), by the Naito Foundation (to T.H.); by the Takeda Foundation (to K.M.); and by the Joint Usage/Research Center program of the Institute for Frontier Life and Medical Sciences, Kyoto University (to T.H.).	Adachi Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11821-6; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Andersson A, 2019, ENVIRON SCI-WAT RES, V5, P861, DOI 10.1039/c9ew00034h; Andreano E, 2021, CELL, V184, P1821, DOI 10.1016/j.cell.2021.02.035; Andreano Emanuele, 2020, bioRxiv, DOI 10.1101/2020.12.28.424451; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Baum A, 2020, SCIENCE, V370, P1110, DOI 10.1126/science.abe2402; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Beniac DR, 2006, NAT STRUCT MOL BIOL, V13, P751, DOI 10.1038/nsmb1123; BHAT NM, 1993, J IMMUNOL, V151, P5011; Brouwer PJM, 2020, SCIENCE, V369, P643, DOI 10.1126/science.abc5902; Choi B, 2020, NEW ENGL J MED, V383, P2291, DOI 10.1056/NEJMc2031364; Darko, SCIENCE, V373; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Dejnirattisai W, 2021, CELL, V184, P2939, DOI 10.1016/j.cell.2021.03.055; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Faria NR, 2021, SCIENCE, V372, P815, DOI [10.1126/science.abh2644, 10.1101/2021.02.26.21252554, 10.1126/science.abh2644Article]; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Galimidi RP, 2015, CELL, V160, P433, DOI 10.1016/j.cell.2015.01.016; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1016/j.cell.2021.04.006]; Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Harada T, 2021, PERIPHERAL T CELL PO, DOI [10.1101/2021.2001, DOI 10.1101/2021.2001]; Hoffmann M, 2021, CELL, V184, P2384, DOI 10.1016/j.cell.2021.03.036; Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; Itokawa K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239403; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Ke ZL, 2020, NATURE, V588, P498, DOI 10.1038/s41586-020-2665-2; Kobayashi M, 2008, ANTIVIR RES, V80, P213, DOI 10.1016/j.antiviral.2008.06.012; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; McMahan K, 2021, NATURE, V590, DOI 10.1038/s41586-020-03041-6; Menachery VD, 2016, P NATL ACAD SCI USA, V113, P3048, DOI 10.1073/pnas.1517719113; Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Rappazzo CG, 2021, SCIENCE, V371, P823, DOI 10.1126/science.abf4830; Raybould Matthew I J, 2021, Bioinformatics, V37, P734, DOI 10.1093/bioinformatics/btaa739; Richardson SI, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008064; Robbiani Davide F, 2020, Nature, V584, P437, DOI [10.1101/2020.05.13.092619, 10.1038/s41586-020-2456-9]; Rogers Thomas F, 2020, bioRxiv, DOI 10.1101/2020.05.11.088674; Sakakibara S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16681-y; Scharf O, 2001, J VIROL, V75, P6558, DOI 10.1128/JVI.75.14.6558-6565.2001; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Spellerberg M, 1995, ANN NY ACAD SCI, V764, P427; Starr Tyler N, 2020, bioRxiv, DOI [10.1126/science.abf9302, 10.1101/2020.11.30.405472]; Supasa P, 2021, CELL, V184, P2201, DOI 10.1016/j.cell.2021.02.033; Takayama H, 2020, RES SQUARE; Tani H, 2021, VIROL J, V18, DOI 10.1186/s12985-021-01490-7; Tegally H, 2021, NATURE, V592, P438, DOI 10.1038/s41586-021-03402-9; Thiel V, 2003, J GEN VIROL, V84, P2305, DOI 10.1099/vir.0.19424-0; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; van Deventer E, 2006, PLOS MED, V3; Volz E, 2021, NATURE, V593, P266, DOI 10.1038/s41586-021-03470-x; Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907; Weinreich DM, 2021, NEW ENGL J MED, V385, DOI 10.1056/NEJMoa2108163; Weisblum Yiska, 2020, bioRxiv, DOI 10.1101/2020.07.21.214759; Weissman D, 2021, CELL HOST MICROBE, V29, P23, DOI 10.1016/j.chom.2020.11.012; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Winkler ES, 2021, CELL, V184, P1804, DOI 10.1016/j.cell.2021.02.026; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; Yuan M, 2021, BIOCHEM BIOPH RES CO, V538, P192, DOI 10.1016/j.bbrc.2020.10.012; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zhang Lizhou, 2020, bioRxiv, DOI 10.1101/2020.06.12.148726; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037; Zohar T, 2020, CELL, V183, P1508, DOI 10.1016/j.cell.2020.10.052; Zost SJ, 2020, NAT MED, V26, DOI [10.1038/s41591-020-0998-x, 10.1101/2020.05.12.091462]	76	15	15	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2385	+		10.1016/j.immuni.2021.08.025	http://dx.doi.org/10.1016/j.immuni.2021.08.025		OCT 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34508662	hybrid, Green Published			2022-12-18	WOS:000706854100022
J	Sakamoto, K; Jin, SP; Goel, S; Jo, JH; Voisin, B; Kim, D; Nadella, V; Liang, H; Kobayashi, T; Huang, X; Deming, C; Horiuchi, K; Segre, JA; Kong, HH; Nagao, K				Sakamoto, Keiko; Jin, Seon-Pil; Goel, Shubham; Jo, Jay-Hyun; Voisin, Benjamin; Kim, Doyoung; Nadella, Vinod; Liang, Hai; Kobayashi, Tetsuro; Huang, Xin; Deming, Clay; Horiuchi, Keisuke; Segre, Julia A.; Kong, Heidi H.; Nagao, Keisuke			Disruption of the endopeptidase ADAM10-Notch signaling axis leads to skin dysbiosis and innate lymphoid cell-mediated hair follicle destruction	IMMUNITY			English	Article							EPITHELIAL-CELLS; STEM-CELLS; TRAFFICKING; MICROBIOTA; EXPRESSION; DEFENSINS; RECEPTORS; MULTIPLE; REVEALS	Hair follicles (HFs) function as hubs for stem cells, immune cells, and commensal microbes, which must be tightly regulated during homeostasis and transient inflammation. Here we found that transmembrane endopeptidase ADAM10 expression in upper HFs was crucial for regulating the skin microbiota and protecting HFs and their stem cell niche from inflammatory destruction. Ablation of the ADAM10-Notch signaling axis impaired the innate epithelial barrier and enabled Corynebacterium species to predominate the microbiome. Dysbiosis triggered group 2 innate lymphoid cell-mediated inflammation in an interleukin-7 (IL-7) receptor-, S1P receptor 1-, and CCR6-dependent manner, leading to pyroptotic cell death of HFs and irreversible alopecia. Double-stranded RNA-induced ablation models indicated that the ADAM10-Notch signaling axis bolsters epithelial innate immunity by promoting b-defensin-6 expression downstream of type I interferon responses. Thus, ADAM10-Notch signaling axis-mediated regulation of host-microbial symbiosis crucially protects HFs from inflammatory destruction, which has implications for strategies to sustain tissue integrity during chronic inflammation.	[Sakamoto, Keiko; Jin, Seon-Pil; Goel, Shubham; Voisin, Benjamin; Kim, Doyoung; Nadella, Vinod; Kobayashi, Tetsuro; Nagao, Keisuke] NIAMSD, Cutaneous Leukocyte Biol Sect, Dermatol Branch, NIH, Bethesda, MD 20892 USA; [Jo, Jay-Hyun; Liang, Hai; Kong, Heidi H.] NIAMSD, Cutaneous Microbiome & Inflammat Sect, Dermatol Branch, NIH, Bethesda, MD 20892 USA; [Huang, Xin; Deming, Clay; Segre, Julia A.] NHGRI, Microbial Genom Sect, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA; [Horiuchi, Keisuke] Natl Def Med Coll, Dept Orthoped Surg, Saitama 3598513, Japan; [Voisin, Benjamin] Univ Strasbourg, IBMC, CNRS UPR 3572, F-67000 Strasbourg, France; [Kim, Doyoung] Yonsei Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Kim, Doyoung] Yonsei Univ, Coll Med, Cutaneous Biol Res Inst, Seoul, South Korea; [Kobayashi, Tetsuro] RIKEN Ctr Integrat Med Sci, Lab Innate Immune Syst, Yokohama, Kanagawa, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Defense Medical College - Japan; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; RIKEN	Nagao, K (corresponding author), NIAMSD, Cutaneous Leukocyte Biol Sect, Dermatol Branch, NIH, Bethesda, MD 20892 USA.	keisuke.nagao@nih.gov	Nadella, Vinod/AHC-8377-2022; Horiuchi, Keisuke/L-2277-2013	Nadella, Vinod/0000-0002-1122-7820; Horiuchi, Keisuke/0000-0001-7063-9609; Kobayashi, Tetsuro/0000-0003-2316-4748; Voisin, Benjamin/0000-0003-1314-2908; Liang, Hai/0000-0001-5354-9740; Kim, Do Young/0000-0002-0194-9854	NIAMS; NHGRI	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	The authors thank the Genome Analysis Core Facility, Flow Cytometry Section, Light Imaging Section, H. Nagashima (NIAMS), and T. Nakatsuji (UC San Diego) for technical support and advice. This work was supported by the intramural research programs of NIAMS and NHGRI.	Abu Khweek A, 2020, IMMUNOL REV, V297, P39, DOI 10.1111/imr.12910; Adachi T, 2015, NAT MED, V21, P1272, DOI 10.1038/nm.3962; Adler BL, 2018, DISCOV MED, V25, P75; Ali RS, 2001, J INVEST DERMATOL, V117, P106; AlmazanFernandez F.M., 2017, DERMATOL ONLINE J, V23, P13030; Anzai A, 2019, INT IMMUNOL, V31, P439, DOI 10.1093/intimm/dxz039; Barreiro O, 2016, ELIFE, V5, DOI 10.7554/eLife.15251; Belkaid Y, 2014, SCIENCE, V346, P954, DOI 10.1126/science.1260144; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Casson CN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003400; Chessa C, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01155; Cobo ER, 2013, PATHOGENS, V2, P177, DOI 10.3390/pathogens2010177; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Di Domizio J, 2020, NAT IMMUNOL, V21, P1034, DOI 10.1038/s41590-020-0721-6; Dickensheets H, 2013, J LEUKOCYTE BIOL, V93, P377, DOI 10.1189/jlb.0812395; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Filippi CM, 2008, DIABETES, V57, P2863, DOI 10.2337/db07-1023; Flamm A, 2020, J CUTAN PATHOL, V47, P530, DOI 10.1111/cup.13666; Geoghegan JA, 2018, TRENDS MICROBIOL, V26, P484, DOI 10.1016/j.tim.2017.11.008; Gonzales KAU, 2017, DEV CELL, V43, P387, DOI 10.1016/j.devcel.2017.10.001; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harries MJ, 2010, AM J PATHOL, V177, P2152, DOI 10.2353/ajpath.2010.100454; Harrison OJ, 2019, SCIENCE, V363, P43, DOI 10.1126/science.aat6280; Hartmann D, 2002, HUM MOL GENET, V11, P2615, DOI 10.1093/hmg/11.21.2615; Hou JW, 2020, NAT CELL BIOL, V22, P1264, DOI 10.1038/s41556-020-0575-z; Huang YF, 2018, SCIENCE, V359, P114, DOI 10.1126/science.aam5809; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Illescas-Montes R, 2019, IMMUNOLOGY, V158, P153, DOI 10.1111/imm.13103; Ito T, 2012, J DERMATOL, V39, P863, DOI 10.1111/j.1346-8138.2011.01437.x; Joost S, 2016, CELL SYST, V3, P221, DOI 10.1016/j.cels.2016.08.010; Joshi SS, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008034; Kesavardhana S, 2020, ANNU REV IMMUNOL, V38, P567, DOI 10.1146/annurev-immunol-073119-095439; Klotman ME, 2006, NAT REV IMMUNOL, V6, P447, DOI 10.1038/nri1860; Kobayashi T, 2019, CELL, V176, P982, DOI 10.1016/j.cell.2018.12.031; Kobayashi T, 2015, IMMUNITY, V42, P756, DOI 10.1016/j.immuni.2015.03.014; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Kubo A, 2012, J CLIN INVEST, V122, P440, DOI 10.1172/JCI57416; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Linehan JL, 2018, CELL, V172, P784, DOI 10.1016/j.cell.2017.12.033; Loschko J, 2016, J IMMUNOL METHODS, V434, P32, DOI 10.1016/j.jim.2016.04.004; Manohar P, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01434; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Meade KG, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03072; Melo-Gonzalez F, 2017, IMMUNOLOGY, V150, P265, DOI 10.1111/imm.12697; Merad M, 2002, NAT IMMUNOL, V3, P1135, DOI 10.1038/ni852; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Murtaugh LC, 2003, P NATL ACAD SCI USA, V100, P14920, DOI 10.1073/pnas.2436557100; Nagao K, 2012, NAT IMMUNOL, V13, P744, DOI 10.1038/ni.2353; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Rodriguez TA, 2008, J AM ACAD DERMATOL, V59, P137, DOI 10.1016/j.jaad.2008.02.005; Rosenblum MD, 2004, J INVEST DERMATOL, V123, P880, DOI 10.1111/j.0022-202X.2004.23461.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Semple CAM, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-32; Sheikh A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02897; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Silva PM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00097; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Veniaminova NA, 2013, DEVELOPMENT, V140, P4870, DOI 10.1242/dev.101725; Weber S, 2011, DEVELOPMENT, V138, P495, DOI 10.1242/dev.055210; Whiting DA, 2008, DERMATOL THER, V21, P268, DOI 10.1111/j.1529-8019.2008.00209.x; Wilke GA, 2010, P NATL ACAD SCI USA, V107, P13473, DOI 10.1073/pnas.1001815107; Yamaguchi Y, 2002, J IMMUNOL, V169, P2516, DOI 10.4049/jimmunol.169.5.2516; Yi BQ, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.548613; Yoda M, 2011, BLOOD, V118, P6939, DOI 10.1182/blood-2011-06-357210; Zhao L, 2020, INT J OBESITY, V44, P226, DOI 10.1038/s41366-019-0330-3	72	15	15	3	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2321	+		10.1016/j.immuni.2021.09.001	http://dx.doi.org/10.1016/j.immuni.2021.09.001		OCT 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34582748	Bronze, Green Accepted			2022-12-18	WOS:000706854100018
J	Reglero-Real, N; Perez-Gutierrez, L; Yoshimura, A; Rolas, L; Garrido-Mesa, J; Barkaway, A; Pickworth, C; Saleeb, RS; Gonzalez-Nunez, M; Austin-Williams, SN; Cooper, D; Vazquez-Martinez, L; Fu, T; De Rossi, G; Golding, M; Voisin, MB; Boulanger, CM; Kubota, Y; Muller, WA; Tooze, SA; Nightingale, TD; Collinson, L; Perretti, M; Aksoy, E; Nourshargh, S				Reglero-Real, Natalia; Perez-Gutierrez, Lorena; Yoshimura, Azumi; Rolas, Loic; Garrido-Mesa, Jose; Barkaway, Anna; Pickworth, Catherine; Saleeb, Rebeca S.; Gonzalez-Nunez, Maria; Austin-Williams, Shani N.; Cooper, Dianne; Vazquez-Martinez, Laura; Fu, Tao; De Rossi, Giulia; Golding, Matthew; Voisin, Mathieu-Benoit; Boulanger, Chantal M.; Kubota, Yoshiaki; Muller, William A.; Tooze, Sharon A.; Nightingale, Thomas D.; Collinson, Lucy; Perretti, Mauro; Aksoy, Ezra; Nourshargh, Sussan			Autophagy modulates endothelial junctions to restrain neutrophil diapedesis during inflammation	IMMUNITY			English	Article							TRANSENDOTHELIAL MIGRATION; VASCULAR-PERMEABILITY; IN-VIVO; JAM-C; MECHANISMS; PROTEIN; PECAM-1; PHAGOCYTOSIS; ASSOCIATION; DEFICIENCY	The migration of neutrophils from the blood circulation to sites of infection or injury is a key immune response and requires the breaching of endothelial cells (ECs) that line the inner aspect of blood vessels. Unregulated neutrophil transendothelial cell migration (TEM) is pathogenic, but the molecular basis of its physiological termination remains unknown. Here, we demonstrated that ECs of venules in inflamed tissues exhibited a robust autophagic response that was aligned temporally with the peak of neutrophil trafficking and was strictly localized to EC contacts. Genetic ablation of EC autophagy led to excessive neutrophil TEM and uncontrolled leukocyte migration in murine inflammatory models, while pharmacological induction of autophagy suppressed neutrophil infiltration into tissues. Mechanistically, autophagy regulated the remodeling of EC junctions and expression of key EC adhesion molecules, facilitating their intracellular trafficking and degradation. Collectively, we have identified autophagy as a modulator of EC leukocyte trafficking machinery aimed at terminating physiological inflammation.	[Reglero-Real, Natalia; Perez-Gutierrez, Lorena; Rolas, Loic; Barkaway, Anna; Pickworth, Catherine; Saleeb, Rebeca S.; Vazquez-Martinez, Laura; Golding, Matthew; Voisin, Mathieu-Benoit; Nightingale, Thomas D.; Nourshargh, Sussan] Queen Mary Univ London, Ctr Microvasc Res, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Yoshimura, Azumi; Collinson, Lucy] Francis Crick Inst, Electron Microscopy Sci Technol Platform, London NW1 1AT, England; [Garrido-Mesa, Jose; Gonzalez-Nunez, Maria; Austin-Williams, Shani N.; Cooper, Dianne; Perretti, Mauro; Aksoy, Ezra] Queen Mary Univ London, Ctr Biochem Pharmacol, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England; [Fu, Tao; Muller, William A.] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [De Rossi, Giulia] UCL, Inst Ophthalmol, Dept Cell Biol, London EC1V 9EL, England; [Boulanger, Chantal M.] Univ Paris, INSERM, PARCC, F-75015 Paris, France; [Kubota, Yoshiaki] Keio Univ, Dept Anat, Sch Med, Tokyo 1130022, Japan; [Tooze, Sharon A.] Francis Crick Inst, Mol Cell Biol Autophagy Lab, London NW1 1AT, England; [Cooper, Dianne; Perretti, Mauro; Nourshargh, Sussan] Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London EC1M 6BQ, England	University of London; Queen Mary University London; Francis Crick Institute; University of London; Queen Mary University London; Northwestern University; Feinberg School of Medicine; University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Keio University; Francis Crick Institute; University of London; Queen Mary University London	Reglero-Real, N; Nourshargh, S (corresponding author), Queen Mary Univ London, Ctr Microvasc Res, Barts & London Sch Med & Dent, William Harvey Res Inst, London EC1M 6BQ, England.; Nourshargh, S (corresponding author), Queen Mary Univ London, Ctr Inflammat & Therapeut Innovat, London EC1M 6BQ, England.	n.reglero@qmul.ac.uk; s.nourshargh@qmul.ac.uk	Rolas, Loic/AAA-6717-2022; Boulanger, Chantal M./K-4349-2017; Garrido Mesa, Jose/AAP-3208-2020	Boulanger, Chantal M./0000-0002-3687-651X; Garrido Mesa, Jose/0000-0001-6420-9055; Perez-Gutierrez, Lorena/0000-0001-8135-4975; De Rossi, Giulia/0000-0001-6163-4590; Rolas, Loic/0000-0001-7617-0768; Reglero Real, Natalia/0000-0002-3916-119X; , Mathieu-Benoit/0000-0003-3001-0894; Barkaway, Anna/0000-0003-4366-0378; Aksoy, Ezra/0000-0002-6962-1572	Wellcome Trust [FC001999, 098291/Z/12/Z, FC001187]; People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA [608765]; Francis Crick Institute - Cancer Research UK [FC001999, FC001187]; UK Medical Research Council [FC001999, FC001187]; Barts charity grants [MR/M023230/1, MGU0488]; UK Medical Research Council	Wellcome Trust(Wellcome TrustEuropean Commission); People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA; Francis Crick Institute - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Barts charity grants; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was principally funded by the Wellcome Trust (098291/Z/12/Z, to S.N.). N.R.-R. is additionally supported by funding from the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme (FP7/2007-2013) under REA grant agreement no. 608765. The work in the labs of S.A.T. and L.C. was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001187 and FC001999), the UK Medical Research Council (FC001187 and FC001999), and the Wellcome Trust (FC001187 and FC001999). E.A. was supported by the UK Medical Research Council and Barts charity grants MR/M023230/1 and MGU0488.	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Arganda-Carreras I, 2006, LECT NOTES COMPUT SC, V4241, P85; Bejarano E, 2014, NAT CELL BIOL, V16, P401, DOI 10.1038/ncb2934; Bejarano E, 2012, MOL BIOL CELL, V23, P2156, DOI 10.1091/mbc.E11-10-0844; Bentham J, 2015, NAT GENET, V47, P1457, DOI 10.1038/ng.3434; Bhattacharya A, 2015, CELL REP, V12, P1731, DOI 10.1016/j.celrep.2015.08.019; Bogovic JA, 2016, I S BIOMED IMAGING, P1123, DOI 10.1109/ISBI.2016.7493463; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Cardona A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038011; Damazo AS, 2006, J IMMUNOL, V176, P4410, DOI 10.4049/jimmunol.176.7.4410; Deerinck TJ, 2018, J MICROSC-OXFORD, V270, P142, DOI 10.1111/jmi.12667; Deerinck T.J., 2010, NCMIR METHODS 3D NEW, DOI 10.17504/protocols.io.36wgq7je5vk5/v2; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Deretic V, 2021, IMMUNITY, V54, P437, DOI 10.1016/j.immuni.2021.01.018; Deretic V, 2018, AUTOPHAGY, V14, P243, DOI 10.1080/15548627.2017.1402992; Dooley HC, 2014, MOL CELL, V55, P238, DOI 10.1016/j.molcel.2014.05.021; Pham DL, 2016, KOREAN J INTERN MED, V31, P375, DOI 10.3904/kjim.2014.390; Engelhardt B, 2012, TRENDS IMMUNOL, V33, P579, DOI 10.1016/j.it.2012.07.004; Faust N, 2000, BLOOD, V96, P719; Feng D, 2004, J HISTOCHEM CYTOCHEM, V52, P87, DOI 10.1177/002215540405200109; Fernandez-Martin L, 2012, ARTERIOSCL THROM VAS, V32, pE90, DOI 10.1161/ATVBAHA.112.252080; Fletcher K, 2018, EMBO J, V37, DOI 10.15252/embj.201797840; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Girbl T, 2018, IMMUNITY, V49, P1062, DOI 10.1016/j.immuni.2018.09.018; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harle G, 2021, J EXP MED, V218, DOI 10.1084/jem.20201776; Heckmann BL, 2017, J MOL BIOL, V429, P3561, DOI 10.1016/j.jmb.2017.08.012; Hobbs JAR, 2003, MOL CELL BIOL, V23, P2564, DOI 10.1128/MCB.23.7.2564-2576.2003; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Jiang LG, 2016, INT J BIOCHEM CELL B, V77, P102, DOI 10.1016/j.biocel.2016.06.001; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Ktistakis NT, 2016, TRENDS CELL BIOL, V26, P624, DOI 10.1016/j.tcb.2016.03.006; Lamagna C, 2005, MOL BIOL CELL, V16, P4992, DOI 10.1091/mbc.E05-04-0310; Levine B, 2019, CELL, V176, P11, DOI 10.1016/j.cell.2018.09.048; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Majolee J, 2019, J CELL SCI, V132, DOI 10.1242/jcs.227728; Mamdouh Z, 2003, NATURE, V421, P748, DOI 10.1038/nature01300; Martinez J, 2016, NATURE, V533, P115, DOI 10.1038/nature17950; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Martinez-Martin N, 2017, SCIENCE, V355, P641, DOI 10.1126/science.aal3908; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; MULLER WA, 1993, J EXP MED, V178, P449, DOI 10.1084/jem.178.2.449; Muller WA, 2008, METHOD ENZYMOL, V443, P155, DOI 10.1016/S0076-6879(08)02009-0; Muller WA, 2016, CURR OPIN IMMUNOL, V38, P24, DOI 10.1016/j.coi.2015.10.006; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Nighot PK, 2015, J BIOL CHEM, V290, P7234, DOI 10.1074/jbc.M114.597492; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Nourshargh S, 2010, NAT REV MOL CELL BIO, V11, P366, DOI 10.1038/nrm2889; Nussenzweig SC, 2015, CIRC RES, V116, P480, DOI 10.1161/CIRCRESAHA.116.303805; Okabe K, 2014, CELL, V159, P584, DOI 10.1016/j.cell.2014.09.025; Peraro L, 2017, J AM CHEM SOC, V139, P7792, DOI 10.1021/jacs.7b01698; Perretti M, 2017, NAT REV RHEUMATOL, V13, P87, DOI 10.1038/nrrheum.2016.193; Rai S, 2019, AUTOPHAGY, V15, P599, DOI 10.1080/15548627.2018.1534507; Reglero-Real N, 2016, ARTERIOSCL THROM VAS, V36, P2048, DOI 10.1161/ATVBAHA.116.307610; Reglero-Real N, 2012, CELL MOL LIFE SCI, V69, P3079, DOI 10.1007/s00018-012-0987-4; Riffelmacher T, 2017, IMMUNITY, V47, P466, DOI 10.1016/j.immuni.2017.08.005; Sachdev U, 2017, J LEUKOCYTE BIOL, V102, P221, DOI 10.1189/jlb.3RU1116-484RR; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Santovito D, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz2294; Schaaf MB, 2019, CELL DEATH DIFFER, V26, P665, DOI 10.1038/s41418-019-0287-8; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Serhan CN, 2018, J CLIN INVEST, V128, P2657, DOI 10.1172/JCI97943; Serramito-Gomez I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19670-4; Sprott D, 2019, ARTERIOSCL THROM VAS, V39, P1137, DOI 10.1161/ATVBAHA.119.309973; Tauseef M, 2012, J EXP MED, V209, P1953, DOI 10.1084/jem.20111355; Torisu T, 2013, NAT MED, V19, P1281, DOI 10.1038/nm.3288; Verhoeven J, 2021, FEBS LETT, V595, P1497, DOI 10.1002/1873-3468.14087; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Vion AC, 2017, P NATL ACAD SCI USA, V114, pE8675, DOI 10.1073/pnas.1702223114; Wang BS, 2014, MOL CARCINOGEN, V53, P514, DOI 10.1002/mc.22003; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Westman J, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13016; Woodfin A, 2011, NAT IMMUNOL, V12, P761, DOI 10.1038/ni.2062; Yu L, 2018, AUTOPHAGY, V14, P207, DOI 10.1080/15548627.2017.1378838; Zhang XB, 2020, ARTERIOSCL THROM VAS, V40, P1510, DOI 10.1161/ATVBAHA.120.314291	79	15	15	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					1989	+		10.1016/j.immuni.2021.07.012	http://dx.doi.org/10.1016/j.immuni.2021.07.012		SEP 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34363750	hybrid, Green Published, Green Submitted			2022-12-18	WOS:000695789800010
J	Zaman, R; Hamidzada, H; Kantores, C; Wong, A; Dick, SA; Wang, YM; Momen, A; Aronoff, L; Lin, JL; Razani, B; Mital, S; Billia, F; Lavine, KJ; Nejat, S; Epelman, S				Zaman, Rysa; Hamidzada, Homaira; Kantores, Crystal; Wong, Anthony; Dick, Sarah A.; Wang, Yiming; Momen, Abdul; Aronoff, Laura; Lin, Julia; Razani, Babak; Mital, Seema; Billia, Filio; Lavine, Kory J.; Nejat, Sara; Epelman, Slava			Selective loss of resident macrophage-derived insulin-like growth factor-1 abolishes adaptive cardiac growth to stress	IMMUNITY			English	Article							CONVERTING ENZYME-INHIBITION; ANGIOTENSIN-II; HEART-FAILURE; DYSFUNCTION; INFLAMMATION; PROGRESSION; EXPRESSION; NETWORK; STATE; RAT	Hypertension affects one-third of the world's population, leading to cardiac dysfunction that is modulated by resident and recruited immune cells. Cardiomyocyte growth and increased cardiac mass are essential to withstand hypertensive stress; however, whether immune cells are involved in this compensatory cardioprotective process is unclear. In normotensive animals, single-cell transcriptomics of fate-mapped self-renewing cardiac resident macrophages (RMs) revealed transcriptionally diverse cell states with a core repertoire of reparative gene programs, including high expression of insulin-like growth factor-1 (Igf1). Hypertension drove selective in situ proliferation and transcriptional activation of some cardiac RM states, directly correlating with increased cardiomyocyte growth. During hypertension, inducible ablation of RMs or selective deletion of RM-derived Igf1 prevented adaptive cardiomyocyte growth, and cardiac mass failed to increase, which led to cardiac dysfunction. Single-cell transcriptomics identified a conserved IGF1-expressing macrophage sub-population in human cardiomyopathy. Here we defined the absolute requirement of RM-produced IGF-1 in cardiac adaptation to hypertension.	[Zaman, Rysa; Hamidzada, Homaira; Kantores, Crystal; Wong, Anthony; Dick, Sarah A.; Wang, Yiming; Momen, Abdul; Aronoff, Laura; Lin, Julia; Billia, Filio; Nejat, Sara; Epelman, Slava] Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada; [Zaman, Rysa; Hamidzada, Homaira; Wong, Anthony; Dick, Sarah A.; Aronoff, Laura; Lin, Julia; Mital, Seema; Billia, Filio; Nejat, Sara; Epelman, Slava] Ted Rogers Ctr Heart Res, Toronto, ON, Canada; [Zaman, Rysa; Hamidzada, Homaira; Wong, Anthony; Lin, Julia; Epelman, Slava] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Aronoff, Laura; Lavine, Kory J.; Epelman, Slava] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Razani, Babak] Washington Univ, Sch Med, Div Cardiol, St Louis, MO USA; [Mital, Seema] Hosp Sick Children, Div Cardiol, Toronto, ON, Canada; [Mital, Seema] Univ Toronto, Dept Paediat, Toronto, ON, Canada; [Billia, Filio; Nejat, Sara; Epelman, Slava] Peter Munk Cardiac Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; Washington University (WUSTL); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; Peter Munk Cardiac Centre	Epelman, S (corresponding author), Univ Hlth Network, Toronto Gen Hosp, Res Inst, Toronto, ON, Canada.; Epelman, S (corresponding author), Ted Rogers Ctr Heart Res, Toronto, ON, Canada.; Epelman, S (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.; Epelman, S (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.; Epelman, S (corresponding author), Peter Munk Cardiac Ctr, Toronto, ON, Canada.	slava.epelman@uhn.ca	Epelman, Slava/AAO-1728-2020; Zaman, Rysa Zuaira/AGY-0565-2022	Epelman, Slava/0000-0003-3400-4475; Zaman, Rysa Zuaira/0000-0002-0007-4128	Canadian Institutes of Health Research [PJT364831]; Heart and Stroke Foundation of Canada; Ted Rogers Centre for Heart Research; Peter Munk Cardiac Centre	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Ted Rogers Centre for Heart Research; Peter Munk Cardiac Centre(University of Toronto)	This work was supported by the Canadian Institutes of Health Research (PJT364831 to S.E., R.Z., H.H., and A.W.), the Heart and Stroke Foundation of Canada (to S.E.), the Ted Rogers Centre for Heart Research (to S.E., R.Z., and H.H.), and the Peter Munk Cardiac Centre (to S.E.). We would like to thank the Princess Margaret Genomics Centre for single-cell RNA sequencing data processing.	Bajpai G, 2019, CIRC RES, V124, P263, DOI 10.1161/CIRCRESAHA.118.314028; Chakarov S, 2019, SCIENCE, V363, P1190, DOI 10.1126/science.aau0964; Chamsi-Pasha Mohammed A R, 2014, Curr Heart Fail Rep, V11, P58, DOI 10.1007/s11897-013-0178-0; Cittadini A, 1996, CIRCULATION, V93, P800, DOI 10.1161/01.CIR.93.4.800; Dandona P, 2007, J HUM HYPERTENS, V21, P20, DOI 10.1038/sj.jhh.1002101; Dick SA, 2019, NAT IMMUNOL, V20, P29, DOI [10.1038/s41590-018-0272-2, 10.1038/s41590-019-0363-8]; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Duan CM, 1998, J BIOL CHEM, V273, P16836, DOI 10.1074/jbc.273.27.16836; Emanuel R, 2014, ARTERIOSCL THROM VAS, V34, P1942, DOI 10.1161/ATVBAHA.114.303342; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Fujiu K, 2017, NAT MED, V23, P611, DOI 10.1038/nm.4326; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Heran BS, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003040.pub2; Hulsmans M, 2018, J EXP MED, V215, P423, DOI 10.1084/jem.20171274; Hulsmans M, 2017, CELL, V169, P510, DOI 10.1016/j.cell.2017.03.050; Ishibashi M, 2004, CIRC RES, V94, P1203, DOI 10.1161/01.RES.0000126924.23467.A3; ITO H, 1993, CIRCULATION, V87, P1715, DOI 10.1161/01.CIR.87.5.1715; Kain D, 2016, INT J CARDIOL, V203, P381, DOI 10.1016/j.ijcard.2015.10.126; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Kuwahara F, 2004, HYPERTENSION, V43, P739, DOI 10.1161/01.HYP.0000118584.33350.7d; Lavine KJ, 2014, P NATL ACAD SCI USA, V111, P16029, DOI 10.1073/pnas.1406508111; Leid J, 2016, CIRC RES, V118, P1498, DOI 10.1161/CIRCRESAHA.115.308270; Li QY, 2019, NEURON, V101, P207, DOI 10.1016/j.neuron.2018.12.006; Liao XD, 2018, P NATL ACAD SCI USA, V115, pE4661, DOI 10.1073/pnas.1720065115; Lin SY, 2017, CELL PROLIFERAT, V50, DOI 10.1111/cpr.12390; Litvinukova M, 2020, NATURE, V588, P466, DOI 10.1038/s41586-020-2797-4; Liu YH, 2002, HYPERTENSION, V39, P375, DOI 10.1161/hy02t2.102796; McGinnis CS, 2019, NAT METHODS, V16, P619, DOI 10.1038/s41592-019-0433-8; Nicolas-Avila JA, 2020, CELL, V183, P94, DOI 10.1016/j.cell.2020.08.031; O'Flanagan CH, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1830-0; Opie LH, 2001, CIRC RES, V88, P654, DOI 10.1161/hh0701.089175; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Pliner HA, 2019, NAT METHODS, V16, P983, DOI 10.1038/s41592-019-0535-3; Schaupp L, 2020, CELL, V181, P1080, DOI 10.1016/j.cell.2020.04.022; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sjogren K, 1999, P NATL ACAD SCI USA, V96, P7088, DOI 10.1073/pnas.96.12.7088; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stratikopoulos E, 2008, P NATL ACAD SCI USA, V105, P19378, DOI 10.1073/pnas.0809223105; Stuart T, 2019, NAT REV GENET, V20, P257, DOI 10.1038/s41576-019-0093-7; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Takemoto M, 1997, HYPERTENSION, V30, P1621, DOI 10.1161/01.HYP.30.6.1621; Wenzel P, 2011, CIRCULATION, V124, P1370, DOI 10.1161/CIRCULATIONAHA.111.034470; Wong NR, 2021, IMMUNITY, V54, P2072, DOI 10.1016/j.immuni.2021.07.003; Yakar S, 1999, P NATL ACAD SCI USA, V96, P7324, DOI 10.1073/pnas.96.13.7324; Zandbergen HR, 2009, J CARDIOVASC PHARM T, V14, P68, DOI 10.1177/1074248408329860	47	15	15	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					2057	+		10.1016/j.immuni.2021.07.006	http://dx.doi.org/10.1016/j.immuni.2021.07.006		SEP 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB		Bronze			2022-12-18	WOS:000695789800014
J	Sundling, C; Lau, AWY; Bourne, K; Young, C; Laurianto, C; Hermes, JR; Menzies, RJ; Butt, D; Krautler, NJ; Zahra, D; Suan, D; Brink, R				Sundling, Christopher; Lau, Angelica W. Y.; Bourne, Katherine; Young, Clara; Laurianto, Candy; Hermes, Jana R.; Menzies, Rosemary J.; Butt, Danyal; Krautler, Nike J.; Zahra, David; Suan, Dan; Brink, Robert			Positive selection of IgG(+) over IgM(+) B cells in the germinal center reaction	IMMUNITY			English	Article							CLASS-SWITCH RECOMBINATION; IMMUNOGLOBULIN-D; PLASMA-CELL; CYTOPLASMIC TAIL; ANTIGEN; AFFINITY; MEMORY; ANTIBODIES; DIFFERENTIATION; RECRUITMENT	Positive selection of high-affinity B cells within germinal centers (GCs) drives affinity maturation of antibody responses. Here, we examined the mechanism underlying the parallel transition from immunoglobulin M (IgM) to IgG. Early GCs contained mostly unswitched IgM(+) B cells; IgG(+) B cells subsequently increased in frequency, dominating GC responses 14-21 days after antigen challenge. Somatic hypermutation and generation of high-affinity clones occurred with equal efficiency among IgM(+) and IgG(+) GC B cells, and inactivation of Ig class-switch recombination did not prevent depletion of IgM(+) GC B cells. Instead, high-affinity IgG(+) GC B cells outcompeted high-affinity IgM(+) GC B cells via a selective advantage associated with IgG antigen receptor structure but independent of the extended cytoplasmic tail. Thus, two parallel forms of GC B-cell-positive selection, based on antigen receptor variable and constant regions, respectively, operate in tandem to ensure high-affinity IgG antibodies predominate in mature serum antibody responses.	[Sundling, Christopher; Lau, Angelica W. Y.; Bourne, Katherine; Young, Clara; Laurianto, Candy; Hermes, Jana R.; Menzies, Rosemary J.; Butt, Danyal; Krautler, Nike J.; Zahra, David; Suan, Dan; Brink, Robert] Garvan Inst Med Res, Immunol Div, Darlinghurst, NSW 2010, Australia; [Sundling, Christopher] Karolinska Inst, Dept Med Solna, Div Infect Dis, S-17176 Stockholm, Sweden; [Sundling, Christopher] Karolinska Inst, Dept Med Solna, Ctr Mol Med, S-17176 Stockholm, Sweden; [Sundling, Christopher] Karolinska Univ Hosp, Dept Infect Dis, S-17176 Stockholm, Sweden; [Lau, Angelica W. Y.; Young, Clara; Laurianto, Candy; Zahra, David; Suan, Dan; Brink, Robert] UNSW Sydney, St Vincents Clin Sch, Sydney, NSW 2010, Australia; [Butt, Danyal] AbbVie, 100 Res Dr, Worcester, MA 01605 USA; [Krautler, Nike J.] Neurimmune AG, Wagistr 13, CH-8952 Schlieren 8952, Switzerland	Garvan Institute of Medical Research; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of New South Wales Sydney; AbbVie	Brink, R (corresponding author), Garvan Inst Med Res, Immunol Div, Darlinghurst, NSW 2010, Australia.; Brink, R (corresponding author), UNSW Sydney, St Vincents Clin Sch, Sydney, NSW 2010, Australia.	r.brink@garvan.org.au	Sundling, Christopher/H-7707-2019	Sundling, Christopher/0000-0002-6138-690X; Menzies, Rosemary/0000-0002-1894-5657; Lau, Angelica WY/0000-0002-5306-5911	National Health and Medical Research Council of Australia; Swedish Research Council [2013-7333]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank staff of the Flow Cytometry Facility at the Garvan Institute for cell sorting, staff at Australian BioResources (ABR) for animal husbandry, and staff of Mouse Engineering Garvan/ABR (MEGA) for production of genetically modified CRISPR-Cas9 mice. Funding was from the National Health and Medical Research Council of Australia through a program grant and research fellowship to R.B. C.S. was supported by a postdoctoral fellowship from the Swedish Research Council (2013-7333).	[Anonymous], 2013, VACCINES-BASEL; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; BEST JM, 1969, LANCET, V2, P65; BORSOS T, 1965, SCIENCE, V150, P505, DOI 10.1126/science.150.3695.505; Brink R, 2015, METHODS MOL BIOL, V1291, P103, DOI 10.1007/978-1-4939-2498-1_9; BRINK R, 1992, J EXP MED, V176, P991, DOI 10.1084/jem.176.4.991; Chan TD, 2012, IMMUNITY, V37, P893, DOI 10.1016/j.immuni.2012.07.017; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Ehrenstein MR, 1998, P NATL ACAD SCI USA, V95, P10089, DOI 10.1073/pnas.95.17.10089; EISEN HN, 1964, BIOCHEMISTRY-US, V3, P996, DOI 10.1021/bi00895a027; Engels N, 2009, NAT IMMUNOL, V10, P1018, DOI 10.1038/ni.1764; Feng YQ, 2020, TRENDS IMMUNOL, V41, P586, DOI 10.1016/j.it.2020.04.009; Gitlin AD, 2014, NATURE, V509, P637, DOI 10.1038/nature13300; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Horikawa K, 2007, J EXP MED, V204, P759, DOI 10.1084/jem.20061923; HUBER R, 1976, NATURE, V264, P415, DOI 10.1038/264415a0; HURWITZ JL, 1980, CELL, V22, P349, DOI 10.1016/0092-8674(80)90345-1; JACOB J, 1991, NATURE, V354, P389, DOI 10.1038/354389a0; Kaisho T, 1997, SCIENCE, V276, P412, DOI 10.1126/science.276.5311.412; Kallies A, 2004, J EXP MED, V200, P967, DOI 10.1084/jem.20040973; Khamlichi AA, 2004, BLOOD, V103, P3828, DOI 10.1182/blood-2003-10-3470; KIM S, 1981, CELL, V27, P573, DOI 10.1016/0092-8674(81)90399-8; King HW, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe6291; Kodama T, 2020, INT IMMUNOL, V32, P385, DOI 10.1093/intimm/dxaa009; Krautler NJ, 2017, J EXP MED, V214, P1259, DOI 10.1084/jem.20161533; MAKELA O, 1970, IMMUNOCHEMISTRY, V7, P917, DOI 10.1016/0019-2791(70)90053-4; Martin SW, 2002, NAT IMMUNOL, V3, P182, DOI 10.1038/ni752; Mayer CT, 2017, SCIENCE, V358, DOI 10.1126/science.aao2602; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Noviski M, 2018, ELIFE, V7, DOI 10.7554/eLife.35074; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Phan TG, 2003, J EXP MED, V197, P845, DOI 10.1084/jem.20022144; Phan TG, 2006, J EXP MED, V203, P2419, DOI 10.1084/jem.20061254; Roco JA, 2019, IMMUNITY, V51, P337, DOI 10.1016/j.immuni.2019.07.001; ROES J, 1993, J EXP MED, V177, P45, DOI 10.1084/jem.177.1.45; Sabouri Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13381; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Sharp TH, 2019, P NATL ACAD SCI USA, V116, P11900, DOI 10.1073/pnas.1901841116; SMITH TJ, 1993, P NATL ACAD SCI USA, V90, P7015, DOI 10.1073/pnas.90.15.7015; STEINER LA, 1967, J EXP MED, V126, P1161, DOI 10.1084/jem.126.6.1161; Suan D, 2017, IMMUNITY, V47, P1142, DOI 10.1016/j.immuni.2017.11.022; Ubelhart R, 2015, NAT IMMUNOL, V16, P534, DOI 10.1038/ni.3141; UHR JW, 1963, J EXP MED, V117, P457, DOI 10.1084/jem.117.3.457; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; WHITE MB, 1985, SCIENCE, V228, P733, DOI 10.1126/science.3922054; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Ye XH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005454	50	15	15	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					988	+		10.1016/j.immuni.2021.03.013	http://dx.doi.org/10.1016/j.immuni.2021.03.013		MAY 2021	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33857421	Bronze			2022-12-18	WOS:000652019500015
J	Wang, Y; Fu, ZY; Li, XT; Liang, YM; Pei, SY; Hao, SM; Zhu, QC; Yu, T; Pei, YF; Yuan, J; Ye, JL; Fu, JM; Xu, J; Hong, J; Yang, RR; Hou, H; Huang, XF; Peng, C; Zheng, MY; Xiao, YC				Wang, Yan; Fu, Zunyun; Li, Xutong; Liang, Yinming; Pei, Siyu; Hao, Shumeng; Zhu, Qingchen; Yu, Tao; Pei, Yifei; Yuan, Jia; Ye, Jialin; Fu, Jiemeng; Xu, Jing; Hong, Jin; Yang, Ruirui; Hou, Hui; Huang, Xinfang; Peng, Chao; Zheng, Mingyue; Xiao, Yichuan			Cytoplasmic DNA sensing by KU complex in aged CD4(+) T cell potentiates T cell activation and aging-related autoimmune inflammation	IMMUNITY			English	Article							DEPENDENT PROTEIN-KINASE; GMP-AMP SYNTHASE; CATALYTIC SUBUNIT; EXONUCLEASE TREX1; DAMAGE RESPONSES; IMMUNE-SYSTEM; SENSOR CGAS; PROMOTES; REPAIR; IDENTIFICATION	Aging is associated with DNA accumulation and increased homeostatic proliferation of circulating T cells. Although these attributes are associated with aging-related autoimmunity, their direct contributions remain unclear. Conventionally, KU complex, the regulatory subunit of DNA-dependent protein kinase (DNA-PK), together with the catalytic subunit of DNA-PK (DNA-PKcs), mediates DNA damage repair in the nucleus. Here, we found KU complex abundantly expressed in the cytoplasm, where it recognized accumulated cytoplasmic DNA in aged human and mouse CD4(+) T cells. This process enhanced T cell activation and pathology of experimental autoimmune encephalomyelitis EAE) in aged mice. Mechanistically, KU-mediated DNA sensing facilitated DNA-PKcs recruitment and phosphorylation of the kinase ZAK. This activated AKT and mTOR pathways, promoting CD4(+) T cell proliferation and activation. We developed a specific ZAK inhibitor, which dampened EAE pathology in aged mice. Overall, these findings demonstrate a KU-mediated cytoplasmic DNA-sensing pathway in CD4(+) T cells that potentiates aging-related autoimmunity.	[Wang, Yan; Pei, Siyu; Hao, Shumeng; Zhu, Qingchen; Yu, Tao; Pei, Yifei; Yuan, Jia; Ye, Jialin; Fu, Jiemeng; Xu, Jing; Hong, Jin; Xiao, Yichuan] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Tissue Microenvironm & Tumor, Shanghai 200031, Peoples R China; [Fu, Zunyun; Li, Xutong; Yang, Ruirui; Hou, Hui; Zheng, Mingyue] Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr,State Key Lab Drug Re, Shanghai 201203, Peoples R China; [Fu, Zunyun] Nanjing Univ Chinese Med, Sch Chinese Mat Med, Nanjing 210023, Peoples R China; [Liang, Yinming] Xinxiang Med Univ, Sch Lab Med, Xinxiang 453003, Henan, Peoples R China; [Hong, Jin] Shanghai Jiao Tong Univ, Ruijin Hosp, Comprehens Breast Hlth Ctr, Sch Med, Shanghai 200025, Peoples R China; [Yang, Ruirui] ShanghaiTech Univ, Shanghai Inst Adv Immunochem Studies, Shanghai 200031, Peoples R China; [Yang, Ruirui] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China; [Huang, Xinfang] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Rheumatol, Shanghai 200120, Peoples R China; [Peng, Chao] Zhangjiang Lab, Natl Facil Prot Sci Shanghai, Shanghai 201210, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Nutrition & Health, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; University of Chinese Academy of Sciences, CAS; Nanjing University of Chinese Medicine; Xinxiang Medical University; Shanghai Jiao Tong University; ShanghaiTech University; ShanghaiTech University; Tongji University	Xiao, YC (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Nutr & Hlth, CAS Key Lab Tissue Microenvironm & Tumor, Shanghai 200031, Peoples R China.; Zheng, MY (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr,State Key Lab Drug Re, Shanghai 201203, Peoples R China.	myzheng@simm.ac.cn; ycxiao@sibs.ac.cn	Zheng, Mingyue/AAJ-8027-2020	Zheng, Mingyue/0000-0002-3323-3092; Liang, Yinming/0000-0001-9174-4037	Strategic Priority Research Program of the Chinese Academy of Sciences [XDB39030300]; National Key R&D Program of China [2018YFA0107201, 2018YFA0902703]; National Natural Science Foundation of China [82030041, 81770567]; Program of Shanghai Academic/Technology Research Leader [20XD1424600]; 111 program [D20036]; CAS Key Laboratory of Tissue Microenvironment and Tumor	Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Shanghai Academic/Technology Research Leader; 111 program(Ministry of Education, China - 111 Project); CAS Key Laboratory of Tissue Microenvironment and Tumor	We would like to thank Drs. Hong-Bing Shu, Bo Zhong (Wuhan University, China), Tao Li (National Center of Biomedical Analysis, China), Pinglong Xu (Zhejiang University, China), Hui Xiao (Institut Pasteur of Shanghai, CAS, China), Baoxue Ge (Tongji University, China), and Xing Chang (Westlake University, China) for their kindly help in this study. This research was supported by the grants from the Strategic Priority Research Program of the Chinese Academy of Sciences (XDB39030300), the National Key R&D Program of China (2018YFA0107201 and 2018YFA0902703), the National Natural Science Foundation of China (82030041 and 81770567), the Program of Shanghai Academic/Technology Research Leader (20XD1424600), the 111 program (D20036; for the generation of Trex1-KO and Zak-T169A knockin mice), and CAS Key Laboratory of Tissue Microenvironment and Tumor.	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Block WD, 2004, NUCLEIC ACIDS RES, V32, P4351, DOI 10.1093/nar/gkh761; Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024; Brandhorst S, 2015, CELL METAB, V22, P86, DOI 10.1016/j.cmet.2015.05.012; Burleigh K, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba4219; Cejka D, 2010, ARTHRITIS RHEUM-US, V62, P2294, DOI 10.1002/art.27504; Chalan Paulina, 2015, Curr Aging Sci, V8, P131; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845; Crowl JT, 2017, ANNU REV IMMUNOL, V35, P313, DOI 10.1146/annurev-immunol-051116-052331; Dai J, 2019, CELL, V176, P1447, DOI 10.1016/j.cell.2019.01.016; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Ferguson BJ, 2012, ELIFE, V1, DOI 10.7554/eLife.00047; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; FOURNIE GJ, 1993, GERONTOLOGY, V39, P215; Gaidt MM, 2017, CELL, V171, P1110, DOI 10.1016/j.cell.2017.09.039; Gall A, 2012, IMMUNITY, V36, P120, DOI 10.1016/j.immuni.2011.11.018; Gao DX, 2015, P NATL ACAD SCI USA, V112, pE5699, DOI 10.1073/pnas.1516465112; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Ginaldi L, 2004, IMMUNOL RES, V30, P81, DOI 10.1385/IR:30:1:081; Goronzy JJ, 2012, CELL MOL LIFE SCI, V69, P1615, DOI 10.1007/s00018-012-0970-0; Gotoh I, 2001, J BIOL CHEM, V276, P4276, DOI 10.1074/jbc.M008595200; Gruver AL, 2007, J PATHOL, V211, P144, DOI 10.1002/path.2104; Gulen MF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00573-w; Han CH, 2020, NAT IMMUNOL, V21, P546, DOI 10.1038/s41590-020-0641-5; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hu MM, 2016, IMMUNITY, V45, P555, DOI 10.1016/j.immuni.2016.08.014; Johnson SC, 2013, NATURE, V493, P338, DOI 10.1038/nature11861; King C, 2004, CELL, V117, P265, DOI 10.1016/S0092-8674(04)00335-6; Lan YY, 2019, AGING CELL, V18, DOI 10.1111/acel.12901; Lee-Kirsch MA, 2007, NAT GENET, V39, P1065, DOI 10.1038/ng2091; Li YY, 2018, EXP GERONTOL, V105, P118, DOI 10.1016/j.exger.2017.10.027; Li YY, 2016, IMMUNITY, V45, P903, DOI 10.1016/j.immuni.2016.09.013; Li ZY, 1995, CELL, V83, P1079, DOI 10.1016/0092-8674(95)90135-3; Linton PJ, 2004, NAT IMMUNOL, V5, P133, DOI 10.1038/ni1033; Liu JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4830; Liu TH, 2017, CELL CYCLE, V16, P861, DOI 10.1080/15384101.2017.1304339; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Monroe KM, 2014, SCIENCE, V343, P428, DOI 10.1126/science.1243640; Napirei M, 2000, NAT GENET, V25, P177, DOI 10.1038/76032; O'Neill LAJ, 2013, SCIENCE, V339, P763, DOI 10.1126/science.1234724; Okabe Y, 2005, J EXP MED, V202, P1333, DOI 10.1084/jem.20051654; Ou HL, 2018, BLOOD, V131, P488, DOI 10.1182/blood-2017-07-746396; Pahlavani MA, 1996, MECH AGEING DEV, V89, P125, DOI 10.1016/0047-6374(96)01725-3; Park SJ, 2017, CELL METAB, V25, P1135, DOI [10.1016/j.cmet.2017.04.008, 10.1016/j.cmet.2017.07.005]; Perl A, 2015, ANN NY ACAD SCI, V1346, P33, DOI 10.1111/nyas.12756; Ribezzo F, 2016, SEMIN CANCER BIOL, V37-38, P26, DOI 10.1016/j.semcancer.2015.12.005; Sakata-Kaneko S, 2000, CLIN EXP IMMUNOL, V120, P267, DOI 10.1046/j.1365-2249.2000.01224.x; Scarpaci S, 2003, MECH AGEING DEV, V124, P517, DOI 10.1016/S0047-6374(03)00030-7; Sedelnikova OA, 2004, NAT CELL BIOL, V6, P168, DOI 10.1038/ncb1095; Shao L, 2010, EMBO MOL MED, V2, P415, DOI 10.1002/emmm.201000096; Shao L, 2009, J EXP MED, V206, P1435, DOI 10.1084/jem.20082251; Soares JP, 2014, AGING-US, V6, P432, DOI 10.18632/aging.100667; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Sui HY, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah5054; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Theofilopoulos AN, 2001, J CLIN INVEST, V108, P335, DOI 10.1172/JCI200112173; Voisinne G, 2019, NAT IMMUNOL, V20, P1530, DOI 10.1038/s41590-019-0489-8; WALFORD RL, 1964, GERONTOLOGIST, V4, P195, DOI 10.1093/geront/4.4.195; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000; Wang DY, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00924; Wang ZZ, 2018, IMMUNITY, V49, P80, DOI 10.1016/j.immuni.2018.05.008; Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001; Weterings E, 2016, DNA REPAIR, V43, P98, DOI 10.1016/j.dnarep.2016.03.014; Weyand CM, 2014, CURR OPIN RHEUMATOL, V26, P93, DOI 10.1097/BOR.0000000000000011; Whisler RL, 1996, CELL IMMUNOL, V169, P185, DOI 10.1006/cimm.1996.0109; Wu JJ, 2020, IMMUNITY, V53, P115, DOI 10.1016/j.immuni.2020.06.009; Xia JY, 2012, AGING DIS, V3, P248; Xing J, 2017, J CHEM INF MODEL, V57, P1677, DOI 10.1021/acs.jcim.7b00098; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Yang YG, 2007, CELL, V131, P873, DOI 10.1016/j.cell.2007.10.017; Yasutomo K, 2001, NAT GENET, V28, P313, DOI 10.1038/91070; Zhang X, 2011, J IMMUNOL, V186, P4541, DOI 10.4049/jimmunol.1003389; Zhang XL, 2018, J EXP MED, V215, P1365, DOI 10.1084/jem.20171417; Zierhut C, 2019, CELL, V178, P302, DOI 10.1016/j.cell.2019.05.035	79	15	16	3	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					632	+		10.1016/j.immuni.2021.02.003	http://dx.doi.org/10.1016/j.immuni.2021.02.003		APR 2021	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33667382	Bronze			2022-12-18	WOS:000640102800007
J	Dubrot, J; Lane-Reticker, SK; Kessler, EA; Ayer, A; Mishra, G; Wolfe, CH; Zimmer, MD; Du, PP; Mahapatra, A; Ockerman, KM; Davis, TGR; Kohnle, IC; Pope, HW; Allen, PM; Olander, KE; Iracheta-Vellve, A; Doench, JG; Haining, WN; Yates, KB; Manguso, RT				Dubrot, Juan; Lane-Reticker, Sarah Kate; Kessler, Emily A.; Ayer, Austin; Mishra, Gargi; Wolfe, Clara H.; Zimmer, Margaret D.; Du, Peter P.; Mahapatra, Animesh; Ockerman, Kyle M.; Davis, Thomas G. R.; Kohnle, Ian C.; Pope, Hans W.; Allen, Peter M.; Olander, Kira E.; Iracheta-Vellve, Arvin; Doench, John G.; Haining, W. Nicholas; Yates, Kathleen B.; Manguso, Robert T.			In vivo screens using a selective CRISPR antigen removal lentiviral vector system reveal immune dependencies in renal cell carcinoma	IMMUNITY			English	Article							NK CELLS; ACQUIRED-RESISTANCE; RATIONAL DESIGN; GENETIC SCREENS; TUMOR-CELLS; DNA; ACTIVATION; EXPRESSION; AUTOPHAGY; NKG2D	CRISPR-Cas9 genome engineering has increased the pace of discovery for immunology and cancer biology, revealing potential therapeutic targets and providing insight into mechanisms underlying resistance to immunotherapy. However, endogenous immune recognition of Cas9 has limited the applicability of CRISPR technologies in vivo. Here, we characterized immune responses against Cas9 and other expressed CRISPR vector components that cause antigen-specific tumor rejection in several mouse cancer models. To avoid unwanted immune recognition, we designed a lentiviral vector system that allowed selective CRISPR antigen removal (SCAR) from tumor cells. The SCAR system reversed immune-mediated rejection of CRISPR-modified tumor cells in vivo and enabled high-throughput genetic screens in previously intractable models. A pooled in vivo screen using SCAR in a CRISPR-antigen-sensitive renal cell carcinoma revealed resistance pathways associated with autophagy and major histocompatibility complex class I (MHC class I) expression. Thus, SCAR presents a resource that enables CRISPR-based studies of tumor-immune interactions and prevents unwanted immune recognition of genetically engineered cells, with implications for clinical applications.	[Dubrot, Juan; Lane-Reticker, Sarah Kate; Kessler, Emily A.; Ayer, Austin; Mishra, Gargi; Wolfe, Clara H.; Zimmer, Margaret D.; Du, Peter P.; Mahapatra, Animesh; Ockerman, Kyle M.; Davis, Thomas G. R.; Kohnle, Ian C.; Pope, Hans W.; Allen, Peter M.; Olander, Kira E.; Iracheta-Vellve, Arvin; Doench, John G.; Haining, W. Nicholas; Yates, Kathleen B.; Manguso, Robert T.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Haining, W. Nicholas] Childrens Hosp, Div Pediat Hematol & Oncol, 300 Longwood Ave, Boston, MA 02115 USA; [Haining, W. Nicholas] Merck Res Labs, Boston, MA USA; [Yates, Kathleen B.; Manguso, Robert T.] Harvard Med Sch, Ctr Canc Res, Massachusetts Gen Hosp, Charlestown, MA 02129 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Boston Children's Hospital; Merck & Company; Harvard University; Massachusetts General Hospital	Yates, KB; Manguso, RT (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.; Yates, KB; Manguso, RT (corresponding author), Harvard Med Sch, Ctr Canc Res, Massachusetts Gen Hosp, Charlestown, MA 02129 USA.	yates@broadinstitute.org; rmanguso@broadinstitute.org	Dubrot, Juan/ABI-1676-2020; Doench, John G/HCI-9570-2022	Dubrot, Juan/0000-0002-8093-2208; Doench, John G/0000-0002-3707-9889; Mishra, Gargi/0000-0002-4063-6797; Wolfe, Clara/0000-0003-4862-8254; Kessler, Emily/0000-0002-2608-6020; Ockerman, Kyle/0000-0002-6500-6740; Zimmer, Margaret/0000-0002-3317-6569; Lane-Reticker, Sarah/0000-0001-7267-9882; Du, Peter/0000-0003-2652-0541; Allen, Peter/0000-0002-1827-5091	Calico Life Sciences	Calico Life Sciences	This work was supported in part by funding from Calico Life Sciences. J.D., W.N.H., K.B.Y., and R.T.M. are authors of a patent application related to the SCAR vector system. R.T.M. consults for Bristol-Myers Squibb and Tango Therapeutics; W.N.H. is an employee of Merck & Co and has equity in Tango Therapeutics and ArsenalBio. H.W.P. is an employee of Arsenal Bio. I.C.K. is an employee of eGenesis Bio. J.G.D. consults for Foghorn Therapeutics, Maze Therapeutics, Merck & Co, Agios, and Pfizer and consults for and has equity in Tango Therapeutics.	Ahn E, 2018, P NATL ACAD SCI USA, V115, P4749, DOI 10.1073/pnas.1718217115; Andre P, 2018, CELL, V175, P1731, DOI 10.1016/j.cell.2018.10.014; Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Baginska J, 2013, P NATL ACAD SCI USA, V110, P17450, DOI 10.1073/pnas.1304790110; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Benci JL, 2019, CELL, V178, P933, DOI 10.1016/j.cell.2019.07.019; Canver MC, 2018, NAT PROTOC, V13, P946, DOI 10.1038/nprot.2018.005; Carpenter MA, 2019, METHODS, V156, P79, DOI 10.1016/j.ymeth.2018.12.006; Certo MT, 2011, NAT METHODS, V8, P671, DOI [10.1038/NMETH.1648, 10.1038/nmeth.1648]; Charlesworth CT, 2019, NAT MED, V25, P249, DOI 10.1038/s41591-018-0326-x; Chen RQ, 2014, IMMUNITY, V41, P325, DOI 10.1016/j.immuni.2014.08.002; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dever DP, 2016, NATURE, V539, P384, DOI 10.1038/nature20134; DeWitt MA, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf9336; Diefenbach A, 2000, NAT IMMUNOL, V1, P119, DOI 10.1038/77793; Doench JG, 2018, NAT REV GENET, V19, P67, DOI 10.1038/nrg.2017.97; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doench JG, 2014, NAT BIOTECHNOL, V32, P1262, DOI 10.1038/nbt.3026; Dong MB, 2019, CELL, V178, P1189, DOI 10.1016/j.cell.2019.07.044; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; Freeman AJ, 2019, CELL REP, V28, P2784, DOI 10.1016/j.celrep.2019.08.017; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Gettinger S, 2017, CANCER DISCOV, V7, P1420, DOI 10.1158/2159-8290.CD-17-0593; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Hanlon KS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12449-2; Hartenian E, 2015, FEBS J, V282, P1383, DOI 10.1111/febs.13248; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu JH, 2018, MOL THER-METH CLIN D, V9, P203, DOI 10.1016/j.omtm.2018.02.009; Ishizuka JJ, 2019, NATURE, V565, P43, DOI 10.1038/s41586-018-0768-9; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung J, 2017, NAT PROTOC, V12, P828, DOI 10.1038/nprot.2017.016; Jurtz V, 2017, J IMMUNOL, V199, P3360, DOI 10.4049/jimmunol.1700893; Kantor B, 2011, MOL THER, V19, P547, DOI 10.1038/mt.2010.277; Kearney CJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3451; Kimmelman AC, 2017, CELL METAB, V25, P1037, DOI 10.1016/j.cmet.2017.04.004; Kweon J, 2020, ONCOGENE, V39, P30, DOI 10.1038/s41388-019-0968-2; LaFleur MW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09656-2; Lawson KA, 2020, NATURE, V586, P120, DOI 10.1038/s41586-020-2746-2; Lee G, 1998, GENE, V216, P55, DOI 10.1016/S0378-1119(98)00325-4; Li F, 2020, CANCER DISCOV, V10, P270, DOI 10.1158/2159-8290.CD-19-0780; Lino CA, 2018, DRUG DELIV, V25, P1234, DOI 10.1080/10717544.2018.1474964; Liu TY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10780-2; Liu XJ, 2017, CELL RES, V27, P154, DOI 10.1038/cr.2016.142; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Manguso RT, 2017, NATURE, V547, P413, DOI 10.1038/nature23270; Mgrditchian T, 2017, P NATL ACAD SCI USA, V114, pE9271, DOI 10.1073/pnas.1703921114; Middha S, 2019, JCO PRECIS ONCOL, V3, DOI 10.1200/PO.18.00321; Nicolai CJ, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaz2738; Nightingale SJ, 2006, MOL THER, V13, P1121, DOI 10.1016/j.ymthe.2006.01.008; Pan D, 2018, SCIENCE, V359, P770, DOI 10.1126/science.aao1710; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Poillet-Perez L, 2018, NATURE, V563, P569, DOI 10.1038/s41586-018-0697-7; Raulet DH, 2013, ANNU REV IMMUNOL, V31, P413, DOI 10.1146/annurev-immunol-032712-095951; Rodig SJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar3342; Sade-Feldman M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01062-w; Sanson KR, 2019, GENETICS, DOI [10.1101/747170 ., DOI 10.1101/747170]; Schmidts A, 2019, BLOOD ADV, V3, P3248, DOI 10.1182/bloodadvances.2019000703; Shalem O, 2014, PLOS GENET, V4, pe9; Shifrut E, 2018, CELL, V175, P1958, DOI 10.1016/j.cell.2018.10.024; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Torrejon DY, 2020, CANCER DISCOV, V10, P1140, DOI 10.1158/2159-8290.CD-19-1409; Wagner DL, 2019, NAT MED, V25, P242, DOI 10.1038/s41591-018-0204-6; Wang D, 2015, HUM GENE THER, V26, P432, DOI 10.1089/hum.2015.087; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Williams JB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14290-4; Yamamoto K, 2020, NATURE, V581, P100, DOI 10.1038/s41586-020-2229-5; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zemek RM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav7816; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737	73	15	15	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					571	+		10.1016/j.immuni.2021.01.001	http://dx.doi.org/10.1016/j.immuni.2021.01.001		MAR 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33497609	Bronze			2022-12-18	WOS:000627409300021
J	Yun, HM; Yee, MB; Lathrop, KL; Kinchington, PR; Hendricks, RL; St Leger, AJ				Yun, Hongmin; Yee, Michael B.; Lathrop, Kira L.; Kinchington, Paul R.; Hendricks, Robert L.; St Leger, Anthony J.			Production of the Cytokine VEGF-A by CD4(+) T and Myeloid Cells Disrupts the Corneal Nerve Landscape and Promotes Herpes Stromal Keratitis	IMMUNITY			English	Article							ENDOTHELIAL GROWTH-FACTOR; VIVO-CONFOCAL-MICROSCOPY; VIRUS TYPE-1 INFECTION; IMMUNOPATHOLOGIC DISEASE; SENSORY NEURONS; IFN-GAMMA; DEGENERATION; RESPONSES; IL-17; RECONSTRUCTION	Herpes simplex virus type 1 (HSV-1)-infected corneas can develop a blinding immunoinflammatory condition called herpes stromal keratitis (HSK), which involves the loss of corneal sensitivity due to retraction of sensory nerves and subsequent hyperinnervation with sympathetic nerves. Increased concentrations of the cytokine VEGF-A in the cornea are associated with HSK severity. Here, we examined the impact of VEGFA on neurologic changes that underly HSK using a mouse model of HSV-1 corneal infection. Both CD4(+) T cells and myeloid cells produced pathogenic levels of VEGF-A within HSV-1-infected corneas, and CD4(+) cell depletion promoted reinnervation of HSK corneas with sensory nerves. In vitro, VEGF-A from infected comeas repressed sensory nerve growth and promoted sympathetic nerve growth. Neutralizing VEGF-A in vivo using bevacizumab inhibited sympathetic innervation, promoted sensory nerve regeneration, and alleviated disease. Thus, VEGF-A can shape the sensory and sympathetic nerve landscape within the cornea, with implications for the treatment of blinding comeal disease.	[Yun, Hongmin; Yee, Michael B.; Lathrop, Kira L.; Kinchington, Paul R.; Hendricks, Robert L.; St Leger, Anthony J.] Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA; [Kinchington, Paul R.; Hendricks, Robert L.] Univ Pittsburgh, Dept Mol Microbiol & Genet, Sch Med, Pittsburgh, PA 15213 USA; [Hendricks, Robert L.; St Leger, Anthony J.] Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15213 USA; [Lathrop, Kira L.] Univ Pittsburgh, Swanson Sch Med, Dept Bioengn, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	St Leger, AJ (corresponding author), Univ Pittsburgh, Sch Med, Dept Ophthalmol, Pittsburgh, PA 15261 USA.; St Leger, AJ (corresponding author), Univ Pittsburgh, Dept Immunol, Sch Med, Pittsburgh, PA 15213 USA.	anthony.stleger@pitt.edu			NIH [R01 EY026891, R00 EY025761, R01 EY 015291, AI122640, P30 EY0898]; Eye & Ear Foundation of Pittsburgh; Research to Prevent Blindness Inc.	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eye & Ear Foundation of Pittsburgh; Research to Prevent Blindness Inc.(Research to Prevent Blindness (RPB))	We would like to thank Nancy Zurowski for assistance with operating the flow cytometer during experiments. We thank Dr. Esta Albelev and the Pittsburgh Nanofabrication Facility for assistance in generating the silicon templates for generating microfluidic channeled platforms. The graphical abstract was created using http://Biorender.com.The work was supported by NIH grants R01 EY026891 (R.L.H. and A.J.S.), R00 EY025761 (A.J.S.), R01 EY 015291, and AI122640 (P.R.K.) and core grant P30 EY0898. In addition, we acknowledge support from the Eye & Ear Foundation of Pittsburgh and unrestricted grants from Research to Prevent Blindness Inc.	Acosta MC, 2001, INVEST OPHTH VIS SCI, V42, P2063; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Arbore G, 2016, SCIENCE, V352, DOI 10.1126/science.aad1210; Arganda-Carreras I, 2010, MICROSC RES TECHNIQ, V73, P1019, DOI 10.1002/jemt.20829; Baral P, 2018, NAT MED, V24, P1625, DOI 10.1038/s41591-018-0093-8; Baral P, 2018, NAT MED, V24, P417, DOI 10.1038/nm.4501; BELMONTE C, 1981, J PHYSIOL-LONDON, V321, P355, DOI 10.1113/jphysiol.1981.sp013989; Bertke AS, 2011, J VIROL, V85, P6669, DOI 10.1128/JVI.00204-11; Bonini S, 2003, EYE, V17, P989, DOI 10.1038/sj.eye.6700616; BOULEY DM, 1995, J IMMUNOL, V155, P3964; Brash JT, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.130979; Calippe B, 2017, IMMUNITY, V46, P261, DOI 10.1016/j.immuni.2017.01.006; Cardone J, 2010, NAT IMMUNOL, V11, P862, DOI 10.1038/ni.1917; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Chiu IM, 2016, PAIN, V157, P1192, DOI 10.1097/j.pain.0000000000000559; Chucair-Elliott AJ, 2015, INVEST OPHTH VIS SCI, V56, P1097, DOI 10.1167/iovs.14-15596; Cohen JA, 2019, CELL, V178, P919, DOI 10.1016/j.cell.2019.06.022; Cruzat A, 2011, INVEST OPHTH VIS SCI, V52, P5136, DOI 10.1167/iovs.10-7048; Cruzat A, 2010, SEMIN OPHTHALMOL, V25, P171, DOI 10.3109/08820538.2010.518133; DOYMAZ MZ, 1992, INVEST OPHTH VIS SCI, V33, P2165; FERREIRA SH, 1988, NATURE, V334, P698, DOI 10.1038/334698a0; Gallar J, 2010, INVEST OPHTH VIS SCI, V51, P4516, DOI 10.1167/iovs.10-5225; Hamrah P, 2010, OPHTHALMOLOGY, V117, P1930, DOI 10.1016/j.ophtha.2010.07.010; HENDRICKS RL, 1992, J IMMUNOL, V149, P3023; Huang W, 2011, CELL BIOCHEM BIOPHYS, V61, P115, DOI 10.1007/s12013-011-9167-7; Jeon S, 2018, J IMMUNOL, V200, P3711, DOI 10.4049/jimmunol.1700417; Jin KL, 2006, J NEUROBIOL, V66, P236, DOI 10.1002/neu.20215; Julian K, 2011, ACTA OPHTHALMOL, V89, P179, DOI 10.1111/j.1755-3768.2010.02046.x; KAPLAN PE, 1980, ARCH PHYS MED REHAB, V61, P30; Kurbanyan K, 2012, EYE, V26, P126, DOI 10.1038/eye.2011.270; Labetoulle M, 2019, ACTA OPHTHALMOL, V97, P137, DOI 10.1111/aos.13844; Lepisto AJ, 2006, INVEST OPHTH VIS SCI, V47, P3400, DOI 10.1167/iovs.05-0898; Longair MH, 2011, BIOINFORMATICS, V27, P2453, DOI 10.1093/bioinformatics/btr390; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; MARTIN JR, 1991, ACTA NEUROPATHOL, V82, P353, DOI 10.1007/BF00296546; Matheis F, 2020, CELL, V180, P64, DOI 10.1016/j.cell.2019.12.002; McNamee KE, 2011, PAIN, V152, P1838, DOI 10.1016/j.pain.2011.03.035; Molesworth-Kenyon SJ, 2008, J LEUKOCYTE BIOL, V83, P401, DOI 10.1189/jlb.0807571; Muller RT, 2015, OPHTHALMOLOGY, V122, P2200, DOI 10.1016/j.ophtha.2015.06.047; Muller LJ, 2003, EXP EYE RES, V76, P521, DOI 10.1016/S0014-4835(03)00050-2; NEWELL C K, 1989, Regional Immunology, V2, P366; NEWELL CK, 1989, J VIROL, V63, P769, DOI 10.1128/JVI.63.2.769-775.1989; Nishida T, 2009, CURR OPIN OPHTHALMOL, V20, P276, DOI 10.1097/ICU.0b013e32832b758f; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; NORN MS, 1970, ACTA OPHTHALMOL, V48, P383; Oetjen LK, 2017, CELL, V171, P217, DOI 10.1016/j.cell.2017.08.006; Okada Y, 2019, LAB INVEST, V99, P210, DOI 10.1038/s41374-018-0118-4; Oliveira-Soto L, 2001, CORNEA, V20, P374, DOI 10.1097/00003226-200105000-00008; Pinto LG, 2010, PAIN, V148, P247, DOI 10.1016/j.pain.2009.11.006; Reeves AG, 2008, DISORDERS NERVOUS SY; Reyes JL, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/2532314; Rosenberg ME, 2002, CORNEA, V21, P265, DOI 10.1097/00003226-200204000-00006; Royer DJ, 2019, ELIFE, V8, DOI 10.7554/eLife.48378; Sondell M, 2000, EUR J NEUROSCI, V12, P4243, DOI 10.1046/j.0953-816X.2000.01326.x; Storkebaum E, 2005, NAT NEUROSCI, V8, P85, DOI 10.1038/nn1360; Suryawanshi A, 2012, J IMMUNOL, V188, P3434, DOI 10.4049/jimmunol.1102602; Suryawanshi A, 2011, J IMMUNOL, V187, P1919, DOI 10.4049/jimmunol.1100736; Suryawanshi A, 2011, J IMMUNOL, V186, P3653, DOI 10.4049/jimmunol.1003239; TANELIAN DL, 1984, EXP NEUROL, V84, P165, DOI 10.1016/0014-4886(84)90013-X; Tang QZ, 1997, J IMMUNOL, V158, P1275; Thomas J, 1997, J IMMUNOL, V158, P1383; Tovar-y-Romo LB, 2007, J NEUROPATH EXP NEUR, V66, P913, DOI 10.1097/nen.0b013e3181567c16; Treat B.R., 2020, J VIROL, V94; Tuominen ISJ, 2003, INVEST OPHTH VIS SCI, V44, P2545, DOI 10.1167/iovs.02-1260; Verjans GMGM, 1998, J INFECT DIS, V177, P484, DOI 10.1086/517382; Wang MTM, 2018, OCUL SURF, V16, P424, DOI 10.1016/j.jtos.2018.06.001; Yun H, 2016, INVEST OPHTH VIS SCI, V57, P1749, DOI 10.1167/iovs.16-19183; Yun HM, 2014, J VIROL, V88, P7870, DOI 10.1128/JVI.01146-14; ZANDER E, 1951, J ANAT, V85, P68; Zheng M, 2002, P NATL ACAD SCI USA, V99, P8944, DOI 10.1073/pnas.132605599	70	15	15	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					1050	+		10.1016/j.immuni.2020.10.013	http://dx.doi.org/10.1016/j.immuni.2020.10.013			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33207210	Bronze, Green Accepted			2022-12-18	WOS:000599348200015
J	Chang, DH; Xing, Q; Su, Y; Zhao, XH; Xu, W; Wang, XH; Dong, C				Chang, Dehui; Xing, Qi; Su, Yang; Zhao, Xiaohong; Xu, Wei; Wang, Xiaohu; Dong, Chen			The Conserved Non-coding Sequences CNS6 and CNS9 Control Cytokine-Induced Rorc Transcription during T Helper 17 Cell Differentiation	IMMUNITY			English	Article							INNATE LYMPHOID-CELLS; TGF-BETA; GAMMA-T; C-MAF; PROINFLAMMATORY IL-17(+); IL-22 PRODUCTION; DNA METHYLATION; FOXP3 GENE; GENERATION; T(H)17	ROR gamma t is the lineage-specific transcription factor for T helper 17 (Th17) cells whose upregulation in developing Th17 cells is critically regulated by interleukin-6 (IL-6) and TGF-beta, the molecular mechanisms of which remain largely unknown. Here we identified conserved non-coding sequences (CNSs) 6 and 9 at the Rorc gene, essential for its expression during Th17 cell differentiation but not required for ROR gamma t expression in innate lymphocytes and gamma delta T cells. Mechanistically, the IL-6-signal transducer and activator of transcription 3 (STAT3) axis appeared to be largely dependent on CNS9 and only partially on CNS6 in controlling ROR gamma t expression and epigenetic activation of the Rorc locus. TGF-beta alone was sufficient to induce ROR gamma t expression in a CNS6- but not CNS9-dependent manner through CNS6 binding by SMAD proteins. Our study reveals an important synergistic mechanism downstream of IL-6 and TGF-beta in regulation of ROR gamma t expression and Th17 cell commitment via distinct cis-regulatory elements.	[Chang, Dehui; Xing, Qi; Su, Yang; Zhao, Xiaohong; Xu, Wei; Wang, Xiaohu; Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China; [Chang, Dehui; Xing, Qi; Su, Yang; Zhao, Xiaohong; Xu, Wei; Wang, Xiaohu; Dong, Chen] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Xu, Wei] Peking Univ, Col Life Sci, Beijing 10084, Peoples R China; [Xu, Wei] Peking Univ, Peking Univ Tsinghua Univ Natl Inst Biol Sci Join, Beijing 10084, Peoples R China; [Dong, Chen] Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China	Tsinghua University; Tsinghua University; Peking University; Peking University; Tsinghua University	Wang, XH; Dong, C (corresponding author), Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China.; Wang, XH; Dong, C (corresponding author), Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China.; Dong, C (corresponding author), Beijing Key Lab Immunol Res Chron Dis, Beijing 100084, Peoples R China.	wangxhu@tsinghua.edu.cn; chendong@tsinghua.edu.cn	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130; XU, Wei/0000-0002-8368-7543; Dehui, Chang/0000-0002-0864-9141; Xing, Qi/0000-0002-8246-5949	National Key Research and Development Program of China [2016YFC0906200, 2016YFC130390, 2020YFA0707800]; National Natural Science Foundation of China [31630022, 31991173, 31821003, 91642201]; Beijing Municipal Science and Technology [Z181100001318007, Z181100006318015, Z171100000417005]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Municipal Science and Technology	We thank the Tsinghua University Genetic Engineering Facility for assistance with generation of CNS6-deficient and CNS9-deficient mice. We thank Dr. Shizuo Akira for providing Stat3<SUP>fl/fl</SUP> mice and Dr. Elizabeth J. Robertson for providing Smad4<SUP>fl/fl</SUP> and Smad2<SUP>fl/fl</SUP> mice. We thank the Immunology Core Facility for FACS and all Dong lab members for help. This work was supported by grants from the National Key Research and Development Program of China (2016YFC0906200 and 2016YFC130390 to C.D. and 2020YFA0707800 to X.W.), the National Natural Science Foundation of China (31630022, 31991173, 31821003, and 91642201 to C.D), and Beijing Municipal Science and Technology (Z181100001318007, Z181100006318015, and Z171100000417005 to C.D.).	Akimzhanov AM, 2007, J BIOL CHEM, V282, P5969, DOI 10.1074/jbc.C600322200; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Balasubramani A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1003969; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brustle A, 2007, NAT IMMUNOL, V8, P958, DOI 10.1038/ni1500; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chu GC, 2004, DEVELOPMENT, V131, P3501, DOI 10.1242/dev.01248; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Pham D, 2019, CELL REP, V29, P1203, DOI 10.1016/j.celrep.2019.09.064; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Ebihara T, 2015, NAT IMMUNOL, V16, P1124, DOI 10.1038/ni.3272; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Gabrysova L, 2018, NAT IMMUNOL, V19, P497, DOI 10.1038/s41590-018-0083-5; Guo XH, 2014, IMMUNITY, V40, P25, DOI 10.1016/j.immuni.2013.10.021; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kim BS, 2017, CELL REP, V21, P195, DOI 10.1016/j.celrep.2017.09.021; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee GR, 2006, IMMUNITY, V24, P369, DOI 10.1016/j.immuni.2006.03.007; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Lochner M, 2008, J EXP MED, V205, P1381, DOI 10.1084/jem.20080034; Lu L, 2010, J IMMUNOL, V184, P4295, DOI 10.4049/jimmunol.0903418; Malhotra N, 2010, J BIOL CHEM, V285, P29044, DOI 10.1074/jbc.C110.156745; Mangan PR, 2006, NATURE, V441, P231, DOI 10.1038/nature04754; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Martinez GJ, 2010, J BIOL CHEM, V285, P29039, DOI 10.1074/jbc.C110.155820; Meireles ACA, 2009, CURR OPIN GENET DEV, V19, P565, DOI 10.1016/j.gde.2009.10.006; Mielke LA, 2013, J EXP MED, V210, P1117, DOI 10.1084/jem.20121588; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Nishihara M, 2007, INT IMMUNOL, V19, P695, DOI 10.1093/intimm/dxm045; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Sonnenberg GF, 2015, NAT MED, V21, P698, DOI 10.1038/nm.3892; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Takeda K, 1998, J IMMUNOL, V161, P4652; Tanaka S, 2014, J EXP MED, V211, P1857, DOI 10.1084/jem.20130791; Tanaka S, 2018, J EXP MED, V215, P1853, DOI 10.1084/jem.20170779; Thomas RM, 2012, J BIOL CHEM, V287, P25049, DOI 10.1074/jbc.M112.351916; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; van de Pavert S.A., 2014, NATURE, P1; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Vincent SD, 2003, GENE DEV, V17, P1646, DOI 10.1101/gad.1100503; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang XH, 2012, IMMUNITY, V36, P23, DOI 10.1016/j.immuni.2011.10.019; Xu W, 2019, IMMUNITY, V51, P826, DOI 10.1016/j.immuni.2019.10.006; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yoon JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8600; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663; Zhang S, 2017, NATURE, V551, P105, DOI 10.1038/nature24283; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng Y, 2010, NATURE, V463, P808, DOI 10.1038/nature08750; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	66	15	16	2	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2020	53	3					614	+		10.1016/j.immuni.2020.07.012	http://dx.doi.org/10.1016/j.immuni.2020.07.012			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NO9KZ	32827457	Bronze			2022-12-18	WOS:000569806100010
J	Liu, D; Yin, XY; Olyha, SJ; Nascimento, MSL; Chen, P; White, T; Gowthaman, U; Zhang, TT; Gertie, JA; Zhang, BY; Xu, L; Yurieva, M; Devine, L; Williams, A; Eisenbarth, SC				Liu, Dong; Yin, Xiangyun; Olyha, Sam J.; Nascimento, Manuela Sales L.; Chen, Pei; White, Theresa; Gowthaman, Uthaman; Zhang, Tingting; Gertie, Jake A.; Zhang, Biyan; Xu, Lan; Yurieva, Marina; Devine, Lesley; Williams, Adam; Eisenbarth, Stephanie C.			IL-10-Dependent Crosstalk between Murine Marginal Zone B Cells, Macrophages, and CD8 alpha(+) Dendritic Cells Promotes Listeria monocytogenes Infection	IMMUNITY			English	Article							IMMUNE-RESPONSES; ANTIGEN PRESENTATION; PROTECTIVE-IMMUNITY; MAJOR SOURCE; T-CELLS; INNATE; DOCK8; INTERLEUKIN-10; IL-10; MIGRATION	Type 1 CD8 alpha(+) conventional dendritic cells (cDC1s) are required for CD8(+) T cell priming but, paradoxically, promote splenic Listeria monocytogenes infection. Using mice with impaired cDC2 function, we ruled out a role for cDC2s in this process and instead discovered an interleukin-10 (IL-10)-dependent cellular crosstalk in the marginal zone (MZ) that promoted bacterial infection. Mice lacking the guanine nucleotide exchange factor DOCK8 or CD19 lost IL-10-producing MZ B cells and were resistant to Listeria. IL-10 increased intracellular Listeria in cDC1s indirectly by reducing inducible nitric oxide synthase expression early after infection and increasing intracellular Listeria in MZ metallophilic macrophages (MMMs). These MMMs trans-infected cDC1s, which, in turn, transported Listeria into the white pulp to prime CD8(+) T cells. However, this also facilitated bacterial expansion. Therefore, IL-10-mediated crosstalk between B cells, macrophages, and cDC1s in the MZ promotes both Listeria infection and CD8(+) T cell activation.	[Liu, Dong; Yin, Xiangyun; Olyha, Sam J.; Gowthaman, Uthaman; Gertie, Jake A.; Zhang, Biyan; Xu, Lan; Devine, Lesley; Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA; [Liu, Dong; Yin, Xiangyun; Olyha, Sam J.; Gowthaman, Uthaman; Zhang, Tingting; Gertie, Jake A.; Zhang, Biyan; Xu, Lan; Eisenbarth, Stephanie C.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Nascimento, Manuela Sales L.] Santos Dumont Inst, ELS IIN, BR-59280000 Macaiba, RN, Brazil; [Chen, Pei] Sun Yat Sen Univ, Dept Neurol, Affiliated Hosp 1, Guangzhou 510080, Guangdong, Peoples R China; [White, Theresa] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15224 USA; [Yurieva, Marina; Williams, Adam] Univ Connecticut, Ctr Hlth, Jackson Lab Genom Med, Farmington, CT 06032 USA; [Williams, Adam] Univ Connecticut, Ctr Hlth, Dept Genet & Genome Sci, Farmington, CT 06032 USA	Yale University; Yale University; Sun Yat Sen University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Jackson Laboratory; University of Connecticut; University of Connecticut	Eisenbarth, SC (corresponding author), Yale Univ, Sch Med, Dept Lab Med, New Haven, CT 06520 USA.; Eisenbarth, SC (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.; Williams, A (corresponding author), Univ Connecticut, Ctr Hlth, Jackson Lab Genom Med, Farmington, CT 06032 USA.; Williams, A (corresponding author), Univ Connecticut, Ctr Hlth, Dept Genet & Genome Sci, Farmington, CT 06032 USA.	adam.williams@jax.org; stephanie.eisenbarth@yale.edu	nascimento, manuela sales lima/C-8628-2018; Yurieva, Marina/V-2432-2018	nascimento, manuela sales lima/0000-0002-6887-8931; , UTHAMAN GOWTHAMAN/0000-0002-5484-7851; Zhang, Biyan/0000-0003-0329-2451	CIHR postdoctoral fellowship [P01 HL132819, R01 AI108829, R21 AI135221, R21 AI133440]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL132819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108829, R01AI136942, R21AI135221] Funding Source: NIH RePORTER	CIHR postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would like to thank M. Firla for technical assistance, M. Wimsatt for the illustration, L.A. Zenewicz and H. Agaisse for providing strains of Lm, E. Hoffman for technical guidance regarding phagosome analysis, T. Zhang for help with imaging, S. Calabro and J. Krishnaswamy for helpful discussions, and E.G. Pamer for RFP-Lm and critical review of the manuscript. This work was supported by a CIHR postdoctoral fellowship (to D.L.), P01 HL132819 (to S.C.E.), R01 AI108829 (to S.C.E.), and R21 AI135221 and R21 AI133440 (to A.W.).	Alaniz RC, 2004, J IMMUNOL, V172, P3725, DOI 10.4049/jimmunol.172.6.3725; Alexandre YO, 2016, J EXP MED, V213, P75, DOI 10.1084/jem.20142350; Alloatti A, 2015, IMMUNITY, V43, P1087, DOI 10.1016/j.immuni.2015.11.006; Anzelon AN, 2003, NAT IMMUNOL, V4, P287, DOI 10.1038/ni892; Aoshi T, 2008, IMMUNITY, V29, P476, DOI 10.1016/j.immuni.2008.06.013; Backer R, 2010, P NATL ACAD SCI USA, V107, P216, DOI 10.1073/pnas.0909541107; Bajana S, 2012, J IMMUNOL, V189, P3368, DOI 10.4049/jimmunol.1102613; Calabro S, 2016, CELL REP, V16, P2472, DOI 10.1016/j.celrep.2016.07.076; Calabro S, 2016, J EXP MED, V213, P887, DOI 10.1084/jem.20151720; Cerutti A, 2013, NAT REV IMMUNOL, V13, P118, DOI 10.1038/nri3383; CHESLYNCURTIS S, 1988, BRIT J SURG, V75, P177, DOI 10.1002/bjs.1800750231; Chong R, 2009, CELL HOST MICROBE, V6, P268, DOI 10.1016/j.chom.2009.08.006; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; CULLINGFORD GL, 1991, BRIT J SURG, V78, P716, DOI 10.1002/bjs.1800780626; Czuczman MA, 2014, NATURE, V509, P230, DOI 10.1038/nature13168; D'Amico G, 2000, NAT IMMUNOL, V1, P387, DOI 10.1038/80819; Dai WJ, 1997, J IMMUNOL, V158, P2259; de Noordhout CM, 2014, LANCET INFECT DIS, V14, P1073, DOI 10.1016/S1473-3099(14)70870-9; DeSmedt T, 1997, EUR J IMMUNOL, V27, P1229, DOI 10.1002/eji.1830270526; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Eisenbarth SC, 2019, NAT REV IMMUNOL, V19, P89, DOI 10.1038/s41577-018-0088-1; Fleming SD, 1999, J LEUKOCYTE BIOL, V66, P961, DOI 10.1002/jlb.66.6.961; Foulds KE, 2006, J IMMUNOL, V177, P2565, DOI 10.4049/jimmunol.177.4.2565; Foulds KE, 2002, J IMMUNOL, V168, P1528, DOI 10.4049/jimmunol.168.4.1528; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Gunn GR, 2001, J IMMUNOL, V167, P6471, DOI 10.4049/jimmunol.167.11.6471; Harada Y, 2012, BLOOD, V119, P4451, DOI 10.1182/blood-2012-01-407098; Helft J, 2015, IMMUNITY, V42, P1197, DOI 10.1016/j.immuni.2015.05.018; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hoffmann Eik, 2016, Bio Protoc, V6; Hop HT, 2018, J BIOL CHEM, V293, P3134, DOI [10.1074/jbc.m117.805556, 10.1074/jbc.M117.805556]; Horikawa M, 2013, J IMMUNOL, V190, P1158, DOI 10.4049/jimmunol.1201427; Joffre OP, 2012, NAT REV IMMUNOL, V12, P557, DOI 10.1038/nri3254; Kang SJ, 2008, IMMUNITY, V29, P819, DOI 10.1016/j.immuni.2008.09.017; Krishnaswamy JK, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam9169; Krishnaswamy JK, 2015, P NATL ACAD SCI USA, V112, P3056, DOI 10.1073/pnas.1501554112; Laidlaw BJ, 2015, NAT IMMUNOL, V16, P871, DOI 10.1038/ni.3224; Lee CC, 2012, J IMMUNOL, V189, P3319, DOI 10.4049/jimmunol.1201247; Lewis SM, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6085; Li M, 2001, J IMMUNOL, V166, P6099, DOI 10.4049/jimmunol.166.10.6099; Lopes-Carvalho T, 2004, IMMUNOL REV, V197, P192, DOI 10.1111/j.0105-2896.2004.0112.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matsumura F, 2013, J IMMUNOL, V191, P6156, DOI 10.4049/jimmunol.1300498; Mittal SK, 2015, CURR OPIN IMMUNOL, V34, P22, DOI 10.1016/j.coi.2014.12.009; Neuenhahn M, 2006, IMMUNITY, V25, P619, DOI 10.1016/j.immuni.2006.07.017; O'Leary S, 2011, AM J RESP CELL MOL, V45, P172, DOI 10.1165/rcmb.2010-0319OC; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Pasche B, 2005, INFECT IMMUN, V73, P5952, DOI 10.1128/IAI.73.9.5952-5960.2005; Paterson Y, 2005, CURR OPIN MOL THER, V7, P454; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Perez OA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah5520; Prajeeth CK, 2010, EUR J IMMUNOL, V40, P1272, DOI 10.1002/eji.200939790; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Qiu ZJ, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020055; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Schuette V, 2014, CURR OPIN IMMUNOL, V26, P63, DOI 10.1016/j.coi.2013.11.001; Seillet C, 2013, BLOOD, V121, P1574, DOI 10.1182/blood-2012-07-445650; Shahabi V, 2008, CANCER IMMUNOL IMMUN, V57, P1301, DOI 10.1007/s00262-008-0463-z; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Singh R, 2005, J IMMUNOL, V175, P3663, DOI 10.4049/jimmunol.175.6.3663; SKAMENE E, 1977, IMMUNOLOGY, V33, P851; Steele S, 2016, ELIFE, V5, DOI 10.7554/eLife.10625; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Sun XY, 2018, BLOOD ADV, V2, P401, DOI 10.1182/bloodadvances.2017007880; Teitz-Tennenbaum S, 2018, J IMMUNOL, V201, P2004, DOI 10.4049/jimmunol.1800070; Theisen Derek, 2017, F1000Res, V6, P98, DOI 10.12688/f1000research.9997.1; Verschoor A, 2011, NAT IMMUNOL, V12, P1194, DOI 10.1038/ni.2140; Westcott MM, 2010, INFECT IMMUN, V78, P2956, DOI 10.1128/IAI.01027-09; Williams Adam, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.top087536; Wu XZ, 2015, J BIOL CHEM, V290, P23135, DOI 10.1074/jbc.M115.671065; Yamakita Y, 2011, J IMMUNOL, V186, P2850, DOI 10.4049/jimmunol.1001667; You Y, 2011, J IMMUNOL, V186, P2172, DOI 10.4049/jimmunol.1002106; Zenewicz LA, 2007, MICROBES INFECT, V9, P1208, DOI 10.1016/j.micinf.2007.05.008; Zhang Q, 2014, J EXP MED, V211, P2549, DOI 10.1084/jem.20141307; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	75	15	15	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 16	2019	51	1					64	+		10.1016/j.immuni.2019.05.011	http://dx.doi.org/10.1016/j.immuni.2019.05.011			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	II9ZW	31231033	Green Accepted, Bronze			2022-12-18	WOS:000475561000011
J	Metidji, A; Omenetti, S; Crotta, S; Li, Y; Nye, E; Ross, E; Li, V; Maradana, MR; Schiering, C; Stockinger, B				Metidji, Amina; Omenetti, Sara; Crotta, Stefania; Li, Ying; Nye, Emma; Ross, Ellie; Li, Vivian; Maradana, Muralidhara R.; Schiering, Chris; Stockinger, Brigitta			The Environmental Sensor AHR Protects from Inflammatory Damage by Maintaining Intestinal Stem Cell Homeostasis and Barrier Integrity (vol 49, pg 353, 2018)	IMMUNITY			English	Correction												c.schiering@lms.mrc.ac.uk; brigitta.stockinger@crick.ac.uk		Crotta, Stefania/0000-0003-4676-8616				Metidji A, 2018, IMMUNITY, V49, P353, DOI 10.1016/j.immuni.2018.07.010	1	15	15	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 18	2019	50	6					1542	1542		10.1016/j.immuni.2019.05.024	http://dx.doi.org/10.1016/j.immuni.2019.05.024			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7PZ	31216463	Green Published, hybrid			2022-12-18	WOS:000471876100022
J	Elliott, EI; Sutterwala, FS				Elliott, Eric I.; Sutterwala, Fayyaz S.			Monocytes Take Their Own Path to IL-1 beta	IMMUNITY			English	Editorial Material							INFLAMMASOME ACTIVATION; NLRP3 INFLAMMASOME; CASPASE-8	Generally, two signals are required to activate the NLRP3 inflammasome. In this issue of Immunity, Hornung and colleagues (2016) describe an alternative inflammasome activation pathway in human monocytes triggering activation of the NLRP3 inflammasome in response to a single stimulus.	[Elliott, Eric I.; Sutterwala, Fayyaz S.] Univ Iowa, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA; [Elliott, Eric I.; Sutterwala, Fayyaz S.] Univ Iowa, Med Scientist Training Program, Iowa City, IA 52242 USA; [Sutterwala, Fayyaz S.] Cedars Sinai Med Ctr, Dept Med, Div Infect Dis, Los Angeles, CA 90048 USA	University of Iowa; University of Iowa; Cedars Sinai Medical Center	Sutterwala, FS (corresponding author), Univ Iowa, Interdisciplinary Grad Program Mol & Cellular Bio, Iowa City, IA 52242 USA.; Sutterwala, FS (corresponding author), Univ Iowa, Med Scientist Training Program, Iowa City, IA 52242 USA.; Sutterwala, FS (corresponding author), Cedars Sinai Med Ctr, Dept Med, Div Infect Dis, Los Angeles, CA 90048 USA.	fayyaz.sutterwala@cshs.org	Cassel, Suzanne/AAI-3947-2021; Sutterwala, Fayyaz/AAH-5859-2021	Cassel, Suzanne/0000-0003-2492-1923; Elliott, Eric/0000-0003-0630-3478	NIAID NIH HHS [R56 AI118719] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI118719] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allam R, 2014, EMBO REP, V15, P982, DOI 10.15252/embr.201438463; Gaidt MM, 2016, IMMUNITY, V44, P833, DOI 10.1016/j.immuni.2016.01.012; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Gurung P, 2015, TRENDS MOL MED, V21, P193, DOI 10.1016/j.molmed.2014.11.008; Gurung P, 2014, J IMMUNOL, V192, P1835, DOI 10.4049/jimmunol.1302839; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Piccini A, 2008, P NATL ACAD SCI USA, V105, P8067, DOI 10.1073/pnas.0709684105; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Vigano E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9761	10	15	15	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 19	2016	44	4					713	715		10.1016/j.immuni.2016.03.015	http://dx.doi.org/10.1016/j.immuni.2016.03.015			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DJ8EC	27096310	Bronze			2022-12-18	WOS:000374444300001
J	Foster, SL; Talbot, S; Woolf, CJ				Foster, Simmie L.; Talbot, Sebastien; Woolf, Clifford J.			CNS Injury: IL-33 Sounds the Alarm	IMMUNITY			English	Editorial Material							SPINAL-CORD-INJURY; MACROPHAGES		[Foster, Simmie L.; Talbot, Sebastien; Woolf, Clifford J.] Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Foster, Simmie L.; Talbot, Sebastien; Woolf, Clifford J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Woolf, CJ (corresponding author), Childrens Hosp Boston, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA.	clifford.woolf@childrens.harvard.edu	Woolf, Clifford/A-9784-2010					David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Gadani SP, 2015, NEURON, V85, P703, DOI 10.1016/j.neuron.2015.01.013; Han P, 2011, NEUROSCI BULL, V27, P351, DOI 10.1007/s12264-011-1025-5; Jiang HR, 2012, EUR J IMMUNOL, V42, P1804, DOI 10.1002/eji.201141947; Komohara Y, 2011, J CLIN EXP HEMATOP, V51, P93, DOI 10.3960/jslrt.51.93; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Miron VE, 2014, J NEUROCHEM, V130, P165, DOI 10.1111/jnc.12705; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Pomeshchik Y, 2015, BRAIN BEHAV IMMUN, V44, P68, DOI 10.1016/j.bbi.2014.08.002; Shechter R, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000113	10	15	17	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 17	2015	42	3					403	405		10.1016/j.immuni.2015.02.019	http://dx.doi.org/10.1016/j.immuni.2015.02.019			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CD7VE	25786172	Bronze			2022-12-18	WOS:000351301900006
J	Wang, TT; Ravetch, JV				Wang, Taia T.; Ravetch, Jeffrey V.			Immune Complexes: Not Just an Innocent Bystander in Chronic Viral Infection	IMMUNITY			English	Editorial Material							SYSTEMIC-LUPUS-ERYTHEMATOSUS	Understanding of how persistent viral infection impacts humoral immunity is incomplete. In this issue of Immunity, Wieland et al. (2015) and Yamada et al. (2015) find that high amounts of IgG-antigen complexes formed during chronic lymphocytic choriomeningitis infection can interfere with Fcg-receptor-mediated effector activities, potentially contributing to immune dysfunction.	[Wang, Taia T.; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA	Rockefeller University	Ravetch, JV (corresponding author), Rockefeller Univ, Lab Mol Genet & Immunol, 1230 York Ave, New York, NY 10065 USA.	ravetch@mail.rockefeller.edu	Ravetch, Jeffrey/Z-1596-2019	Ravetch, Jeffrey/0000-0003-2024-9041	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR000151, UL1TR000043] Funding Source: NIH RePORTER; NCATS NIH HHS [KL2TR000151, UL1 TR000043] Funding Source: Medline	NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		Abes R, 2010, BLOOD, V116, P926, DOI 10.1182/blood-2009-10-248609; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bournazos S, 2014, CELL, V158, P1243, DOI 10.1016/j.cell.2014.08.023; COUSER WG, 1980, KIDNEY INT, V17, P1, DOI 10.1038/ki.1980.1; DAVIES KA, 1992, J CLIN INVEST, V90, P2075, DOI 10.1172/JCI116090; Goede V, 2014, NEW ENGL J MED, V370, P1101, DOI 10.1056/NEJMoa1313984; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Pincetic A, 2014, NAT IMMUNOL, V15, P707, DOI 10.1038/ni.2939; VALDES AJ, 1969, JOHNS HOPKINS MED J, V124, P9; Wieland A, 2015, IMMUNITY, V42, P367, DOI 10.1016/j.immuni.2015.01.009; Yamada DH, 2015, IMMUNITY, V42, P379, DOI 10.1016/j.immuni.2015.01.005	11	15	15	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 17	2015	42	2					213	215		10.1016/j.immuni.2015.01.022	http://dx.doi.org/10.1016/j.immuni.2015.01.022			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB8XT	25692698	Bronze			2022-12-18	WOS:000349916400006
J	Yang, K; Chi, HB				Yang, Kai; Chi, Hongbo			AMPK Helps T Cells Survive Nutrient Starvation	IMMUNITY			English	Editorial Material							MEMORY; METABOLISM		[Yang, Kai; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	hongbo.chi@stjude.org	Chi, Hongbo/M-9397-2018	Chi, Hongbo/0000-0002-9997-2496				Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Gerriets V. A., 2014, J CLIN INVE IN PRESS; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sukumar M, 2013, J CLIN INVEST, V123, P4479, DOI 10.1172/JCI69589; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021	9	15	15	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 20	2015	42	1					4	6		10.1016/j.immuni.2014.12.029	http://dx.doi.org/10.1016/j.immuni.2014.12.029			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ4NC	25607450	Bronze			2022-12-18	WOS:000348197500002
J	Linterman, MA; Denton, AE				Linterman, Michelle A.; Denton, Alice E.			Treg Cells and CTLA-4: The Ball and Chain of the Germinal Center Response	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; FOLLICULAR HELPER		[Linterman, Michelle A.] Babraham Inst, Cambridge CB22 3AT, England; [Denton, Alice E.] Univ Cambridge, CRUK Cambridge Inst, Cambridge CB2 0RE, England; [Denton, Alice E.] Univ Cambridge, Dept Med, Cambridge CB2 0RE, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; CRUK Cambridge Institute; University of Cambridge; University of Cambridge	Linterman, MA (corresponding author), Babraham Inst, Babraham Res Campus, Cambridge CB22 3AT, England.	michelle.linterman@babraham.ac.uk	Linterman, Michelle/AAN-4210-2021	Linterman, Michelle/0000-0001-6047-1996; Denton, Alice/0000-0002-4580-3443	BBSRC [BBS/E/B/000C0409, BBS/E/B/000C0407] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407, BBS/E/B/000C0409] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Cai G, 2012, J IMMUNOL, V189, P1294, DOI 10.4049/jimmunol.1102948; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Linterman MA, 2014, ELIFE, V3, DOI 10.7554/eLife.03180; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Sage PT, 2014, IMMUNITY, V41, P1026, DOI 10.1016/j.immuni.2014.12.005; Walker LSK, 2003, J IMMUNOL, V170, P91, DOI 10.4049/jimmunol.170.1.91; Walker LSK, 2011, NAT REV IMMUNOL, V11, P852, DOI 10.1038/nri3108; Wing JB, 2014, IMMUNITY, V41, P1013, DOI 10.1016/j.immuni.2014.12.006; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328	11	15	18	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					876	878		10.1016/j.immuni.2014.12.009	http://dx.doi.org/10.1016/j.immuni.2014.12.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526300	Bronze			2022-12-18	WOS:000346654100004
J	Hayday, A; Vantourout, P				Hayday, Adrian; Vantourout, Pierre			A Long-Playing CD about the gamma delta TCR Repertoire	IMMUNITY			English	Editorial Material							CELL ANTIGEN RECEPTOR; RECOGNITION; SELECTION	In this issue of Immunity, a study by Luoma et al. ( 2013) provides structural evidence for direct interactions of human V delta 1(+) T cell receptors with CD1d, capping a long trail of evidence that CD1 might be a major influence on gamma delta T cell biology.	[Hayday, Adrian; Vantourout, Pierre] Kings Coll London, Peter Gorer Dept Immunobiol, London SE1 9RT, England; [Hayday, Adrian; Vantourout, Pierre] Canc Res UK London Res Inst, London WC2A 3LY, England; [Hayday, Adrian] MRC, Ctr Transplantat Biol, London SE1 9RT, England; [Hayday, Adrian] Guys & St Thomas Hosp, Comprehens Biomed Res Ctr, London SE1 9RT, England; [Hayday, Adrian] Kings Coll London, London SE1 9RT, England	University of London; King's College London; Cancer Research UK; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Hayday, A (corresponding author), Kings Coll London, Peter Gorer Dept Immunobiol, London SE1 9RT, England.	adrian.hayday@kcl.ac.uk		HAYDAY, ADRIAN/0000-0002-9495-5793; Vantourout, Pierre/0000-0001-7287-5517				Adams EJ, 2005, SCIENCE, V308, P227, DOI 10.1126/science.1106885; BENDELAC A, 1995, J EXP MED, V182, P2091, DOI 10.1084/jem.182.6.2091; Dieude M, 2011, J IMMUNOL, V186, P4771, DOI 10.4049/jimmunol.1000921; Harly C, 2012, BLOOD, V120, P2269, DOI 10.1182/blood-2012-05-430470; Holtmeier V, 2001, J INVEST DERMATOL, V116, P275, DOI 10.1046/j.1523-1747.2001.01250.x; Huber S, 2006, VIRAL IMMUNOL, V19, P156, DOI 10.1089/vim.2006.19.156; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Luoma AM, 2013, IMMUNITY, V39, P1032, DOI 10.1016/j.immuni.2013.11.001; Patel O, 2012, NAT IMMUNOL, V13, P857, DOI 10.1038/ni.2372; Uldrich AP, 2013, NAT IMMUNOL, V14, P1137, DOI 10.1038/ni.2713; Willcox CR, 2012, NAT IMMUNOL, V13, P872, DOI 10.1038/ni.2394	11	15	15	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					994	996		10.1016/j.immuni.2013.11.016	http://dx.doi.org/10.1016/j.immuni.2013.11.016			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24332025	Bronze			2022-12-18	WOS:000330951000004
J	Moresco, EMY; Beutler, B				Moresco, Eva Marie Y.; Beutler, Bruce			Special Delivery: Granulin Brings CpG DNA to Toll-like Receptor 9	IMMUNITY			English	Editorial Material							HOST-DEFENSE; PROGRANULIN; DEMENTIA; SORTILIN	Foreign DNA activates the innate immune response through Toll-like receptor 9 (TLR9). In this issue of Immunity, Park et al. (2011) present evidence that granulin is a cofactor for TLR9 activation, delivering CpG-oligodeoxynucleotides to TLR9 in endolysosomes.	[Moresco, Eva Marie Y.; Beutler, Bruce] Scripps Res Inst, Dept Genet, La Jolla, CA 92037 USA	Scripps Research Institute	Beutler, B (corresponding author), Scripps Res Inst, Dept Genet, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	bruce@scripps.edu		Moresco, Eva Marie/0000-0002-2049-7291	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI070167] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI070167-01, P01 AI070167] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Blasius AL, 2010, P NATL ACAD SCI USA, V107, P19973, DOI 10.1073/pnas.1014051107; Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Ivanov S, 2007, BLOOD, V110, P1970, DOI 10.1182/blood-2006-09-044776; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Tolkatchev D, 2008, PROTEIN SCI, V17, P711, DOI 10.1110/ps.073295308; Wahe A, 2010, J CELL SCI, V123, P2502, DOI 10.1242/jcs.067686; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	10	15	17	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 22	2011	34	4					453	455		10.1016/j.immuni.2011.04.001	http://dx.doi.org/10.1016/j.immuni.2011.04.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21511177	Green Accepted, Bronze			2022-12-18	WOS:000290367300002
J	Adams, EJ; Lopez-Sagaseta, J				Adams, Erin J.; Lopez-Sagaseta, Jacinto			The Immutable Recognition of CD1d	IMMUNITY			English	Editorial Material							CELL-ACTIVATION; NKT; VARIANTS	CD1d presents lipid antigens to natural killer T cells. In this issue of Immunity, Wun et al. (2011) and Mallevaey et al. (2011) explore the molecular details of nonself lipid discrimination and self-recognition.	[Adams, Erin J.; Lopez-Sagaseta, Jacinto] Univ Chicago, Comm Immunol, Dept Biochem & Mol Biol, Chicago, IL 60637 USA	University of Chicago	Adams, EJ (corresponding author), Univ Chicago, Comm Immunol, Dept Biochem & Mol Biol, Chicago, IL 60637 USA.	ejadams@uchicago.edu	López-Sagaseta, Jacinto/C-1987-2019	López-Sagaseta, Jacinto/0000-0002-7774-4361				Bai L, 2009, P NATL ACAD SCI USA, V106, P10254, DOI 10.1073/pnas.0901228106; Borg NA, 2007, NATURE, V448, P44, DOI 10.1038/nature05907; Im JS, 2009, IMMUNITY, V30, P888, DOI 10.1016/j.immuni.2009.03.022; Mallevaey T, 2011, IMMUNITY, V34, P315, DOI 10.1016/j.immuni.2011.01.013; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Oki S, 2004, J CLIN INVEST, V113, P1631, DOI 10.1172/JCI200420862; Pellicci DG, 2009, IMMUNITY, V31, P47, DOI 10.1016/j.immuni.2009.04.018; Sullivan BA, 2010, J IMMUNOL, V184, P141, DOI 10.4049/jimmunol.0902880; Wun KS, 2008, J EXP MED, V205, P939, DOI 10.1084/jem.20072141; Wun KS, 2011, IMMUNITY, V34, P327, DOI 10.1016/j.immuni.2011.02.001; Yu KOA, 2005, P NATL ACAD SCI USA, V102, P3383, DOI 10.1073/pnas.0407488102	11	15	15	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 25	2011	34	3					281	283		10.1016/j.immuni.2011.03.006	http://dx.doi.org/10.1016/j.immuni.2011.03.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	743JL	21435579	Bronze			2022-12-18	WOS:000289014500001
J	Kassiotis, G; O'Garra, A				Kassiotis, George; O'Garra, Anne			Establishing the Follicular Helper Identity	IMMUNITY			English	Editorial Material							T-CELLS; DIFFERENTIATION; GENERATION; LINEAGE; BCL6	Among other genes, expression of the Bcl-6 transcriptional repressor distinguishes follicular helper T (Tfh) cells from other helper T cell subsets. In this issue of Immunity, Yu et al. (2009) demonstrate that Bcl-6 directs Tfh cell differentiation.	[Kassiotis, George; O'Garra, Anne] Natl Inst Med Res, MRC, Div Immunoregulat, London NW7 1AA, England	MRC National Institute for Medical Research	O'Garra, A (corresponding author), Natl Inst Med Res, MRC, Div Immunoregulat, London NW7 1AA, England.	aogarra@nimr.mrc.ac.uk		O'Garra, Anne/0000-0001-9845-6134; Kassiotis, George/0000-0002-8457-2633	Medical Research Council [MC_U117565642, MC_U117581330] Funding Source: Medline; MRC [MC_U117581330, MC_U117565642] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Fazilleau N, 2009, IMMUNITY, V30, P324, DOI 10.1016/j.immuni.2009.03.003; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kusam S, 2003, J IMMUNOL, V170, P2435, DOI 10.4049/jimmunol.170.5.2435; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	12	15	16	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 18	2009	31	3					450	452		10.1016/j.immuni.2009.08.017	http://dx.doi.org/10.1016/j.immuni.2009.08.017			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	503IA	19766087	Bronze			2022-12-18	WOS:000270525900010
J	Klenerman, P; Dunbar, PR				Klenerman, Paul; Dunbar, P. Rod			CMV and the Art of Memory Maintenance	IMMUNITY			English	Editorial Material							CD8(+) T-CELLS; MURINE CYTOMEGALOVIRUS-INFECTION; RESPONSES		[Klenerman, Paul] Univ Oxford, Oxford OX1 3SY, England; [Dunbar, P. Rod] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand; [Dunbar, P. Rod] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1142, New Zealand	University of Oxford; University of Auckland; University of Auckland	Klenerman, P (corresponding author), Univ Oxford, Peter Medawar Bldg Pathogen Res, Oxford OX1 3SY, England.	paul.klenerman@ndm.ox.ac.uk	Dunbar, Rod/C-2570-2012	Dunbar, Rod/0000-0001-9626-2600; klenerman, paul/0000-0003-4307-9161				Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Holtappels R, 2000, J VIROL, V74, P11495, DOI 10.1128/JVI.74.24.11495-11503.2000; Karrer U, 2004, J VIROL, V78, P2255, DOI 10.1128/JVI.78.5.2255-2264.2004; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Munks MW, 2006, J IMMUNOL, V177, P450, DOI 10.4049/jimmunol.177.1.450; Simon CO, 2006, J VIROL, V80, P10436, DOI 10.1128/JVI.01248-06; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882; Waller ECP, 2008, MED MICROBIOL IMMUN, V197, P83, DOI 10.1007/s00430-008-0082-5	10	15	20	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					520	522		10.1016/j.immuni.2008.09.008	http://dx.doi.org/10.1016/j.immuni.2008.09.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18957264	Bronze			2022-12-18	WOS:000260316700006
J	Zeng, WW; Chen, ZJ				Zeng, Wenwen; Chen, Zhijian J.			MITAgating Viral Infection	IMMUNITY			English	Editorial Material							INNATE IMMUNE-RESPONSES; MEMBRANE; VIRUSES		[Zeng, Wenwen; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Chen, ZJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	zhijian.chen@utsouthwestern.edu	Chen, Zhijian/C-6039-2012; Zeng, Wenwen/D-7276-2017	Chen, Zhijian/0000-0002-8475-8251; Zeng, Wenwen/0000-0001-8544-3318				Chien YC, 2006, CELL, V127, P157, DOI 10.1016/j.cell.2006.08.034; ISHIKAWA H, 2008, NATURE IN PRESS 0707, DOI DOI 10.1038/NATURE0731; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003	9	15	17	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2008	29	4					513	515		10.1016/j.immuni.2008.09.010	http://dx.doi.org/10.1016/j.immuni.2008.09.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364DP	18957261	Bronze			2022-12-18	WOS:000260316700003
J	Zhu, MZ; Fu, YX				Zhu, Mingzhao; Fu, Yang-Xin			Coordinating development of medullary thymic epithelial cells	IMMUNITY			English	Editorial Material							CENTRAL TOLERANCE; AIRE; PATHWAY	Three papers in this issue of Immunity (Akiyama et al., 2008; Hikosaka et al., 2008; Irla et al., 2008) together reveal coordinating roles for autoreactive T cells and TNF receptor superfamily members in the development of medullary thymic epithelial cells.	[Zhu, Mingzhao; Fu, Yang-Xin] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Zhu, Mingzhao; Fu, Yang-Xin] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Zhu, MZ (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	zhumz@uchicago.edu; yfu@uchicago.edu	Zhu, Mingzhao/L-8662-2019	Zhu, Mingzhao/0000-0003-2001-2669; fu, yang-xin/0000-0001-8441-6617	NATIONAL CANCER INSTITUTE [R01CA141975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058897] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akiyama T, 2008, IMMUNITY, V29, P423, DOI 10.1016/j.immuni.2008.06.015; Anderson G, 2007, NAT REV IMMUNOL, V7, P954, DOI 10.1038/nri2187; Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Boehm T, 2003, J EXP MED, V198, P757, DOI 10.1084/jem.20030794; Chin RK, 2003, NAT IMMUNOL, V4, P1121, DOI 10.1038/ni982; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Hikosaka Y, 2008, IMMUNITY, V29, P438, DOI 10.1016/j.immuni.2008.06.018; Irla M, 2008, IMMUNITY, V29, P451, DOI 10.1016/j.immuni.2008.08.007; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Rossi SW, 2007, J EXP MED, V204, P1267, DOI 10.1084/jem.20062497; SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611; Zhu MZ, 2006, J CLIN INVEST, V116, P2964, DOI 10.1172/JCI28326	12	15	15	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2008	29	3					386	388		10.1016/j.immuni.2008.09.001	http://dx.doi.org/10.1016/j.immuni.2008.09.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	355KX	18799147	Bronze			2022-12-18	WOS:000259708900008
J	Hamilton, SE; Jameson, SC				Hamilton, Sara E.; Jameson, Stephen C.			CD8(+) T cell differentiation: Choosing a path through T-bet	IMMUNITY			English	Editorial Material							CUTTING EDGE; EFFECTOR; EOMESODERMIN; EXPRESSION	Activated CD8(+) T cells can differentiate into transient effector cells or long-lived memory cells. In this issue of Immunity, Joshi et al. (2007) suggest that inflammatory cytokines dictate this balance by regulating the expression of the transcription factor T-bet.	Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55454 USA; Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55454 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Jameson, SC (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Minneapolis, MN 55454 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146				Badovinac VP, 2004, NAT IMMUNOL, V5, P809, DOI 10.1038/ni1098; Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465; Hand TW, 2007, P NATL ACAD SCI USA, V104, P11730, DOI 10.1073/pnas.0705007104; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Takemoto N, 2006, J IMMUNOL, V177, P7515, DOI 10.4049/jimmunol.177.11.7515; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548	10	15	15	1	4	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2007	27	2					180	182		10.1016/j.immuni.2007.08.003	http://dx.doi.org/10.1016/j.immuni.2007.08.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204PK	17723210	Bronze			2022-12-18	WOS:000249056300003
J	Marshak-Rothstein, A				Marshak-Rothstein, Ann			Tolling for Autoimmunity - Prime time for 7	IMMUNITY			English	Editorial Material							MURINE; RECOGNITION; MODEL; TLR9; RNA	The reason certain self-antigens are consistently targeted by autoantibodies may be because they are self-adjuvants. Two papers in this issue of Immunity provide important insights into the contribution of Toll-like receptors in systemic autoimmune disease (Berland et al., 2006; Christensen et al., 2006).	Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02215 USA	Boston University	Marshak-Rothstein, A (corresponding author), Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02215 USA.							Berland R, 2006, IMMUNITY, V25, P429, DOI 10.1016/j.immuni.2006.07.014; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Ishii KJ, 2005, INT J CANCER, V117, P517, DOI 10.1002/ijc.21402; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Lartigue A, 2006, J IMMUNOL, V177, P1349, DOI 10.4049/jimmunol.177.2.1349; Moll T, 2005, J IMMUNOL, V174, P702, DOI 10.4049/jimmunol.174.2.702; Pisitkun P, 2006, SCIENCE, V312, P1669, DOI 10.1126/science.1124978; Subramanian S, 2006, P NATL ACAD SCI USA, V103, P9970, DOI 10.1073/pnas.0603912103; Wu XB, 2006, ARTHRITIS RHEUM-US, V54, P336, DOI 10.1002/art.21553; Yu P, 2006, INT IMMUNOL, V18, P1211, DOI 10.1093/intimm/dxl067	11	15	16	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP	2006	25	3					397	399		10.1016/j.immuni.2006.08.011	http://dx.doi.org/10.1016/j.immuni.2006.08.011			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	089ED	16979573	Bronze			2022-12-18	WOS:000240862200008
J	Randolph, GJ				Randolph, Gwendalyn J.			Migratory dendritic cells: Sometimes simply ferries?	IMMUNITY			English	Editorial Material							LANGERHANS CELLS; RESPONSES; IMMUNITY	In this issue, Allan et al. (2006) conclude that transport of herpes-virus antigens to lymph nodes by dendritic cells is crucial for antiviral immunity, but migrating DCs do not present herpes antigens to CD8(+) lymphocytes.	Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Randolph, GJ (corresponding author), Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA.							Allan RS, 2006, IMMUNITY, V25, P153, DOI 10.1016/j.immuni.2006.04.017; Allan RS, 2003, SCIENCE, V301, P1925, DOI 10.1126/science.1087576; Angeli V, 2006, IMMUNITY, V24, P203, DOI 10.1016/j.immuni.2006.01.003; Belz GT, 2004, P NATL ACAD SCI USA, V101, P8670, DOI 10.1073/pnas.0402644101; He YK, 2006, IMMUNITY, V24, P643, DOI 10.1016/j.immuni.2006.03.014; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Kamath AT, 2002, BLOOD, V100, P1734, DOI 10.1182/blood.V100.5.1734.h81702001734_1734_1741; Trottein F, 2004, CRIT REV IMMUNOL, V24, P349, DOI 10.1615/CritRevImmunol.v24.i5.30; Yoneyama H, 2005, J EXP MED, V202, P425, DOI 10.1084/jem.20041961; Zhao XY, 2003, J EXP MED, V197, P153, DOI 10.1084/jem.20021109	10	15	17	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2006	25	1					15	18		10.1016/j.immuni.2006.07.003	http://dx.doi.org/10.1016/j.immuni.2006.07.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860753	Bronze			2022-12-18	WOS:000239713000006
J	Lich, JD; Arthur, JC; Ting, JPY				Lich, JD; Arthur, JC; Ting, JPY			Cryopyrin: In from the cold	IMMUNITY			English	Editorial Material							INFLAMMASOME; ACTIVATION	Mutations in CIAS1/cryopyrin are linked to several autoinflammatory diseases. In this issue of Immunity, Sutterwala et al. (2006) uncover a critical role for cryopyrin in the caspase-1/IL-1 beta axis and reveal a broader role for cryopyrin than anticipated.	Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Lich, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.			Arthur, Janelle/0000-0002-4796-0207	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063031] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016326] Funding Source: NIH RePORTER; NIAID NIH HHS [AI063031] Funding Source: Medline; NIDCR NIH HHS [DE016326] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Dinarello CA, 2005, J EXP MED, V201, P1355, DOI 10.1084/jem.20050640; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; KANNEGANTI TD, 2006, IN PRESS NATURE; Mariathasan S, 2004, NATURE, V430, P213, DOI 10.1038/nature02664; MARIATHASAN S, 2006, IN PRESS NATURE; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; MARTINON F, 2006, IN PRESS NATURE; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; TING JP, 2004, ANNU REV IMMUNOL, V19, P19	10	15	16	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2006	24	3					241	243		10.1016/j.immuni.2006.03.004	http://dx.doi.org/10.1016/j.immuni.2006.03.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	028QY	16546091	Bronze			2022-12-18	WOS:000236504500003
J	Hanna, BS; Llao-Cid, L; Iskar, M; Roessner, PM; Klett, LC; Wong, JKL; Paul, Y; Ioannou, N; Ozturk, S; Mack, N; Kalter, V; Colomer, D; Campo, E; Bloehdorn, J; Stilgenbauer, S; Dietrich, S; Schmidt, M; Gabriel, R; Rippe, K; Feuerer, M; Ramsay, AG; Lichter, P; Zapatka, M; Seiffert, M				Hanna, Bola S.; Llao-Cid, Laura; Iskar, Murat; Roessner, Philipp M.; Klett, Lara C.; Wong, John K. L.; Paul, Yashna; Ioannou, Nikolaos; Ozturk, Selcen; Mack, Norman; Kalter, Verena; Colomer, Dolors; Campo, Elias; Bloehdorn, Johannes; Stilgenbauer, Stephan; Dietrich, Sascha; Schmidt, Manfred; Gabriel, Richard; Rippe, Karsten; Feuerer, Markus; Ramsay, Alan G.; Lichter, Peter; Zapatka, Marc; Seiffert, Martina			Interleukin-10 receptor signaling promotes the maintenance of a PD-1(i)(nt) TCF-1(+) CD8(+) T cell population that sustains anti-tumor immunity	IMMUNITY			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; CHRONIC VIRAL-INFECTION; R/BIOCONDUCTOR PACKAGE; CHECKPOINT BLOCKADE; MOUSE MODEL; IL-10; EXHAUSTION; EXPRESSION; DIFFERENTIATION; DYSFUNCTION	T cell exhaustion limits anti-tumor immunity and responses to immunotherapy, Here, we explored the microenvironmental signals regulating T cell exhaustion using a model of chronic lymphocytic leukemia (CLL). Single-cell analyses identified a subset of PD-1(hi), functionally impaired CD8(+) T cells that accumulated in secondary lymphoid organs during disease progression and a functionally competent PD-1(int) subset. Frequencies of PD-1(i)(nt) TCF-1(+) CD8(+) T cells decreased upon Il10rb or Stat3 deletion, leading to accumulation of PD-1(hi) cells and accelerated tumor progression. Mechanistically, inhibition of IL-10R signaling altered chromatin accessibility and disrupted cooperativity between the transcription factors NFAT and AP-1, promoting a distinct NFAT-associated program. Low IL10 expression or loss of IL-10R-STAT3 signaling correlated with increased frequencies of exhausted CD8(+) T cells and poor survival in CLL and in breast cancer patients, Thus, balance between PD-1(hi), exhausted CD8(+) T cells and functional PD-1(i)(nt) TCF-1(+) CD8(+) T cells is regulated by cell-intrinsic IL-10R signaling, with implications for immunotherapy.	[Hanna, Bola S.; Llao-Cid, Laura; Iskar, Murat; Roessner, Philipp M.; Wong, John K. L.; Paul, Yashna; Ozturk, Selcen; Mack, Norman; Kalter, Verena; Lichter, Peter; Zapatka, Marc; Seiffert, Martina] German Canc Res Ctr, Mol Genet, D-69120 Heidelberg, Germany; [Llao-Cid, Laura] Heidelberg Univ, Fac Biosci, Heidelberg, Germany; [Klett, Lara C.; Rippe, Karsten] German Canc Res Ctr, Chromatin Networks, D-69120 Heidelberg, Germany; [Ioannou, Nikolaos; Ramsay, Alan G.] Kings Coll London, Fac Life Sci & Med, Sch Canc & Pharmaceut Sci, London, England; [Colomer, Dolors; Campo, Elias] Univ Barcelona, Hosp Clin, Pathol Dept,Hematopathol Unit, CIBERONC,Inst Invest Biomed August Pi & Sunyer ID, Barcelona 08036, Spain; [Bloehdorn, Johannes; Stilgenbauer, Stephan] Univ Ulm, Internal Med 3, D-89081 Ulm, Germany; [Dietrich, Sascha] Univ Hosp Heidelberg, Med 5, D-69120 Heidelberg, Germany; [Schmidt, Manfred; Gabriel, Richard] Natl Ctr Tumor Dis, Translat Oncol, D-69120 Heidelberg, Germany; [Schmidt, Manfred; Gabriel, Richard] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Feuerer, Markus] German Canc Res Ctr, Tumor Immunol Program, Immune Tolerance, D-69120 Heidelberg, Germany; [Feuerer, Markus] Univ Regensburg, Regensburg Ctr Intervent Immunol RCI, Chair Immunol, D-93053 Regensburg, Germany; [Hanna, Bola S.] Harvard Med Sch, Dept Immunol, Boston, MA 02115 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); University of London; King's College London; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; University of Barcelona; Hospital Clinic de Barcelona; Ulm University; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); University of Regensburg; Harvard University; Harvard Medical School	Seiffert, M (corresponding author), German Canc Res Ctr, Mol Genet, D-69120 Heidelberg, Germany.	bola.hanna@hms.harvard.edu; m.seiffert@dkfz.de	Wong, Kwong Leong/AAE-2434-2022; Rippe, Karsten/A-3562-2012; Ramsay, Alan/A-8374-2015	Wong, Kwong Leong/0000-0001-6362-373X; Rippe, Karsten/0000-0001-9951-9395; Ramsay, Alan/0000-0002-0452-0420; Klett, Lara/0000-0003-2565-5268; Ioannou, Nikolaos/0000-0002-7956-5543; Bloehdorn, Johannes/0000-0003-1433-9702	German Research Foundation (DFG) project EV-RNA [SE 2331/2-1]; Eurostars project - German Ministry of Education and Research (BMBF) [E!10865-LeukeMab, 01QE1716]; German JoseCarreras Foundation [13R/2018]; German Cancer Aid [70114114, 112069]; NCT 3.0 funding program [NCT3.0_2015.13 ImmunOmics, NCT3.0_2015.2 SPL/RP]; Ministerio de Ciencia e Innovacien; ERDF [SAF15-67633-R]; "la Caixa"Foundation [CLLEvolution-LCF/PR/HR17/521500 17, HR17-00221]; European Research Council (ERC) [810287]; DFG [SFB1074]; ERC (ERC-CoG) [648145]; BMBF-Network "PRECiSe" [031L0076A]; ERA-NET TRANSCAN-2 program JTC 2014-project FIRE-CLL	German Research Foundation (DFG) project EV-RNA(German Research Foundation (DFG)); Eurostars project - German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German JoseCarreras Foundation; German Cancer Aid(Deutsche Krebshilfe); NCT 3.0 funding program; Ministerio de Ciencia e Innovacien; ERDF(European Commission); "la Caixa"Foundation(La Caixa Foundation); European Research Council (ERC)(European Research Council (ERC)European Commission); DFG(German Research Foundation (DFG)); ERC (ERC-CoG); BMBF-Network "PRECiSe"; ERA-NET TRANSCAN-2 program JTC 2014-project FIRE-CLL	We thank Dietmar Zehn (Technical University of Munich, Germany) for scien-tific discussions and input and Christoph Schiffler (DKFZ) for experimental support. Thanks also to the Central Animal Laboratory, the Single-cell Open Lab, and the Genomics and Proteomics Core Facility at the DKFZ, to the Nikon Imaging Facility at King's College London for technical assis-tance, and to Michael Hain for computational support. We further thank Ul-rike TraEuroger (DKFZ) for editing the material and methods part of this manu-script and Clemens Neufert (University Clinic Erlangen, Germany) and Ekaterina Lupar (Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany) for providing Stat3-deficient and FIR 3 tiger mice, respectively. This study was supported by the German Research Foundation (DFG) proj-ect EV-RNA (SE 2331/2-1) , by the Eurostars project E!10865-LeukeMab (01QE1716) , funded by the German Ministry of Education and Research (BMBF) , by the German JoseCarreras Foundation (grant 13R/2018) to M. Seif-fert, by the German Cancer Aid to M. Seiffert (grant no. 70114114) and to P.M.R. (grant no. 112069) , by an NCT 3.0 funding program (NCT3.0_2015.13 ImmunOmics, NCT3.0_2015.2 SPL/RP) to M. Schmidt and R.G., by a grant from Ministerio de Ciencia e Innovacien and ERDF (SAF15-67633-R) to D.C., by the "la Caixa"Foundation (CLLEvolution-LCF/PR/HR17/521500 17, Health Research 2017 Program HR17-00221) and the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation pro-gram (grant agreement No 810287, BCLLatlas) to E.C., by the DFG (SFB1074 project B1) to St.St., by a grant from the ERC (ERC-CoG, #648145 REGiREG) to M.F., and by the BMBF-Network "PRECiSe" (031L0076A) and the ERA-NET TRANSCAN-2 program JTC 2014-project FIRE-CLL to St.St., P.L., and M. Seiffert. The graphical abstract was created using BioRender.com .	Adey A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r119; Alquicira-Hernandez J, 2021, BIOINFORMATICS, V37, P2485, DOI 10.1093/bioinformatics/btab003; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Bengtsson H., 2008, 745 U CAL DEP STAT; Betts MR, 2003, J IMMUNOL METHODS, V281, P65, DOI 10.1016/S0022-1759(03)00265-5; Bichi R, 2002, P NATL ACAD SCI USA, V99, P6955, DOI 10.1073/pnas.102181599; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Blazar BR, 1998, TRANSPLANTATION, V66, P1220, DOI 10.1097/00007890-199811150-00018; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bolotin DA, 2015, NAT METHODS, V12, P380, DOI 10.1038/nmeth.3364; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Cui WG, 2011, IMMUNITY, V35, P792, DOI 10.1016/j.immuni.2011.09.017; Dietrich S, 2018, J CLIN INVEST, V128, P427, DOI 10.1172/JCI93801; DiLillo DJ, 2013, LEUKEMIA, V27, P170, DOI 10.1038/leu.2012.165; Ding W, 2017, BLOOD, V129, P3419, DOI 10.1182/blood-2017-02-765685; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Emmerich J, 2012, CANCER RES, V72, P3570, DOI 10.1158/0008-5472.CAN-12-0721; Fayad L, 2001, BLOOD, V97, P256, DOI 10.1182/blood.V97.1.256; FINBLOOM DS, 1995, J IMMUNOL, V155, P1079; Foulds KE, 2006, J IMMUNOL, V177, P2565, DOI 10.4049/jimmunol.177.4.2565; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Groux H, 1998, J IMMUNOL, V160, P3188; Guo YG, 2021, NAT IMMUNOL, V22, P746, DOI 10.1038/s41590-021-00940-2; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Hanna BS, 2016, LEUKEMIA, V30, P570, DOI 10.1038/leu.2015.305; Hanna BS, 2021, HAEMATOLOGICA, V106, P968, DOI 10.3324/haematol.2019.238154; Hanna BS, 2019, LEUKEMIA, V33, P625, DOI 10.1038/s41375-018-0250-6; Hao Yuhan, 2021, Cell, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hofbauer JP, 2011, LEUKEMIA, V25, P1452, DOI 10.1038/leu.2011.111; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.162; Kamanaka M, 2006, IMMUNITY, V25, P941, DOI 10.1016/j.immuni.2006.09.013; Laidlaw BJ, 2015, NAT IMMUNOL, V16, P871, DOI 10.1038/ni.3224; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Liu YY, 2021, NAT IMMUNOL, V22, P358, DOI 10.1038/s41590-020-00850-9; Lockstone HE, 2011, BRIEF BIOINFORM, V12, P634, DOI 10.1093/bib/bbq086; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Maintainer B., 2015, TXDB MMUSCULUS UCSC; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; McClanahan F, 2015, BLOOD, V126, P203, DOI 10.1182/blood-2015-01-622936; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Montraveta A, 2016, ONCOTARGET, V7, P5507, DOI 10.18632/oncotarget.6685; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Naing A, 2018, CANCER CELL, V34, P775, DOI 10.1016/j.ccell.2018.10.007; Naing A, 2016, J CLIN ONCOL, V34, P3562, DOI 10.1200/JCO.2016.68.1106; Neven B, 2013, BLOOD, V122, P3713, DOI 10.1182/blood-2013-06-508267; Nizzoli G, 2016, EUR J IMMUNOL, V46, P1622, DOI 10.1002/eji.201546136; O'Garra A, 2007, NAT REV IMMUNOL, V7, P425, DOI 10.1038/nri2097; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Parish IA, 2014, J CLIN INVEST, V124, P3455, DOI [10.1172/JC166108, 10.1172/JCI66108]; Pauken KE, 2015, TRENDS IMMUNOL, V36, P265, DOI 10.1016/j.it.2015.02.008; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Porter DL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5415; Qiao J, 2019, CANCER CELL, V35, P901, DOI 10.1016/j.ccell.2019.05.005; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Ramsay AG, 2008, J CLIN INVEST, V118, P2427, DOI 10.1172/JCI35017; Ray JP, 2014, IMMUNITY, V40, P367, DOI 10.1016/j.immuni.2014.02.005; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; Ruffell B, 2014, CANCER CELL, V26, P623, DOI 10.1016/j.ccell.2014.09.006; Ruggiero E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9081; Sadik A, 2020, CELL, V182, P1252, DOI 10.1016/j.cell.2020.07.038; Sarkar S, 2008, J EXP MED, V205, P625, DOI 10.1084/jem.20071641; Sawant DV, 2019, NAT IMMUNOL, V20, P724, DOI 10.1038/s41590-019-0346-9; Schietinger A, 2016, IMMUNITY, V45, P389, DOI 10.1016/j.immuni.2016.07.011; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI DOI 10.1002/J.1538-7305.1948.TB01338.X; Shen L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-284; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; Shugay M, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004503; Sjoberg J, 1996, BRIT J HAEMATOL, V92, P393, DOI 10.1046/j.1365-2141.1996.00358.x; Smith LK, 2018, IMMUNITY, V48, P299, DOI 10.1016/j.immuni.2018.01.006; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Snell LM, 2018, IMMUNITY, V49, P378, DOI 10.1016/j.immuni.2018.08.002; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Stilgenbauer S, 2009, J CLIN ONCOL, V27, P3994, DOI 10.1200/JCO.2008.21.1128; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeda K, 1998, J IMMUNOL, V161, P4652; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; West EE, 2011, IMMUNITY, V35, P285, DOI 10.1016/j.immuni.2011.05.017; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Yates A, 2016, NUCLEIC ACIDS RES, V44, pD710, DOI 10.1093/nar/gkv1157; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zenz T, 2010, NAT REV CANCER, V10, P37, DOI 10.1038/nrc2764; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao SL, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S10-P16	116	14	14	4	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2825	+		10.1016/j.immuni.2021.11.004	http://dx.doi.org/10.1016/j.immuni.2021.11.004		DEC 2021	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6LX	34879221				2022-12-18	WOS:000731658800003
J	Faas, M; Ipseiz, N; Ackermann, J; Culemann, S; Gruneboom, A; Schroder, F; Rothe, T; Scholtysek, C; Eberhardt, M; Bottcher, M; Kirchner, P; Stoll, C; Ekici, A; Fuchs, M; Kunz, M; Weigmann, B; Wirtz, S; Lang, R; Hofmann, J; Vera, J; Voehringer, D; Michelucci, A; Mougiakakos, D; Uderhardt, S; Schett, G; Kronke, G				Faas, Maria; Ipseiz, Natacha; Ackermann, Jochen; Culemann, Stephan; Grueneboom, Anika; Schroeder, Fenja; Rothe, Tobias; Scholtysek, Carina; Eberhardt, Martin; Boettcher, Martin; Kirchner, Philipp; Stoll, Cornelia; Ekici, Arif; Fuchs, Maximilian; Kunz, Meik; Weigmann, Benno; Wirtz, Stefan; Lang, Roland; Hofmann, Joerg; Vera, Julio; Voehringer, David; Michelucci, Alessandro; Mougiakakos, Dimitrios; Uderhardt, Stefan; Schett, Georg; Kroenke, Gerhard			IL-33-induced metabolic reprogramming controls the differentiation of alternatively activated macrophages and the resolution of inflammation	IMMUNITY			English	Article							SKELETAL-MUSCLE; CELLS; INTERLEUKIN-33; REGULATOR; MONOCYTES; DYNAMICS; INSIGHTS; REVEALS; REPAIR; ROLES	Alternatively activated macrophages (AAMs) contribute to the resolution of inflammation and tissue repair. However, molecular pathways that govern their differentiation have remained incompletely understood. Here, we show that uncoupling protein-2-mediated mitochondrial reprogramming and the transcription factor GATA3 specifically controlled the differentiation of pro-resolving AAMs in response to the alarmin IL-33. In macrophages, IL-33 sequentially triggered early expression of pro-inflammatory genes and subsequent differentiation into AAMs. Global analysis of underlying signaling events revealed that IL-33 induced a rapid metabolic rewiring of macrophages that involved uncoupling of the respiratory chain and increased production of the metabolite itaconate, which subsequently triggered a GATA3-mediated AAM polarization. Conditional deletion of GATA3 in mononuclear phagocytes accordingly abrogated IL-33-induced differentiation of AAMs and tissue repair upon muscle injury. Our data thus identify an IL-4-independent and GATA3-dependent pathway in mononuclear phagocytes that results from mitochondrial rewiring and controls macrophage plasticity and the resolution of inflammation.	[Faas, Maria; Ipseiz, Natacha; Ackermann, Jochen; Culemann, Stephan; Schroeder, Fenja; Rothe, Tobias; Scholtysek, Carina; Stoll, Cornelia; Uderhardt, Stefan; Schett, Georg; Kroenke, Gerhard] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Internal Med Rheumatol & Immunol 3, D-91054 Erlangen, Germany; [Faas, Maria; Ipseiz, Natacha; Ackermann, Jochen; Culemann, Stephan; Schroeder, Fenja; Rothe, Tobias; Scholtysek, Carina; Eberhardt, Martin; Boettcher, Martin; Kirchner, Philipp; Stoll, Cornelia; Ekici, Arif; Fuchs, Maximilian; Kunz, Meik; Weigmann, Benno; Wirtz, Stefan; Lang, Roland; Vera, Julio; Voehringer, David; Mougiakakos, Dimitrios; Uderhardt, Stefan; Schett, Georg; Kroenke, Gerhard] Univ Klinikum Erlangen, D-91054 Erlangen, Germany; [Faas, Maria; Ipseiz, Natacha; Ackermann, Jochen; Culemann, Stephan; Schroeder, Fenja; Rothe, Tobias; Scholtysek, Carina; Eberhardt, Martin; Boettcher, Martin; Stoll, Cornelia; Weigmann, Benno; Wirtz, Stefan; Vera, Julio; Mougiakakos, Dimitrios; Uderhardt, Stefan; Schett, Georg; Kroenke, Gerhard] Friedrich Alexander Univ Erlangen Nurnberg FAU, Deutsch Zentrum Immuntherapie DZI, D-91054 Erlangen, Germany; [Ipseiz, Natacha] Cardiff Univ, Syst Immun Res Inst, Heath Pk, Cardiff CF14 4XN, Wales; [Grueneboom, Anika] Leibniz Inst Analyt Wissensch ISAS eV, Dept Biospect, D-44139 Dortmund, Germany; [Grueneboom, Anika] Univ Duisburg Essen, Univ Hosp, Med Fac, D-45147 Essen, Germany; [Eberhardt, Martin; Vera, Julio] Univ Klinikum Erlangen, Dept Dermatol, Lab Syst Tumor Immunol, D-91054 Erlangen, Germany; [Eberhardt, Martin; Vera, Julio] Friedrich Alexander Univ Erlangen Nurnberg FAU, D-91054 Erlangen, Germany; [Boettcher, Martin; Mougiakakos, Dimitrios] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Internal Med 5, Erlangen, Germany; [Kirchner, Philipp; Ekici, Arif] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Human Genet, D-91054 Erlangen, Germany; [Fuchs, Maximilian; Kunz, Meik] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Med Informat, D-91054 Erlangen, Germany; [Weigmann, Benno; Wirtz, Stefan] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Internal Med 1, D-91054 Erlangen, Germany; [Lang, Roland] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Clin Microbiol, D-91054 Erlangen, Germany; [Hofmann, Joerg] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Biol, Div Biochem, D-91054 Erlangen, Germany; [Voehringer, David] Friedrich Alexander Univ Erlangen Nurnberg FAU, Inst Clin Microbiol, Div Infect Biol, D-91054 Erlangen, Germany; [Michelucci, Alessandro] Luxembourg Inst Hlth LIH, Dept Oncol, Neuro Immunol Grp, L-1526 Luxembourg, Luxembourg	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Cardiff University; Dortmund University of Technology; Leibniz Institut fur Analytische Wissenschaften (ISAS); University of Duisburg Essen; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; Luxembourg Institute of Health	Kronke, G (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Internal Med Rheumatol & Immunol 3, D-91054 Erlangen, Germany.; Kronke, G (corresponding author), Univ Klinikum Erlangen, D-91054 Erlangen, Germany.; Kronke, G (corresponding author), Friedrich Alexander Univ Erlangen Nurnberg FAU, Deutsch Zentrum Immuntherapie DZI, D-91054 Erlangen, Germany.	gerhard.kroenke@uk-erlangen.de	Krönke, Gerhard/C-6615-2014; Ekici, Arif B/C-3971-2013; Böttcher, Martin/AFQ-7409-2022; Vera, Julio/O-4134-2015	Krönke, Gerhard/0000-0002-7566-4325; Ekici, Arif B/0000-0001-6099-7066; Böttcher, Martin/0000-0003-2911-8830; Kirchner, Philipp/0000-0002-7972-2318; Hofmann Dr.rer.nat., Joerg/0000-0001-7387-1569; Fuchs, Maximilian/0000-0002-8099-9541; Michelucci, Alessandro/0000-0003-1230-061X; Vera, Julio/0000-0002-3076-5122	Deutsche Forschungsgemeinschaft (DFG) [CRC1181-A03/A01/A02/Z2, GK1660, FG 2886]; Emerging Field Initiative (EFI) of Friedrich-Alexander University Erlangen-NuEurornberg (FAU) [EFI_Verbund_Med_05_MIRACLE]; Bundesministerium fuEuror Bildung und Forschung (BMBF) [FKZ:01ZX1905A]; DFG (German Research Foundation) [261193037]; European Union (Horizon 2020 ERC-2014-StG) [640087]; European Union (Horizon 2020 ERC-2020-CoG) [101001866]; European Union (Horizon 2020 ERC-2018-SyG nano-SCOPE and RTCure)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Emerging Field Initiative (EFI) of Friedrich-Alexander University Erlangen-NuEurornberg (FAU); Bundesministerium fuEuror Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG (German Research Foundation)(German Research Foundation (DFG)); European Union (Horizon 2020 ERC-2014-StG); European Union (Horizon 2020 ERC-2020-CoG); European Union (Horizon 2020 ERC-2018-SyG nano-SCOPE and RTCure)	We thank A. Klej, R. Weinkam, and R. Palmisano as well as the Optical Imaging Center Erlangen (OICE) for excellent technical assistance. M. Mroz and U. Ap-pelt provided help during cell sorting. We want to additionally thank Yolanda Pires-Afonso from the Luxembourg Institute of Health (LIH) for help during isolation of macrophages from Irg1<SUP>-/-</SUP> mice. This work was supported by Deutsche Forschungsgemeinschaft (DFG; CRC1181-A03/A01/A02/Z2 to G.K., G.S., and D.V.; GK1660 to G.K.; and FG 2886 "PANDORA"- B01/A03 to G.K. and G.S.) , the Emerging Field Initiative (EFI) of Friedrich-Alexander Uni-versity Erlangen-NuEurornberg (FAU) (EFI_Verbund_Med_05_MIRACLE to G.K.) , Bundesministerium fuEuror Bildung und Forschung (BMBF) (MASCARA to G.K. and G.S., MelAutim (FKZ:01ZX1905A) to G.K. and J.V.-G.) , and the European Union (Horizon 2020 ERC-2014-StG 640087 - SOS and Horizon 2020 ERC-2020-CoG 101001866 to G.K. as well as Horizon 2020 ERC-2018-SyG nano-SCOPE and RTCure to G.S.) . Volume imaging was performed on a Zeiss LSM 880 system, funded by DFG (German Research Foundation) , project 261193037.	Allen JE, 2014, SEMIN IMMUNOL, V26, P329, DOI 10.1016/j.smim.2014.06.003; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Chazaud B, 2020, TRENDS IMMUNOL, V41, P481, DOI 10.1016/j.it.2020.04.006; Coakley G, 2020, PARASITE IMMUNOL, V42, DOI 10.1111/pim.12717; Cochain C, 2018, CIRC RES, V122, P1661, DOI 10.1161/CIRCRESAHA.117.312509; Cohen M, 2014, EMBO J, V33, P2906, DOI 10.15252/embj.201489293; Culemann S, 2019, NATURE, V572, P670, DOI 10.1038/s41586-019-1471-1; Folker ES, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00363; Giannakis N, 2019, NAT IMMUNOL, V20, P626, DOI 10.1038/s41590-019-0356-7; Ginhoux F, 2016, NAT IMMUNOL, V17, P34, DOI 10.1038/ni.3324; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; He J, 2019, CELL REP, V29, P2718, DOI 10.1016/j.celrep.2019.10.077; Heredia JE, 2013, CELL, V153, P376, DOI 10.1016/j.cell.2013.02.053; Hofmann J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00082; Jackson-Jones LH, 2016, EUR J IMMUNOL, V46, P2311, DOI 10.1002/eji.201646442; Jaitin DA, 2019, CELL, V178, P686, DOI 10.1016/j.cell.2019.05.054; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Knipper JA, 2015, IMMUNITY, V43, P803, DOI 10.1016/j.immuni.2015.09.005; Kolde Raivo, 2019, CRAN; Kurowska-Stolarska M, 2009, J IMMUNOL, V183, P6469, DOI 10.4049/jimmunol.0901575; Kuswanto W, 2016, IMMUNITY, V44, P355, DOI 10.1016/j.immuni.2016.01.009; Lantz C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70353-y; Li WZ, 2019, NAT PROTOC, V14, P1708, DOI 10.1038/s41596-019-0156-4; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lu RQ, 2001, J BIOL CHEM, V276, P45491, DOI 10.1074/jbc.C100421200; Lu YN, 2020, IMMUNITY, V52, P782, DOI 10.1016/j.immuni.2020.03.006; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Mills EL, 2017, NAT IMMUNOL, V18, P488, DOI 10.1038/ni.3704; Mills EL, 2016, EUR J IMMUNOL, V46, P13, DOI 10.1002/eji.201445427; Molgora M, 2020, CELL, V182, P886, DOI 10.1016/j.cell.2020.07.013; Murray PJ, 2017, ANNU REV PHYSIOL, V79, P541, DOI 10.1146/annurev-physiol-022516-034339; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nair MG, 2009, J EXP MED, V206, P937, DOI 10.1084/jem.20082048; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Park D, 2011, NATURE, V477, P220, DOI 10.1038/nature10340; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Rockwell CE, 2012, J IMMUNOL, V188, P1630, DOI 10.4049/jimmunol.1101712; Salem M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-181; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Sluse FE, 2006, BBA-BIOENERGETICS, V1757, P480, DOI 10.1016/j.bbabio.2006.02.004; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Uderhardt S, 2019, CELL, V177, P541, DOI 10.1016/j.cell.2019.02.028; Varga T, 2016, J IMMUNOL, V196, P4771, DOI 10.4049/jimmunol.1502490; Wan YY, 2014, TRENDS IMMUNOL, V35, P233, DOI 10.1016/j.it.2014.04.002; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Yang MJ, 2018, J AM COLL CARDIOL, V72, P885, DOI 10.1016/j.jacc.2018.05.061; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Yurdagul A, 2020, CELL METAB, V31, P518, DOI 10.1016/j.cmet.2020.01.001	52	14	15	13	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2531	+		10.1016/j.immuni.2021.09.010	http://dx.doi.org/10.1016/j.immuni.2021.09.010		NOV 2021	22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LS	34644537	Bronze, Green Accepted			2022-12-18	WOS:000718366000011
J	Hernandez, DC; Juelke, K; Muller, NC; Durek, P; Ugursu, B; Mashreghi, MF; Ruckert, T; Romagnani, C				Hernandez, Daniela Carolina; Juelke, Kerstin; Mueller, Nils Christian; Durek, Pawel; Ugursu, Bilge; Mashreghi, Mir-Farzin; Rueckert, Timo; Romagnani, Chiara			An in vitro platform supports generation of human innate lymphoid cells from CD34(+) hematopoietic progenitors that recapitulate ex vivo identity	IMMUNITY			English	Article							TRANSCRIPTION FACTOR BCL11B; NATURAL-KILLER; NK CELLS; STEM-CELLS; UP-REGULATION; FACTOR GATA3; EXPRESSION; FETAL; DIFFERENTIATION; HETEROGENEITY	Innate lymphoid cells (ILCs) are critical effectors of innate immunity and inflammation, whose development and activation pathways make for attractive therapeutic targets. However, human ILC generation has not been systematically explored, and previous in vitro investigations relied on the analysis of few markers or cytokines, which are suboptimal to assign lineage identity. Here, we developed a platform that reliably generated human ILC lineages from CD34(+) hematopoietic progenitors derived from cord blood and bone marrow. We showed that one culture condition is insufficient to generate all ILC subsets, and instead, distinct combination of cytokines and Notch signaling are essential. The identity of natural killer (NK)/ILC1s, ILC2s, and ILC3s generated in vitro was validated by protein expression, functional assays, and both global and single-cell transcriptome analysis, recapitulating the signatures and functions of their ex vivo ILC counterparts. These data represent a resource to aid in clarifying ILC biology and differentiation.	[Hernandez, Daniela Carolina; Juelke, Kerstin; Mueller, Nils Christian; Ugursu, Bilge; Rueckert, Timo; Romagnani, Chiara] Leibniz Assoc, German Rheumatism Res Ctr DRFZ, Innate Immun, D-10117 Berlin, Germany; [Hernandez, Daniela Carolina; Romagnani, Chiara] Charite Univ Med Berlin, D-10117 Berlin, Germany; [Hernandez, Daniela Carolina; Romagnani, Chiara] Free Univ Berlin, D-10117 Berlin, Germany; [Hernandez, Daniela Carolina; Romagnani, Chiara] Humboldt Univ, Dept Gastroenterol Infect Dis Rheumatol, D-10117 Berlin, Germany; [Durek, Pawel; Mashreghi, Mir-Farzin] Leibniz Assoc, German Rheumatism Res Ctr DRFZ, Therapeut Gene Regulat, D-10117 Berlin, Germany; [Juelke, Kerstin; Mashreghi, Mir-Farzin] Berlin Inst Hlth, BIH Ctr Regenerat Therapies BCRT, D-13353 Berlin, Germany; [Juelke, Kerstin] CheckImmune GmbH, D-13353 Berlin, Germany	Deutsches Rheuma-Forschungszentrum (DRFZ); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Deutsches Rheuma-Forschungszentrum (DRFZ); Berlin Institute of Health	Romagnani, C (corresponding author), Leibniz Assoc, German Rheumatism Res Ctr DRFZ, Innate Immun, D-10117 Berlin, Germany.; Romagnani, C (corresponding author), Charite Univ Med Berlin, D-10117 Berlin, Germany.; Romagnani, C (corresponding author), Free Univ Berlin, D-10117 Berlin, Germany.; Romagnani, C (corresponding author), Humboldt Univ, Dept Gastroenterol Infect Dis Rheumatol, D-10117 Berlin, Germany.	romagnani@drfz.de		Ugursu, Bilge/0000-0002-2488-4141; Muller, Nils Christian/0000-0003-1559-7711; Ruckert, Timo/0000-0003-1433-1372; Mashreghi, Mir-Farzin/0000-0002-8015-6907; Julke, Kerstin/0000-0002-3910-817X; Hernandez, Daniela/0000-0001-5960-160X	Leibniz-Science Campus Chronic Inflammation; Deutsche Forschungsgemeinschaft (DFG) grants Heisenberg Program [RO3565/1-1, RO3565/2-1, SPP 1937 (RO3565/4-1), SPP 1937 (RO3565/4-2), SFB TRR241 B02]; INST [335/597-1 FUGG]; state of Berlin; European Regional Development Fund (ERDF) [EFRE 1.8/11]; Leibniz-Kooperative ExzellenzK [259/2019]	Leibniz-Science Campus Chronic Inflammation; Deutsche Forschungsgemeinschaft (DFG) grants Heisenberg Program(German Research Foundation (DFG)); INST; state of Berlin; European Regional Development Fund (ERDF)(European Commission); Leibniz-Kooperative ExzellenzK	We thank the DRFZ FCCF for cell sorting and flow cytometry assistance, Tom Taghon for critical reading of the manuscript and insightful comments, and Ulrike Uhlig, Katrin Lehmann, and Marion Klemm for technical assistance. We thank Simon Reinke and the Core Unit of Cell & Tissue Harvesting for the provision of BM samples. This work was funded by the Leibniz-Science Campus Chronic Inflammation and Leibniz-Kooperative ExzellenzK259/2019, as well as the Deutsche Forschungsgemeinschaft (DFG) grants Heisenberg Program (RO3565/1-1), RO3565/2-1, SPP 1937 (RO3565/4-1 and 4-2), and SFB TRR241 B02, to C.R. This work was also supported by INST 335/597-1 FUGG. M.-F.M. is funded by the state of Berlin and the European Regional Development Fund (ERDF 2014-2020, EFRE 1.8/11).	Amir ED, 2013, NAT BIOTECHNOL, V31, P545, DOI 10.1038/nbt.2594; Bal SM, 2016, NAT IMMUNOL, V17, P636, DOI 10.1038/ni.3444; Bar-Ephraim YE, 2017, CELL REP, V21, P823, DOI 10.1016/j.celrep.2017.09.070; Benne C, 2009, STEM CELLS, V27, P1676, DOI 10.1002/stem.94; Bernink JH, 2015, IMMUNITY, V43, P146, DOI 10.1016/j.immuni.2015.06.019; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Blom B, 2006, ANNU REV IMMUNOL, V24, P287, DOI 10.1146/annurev.immunol.24.021605.090612; Brauer PM, 2016, TRENDS IMMUNOL, V37, P889, DOI 10.1016/j.it.2016.09.008; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Burgueno-Bucio E, 2019, J LEUKOCYTE BIOL, V105, P891, DOI 10.1002/JLB.MR0618-226R; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Califano D, 2015, IMMUNITY, V43, P354, DOI 10.1016/j.immuni.2015.07.005; Cella M, 2010, P NATL ACAD SCI USA, V107, P10961, DOI 10.1073/pnas.1005641107; Cella M, 2009, NATURE, V457, P722, DOI 10.1038/nature07537; Chea S, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2223; Chen LX, 2018, IMMUNITY, V49, P464, DOI 10.1016/j.immuni.2018.08.010; Collins PL, 2019, CELL, V176, P348, DOI 10.1016/j.cell.2018.11.045; Constantinides MG, 2014, NATURE, V508, P397, DOI 10.1038/nature13047; Cortez VS, 2017, NAT IMMUNOL, V18, P995, DOI 10.1038/ni.3809; Cupedo T, 2009, NAT IMMUNOL, V10, P66, DOI 10.1038/ni.1668; De Smedt M, 2007, BLOOD, V110, P2696, DOI 10.1182/blood-2007-03-082206; Ettersperger J, 2016, IMMUNITY, V45, P610, DOI 10.1016/j.immuni.2016.07.018; Ferreira ACF, 2021, NAT IMMUNOL, V22, P166, DOI 10.1038/s41590-020-00833-w; Frankish A, 2019, NUCLEIC ACIDS RES, V47, pD766, DOI 10.1093/nar/gky955; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; GALY A, 1995, IMMUNITY, V3, P459, DOI 10.1016/1074-7613(95)90175-2; Gao YL, 2017, NAT IMMUNOL, V18, P1004, DOI 10.1038/ni.3800; Gentek R, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00334; Ghaedi M, 2020, J EXP MED, V217, DOI 10.1084/jem.20182293; Golebski K, 2021, IMMUNITY, V54, P291, DOI 10.1016/j.immuni.2020.12.013; Grzywacz B, 2006, BLOOD, V108, P3824, DOI 10.1182/blood-2006-04-020198; Hochdorfer T, 2019, EUR J IMMUNOL, V49, P884, DOI 10.1002/eji.201848006; Hordyjewska A, 2015, CYTOTECHNOLOGY, V67, P387, DOI 10.1007/s10616-014-9796-y; Hoyler T, 2012, IMMUNITY, V37, P634, DOI 10.1016/j.immuni.2012.06.020; Huang YF, 2015, NAT IMMUNOL, V16, P161, DOI 10.1038/ni.3078; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klose CSN, 2014, CELL, V157, P340, DOI 10.1016/j.cell.2014.03.030; Kotecha N., 2010, CURR PROTOC CYTOM, DOI DOI 10.1002/0471142956.CY1017S53; La Motte-Mohs RN, 2005, BLOOD, V105, P1431, DOI 10.1182/blood-2004-04-1293; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee JS, 2012, NAT IMMUNOL, V13, P144, DOI 10.1038/ni.2187; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lim AI, 2017, CELL, V168, P1086, DOI 10.1016/j.cell.2017.02.021; Lim AI, 2016, J EXP MED, V213, P569, DOI 10.1084/jem.20151750; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lun Aaron T L, 2016, F1000Res, V5, P2122; Mazzurana L, 2021, CELL RES, V31, P554, DOI 10.1038/s41422-020-00445-x; Melsted P, 2019, MODULAR EFFICIENT PR, DOI [10.1101/673285, DOI 10.1101/673285]; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Mjosberg J, 2012, IMMUNITY, V37, P649, DOI 10.1016/j.immuni.2012.08.015; Mjosberg JM, 2011, NAT IMMUNOL, V12, P1055, DOI 10.1038/ni.2104; Montaldo E, 2014, IMMUNITY, V41, P988, DOI 10.1016/j.immuni.2014.11.010; Morita H, 2019, J ALLERGY CLIN IMMUN, V143, P2190, DOI 10.1016/j.jaci.2018.12.1018; Mrozek E, 1996, BLOOD, V87, P2632, DOI 10.1182/blood.V87.7.2632.bloodjournal8772632; Nagasawa M, 2019, J EXP MED, V216, P1762, DOI 10.1084/jem.20190490; Nagasawa M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01047; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Ohne Y, 2016, NAT IMMUNOL, V17, P646, DOI 10.1038/ni.3447; PHILLIPS JH, 1992, J EXP MED, V175, P1055, DOI 10.1084/jem.175.4.1055; Possot C, 2011, NAT IMMUNOL, V12, P949, DOI 10.1038/ni.2105; Qian LY, 2019, J EXP MED, V216, P884, DOI 10.1084/jem.20182100; Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545; RAWLINGS DJ, 1995, P NATL ACAD SCI USA, V92, P1570, DOI 10.1073/pnas.92.5.1570; Renoux VM, 2015, IMMUNITY, V43, P394, DOI 10.1016/j.immuni.2015.07.011; Riggan L, 2019, TRENDS IMMUNOL, V40, P909, DOI 10.1016/j.it.2019.08.005; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rohart F, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005752; Rothenberg EV, 2011, J IMMUNOL, V186, P6649, DOI 10.4049/jimmunol.1003703; Salimi M, 2016, J IMMUNOL, V196, P45, DOI 10.4049/jimmunol.1501102; Scoville SD, 2016, IMMUNITY, V44, P1140, DOI 10.1016/j.immuni.2016.04.007; Shikhagaie MM, 2017, CELL REP, V18, P1761, DOI 10.1016/j.celrep.2017.01.063; Silver JS, 2016, NAT IMMUNOL, V17, P626, DOI 10.1038/ni.3443; Simoni Y, 2018, IMMUNOLOGY, V153, P297, DOI 10.1111/imm.12862; Sojka DK, 2014, ELIFE, V3, DOI 10.7554/eLife.01659; Spits H, 2016, NAT IMMUNOL, V17, P758, DOI 10.1038/ni.3482; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tang Q, 2011, BLOOD, V117, P4052, DOI 10.1182/blood-2010-09-303081; Viant C, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf2176; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Vranjkovic A, 2007, INT IMMUNOL, V19, P1329, DOI 10.1093/intimm/dxm102; Walker JA, 2019, IMMUNITY, V51, P104, DOI 10.1016/j.immuni.2019.05.002; Walker JA, 2015, J EXP MED, V212, P875, DOI 10.1084/jem.20142224; Weston CA, 2019, J ALLERGY CLIN IMMUN, V143, P410, DOI 10.1016/j.jaci.2018.08.030; Wong SH, 2012, NAT IMMUNOL, V13, P229, DOI 10.1038/ni.2208; Xu W, 2019, IMMUNITY, V50, P1054, DOI 10.1016/j.immuni.2019.02.022; Yang Q, 2015, NAT IMMUNOL, V16, P1044, DOI 10.1038/ni.3248; Yang Q, 2013, IMMUNITY, V38, P694, DOI 10.1016/j.immuni.2012.12.003; Yu Y, 2015, J EXP MED, V212, P865, DOI 10.1084/jem.20142318; Yudanin NA, 2019, IMMUNITY, V50, P505, DOI 10.1016/j.immuni.2019.01.012; Zeis P, 2020, IMMUNITY, V53, P775, DOI 10.1016/j.immuni.2020.09.002	92	14	14	3	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2417	+		10.1016/j.immuni.2021.07.019	http://dx.doi.org/10.1016/j.immuni.2021.07.019		OCT 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34453879	Bronze			2022-12-18	WOS:000706854100024
J	Tang, QN; Rigby, RE; Young, GR; Hvidt, AK; Davis, T; Tan, TK; Bridgeman, A; Townsend, AR; Kassiotis, G; Rehwinkel, J				Tang, Qiannan; Rigby, Rachel E.; Young, George R.; Hvidt, Astrid Korning; Davis, Tanja; Tan, Tiong Kit; Bridgeman, Anne; Townsend, Alain R.; Kassiotis, George; Rehwinkel, Jan			Adenosine-to-inosine editing of endogenous Z-form RNA by the deaminase ADAR1 prevents spontaneous MAVS-dependent type I interferon responses	IMMUNITY			English	Article							Z-DNA SEGMENTS; Z-ALPHA DOMAIN; HANDED Z-RNA; HUMAN C-MYC; REGULATORY FACTOR-3; CRYSTAL-STRUCTURE; INFLUENZA-VIRUS; ACID; DSRNA; TRANSCRIPTION	Nucleic acids are powerful triggers of innate immunity and can adopt the Z-conformation, an unusual left-handed double helix. Here, we studied the biological function(s) of Z-RNA recognition by the adenosine deaminase ADAR1, mutations in which cause Aicardi-Goutieres syndrome. Adar1(mZ alpha/mZ alpha) mice, bearing two point mutations in the Z-nucleic acid binding (Z alpha) domain that abolish Z-RNA binding, displayed spontaneous induction of type I interferons (IFNs) in multiple organs, including in the lung, where both stromal and hematopoietic cells showed IFN-stimulated gene (ISG) induction. Lung neutrophils expressed ISGs induced by the transcription factor IRF3, indicating an initiating role for neutrophils in this IFN response. The IFN response in Adar1mZ alpha/mZ alpha mice required the adaptor MAVS, implicating cytosolic RNA sensing. Adenosine-to-inosine changes were enriched in transposable elements and revealed a specific requirement of ADAR1's Z alpha domain in editing of a subset of RNAs. Thus, endogenous RNAs in Z-conformation have immunostimulatory potential curtailed by ADAR1, with relevance to autoinflammatory disease in humans.	[Tang, Qiannan; Rigby, Rachel E.; Hvidt, Astrid Korning; Davis, Tanja; Tan, Tiong Kit; Bridgeman, Anne; Townsend, Alain R.; Rehwinkel, Jan] Univ Oxford, MRC, Human Immunol Unit, Radcliffe Dept Med,Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Young, George R.] Francis Crick Inst, Bioinformat & Biostat STP, London NW1 1AT, England; [Townsend, Alain R.] Univ Oxford, Chinese Acad Med Sci, Ctr Translat Immunol, Oxford Inst, Oxford OX3 7FZ, England; [Kassiotis, George] Francis Crick Inst, Retroviral Immunol, London NW 1AT, England; [Kassiotis, George] Imperial Coll London, Fac Med, Dept Infect Dis, London W2 1NY, England	University of Oxford; Francis Crick Institute; University of Oxford; Imperial College London	Rehwinkel, J (corresponding author), Univ Oxford, MRC, Human Immunol Unit, Radcliffe Dept Med,Weatherall Inst Mol Med, Oxford OX3 9DS, England.	jan.rehwinkel@imm.ox.ac.uk	Young, George/C-6733-2009; Rehwinkel, Jan/CAG-1436-2022	Young, George/0000-0002-1203-588X; Rehwinkel, Jan/0000-0003-3841-835X; Tan, Tiong Kit/0000-0001-8746-8308; Rigby, Rachel Elizabeth/0000-0001-5201-9422; Hvidt, Astrid Korning/0000-0002-4527-1846	U.K. Medical Research Council (MRC); Wellcome Trust [100954]; Lister Institute; Francis Crick Institute from Cancer Research UK; Townsend-Jeantet Charitable Trust [1011770]; EPA Cephalosporin Early Career Researcher Fund; MRC	U.K. Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Lister Institute; Francis Crick Institute from Cancer Research UK; Townsend-Jeantet Charitable Trust; EPA Cephalosporin Early Career Researcher Fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. Shing Ho and Craig Benham for providing access to the Z-hunt and SIBZ codes, respectively, and for their helpful correspondence. We further thank Daniel Stetson, Andrew Oberst, Jonathan Maelfait, Caetano Reis e Sousa, David Ron, Annemarthe van Der Veen, Irina Udalova, Erinke van Grinsven, and members of the Rehwinkel lab for discussion. We thank Ziqi Long and Oliver Bannard for their help with generating BM chimeras and Hal Drakesmith for support of the IAV work. This work was funded by the U.K. Medical Research Council (MRC) (MRC core funding of the MRC Human Immunology Unit to J.R.), the Wellcome Trust (grant 100954 to J.R.), the Lister Institute (to J.R.), and the Francis Crick Institute (to G.K.), which receives its core funding from Cancer Research UK, the MRC, and the Wellcome Trust. T.K.T. was funded by the Townsend-Jeantet Charitable Trust (charity number 1011770) and the EPA Cephalosporin Early Career Researcher Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Ahmad S, 2018, CELL, V172, P797, DOI 10.1016/j.cell.2017.12.016; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Ashley CL, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030246; Athanasiadis A, 2005, J MOL BIOL, V351, P496, DOI 10.1016/j.jmb.2005.06.028; Athanasiadis A, 2012, SEMIN CELL DEV BIOL, V23, P275, DOI 10.1016/j.semcdb.2011.11.001; Attig J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02489; Bajad P, 2020, NUCLEIC ACIDS RES, V48, P3286, DOI 10.1093/nar/gkaa025; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Bartok E, 2020, IMMUNITY, V53, P54, DOI 10.1016/j.immuni.2020.06.014; Brown BA, 2000, P NATL ACAD SCI USA, V97, P13532, DOI 10.1073/pnas.240464097; Casey JL, 2012, CURR TOP MICROBIOL, V353, P123, DOI 10.1007/82_2011_146; Cavalcante RG, 2017, BIOINFORMATICS, V33, P2381, DOI 10.1093/bioinformatics/btx183; Champ PC, 2004, NUCLEIC ACIDS RES, V32, P6501, DOI 10.1093/nar/gkh988; Chung HC, 2018, CELL, V172, P811, DOI 10.1016/j.cell.2017.12.038; Chuong EB, 2016, SCIENCE, V351, P1083, DOI 10.1126/science.aad5497; DAVIS PW, 1986, NUCLEIC ACIDS RES, V14, P1279, DOI 10.1093/nar/14.3.1279; DeFilippis VR, 2006, J VIROL, V80, P1032, DOI 10.1128/JVI.80.2.1032-1037.2006; Devos M, 2020, J EXP MED, V217, DOI 10.1084/jem.20191913; Di Tommaso P, 2017, NAT BIOTECHNOL, V35, P316, DOI 10.1038/nbt.3820; Dias AG, 2019, TRENDS MICROBIOL, V27, P75, DOI 10.1016/j.tim.2018.08.007; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eisenberg E, 2018, NAT REV GENET, V19, P473, DOI 10.1038/s41576-018-0006-1; Feng S, 2011, NAT STRUCT MOL BIOL, V18, P169, DOI 10.1038/nsmb.1962; Gannon HS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07824-4; Gel B, 2016, BIOINFORMATICS, V32, P289, DOI 10.1093/bioinformatics/btv562; Goubau D, 2009, EUR J IMMUNOL, V39, P527, DOI 10.1002/eji.200838832; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Guallar D, 2020, CELL STEM CELL, V27, P300, DOI 10.1016/j.stem.2020.04.016; HALL K, 1984, NATURE, V311, P584, DOI 10.1038/311584a0; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Heraud-Farlow JE, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200085; Herbert A, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0237-x; HO PS, 1986, EMBO J, V5, P2737, DOI 10.1002/j.1460-2075.1986.tb04558.x; Ishizuka JJ, 2019, NATURE, V565, P43, DOI 10.1038/s41586-018-0768-9; Jiao HP, 2020, NATURE, V580, P391, DOI 10.1038/s41586-020-2129-8; Kesavardhana S., 2020, J EXP MED, V217; Kim D, 2019, NAT BIOTECHNOL, V37, P907, DOI 10.1038/s41587-019-0201-4; Kim SH, 2018, NUCLEIC ACIDS RES, V46, P4129, DOI 10.1093/nar/gky200; Kim YG, 2003, P NATL ACAD SCI USA, V100, P6974, DOI 10.1073/pnas.0431131100; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509; Li H, 2009, NUCLEIC ACIDS RES, V37, P2737, DOI 10.1093/nar/gkp124; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Li YZ, 2017, ELIFE, V6, DOI 10.7554/eLife.25687; Li ZQ, 2010, VIROLOGY, V396, P316, DOI 10.1016/j.virol.2009.10.026; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Liu HY, 2019, NAT MED, V25, P95, DOI 10.1038/s41591-018-0302-5; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo H, 2012, EXP THER MED, V3, P76, DOI 10.3892/etm.2011.350; Maelfait J, 2020, J MOL BIOL, V432, P552, DOI 10.1016/j.jmb.2019.11.016; Maelfait J, 2017, EMBO J, V36, P2529, DOI 10.15252/embj.201796476; Malik T.N., 2021, NUCLEIC ACIDS RES, V49, P4020, DOI DOI 10.1093/NAR/GKAB157; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; Maurano Megan, 2021, Immunity, V54, P1948, DOI 10.1016/j.immuni.2021.07.001; Mehdipour P, 2020, NATURE, V588, P169, DOI 10.1038/s41586-020-2844-1; Michallet MC, 2008, IMMUNITY, V28, P651, DOI 10.1016/j.immuni.2008.03.013; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Paste M, 2003, EUR J BIOCHEM, V270, P1590, DOI 10.1046/j.1432-1033.2003.03530.x; Perng YC, 2018, NAT REV MICROBIOL, V16, P423, DOI 10.1038/s41579-018-0020-5; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Pfaller CK, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006577; Pichlmair A, 2011, NAT IMMUNOL, V12, P624, DOI 10.1038/ni.2048; Piechotta M, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1432-8; Piechotta M, 2013, BIOINFORMATICS, V29, P1809, DOI 10.1093/bioinformatics/btt268; Porath HT, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1315-y; Powell TJ, 2019, J GEN VIROL, V100, P431, DOI 10.1099/jgv.0.001228; Powell TJ, 2012, J VIROL, V86, P13397, DOI 10.1128/JVI.01820-12; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reich DP, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a035352; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Rigby RE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43632-6; Schade M, 1999, EMBO J, V18, P470, DOI 10.1093/emboj/18.2.470; Schoggins JW, 2019, ANNU REV VIROL, V6, P567, DOI 10.1146/annurev-virology-092818-015756; Schwartz T, 1999, SCIENCE, V284, P1841, DOI 10.1126/science.284.5421.1841; Solomon O, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01458-8; Song YL, 2020, NAT STRUCT MOL BIOL, V27, P351, DOI 10.1038/s41594-020-0398-4; Sridharan H, 2017, EMBO REP, V18, P1429, DOI 10.15252/embr.201743947; Uggenti C, 2019, ANNU REV IMMUNOL, V37, P247, DOI 10.1146/annurev-immunol-042718-041257; Ulfig A, 2021, CELL MOL LIFE SCI, V78, P385, DOI 10.1007/s00018-020-03591-y; Uzonyi Anna, 2021, GEO; Vogel OA, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008842; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Wang RC, 2020, NATURE, V580, P386, DOI 10.1038/s41586-020-2127-x; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Weiden MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108476; WHITTEMORE LA, 1990, MOL CELL BIOL, V10, P1329, DOI 10.1128/MCB.10.4.1329; WITTIG B, 1992, EMBO J, V11, P4653, DOI 10.1002/j.1460-2075.1992.tb05567.x; Wolfl S, 1995, BBA-GENE STRUCT EXPR, V1264, P294, DOI 10.1016/0167-4781(95)00155-7; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Zhabinskaya D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001051; Zhang HR, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107564; Zhang T, 2020, CELL, V180, P1115, DOI 10.1016/j.cell.2020.02.050; Zhou SL, 2019, J BIOL CHEM, V294, P18168, DOI 10.1074/jbc.RA119.009113	100	14	14	2	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					1961	+		10.1016/j.immuni.2021.08.011	http://dx.doi.org/10.1016/j.immuni.2021.08.011		SEP 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34525337	Green Published, hybrid			2022-12-18	WOS:000695789800008
J	Chen, F; Tzarum, N; Lin, XH; Giang, E; Velazquez-Moctezuma, R; Augestad, EH; Nagy, K; He, LL; Hernandez, M; Fouch, ME; Grinyo, A; Chavez, D; Doranz, BJ; Prentoe, J; Stanfield, RL; Lanford, R; Bukh, J; Wilson, IA; Zhu, J; Law, MS				Chen, Fang; Tzarum, Netanel; Lin, Xiaohe; Giang, Erick; Velazquez-Moctezuma, Rodrigo; Augestad, Elias H.; Nagy, Kenna; He, Linling; Hernandez, Mayda; Fouch, Mallorie E.; Grinyo, Ariadna; Chavez, Deborah; Doranz, Benjamin J.; Prentoe, Jannick; Stanfield, Robyn L.; Lanford, Robert; Bukh, Jens; Wilson, Ian A.; Zhu, Jiang; Law, Mansun			Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins	IMMUNITY			English	Article							CELL-CULTURE SYSTEMS; HUMAN MONOCLONAL-ANTIBODIES; C-VIRUS PSEUDOPARTICLES; MEMORY B-CELLS; E2 GLYCOPROTEIN; RAPID DEVELOPMENT; MATURATION; GENOTYPES; RECOGNITION; GENERATION	Human IGHV1-69-encoded broadly neutralizing antibodies (bnAbs) that target the hepatitis C virus (HCV) envelope glycoprotein (Env) E2 are important for protection against HCV infection. An IGHV1-69 ortholog gene, VH1.36, is preferentially used for bnAbs isolated from HCV Env-immunized rhesus macaques (RMs). Here, we studied the genetic, structural, and functional properties of VH1.36-encoded bnAbs generated by vaccination, in comparison to IGHV1-69-encoded bnAbs from HCV patients. Global B cell repertoire analysis confirmed the expansion of VH1.36-derived B cells in immunized animals. Most E2-specific, VH1.36-encoded antibodies cross-neutralized HCV. Crystal structures of two RM bnAbs with E2 revealed that the RM bnAbs engaged conserved E2 epitopes using similar molecular features as human bnAbs but with a different binding mode. Longitudinal analyses of the RM antibody repertoire responses during immunization indicated rapid lineage development of VH1.36-encoded bnAbs with limited somatic hypermutation. Our findings suggest functional convergence of a germline-encoded bnAb response to HCV Env with implications for vaccination in humans.	[Chen, Fang; Lin, Xiaohe; Giang, Erick; Nagy, Kenna; He, Linling; Zhu, Jiang; Law, Mansun] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Tzarum, Netanel; Stanfield, Robyn L.; Wilson, Ian A.; Zhu, Jiang] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Velazquez-Moctezuma, Rodrigo; Augestad, Elias H.; Prentoe, Jannick; Bukh, Jens] Univ Copenhagen, Hvidovre Hosp, Copenhagen Hepatitis C Program CO HEP, Dept Infect Dis, Copenhagen, Denmark; [Velazquez-Moctezuma, Rodrigo; Augestad, Elias H.; Prentoe, Jannick; Bukh, Jens] Univ Copenhagen, Fac Hlth & Med Sci, Dept Immunol & Microbiol, Copenhagen, Denmark; [Hernandez, Mayda; Fouch, Mallorie E.; Grinyo, Ariadna; Doranz, Benjamin J.] Integral Mol Inc, Philadelphia, PA 19104 USA; [Chavez, Deborah; Lanford, Robert] Texas Biomed Res Inst, Southwest Natl Primate Res Ctr, San Antonio, TX 78227 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Tzarum, Netanel] Hebrew Univ Jerusalem, Fac Math & Sci, Alexander Silberman Inst Life Sci, Dept Biol Chem, IL-9190401 Jerusalem, Israel	Scripps Research Institute; Scripps Research Institute; University of Copenhagen; University of Copenhagen; Texas Biomedical Research Institute; Scripps Research Institute; Hebrew University of Jerusalem	Zhu, J; Law, MS (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.; Wilson, IA; Zhu, J (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Wilson, IA (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	wilson@scripps.edu; jiang@scripps.edu; mlaw@scripps.edu		Lin, Xiaohe/0000-0001-6761-3897; Nagy, Kenna/0000-0002-3772-3160; Velazquez-Moctezuma, Rodrigo/0000-0001-9865-152X; Prentoe, Jannick/0000-0003-2203-9478; Grinyo i Escuer, Ariadna/0000-0003-0185-2734; Bukh, Jens/0000-0002-7815-4806	NIH [AI079031, AI123861, AI123365, AI106005]; Independent Research Fund Denmark [DFF-4004-00598, DFF-8020-00391]; Novo Nordisk Foundation [NNF17OC0029372, NNF19OC0054518]; Candys Foundation; Lundbeck Foundation [R303-2018-3396, R324-2019-1375]; U.S. Department of Health and Human Services (HHS) [HHSN272201400058C]; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; DOE Office of Science [DE-AC02-06CH11357]; Southwest National Primate Research Center (SNPRC) from the Office of Research Infrastructure Programs, NIH [P51 OD011133, U42OD010442]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Independent Research Fund Denmark; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Candys Foundation; Lundbeck Foundation(Lundbeckfonden); U.S. Department of Health and Human Services (HHS); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); Southwest National Primate Research Center (SNPRC) from the Office of Research Infrastructure Programs, NIH	This work was funded in part by NIH Grants AI079031 (to M.L.), AI123861 (to M.L., J.Z., and R.L.), AI123365 and AI106005 (to M.L. and I.A.W.), Independent Research Fund Denmark (DFF-4004-00598 and DFF-8020-00391B to J.B.), Novo Nordisk Foundation (NNF17OC0029372 and NNF19OC0054518 to J.B.), Candys Foundation (to J.P., E.A., and J.B.) and Lundbeck Foundation (R303-2018-3396 to R.V.-M. and R324-2019-1375 to J.P.). Integral Molecular, Inc. is supported by U.S. Department of Health and Human Services (HHS) contract (HHSN272201400058C to B.J.D.). We thank E. Davidson for coordinating epitope mapping, X. Dai and M. Elsliger for crystallographic and computational support, and H. Tien for automated crystal screening. X-ray data sets were collected at APS beamline 23ID-B (GM/CA CAT). GM/CA@APS has been funded in whole or in part with Federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. This investiga-tion used resources that were supported by Southwest National Primate Research Center (SNPRC) grant P51 OD011133 and U42OD010442 from the Office of Research Infrastructure Programs, NIH. This is manuscript #30055 from The Scripps Research Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Bailey JR, 2019, METHODS MOL BIOL, V1911, P441, DOI 10.1007/978-1-4939-8976-8_30; Bailey JR, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92872; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Briney B, 2019, NATURE, V566, P393, DOI 10.1038/s41586-019-0879-y; Bukh J, 2010, J INFECT DIS, V201, P1381, DOI 10.1086/651579; Carlsen THR, 2014, HEPATOLOGY, V60, P1551, DOI 10.1002/hep.27298; Chen F, 2020, GASTROENTEROLOGY, V158, P1058, DOI 10.1053/j.gastro.2019.11.282; Chen F, 2019, CURR OPIN VIROL, V34, P149, DOI 10.1016/j.coviro.2019.02.004; Cirelli KM, 2019, CELL, V177, P1153, DOI 10.1016/j.cell.2019.04.012; Colbert MD, 2019, J VIROL, V93, DOI 10.1128/JVI.02070-18; Cox A.L., 2019, OPEN FORUM INFECT DI, V6, pS997, DOI [10.1093/ofid/ofz415.2493, DOI 10.1093/OFID/OFZ415.2493]; Dai KF, 2015, MBIO, V6, DOI 10.1128/mBio.01375-15; de Jong YP, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009512; DeWitt WS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160853; Di Niro R, 2010, J IMMUNOL, V185, P5377, DOI 10.4049/jimmunol.1001587; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flyak AI, 2020, ELIFE, V9, DOI 10.7554/eLife.53169; Flyak AI, 2018, CELL HOST MICROBE, V24, P703, DOI 10.1016/j.chom.2018.10.009; Gao F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02424; Giang E, 2012, P NATL ACAD SCI USA, V109, P6205, DOI 10.1073/pnas.1114927109; Gopal R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006735; Gottwein JM, 2009, HEPATOLOGY, V49, P364, DOI 10.1002/hep.22673; He LL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz6225; Huang DL, 2020, P NATL ACAD SCI USA, V117, P22920, DOI 10.1073/pnas.2004489117; Jensen TB, 2008, J INFECT DIS, V198, P1756, DOI 10.1086/593021; Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043; Keck ZY, 2008, J VIROL, V82, P6061, DOI 10.1128/JVI.02475-07; Keck ZY, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007772; Keck ZY, 2016, HEPATOLOGY, V64, P1922, DOI 10.1002/hep.28850; Kinchen VJ, 2018, TRENDS MICROBIOL, V26, P854, DOI 10.1016/j.tim.2018.04.002; Kong L, 2016, P NATL ACAD SCI USA, V113, P12768, DOI 10.1073/pnas.1609780113; Kong L, 2016, IMMUNITY, V44, P939, DOI 10.1016/j.immuni.2016.03.006; Kong L, 2013, SCIENCE, V342, P1090, DOI 10.1126/science.1243876; Krey T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003364; Lang SS, 2017, CELL REP, V20, P2935, DOI 10.1016/j.celrep.2017.08.084; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Li YP, 2015, J VIROL, V89, P811, DOI 10.1128/JVI.02877-14; Lingwood D, 2012, NATURE, V489, P566, DOI 10.1038/nature11371; Major M, 2019, METHODS MOL BIOL, V1911, P421, DOI 10.1007/978-1-4939-8976-8_28; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Merat SJ, 2019, J HEPATOL, V71, P14, DOI 10.1016/j.jhep.2019.02.013; Merat SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165047; Meunier JC, 2005, P NATL ACAD SCI USA, V102, P4560, DOI 10.1073/pnas.0501275102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Pedersen J, 2013, HEPATOLOGY, V58, P1587, DOI 10.1002/hep.26524; Prentoe J, 2019, METHODS MOL BIOL, V1911, P433, DOI 10.1007/978-1-4939-8976-8_29; Prentoe J, 2011, J VIROL, V85, P2224, DOI 10.1128/JVI.01594-10; Ramesh A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01407; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Roccasecca R, 2003, J VIROL, V77, P1856, DOI 10.1128/JVI.77.3.1856-1867.2003; Sangesland M, 2019, IMMUNITY, V51, P735, DOI 10.1016/j.immuni.2019.09.001; Scheel TKH, 2008, P NATL ACAD SCI USA, V105, P997, DOI 10.1073/pnas.0711044105; Scheel TKH, 2011, J VIROL, V85, P2891, DOI 10.1128/JVI.01605-10; Sundling C, 2012, J IMMUNOL METHODS, V386, P85, DOI 10.1016/j.jim.2012.09.003; Sundling C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003752; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tzarum N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb5642; Tzarum N, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav1882; Tzarum N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01315; Umotoy J, 2019, IMMUNITY, V51, P141, DOI 10.1016/j.immuni.2019.06.004; Velazquez-Moctezuma R, 2019, J VIROL, V93, DOI 10.1128/JVI.01909-18; Velazquez-Moctezuma R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006214; Vigdorovich V, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.42; Weitkamp JH, 2005, J IMMUNOL, V174, P3454, DOI 10.4049/jimmunol.174.6.3454; Wen GP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17737-w; Wheatley AK, 2015, J IMMUNOL, V195, P602, DOI 10.4049/jimmunol.1402835; Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007	76	14	14	2	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					781	+		10.1016/j.immuni.2021.02.013	http://dx.doi.org/10.1016/j.immuni.2021.02.013		APR 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33675683	Green Accepted, Bronze			2022-12-18	WOS:000640102800017
J	Graham, RL; Baric, RS				Graham, Rachel L.; Baric, Ralph S.			SARS-CoV-2: Combating Coronavirus Emergence	IMMUNITY			English	Editorial Material								The emergence and rapid global spread of SARS-CoV-2 mark the third such identification of a novel coronavirus capable of causing severe, potentially fatal disease in humans in the 21st century. As noted by Andersen et al. (Nature Medicine), the sequencing of proximal zoonotic ancestors to SARS-CoV-2 has aided in the identification of alleles that may contribute to the virus' virulence in humans.	[Graham, Rachel L.; Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Baric, Ralph S.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Baric, RS (corresponding author), Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27515 USA.; Baric, RS (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.	rbaric@email.unc.edu						Andersen KG, 2020, NAT MED, V26, P450, DOI 10.1038/s41591-020-0820-9; Bagdonaite I, 2018, GLYCOBIOLOGY, V28, P443, DOI 10.1093/glycob/cwy021; Lam TTY, 2020, NATURE, V583, P282, DOI 10.1038/s41586-020-2169-0; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Nao N, 2017, MBIO, V8, DOI 10.1128/mBio.02298-16; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zeng LP, 2016, J VIROL, V90, P6573, DOI 10.1128/JVI.03079-15; Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022; Zhou P, 2020, NATURE, V588, pE6, DOI [10.1038/s41586-020-2012-7, 10.1038/s41586-020-2951-z]	10	14	14	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					734	736		10.1016/j.immuni.2020.04.016	http://dx.doi.org/10.1016/j.immuni.2020.04.016			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32392464	Bronze, Green Published			2022-12-18	WOS:000535371100007
J	Lu, YN; Basatemur, G; Scott, IC; Chiarugi, D; Clement, M; Harrison, J; Jugdaohsingh, R; Yu, X; Newland, SA; Jolin, HE; Li, X; Chen, X; Szymanska, M; Haraldsen, G; Palmer, G; Fallon, PG; Cohen, ES; McKenzie, ANJ; Mallat, Z				Lu, Yuning; Basatemur, Gemma; Scott, Ian C.; Chiarugi, Davide; Clement, Marc; Harrison, James; Jugdaohsingh, Ravin; Yu, Xian; Newland, Stephen A.; Jolin, Helen E.; Li, Xuan; Chen, Xiao; Szymanska, Monika; Haraldsen, Guttorm; Palmer, Gaby; Fallon, Padraic G.; Cohen, E. Suzanne; McKenzie, Andrew N. J.; Mallat, Ziad			Interleukin-33 Signaling Controls the Development of Iron-Recycling Macrophages	IMMUNITY			English	Article							MYELOID PROGENITOR; CIS-ELEMENT; IL-33; DIFFERENTIATION; CELLS; TRANSCRIPTION; OSTEOCLAST; GROWTH; BLOOD; LIFE	Splenic red pulp macrophages (RPMs) contribute to erythrocyte homeostasis and are required for iron recycling. Heme induces the expression of SPIC transcription factor in monocyte-derived macrophages and promotes their differentiation into RPM precursors, pre-RPMs. However, the requirements for differentiation into mature RPMs remain unknown. Here, we have demonstrated that interleukin (IL)-33 associated with erythrocytes and co-cooperated with heme to promote the generation of mature RPMs through activation of the MyD88 adaptor protein and ERK1/2 kinases downstream of the IL-33 receptor, IL1RL1. IL-33- and IL1RL1-deficient mice showed defective iron recycling and increased splenic iron deposition. Gene expression and chromatin accessibility studies revealed a role for GATA transcription factors downstream of IL-33 signaling during the development of pre-RPMs that retained full potential to differentiate into RPMs. Thus, IL-33 instructs the development of RPMs as a response to physiological erythrocyte damage with important implications to iron recycling and iron homeostasis.	[Lu, Yuning; Basatemur, Gemma; Clement, Marc; Harrison, James; Yu, Xian; Newland, Stephen A.; Li, Xuan; Chen, Xiao; Mallat, Ziad] Univ Cambridge, Div Cardiovasc Med, Cambridge, England; [Scott, Ian C.] AstraZeneca, Early Resp & Immunol, Translat Sci & Expt Med, Biopharmaceut R&D, Cambridge, England; [Chiarugi, Davide] Wellcome MRC Inst Metab Sci Metab Res Labs, Cambridge, England; [Jugdaohsingh, Ravin] Univ Cambridge, Dept Vet Med, Cambridge, England; [Jolin, Helen E.; McKenzie, Andrew N. J.] MRC, Lab Mol Biol, Cambridge, England; [Chen, Xiao] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol, Wuhan, Hubei, Peoples R China; [Szymanska, Monika; Haraldsen, Guttorm] Oslo Univ Hosp, Dept Pathol, Rikshosp, Oslo, Norway; [Palmer, Gaby] Univ Hosp Geneva, Dept Internal Med Specialties, Div Rheumatol, Geneva, Switzerland; [Palmer, Gaby] Univ Geneva, Dept Pathol Immunol, Sch Med, Geneva, Switzerland; [Fallon, Padraic G.] Trinity Coll Dublin, Sch Med, Trinity Biomed Sci Inst, Dublin 2, Ireland; [Cohen, E. Suzanne] AstraZeneca, BioPharmaceut R&D, Biosci Asthma Early Resp & Immunol, Cambridge, England; [Mallat, Ziad] INSERM, Paris Cardiovasc Res Ctr, Paris, France	University of Cambridge; AstraZeneca; University of Cambridge; MRC Laboratory Molecular Biology; Huazhong University of Science & Technology; University of Oslo; National Hospital Norway; University of Geneva; University of Geneva; Trinity College Dublin; AstraZeneca; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Mallat, Z (corresponding author), Univ Cambridge, Div Cardiovasc Med, Cambridge, England.; Mallat, Z (corresponding author), INSERM, Paris Cardiovasc Res Ctr, Paris, France.	zm255@medschl.cam.ac.uk	CLEMENT, Marc/GVS-8052-2022; Mallat, Ziad/D-4041-2012; palmer, gaby/AAA-7117-2021; Fallon, Padraic/Y-2711-2019	CLEMENT, Marc/0000-0002-6479-8360; Mallat, Ziad/0000-0003-0443-7878; palmer, gaby/0000-0001-7567-1798; Fallon, Padraic/0000-0002-8401-7293; Chiarugi, Davide/0000-0003-2752-3189; Haraldsen, Guttorm/0000-0002-0064-9665	British Heart Foundation [CH/10/001/27642, RG/15/11/31593, PG/17/9/32834]; Inserm; Science Foundation Ireland; MRC [MC_U105178805, MR/R005699/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Z.M. is supported by a British Heart Foundation professorship and grants (CH/10/001/27642, RG/15/11/31593, and PG/17/9/32834), and by Inserm. P.G.F. is supported by Science Foundation Ireland. We would like to thank Kenneth Murphy, Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, MO, USA, for providing the Spicigfp/igfp reporter mouse strain, and for discussing the results of the manuscript. We acknowledge A. Petrunkina and colleagues in the Phenotyping Hub of the Department of Medicine (University of Cambridge) for their help in flow cytometry and sorting, and the Genomics and Transcriptomics Core and Bioinformatics and Biostatistics (Bio2) Core Facility of the Wellcome-MRC IMS-MRL for help in library preparation and support provided for data analysis, respectively. We thank Keith Burling at the Core Biochemical Assay Laboratory, Addenbrooke's Hospital, Cambridge, UK, for help in determination of IL-33 in plasma and red blood cell lysates. We thank Helen Killick, Translational Sciences and Experimental Medicine, Early Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK, for experimental support on detection of IL-33 in red blood cells.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Amit I, 2016, NAT IMMUNOL, V17, P18, DOI 10.1038/ni.3325; Andersson P, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122375; Bosurgi L, 2017, SCIENCE, V356, P1072, DOI 10.1126/science.aai8132; Bresnick EH, 2010, J BIOL CHEM, V285, P31087, DOI 10.1074/jbc.R110.159079; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cayrol C, 2018, NAT IMMUNOL, V19, P375, DOI 10.1038/s41590-018-0067-5; Cayrol C, 2018, IMMUNOL REV, V281, P154, DOI 10.1111/imr.12619; Chou ST, 2009, BLOOD, V114, P983, DOI 10.1182/blood-2009-03-207944; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; da Silva HB, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00480; Enders M, 2020, J IMMUNOL, V204, P87, DOI 10.4049/jimmunol.1900021; Gao X, 2013, J EXP MED, V210, P2833, DOI 10.1084/jem.20130733; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Guilliams M, 2013, J EXP MED, V210, P1977, DOI 10.1084/jem.20131199; Haldar M, 2014, CELL, V156, P1223, DOI 10.1016/j.cell.2014.01.069; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Howangyin KY, 2016, CIRCULATION, V133, P826, DOI 10.1161/CIRCULATIONAHA.115.020857; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Johnson KD, 2012, J CLIN INVEST, V122, P3692, DOI 10.1172/JCI61623; Karsten E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21387-w; Kearley J, 2015, IMMUNITY, V42, P566, DOI 10.1016/j.immuni.2015.02.011; Kitajima K, 2006, BLOOD, V107, P1857, DOI 10.1182/blood-2005-06-2527; Kiyomiya H, 2015, BIOCHEM BIOPH RES CO, V460, P320, DOI 10.1016/j.bbrc.2015.03.033; Koulnis M, 2011, JOVE-J VIS EXP, DOI 10.3791/2809; Kurotaki D, 2015, MICROBIOL IMMUNOL, V59, P55, DOI 10.1111/1348-0421.12228; Lefrancais E, 2014, P NATL ACAD SCI USA, V111, P15502, DOI 10.1073/pnas.1410700111; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; Linnemann AK, 2011, P NATL ACAD SCI USA, V108, P13641, DOI 10.1073/pnas.1108440108; Lopez-Yrigoyen M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08705-0; Ma WX, 2014, NAT PROTOC, V9, P1428, DOI 10.1038/nprot.2014.083; Marampon F, 2009, MOL CANCER THER, V8, P543, DOI 10.1158/1535-7163.MCT-08-0570; Mass E, 2016, SCIENCE, V353, DOI 10.1126/science.aaf4238; McLaren JE, 2010, J IMMUNOL, V185, P1222, DOI 10.4049/jimmunol.1000520; Minutti CM, 2017, SCIENCE, V356, P1076, DOI 10.1126/science.aaj2067; Nandakumar SK, 2015, EXP HEMATOL, V43, P565, DOI 10.1016/j.exphem.2015.04.002; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Pinto SM, 2015, PROTEOMICS, V15, P532, DOI 10.1002/pmic.201400303; Scott CL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10321; Scott IC, 2018, BIOCHEM SOC T, V46, P1345, DOI 10.1042/BST20170567; Scott IC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21589-2; Takeda T, 2016, J ALLERGY CLIN IMMUN, V138, P1395, DOI 10.1016/j.jaci.2016.01.032; Tanimura N, 2016, EMBO REP, V17, P249, DOI 10.15252/embr.201541465; Theurl I, 2016, NAT MED, V22, P945, DOI 10.1038/nm.4146; Vainchtein ID, 2018, SCIENCE, V359, P1269, DOI 10.1126/science.aal3589; Velickovic M, 2015, J ENDODONT, V41, P369, DOI 10.1016/j.joen.2014.11.017; Wang YM, 2012, NAT IMMUNOL, V13, P753, DOI 10.1038/ni.2360; Wei JX, 2015, J INVEST MED, V63, P806, DOI 10.1097/JIM.0000000000000213; Xiao X, 2017, ANNU REV NUTR, V37, P103, DOI 10.1146/annurev-nutr-071816-064559; Zaiss MM, 2011, J IMMUNOL, V186, P6097, DOI 10.4049/jimmunol.1003487	52	14	15	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					782	+		10.1016/j.immuni.2020.03.006	http://dx.doi.org/10.1016/j.immuni.2020.03.006			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32272082	Green Published, hybrid, Green Submitted			2022-12-18	WOS:000535371100012
J	Chng, MHY; Lim, MQ; Rouers, A; Becht, E; Lee, B; MacAry, PA; Lye, DC; Leo, YS; Chen, JM; Fink, K; Rivino, L; Newell, EW				Chng, Melissa Hui Yen; Lim, Mei Qiu; Rouers, Angeline; Becht, Etienne; Lee, Bernett; MacAry, Paul A.; Lye, David Chien; Leo, Yee Sin; Chen, Jinmiao; Fink, Katja; Rivino, Laura; Newell, Evan W.			Large-Scale HLA Tetramer Tracking of T Cells during Dengue Infection Reveals Broad Acute Activation and Differentiation into Two Memory Cell Fates	IMMUNITY			English	Article							HEMORRHAGIC-FEVER; IMMUNE-RESPONSES; VIRUS-INFECTION; EXPRESSION; EFFECTOR; CD4(+); LYMPHOCYTES; BLOOD; CHILDREN; RECEPTOR	T cells play important multifaceted roles during dengue infection, and understanding their responses is important for defining correlates of protective immunity and identifying effective vaccine antigens. Using mass cytometry and a highly multiplexed peptide-HLA (human leukocyte antigen) tetramer staining strategy, we probed T cells from dengue patients-a total of 430 dengue and control candidate epitopes-together with key markers of activation, trafficking, and differentiation. During acute disease, dengue-specific CD8(+) T cells expressed a distinct profile of activation and trafficking receptors that distinguished them from non-dengue-specific T cells. During convalescence, dengue-specific T cells differentiated into two major cell fates, CD57(+) CD127(-) -resembling terminally differentiated senescent memory cells and CD127(+) CD57(-)-resembling proliferation-capable memory cells. Validation in an independent cohort showed that these subsets remained at elevated frequencies up to one year after infection. These analyses aid our understanding of the generation of T cell memory in dengue infection or vaccination.	[Chng, Melissa Hui Yen; Rouers, Angeline; Becht, Etienne; Lee, Bernett; Chen, Jinmiao; Fink, Katja; Newell, Evan W.] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore; [Lim, Mei Qiu; Rivino, Laura] Duke NUS Med Sch, Emerging Infect Dis Programme, Singapore 169857, Singapore; [MacAry, Paul A.] Natl Univ Singapore, Life Sci Inst, Dept Microbiol & Immunol, Immunol Programme, Singapore 117456, Singapore; [Lye, David Chien; Leo, Yee Sin] Natl Ctr Infect Dis, Singapore 308442, Singapore; [Lye, David Chien; Leo, Yee Sin] Tan Tock Seng Hosp, Singapore 308433, Singapore; [Lye, David Chien; Leo, Yee Sin] Lee Kong Chian Sch Med, Singapore 308232, Singapore; [Lye, David Chien; Leo, Yee Sin] Yong Loo Lin Sch Med, Singapore 119228, Singapore; [Leo, Yee Sin] Saw Swee Hock Sch Publ Hlth, Singapore 117549, Singapore; [Rivino, Laura] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Newell, Evan W.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; National University of Singapore; National Centre for Infectious Diseases Singapore; Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; University of Bristol; Fred Hutchinson Cancer Center	Newell, EW (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138648, Singapore.; Rivino, L (corresponding author), Duke NUS Med Sch, Emerging Infect Dis Programme, Singapore 169857, Singapore.; Rivino, L (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England.; Newell, EW (corresponding author), Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA.	laura.rivino@bristol.ac.uk; enewell@fredhutch.org	Chen, Jinmiao/ABE-5601-2021; Newell, Evan W/F-9711-2012; Lye, David/ABF-4402-2021; Fink, Katja/AAI-1881-2021; Rouers, Angeline/AAS-4485-2021	Newell, Evan W/0000-0002-2889-243X; Fink, Katja/0000-0002-3571-0390; Lye, David/0000-0003-0324-0205; Becht, Etienne/0000-0003-1859-9202; Rivino, Laura/0000-0001-6213-9794	SIgN immunomonitoring platform [BMRC IAF 311006, H16/99/b0/011]; SIgN immunomonitoring service platform [NRF2017_SISF09]; SIgN core funding; Singapore NMRC new investigator grant; NMRC Open Fund individual research grant; MSD International GmbH; Merck Sharp Dohme	SIgN immunomonitoring platform; SIgN immunomonitoring service platform; SIgN core funding; Singapore NMRC new investigator grant(National Medical Research Council, Singapore); NMRC Open Fund individual research grant; MSD International GmbH; Merck Sharp Dohme(Merck & Company)	The authors thank Dr. Brendon Hanson's team for HLA typing of patient samples. Wethank Loh ChiewYee, Chen Xiao Yang, Nicholas Ang, and Esther Mok for assistance in preparing reagents and performing experiments and Emmanuelle Kumaran for assistance in PBMC isolation. We also thank Alessandro Sette for providing some peptides used for preliminary analysis. This work was supported by the SIgN immunomonitoring platform (BMRC IAF 311006, BMRC #H16/99/b0/011), the SIgN immunomonitoring service platform (NRF2017_SISF09), and SIgN core funding (to E.W.N.); and a Singapore NMRC new investigator grant and NMRC Open Fund individual research grant (to L.R.). The LNA cohort study was funded by a grant from MSD International GmbH and Merck Sharp & Dohme. We would like to acknowledge the support from Bing Lim from MSD and Danilo Casimiro and Kalpit Vora from Merck in enabling this cohort study.	Aberle JH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140545; Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P639, DOI 10.1038/ni1467; Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633; Akondy RS, 2015, P NATL ACAD SCI USA, V112, P3050, DOI 10.1073/pnas.1500475112; Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903; Amir E.D., 2019, CYTOMETRY QUALITY CO; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Becht E, 2019, BIOINFORMATICS, V35, P301, DOI 10.1093/bioinformatics/bty491; Bengsch B, 2018, J IMMUNOL METHODS, V453, P3, DOI 10.1016/j.jim.2017.03.009; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Blom K, 2013, J IMMUNOL, V190, P2150, DOI 10.4049/jimmunol.1202234; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Cellerai C, 2010, J VIROL, V84, P3868, DOI 10.1128/JVI.02565-09; Chandele A, 2016, J VIROL, V90, P11259, DOI 10.1128/JVI.01424-16; Chattopadhyay PK, 2009, J LEUKOCYTE BIOL, V85, P88, DOI 10.1189/jlb.0208107; Cheng Y, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau6905; Conroy AL, 2015, INT J INFECT DIS, V40, P45, DOI 10.1016/j.ijid.2015.07.027; de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15; Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107; Finck R, 2013, CYTOM PART A, V83A, P483, DOI 10.1002/cyto.a.22271; Friberg H, 2011, SCI REP-UK, V1, DOI 10.1038/srep00051; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Green S, 1999, J INFECT DIS, V180, P1429, DOI 10.1086/315072; Gupta S, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004828; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; Her Z, 2017, J INFECT DIS, V215, P42, DOI 10.1093/infdis/jiw494; Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855; Huang JY, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/8403937; Ibegbu CC, 2005, J IMMUNOL, V174, P6088, DOI 10.4049/jimmunol.174.10.6088; James EA, 2013, J VIROL, V87, P12794, DOI 10.1128/JVI.01160-13; Jayaratne HE, 2018, IMMUNOLOGY, V154, P89, DOI 10.1111/imm.12863; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Keawvichit R, 2018, IMMUNOLOGY, V153, P455, DOI 10.1111/imm.12858; Kunicki MA, 2018, J IMMUNOL, V200, P336, DOI 10.4049/jimmunol.1701025; Le Priol Y, 2006, J IMMUNOL, V177, P5145, DOI 10.4049/jimmunol.177.8.5145; Leong ML, 2015, METHODS MOL BIOL, V1346, P115, DOI 10.1007/978-1-4939-2987-0_9; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381; McInnes L., 2018, ARXIV180203426CSSTAT; Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011; Metzemaekers M, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01970; Miller JD, 2008, IMMUNITY, V28, P710, DOI 10.1016/j.immuni.2008.02.020; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821; Napolitani G, 2018, NAT IMMUNOL, V19, P742, DOI 10.1038/s41590-018-0133-z; Newell EW, 2013, NAT BIOTECHNOL, V31, P623, DOI 10.1038/nbt.2593; Nguyen TPD, 2010, J IMMUNOL, V184, P7281, DOI 10.4049/jimmunol.0903262; Paquin-Proulx D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006154; Paul S, 2013, J IMMUNOL, V191, P5831, DOI 10.4049/jimmunol.1302101; Petitdemange C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004499; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Ramachandiran V, 2007, J IMMUNOL METHODS, V319, P13, DOI 10.1016/j.jim.2006.08.014; Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215; Rivino L, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0526; Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Simmons CP, 2005, J VIROL, V79, P5665, DOI 10.1128/JVI.79.9.5665-5675.2005; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820; St John AL, 2019, NAT REV IMMUNOL, V19, P218, DOI 10.1038/s41577-019-0123-x; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Tian Y, 2019, J CLIN INVEST, V129, P1727, DOI 10.1172/JCI123726; Tian Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01728-5; Townsley E, 2014, IMMUNOLOGY, V141, P27, DOI 10.1111/imm.12161; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Tsai CY, 2015, J IMMUNOL, V194, P3890, DOI 10.4049/jimmunol.1303343; van Leeuwen EMM, 2005, BLOOD, V106, P2091, DOI 10.1182/blood-2005-02-0449; van Wilgenburg B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11653; Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048; Vermijlen D, 2018, SEMIN CELL DEV BIOL, V84, P75, DOI 10.1016/j.semcdb.2017.10.009; Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006; Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112; Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110; WELLS RA, 1980, INFECT IMMUN, V28, P428; Wong MT, 2015, CELL REP, V11, P1822, DOI 10.1016/j.celrep.2015.05.022; Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Zaunders JJ, 2005, BLOOD, V106, P1660, DOI 10.1182/blood-2005-01-0206	81	14	14	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 17	2019	51	6					1119	+		10.1016/j.immuni.2019.10.007	http://dx.doi.org/10.1016/j.immuni.2019.10.007			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JW6ME	31757672	Bronze, Green Accepted			2022-12-18	WOS:000503162900016
J	Fernandez-Ruiz, D; Ng, WY; Holz, LE; Ma, JZ; Zaid, A; Wong, YC; Lau, LS; Mollard, V; Cozijnsen, A; Collins, N; Li, J; Davey, GM; Kato, Y; Devi, S; Skandari, R; Pauley, M; Manton, JH; Godfrey, DI; Braun, A; Tay, SS; Tan, PS; Bowen, DG; Koch-Nolte, F; Rissiek, B; Carbone, FR; Crabb, BS; Lahoud, M; Cockburn, IA; Mueller, SN; Bertolino, P; McFadden, GI; Caminschi, I; Heath, WR				Fernandez-Ruiz, Daniel; Ng, Wei Yi; Holz, Lauren E.; Ma, Joel Z.; Zaid, Ali; Wong, Yik Chun; Lau, Lei Shong; Mollard, Vanessa; Cozijnsen, Anton; Collins, Nicholas; Li, Jessica; Davey, Gayle M.; Kato, Yu; Devi, Sapna; Skandari, Roghieh; Pauley, Michael; Manton, Jonathan H.; Godfrey, Dale I.; Braun, Asolina; Tay, Szun Szun; Tan, Peck Szee; Bowen, David G.; Koch-Nolte, Friedrich; Rissiek, Bjorn; Carbone, Francis R.; Crabb, Brendan S.; Lahoud, Mireille; Cockburn, Ian A.; Mueller, Scott N.; Bertolino, Patrick; McFadden, Geoffrey I.; Caminschi, Irina; Heath, William R.			Liver-Resident Memory CD8(+) T Cells Form a Front-Line Defense against Malaria Liver-Stage Infection (vol 45, pg 889, 2016)	IMMUNITY			English	Correction												irina.caminschi@monash.edu.au; wrheath@unimelb.edu.au	Rissiek, Björn/J-4252-2019; Carbone, Francis/ABF-2141-2020	Rissiek, Björn/0000-0001-5327-5479; Bertolino, Patrick/0000-0001-8244-7057; Devi, Sapna/0000-0003-4714-6018; Heath, William/0000-0001-9670-259X; Zaid, Ali/0000-0002-2528-2783				Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011	1	14	14	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					780	780		10.1016/j.immuni.2019.09.019	http://dx.doi.org/10.1016/j.immuni.2019.09.019			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31618655	Bronze			2022-12-18	WOS:000490141700021
J	Kurachi, M; Ngiow, SF; Kurachi, J; Chen, ZY; Wherry, EJ				Kurachi, Makoto; Ngiow, Shin Foong; Kurachi, Junko; Chen, Zeyu; Wherry, E. John			Hidden Caveat of Inducible Cre Recombinase	IMMUNITY			English	Letter									[Kurachi, Makoto; Ngiow, Shin Foong; Kurachi, Junko; Chen, Zeyu; Wherry, E. John] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Kurachi, Makoto; Ngiow, Shin Foong; Kurachi, Junko; Chen, Zeyu; Wherry, E. John] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Kurachi, Makoto; Kurachi, Junko] Kanazawa Univ, Grad Sch Med, Dept Mol Genet, Kanazawa, Ishikawa 9201192, Japan	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Kanazawa University	Wherry, EJ (corresponding author), Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA.	wherry@pennmedicine.upenn.edu	Chen, Zeyu/HGE-0239-2022; Wherry, John/ABI-1280-2020		NIH [AI105343, AI117950, AI082630, AI112521, AI115712, AI108545, CA210944]; Stand Up to Cancer; Parker Institute for Cancer Immunotherapy at University of Pennsylvania	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stand Up to Cancer; Parker Institute for Cancer Immunotherapy at University of Pennsylvania	This work was supported by NIH grants (AI105343, AI117950, AI082630, AI112521, AI115712, AI108545, CA210944) and Stand Up to Cancer to E.J.W.; E.J.W. is supported by the Parker Institute for Cancer Immunotherapy, which supports the cancer immunology program at University of Pennsylvania.	Becher B, 2018, IMMUNITY, V48, P835, DOI 10.1016/j.immuni.2018.05.002; Higashi AY, 2009, J IMMUNOL, V182, P5633, DOI 10.4049/jimmunol.0802413; Janbandhu VC, 2014, CELL CYCLE, V13, P462, DOI 10.4161/cc.27271; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Schmidt-Supprian M, 2007, NAT IMMUNOL, V8, P665, DOI 10.1038/ni0707-665	5	14	16	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 15	2019	51	4					591	592		10.1016/j.immuni.2019.09.010	http://dx.doi.org/10.1016/j.immuni.2019.09.010			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD7DP	31618646	Bronze			2022-12-18	WOS:000490141700001
J	Simoni, Y; Fehlings, M; Kloverpris, HN; McGovern, N; Koo, SL; Loh, CY; Lim, S; Kurioka, A; Fergusson, JR; Tang, CL; Kam, MH; Dennis, K; Lim, TKH; Fui, ACY; Hoong, CW; Chan, JKY; de Lafaille, MC; Narayanan, S; Baig, S; Shabeer, M; Toh, SAES; Tan, HKK; Anicete, R; Tan, EH; Takano, A; Klenerman, P; Leslie, A; Tan, DSW; Tan, IB; Ginhoux, F; Newell, EW				Simoni, Yannick; Fehlings, Michael; Kloverpris, Henrik N.; McGovern, Naomi; Koo, Si-Lin; Loh, Chiew Yee; Lim, Shawn; Kurioka, Ayako; Fergusson, Joannah R.; Tang, Choong-Leong; Kam, Ming Hian; Dennis, Koh; Lim, Tony Kiat Hon; Fui, Alexander Chung Yaw; Hoong, Chan Weng; Chan, Jerry Kok Yen; de Lafaille, Maria Curotto; Narayanan, Sriram; Baig, Sonia; Shabeer, Muhammad; Toh, Sue-Anne Ee Shiow; Tan, Henry Kun Kiaang; Anicete, Rosslyn; Tan, Eng-Huat; Takano, Angela; Klenerman, Paul; Leslie, Alasdair; Tan, Daniel S. W.; Tan, Iain Beehuat; Ginhoux, Florent; Newell, Evan W.			Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency (vol 46, pg 148, 2017)	IMMUNITY			English	Correction												yannick_simoni@immunol.a-star.edu.sg; evan_newell@immunol.a-star.edu.sg	Newell, Evan W/F-9711-2012	Newell, Evan W/0000-0002-2889-243X; Koo, Si-Lin/0000-0002-8217-3321; leslie, alasdair/0000-0003-2538-6467; SIMONI, Yannick/0000-0002-9086-3680	Wellcome Trust [109965/Z/15/Z] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005	1	14	14	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2018	48	5					1060	1060		10.1016/j.immuni.2018.04.028	http://dx.doi.org/10.1016/j.immuni.2018.04.028			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG1ZI	29768165	Bronze, Green Submitted			2022-12-18	WOS:000432488600023
J	Roan, F; Ziegler, SF				Roan, Florence; Ziegler, Steven F.			Human Group 1 Innate Lymphocytes Are Negative for Surface CD3 epsilon but Express CD5	IMMUNITY			English	Letter							CELLS; HETEROGENEITY		[Roan, Florence; Ziegler, Steven F.] Benaroya Res Inst, Immunol Program, Seattle, WA 98101 USA; [Ziegler, Steven F.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	Benaroya Research Institute; University of Washington; University of Washington Seattle	Ziegler, SF (corresponding author), Benaroya Res Inst, Immunol Program, Seattle, WA 98101 USA.; Ziegler, SF (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	sziegler@benaroyaresearch.org			NCI NIH HHS [R01 CA182783] Funding Source: Medline; NIAID NIH HHS [R01 AI068731, R01 AI124220] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA182783] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068731, R01AI124220] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bekiaris V, 2013, J IMMUNOL, V191, P4611, DOI 10.4049/jimmunol.1301672; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Ettersperger J, 2016, IMMUNITY, V45, P610, DOI 10.1016/j.immuni.2016.07.018; Roan F, 2016, J IMMUNOL, V196, P2051, DOI 10.4049/jimmunol.1501491; Simoni Y, 2017, IMMUNITY, V46, P148, DOI 10.1016/j.immuni.2016.11.005; Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553; Zhang CY, 2016, IMMUNITY, V44, P913, DOI 10.1016/j.immuni.2016.04.003	8	14	15	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					758	759		10.1016/j.immuni.2017.04.024	http://dx.doi.org/10.1016/j.immuni.2017.04.024			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514677	Green Accepted, Bronze			2022-12-18	WOS:000401316300006
J	Abken, H				Abken, Hinrich			Costimulation Engages the Gear in Driving CARs	IMMUNITY			English	Editorial Material							CHIMERIC ANTIGEN RECEPTORS; REDIRECTED T-CELLS; EFFICACY	In this issue of Immunity, Kawalekar et al. (2016) find that costimulation by a chimeric antigen receptor (CAR) can control T cell metabolism and balance the response toward long-lived memory or short-lived effector cells. The results provide a rationale of how to tune cancer immunotherapy more effectively in a hostile tumor environment.	[Abken, Hinrich] Univ Cologne, Ctr Mol Med Cologne, Robert Koch Str 21, D-50931 Cologne, Germany; [Abken, Hinrich] Univ Hosp Cologne, Dept Internal Med 1, Robert Koch Str 21, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Abken, H (corresponding author), Univ Cologne, Ctr Mol Med Cologne, Robert Koch Str 21, D-50931 Cologne, Germany.; Abken, H (corresponding author), Univ Hosp Cologne, Dept Internal Med 1, Robert Koch Str 21, D-50931 Cologne, Germany.	hinrich.abken@uk-koeln.de						Guedan S, 2014, BLOOD, V124, P1070, DOI 10.1182/blood-2013-10-535245; Hombach AA, 2013, HUM GENE THER, V24, P259, DOI 10.1089/hum.2012.247; Kawalekar OU, 2016, IMMUNITY, V44, P380, DOI 10.1016/j.immuni.2016.01.021; Kofler DM, 2011, MOL THER, V19, P760, DOI 10.1038/mt.2011.9; Ligtenberg MA, 2016, J IMMUNOL, V196, P759, DOI 10.4049/jimmunol.1401710; Long AH, 2015, NAT MED, V21, P581, DOI 10.1038/nm.3838; Textor A, 2014, CANCER RES, V74, P6796, DOI 10.1158/0008-5472.CAN-14-0079; Zhang TF, 2015, ONCOTARGET, V6, P33961, DOI 10.18632/oncotarget.5582; Zhao ZG, 2015, CANCER CELL, V28, P415, DOI 10.1016/j.ccell.2015.09.004	9	14	15	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 16	2016	44	2					214	216		10.1016/j.immuni.2016.02.001	http://dx.doi.org/10.1016/j.immuni.2016.02.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DE0DC	26885852	Bronze			2022-12-18	WOS:000370294000004
J	Ernst, M; Putoczki, T				Ernst, Matthias; Putoczki, Tracy			IL-17 Cuts to the Chase in Colon Cancer	IMMUNITY			English	Editorial Material							TUMORIGENESIS; RECEPTOR; COLITIS		[Ernst, Matthias; Putoczki, Tracy] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Ernst, Matthias; Putoczki, Tracy] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Walter & Eliza Hall Institute; University of Melbourne	Ernst, M (corresponding author), Olivia Newton John Canc Res Inst, 145-163 Studley Rd, Heidelberg, Vic 3084, Australia.	matthias.ernst@onjcri.org.au; tracy.putoczki@wehi.edu.au	Ernst, Matthias/D-5111-2012	Ernst, Matthias/0000-0002-6399-1177				Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Hyun YS, 2012, CARCINOGENESIS, V33, P931, DOI 10.1093/carcin/bgs106; Martin-Orozco N, 2009, IMMUNITY, V31, P787, DOI 10.1016/j.immuni.2009.09.014; Ogawa A, 2004, CLIN IMMUNOL, V110, P55, DOI 10.1016/j.clim.2003.09.013; Phesse TJ, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005411; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Wang KP, 2014, IMMUNITY, V41, P1052, DOI 10.1016/j.immuni.2014.11.009; Wu SG, 2009, NAT MED, V15, P1016, DOI 10.1038/nm.2015; Yang B, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/623759	10	14	14	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2014	41	6					880	882		10.1016/j.immuni.2014.12.004	http://dx.doi.org/10.1016/j.immuni.2014.12.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AX0PM	25526302	Bronze			2022-12-18	WOS:000346654100006
J	Haase, H				Haase, Hajo			An Element of Life: Competition for Zinc in Host-Pathogen Interaction	IMMUNITY			English	Editorial Material							SIGNALING PATHWAYS; IMMUNITY	Zinc homeostasis plays a plethora of different roles in the immune response. In this issue of Immunity, Vignesh et al. (2013) demonstrate that stimulation of macrophages with GM-CSF deprives intracellular Histoplasma capsulatum of zinc, improving pathogen clearance.	Rhein Westfal TH Aachen, Fac Med, Inst Immunol, D-52074 Aachen, Germany	RWTH Aachen University	Haase, H (corresponding author), Rhein Westfal TH Aachen, Fac Med, Inst Immunol, D-52074 Aachen, Germany.	hhaase@ukaachen.de	Haase, Hajo/B-9280-2009	Haase, Hajo/0000-0002-1622-8718				Botella H, 2012, TRENDS MICROBIOL, V20, P106, DOI 10.1016/j.tim.2012.01.005; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Haase H, 2009, ANNU REV NUTR, V29, P133, DOI 10.1146/annurev-nutr-080508-141119; Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kitamura H, 2006, NAT IMMUNOL, V7, P971, DOI 10.1038/ni1373; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Maret W, 2006, ANTIOXID REDOX SIGN, V8, P1419, DOI 10.1089/ars.2006.8.1419; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; Vignesh KS, 2013, IMMUNITY, V39, P697, DOI 10.1016/j.immuni.2013.09.006	10	14	15	1	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2013	39	4					623	624		10.1016/j.immuni.2013.09.009	http://dx.doi.org/10.1016/j.immuni.2013.09.009			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UP	24138875	Bronze			2022-12-18	WOS:000330950000001
J	Kanneganti, TD; Lamkanfi, M				Kanneganti, Thirumala-Devi; Lamkanfi, Mohamed			K+ Drops Tilt the NLRP3 Inflammasome	IMMUNITY			English	Editorial Material							NALP3 INFLAMMASOME; ACTIVATION; DEUBIQUITINATION		[Kanneganti, Thirumala-Devi] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Lamkanfi, Mohamed] VIB, Dept Med Prot Res, B-9000 Ghent, Belgium; [Lamkanfi, Mohamed] Univ Ghent, Dept Biochem, B-9000 Ghent, Belgium	St Jude Children's Research Hospital; Flanders Institute for Biotechnology (VIB); Ghent University	Lamkanfi, M (corresponding author), VIB, Dept Med Prot Res, B-9000 Ghent, Belgium.	mohamed.lamkanfi@vib-ugent.be	Kanneganti, Thirumala-Devi/M-9435-2018; Kanneganti, Thirumala-Devi/Y-2503-2019	Kanneganti, Thirumala-Devi/0000-0002-6395-6443; Kanneganti, Thirumala-Devi/0000-0002-6395-6443				Bauernfeind F, 2011, J IMMUNOL, V187, P613, DOI 10.4049/jimmunol.1100613; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; Jin CC, 2011, P NATL ACAD SCI USA, V108, P14867, DOI 10.1073/pnas.1111101108; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Lamkanfi M, 2012, ANNU REV CELL DEV BI, V28, P137, DOI 10.1146/annurev-cellbio-101011-155745; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Schorn C, 2011, J BIOL CHEM, V286, P35, DOI 10.1074/jbc.M110.139048	9	14	15	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 27	2013	38	6					1085	1088		10.1016/j.immuni.2013.06.001	http://dx.doi.org/10.1016/j.immuni.2013.06.001			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TR	23809157	Bronze			2022-12-18	WOS:000330947500003
J	Maloy, KJ; Uhlig, HH				Maloy, Kevin J.; Uhlig, Holm H.			ILC1 Populations Join the Border Patrol	IMMUNITY			English	Editorial Material							INNATE LYMPHOID-CELLS; PATHOLOGY; INSIGHTS; DISEASE	It has been unclear whether an innate lymphoid cell (ILC) counterpart to the T helper 1 cell type exists. New studies, including Fuchs et al. (2013) in this issue of Immunity, identify T-bet(+)IFN-gamma(+) ILC1 that accumulate in the inflamed intestine of IBD patients.	[Maloy, Kevin J.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Uhlig, Holm H.] John Radcliffe Hosp, Nuffield Dept Clin Med, Translat Gastroenterol Unit, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Maloy, KJ (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	kevin.maloy@path.ox.ac.uk; holm.uhlig@ndm.ox.ac.uk		Maloy, Kevin/0000-0001-5795-7688; Uhlig, Holm/0000-0002-6111-7355	Wellcome Trust [086354] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abadie V, 2011, ANNU REV IMMUNOL, V29, P493, DOI 10.1146/annurev-immunol-040210-092915; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Fuchs A, 2013, IMMUNITY, V38, P769, DOI 10.1016/j.immuni.2013.02.010; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Reinisch W, 2010, INFLAMM BOWEL DIS, V16, P233, DOI 10.1002/ibd.21038; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Spits H, 2012, ANNU REV IMMUNOL, V30, P647, DOI 10.1146/annurev-immunol-020711-075053; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017	10	14	18	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					630	632		10.1016/j.immuni.2013.03.005	http://dx.doi.org/10.1016/j.immuni.2013.03.005			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23601681	Bronze			2022-12-18	WOS:000330942100006
J	Rathmell, JC				Rathmell, Jeffrey C.			T Cell Myc-tabolism	IMMUNITY			English	Editorial Material							ACTIVATION		Duke Univ, Dept Immunol, Dept Pharmacol & Canc Biol, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA	Duke University	Rathmell, JC (corresponding author), Duke Univ, Dept Immunol, Dept Pharmacol & Canc Biol, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA.	jeff.rathmell@duke.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108006] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL108006-01, R01 HL108006] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Dang CV, 2009, CLIN CANCER RES, V15, P6479, DOI 10.1158/1078-0432.CCR-09-0889; Douglas NC, 2001, NAT IMMUNOL, V2, P307, DOI 10.1038/86308; Gatza E, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001975; Jacobs SR, 2008, J IMMUNOL, V180, P4476, DOI 10.4049/jimmunol.180.7.4476; Michalek RD, 2011, P NATL ACAD SCI USA, V108, P18348, DOI 10.1073/pnas.1108856108; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021	10	14	14	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 23	2011	35	6					845	846		10.1016/j.immuni.2011.12.001	http://dx.doi.org/10.1016/j.immuni.2011.12.001			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	871ZX	22195738	Green Accepted, Bronze			2022-12-18	WOS:000298777300001
J	Blankson, JN; Siliciano, RF				Blankson, Joel N.; Siliciano, Robert F.			Elite Suppression of HIV-1 Replication	IMMUNITY			English	Editorial Material								Rare HIV-1-infected individuals are able to control viral replication without antiretroviral therapy. In this issue of Immunity, Migueles et al. (2008) show that HIV-1-specific CD8(+) T cells from these individuals effectively suppress viral replication by granzyme B-mediated killing of target cells.	[Blankson, Joel N.; Siliciano, Robert F.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Siliciano, Robert F.] Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute	Siliciano, RF (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA.	rsilici1@jhmi.edu						Bailey JR, 2008, J VIROL, V82, P7395, DOI 10.1128/JVI.00800-08; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104	10	14	15	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 19	2008	29	6					845	847		10.1016/j.immuni.2008.12.002	http://dx.doi.org/10.1016/j.immuni.2008.12.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	388IB	19100698	Bronze			2022-12-18	WOS:000262012400005
J	Peter, ME				Peter, Marcus E.			ROS eliminate danger	IMMUNITY			English	Editorial Material							CHROMATIN PROTEIN HMGB1; DENDRITIC CELLS; APOPTOSIS; TRANSPORT; RELEASE; DEATH		Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Chicago	Peter, ME (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	mpeter@uchicago.edu		Peter, Marcus Ernst/0000-0003-3216-036X				Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Ferguson TA, 2002, J IMMUNOL, V168, P5589, DOI 10.4049/jimmunol.168.11.5589; Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Griffith TS, 1996, IMMUNITY, V5, P7, DOI 10.1016/S1074-7613(00)80305-2; Hoppe G, 2006, EXP CELL RES, V312, P3526, DOI 10.1016/j.yexcr.2006.07.020; Kazama H, 2008, IMMUNITY, V29, P21, DOI 10.1016/j.immuni.2008.05.013; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Tesniere A, 2008, CELL DEATH DIFFER, V15, P3, DOI 10.1038/sj.cdd.4402269	10	14	14	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 18	2008	29	1					1	2		10.1016/j.immuni.2008.06.006	http://dx.doi.org/10.1016/j.immuni.2008.06.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18631448	Bronze			2022-12-18	WOS:000257905400001
J	Kubo, M				Kubo, Masato			Notch: Filling a hole in T helper 2 cell differentiation	IMMUNITY			English	Editorial Material							T-CELLS; COMMITMENT; EXPRESSION	In this issue of Immunity, Arnsen et al. (2007) and Fang et al. (2007) propose a direct role for Notch signaling in the expression of GATA-3 transcription factor and T helper 2 cell differentiation.	RIKEN, Yokohama Inst, Res Ctr Allergy & Immunol, Lab Singal Network, Yokohama, Kanagawa 2300045, Japan	RIKEN	Kubo, M (corresponding author), RIKEN, Yokohama Inst, Res Ctr Allergy & Immunol, Lab Singal Network, Suehiro Cho 1-7-22, Yokohama, Kanagawa 2300045, Japan.	raysolfc@rcai.riken.jp	Kubo, Masato/A-5918-2016					Amsen D, 2004, CELL, V117, P515, DOI 10.1016/S0092-8674(04)00451-9; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Asnagli H, 2002, J IMMUNOL, V168, P4268, DOI 10.4049/jimmunol.168.9.4268; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Maekawa Y, 2003, IMMUNITY, V19, P549, DOI 10.1016/S1074-7613(03)00270-X; Minter LM, 2005, NAT IMMUNOL, V6, P680, DOI 10.1038/ni1209x; Ouyang WJ, 2000, IMMUNITY, V12, P27, DOI 10.1016/S1074-7613(00)80156-9; Tanaka S, 2006, IMMUNITY, V24, P689, DOI 10.1016/j.immuni.2006.04.009; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923	10	14	15	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2007	27	1					3	5		10.1016/j.immuni.2007.07.005	http://dx.doi.org/10.1016/j.immuni.2007.07.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	195FO	17663978	Bronze			2022-12-18	WOS:000248398100002
J	Hidalgo, A; Frenette, PS				Hidalgo, Andres; Frenette, Paul S.			Leukocyte podosornes sense their way through the endotheliurn	IMMUNITY			English	Editorial Material							NEUTROPHILS; ICAM-1; CELLS	Whether leukocytes can transmigrate through endothelial cells, rather than between them, is controversial. In this issue, Carman et al. (2007) demonstrate that lymphocytes can extend podosomes to palpate endothelial cells searching for areas permissive for transcellular diapedesis.	Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Frenette, PS (corresponding author), Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA.	paul.frenette@mssm.edu	Hidalgo, Andrés/L-5643-2014; Frenette, Paul S/J-8272-2012	Hidalgo, Andrés/0000-0001-5513-555X; Frenette, Paul S/0000-0003-0862-9922				Adami JG, 1909, INFLAMMATION; ARNOLD J, 1873, VIRCHOWS ARCH, V58, P203; Barreiro O, 2002, J CELL BIOL, V157, P1233, DOI 10.1083/jcb.200112126; Carman CV, 2007, IMMUNITY, V26, P784, DOI 10.1016/j.immuni.2007.04.015; Carman CV, 2004, J CELL BIOL, V167, P377, DOI 10.1083/jcb.200404129; Feng D, 1998, J EXP MED, V187, P903, DOI 10.1084/jem.187.6.903; Linder S, 2003, TRENDS CELL BIOL, V13, P376, DOI 10.1016/S0962-8924(03)00128-4; Millan J, 2006, NAT CELL BIOL, V8, P113, DOI 10.1038/ncb1356; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Wang SJ, 2006, J EXP MED, V203, P1519, DOI 10.1084/jem.20051210	10	14	14	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2007	26	6					753	755		10.1016/j.immuni.2007.06.002	http://dx.doi.org/10.1016/j.immuni.2007.06.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	184MX	17582348	Bronze			2022-12-18	WOS:000247646900010
J	Boggiano, C; Littman, DR				Boggiano, Cesar; Littman, Dan R.			HIV's vagina travelogue	IMMUNITY			English	Editorial Material							T-CELL DEPLETION; DENDRITIC CELLS; INFECTION	Details of how HIV-1 is transmitted across mucosal barriers remain sparse. In this issue of Immunity, Hladik et al. (2007) describe an organ culture system for imaging HIV-1 interaction with vaginal epithelial T cells and Langerhans cells early after infection.	NYU, Howard Hughes Med Inst, Skirball Inst Biomol Med, Sch Med, New York, NY 10016 USA	Howard Hughes Medical Institute; New York University	Littman, DR (corresponding author), NYU, Howard Hughes Med Inst, Skirball Inst Biomol Med, Sch Med, New York, NY 10016 USA.	littman@saturn.med.nyu.edu						Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; CAMERON PU, 1992, SCIENCE, V257, P383, DOI 10.1126/science.1352913; Cavrois M, 2007, PLOS PATHOG, V3, P38, DOI 10.1371/journal.ppat.0030004; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hladik F, 2007, IMMUNITY, V26, P257, DOI 10.1016/j.immuni.2007.01.007; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Pope M, 2003, NAT MED, V9, P847, DOI 10.1038/nm0703-847; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182	10	14	14	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2007	26	2					145	147		10.1016/j.immuni.2007.02.001	http://dx.doi.org/10.1016/j.immuni.2007.02.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	142DE	17307703	Bronze			2022-12-18	WOS:000244628600006
J	Burns, CE; Zon, LI				Burns, Caroline Erter; Zon, Leonard I.			Homing sweet homing: Odyssey of hematopoietic stem cells	IMMUNITY			English	Editorial Material									Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Dana Farber Canc Inst, Howard Hughes Med Inst,Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Burns, CE (corresponding author), Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.							Davidson AJ, 2004, ONCOGENE, V23, P7233, DOI 10.1038/sj.onc.1207943; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Gothert JR, 2005, BLOOD, V105, P2724, DOI 10.1182/blood-2004-08-3037; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Sasaki K, 2000, ARCH HISTOL CYTOL, V63, P137, DOI 10.1679/aohc.63.137; Turpen JB, 1997, IMMUNITY, V7, P325, DOI 10.1016/S1074-7613(00)80354-4	9	14	16	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2006	25	6					859	862		10.1016/j.immuni.2006.11.006	http://dx.doi.org/10.1016/j.immuni.2006.11.006			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17174927	Bronze			2022-12-18	WOS:000243087500003
J	Melchers, F				Melchers, Fritz			Anergic B cells caught in the act	IMMUNITY			English	Editorial Material							IMMATURE; LYMPHOCYTES; SELECTION; ANTIBODY; ANTIGEN		Max Planck Inst Infect Biol, Senior Res Grp Lymphocyte Dev, D-10117 Berlin, Germany; Univ Basel, Dept Cell Biol, Biozentrum, CH-4058 Basel, Switzerland	Max Planck Society; University of Basel	Melchers, F (corresponding author), Max Planck Inst Infect Biol, Senior Res Grp Lymphocyte Dev, D-10117 Berlin, Germany.							Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Gauld SB, 2005, NAT IMMUNOL, V6, P1160, DOI 10.1038/ni1256; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1111/j.1600-065X.2000.imr017510.x; Merrell KT, 2006, IMMUNITY, V25, P953, DOI 10.1016/j.immuni.2006.10.017; Nemazee D, 2000, J EXP MED, V191, P1813, DOI 10.1084/jem.191.11.1813; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NOSSAL GJV, 1980, P NATL ACAD SCI-BIOL, V77, P1602, DOI 10.1073/pnas.77.3.1602; Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q; Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907	10	14	14	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2006	25	6					864	867		10.1016/j.immuni.2006.11.003	http://dx.doi.org/10.1016/j.immuni.2006.11.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17174929	Bronze			2022-12-18	WOS:000243087500005
J	Santambrogio, L; Strominger, JL				Santambrogio, Laura; Strominger, Jack L.			The ins and outs of MHC class II proteins in dendritic cells	IMMUNITY			English	Editorial Material							EXPRESSION; CLATHRIN		Albert Einstein Coll Med, Dept Pathol, New York, NY 10461 USA; Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Yeshiva University; Harvard University	Santambrogio, L (corresponding author), Albert Einstein Coll Med, Dept Pathol, New York, NY 10461 USA.							Cella M, 1997, NATURE, V388, P782, DOI 10.1038/42030; Dugast M, 2005, J BIOL CHEM, V280, P19656, DOI 10.1074/jbc.M501357200; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; Landmann S, 2001, J EXP MED, V194, P379, DOI 10.1084/jem.194.4.379; McCormick PJ, 2005, P NATL ACAD SCI USA, V102, P7910, DOI 10.1073/pnas.0502206102; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Potolicchio H, 2005, J IMMUNOL, V175, P4935, DOI 10.4049/jimmunol.175.8.4935; Shin JS, 2006, NATURE, V444, P115, DOI 10.1038/nature05261; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Villadangos JA, 2001, IMMUNITY, V14, P739, DOI 10.1016/S1074-7613(01)00148-0; Wong SH, 2004, P NATL ACAD SCI USA, V101, P17783, DOI 10.1073/pnas.0408229102	11	14	14	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2006	25	6					857	859		10.1016/j.immuni.2006.11.007	http://dx.doi.org/10.1016/j.immuni.2006.11.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	120LY	17174926	Bronze			2022-12-18	WOS:000243087500002
J	Kronenberg, M; Kinjo, Y				Kronenberg, M; Kinjo, Y			Infection, autoimmunity, and glycolipids: T cells detect microbes through self-recognition	IMMUNITY			English	Editorial Material							NKT CELLS; CD1	De Libero et al. (2005) demonstrate in this issue of Immunity that bacterial infection leads to increased synthesis of autologous glycolipids that are recognized by CD1-restricted human T cells, indicating that recognition of inducible self-glycolipids could be a mechanism for microbial detection. This mechanism also may provide a connection between infection and autoimmunity.	La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA	La Jolla Institute for Immunology	Kronenberg, M (corresponding author), La Jolla Inst Allergy & Immunol, San Diego, CA 92121 USA.							Brigl M, 2003, NAT IMMUNOL, V4, P1230, DOI 10.1038/ni1002; Brigl M, 2004, ANNU REV IMMUNOL, V22, P817, DOI 10.1146/annurev.immunol.22.012703.104608; De Libero G, 2005, IMMUNITY, V22, P763, DOI 10.1016/j.immuni.2005.04.013; Jahng A, 2004, J EXP MED, V199, P947, DOI 10.1084/jem.20031389; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Mattner J, 2005, NATURE, V434, P525, DOI 10.1038/nature03408; PORCELLI SA, 1995, ADV IMMUNOL, V59, P1, DOI 10.1016/S0065-2776(08)60629-X; Shamshiev A, 1999, EUR J IMMUNOL, V29, P1667, DOI 10.1002/(SICI)1521-4141(199905)29:05<1667::AID-IMMU1667>3.0.CO;2-U; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	9	14	14	0	3	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUN	2005	22	6					657	659		10.1016/j.immuni.2005.06.001	http://dx.doi.org/10.1016/j.immuni.2005.06.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	940XX	15963780	Bronze			2022-12-18	WOS:000230180300003
J	Sun, TH; Clark, MR; Storb, U				Sun, TH; Clark, MR; Storb, U			A point mutation in the constant region of Ig lambda1 prevents normal B cell development due to defective BCR signaling	IMMUNITY			English	Article							INTRACELLULAR IONIZED CALCIUM; ANTIGEN-RECEPTOR; MONOCLONAL-ANTIBODIES; MOUSE STRAIN; IMMUNOGLOBULIN; GENE; REARRANGEMENT; MICE; ACTIVATION; KAPPA	Surface expression of B cell antigen receptors (BCRs) containing Ig and Igalpha/Igbeta generates signals required to transit discrete developmental checkpoints. The mechanism by which BCR components collaborate to initiate signals is still unclear. The expression of Iglambda1 in SJL mice is 50-fold lower than in other strains. Here, we demonstrate by gene targeting that a point mutation, which changes a glycine to a valine in the lambda1 constant region, is responsible for this defect. In vitro experiments show that Ig receptors bearing this mutation, while expressed normally, are deficient in signaling. These findings reveal a direct involvement of the Ig light chain (IgL) in B cell signaling and development beyond the requirement of light chains for BCR assembly.	Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; Univ Chicago, Dept Med, Rheumatol Sect, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Storb, U (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.				NATIONAL CANCER INSTITUTE [P30CA014599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039535] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052736] Funding Source: NIH RePORTER; NCI NIH HHS [CA 14599] Funding Source: Medline; NIAID NIH HHS [AI39535] Funding Source: Medline; NIGMS NIH HHS [GM52736] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARP B, 1982, NATURE, V298, P184, DOI 10.1038/298184a0; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; BOGEN B, 1989, SCAND J IMMUNOL, V29, P273, DOI 10.1111/j.1365-3083.1989.tb01125.x; BOUDINOT P, 1995, EUR J IMMUNOL, V25, P2499, DOI 10.1002/eji.1830250914; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; CHEN JZ, 1993, EMBO J, V12, P821, DOI 10.1002/j.1460-2075.1993.tb05722.x; Dammers PM, 1999, EUR J IMMUNOL, V29, P1522, DOI 10.1002/(SICI)1521-4141(199905)29:05<1522::AID-IMMU1522>3.0.CO;2-0; Engel H, 1999, EUR J IMMUNOL, V29, P2167, DOI 10.1002/(SICI)1521-4141(199907)29:07<2167::AID-IMMU2167>3.3.CO;2-8; EPSTEIN R, 1984, IMMUNOGENETICS, V19, P527, DOI 10.1007/BF00403444; EPSTEIN R, 1983, J EXP MED, V157, P1681, DOI 10.1084/jem.157.5.1681; EPSTEIN R, 1984, THESIS U CALIFORNIA; FINCH JT, 1973, P NATL ACAD SCI USA, V70, P718, DOI 10.1073/pnas.70.3.718; FLASWINKEL H, 1994, EMBO J, V13, P83, DOI 10.1002/j.1460-2075.1994.tb06237.x; GECKELER W, 1978, J EXP MED, V148, P1122, DOI 10.1084/jem.148.5.1122; GOROFF DK, 1991, J IMMUNOL, V146, P18; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; JU ST, 1986, J IMMUNOL, V136, P2684; JUNE CH, 1994, METHOD CELL BIOL, V41, P149; KIM JY, 1994, EMBO J, V13, P827, DOI 10.1002/j.1460-2075.1994.tb06325.x; KITAMURA D, 1992, CELL, V69, P823, DOI 10.1016/0092-8674(92)90293-L; KITAMURA D, 1991, NATURE, V350, P423, DOI 10.1038/350423a0; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; LOVE RA, 1993, BIOCHEMISTRY-US, V32, P10950, DOI 10.1021/bi00092a004; Makowska A, 1999, EUR J IMMUNOL, V29, P3285, DOI 10.1002/(SICI)1521-4141(199910)29:10<3285::AID-IMMU3285>3.3.CO;2-G; NOVAK EJ, 1994, CYTOMETRY, V17, P135, DOI 10.1002/cyto.990170205; Pillai S, 1999, IMMUNITY, V10, P493, DOI 10.1016/S1074-7613(00)80049-7; PLEIMAN CM, 1994, J IMMUNOL, V152, P2837; RETH M, 1987, EMBO J, V6, P3299, DOI 10.1002/j.1460-2075.1987.tb02649.x; Reth M, 2000, IMMUNOL REV, V176, P10; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Sleckman BP, 1996, ANNU REV IMMUNOL, V14, P459, DOI 10.1146/annurev.immunol.14.1.459; STORB U, 1989, MOL CELL BIOL, V9, P711, DOI 10.1128/MCB.9.2.711; Sun T, 2001, J EXP MED, V193, P699, DOI 10.1084/jem.193.6.699; Torres RM, 1996, SCIENCE, V272, P1804, DOI 10.1126/science.272.5269.1804; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; WEISS S, 1983, HYBRIDOMA, V2, P49, DOI 10.1089/hyb.1983.2.49; WEISS S, 1985, EUR J IMMUNOL, V15, P768, DOI 10.1002/eji.1830150806	38	14	14	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	FEB	2002	16	2					245	255		10.1016/S1074-7613(02)00270-4	http://dx.doi.org/10.1016/S1074-7613(02)00270-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	524YC	11869685	Bronze			2022-12-18	WOS:000174039600008
J	Simmons, WA; Roopenian, DC; Summerfield, SG; Jones, RC; Galocha, B; Christianson, GJ; Maika, SD; Zhou, M; Gaskell, SJ; Bordoli, RS; Ploegh, HL; Slaughter, CA; Lindahl, KF; Hammer, RE; Taurog, JD				Simmons, WA; Roopenian, DC; Summerfield, SG; Jones, RC; Galocha, B; Christianson, GJ; Maika, SD; Zhou, M; Gaskell, SJ; Bordoli, RS; Ploegh, HL; Slaughter, CA; Lindahl, KF; Hammer, RE; Taurog, JD			RETRACTED: A new MHC locus that influences class I peptide presentation (Retracted article. See vol 11, pg U9, 1999)	IMMUNITY			English	Article; Retracted Publication							MAJOR HISTOCOMPATIBILITY COMPLEX; ANTIGEN PRESENTATION; INFLAMMATORY DISEASE; LINKED TRANSPORTER; TRANSGENIC MICE; CELL-LINE; T-CELLS; RAT; TAP; MOUSE	We have investigated the HLA-B27-restricted CTL response to HY minor histocompatibility antigens in rats and mice transgenic for HLA-B27 and human beta 2-microglobulin. A polymorphism was found at a locus within the H2 complex, producing two distinct but overlapping sets of B27-presented HY peptides. The locus, named Cim2, mapped between the K and Pb loci, and its product is therefore distinct from TAP, LMP, and tapasin. Identical findings in rats and mice, including identical HY peptide sequences and the failure of a rat Tap2A transgene to alter CTL recognition, suggest that a homologous locus with similar polymorphism exists in the rat. Cim2, or a closely linked locus, was found to exert a broad effect on peptide loading of both HLA-B27 and mouse class I alleles. The data thus establish a strong, previously unrecognized MHC-encoded influence on the class I antigen pathway.	UNIV TEXAS, SW MED CTR, HAROLD C SIMMONS ARTHRIT RES CTR, DEPT INTERNAL MED, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, HOWARD HUGHES MED INST, DEPT BIOCHEM, DALLAS, TX 75235 USA; UNIV TEXAS, SW MED CTR, DEPT MICROBIOL, DALLAS, TX 75235 USA; JACKSON LAB, BAR HARBOR, ME 04609 USA; UMIST, DEPT CHEM, MANCHESTER M60 1QD, LANCS, ENGLAND; MIT, CTR CANC RES, CAMBRIDGE, MA 02139 USA; MICROMASS UK LTD, MANCHESTER M23 9LE, LANCS, ENGLAND	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Jackson Laboratory; University of Manchester; Massachusetts Institute of Technology (MIT)				Hammer, Robert E./0000-0001-5487-7551; Christianson, Gregory/0000-0001-5532-342X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI028802] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR038319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047692] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI28802] Funding Source: Medline; NIAMS NIH HHS [R01 AR38319] Funding Source: Medline; NIDDK NIH HHS [R01 DK47692] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CARTER CA, 1991, IMMUNOGENETICS, V33, P202, DOI 10.1007/BF01719242; CERUNDOLO V, 1995, EUR J IMMUNOL, V25, P554, DOI 10.1002/eji.1830250238; delaSalle H, 1997, J IMMUNOL, V158, P4555; DEVERSON EV, 1990, NATURE, V348, P738, DOI 10.1038/348738a0; FEHLING HJ, 1994, SCIENCE, V265, P1234, DOI 10.1126/science.8066463; Groettrup M, 1996, IMMUNOL TODAY, V17, P429, DOI 10.1016/0167-5699(96)10051-7; HAMMER RE, 1990, CELL, V63, P1099, DOI 10.1016/0092-8674(90)90512-D; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; HEEMELS MT, 1994, IMMUNITY, V1, P775, DOI 10.1016/S1074-7613(94)80019-7; HEEMELS MT, 1993, SCIENCE, V262, P2059, DOI 10.1126/science.8266106; HEEMELS MT, 1995, ANNU REV BIOCHEM, V64, P463, DOI 10.1146/annurev.bi.64.070195.002335; JOLY E, 1994, IMMUNOGENETICS, V40, P45, DOI 10.1007/BF00163963; KARLSSON L, 1992, J EXP MED, V176, P477, DOI 10.1084/jem.176.2.477; Klein J., 1986, NATURAL HIST MAJOR H; KLEIN J, 1989, GENETIC VARIANTS STR, P747; Koopmann JO, 1997, CURR OPIN IMMUNOL, V9, P80, DOI 10.1016/S0952-7915(97)80163-X; LEE DR, 1988, J EXP MED, V168, P1719, DOI 10.1084/jem.168.5.1719; Lehner PJ, 1996, CURR OPIN IMMUNOL, V8, P59, DOI 10.1016/S0952-7915(96)80106-3; LIVINGSTONE AM, 1991, IMMUNOGENETICS, V34, P157, DOI 10.1007/BF00205818; LIVINGSTONE AM, 1989, J EXP MED, V170, P777, DOI 10.1084/jem.170.3.777; LOPEZ D, 1994, EUR J IMMUNOL, V24, P1194, DOI 10.1002/eji.1830240528; Marusina K, 1997, J IMMUNOL, V158, P5251; MOMBURG F, 1994, NATURE, V367, P648, DOI 10.1038/367648a0; NAGATA T, 1995, IMMUNOGENETICS, V41, P83, DOI 10.1007/BF00182317; NEEFJES J, 1995, EUR J IMMUNOL, V25, P1133, DOI 10.1002/eji.1830250444; OBST R, 1995, EUR J IMMUNOL, V25, P2170, DOI 10.1002/eji.1830250808; Ortmann B, 1997, SCIENCE, V277, P1306, DOI 10.1126/science.277.5330.1306; OZATO K, 1980, J IMMUNOL, V125, P2473; PAZMANY L, 1992, J EXP MED, V175, P361, DOI 10.1084/jem.175.2.361; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; POULETTY C, 1994, HUM IMMUNOL, V40, P218, DOI 10.1016/0198-8859(94)90072-8; POWIS SJ, 1991, J EXP MED, V173, P913, DOI 10.1084/jem.173.4.913; POWIS SJ, 1991, NATURE, V354, P528, DOI 10.1038/354528a0; POWIS SJ, 1992, NATURE, V357, P211, DOI 10.1038/357211a0; Powis SJ, 1996, IMMUNITY, V4, P159, DOI 10.1016/S1074-7613(00)80680-9; RAMMENSEE HG, 1993, ANNU REV IMMUNOL, V11, P213, DOI 10.1146/annurev.iy.11.040193.001241; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; ROWLANDJONES SL, 1993, EUR J IMMUNOL, V23, P1999, DOI 10.1002/eji.1830230841; SACHS DH, 1979, J IMMUNOL, V123, P1965; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; SCHUMACHER TNM, 1994, P NATL ACAD SCI USA, V91, P13004, DOI 10.1073/pnas.91.26.13004; Simmons WA, 1997, J IMMUNOL, V159, P2750; Simmons WA, 1996, J IMMUNOL, V156, P1661; SIMMONS WA, 1993, IMMUNOGENETICS, V38, P351; TAUROG JD, 1988, J IMMUNOL, V141, P4020; TAUROG JD, 1993, J IMMUNOL, V150, P4168; TAUROG JD, 1990, TRANSGENIC MICE AND MUTANTS IN MHC RESEARCH, P268; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; UEMATSU Y, 1988, IMMUNOGENETICS, V27, P96, DOI 10.1007/BF00351082; VANENDERT PM, 1994, IMMUNITY, V1, P491, DOI 10.1016/1074-7613(94)90091-4; VANKAER L, 1992, CELL, V71, P1205, DOI 10.1016/S0092-8674(05)80068-6; VANKAER L, 1994, IMMUNITY, V1, P553; VANSANTEN HM, 1995, J EXP MED, V181, P787, DOI 10.1084/jem.181.2.787; Walter L, 1996, IMMUNOGENETICS, V44, P218, DOI 10.1007/BF02602588; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369	55	14	14	0	10	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	1074-7613			IMMUNITY	Immunity	NOV	1997	7	5					641	651		10.1016/S1074-7613(00)80385-4	http://dx.doi.org/10.1016/S1074-7613(00)80385-4			11	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YH554	9390688	Bronze			2022-12-18	WOS:A1997YH55400007
J	Kaplonek, P; Fischinger, S; Cizmeci, D; Bartsch, YC; Kang, J; Burke, JS; Shin, SA; Dayal, D; Martin, P; Mann, C; Amanat, F; Julg, B; Nilles, EJ; Musk, ER; Menon, AS; Krammer, F; Saphire, EO; Carfi, A; Alter, G				Kaplonek, Paulina; Fischinger, Stephanie; Cizmeci, Deniz; Bartsch, Yannic C.; Kang, Jaewon; Burke, John S.; Shin, Sally A.; Dayal, Diana; Martin, Patrick; Mann, Colin; Amanat, Fatima; Julg, Boris; Nilles, Eric J.; Musk, Elon R.; Menon, Anil S.; Krammer, Florian; Saphire, Erica Ollman; Carfi, Andrea; Alter, Galit			mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern	IMMUNITY			English	Article								SARS-CoV-2 mRNA vaccines confer robust protection against COVID-19, but the emergence of variants has generated concerns regarding the protective efficacy of the currently approved vaccines, which lose neutralizing potency against some variants. Emerging data suggest that antibody functions beyond neutralization may contribute to protection from the disease, but little is known about SARS-CoV-2 antibody effector functions. Here, we profiled the binding and functional capacity of convalescent antibodies and Moderna mRNA1273 COVID-19 vaccine-induced antibodies across SARS-CoV-2 variants of concern (VOCs). Although the neutralizing responses to VOCs decreased in both groups, the Fc-mediated responses were distinct. In convalescent individuals, although antibodies exhibited robust binding to VOCs, they showed compromised interactions with Fc-receptors. Conversely, vaccine-induced antibodies also bound robustly to VOCs but continued to interact with Fc-receptors and mediate antibody effector functions. These data point to a resilience in the mRNA-vaccine-induced humoral immune response that may continue to offer protection from SARS-CoV-2 VOCs independent of neutralization.	[Kaplonek, Paulina; Fischinger, Stephanie; Cizmeci, Deniz; Bartsch, Yannic C.; Kang, Jaewon; Burke, John S.; Shin, Sally A.; Julg, Boris; Alter, Galit] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Dayal, Diana; Martin, Patrick; Musk, Elon R.; Menon, Anil S.] Space Explorat Technol Corp, Hawthorne, CA USA; [Mann, Colin; Saphire, Erica Ollman] La Jolla Inst Immunol, Ctr Infect Dis & Vaccine Res, La Jolla, CA USA; [Amanat, Fatima; Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Nilles, Eric J.] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Carfi, Andrea] Moderna Inc, Cambridge, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; La Jolla Institute for Immunology; Icahn School of Medicine at Mount Sinai; Harvard University; Brigham & Women's Hospital	Alter, G (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.	galter@mgh.harvard.org	Krammer, Florian/H-3237-2019	Krammer, Florian/0000-0003-4121-776X; Dayal, Diana/0000-0003-3313-0007; Cizmeci, Deniz/0000-0003-3231-7726; Nilles, Eric/0000-0001-7044-5257; Burke, John/0000-0003-1282-8211; Bartsch, Yannic Christoph/0000-0002-3844-3056; mann, Colin/0000-0003-0949-2075; Kang, Jaewon/0000-0003-0846-4611; Shin, Sally/0000-0002-9306-2264	SAMANA Kay MGH Research Scholars award; Ragon Institute of MGH, MIT, and Harvard; Massachusetts Consortium on Pathogen Readiness (MassCPR); NIH [3R37AI080289-11S1, R01AI146785, U19AI42790-01, U19AI135995-02, 1U01CA260476 - 01, CIVIC75N93019C00052, AID AI149644, P51 OD011132]; Gates Foundation Global; Health Vaccine Accelerator Platform [OPP1146996, INV-001650]; Translational Research Institute for Space Health through NASA [NNX16AO69A]; Musk Foundation; National Insti-tute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH), Bethesda, MD; NIAID [UM1AI148373, UM1AI148576, UM1AI148684];  [HHSN272201500002C]	SAMANA Kay MGH Research Scholars award; Ragon Institute of MGH, MIT, and Harvard; Massachusetts Consortium on Pathogen Readiness (MassCPR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gates Foundation Global; Health Vaccine Accelerator Platform; Translational Research Institute for Space Health through NASA; Musk Foundation; National Insti-tute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH), Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); 	We thank Nancy Zimmerman, Mark and Lisa Schwartz, an anonymous donor (financial support) , Terry and Susan Ragon, and the SAMANA Kay MGH Research Scholars award for their support. We acknowledge the support from the Ragon Institute of MGH, MIT, and Harvard, the Massachusetts Consortium on Pathogen Readiness (MassCPR) , the NIH (3R37AI080289-11S1, R01AI146785, U19AI42790-01, U19AI135995-02, U19AI42790-01, 1U01CA260476 - 01, and CIVIC75N93019C00052) , and the Gates Foundation Global. This study was also supported by Health Vaccine Accelerator Platform funding (OPP1146996 and INV-001650) , Translational Research Institute for Space Health through NASA Cooperative Agreement (NNX16AO69A) , and the Musk Foundation. This work used samples from the phase 1 mRNA-1273 study (NCT04283461; doi: 10.1056/NEJMoa2022483) . The mRNA-1273 phase 1 study was sponsored and primarily funded by the National Insti-tute of Allergy and Infectious Diseases (NIAID) and the National Institutes of Health (NIH) , Bethesda, MD. This trial has been partially funded with federal funds from the NIAID under grant awards UM1AI148373 to Kaiser Washington; UM1AI148576, UM1AI148684, and NIH P51 OD011132 to Emory University; and NIH AID AI149644 and contract award HHSN272201500002C to Emmes. Funding for the manufacture of mRNA-1273 phase 1 material was provided by the Coalition for Epidemic Preparedness Innovation.	Karim SAS, 2021, NEW ENGL J MED, V384, P1866, DOI 10.1056/NEJMc2100362; Abu-Raddad LJ, 2021, NEW ENGL J MED, V385, P187, DOI 10.1056/NEJMc2104974; Alter G, 2021, NATURE, V596, P268, DOI 10.1038/s41586-021-03681-2; Andreano Emanuele, 2020, bioRxiv, DOI 10.1101/2020.12.28.424451; Atyeo C, 2020, IMMUNITY, V53, P524, DOI 10.1016/j.immuni.2020.07.020; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Barrett JR, 2021, NAT MED, V27, P279, DOI 10.1038/s41591-020-01179-4; Bartsch YC, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21336-8; Bergwerk M, 2021, NEW ENGL J MED, V385, P1474, DOI 10.1056/NEJMoa2109072; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Boudreau CM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00440; Brown EP, 2017, J IMMUNOL METHODS, V443, P33, DOI 10.1016/j.jim.2017.01.010; Brown EP, 2012, J IMMUNOL METHODS, V386, P117, DOI 10.1016/j.jim.2012.09.007; Butler AL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01851; Chemaitelly H, 2021, NAT MED, V27, P1614, DOI 10.1038/s41591-021-01446-y; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; Cho A, 2021, NATURE, V600, P517, DOI 10.1038/s41586-021-04060-7; Choe PG, 2021, EMERG INFECT DIS, V27, P327, DOI 10.3201/eid2701.203515; Dejnirattisai W, 2021, CELL, V184, P2939, DOI 10.1016/j.cell.2021.03.055; Dejnirattisai W, 2021, CELL, V184, P2183, DOI 10.1016/j.cell.2021.02.032; Fischinger S, 2019, J IMMUNOL METHODS, V473, DOI 10.1016/j.jim.2019.07.002; Garcia-Beltran W.F., CIRCULATING SARS COV; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1016/j.cell.2021.04.006]; GARCIABELTRAN W, CELL; Gorman M.J., 2021, COLLABORATION FAB FC; Greaney AJ, 2021, CELL HOST MICROBE, V29, P44, DOI 10.1016/j.chom.2020.11.007; Gruell H., 2021, MRNA BOOSTER IMMUNIZ, DOI 10.1101/2021.12.14.21267769; Ibarrondo FJ, 2020, NEW ENGL J MED, V383, P1085, DOI 10.1056/NEJMc2025179; Israel A, 2022, VACCINES-BASEL, V10, DOI [10.3390/vaccines10010064, 10.1101/2021.08.19.21262111]; Jackson LA, 2020, NEW ENGL J MED, V383, P1920, DOI 10.1056/NEJMoa2022483; Jalkanen P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24285-4; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Karsten CB, 2019, J IMMUNOL METHODS, V471, P46, DOI 10.1016/j.jim.2019.05.006; Kuri-Cervantes Leticia, 2020, bioRxiv, DOI 10.1101/2020.05.18.101717; Kustin T, 2021, NAT MED, V27, P1379, DOI 10.1038/s41591-021-01413-7; Lu LL, 2018, NAT REV IMMUNOL, V18, P46, DOI 10.1038/nri.2017.106; Mercado NB, 2020, NATURE, V586, P583, DOI 10.1038/s41586-020-2607-z; Meyer M, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abg6128; Nasreen S, 2021, MEDRXIV, DOI [10.1101/2021.06.28.21259420v2, DOI 10.1101/2021.06.28.21259420V2, 10.1101/2021.06.28.21259420]; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pinto D, 2021, SCIENCE, V373, P1109, DOI 10.1126/science.abj3321; Planas D., 2021, NAT MED, V27, P917, DOI [10.1038/s41591-021-01318-5, DOI 10.1038/s41591-021-01318-5]; Planas D., CONSIDERABLE ESCAPE, DOI [10.1101/2021.12.14, DOI 10.1101/2021.12.14]; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Puranik A, 2021, MEDRXIV, V2021, DOI 10.1101/2021.08.06.21261707 (2021); Rees-Spear C, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108890; Sabino EC, 2021, LANCET, V397, P452, DOI 10.1016/S0140-6736(21)00183-5; Sadoff J, 2021, NEW ENGL J MED, V384, P2187, DOI 10.1056/NEJMoa2101544; Stephenson KE, 2021, JAMA-J AM MED ASSOC, V325, P1535, DOI 10.1001/jama.2021.3645; Supasa P, 2021, CELL, V184, P2201, DOI 10.1016/j.cell.2021.02.033; Suscovich TJ, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb4757; Thompson MG, 2021, NEW ENGL J MED, V385, P320, DOI 10.1056/NEJMoa2107058; Wajnberg A, 2020, SCIENCE, V370, P1227, DOI 10.1126/science.abd7728; Wall EC, 2021, LANCET, V397, P2331, DOI 10.1016/S0140-6736(21)01290-3; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Yu JY, 2020, SCIENCE, V369, P806, DOI 10.1126/science.abc6284; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037; Zohar T, 2020, CELL, V183, P1508, DOI 10.1016/j.cell.2020.10.052; Zost SJ, 2020, NATURE, V584, P443, DOI 10.1038/s41586-020-2548-6	63	13	13	8	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					355	+		10.1016/j.immuni.2022.01.001	http://dx.doi.org/10.1016/j.immuni.2022.01.001			16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX8WB	35090580	Green Published, hybrid			2022-12-18	WOS:000754375200004
J	Chapman, NM; Chi, HB				Chapman, Nicole M.; Chi, Hongbo			Metabolic adaptation of lymphocytes in immunity and disease	IMMUNITY			English	Review							CD8(+) T-CELLS; REGULATORY T; TRANSCRIPTION FACTOR; TUMOR MICROENVIRONMENT; EFFECTOR FUNCTION; MITOCHONDRIAL BIOGENESIS; CHRONIC INFECTION; CLONAL EXPANSION; GLUTAMINE UPTAKE; OXIDIZED LIPIDS	Adaptive immune responses mediated by T cells and B cells are crucial for protective immunity against pathogens and tumors. Differentiation and function of immune cells require dynamic reprogramming of cellular metabolism. Metabolic inputs, pathways, and enzymes display remarkable flexibility and heterogeneity, especially in vivo. How metabolic plasticity and adaptation dictate functional specialization of immune cells is fundamental to our understanding and therapeutic modulation of the immune system. Extensive progress has been made in characterizing the effects of metabolic networks on immune cell fate and function in discrete microenvironments or immunological contexts. In this review, we summarize how rewiring of cellular metabolism determines the outcome of adaptive immunity in vivo, with a focus on how metabolites, nutrients, and driver genes in immunometabolism instruct cellular programming and immune responses during infection, inflammation, and cancer in mice and humans. Understanding context-dependent metabolic remodeling will manifest legitimate opportunities for therapeutic intervention of human disease.	[Chapman, Nicole M.; Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Chi, HB (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	hongbo.chi@stjude.org			ALSAC; NIH [AI105887, AI131703, AI140761, AI150241, AI150514, CA253188]	ALSAC(American Lebanese Syrian Associated Charities (ALSAC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge H. Huang, J. Raynor, J. Saravia, and H. Shi for crit-ical reading or editing of the manuscript. This work was supported by ALSAC and NIH grants AI105887, AI131703, AI140761, AI150241, AI150514, and CA253188 (to H.C.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Angin M, 2019, NAT METAB, V1, P704, DOI 10.1038/s42255-019-0081-4; [Anonymous], 2020, CELL, DOI DOI 10.1016/j.cell.2020.05.032; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Araujo L, 2017, ELIFE, V6, DOI 10.7554/eLife.21330; Arthur L., 2021, NAT AGING, V1, P535; Bachem A, 2019, IMMUNITY, V51, P285, DOI 10.1016/j.immuni.2019.06.002; Bailis W, 2019, NATURE, V571, P403, DOI 10.1038/s41586-019-1311-3; Balmer ML, 2020, CELL METAB, V32, P457, DOI 10.1016/j.cmet.2020.07.004; Balmer ML, 2016, IMMUNITY, V44, P1312, DOI 10.1016/j.immuni.2016.03.016; Baumann T, 2020, NAT IMMUNOL, V21, P555, DOI 10.1038/s41590-020-0666-9; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Bian YJ, 2020, NATURE, V585, P277, DOI 10.1038/s41586-020-2682-1; Boothby M, 2017, IMMUNITY, V46, P743, DOI 10.1016/j.immuni.2017.04.009; Brand A, 2016, CELL METAB, V24, P657, DOI 10.1016/j.cmet.2016.08.011; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Bunse L, 2018, NAT MED, V24, P1192, DOI 10.1038/s41591-018-0095-6; Campello S, 2006, J EXP MED, V203, P2879, DOI 10.1084/jem.20061877; Cao W, 2014, J IMMUNOL, V192, P2920, DOI 10.4049/jimmunol.1302801; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Carr EL, 2010, J IMMUNOL, V185, P1037, DOI 10.4049/jimmunol.0903586; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chapman NM, 2020, NAT REV IMMUNOL, V20, P55, DOI 10.1038/s41577-019-0203-y; Chapman NM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04392-5; Choi SC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06686-0; Clerc I, 2019, NAT METAB, V1, P717, DOI 10.1038/s42255-019-0084-1; Clever D, 2016, CELL, V166, P1117, DOI 10.1016/j.cell.2016.07.032; Collier JL, 2021, NAT IMMUNOL, V22, P809, DOI 10.1038/s41590-021-00949-7; Collins N, 2019, CELL, V178, P1088, DOI 10.1016/j.cell.2019.07.049; Corrado M, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.11.003; Cronin SJF, 2018, NATURE, V563, P564, DOI 10.1038/s41586-018-0701-2; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Cubillos-Ruiz JR, 2015, CELL, V161, P1527, DOI 10.1016/j.cell.2015.05.025; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; da Silva HB, 2020, IMMUNITY, V53, P158, DOI 10.1016/j.immuni.2020.06.010; da Silva HB, 2018, NATURE, V559, P264, DOI 10.1038/s41586-018-0282-0; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; De Rosa V, 2015, NAT IMMUNOL, V16, P1174, DOI 10.1038/ni.3269; Do MH, 2020, J EXP MED, V217, DOI 10.1084/jem.20190848; Du XR, 2018, NATURE, V558, P141, DOI 10.1038/s41586-018-0177-0; Dudek M, 2021, NATURE, V592, DOI 10.1038/s41586-021-03233-8; Endo Y, 2019, NAT METAB, V1, P261, DOI 10.1038/s42255-018-0025-4; Endo Y, 2015, CELL REP, V12, P1042, DOI 10.1016/j.celrep.2015.07.014; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Field CS, 2020, CELL METAB, V31, P422, DOI 10.1016/j.cmet.2019.11.021; Frizzell H, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay9283; Fu GT, 2021, NATURE, V595, P724, DOI 10.1038/s41586-021-03692-z; Fu Z, 2019, CELL REP, V28, P159, DOI 10.1016/j.celrep.2019.06.024; Gabriel SS, 2021, IMMUNITY, V54, P1698, DOI 10.1016/j.immuni.2021.06.007; Geiger R, 2016, CELL, V167, P829, DOI 10.1016/j.cell.2016.09.031; Geltink RIK, 2020, NAT METAB, V2, P703, DOI 10.1038/s42255-020-0256-z; Geltink RIK, 2017, CELL, V171, P385, DOI 10.1016/j.cell.2017.08.018; Gemta LF, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aap9520; Gerriets VA, 2015, J CLIN INVEST, V125, P194, DOI 10.1172/JCI76012; Giovanelli P, 2019, TRENDS IMMUNOL, V40, P699, DOI 10.1016/j.it.2019.06.004; Greten FR, 2019, IMMUNITY, V51, P27, DOI 10.1016/j.immuni.2019.06.025; Gu MD, 2021, NAT IMMUNOL, V22, P193, DOI 10.1038/s41590-020-00829-6; Guo HT, 2021, NAT IMMUNOL, V22, P423, DOI 10.1038/s41590-021-00898-1; Guo YG, 2021, NAT IMMUNOL, V22, P746, DOI 10.1038/s41590-021-00940-2; Hagenbeek TJ, 2008, LEUKEMIA, V22, P608, DOI 10.1038/sj.leu.2405056; Han SJ, 2017, IMMUNITY, V47, P1154, DOI 10.1016/j.immuni.2017.11.009; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hang SY, 2019, NATURE, V576, P143, DOI 10.1038/s41586-019-1785-z; Hartleben G, 2018, EMBO J, V37, DOI 10.15252/embj.201798589; Hartmann FJ, 2021, NAT BIOTECHNOL, V39, DOI 10.1038/s41587-020-0651-8; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; Henson SM, 2014, J CLIN INVEST, V124, P4004, DOI 10.1172/JCI75051; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Howden AJM, 2019, NAT IMMUNOL, V20, P1542, DOI 10.1038/s41590-019-0495-x; Hu ZL, 2019, CELL METAB, V30, P290, DOI 10.1016/j.cmet.2019.05.016; Huang DIQ, 2021, NAT REV GASTRO HEPAT, V18, P223, DOI 10.1038/s41575-020-00381-6; Huang HL, 2021, CELL, V184, P1245, DOI 10.1016/j.cell.2021.02.021; Huang LJ, 2021, IMMUNITY, V54, P1728, DOI 10.1016/j.immuni.2021.07.004; Hung MH, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21804-1; Jeltsch KM, 2014, NAT IMMUNOL, V15, P1079, DOI 10.1038/ni.3008; Jiang XD, 2012, NATURE, V483, P227, DOI 10.1038/nature10851; Johnson MO, 2018, CELL, V175, P1780, DOI 10.1016/j.cell.2018.10.001; Jones MA, 2020, ANAL CHEM, V92, P7079, DOI 10.1021/acs.analchem.0c00446; Karmaus PWF, 2019, NATURE, V565, P101, DOI 10.1038/s41586-018-0806-7; Kedia-Mehta N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10015-4; Keren L, 2018, CELL, V174, P1373, DOI 10.1016/j.cell.2018.08.039; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Kilgour MK, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe1174; Kishore M, 2017, IMMUNITY, V47, P875, DOI 10.1016/j.immuni.2017.10.017; Klein-Hessling S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00612-6; Konjar S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aan2543; Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665; Kumagai S, 2020, NAT IMMUNOL, V21, P1346, DOI 10.1038/s41590-020-0769-3; Kumagai S, 2020, IMMUNITY, V53, P187, DOI 10.1016/j.immuni.2020.06.016; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Kurniawan H, 2020, CELL METAB, V31, P920, DOI 10.1016/j.cmet.2020.03.004; Kusnadi A, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe4782; Ledderose C, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aba3300; Ledderose C, 2018, J CLIN INVEST, V128, P3583, DOI 10.1172/JCI120972; Lee DSW, 2021, NAT REV DRUG DISCOV, V20, P179, DOI 10.1038/s41573-020-00092-2; Leone RD, 2019, SCIENCE, V366, P1013, DOI 10.1126/science.aav2588; Lercher A, 2020, IMMUNITY, V53, P496, DOI 10.1016/j.immuni.2020.08.012; Li CF, 2019, IMMUNITY, V51, P491, DOI 10.1016/j.immuni.2019.08.013; Li XY, 2019, NAT REV CLIN ONCOL, V16, P425, DOI 10.1038/s41571-019-0203-7; Li YY, 2019, CELL METAB, V30, P477, DOI 10.1016/j.cmet.2019.06.016; Lian GJ, 2018, ELIFE, V7, DOI 10.7554/eLife.36158; Liikanen I, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143729; Lim SA, 2021, NATURE, V591, P306, DOI 10.1038/s41586-021-03235-6; Ling GS, 2018, SCIENCE, V360, P558, DOI 10.1126/science.aao4555; Liu X, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.aaz6314; Liu XJ, 2021, J IMMUNOL, V206, P2900, DOI 10.4049/jimmunol.2100068; Liu YY, 2021, NAT IMMUNOL, V22, P358, DOI 10.1038/s41590-020-00850-9; Long LY, 2021, NATURE, V600, P308, DOI 10.1038/s41586-021-04109-7; Luckel C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13731-z; Ma EH, 2019, IMMUNITY, V51, P856, DOI 10.1016/j.immuni.2019.09.003; Ma EH, 2017, CELL METAB, V25, P345, DOI 10.1016/j.cmet.2016.12.011; Ma RH, 2018, NAT CELL BIOL, V20, P21, DOI 10.1038/s41556-017-0002-2; Ma XZ, 2021, CELL METAB, V33, P1001, DOI 10.1016/j.cmet.2021.02.015; Ma XZ, 2019, CELL METAB, V30, P143, DOI 10.1016/j.cmet.2019.04.002; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Mager LF, 2020, SCIENCE, V369, P1481, DOI 10.1126/science.abc3421; Mak TW, 2017, IMMUNITY, V46, P1089, DOI 10.1016/j.immuni.2017.06.009; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; McLaughlin T, 2017, J CLIN INVEST, V127, P5, DOI 10.1172/JCI88876; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Moreno-Fernandez ME, 2021, CELL METAB, V33, P1187, DOI 10.1016/j.cmet.2021.04.018; Nakaya M, 2014, IMMUNITY, V40, P692, DOI 10.1016/j.immuni.2014.04.007; Nie X, 2021, CELL, V184, P775, DOI 10.1016/j.cell.2021.01.004; O'Sullivan D, 2019, NAT REV IMMUNOL, V19, P324, DOI 10.1038/s41577-019-0140-9; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Okosun J, 2016, NAT GENET, V48, P183, DOI 10.1038/ng.3473; Ottensmeier CH, 2016, CANCER RES, V76, P4136, DOI 10.1158/0008-5472.CAN-15-3121; Palmer CS, 2014, AIDS, V28, P297, DOI 10.1097/QAD.0000000000000128; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Park J, 2015, MUCOSAL IMMUNOL, V8, P80, DOI 10.1038/mi.2014.44; Patsoukis N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7692; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Phan AT, 2016, IMMUNITY, V45, P1024, DOI 10.1016/j.immuni.2016.10.017; Poffenberger MC, 2018, SCIENCE, V361, P406, DOI 10.1126/science.aan3975; Porsche CE, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.139793; Pucino V, 2019, CELL METAB, V30, P1055, DOI 10.1016/j.cmet.2019.10.004; Puleston DJ, 2021, CELL, V184, P4186, DOI 10.1016/j.cell.2021.06.007; Qiu J, 2019, CELL REP, V27, P2063, DOI 10.1016/j.celrep.2019.04.022; Quintana A, 2007, P NATL ACAD SCI USA, V104, P14418, DOI 10.1073/pnas.0703126104; Rao RR, 2010, IMMUNITY, V32, P67, DOI 10.1016/j.immuni.2009.10.010; Raud B, 2018, CELL METAB, V28, P504, DOI 10.1016/j.cmet.2018.06.002; Ray JP, 2015, IMMUNITY, V43, P690, DOI 10.1016/j.immuni.2015.08.017; Reina-Campos M, 2021, NAT REV IMMUNOL, V21, P718, DOI 10.1038/s41577-021-00537-8; Reinfeld BI, 2021, NATURE, V593, P282, DOI 10.1038/s41586-021-03442-1; Ringel AE, 2020, CELL, V183, P1848, DOI 10.1016/j.cell.2020.11.009; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Roy DG, 2020, CELL METAB, V31, P250, DOI 10.1016/j.cmet.2020.01.006; Sadik A, 2020, CELL, V182, P1252, DOI 10.1016/j.cell.2020.07.038; Saravia J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaw6443; Savage PA, 2020, ANNU REV IMMUNOL, V38, P421, DOI 10.1146/annurev-immunol-100219-020937; Savino AM, 2020, NAT CANCER, V1, P998, DOI 10.1038/s43018-020-00115-2; Scharping NE, 2021, NAT IMMUNOL, V22, P205, DOI 10.1038/s41590-020-00834-9; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Schurich A, 2016, CELL REP, V16, P1243, DOI 10.1016/j.celrep.2016.06.078; Seo H, 2021, NAT IMMUNOL, V22, P983, DOI 10.1038/s41590-021-00964-8; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shen Y, 2017, NAT IMMUNOL, V18, P1025, DOI 10.1038/ni.3808; Shi H, 2021, CELL, V184, P4109, DOI 10.1016/j.cell.2021.07.012; Shi H, 2019, IMMUNITY, V51, P1012, DOI 10.1016/j.immuni.2019.10.001; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shirakawa K, 2016, J CLIN INVEST, V126, P4626, DOI 10.1172/JCI88606; Simula L, 2018, CELL REP, V25, P3059, DOI 10.1016/j.celrep.2018.11.018; Sinclair LV, 2019, ELIFE, V8, DOI 10.7554/eLife.44210; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Siska PJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93411; Song M, 2018, NATURE, V562, P423, DOI 10.1038/s41586-018-0597-x; Stark R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau1022; Su W, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.10.022; Sugiura A., 2021, IMMUNITY, DOI DOI 10.1016/J.IMMUNI.2021.10.011; Sun Z, 2021, ELIFE, V10, DOI 10.7554/eLife.61406; Suzuki A, 2001, IMMUNITY, V14, P523, DOI 10.1016/S1074-7613(01)00134-0; Swamy M, 2016, NAT IMMUNOL, V17, P712, DOI 10.1038/ni.3439; Takeuchi T, 2021, NATURE, V595, P560, DOI 10.1038/s41586-021-03727-5; Tan CL, 2021, J EXP MED, V218, DOI 10.1084/jem.20182232; Tan HY, 2017, IMMUNITY, V46, P488, DOI 10.1016/j.immuni.2017.02.010; Thompson EA, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108863; Trompette A, 2018, IMMUNITY, V48, P992, DOI 10.1016/j.immuni.2018.04.022; Tsai S, 2018, CELL METAB, V28, P922, DOI 10.1016/j.cmet.2018.08.003; Tsui C, 2018, IMMUNITY, V48, P1144, DOI 10.1016/j.immuni.2018.04.031; Tyrakis PA, 2016, NATURE, V540, P236, DOI 10.1038/nature20165; Vaeth M, 2017, IMMUNITY, V47, P664, DOI 10.1016/j.immuni.2017.09.003; Valle-Casuso JC, 2019, CELL METAB, V29, P611, DOI 10.1016/j.cmet.2018.11.015; van der Windt GJW, 2012, IMMUNITY, V36, P68, DOI 10.1016/j.immuni.2011.12.007; Vardhana SA, 2020, NAT IMMUNOL, V21, P1022, DOI 10.1038/s41590-020-0725-2; Veglia F, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02186-9; Verma V, 2021, NAT IMMUNOL, V22, P53, DOI 10.1038/s41590-020-00818-9; Vodnala SK, 2019, SCIENCE, V363, P1417, DOI 10.1126/science.aau0135; Wagner A, 2021, CELL, V184, P4168, DOI 10.1016/j.cell.2021.05.045; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wang F, 2016, NAT IMMUNOL, V17, P844, DOI 10.1038/ni.3462; Wang HP, 2020, NAT IMMUNOL, V21, P298, DOI 10.1038/s41590-019-0589-5; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Wang TT, 2020, NAT METAB, V2, P635, DOI 10.1038/s42255-020-0219-4; Watson MJ, 2021, NATURE, V591, P645, DOI 10.1038/s41586-020-03045-2; Wei J, 2019, NATURE, V576, P471, DOI 10.1038/s41586-019-1821-z; Weil J, 2016, NAT IMMUNOL, V17, P277, DOI 10.1038/ni.3365; Weinberg SE, 2019, NATURE, V565, P495, DOI 10.1038/s41586-018-0846-z; Wu BW, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.10.025; Wu J, 2021, NAT CELL BIOL, V23, DOI 10.1038/s41556-020-00615-4; Wu L, 2020, CELL, V182, P641, DOI 10.1016/j.cell.2020.06.014; Xiao G, 2018, CELL, V173, P470, DOI 10.1016/j.cell.2018.02.048; Xu K, 2021, IMMUNITY, V54, P976, DOI 10.1016/j.immuni.2021.04.008; Xu K, 2021, SCIENCE, V371, P405, DOI 10.1126/science.abb2683; Xu SA, 2021, IMMUNITY, V54, P1561, DOI 10.1016/j.immuni.2021.05.003; Yang HW, 2010, J IMMUNOL, V185, P1836, DOI 10.4049/jimmunol.1000021; Yang JL, 2016, ELIFE, V5, DOI 10.7554/eLife.17936; Yang K, 2013, IMMUNITY, V39, P1043, DOI 10.1016/j.immuni.2013.09.015; Yang W, 2016, NATURE, V531, P651, DOI 10.1038/nature17412; Yang Z, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7151; Yang Z, 2013, J EXP MED, V210, P2119, DOI 10.1084/jem.20130252; Yu YR, 2020, NAT IMMUNOL, V21, P1540, DOI 10.1038/s41590-020-0793-3; Zappasodi R, 2021, NATURE, V591, P652, DOI 10.1038/s41586-021-03326-4; Zeng H, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar5701; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017; Zhang CY, 2020, CELL METAB, V31, P148, DOI 10.1016/j.cmet.2019.10.013; Zhang DF, 2019, IMMUNITY, V51, P671, DOI 10.1016/j.immuni.2019.08.001; Zhang HF, 2020, NAT CELL BIOL, V22, P18, DOI 10.1038/s41556-019-0440-0; Zhao ED, 2016, NAT IMMUNOL, V17, P95, DOI 10.1038/ni.3313; Zheng WT, 2021, BLOOD, V138, P122, DOI 10.1182/blood.2020009309	223	13	12	10	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					14	30		10.1016/j.immuni.2021.12.012	http://dx.doi.org/10.1016/j.immuni.2021.12.012			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI0BU	35021054	hybrid, Green Accepted			2022-12-18	WOS:000743523600006
J	Yewdell, JW				Yewdell, Jonathan W.			Antigenic drift: Understanding COVID-19	IMMUNITY			English	Editorial Material							ADULTS		[Yewdell, Jonathan W.] NIAID, Cellular Biol Sect, Lab Viral Dis, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Yewdell, JW (corresponding author), NIAID, Cellular Biol Sect, Lab Viral Dis, 9000 Rockville Pike, Bethesda, MD 20892 USA.	jyewdell@nih.gov			Division of Intramural Research, NIAID	Division of Intramural Research, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	J.W.Y. is supported by the Division of Intramural Research, NIAID. The author is grateful to Seth Margolis (Johns Hopkins University) and William Yewdell (Memorial Sloan Kettering Institute) for their thoughtful comments and sug-gestions.	Altman MO, 2019, MBIO, V10, DOI 10.1128/mBio.00204-19; Angeletti D, 2017, NAT IMMUNOL, V18, P456, DOI 10.1038/ni.3680; Das SR, 2013, CELL HOST MICROBE, V13, P314, DOI 10.1016/j.chom.2013.02.008; Das SR, 2011, P NATL ACAD SCI USA, V108, pE1417, DOI 10.1073/pnas.1108754108; Davis AKF, 2018, J VIROL, V92, DOI 10.1128/JVI.00859-18; Eguia RT, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009453; Fischer W, 2021, CELL HOST MICROBE, V29, P1093, DOI 10.1016/j.chom.2021.05.012; Fulton BO, 2015, CELL REP, V11, P1331, DOI 10.1016/j.celrep.2015.04.054; Han AX, 2019, NAT ECOL EVOL, V3, P302, DOI 10.1038/s41559-018-0741-x; Huang KYA, 2015, J CLIN INVEST, V125, P2631, DOI 10.1172/JCI81104; Ko SH, 2021, PLOS PATHOG, V17, DOI [10.1371/journal.ppat.1009431, 10.1101/2021.02.21.432184]; Lee J, 2016, NAT MED, V22, P1456, DOI 10.1038/nm.4224; Linderman SL, 2014, P NATL ACAD SCI USA, V111, P15798, DOI 10.1073/pnas.1409171111; Sanjuan R, 2016, CELL MOL LIFE SCI, V73, P4433, DOI 10.1007/s00018-016-2299-6; Wu NC, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a038778	15	13	13	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2681	2687		10.1016/j.immuni.2021.11.016	http://dx.doi.org/10.1016/j.immuni.2021.11.016		DEC 2021	7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6GW	34910934	Green Published, Bronze			2022-12-18	WOS:000731645300004
J	Mirabella, F; Desiato, G; Mancinelli, S; Fossati, G; Rasile, M; Morini, R; Markicevic, M; Grimm, C; Amegandjin, C; Termanini, A; Peano, C; Kunderfranco, P; di Cristo, G; Zerbi, V; Menna, E; Lodato, S; Matteoli, M; Porzzi, D				Mirabella, Filippo; Desiato, Genni; Mancinelli, Sara; Fossati, Giuliana; Rasile, Marco; Morini, Raffaella; Markicevic, Marija; Grimm, Christina; Amegandjin, Clara; Termanini, Alberto; Peano, Clelia; Kunderfranco, Paolo; di Cristo, Graziella; Zerbi, Valerio; Menna, Elisabetta; Lodato, Simona; Matteoli, Michela; Porzzi, Davide			Prenatal interleukin 6 elevation increases glutamatergic synapse density and disrupts hippocampal connectivity in offspring	IMMUNITY			English	Article							MATERNAL IMMUNE ACTIVATION; DENDRITIC SPINE PATHOLOGY; IL-6R MESSENGER-RNAS; BRAIN-DEVELOPMENT; RECEPTOR IL-6R; FUNCTIONAL CONNECTIVITY; SERINE PHOSPHORYLATION; NEURONAL DIVERSITY; RGS4 POLYMORPHISMS; MOUSE-BRAIN	Early prenatal inflammatory conditions are thought to be a risk factor for different neurodevelopmental disorders. Maternal interleukin-6 (IL-6) elevation during pregnancy causes abnormal behavior in offspring, but whether these defects result from altered synaptic developmental trajectories remains unclear. Here we showed that transient IL-6 elevation via injection into pregnant mice or developing embryos enhanced glutamatergic synapses and led to overall brain hyperconnectivity in offspring into adulthood. IL-6 activated synaptogenesis gene programs in glutamatergic neurons and required the transcription factor STAT3 and expression of the RGS4 gene. The STAT3-RGS4 pathway was also activated in neonatal brains during poly(I:C)-induced maternal immune activation, which mimics viral infection during pregnancy. These findings indicate that IL-6 elevation at early developmental stages is sufficient to exert a long-lasting effect on glutamatergic synaptogenesis and brain connectivity, providing a mechanistic framework for the association between prenatal inflammatory events and brain neurodevelopmental disorders.	[Mirabella, Filippo; Rasile, Marco; Lodato, Simona; Porzzi, Davide] Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini 4, I-20090 Milan, Italy; [Mirabella, Filippo; Desiato, Genni; Mancinelli, Sara; Fossati, Giuliana; Morini, Raffaella; Menna, Elisabetta; Lodato, Simona; Matteoli, Michela; Porzzi, Davide] IRCCS Humanitas Res Hosp, Via Manzoni 56, I-20089 Milan, Italy; [Markicevic, Marija; Grimm, Christina; Zerbi, Valerio] Swiss Fed Inst Technol, Neurosci Ctr Zurich, CH-8057 Zurich, Switzerland; [Markicevic, Marija; Grimm, Christina; Zerbi, Valerio] Univ Zurich, CH-8057 Zurich, Switzerland; [Amegandjin, Clara; di Cristo, Graziella] Univ Montreal, Dept Neurosci, Montreal, PQ, Canada; [Amegandjin, Clara; di Cristo, Graziella] CHU St Justine, Res Ctr, Montreal, PQ, Canada; [Termanini, Alberto; Kunderfranco, Paolo] Humanitas Clin & Res Ctr, Bioinformat Unit, I-20089 Milan, Italy; [Peano, Clelia] CNR, Inst Genet & Biomed Res, UoS Milan, I-20089 Milan, Italy; [Peano, Clelia] Humanitas Clin & Res Ctr, Gen Unit, I-20089 Milan, Italy; [Desiato, Genni; Menna, Elisabetta; Matteoli, Michela] CNR, Dept Neurosci, I-20139 Milan, Italy; [Zerbi, Valerio] Swiss Fed Inst Technol, Neural Control Movement Lab, Dept Hlth Sci & Technol, CH-8057 Zurich, Switzerland	Humanitas University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Consiglio Nazionale delle Ricerche (CNR); Istituto di Ricerca Genetica e Biomedica (IRGB-CNR); Consiglio Nazionale delle Ricerche (CNR); Swiss Federal Institutes of Technology Domain; ETH Zurich	Porzzi, D (corresponding author), Humanitas Univ, Dept Biomed Sci, Via Rita Levi Montalcini 4, I-20090 Milan, Italy.; Matteoli, M; Porzzi, D (corresponding author), IRCCS Humanitas Res Hosp, Via Manzoni 56, I-20089 Milan, Italy.; Matteoli, M (corresponding author), CNR, Dept Neurosci, I-20139 Milan, Italy.	michela.matteoli@hunimed.eu; davide.pozzi@humanitasresearch.it	Mancinelli, Sara/HCG-8872-2022; Pozzi, Davide/A-7021-2016; Rasile, Marco/K-1403-2018; Peano, Clelia/C-4015-2018; Fossati, Giuliana/GZL-7688-2022; Lodato, Simona/A-3525-2017; morini, raffaella/K-9370-2016	Mancinelli, Sara/0000-0002-6290-5425; Pozzi, Davide/0000-0001-6436-0556; Rasile, Marco/0000-0001-8713-7218; Peano, Clelia/0000-0001-7055-3629; Fossati, Giuliana/0000-0003-0321-3936; Lodato, Simona/0000-0001-6498-2590; morini, raffaella/0000-0002-4403-6932; Desiato, Genni/0000-0001-5281-0097	PRIN (Ministero dell'Istruzione dell'Universitae della Ricerca) [2017 A9MK4R]; FISM [2019/R-Single/032]; Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health (RMMH); Telethon Foundation [GGP19226A]; Cariplo Foundation [2017-0622, 2019-1785]; Fonda-zione Cassa di Risparmio di Pisa "Studio traslazionale dell'infiammazione nel-l'invecchiamento";  [RF2018-12365280]	PRIN (Ministero dell'Istruzione dell'Universitae della Ricerca); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health (RMMH); Telethon Foundation(Fondazione Telethon); Cariplo Foundation(Fondazione Cariplo); Fonda-zione Cassa di Risparmio di Pisa "Studio traslazionale dell'infiammazione nel-l'invecchiamento"; 	We thank Prof. Valeria Poli (Department of Molecular Biotechnology and Health Sciences, University of Turin, Italy) for kindly providing all plasmids cod-ing for the phosphomimetic mutants of STAT3 and Dr. Marinos Kallikourdis for intellectual input and comments on the manuscript. This work was supported by PRIN (Ministero dell'Istruzione dell'Universitae della Ricerca; 2017 A9MK4R) ; FISM 2019/R-Single/032, The Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health (RMMH) , and Fonda-zione Cassa di Risparmio di Pisa "Studio traslazionale dell'infiammazione nel-l'invecchiamento" (to M.M.) ; Telethon Foundation GGP19226A (to D.P.) ; RF2018-12365280 and Cariplo Foundation 2019-1785 (to S.L.) , and Cariplo Foundation 2017-0622 (to E.M.) . We also thank the Monzino Foundation (Mi-lano, Italy) for its generous gift of the Zeiss LSM800 confocal microscope to the Milan section of the Institute of Neuroscience.	Agostini M, 2016, CELL DEATH DIFFER, V23, P1502, DOI 10.1038/cdd.2016.36; Ajram LA, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.104; Angevine J.B, EXP NEURET S, V2, P1; Aniszewska A, 2015, J NEUROIMMUNOL, V284, P1, DOI 10.1016/j.jneuroim.2015.05.001; Balschun D, 2004, FASEB J, V18, P1788, DOI 10.1096/fj.04-1625fje; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn2054; Bauman MD, 2014, BIOL PSYCHIAT, V75, P332, DOI 10.1016/j.biopsych.2013.06.025; Beckmann CF, 2004, IEEE T MED IMAGING, V23, P137, DOI 10.1109/TMI.2003.822821; Bedogni F, 2016, CEREB CORTEX, V26, P2517, DOI 10.1093/cercor/bhv078; Benedusi V, 2015, ONCOTARGET, V6, P10801, DOI 10.18632/oncotarget.2984; Bergink V, 2014, BIOL PSYCHIAT, V75, P324, DOI 10.1016/j.biopsych.2013.09.037; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Berman DM, 1996, J BIOL CHEM, V271, P27209, DOI 10.1074/jbc.271.44.27209; Blazer LL, 2010, MOL PHARMACOL, V78, P524, DOI 10.1124/mol.110.065128; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Boulanger-Bertolus J, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00230; Buckholtz JW, 2007, J NEUROSCI, V27, P1584, DOI 10.1523/JNEUROSCI.5112-06.2007; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cafferty WBJ, 2004, J NEUROSCI, V24, P4432, DOI 10.1523/JNEUROSCI.2245-02.2004; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Campbell IL, 2014, J NEUROSCI, V34, P2503, DOI 10.1523/JNEUROSCI.2830-13.2014; Cembrowski MS, 2016, ELIFE, V5, DOI 10.7554/eLife.14997; Chao HT, 2007, NEURON, V56, P58, DOI 10.1016/j.neuron.2007.08.018; Cheng YC, 2013, CELL MOL LIFE SCI, V70, P935, DOI 10.1007/s00018-012-1178-z; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Chowdari KV, 2002, HUM MOL GENET, V11, P1373, DOI 10.1093/hmg/11.12.1373; Chung CD, 1997, SCIENCE, V278, P1803, DOI 10.1126/science.278.5344.1803; Chung JK, 1997, MOL CELL BIOL, V17, P6508, DOI 10.1128/MCB.17.11.6508; Cline H, 2005, CURR BIOL, V15, pR203, DOI 10.1016/j.cub.2005.03.010; Corradini I, 2018, BIOL PSYCHIAT, V83, P680, DOI 10.1016/j.biopsych.2017.09.030; Courchesne E, 2007, NEURON, V56, P399, DOI 10.1016/j.neuron.2007.10.016; Dahlgren J, 2006, PEDIATR RES, V60, P147, DOI 10.1203/01.pdr.0000230026.74139.18; Dame JB, 2000, EARLY HUM DEV, V58, P25, DOI 10.1016/S0378-3782(00)00064-5; Dean B, 2009, CURR OPIN PSYCHIATR, V22, P154, DOI 10.1097/YCO.0b013e328323d52e; Deco G, 2014, J NEUROSCI, V34, P7886, DOI 10.1523/JNEUROSCI.5068-13.2014; Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Erdely HA, 2006, SYNAPSE, V59, P472, DOI 10.1002/syn.20265; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Estes ML, 2016, SCIENCE, V353, P772, DOI 10.1126/science.aag3194; Fang XX, 2013, CELL MOL NEUROBIOL, V33, P241, DOI 10.1007/s10571-012-9891-6; Filipello F, 2018, IMMUNITY, V48, P979, DOI 10.1016/j.immuni.2018.04.016; Filippini N, 2009, P NATL ACAD SCI USA, V106, P7209, DOI 10.1073/pnas.0811879106; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; FINLAY BL, 1995, SCIENCE, V268, P1578, DOI 10.1126/science.7777856; Fontana C, 2021, BMC MED, V19, DOI 10.1186/s12916-020-01896-0; Frankle W. Gordon, 2003, Neuron, V39, P205, DOI 10.1016/S0896-6273(03)00423-9; GADIENT RA, 1993, NEUROSCI LETT, V153, P13, DOI 10.1016/0304-3940(93)90065-S; GADIENT RA, 1994, BRAIN RES, V637, P10, DOI 10.1016/0006-8993(94)91211-4; Gadient RA, 1996, BRAIN RES, V724, P41, DOI 10.1016/0006-8993(96)00264-8; Gallagher D, 2013, CELL STEM CELL, V13, P564, DOI 10.1016/j.stem.2013.10.002; Garetto S, 2016, ONCOTARGET, V7, P43010, DOI 10.18632/oncotarget.9280; Gatto Cheryl L, 2010, Front Synaptic Neurosci, V2, P4, DOI 10.3389/fnsyn.2010.00004; Gerber KJ, 2016, MOL PHARMACOL, V89, P273, DOI 10.1124/mol.115.102210; Giovanoli S, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.38; Glausier JR, 2013, NEUROSCIENCE, V251, P90, DOI 10.1016/j.neuroscience.2012.04.044; Grabrucker Andreas M, 2012, Front Psychiatry, V3, P118, DOI 10.3389/fpsyt.2012.00118; Grandjean J, 2014, NEUROIMAGE, V102, P838, DOI 10.1016/j.neuroimage.2014.08.043; Hagenbuch N, 2006, BEHAV PHARMACOL, V17, P31, DOI 10.1097/01.fbp.0000189811.77049.3e; Harris KD, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006387; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Hepler JR, 1997, P NATL ACAD SCI USA, V94, P428, DOI 10.1073/pnas.94.2.428; Hsiao EY, 2011, BRAIN BEHAV IMMUN, V25, P604, DOI 10.1016/j.bbi.2010.12.017; Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153; Huttenlocher PR, 1997, J COMP NEUROL, V387, P167, DOI 10.1002/(SICI)1096-9861(19971020)387:2<167::AID-CNE1>3.0.CO;2-Z; Iidaka T, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00252; Jiang S, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004824; Jones SA, 2001, FASEB J, V15, P43, DOI 10.1096/fj.99-1003rev; Jones SA, 2021, NAT REV IMMUNOL, V21, P337, DOI 10.1038/s41577-021-00553-8; Jones SA, 2011, J CLIN INVEST, V121, P3375, DOI 10.1172/JCI57158; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; Kallikourdis M, 2018, CANCER IMMUNOL IMMUN, V67, P989, DOI 10.1007/s00262-017-2113-9; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD1284, DOI 10.1093/nar/gkx1188; Kim S, 2017, NATURE, V549, P528, DOI 10.1038/nature23910; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Konopaske GT, 2014, JAMA PSYCHIAT, V71, P1323, DOI 10.1001/jamapsychiatry.2014.1582; Kraakman MJ, 2015, CELL METAB, V21, P403, DOI 10.1016/j.cmet.2015.02.006; Lee J, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00094; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.310; Leibinger M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.126; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Levitt P, 2006, BIOL PSYCHIAT, V60, P534, DOI 10.1016/j.biopsych.2006.04.028; Li XH, 2009, J NEUROIMMUNOL, V207, P111, DOI 10.1016/j.jneuroim.2008.12.002; Lim AI, 2021, SCIENCE, V373, DOI 10.1126/science.abf3002; Lim CP, 1999, J BIOL CHEM, V274, P31055, DOI 10.1074/jbc.274.43.31055; Lipina TV, 2013, J NEUROSCI, V33, P7654, DOI 10.1523/JNEUROSCI.0091-13.2013; Lisman J, 2012, CURR OPIN NEUROBIOL, V22, P537, DOI 10.1016/j.conb.2011.10.018; Liu HS, 2014, ELIFE, V3, DOI 10.7554/eLife.01524; Lodato S, 2015, ANNU REV CELL DEV BI, V31, P699, DOI 10.1146/annurev-cellbio-100814-125353; Lodato S, 2014, NAT NEUROSCI, V17, P1046, DOI 10.1038/nn.3757; Lu B, 2009, CURR OPIN NEUROBIOL, V19, P162, DOI 10.1016/j.conb.2009.04.004; Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011; Mancinelli S, 2018, CURR OPIN NEUROBIOL, V53, P146, DOI 10.1016/j.conb.2018.08.001; Maritano D, 2004, NAT IMMUNOL, V5, P401, DOI 10.1038/ni1052; Markicevic M, 2020, CEREB CORTEX, V30, P4922, DOI 10.1093/cercor/bhaa084; MATTEOLI M, 1995, J PHYSIOL-PARIS, V89, P51, DOI 10.1016/0928-4257(96)80551-1; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Melom JE, 2011, CURR OPIN GENET DEV, V21, P256, DOI 10.1016/j.gde.2011.01.002; Missault S, 2014, BRAIN BEHAV IMMUN, V42, P138, DOI 10.1016/j.bbi.2014.06.013; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Munno DW, 2003, J NEUROSCI, V23, P4146; Munoz-Suano A, 2012, J AUTOIMMUN, V38, pJ103, DOI 10.1016/j.jaut.2011.09.007; Murase S, 2012, J NEUROSCI, V32, P15511, DOI 10.1523/JNEUROSCI.2940-12.2012; Nelson SB, 2015, NEURON, V87, P684, DOI 10.1016/j.neuron.2015.07.033; Ni YG, 1999, J NEUROSCI, V19, P3674; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; Nomoto S, 1997, BIOCHEM BIOPH RES CO, V241, P281, DOI 10.1006/bbrc.1997.7802; O'Donnell C, 2017, ELIFE, V6, DOI [10.7554/elife.26724.001, 10.7554/eLife.26724]; Onore C, 2012, BRAIN BEHAV IMMUN, V26, P383, DOI 10.1016/j.bbi.2011.08.007; Pagani M, 2019, J NEUROSCI, V39, P5299, DOI 10.1523/JNEUROSCI.2529-18.2019; Pallaki P, 2017, NEUROPHARMACOLOGY, V117, P408, DOI 10.1016/j.neuropharm.2017.02.012; Park KW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050874; Paspalas CD, 2009, CEREB CORTEX, V19, P2145, DOI 10.1093/cercor/bhn235; Pelkey KA, 2017, PHYSIOL REV, V97, P1619, DOI 10.1152/physrev.00007.2017; Penzes P, 2011, NAT NEUROSCI, V14, P285, DOI 10.1038/nn.2741; Pieraut S, 2011, J NEUROSCI, V31, P13516, DOI 10.1523/JNEUROSCI.3382-11.2011; Potvin S, 2008, BIOL PSYCHIAT, V63, P801, DOI 10.1016/j.biopsych.2007.09.024; Pozzi D, 2013, EMBO J, V32, P2994, DOI 10.1038/emboj.2013.231; Reemst K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00566; Rothaug M, 2016, BBA-MOL CELL RES, V1863, P1218, DOI 10.1016/j.bbamcr.2016.03.018; Rudolph MD, 2018, NAT NEUROSCI, V21, P765, DOI 10.1038/s41593-018-0128-y; Sala C, 2001, NEURON, V31, P115, DOI 10.1016/S0896-6273(01)00339-7; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sando R, 2021, ELIFE, V10, DOI 10.7554/eLife.65717; SAWADA M, 1993, NEUROSCI LETT, V160, P131, DOI 10.1016/0304-3940(93)90396-3; Schumacher N, 2015, J BIOL CHEM, V290, P26059, DOI 10.1074/jbc.M115.649509; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Schwarz E, 2018, AM J MED GENET B, V177, P267, DOI 10.1002/ajmg.b.32547; Shelly M, 2010, SCIENCE, V327, P547, DOI 10.1126/science.1179735; Shen K, 2010, ANNU REV NEUROSCI, V33, P473, DOI 10.1146/annurev.neuro.051508.135302; Shirts Brian H, 2004, Curr Psychiatry Rep, V6, P303, DOI 10.1007/s11920-004-0081-1; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Sohal VS, 2019, MOL PSYCHIATR, V24, P1248, DOI 10.1038/s41380-019-0426-0; Spann MN, 2018, J NEUROSCI, V38, P2877, DOI 10.1523/JNEUROSCI.2272-17.2018; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Supekar K, 2013, CELL REP, V5, P738, DOI 10.1016/j.celrep.2013.10.001; Takeda K, 1997, P NATL ACAD SCI USA, V94, P3801, DOI 10.1073/pnas.94.8.3801; Talkowski ME, 2006, BIOL PSYCHIAT, V60, P152, DOI 10.1016/j.biopsych.2006.02.015; Timper K, 2017, CELL REP, V19, P267, DOI 10.1016/j.celrep.2017.03.043; Tomassy Giulio Srubek, 2010, Science Progress, V93, P151, DOI 10.3184/003685010X12705764469952; Urban N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00396; Vallieres L, 2002, J NEUROSCI, V22, P486, DOI 10.1523/JNEUROSCI.22-02-00486.2002; Velazquez-Salinas L, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01057; Vereyken EJF, 2007, EUR J NEUROSCI, V25, P3605, DOI 10.1111/j.1460-9568.2007.05615.x; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wastnedge EAN, 2021, PHYSIOL REV, V101, P303, DOI 10.1152/physrev.00024.2020; Weidler M, 2000, FEBS LETT, V484, P1, DOI 10.1016/S0014-5793(00)02115-3; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Wierenga CJ, 2006, J NEUROPHYSIOL, V96, P2127, DOI 10.1152/jn.00107.2006; Williams ME, 2010, NEURON, V68, P9, DOI 10.1016/j.neuron.2010.09.007; Willis EF, 2020, CELL, V180, P833, DOI 10.1016/j.cell.2020.02.013; Xiong QJ, 2012, J NEUROSCI, V32, P1643, DOI 10.1523/JNEUROSCI.4480-11.2012; Yim YS, 2017, NATURE, V549, P482, DOI 10.1038/nature23909; York EM, 2018, ENEURO, V5, DOI 10.1523/ENEURO.0266-18.2018; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zaslaysky K, 2019, NAT NEUROSCI, V22, P556, DOI 10.1038/s41593-019-0365-8; Zerbi V, 2019, NEUROIMAGE, V191, P392, DOI 10.1016/j.neuroimage.2019.02.051; Zerbi V, 2018, CEREB CORTEX, V28, P2495, DOI 10.1093/cercor/bhy046; Zerbi V, 2015, NEUROIMAGE, V123, P11, DOI 10.1016/j.neuroimage.2015.07.090; Zerbi V, 2013, BRAIN STRUCT FUNCT, V218, P1085, DOI 10.1007/s00429-012-0448-8; Zerbi V, 2013, NEUROBIOL AGING, V34, P1440, DOI 10.1016/j.neurobiolaging.2012.11.017; Zhang M, 2019, NEURON, V101, P690, DOI 10.1016/j.neuron.2019.01.022; Zhang Z, CELL REP, V29, P49; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]; Zhong SJ, 2020, NATURE, V577, P531, DOI 10.1038/s41586-019-1917-5; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou Y, 2019, NATURE, V570, P326, DOI 10.1038/s41586-019-1278-0; Zuccaro E., 2021, HUMAN SPECIFIC ENRIC, DOI [10.1101/2021.09.10. 459747, DOI 10.1101/2021.09.10.459747]	174	13	13	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2611	+		10.1016/j.immuni.2021.10.006	http://dx.doi.org/10.1016/j.immuni.2021.10.006		NOV 2021	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LN	34758338	Green Published, hybrid			2022-12-18	WOS:000718365500004
J	Wu, YF; Zeng, ZM; Guo, YB; Song, LZ; Weatherhead, JE; Huang, XY; Zeng, YY; Bimler, L; Chang, CY; Knight, JM; Valladolid, C; Sun, H; Cruz, MA; Hube, B; Naglik, JR; Luong, AU; Kheradmand, F; Corry, DB				Wu, Yifan; Zeng, Zhimin; Guo, Yubiao; Song, Lizhen; Weatherhead, Jill E.; Huang, Xinyan; Zeng, Yuying; Bimler, Lynn; Chang, Cheng-Yen; Knight, John M.; Valladolid, Christian; Sun, Hua; Cruz, Miguel A.; Hube, Bernhard; Naglik, Julian R.; Luong, Amber U.; Kheradmand, Farrah; Corry, David B.			Candida albicans elicits protective allergic responses via platelet mediated T helper 2 and T helper 17 cell polarization	IMMUNITY			English	Article							SECRETED ASPARTYL PROTEINASES; TRANSCRIPTION FACTOR; LUNG; DIFFERENTIATION; MYCOSIS; MODEL; SENSITIZATION; ASPERGILLUS; DEFICIENCY; ACTIVATION	Fungal airway infection (airway mycosis) is an important cause of allergic airway diseases such as asthma, but the mechanisms by which fungi trigger asthmatic reactions are poorly understood. Here, we leverage wild-type and mutant Candida albicans to determine how this common fungus elicits characteristic Th2 and Th17 cell-dependent allergic airway disease in mice. We demonstrate that rather than proteinases that are essential virulence factors for molds, C. albicans instead promoted allergic airway disease through the peptide toxin candidalysin. Candidalysin activated platelets through the Von Willebrand factor (VWF) receptor GP1ba to release the Wnt antagonist Dickkopf-1 (Dkk-1) to drive Th2 and Th17 cell responses that correlated with reduced lung fungal burdens. Platelets simultaneously precluded lethal pulmonary hemorrhage resulting from fungal lung invasion. Thus, in addition to hemostasis, platelets promoted protection against C. albicans airway mycosis through an antifungal pathway involving candidalysin, GP1ba, and Dkk-1 that promotes Th2 and Th17 responses.	[Wu, Yifan; Bimler, Lynn; Knight, John M.; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Dept Pathol & Immunol, One Baylor Plaza, Houston, TX 77030 USA; [Zeng, Zhimin; Guo, Yubiao; Huang, Xinyan; Zeng, Yuying] Sun Yat Sen Univ, Affiliated Hosp 1, Div Pulm & Crit Care Med, Guangzhou 510080, Peoples R China; [Song, Lizhen; Weatherhead, Jill E.; Huang, Xinyan; Chang, Cheng-Yen; Valladolid, Christian; Cruz, Miguel A.; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Dept Med, One Baylor Plaza, Houston, TX 77030 USA; [Valladolid, Christian] Baylor Coll Med, Dept Mol Physiol & Biophys, One Baylor Plaza, Houston, TX 77030 USA; [Weatherhead, Jill E.] Baylor Coll Med, Dept Pediat, One Baylor Plaza, Houston, TX 77030 USA; [Chang, Cheng-Yen] Baylor Coll Med, Translat Biol & Mol Med Program, One Baylor Plaza, Houston, TX 77030 USA; [Knight, John M.; Kheradmand, Farrah; Corry, David B.] Baylor Coll Med, Biol Inflammat Ctr, One Baylor Plaza, Houston, TX 77030 USA; [Weatherhead, Jill E.; Bimler, Lynn] Baylor Coll Med, Natl Sch Trop Med, One Baylor Plaza, Houston, TX 77030 USA; [Valladolid, Christian; Cruz, Miguel A.; Kheradmand, Farrah; Corry, David B.] Michael E DeBakey VA Ctr Translat Res Inflammator, Houston, TX 77030 USA; [Sun, Hua; Luong, Amber U.] Univ Texas Hlth Sci Ctr Houston, Dept Otolaryngol, McGovern Med Sch, Houston, TX 77030 USA; [Hube, Bernhard] Hans Knoell Inst Jena HKI, Dept Microbial Pathogen Mech, Leibniz Inst Nat Prod Res & Infect Biol, D-07745 Jena, Germany; [Hube, Bernhard] Friedrich Schiller Univ, Inst Microbiol, D-07737 Jena, Germany; [Naglik, Julian R.] Kings Coll London, Ctr Host Microbiome Interact, Fac Dent Oral & Craniofacial Sci, London SE1 1UL, England	Baylor College of Medicine; Sun Yat Sen University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; Hans Knoll Institute (HKI); Friedrich Schiller University of Jena; University of London; King's College London	Corry, DB (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, One Baylor Plaza, Houston, TX 77030 USA.; Corry, DB (corresponding author), Baylor Coll Med, Dept Med, One Baylor Plaza, Houston, TX 77030 USA.; Corry, DB (corresponding author), Baylor Coll Med, Biol Inflammat Ctr, One Baylor Plaza, Houston, TX 77030 USA.; Corry, DB (corresponding author), Michael E DeBakey VA Ctr Translat Res Inflammator, Houston, TX 77030 USA.	dcorry@bcm.edu		Naglik, Julian/0000-0002-8072-7917	US National Institutes of Health [T32AI053831, R01HL117181, HL140398, R01AI135803, R41AI124997]; VA Office of Research and Development [I01BX004828]; National Natural Science Foundation of China [81770024]; Project of Department of Finance of Guangdong Province [20160907]; Cytometry and Cell Sorting Core at Baylor College of Medicine; CPRIT Core Facility Support Award [CPRIT-RP180672]; NIH [CA125123, RR024574]; Wellcome Trust [214229_Z_18_Z]; National Institutes of Health [R37-DE022550]; NIH Research at Guys and St. Thomas's NHS Foun-dation Trust; King's College London Biomedical Research Centre [IS-BRC-1215-20006]; Deutsche Forschungs-gemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy (Balance of the Microverse Cluster) - EXC 2051 [390713860]; Collaborative Research Centre CRC/TR 124 FungiNet project C1	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Office of Research and Development; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Project of Department of Finance of Guangdong Province; Cytometry and Cell Sorting Core at Baylor College of Medicine; CPRIT Core Facility Support Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Research at Guys and St. Thomas's NHS Foun-dation Trust(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); King's College London Biomedical Research Centre; Deutsche Forschungs-gemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy (Balance of the Microverse Cluster) - EXC 2051(German Research Foundation (DFG)); Collaborative Research Centre CRC/TR 124 FungiNet project C1	The content is solely the responsibility of the authors and does not necessarily represent the official views of the United States National Institutes of Health or the Veterans Administration Office of Research and Development. The authors thank Katherine Polsky for technical assis-tance. This work was supported by US National Institutes of Health grants T32AI053831, R01HL117181, HL140398, R01AI135803, and R41AI124997; VA Office of Research and Development grant I01BX004828; the National Natural Science Foundation of China grant 81770024; and the Project of Department of Finance of Guangdong Province grant 20160907. This proj-ect was further supported by the Cytometry and Cell Sorting Core at Baylor College of Medicine with funding from the CPRIT Core Facility Support Award (CPRIT-RP180672) , the NIH (CA125123 and RR024574) , and the assistance of Joel M. Sederstrom. J.R.N was supported by grants from the Wellcome Trust (214229_Z_18_Z) , National Institutes of Health (R37-DE022550) , the NIH Research at Guys and St. Thomas's NHS Foun-dation Trust, and the King's College London Biomedical Research Centre (IS-BRC-1215-20006) . B.H. was supported by the Deutsche Forschungs-gemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy (Balance of the Microverse Cluster - EXC 2051 - Proj-ect-ID 390713860) and the Collaborative Research Centre CRC/TR 124 FungiNet project C1. All illustrative figures were generated at biorender.com .	Auton M, 2007, J MOL BIOL, V366, P986, DOI 10.1016/j.jmb.2006.10.067; AZUMA H, 1991, J BIOL CHEM, V266, P12342; BAUM GL, 1960, NEW ENGL J MED, V263, P70, DOI 10.1056/NEJM196007142630204; Baurand A, 2001, EUR J PHARMACOL, V412, P213, DOI 10.1016/S0014-2999(01)00733-6; Beckert H, 2018, J IMMUNOL, V201, P1855, DOI 10.4049/jimmunol.1800554; Boos AC, 2014, ALLERGY, V69, P943, DOI 10.1111/all.12416; CALVETE JJ, 1995, P SOC EXP BIOL MED, V208, P346; Chae WJ, 2016, IMMUNITY, V44, P246, DOI 10.1016/j.immuni.2016.01.008; Chu EY, 2012, ARCH DERMATOL, V148, P79, DOI 10.1001/archdermatol.2011.262; Dinkla S, 2016, BLOOD, V127, P1976, DOI 10.1182/blood-2015-04-640300; Engelhardt KR, 2015, J ALLERGY CLIN IMMUN, V136, P402, DOI 10.1016/j.jaci.2014.12.1945; Eppinger TM, 1999, J ALLERGY CLIN IMMUN, V104, P1265, DOI 10.1016/S0091-6749(99)70023-0; Fahy JV, 2001, AM J RESP CRIT CARE, V164, pS46, DOI 10.1164/ajrccm.164.supplement_2.2106066; Gropp K, 2009, MOL IMMUNOL, V47, P465, DOI 10.1016/j.molimm.2009.08.019; Harb H, 2020, NAT IMMUNOL, V21, P1359, DOI 10.1038/s41590-020-0777-3; Ho J, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030699; Huang E, 2018, ANN ALLERG ASTHMA IM, V121, P738, DOI 10.1016/j.anai.2018.07.044; Huang H, 2009, J CELL BIOCHEM, V107, P857, DOI 10.1002/jcb.22184; Hube B, 1997, INFECT IMMUN, V65, P3529, DOI 10.1128/IAI.65.9.3529-3538.1997; ISENBERG WM, 1986, BLOOD CELLS, V12, P191; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Jackson BE, 2007, INVEST OPHTH VIS SCI, V48, P3559, DOI 10.1167/iovs.07-0114; Kammer P, 2020, MBIO, V11, DOI 10.1128/mBio.02435-20; Kanaji T, 2004, BLOOD, V104, P3161, DOI 10.1182/blood-2004-03-0893; Kasper L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06607-1; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Knutsen AP, 2012, J ALLERGY CLIN IMMUN, V129, P280, DOI 10.1016/j.jaci.2011.12.970; Kwak HJ, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.91; Lam FW, 2011, AM J PHYSIOL-HEART C, V300, pH468, DOI 10.1152/ajpheart.00491.2010; Landers CT, 2019, J BIOL CHEM, V294, P8834, DOI 10.1074/jbc.RA118.006724; Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706; Li E, 2019, ADV IMMUNOL, V142, P85, DOI 10.1016/bs.ai.2019.05.002; Li E, 2018, IMMUN INFLAMM DIS, V6, P264, DOI 10.1002/iid3.215; Ma CS, 2008, J EXP MED, V205, P1551, DOI 10.1084/jem.20080218; Mak G, 2013, CLIN IMMUNOL, V146, P77, DOI 10.1016/j.clim.2012.11.005; Masaki K, 2017, ANN ALLERG ASTHMA IM, V119, P253, DOI 10.1016/j.anai.2017.07.008; Meiller TF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005039; Meinders M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154342; Millien Valentine Ongeri, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS277, DOI 10.1513/AnnalsATS.201403-105AW; Millien VO, 2013, SCIENCE, V341, P792, DOI 10.1126/science.1240342; Milner JD, 2008, NATURE, V452, P773, DOI 10.1038/nature06764; Moyes DL, 2016, NATURE, V532, P64, DOI 10.1038/nature17625; Naglik JR, 2003, MICROBIOL MOL BIOL R, V67, P400, DOI 10.1128/MMBR.67.3.400-428.2003; Nagy Bela Jr, 2013, EJIFCC, V23, P124; Pene J, 2008, J IMMUNOL, V180, P7423, DOI 10.4049/jimmunol.180.11.7423; Pitchford SC, 2004, BLOOD, V103, P639, DOI 10.1182/blood-2003-05-1707; Pitchford SC, 2008, AM J RESP CRIT CARE, V177, P604, DOI 10.1164/rccm.200702-214OC; Porter P, 2009, MUCOSAL IMMUNOL, V2, P504, DOI 10.1038/mi.2009.102; Porter P, 2011, MED MYCOL, V49, pS158, DOI 10.3109/13693786.2010.509743; Porter PC, 2014, J ALLERGY CLIN IMMUN, V134, P325, DOI 10.1016/j.jaci.2014.04.028; Porter PC, 2011, INFECT IMMUN, V79, P4459, DOI 10.1128/IAI.05209-11; Porter PC, 2011, TRENDS IMMUNOL, V32, P43, DOI 10.1016/j.it.2010.11.007; Rayes J, 2020, RES PRACT THROMB HAE, V4, P23, DOI 10.1002/rth2.12266; Sambrano GR, 2001, NATURE, V413, P74, DOI 10.1038/35092573; SANDHU RS, 1979, SCAND J RESPIR DIS, V60, P235; Sanglard D, 1997, INFECT IMMUN, V65, P3539, DOI 10.1128/IAI.65.9.3539-3546.1997; Schaller M, 1999, MOL MICROBIOL, V34, P169, DOI 10.1046/j.1365-2958.1999.01590.x; Schaller M, 2000, J INVEST DERMATOL, V114, P712, DOI 10.1046/j.1523-1747.2000.00935.x; Schild L, 2011, EUKARYOT CELL, V10, P98, DOI 10.1128/EC.00210-10; Shah SA, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00129; Shattil SJ, 1999, THROMB HAEMOSTASIS, V82, P318; Shi GF, 2014, J CLIN INVEST, V124, P543, DOI 10.1172/JCI71858; Stoiber D, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040855; Suh DH, 2016, J CELL MOL MED, V20, P333, DOI 10.1111/jcmm.12727; Sullivan PJ, 2000, RESPIRATION, V67, P514, DOI 10.1159/000067466; Svenningsen S, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00158; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Taylor L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101209; Tischler BY, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008544; Tsukiji N, 2018, BLOOD ADV, V2, P2214, DOI 10.1182/bloodadvances.2018016261; Verma AH, 2018, J IMMUNOL, V201, P627, DOI 10.4049/jimmunol.1800515; Verma AH, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8834; Weber AA, 1999, BRIT J PHARMACOL, V126, P415, DOI 10.1038/sj.bjp.0702276; Wu YF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07991-4; Yuan YP, 1999, J BIOL CHEM, V274, P36241, DOI 10.1074/jbc.274.51.36241; Zhao Y, 2010, INT ARCH ALLERGY IMM, V151, P297, DOI 10.1159/000250438; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	77	13	13	4	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 9	2021	54	11					2595	+		10.1016/j.immuni.2021.08.009	http://dx.doi.org/10.1016/j.immuni.2021.08.009		NOV 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WX1LN	34506733	Green Accepted, Green Submitted, Bronze			2022-12-18	WOS:000718365500003
J	Liu, XC; Zhu, RH; Luo, Y; Wang, SS; Zhao, Y; Qiu, ZQ; Zhang, Y; Liu, X; Yao, X; Li, X; Li, W				Liu, Xiaochun; Zhu, Ronghui; Luo, Yang; Wang, Shangshang; Zhao, Yi; Qiu, Zhuoqiong; Zhang, Yu; Liu, Xiao; Yao, Xu; Li, Xiao; Li, Wei			Distinct human Langerhans cell subsets orchestrate reciprocal functions and require different developmental regulation	IMMUNITY			English	Article							DENDRITIC CELLS; R PACKAGE; SKIN; ACTIVATION; ANTIGEN; DOWNSTREAM; MACROPHAGE; EXPOSURE; RECEPTOR; IL-23	Langerhans cells (LCs) play a pivotal role in skin homeostasis, and the heterogeneity of LCs has long been considered. In this study, we have identified two steady-state (LC1 and LC2) and two activated LC subsets in the epidermis of human skin and in LCs derived from CD34(+) hemopoietic stem cells (HSC-LCs) by utilizing single-cell RNA sequencing and mass cytometry. Analysis of HSC-LCs at multiple time-points during differentiation revealed that EGR1 and Notch signaling were among the top pathways regulating the bifurcation of LC1 and LC2. LC1 were characterized as classical LCs, mainly related to innate immunity and antigen processing. LC2 were similar to monocytes or myeloid dendritic cells, involving in immune responses and leukocyte activation. LC1 remained stable under inflammatory microenvironment, whereas LC2 were prone to being activated and demonstrated elevated expression of immuno-suppressive molecules. Werevealed distinct human LC subsets that require different developmental regulation and orchestrate reciprocal functions.	[Liu, Xiaochun; Luo, Yang; Zhang, Yu; Yao, Xu] Chinese Acad Med Sci & Peking Union Med Coll, Inst Dermatol, Hosp Skin Dis, Jiangsu Key Lab Mol Biol Skin Dis & STIs,Dept All, Nanjing 210042, Peoples R China; [Zhu, Ronghui; Wang, Shangshang; Qiu, Zhuoqiong; Li, Wei] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200040, Peoples R China; [Li, Xiao] Texas Heart Inst, Gene Editing Lab, Houston, TX 77030 USA; [Zhao, Yi] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai 200025, Peoples R China; [Liu, Xiao] Tsinghua Univ, Tsinghua Shenzhen Int Grad Sch, Shenzhen 518052, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Dermatology - CAMS; Peking Union Medical College; Fudan University; Texas Heart Institute; Chinese Academy of Sciences; Shanghai Jiao Tong University; Tsinghua University	Yao, X (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Dermatol, Hosp Skin Dis, Jiangsu Key Lab Mol Biol Skin Dis & STIs,Dept All, Nanjing 210042, Peoples R China.; Li, W (corresponding author), Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai 200040, Peoples R China.; Li, X (corresponding author), Texas Heart Inst, Gene Editing Lab, Houston, TX 77030 USA.	dryao_xu@126.com; xli@texasheart.org; liweiderma@fudan.edu.cn		Li, Xiao/0000-0001-8527-4438	Medicine and Health Technology Innovation Project of Chinese Academy of Medical Sciences [2016-I2M-1-005]; Natural Science Foundation of China [81972939, 82073446, 91642116, 81703126, 81803144]; Nanjing Incubation Program for National Clinical Research Centre [2019060001]; Key Project of Social Development in Jiangsu Province [BE2020632]; Key Project of the Innovation Program of Shanghai Municipal Education Commission [2021-01-07-00-07-E00078]; Texas Heart Institute	Medicine and Health Technology Innovation Project of Chinese Academy of Medical Sciences; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Incubation Program for National Clinical Research Centre; Key Project of Social Development in Jiangsu Province; Key Project of the Innovation Program of Shanghai Municipal Education Commission; Texas Heart Institute	We thank Dr. Yuping Lai, Dr. Yufeng Zhou, and Dr. Shau-Ku Huang for their helpful discussion and suggestions. This work was supported by the Medicine and Health Technology Innovation Project of Chinese Academy of Medical Sciences (2016-I2M-1-005), the Natural Science Foundation of China (81972939, 82073446, 91642116, 81703126, 81803144), the Nanjing Incubation Program for National Clinical Research Centre (2019060001), the Key Project of Social Development in Jiangsu Province (BE2020632), and the Key Project of the Innovation Program of Shanghai Municipal Education Commission (2021-01-07-00-07-E00078). This work was also supported by the Don McGill Gene Editing Laboratory of Texas Heart Institute (X. Li). The experiments were conducted in Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs.	Aibar S, 2017, NAT METHODS, V14, P1083, DOI [10.1038/NMETH.4463, 10.1038/nmeth.4463]; Angerer P, 2016, BIOINFORMATICS, V32, P1241, DOI 10.1093/bioinformatics/btv715; Bellmann L, 2021, J INVEST DERMATOL, V141, P84, DOI 10.1016/j.jid.2020.05.098; Bodenhofer U, 2011, BIOINFORMATICS, V27, P2463, DOI 10.1093/bioinformatics/btr406; Bond E, 2009, J IMMUNOL METHODS, V348, P42, DOI 10.1016/j.jim.2009.06.012; Browaeys R, 2020, NAT METHODS, V17, P159, DOI 10.1038/s41592-019-0667-5; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Caux C, 1996, J EXP MED, V184, P695, DOI 10.1084/jem.184.2.695; Cheng JB, 2018, CELL REP, V25, P871, DOI 10.1016/j.celrep.2018.09.006; Clayton K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01676; Condaminet B, 1998, EUR J IMMUNOL, V28, P3541, DOI 10.1002/(SICI)1521-4141(199811)28:11<3541::AID-IMMU3541>3.0.CO;2-4; Doebel T, 2017, TRENDS IMMUNOL, V38, P817, DOI 10.1016/j.it.2017.06.008; Ferrer IR, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aax8704; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Gentek R, 2014, IMMUNOL REV, V262, P56, DOI 10.1111/imr.12224; Giladi A, 2018, NAT CELL BIOL, V20, P836, DOI 10.1038/s41556-018-0121-4; Glitzner E, 2014, EMBO MOL MED, V6, P1312, DOI 10.15252/emmm.201404114; Guo L, 2019, MOL CELL, V73, P815, DOI 10.1016/j.molcel.2019.01.042; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Hahne F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-106; Heinz LX, 2006, BLOOD, V107, P1445, DOI 10.1182/blood-2005-04-1721; Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340; Hoshino N, 2005, J LEUKOCYTE BIOL, V78, P921, DOI 10.1189/jlb.1204746; Hovav AH, 2018, TRENDS IMMUNOL, V39, P788, DOI 10.1016/j.it.2018.08.007; Jorgl A, 2007, BLOOD, V109, P185, DOI 10.1182/blood-2006-05-022954; Kaplan DH, 2017, NAT IMMUNOL, V18, P1068, DOI 10.1038/ni.3815; Kaplansky G, 2001, CELL MOL BIOL, V47, P569; Kashem SW, 2017, ANNU REV IMMUNOL, V35, P469, DOI 10.1146/annurev-immunol-051116-052215; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Liebermann DA, 2002, LEUKEMIA, V16, P527, DOI 10.1038/sj.leu.2402477; Liu XC, 2020, J DERMATOL SCI, V100, P192, DOI 10.1016/j.jdermsci.2020.10.004; Marschall P, 2021, J ALLERGY CLIN IMMUN, V147, P1778, DOI 10.1016/j.jaci.2020.10.006; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; Mei HE, 2016, CYTOM PART A, V89A, P292, DOI 10.1002/cyto.a.22778; Nakajima S, 2012, J ALLERGY CLIN IMMUN, V129, P1048, DOI 10.1016/j.jaci.2012.01.063; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Reynolds G, 2021, SCIENCE, V371, P364, DOI 10.1126/science.aba6500; SCHEIBNER A, 1986, PHOTODERMATOLOGY, V3, P15; Seneschal J, 2012, IMMUNITY, V36, P873, DOI 10.1016/j.immuni.2012.03.018; Sere K, 2012, IMMUNITY, V37, P905, DOI 10.1016/j.immuni.2012.07.019; Singh TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13581; Sirvent S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14125-x; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; THIERS BH, 1984, J INVEST DERMATOL, V82, P223, DOI 10.1111/1523-1747.ep12260055; Wohn C, 2013, P NATL ACAD SCI USA, V110, P10723, DOI 10.1073/pnas.1307569110; Xiao CY, 2017, J DERMATOL SCI, V85, P170, DOI 10.1016/j.jdermsci.2016.12.003; Xu YP, 2012, AGING-US, V4, P742, DOI 10.18632/aging.100501; Yoshiki R, 2014, J INVEST DERMATOL, V134, P1912, DOI 10.1038/jid.2014.98; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	51	13	13	5	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2305	+		10.1016/j.immuni.2021.08.012	http://dx.doi.org/10.1016/j.immuni.2021.08.012		OCT 2021	27	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34508661	Bronze			2022-12-18	WOS:000706854100017
J	Sharma, MD; Pacholczyk, R; Shi, HD; Berrong, ZJ; Zakharia, Y; Greco, A; Chang, CSS; Eathiraj, S; Kennedy, E; Cash, T; Bollag, RJ; Kolhe, R; Sadek, R; McGaha, TL; Rodriguez, P; Mandula, J; Blazar, BR; Johnson, TS; Munn, DH				Sharma, Madhav D.; Pacholczyk, Rafal; Shi, Huidong; Berrong, Zuzana J.; Zakharia, Yousef; Greco, Austin; Chang, Chang-Sheng S.; Eathiraj, Sudharshan; Kennedy, Eugene; Cash, Thomas; Bollag, Roni J.; Kolhe, Ravindra; Sadek, Ramses; McGaha, Tracy L.; Rodriguez, Paulo; Mandula, Jessica; Blazar, Bruce R.; Johnson, Theodore S.; Munn, David H.			Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity	IMMUNITY			English	Article							ANTIGEN-PRESENTING CELLS; BRUTONS TYROSINE KINASE; INDOLEAMINE 2,3-DIOXYGENASE; CHEMOTHERAPY; DEFICIENCY; MATURATION; REVEALS; SUBSET	Monocytic-lineage inflammatory Ly6c(+)CD103(+) dendritic cells (DCs) promote antitumor immunity, but these DCs are infrequent in tumors, even upon chemotherapy. Here, we examined how targeting pathways that inhibit the differentiation of inflammatory myeloid cells affect antitumor immunity. Pharmacologic inhibition of Bruton's tyrosine kinase (BTK) and the tryptophan-degrading enzyme indoleamine 2,3-dioxygenase (IDO) or deletion of Btk or Ido1 allowed robust differentiation of inflammatory Ly6c(+)CD103(+) DCs during chemotherapy, promoting antitumor T cell responses and inhibiting tumor growth. Immature Ly6c(+)c-kit(+) precursor cells had epigenetic profiles similar to conventional DC precursors; deletion of Btk or Ido1 promoted differentiation of these cells. Mechanistically, a BTK-IDO axis inhibited a tryptophan-sensitive differentiation pathway driven by GATOR2 and mTORC1, and disruption of the GATOR2 in monocyte-lineage precursors prevented differentiation into inflammatory DCs in vivo. IDO-expressing DCs and monocytic cells were present across a range of human tumors. Thus, a BTK-IDO axis represses differentiation of inflammatory DCs during chemotherapy, with implications for targeted therapies.	[Sharma, Madhav D.; Pacholczyk, Rafal; Shi, Huidong; Berrong, Zuzana J.; Chang, Chang-Sheng S.; Bollag, Roni J.; Sadek, Ramses; Johnson, Theodore S.; Munn, David H.] Augusta Univ, Med Coll Georgia, Georgia Canc Ctr, Augusta, GA 30912 USA; [Sharma, Madhav D.; Johnson, Theodore S.; Munn, David H.] Augusta Univ, Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA; [Bollag, Roni J.; Kolhe, Ravindra] Augusta Univ, Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA; [Zakharia, Yousef; Greco, Austin] Univ Iowa, Dept Internal Med, Iowa City, IA 52242 USA; [Eathiraj, Sudharshan] ArQule, Burlington, MA 01803 USA; [Kennedy, Eugene] Lumos Pharma, Ames, IA 50010 USA; [Cash, Thomas] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [McGaha, Tracy L.] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada; [Rodriguez, Paulo; Mandula, Jessica] H Lee Moffitt Canc Ctr & Res Inst, Immunol Dept, Tampa, FL 33612 USA; [Blazar, Bruce R.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Blazar, Bruce R.] Univ Minnesota, Div Blood & Marrow Transplantat, Minneapolis, MN 55455 USA; [Chang, Chang-Sheng S.] Augusta Univ, Med Coll Georgia, Bioinformat Shared Resource, Georgia Canc Ctr, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; University of Iowa; Emory University; University of Toronto; H Lee Moffitt Cancer Center & Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University System of Georgia; Augusta University	Munn, DH (corresponding author), Augusta Univ, Med Coll Georgia, Georgia Canc Ctr, Augusta, GA 30912 USA.; Munn, DH (corresponding author), Augusta Univ, Med Coll Georgia, Dept Pediat, Augusta, GA 30912 USA.	dmunn@augusta.edu	Rodríguez, Paulo/HDM-9539-2022	Munn, David/0000-0002-7711-2858; KOLHE, RAVINDRA/0000-0002-8283-2403; Mandula, Jessica/0000-0003-2542-8073; Zakharia, Yousef/0000-0001-9480-2626; McGaha, Tracy/0000-0003-4721-9301; Rodriguez, Paulo/0000-0001-7480-6566; Shi, Huidong/0000-0003-1137-3390; Berrong, Zuzana/0000-0002-8692-4057	NIH [R01CA103320, R01CA211229]; Press-On Foundation; Beloco Foundation;  [R50CA232983];  [R01HL56067];  [R01HL11879]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Press-On Foundation; Beloco Foundation; ; ; 	The authors thank Anita Sharma, Joyce Wilson, and Gabriela Pacholczyk for expert technical assistance; Jeanene Pihkala and the Cancer Center Flow Cytometry Core for cell sorting; Eiko Kitamura and the Cancer Center Integrated Genomics Core for single-cell sequencing; and Dr. S. Chen, Rutgers University, for the gift of Tg(Grm1)Epv mice. This work was supported by NIH R01CA103320 and R01CA211229 (to D.H.M.); R50CA232983 (to M.D.S.); R01HL56067 and R01HL11879 (to B.R.B.); and support from the Press-On Foundation and the Beloco Foundation (to D.H.M. and T.S.J.).	Baban B, 2004, J REPROD IMMUNOL, V61, P67, DOI 10.1016/j.jri.2003.11.003; Balan S, 2018, CELL REP, V24, P1902, DOI 10.1016/j.celrep.2018.07.033; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bottcher JP, 2018, TRENDS CANCER, V4, P784, DOI 10.1016/j.trecan.2018.09.001; Bosteels C, 2020, IMMUNITY, V52, P1039, DOI 10.1016/j.immuni.2020.04.005; Bourdely P, 2020, IMMUNITY, V53, P335, DOI 10.1016/j.immuni.2020.06.002; Brown CC, 2019, CELL, V179, P846, DOI 10.1016/j.cell.2019.09.035; Broz ML, 2014, CANCER CELL, V26, P638, DOI 10.1016/j.ccell.2014.09.007; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cheng SJ, 2021, CELL, V184, P792, DOI 10.1016/j.cell.2021.01.010; Chu RS, 1997, J EXP MED, V186, P1623, DOI 10.1084/jem.186.10.1623; Ciampricotti M, 2012, NAT MED, V18, P344, DOI 10.1038/nm.2652; Cillo AR, 2020, IMMUNITY, V52, P183, DOI 10.1016/j.immuni.2019.11.014; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; de Streel G, 2021, BIOCHEM PHARMACOL, V192, DOI 10.1016/j.bcp.2021.114697; Domingos-Pereira S, 2019, CANCER IMMUNOL RES, V7, P621, DOI 10.1158/2326-6066.CIR-18-0671; Durai V, 2019, NAT IMMUNOL, V20, P1161, DOI 10.1038/s41590-019-0450-x; Dutertre CA, 2019, IMMUNITY, V51, P573, DOI 10.1016/j.immuni.2019.08.008; Gandhi L, 2018, NEW ENGL J MED, V378, P2078, DOI 10.1056/NEJMoa1801005; Gardner A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00924; Garris CS, 2020, CLIN CANCER RES, V26, P3901, DOI 10.1158/1078-0432.CCR-19-1321; Garris CS, 2018, IMMUNITY, V49, P1148, DOI 10.1016/j.immuni.2018.09.024; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; Gujar R, 2016, J IMMUNOL, V197, P1650, DOI 10.4049/jimmunol.1600104; Gunderson AJ, 2016, CANCER DISCOV, V6, P270, DOI 10.1158/2159-8290.CD-15-0827; Hettinger J, 2013, NAT IMMUNOL, V14, P821, DOI 10.1038/ni.2638; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hong D, 2019, ONCOLOGY-BASEL, V97, P102, DOI 10.1159/000500571; Hou DY, 2007, CANCER RES, V67, P792, DOI 10.1158/0008-5472.CAN-06-2925; Johnson TS, 2017, ADV EXP MED BIOL, V1036, P91, DOI 10.1007/978-3-319-67577-0_7; Jonuleit H, 1997, EUR J IMMUNOL, V27, P3135, DOI 10.1002/eji.1830271209; Kawakami Y, 2006, P NATL ACAD SCI USA, V103, P153, DOI 10.1073/pnas.0509784103; Leone RD, 2020, NAT REV CANCER, V20, P516, DOI 10.1038/s41568-020-0273-y; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Long GV, 2019, LANCET ONCOL, V20, P1083, DOI 10.1016/S1470-2045(19)30274-8; Maier B, 2020, NATURE, V580, P257, DOI 10.1038/s41586-020-2134-y; Mandal RK, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00810-7; Mangla A, 2004, BLOOD, V104, P1191, DOI 10.1182/blood-2004-01-0207; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Munn DH, 2004, J IMMUNOL, V172, P4100, DOI 10.4049/jimmunol.172.7.4100; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Oh SA, 2020, NAT CANCER, V1, P681, DOI 10.1038/s43018-020-0075-x; Orabona C, 2008, P NATL ACAD SCI USA, V105, P20828, DOI 10.1073/pnas.0810278105; Overman M, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-000587; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pallotta MT, 2022, FEBS J, V289, P6099, DOI 10.1111/febs.16086; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; R Core Team, 2021, R LANG ENV STAT COMP; Ravishankar B, 2012, P NATL ACAD SCI USA, V109, P3909, DOI 10.1073/pnas.1117736109; Reiff SD, 2018, CANCER DISCOV, V8, P1300, DOI 10.1158/2159-8290.CD-17-1409; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Salas-Benito D, 2021, CANCER DISCOV, V11, P1353, DOI 10.1158/2159-8290.CD-20-1312; Sharma MD, 2007, J CLIN INVEST, V117, P2570, DOI 10.1172/JCI31911; Sharma MD, 2018, IMMUNITY, V48, P91, DOI 10.1016/j.immuni.2017.12.014; Sharma MD, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500845; Sharma MD, 2013, IMMUNITY, V38, P998, DOI 10.1016/j.immuni.2013.01.013; Shin SS, 2008, PIGM CELL MELANOMA R, V21, P368, DOI 10.1111/j.1755-148X.2008.00452.x; Sonpavde G, 2020, FUTURE ONCOL, V16, P4359, DOI 10.2217/fon-2019-0611; Stiff A, 2016, CANCER RES, V76, P2125, DOI 10.1158/0008-5472.CAN-15-1490; Tsushima F, 2003, EUR J IMMUNOL, V33, P2773, DOI 10.1002/eji.200324084; van der Leun AM, 2020, NAT REV CANCER, V20, P218, DOI 10.1038/s41568-019-0235-4; Varikuti S, 2020, BRIT J CANCER, V122, P1005, DOI 10.1038/s41416-020-0743-8; Villar J, 2020, TRENDS IMMUNOL, V41, P1062, DOI 10.1016/j.it.2020.10.002; von Kortzfleisch VT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73503-4; Wolfson RL, 2017, CELL METAB, V26, P301, DOI 10.1016/j.cmet.2017.07.001; Yost KE, 2021, SCIENCE, V372, P130, DOI 10.1126/science.abd1329; Zakharia Y, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2020-002057; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009	70	13	13	5	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 12	2021	54	10					2354	+		10.1016/j.immuni.2021.09.005	http://dx.doi.org/10.1016/j.immuni.2021.09.005		OCT 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WG2VB	34614413	Green Accepted, Bronze			2022-12-18	WOS:000706854100020
J	Nakahama, T; Kato, Y; Shibuya, T; Inoue, M; Kim, JI; Vongpipatana, T; Todo, H; Xing, YF; Kawahara, Y				Nakahama, Taisuke; Kato, Yuki; Shibuya, Toshiharu; Inoue, Maal; Kim, Jung In; Vongpipatana, Tuangtong; Todo, Hiroyuki; Xing, Yanfang; Kawahara, Yukio			Mutations in the adenosine deaminase ADAR1 that prevent endogenous Z-RNA binding induce Aicardi-Goutieres-syndrome-like encephalopathy	IMMUNITY			English	Article							Z-ALPHA DOMAIN; EDITING ENZYME; Z-DNA; GENE; REVEALS; GENOME; DSRNA; SITES; IDENTIFICATION; TRANSCRIPTS	Mutations in the adenosine-to-inosine RNA-editing enzyme ADAR1 p150, including point mutations in the Z-RNA recognition domain Z alpha, are associated with Aicardi-Goutieres syndrome (AGS). Here, we examined the in vivo relevance of ADAR1 binding of Z-RNA. Mutation of W197 in Z alpha, which abolished Z-RNA binding, reduced RNA editing. Adar1(W197A/W197A) mice displayed severe growth retardation after birth, broad expression of interferon-stimulated genes (ISGs), and abnormal development of multiple organs. Notably, malformation of the brain was accompanied by white matter vacuolation and gliosis, reminiscent of AGS-associated encephalopathy. Concurrent deletion of the double-stranded RNA sensor MDA5 ameliorated these abnormalities. ADAR1 (W197A) expression increased in a feedback manner downstream of type I interferons, resulting in increased RNA editing at a subset of, but not all, ADAR1 target sites. This increased expression did not ameliorate inflammationin Adar1(W197A/W197A) mice. Thus, editing of select endogenous RNAs by ADAR1 is essential for preventing inappropriate MDA5-mediated inflammation, with relevance to the pathogenesis of AGS.	[Nakahama, Taisuke; Kato, Yuki; Shibuya, Toshiharu; Inoue, Maal; Kim, Jung In; Vongpipatana, Tuangtong; Todo, Hiroyuki; Xing, Yanfang; Kawahara, Yukio] Osaka Univ, Dept RNA Biol & Neurosci, Suita, Osaka 5650871, Japan; [Kato, Yuki; Kawahara, Yukio] Osaka Univ, Inst Open & Transdisciplinary Res Initiat OTRI, Integrated Frontier Res Med Sci Div, Suita, Osaka 5650871, Japan; [Kawahara, Yukio] Osaka Univ, Genome Editing Res & Dev Ctr, Grad Sch Med, Suita, Osaka 5650871, Japan	Osaka University; Osaka University; Osaka University	Kawahara, Y (corresponding author), Osaka Univ, Dept RNA Biol & Neurosci, Suita, Osaka 5650871, Japan.; Kawahara, Y (corresponding author), Osaka Univ, Inst Open & Transdisciplinary Res Initiat OTRI, Integrated Frontier Res Med Sci Div, Suita, Osaka 5650871, Japan.; Kawahara, Y (corresponding author), Osaka Univ, Genome Editing Res & Dev Ctr, Grad Sch Med, Suita, Osaka 5650871, Japan.	ykawahara@rna.med.osaka-u.ac.jp		Inoue, Maal/0000-0003-1142-1516	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [19K22580, 20H03341, 18K15186, 21K07080, 20J11266, 18K11526]; Japan Agency for Medical Research and Development (AMED) [JP20ek0109433, JP21ek0109433]; Tokyo Biochemical Research Foundation; Naito Foundation; Novartis; Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation; Osaka Medical Research Foundation for Intractable Diseases; Takeda Science Foundation; MEXT scholarships; Korean Scholarship Foundation; Japan Society for the Promotion of Science (JSPS)	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Tokyo Biochemical Research Foundation; Naito Foundation(Naito Memorial Foundation); Novartis(Novartis); Mochida Memorial Foundation for Medical and Pharmaceutical Research; Astellas Foundation for Research on Metabolic Disorders; Uehara Memorial Foundation(Uehara Memorial Foundation); Osaka Medical Research Foundation for Intractable Diseases; Takeda Science Foundation(Takeda Science Foundation (TSF)); MEXT scholarships(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Korean Scholarship Foundation; Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank all staff at the Genome Editing Research and Development Center, the Center for Medical Research and Education, the CoMIT Omics Center, and the Institute of Experimental Animal Sciences, Graduate School of Medicine, Osaka University, for technical support. We also thank Prof. P. Shing Ho at Colorado State University for providing ZHUNT source code. Computations were partially performed on the NIG supercomputer at ROIS National Institute of Genetics, Japan. This work was supported by Grants-in-Aid KAKENHI (19K22580 and 20H03341 to Y. Kawahara, 18K15186 and 21K07080 to T.N., 20J11266 to J.I.K., and 18K11526 to Y. Kato) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; a grant (JP20ek0109433 and JP21ek0109433 to T.N.) from the Japan Agency for Medical Research and Development (AMED); and grants from the Tokyo Biochemical Research Foundation (to Y. Kawahara), the Naito Foundation, Novartis, the Mochida Memorial Foundation for Medical and Pharmaceutical Research, Astellas Foundation for Research on Metabolic Disorders, the Uehara Memorial Foundation, the Osaka Medical Research Foundation for Intractable Diseases (to T.N.), and the Takeda Science Foundation (to Y. Kawahara and T.N.). F.X. was supported by MEXT scholarships. J.I.K. was supported by the Korean Scholarship Foundation. J.I.K. and T.V. were supported by a research fellowship for young scientists from the Japan Society for the Promotion of Science (JSPS).	Aguet F, 2017, NATURE, V550, P204, DOI 10.1038/nature24277; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Bazak L, 2014, GENOME RES, V24, P365, DOI 10.1101/gr.164749.113; Brown BA, 2000, P NATL ACAD SCI USA, V97, P13532, DOI 10.1073/pnas.240464097; Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887; Cruz PHC, 2020, RNA, V26, P454, DOI 10.1261/rna.072728.119; Cuadrado E, 2015, J IMMUNOL, V194, P3623, DOI 10.4049/jimmunol.1401334; Devos M, 2020, J EXP MED, V217, DOI 10.1084/jem.20191913; Galipon J, 2018, METHODS MOL BIOL, V1823, P167, DOI 10.1007/978-1-4939-8624-8_13; George CX, 1999, P NATL ACAD SCI USA, V96, P4621, DOI 10.1073/pnas.96.8.4621; George CX, 2005, J BIOL CHEM, V280, P15020, DOI 10.1074/jbc.M500476200; George CX, 2008, VIROLOGY, V380, P338, DOI 10.1016/j.virol.2008.07.029; Hartner JC, 2004, J BIOL CHEM, V279, P4894, DOI 10.1074/jbc.M311347200; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; Heraud-Farlow JE, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200085; Herbert A, 1997, P NATL ACAD SCI USA, V94, P8421, DOI 10.1073/pnas.94.16.8421; HERBERT A, 1995, P NATL ACAD SCI USA, V92, P7550, DOI 10.1073/pnas.92.16.7550; Herbert A, 2020, EUR J HUM GENET, V28, P114, DOI 10.1038/s41431-019-0458-6; Herbert A, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0237-x; Hsiao YHE, 2018, GENOME RES, V28, P812, DOI 10.1101/gr.231209.117; Huntley MA, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2291-9; Jiao HP, 2020, NATURE, V580, P391, DOI 10.1038/s41586-020-2129-8; Kawakubo K, 2000, GENE, V258, P165, DOI 10.1016/S0378-1119(00)00368-1; Kesavardhana S, 2020, J BIOL CHEM, V295, P8325, DOI 10.1074/jbc.RA120.013752; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim JI, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009516; Kiran AM, 2013, NUCLEIC ACIDS RES, V41, pD258, DOI 10.1093/nar/gks961; Koeris M, 2005, NUCLEIC ACIDS RES, V33, P5362, DOI 10.1093/nar/gki849; Lee AR, 2018, MOLECULES, V23, DOI 10.3390/molecules23112748; Lee CM, 2020, NUCLEIC ACIDS RES, V48, pD756, DOI 10.1093/nar/gkz1012; Levanon EY, 2005, NUCLEIC ACIDS RES, V33, P1162, DOI 10.1093/nar/gki239; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Licht K, 2019, GENOME RES, V29, P1453, DOI 10.1101/gr.242636.118; Liddicoat BJ, 2016, EXP HEMATOL, V44, P947, DOI 10.1016/j.exphem.2016.06.250; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Lo Giudice C, 2020, NAT PROTOC, V15, P1098, DOI 10.1038/s41596-019-0279-7; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Mannion NM, 2014, CELL REP, V9, P1482, DOI 10.1016/j.celrep.2014.10.041; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miyake K, 2016, CELL REP, V17, P2004, DOI 10.1016/j.celrep.2016.10.073; Nakahama T, 2020, CELL MOL LIFE SCI, V77, P2931, DOI 10.1007/s00018-020-03466-2; Nakahama T, 2018, EMBO REP, V19, DOI 10.15252/embr.201846303; Nichols PJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21039-0; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Nishimoto Y, 2008, NEUROSCI RES, V61, P201, DOI 10.1016/j.neures.2008.02.009; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Onizawa H, 2021, INT IMMUNOL, V33, P225, DOI 10.1093/intimm/dxaa073; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Pestal K, 2015, IMMUNITY, V43, P933, DOI 10.1016/j.immuni.2015.11.001; Placido D, 2007, STRUCTURE, V15, P395, DOI 10.1016/j.str.2007.03.001; Porath HT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5726; Ramaswami G, 2014, NUCLEIC ACIDS RES, V42, pD109, DOI 10.1093/nar/gkt996; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/NMETH.2330, 10.1038/nmeth.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414; Riedmann EM, 2008, RNA, V14, P1110, DOI 10.1261/rna.923308; Sase S, 2018, BRAIN PATHOL, V28, P399, DOI 10.1111/bpa.12600; Schade M, 1999, EMBO J, V18, P470, DOI 10.1093/emboj/18.2.470; SCHROTH GP, 1992, J BIOL CHEM, V267, P11846; Schwartz T, 2001, NAT STRUCT BIOL, V8, P761, DOI 10.1038/nsb0901-761; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Valente L, 2007, J BIOL CHEM, V282, P16054, DOI 10.1074/jbc.M611392200; van Heteren JT, 2008, GLIA, V56, P568, DOI 10.1002/glia.20639; Vongpipatana T, 2020, J IMMUNOL, V204, P2156, DOI 10.4049/jimmunol.1900929; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang Q, 2000, SCIENCE, V290, P1765, DOI 10.1126/science.290.5497.1765; Wang QD, 2004, J BIOL CHEM, V279, P4952, DOI 10.1074/jbc.M310162200; Ward SV, 2011, P NATL ACAD SCI USA, V108, P331, DOI 10.1073/pnas.1017241108; Zhang T, 2020, CELL, V180, P1115, DOI 10.1016/j.cell.2020.02.050; Zipeto MA, 2015, TRENDS MOL MED, V21, P549, DOI 10.1016/j.molmed.2015.07.001	72	13	13	2	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					1976	+		10.1016/j.immuni.2021.08.022	http://dx.doi.org/10.1016/j.immuni.2021.08.022		SEP 2021	20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34525338	Bronze			2022-12-18	WOS:000695789800009
J	Procaccini, C; Garavelli, S; Carbone, F; Di Silvestre, D; La Rocca, C; Greco, D; Colamatteo, A; Lepore, MT; Russo, C; De Rosa, G; Faicchia, D; Prattichizzo, F; Grossi, S; Campomenosi, P; Buttari, F; Mauri, P; Uccelli, A; Salvetti, M; Morra, VB; Vella, D; Galgani, M; Mottola, M; Zuccarelli, B; Lanzillo, R; Maniscalco, GT; Centonze, D; de Candia, P; Matarese, G				Procaccini, Claudio; Garavelli, Silvia; Carbone, Fortunata; Di Silvestre, Dario; La Rocca, Claudia; Greco, Dario; Colamatteo, Alessandra; Lepore, Maria Teresa; Russo, Claudia; De Rosa, Giusy; Faicchia, Deriggio; Prattichizzo, Francesco; Grossi, Sarah; Campomenosi, Paola; Buttari, Fabio; Mauri, Pierluigi; Uccelli, Antonio; Salvetti, Marco; Morra, Vincenzo Brescia; Vella, Danila; Galgani, Mario; Mottola, Maria; Zuccarelli, Bruno; Lanzillo, Roberta; Maniscalco, Giorgia Teresa; Centonze, Diego; de Candia, Paola; Matarese, Giuseppe			Signals of pseudo-starvation unveil the amino acid transporter SLC7A11 as key determinant in the control of Treg cell proliferative potential	IMMUNITY			English	Article							REGULATORY T-CELLS; RELEASE DIMETHYL FUMARATE; TRANSCRIPTION FACTOR NRF2; KEAP1-NRF2 PATHWAY; AUTOIMMUNE ENCEPHALOMYELITIS; CYSTINE TRANSPORTER; OXIDATIVE STRESS; LEPTIN; GENE; ACTIVATION	Human CD4(+)CD25(hi)FOXP3(+) regulatory T (Treg) cells are key players in the control of immunological self-tolerance and homeostasis. Here, we report that signals of pseudo-starvation reversed human Treg cell in vitro anergy through an integrated transcriptional response, pertaining to proliferation, metabolism, and transmembrane solute carrier transport. At the molecular level, the Treg cell proliferative response was dependent on the induction of the cystine/ glutamate antiporter solute carrier (SLC)7A11, whose expression was controlled by the nuclear factor erythroid 2-related factor 2 (NRF2). SLC7A11 induction in Treg cells was impaired in subjects with relapsing-remitting multiple sclerosis (RRMS), an autoimmune disorder associated with reduced Treg cell proliferative capacity. Treatment of RRMS subjects with dimethyl fumarate (DMF) rescued SLC7A11 induction and fully recovered Treg cell expansion. These results suggest a previously unrecognized mechanism that may account for the progressive loss of Treg cells in autoimmunity and unveil SLC7A11 as major target for the rescue of Treg cell proliferation.	[Procaccini, Claudio; Garavelli, Silvia; Carbone, Fortunata; La Rocca, Claudia; Lepore, Maria Teresa; Faicchia, Deriggio; Galgani, Mario; Matarese, Giuseppe] Consiglio Nazl Ric IEOS CNR, Ist Endocrinol & Oncol Sperimentale, Lab Immunol, I-80131 Naples, Italy; [Procaccini, Claudio; Carbone, Fortunata; Russo, Claudia] IRCCS Fdn Santa Lucia, Unita Neuroimmunol, I-00143 Rome, Italy; [Di Silvestre, Dario; Mauri, Pierluigi] Consiglio Nazl Ric ITB CNR, Ist Tecnol Biomed, I-20090 Milan, Italy; [Greco, Dario] Univ Helsinki, Inst Biotechnol, Helsinki 00014, Finland; [Greco, Dario] Tampere Univ, Fac Med & Hlth Technol, Tampere 33520, Finland; [Greco, Dario] Tampere Univ, Inst Biosci & Med Technol BioMediTech, Tampere 33520, Finland; [Colamatteo, Alessandra; De Rosa, Giusy; Galgani, Mario; Matarese, Giuseppe] Univ Napoli Federico II, Treg Cell Lab, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy; [Prattichizzo, Francesco; de Candia, Paola] IRCCS MultiMed, I-20138 Milan, Italy; [Grossi, Sarah; Campomenosi, Paola] Univ Insubria, Dipartimento Biotecnol & Sci Vita, I-21100 Varese, Italy; [Buttari, Fabio; Salvetti, Marco; Centonze, Diego] IRCCS Neuromed, Unita Neurol, I-86077 Pozzilli, Isernia, Italy; [Uccelli, Antonio] IRCCS Osped Policlin San Martino, I-16132 Genoa, Italy; [Uccelli, Antonio] Univ Genoa, Dipartimento Neurosci Riabilitaz Oftalmol Genet &, I-16132 Genoa, Italy; [Salvetti, Marco] Univ Roma La Sapienza, Ctr Neurol & Terapie Sperimentali, Dipartimento Neurosci Salute Mentale & Organi Sen, I-00189 Rome, Italy; [Morra, Vincenzo Brescia; Lanzillo, Roberta] Univ Napoli Federico II, Ctr Sclerosi Multipla, Dipartimento Neurosci Sci Riprodutt & Odontostoma, I-80131 Naples, Italy; [Vella, Danila] Fdn Ri MED, I-90133 Palermo, Italy; [Mottola, Maria; Zuccarelli, Bruno] Azienda Osped Specialist Colli, Unita Operat Complessa Med Trasfus, I-80131 Naples, Italy; [Maniscalco, Giorgia Teresa] Azienda Osped A Cardarelli, Ctr Reg Sclerosi Multipla, Dipartimento Neurol, I-80131 Naples, Italy; [Centonze, Diego] Univ Roma Tor Vergata, Lab Immunopatol Sinapt, Dipartimento Med Sistemi, I-00133 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); IRCCS Santa Lucia; Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR); University of Helsinki; Tampere University; Tampere University; University of Naples Federico II; IRCCS Multimedica; University of Insubria; IRCCS Neuromed; University of Genoa; Sapienza University Rome; University of Naples Federico II; Antonio Cardarelli Hospital; University of Rome Tor Vergata	Matarese, G (corresponding author), Consiglio Nazl Ric IEOS CNR, Ist Endocrinol & Oncol Sperimentale, Lab Immunol, I-80131 Naples, Italy.; Matarese, G (corresponding author), Univ Napoli Federico II, Treg Cell Lab, Dipartimento Med Mol & Biotecnol Med, I-80131 Naples, Italy.; de Candia, P (corresponding author), IRCCS MultiMed, I-20138 Milan, Italy.	paola.decandia@multimedica.it; giuseppe.matarese@unina.it	, Danila/AAM-3407-2021; de Candia, Paola/HGC-8826-2022; La Rocca, Claudia/AAB-2095-2022; de Candia, Paola/Z-1498-2019; Matarese, Giuseppe/AAO-4077-2021; di silvestre, dario/AAB-5037-2022; Carbone, Fortunata/K-3176-2016; Galgani, Mario/AAC-3298-2022; Prattichizzo, Francesco/J-3046-2018; Salvetti, Marco/K-3836-2016; Lanzillo, Roberta/AFA-8874-2022	, Danila/0000-0001-6251-3651; de Candia, Paola/0000-0003-4767-446X; de Candia, Paola/0000-0003-4767-446X; Matarese, Giuseppe/0000-0001-9429-0616; di silvestre, dario/0000-0002-7143-6229; Carbone, Fortunata/0000-0003-4299-6515; Prattichizzo, Francesco/0000-0002-2959-2658; Greco, Dario/0000-0001-9195-9003; Lanzillo, Roberta/0000-0001-6388-8180	Fondazione Italiana Sclerosi Multipla (FISM) [2016/R/18, 2018/S/5]; Progetti di Rilevante Interesse Nazionale (PRIN) [2017 K55HLC 001]; Ministero della Salute [RF-2019-12371111]; National Multiple Sclerosis Society (NMSS) [PP-160624687]; FISM [2016/R/10, 2018/R/4]; Juvenile Diabetes Research Foundation (JDRF) [1-SRA-2018-477-S-B]; Italian Ministry of Health [GR-2016-02363749, GR-2018-12366154, GR-2016-02362380, GR-2016-02363725]; JDRF [2-SRA-2018-479-S-B]; NMSS [PP-1804-30725]; Italian Ministry of Health Ricerca Corrente -IRCCS MultiMedica	Fondazione Italiana Sclerosi Multipla (FISM)(Fondazione Italiana Sclerosi Multipla (FISM)); Progetti di Rilevante Interesse Nazionale (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ministero della Salute(Ministry of Health, Italy); National Multiple Sclerosis Society (NMSS)(National Multiple Sclerosis Society); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Italian Ministry of Health(Ministry of Health, Italy); JDRF(Juvenile Diabetes Research Foundation); NMSS(National Multiple Sclerosis Society); Italian Ministry of Health Ricerca Corrente -IRCCS MultiMedica	G.M. is funded by Fondazione Italiana Sclerosi Multipla (FISM; grants 2016/R/18 and 2018/S/5), Progetti di Rilevante Interesse Nazionale (PRIN; grant 2017 K55HLC 001), and Ministero della Salute (grant RF-2019-12371111). P.d.C. is supported by the National Multiple Sclerosis Society (NMSS; grant PP-160624687), FISM (grants 2016/R/10 and 2018/R/4), and the Juvenile Diabetes Research Foundation (JDRF; grant 1-SRA-2018-477-S-B). C.P., F.B., and F.C. are supported by the Italian Ministry of Health (grants GR-2016-02363749 to C.P., GR-2018-12366154 to C.P. and F.B., GR-2016-02362380 to F.B., and GR-2016-02363725 to F.C.). M.G. is supported by the JDRF (grant 2-SRA-2018-479-S-B) and the NMSS (grant PP-1804-30725). S. Grossi is a PhD student of biotechnology, biosciences, and surgical technology at Universita` degli Studi dell'Insubria. The authors thank Maria Rosaria Montagna and Salvatore De Simone for technical help. This work has also been supported by Italian Ministry of Health Ricerca Corrente -IRCCS MultiMedica. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript. Schematic figures were created with images adapted from Smart Servier Medical Art (http://www.servier.fr/servier-medical-art).	Ang QY, 2020, CELL, V181, P1263, DOI 10.1016/j.cell.2020.04.027; Barbi J, 2013, IMMUNOL REV, V252, P52, DOI 10.1111/imr.12029; Becher J, 2018, DEV CELL, V47, P592, DOI 10.1016/j.devcel.2018.11.010; Berger T, 2019, MULT SCLER J-EXP TRA, V5, DOI 10.1177/2055217319887191; Carbone F, 2014, NAT MED, V20, P69, DOI 10.1038/nm.3411; Chan JL, 2006, P NATL ACAD SCI USA, V103, P8481, DOI 10.1073/pnas.0505429103; Choi IY, 2016, CELL REP, V15, P2136, DOI 10.1016/j.celrep.2016.05.009; Cignarella F, 2018, CELL METAB, V27, P1222, DOI 10.1016/j.cmet.2018.05.006; Conrad M, 2012, AMINO ACIDS, V42, P231, DOI 10.1007/s00726-011-0867-5; De Rosa V, 2007, IMMUNITY, V26, P241, DOI 10.1016/j.immuni.2007.01.011; De Rosa V, 2015, NAT IMMUNOL, V16, P1174, DOI 10.1038/ni.3269; Doncheva NT, 2019, J PROTEOME RES, V18, P623, DOI 10.1021/acs.jproteome.8b00702; Feuerer M, 2010, P NATL ACAD SCI USA, V107, P5919, DOI 10.1073/pnas.1002006107; Filadi R, 2018, CURR BIOL, V28, P369, DOI 10.1016/j.cub.2017.12.047; Garg SK, 2011, ANTIOXID REDOX SIGN, V15, P39, DOI 10.1089/ars.2010.3496; Gold R, 2017, MULT SCLER J, V23, P253, DOI 10.1177/1352458516649037; Gold R, 2016, NEUROL THER, V5, P45, DOI 10.1007/s40120-016-0042-8; Gout PW, 2001, LEUKEMIA, V15, P1633, DOI 10.1038/sj.leu.2402238; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hammer A, 2018, ANN CLIN TRANSL NEUR, V5, P668, DOI 10.1002/acn3.553; Harrison OJ, 2015, MUCOSAL IMMUNOL, V8, P1226, DOI 10.1038/mi.2015.13; He F, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134777; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Ishii T, 2014, REDOX BIOL, V2, P786, DOI 10.1016/j.redox.2014.04.008; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Johansson K, 2017, ANTIOXID REDOX SIGN, V26, P229, DOI 10.1089/ars.2015.6419; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Katsuragi Yoshinori, 2016, Current Opinion in Toxicology, V1, P54, DOI 10.1016/j.cotox.2016.09.005; Kesarwani P, 2013, ANTIOXID REDOX SIGN, V18, P1497, DOI 10.1089/ars.2011.4073; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Krishnamurthy P, 2016, IMMUNE NETW, V16, P201, DOI 10.4110/in.2016.16.4.201; Kurniawan H, 2020, CELL METAB, V31, P920, DOI 10.1016/j.cmet.2020.03.004; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lepesheva GI, 2004, MOL CELL ENDOCRINOL, V215, P165, DOI 10.1016/j.mce.2003.11.016; Leung CS, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0581-y; Levring TB, 2012, SCI REP-UK, V2, DOI 10.1038/srep00266; Liu YY, 2012, J IMMUNOL, V188, P2070, DOI 10.4049/jimmunol.1102835; Longo VD, 2010, TRENDS PHARMACOL SCI, V31, P89, DOI 10.1016/j.tips.2009.11.004; Luo YJ, 2017, ONCOTARGET, V8, P112530, DOI 10.18632/oncotarget.22486; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mak TW, 2017, IMMUNITY, V46, P675, DOI 10.1016/j.immuni.2017.03.019; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Matarese G, 2001, J IMMUNOL, V166, P5909, DOI 10.4049/jimmunol.166.10.5909; Matarese G, 2001, EUR J IMMUNOL, V31, P1324, DOI 10.1002/1521-4141(200105)31:5<1324::AID-IMMU1324>3.0.CO;2-Y; Matarese G, 2014, IMMUNOL LETT, V161, P174, DOI 10.1016/j.imlet.2013.12.012; Miragaia RJ, 2019, IMMUNITY, V50, P493, DOI 10.1016/j.immuni.2019.01.001; Nakamura E, 1999, J BIOL CHEM, V274, P3009, DOI 10.1074/jbc.274.5.3009; Negrotto L, 2016, JAMA NEUROL, V73, P520, DOI 10.1001/jamaneurol.2015.4807; Ohkura N, 2013, IMMUNITY, V38, P414, DOI 10.1016/j.immuni.2013.03.002; Ohl K, 2016, EXP NEUROL, V277, P58, DOI 10.1016/j.expneurol.2015.11.010; Owen DL, 2019, NAT IMMUNOL, V20, P195, DOI 10.1038/s41590-018-0289-6; Park Y, 2013, J CLIN INVEST, V123, P5165, DOI 10.1172/JCI69751; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Piccio L, 2008, J LEUKOCYTE BIOL, V84, P940, DOI 10.1189/jlb.0208133; Procaccini C, 2016, IMMUNITY, V44, P712, DOI 10.1016/j.immuni.2016.02.022; Procaccini C, 2012, J IMMUNOL, V189, P2941, DOI 10.4049/jimmunol.1200935; Procaccini C, 2010, IMMUNITY, V33, P929, DOI 10.1016/j.immuni.2010.11.024; Roy S, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S10; SAETRE R, 1978, ANAL BIOCHEM, V90, P684, DOI 10.1016/0003-2697(78)90161-6; Sanna V, 2003, J CLIN INVEST, V111, P241, DOI 10.1172/JCI200316721; Saravia J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaw6443; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Scardoni Giovanni, 2015, F1000Res, V4, P484; Scardoni G, 2009, BIOINFORMATICS, V25, P2857, DOI 10.1093/bioinformatics/btp517; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Sereni L, 2019, J ALLERGY CLIN IMMUN, V144, P825, DOI 10.1016/j.jaci.2019.03.012; Sha LK, 2015, FREE RADICAL BIO MED, V83, P77, DOI 10.1016/j.freeradbiomed.2015.02.004; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin CS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15074; Singh A, 2016, ACS CHEM BIOL, V11, P3214, DOI 10.1021/acschembio.6b00651; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Suzuki T, 2013, TRENDS PHARMACOL SCI, V34, P340, DOI 10.1016/j.tips.2013.04.005; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Wang RN, 2012, IMMUNOL REV, V249, P14, DOI 10.1111/j.1600-065X.2012.01155.x; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; Weil J, 2016, NAT IMMUNOL, V17, P277, DOI 10.1038/ni.3365; Ye P, 2014, MOL CELL BIOL, V34, P3421, DOI 10.1128/MCB.00221-14; Zhang CY, 2015, BIOMED PHARMACOTHER, V69, P242, DOI 10.1016/j.biopha.2014.12.008	81	13	14	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1543	+		10.1016/j.immuni.2021.04.014	http://dx.doi.org/10.1016/j.immuni.2021.04.014		JUL 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34004141	Bronze			2022-12-18	WOS:000672812100017
J	Schiller, M; Azulay-Debby, H; Boshnak, N; Elyahu, Y; Korin, B; Ben-Shaanan, TL; Koren, T; Krot, M; Hakim, F; Rolls, A				Schiller, Maya; Azulay-Debby, Hilla; Boshnak, Nadia; Elyahu, Yehezqel; Korin, Ben; Ben-Shaanan, Tamar L.; Koren, Tamar; Krot, Maria; Hakim, Fahed; Rolls, Asya			Optogenetic activation of local colonic sympathetic innervations attenuates colitis by limiting immune cell extravasation	IMMUNITY			English	Article							BETA-ADRENERGIC-RECEPTOR; NERVOUS-SYSTEM; TYROSINE-HYDROXYLASE; LEUKOCYTE TRAFFICKING; PSYCHOLOGICAL STRESS; NEUROPEPTIDE-Y; SOCIAL STRESS; 10-HZ RHYTHM; T-CELLS; IN-VIVO	The sympathetic nervous system is composed of an endocrine arm, regulating blood adrenaline and noradrenaline, and a local arm, a network of fibers innervating immune organs. Here, we investigated the impact of the local arm of the SNS in an inflammatory response in the colon. Intra-rectal insertion of an optogenetic probe in mice engineered to express channel rhodopsin-2 in tyrosine hydroxylase cells activated colonic sympathetic fibers. In contrast to systemic application of noradrenaline, local activation of sympathetic fibers attenuated experimental colitis and reduced immune cell abundance. Gene expression profiling showed decreased endothelial expression of the adhesion molecule MAdCAM-1 upon optogenetic stimulation; this decrease was sensitive to adrenergic blockers and 6-hydroxydopamine. Antibody blockade of MAdCAM-1 abrogated the optogenetic effect on immune cell extravasation into the colon and the pathology. Thus, sympathetic fibers control colonic inflammation by regulating immune cell extravasation from circulation, a mechanism likely relevant in multiple organs.	[Schiller, Maya; Azulay-Debby, Hilla; Boshnak, Nadia; Korin, Ben; Ben-Shaanan, Tamar L.; Koren, Tamar; Krot, Maria; Rolls, Asya] Technion Israel Inst Technol, Rappaport Fac Med, Dept Immunol, IL-3525422 Haifa, Israel; [Schiller, Maya; Azulay-Debby, Hilla; Boshnak, Nadia; Korin, Ben; Ben-Shaanan, Tamar L.; Koren, Tamar; Krot, Maria; Rolls, Asya] Technion Israel Inst Technol, Rappaport Fac Med, Dept Neurosci, IL-3525422 Haifa, Israel; [Schiller, Maya; Azulay-Debby, Hilla; Boshnak, Nadia; Korin, Ben; Ben-Shaanan, Tamar L.; Koren, Tamar; Krot, Maria; Rolls, Asya] Technion Integrated Canc Ctr, Technion Israel Inst Technol, IL-3525422 Haifa, Israel; [Elyahu, Yehezqel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Microbiol Immunol & Genet, IL-8410501 Beer Sheva, Israel; [Hakim, Fahed] EMMS Nazareth, Canc Res Ctr, IL-16100 Nazareth, Israel; [Hakim, Fahed] Bar Ilan Univ, Azrieli Fac Med, IL-1311502 Safed, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Ben Gurion University; Bar Ilan University	Rolls, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Immunol, IL-3525422 Haifa, Israel.; Rolls, A (corresponding author), Technion Israel Inst Technol, Rappaport Fac Med, Dept Neurosci, IL-3525422 Haifa, Israel.; Rolls, A (corresponding author), Technion Integrated Canc Ctr, Technion Israel Inst Technol, IL-3525422 Haifa, Israel.	rolls.asya@gmail.com		Rolls, Asya/0000-0001-5862-4287; Koren, Tamar/0000-0003-0387-462X; Korin, Ben/0000-0001-8867-7902; Schiller, Maya/0000-0001-5438-0174	Adelis Foundation; Allen and Jewel Prince Center for Neurodegenerative Processes of the Brain; Colleck Research Fund; European Commission Horizon 2020 research and innovation program [758952-ERC-2017-STG]	Adelis Foundation; Allen and Jewel Prince Center for Neurodegenerative Processes of the Brain; Colleck Research Fund; European Commission Horizon 2020 research and innovation program	We thank O. Barak for ``asking the right question,'' helpful discussions and for commenting on the manuscript; I. Kahn for the optogenetics equipment; O. Izhar and A. Aronhiem for sharing mice; A. Monsonego for assisting with immunohistochemistry; and M. Schwartz, M. Rivlin, I. Goshen, D. Farfara and S. Berger for helpful discussions. We are grateful to J. Schiller, B. Maman, and S. Schwartz for their advice and help with the calcium imaging experiments and S. Berlin and R. Heinrich for their help with the clearing technique. We thank S. Schwarzbaum and U. Rolls for editing the manuscript and O. Shenker, A. Grau, E. Suss-Toby, M. Holdengreber and M. Gurewitz for technical support. We are grateful to the Adelis Foundation, the Allen and Jewel Prince Center for Neurodegenerative Processes of the Brain, and Colleck Research Fund for their support. This project has received funding from the European Commission Horizon 2020 research and innovation program under grant agreement no. 758952-ERC-2017-STG (NEIMO). A.R is an international Howard Hughes Medical Institute HHMI-Wellcome Trust scholar.	ALTSCHULER SM, 1993, GASTROENTEROLOGY, V104, P502, DOI 10.1016/0016-5085(93)90419-D; Ando Tomoaki, 2007, BMC Physiology, V7, P10, DOI 10.1186/1472-6793-7-10; Anlauf M, 2003, J COMP NEUROL, V459, P90, DOI 10.1002/cne.10599; Bai A, 2009, CLIN EXP IMMUNOL, V156, P353, DOI 10.1111/j.1365-2249.2009.03894.x; Basar E, 2011, BRAIN-BODY-MIND IN THE NEBULOUS CARTESIAN SYSTEM: A HOLISTIC APPROACH BY OSCILLATIONS, P1, DOI 10.1007/978-1-4419-6136-5; BELL C, 1981, J NEUROCHEM, V36, P703, DOI 10.1111/j.1471-4159.1981.tb01645.x; Bellono NW, 2017, CELL, V170, DOI 10.1016/j.cell.2017.05.034; Ben-Shaanan TL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05283-5; Ben-Shaanan TL, 2016, NAT MED, V22, P940, DOI 10.1038/nm.4133; BERLIN C, 1993, CELL, V74, P185, DOI 10.1016/0092-8674(93)90305-A; Blaugrund E, 1996, DEVELOPMENT, V122, P309; Briskin M, 1997, AM J PATHOL, V151, P97; Browning KN, 2014, COMPR PHYSIOL, V4, P1339, DOI 10.1002/cphy.c130055; Brumovsky P, 2006, EXP NEUROL, V200, P153, DOI 10.1016/j.expneurol.2006.01.023; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Cheroutre H, 2011, NAT REV IMMUNOL, V11, P445, DOI 10.1038/nri3007; Cohen JA, 2019, CELL, V178, P919, DOI 10.1016/j.cell.2019.06.022; Coombes JL, 2008, NAT REV IMMUNOL, V8, P435, DOI 10.1038/nri2335; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Dantzer R, 2018, PHYSIOL REV, V98, P477, DOI 10.1152/physrev.00039.2016; Daubner SC, 2011, ARCH BIOCHEM BIOPHYS, V508, P1, DOI 10.1016/j.abb.2010.12.017; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI [10.1038/nmeth.f.324, 10.1038/NMETH.F.324]; Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Eichele DD, 2017, WORLD J GASTROENTERO, V23, P6016, DOI 10.3748/wjg.v23.i33.6016; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Fagarasan S, 2003, NAT REV IMMUNOL, V3, P63, DOI 10.1038/nri982; FELTEN DL, 1985, J IMMUNOL, V135, pS755; Flierl MA, 2008, MOL MED, V14, P195, DOI 10.2119/2007-00105.Flierl; Foster JA, 2013, TRENDS NEUROSCI, V36, P305, DOI 10.1016/j.tins.2013.01.005; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Godbout JP, 2006, J NEUROIMMUNE PHARM, V1, P421, DOI 10.1007/s11481-006-9036-0; Gracie DJ, 2019, LANCET GASTROENTEROL, V4, P632, DOI 10.1016/S2468-1253(19)30089-5; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Habtezion A, 2016, GASTROENTEROLOGY, V150, P340, DOI 10.1053/j.gastro.2015.10.046; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Han WF, 2018, CELL, V175, P887, DOI 10.1016/j.cell.2018.10.018; Hart A, 2002, ALIMENT PHARM THER, V16, P2017, DOI 10.1046/j.1365-2036.2002.01359.x; Janig W, 2014, AUTON NEUROSCI-BASIC, V182, P4, DOI 10.1016/j.autneu.2014.01.004; Johnson JD, 2005, NEUROSCIENCE, V135, P1295, DOI 10.1016/j.neuroscience.2005.06.090; Kaelberer MM, 2018, SCIENCE, V361, P1219, DOI 10.1126/science.aat5236; Karasawa N, 1997, DEV BRAIN RES, V99, P121, DOI 10.1016/S0165-3806(96)00203-9; Koelink PJ, 2018, J CROHNS COLITIS, V12, P794, DOI 10.1093/ecco-jcc/jjy035; KOSTRZEWA RM, 1974, PHARMACOL REV, V26, P199; KUBOTA A, 1995, NEUROSCI LETT, V196, P173, DOI 10.1016/0304-3940(95)11868-W; Kuhar M.J., 1999, PHARM REP, V61, P22; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Liu YZ, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00316; Lorton D, 2015, INT J MOL SCI, V16, P5635, DOI 10.3390/ijms16035635; MACKAY CR, 1993, IMMUNOL TODAY, V14, P99, DOI 10.1016/0167-5699(93)90205-Y; Marra S, 2005, J NEUROIMMUNOL, V158, P76, DOI 10.1016/j.jneuroim.2004.08.008; Maryanovich M, 2018, NAT MED, V24, P782, DOI 10.1038/s41591-018-0030-x; Mawdsley JE, 2005, GUT, V54, P1481, DOI 10.1136/gut.2005.064261; Meenan J, 1997, GUT, V40, P241, DOI 10.1136/gut.40.2.241; Montgomery KL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7577; Morey JN, 2015, CURR OPIN PSYCHOL, V5, P13, DOI 10.1016/j.copsyc.2015.03.007; Nance DM, 2007, BRAIN BEHAV IMMUN, V21, P736, DOI 10.1016/j.bbi.2007.03.008; Natale G, 2017, ARCH ITAL BIOL, V155, P118, DOI 10.12871/00039829201733; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; Obermayr F, 2013, NEUROGASTROENT MOTIL, V25, pe283, DOI 10.1111/nmo.12105; Ogawa H, 2005, AM J PHYSIOL-CELL PH, V288, pC272, DOI 10.1152/ajpcell.00406.2003; OOTSUKA Y, 1995, J AUTONOM NERV SYST, V54, P89, DOI 10.1016/0165-1838(94)00194-O; Pirzgalska RM, 2017, NAT MED, V23, P1309, DOI 10.1038/nm.4422; Pongratz G, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0504-2; Pullen N, 2009, BRIT J PHARMACOL, V157, P281, DOI 10.1111/j.1476-5381.2009.00137.x; Reichmann F, 2016, NEUROPEPTIDES, V55, P99, DOI 10.1016/j.npep.2015.09.008; RINNER I, 1992, BRAIN BEHAV IMMUN, V6, P130, DOI 10.1016/0889-1591(92)90013-E; Sanders VM, 2002, BRAIN BEHAV IMMUN, V16, P290, DOI 10.1006/brbi.2001.0639; Saunders PR, 2006, AUTON NEUROSCI-BASIC, V124, P56, DOI 10.1016/j.autneu.2005.12.002; Scanzano A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00171; Scheiermann C, 2012, IMMUNITY, V37, P290, DOI 10.1016/j.immuni.2012.05.021; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Sheng Yulan, 2018, Int J Physiol Pathophysiol Pharmacol, V10, P17; Sloan EK, 2007, J NEUROSCI, V27, P8857, DOI 10.1523/JNEUROSCI.1247-07.2007; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Steptoe A, 2007, BRAIN BEHAV IMMUN, V21, P901, DOI 10.1016/j.bbi.2007.03.011; Straub RH, 2006, GUT, V55, P1640, DOI 10.1136/gut.2006.091322; Suzuki K, 2016, J EXP MED, V213, P2567, DOI 10.1084/jem.20160723; Takahashi A, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00056; Taylor CT, 2007, AUTON NEUROSCI-BASIC, V133, P104, DOI 10.1016/j.autneu.2006.11.005; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Varol C, 2010, NAT REV IMMUNOL, V10, P415, DOI 10.1038/nri2778; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Veiga-Fernandes H, 2016, CELL, V165, P801, DOI 10.1016/j.cell.2016.04.041; Vermeire S, 2017, LANCET, V390, P135, DOI 10.1016/S0140-6736(17)30930-3; Viswanathan K, 2005, P NATL ACAD SCI USA, V102, P5808, DOI 10.1073/pnas.0501650102; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wehrwein EA, 2016, COMPR PHYSIOL, V6, P1239, DOI 10.1002/cphy.c150037; Wong CHY, 2011, SCIENCE, V334, P101, DOI 10.1126/science.1210301; Xie FC, 2015, J MED CHEM, V58, P5075, DOI 10.1021/acs.jmedchem.5b00468; Zadori ZS, 2016, J PHARMACOL EXP THER, V358, P483, DOI 10.1124/jpet.116.235101; Zhang L, 2018, MED SCI MONITOR, V24, P1802, DOI 10.12659/MSM.905151; Zukowska-Grojec Z, 1998, CIRC RES, V83, P187, DOI 10.1161/01.RES.83.2.187	95	13	13	2	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					1022	+		10.1016/j.immuni.2021.04.007	http://dx.doi.org/10.1016/j.immuni.2021.04.007		MAY 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33932356	Green Published, hybrid			2022-12-18	WOS:000652019500017
J	Deerhake, ME; Danzaki, K; Inoue, M; Cardakli, ED; Nonaka, T; Aggarwal, N; Barclay, WE; Ji, RR; Shinohara, ML				Deerhake, M. Elizabeth; Danzaki, Keiko; Inoue, Makoto; Cardakli, Emre D.; Nonaka, Toshiaki; Aggarwal, Nupur; Barclay, William E.; Ji, Ru-Rong; Shinohara, Mari L.			Dectin-1 limits autoimmune neuroinflammation and promotes myeloid cell-astrocyte crosstalk via Card9-independent expression of Oncostatin M	IMMUNITY			English	Article							MULTIPLE-SCLEROSIS; SUPPRESSOR-CELLS; GENE-EXPRESSION; RECEPTOR; SYSTEM; ZYMOSAN; CNS; MACROPHAGES; RECOGNITION; NEUTROPHILS	Pathologic roles of innate immunity in neurologic disorders are well described, but their beneficial aspects are less understood. Dectin-1, a C-type lectin receptor (CLR), is largely known to induce inflammation. Here, we report that Dectin-1 limited experimental autoimmune encephalomyelitis (EAE), while its down-stream signaling molecule, Card9, promoted the disease. Myeloid cells mediated the pro-resolution function of Dectin-1 in EAE with enhanced gene expression of the neuroprotective molecule, Oncostatin M (Osm), through a Card9-independent pathway, mediated by the transcription factor NFAT. Furthermore, we find that the Osm receptor (OsmR) functioned specifically in astrocytes to reduce EAE severity. Notably, Dectin-1 did not respond to heat-killed Mycobacteria, an adjuvant to induce EAE. Instead, endogenous Dectin-1 ligands, including galectin-9, in the central nervous system (CNS) were involved to limit EAE. Our study reveals a mechanism of beneficial myeloid cell-astrocyte crosstalk regulated by a Dectin-1 pathway and identifies potential therapeutic targets for autoimmune neuroinflammation.	[Deerhake, M. Elizabeth; Danzaki, Keiko; Inoue, Makoto; Cardakli, Emre D.; Nonaka, Toshiaki; Aggarwal, Nupur; Barclay, William E.; Shinohara, Mari L.] Duke Univ, Dept Immunol, Sch Med, Durham, NC 27710 USA; [Inoue, Makoto] Univ Illinois, Dept Comparat Biosci, Urbana, IL 61820 USA; [Ji, Ru-Rong] Duke Univ, Dept Anesthesiol, Sch Med, Durham, NC 27710 USA; [Shinohara, Mari L.] Duke Univ, Dept Mol Genet & Microbiol, Sch Med, Durham, NC 27710 USA	Duke University; University of Illinois System; University of Illinois Urbana-Champaign; Duke University; Duke University	Shinohara, ML (corresponding author), Duke Univ, Dept Immunol, Sch Med, Durham, NC 27710 USA.; Shinohara, ML (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Sch Med, Durham, NC 27710 USA.	mari.shinohara@duke.edu	Deerhake, M. Elizabeth/AGE-0680-2022; Ji, Ru-Rong/L-7070-2017; Deerhake, Marion/GXG-1688-2022	Deerhake, M. Elizabeth/0000-0003-4061-5766; Ji, Ru-Rong/0000-0002-9355-3688; Aggarwal, Nupur/0000-0002-7992-0023; Cardakli, Emre/0000-0002-8473-0558	National Multiple Sclerosis Society [PP-1509-06274, RG 4536B2/1]; NIH [F30-AI140497, T32-GM007171]	National Multiple Sclerosis Society(National Multiple Sclerosis Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the National Multiple Sclerosis Society (pilot grant PP-1509-06274 and research grant RG 4536B2/1), the NIH (R01-AI088100) to M.L.S., and the NIH (F30-AI140497 and T32-GM007171) to M.E.D.	Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Baldwin KT, 2015, P NATL ACAD SCI USA, V112, P2581, DOI 10.1073/pnas.1423221112; Bode K, 2019, CELL REP, V29, P4435, DOI 10.1016/j.celrep.2019.11.086; Brown BR, 2017, CLIN EXP IMMUNOL, V190, P293, DOI 10.1111/cei.13021; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Caravagna C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22872-y; Carlson T, 2008, J EXP MED, V205, P811, DOI 10.1084/jem.20072404; Casacuberta-Serra S, 2016, EXP NEUROL, V286, P50, DOI 10.1016/j.expneurol.2016.09.012; Chamessian A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25110-7; Chiba S, 2014, ELIFE, V3, DOI 10.7554/eLife.04177; Christy AL, 2013, J AUTOIMMUN, V42, P50, DOI 10.1016/j.jaut.2012.11.003; Daley D, 2017, NAT MED, V23, P556, DOI 10.1038/nm.4314; Deczkowska A, 2018, CELL, V173, P1073, DOI 10.1016/j.cell.2018.05.003; Deerhake ME, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02644; Dendrou CA, 2015, NAT REV IMMUNOL, V15, P545, DOI 10.1038/nri3871; Dillon S, 2006, J CLIN INVEST, V116, P916, DOI 10.1172/JCI27203; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Elliott DM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01782; Ensoli F, 2002, MULT SCLER J, V8, P284, DOI 10.1191/1352458502ms817oa; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Gensel JC, 2015, J NEUROSCI, V35, P9966, DOI 10.1523/JNEUROSCI.0337-15.2015; Glenn JD, 2019, J LEUKOCYTE BIOL, V105, P829, DOI 10.1002/JLB.4HI0818-335R; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Gour N, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aam9841; Griffiths MR, 2018, IMMUNOLOGY, V155, P346, DOI 10.1111/imm.12974; Gross O, 2006, NATURE, V442, P651, DOI 10.1038/nature04926; Guo S, 2015, J NEUROSCI, V35, P12047, DOI 10.1523/JNEUROSCI.1800-15.2015; Haroon F, 2011, J IMMUNOL, V186, P6521, DOI 10.4049/jimmunol.1001135; Hawkins RFW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96882; Hemond CC, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1245-2; Hendrickx DAE, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01810; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hertwig L, 2016, MULT SCLER J, V22, P160, DOI 10.1177/1352458515586084; Houben E, 2020, P NATL ACAD SCI USA, V117, P5028, DOI 10.1073/pnas.1912910117; Houben E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01165; Hsu YMS, 2007, NAT IMMUNOL, V8, P198, DOI 10.1038/ni1426; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Ikeda Y, 2008, BIOL PHARM BULL, V31, P13, DOI 10.1248/bpb.31.13; Ioannou M, 2012, J IMMUNOL, V188, P1136, DOI 10.4049/jimmunol.1101816; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Janssens K, 2015, GLIA, V63, P1729, DOI 10.1002/glia.22840; Karumuthil-Melethil S, 2014, J IMMUNOL, V193, P3308, DOI 10.4049/jimmunol.1400186; Kersey PJ, 2012, NUCLEIC ACIDS RES, V40, pD91, DOI 10.1093/nar/gkr895; Knier B, 2018, NAT IMMUNOL, V19, P1341, DOI 10.1038/s41590-018-0237-5; Larochelle A, 2016, BBA-MOL BASIS DIS, V1862, P310, DOI 10.1016/j.bbadis.2015.09.017; Law CL, 1996, MOL CELL BIOL, V16, P1305; Lee EJ, 2016, J IMMUNOL, V196, P3148, DOI 10.4049/jimmunol.1502355; LeibundGut-Landmann S, 2007, NAT IMMUNOL, V8, P630, DOI 10.1038/ni1460; Li HM, 2013, J NEUROIMMUNOL, V254, P28, DOI 10.1016/j.jneuroim.2012.08.013; Liu YD, 2015, J IMMUNOL, V195, P841, DOI 10.4049/jimmunol.1403063; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Pyz E, 2008, EUR J IMMUNOL, V38, P1157, DOI 10.1002/eji.200738057; R Core Team, 2020, R LANG ENV STAT COMP; Roesner LM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47769-2; Ruprecht K, 2001, J NEUROPATH EXP NEUR, V60, P1087, DOI 10.1093/jnen/60.11.1087; Sas AR, 2020, NAT IMMUNOL, V21, P1496, DOI 10.1038/s41590-020-00813-0; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seno A, 2015, EXP ANIM TOKYO, V64, P109, DOI 10.1538/expanim.14-0079; Shan MM, 2013, SCIENCE, V342, P447, DOI 10.1126/science.1237910; Shenderov K, 2013, J IMMUNOL, V190, P5722, DOI 10.4049/jimmunol.1203343; Slaets H, 2014, MOL NEUROBIOL, V50, P1142, DOI 10.1007/s12035-014-8795-5; Soulika AM, 2009, J NEUROSCI, V29, P14965, DOI 10.1523/JNEUROSCI.3794-09.2009; Stanojlovic M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160158; Steelman AJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0144-0; Steinbach K, 2013, J IMMUNOL, V191, P4531, DOI 10.4049/jimmunol.1202613; Stirling DP, 2009, J NEUROSCI, V29, P753, DOI 10.1523/JNEUROSCI.4918-08.2009; Stoppelkamp S, 2015, MOL IMMUNOL, V67, P398, DOI 10.1016/j.molimm.2015.07.002; Taylor PR, 2007, NAT IMMUNOL, V8, P31, DOI 10.1038/ni1408; Thiagarajan PS, 2013, CARDIOVASC RES, V99, P494, DOI 10.1093/cvr/cvt117; Uto T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11273; Vandenbroeck K, 2012, GENES IMMUN, V13, P21, DOI 10.1038/gene.2011.44; Voskuhl RR, 2019, P NATL ACAD SCI USA, V116, P10130, DOI 10.1073/pnas.1821306116; Voskuhl RR, 2009, J NEUROSCI, V29, P11511, DOI 10.1523/JNEUROSCI.1514-09.2009; Wallace PM, 1999, J IMMUNOL, V162, P5547; Wheeler MA, 2020, NATURE, V578, P593, DOI 10.1038/s41586-020-1999-0; Wheeler MA, 2019, CSH PERSPECT MED, V9, DOI 10.1101/cshperspect.a029009; Wlodarczyk A, 2019, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00523; Wu FL, 2010, HISTOCHEM CELL BIOL, V133, P313, DOI 10.1007/s00418-009-0673-2; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Ye XC, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-019-1693-z; Yonekawa A, 2014, IMMUNITY, V41, P402, DOI 10.1016/j.immuni.2014.08.005; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Young MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r14; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	87	13	13	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					484	+		10.1016/j.immuni.2021.01.004	http://dx.doi.org/10.1016/j.immuni.2021.01.004		MAR 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33581044	Green Accepted, Bronze			2022-12-18	WOS:000627409300015
J	Bernat, NV; Corcoran, M; Nowak, I; Kaduk, M; Dopico, XC; Narang, S; Maisonasse, P; Dereuddre-Bosquet, N; Murrell, B; Hedestam, GBK				Bernat, Nestor Vazquez; Corcoran, Martin; Nowak, Izabela; Kaduk, Mateusz; Dopico, Xaquin Castro; Narang, Sanjana; Maisonasse, Pauline; Dereuddre-Bosquet, Nathalie; Murrell, Ben; Hedestam, Gunilla B. Karlsson			Rhesus and cynomolgus macaque immunoglobulin heavy-chain genotyping yields comprehensive databases of germline VDJ alleles	IMMUNITY			English	Article							GENES; REPERTOIRE; HAPLOTYPES; SEQUENCES; ANTIBODY; REVEALS; BROAD	Definition of the specific germline immunoglobulin (Ig) alleles present in an individual is a critical first step to delineate the ontogeny and evolution of antigen-specific antibody responses. Rhesus and cynomolgus macaques are important animal models for pre-clinical studies, with four main sub-groups being used: Indianand Chinese-origin rhesus macaques and Mauritian and Indonesian cynomolgus macaques. We applied the (Ig) gene inference tool IgDiscover and performed extensive Sanger sequencing-based genomic validation to define germline VDJ alleles in these 4 sub-groups, comprising 45 macaques in total. There was allelic overlap between Chinese- and Indian-origin rhesus macaques and also between the two macaque species, which is consistent with substantial admixture. The island-restricted Mauritian cynomolgus population displayed the lowest number of alleles of the sub-groups, yet maintained high individual allelic diversity. These comprehensive databases of germline IGH alleles for rhesus and cynomolgus macaques provide a resource toward the study of B cell responses in these important pre-clinical models.	[Bernat, Nestor Vazquez; Corcoran, Martin; Nowak, Izabela; Kaduk, Mateusz; Dopico, Xaquin Castro; Narang, Sanjana; Murrell, Ben; Hedestam, Gunilla B. Karlsson] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden; [Maisonasse, Pauline; Dereuddre-Bosquet, Nathalie] Univ Paris Saclay, Ctr Immunol Viral Auto Immune Hematol & Bacterial, CEA, IMVA HB IDMIT,Inserm, F-92260 Fontenay Aux Roses, France; [Maisonasse, Pauline; Dereuddre-Bosquet, Nathalie] Univ Paris Saclay, Ctr Immunol Viral Auto Immune Hematol & Bacterial, CEA, IMVA HB IDMIT,Inserm, F-92260 Le Kremlin Bicetre, France	Karolinska Institutet; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Hedestam, GBK (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden.	gunilla.karlsson.hedestam@ki.se	Murrell, Ben/AAM-1188-2021; Hedestam, Gunilla Karlsson/AAN-9616-2021	Murrell, Ben/0000-0002-0393-4445; Castro Dopico, Xaquin/0000-0002-9005-6774; Maisonnasse, Pauline/0000-0002-0555-207X	European AIDS Vaccine Initiative (EAVI) [681137]; Swedish Research Council [2017-00968]; National Institutes of Health (NIH) [AI104722, AI078064, OD011092]; "Programme Investissements d'Avenir'' (PIA) by the ANR [ANR-11-INBS-0008]; Infectious Disease Models and Innovative Therapies (IDMIT, Fontenay-aux-Roses, France) infrastructure at CEA (LeGrand)	European AIDS Vaccine Initiative (EAVI); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); "Programme Investissements d'Avenir'' (PIA) by the ANR(French National Research Agency (ANR)); Infectious Disease Models and Innovative Therapies (IDMIT, Fontenay-aux-Roses, France) infrastructure at CEA (LeGrand)	We thank all of the personnel at the Astrid Fagraeus Laboratory at Karolinska Institutet for assistance with work related to NHPs. We also thank Nancy Haigwood, Ann Hessell, and David Spencer at the Oregon National Primate Research Center; Roger LeGrand at the CEA, IMVA-HB/IDMIT, Fontenayaux-Roses & Le Kremlin-Bicetre; and Karin Lore at Karolinska Institutet for generous sample contributions. This work was funded by a European AIDS Vaccine Initiative (EAVI) 2020 (681137) grant, a Distinguished Professor grant from the Swedish Research Council (grant agreement 2017-00968), grants from the National Institutes of Health (NIH) (P01 HIVRAD grant agreement AI104722 (Wyatt and Karlsson Hedestam), AI078064 (Haigwood), P51 grant agreement OD011092 (Oregon National Primate Research Center), and a "Programme Investissements d'Avenir'' (PIA) grant managed by the ANR reference ANR-11-INBS-0008, funding the Infectious Disease Models and Innovative Therapies (IDMIT, Fontenay-aux-Roses, France) infrastructure at CEA (LeGrand).	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Avnir Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20842; Bernat NV, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00660; Bible JM, 2003, IMMUNOGENETICS, V54, P867, DOI 10.1007/s00251-003-0536-2; Bonhomme M, 2009, J HERED, V100, P158, DOI 10.1093/jhered/esn093; Boyd SD, 2010, J IMMUNOL, V184, P6986, DOI 10.4049/jimmunol.1000445; Budde ML, 2010, IMMUNOGENETICS, V62, P773, DOI 10.1007/s00251-010-0481-9; Cirelli KM, 2019, CELL, V177, P1153, DOI 10.1016/j.cell.2019.04.012; Corcoran MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13642; Fu LF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182733; Gadala-Maria D, 2015, P NATL ACAD SCI USA, V112, pE862, DOI 10.1073/pnas.1417683112; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gidoni M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08489-3; Helmuth EF, 2000, IMMUNOGENETICS, V51, P519, DOI 10.1007/s002510000170; Howard WA, 2005, IMMUNOGENETICS, V57, P655, DOI 10.1007/s00251-005-0020-2; Howard WA, 2005, IMMUNOGENETICS, V57, P210, DOI 10.1007/s00251-005-0794-2; Huang JH, 2014, NATURE, V515, P138, DOI 10.1038/nature13601; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Kanthaswamy S, 2013, J MED PRIMATOL, V42, P120, DOI 10.1111/jmp.12043; Karl JA, 2017, IMMUNOGENETICS, V69, P211, DOI 10.1007/s00251-017-0969-7; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kidd MJ, 2012, J IMMUNOL, V188, P1333, DOI 10.4049/jimmunol.1102097; Kirik U, 2017, DATA BRIEF, V13, P620, DOI 10.1016/j.dib.2017.06.031; Kong R, 2019, CELL, V178, P567, DOI 10.1016/j.cell.2019.06.030; Kumar V, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz657; Lefranc MP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00022; Martinez-Murillo P, 2017, IMMUNITY, V46, P804, DOI 10.1016/j.immuni.2017.04.021; McKinney W., 2010, 9 PYTH SCI C SCIPY 2, DOI [10.25080/Majora-92bf1922-00a, DOI 10.25080/MAJORA-92BF1922-00A]; Ohlin M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00435; Osada N, 2015, GENOME BIOL EVOL, V7, P821, DOI 10.1093/gbe/evv033; Phad GE, 2020, J EXP MED, V217, DOI 10.1084/jem.20191155; Ramesh A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01407; Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024; Rosenfeld R, 2019, J IMMUNOL METHODS, V465, P67, DOI 10.1016/j.jim.2018.11.011; RStudioTeam, 2019, RSTUDIO INT DEV ENV; Street SL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-480; Sussman R.T.I., 1986, SW INDIAN OCEAN, V46; Tang Y, 2016, R J, V8, P474, DOI 10.32614/rj-2016-060; Thornqvist L, 2018, MOL IMMUNOL, V103, P1, DOI 10.1016/j.molimm.2018.08.018; Waskom M., 2017, MWASK SEAB V0 8 1, DOI [10.5281/zenodo.883859, DOI 10.5281/ZENODO.883859]; Watson CT, 2013, AM J HUM GENET, V92, P530, DOI 10.1016/j.ajhg.2013.03.004; Yu GY, 2016, IMMUNOGENETICS, V68, P417, DOI 10.1007/s00251-016-0921-2; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Zhang W, 2019, J IMMUNOL, V202, P1612, DOI 10.4049/jimmunol.1800342	44	13	13	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					355	+		10.1016/j.immuni.2020.12.018	http://dx.doi.org/10.1016/j.immuni.2020.12.018		FEB 2021	16	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33484642	hybrid			2022-12-18	WOS:000627407700017
J	Rajaram, S; Canaday, LM; Ochayon, DE; Rangel, KM; Ali, A; Gyurova, IE; Krishnamurthy, D; Fletcher, JS; Reighard, SD; Cox, A; Weirauch, MT; Kottyan, LC; Deshmukh, H; Zacharias, WJ; Borchers, MT; Waggoner, SN				Rajaram, Sanjeeth; Canaday, Laura M.; Ochayon, David E.; Rangel, Kelly M.; Ali, Ayad; Gyurova, Ivayla E.; Krishnamurthy, Durga; Fletcher, Jonathan S.; Reighard, Seth D.; Cox, Andrew; Weirauch, Matthew T.; Kottyan, Leah C.; Deshmukh, Hitesh; Zacharias, William J.; Borchers, Michael T.; Waggoner, Stephen N.			The Promise and Peril of Natural Killer Cell Therapies in Pulmonary Infection	IMMUNITY			English	Letter							PATHOGENESIS; INJURY		[Rajaram, Sanjeeth; Canaday, Laura M.; Ochayon, David E.; Rangel, Kelly M.; Ali, Ayad; Gyurova, Ivayla E.; Krishnamurthy, Durga; Weirauch, Matthew T.; Kottyan, Leah C.; Waggoner, Stephen N.] Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA; [Rajaram, Sanjeeth] Univ Cincinnati, Coll Med, Med Sci Undergrad Program, Cincinnati, OH USA; [Canaday, Laura M.; Ali, Ayad; Weirauch, Matthew T.; Kottyan, Leah C.; Deshmukh, Hitesh; Waggoner, Stephen N.] Univ Cincinnati, Coll Med, Immunol Grad Program, Cincinnati, OH 45221 USA; [Rangel, Kelly M.] Univ Cincinnati, Coll Med, Biomed Res Technol Program, Cincinnati, OH USA; [Rangel, Kelly M.; Weirauch, Matthew T.; Zacharias, William J.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Ali, Ayad; Fletcher, Jonathan S.; Reighard, Seth D.; Kottyan, Leah C.; Deshmukh, Hitesh; Zacharias, William J.; Waggoner, Stephen N.] Univ Cincinnati, Coll Med, Med Scientist Training Program, Cincinnati, OH 45221 USA; [Gyurova, Ivayla E.; Waggoner, Stephen N.] Univ Cincinnati, Coll Med, Pathobiol & Mol Med Grad Program, Cincinnati, OH 45221 USA; [Cox, Andrew] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Pediat Residency, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.] Cincinnati Childrens Hosp Med Ctr, Div Biomed Informat, Cincinnati, OH 45229 USA; [Weirauch, Matthew T.; Kottyan, Leah C.; Deshmukh, Hitesh; Zacharias, William J.; Waggoner, Stephen N.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA; [Kottyan, Leah C.] Cincinnati Childrens Hosp Med Ctr, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Deshmukh, Hitesh] Cincinnati Childrens Hosp Med Ctr, Div Neonatol, Cincinnati, OH 45229 USA; [Deshmukh, Hitesh; Zacharias, William J.] Cincinnati Childrens Hosp Med Ctr, Div Pulm Biol, Cincinnati, OH 45229 USA; [Zacharias, William J.] Univ Cincinnati, Coll Med, Dept Med, Cincinnati, OH USA; [Zacharias, William J.; Borchers, Michael T.] Univ Cincinnati, Coll Med, Dept Internal Med, Div Pulm Crit Care & Sleep Med, Cincinnati, OH USA; [Borchers, Michael T.] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center	Waggoner, SN (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Autoimmune Genom & Etiol, Cincinnati, OH 45229 USA.; Waggoner, SN (corresponding author), Univ Cincinnati, Coll Med, Immunol Grad Program, Cincinnati, OH 45221 USA.; Waggoner, SN (corresponding author), Univ Cincinnati, Coll Med, Med Scientist Training Program, Cincinnati, OH 45221 USA.; Waggoner, SN (corresponding author), Univ Cincinnati, Coll Med, Pathobiol & Mol Med Grad Program, Cincinnati, OH 45221 USA.; Waggoner, SN (corresponding author), Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45221 USA.	stephen.waggoner@cchmc.org		Rajaram, Sanjeeth/0000-0002-9336-422X; Zacharias, William/0000-0002-2643-0610; Canaday, Laura/0000-0002-8053-2431; Kottyan, Leah/0000-0003-3979-2220; Ohayon, David/0000-0002-5226-5110; Deshmukh, Hitesh/0000-0001-9632-164X; Ali, Ayad/0000-0002-0213-9511; Cox, Andrew/0000-0003-3485-8892; Gyurova, Ivayla/0000-0001-8615-6193	NIH [AI148080, DA038017, AR073228, DK107502, NS099068, HL140178, HL142708, T32 AI118697, T32GM063483, HL141236]; Veteran's Administration [I01BX002347]; American Heart Association	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veteran's Administration(US Department of Veterans Affairs); American Heart Association(American Heart Association)	Funding for this study was provided by NIH grants AI148080 and DA038017 (S.N.W.), AR073228 (S.N.W., L.C.K., and M.T.W.), DK107502 (L.C.K.), NS099068 (M.T.W.), HL140178 (W.Z.), HL142708 (H.D.), T32 AI118697 (A.A.), T32GM063483 (A.A., J.S.F., and S.D.R.) and HL141236; the Veteran's Administration I01BX002347 (M.T.B.); and a postdoctoral fellowship from the American Heart Association (D.E.O.).	Abdul-Careem MF, 2012, J INFECT DIS, V206, P167, DOI 10.1093/infdis/jis340; Cifaldi L, 2015, ARTHRITIS RHEUMATOL, V67, P3037, DOI 10.1002/art.39295; Cong JJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01416; Fan XX, 2021, J INVEST SURG, V34, P826, DOI 10.1080/08941939.2019.1698679; Harker JA, 2010, J VIROL, V84, P4073, DOI 10.1128/JVI.02014-09; Kang L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00101; Li FA, 2012, J VIROL, V86, P2251, DOI 10.1128/JVI.06209-11; Liao M., 2020, CUREUS, DOI [10.1101/2020.02.23.20026690, DOI 10.1038/S41591-020-0901-9, 10.1101/2020.02.23.20026690v1]; Liu EL, 2020, NEW ENGL J MED, V382, P545, DOI 10.1056/NEJMoa1910607; Marquardt N, 2017, J ALLERGY CLIN IMMUN, V139, P1321, DOI 10.1016/j.jaci.2016.07.043; McKinstry KK, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007989; Mostafa HH, 2018, J VIROL, V92; Okamoto M, 2002, BLOOD, V99, P1289, DOI 10.1182/blood.V99.4.1289; Romee R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2341	14	13	14	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 16	2020	52	6					887	889		10.1016/j.immuni.2020.04.018	http://dx.doi.org/10.1016/j.immuni.2020.04.018			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MA4MT	32405233	Green Published, Bronze			2022-12-18	WOS:000541890000001
J	van Maldegem, F; Downward, J				van Maldegem, Febe; Downward, Julian			Mutant KRAS at the Heart of Tumor Immune Evasion	IMMUNITY			English	Editorial Material								In the search for therapeutic combinations for the treatment of cancer, the pairing of targeted inhibitors of oncogenic driver pathways with immunotherapy has largely been overlooked. In Nature, Canon et al. (2019) describe how the novel KRAS-G12C inhibitor AMG 510 can potentiate immune rejection in combination with immune checkpoint blockade.	[van Maldegem, Febe; Downward, Julian] Francis Crick Inst, Oncogene Biol, London NW1 1AT, England; [Downward, Julian] Inst Canc Res, Lung Canc Grp, London SW3 6JB, England	Francis Crick Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University College London	van Maldegem, F; Downward, J (corresponding author), Francis Crick Inst, Oncogene Biol, London NW1 1AT, England.; Downward, J (corresponding author), Inst Canc Res, Lung Canc Grp, London SW3 6JB, England.	febe.vanmaldegem@crick.ac.uk; julian.downward@crick.ac.uk		van Maldegem, Febe/0000-0002-2544-544X; Downward, Julian/0000-0002-2331-4729				Ascierto PA, 2019, NAT MED, V25, P941, DOI 10.1038/s41591-019-0448-9; Bardia A, 2020, ONCOLOGIST, V25, pE160, DOI 10.1634/theoncologist.2019-0297; Canon J, 2019, NATURE, V575, P217, DOI 10.1038/s41586-019-1694-1; Cullis J, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a031849; Hallin J, 2020, CANCER DISCOV, V10, P54, DOI 10.1158/2159-8290.CD-19-1167; Janne PA, 2017, JAMA-J AM MED ASSOC, V317, P1844, DOI 10.1001/jama.2017.3438; McCormick F, 2019, BIOCHEM J, V476, P365, DOI 10.1042/BCJ20170441; Molina-Arcas M, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aaw7999; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Stroppa A., 2019, INSTAGRAM COUNTERFEI	10	13	13	1	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					14	16		10.1016/j.immuni.2019.12.013	http://dx.doi.org/10.1016/j.immuni.2019.12.013			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31951548	Bronze			2022-12-18	WOS:000507384600006
J	Evavold, CL; Kagan, JC				Evavold, Charles L.; Kagan, Jonathan C.			Defying Death: The (W)hole Truth about the Fate of GSDMD Pores	IMMUNITY			English	Editorial Material							DOWNSTREAM; PYROPTOSIS; SECRETION; ACTS	Pyroptosis is an inflammatory cell death response initiated by supramolecular organizing centers known as inflammasomes. In a recent issue of Science, Ruhl et al. (2018) challenge the paradigm that inflammasome signaling necessitates pyroptosis by demonstrating that ESCRTIII-dependent membrane repair can delay or prevent gasdermin D-mediated cell death.	[Evavold, Charles L.; Kagan, Jonathan C.] Harvard Med Sch, Boston, MA 02115 USA; [Evavold, Charles L.; Kagan, Jonathan C.] Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA; [Evavold, Charles L.; Kagan, Jonathan C.] Harvard Med Sch, Program Immunol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Kagan, JC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Kagan, JC (corresponding author), Boston Childrens Hosp, Div Gastroenterol, Boston, MA 02115 USA.; Kagan, JC (corresponding author), Harvard Med Sch, Program Immunol, Boston, MA 02115 USA.	jonathan.kagan@childrens.harvard.edu		Evavold, Charles/0000-0003-3913-5626	NIH [AI133524, AI093589, AI116550, P30DK34854]; Harvard Herchel Smith Fellowship; Landry Cancer Biology Fellowship; Albert J. Ryan Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI093589, R01AI116550, U19AI133524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034854] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Herchel Smith Fellowship; Landry Cancer Biology Fellowship; Albert J. Ryan Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the NIH grants AI133524, AI093589, AI116550, and P30DK34854 to J.C.K. C.L.E. is supported by the Harvard Herchel Smith, Landry Cancer Biology, and Albert J. Ryan Fellowships.	Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Cooper ST, 2015, PHYSIOL REV, V95, P1205, DOI 10.1152/physrev.00037.2014; Evavold CL, 2018, IMMUNITY, V48, P35, DOI 10.1016/j.immuni.2017.11.013; Gong YN, 2017, CELL, V169, P286, DOI 10.1016/j.cell.2017.03.020; Heilig R, 2018, EUR J IMMUNOL, V48, P584, DOI 10.1002/eji.201747404; Kovacs SB, 2017, TRENDS CELL BIOL, V27, P673, DOI 10.1016/j.tcb.2017.05.005; Liu X, 2016, NATURE, V535, P153, DOI 10.1038/nature18629; Ruhl S, 2018, SCIENCE, V362, P956, DOI 10.1126/science.aar7607; Wolf AJ, 2016, CELL, V166, P624, DOI 10.1016/j.cell.2016.05.076; Zanoni I, 2016, SCIENCE, V352, P1232, DOI 10.1126/science.aaf3036	10	13	15	3	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					15	17		10.1016/j.immuni.2018.12.032	http://dx.doi.org/10.1016/j.immuni.2018.12.032			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30650374	Green Accepted, Bronze			2022-12-18	WOS:000455661600007
J	Haase, H				Haase, Hajo			Innate Immune Cells Speak Manganese	IMMUNITY			English	Editorial Material							MICE	Some metal ions, such as Ca2+ and Zn2+, are involved in intracellular communication in immune cells by acting as second messengers. In this issue of Immunity, Wang et al. (2018) present findings implying a similar role for an additional metal ion, by showing that manganese participates in the recognition of cytoplasmic DNA.	[Haase, Hajo] Berlin Inst Technol, Dept Food Chem & Toxicol, Gustav Meyer Allee 25, D-13355 Berlin, Germany; [Haase, Hajo] TraceAge DFG Res Unit Interact Essential Trace El, Potsdam, Germany	Technical University of Berlin	Haase, H (corresponding author), Berlin Inst Technol, Dept Food Chem & Toxicol, Gustav Meyer Allee 25, D-13355 Berlin, Germany.; Haase, H (corresponding author), TraceAge DFG Res Unit Interact Essential Trace El, Potsdam, Germany.	haase@tu-berlin.de	Haase, Hajo/B-9280-2009	Haase, Hajo/0000-0002-1622-8718	Deutsche Forschungsgemeinschaft (TraceAge - DFG Research Unit on Interactions of essential trace elements in healthy and diseased elderly, Potsdam-Berlin-Jena) [FOR 2558/1, HA 4318/4-1]	Deutsche Forschungsgemeinschaft (TraceAge - DFG Research Unit on Interactions of essential trace elements in healthy and diseased elderly, Potsdam-Berlin-Jena)	The work of the author is supported by the Deutsche Forschungsgemeinschaft (TraceAge - DFG Research Unit on Interactions of essential trace elements in healthy and diseased elderly, Potsdam-Berlin-Jena, FOR 2558/1, HA 4318/4-1).	[Anonymous], [No title captured]; Aschner Judy L., 2005, Molecular Aspects of Medicine, V26, P353, DOI 10.1016/j.mam.2005.07.003; Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; Chen P, 2015, J NEUROCHEM, V134, P601, DOI 10.1111/jnc.13170; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Maares M, 2016, ARCH BIOCHEM BIOPHYS, V611, P58, DOI 10.1016/j.abb.2016.03.022; SMIALOWICZ RJ, 1988, IMMUNOPHARM IMMUNOT, V10, P93, DOI 10.3109/08923978809014404; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Wang CG, 2018, IMMUNITY, V48, P675, DOI 10.1016/j.immuni.2018.03.017	10	13	13	3	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2018	48	4					616	618		10.1016/j.immuni.2018.03.031	http://dx.doi.org/10.1016/j.immuni.2018.03.031			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD0OA	29669242	Bronze			2022-12-18	WOS:000430198900006
J	Cullen, BR				Cullen, Bryan R.			RNA Interference in Mammals: The Virus Strikes Back	IMMUNITY			English	Editorial Material							INFLUENZA-A VIRUS; CELLS	The importance of RNA interference (RNAi) as a mammalian antiviral defense mechanism has been controversial. Qiu et al. (2017) now present data suggesting that the difficulty of detecting RNAi in virus-infected mammalian cells reflects the expression of highly effective viral suppressors of RNAi.	[Cullen, Bryan R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA; [Cullen, Bryan R.] Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27710 USA	Duke University; Duke University	Cullen, BR (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27710 USA.; Cullen, BR (corresponding author), Duke Univ, Med Ctr, Ctr Virol, Durham, NC 27710 USA.	bryan.cullen@duke.edu						Benitez AA, 2015, CELL REP, V13, P1456, DOI 10.1016/j.celrep.2015.10.020; Bogerd HP, 2014, J VIROL, V88, P8065, DOI 10.1128/JVI.00985-14; Bucher E, 2004, J GEN VIROL, V85, P983, DOI 10.1099/vir.0.19734-0; Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011; Garcia-Sastre A, 1998, VIROLOGY, V252, P324, DOI 10.1006/viro.1998.9508; Kennedy EM, 2015, P NATL ACAD SCI USA, V112, pE6945, DOI 10.1073/pnas.1513421112; Li Y, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.250; Maillard PV, 2016, EMBO J, V35, P2505, DOI 10.15252/embj.201695086; Parameswaran P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000764; Qiu Y, 2017, IMMUNITY, V46, P992, DOI 10.1016/j.immuni.2017.05.006	10	13	13	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 20	2017	46	6					970	972		10.1016/j.immuni.2017.05.004	http://dx.doi.org/10.1016/j.immuni.2017.05.004			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0RM	28636964	Bronze			2022-12-18	WOS:000403665900007
J	Miner, JJ; Diamond, MS				Miner, Jonathan J.; Diamond, Michael S.			Dengue Antibodies, then Zika: A Fatal Sequence in Mice	IMMUNITY			English	Editorial Material							VIRUS; PATHOGENESIS; ENHANCEMENT	Anti-Dengue virus (DENV) antibodies can be either protective or pathogenic in humans with prior DENV infection. In a recent issue of Science, Bardina et al. (2017) demonstrated that passive transfer of immune plasma against DENV and West Nile virus (WNV) can enhance Zika virus (ZIKV) infection and pathogenesis in mice.	[Miner, Jonathan J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Miner, Jonathan J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Miner, Jonathan J.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Ctr Human Immunol, St Louis, MO 63110 USA; [Diamond, Michael S.] Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Miner, JJ; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.; Miner, JJ; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.; Miner, JJ; Diamond, MS (corresponding author), Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Ctr Human Immunol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Immunotherapy Programs, St Louis, MO 63110 USA.	miner@wustl.edu; diamond@wusm.wustl.edu	Diamond, Michael/AAH-1733-2019	Diamond, Michael/0000-0002-8791-3165				Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009; HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268; Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015; Simister NE, 1996, EUR J IMMUNOL, V26, P1527, DOI 10.1002/eji.1830260718; Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258; Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128	10	13	13	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 16	2017	46	5					771	773		10.1016/j.immuni.2017.04.023	http://dx.doi.org/10.1016/j.immuni.2017.04.023			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EU8VJ	28514683	Bronze			2022-12-18	WOS:000401316300012
J	Sparks, R; Lau, WW; Tsang, JS				Sparks, Rachel; Lau, William W.; Tsang, John S.			Expanding the Immunology Toolbox: Embracing Public-Data Reuse and Crowdsourcing	IMMUNITY			English	Article							GENOME-WIDE ASSOCIATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROTEIN-PROTEIN INTERACTION; MICROARRAY EXPERIMENT MIAME; GENE-EXPRESSION PROFILES; MOLECULAR CLASSIFICATION; RHEUMATOID-ARTHRITIS; BIG DATA; STATISTICAL CONSIDERATIONS; METAANALYSIS METHODS	New technologies have been propelling dramatic increases in the volume and diversity of large-scale public data, which can potentially be reused to answer questions beyond those originally envisioned. However, this often requires computational and statistical skills beyond the reach of most bench scientists. The development of educational and accessible computational tools is thus critical, as are crowdsourcing efforts that utilize the community's expertise to curate public data for hypothesis generation and testing. Here we review the history of public-data reuse and argue for greater incorporation of computational and statistical sciences into the biomedical education curriculum and the development of biologist-friendly crowdsourcing tools. Finally, we provide a resource list for the reuse of public data and highlight an illustrative crowdsourcing exercise to explore public gene-expression data of human autoimmune diseases and corresponding mouse models. Through education, tool development, and community engagement, immunologists will be poised to transform public data into biological insights.	[Sparks, Rachel; Tsang, John S.] NIAID, Syst Genom & Bioinformat Unit, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Lau, William W.] NIH, Off Intramural Res, Ctr Informat Technol, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT)	Tsang, JS (corresponding author), NIAID, Syst Genom & Bioinformat Unit, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	john.tsang@nih.gov			Intramural Programs of the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH; Center for Information Technology (CIT) at the NIH; CENTER FOR INFORMATION TECHNOLOGY [ZIHCT000200] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001152] Funding Source: NIH RePORTER	Intramural Programs of the National Institute of Allergy and Infectious Diseases (NIAID) at the NIH; Center for Information Technology (CIT) at the NIH; CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the jamboree participants for their contributions, including data gathering, annotation, comparison-group formation via OMiCC, as well as feedback on the manuscript. Participants include (listed alphabetically by last name): James Austin, Julian Candia, William Coley, Ehren Dancy, Karen L. Elkins, Sara Faghihi-Kashani, Julio Gomez-Rodriguez, Liliana Guedez, Maria J. Gutierrez, Trung Ho, Reiko Horai, Sunmee Huh, Chie Iwamura, Jaimy Joy, Ju-Gyeong Kang, Sunil Kaul, Laura B. Lewandowski, Nathan P. Manes, Mary J. Mattapallil, Sarfraz Memon, M. Jubayer Rahman, Kameron B. Rodrigues, Bruno Silva, Amit Singh, Anthony J. St. Leger, Jessica Tang, Hang Xie, Yongge Zhao, and Ofer Zimmerman. We also thank Neha Bansal, Candace Liu, and Abigail Thorpe for assisting with the jamboree; Yongjian Guo and Yong Lu for OMiCC support; BCBB/OCICB of NIAID for providing computing support and web hosting; NIH Facilities for providing the OMiCC Jamboree hosting venue; and members of the J.S.T. lab for discussions. This research was funded by the Intramural Programs of the National Institute of Allergy and Infectious Diseases (NIAID) and the Center for Information Technology (CIT) at the NIH.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Aghaeepour N, 2013, NAT METHODS, V10, P228, DOI [10.1038/NMETH.2365, 10.1038/nmeth.2365]; Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Andres-Terre M, 2015, IMMUNITY, V43, P1199, DOI 10.1016/j.immuni.2015.11.003; Baechler EC, 2003, P NATL ACAD SCI USA, V100, P2610, DOI 10.1073/pnas.0337679100; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Begum F, 2012, NUCLEIC ACIDS RES, V40, P3777, DOI 10.1093/nar/gkr1255; Bendall SC, 2012, TRENDS IMMUNOL, V33, P323, DOI 10.1016/j.it.2012.02.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett L, 2003, J EXP MED, V197, P711, DOI 10.1084/jem.20021553; Bhattacharya S, 2014, IMMUNOL RES, V58, P234, DOI 10.1007/s12026-014-8516-1; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brazma A, 2009, THESCIENTIFICWORLDJO, V9, P420, DOI 10.1100/tsw.2009.57; Brusic V, 2014, NAT BIOTECHNOL, V32, P146, DOI 10.1038/nbt.2777; Califano A, 2012, NAT GENET, V44, P841, DOI 10.1038/ng.2355; Campain A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-408; Celi Leo Anthony, 2014, J Med Internet Res, V16, pe216, DOI 10.2196/jmir.3761; Chang LC, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-368; Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Chaussabel D, 2014, NAT REV IMMUNOL, V14, P271, DOI 10.1038/nri3642; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Chen B, 2016, CLIN PHARMACOL THER, V99, P285, DOI 10.1002/cpt.318; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Coletta A, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-11-r104; Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Darmanis S, 2016, CELL REP, V14, P380, DOI 10.1016/j.celrep.2015.12.021; Dolinski K, 2015, MOL BIOL CELL, V26, P2575, DOI 10.1091/mbc.E13-12-0756; Doshi P, 2013, TRENDS PHARMACOL SCI, V34, P645, DOI 10.1016/j.tips.2013.10.006; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351; Fehrmann RSN, 2015, NAT GENET, V47, P115, DOI 10.1038/ng.3173; Finak G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20686; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Germain RN, 2011, ANNU REV IMMUNOL, V29, P527, DOI 10.1146/annurev-immunol-030409-101317; Gibson G, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0186-7; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Goodman SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5027; Gorenshteyn D, 2015, IMMUNITY, V43, P605, DOI 10.1016/j.immuni.2015.08.014; Gross AM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142618; Grover MP, 2015, BMC MED GENOMICS, V8, DOI 10.1186/1755-8794-8-S2-S1; Haynes W. A., 2016, PAC S BIOCOMPUT, V22, P144; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Higgs BW, 2012, INT J RHEUM DIS, V15, P25, DOI 10.1111/j.1756-185X.2011.01654.x; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Huan TX, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005035; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5; Hurle MR, 2013, CLIN PHARMACOL THER, V93, P335, DOI 10.1038/clpt.2013.1; Ioannidis JPA, 2009, NAT GENET, V41, P149, DOI 10.1038/ng.295; Iorio F, 2013, DRUG DISCOV TODAY, V18, P350, DOI 10.1016/j.drudis.2012.07.014; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Jujjavarapu C., 2016, J IMMUNOL, V196, p69 16; Karpinski P, 2016, BRAIN BEHAV IMMUN, V54, P194, DOI 10.1016/j.bbi.2016.02.005; Kaye J, 2009, NAT REV GENET, V10, P331, DOI 10.1038/nrg2573; Khatri P, 2013, J EXP MED, V210, P2205, DOI 10.1084/jem.20122709; Kidd BA, 2016, NAT BIOTECHNOL, V34, P47, DOI 10.1038/nbt.3367; Klingstrom T, 2011, BRIEF BIOINFORM, V12, P702, DOI 10.1093/bib/bbq064; Kolesnikov N, 2015, NUCLEIC ACIDS RES, V43, pD1113, DOI 10.1093/nar/gku1057; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Lage K, 2014, BBA-MOL BASIS DIS, V1842, P1971, DOI 10.1016/j.bbadis.2014.05.028; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lamb J, 2007, NAT REV CANCER, V7, P54, DOI 10.1038/nrc2044; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Larance M, 2015, NAT REV MOL CELL BIO, V16, P269, DOI 10.1038/nrm3970; Lau W. W., 2016, F1000RESEARCH; Li B, 2016, NAT GENET, V48, P725, DOI 10.1038/ng.3581; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Lu Y, 2016, IMMUNITY, V45, P1162, DOI 10.1016/j.immuni.2016.10.025; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Marquez A., 2016, ANN RHEUM DIS; Morris DL, 2016, NAT GENET, V48, P940, DOI 10.1038/ng.3603; Musen MA, 2012, J AM MED INFORM ASSN, V19, P190, DOI 10.1136/amiajnl-2011-000523; Nelson MR, 2015, NAT GENET, V47, P856, DOI 10.1038/ng.3314; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Okada Y, 2014, NATURE, V506, P376, DOI 10.1038/nature12873; Olsen JV, 2013, MOL CELL PROTEOMICS, V12, P3444, DOI 10.1074/mcp.O113.034181; Orchard S, 2012, NAT METHODS, V9, P345, DOI [10.1038/NMETH.1931, 10.1038/nmeth.1931]; Paltoo DN, 2014, NAT GENET, V46, P934, DOI 10.1038/ng.3062; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Pe'er D, 2001, Bioinformatics, V17 Suppl 1, pS215; Pennisi E, 2000, SCIENCE, V287, P2182, DOI 10.1126/science.287.5461.2182; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pop M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0668-z; Ramasamy A, 2008, PLOS MED, V5, P1320, DOI 10.1371/journal.pmed.0050184; Raychaudhuri S, 2008, NAT GENET, V40, P1216, DOI 10.1038/ng.233; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2002, CANCER RES, V62, P4427; Roedder S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056657; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rooney MS, 2015, CELL, V160, P48, DOI 10.1016/j.cell.2014.12.033; Ross JS, 2013, JAMA-J AM MED ASSOC, V309, P1355, DOI 10.1001/jama.2013.1299; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Ruepp A, 2010, NUCLEIC ACIDS RES, V38, pD497, DOI 10.1093/nar/gkp914; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Saeys Y, 2016, NAT REV IMMUNOL, V16, P449, DOI 10.1038/nri.2016.56; Saez-Rodriguez J, 2016, NAT REV GENET, V17, P470, DOI 10.1038/nrg.2016.69; Sanseau P, 2012, NAT BIOTECHNOL, V30, P317, DOI 10.1038/nbt.2151; Satija R, 2014, TRENDS IMMUNOL, V35, P219, DOI 10.1016/j.it.2014.03.004; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schwartzman O, 2015, NAT REV GENET, V16, P716, DOI 10.1038/nrg3980; Segal E, 2005, NAT GENET, V37, pS38, DOI 10.1038/ng1561; Segal E, 2003, BIOINFORMATICS, V19, pi273, DOI 10.1093/bioinformatics/btg1038; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shah N, 2016, NAT BIOTECHNOL, V34, P803, DOI 10.1038/nbt.3603; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Silberzahn R, 2015, NATURE, V526, P189, DOI 10.1038/526189a; Sirota M., 2011, SCI TRANSL, V3; Speake C, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0541-x; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; Spidlen J, 2012, CYTOM PART A, V81A, P727, DOI 10.1002/cyto.a.22106; Stahl EA, 2010, NAT GENET, V42, P508, DOI 10.1038/ng.582; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sweeney T. E., 2016, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKW797; Sweeney TE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa5993; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Toro-Dominguez D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0489-x; Toronto Int Data Release Workshop, 2009, NATURE, V461, P168, DOI 10.1038/461168a; Torrente A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157484; Tsalik EL, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad6873; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wang T, 2000, ONCOGENE, V19, P1519, DOI 10.1038/sj.onc.1203457; Wang XB, 2012, BIOINFORMATICS, V28, P2534, DOI 10.1093/bioinformatics/bts485; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Zhu Q, 2015, NAT METHODS, V12, P211, DOI [10.1038/NMETH.3249, 10.1038/nmeth.3249]; Zhu ZH, 2016, NAT GENET, V48, P481, DOI 10.1038/ng.3538	145	13	13	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1191	1204		10.1016/j.immuni.2016.12.008	http://dx.doi.org/10.1016/j.immuni.2016.12.008			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	28002728	Bronze			2022-12-18	WOS:000392918100007
J	Pardoll, DM				Pardoll, Drew M.			Distinct Mechanisms of Tumor Resistance to NK Killing: Of Mice and Men	IMMUNITY			English	Editorial Material							CELL ACTIVATION; NKG2D; RECEPTORS; LIGANDS		Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21287 USA	Johns Hopkins University; Johns Hopkins Medicine	Pardoll, DM (corresponding author), Johns Hopkins Univ, Dept Oncol, Sidney Kimmel Comprehens Canc Ctr, Sch Med, Baltimore, MD 21287 USA.	dpardol1@jhmi.edu			NCI NIH HHS [P30 CA006973] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Deng WW, 2015, SCIENCE, V348, P136, DOI 10.1126/science.1258867; Eidenschenk C, 2006, AM J HUM GENET, V78, P721, DOI 10.1086/503269; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Jinushi M, 2006, P NATL ACAD SCI USA, V103, P9190, DOI 10.1073/pnas.0603503103; KARLHOFER FM, 1992, NATURE, V358, P66, DOI 10.1038/358066a0; Lanier LL, 2009, IMMUNOL REV, V227, P150, DOI 10.1111/j.1600-065X.2008.00720.x; Raulet DH, 2009, NAT REV IMMUNOL, V9, P568, DOI 10.1038/nri2604; Yokoyama WM, 2005, IMMUNOL RES, V32, P317, DOI 10.1385/IR:32:1-3:317	9	13	13	1	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					605	606		10.1016/j.immuni.2015.04.007	http://dx.doi.org/10.1016/j.immuni.2015.04.007			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25902479	Green Accepted, Bronze			2022-12-18	WOS:000353347500007
J	Behnsen, J; Raffatellu, M				Behnsen, Judith; Raffatellu, Manuela			Keeping the Peace: Aryl Hydrocarbon Receptor Signaling Modulates the Mucosal Microbiota	IMMUNITY			English	Editorial Material							HOST; IMMUNITY; GUT	In this issue of Immunity, Zelante et al. (2013) and Qiu et al. (2013) provide mechanistic insights into functional interactions between commensal microbes and innate lymphoid cells via the aryl hydrocarbon receptor.	[Behnsen, Judith; Raffatellu, Manuela] Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA; [Behnsen, Judith; Raffatellu, Manuela] Univ Calif Irvine, Inst Immunol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Raffatellu, M (corresponding author), Univ Calif Irvine, Sch Med, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA.	manuelar@uci.edu	Behnsen, Judith/O-2656-2015	Behnsen, Judith/0000-0003-0109-1090; Raffatellu, Manuela/0000-0001-6487-4215				Hood MI, 2012, NAT REV MICROBIOL, V10, P525, DOI 10.1038/nrmicro2836; Liu JZ, 2009, CYTOKINE, V48, P156, DOI 10.1016/j.cyto.2009.07.005; Monteleone I, 2011, GASTROENTEROLOGY, V141, P237, DOI 10.1053/j.gastro.2011.04.007; Qiu J, 2012, IMMUNITY, V36, P92, DOI 10.1016/j.immuni.2011.11.011; Urban CF, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000639; Vaishnava S, 2011, SCIENCE, V334, P255, DOI 10.1126/science.1209791; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Zelante T, 2013, IMMUNITY, V39, P372, DOI 10.1016/j.immuni.2013.08.003	8	13	15	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 22	2013	39	2					206	207		10.1016/j.immuni.2013.08.012	http://dx.doi.org/10.1016/j.immuni.2013.08.012			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UE	23973218	Bronze			2022-12-18	WOS:000330948800004
J	Ivashkiv, LB				Ivashkiv, Lionel B.			PTPN22 in Autoimmunity: Different Cell and Different Way	IMMUNITY			English	Editorial Material							ARTHRITIS	The tyrosine phosphatase PTPN22 regulates T cell receptor signaling. In this issue of Immunity, Wang et al. (2013) show that in myeloid cells PTPN22 potentiates TLR-induced type I interferon production and that autoimmunity-associated allele PTPN22W encodes a reduced-function variant.	[Ivashkiv, Lionel B.] Weill Cornell Grad Sch Med Sci, Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA; [Ivashkiv, Lionel B.] Weill Cornell Grad Sch Med Sci, Hosp Special Surg, Genom Ctr, Immunol & Microbial Pathogenesis Program, New York, NY 10021 USA	Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Ivashkiv, LB (corresponding author), Weill Cornell Grad Sch Med Sci, Hosp Special Surg, Arthrit & Tissue Degenerat Program, New York, NY 10021 USA.	ivashkivl@hss.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046713, R01AR050401] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI046712] Funding Source: Medline; NIAMS NIH HHS [R01 AR050401, R01 AR046713] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Burn GL, 2011, FEBS LETT, V585, P3689, DOI 10.1016/j.febslet.2011.04.032; Fiorillo E, 2010, J BIOL CHEM, V285, P26506, DOI 10.1074/jbc.M110.111104; Gordon RA, 2012, ARTHRITIS RHEUM-US, V64, P3119, DOI 10.1002/art.34544; Hacker H, 2011, NAT REV IMMUNOL, V11, P457, DOI 10.1038/nri2998; Kalliolias GD, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2881; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Wang YY, 2013, IMMUNITY, V39, P111, DOI 10.1016/j.immuni.2013.06.013; Yarilina A, 2007, J IMMUNOL, V178, P2204, DOI 10.4049/jimmunol.178.4.2204; Zheng J, 2012, GENES IMMUN, V13, P641, DOI 10.1038/gene.2012.46	10	13	13	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 25	2013	39	1					91	93		10.1016/j.immuni.2013.07.007	http://dx.doi.org/10.1016/j.immuni.2013.07.007			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2TZ	23890067	Green Accepted, Bronze			2022-12-18	WOS:000330948300009
J	Nonaka, M; Fukuda, M				Nonaka, Motohiro; Fukuda, Minoru			Galectin-1 for Neuroprotection?	IMMUNITY			English	Editorial Material							MULTIPLE-SCLEROSIS; IMMUNE	Classically activated microglia (M1) are believed to play a key role in neuronal degeneration in multiple sclerosis (MS). In this issue of Immunity, Starossom et al. (2012) show that Galectin-1 exerts a neuroprotective function through glycosylation-dependent inactivation with M1 cells.	[Nonaka, Motohiro; Fukuda, Minoru] Sanford Burnham Med Res Inst, Ctr Canc, Tumor Microenvironm Program, Glycobiol Unit, La Jolla, CA 92037 USA; [Nonaka, Motohiro] Ritsumeikan Univ, Res Ctr Glycobiotechnol, Shiga 5250058, Japan; [Nonaka, Motohiro] Japan Soc Promot Sci, Tokyo 1028472, Japan	Sanford Burnham Prebys Medical Discovery Institute; Ritsumeikan University; Japan Society for the Promotion of Science	Fukuda, M (corresponding author), Sanford Burnham Med Res Inst, Ctr Canc, Tumor Microenvironm Program, Glycobiol Unit, La Jolla, CA 92037 USA.	minoru@sanfordburnham.org						Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Bo L, 2003, MULT SCLER, V9, P323, DOI 10.1191/1352458503ms917oa; Kang ZZ, 2010, IMMUNITY, V32, P414, DOI 10.1016/j.immuni.2010.03.004; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Penninger JM, 2001, NAT IMMUNOL, V2, P389, DOI 10.1038/87687; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313	10	13	14	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 24	2012	37	2					187	189		10.1016/j.immuni.2012.08.006	http://dx.doi.org/10.1016/j.immuni.2012.08.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22921113	Bronze			2022-12-18	WOS:000308261800001
J	Broxmeyer, HE				Broxmeyer, Hal E.			Erythropoietin Surprises: An Immune Saga	IMMUNITY			English	Editorial Material							CDNA	Erythropoietin (EPO) an erythropoietic stimulating agent also exerts effects on other cell systems. Nairz et al. (2011) now link EPO and intracellular signaling through the EPO receptor (EPOR) to innate immune cell activity via macrophages.	Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington	Broxmeyer, HE (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	hbroxmey@iupui.edu						JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; Jelkmann W, 2010, BLOOD, V115, P4151, DOI 10.1182/blood-2010-03-271395; LIN FK, 1985, P NATL ACAD SCI USA, V82, P7580, DOI 10.1073/pnas.82.22.7580; Lu L, 1998, J LEUKOCYTE BIOL, V63, P389, DOI 10.1002/jlb.63.3.389; Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002; Papayannopoulou T., 2009, BIOL ERYTHROPOIESIS, P276; Rizzo JD, 2010, BLOOD, V116, P4045, DOI 10.1182/blood-2010-08-300541; Shaheen MA, 2009, HEMATOLOGY BASIC PRI, P253; Unger EF, 2010, NEW ENGL J MED, V362, P189, DOI 10.1056/NEJMp0912328	9	13	13	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 28	2011	34	1					6	7		10.1016/j.immuni.2011.01.004	http://dx.doi.org/10.1016/j.immuni.2011.01.004			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO	21272782	Bronze			2022-12-18	WOS:000287336600003
J	van der Merwe, PA; Cordoba, SP				van der Merwe, P. Anton; Cordoba, Shaun-Paul			Late Arrival: Recruiting Coreceptors to the T Cell Receptor Complex	IMMUNITY			English	Editorial Material							RECOGNITION; ACTIVATION; KINETICS	In this issue of Immunity, Jiang et al. (2011) provide evidence that the CD8 coreceptor is recruited to the T cell receptor (TCR) complex after initial TCR triggering where it stabilizes the TCR-peptide-major histocompatibility complex interaction.	[van der Merwe, P. Anton; Cordoba, Shaun-Paul] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Cordoba, SP (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	anton.vandermerwe@path.ox.ac.uk	van der Merwe, P. Anton/F-8539-2011		Medical Research Council [MR/J002011/1, G19/31, G9722488] Funding Source: Medline; MRC [G9722488] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Huang J, 2007, J IMMUNOL, V179, P7653, DOI 10.4049/jimmunol.179.11.7653; Huang J, 2010, NATURE, V464, P932, DOI 10.1038/nature08944; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; JANEWAY CA, 1992, ANNU REV IMMUNOL, V10, P645, DOI 10.1146/annurev.immunol.10.1.645; Jiang N, 2011, IMMUNITY, V34, P13, DOI 10.1016/j.immuni.2010.12.017; Palmer E, 2009, NAT REV IMMUNOL, V9, P206, DOI 10.1038/nri2469; SCHILHAM MW, 1993, EUR J IMMUNOL, V23, P1299, DOI 10.1002/eji.1830230617; THOME M, 1995, J EXP MED, V181, P1997, DOI 10.1084/jem.181.6.1997; van der Merwe PA, 2003, ANNU REV IMMUNOL, V21, P659, DOI 10.1146/annurev.immunol.21.120601.141036; XU H, 1993, CELL, V74, P633, DOI 10.1016/0092-8674(93)90511-N	10	13	13	1	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 28	2011	34	1					1	3		10.1016/j.immuni.2011.01.001	http://dx.doi.org/10.1016/j.immuni.2011.01.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721EO	21272780	Bronze			2022-12-18	WOS:000287336600001
J	Rodgers, JM; Zhou, L; Miller, SD				Rodgers, Jane M.; Zhou, Liang; Miller, Stephen D.			Act1, Scene Brain: Astrocytes Play a Lead Role	IMMUNITY			English	Editorial Material							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RECEPTOR		[Rodgers, Jane M.; Zhou, Liang; Miller, Stephen D.] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA; [Zhou, Liang] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Zhou, Liang] Northwestern Univ, Feinberg Sch Med, Interdepartmental Immunobiol Ctr, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Miller, SD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, 303 E Chicago Ave, Chicago, IL 60611 USA.	s-d-miller@northwestern.edu			NINDS NIH HHS [R01 NS026543-20, R01 NS030871-16, R01 NS030871, R01 NS026543] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030871, R01NS026543] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Bailey SL, 2007, NAT IMMUNOL, V8, P172, DOI 10.1038/ni1430; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Gilyarov A V, 2008, Neurosci Behav Physiol, V38, P165, DOI 10.1007/s11055-008-0025-z; Hartupee J, 2007, J IMMUNOL, V179, P4135, DOI 10.4049/jimmunol.179.6.4135; Qian YC, 2004, IMMUNITY, V21, P575, DOI 10.1016/j.immuni.2004.09.001; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Tompkins SM, 2002, J IMMUNOL, V168, P4173, DOI 10.4049/jimmunol.168.8.4173; YEDNOCK TA, 1992, NATURE, V356, P63, DOI 10.1038/356063a0	9	13	15	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 26	2010	32	3					302	304		10.1016/j.immuni.2010.03.009	http://dx.doi.org/10.1016/j.immuni.2010.03.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	576DV	20346771	Bronze, Green Accepted			2022-12-18	WOS:000276125400004
J	Ozato, K				Ozato, Keiko			PLZF Outreach: A Finger in Interferon's Pie	IMMUNITY			English	Editorial Material							REPRESSION; PROTEIN	In this issue of Immunity, Xu et al. (2009) find that the transcription factor PLZF activates interferon-stimulated genes and facilitates natural killer cell functions. Interferon-induced PLZF phosphorylation and histone deacetylase 1 recruitment probably mediates the repressor-to-activator conversion.	NICHHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Ozato, K (corresponding author), NICHHD, Program Genom Differentiat, NIH, Bethesda, MD 20892 USA.	ozatok@nih.gov			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD001310] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 HD001310-21] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Caligiuri MA, 2008, BLOOD, V112, P461, DOI 10.1182/blood-2007-09-077438; Guidez F, 2005, MOL CELL BIOL, V25, P5552, DOI 10.1128/MCB.25.13.5552-5566.2005; Hiscott J, 2003, ANN NY ACAD SCI, V1010, P237, DOI 10.1196/annals.1299.042; Kovalovsky D, 2008, NAT IMMUNOL, V9, P1055, DOI 10.1038/ni.1641; Kramer OH, 2009, GENE DEV, V23, P223, DOI 10.1101/gad.479209; McConnell MJ, 2003, MOL CELL BIOL, V23, P9375, DOI 10.1128/MCB.23.24.9375-9388.2003; Savage AK, 2008, IMMUNITY, V29, P391, DOI 10.1016/j.immuni.2008.07.011; Xu DK, 2009, IMMUNITY, V30, P802, DOI 10.1016/j.immuni.2009.04.013; Yamagoe S, 2003, MOL CELL BIOL, V23, P1025, DOI 10.1128/MCB.23.3.1025-1033.2003	9	13	13	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUN 19	2009	30	6					757	758		10.1016/j.immuni.2009.06.003	http://dx.doi.org/10.1016/j.immuni.2009.06.003			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	461MI	19538924	Green Accepted, Bronze			2022-12-18	WOS:000267270700002
J	Harwood, NE; Batista, FD				Harwood, Naomi E.; Batista, Facundo D.			The Antigen Expressway: Follicular Conduits Carry Antigen to B Cells	IMMUNITY			English	Editorial Material							LYMPH-NODE; SUBCAPSULAR SINUS; FOLLICLES; AREA		[Harwood, Naomi E.; Batista, Facundo D.] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Lymphocyte Interact Lab, London WC2A 3PX, England	Cancer Research UK	Batista, FD (corresponding author), Canc Res UK London Res Inst, Lincolns Inn Fields Labs, Lymphocyte Interact Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	facundo.batista@cancer.org.uk						Allen CDC, 2008, SEMIN IMMUNOL, V20, P14, DOI 10.1016/j.smim.2007.12.001; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Gretz JE, 2000, J EXP MED, V192, P1425, DOI 10.1084/jem.192.10.1425; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; NOSSAL GJV, 1968, J EXP MED, V127, P277, DOI 10.1084/jem.127.2.277; Pape KA, 2007, IMMUNITY, V26, P491, DOI 10.1016/j.immuni.2007.02.011; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Roozendaal R, 2009, IMMUNITY, V30, P264, DOI 10.1016/j.immuni.2008.12.014; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013	10	13	13	1	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 20	2009	30	2					177	179		10.1016/j.immuni.2009.01.004	http://dx.doi.org/10.1016/j.immuni.2009.01.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	412FT	19239901	Bronze			2022-12-18	WOS:000263710500005
J	Ley, K; Zarbock, A				Ley, Klaus; Zarbock, Alexander			Hold on to your endothelium: Postarrest steps of the leukocyte adhesion cascade	IMMUNITY			English	Editorial Material							NEUTROPHILS		Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA; Univ Virginia, Dept Physiol & Mol Biophys, Charlottesville, VA 22908 USA; Univ Munster, Dept Anesthesiol, D-48149 Munster, Germany	University of Virginia; University of Virginia; University of Virginia; University of Munster	Ley, K (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.							Burns S, 2004, BLOOD, V104, P3454, DOI 10.1182/blood-2004-04-1678; Gakidis MAM, 2004, J CELL BIOL, V166, P273, DOI 10.1083/jcb.200404166; Giagulli C, 2006, J IMMUNOL, V177, P604, DOI 10.4049/jimmunol.177.1.604; Hirahashi J, 2006, IMMUNITY, V25, P271, DOI 10.1016/j.immuni.2006.05.014; Kucik DF, 1996, J CLIN INVEST, V97, P2139, DOI 10.1172/JCI118651; Laudanna C, 2006, THROMB HAEMOSTASIS, V95, P5, DOI 10.1160/TH05-07-0482; Ley K, 1999, MICROCIRCULATION, V6, P259, DOI 10.1038/sj.mn.7300075; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Mocsai A, 2002, IMMUNITY, V16, P547, DOI 10.1016/S1074-7613(02)00303-5; NATHAN C, 1989, J CELL BIOL, V109, P1341, DOI 10.1083/jcb.109.3.1341; Zhang H, 2006, IMMUNITY, V25, P285, DOI 10.1016/j.immuni.2006.06.014	11	13	13	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	AUG	2006	25	2					185	187		10.1016/j.immuni.2006.08.001	http://dx.doi.org/10.1016/j.immuni.2006.08.001			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16920634	Bronze			2022-12-18	WOS:000240047500002
J	Lieber, MR				Lieber, Michael R.			The polymerases for V(D)J recombination	IMMUNITY			English	Editorial Material							END; DEPENDENCE; MU	DNA transactions of a wide variety generally require three major types of enzymatic activities: nucleases polymerases, and ligases. V(D)J recombination is no exception. In this issue, Bertocci et al. (2006) have provided new insight by generating mice deficient in one or more of the polymerases.	Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90089 USA	University of Southern California	Lieber, MR (corresponding author), Univ So Calif, Kenneth Norris Jr Comprehens Canc Ctr, Los Angeles, CA 90089 USA.			Lieber, Michael/0000-0001-8809-0909; Lieber, Michael/0000-0003-3700-6345				Bertocci B, 2003, IMMUNITY, V19, P203, DOI 10.1016/S1074-7613(03)00203-6; Bertocci B, 2006, IMMUNITY, V25, P31, DOI 10.1016/j.immuni.2006.04.013; Daley JM, 2005, J BIOL CHEM, V280, P29030, DOI 10.1074/jbc.M505277200; Lee JW, 2004, J BIOL CHEM, V279, P805, DOI 10.1074/jbc.M307913200; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Mahajan KN, 2002, MOL CELL BIOL, V22, P5194, DOI 10.1128/MCB.22.14.5194-5202.2002; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; Wilson TE, 1999, J BIOL CHEM, V274, P23599, DOI 10.1074/jbc.274.33.23599	9	13	13	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL	2006	25	1					7	9		10.1016/j.immuni.2006.07.007	http://dx.doi.org/10.1016/j.immuni.2006.07.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	072ZX	16860749	Bronze			2022-12-18	WOS:000239713000002
J	Fischer, A; Hacein-Bey, S; Le Deist, F; de Saint Basile, G; Cavazzana-Calvo, M				Fischer, A; Hacein-Bey, S; Le Deist, F; de Saint Basile, G; Cavazzana-Calvo, M			Gene therapy for human severe combined immunodeficiencies	IMMUNITY			English	Article							STEM-CELL TRANSPLANTATION; IN-VIVO; MICE; RETROVIRUS; DISEASE		Hop Necker Enfants Malad, INSERM U429, F-75015 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Fischer, A (corresponding author), Hop Necker Enfants Malad, INSERM U429, 149 Rue Sevres, F-75015 Paris, France.		; de Saint Basile, Genevieve/G-9731-2017	Cavazzana, Marina/0000-0002-0264-0891; de Saint Basile, Genevieve/0000-0002-1913-5269				Bousso P, 2000, P NATL ACAD SCI USA, V97, P274, DOI 10.1073/pnas.97.1.274; Buckley RH, 1999, NEW ENGL J MED, V340, P508, DOI 10.1056/NEJM199902183400703; Bunting KD, 2000, HUM GENE THER, V11, P2353, DOI 10.1089/104303400750038462; Candotti F, 2000, PEDIATR CLIN N AM, V47, P1389, DOI 10.1016/S0031-3955(05)70277-7; Cavazzana-Calvo M, 2000, SCIENCE, V288, P669, DOI 10.1126/science.288.5466.669; Fischer A, 2000, IMMUNOL REV, V178, P13, DOI 10.1034/j.1600-065X.2000.17806.x; HaceinBey S, 1996, BLOOD, V87, P3108, DOI 10.1182/blood.V87.8.3108.bloodjournal8783108; Halene S, 2000, HUM GENE THER, V11, P1259, DOI 10.1089/10430340050032366; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Hirschhorn R, 1996, NAT GENET, V13, P290, DOI 10.1038/ng0796-290; Kelly PF, 2000, BLOOD, V96, P1206, DOI 10.1182/blood.V96.4.1206.h8001206_1206_1214; Klug CA, 2000, BLOOD, V96, P894, DOI 10.1182/blood.V96.3.894.015k35_894_901; Kohn DB, 1998, NAT MED, V4, P775, DOI 10.1038/nm0798-775; Lo M, 1999, BLOOD, V94, P3027, DOI 10.1182/blood.V94.9.3027.421k11_3027_3036; Malech HL, 1997, P NATL ACAD SCI USA, V94, P12133, DOI 10.1073/pnas.94.22.12133; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; MILLER AD, 1992, CURR TOP MICROBIOL, V158, P1; Notarangelo LD, 2000, IMMUNOL REV, V178, P39, DOI 10.1034/j.1600-065X.2000.17812.x; Otsu M, 2000, MOL THER, V1, P145, DOI 10.1006/mthe.1999.0020; Otsu M, 2001, BLOOD, V97, P1618, DOI 10.1182/blood.V97.6.1618; Patel DD, 2000, NEW ENGL J MED, V342, P1325, DOI 10.1056/NEJM200005043421804; ROBERTS JL, 1989, NEW ENGL J MED, V340, P508; Sadelain M, 2000, CURR OPIN HEMATOL, V7, P364, DOI 10.1097/00062752-200011000-00008; Soudais C, 2000, BLOOD, V95, P3071, DOI 10.1182/blood.V95.10.3071.010k06_3071_3077; Williams DA, 2000, HUM GENE THER, V11, P2059, DOI 10.1089/104303400750001372	25	13	15	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTES AVE,, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	JUL	2001	15	1					1	4		10.1016/S1074-7613(01)00175-3	http://dx.doi.org/10.1016/S1074-7613(01)00175-3			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	457TQ	11485732	Bronze			2022-12-18	WOS:000170153300001
J	Sokal, A; Broketa, M; Barba-Spaeth, G; Meola, A; Fernandez, I; Fourati, S; Azzaoui, I; de La Selle, A; Vandenberghe, A; Roeser, A; Bouvier-Alias, M; Crickx, E; Languille, L; Michel, M; Godeau, B; Gallien, S; Melica, G; Nguyen, Y; Zarrouk, V; Canoui-Poitrine, F; Noizat-Pirenne, F; Megret, J; Pawlotsky, JM; Fillatreau, S; Simon-Loriere, E; Weill, JC; Reynaud, CA; Rey, FA; Bruhns, P; Chappert, P; Mahevas, M				Sokal, Aurelien; Broketa, Matteo; Barba-Spaeth, Giovanna; Meola, Annalisa; Fernandez, Ignacio; Fourati, Slim; Azzaoui, Imane; de La Selle, Andrea; Vandenberghe, Alexis; Roeser, Anais; Bouvier-Alias, Magali; Crickx, Etienne; Languille, Laetitia; Michel, Marc; Godeau, Bertrand; Gallien, Sebastien; Melica, Giovanna; Nguyen, Yann; Zarrouk, Virginie; Canoui-Poitrine, Florence; Noizat-Pirenne, France; Megret, Jerome; Pawlotsky, Jean-Michel; Fillatreau, Simon; Simon-Loriere, Etienne; Weill, Jean-Claude; Reynaud, Claude-Agnes; Rey, Felix A.; Bruhns, Pierre; Chappert, Pascal; Mahevas, Matthieu			Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant	IMMUNITY			English	Article							MATURATION; ANTIBODIES	The SARS-CoV-2 Omicron variant can escape neutralization by vaccine-elicited and convalescent antibodies. Memory B cells (MBCs) represent another layer of protection against SARS-CoV-2, as they persist after infection and vaccination and improve their affinity. Whether MBCs elicited by mRNA vaccines can recognize the Omicron variant remains unclear. We assessed the affinity and neutralization potency against the Omicron variant of several hundred naturally expressed MBC-derived monoclonal IgG antibodies from vaccinated COVID-19-recovered and-naive individuals. Compared with other variants of concern, Omicron evaded recognition by a larger proportion of MBC-derived antibodies, with only 30% retaining high affinity against the Omicron RBD, and the reduction in neutralization potency was even more pronounced. Nonetheless, neutralizing MBC clones could be found in all the analyzed individuals. Therefore, despite the strong immune escape potential of the Omicron variant, these results suggest that the MBC repertoire generated by mRNA vaccines still provides some protection against the Omicron variant in vaccinated individuals.	[Sokal, Aurelien; de La Selle, Andrea; Roeser, Anais; Crickx, Etienne; Fillatreau, Simon; Weill, Jean-Claude; Reynaud, Claude-Agnes; Chappert, Pascal; Mahevas, Matthieu] Univ Paris Cite, Inst Necker Enfants Malad INEM, INSERM, U1151,CNRS UMR 8253, Paris, France; [Broketa, Matteo; Bruhns, Pierre] Univ Paris Cite, Inst Pasteur, Unit Antibodies Therapy & Pathol, INSERM,UMR1222, Paris, France; [Barba-Spaeth, Giovanna; Meola, Annalisa; Fernandez, Ignacio; Rey, Felix A.] Univ Paris Cite, Unite Virol Struct, CNRS UMR 3569, Inst Pasteur, Paris, France; [Fourati, Slim; Bouvier-Alias, Magali; Pawlotsky, Jean-Michel] Ctr Hosp Univ Henri Mondor, AP HP, Dept Virol Bacteriol Hyg & Mycol Parasitol, Creteil, France; [Fourati, Slim; Bouvier-Alias, Magali; Pawlotsky, Jean-Michel] Univ Paris Est Creteil UPEC, Inst Mondor Rech Biorned IMRB, Equipe 18, INSERM,U955, Creteil, France; [Azzaoui, Imane; de La Selle, Andrea; Vandenberghe, Alexis; Roeser, Anais; Crickx, Etienne; Languille, Laetitia; Michel, Marc; Godeau, Bertrand; Mahevas, Matthieu] Univ Paris Est Creteil, Ctr Hosp Univ Henri Mondor, AP HP, Serv Med Interne, Creteil, France; [Azzaoui, Imane; Vandenberghe, Alexis; Noizat-Pirenne, France; Chappert, Pascal; Mahevas, Matthieu] Univ Paris Est Creteil, Inst Mondor Rech Biorned IMRB, Equipe 2, INSERM,U955, Creteil, France; [Gallien, Sebastien; Melica, Giovanna] Univ Paris Est Creteil UPEC, Ctr Hosp Univ Henri Mondor, AP HP, Serv Malad Infect, Creteil, France; [Nguyen, Yann; Zarrouk, Virginie] Univ Paris, Hop Beaujon, AP HP, Serv Med Interne, Clichy, France; [Canoui-Poitrine, Florence] Univ Paris Est Creteil UPEC, Ctr Hosp Univ Henri Mondor, AP HP,EA 7376,Unite Rech Clin URC,Dept Sante Publ, Inst Mondor Rech Biomed IMRB,CEpiA Clin Epidemiol, Creteil, France; [Noizat-Pirenne, France] Etab Frangais Sang EFS Ile France, Creteil, France; [Megret, Jerome] INSERM, Plateforme Cytornetrie Flux, Struct Federat Rech Necker, US24,CNRS,UMS3633, Paris, France; [Simon-Loriere, Etienne] Univ Paris Cite, Evolutionary Genom RNA Viruses, Inst Pasteur, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Chappert, P; Mahevas, M (corresponding author), Univ Paris Cite, Inst Necker Enfants Malad INEM, INSERM, U1151,CNRS UMR 8253, Paris, France.; Mahevas, M (corresponding author), Univ Paris Est Creteil, Ctr Hosp Univ Henri Mondor, AP HP, Serv Med Interne, Creteil, France.; Chappert, P; Mahevas, M (corresponding author), Univ Paris Est Creteil, Inst Mondor Rech Biorned IMRB, Equipe 2, INSERM,U955, Creteil, France.	pascal.chappert@inserm.fr; matthieu.mahevas@aphp.fr	; BRUHNS, Pierre/F-5567-2013	Fernandez, Ignacio/0000-0003-2632-8111; Barba Spaeth, Giovanna/0000-0003-2069-9501; chappert, pascal/0000-0002-9799-4608; Nguyen, Yann/0000-0002-0866-3824; BRUHNS, Pierre/0000-0002-4709-8936	Agence Nationale de la Recherche; Fondation pour la Recherche Medicale (ANR); Fondation pour la Recherche Medicale (MEMOCOV-2-FRM); Fondation Princesse Grace; ERC Advanced Investigator Grant (B-response); French Ministry of Health (Soutien Exceptionnel a la Recherche Clinique 2022, CAPNET [Comite ad-hoc de pilotage national des essais the rapeutiques et autres recherches]); MEMO-COV-2; Poste d'accueil from INSERM; Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS); CIFRE fellowship from the Association Nationale de la Recherche et de la Technologie (ANRT); SNFMI fellowship; French National Research Agency [ANR-14-CE16-0011]; Institut Carnot Pasteur Microbes et Sante [ANR 11 CARN 0017-01]; Institut Pasteur; Institut National de la Sante et de la Recherche Medicale (INSERM)	Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (ANR)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale (MEMOCOV-2-FRM)(Fondation pour la Recherche Medicale); Fondation Princesse Grace; ERC Advanced Investigator Grant (B-response); French Ministry of Health (Soutien Exceptionnel a la Recherche Clinique 2022, CAPNET [Comite ad-hoc de pilotage national des essais the rapeutiques et autres recherches]); MEMO-COV-2; Poste d'accueil from INSERM; Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); CIFRE fellowship from the Association Nationale de la Recherche et de la Technologie (ANRT)(French National Research Agency (ANR)); SNFMI fellowship; French National Research Agency(French National Research Agency (ANR)); Institut Carnot Pasteur Microbes et Sante; Institut Pasteur(European Commission); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm))	This work was initiated by a grant from the Agence Nationale de la Recherche and the Fondation pour la Recherche Medicale (ANR and MEMOCOV-2-FRM) and funded by the Fondation Princesse Grace, an ERC Advanced Investigator Grant (B-response), and a grant from the French Ministry of Health (Soutien Exceptionnel a la Recherche Clinique 2022, CAPNET [Comite ad-hoc de pilotage national des essais the rapeutiques et autres recherches]). Assistance Publique -Hopitaux de Paris (AP-HP, Departement de la Recherche Clinique et du Developpement) was the promotor and the sponsor of MEMO-COV-2. Work in the Unit of Structural Virology was funded by Institut Pasteur, Urgence COVID-19 Fundraising Campaign of Institut Pasteur. A.S. was supported by a Poste d'accueil from INSERM, I.F. by a fellowship from the Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS), M.B. by a CIFRE fellowship from the Association Nationale de la Recherche et de la Technologie (ANRT), and A.D.L.S by a SNFMI fellowship. P.B. acknowledges funding from the French National Research Agency grant ANR-14-CE16-0011 project DROPmAbs, the Institut Carnot Pasteur Microbes et Sante (ANR 11 CARN 0017-01), the Institut Pasteur, and the Institut National de la Sante ' et de la Recherche Me ' dicale (INSERM).	Barnes CO, 2020, CELL, V182, P828, DOI [10.1016/j.cell.2020.06.025, 10.1101/2020.05.28.121533]; Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; Cameroni E, 2022, NATURE, V602, P664, DOI [10.1101/2021.12.12.472269, 10.1038/s41586-021-04386-2]; Carreno JM, 2022, NATURE, V602, P682, DOI 10.1038/s41586-022-04399-5; Cerutti G, 2022, CELL REP, V38, DOI 10.1016/j.celrep.2022.110428; Cho A, 2021, NATURE, V600, P517, DOI 10.1038/s41586-021-04060-7; Crickx E, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abc3961; Dejnirattisai W, 2022, CELL, V185, P467, DOI 10.1016/j.cell.2021.12.046; Dugan HL, 2021, IMMUNITY, V54, P1290, DOI 10.1016/j.immuni.2021.05.001; Gaebler C, 2021, NATURE, V591, P639, DOI [10.1038/s41586-021-03207-w, 10.1101/2020.11.03.367391]; Garcia-Beltran WF, 2022, CELL, V185, P457, DOI [10.1016/j.cell.2021.12.033, 10.1101/2021.12.14.21267755]; Goel RR, 2021, SCIENCE, V374, P1214, DOI 10.1126/science.abm0829; Gruell H, 2022, NAT MED, V28, P477, DOI 10.1038/s41591-021-01676-0; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Hoffmann M, 2022, CELL, V185, P447, DOI 10.1016/j.cell.2021.12.032; Kotaki R, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abn8590; Lad L, 2015, J BIOMOL SCREEN, V20, P498, DOI 10.1177/1087057114560123; Luo XM, 2009, BLOOD, V113, P1422, DOI 10.1182/blood-2008-09-177139; Muik A, 2022, SCIENCE, V375, P678, DOI 10.1126/science.abn7591; Nemet I, 2022, NEW ENGL J MED, V386, P492, DOI 10.1056/NEJMc2119358; Planas D, 2022, NATURE, V602, P671, DOI 10.1038/s41586-021-04389-z; Purtha WE, 2011, J EXP MED, V208, P2599, DOI 10.1084/jem.20110740; Rodda LB, 2021, CELL, V184, P169, DOI [10.1016/j.cell.2020.11.029, 10.21203/rs.3.rs-57112/v1, 10.1101/2020.08.11.20171843]; Sokal A, 2021, IMMUNITY, V54, P2893, DOI 10.1016/j.immuni.2021.09.011; Sokal A, 2021, CELL, V184, P1201, DOI 10.1016/j.cell.2021.01.050; Starr TN, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100255; Tarke A, 2022, CELL, V185, P847, DOI 10.1016/j.cell.2022.01.015; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tong P, 2021, CELL, V184, P4969, DOI [10.1016/j.cell.2021.07.025, 10.1101/2021.03.10.434840]; Vanshylla K, 2022, CELL HOST MICROBE, V30, P69, DOI 10.1016/j.chom.2021.12.010; Wang K, 2022, NATURE, V603, P919, DOI 10.1038/s41586-022-04466-x; Wang Z., BIORXIV; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Weisel F, 2017, ANNU REV IMMUNOL, V35, P255, DOI 10.1146/annurev-immunol-041015-055531; Yin WC, 2022, SCIENCE, V375, P1048, DOI 10.1126/science.abn8863; Yuan M, 2021, SCIENCE, V373, P818, DOI 10.1126/science.abh1139; Zahradnik J, 2021, NAT MICROBIOL, V6, P1188, DOI 10.1038/s41564-021-00954-4	37	12	13	7	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 14	2022	55	6					1096	+		10.1016/j.immuni.2022.04.002	http://dx.doi.org/10.1016/j.immuni.2022.04.002			14	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3F2TY	35483354	Green Published, Bronze			2022-12-18	WOS:000830524400004
J	Ginhoux, F; Yalin, A; Dutertre, CA; Amit, I				Ginhoux, Florent; Yalin, Adam; Dutertre, Charles Antoine; Amit, Ido			Single-cell immunology: Past, present, and future	IMMUNITY			English	Review							GENOME-WIDE EXPRESSION; MESSENGER-RNA-SEQ; TRANSCRIPTIONAL LANDSCAPE; GENE-EXPRESSION; IMMUNE-SYSTEM; CHROMATIN ACCESSIBILITY; T-CELLS; REVEALS; CANCER; ATLAS	The immune system is a complex, dynamic, and plastic ecosystem composed of multiple cell types that constantly sense and interact with their local microenvironment to protect from infection and maintain homeostasis. For over a century, great efforts and ingenuity have been applied to the characterization of immune cells and their microenvironments, but traditional marker-based and bulk technologies left key questions unanswered. In the past decade, the advent of single-cell genomic approaches has revolutionized our knowledge of the cellular and molecular makeup of the immune system. In this perspective, we outline the past, present, and future applications of single-cell genomics in immunology and discuss how the integration of multiomics at the single-cell level will pave the way for future advances in immunology research and clinical translation.	[Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore; [Ginhoux, Florent; Dutertre, Charles Antoine] Gustave Roussy, Canc Campus, F-94800 Villejuif, France; [Ginhoux, Florent; Dutertre, Charles Antoine] Gustave Roussy, Inserm U1015, F-94800 Villejuif, France; [Ginhoux, Florent] Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai 200025, Peoples R China; [Ginhoux, Florent] SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore 169856, Singapore; [Yalin, Adam; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Chinese Academy of Sciences; Shanghai Jiao Tong University; Weizmann Institute of Science	Ginhoux, F (corresponding author), ASTAR, Singapore Immunol Network SIgN, Singapore 138648, Singapore.; Ginhoux, F; Dutertre, CA (corresponding author), Gustave Roussy, Canc Campus, F-94800 Villejuif, France.; Ginhoux, F; Dutertre, CA (corresponding author), Gustave Roussy, Inserm U1015, F-94800 Villejuif, France.; Ginhoux, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Inst Immunol, Sch Med, Shanghai 200025, Peoples R China.; Ginhoux, F (corresponding author), SingHlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore 169856, Singapore.; Yalin, A; Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-7610001 Rehovot, Israel.	florent_ginhoux@immunol.a-star.edu.sg; adam.jelinski@weizmann.ac.il; charles-antoine.dutertre@inserm.fr; ido.amit@weizmann.ac.il			Merck KGaA, Darmstadt, Germany; Chan Zuckerberg Initiative (CZI); HHMI International Scholar award; European Research Council Consolidator Grant (ERC-COG) [724471-HemTree2.0]; SCA award of the Wolfson Foundation; Thompson Family Foundation; MRA Established Investigator Award [509044]; Israel Science Foundation [703/15]; Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; NeuroMac DFG/Transregional Collaborative Research Center Grant; In-ternational Progressive MS Alliance/NMSS [PA-1604 08459]; Adelis Foundation grant; EMBO YIP; Singapore Immunology Network core funding (A*STAR); Singapore NRF Senior Investigatorship [NRFI2017-02]; INSERM; Gustave Roussy	Merck KGaA, Darmstadt, Germany; Chan Zuckerberg Initiative (CZI); HHMI International Scholar award(Howard Hughes Medical Institute); European Research Council Consolidator Grant (ERC-COG); SCA award of the Wolfson Foundation; Thompson Family Foundation; MRA Established Investigator Award; Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; Helen and Martin Kimmel award for innovative investigation; NeuroMac DFG/Transregional Collaborative Research Center Grant; In-ternational Progressive MS Alliance/NMSS; Adelis Foundation grant; EMBO YIP(European Molecular Biology Organization (EMBO)); Singapore Immunology Network core funding (A*STAR)(Agency for Science Technology & Research (A*STAR)); Singapore NRF Senior Investigatorship(National Research Foundation, Singapore); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Gustave Roussy	We thank Tal Bigdary from the Scientific Illustration unit of the Weizmann Insti-tute for artwork. We thank Dr. Ido Yofe, Kathleen Abadie, and Kevin Mudler for reviewing this manuscript. I.A. is an Eden and Steven Romick Professorial Chair, supported by Merck KGaA, Darmstadt, Germany; the Chan Zuckerberg Initiative (CZI) ; the HHMI International Scholar award; the European Research Council Consolidator Grant (ERC-COG) 724471-HemTree2.0; an SCA award of the Wolfson Foundation; the Thompson Family Foundation; an MRA Established Investigator Award (509044) ; the Israel Science Foundation (703/15) ; the Ernest and Bonnie Beutler Research Program for Excellence in Genomic Medicine; the Helen and Martin Kimmel award for innovative investigation; the NeuroMac DFG/Transregional Collaborative Research Center Grant; an In-ternational Progressive MS Alliance/NMSS PA-1604 08459, and an Adelis Foundation grant. F.G is supported by EMBO YIP, Singapore Immunology Network core funding (A*STAR) , and Singapore NRF Senior Investigatorship (NRFI2017-02) . C.A.D is supported by INSERM and Gustave Roussy.	Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Andrews TS, 2021, NAT PROTOC, V16, P1, DOI 10.1038/s41596-020-00409-w; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Baek S, 2020, COMPUT STRUCT BIOTEC, V18, P1429, DOI 10.1016/j.csbj.2020.06.012; Baran Y, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1812-2; Barrow AD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00909; Blach J, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22169030; Boisset JC, 2018, NAT METHODS, V15, P547, DOI 10.1038/s41592-018-0009-z; Browaeys R, 2020, NAT METHODS, V17, P159, DOI 10.1038/s41592-019-0667-5; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Buus TB, 2021, ELIFE, V10, DOI 10.7554/eLife.61973; Camp JG, 2017, NATURE, V546, P533, DOI 10.1038/nature22796; Cao JY, 2019, NATURE, V566, P496, DOI 10.1038/s41586-019-0969-x; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Chaussabel D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-84; Chen A., 2021, BIORXIV, DOI [DOI 10.1101/2021.01.17.427004, 10.1101/2021.01.17.427004]; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Chen W., 2021, BIORXIV, DOI [10.1101/2021.03.24.436752, DOI 10.1101/2021.03.24.436752]; Chen Y, 2021, J EXP MED, V218, DOI 10.1084/jem.20202717; Cheng SJ, 2021, CELL, V184, P792, DOI 10.1016/j.cell.2021.01.010; Cho CS, 2021, CELL, V184, P3559, DOI 10.1016/j.cell.2021.05.010; Clark IC, 2021, SCIENCE, V372, P360, DOI 10.1126/science.abf1230; Cohen YC, 2021, NAT MED, V27, P491, DOI 10.1038/s41591-021-01232-w; Collins FS, 2003, SCIENCE, V300, P286, DOI 10.1126/science.1084564; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Deczkowska A, 2020, CELL, V181, P1207, DOI 10.1016/j.cell.2020.05.003; Demaria O, 2019, NATURE, V574, P45, DOI 10.1038/s41586-019-1593-5; Ding J, 2020, NAT BIOTECHNOL, V38, P737, DOI 10.1038/s41587-020-0465-8; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; Dominguez-Villar M, 2018, NAT IMMUNOL, V19, P665, DOI 10.1038/s41590-018-0120-4; Dutertre CA, 2019, IMMUNITY, V51, P573, DOI 10.1016/j.immuni.2019.08.008; Efremova M, 2020, NAT PROTOC, V15, P1484, DOI 10.1038/s41596-020-0292-x; Eng CHL, 2019, NATURE, V568, P235, DOI 10.1038/s41586-019-1049-y; Erhard F, 2019, NATURE, V571, P419, DOI 10.1038/s41586-019-1369-y; Fan J, 2016, NAT METHODS, V13, P241, DOI [10.1038/NMETH.3734, 10.1038/nmeth.3734]; Fang RX, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21583-9; Geirsdottir L, 2020, CELL, V181, P746, DOI 10.1016/j.cell.2020.04.002; Gierahn TM, 2017, NAT METHODS, V14, P395, DOI 10.1038/nmeth.4179; Giladi A, 2020, NAT BIOTECHNOL, V38, P629, DOI 10.1038/s41587-020-0442-2; Giladi A, 2018, CELL, V172, P14, DOI 10.1016/j.cell.2017.11.011; Ginhoux F, 2022, NAT REV IMMUNOL, V22, P67, DOI 10.1038/s41577-022-00675-7; Hagemann-Jensen M, 2020, NAT BIOTECHNOL, V38, P708, DOI 10.1038/s41587-020-0497-0; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Hendriks GJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11028-9; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Hie B, 2020, ANNU REV BIOMED DA S, V3, P339, DOI 10.1146/annurev-biodatasci-012220-100601; Huang SY, 2021, CELL, V184, P441, DOI 10.1016/j.cell.2020.11.028; Islam S, 2011, GENOME RES, V21, P1160, DOI 10.1101/gr.110882.110; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Katzenelenbogen Y, 2020, CELL, V182, P872, DOI 10.1016/j.cell.2020.06.032; Keren-Shaul H, 2019, NAT PROTOC, V14, P1841, DOI 10.1038/s41596-019-0164-4; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kiss M, 2018, CELL IMMUNOL, V330, P188, DOI 10.1016/j.cellimm.2018.02.008; Klein AM, 2017, LAB CHIP, V17, P2540, DOI 10.1039/c7lc90070h; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kotas ME, 2018, IMMUNITY, V48, P1081, DOI 10.1016/j.immuni.2018.06.002; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Ledergor G, 2018, NAT MED, V24, P1867, DOI 10.1038/s41591-018-0269-2; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Loering S, 2019, J PATHOL, V247, P686, DOI 10.1002/path.5211; Lohoff T, 2022, NAT BIOTECHNOL, V40, P74, DOI 10.1038/s41587-021-01006-2; Longo SK, 2021, NAT REV GENET, V22, P627, DOI 10.1038/s41576-021-00370-8; Luecken MD, 2019, MOL SYST BIOL, V15, DOI 10.15252/msb.20188746; Luoma AM, 2020, CELL, V182, P655, DOI 10.1016/j.cell.2020.06.001; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Martinez NM, 2013, IMMUNOL REV, V253, P216, DOI 10.1111/imr.12047; Marx V, 2021, NAT METHODS, V18, P9, DOI 10.1038/s41592-020-01033-y; Medaglia C, 2017, SCIENCE, V358, P1622, DOI 10.1126/science.aao4277; Molgora M, 2020, CELL, V182, P886, DOI 10.1016/j.cell.2020.07.013; Morimoto K, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00916; Mulder K, 2021, IMMUNITY, V54, P1883, DOI 10.1016/j.immuni.2021.07.007; Nagano T, 2013, NATURE, V502, P59, DOI 10.1038/nature12593; Neal JT, 2018, CELL, V175, P1972, DOI 10.1016/j.cell.2018.11.021; Ner-Gaon H, 2017, J IMMUNOL, V198, P3375, DOI 10.4049/jimmunol.1700272; Nerurkar SN, 2020, CANCERS, V12, DOI 10.3390/cancers12092572; Okabe Y, 2016, NAT IMMUNOL, V17, P9, DOI 10.1038/ni.3320; Pai JA, 2021, NAT METHODS, V18, P881, DOI 10.1038/s41592-021-01201-8; Papalexi E, 2018, NAT REV IMMUNOL, V18, P35, DOI 10.1038/nri.2017.76; Pasqualini C, 2020, NEURON, V108, P1025, DOI 10.1016/j.neuron.2020.09.018; Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Paul F, 2015, CELL, V163, P1663, DOI 10.1016/j.cell.2015.11.013; Pellin D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10291-0; Peterson VM, 2017, NAT BIOTECHNOL, V35, P936, DOI 10.1038/nbt.3973; Pongubala JMR, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.633825; Pritykin Y, 2021, MOL CELL, V81, P2477, DOI 10.1016/j.molcel.2021.03.045; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Regev A., 2017, eLife, V6; Ren XW, 2021, ANNU REV IMMUNOL, V39, P583, DOI 10.1146/annurev-immunol-110519-071134; Rodriques SG, 2019, SCIENCE, V363, P1463, DOI 10.1126/science.aaw1219; Rosenberg AB, 2018, SCIENCE, V360, P176, DOI 10.1126/science.aam8999; Rotem A, 2015, NAT BIOTECHNOL, V33, P1165, DOI 10.1038/nbt.3383; Rozenblatt-Rosen O, 2020, CELL, V181, P236, DOI 10.1016/j.cell.2020.03.053; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Savas P, 2018, NAT MED, V24, P986, DOI 10.1038/s41591-018-0078-7; Schmiechen ZC, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.613815; See P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02425; See P, 2017, SCIENCE, V356, DOI 10.1126/science.aag3009; Setty M, 2019, NAT BIOTECHNOL, V37, P451, DOI 10.1038/s41587-019-0068-4; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Sharma A., 2020, Cell, V183; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Singh M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11049-4; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/NMETH.3035, 10.1038/nmeth.3035]; Smillie CS, 2019, CELL, V178, P714, DOI 10.1016/j.cell.2019.06.029; Spits H, 2013, NAT REV IMMUNOL, V13, P145, DOI 10.1038/nri3365; Stahl PL, 2016, SCIENCE, V353, P78, DOI 10.1126/science.aaf2403; Stickels RR, 2021, NAT BIOTECHNOL, V39, P313, DOI 10.1038/s41587-020-0739-1; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stuart T, 2019, NAT REV GENET, V20, P257, DOI 10.1038/s41576-019-0093-7; Stubbington MJT, 2017, SCIENCE, V358, P58, DOI 10.1126/science.aan6828; Stubbington MJT, 2016, NAT METHODS, V13, P329, DOI [10.1038/NMETH.3800, 10.1038/nmeth.3800]; Svensson V, 2020, DATABASE-OXFORD, DOI 10.1093/database/baaa073; Tanay A, 2017, NATURE, V541, P331, DOI 10.1038/nature21350; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thion MS, 2018, SCIENCE, V362, P185, DOI 10.1126/science.aat0474; Tian Y, 2022, NAT BIOTECHNOL, V40, P30, DOI 10.1038/s41587-021-01131-y; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van der Leun AM, 2020, NAT REV CANCER, V20, P218, DOI 10.1038/s41568-019-0235-4; Veglia F, 2021, NAT REV IMMUNOL, V21, P485, DOI 10.1038/s41577-020-00490-y; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Wang BY, 2021, J HUM HYPERTENS, V35, P74, DOI 10.1038/s41371-020-0314-8; Wilson CB, 2009, NAT REV IMMUNOL, V9, P91, DOI 10.1038/nri2487; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yofe I, 2020, NAT MED, V26, P171, DOI 10.1038/s41591-019-0736-4; Zappia L, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006245; Zemmour D, 2018, NAT IMMUNOL, V19, P291, DOI 10.1038/s41590-018-0051-0; Zhang F, 2020, CANCER IMMUNOL IMMUN, V69, P2599, DOI 10.1007/s00262-020-02642-4; Zhang XN, 2019, MOL CELL, V73, P130, DOI 10.1016/j.molcel.2018.10.020; Zhang YY, 2021, CANCER CELL, V39, P1578, DOI 10.1016/j.ccell.2021.09.010; Zhao MM, 2021, CLIN REV ALLERG IMMU, V60, P68, DOI 10.1007/s12016-020-08813-6; Zheng CH, 2017, CELL, V169, P1342, DOI 10.1016/j.cell.2017.05.035; Zheng L., 2021, Science, V374; Ziegenhain C, 2017, MOL CELL, V65, P631, DOI 10.1016/j.molcel.2017.01.023; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009; Zitvogel L, 2006, NAT REV IMMUNOL, V6, P715, DOI 10.1038/nri1936	146	12	12	9	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 8	2022	55	3					393	404		10.1016/j.immuni.2022.02.006	http://dx.doi.org/10.1016/j.immuni.2022.02.006			12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0Z4IZ	35263567				2022-12-18	WOS:000791044400007
J	Burnett, DL; Jackson, KJL; Langley, DB; Aggrawal, A; Stella, AO; Johansen, MD; Balachandran, H; Lenthall, H; Rouet, R; Walker, G; Saunders, BM; Singh, M; Li, H; Henry, JY; Jackson, J; Stewart, AG; Witthauer, F; Spence, MA; Hansbro, NG; Jackson, C; Schofield, P; Milthorpe, C; Martinello, M; Schulz, SR; Roth, E; Kelleher, A; Emery, S; Britton, WJ; Rawlinson, WD; Karl, R; Schafer, S; Winkler, TH; Brink, R; Bull, RA; Hansbro, PM; Jack, HM; Turville, S; Christ, D; Goodnow, CC				Burnett, Deborah L.; Jackson, Katherine J. L.; Langley, David B.; Aggrawal, Anupria; Stella, Alberto Ospina; Johansen, Matt D.; Balachandran, Harikrishnan; Lenthall, Helen; Rouet, Romain; Walker, Gregory; Saunders, Bernadette M.; Singh, Mandeep; Li, Hui; Henry, Jake Y.; Jackson, Jennifer; Stewart, Alastair G.; Witthauer, Franka; Spence, Matthew A.; Hansbro, Nicole G.; Jackson, Colin; Schofield, Peter; Milthorpe, Claire; Martinello, Marianne; Schulz, Sebastian R.; Roth, Edith; Kelleher, Anthony; Emery, Sean; Britton, Warwick J.; Rawlinson, William D.; Karl, Rudolfo; Schaefer, Simon; Winkler, Thomas H.; Brink, Robert; Bull, Rowena A.; Hansbro, Philip M.; Jaeck, Hans-Martin; Turville, Stuart; Christ, Daniel; Goodnow, Christopher C.			Immunizations with diverse sarbecovirus receptor-binding domains elicit SARS-CoV-2 neutralizing antibodies against a conserved site of vulnerability	IMMUNITY			English	Article							RED-BLOOD-CELLS; RNA-SEQ; CORONAVIRUS; MUTATIONS; RESPONSES; TOOLKIT	Viral mutations are an emerging concern in reducing SARS-CoV-2 vaccination efficacy. Second-generation vaccines will need to elicit neutralizing antibodies against sites that are evolutionarily conserved across the sarbecovirus subgenus. Here, we immunized mice containing a human antibody repertoire with diverse sarbecovirus receptor-binding domains (RBDs) to identify antibodies targeting conserved sites of vulnerability. Antibodies with broad reactivity against diverse clade B RBDs targeting the conserved class 4 epitope, with recurring IGHV/IGKV pairs, were readily elicited but were non-neutralizing. However, rare class 4 antibodies binding this conserved RBD supersite showed potent neutralization of SARS-CoV-2 and all variants of concern. Structural analysis revealed that the neutralizing ability of cross-reactive antibodies was reserved only for those with an elongated CDRH3 that extends the antiparallel beta-sheet RBD core and orients the antibody light chain to obstruct ACE2-RBD interactions. These results identify a structurally defined pathway for vaccine strategies eliciting escape-resistant SARS-CoV-2 neutralizing antibodies.	[Burnett, Deborah L.; Jackson, Katherine J. L.; Langley, David B.; Lenthall, Helen; Rouet, Romain; Singh, Mandeep; Henry, Jake Y.; Jackson, Jennifer; Schofield, Peter; Milthorpe, Claire; Brink, Robert; Christ, Daniel; Goodnow, Christopher C.] Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Burnett, Deborah L.; Rouet, Romain; Walker, Gregory; Singh, Mandeep; Stewart, Alastair G.; Schofield, Peter; Rawlinson, William D.; Brink, Robert; Bull, Rowena A.; Turville, Stuart; Christ, Daniel] UNSW Sydney, Fac Med, Sydney, NSW 2010, Australia; [Aggrawal, Anupria; Stella, Alberto Ospina; Balachandran, Harikrishnan; Li, Hui; Martinello, Marianne; Kelleher, Anthony; Emery, Sean; Bull, Rowena A.; Turville, Stuart] UNSW, Kirby Inst, Sydney, NSW 2052, Australia; [Johansen, Matt D.; Saunders, Bernadette M.; Hansbro, Nicole G.; Hansbro, Philip M.] Centenary Inst, Ctr Inflammat, Sydney, NSW 2006, Australia; [Johansen, Matt D.; Saunders, Bernadette M.; Hansbro, Nicole G.; Hansbro, Philip M.] Univ Technol Sydney, Fac Sci, Sch Life Sci, Sydney, NSW 2006, Australia; [Stewart, Alastair G.] Victor Chang Cardiac Res Inst, Sydney, NSW 2010, Australia; [Rawlinson, William D.] SEALS Randwick, Serol & Virol Div SAViD, NSW Hlth Pathol, Sydney, NSW 2031, Australia; [Witthauer, Franka; Schulz, Sebastian R.; Roth, Edith; Jaeck, Hans-Martin] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Div Mol Immunol, D-91054 Erlangen, Germany; [Spence, Matthew A.; Jackson, Colin] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia; [Karl, Rudolfo; Schaefer, Simon; Winkler, Thomas H.] Friedrich Alexander Univ Erlangen Nurnberg FAU, Dept Biol, Div Genet, D-91054 Erlangen, Germany; [Britton, Warwick J.] Univ Sydney, Centenary Inst, Sydney, NSW 2006, Australia; [Goodnow, Christopher C.] UNSW Sydney, Cellular Genom Futures Inst, Sydney, NSW 2052, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney; Kirby Institute; University of Sydney; Centenary Institute; University of Technology Sydney; University of Technology Sydney; Victor Chang Cardiac Research Institute; University of Erlangen Nuremberg; Australian National University; University of Erlangen Nuremberg; University of Sydney; Centenary Institute; University of New South Wales Sydney	Burnett, DL (corresponding author), Garvan Inst Med Res, Sydney, NSW 2010, Australia.; Burnett, DL (corresponding author), UNSW Sydney, Fac Med, Sydney, NSW 2010, Australia.	d.burnett@garvan.org.au	Hansbro, Phil/G-7486-2013; Langley, David/B-1861-2009; Christ, Daniel/C-1861-2018	Hansbro, Phil/0000-0002-4741-3035; Henry, Jake/0000-0003-0435-3308; Spence, Matthew/0000-0003-2284-2498; Stewart, Alastair/0000-0002-2070-6030; Aggarwal, Anupriya/0000-0001-8678-0519; Saunders, Bernadette/0000-0003-0540-4445; Langley, David/0000-0003-2752-0041; Christ, Daniel/0000-0002-7313-3977	National Health and Medical Research Council (NHMRC) [585490, 1157744, 190774, 1176351, 1176134, 1081858, 1016953, 1113904]; Australian Research Council [160104915, 140103465]; Garvan COVID-19 Catalytic Funding; Bill and Patricia Ritchie Family Foundation; University of Technology Sydney and Rainbow Foundation; Snow Foundation; Bundesmininisterium f_ur Bildung und Forschung (BMBF) [01KI2043]; DFG [TRR130]; Bayersiche Forschungsstiftung (CORAdc); The Bavarian State Ministry for Science; BMBF	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Garvan COVID-19 Catalytic Funding; Bill and Patricia Ritchie Family Foundation; University of Technology Sydney and Rainbow Foundation; Snow Foundation; Bundesmininisterium f_ur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Bayersiche Forschungsstiftung (CORAdc); The Bavarian State Ministry for Science; BMBF(Federal Ministry of Education & Research (BMBF))	We thank the Garvan Institute Australian BioResources, Garvan Molecular Genetics, Flow Cytometry, and Garvan-Weizmann Single Cell facilities. We thank the Krammer lab for the plasmid-encoding CoV2 spike. Part of this work was performed on the MX2 beamline at the Australian Synchrotron, part of ANSTO. We thank L. Burnett for his comments on the manuscript. The authors would like to thank the study participants for their contribution to the research. They would like to acknowledge members of the study group. Protocol steering committee: Andrew R. Lloyd (The Kirby Institute), John Kaldor (The Kirby Institute), Greg Dore (The Kirby Institute), Tania Sorrell (Marie Bashir Institute, University of Sydney, Sydney, Australia), Jeffrey J. Post (Prince of Wales Hospital [POWH]), Bernard Hudson (Royal North Shore Hospital [RNSH], Sydney, Australia), Dominic Dwyer (NSWHP), Adam Bartlett (Sydney Children's Hospital [SCH], Sydney, Australia), Sarah C. Sasson (UNSW), Nick Di Girolamo (UNSW), and Daniel Lemberg (SCH). Coordinating center: Marianne Byrne (clinical trials manager), Mohammed Hammoud (post-doctoral fellow and data manager), Andrew R. Lloyd (investigator), and Roshana Sultan (study coordinator). Site principal investigators: Jeffrey J. Post (POWH), Michael Mina (Northern Beaches Hospital [NBH], Sydney, Australia), Bernard Hudson (RNSH), Nicky Gilroy (Westmead Hospital, Sydney, Australia), William Rawlinson (NSWHP); Pam Konecny (St George Hospital [SGH], Sydney, Australia), Marianne Martinello (Blacktown Hospital, Blacktown, Australia), Adam Bartlett (SCH), and Gail Matthews (St Vincent's Hospital [SVH], Sydney, Australia). Site coordinators: Dmitrii Shek and Susan Holdaway (Blacktown Hospital); Katerina Mitsakos (RNSH); Dianne HowChow and Renier Lagunday (POWH); Sharon Robinson (SGH); Lenae Terrill (NBH); Neela Joshi (Westmead Hospital), Ying Li (Westmead Hospital), and Satinder Gill (Westmead Hospital); and Alison Sevehon (SVH).; This work received funding from National Health and Medical Research Council (NHMRC) grants 585490, 1157744, 190774, 1176351, 1176134, 1081858, 1016953, and 1113904; Australian Research Council Discovery grants 160104915 and 140103465; Garvan COVID-19 Catalytic Funding; Bill and Patricia Ritchie Family Foundation; University of Technology Sydney and Rainbow Foundation; the Snow Foundation; Bundesmininisterium f_ur Bildung und Forschung (BMBF, 01KI2043); DFG (TRR130); the Bayersiche Forschungsstiftung (CORAdc); The Bavarian State Ministry for Science; and the BMBF-funded COVIM project (NaFoUniMedCovid19)	Alamyar Eltaf, 2012, Methods Mol Biol, V882, P569, DOI 10.1007/978-1-61779-842-9_32; Amanat F, 2020, NAT MED, V26, P1033, DOI [10.1038/s41591-020-0913-5, 10.1101/2020.03.17.20037713]; Andreano E, 2021, J EXP MED, V218, DOI 10.1084/jem.20210281; Asensio MA, 2019, MABS-AUSTIN, V11, P870, DOI 10.1080/19420862.2019.1583995; Banerjee A, 2021, CELL HOST MICROBE, V29, P160, DOI 10.1016/j.chom.2021.01.004; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Bolotin DA, 2017, NAT BIOTECHNOL, V35, P908, DOI 10.1038/nbt.3979; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Burnett DL, 2018, SCIENCE, V360, P223, DOI 10.1126/science.aao3859; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; COHEN AA, 2021, SCIENCE, V371, P735, DOI DOI 10.1126/SCIENCE.ABF6840; Collins AM, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0236; Dhar A, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008030; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Garcia-Beltran WF, 2021, CELL, V184, P2372, DOI [10.1016/j.cell.2021.03.013, 10.1016/j.cell.2021.04.006]; Greaney Allison J, 2020, bioRxiv, DOI [10.1016/j.chom.2020.11.007, 10.1101/2020.09.10.292078]; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Hacisuleyman E, 2021, NEW ENGL J MED, V384, P2212, DOI [10.1056/NEJMoa2105000, 10.1056/NEJMc2107808]; He W.-t., 2007, BROADLY NEUTRALIZING, V2005; HOFFMANN MK, 1973, NATURE, V243, P408, DOI 10.1038/243408a0; Ikegame S, 2021, NAT COMMUN, V12, DOI [10.1038/s41467-021-24909-9, 10.21203/rs.3.rs-400230/v1, 10.1101/2021.03.31.21254660]; Jette CA, 2021, CELL REP, V36, DOI [10.1016/j.celrep.2021.109760, 10.1101/2021.04.23.441195]; Johansen MD, 2020, MUCOSAL IMMUNOL, V13, P877, DOI 10.1038/s41385-020-00340-z; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kreer Christoph, 2020, J Immunol Methods, V480, P112752, DOI 10.1016/j.jim.2020.112752; LEIKOLA J, 1969, CLIN EXP IMMUNOL, V5, P67; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu Hejun, 2020, Immunity, V53, P1272, DOI [10.1101/2020.08.02.233536, 10.1016/j.immuni.2020.10.023]; Liu Y, 2021, NEW ENGL J MED, V384, P1466, DOI 10.1056/NEJMc2102017; Madhi SA, 2021, NEW ENGL J MED, V384, P1885, DOI 10.1056/NEJMoa2102214; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moorhouse MJ, 2014, BMC IMMUNOL, V15, DOI 10.1186/s12865-014-0059-7; Mouquet H, 2010, NATURE, V467, P591, DOI 10.1038/nature09385; Munnink Bas B. Oude, 2021, Science (Washington D C), V371, P172, DOI 10.1126/science.abe5901; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nielsen Sandra C A, 2020, Res Sq, DOI 10.21203/rs.3.rs-27220/v1; Paus D, 2006, J EXP MED, V203, P1081, DOI 10.1084/jem.20060087; Peter AS, 2022, EUR J IMMUNOL, V52, P770, DOI 10.1002/eji.202149374; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Rappazzo CG, 2021, SCIENCE, V371, P823, DOI 10.1126/science.abf4830; Raybould Matthew I J, 2021, Bioinformatics, V37, P734, DOI 10.1093/bioinformatics/btaa739; Rouet R, 2021, MABS-AUSTIN, V13, DOI 10.1080/19420862.2021.1922134; Saleh FM, 2020, J IMMUNOL, V204, P1998, DOI 10.4049/jimmunol.1901385; Saunders KO, 2021, NATURE, V594, P553, DOI 10.1038/s41586-021-03594-0; Starr Tyler N, 2020, bioRxiv, DOI [10.1126/science.abf9302, 10.1101/2020.11.30.405472]; ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; VILLA ML, 1983, CELL IMMUNOL, V81, P323, DOI 10.1016/0008-8749(83)90240-X; Wahl A, 2021, NATURE, V591, P451, DOI 10.1038/s41586-021-03312-w; Wang N, 2018, VIROL SIN, V33, P104, DOI 10.1007/s12250-018-0012-7; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wec AZ, 2020, SCIENCE, V369, P731, DOI 10.1126/science.abc7424; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wrapp D, 2020, CELL, V181, P1004, DOI 10.1016/j.cell.2020.04.031; Wu K, 2021, NEW ENGL J MED, V384, P1468, DOI 10.1056/NEJMc2102179; Yang H, 2014, NAT PROTOC, V9, P1956, DOI 10.1038/nprot.2014.134; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Yi TS, 2015, IMMUNITY, V43, P764, DOI 10.1016/j.immuni.2015.08.021; Yu Guangchuang, 2020, Curr Protoc Bioinformatics, V69, pe96, DOI 10.1002/cpbi.96; Yuan M, 2021, BIOCHEM BIOPH RES CO, V538, P192, DOI 10.1016/j.bbrc.2020.10.012; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Zhang T, 2020, CURR BIOL, V30, P1346, DOI 10.1016/j.cub.2020.03.022; Zhang ZG, 2021, IMMUNOL CELL BIOL, V99, P865, DOI 10.1111/imcb.12478; Zhou DM, 2020, NAT STRUCT MOL BIOL, V27, P950, DOI 10.1038/s41594-020-0480-y	67	12	12	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 14	2021	54	12					2908	+		10.1016/j.immuni.2021.10.019	http://dx.doi.org/10.1016/j.immuni.2021.10.019		DEC 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XQ6EH	34788600	Green Published, hybrid			2022-12-18	WOS:000731638600002
J	Nascimento, DC; Viacava, PR; Ferreira, RG; Damaceno, MA; Pineros, AR; Melo, PH; Donate, PB; Toller-Kawahisa, JE; Zoppi, D; Veras, FP; Peres, RS; Menezes-Silva, L; Caetite, D; Oliveira, AER; Castro, IMS; Kauffenstein, G; Nakaya, HI; Borges, MC; Zamboni, DS; Fonseca, DM; Paschoal, JAR; Cunha, TM; Quesniaux, V; Linden, J; Cunha, FQ; Ryffel, B; Alves, JC				Nascimento, Daniele Carvalho; Viacava, Paula Ramos; Ferreira, Raphael Gomes; Damaceno, Marina Alves; Pineros, Annie Rocio; Melo, Paulo Henrique; Donate, Paula Barbim; Toller-Kawahisa, Juliana Escher; Zoppi, Daniel; Veras, Flavio Protasio; Peres, Raphael Sanches; Menezes-Silva, Luisa; Caetite, Diego; Rocha Oliveira, Antonio Edson; Santos Castro, Icaro Maia; Kauffenstein, Gilles; Nakaya, Helder Imoto; Borges, Marcos Carvalho; Zamboni, Dario Simoes; Fonseca, Denise Morais; Rizzato Paschoal, Jonas Augusto; Cunha, Thiago Mattar; Quesniaux, Valerie; Linden, Joel; Cunha, Fernando Queiroz; Ryffel, Bernhard; Alves-Filho, Jose Carlos			Sepsis expands a CD39(+) plasmablast population that promotes immunosuppression via adenosine-mediated inhibition of macrophage antimicrobial activity	IMMUNITY			English	Article							REGULATORY T-CELLS; B-CELLS; CD73; ACTIVATION; EXPRESSION; SUPPRESSION; CHECKPOINT; IMMUNITY; ANTIGEN; IL-10	Sepsis results in elevated adenosine in circulation. Extracellular adenosine triggers immunosuppressive signaling via the A2a receptor (A2aR). Sepsis survivors develop persistent immunosuppression with increased risk of recurrent infections. We utilized the cecal ligation and puncture (CLP) model of sepsis and subsequent infection to assess the role of adenosine in post-sepsis immune suppression. A2aR-deficient mice showed improved resistance to post-sepsis infections. Sepsis expanded a subset of CD39(hi) B cells and elevated extracellular adenosine, which was absent in mice lacking CD39-expressing B cells. Sepsis-surviving B cell-deficient mice were more resistant to secondary infections. Mechanistically, metabolic reprogramming of septic B cells increased production of ATP, which was converted into adenosine by CD39 on plasmablasts. Adenosine signaling via A2aR impaired macrophage bactericidal activity and enhanced interleukin-10 production. Septic individuals exhibited expanded CD39(hi) plasmablasts and adenosine accumulation. Our study reveals CD39(hi) plasmablasts and adenosine as important drivers of sepsisinduced immunosuppression with relevance in human disease.	[Nascimento, Daniele Carvalho; Viacava, Paula Ramos; Ferreira, Raphael Gomes; Pineros, Annie Rocio; Melo, Paulo Henrique; Donate, Paula Barbim; Toller-Kawahisa, Juliana Escher; Veras, Flavio Protasio; Peres, Raphael Sanches; Caetite, Diego; Cunha, Thiago Mattar; Cunha, Fernando Queiroz; Alves-Filho, Jose Carlos] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, BR-14049900 Ribeirao Preto, SP, Brazil; [Nascimento, Daniele Carvalho; Viacava, Paula Ramos; Ferreira, Raphael Gomes; Pineros, Annie Rocio; Melo, Paulo Henrique; Donate, Paula Barbim; Toller-Kawahisa, Juliana Escher; Veras, Flavio Protasio; Peres, Raphael Sanches; Caetite, Diego; Zamboni, Dario Simoes; Cunha, Thiago Mattar; Cunha, Fernando Queiroz; Alves-Filho, Jose Carlos] Univ Sao Paulo, Ctr Res Inflammatory Dis, Ribeirao Preto Med Sch, BR-14049900 Ribeirao Preto, SP, Brazil; [Nascimento, Daniele Carvalho; Quesniaux, Valerie; Ryffel, Bernhard] CNRS, UMR7355, F-45071 Orleans, France; [Damaceno, Marina Alves; Rizzato Paschoal, Jonas Augusto] Univ Sao Paulo, Sch Pharmaceut Sci Ribeirao Preto, Dept Biomol Sci, BR-14049900 Ribeirao Preto, SP, Brazil; [Zoppi, Daniel; Borges, Marcos Carvalho] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Internal Med, BR-14049900 Ribeirao Preto, SP, Brazil; [Menezes-Silva, Luisa; Fonseca, Denise Morais] Univ Sao Paulo, Inst Biomed Sci, BR-05508000 Sao Paulo, SP, Brazil; [Rocha Oliveira, Antonio Edson; Santos Castro, Icaro Maia] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, BR-05508000 Sao Paulo, SP, Brazil; [Kauffenstein, Gilles] Univ Strasbourg, Regenerat NanoMed, UMR INSERM 1260, F-60026 Strasbourg, France; [Nakaya, Helder Imoto] Hosp Israelita Albert Einstein, BR-05620900 Sao Paulo, Brazil; [Zamboni, Dario Simoes] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell Biol, BR-14049900 Ribeirao Preto, SP, Brazil; [Linden, Joel] Univ Virginia, Ctr Immun Inflammat & Regenerat Med, Div Nephrol, Sch Med, Charlottesville, VA 22903 USA; [Quesniaux, Valerie; Ryffel, Bernhard] Univ Orleans, Expt & Mol Immunol & Neurogenet, F-45071 Orleans, France	Universidade de Sao Paulo; Universidade de Sao Paulo; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Hospital Israelita Albert Einstein; Universidade de Sao Paulo; University of Virginia; Universite de Orleans	Nascimento, DC; Alves, JC (corresponding author), Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Pharmacol, BR-14049900 Ribeirao Preto, SP, Brazil.; Nascimento, DC; Alves, JC (corresponding author), Univ Sao Paulo, Ctr Res Inflammatory Dis, Ribeirao Preto Med Sch, BR-14049900 Ribeirao Preto, SP, Brazil.; Nascimento, DC (corresponding author), CNRS, UMR7355, F-45071 Orleans, France.	danielecbn@usp.br; jcafilho@usp.br	Alves-Filho, Jose Carlos/B-5814-2008; Paschoal, Jonas Augusto Rizzato/F-4260-2012; Borges, Marcos Carvalho/A-3585-2014; Castro, Ícaro/AAK-4962-2020; Caetité, Diego/FOL-6672-2022; Zamboni, Dario S/D-3024-2012	Alves-Filho, Jose Carlos/0000-0002-9918-8714; Paschoal, Jonas Augusto Rizzato/0000-0002-7372-0936; Borges, Marcos Carvalho/0000-0001-6280-0714; Castro, Ícaro/0000-0002-3484-8718; Zamboni, Dario S/0000-0002-7856-7512; Nascimento, Daniele Carvalho/0000-0002-0620-339X; Caetite, Diego/0000-0003-3916-6748; PINEROS ALVAREZ, ANNIE ROCIO/0000-0003-0135-7549; Menezes Silva, Luisa/0000-0002-6860-6522; R. Oliveira, Antonio Edson/0000-0001-8783-9009	Sao Paulo Research Foundation (FAPESP) [2013/08216-2, 2015/25364-0]; National Council for Scientific and Technological Development (CNPq) [483659/2013-4]; FAPESP [2012/10100-0, 2015/25974-3]; Region Centre-Val de Loire [FEDER 2016-00110366, EX005756, EUROFeRI EX010381]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Region Centre-Val de Loire(Region Centre-Val de Loire)	We thank Ieda Schivo, Sergio Rosa, Ana Katia Santos, Denise Ferraz, and Marc Le Bert for technical assistance. This work was supported by Brazilian research founding from Sao Paulo Research Foundation (FAPESP) (2013/08216-2 to the Center for Research in Inflammatory Diseases; and 2015/25364-0 to D.M.F.), National Council for Scientific and Technological Development (CNPq) (483659/2013-4), FAPESP fellowships (2012/10100-0 and 2015/25974-3 to D.C.N.); and European funding from Region Centre-Val de Loire (FEDER 2016-00110366, EX005756, and EUROFe ' RI EX010381).	Allard B, 2017, IMMUNOL REV, V276, P121, DOI 10.1111/imr.12528; [Anonymous], 2014, J INTENSIVE CARE MED, V29, P87, DOI 10.1177/0885066612467162; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Beauvais A, 1997, J BIOL CHEM, V272, P6238, DOI 10.1074/jbc.272.10.6238; Behnsen J, 2008, INFECT IMMUN, V76, P820, DOI 10.1128/IAI.01037-07; Benjamim CF, 2003, AM J PATHOL, V163, P2605, DOI 10.1016/S0002-9440(10)63615-2; Berjeaud JM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00486; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Borsellino G, 2007, BLOOD, V110, P1225, DOI 10.1182/blood-2006-12-064527; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Cekic C, 2013, J EXP MED, V210, P2693, DOI 10.1084/jem.20130249; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Couper KN, 2008, J IMMUNOL, V180, P5771, DOI 10.4049/jimmunol.180.9.5771; Culton DA, 2006, J IMMUNOL, V176, P790, DOI 10.4049/jimmunol.176.2.790; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Dwyer KM, 2007, PURINERG SIGNAL, V3, P171, DOI 10.1007/s11302-006-9050-y; Edelstein PH, 2003, ANTIMICROB AGENTS CH, V47, P533, DOI 10.1128/AAC.47.2.533-540.2003; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Figueiro F, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2015.1082703; Fredholm BB, 2001, PHARMACOL REV, V53, P527; GERDES J, 1984, J IMMUNOL, V133, P1710; Goncalves AV, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007886; Guzik TJ, 2007, J EXP MED, V204, P2449, DOI 10.1084/jem.20070657; Hasko G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00085; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hasko G, 2012, ARTERIOSCL THROM VAS, V32, P865, DOI 10.1161/ATVBAHA.111.226852; Jabs CM, 1998, SURGERY, V124, P65, DOI 10.1067/msy.1998.87894; JACOBSON KA, 1993, FEBS LETT, V323, P141, DOI 10.1016/0014-5793(93)81466-D; Kaku H, 2014, J IMMUNOL, V193, P5904, DOI 10.4049/jimmunol.1400336; Levesque SA, 2007, BRIT J PHARMACOL, V152, P141, DOI 10.1038/sj.bjp.0707361; MALISZEWSKI CR, 1994, J IMMUNOL, V153, P3574; Martin C, 2000, CRIT CARE MED, V28, P3198, DOI 10.1097/00003246-200009000-00014; Mempin R, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-301; Nascimento DC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14919; Nascimento DC, 2010, CRIT CARE MED, V38, P1718, DOI 10.1097/CCM.0b013e3181e78ad0; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; Peres RS, 2015, P NATL ACAD SCI USA, V112, P2509, DOI 10.1073/pnas.1424792112; Prescott HC, 2018, JAMA-J AM MED ASSOC, V319, P62, DOI 10.1001/jama.2017.17687; Ramakers BP, 2011, CRIT CARE, V15, DOI 10.1186/cc9400; Reyes M, 2020, NAT MED, V26, P333, DOI 10.1038/s41591-020-0752-4; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Rosser EC, 2020, CELL METAB, V31, P837, DOI 10.1016/j.cmet.2020.03.003; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Sattler S, 2014, J AUTOIMMUN, V50, P107, DOI 10.1016/j.jaut.2014.01.032; Saze Z, 2013, BLOOD, V122, P9, DOI 10.1182/blood-2013-02-482406; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Solomkin JS, 2010, SURG INFECT, V11, P79, DOI 10.1089/sur.2009.9930; Steinhauser ME, 1999, J IMMUNOL, V162, P392; Stuart T., 2019, CELL, V177, P1888, DOI [DOI 10.1016/j.cell.2019.05.031, DOI 10.1016/J.CELL.2019.05.031]; Tsui C, 2018, IMMUNITY, V48, P1144, DOI 10.1016/j.immuni.2018.04.031; Tung JW, 2006, P NATL ACAD SCI USA, V103, P6293, DOI 10.1073/pnas.0511305103; Venet F, 2018, NAT REV NEPHROL, V14, P121, DOI 10.1038/nrneph.2017.165; Veras FP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15171; Waters LR, 2018, ISCIENCE, V5, P99, DOI 10.1016/j.isci.2018.07.005; Yoshizaki A, 2012, NATURE, V491, P264, DOI 10.1038/nature11501; Zamboni DS, 2006, NAT IMMUNOL, V7, P318, DOI 10.1038/ni1305	58	12	12	3	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					2024	+		10.1016/j.immuni.2021.08.005	http://dx.doi.org/10.1016/j.immuni.2021.08.005		SEP 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34473957	Green Published, Green Submitted, Bronze			2022-12-18	WOS:000695789800012
J	Jugder, BE; Kamareddine, L; Watnick, PI				Jugder, Bat-Erdene; Kamareddine, Layla; Watnick, Paula, I			Microbiota-derived acetate activates intestinal innate immunity via the Tip60 histone acetyltransferase complex	IMMUNITY			English	Article							DROSOPHILA-MELANOGASTER; ECDYSONE BIOSYNTHESIS; ENTEROENDOCRINE CELLS; VARIANT EXCHANGE; PGRP-SD; PEPTIDOGLYCAN; RECEPTOR; IMD; GENE; INFECTION	Microbe-derived acetate activates the Drosophila immunodeficiency (IMD) pathway in a subset of enteroendocrine cells (EECs) of the anterior midgut. In these cells, the IMD pathway co-regulates expression of antimicrobial and enteroendocrine peptides including tachykinin, a repressor of intestinal lipid synthesis. To determine whether acetate acts on a cell surface pattern recognition receptor or an intracellular target, we asked whether acetate import was essential for IMD signaling. Mutagenesis and RNA interference revealed that the putative monocarboxylic acid transporter Tarag was essential for enhancement of IMD signaling by dietary acetate. Interference with histone deacetylation in EECs augmented transcription of genes regulated by the steroid hormone ecdysone including IMD targets. Reduced expression of the histone acetyltransferase Tip60 decreased IMD signaling and blocked rescue by dietary acetate and other sources of intracellular acetyl-CoA. Thus, microbe-derived acetate induces chromatin remodeling within enteroendocrine cells, co-regulating host metabolism and intestinal innate immunity via a Tip60-steroid hormone axis that is conserved in mammals.	[Jugder, Bat-Erdene; Watnick, Paula, I] Harvard Med Sch, Boston Childrens Hosp, Div Infect Dis, 300 Longwood Ave, Boston, MA 02115 USA; [Kamareddine, Layla] Qatar Univ, Coll Hlth Sci, QU Hlth, Dept Biomed Sci, Doha, Qatar; [Kamareddine, Layla] Qatar Univ, Biomed Res Ctr, Doha, Qatar; [Kamareddine, Layla] Qatar Univ, QU Hlth, Biomed & Pharmaceut Res Unit, Doha, Qatar	Harvard University; Boston Children's Hospital; Harvard Medical School; Qatar University; Qatar University; Qatar University	Watnick, PI (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Div Infect Dis, 300 Longwood Ave, Boston, MA 02115 USA.	paula.watnick@childrens.harvard.edu	; Jugder, Bat-Erdene/A-8476-2017	Kamareddine, Layla/0000-0002-4988-237X; Jugder, Bat-Erdene/0000-0002-8893-1170	NIH [R21 AI109436, R01 AI162701]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH R21 AI109436 and R01 AI162701 (P.I.W.). Stocks as noted were obtained from the Bloomington Drosophila stock center (NIH P40OD018537) or provided by Dr. Bruno Lemaitre. The Tk antibody was a gift of Dr. Jan-Adrianus Veenstra. Microscopy was performed at the Microscopy Resources on the North Quad (MicRoN) core facility at Harvard Medical School. We thank Daniela Barraza for careful reading of the manuscript and helpful suggestions.	Badenhorst P, 2005, GENE DEV, V19, P2540, DOI 10.1101/gad.1342605; Bakshi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03783-w; Benguettat O, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007279; Berkey CD, 2009, CELL MICROBIOL, V11, P461, DOI 10.1111/j.1462-5822.2008.01267.x; Bodai L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040565; Bogunovic M, 2007, AM J PHYSIOL-GASTR L, V292, pG1770, DOI 10.1152/ajpgi.00249.2006; Borsos BN, 2015, DEV BIOL, V404, P80, DOI 10.1016/j.ydbio.2015.04.020; Brady ME, 1999, J BIOL CHEM, V274, P17599, DOI 10.1074/jbc.274.25.17599; Bundgaard-Nielsen C, 2020, GUT MICROBES, V11, P1172, DOI 10.1080/19490976.2020.1748258; Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056; Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102; Choe KM, 2005, P NATL ACAD SCI USA, V102, P1122, DOI 10.1073/pnas.0404952102; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Drucker DJ, 2016, J CLIN ENDOCR METAB, V101, P778, DOI 10.1210/jc.2015-3449; Dutta D, 2015, CELL REP, V12, P346, DOI 10.1016/j.celrep.2015.06.009; Fast D, 2020, CELL REP, V30, P1088, DOI 10.1016/j.celrep.2019.12.094; Fast D, 2018, P NATL ACAD SCI USA, V115, P7099, DOI 10.1073/pnas.1802165115; Flatt T, 2008, J EXP BIOL, V211, P2712, DOI 10.1242/jeb.014878; Fukuyama H, 2013, P NATL ACAD SCI USA, V110, P10717, DOI 10.1073/pnas.1304380110; Georgiakaki M, 2006, MOL ENDOCRINOL, V20, P2122, DOI 10.1210/me.2005-0149; Giaimo BD, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0274-9; Gilbert LI, 2004, MOL CELL ENDOCRINOL, V215, P1, DOI 10.1016/j.mce.2003.11.003; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Handgraaf S, 2019, ENDOCR REV, V40, P1152, DOI 10.1210/er.2019-00004; Handgraaf S, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98569; Hang SY, 2014, CELL HOST MICROBE, V16, P592, DOI 10.1016/j.chom.2014.10.006; Iatsenko I, 2016, IMMUNITY, V45, P1013, DOI 10.1016/j.immuni.2016.10.029; Jaiswal B, 2018, ENDOCRINOLOGY, V159, P2199, DOI 10.1210/en.2017-03190; Kamareddine L, 2018, CELL METAB, V28, P449, DOI 10.1016/j.cmet.2018.05.026; Kamareddine L, 2018, NAT MICROBIOL, V3, P243, DOI 10.1038/s41564-017-0065-7; Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9; Kleino A, 2019, INSECT BIOCHEM MOLEC, V108, P16, DOI 10.1016/j.ibmb.2019.03.003; Kleino A, 2017, IMMUNITY, V47, P635, DOI 10.1016/j.immuni.2017.09.011; Kleino A, 2014, DEV COMP IMMUNOL, V42, P25, DOI 10.1016/j.dci.2013.05.014; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Kusch T, 2014, P NATL ACAD SCI USA, V111, P4850, DOI 10.1073/pnas.1320337111; Kwon MH, 2013, G3-GENES GENOM GENET, V3, P815, DOI 10.1534/g3.112.005496; Lee MT, 2013, J BIOL CHEM, V288, P25038, DOI 10.1074/jbc.M113.476952; Leone P, 2008, MOL IMMUNOL, V45, P2521, DOI 10.1016/j.molimm.2008.01.015; Luk E, 2010, CELL, V143, P725, DOI 10.1016/j.cell.2010.10.019; Mellroth P, 2005, P NATL ACAD SCI USA, V102, P6455, DOI 10.1073/pnas.0407559102; Miguel-Aliaga I, 2018, GENETICS, V210, P357, DOI 10.1534/genetics.118.300224; Myllymaki H, 2014, J IMMUNOL, V192, P3455, DOI 10.4049/jimmunol.1303309; Neyen C, 2012, J IMMUNOL, V189, P1886, DOI 10.4049/jimmunol.1201022; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Overend G, 2016, SCI REP-UK, V6, DOI 10.1038/srep27242; Pace F, 2021, TRENDS MICROBIOL, V29, P849, DOI 10.1016/j.tim.2020.11.001; Pahi Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142226; Pankotai T, 2010, MOL CELL BIOL, V30, P4254, DOI 10.1128/MCB.00142-10; Pascale A, 2019, CURR OPIN PHARMACOL, V49, P1, DOI 10.1016/j.coph.2019.03.011; Pirooznia SK, 2012, GENETICS, V192, P1327, DOI 10.1534/genetics.112.144667; Ruhf ML, 2001, DEVELOPMENT, V128, P1429; Rus F, 2013, EMBO J, V32, P1626, DOI 10.1038/emboj.2013.100; Salem F, 2019, UNITED EUR GASTROENT, V7, P1008, DOI 10.1177/2050640619867555; Scacchetti A, 2020, ELIFE, V9, DOI 10.7554/eLife.56325; Schmidt RL, 2008, FASEB J, V22, P918, DOI 10.1096/fj.06-7907com; Sedkov Y, 2003, NATURE, V426, P78, DOI 10.1038/nature02080; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Song W, 2014, CELL REP, V9, P40, DOI 10.1016/j.celrep.2014.08.060; Takahashi H, 2006, MOL CELL, V23, P207, DOI 10.1016/j.molcel.2006.05.040; Tao D, 2004, ACTA BIOCH BIOPH SIN, V36, P618, DOI 10.1093/abbs/36.9.618; THOMAS HE, 1993, NATURE, V362, P471, DOI 10.1038/362471a0; van Beekum O, 2008, ENDOCRINOLOGY, V149, P1840, DOI 10.1210/en.2007-0977; Veenstra JA, 2009, CELL TISSUE RES, V336, P309, DOI 10.1007/s00441-009-0769-y; Veenstra JA, 2008, CELL TISSUE RES, V334, P499, DOI 10.1007/s00441-008-0708-3; Wang ZP, 2013, MBIO, V4, DOI 10.1128/mBio.00337-13; Watnick PI, 2020, TRENDS MICROBIOL, V28, P141, DOI 10.1016/j.tim.2019.09.005; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Werner T, 2003, J BIOL CHEM, V278, P26319, DOI 10.1074/jbc.C300184200; Worthington JJ, 2015, BIOCHEM SOC T, V43, P727, DOI 10.1042/BST20150090; Xu SJ, 2014, GENETICS, V198, P1571, DOI 10.1534/genetics.114.171660; Xu TQ, 2020, CELL DEATH DIFFER, V27, P1, DOI 10.1038/s41418-019-0456-9; Yamanaka N, 2013, ANNU REV ENTOMOL, V58, P497, DOI 10.1146/annurev-ento-120811-153608; Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914; Zheng WJ, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0532-5; Zietek T, 2015, CURR OPIN CLIN NUTR, V18, P381, DOI 10.1097/MCO.0000000000000187	77	12	12	6	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1683	+		10.1016/j.immuni.2021.05.017	http://dx.doi.org/10.1016/j.immuni.2021.05.017		AUG 2021	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34107298	Bronze, Green Accepted			2022-12-18	WOS:000684589700009
J	Mikami, Y; Philips, RL; Sciume, G; Petermann, F; Meylan, F; Nagashima, H; Yao, C; Davis, FP; Brooks, SR; Sun, HW; Takahashi, H; Poholek, AC; Shih, HY; Afzali, B; Muljo, SA; Hafner, M; Kanno, Y; O'Shea, JJ				Mikami, Yohei; Philips, Rachael L.; Sciume, Giuseppe; Petermann, Franziska; Meylan, Francoise; Nagashima, Hiroyuki; Yao, Chen; Davis, Fred P.; Brooks, Stephen R.; Sun, Hong-Wei; Takahashi, Hayato; Poholek, Amanda C.; Shih, Han-Yu; Afzali, Behdad; Muljo, Stefan A.; Hafner, Markus; Kanno, Yuka; O'Shea, John J.			MicroRNA-221 and-222 modulate intestinal inflammatory Th17 cell response as negative feedback regulators downstream of interleukin-23	IMMUNITY			English	Article							C-MAF; TGF-BETA; AUTOIMMUNE INFLAMMATION; GENE-EXPRESSION; T(H)17 CELLS; DIFFERENTIATION; CYTOKINE; GENERATION; INDUCTION; TARGETS	MicroRNAs are important regulators of immune responses. Here, we show miR-221 and miR-222 modulate the intestinal Th17 cell response. Expression of miR-221 and miR-222 was induced by proinflammatory cytokines and repressed by the cytokine TGF-beta. Molecular targets of miR-221 and miR-222 included Maf and Il23r, and loss of miR-221 and miR-222 expression shifted the transcriptomic spectrum of intestinal Th17 cells to a proinflammatory signature. Although the loss of miR-221 and miR-222 was tolerated for maintaining intestinal Th17 cell homeostasis in healthy mice, Th17 cells lacking miR-221 and miR-222 expanded more efficiently in response to IL-23. Both global and T cell-specific deletion of miR-221 and miR-222 rendered mice prone to mucosal barrier damage. Collectively, these findings demonstrate that miR-221 and miR-222 are an integral part of intestinal Th17 cell response that are induced after IL-23 stimulation to constrain the magnitude of proinflammatory response.	[Mikami, Yohei; Philips, Rachael L.; Sciume, Giuseppe; Petermann, Franziska; Meylan, Francoise; Nagashima, Hiroyuki; Yao, Chen; Davis, Fred P.; Takahashi, Hayato; Poholek, Amanda C.; Shih, Han-Yu; Afzali, Behdad; Kanno, Yuka; O'Shea, John J.] NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Philips, Rachael L.] NIGMS, Postdoctoral Res Associate Program, NIH, Bethesda, MD 20892 USA; [Brooks, Stephen R.; Sun, Hong-Wei] NIAMSD, Biodata Min & Discovery Sect, NIH, Bethesda, MD 20892 USA; [Muljo, Stefan A.] NIAID, Lab Immune Syst Biol, NIH, Bethesda, MD 20892 USA; [Hafner, Markus] NIAMSD, RNA Mol Biol Grp, NIH, Bethesda, MD 20892 USA; [Mikami, Yohei] Keio Univ, Dept Internal Med, Div Gastroenterol & Hepatol, Sch Med, Tokyo 1608582, Japan; [Sciume, Giuseppe] Sapienza Univ Rome, Dept Mol Med, I-00185 Rome, Italy; [Davis, Fred P.] Celsius Therapeut, Cambridge, MA 02139 USA; [Petermann, Franziska] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Takahashi, Hayato] Keio Univ, Dept Dermatol, Tokyo 1608582, Japan; [Poholek, Amanda C.] Univ Pittsburgh, Dept Pediat, Div Pediat Rheumatol, Sch Med, Pittsburgh, PA 15260 USA; [Shih, Han-Yu] NEI, Neuroimmune Regulome Unit, NIH, Bethesda, MD USA; [Afzali, Behdad] NIDDK, Immunoregulat Sect, NIH, Bethesda, MD 20892 USA; [Meylan, Francoise] NIAMSD, Translat Immunol Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of General Medical Sciences (NIGMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Keio University; Sapienza University Rome; Helmholtz Association; German Cancer Research Center (DKFZ); Keio University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Kanno, Y; O'Shea, JJ (corresponding author), NIAMSD, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA.	kannoy@mail.nih.gov; john.oshea@nih.gov	MIKAMI, YOHEI/GRJ-8133-2022; Kanno, Yuka/B-5802-2013; Nagashima, Hiroyuki/AAL-3128-2021; Sciume, Giuseppe/K-8985-2016; Takahashi, Hayato/AAV-7707-2021; Afzali, Behdad/H-8565-2013	MIKAMI, YOHEI/0000-0001-5104-4415; Kanno, Yuka/0000-0001-5668-9319; Sciume, Giuseppe/0000-0003-0131-512X; Takahashi, Hayato/0000-0001-6768-8821; Afzali, Behdad/0000-0003-2968-1156; Shih, Han-Yu/0000-0002-7525-5433	NIAMS; NIAID; Japan Society for the Promotion of Science (JSPS) KAKENHI [20H03666]; NIH; Postdoctoral Research Associate (PRAT) fellowship from the National Institute of General Medical Sciences (NIGMS) [1Fi2GM137942-01]	NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Postdoctoral Research Associate (PRAT) fellowship from the National Institute of General Medical Sciences (NIGMS)	We thank J. Simone, J. Lay, K. Tinsley (NIAMS) for flow cytometry; G. Gutierrez-Cruz, S. Dell'Orso, F. Naz (NIAMS) for deep sequencing; K. Jiang and Dimitrios Anastasakis (NIAMS) for bioinformatics support; Ivan Fuss (NIAID) for histopathologic scoring; and the NIAMS LACU staff and Y. Morimoto (NIAMS) for their technical support to handle mice. We thank Vanja Lazarevic (NCI) and Mark Ansel (UCSF) for critical reading, the members of the O'Shea laboratory for helpful discussions, and Tomoya Kanno for graphics. This study utilized the high-performance computational capabilities of the Biowulf Linux cluster at the NIH. This work was supported by the Intramural Research Programs of NIAMS and NIAID. Y.M. was supported by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant-in-Aid (B) 20H03666 and Japanese Researcher Fellowships at NIH. R.L.P. was supported by a Postdoctoral Research Associate (PRAT) fellowship from the National Institute of General Medical Sciences (NIGMS), award number 1Fi2GM137942-01.	Aschenbrenner D, 2018, NAT IMMUNOL, V19, P1126, DOI 10.1038/s41590-018-0200-5; Bartel DP, 2018, CELL, V173, P20, DOI 10.1016/j.cell.2018.03.006; Baumjohann D, 2013, NAT REV IMMUNOL, V13, P666, DOI 10.1038/nri3494; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Betel D, 2008, NUCLEIC ACIDS RES, V36, pD149, DOI 10.1093/nar/gkm995; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Escobar TM, 2014, IMMUNITY, V40, P865, DOI 10.1016/j.immuni.2014.03.014; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Garofalo M, 2012, CURR MOL MED, V12, P27, DOI 10.2174/156652412798376170; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Hirahara K, 2015, IMMUNITY, V42, P877, DOI 10.1016/j.immuni.2015.04.014; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Ichiyama K, 2016, IMMUNITY, V44, P1284, DOI 10.1016/j.immuni.2016.05.015; Imbratta C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00206; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kaplan MH, 1996, NATURE, V382, P174, DOI 10.1038/382174a0; Kent WJ, 2010, BIOINFORMATICS, V26, P2204, DOI 10.1093/bioinformatics/btq351; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Liu RQ, 2017, J IMMUNOL, V198, P2626, DOI 10.4049/jimmunol.1601727; Mycko MP, 2012, P NATL ACAD SCI USA, V109, pE1248, DOI 10.1073/pnas.1114325109; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; O'Shea JJ, 2010, SCIENCE, V327, P1098, DOI 10.1126/science.1178334; Omenetti S, 2019, IMMUNITY, V51, P77, DOI 10.1016/j.immuni.2019.05.004; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Pfeifle R, 2017, NAT IMMUNOL, V18, P104, DOI 10.1038/ni.3579; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quintana FJ, 2008, NATURE, V453, P65, DOI 10.1038/nature06880; Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093; Rutz S, 2011, NAT IMMUNOL, V12, P1238, DOI 10.1038/ni.2134; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Sato K, 2011, J BIOL CHEM, V286, P14963, DOI 10.1074/jbc.M111.218867; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Sciume G, 2012, J EXP MED, V209, P2331, DOI 10.1084/jem.20122097; Seeley JJ, 2018, NATURE, V559, P114, DOI 10.1038/s41586-018-0253-5; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shih HY, 2016, CELL, V165, P1120, DOI 10.1016/j.cell.2016.04.029; Stockinger B, 2017, NAT REV IMMUNOL, V17, P535, DOI 10.1038/nri.2017.50; Takahashi H, 2012, NAT IMMUNOL, V13, P587, DOI 10.1038/ni.2286; Tanaka S, 2014, J EXP MED, V211, P1857, DOI 10.1084/jem.20130791; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vahedi G, 2012, CELL, V151, P981, DOI 10.1016/j.cell.2012.09.044; Veldhoen M, 2008, NATURE, V453, P106, DOI 10.1038/nature06881; Wei L, 2010, IMMUNITY, V32, P840, DOI 10.1016/j.immuni.2010.06.003; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212; Zuberbuehler MK, 2019, NAT IMMUNOL, V20, P73, DOI 10.1038/s41590-018-0274-0	66	12	12	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					514	+		10.1016/j.immuni.2021.02.015	http://dx.doi.org/10.1016/j.immuni.2021.02.015		MAR 2021	18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU	33657395	Green Published, Bronze, Green Accepted			2022-12-18	WOS:000627409300017
J	Xu, WX; Snell, LM; Guo, MD; Boukhaled, G; Macleod, BL; Li, M; Tullius, MV; Guidos, CJ; Tsao, MS; Divangahi, M; Horwitz, MA; Liu, J; Brooks, DG				Xu, Wenxi; Snell, Laura M.; Guo, Mengdi; Boukhaled, Giselle; Macleod, Bethany L.; Li, Ming; Tullius, Michael, V; Guidos, Cynthia J.; Tsao, Ming-Sound; Divangahi, Maziar; Horwitz, Marcus A.; Liu, Jun; Brooks, David G.			Early innate and adaptive immune perturbations determine long-term severity of chronic virus and Mycobacterium tuberculosis coinfection	IMMUNITY			English	Article							T-CELL RESPONSES; NECROSIS-FACTOR-ALPHA; PULMONARY TUBERCULOSIS; ALVEOLAR MACROPHAGES; DENDRITIC CELLS; RECEPTOR; BLOOD; IMMUNOPATHOLOGY; INFECTION; DIFFERENTIATION	Chronic viral infections increase severity of Mycobacterium tuberculosis (Mtb) coinfection. Here, we examined how chronic viral infections alter the pulmonary microenvironment to foster coinfection and worsen disease severity. We developed a coordinated system of chronic virus and Mtb infection that induced central clinical manifestations of coinfection, including increased Mtb burden, extra-pulmonary dissemination, and heightened mortality. These disease states were not due to chronic virus-induced immunosuppression or exhaustion; rather, increased amounts of the cytokine TNF alpha initially arrested pulmonary Mtb growth, impeding dendritic cell mediated antigen transportation to the lymph node and subverting immune-surveillance, allowing bacterial sanctuary. The cryptic Mtb replication delayed CD4 T cell priming, redirecting T helper (Th) 1 toward Th17 differentiation and increasing pulmonary neutrophilia, which diminished long-term survival. Temporally restoring CD4 T cell induction overcame these diverse disease sequelae to enhance Mtb control. Thus, Mtb co-opts TNF alpha from the chronic inflammatory environment to subvert immune-surveillance, avert early immune function, and foster long-term coinfection.	[Xu, Wenxi; Snell, Laura M.; Guo, Mengdi; Boukhaled, Giselle; Macleod, Bethany L.; Li, Ming; Tsao, Ming-Sound; Brooks, David G.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Guo, Mengdi; Brooks, David G.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Li, Ming; Liu, Jun] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Tullius, Michael, V; Horwitz, Marcus A.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90095 USA; [Tullius, Michael, V; Horwitz, Marcus A.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Guidos, Cynthia J.] Hosp Sick Children, Program Dev & Stem Cell Biol, Res Inst, Toronto, ON M5G 0A4, Canada; [Divangahi, Maziar] McGill Univ, McGill Int TB Ctr, Dept Pathol, Hlth Ctr,Meakins Christie Labs,Dept Med,Dept Micr, Montreal, PQ H4A 3J1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McGill University	Brooks, DG (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada.; Brooks, DG (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada.	dbrooks@uhnresearch.ca	Tsao, Ming Sound/AFQ-7332-2022	Tsao, Ming Sound/0000-0002-9160-5405	Canadian Institutes of Health Research [FDN148386]; National Institutes of Health (NIH) [AI085043]; Scotiabank Research Chair; Fonds de la recherche en sante du Quebec; Princess Margaret Holdem for Life Cancer Research Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Scotiabank Research Chair; Fonds de la recherche en sante du Quebec(Fonds de la Recherche en Sante du Quebec); Princess Margaret Holdem for Life Cancer Research Fellowship	We thank Barbara Jane Dillon for excellent technical assistance. These researchers are supported by Canadian Institutes of Health Research grant FDN148386 (to D.G.B.), National Institutes of Health (NIH) grant AI085043 (to D.G.B.), the Scotiabank Research Chair (to D.G.B.), a training grant from the Fonds de la recherche en sante du Quebec (to L.M.S.), and the Princess Margaret Hold`em for Life Cancer Research Fellowship (to G.B.).	Abay Solomon M, 2015, J Int Assoc Provid AIDS Care, V14, P560, DOI 10.1177/2325957415599210; Aegerter H, 2020, NAT IMMUNOL, V21, P145, DOI 10.1038/s41590-019-0568-x; Ahn SK, 2018, MOL THER, V26, P2863, DOI 10.1016/j.ymthe.2018.08.023; Baker MA, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-81; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Brooks DG, 2005, J VIROL, V79, P10514, DOI 10.1128/JVI.79.16.10514-10527.2005; Bucsan AN, 2019, J CLIN INVEST, V129, P5254, DOI 10.1172/JCI125810; Cardona P, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02139; Chen H, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005112; Chen L, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.congress-2018.PA4099; Cohen SB, 2018, CELL HOST MICROBE, V24, P439, DOI 10.1016/j.chom.2018.08.001; Costiniuk CT, 2014, REV MED VIROL, V24, P35, DOI 10.1002/rmv.1772; Cunningham CR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005356; Dorhoi A, 2014, EUR J IMMUNOL, V44, P2380, DOI 10.1002/eji.201344219; Dorhoi A, 2014, SEMIN IMMUNOL, V26, P203, DOI 10.1016/j.smim.2014.04.003; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Esmail H, 2018, ANNU REV IMMUNOL, V36, P603, DOI 10.1146/annurev-immunol-042617-053420; Eum SY, 2010, CHEST, V137, P122, DOI 10.1378/chest.09-0903; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Feng JY, 2012, J GASTROENTEROL, V47, P1048, DOI 10.1007/s00535-012-0568-1; Gallegos AM, 2008, J EXP MED, V205, P2359, DOI 10.1084/jem.20080353; Gillis TP, 2014, INFECT IMMUN, V82, P3900, DOI 10.1128/IAI.01499-13; Grant PM, 2012, J INFECT DIS, V206, P1715, DOI 10.1093/infdis/jis604; Gupta A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034156; Han Y, 2018, J THORAC DIS, V10, P339, DOI 10.21037/jtd.2017.12.65; Horwitz MA, 2000, P NATL ACAD SCI USA, V97, P13853, DOI 10.1073/pnas.250480397; Huang L, 2018, J EXP MED, V215, P1135, DOI 10.1084/jem.20172020; ISRAELBIET D, 1991, J IMMUNOL, V147, P490; Jambo KC, 2014, MUCOSAL IMMUNOL, V7, P1116, DOI 10.1038/mi.2013.127; Kang BK, 1998, INFECT IMMUN, V66, P2769, DOI 10.1128/IAI.66.6.2769-2777.1998; Khader SA, 2007, NAT IMMUNOL, V8, P369, DOI 10.1038/ni1449; Kimmey JM, 2015, NATURE, V528, P565, DOI 10.1038/nature16451; Kumar NP, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz257; Kumar Nathella Pavan, 2013, Ann Am Thorac Soc, V10, P441, DOI 10.1513/AnnalsATS.201305-112OC; Kumar NP, 2013, J INFECT DIS, V208, P739, DOI 10.1093/infdis/jit241; Lai R, 2018, J IMMUNOL, V200, P1746, DOI 10.4049/jimmunol.1701109; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Lombard R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149455; Lukhele S, 2019, SEMIN IMMUNOL, V43, DOI 10.1016/j.smim.2019.05.001; Macleod BL, 2020, J EXP MED, V217, DOI 10.1084/jem.20191473; Manca C, 2005, J INTERF CYTOK RES, V25, P694, DOI 10.1089/jir.2005.25.694; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; Mayer-Barber KD, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a018424; McInnes L., 2018, ARXIV180203426; MILLAR AB, 1991, AM J RESP CELL MOL, V5, P144, DOI 10.1165/ajrcmb/5.2.144; Miyahara R, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4292-9; Moguche AO, 2017, CELL HOST MICROBE, V21, P695, DOI 10.1016/j.chom.2017.05.012; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; Mourik BC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00294; Muller J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.130090; Nandi B, 2011, J EXP MED, V208, P2251, DOI 10.1084/jem.20110919; Osokine I, 2014, P NATL ACAD SCI USA, V111, P7409, DOI 10.1073/pnas.1401662111; Panteleev AV, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00963; Pedroza-Roldan C, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx079; Petrovas C, 2012, J CLIN INVEST, V122, P3281, DOI 10.1172/JCI63039; Plumlee CR, 2021, CELL HOST MICROBE, V29, P68, DOI 10.1016/j.chom.2020.10.003; Redford PS, 2014, J INFECT DIS, V209, P270, DOI 10.1093/infdis/jit424; Reiley WW, 2008, P NATL ACAD SCI USA, V105, P10961, DOI 10.1073/pnas.0801496105; Grassi MFR, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1428-z; Roney Kelly, 2013, Methods Mol Biol, V1031, P71, DOI 10.1007/978-1-62703-481-4_9; Samstein M, 2013, ELIFE, V2, DOI 10.7554/eLife.01086; Snell LM, 2018, IMMUNITY, V49, P378, DOI 10.1016/j.immuni.2018.08.002; Snell LM, 2016, CELL REP, V16, P3286, DOI 10.1016/j.celrep.2016.08.065; STEFFEN M, 1993, CLIN EXP IMMUNOL, V91, P30; Stelekati E, 2012, CELL HOST MICROBE, V12, P458, DOI 10.1016/j.chom.2012.10.001; Suthar AB, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001270; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Urdahl KB, 2011, MUCOSAL IMMUNOL, V4, P288, DOI 10.1038/mi.2011.10; Weber LM, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0415-5; WHO (World Health Organization), 2020, SCIENCE; Wolf AJ, 2008, J EXP MED, V205, P105, DOI 10.1084/jem.20071367; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Wu PH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001328; Yamada DH, 2015, IMMUNITY, V42, P379, DOI 10.1016/j.immuni.2015.01.005	76	12	12	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 9	2021	54	3					526	+		10.1016/j.immuni.2021.01.003	http://dx.doi.org/10.1016/j.immuni.2021.01.003		MAR 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RU		Bronze, Green Accepted			2022-12-18	WOS:000627409300018
J	Guendel, F; Kofoed-Branzk, M; Gronke, K; Tizian, C; Witkowski, M; Cheng, HW; Heinz, GA; Heinrich, F; Durek, P; Norris, PS; Ware, CF; Ruedl, C; Herold, S; Pfeffer, K; Hehlgans, T; Waisman, A; Becher, B; Giannou, AD; Brachs, S; Ebert, K; Tanriver, Y; Ludewig, B; Mashreghi, MF; Kruglov, AA; Diefenbach, A				Guendel, Fabian; Kofoed-Branzk, Michael; Gronke, Konrad; Tizian, Caroline; Witkowski, Mario; Cheng, Hung-Wei; Heinz, Gitta Anne; Heinrich, Frederik; Durek, Pawel; Norris, Paula S.; Ware, Carl F.; Ruedl, Christiane; Herold, Susanne; Pfeffer, Klaus; Hehlgans, Thomas; Waisman, Ari; Becher, Burkhard; Giannou, Anastasios D.; Brachs, Sebastian; Ebert, Karolina; Tanriver, Yakup; Ludewig, Burkhard; Mashreghi, Mir-Farzin; Kruglov, Andrey A.; Diefenbach, Andreas			Group 3 Innate Lymphoid Cells Program a Distinct Subset of IL-22BP-Producing Dendritic Cells Demarcating Solitary Intestinal Lymphoid Tissues	IMMUNITY			English	Article							ROR-GAMMA-T; GREEN FLUORESCENT PROTEIN; SIGNALING CONTROLS; INDUCER CELLS; RECEPTOR; LYMPHOTOXIN; EXPRESSION; IL-22; MICE; MACROPHAGES	Solitary intestinal lymphoid tissues such as cryptopatches (CPs) and isolated lymphoid follicles (ILFs) constitute steady-state activation hubs containing group 3 innate lymphoid cells (ILC3) that continuously produce interleukin (IL)-22. The outer surface of CPs and ILFs is demarcated by a poorly characterized population of CD11c(+) cells, Using genome-wide single-cell transcriptional profiling of intestinal mononuclear phagocytes and multidimensional flow cytometry, we found that CP- and ILF-associated CD11c(+) cells were a transcriptionally distinct subset of intestinal cDCs, which we term CIA-DCs. CIA-DCs required programming by CP- and ILF-resident CCR6+ ILC3 via lymphotoxin-beta receptor signaling in cDCs. CIA-DCs differentially expressed genes associated with immunoregulation and were the major cellular source of IL-22 binding protein (IL-22BP) at steady state. Mice lacking CIA-DC-derived IL-22BP exhibited diminished expression of epithelial lipid transporters, reduced lipid resorption, and changes in body fat homeostasis. Our findings provide insight into the design principles of an immunoregulatory checkpoint controlling nutrient absorption.	[Guendel, Fabian; Kofoed-Branzk, Michael; Gronke, Konrad; Tizian, Caroline; Witkowski, Mario; Diefenbach, Andreas] Charite Univ Med Berlin, Dept Microbiol Infect Dis & Immunol, Lab Innate Immun, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany; [Guendel, Fabian; Kofoed-Branzk, Michael; Gronke, Konrad; Tizian, Caroline; Witkowski, Mario; Diefenbach, Andreas] Berlin Inst Hlth BIH, Anna Louisa Karsch Str 2, D-10117 Berlin, Germany; [Guendel, Fabian; Kofoed-Branzk, Michael; Gronke, Konrad; Tizian, Caroline; Witkowski, Mario; Diefenbach, Andreas] Deutsch Rheuma Forschungszentrum DRFZ, Mucosal & Dev Immunol, D-10117 Berlin, Germany; [Cheng, Hung-Wei; Ludewig, Burkhard] Kantonsspital St Gallen, Inst Immunobiol, St Gallen, Switzerland; [Heinz, Gitta Anne; Heinrich, Frederik; Durek, Pawel; Mashreghi, Mir-Farzin] Deutsch Rheuma Forschungszentrum DRFZ, Therapeut Gene Regulat, D-10117 Berlin, Germany; [Mashreghi, Mir-Farzin] Charite Univ Med Berlin, BIH Ctr Regenerat Therapies BCRT, Berlin, Germany; [Norris, Paula S.; Ware, Carl F.] Sanford Burnham Prebys Med Discovery Inst, Lab Mol Immunol, 10901 North Torrey Pines Rd, La Jolla, CA 92037 USA; [Ruedl, Christiane] Nanyang Technol Univ Singapore, Sch Biol Sci, Singapore, Singapore; [Herold, Susanne] Univ Giessen & Marburg Lung Ctr, Dept Internal Med 2, German Ctr Lung Res DZL, Giessen, Germany; [Pfeffer, Klaus] Heinrich Heine Univ Dusseldorf, Inst Med Microbiol & Hosp Hyg, Dusseldorf, Germany; [Hehlgans, Thomas] Regensburg Ctr Intervent Immunol RCI, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany; [Hehlgans, Thomas] Regensburg Univ, Chair Immunol, Franz Josef Strauss Allee 11, D-93053 Regensburg, Germany; [Waisman, Ari] Johannes Gutenberg Univ Mainz, Inst Mol Med, Univ Med Ctr, Mainz, Germany; [Becher, Burkhard; Ludewig, Burkhard] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Giannou, Anastasios D.] Univ Med Ctr Hamburg Eppendorf, Dept Med, Sect Mol Immunol & Gastroenterol, D-20246 Hamburg, Germany; [Giannou, Anastasios D.] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, D-20246 Hamburg, Germany; [Brachs, Sebastian] Charite Univ Med Berlin, Dept Endocrinol & Metab, Charitepl 1, D-10117 Berlin, Germany; [Brachs, Sebastian] DZHK German Ctr Cardiovasc Res, Partner Site Berlin, Berlin, Germany; [Brachs, Sebastian] Charite Univ Med Berlin, Ctr Cardiovasc Res CCR, Hessische Str 3-4, D-10115 Berlin, Germany; [Ebert, Karolina; Tanriver, Yakup] Univ Freiburg, Fac Med, Inst Med Microbiol & Hyg, Freiburg, Germany; [Tanriver, Yakup] Univ Freiburg, Med Ctr Univ Freiburg, Fac Med, Dept Internal Med 4, Freiburg, Germany; [Kruglov, Andrey A.] Deutsch Rheuma Forschungszentrum DRFZ, Microbiota & Chron Inflammat, D-10117 Berlin, Germany; [Kruglov, Andrey A.] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119234, Russia; [Kruglov, Andrey A.] Moscow MV Lomonosov State Univ, Biol Fac, Moscow 119234, Russia; [Kruglov, Andrey A.] Russian Acad Sci, Ctr Precis Genome Editing & Genet Technol Biomed, Engelhardt Inst Mol Biol, Moscow 119991, Russia	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Berlin Institute of Health; Kantonsspital St. Gallen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Sanford Burnham Prebys Medical Discovery Institute; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Heinrich Heine University Dusseldorf; University of Regensburg; Johannes Gutenberg University of Mainz; University of Zurich; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; German Centre for Cardiovascular Research; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Freiburg; University of Freiburg; Lomonosov Moscow State University; Lomonosov Moscow State University; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Diefenbach, A (corresponding author), Charite Univ Med Berlin, Dept Microbiol Infect Dis & Immunol, Lab Innate Immun, Campus Benjamin Franklin,Hindenburgdamm 30, D-12203 Berlin, Germany.; Diefenbach, A (corresponding author), Berlin Inst Hlth BIH, Anna Louisa Karsch Str 2, D-10117 Berlin, Germany.; Diefenbach, A (corresponding author), Deutsch Rheuma Forschungszentrum DRFZ, Mucosal & Dev Immunol, D-10117 Berlin, Germany.	andreas.diefenbach@charite.de	Kruglov, Andrey/AAP-2023-2021; Mashreghi, Mir-Farzin/S-2911-2019; Kruglov, Andrey A/F-7543-2017; Tanriver, Yakup/AAU-7064-2020; Diefenbach, Andreas/T-2589-2018	Mashreghi, Mir-Farzin/0000-0002-8015-6907; Kruglov, Andrey A/0000-0002-4597-2087; Diefenbach, Andreas/0000-0002-9176-9530; Brachs, Sebastian/0000-0002-6336-3939; Heinz, Gitta Anne/0000-0002-9330-3689; Tizian, Caroline/0000-0002-6798-3406; Tanriver, Yakup/0000-0002-4806-2548	European Research Council [ERC StG 311377]; Deutsche Forschungsgemeinschaft [TR-SFB241/A01, SPP1656-DI764/3, GRK1104, TR-SFB241/A04, SFB1292, SFB1021/C05, SFB-TR84/B09, KFO309/P8]; Excellence Cluster Cardio-Pulmonary Institute, CPI [TA436/4-1, SFB 1160/B08]; Einstein Foundation Berlin (Einstein Professorship); German Rheumatism Research Centre; Swiss National Science Foundation [182583, 310030_170320, 310030_188450]; state of Berlin; European Regional Development Fund (ERDF) [EFRE 1.8/11]; Institute for Lung Health; Juergen Manchot Foundation; Singapore Ministry of Education Academic Research Fund Tier 1 grant; Else Kroner-Fresenius-Stiftung [2017_EKFS.34]	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Cluster Cardio-Pulmonary Institute, CPI; Einstein Foundation Berlin (Einstein Professorship); German Rheumatism Research Centre; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); state of Berlin; European Regional Development Fund (ERDF)(European Commission); Institute for Lung Health; Juergen Manchot Foundation; Singapore Ministry of Education Academic Research Fund Tier 1 grant(Ministry of Education, Singapore); Else Kroner-Fresenius-Stiftung	We thank members of the Diefenbach laboratory and Pedro Hernandez for valuable discussions on the manuscript and Karin Oberle and Thordis Hohnstein for excellent technical assistance. We are grateful to the Benjamin Franklin Flow Cytometry Core Facility (M. Fernandes), IMB Flow Cytometry Core Facility (J. Hartwig, I. Schafer, and S. Mockel), IMB Microscopy Core Facility (S. Ritz and J. Schwirz), and IMB Sequencing Facility. The work was supported by the European Research Council (ERC StG 311377 to A.D.); Deutsche Forschungsgemeinschaft (TR-SFB241/A01, SPP1656-DI764/3, and GRK1104 to A.D.; TR-SFB241/A04 to A.A.K.; SFB1292 to A.W.; SFB1021/C05, SFB-TR84/B09, KFO309/P8, and Excellence Cluster Cardio-Pulmonary Institute, CPI to S.H.; and TA436/4-1 and SFB 1160/B08 to Y.T.), Einstein Foundation Berlin (Einstein Professorship to A.D.), German Rheumatism Research Centre (to A.D.), and Swiss National Science Foundation (182583 to B.L. and 310030_170320 and 310030_188450 to B.B.). M.-F.M. was supported by the state of Berlin and the European Regional Development Fund (ERDF 2014-2020, EFRE 1.8/11, Deutsches Rheuma-Forschungszentrum). S.H. is supported by the Institute for Lung Health (ILH). K.P. was supported by the Juergen Manchot Foundation. C.R. was supported by a Singapore Ministry of Education Academic Research Fund Tier 1 grant. Y.T. was supported by Else Kroner-Fresenius-Stiftung (2017_EKFS.34). We are grateful to S. Huber (UKE Hamburg) for providing Il22ra2<SUP>-/-</SUP> mice.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Bonnardel J, 2015, CELL REP, V11, P770, DOI 10.1016/j.celrep.2015.03.067; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Bouskra D, 2008, NATURE, V456, P507, DOI 10.1038/nature07450; Brestoff JR, 2015, NATURE, V519, P242, DOI 10.1038/nature14115; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Cabeza-Cabrerizo M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw1941; CARTER DB, 1990, NATURE, V344, P633, DOI 10.1038/344633a0; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cerovic V, 2013, MUCOSAL IMMUNOL, V6, P104, DOI 10.1038/mi.2012.53; Da Silva C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01254; Diefenbach A, 2020, IMMUNITY, V52, P452, DOI 10.1016/j.immuni.2020.02.016; Dubikovskaya E, 2014, METHOD ENZYMOL, V538, P107, DOI 10.1016/B978-0-12-800280-3.00007-4; Dumoutier L, 2001, J IMMUNOL, V166, P7090, DOI 10.4049/jimmunol.166.12.7090; Eberl G, 2005, NAT REV IMMUNOL, V5, P413, DOI 10.1038/nri1600; Eberl G, 2004, SCIENCE, V305, P248, DOI 10.1126/science.1096472; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Edelson BT, 2010, J EXP MED, V207, P823, DOI 10.1084/jem.20091627; Faust N, 2000, BLOOD, V96, P719; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; Gronke K, 2019, NATURE, V566, P249, DOI 10.1038/s41586-019-0899-7; Guilliams M, 2016, IMMUNITY, V45, P669, DOI 10.1016/j.immuni.2016.08.015; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Herbrand H, 2008, CRIT REV IMMUNOL, V28, P1; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Jaensson E, 2008, J EXP MED, V205, P2139, DOI 10.1084/jem.20080414; Jinnohara T, 2017, J EXP MED, V214, P1607, DOI 10.1084/jem.20160770; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kabashima K, 2005, IMMUNITY, V22, P439, DOI 10.1016/j.immuni.2005.02.007; Kanamori Y, 1996, J EXP MED, V184, P1449, DOI 10.1084/jem.184.4.1449; Karrich JJ, 2019, EUR J IMMUNOL, V49, P290, DOI 10.1002/eji.201847671; Kempski J, 2020, GASTROENTEROLOGY, V159, P1417, DOI 10.1053/j.gastro.2020.06.033; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Kotenko SV, 2001, J IMMUNOL, V166, P7096, DOI 10.4049/jimmunol.166.12.7096; Kruglov AA, 2013, SCIENCE, V342, P1243, DOI 10.1126/science.1243364; Kumamoto Y, 2013, IMMUNITY, V39, P733, DOI 10.1016/j.immuni.2013.08.029; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lewis KL, 2011, IMMUNITY, V35, P780, DOI 10.1016/j.immuni.2011.08.013; Liepinsh DJ, 2006, MOL CELL BIOL, V26, P4214, DOI 10.1128/MCB.01751-05; Lindemans CA, 2015, NATURE, V528, P560, DOI 10.1038/nature16460; Liu K, 2010, IMMUNOL REV, V234, P45, DOI 10.1111/j.0105-2896.2009.00879.x; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Longman RS, 2014, J EXP MED, V211, P1571, DOI 10.1084/jem.20140678; Lugering A, 2010, CLIN EXP IMMUNOL, V160, P440, DOI 10.1111/j.1365-2249.2010.04103.x; MacDonald KPA, 2010, BLOOD, V116, P3955, DOI 10.1182/blood-2010-02-266296; Mair F, 2015, ELIFE, V4, DOI 10.7554/eLife.10087; Manta C, 2013, MUCOSAL IMMUNOL, V6, P177, DOI 10.1038/mi.2012.61; Mao KR, 2018, NATURE, V554, P255, DOI 10.1038/nature25437; Martin D, 2014, SOCIAL POLICIES AND SOCIAL CONTROL: NEW PERSPECTIVES ON THE NOT-SO-BIG SOCIETY, P101; Martin JC, 2016, MUCOSAL IMMUNOL, V9, P539, DOI 10.1038/mi.2015.83; McDonald KG, 2010, AM J PATHOL, V176, P2367, DOI 10.2353/ajpath.2010.090723; Mebius RE, 1997, IMMUNITY, V7, P493, DOI 10.1016/S1074-7613(00)80371-4; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Onder L, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00050; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pelczar P, 2016, SCIENCE, V354, P358, DOI 10.1126/science.aah5903; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Pickard JM, 2014, NATURE, V514, P638, DOI 10.1038/nature13823; Rapp M, 2019, J EXP MED, V216, P1170, DOI 10.1084/jem.20170277; Reboldi A, 2016, SCIENCE, V352, DOI 10.1126/science.aaf4822; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Satpathy AT, 2013, NAT IMMUNOL, V14, P937, DOI 10.1038/ni.2679; Satpathy AT, 2012, J EXP MED, V209, P1135, DOI 10.1084/jem.20120030; Savage AK, 2017, J IMMUNOL, V199, P1912, DOI 10.4049/jimmunol.1700155; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Schulz O, 2009, J EXP MED, V206, P3101, DOI 10.1084/jem.20091925; Scott CL, 2015, MUCOSAL IMMUNOL, V8, P327, DOI 10.1038/mi.2014.70; Srinivas S., 2001, BMC DEV BIOL, V1, DOI [10.1186/1471-213x-1-4, DOI 10.1186/1471-213X-1-4.]; Talbot J, 2020, NATURE, V579, P575, DOI 10.1038/s41586-020-2039-9; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Tumanov AV, 2002, IMMUNITY, V17, P239, DOI 10.1016/S1074-7613(02)00397-7; Tussiwand R, 2015, IMMUNITY, V42, P916, DOI 10.1016/j.immuni.2015.04.017; Velaga S, 2009, J IMMUNOL, V182, P2610, DOI 10.4049/jimmunol.0801141; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Vonarbourg C, 2010, IMMUNITY, V33, P736, DOI 10.1016/j.immuni.2010.10.017; Wimmer N, 2012, J IMMUNOL, V188, P3426, DOI 10.4049/jimmunol.1103324; Xu WF, 2001, P NATL ACAD SCI USA, V98, P9511, DOI 10.1073/pnas.171303198; Zhu JB, 2009, J LIPID RES, V50, P1080, DOI 10.1194/jlr.M800555-JLR200	83	12	12	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					1015	+		10.1016/j.immuni.2020.10.012	http://dx.doi.org/10.1016/j.immuni.2020.10.012			26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33207209	Bronze			2022-12-18	WOS:000599348200013
J	Knipper, JA; Ding, XL; Eming, SA				Knipper, Johanna A.; Ding, Xiaolei; Eming, Sabine A.			Diabetes Impedes the Epigenetic Switch of Macrophages into Repair Mode	IMMUNITY			English	Editorial Material							CELL	In this issue of Immunity, Kimball et al. (2019) show that restoring expression of the chromatin modifying enzyme Setdb2 in macrophages rescues impaired wound healing associated with type 2 diabetes. Their findings reveal epigenetic regulation as central to the resolution of macrophage-mediated inflammation in tissue repair and have therapeutic implications for the treatment of diabetic wounds.	[Knipper, Johanna A.] Univ Edinburgh, Inst Immunol & Infect Res, Edinburgh EH9 3FL, Midlothian, Scotland; [Ding, Xiaolei; Eming, Sabine A.] Univ Cologne, Dept Dermatol, Kerpenerstr 62, D-50937 Cologne, Germany; [Eming, Sabine A.] Univ Cologne, CMMC, D-50931 Cologne, Germany; [Eming, Sabine A.] Univ Cologne, Cluster Excellence Cellular Stress Responses Agin, D-50931 Cologne, Germany	University of Edinburgh; University of Cologne; University of Cologne; University of Cologne	Eming, SA (corresponding author), Univ Cologne, Dept Dermatol, Kerpenerstr 62, D-50937 Cologne, Germany.; Eming, SA (corresponding author), Univ Cologne, CMMC, D-50931 Cologne, Germany.; Eming, SA (corresponding author), Univ Cologne, Cluster Excellence Cellular Stress Responses Agin, D-50931 Cologne, Germany.	sabine.eming@uni-koeln.de		Knipper, Johanna/0000-0002-9038-0566				Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Kimball AS, 2019, IMMUNITY, V51, P258, DOI 10.1016/j.immuni.2019.06.015; Lin ES, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010073; Phan AT, 2017, IMMUNITY, V46, P714, DOI 10.1016/j.immuni.2017.04.016; Schliehe C, 2015, NAT IMMUNOL, V16, P67, DOI 10.1038/ni.3046; Shaw TJ, 2016, CURR OPIN CELL BIOL, V42, P29, DOI 10.1016/j.ceb.2016.04.001; Shibata Tomoyuki, 2019, JAAD Case Rep, V5, P518, DOI 10.1016/j.jdcr.2019.03.024; Tsai TF, 2010, AM J CLIN DERMATOL, V11, P225, DOI 10.2165/11533190-000000000-00000; Zhang LJ, 2016, IMMUNITY, V45, P119, DOI 10.1016/j.immuni.2016.06.021	10	12	13	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 20	2019	51	2					199	201		10.1016/j.immuni.2019.07.009	http://dx.doi.org/10.1016/j.immuni.2019.07.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS3XX	31433963	Bronze			2022-12-18	WOS:000482088500001
J	Liu, XY; Nemeth, DP; Mckim, DB; Zhu, L; DiSabato, DJ; Berdysz, O; Gorantla, G; Oliver, B; Witcher, KG; Wang, YF; Negray, CE; Vegesna, RS; Sheridan, JF; Godbout, JP; Robson, MJ; Blakely, RD; Popovich, PG; Bilbo, SD; Quan, N				Liu, Xiaoyu; Nemeth, Daniel P.; Mckim, Daniel B.; Zhu, Ling; DiSabato, Damon J.; Berdysz, Olimpia; Gorantla, Gowthami; Oliver, Braedan; Witcher, Kristina G.; Wang, Yufen; Negray, Christina E.; Vegesna, Rekha S.; Sheridan, John F.; Godbout, Jonathan P.; Robson, Matthew J.; Blakely, Randy D.; Popovich, Phillip G.; Bilbo, Staci D.; Quan, Ning			Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities (vol 50, pg 317, 2019)	IMMUNITY			English	Correction												quan.14@osu.edu						Liu XY, 2019, IMMUNITY, V50, P317, DOI [10.1016/j.immuni.2019.02.012, 10.1016/j.immuni.2018.12.012]	1	12	12	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 19	2019	50	3					764	766		10.1016/j.immuni.2019.02.012	http://dx.doi.org/10.1016/j.immuni.2019.02.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP4QH		Bronze			2022-12-18	WOS:000461660500025
J	de Jong, RJ; Ohnmacht, C				de Jong, Renske J.; Ohnmacht, Caspar			Defining Dysbiosis in Inflammatory Bowel Disease	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; TOLERANCE	In this issue of Immunity, Britton et al. (2019) demonstrate that the colonization of germ-free mice with microbiotas from inflammatory bowel disease patients induces an altered ratio of ROR gamma t(+) regulatory T cells to T(h17) effector cells and recapitulates human disease severity in colitis-susceptible mice.	[de Jong, Renske J.; Ohnmacht, Caspar] Helmholtz Ctr, Ctr Allergy & Environm ZAUM, Munich, Germany; [de Jong, Renske J.; Ohnmacht, Caspar] Tech Univ Munich, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich	Ohnmacht, C (corresponding author), Helmholtz Ctr, Ctr Allergy & Environm ZAUM, Munich, Germany.; Ohnmacht, C (corresponding author), Tech Univ Munich, Munich, Germany.	caspar.ohnmacht@tum.de	Ohnmacht, Caspar/M-8033-2013					Britton GJ, 2019, IMMUNITY, V50, P212, DOI 10.1016/j.immuni.2018.12.015; Cebula A, 2013, NATURE, V497, P258, DOI 10.1038/nature12079; Geuking MB, 2011, IMMUNITY, V34, P794, DOI 10.1016/j.immuni.2011.03.021; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Verma R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat6975; Xu M, 2018, NATURE, V554, P373, DOI 10.1038/nature25500; Yang BH, 2016, MUCOSAL IMMUNOL, V9, P444, DOI 10.1038/mi.2015.74	10	12	12	1	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 15	2019	50	1					8	10		10.1016/j.immuni.2018.12.028	http://dx.doi.org/10.1016/j.immuni.2018.12.028			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HH4AF	30650382	Bronze, Green Submitted			2022-12-18	WOS:000455661600004
J	Moussion, C; Mellman, I				Moussion, Christine; Mellman, Ira			The Dendritic Cell Strikes Back	IMMUNITY			English	Editorial Material							TUMOR; TRAFFICKING; ACTIVATION	The field of cancer immunotherapy and checkpoint blockade has focused largely on direct effects on T cells. In this issue of Immunity, Garris et al. (2018) show that the efficacy of anti-PD-1 therapy depends on a T-celldendritic-cell (DC) licensing loop fueled by IFN-gamma and IL-12, thereby establishing a central role for DCs in promoting anti-cancer T cell immunity during checkpoint blockade.	[Moussion, Christine; Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA	Roche Holding; Genentech	Mellman, I (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	mellman.ira@gene.com	Mellman, Ira/ABG-5896-2020					Barry KC, 2018, NAT MED, V24, P1178, DOI 10.1038/s41591-018-0085-8; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Garris CS, 2018, IMMUNITY, V49, P1148, DOI 10.1016/j.immuni.2018.09.024; Hui EF, 2017, SCIENCE, V355, P1428, DOI 10.1126/science.aaf1292; Lau J, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14572; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Salmon H, 2016, IMMUNITY, V44, P924, DOI 10.1016/j.immuni.2016.03.012; Sharma MD, 2018, IMMUNITY, V48, P91, DOI 10.1016/j.immuni.2017.12.014; Spranger S, 2017, CANCER CELL, V31, P711, DOI 10.1016/j.ccell.2017.04.003; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404	10	12	12	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 18	2018	49	6					997	999		10.1016/j.immuni.2018.12.007	http://dx.doi.org/10.1016/j.immuni.2018.12.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HE6VX	30566889	Bronze			2022-12-18	WOS:000453556500005
J	Shimada, K; Porritt, RA; Markman, JL; O'Rourke, JG; Wakita, D; Rivas, MN; Ogawa, C; Kozhaya, L; Martins, GA; Unutmaz, D; Baloh, RH; Crother, TR; Chen, S; Arditi, M				Shimada, Kenichi; Porritt, Rebecca A.; Markman, Janet L.; O'Rourke, Jacqueline Gire; Wakita, Daiko; Rivas, Magali Noval; Ogawa, Chihiro; Kozhaya, Lina; Martins, Gislaine A.; Unutmaz, Derya; Baloh, Robert H.; Crother, Timothy R.; Chen, Shuang; Arditi, Moshe			T-Cell-Intrinsic Receptor Interacting Protein 2 Regulates Pathogenic T Helper 17 Cell Differentiation	IMMUNITY			English	Article							INNATE IMMUNE-RESPONSES; HOST-DEFENSE; T(H)17 CELLS; TGF-BETA; INFECTION; RIP2; ATHEROSCLEROSIS; INFLAMMASOME; GENERATION; ABSENCE	Receptor interacting protein 2 (RIP2) plays a role in sensing intracellular pathogens, but its function in T cells is unclear. We show that RIP2 deficiency in CD4(+) T cells resulted in chronic and severe interleukin-17A-mediated inflammation during Chlamydia pneumoniae lung infection, increased T helper 17 (Th17) cell formation in lungs of infected mice, accelerated atherosclerosis, and more severe experimental autoimmune encephalomyelitis. While RIP2 deficiency resulted in reduced conventional Th17 cell differentiation, it led to significantly enhanced differentiation of pathogenic (p)Th17 cells, which was dependent on RORct transcription factor and interleukin-1 but independent of nucleotide oligomerization domain (NOD) 1 and 2. Overexpression of RIP2 resulted in suppression of pTh17 cell differentiation, an effect mediated by its CARD domain, and phenocopied by a cell-permeable RIP2 CARD peptide. Our data suggest that RIP2 has a T cell-intrinsic role in determining the balance between homeostatic and pathogenic Th17 cell responses.	[Shimada, Kenichi; Porritt, Rebecca A.; Markman, Janet L.; Wakita, Daiko; Rivas, Magali Noval; Crother, Timothy R.; Chen, Shuang; Arditi, Moshe] Cedars Sinai Med Ctr, Dept Pediat, Div Infect Dis & Immunol, Los Angeles, CA 90048 USA; [Shimada, Kenichi; Rivas, Magali Noval; Crother, Timothy R.; Chen, Shuang; Arditi, Moshe] Cedars Sinai Med Ctr, Infect & Immunol Dis Res Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA; [Shimada, Kenichi; Rivas, Magali Noval; Martins, Gislaine A.; Crother, Timothy R.; Chen, Shuang; Arditi, Moshe] Cedars Sinai Med Ctr, Div Immunol Res, Dept Biomed Sci, Los Angeles, CA 90048 USA; [O'Rourke, Jacqueline Gire; Baloh, Robert H.] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA; [Baloh, Robert H.] Cedars Sinai Med Ctr, Dept Neurol, Los Angeles, CA 90048 USA; [Ogawa, Chihiro; Martins, Gislaine A.] Cedars Sinai Med Ctr, F Widjaja Fdn Inflammatory Bowel & Immunobiol Res, Los Angeles, CA 90048 USA; [Shimada, Kenichi; Rivas, Magali Noval; Martins, Gislaine A.; Crother, Timothy R.; Chen, Shuang; Arditi, Moshe] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Kozhaya, Lina; Unutmaz, Derya] Jackson Lab Genom Med, Farmington, CT 06032 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Jackson Laboratory	Arditi, M (corresponding author), Cedars Sinai Med Ctr, Dept Pediat, Div Infect Dis & Immunol, Los Angeles, CA 90048 USA.; Arditi, M (corresponding author), Cedars Sinai Med Ctr, Infect & Immunol Dis Res Ctr, Dept Biomed Sci, Los Angeles, CA 90048 USA.; Arditi, M (corresponding author), Cedars Sinai Med Ctr, Div Immunol Res, Dept Biomed Sci, Los Angeles, CA 90048 USA.; Arditi, M (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	moshe.arditi@cshs.org	Crother, Timothy R/E-2879-2010; Noval Rivas, Magali/R-4987-2016	Crother, Timothy R/0000-0001-8465-6127; Noval Rivas, Magali/0000-0001-5570-8928; Markman, Janet/0000-0003-4691-2964; Porritt, Rebecca/0000-0002-0973-5092	National Institutes of Health (NIH) [AI067995, 2R56AI067995-06, AI117968, HL111483-01, R01AI103542, AI112826]; American Heart Association [09BGIA2060145]; IBIRI-CSMC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL111483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI117968, R56AI117968, R01AI103542, R21AI112826, R01AI067995, R56AI067995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS097545] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); IBIRI-CSMC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Wenxuan Zhang, Ganghua Huang, and Malcolm Lane for their excellent technical assistance. We thank Dr. Masayuki Fukata at Cedars-Sinai Medical Center for Ifng<SUP>Thy1.1</SUP>Il17a<SUP>EGFP</SUP> mice. We thank Dr. Jay K. Kolls (Univ. of Pittsburgh) and Dr. Yoichiro Iwakura (Tokyo Univ. of Science) for kindly providing Il17a<SUP>-/-</SUP> mice. We thank Dr. Andreas J. Baumler (Univ. California Davis, Davis, CA) for kindly providing Nod1<SUP>-/-</SUP> Nod2<SUP>-/-</SUP> mice. We also thank Polly Sun for technical assistance. We thank Dr. Alan Daugherty (Univ. Kentucky) for kindly providing AAV-PCSK9. This work was supported by National Institutes of Health (NIH) grants AI067995, 2R56AI067995-06, and AI117968 to M.A., HL111483-01 to S.C., R01AI103542 to G.A.M., and AI112826 to T.R.C.; American Heart Association grant 09BGIA2060145 to S. C.; and IBIRI-CSMC to G.A.M.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Balamayooran T, 2011, INFECT IMMUN, V79, P4588, DOI 10.1128/IAI.05641-11; Barros-Martins J, 2016, J IMMUNOL, V196, P3642, DOI 10.4049/jimmunol.1501921; Butcher MJ, 2012, CIRC RES, V110, P675, DOI 10.1161/CIRCRESAHA.111.261784; Chen SA, 2010, J IMMUNOL, V185, P5619, DOI 10.4049/jimmunol.1001879; Chin AI, 2002, NATURE, V416, P190, DOI 10.1038/416190a; Chung Y, 2009, IMMUNITY, V30, P576, DOI 10.1016/j.immuni.2009.02.007; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fairhead T, 2008, AM J TRANSPLANT, V8, P1143, DOI 10.1111/j.1600-6143.2008.02236.x; Gao Q, 2010, J IMMUNOL, V185, P5820, DOI 10.4049/jimmunol.1000116; Ghoreschi K, 2010, NATURE, V467, P967, DOI 10.1038/nature09447; Girardin SE, 2003, J BIOL CHEM, V278, P41702, DOI 10.1074/jbc.M307198200; Hall HTL, 2008, EUR J IMMUNOL, V38, P64, DOI 10.1002/eji.200737393; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Keestra-Gounder AM, 2016, NATURE, V532, P394, DOI 10.1038/nature17631; Kelly MN, 2005, INFECT IMMUN, V73, P617, DOI 10.1128/IAI.73.1.617-621.2005; Kobayashi K, 2002, NATURE, V416, P194, DOI 10.1038/416194a; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Legrand-Poels S, 2007, J CELL SCI, V120, P1299, DOI 10.1242/jcs.03424; Levin MC, 2011, CIRC RES, V109, P1210, DOI 10.1161/CIRCRESAHA.111.246702; Li LP, 2015, BASIC RES CARDIOL, V110, DOI 10.1007/s00395-015-0515-4; Lim S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9244; Lupfer C, 2013, NAT IMMUNOL, V14, P480, DOI 10.1038/ni.2563; Miossec P, 2012, NAT REV DRUG DISCOV, V11, P763, DOI 10.1038/nrd3794; Mosolygo T, 2013, INFLAMM RES, V62, P451, DOI 10.1007/s00011-013-0596-1; Nembrini C, 2008, MICROBES INFECT, V10, P522, DOI 10.1016/j.micinf.2008.01.016; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Park JH, 2007, J IMMUNOL, V178, P2380, DOI 10.4049/jimmunol.178.4.2380; Patel DD, 2015, IMMUNITY, V43, P1040, DOI 10.1016/j.immuni.2015.12.003; Ruefli-Brasse AA, 2004, J BIOL CHEM, V279, P1570, DOI 10.1074/jbc.C300460200; Shaw PJ, 2011, IMMUNITY, V34, P75, DOI 10.1016/j.immuni.2010.12.015; Shimada K, 2012, MICROBES INFECT, V14, P1301, DOI 10.1016/j.micinf.2012.08.004; Shimada K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021477; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Stockinger B, 2017, NAT REV IMMUNOL, V17, P535, DOI 10.1038/nri.2017.50; Tumurkhuu G, 2016, CIRC RES, V119, pE76, DOI 10.1161/CIRCRESAHA.116.308362; Unutmaz D, 1999, J EXP MED, V189, P1735, DOI 10.1084/jem.189.11.1735; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Wright JF, 2007, J BIOL CHEM, V282, P13447, DOI 10.1074/jbc.M700499200; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Yosef N, 2013, NATURE, V496, P461, DOI 10.1038/nature11981	44	12	12	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2018	49	5					873	+		10.1016/j.immuni.2018.08.022	http://dx.doi.org/10.1016/j.immuni.2018.08.022			20	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HB1AY	30366765	Green Accepted, Bronze			2022-12-18	WOS:000450752200013
J	Kerdiles, YM; Almeida, FF; Thompson, T; Chopin, M; Vienne, M; Bruhns, P; Huntington, ND; Raulet, DH; Nutt, SL; Belz, GT; Vivier, E				Kerdiles, Yann M.; Almeida, Francisca F.; Thompson, Thornton; Chopin, Michael; Vienne, Margaux; Bruhns, Pierre; Huntington, Nicholas D.; Raulet, David H.; Nutt, Stephen L.; Belz, Gabrielle T.; Vivier, Eric			Natural-Killer-like B Cells Display the Phenotypic and Functional Characteristics of Conventional B Cells	IMMUNITY			English	Letter							RECEPTOR; MOUSE; LYMPHOCYTES; INFECTION; FATE; GENE		[Kerdiles, Yann M.; Vienne, Margaux; Vivier, Eric] Aix Marseille Univ, INSERM, CNRS, Ctr Immunol Marseille Luminy, Marseille, France; [Almeida, Francisca F.; Chopin, Michael; Huntington, Nicholas D.; Nutt, Stephen L.; Belz, Gabrielle T.] Walter & Eliza Hall Inst Med Res, 1G Royal Parade, Parkville, Vic 3052, Australia; [Almeida, Francisca F.; Chopin, Michael; Huntington, Nicholas D.; Nutt, Stephen L.; Belz, Gabrielle T.] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3010, Australia; [Thompson, Thornton; Raulet, David H.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Thompson, Thornton; Raulet, David H.] Univ Calif Berkeley, Immunotherapeut & Vaccine Res Initiat, Berkeley, CA 94720 USA; [Bruhns, Pierre] Inst Pasteur, Dept Immunol, Unit Antibodies Therapy & Pathol, Paris, France; [Bruhns, Pierre] INSERM, U1222, Paris, France; [Vivier, Eric] Hop La Timone, AP HM, Serv Immunol, Marseille, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Walter & Eliza Hall Institute; University of Melbourne; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Kerdiles, YM (corresponding author), Aix Marseille Univ, INSERM, CNRS, Ctr Immunol Marseille Luminy, Marseille, France.	kerdiles@ciml.univ-mrs.fr	Bruhns, Pierre/F-5567-2013; kerdiles, yann/U-2190-2018; Vienne, Margaux/AAI-2109-2021; Huntington, NICHOLAS/AAV-4704-2020; Chopin, Michael/AAD-3661-2020; Nutt, Stephen L/C-9256-2013; Belz, Gabrielle T/C-9350-2013; Vivier, Eric/F-8939-2010	Bruhns, Pierre/0000-0002-4709-8936; kerdiles, yann/0000-0002-8605-1073; Huntington, NICHOLAS/0000-0002-5267-7211; Nutt, Stephen L/0000-0002-0020-6637; Belz, Gabrielle T/0000-0002-9660-9587; Vivier, Eric/0000-0001-7022-8287; F. de Almeida, Francisca/0000-0001-6632-7610; Michael, Chopin/0000-0001-8812-2763; Raulet, David/0000-0002-1257-8649	NATIONAL CANCER INSTITUTE [R01CA093678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI113041, R01AI039642] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA093678] Funding Source: Medline; NIAID NIH HHS [R01 AI039642, R01 AI113041] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Carlyle JR, 2006, J IMMUNOL, V176, P7511, DOI 10.4049/jimmunol.176.12.7511; Deauvieau F, 2016, CURR TOP MICROBIOL, V395, P173, DOI 10.1007/82_2015_473; Delconte RB, 2016, IMMUNITY, V44, P103, DOI 10.1016/j.immuni.2015.12.007; Fairfax KA, 2007, J IMMUNOL, V178, P4104, DOI 10.4049/jimmunol.178.7.4104; Gazit R, 2006, NAT IMMUNOL, V7, P517, DOI 10.1038/ni1322; Gillis CM, 2017, J AUTOIMMUN, V80, P95, DOI 10.1016/j.jaut.2016.09.009; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Narni-Mancinelli E, 2011, P NATL ACAD SCI USA, V108, P18324, DOI 10.1073/pnas.1112064108; Sathe P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5539; Wang S, 2016, IMMUNITY, V45, P131, DOI 10.1016/j.immuni.2016.06.019	10	12	12	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 15	2017	47	2					199	200		10.1016/j.immuni.2017.07.026	http://dx.doi.org/10.1016/j.immuni.2017.07.026			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FD8QD	28813647	Green Accepted, Green Published, Bronze			2022-12-18	WOS:000407788300001
J	Skrzypczynska, KM; Zhu, JW; Weiss, A				Skrzypczynska, Katarzyna M.; Zhu, Jing W.; Weiss, Arthur			Positive Regulation of Lyn Kinase by CD148 Is Required for B Cell Receptor Signaling in B1 but Not B2 B Cells	IMMUNITY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; SRC-FAMILY KINASES; INDEPENDENT ANTIBODY-RESPONSES; NEGATIVE REGULATION; MARGINAL ZONE; B-1 CELLS; STREPTOCOCCUS-PNEUMONIAE; CD22-DEFICIENT MICE; ANTIGEN; EXPRESSION	B1 and B2 B cells differ in their ability to respond to T-cell-independent (TI) antigens. Here we report that the Src-family kinase (SFK) regulator CD148 has a unique and critical role in the initiation of B1 but not B2 cell antigen receptor signaling. CD148 loss-of-function mice were found to have defective B1 B-cell-mediated antibody responses against the T-cell-independent antigens NP-ficoll and Pneumovax 23 and had impaired selection of the B1 B cell receptor (BCR) repertoire. These deficiencies were associated with a decreased ability of B1 B cells to induce BCR signaling downstream of the SFK Lyn. Notably, Lyn appeared to be selectively regulated by CD148 and loss of this SFK resulted in opposite signaling phenotypes in B1 and B2 B cells. These findings reveal that the function and regulation of Lyn during B1 cell BCR signaling is distinct from other B cell subsets.	[Skrzypczynska, Katarzyna M.; Zhu, Jing W.; Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, Rosalind Russell & Ephraim P Engleman Rheumatol R, San Francisco, CA 94143 USA; [Skrzypczynska, Katarzyna M.; Zhu, Jing W.; Weiss, Arthur] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, Rosalind Russell & Ephraim P Engleman Rheumatol R, San Francisco, CA 94143 USA; [Zhu, Jing W.] Genentech Inc, Canc Immunol, San Francisco, CA 94080 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; Roche Holding; Genentech	Weiss, A (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Med, Rosalind Russell & Ephraim P Engleman Rheumatol R, San Francisco, CA 94143 USA.; Weiss, A (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Microbiol & Immunol, Rosalind Russell & Ephraim P Engleman Rheumatol R, San Francisco, CA 94143 USA.	art.weiss@ucsf.edu			Howard Hughes Medical Institute; Rosalind Russell/Ephraim Engleman Rheumatology Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060537] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Rosalind Russell/Ephraim Engleman Rheumatology Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank J. Cyster and A. DeFranco for helpful discussions and critical reading of the manuscript. A. Roque provided excellent assistance with animal husbandry. J. Zikherman and members of A.W. lab provided helpful advice. We thank Z. Wang for cell sorting. This work was supported by the Howard Hughes Medical Institute and the Rosalind Russell/Ephraim Engleman Rheumatology Research Center.	Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Baker JE, 2001, MOL CELL BIOL, V21, P2393, DOI 10.1128/MCB.21.7.2393-2403.2001; Balazs M, 2002, IMMUNITY, V17, P341, DOI 10.1016/S1074-7613(02)00389-8; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Baumgarth N, 1999, P NATL ACAD SCI USA, V96, P2250, DOI 10.1073/pnas.96.5.2250; Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; Bikah G, 1996, SCIENCE, V274, P1906, DOI 10.1126/science.274.5294.1906; BRILES DE, 1981, J EXP MED, V153, P694, DOI 10.1084/jem.153.3.694; Casola S, 2004, NAT IMMUNOL, V5, P317, DOI 10.1038/ni1036; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Chumley MJ, 2002, J IMMUNOL, V169, P1735, DOI 10.4049/jimmunol.169.4.1735; Cyster JG, 1996, NATURE, V381, P325, DOI 10.1038/381325a0; Dal Porto JM, 2004, IMMUNITY, V21, P443, DOI 10.1016/j.immuni.2004.07.018; DINTZIS RZ, 1989, J IMMUNOL, V143, P1239; Fujimoto M, 2001, J BIOL CHEM, V276, P44820, DOI 10.1074/jbc.M107559200; Gauld SB, 2004, ONCOGENE, V23, P8001, DOI 10.1038/sj.onc.1208075; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hobeika E, 2006, P NATL ACAD SCI USA, V103, P13789, DOI 10.1073/pnas.0605944103; Hoffmann A, 2007, NAT IMMUNOL, V8, P694, DOI 10.1038/ni1480; Horikawa K, 1999, INT IMMUNOL, V11, P1441, DOI 10.1093/intimm/11.9.1441; Jellusova J, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00096; Katsumoto TR, 2013, J CLIN INVEST, V123, P2037, DOI 10.1172/JCI66397; Krop I, 1996, EUR J IMMUNOL, V26, P238, DOI 10.1002/eji.1830260137; Lajaunias F, 2002, J IMMUNOL, V168, P6078, DOI 10.4049/jimmunol.168.12.6078; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; Lin J, 2004, J IMMUNOL, V173, P2324, DOI 10.4049/jimmunol.173.4.2324; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Mukherjee S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003220; OKeefe TL, 1996, SCIENCE, V274, P798, DOI 10.1126/science.274.5288.798; Racine R, 2008, J IMMUNOL, V181, P1375, DOI 10.4049/jimmunol.181.2.1375; Rawlings DJ, 2012, NAT REV IMMUNOL, V12, P282, DOI 10.1038/nri3190; Samardzic T, 2002, EUR J IMMUNOL, V32, P561, DOI 10.1002/1521-4141(200202)32:2<561::AID-IMMU561>3.0.CO;2-H; Sato S, 1996, J IMMUNOL, V157, P4371; Sen G, 1999, EUR J IMMUNOL, V29, P3319; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695; Takahashi K, 2012, P NATL ACAD SCI USA, V109, P1985, DOI 10.1073/pnas.1106171109; Weber GF, 2014, J EXP MED, V211, P1243, DOI 10.1084/jem.20131471; Whiteford JR, 2011, MOL BIOL CELL, V22, P3609, DOI 10.1091/mbc.E11-02-0099; Zhu JW, 2008, IMMUNITY, V28, P183, DOI 10.1016/j.immuni.2007.11.024; Zhu JW, 2011, IMMUNITY, V35, P757, DOI 10.1016/j.immuni.2011.09.011; Zikherman J, 2012, P NATL ACAD SCI USA, V109, pE3, DOI 10.1073/pnas.1117374108	43	12	12	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 20	2016	45	6					1232	1244		10.1016/j.immuni.2016.10.013	http://dx.doi.org/10.1016/j.immuni.2016.10.013			13	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RN	27889108	Bronze, Green Accepted			2022-12-18	WOS:000392918100010
J	Simon, T; Bromberg, JS				Simon, Thomas; Bromberg, Jonathan S.			BTLA(+) Dendritic Cells: The Regulatory T Cell Force Awakens	IMMUNITY			English	Editorial Material							IN-VIVO; UNRESPONSIVENESS; CD5	The role of dendritic cells (DCs) in the induction of antigen-specific tolerance mediated by extrathymic regulatory T (Treg) cells remains incompletely defined. In this issue of Immunity, Jones et al. (2016) show that BTLA(+)DEC205(+)CD8(+)CD11c(+) DCs efficiently induce peripheral Treg cells via the engagement of HVEM, a receptor for BTLA.	[Simon, Thomas; Bromberg, Jonathan S.] Univ Maryland, Sch Med, Dept Surg, 29 South Greene St, Baltimore, MD 21201 USA; [Simon, Thomas; Bromberg, Jonathan S.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 West Baltimore St, Baltimore, MD 21201 USA; [Bromberg, Jonathan S.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 West Baltimore St, Baltimore, MD 21201 USA; [Bromberg, Jonathan S.] Marlene & Stewart Greenebaum Canc Ctr, 22 South Greene St, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Bromberg, JS (corresponding author), Univ Maryland, Sch Med, Dept Surg, 29 South Greene St, Baltimore, MD 21201 USA.; Bromberg, JS (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, 800 West Baltimore St, Baltimore, MD 21201 USA.; Bromberg, JS (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 685 West Baltimore St, Baltimore, MD 21201 USA.; Bromberg, JS (corresponding author), Marlene & Stewart Greenebaum Canc Ctr, 22 South Greene St, Baltimore, MD 21201 USA.	jbromberg@smail.umaryland.edu	Simon, Thomas/D-7343-2019; Simon, Thomas/N-8879-2019	Simon, Thomas/0000-0001-9699-959X; Simon, Thomas/0000-0001-9699-959X				Flynn R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077991; Hawiger D, 2004, IMMUNITY, V20, P695, DOI 10.1016/j.immuni.2004.05.002; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Henderson JG, 2015, IMMUNITY, V42, P471, DOI 10.1016/j.immuni.2015.02.010; Idoyaga J, 2013, J CLIN INVEST, V123, P844, DOI 10.1172/JCI65260; Jones A, 2016, IMMUNITY, V45, P1066, DOI 10.1016/j.immuni.2016.10.008; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Steinberg MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077992; Uchiyama M, 2014, TRANSPLANTATION, V97, P301, DOI 10.1097/01.TP.0000438204.96723.8b	10	12	14	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 15	2016	45	5					956	958		10.1016/j.immuni.2016.10.030	http://dx.doi.org/10.1016/j.immuni.2016.10.030			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FP	27851922	Bronze			2022-12-18	WOS:000389473500006
J	Sheng, JP; Ruedl, C; Karjalainen, K				Sheng, Jianpeng; Ruedl, Christiane; Karjalainen, Klaus			Fetal HSCs versus EMP2s	IMMUNITY			English	Letter							TISSUE-RESIDENT MACROPHAGES		[Sheng, Jianpeng; Ruedl, Christiane; Karjalainen, Klaus] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Karjalainen, K (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	klaus@ntu.edu.sg	Karjalainen, Klaus/A-2206-2011; Ruedl, christiane/A-2219-2011	Ruedl, christiane/0000-0002-5599-6541				Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Sheng JP, 2015, IMMUNITY, V43, P382, DOI 10.1016/j.immuni.2015.07.016	3	12	13	1	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 15	2015	43	6					1025	1025		10.1016/j.immuni.2015.11.023	http://dx.doi.org/10.1016/j.immuni.2015.11.023			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CZ1DS	26682974	Bronze			2022-12-18	WOS:000366846600002
J	Macpherson, AJ; Mccoy, KD				Macpherson, Andrew J.; Mccoy, Kathy D.			Independence Day for IgA	IMMUNITY			English	Editorial Material							GUT HOMEOSTASIS; BACTERIA; MICE	IgA is induced through T-cell-dependent and -independent pathways. In this issue, Bunker et al. (2015) now show that the T-cell-independent pathway is sufficient to coat most small intestinal microbes specifically, and Fransen et al. (2015) find that IgA coating promotes uptake of microbes into Peyer's patches and drives further induction in a positive-feedback loop.	[Macpherson, Andrew J.; Mccoy, Kathy D.] Univ Hosp Bern, UVCM, Maurice Muller Labs, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern	Macpherson, AJ (corresponding author), Univ Hosp Bern, UVCM, Maurice Muller Labs, CH-3010 Bern, Switzerland.	andrew.macpherson@insel.ch	McCoy, Kathy/ABD-5814-2021					Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Corthesy B, 2007, J IMMUNOL, V178, P27, DOI 10.4049/jimmunol.178.1.27; Fransen F, 2015, IMMUNITY, V43, P527, DOI 10.1016/j.immuni.2015.08.011; Johansen FE, 1999, J EXP MED, V190, P915, DOI 10.1084/jem.190.7.915; Kau AL, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4877; LYCKE N, 1987, SCAND J IMMUNOL, V25, P413, DOI 10.1111/j.1365-3083.1987.tb02208.x; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Palm NW, 2014, CELL, V158, P1000, DOI 10.1016/j.cell.2014.08.006; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Wei M, 2011, NAT IMMUNOL, V12, P264, DOI 10.1038/ni.1991	10	12	12	1	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 15	2015	43	3					416	418		10.1016/j.immuni.2015.08.024	http://dx.doi.org/10.1016/j.immuni.2015.08.024			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR8BE	26377894	Bronze			2022-12-18	WOS:000361575300004
J	Keely, S; Foster, PS				Keely, Simon; Foster, Paul S.			Stop Press: Eosinophils Drafted to Join the Th17 Team	IMMUNITY			English	Editorial Material							ULCERATIVE-COLITIS; GM-CSF; DISEASE	Eosinophils are commonly associated with Th2 cell-driven inflammation. In this issue of Immunity, Griseri et al. (2015) identify a new GM-CSF-dependent role for eosinophils in the pathogenesis of IL-23-Th17 cell-induced colitis.	[Keely, Simon; Foster, Paul S.] Hunter Med Res Inst, Prior Res Ctr Asthma & Resp Dis, Newcastle, NSW 2308, Australia; [Keely, Simon; Foster, Paul S.] Univ Newcastle, Newcastle, NSW 2308, Australia	Hunter Medical Research Institute; University of Newcastle; University of Newcastle	Keely, S (corresponding author), Hunter Med Res Inst, Prior Res Ctr Asthma & Resp Dis, Newcastle, NSW 2308, Australia.	simon.keely@newcastle.edu.au; paul.foster@newcastle.edu.au	Keely, Simon/AAV-9973-2020; Foster, Paul/G-5057-2013	Keely, Simon/0000-0002-1248-9590; , Paul/0000-0002-0827-8299				El-Behi M, 2011, NAT IMMUNOL, V12, P568, DOI 10.1038/ni.2031; Goldstein JI, 2011, GASTROENTEROLOGY, V141, P208, DOI 10.1053/j.gastro.2011.03.060; Griseri T, 2015, IMMUNITY, V43, P187, DOI 10.1016/j.immuni.2015.07.008; Jung Y, 2014, J IMMUNOL, V193, P999, DOI 10.4049/jimmunol.1400413; Kobayashi T, 2008, GUT, V57, P1682, DOI 10.1136/gut.2007.135053; Lampinen M, 2005, GUT, V54, P1714, DOI 10.1136/gut.2005.066423; Maltby S, 2010, AM J PATHOL, V177, P1244, DOI 10.2353/ajpath.2010.100191; Masterson JC, 2011, AM J PATHOL, V179, P2302, DOI 10.1016/j.ajpath.2011.07.039; Mirbagheri SA, 2008, WORLD J GASTROENTERO, V14, P5990, DOI 10.3748/wjg.14.5990; Mould AW, 1997, J CLIN INVEST, V99, P1064, DOI 10.1172/JCI119234	10	12	12	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 21	2015	43	1					7	9		10.1016/j.immuni.2015.07.010	http://dx.doi.org/10.1016/j.immuni.2015.07.010			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP7WV	26200007	Bronze			2022-12-18	WOS:000360101100004
J	Gopinath, S; Iwasaki, A				Gopinath, Smita; Iwasaki, Akiko			Cervicovaginal Microbiota: Simple Is Better	IMMUNITY			English	Editorial Material							VAGINAL MICROBIOME; T-CELLS	Vaginal microbiota differs within individuals and between human populations. Anahtar et al. (2015) identify a specific vaginal cervicotype commonly found in healthy South African women that causes localized inflammation including activation of antigen-presenting cells and vaginal recruitment of HIV target cells.	[Gopinath, Smita; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Iwasaki, Akiko] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA	Yale University; Howard Hughes Medical Institute; Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856; Gopinath, Smita/0000-0003-3672-3780	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI054359, R01 AI062428] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054359, R01AI062428] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; Brotman RM, 2011, J CLIN INVEST, V121, P4610, DOI 10.1172/JCI57172; Cox LM, 2013, CELL METAB, V17, P883, DOI 10.1016/j.cmet.2013.05.004; Doerflinger SY, 2014, J INFECT DIS, V209, P1989, DOI 10.1093/infdis/jiu004; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; Mitchell C, 2011, AIDS RES HUM RETROV, V27, P35, DOI 10.1089/aid.2010.0129; Petrova MI, 2013, FEMS MICROBIOL REV, V37, P762, DOI 10.1111/1574-6976.12029; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Shin H, 2013, IMMUNOL REV, V255, P165, DOI 10.1111/imr.12087	10	12	16	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2015	42	5					790	791		10.1016/j.immuni.2015.05.006	http://dx.doi.org/10.1016/j.immuni.2015.05.006			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CI5VH	25992855	Bronze			2022-12-18	WOS:000354827400006
J	Koltsova, EK; Grivennikov, SI				Koltsova, Ekaterina K.; Grivennikov, Sergei I.			IL-22 Gets to the Stem of Colorectal Cancer	IMMUNITY			English	Editorial Material							TUMORIGENESIS; CELLS; INTESTINE		[Koltsova, Ekaterina K.] Fox Chase Canc Ctr, Immune Cell Dev & Host Def Program, Philadelphia, PA 19111 USA; [Grivennikov, Sergei I.] Fox Chase Canc Ctr, Canc Prevent & Control Program, Philadelphia, PA 19111 USA	Fox Chase Cancer Center; Fox Chase Cancer Center	Grivennikov, SI (corresponding author), Fox Chase Canc Ctr, Canc Prevent & Control Program, 333 Cottman Ave, Philadelphia, PA 19111 USA.	sergey.grivennikov@fccc.edu	Grivennikov, Sergei/AAE-7365-2019	Grivennikov, Sergei/0000-0003-2987-0555				Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Ho LL, 2013, MOL CELL BIOL, V33, P1735, DOI 10.1128/MCB.01463-12; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Kryczek I, 2014, IMMUNITY, V40, P772, DOI 10.1016/j.immuni.2014.03.010; Matthews JR, 2011, CELL DEATH DIFFER, V18, P1934, DOI 10.1038/cdd.2011.77; Pickert G, 2009, J EXP MED, V206, P1465, DOI 10.1084/jem.20082683; Putoczki TL, 2013, CANCER CELL, V24, P257, DOI 10.1016/j.ccr.2013.06.017; Schwitalla S, 2013, CELL, V152, P25, DOI 10.1016/j.cell.2012.12.012; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907	10	12	12	0	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 15	2014	40	5					639	641		10.1016/j.immuni.2014.04.014	http://dx.doi.org/10.1016/j.immuni.2014.04.014			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH3LW	24837100	Bronze			2022-12-18	WOS:000336026100004
J	Lee, YK; Mazmanian, SK				Lee, Yun Kyung; Mazmanian, Sarkis K.			Microbial Learning Lessons: SFB Educate the Immune System	IMMUNITY			English	Editorial Material							SEGMENTED FILAMENTOUS BACTERIA; T-CELL RESPONSES	Segmented filamentous bacteria (SFB) contribute to immune-system maturation. In this issue of Immunity, Goto et al. (2014) and Lecuyer et al. (2014) provide evidence for how SFB induce antigen-specific T helper 17 cells and promote development of adaptive immunity at discrete mucosal sites.	[Lee, Yun Kyung; Mazmanian, Sarkis K.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA	California Institute of Technology	Mazmanian, SK (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.	sarkis@caltech.edu						Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Ivanov II, 2008, CELL HOST MICROBE, V4, P337, DOI 10.1016/j.chom.2008.09.009; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; KLAASEN HLBM, 1993, INFECT IMMUN, V61, P303, DOI 10.1128/IAI.61.1.303-306.1993; Lecuyer E, 2014, IMMUNITY, V40, P608, DOI 10.1016/j.immuni.2014.03.009; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; Lee YK, 2010, SCIENCE, V330, P1768, DOI 10.1126/science.1195568; Talham GL, 1999, INFECT IMMUN, V67, P1992; Umesaki Y, 1999, INFECT IMMUN, V67, P3504, DOI 10.1128/IAI.67.7.3504-3511.1999; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	11	12	15	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 17	2014	40	4					457	460		10.1016/j.immuni.2014.04.002	http://dx.doi.org/10.1016/j.immuni.2014.04.002			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AF6UF	24745329	Bronze			2022-12-18	WOS:000334849400004
J	Cohen, HB; Mosser, DM				Cohen, Heather B.; Mosser, David M.			Cardiac Macrophages: How to Mend a Broken Heart	IMMUNITY			English	Editorial Material							MONOCYTES; HOMEOSTASIS; REVEALS; CELLS		[Cohen, Heather B.; Mosser, David M.] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Mosser, DM (corresponding author), Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA.	dmosser@umd.edu	Mosser, David M/I-6697-2016	Mosser, David M/0000-0002-9503-4187	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102589] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM102589] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; HUME DA, 1984, ANAT REC, V210, P503, DOI 10.1002/ar.1092100311; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Klein I, 2007, BLOOD, V110, P4077, DOI 10.1182/blood-2007-02-073841; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zigmond E, 2012, IMMUNITY, V37, P1076, DOI 10.1016/j.immuni.2012.08.026	10	12	13	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2014	40	1					3	5		10.1016/j.immuni.2013.12.005	http://dx.doi.org/10.1016/j.immuni.2013.12.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB0JD	24439261	Bronze			2022-12-18	WOS:000331476900002
J	Wallach, D; Kovalenko, A				Wallach, David; Kovalenko, Andrew			Phosphorylation and Dephosphorylation of the RIG-I-like Receptors: A Safety Latch on a Fateful Pathway	IMMUNITY			English	Editorial Material							INNATE IMMUNE-RESPONSE	Activation of antiviral responses by RNA sensors RIG-I and MDA5 must be stringently controlled. In this issue of Immunity, Wies et al. (2013) show that a requirement for activation-induced dephosphorylation of these proteins reinforces this restriction.	[Wallach, David; Kovalenko, Andrew] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Wallach, D (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	d.wallach@weizmann.ac.il						Gack MU, 2010, J VIROL, V84, P3220, DOI 10.1128/JVI.02241-09; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kolakofsky D, 2012, RNA, V18, P2118, DOI 10.1261/rna.035949.112; Maharaj NP, 2012, J VIROL, V86, P1358, DOI 10.1128/JVI.06543-11; Nistal-Villan E, 2010, J BIOL CHEM, V285, P20252, DOI 10.1074/jbc.M109.089912; Ramos HJ, 2011, CURR OPIN VIROL, V1, P167, DOI 10.1016/j.coviro.2011.04.004; Sun ZG, 2011, J VIROL, V85, P1036, DOI 10.1128/JVI.01734-10; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018	9	12	13	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 21	2013	38	3					402	403		10.1016/j.immuni.2013.02.014	http://dx.doi.org/10.1016/j.immuni.2013.02.014			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RJ	23521878	Bronze			2022-12-18	WOS:000330941500003
J	Honda, K				Honda, Kenya			IL-22 from T Cells: Better Late than Never	IMMUNITY			English	Editorial Material							HOST-DEFENSE; DISEASE	Interleukin-22 (IL-22) enhances mucosal barrier function and is important in antimicrobial host defense. In this issue of Immunity, Basu et al. (2012) reveal that Th22 cells are the critical adaptive source of IL-22 during late-phase infection by Citrobacter rodentium.	[Honda, Kenya] Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo 1130033, Japan; [Honda, Kenya] Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; [Honda, Kenya] JST, CREST, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; RIKEN; Japan Science & Technology Agency (JST)	Honda, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Immunol, Tokyo 1130033, Japan.	kenya@m.u-tokyo.ac.jp						Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Duhen T, 2009, NAT IMMUNOL, V10, P857, DOI 10.1038/ni.1767; Huber S, 2012, NATURE, V491, P259, DOI 10.1038/nature11535; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Sonnenberg GF, 2012, IMMUNITY, V37, P601, DOI 10.1016/j.immuni.2012.10.003; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; Sonnenberg GF, 2011, IMMUNITY, V34, P122, DOI 10.1016/j.immuni.2010.12.009; Volpe E, 2009, BLOOD, V114, P3610, DOI 10.1182/blood-2009-05-223768; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	10	12	14	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	DEC 14	2012	37	6					952	954		10.1016/j.immuni.2012.11.006	http://dx.doi.org/10.1016/j.immuni.2012.11.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	057PH	23244715	Bronze			2022-12-18	WOS:000312575000003
J	Bilate, AB; Lafaille, JJ				Bilate, Angelina B.; Lafaille, Juan J.			It Takes Two to Tango	IMMUNITY			English	Editorial Material							REGULATORY T-CELLS; ENTEROPATHY; TOLERANCE; SCURFY; FOXP3; MOUSE		[Bilate, Angelina B.; Lafaille, Juan J.] NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Lafaille, Juan J.] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA	New York University; New York University	Lafaille, JJ (corresponding author), NYU, Sch Med, Mol Pathogenesis Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA.	juan.lafaille@med.nyu.edu						Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; de Lafaille MAC, 2008, IMMUNITY, V29, P114, DOI 10.1016/j.immuni.2008.05.010; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Haribhai D, 2011, IMMUNITY, V35, P109, DOI 10.1016/j.immuni.2011.03.029; Haribhai D, 2009, J IMMUNOL, V182, P3461, DOI 10.4049/jimmunol.0802535; Mucida D, 2005, J CLIN INVEST, V115, P1923, DOI 10.1172/JCI24487; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Wildin RS, 2001, NAT GENET, V27, P18, DOI 10.1038/83707	10	12	12	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JUL 22	2011	35	1					6	8		10.1016/j.immuni.2011.07.003	http://dx.doi.org/10.1016/j.immuni.2011.07.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	797EM	21777793	Bronze			2022-12-18	WOS:000293107300003
J	Mitchell, DM; Williams, MA				Mitchell, Diana M.; Williams, Matthew A.			An Activation Marker Finds a Function	IMMUNITY			English	Editorial Material							T-CELLS; CD44; DEATH; HYALURONAN		[Mitchell, Diana M.; Williams, Matthew A.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Williams, MA (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	matthew.williams@path.utah.edu		Williams, Matthew/0000-0002-4721-4482				Baaten BJG, 2010, IMMUNITY, V32, P104, DOI 10.1016/j.immuni.2009.10.011; Bouillet P, 2009, NAT REV IMMUNOL, V9, P514, DOI 10.1038/nri2570; Graham VA, 2007, EUR J IMMUNOL, V37, P925, DOI 10.1002/eji.200635882; Jackson DG, 2009, IMMUNOL REV, V230, P216, DOI 10.1111/j.1600-065X.2009.00803.x; Krammer PH, 2007, NAT REV IMMUNOL, V7, P532, DOI 10.1038/nri2115; Nakano K, 2007, APOPTOSIS, V12, P45, DOI 10.1007/s10495-006-0488-8; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Ruffell B, 2008, J IMMUNOL, V181, P7044, DOI 10.4049/jimmunol.181.10.7044; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; Wang KX, 2008, CYTOKINE GROWTH F R, V19, P333, DOI 10.1016/j.cytogfr.2008.08.001	10	12	12	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 29	2010	32	1					9	11		10.1016/j.immuni.2010.01.003	http://dx.doi.org/10.1016/j.immuni.2010.01.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	550HW	20152166	Bronze			2022-12-18	WOS:000274119900006
J	Neuenhahn, M; Busch, DH				Neuenhahn, Michael; Busch, Dirk H.			The Quest for CD8(+) Memory Stem Cells	IMMUNITY			English	Editorial Material							ADOPTIVE TRANSFER; T-LYMPHOCYTES; BONE-MARROW; EFFECTOR; DIFFERENTIATION; SUBSETS	In this issue of Immunity, Turtle et al. (2009) describe the identification of a distinct CD8(+) memory T cell subset in humans, which could bring us closer to the identification of the enigmatic "memory stem cell."	[Neuenhahn, Michael; Busch, Dirk H.] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany; [Busch, Dirk H.] Tech Univ Munich, Focus Grp Clin Cell Proc & Purificat, Inst Adv Studies, D-81675 Munich, Germany; [Neuenhahn, Michael; Busch, Dirk H.] Helmholtz Ctr Munich Neuherberg, Clin Cooperat Grp Antigen Specif Immunotherapy, D-81675 Munich, Germany; [Neuenhahn, Michael; Busch, Dirk H.] Helmholtz Ctr Munich Neuherberg, Clin Cooperat Grp Immune Monitoring, D-81675 Munich, Germany	Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Busch, DH (corresponding author), Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-81675 Munich, Germany.	dirk.busch@mikrobio.med.tum.de						Berger C, 2008, J CLIN INVEST, V118, P294, DOI 10.1172/JCI32103; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Knabel M, 2002, NAT MED, V8, P631, DOI 10.1038/nm0602-631; Mazo IB, 2005, IMMUNITY, V22, P259, DOI 10.1016/j.immuni.2005.01.008; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; SCHEINBERG P, 2009, BLOOD IN PRESS; Stemberger C, 2007, IMMUNITY, V27, P985, DOI 10.1016/j.immuni.2007.10.012; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015; Turtle CJ, 2009, IMMUNITY, V31, P834, DOI 10.1016/j.immuni.2009.09.015; Williams MA, 2007, ANNU REV IMMUNOL, V25, P171, DOI 10.1146/annurev.immunol.25.022106.141548	10	12	12	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 20	2009	31	5					702	704		10.1016/j.immuni.2009.10.002	http://dx.doi.org/10.1016/j.immuni.2009.10.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	523TQ	19932070	Bronze			2022-12-18	WOS:000272097900005
J	Berg, LJ				Berg, Leslie J.			Strength of T Cell Receptor Signaling Strikes Again	IMMUNITY			English	Editorial Material							DIFFERENTIATION; EXPRESSION	In this issue of Immunity, Gomez-Rodriguez et al. (2009) demonstrate that signaling via the ltk kinase, a component of the T cell receptor signaling pathway, is required for interleukin-17A but not interleukin-17F expression in T helper 17 cells.	Univ Massachusetts, Sch Med, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Berg, LJ (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01655 USA.	leslie.berg@umassmed.edu						Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Fowell DJ, 1999, IMMUNITY, V11, P399, DOI 10.1016/S1074-7613(00)80115-6; Gomez-Rodriguez J, 2009, IMMUNITY, V31, P587, DOI 10.1016/j.immuni.2009.07.009; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Letimier FA, 2007, EMBO J, V26, P1292, DOI 10.1038/sj.emboj.7601586; Nurieva RI, 2007, J IMMUNOL, V179, P1096, DOI 10.4049/jimmunol.179.2.1096; Wurster AL, 2008, MOL CELL BIOL, V28, P7274, DOI 10.1128/MCB.00835-08; Zhang FP, 2006, J EXP MED, V203, P1493, DOI 10.1084/jem.20060066	8	12	12	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 16	2009	31	4					529	531		10.1016/j.immuni.2009.09.008	http://dx.doi.org/10.1016/j.immuni.2009.09.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	514OI	19833081	Bronze			2022-12-18	WOS:000271403900002
J	Hertzog, P				Hertzog, Paul			A Notch in the Toll Belt	IMMUNITY			English	Editorial Material							NEGATIVE REGULATION; PATHWAYS; RECEPTOR	Two cell response pathways, Toll-like receptor (TLR) and Notch, conserved from Drosophila to mammals are well characterized for distinct roles in innate immunity and cell development, respectively. In this issue of Immunity, Hu et al. (2008) describe and characterize the direct cooperation of these two pathways.	Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Clayton, Vic, Australia	Monash University	Hertzog, P (corresponding author), Monash Inst Med Res, Ctr Innate Immun & Infect Dis, 27-31 Wright St, Clayton, Vic, Australia.	Paul.Hertzog@med.monash.edu.au	Hertzog, Paul J/G-6734-2013; Hertzog, Paul J/I-7053-2013	Hertzog, Paul J/0000-0002-1373-8472; Hertzog, Paul J/0000-0002-1373-8472				Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Hu XY, 2008, IMMUNITY, V29, P691, DOI 10.1016/j.immuni.2008.08.016; Jenkinson EJ, 2006, NAT REV IMMUNOL, V6, P551, DOI 10.1038/nri1883; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Lang T, 2007, IMMUNOL CELL BIOL, V85, P425, DOI 10.1038/sj.icb.7100094; Maekawa Y, 2008, NAT IMMUNOL, V9, P1140, DOI 10.1038/ni.1649; O'Neill LAJ, 2008, IMMUNITY, V29, P12, DOI 10.1016/j.immuni.2008.06.004; Okamoto M, 2008, J EXP MED, V205, P1087, DOI 10.1084/jem.20072200; Palaga T, 2008, EUR J IMMUNOL, V38, P174, DOI 10.1002/eji.200636999	10	12	12	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	NOV 14	2008	29	5					663	665		10.1016/j.immuni.2008.10.006	http://dx.doi.org/10.1016/j.immuni.2008.10.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	374IC	19006687	Bronze			2022-12-18	WOS:000261036000001
J	Gold, MR				Gold, Michael R.			B cell development: Important work for ERK	IMMUNITY			English	Editorial Material							MULTIPLE STAGES; DIFFERENTIATION; RECEPTOR; PATHWAY	The B cell receptor (BCR) activates the ERK kinases, but what does ERK do? In this issue of Immunity, Yasuda et al. (2008) show that ERK controls a transcription factor network by which the pre-BCR drives early B cell development.	[Gold, Michael R.] Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Gold, Michael R.] Univ British Columbia, Inst Life Sci, I3 & CELL Res Grp, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Gold, MR (corresponding author), Univ British Columbia, Inst Life Sci, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada.	mgold@interchange.ubc.ca	Gold, Michael/AAF-2081-2021	Gold, Michael/0000-0003-1222-3191				Chen HC, 2006, J IMMUNOL, V176, P2208, DOI 10.4049/jimmunol.176.4.2208; Cooper AB, 2006, NAT IMMUNOL, V7, P489, DOI 10.1038/ni1324; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Fleming HE, 2001, IMMUNITY, V15, P521, DOI 10.1016/S1074-7613(01)00216-3; Habib T, 2007, J CELL BIOL, V179, P717, DOI 10.1083/jcb.200704173; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Konrad MAP, 2005, EUR J IMMUNOL, V35, P3030, DOI 10.1002/eji.200526345; Richards JD, 2001, J IMMUNOL, V166, P3855, DOI 10.4049/jimmunol.166.6.3855; Schuh W, 2008, MOL IMMUNOL, V45, P362, DOI 10.1016/j.molimm.2007.06.154; Yasuda T, 2008, IMMUNITY, V28, P499, DOI 10.1016/j.immuni.2008.02.015	10	12	13	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR	2008	28	4					488	490		10.1016/j.immuni.2008.03.008	http://dx.doi.org/10.1016/j.immuni.2008.03.008			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	287TM	18400191	Bronze			2022-12-18	WOS:000254939400007
J	Sundrud, MS; Rao, A				Sundrud, Mark S.; Rao, Aniana			Regulation of T helper 17 differentiation by orphan nuclear receptors: It's not just ROR gamma t anymore	IMMUNITY			English	Editorial Material							CELL-DIFFERENTIATION; ALPHA	T cells that produce IL-17 (T helper 17 cells) are implicated in autoimmune pathogenesis. In this issue of Immunity, Yang et al. (2008) report that the closely related orphan nuclear receptors ROR alpha and ROR gamma t work together to regulate T helper (Th) 17 cell differentiation.	[Sundrud, Mark S.; Rao, Aniana] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Sundrud, Mark S.; Rao, Aniana] Immune Dis Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Rao, A (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	arao@cbr.med.harvard.edu						Dhingra K, 2001, CANCER INVEST, V19, P649, DOI 10.1081/CNV-100104293; Dussault I, 1998, MECH DEVELOP, V70, P147, DOI 10.1016/S0925-4773(97)00187-1; Giguere V, 1999, ENDOCR REV, V20, P689, DOI 10.1210/er.20.5.689; Gold DA, 2007, BRAIN RES, V1140, P19, DOI 10.1016/j.brainres.2005.11.080; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; MCBROOM LDB, 1995, MOL CELL BIOL, V15, P796; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; Weaver CT, 2006, IMMUNITY, V24, P677, DOI 10.1016/j.immuni.2006.06.002; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	10	12	14	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN	2008	28	1					5	7		10.1016/j.immuni.2007.12.006	http://dx.doi.org/10.1016/j.immuni.2007.12.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254ZU	18199410	Bronze			2022-12-18	WOS:000252627300002
J	Gross, S; Moss, BL; Piwnica-Worms, D				Gross, Shimon; Moss, Britney L.; Piwnica-Worms, David			Veni, Vidi, Vidi: In vivo molecular Imaging of immune response	IMMUNITY			English	Article							VERSUS-HOST-DISEASE; LIVING MICE; BIOLUMINESCENCE; CELLS; ATHEROSCLEROSIS; VISUALIZATION; INFLAMMATION; INFECTION; ARTHRITIS; SELECTION	I came, I saw, I conquered," Julius Caesar proclaimed, highlighting the importance of direct visualization as a winning strategy. Continuing the "From the Field" series (see Editorial [2007] 26, 131), Gross et al. summarize how modern molecular imaging techniques can successfully dissect the complexities of immune response in vivo.	Washington Univ, Sch Med, Mol Imaging Ctr, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Piwnica-Worms, D (corresponding author), Washington Univ, Sch Med, Mol Imaging Ctr, Mallinckrodt Inst Radiol, St Louis, MO 63110 USA.	piwnica-wormsd@mir.wustl.edu		Moss, Britney/0000-0002-1037-5717	NATIONAL CANCER INSTITUTE [P50CA094056] Funding Source: NIH RePORTER; NCI NIH HHS [P50 CA94056] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Beilhack A, 2005, BLOOD, V106, P1113, DOI 10.1182/blood-2005-02-0509; Bullok KE, 2007, BIOCHEMISTRY-US, V46, P4055, DOI 10.1021/bi061959n; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Chen JW, 2006, RADIOLOGY, V240, P473, DOI 10.1148/radiol.2402050994; Germain RN, 2006, NAT REV IMMUNOL, V6, P497, DOI 10.1038/nri1884; Gross S, 2005, NAT METHODS, V2, P607, DOI 10.1038/NMETH779; Gross S, 2005, CANCER CELL, V7, P5, DOI 10.1016/j.ccr.2004.12.011; Jaffer FA, 2007, CIRCULATION, V115, P2292, DOI 10.1161/CIRCULATIONAHA.106.660340; Kaufmann BA, 2007, CIRCULATION, V116, P276, DOI 10.1161/CIRCULATIONAHA.106.684738; Lazovic J, 2005, STROKE, V36, P2226, DOI 10.1161/01.STR.0000182255.08162.6a; Lin AH, 2005, J IMMUNOL, V175, P547, DOI 10.4049/jimmunol.175.1.547; Love C, 2005, RADIOGRAPHICS, V25, P1357, DOI 10.1148/rg.255045122; Luker KE, 2006, VIROLOGY, V347, P286, DOI 10.1016/j.virol.2005.12.016; Luker KE, 2005, VIROLOGY, V341, P284, DOI 10.1016/j.virol.2005.06.049; Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101; Nakamichi I, 2005, J CLIN INVEST, V115, P3007, DOI 10.1172/JCI24912; Negrin RS, 2006, NAT REV IMMUNOL, V6, P484, DOI 10.1038/nri1879; Swirski FK, 2006, P NATL ACAD SCI USA, V103, P10340, DOI 10.1073/pnas.0604260103; Tsien RY, 2003, NAT REV MOL CELL BIO, pSS16, DOI 10.1038/nrm1196; van Eerd JEM, 2004, J NUCL MED, V45, P89; Wipke BT, 2002, NAT IMMUNOL, V3, P366, DOI 10.1038/ni775; Wipke BT, 2004, J IMMUNOL, V172, P7694, DOI 10.4049/jimmunol.172.12.7694; Zhang N, 2005, J IMMUNOL, V174, P8125, DOI 10.4049/jimmunol.174.12.8125; Zlokarnik G, 1998, SCIENCE, V279, P84, DOI 10.1126/science.279.5347.84	25	12	12	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2007	27	4					533	538		10.1016/j.immuni.2007.10.006	http://dx.doi.org/10.1016/j.immuni.2007.10.006			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17967405	Bronze			2022-12-18	WOS:000250490700002
J	van den Broek, M				van den Broek, Maries			Dendritic cells break bonds to tolerize	IMMUNITY			English	Editorial Material							TOLERANCE	Typically, dendritic cells (DCs) induce peripheral tolerance under steady state but immunity during inflammation or infection. In this issue of Immunity, Jiang et al. (2007) identify disruption of E-cadherin interactions as a unique maturation pathway by which DCs are capable of mediating tolerance.	Univ Zurich, Inst Expt Immunol, CH-8091 Zurich, Switzerland	University of Zurich	van den Broek, M (corresponding author), Lab Tumor Immunol, Dept Oncol, NORD1 C100,Frauenklin Str 10, CH-8091 Zurich, Switzerland.	maries@van-den-broek.ch	van den Broek, Maries/L-6532-2019; van den Broek, Maries/G-4128-2016	van den Broek, Maries/0000-0002-9489-3692				Gallucci S, 1999, NAT MED, V5, P1249, DOI 10.1038/15200; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; Kissenpfennig A, 2005, IMMUNITY, V22, P643, DOI 10.1016/j.immuni.2005.04.004; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Nelson WJ, 2004, SCIENCE, V303, P1483, DOI 10.1126/science.1094291; Probst HC, 2005, NAT IMMUNOL, V6, P280, DOI 10.1038/ni1165; Riedl E, 2000, BLOOD, V96, P4276; ROAKE JA, 1995, J EXP MED, V181, P2237, DOI 10.1084/jem.181.6.2237; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Steinman RM, 2003, ANNU REV IMMUNOL, V21, P685, DOI 10.1146/annurev.immunol.21.120601.141040	10	12	16	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT	2007	27	4					544	546		10.1016/j.immuni.2007.10.004	http://dx.doi.org/10.1016/j.immuni.2007.10.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17967408	Bronze			2022-12-18	WOS:000250490700005
J	Klein, U; Dalla-Favera, R				Klein, Ulf; Dalla-Favera, Riccardo			Unexpected steps in plasma-cell differentiation	IMMUNITY			English	Editorial Material							BLIMP-1; PROTEIN; PAX5	The transcriptional repressor Blimp-1 is considered the master regulator of plasma-cell differentiation. In this issue of Immunity, Kallies et al. (2007) identify a Blimp-1-independent stage of differentiation, followed by Blimp-1-dependent terminal differentiation.	Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; Columbia Univ, Herbert Irving Comprehens Canc Ctr, New York, NY 10032 USA	Columbia University; Columbia University	Dalla-Favera, R (corresponding author), Columbia Univ, Inst Canc Genet, 1130 St Nicholas Ave, New York, NY 10032 USA.	rd10@columbia.edu						Delogu A, 2006, IMMUNITY, V24, P269, DOI 10.1016/j.immuni.2006.01.012; Kallies A, 2007, IMMUNITY, V26, P555, DOI 10.1016/j.immuni.2007.04.007; Klein U, 2006, NAT IMMUNOL, V7, P773, DOI 10.1038/ni1357; Nera KP, 2006, IMMUNITY, V24, P283, DOI 10.1016/j.immuni.2006.02.003; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Sciammas R, 2006, IMMUNITY, V25, P225, DOI 10.1016/j.immuni.2006.07.009; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Shapiro-Shelef M, 2005, NAT REV IMMUNOL, V5, P230, DOI 10.1038/nri1572; TURNER CA, 1994, CELL, V77, P297, DOI 10.1016/0092-8674(94)90321-2; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161	10	12	12	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2007	26	5					543	544		10.1016/j.immuni.2007.05.005	http://dx.doi.org/10.1016/j.immuni.2007.05.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17521580	Bronze			2022-12-18	WOS:000246895900004
J	Fukuyama, S; Kiyono, H				Fukuyama, Satoshi; Kiyono, Hiroshi			Neuroregulator RET initiates Peyer's-patch tissue genesis	IMMUNITY			English	Editorial Material							ORGANOGENESIS; IMMUNITY	The tyrosine kinase receptor RET regulates the intestinal nervous system. A recent paper by Veiga-Fernandes et al. (2007) demonstrates that RET is also involved in the intestinal immune system through the initiation of Peyer's-patch tissue genesis.	Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol,Minato Ku, Tokyo 1088639, Japan	University of Tokyo	Kiyono, H (corresponding author), Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mucosal Immunol,Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	kiyono@ims.u-tokyo.ac.jp	Kiyono, Hiroshi/AAC-6735-2022					Barlow A, 2003, NEURON, V40, P905, DOI 10.1016/S0896-6273(03)00730-X; Fitze G, 2002, LANCET, V359, P1200, DOI 10.1016/S0140-6736(02)08218-1; Kiyono H, 2004, NAT REV IMMUNOL, V4, P699, DOI 10.1038/nri1439; Marinkovic T, 2006, J CLIN INVEST, V116, P2622, DOI 10.1172/JCI28993; Mebius RE, 2003, NAT REV IMMUNOL, V3, P292, DOI 10.1038/nri1054; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Newberry RD, 2005, IMMUNOL REV, V206, P6, DOI 10.1111/j.0105-2896.2005.00282.x; Nishikawa SI, 2003, IMMUNOL REV, V195, P72, DOI 10.1034/j.1600-065X.2003.00063.x; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597	9	12	12	0	1	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	2007	26	4					393	395		10.1016/j.immuni.2007.04.004	http://dx.doi.org/10.1016/j.immuni.2007.04.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	162YW	17459808	Bronze			2022-12-18	WOS:000246126400005
J	Kinashi, T				Kinashi, Tatsuo			Adhere upright: A switchblade-like extension of beta 2 integrins	IMMUNITY			English	Editorial Material								In this issue of Immunity, Nishida et al., (2006) demonstrate a spectrum of dynamic conformation changes from a bent form to extended forms, in extracellular domains in alpha(X)beta(2) and alpha(L)beta(2) upon separation of the alpha and beta subunits, providing structural evidence for activation of leukocyte integrins.	Kansai Med Univ, Dept Mol Genet, Inst Biomed Sci, Moriguchi, Osaka 5708506, Japan	Kansai Medical University	Kinashi, T (corresponding author), Kansai Med Univ, Dept Mol Genet, Inst Biomed Sci, Moriguchi, Osaka 5708506, Japan.							Adair BD, 2005, J CELL BIOL, V168, P1109, DOI 10.1083/jcb.200410068; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Nishida N, 2006, IMMUNITY, V25, P583, DOI 10.1016/j.immuni.2006.07.016; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2003, IMMUNITY, V19, P391, DOI 10.1016/S1074-7613(03)00238-3; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x	10	12	12	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	OCT	2006	25	4					521	522		10.1016/j.immuni.2006.09.002	http://dx.doi.org/10.1016/j.immuni.2006.09.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097WZ	17046677	Bronze			2022-12-18	WOS:000241481500001
J	Frazer, I				Frazer, Ian			God's gift to women: The human papillomavirus vaccine	IMMUNITY			English	Editorial Material							VIRUS-LIKE PARTICLES; L1 PROTEIN; IMMUNOLOGICAL RESPONSES; CERVICAL-CANCER; HOMOSEXUAL MEN; ANTIBODIES; TYPE-16; NEUTRALIZATION; IMMUNIZATION; EXPRESSION	An Australian newspaper recently bestowed Ian Frazer the title of "God's gift to women" for his research team's part in developing a vaccine to help control cervical cancer. Here Frazer discusses this work and the science behind the vaccine.	Univ Queensland, Princess Alexandra Hosp, Ctr Immunol & Canc Res, Woolloongabba, Qld 4102, Australia	University of Queensland	Frazer, I (corresponding author), Univ Queensland, Princess Alexandra Hosp, Ctr Immunol & Canc Res, 4th Floor Res Extens,Bldg 1,Ipswich Rd, Woolloongabba, Qld 4102, Australia.	ifrazer@cicr.uq.edu.au	Frazer, Ian/A-1137-2007	Frazer, Ian/0000-0002-8002-4680				Buck CB, 2005, METH MOLEC MED, V119, P445; Campo M S, 1994, Curr Top Microbiol Immunol, V186, P255; Carter JJ, 1996, J INFECT DIS, V174, P927, DOI 10.1093/infdis/174.5.927; Carter JJ, 2006, J VIROL, V80, P4664, DOI 10.1128/JVI.80.10.4664-4672.2006; Chen XJS, 2000, MOL CELL, V5, P557, DOI 10.1016/S1097-2765(00)80449-9; Christensen ND, 1996, VIROLOGY, V224, P477, DOI 10.1006/viro.1996.0554; Ferguson M, 2006, INT J CANCER, V118, P1508, DOI 10.1002/ijc.21515; Frazer IH, 2004, NAT REV IMMUNOL, V4, P46, DOI 10.1038/nri1260; FRAZER IH, 1986, Q J MED, V61, P921; FRAZER IH, 1995, CANCER RES, V55, P2635; FRAZER IH, 1986, LANCET, V2, P657; Harper DM, 2006, LANCET, V367, P1247, DOI 10.1016/S0140-6736(06)68439-0; HAUSEN HZ, 1977, CURR TOP MICROBIOL, P1; Kidd JG, 1936, J EXP MED, V64, P63, DOI 10.1084/jem.64.1.63; KIRNBAUER R, 1992, P NATL ACAD SCI USA, V89, P12180, DOI 10.1073/pnas.89.24.12180; Lowy DR, 2006, J CLIN INVEST, V116, P1167, DOI 10.1172/JCI28607; MCFADYEAN J, 1898, J COMP PATHOL THER, V11, P341; Ramoz N, 2002, NAT GENET, V32, P579, DOI 10.1038/ng1044; ROSE RC, 1993, J VIROL, V67, P1936, DOI 10.1128/JVI.67.4.1936-1944.1993; SUZICH JA, 1995, P NATL ACAD SCI USA, V92, P11553, DOI 10.1073/pnas.92.25.11553; TINDLE RW, 1991, P NATL ACAD SCI USA, V88, P5887, DOI 10.1073/pnas.88.13.5887; Villa LL, 2006, VACCINE, V24, P5571, DOI 10.1016/j.vaccine.2006.04.068; Yuan H, 2001, J VIROL, V75, P7848, DOI 10.1128/JVI.75.17.7848-7853.2001; Zhang LF, 2000, VACCINE, V18, P1051, DOI 10.1016/S0264-410X(99)00351-5; ZHOU J, 1993, J GEN VIROL, V74, P763, DOI 10.1099/0022-1317-74-4-763; ZHOU J, 1991, VIROLOGY, V185, P251, DOI 10.1016/0042-6822(91)90772-4	26	12	12	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG	2006	25	2					179	184		10.1016/j.immuni.2006.08.002	http://dx.doi.org/10.1016/j.immuni.2006.08.002			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	077RM	16920633	Bronze			2022-12-18	WOS:000240047500001
J	Lehner, PJ				Lehner, PJ			The calculus of immunity: Quantitating antigen processing	IMMUNITY			English	Review							NEWLY SYNTHESIZED PROTEINS; CLASS-I MOLECULES; DEGRADATION; PEPTIDE; PROTEASOMES; GENERATION	Peptide ligands destined for binding MHC class I molecules are generated by the proteasome in the cytoplasm and transported to the endoplasmic reticulum for loading onto newly synthesized class I molecules. A new study now provides a quantitative analysis of how total protein turnover in the cell relates to the efficiency of generating peptide epitopes presented by class I molecules.	Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge CB2 2XY, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Lehner, PJ (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 2XY, England.	pjl30@cam.ac.uk		Lehner, Paul Joseph/0000-0001-9383-1054	MRC [G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Cascio P, 2001, EMBO J, V20, P2357, DOI 10.1093/emboj/20.10.2357; Cresswell P, 1999, IMMUNOL REV, V172, P21, DOI 10.1111/j.1600-065X.1999.tb01353.x; Montoya M, 1999, J IMMUNOL, V163, P1914; Princiotta MF, 2003, IMMUNITY, V18, P343, DOI 10.1016/S1074-7613(03)00051-7; Reits EAJ, 2000, NATURE, V404, P774, DOI 10.1038/35008103; Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8; Schubert U, 2000, NATURE, V404, P770, DOI 10.1038/35008096; Shastri N, 2002, ANNU REV IMMUNOL, V20, P463, DOI 10.1146/annurev.immunol.20.100301.064819; VILLANUEVA MS, 1994, IMMUNITY, V1, P479, DOI 10.1016/1074-7613(94)90090-6; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Yewdell JW, 2001, TRENDS CELL BIOL, V11, P294, DOI 10.1016/S0962-8924(01)02030-X; Yewdell JW, 2001, J CELL SCI, V114, P845	12	12	12	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAR	2003	18	3					315	317		10.1016/S1074-7613(03)00061-X	http://dx.doi.org/10.1016/S1074-7613(03)00061-X			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	658GR	12648449	Bronze			2022-12-18	WOS:000181713700002
J	Lehar, SM; Bevan, MJ				Lehar, SM; Bevan, MJ			T cell development in culture	IMMUNITY			English	Review							NOTCH; THYMUS	The T cell compartment is continuously replenished by a renewable source of stem cells. In the adult, bone marrow-derived stem cells seed the thymus and initiate a developmental program that requires a series of incompletely understood signals that are normally provided by the thymus. Failure to recapitulate this process in simple in vitro cultures has hampered efforts to fully characterize these unique signals. In this issue of Immunity, Schmitt and Zuniga-Pflucker describe a simple in vitro culture system that is able to generate mature T cells from fetal liver stem cells by expressing the Notch ligand Delta-1 on the OP9 stromal cell line. This finding should greatly enhance efforts to study T cell development and may provide a tool for generating defined T cell populations in vitro.	Univ Washington, Dept Immunol, Seattle, WA 98195 USA; Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Bevan, MJ (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	mbevan@u.washington.edu						Anderson G, 2001, NAT REV IMMUNOL, V1, P31, DOI 10.1038/35095500; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bertrand FE, 2000, LEUKEMIA, V14, P2095, DOI 10.1038/sj.leu.2401942; Deftos ML, 2000, IMMUNITY, V13, P73, DOI 10.1016/S1074-7613(00)00009-1; Greenberg PD, 1999, SCIENCE, V285, P546, DOI 10.1126/science.285.5427.546; Hare KJ, 1999, SEMIN IMMUNOL, V11, P3, DOI 10.1006/smim.1998.0151; Izon DJ, 2002, CURR OPIN IMMUNOL, V14, P192, DOI 10.1016/S0952-7915(02)00321-7; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; Koch U, 2001, IMMUNITY, V15, P225, DOI 10.1016/S1074-7613(01)00189-3; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Milner LA, 1999, BLOOD, V93, P2431, DOI 10.1182/blood.V93.8.2431.408k33_2431_2448; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Radtke F, 2002, IMMUNOL REV, V187, P65, DOI 10.1034/j.1600-065X.2002.18706.x; Rolink A, 1995, Semin Immunol, V7, P155, DOI 10.1016/1044-5323(95)90043-8; Rothenberg EV, 2000, CURR OPIN GENET DEV, V10, P370, DOI 10.1016/S0959-437X(00)00098-8; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8	17	12	13	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC	2002	17	6					689	692		10.1016/S1074-7613(02)00477-6	http://dx.doi.org/10.1016/S1074-7613(02)00477-6			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628GU	12479815	Bronze			2022-12-18	WOS:000179985500001
J	Liu, SS; Liu, C; Lv, XX; Cui, B; Yan, J; Li, YX; Li, K; Hua, F; Zhang, XW; Yu, JJ; Yu, JM; Wang, F; Shang, S; Li, PP; Zhou, ZG; Xiao, Y; Hu, ZW				Liu, Shan-Shan; Liu, Chang; Lv, Xiao-Xi; Cui, Bing; Yan, Jun; Li, Yun-Xuan; Li, Ke; Hua, Fang; Zhang, Xiao-Wei; Yu, Jiao-Jiao; Yu, Jin-Mei; Wang, Feng; Shang, Shuang; Li, Ping-Ping; Zhou, Zhi-Guang; Xiao, Yang; Hu, Zhuo-Wei			The chemokine CCL1 triggers an AMFR-SPRY1 pathway that promotes differentiation of lung fibroblasts into myofibroblasts and drives pulmonary fibrosis	IMMUNITY			English	Article							AUTOCRINE MOTILITY FACTOR; FACTOR-RECEPTOR; SPROUTY PROTEINS; GP78; E3; KINASE; ASSOCIATION; DEGRADATION; RECRUITMENT; MACROPHAGES	Recruitment of immune cells to the site of inflammation by the chemokine CCL1 is important in the pathology of inflammatory diseases. Here, we examined the role of CCL1 in pulmonary fibrosis (PF). Bronchoalveolar lavage fluid from PF mouse models contained high amounts of CCL1, as did lung biopsies from PF patients. Immunofluorescence analyses revealed that alveolar macrophages and CD4(+) T cells were major producers of CCL1 and targeted deletion of Ccl1 in these cells blunted pathology. Deletion of the CCL1 receptor Ccr8 in fibroblasts limited migration, but not activation, in response to CCL1. Mass spectrometry analyses of CCL1 complexes identified AMFR as a CCL1 receptor, and deletion of Amfr impaired fibroblast activation. Mechanistically, CCL1 binding triggered ubiquitination of the ERK inhibitor Spry1 by AMFR, thus activating Ras-mediated profibrotic protein synthesis. Antibody blockade of CCL1 ameliorated PF pathology, supporting the therapeutic potential of targeting this pathway for treating fibroproliferative lung diseases.	[Liu, Shan-Shan; Zhou, Zhi-Guang; Xiao, Yang; Hu, Zhuo-Wei] Cent South Univ, Xiangya Hosp 2, Natl Clin Res Ctr Metab Dis, Key Lab Diabet Immunol,Minist Educ, Changsha 410011, Hunan, Peoples R China; [Liu, Shan-Shan; Zhou, Zhi-Guang; Xiao, Yang; Hu, Zhuo-Wei] Cent South Univ, Dept Metab & Endocrinol, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China; [Liu, Shan-Shan; Liu, Chang; Lv, Xiao-Xi; Cui, Bing; Li, Yun-Xuan; Hua, Fang; Zhang, Xiao-Wei; Yu, Jiao-Jiao; Yu, Jin-Mei; Wang, Feng; Shang, Shuang; Li, Ping-Ping; Hu, Zhuo-Wei] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Yan, Jun] Capital Med Univ, Beijing Inst Brain Disorders, Beijing 100050, Peoples R China; [Li, Ke] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, Beijing 100050, Peoples R China	Central South University; Central South University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Biotechnology - CAMS; Peking Union Medical College	Xiao, Y; Hu, ZW (corresponding author), Cent South Univ, Xiangya Hosp 2, Natl Clin Res Ctr Metab Dis, Key Lab Diabet Immunol,Minist Educ, Changsha 410011, Hunan, Peoples R China.; Xiao, Y; Hu, ZW (corresponding author), Cent South Univ, Dept Metab & Endocrinol, Xiangya Hosp 2, Changsha 410011, Hunan, Peoples R China.; Hu, ZW (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	xiaoyang29@csu.edu.cn; huzhuowei@csu.edu.cn	Li, Ping/GYV-4914-2022; zhang, xiaowei/GQH-5387-2022; Xiao, Yang/N-5021-2017	Hua, Fang/0000-0001-6214-1384; Xiao, Yang/0000-0003-3927-1839; Yan, Jun/0000-0002-3261-0749; Zhang, Xiao-Wei/0000-0002-9903-6980	National Key R&D Program of China [2017YFA0205400, 2018YFE0114500]; "361 Project'' Outstanding Leading Talent of the Second Xiangya Hospital of Central South University; National Natural Science Foundation of China [81530093, 81773781, 81803604, 81622010, 81770800]; National Science Foundation of Hunan Province for Excellent Young Scholars [2020JJ3056]; Chinese Academy of Medical Sciences (CAMS) Central Public-interest Scientific Institution Basal Research Fund (Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, CAMS Key Lab) [2018PT35004]; Beijing Outstanding Young Scientist Program [BJJWZYJH01201910023028]; CAMS Innovation Fund for Medical Sciences [2016-I2M-1-007, 2016-I2M-3-008]	National Key R&D Program of China; "361 Project'' Outstanding Leading Talent of the Second Xiangya Hospital of Central South University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Hunan Province for Excellent Young Scholars; Chinese Academy of Medical Sciences (CAMS) Central Public-interest Scientific Institution Basal Research Fund (Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, CAMS Key Lab); Beijing Outstanding Young Scientist Program; CAMS Innovation Fund for Medical Sciences	We cordially thank J.L.M. and Q.L. for experimental work and data processing. This work was supported by grants from the National Key R&D Programof China (2017YFA0205400 and 2018YFE0114500), the "361 Project'' Outstanding Leading Talent of the Second Xiangya Hospital of Central South University, the National Natural Science Foundation of China (81530093, 81773781, 81803604, 81622010, and 81770800), the National Science Foundation of Hunan Province for Excellent Young Scholars (2020JJ3056), the Chinese Academy of Medical Sciences (CAMS) Central Public-interest Scientific Institution Basal Research Fund (2018PT35004, Molecular Mechanism and Target Discovery of Metabolic Disorder and Tumorigenesis, CAMS Key Lab), the Beijing Outstanding Young Scientist Program (BJJWZYJH01201910023028), and the CAMS Innovation Fund for Medical Sciences (2016-I2M-1-007 and 2016-I2M-3-008).	Antoniou KM, 2010, CONNECT TISSUE RES, V51, P71, DOI 10.3109/03008200903056150; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Chow LN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151765; Degryse AL, 2010, AM J PHYSIOL-LUNG C, V299, pL442, DOI 10.1152/ajplung.00026.2010; Fairbank M, 2009, MOL BIOSYST, V5, P793, DOI 10.1039/b820820b; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gharaee-Kermani M, 2003, CYTOKINE, V24, P266, DOI 10.1016/j.cyto.2003.08.003; Gombert M, 2005, J IMMUNOL, V174, P5082, DOI 10.4049/jimmunol.174.8.5082; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Guy GR, 2009, J ENDOCRINOL, V203, P191, DOI 10.1677/JOE-09-0110; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Jin T, 2008, CYTOKINE, V44, P1, DOI 10.1016/j.cyto.2008.06.017; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/expphysiol.2010.053793, 10.1113/jphysiol.2010.192278]; Knipfer L, 2019, J EXP MED, V216, P2763, DOI 10.1084/jem.20182111; Koledova Z, 2016, P NATL ACAD SCI USA, V113, pE5731, DOI 10.1073/pnas.1611532113; Lemmon MA, 2016, CELL, V164, P1172, DOI 10.1016/j.cell.2016.02.047; Li L, 2015, MOL BIOL CELL, V26, P3828, DOI 10.1091/mbc.E15-02-0120; Liu SS, 2019, IMMUNITY, V51, P522, DOI 10.1016/j.immuni.2019.06.014; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Menzies SA, 2018, ELIFE, V7, DOI [10.7554/eLife.40009.001, 10.7554/eLife.40009]; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Murray LA, 2008, INT J BIOCHEM CELL B, V40, P2174, DOI 10.1016/j.biocel.2008.02.016; NABI IR, 1992, CANCER METAST REV, V11, P5, DOI 10.1007/BF00047599; NABI IR, 1990, CANCER RES, V50, P409; Nadeau RJ, 2007, J CELL BIOCHEM, V100, P151, DOI 10.1002/jcb.21040; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; Pardo A, 2016, ANN AM THORAC SOC, V13, pS417, DOI 10.1513/AnnalsATS.201605-341AW; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Putman RK, 2016, JAMA-J AM MED ASSOC, V315, P672, DOI 10.1001/jama.2016.0518; Richeldi L, 2017, LANCET, V389, P1941, DOI 10.1016/S0140-6736(17)30866-8; Sallusto F, 2008, NAT IMMUNOL, V9, P949, DOI 10.1038/ni.f.214; Shimizu K, 1999, FEBS LETT, V456, P295, DOI 10.1016/S0014-5793(99)00966-7; Shu HKG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079768; Taskar Varsha S, 2006, Proc Am Thorac Soc, V3, P293, DOI 10.1513/pats.200512-131TK; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Tsai YC, 2007, NAT MED, V13, P1504, DOI 10.1038/nm1686; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zen Y, 2013, J HEPATOL, V59, P1059, DOI 10.1016/j.jhep.2013.06.016; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008	43	11	11	12	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					2042	+		10.1016/j.immuni.2021.06.008	http://dx.doi.org/10.1016/j.immuni.2021.06.008		SEP 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34407391	Bronze			2022-12-18	WOS:000695789800013
J	Mourcin, F; Verdiere, L; Roulois, D; Amin, R; Lamaison, C; Sibut, V; Thamphya, B; Pangault, C; Monvoisin, C; Huet, S; Seffals, M; Baulande, S; Mechta-Grigoriou, F; Legoix, P; Rossille, D; Guirriec, M; Leonard, S; Cartron, G; Salles, G; Fest, T; Tarte, K				Mourcin, Frederic; Verdiere, Lea; Roulois, David; Amin, Rada; Lamaison, Claire; Sibut, Vonick; Thamphya, Brice; Pangault, Celine; Monvoisin, Celine; Huet, Sarah; Seffals, Marine; Baulande, Sylvain; Mechta-Grigoriou, Fatima; Legoix, Patricia; Rossille, Delphine; Guirriec, Marion; Leonard, Simon; Cartron, Guillaume; Salles, Gilles; Fest, Thierry; Tarte, Karin			Follicular lymphoma triggers phenotypic and functional remodeling of the human lymphoid stromal cell landscape	IMMUNITY			English	Article							FIBROBLASTIC RETICULAR CELLS; MESENCHYMAL STEM-CELLS; CENTER B-CELLS; DENDRITIC CELLS; GERMINAL CENTER; T-CELLS; BONE-MARROW; LYMPHOTOXIN-BETA; EXPRESSION; GROWTH	Lymphoid stromal cells (LSCs) are essential organizers of immune responses. We analyzed tonsillar tissue by combining flow cytometry, in situ imaging, RNA sequencing, and functional assays, defining three distinct human LSC subsets. The integrin CD49a designated perivascular stromal cells exhibiting features of local committed LSC precursors and segregated cytokine and chemokine-producing fibroblastic reticular cells (FRCs) supporting B and T cell survival. The follicular dendritic cell transcriptional profile reflected active responses to B cell and non-B cell stimuli. We therefore examined the effect of B cell stimuli on LSCs in follicular lymphoma (FL). FL B cells interacted primarily with CD49a(+) FRCs. Transcriptional analyses revealed LSC reprogramming in situ downstream of the cytokines tumor necrosis factor (TNF) and transforming growth factor beta (TGF-beta), including increased expression of the chemokines CCL19 and CCL21. Our findings define human LSC populations in healthy tissue and reveal bidirectional crosstalk between LSCs and malignant B cells that may present a targetable axis in lymphoma.	[Mourcin, Frederic; Verdiere, Lea; Roulois, David; Amin, Rada; Lamaison, Claire; Sibut, Vonick; Thamphya, Brice; Pangault, Celine; Monvoisin, Celine; Rossille, Delphine; Guirriec, Marion; Leonard, Simon; Fest, Thierry; Tarte, Karin] Univ Rennes, Etab Francais Sang Bretagne, INSERM, UMR 1236, F-35043 Rennes, France; [Pangault, Celine; Rossille, Delphine; Fest, Thierry; Tarte, Karin] CHU Rennes, Pole Biol, F-35033 Rennes, France; [Huet, Sarah] Univ Claude Bernard Lyon 1, Equipe Lymphoma Immuno Biol, Equipe Labellisee Ligue Natl Canc, F-69921 Oullins, France; [Huet, Sarah] Hosp Civils Lyon, Serv Hematol Biol, F-69395 Pierre Benite, France; [Seffals, Marine] Univ Rennes, INSERM, CNRS, UMS Biosit,Core Facil H2P2, F-35043 Rennes, France; [Baulande, Sylvain; Legoix, Patricia] PSL Res Univ, Inst Curie Res Ctr, Inst Curie Genom Excellence ICGex Platform, F-75005 Paris, France; [Mechta-Grigoriou, Fatima] PSL Res Univ, Equipe Labellisee Ligue Natl Canc, Stress & Canc Lab, Inst Curie, 26 Rue Ulm, F-75248 Paris, France; [Cartron, Guillaume] CHU Montpellier, Dept Hematol, F-34000 Montpellier, France; [Salles, Gilles] Mem Sloan Kettering Canc Ctr, Lymphoma Serv, 1275 York Ave, New York, NY 10021 USA; [Amin, Rada] Univ Nebraska, Beadle Ctr, Dept Biochem, Lincoln, NE 68503 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite de Montpellier; CHU de Montpellier; Memorial Sloan Kettering Cancer Center; University of Nebraska System; University of Nebraska Lincoln	Tarte, K (corresponding author), Univ Rennes, Etab Francais Sang Bretagne, INSERM, UMR 1236, F-35043 Rennes, France.; Tarte, K (corresponding author), CHU Rennes, Pole Biol, F-35033 Rennes, France.	karin.tarte@univ-rennes1.fr	Salles, Gilles/Z-2336-2019; lamaison, claire/GVS-3267-2022; tarte, karin/GXV-1815-2022; Amin, Rada/AAY-3950-2021; Roulois, David/F-3732-2017; Pangault, Celine/C-3254-2017	Salles, Gilles/0000-0002-9541-8666; lamaison, claire/0000-0003-1180-7902; tarte, karin/0000-0002-6809-917X; Roulois, David/0000-0002-8966-0608; Pangault, Celine/0000-0003-3978-2209; Amin, Rada/0000-0002-9907-1831	Fondation ARC pour la Recherche sur le Cancer [PGA1 RF20170205386]; Institut National Du Cancer (INCA) [AAP PLBIO-17-06]; Agence Nationale de la Recherche (ANR) - LLS [ANR-16-CE150019-03, TRP 6593-20]; Association pour le Developpement de l'Hematologie Oncologie (ADHO); Labex IGO; Ligue Regionale contre le Cancer; Region Bretagne; Chair d'Excellence of the Fondation Rennes 1; La Ligue Regionale contre le Cancer; ANR [ANR-10-INBS-04]; SiRIC-Curie Program (SiRIC) [INCa-DGOS-4654]; Centre de Ressources Biologiques (CRB)-Sante [BB-0033-00056]; Lymphoma Academic Research Organisation (LYSA).;  [ANR-10-EQPX-03];  [ANR-10-INBS-09-08]	Fondation ARC pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le Cancer); Institut National Du Cancer (INCA)(Institut National du Cancer (INCA) France); Agence Nationale de la Recherche (ANR) - LLS(French National Research Agency (ANR)); Association pour le Developpement de l'Hematologie Oncologie (ADHO); Labex IGO; Ligue Regionale contre le Cancer(Ligue nationale contre le cancer); Region Bretagne(Region Bretagne); Chair d'Excellence of the Fondation Rennes 1; La Ligue Regionale contre le Cancer; ANR(French National Research Agency (ANR)); SiRIC-Curie Program (SiRIC); Centre de Ressources Biologiques (CRB)-Sante; Lymphoma Academic Research Organisation (LYSA).; ; 	This work is supported by the Fondation ARC pour la Recherche sur le Cancer (grant PGA1 RF20170205386), the Institut National Du Cancer (INCA; AAP PLBIO-17-06), the Agence Nationale de la Recherche (ANR; ANR-16-CE150019-03), the LLS (TRP 6593-20), and the Association pour le Developpement de l'Hematologie Oncologie (ADHO). L.V. is a recipient of a doctoral fellowship from the Labex IGO and C.L. from the FHU CAMIn, the Ligue Regionale contre le Cancer, and the Region Bretagne. S.L. is supported by a Chair d'Excellence of the Fondation Rennes 1 and Labex IGO. F.M. is supported by research grants from La Ligue Regionale contre le Cancer. Immunofluorescence studies were performed at the Microscopy Rennes Imaging Center (MRic) and on the H2P2 platform, members of the UMS 6480 Biosit and of the national infrastructure France-BioImaging supported by the ANR (ANR-10-INBS-04). Cell sorting was performed at the UMS 6480 Biosit CytomeTRI facility. High-throughput sequencing was performed by the ICGex NGS platform of Institut Curie supported by grants ANR-10-EQPX-03 (Equipex) and ANR-10-INBS-09-08 (France Genomique Consortium) from the ANR, by ITMO-CANCER, and by the SiRIC-Curie Program (SiRIC grant INCa-DGOS-4654). The authors are indebted to the Centre de Ressources Biologiques (CRB)-Sante(BB-0033-00056) of Rennes Hospital for processing biological samples, Christophe Ruaux for providing tonsil samples, Erwan Flecher for providing normal bone marrow samples, and LYSA-P for generating TMA from individuals included in the FLIRT trial (NCT02303119), sponsored by the Lymphoma Academic Research Organisation (LYSA).	Al-Alwan M, 2007, J IMMUNOL, V178, P7859, DOI 10.4049/jimmunol.178.12.7859; Ame-Thomas P, 2012, LEUKEMIA, V26, P1053, DOI 10.1038/leu.2011.301; Ame-Thomas P, 2007, BLOOD, V109, P693, DOI 10.1182/blood-2006-05-020800; Ame-Thomas P, 2014, SEMIN CANCER BIOL, V24, P23, DOI 10.1016/j.semcancer.2013.08.001; Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035; Bahsoun S, 2018, STEM CELLS DEV, V27, P1303, DOI 10.1089/scd.2017.0291; Bar-Ephraim YE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167555; Bararia D, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107522; Beguelin W, 2020, CANCER CELL, V37, P655, DOI 10.1016/j.ccell.2020.04.004; Boice M, 2016, CELL, V167, P405, DOI 10.1016/j.cell.2016.08.032; Boles KS, 2009, EUR J IMMUNOL, V39, P695, DOI 10.1002/eji.200839116; Browaeys R, 2020, NAT METHODS, V17, P159, DOI 10.1038/s41592-019-0667-5; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Chang KC, 2003, J PATHOL, V201, P404, DOI 10.1002/path.1478; Cheng HW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09728-3; Collins PJ, 2017, FASEB J, V31, P3084, DOI 10.1096/fj.201700013R; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Culhane AC, 2005, BIOINFORMATICS, V21, P2789, DOI 10.1093/bioinformatics/bti394; Desmots F, 2019, CLIN CANCER RES, V25, P735, DOI 10.1158/1078-0432.CCR-18-1153; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dubey LK, 2019, CELL REP, V27, P2442, DOI 10.1016/j.celrep.2019.04.079; Dubey LK, 2016, CELL REP, V15, P1527, DOI 10.1016/j.celrep.2016.04.023; Dumontet E, 2021, BLOOD, V138, P57, DOI 10.1182/blood.2020008791; Efremova M, 2020, NAT PROTOC, V15, P1484, DOI 10.1038/s41596-020-0292-x; Endres R, 1999, J EXP MED, V189, P159, DOI 10.1084/jem.189.1.159; Farinello D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04150-7; Fletcher AL, 2015, NAT REV IMMUNOL, V15, P350, DOI 10.1038/nri3846; Frontera V, 2011, J IMMUNOL, V187, P603, DOI 10.4049/jimmunol.1003441; Garin A, 2010, IMMUNITY, V33, P84, DOI 10.1016/j.immuni.2010.07.005; Gindraux F, 2007, CELL TISSUE RES, V327, P471, DOI 10.1007/s00441-006-0292-3; Godefroy E, 2015, HAEMATOLOGICA, V100, P1415, DOI 10.3324/haematol.2015.132738; Green MR, 2015, P NATL ACAD SCI USA, V112, pE1116, DOI 10.1073/pnas.1501199112; Gregoire M, 2015, ONCOTARGET, V6, P16471, DOI 10.18632/oncotarget.4106; Gregory JL, 2017, CELL REP, V18, P406, DOI 10.1016/j.celrep.2016.12.038; Gribov A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-21; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Guilloton F, 2012, BLOOD, V119, P2556, DOI 10.1182/blood-2011-08-370908; Heesters BA, 2014, NAT REV IMMUNOL, V14, P495, DOI 10.1038/nri3689; Heinig K, 2014, CANCER DISCOV, V4, P1448, DOI 10.1158/2159-8290.CD-14-0096; Huang HY, 2018, P NATL ACAD SCI USA, V115, pE6826, DOI 10.1073/pnas.1712628115; Huet S, 2018, LANCET ONCOL, V19, P549, DOI 10.1016/S1470-2045(18)30102-5; Huet S, 2018, NAT REV CANCER, V18, P224, DOI 10.1038/nrc.2017.127; Jarjour M, 2014, J EXP MED, V211, P1109, DOI 10.1084/jem.20132409; Kim J, 2013, MOL IMMUNOL, V55, P418, DOI 10.1016/j.molimm.2013.03.019; Kim J, 2012, J IMMUNOL, V188, P182, DOI 10.4049/jimmunol.1102297; Knoblich K, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005046; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; Krishnamurty AT, 2020, NAT IMMUNOL, V21, P369, DOI 10.1038/s41590-020-0635-3; Lamaison C, 2019, IMMUNOL LETT, V215, P12, DOI 10.1016/j.imlet.2019.02.005; Li HZ, 2014, STEM CELL REP, V3, P965, DOI 10.1016/j.stemcr.2014.09.018; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Liu YJ, 1997, J EXP MED, V185, P165, DOI 10.1084/jem.185.1.165; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malhotra D, 2012, NAT IMMUNOL, V13, P499, DOI 10.1038/ni.2262; Menard C, 2020, STEM CELLS, V38, P146, DOI 10.1002/stem.3077; Middendorp S, 2009, BLOOD, V114, P2280, DOI 10.1182/blood-2009-03-208215; Mueller SN, 2009, NAT REV IMMUNOL, V9, P618, DOI 10.1038/nri2588; Munoz O, 2004, LEUKEMIA, V18, P2015, DOI 10.1038/sj.leu.2403485; Muppidi JR, 2014, NATURE, V516, P254, DOI 10.1038/nature13765; O'Donnell JS, 2020, SEMIN CANCER BIOL, V65, P189, DOI 10.1016/j.semcancer.2019.11.013; Ortega-Molina A, 2019, NAT METAB, V1, P775, DOI 10.1038/s42255-019-0098-8; Pandey S, 2017, BLOOD, V129, P2507, DOI 10.1182/blood-2016-08-737239; Pangault C, 2010, LEUKEMIA, V24, P2080, DOI 10.1038/leu.2010.223; Pangault C, 2020, CANCERS, V12, DOI 10.3390/cancers12102865; Park E, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax9340; Pepe G, 2018, J PATHOL CLIN RES, V4, P124, DOI 10.1002/cjp2.97; Perez-Shibayama C, 2019, IMMUNOL REV, V289, P31, DOI 10.1111/imr.12748; Pikor NB, 2020, NAT IMMUNOL, V21, P649, DOI 10.1038/s41590-020-0672-y; Riedel A, 2016, NAT IMMUNOL, V17, P1118, DOI 10.1038/ni.3492; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sacchetti B, 2016, STEM CELL REP, V6, P897, DOI 10.1016/j.stemcr.2016.05.011; Sahai E, 2020, NAT REV CANCER, V20, P174, DOI 10.1038/s41568-019-0238-1; Salmon H, 2012, J CLIN INVEST, V122, P899, DOI 10.1172/JCI45817; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Severino P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00141; Shibuya A, 2015, IMMUNOL REV, V268, P288, DOI 10.1111/imr.12345; Smedley D, 2015, NUCLEIC ACIDS RES, V43, pW589, DOI 10.1093/nar/gkv350; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Suzuki K, 2010, IMMUNITY, V33, P71, DOI 10.1016/j.immuni.2010.07.003; Takeuchi A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02196; Thomazy VA, 2003, AM J PATHOL, V163, P165, DOI 10.1016/S0002-9440(10)63640-1; Wu XC, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1699-6; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111; Yang ZZ, 2014, LEUKEMIA, V28, P1872, DOI 10.1038/leu.2014.84; Yang ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059456; Yoon SO, 2009, J IMMUNOL, V183, P352, DOI 10.4049/jimmunol.0803183; Zhang Y, 2018, J EXP MED, V215, P1227, DOI 10.1084/jem.20160832	93	11	11	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1788	+		10.1016/j.immuni.2021.05.019	http://dx.doi.org/10.1016/j.immuni.2021.05.019		AUG 2021	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34166622	Green Submitted, Bronze			2022-12-18	WOS:000684589700016
J	Stutz, MD; Allison, CC; Ojaimi, S; Preston, SP; Doerflinger, M; Arandjelovic, P; Whitehead, L; Bader, SM; Batey, D; Asselin-Labat, ML; Herold, MJ; Strasser, A; West, NP; Pellegrini, M				Stutz, Michael Dominic; Allison, Cody Charles; Ojaimi, Samar; Preston, Simon Peter; Doerflinger, Marcel; Arandjelovic, Philip; Whitehead, Lachlan; Bader, Stefanie M.; Batey, Daniel; Asselin-Labat, Marie-Liesse; Herold, Marco J.; Strasser, Andreas; West, Nicholas P.; Pellegrini, Marc			Macrophage and neutrophil death programs differentially confer resistance to tuberculosis	IMMUNITY			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INFECTED MACROPHAGES; INDUCED APOPTOSIS; PSEUDOKINASE MLKL; ADAPTIVE IMMUNITY; T-CELLS; BCL-2; NECROSIS; BAX; IMMUNOPATHOLOGY	Apoptosis can potently defend against intracellular pathogens by directly killing microbes and eliminating their replicative niche. However, the reported ability of Mycobacterium tuberculosis to restrict apoptotic pathways in macrophages in vitro has led to apoptosis being dismissed as a host-protective process in tuberculosis despite a lack of in vivo evidence. Here we define crucial in vivo functions of the death receptor-mediated and BCL-2-regulated apoptosis pathways in mediating protection against tuberculosis by eliminating distinct populations of infected macrophages and neutrophils and priming T cell responses. We further show that apoptotic pathways can be targeted therapeutically with clinical-stage compounds that antagonize inhibitor of apoptosis (IAP) proteins to promote clearance of M. tuberculosis in mice. These findings reveal that any inhibition of apoptosis by M. tuberculosis is incomplete in vivo, advancing our understanding of host-protective responses to tuberculosis (TB) and revealing host pathways that may be targetable for treatment of disease.	[Stutz, Michael Dominic; Allison, Cody Charles; Ojaimi, Samar; Preston, Simon Peter; Doerflinger, Marcel; Arandjelovic, Philip; Whitehead, Lachlan; Bader, Stefanie M.; Batey, Daniel; Asselin-Labat, Marie-Liesse; Herold, Marco J.; Strasser, Andreas; Pellegrini, Marc] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Stutz, Michael Dominic; Allison, Cody Charles; Ojaimi, Samar; Preston, Simon Peter; Arandjelovic, Philip; Whitehead, Lachlan; Bader, Stefanie M.; Batey, Daniel; Asselin-Labat, Marie-Liesse; Herold, Marco J.; Strasser, Andreas; Pellegrini, Marc] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [West, Nicholas P.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld 4072, Australia; [Stutz, Michael Dominic] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA; [Ojaimi, Samar] Monash Hlth, Clayton, Vic 3168, Australia; [Ojaimi, Samar] Monash Univ, Clayton, Vic 3168, Australia; [Arandjelovic, Philip] Cartherics Pty Ltd, Clayton, Vic 3168, Australia	Walter & Eliza Hall Institute; University of Melbourne; University of Queensland; Oregon Health & Science University; Monash University	Pellegrini, M (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.; Pellegrini, M (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia.	pellegrini@wehi.edu.au	Herold, Marco J/C-8039-2013; Strasser, Andreas/C-7581-2013; West, Nicholas P/C-3119-2008	Herold, Marco J/0000-0001-7539-7581; Strasser, Andreas/0000-0002-5020-4891; West, Nicholas P/0000-0003-0955-9890; Preston, Simon/0000-0001-8969-8297; Mendes Bader, Stefanie/0000-0002-7901-9833	National Health and Medical Research Council Australia [1147010, 101671, 1020363, GNT1182155, 1056282, 1039014]; Sylvia and Charles Viertel Charitable Foundation Senior Medical Research Fellowship; Harry Secomb Trust; Victorian State Government Operational Infrastructure Support; Independent Research Institutes Infrastructure Support Scheme of the Australian Government National Health and Medical Research Council	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Charitable Foundation Senior Medical Research Fellowship; Harry Secomb Trust; Victorian State Government Operational Infrastructure Support; Independent Research Institutes Infrastructure Support Scheme of the Australian Government National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Australia (1147010 to M.P. and N.P.W., 101671 and 1020363 to A.S., GNT1182155 to M.-L.A.-L., 1056282 to S.O., and 1039014 to S.P.), The Sylvia and Charles Viertel Charitable Foundation Senior Medical Research Fellowship (to M.P. and M.-L.A.-L.), The Harry Secomb Trust (M.-L.A.-L.), and the Victorian State Government Operational Infrastructure Support and the Independent Research Institutes Infrastructure Support Scheme of the Australian Government National Health and Medical Research Council. We thank V. Dixit and N. Kayagaki (Genentech) for discussions and gasdermin-deficient mouse strains, J. Vince and K. Lawlor for Casp8<SUP>lox/lox</SUP>;Lyz2-Cre mice, B. Kile and S. Chappaz (Monash University) for Bax<SUP>lox/lox</SUP>;Lyz2-Cre;Bak<SUP>-/-</SUP> mice, C. Weeden for technical support, and L. Mackiewicz, M. Hobbs, and M. Dayton for animal care.	Aachoui Y, 2013, SCIENCE, V339, P975, DOI 10.1126/science.1230751; Adams JM, 2018, CELL DEATH DIFFER, V25, P27, DOI 10.1038/cdd.2017.161; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; Alvarez-Diaz S, 2016, IMMUNITY, V45, P513, DOI 10.1016/j.immuni.2016.07.016; Arnett E, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007100; Bean AGD, 1999, J IMMUNOL, V162, P3504; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Blomgran R, 2012, CELL HOST MICROBE, V11, P81, DOI 10.1016/j.chom.2011.11.012; Bunch KP, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.5585; Cadena AM, 2016, MBIO, V7, DOI 10.1128/mBio.00342-16; Campbell GR, 2018, CELL HOST MICROBE, V24, P689, DOI 10.1016/j.chom.2018.09.007; Cummins NW, 2016, J VIROL, V90, P4032, DOI 10.1128/JVI.03179-15; Deo P, 2020, NAT MICROBIOL, V5, P1418, DOI 10.1038/s41564-020-0773-2; Di Paolo NC, 2015, IMMUNITY, V43, P1125, DOI 10.1016/j.immuni.2015.11.016; Dibbert B, 1999, P NATL ACAD SCI USA, V96, P13330, DOI 10.1073/pnas.96.23.13330; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Dorhoi A, 2014, EUR J IMMUNOL, V44, P2380, DOI 10.1002/eji.201344219; Ebert G, 2015, P NATL ACAD SCI USA, V112, P5803, DOI 10.1073/pnas.1502400112; Francois S, 2005, J IMMUNOL, V174, P3633, DOI 10.4049/jimmunol.174.6.3633; Fuller CL, 2003, INFECT IMMUN, V71, P7023, DOI 10.1128/IAI.71.12.7023-7034.2003; Gan HX, 2008, NAT IMMUNOL, V9, P1189, DOI 10.1038/ni.1654; Hinchey J, 2007, J CLIN INVEST, V117, P2279, DOI 10.1172/JCI31947; Inaba K, 1998, J EXP MED, V188, P2163, DOI 10.1084/jem.188.11.2163; Infante JR, 2014, J CLIN ONCOL, V32, P3103, DOI 10.1200/JCO.2013.52.3993; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kaufmann T, 2007, CELL, V129, P423, DOI 10.1016/j.cell.2007.03.017; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Keane J, 2000, J IMMUNOL, V164, P2016, DOI 10.4049/jimmunol.164.4.2016; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Keller C, 2006, INFECT IMMUN, V74, P4295, DOI 10.1128/IAI.00057-06; Kimmey JM, 2015, NATURE, V528, P565, DOI 10.1038/nature16451; Klingler K, 1997, INFECT IMMUN, V65, P5272, DOI 10.1128/IAI.65.12.5272-5278.1997; Koedel U, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000461; Lamkanfi M, 2010, CELL HOST MICROBE, V8, P44, DOI 10.1016/j.chom.2010.06.007; Lawlor KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7282; Lee J, 2006, J IMMUNOL, V176, P4267, DOI 10.4049/jimmunol.176.7.4267; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Lyadova IV, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/8619307; Maelfait J, 2008, J EXP MED, V205, P1967, DOI 10.1084/jem.20071632; Mahamed D, 2017, ELIFE, V6, DOI 10.7554/eLife.22028; Marakalala MJ, 2016, NAT MED, V22, P531, DOI 10.1038/nm.4073; Martin CJ, 2012, CELL HOST MICROBE, V12, P289, DOI 10.1016/j.chom.2012.06.010; Mayer-Barber KD, 2010, J IMMUNOL, V184, P3326, DOI 10.4049/jimmunol.0904189; Miao EA, 2010, NAT IMMUNOL, V11, P1136, DOI 10.1038/ni.1960; Mogues T, 2001, J EXP MED, V193, P271, DOI 10.1084/jem.193.3.271; MOLLOY A, 1994, J EXP MED, V180, P1499, DOI 10.1084/jem.180.4.1499; Murphy JM, 2013, IMMUNITY, V39, P443, DOI 10.1016/j.immuni.2013.06.018; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Oddo M, 1998, J IMMUNOL, V160, P5448; Orning P, 2018, SCIENCE, V362, P1064, DOI 10.1126/science.aau2818; Placido R, 1997, J PATHOL, V181, P31, DOI 10.1002/(SICI)1096-9896(199701)181:1<31::AID-PATH722>3.0.CO;2-G; Repasy T, 2015, MICROBES INFECT, V17, P564, DOI 10.1016/j.micinf.2015.03.013; Repasy T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003190; Rogers C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14128; Salvamoser R, 2019, CELL DEATH DIFFER, V26, P1124, DOI 10.1038/s41418-018-0188-2; Sarhan J, 2018, P NATL ACAD SCI USA, V115, pE10888, DOI 10.1073/pnas.1809548115; Schaaf K, 2017, SCI REP-UK, V7, DOI 10.1038/srep42101; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Sly LM, 2003, J IMMUNOL, V170, P430, DOI 10.4049/jimmunol.170.1.430; Speir M, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.34, 10.1038/nmicrobiol.2015.34]; Steimer DA, 2009, BLOOD, V113, P2805, DOI 10.1182/blood-2008-05-159145; Strasser A, 2018, CELL DEATH DIFFER, V25, P13, DOI 10.1038/cdd.2017.145; Stutz MD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01178; Stutz MD, 2018, CELL DEATH DIFFER, V25, P951, DOI 10.1038/s41418-017-0031-1; Stutz MD, 2018, J LEUKOCYTE BIOL, V103, P259, DOI 10.1002/JLB.4MR0717-277R; Tabtieng T, 2018, J VIROL, V92, DOI 10.1128/JVI.00078-18; Tanaka S, 2012, J IMMUNOL, V188, P6145, DOI 10.4049/jimmunol.1103660; TeKippe EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012320; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Velmurugan K, 2007, PLOS PATHOG, V3, P972, DOI 10.1371/journal.ppat.0030110; Villunger A, 2003, BLOOD, V101, P2393, DOI 10.1182/blood-2002-07-2132; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang YP, 2017, NATURE, V547, P99, DOI 10.1038/nature22393; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; WHO, 2021, TUBERCULOSIS; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Witt A, 2017, CELL DEATH DIFFER, V24, P1160, DOI 10.1038/cdd.2017.33; Yrlid U, 2000, J EXP MED, V191, P613, DOI 10.1084/jem.191.4.613	85	11	11	2	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1758	+		10.1016/j.immuni.2021.06.009	http://dx.doi.org/10.1016/j.immuni.2021.06.009		AUG 2021	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34256013	Bronze			2022-12-18	WOS:000684589700014
J	Xu, K; Yin, N; Peng, M; Stamatiades, EG; Chhangawala, S; Shyu, A; Li, P; Zhang, X; Do, MH; Capistrano, KJ; Chou, C; Leslie, CS; Li, MO				Xu, Ke; Yin, Na; Peng, Min; Stamatiades, Efstathios G.; Chhangawala, Sagar; Shyu, Amy; Li, Peng; Zhang, Xian; Do, Mytrang H.; Capistrano, Kristelle J.; Chou, Chun; Leslie, Christina S.; Li, Ming O.			Glycolytic ATP fuels phosphoinositide 3-kinase signaling to support effector T helper 17 cell responses	IMMUNITY			English	Article							FOXO TRANSCRIPTION FACTORS; METABOLIC CHECKPOINT; AEROBIC GLYCOLYSIS; KINASE; DIFFERENTIATION; GROWTH; ACTIVATION; GLUT1; PI3K; PERMEABILIZATION	Aerobic glycolysis-the Warburg effect-converts glucose to lactate via the enzyme lactate dehydrogenase A (LDHA) and is a metabolic feature of effector T cells. Cells generate ATP through various mechanisms and Warburg metabolism is comparatively an energy-inefficient glucose catabolism pathway. Here, we examined the effect of ATP generated via aerobic glycolysis in antigen-driven T cell responses. Cd4(Cre)Ldha(fl/fl) mice were resistant to Th17-cell-mediated experimental autoimmune encephalomyelitis and exhibited defective T cell activation, migration, proliferation, and differentiation. LDHA deficiency crippled cellular redox balance and inhibited ATP production, diminishing PI3K-dependent activation of Akt kinase and thereby phosphorylation-mediated inhibition of Foxo1, a transcriptional repressor of T cell activation programs. Th17-cell-specific expression of an Akt-insensitive Foxo1 recapitulated the defects seen in Cd4(Cre)Ldha(fl/fl) mice. Induction of LDHA required PI3K signaling and LDHA deficiency impaired PI3K-catalyzed PIP3 generation. Thus, Warburg metabolism augments glycolytic ATP production, fueling a PI3K-centered positive feedback regulatory circuit that drives effector T cell responses.	[Xu, Ke; Yin, Na; Peng, Min; Stamatiades, Efstathios G.; Shyu, Amy; Li, Peng; Zhang, Xian; Do, Mytrang H.; Capistrano, Kristelle J.; Chou, Chun; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA; [Xu, Ke; Do, Mytrang H.; Li, Ming O.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Grad Program, New York, NY 10065 USA; [Chhangawala, Sagar; Leslie, Christina S.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA; [Chhangawala, Sagar; Leslie, Christina S.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Physiol Biophys & Syst Biol Grad Program, New York, NY 10065 USA; [Shyu, Amy; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA; [Yin, Na; Peng, Min] Tsinghua Univ, Inst Immunol, Beijing 100084, Peoples R China; [Yin, Na; Peng, Min] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Memorial Sloan Kettering Cancer Center; Tsinghua University; Tsinghua University	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, New York, NY 10065 USA.; Li, MO (corresponding author), Cornell Univ, Weill Cornell Grad Sch Med Sci, Immunol & Microbial Pathogenesis Grad Program, New York, NY 10065 USA.; Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, New York, NY 10065 USA.	lim@mskcc.org	; Peng, Min/O-3770-2017	Stamatiades, Efstathios/0000-0002-2785-9005; Peng, Min/0000-0002-5885-0660; Xu, Ke/0000-0002-6707-1052; Zhang, Xian/0000-0001-9674-7886	National Institutes of Health [R01 AI 102888]; Howard Hughes Medical Institute (Faculty Scholar Award); Memorial Sloan Kettering Cancer Center Support Grant/Core Grant [P30 CA08748]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (Faculty Scholar Award); Memorial Sloan Kettering Cancer Center Support Grant/Core Grant	The authors thank members of the Li laboratory and Morgan Huse for helpful discussions. This work was supported by the National Institutes of Health (R01 AI 102888 to M.O.L.), the Howard Hughes Medical Institute (Faculty Scholar Award to M.O.L.), and the Memorial Sloan Kettering Cancer Center Support Grant/Core Grant (P30 CA08748).	ALEXANDER DR, 1989, BIOCHEM J, V260, P893, DOI 10.1042/bj2600893; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Andrews S., 2010, FASTQC QUALITY CONTR; Bantug GR, 2018, NAT REV IMMUNOL, V18, P19, DOI 10.1038/nri.2017.99; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Cham CM, 2005, J IMMUNOL, V174, P4670, DOI 10.4049/jimmunol.174.8.4670; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Goncalves MD, 2018, NEW ENGL J MED, V379, P2052, DOI 10.1056/NEJMra1704560; Gottlob K, 2001, GENE DEV, V15, P1406, DOI 10.1101/gad.889901; GUPPY M, 1993, EUR J BIOCHEM, V212, P95, DOI 10.1111/j.1432-1033.1993.tb17637.x; Gutcher I, 2011, IMMUNITY, V34, P396, DOI 10.1016/j.immuni.2011.03.005; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Ho PC, 2015, CELL, V162, P1217, DOI 10.1016/j.cell.2015.08.012; Hu H, 2016, CELL, V164, P433, DOI 10.1016/j.cell.2015.12.042; HUME DA, 1978, BIOCHEM J, V174, P703, DOI 10.1042/bj1740703; Isakov N, 1996, J BIOL CHEM, V271, P15753, DOI 10.1074/jbc.271.26.15753; Jang S, 2016, NEURON, V90, P278, DOI 10.1016/j.neuron.2016.03.011; Johnson JA, 1996, CIRC RES, V79, P1086, DOI 10.1161/01.RES.79.6.1086; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Kerdiles YM, 2009, NAT IMMUNOL, V10, P176, DOI 10.1038/ni.1689; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lucas CL, 2016, NAT REV IMMUNOL, V16, P702, DOI 10.1038/nri.2016.93; Luo CT, 2016, NATURE, V529, P532, DOI 10.1038/nature16486; Ma EH, 2019, IMMUNITY, V51, P856, DOI 10.1016/j.immuni.2019.09.003; Macintyre AN, 2014, CELL METAB, V20, P61, DOI 10.1016/j.cmet.2014.05.004; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Nish SA, 2017, TRENDS CELL BIOL, V27, P946, DOI 10.1016/j.tcb.2017.07.005; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Okkenhaug K, 2006, J IMMUNOL, V177, P5122, DOI 10.4049/jimmunol.177.8.5122; Olenchock BA, 2017, IMMUNITY, V46, P703, DOI 10.1016/j.immuni.2017.04.013; Ouyang WM, 2012, NATURE, V491, P554, DOI 10.1038/nature11581; Ouyang WM, 2011, TRENDS IMMUNOL, V32, P26, DOI 10.1016/j.it.2010.10.005; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Peng M, 2016, SCIENCE, V354, P481, DOI 10.1126/science.aaf6284; Preite S, 2019, IMMUNOL REV, V291, P154, DOI 10.1111/imr.12790; Rathmell JC, 2003, MOL CELL BIOL, V23, P7315, DOI 10.1128/MCB.23.20.7315-7328.2003; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; SEGEL GB, 1981, BLOOD, V57, P894; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Somoza JR, 2015, J BIOL CHEM, V290, P8439, DOI 10.1074/jbc.M114.634683; Thompson CB, 2011, COLD SH Q B, V76, P23, DOI 10.1101/sqb.2012.76.010496; Toriyama K, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01122-w; Vander Heiden MG, 2001, MOL CELL BIOL, V21, P5899, DOI 10.1128/MCB.21.17.5899-5912.2001; Walev I, 2001, P NATL ACAD SCI USA, V98, P3185, DOI 10.1073/pnas.051429498; Wang RN, 2012, NAT IMMUNOL, V13, P907, DOI 10.1038/ni.2386; Wang RN, 2011, IMMUNITY, V35, P871, DOI 10.1016/j.immuni.2011.09.021; WARBURG O, 1958, Z NATURFORSCH PT B, V13, P515, DOI 10.1515/znb-1958-0806; Warburg O., 1925, J CANCER RES CLIN, V9, P148, DOI [10.1158/jcr.1925.148, DOI 10.1158/JCR.1925.148]; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498; Wu C, 2013, NATURE, V496, P513, DOI 10.1038/nature11984; Wu L, 2020, CELL, V182, P641, DOI 10.1016/j.cell.2020.06.014; Xu K, 2021, SCIENCE, V371, P405, DOI 10.1126/science.abb2683	64	11	11	4	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 11	2021	54	5					976	+		10.1016/j.immuni.2021.04.008	http://dx.doi.org/10.1016/j.immuni.2021.04.008		MAY 2021	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SE4BY	33979589	Bronze, Green Accepted			2022-12-18	WOS:000652019500014
J	Chen, XJ; Zhou, TQ; Schmidt, SD; Duan, HY; Cheng, C; Chuang, GY; Gu, Y; Louder, MK; Lin, BC; Shen, CH; Sheng, ZZ; Zheng, MX; Doria-Rose, NA; Joyce, MG; Shapiro, L; Tian, M; Alt, FW; Kwong, PD; Mascola, JR				Chen, Xuejun; Zhou, Tongqing; Schmidt, Stephen D.; Duan, Hongying; Cheng, Cheng; Chuang, Gwo-Yu; Gu, Ying; Louder, Mark K.; Lin, Bob C.; Shen, Chen-Hsiang; Sheng, Zizhang; Zheng, Michelle X.; Doria-Rose, Nicole A.; Joyce, M. Gordon; Shapiro, Lawrence; Tian, Ming; Alt, Frederick W.; Kwong, Peter D.; Mascola, John R.			Vaccination induces maturation in a mouse model of diverse unmutated VRC01-class precursors to HIV-neutralizing antibodies with > 50% breadth	IMMUNITY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; ANTI-HIV-1 ANTIBODIES; ENVELOPE; BINDING; BROAD; CD4; IG; SEQUENCE; POTENT; SITE	Vaccine elicitation of broadly neutralizing antibodies (bnAbs) is a key HIV-research goal. The VRC01 class of bnAbs targets the CD4-binding site on the HIV-envelope trimer and requires extensive somatic hypermutation (SHM) to neutralize effectively. Despite substantial progress, vaccine-induced VRC01-class antibodies starting from unmutated precursors have exhibited limited neutralization breadth, particularly against viruses bearing glycan on loop D residue N276 (glycan276), present on most circulating strains. Here, using sequential immunization of immunoglobulin (Ig)-humanized mice expressing diverse unmutated VRC01-class antibody precursors, we elicited serum responses capable of neutralizing viruses bearing glycan276 and isolated multiple lineages of VRC01-class bnAbs, including two with >50% breadth on a 208-strain panel. Crystal structures of representative bnAbs revealed the same mode of recognition as known VRC01-class bnAbs. Structure-function studies further pinpointed key mutations and correlated their induction with specific immunizations. VRC01-class bnAbs can thus be matured by sequential immunization from unmutated ancestors to >50% breadth, and we delineate immunogens and regimens inducing key SHM.	[Chen, Xuejun; Zhou, Tongqing; Schmidt, Stephen D.; Duan, Hongying; Cheng, Cheng; Chuang, Gwo-Yu; Gu, Ying; Louder, Mark K.; Lin, Bob C.; Shen, Chen-Hsiang; Zheng, Michelle X.; Doria-Rose, Nicole A.; Joyce, M. Gordon; Shapiro, Lawrence; Kwong, Peter D.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Sheng, Zizhang; Shapiro, Lawrence] Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA; [Joyce, M. Gordon] Walter Reed Army Inst Res, Ctr Infect Dis Res, Silver Spring, MD 20910 USA; [Shapiro, Lawrence; Kwong, Peter D.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA; [Tian, Ming; Alt, Frederick W.] Boston Childrens Hosp, Program Cellular & Mol Med, Howard Hughes Med Inst, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Columbia University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Columbia University; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Howard Hughes Medical Institute	Kwong, PD; Mascola, JR (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.; Kwong, PD (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.	pdkwong@nih.gov; jmascola@nih.go	Sheng, Zizhang/AFR-8049-2022	Sheng, Zizhang/0000-0002-3253-3309	Intramural Research Program of the Vaccine Research Center, NIAID, NIH; NIH [P01-AI104722]; NIAID, Division of AIDS, Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVI-ID) [5UM1 AI100645]; Bill and Melinda Gates Foundation [OPP1162123]; US Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]	Intramural Research Program of the Vaccine Research Center, NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID, Division of AIDS, Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVI-ID); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE))	We thank D. Ambrozak and R. Nguyen for assistance in single-cell sorting; C. Chiedi, M. Dillon, and S. Gloria for animal care and maintenance; the NISC Comparative Sequencing Program for NGS of B cell transcripts; members of the Structural Biology Section of the Vaccine Research Center for helpful discussions; and B. Hartman for help in manuscript submission. We thank J. Baalwa, D. Ellenberger, F. Gao, B. Hahn, K. Hong, J. Kim, F. McCutchan, D. Montefiori, L. Morris, E. Sanders-Buell, G. Shaw, R. Swanstrom, M. Thomson, S. Tovanabutra, C. Williamson, and L. Zhang for contributing the HIV-Env plasmids used in our neutralization panel. We thank C. Moore, C. Whittaker, J. Rathmann, G. Padilla, and A.B. McDermott for assistance with neutralization assessments on the 208-strain panel. Support for this work was provided by the Intramural Research Program of the Vaccine Research Center, NIAID, NIH; NIH grant P01-AI104722 (to L.S.); NIAID, Division of AIDS, Center for HIV/AIDS Vaccine Immunology-Immunogen Discovery (CHAVI-ID) grant 5UM1 AI100645 (to F.W.A.); and the Bill and Melinda Gates Foundation (OPP1162123 to T.Z.). Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the US Department of Energy, Basic Energy Sciences, Office of Science under contract number W-31-109-Eng-38. F.W.A. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2004, J SYNCHROTRON RADIAT, V11, P53, DOI 10.1107/S0909049503024130; Brochet X, 2008, NUCLEIC ACIDS RES, V36, pW503, DOI 10.1093/nar/gkn316; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Do Kwon Y, 2015, NAT STRUCT MOL BIOL, V22, P522, DOI 10.1038/nsmb.3051; Dosenovic P, 2015, CELL, V161, P1505, DOI 10.1016/j.cell.2015.06.003; Duan HY, 2018, IMMUNITY, V49, P301, DOI 10.1016/j.immuni.2018.07.005; Escolano A, 2016, CELL, V166, P1445, DOI 10.1016/j.cell.2016.07.030; Falkowska E, 2012, J VIROL, V86, P4394, DOI 10.1128/JVI.06973-11; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989; Giudicelli Veronique, 2011, Cold Spring Harb Protoc, V2011, P695, DOI 10.1101/pdb.prot5633; Guo YC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02365; Hessell AJ, 2016, NAT MED, V22, P362, DOI 10.1038/nm.4063; Huang JH, 2016, IMMUNITY, V45, P1108, DOI 10.1016/j.immuni.2016.10.027; Jardine J, 2013, SCIENCE, V340, P711, DOI 10.1126/science.1234150; Jardine JG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005815; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Jardine JG, 2015, SCIENCE, V349, P156, DOI 10.1126/science.aac5894; Joyce MG, 2017, CELL REP, V21, P2992, DOI 10.1016/j.celrep.2017.11.016; Kong L, 2016, IMMUNITY, V44, P939, DOI 10.1016/j.immuni.2016.03.006; Kong R, 2019, CELL, V178, P567, DOI 10.1016/j.cell.2019.06.030; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; McGuire AT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10618; McGuire AT, 2013, J EXP MED, V210, P655, DOI 10.1084/jem.20122824; Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2; Pancera M, 2014, NATURE, V514, P455, DOI 10.1038/nature13808; Pegu A, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008992; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Schramm CA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00372; Sheng ZZ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00537; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Sok D, 2016, IMMUNITY, V45, P31, DOI 10.1016/j.immuni.2016.06.026; Stewart-Jones GBE, 2016, CELL, V165, P813, DOI 10.1016/j.cell.2016.04.010; Tian M, 2016, CELL, V166, P1471, DOI 10.1016/j.cell.2016.07.029; Tiller T, 2009, J IMMUNOL METHODS, V350, P183, DOI 10.1016/j.jim.2009.08.009; Travers Simon A, 2012, ISRN AIDS, V2012, P823605, DOI 10.5402/2012/823605; Umotoy J, 2019, IMMUNITY, V51, P141, DOI 10.1016/j.immuni.2019.06.004; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Yacoob C, 2016, CELL REP, V17, P1560, DOI 10.1016/j.celrep.2016.10.017; Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007; Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	51	11	11	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 9	2021	54	2					324	+		10.1016/j.immuni.2020.12.014	http://dx.doi.org/10.1016/j.immuni.2020.12.014		FEB 2021	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QU6RE	33453152	Bronze, Green Accepted			2022-12-18	WOS:000627407700015
J	Kazer, SW; Walker, BD; Shalek, AK				Kazer, Samuel W.; Walker, Bruce D.; Shalek, Alex K.			Evolution and Diversity of Immune Responses during Acute HIV Infection	IMMUNITY			English	Review							INNATE LYMPHOID-CELLS; CD4(+) T-CELLS; BROADLY NEUTRALIZING ANTIBODIES; PLASMACYTOID DENDRITIC CELLS; SINGLE-CELL; ANTIRETROVIRAL THERAPY; MICROBIAL TRANSLOCATION; DISEASE PROGRESSION; EARLY INITIATION; CHROMATIN ACCESSIBILITY	Understanding the earliest immune responses following HIV infection is critical to inform future vaccines and therapeutics. Here, we review recent prospective human studies in at-risk populations that have provided insight into immune responses during acute infection, including additional relevant data from non-human primate (NHP) studies. We discuss the timing, nature, and function of the diverse immune responses induced, the onset of immune dysfunction, and the effects of early anti-retroviral therapy administration. Treatment at onset of viremia mitigates peripheral T and B cell dysfunction, limits seroconversion, and enhances cellular antiviral immunity despite persistence of infection in lymphoid tissues. We highlight pertinent areas for future investigation, and how application of high-throughput technologies, alongside targeted NHP studies, may elucidate immune response features to target in novel preventions and cures.	[Kazer, Samuel W.; Walker, Bruce D.; Shalek, Alex K.] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA; [Kazer, Samuel W.; Walker, Bruce D.; Shalek, Alex K.] MIT, Inst Med Engn & Sci IMES, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Kazer, Samuel W.; Shalek, Alex K.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Kazer, Samuel W.; Shalek, Alex K.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Walker, Bruce D.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Walker, Bruce D.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Shalek, Alex K.] MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Kwazulu Natal; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Kazer, SW; Walker, BD; Shalek, AK (corresponding author), Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA.; Kazer, SW; Walker, BD; Shalek, AK (corresponding author), MIT, Inst Med Engn & Sci IMES, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Kazer, SW; Shalek, AK (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.; Kazer, SW; Shalek, AK (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Walker, BD (corresponding author), Univ KwaZulu Natal, Nelson R Mandela Sch Med, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa.; Walker, BD (corresponding author), Howard Hughes Med Inst, Chevy Chase, MD 20815 USA.; Shalek, AK (corresponding author), MIT, Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	skazer@mit.edu; bwalker@mgh.harvard.edu; shalek@mit.edu		Shalek, Alex K./0000-0001-5670-8778	Beckman Young Investigator Program; Sloan Fellowship in Chemistry; NIH [5U24AI118672, 1R01AI138546, 1R01HL134539, 1R01DA046277, UM1AI100663, UM1AI144462, R37AI067073, R01A149704, R01A118574]; Bill and Melinda Gates Foundation; Richard and Lisa Witten Foundation; Hugh Hampton Young Memorial Fund Fellowship	Beckman Young Investigator Program; Sloan Fellowship in Chemistry; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Richard and Lisa Witten Foundation; Hugh Hampton Young Memorial Fund Fellowship	Wewould like to thank M. Carrington for her insight and suggestions. This work was supported in part by the Beckman Young Investigator Program, a Sloan Fellowship in Chemistry, the NIH (5U24AI118672, 1R01AI138546, 1R01HL134539, and 1R01DA046277), and the Bill and Melinda Gates Foundation to A.K.S.; the NIH (UM1AI100663, UM1AI144462, R37AI067073, R01A149704, and R01A118574), the Richard and Lisa Witten Foundation, and the Bill and Melinda Gates Foundation to B.D. W.; and the Hugh Hampton Young Memorial Fund Fellowship to S.W.K.	Abbott RK, 2018, IMMUNITY, V48, P133, DOI 10.1016/j.immuni.2017.11.023; Adams NM, 2016, J IMMUNOL, V197, P2963, DOI 10.4049/jimmunol.1600973; Allers K, 2016, MUCOSAL IMMUNOL, V9, P265, DOI 10.1038/mi.2015.58; Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Altfeld M, 2015, NAT IMMUNOL, V16, P554, DOI 10.1038/ni.3157; Ananworanich J, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21652; Ananworanich J, 2015, CURR OPIN HIV AIDS, V10, P198, DOI 10.1097/COH.0000000000000144; Ananworanich J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033948; Ardain A, 2019, NATURE, V570, P528, DOI 10.1038/s41586-019-1276-2; Arthos J, 2008, NAT IMMUNOL, V9, P301, DOI 10.1038/ni1566; Arts RJW, 2018, CELL HOST MICROBE, V23, P89, DOI 10.1016/j.chom.2017.12.010; Atkuri KR, 2015, DRUG METAB DISPOS, V43, P227, DOI 10.1124/dmd.114.060798; Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Baharlou H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02657; Baiyegunhi O, 2018, J VIROL, V92, DOI 10.1128/JVI.00659-18; Barouch DH, 2016, CELL, V165, P656, DOI 10.1016/j.cell.2016.03.021; Barouch DH, 2014, SCIENCE, V345, P169, DOI 10.1126/science.1255512; Bhatnagar N, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01189; Bordoni V, 2018, CYTOKINE, V103, P34, DOI 10.1016/j.cyto.2017.12.033; Borhis G, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00252; Borhis G, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01338; Borhis G, 2016, AIDS, V30, P365, DOI 10.1097/QAD.0000000000000965; Bosinger SE, 2015, CURR HIV-AIDS REP, V12, P41, DOI 10.1007/s11904-014-0244-6; Bosinger SE, 2012, CURR OPIN HIV AIDS, V7, P71, DOI 10.1097/COH.0b013e32834dde01; Branzk N, 2018, IMMUNOL REV, V286, P86, DOI 10.1111/imr.12718; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Buzon MJ, 2014, J VIROL, V88, P10056, DOI 10.1128/JVI.01046-14; Cantero-Perez J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12732-2; Cao JY, 2017, SCIENCE, V357, P661, DOI 10.1126/science.aam8940; Cao W, 2016, CLIN INFECT DIS, V62, P250, DOI 10.1093/cid/civ809; Carlson JM, 2015, TRENDS MICROBIOL, V23, P212, DOI 10.1016/j.tim.2014.12.008; Chappell L, 2018, ANNU REV GENOM HUM G, V19, P15, DOI 10.1146/annurev-genom-091416-035324; Chen P, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00272; Cheng L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.94366; Chevalier MF, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00395; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chung AW, 2017, RETROVIROLOGY, V14, DOI 10.1186/s12977-017-0380-3; Cogswell A, 2020, J VIROL, V94, DOI 10.1128/JVI.01914-19; Coindre S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01217; Colby DJ, 2018, NAT MED, V24, P923, DOI 10.1038/s41591-018-0026-6; Colomer-Lluch M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02876; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Corleis B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173161; Cosgrove C, 2013, BLOOD, V121, P951, DOI 10.1182/blood-2012-06-436436; Costa AI, 2015, J VIROL, V89, P110, DOI 10.1128/JVI.01765-14; Crowell TA, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.21163; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Dashti A, 2019, TRENDS MOL MED, V25, P228, DOI 10.1016/j.molmed.2019.01.007; Davey RT, 1999, P NATL ACAD SCI USA, V96, P15109, DOI 10.1073/pnas.96.26.15109; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Deleage C, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav7116; Deleage C, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.87065; Demers KR, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005805; Doitsh G, 2014, NATURE, V505, P509, DOI 10.1038/nature12940; Dong KL, 2018, LANCET HIV, V5, pE35, DOI 10.1016/S2352-3018(17)30146-7; dos Santos PR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019493; Du VY, 2016, J IMMUNOL, V196, P3276, DOI 10.4049/jimmunol.1502411; Ebbo M, 2017, NAT REV IMMUNOL, V17, P665, DOI 10.1038/nri.2017.86; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Einkauf KB, 2019, J CLIN INVEST, V129, P988, DOI 10.1172/JCI124291; Eller MA, 2016, J VIROL, V90, P4005, DOI 10.1128/JVI.02785-15; Estes JD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00423; Evans DT, 2013, CURR OPIN HIV AIDS, V8, P255, DOI 10.1097/COH.0b013e328361cee8; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Freel SA, 2012, J VIROL, V86, P6835, DOI 10.1128/JVI.00437-12; Fukazawa Y, 2015, NAT MED, V21, P132, DOI 10.1038/nm.3781; Garcia-Tellez T, 2016, INFECT GENET EVOL, V46, P324, DOI 10.1016/j.meegid.2016.07.012; George MD, 2005, J VIROL, V79, P2709, DOI 10.1128/JVI.79.5.2709-2719.2005; Gierahn TM, 2017, NAT METHODS, V14, P395, DOI 10.1038/nmeth.4179; Gonzalez SM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00144; Gorini G, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008377; Goulder PJR, 2012, IMMUNITY, V37, P426, DOI 10.1016/j.immuni.2012.09.005; Grainger JR, 2017, PFLUG ARCH EUR J PHY, V469, P527, DOI [10.1007/s00424-017-1958, 10.1007/s00424-017-1958-2]; Guilliams M, 2020, IMMUNITY, V52, P434, DOI 10.1016/j.immuni.2020.02.015; Haase AT, 2011, ANNU REV MED, V62, P127, DOI 10.1146/annurev-med-080709-124959; HAN DG, 2020, SCI TRANSL MED, V15, DOI DOI 10.1007/S43037-020-00086-7; Han XP, 2018, CELL, V172, P1091, DOI 10.1016/j.cell.2018.02.001; Hargreaves J, 2020, LANCET HIV, V7, pE309, DOI 10.1016/S2352-3018(20)30110-7; Hartmann FJ, 2020, NAT REV RHEUMATOL, V16, P87, DOI 10.1038/s41584-019-0338-z; Hellmuth J, 2019, J INFECT DIS, V220, P1885, DOI 10.1093/infdis/jiz030; Henrich TJ, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002417; Heung LJ, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007627; Hong JJ, 2017, AIDS, V31, P1819, DOI 10.1097/QAD.0000000000001576; Hueber B, 2020, J VIROL, V94, DOI 10.1128/JVI.01644-19; Hughes D, 2015, NAT REV GENET, V16, P459, DOI 10.1038/nrg3922; Iwasaki A, 2015, NAT IMMUNOL, V16, P343, DOI 10.1038/ni.3123; Jiao YM, 2012, VIRAL IMMUNOL, V25, P333, DOI 10.1089/vim.2012.0011; Johnson JS, 2018, CELL HOST MICROBE, V23, P366, DOI 10.1016/j.chom.2018.01.012; Juno JA, 2019, CLIN TRANSL IMMUNOL, V8, DOI 10.1002/cti2.1069; Kardava L, 2014, J CLIN INVEST, V124, P3252, DOI 10.1172/JCI74351; Katsikis PD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002055; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Kaya-Okur HS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09982-5; Kazer SW, 2020, NAT MED, V26, P511, DOI 10.1038/s41591-020-0799-2; Keating SM, 2016, J VIROL, V90, P10339, DOI 10.1128/JVI.01061-16; Kessing CF, 2017, JAIDS-J ACQ IMM DEF, V75, P108, DOI 10.1097/qai.0000000000001301; Klase Z, 2015, MUCOSAL IMMUNOL, V8, P1009, DOI 10.1038/mi.2014.128; Klatt NR, 2010, MUCOSAL IMMUNOL, V3, P387, DOI 10.1038/mi.2010.14; Kloverpris HN, 2016, IMMUNITY, V44, P391, DOI 10.1016/j.immuni.2016.01.006; Knox JJ, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92943; Kok A, 2015, MUCOSAL IMMUNOL, V8, P127, DOI 10.1038/mi.2014.50; Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001; Lal KG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13975-9; Lavin Y, 2015, NAT REV IMMUNOL, V15, P731, DOI 10.1038/nri3920; Leyre L, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aav3491; Li HY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004551; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Li SB, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007311; Liechti T, 2019, J EXP MED, V216, P2071, DOI 10.1084/jem.20181124; Lindqvist M, 2012, J CLIN INVEST, V122, P3271, DOI 10.1172/JCI64314; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Liu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089236; Liu LF, 2019, BMC IMMUNOL, V20, DOI 10.1186/s12865-019-0319-7; Lu WX, 2016, J VIROL, V90, P1080, DOI 10.1128/JVI.02297-15; Lu WX, 2014, VIROLOGY, V464, P406, DOI 10.1016/j.virol.2014.07.010; Lu XF, 2016, CELL MOL IMMUNOL, V13, P776, DOI 10.1038/cmi.2015.60; Mabuka JM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01104; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Maenetje P, 2010, J IMMUNOL, V184, P4926, DOI 10.4049/jimmunol.0903771; Manak MM, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00757-19; Manganaro L, 2018, P NATL ACAD SCI USA, V115, pE9659, DOI 10.1073/pnas.1806695115; Martin-Gayo E, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1385-x; Martin-Gayo E, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004930; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; McGary CS, 2017, IMMUNITY, V47, P776, DOI 10.1016/j.immuni.2017.09.018; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; McManus WR, 2019, J CLIN INVEST, V129, P4529, DOI 10.1172/JCI126714; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Meyer-Olson D, 2010, BLOOD, V116, P396, DOI 10.1182/blood-2009-11-254136; Michlmayr D, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107569; Mitchell JL, 2020, J CLIN INVEST, V130, P2845, DOI 10.1172/JCI130597; Moir S, 2010, BLOOD, V116, P5571, DOI 10.1182/blood-2010-05-285528; Muema DM, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01529-6; Muir R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005777; Naranbhai V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053251; Ndhlovu ZM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau0528; Ndhlovu ZM, 2015, IMMUNITY, V43, P591, DOI 10.1016/j.immuni.2015.08.012; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; O'Brien M, 2013, ADV EXP MED BIOL, V762, P71, DOI 10.1007/978-1-4614-4433-6_3; Okumura R, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.20; Ordovas-Montanes J, 2020, NAT REV IMMUNOL, V20, P308, DOI 10.1038/s41577-019-0263-z; Pantazi E, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00676; Petrovas C, 2007, BLOOD, V110, P928, DOI 10.1182/blood-2007-01-069112; Petrovas C, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag2285; Planchais C, 2018, J IMMUNOL, V200, P3519, DOI 10.4049/jimmunol.1701615; Policicchio BB, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00012; Price DA, 2009, J EXP MED, V206, P923, DOI 10.1084/jem.20081127; Pusnik J, 2019, J VIROL, V93, DOI 10.1128/JVI.00377-19; Rabezanahary H, 2020, MUCOSAL IMMUNOL, V13, P149, DOI 10.1038/s41385-019-0221-x; Raehtz KD, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008333; Rahman MA, 2019, J IMMUNOL, V203, P2459, DOI 10.4049/jimmunol.1900572; Redd AD, 2009, P NATL ACAD SCI USA, V106, P6718, DOI 10.1073/pnas.0901983106; Reeves RK, 2015, NAT IMMUNOL, V16, P927, DOI 10.1038/ni.3227; Robb ML, 2016, CURR OPIN HIV AIDS, V11, P555, DOI 10.1097/COH.0000000000000316; Robb ML, 2016, NEW ENGL J MED, V374, P2120, DOI 10.1056/NEJMoa1508952; Roider J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01975; Rosenberg AB, 2018, SCIENCE, V360, P176, DOI 10.1126/science.aam8999; Rozenblatt-Rosen O, 2020, CELL, V181, P236, DOI 10.1016/j.cell.2020.03.053; Sadanand S, 2016, ANNU REV MED, V67, P185, DOI 10.1146/annurev-med-091014-090749; Saez-Cirion A, 2011, BLOOD, V118, P955, DOI 10.1182/blood-2010-12-327106; Sannier G, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00297; Schieffer M, 2014, J VIROL, V88, P7357, DOI 10.1128/JVI.00728-14; Schuetz A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004543; Seay K, 2015, J VIROL, V89, P6264, DOI 10.1128/JVI.00563-15; Sereti I, 2017, CLIN INFECT DIS, V64, P124, DOI 10.1093/cid/ciw683; Shah SV, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01818; Shalek AK, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan4730; Shang L, 2014, J IMMUNOL, V193, P277, DOI 10.4049/jimmunol.1400417; Shema E, 2019, NAT GENET, V51, P19, DOI 10.1038/s41588-018-0290-x; Sivro A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam6354; Skene PJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21856; Slyper M, 2020, NAT MED, V26, P792, DOI 10.1038/s41591-020-0844-1; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Somsouk M, 2015, AIDS, V29, P43, DOI 10.1097/QAD.0000000000000511; Soper A, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01823; Stacey AR, 2009, J VIROL, V83, P3719, DOI 10.1128/JVI.01844-08; Starke CE, 2020, J CLIN INVEST, V130, P789, DOI 10.1172/JCI129161; Stehle C, 2018, IMMUNOL REV, V286, P102, DOI 10.1111/imr.12712; Stephenson KE, 2018, CURR OPIN HIV AIDS, V13, P408, DOI 10.1097/COH.0000000000000491; Strauss-Albee DM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5722; Streeck H, 2014, J VIROL, V88, P12793, DOI 10.1128/JVI.02016-14; Stubbington MJT, 2017, SCIENCE, V358, P58, DOI 10.1126/science.aan6828; Sun T, 2020, J IMMUNOL, V204, P1075, DOI 10.4049/jimmunol.1900710; Swan ZD, 2017, EUR J IMMUNOL, V47, P1925, DOI 10.1002/eji.201646904; Takata H, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aag1809; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Tovanabutra S., 2019, CELLS, V8, P8; Trautmann L, 2012, BLOOD, V120, P3466, DOI 10.1182/blood-2012-04-422550; Tu AA, 2019, NAT IMMUNOL, V20, P1692, DOI 10.1038/s41590-019-0544-5; Verhoeven D, 2008, J VIROL, V82, P4016, DOI 10.1128/JVI.02164-07; Walker BD, 2013, NAT REV IMMUNOL, V13, P487, DOI 10.1038/nri3478; Walker WE, 2015, J VIROL, V89, P5502, DOI 10.1128/JVI.00118-15; Wang BW, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01431; Wang Q, 2020, FRONT MED-PRC, V14, P30, DOI 10.1007/s11684-019-0721-9; Wang YT, 2020, NAT IMMUNOL, V21, P274, DOI 10.1038/s41590-020-0593-9; Whitney JB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07881-9; Whitney JB, 2014, NATURE, V512, P74, DOI 10.1038/nature13594; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xia H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00616; Yero A, 2019, J VIROL, V93, DOI 10.1128/JVI.00371-19; Youngblood B, 2012, CURR OPIN HIV AIDS, V7, P50, DOI 10.1097/COH.0b013e32834ddcf2; Yue FY, 2008, J VIROL, V82, P6767, DOI 10.1128/JVI.02550-07; Yue FY, 2017, J VIROL, V91, DOI 10.1128/JVI.02233-16; Zhen A, 2017, J CLIN INVEST, V127, P260, DOI 10.1172/JCI89488; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	208	11	12	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 17	2020	53	5					908	924		10.1016/j.immuni.2020.10.015	http://dx.doi.org/10.1016/j.immuni.2020.10.015			17	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PF9ED	33207216	Green Accepted, hybrid, Green Published			2022-12-18	WOS:000599348200006
J	Ireland, AS; Oliver, TG				Ireland, Abbie S.; Oliver, Trudy G.			Neutrophils Create an ImpeNETrable Shield between Tumor and Cytotoxic Immune Cells	IMMUNITY			English	Editorial Material							EXTRACELLULAR TRAPS	Neutrophil extracellular traps (NETs) can promote tumor growth and metastases, but whether NETs impact the tumor immune microenvironment remains underexplored. In this issue of Immunity, Teijeira et al. discover that NETs shield tumor cells from cytotoxic immune cells, resulting in impaired tumor clearance.	[Ireland, Abbie S.; Oliver, Trudy G.] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Oliver, TG (corresponding author), Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT 84112 USA.	trudy.oliver@hci.utah.edu			NCI NIH HHS [R01 CA244841] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albrengues J, 2018, SCIENCE, V361, P1353, DOI 10.1126/science.aao4227; Ali RA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09801-x; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Cedervall J, 2016, CANCER RES, V76, P4311, DOI 10.1158/0008-5472.CAN-15-3051; Cools-Lartigue J, 2013, J CLIN INVEST, V123, P3446, DOI 10.1172/JCI67484; Demers M, 2012, P NATL ACAD SCI USA, V109, P13076, DOI 10.1073/pnas.1200419109; Kim K, 2014, P NATL ACAD SCI USA, V111, P11774, DOI 10.1073/pnas.1410626111; Papayannopoulos V, 2018, NAT REV IMMUNOL, V18, P134, DOI 10.1038/nri.2017.105; Teijeira A, 2020, IMMUNITY, V52, P856, DOI 10.1016/j.immuni.2020.03.001; Yazdani HO, 2019, CANCER RES, V79, P5626, DOI 10.1158/0008-5472.CAN-19-0800	10	11	11	3	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					729	731		10.1016/j.immuni.2020.04.009	http://dx.doi.org/10.1016/j.immuni.2020.04.009			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32433945	Green Accepted, Bronze			2022-12-18	WOS:000535371100005
J	Kohanim, YK; Tendler, A; Mayo, A; Friedman, N; Alon, U				Kohanim, Yael Korem; Tendler, Avichai; Mayo, Avi; Friedman, Nir; Alon, Uri			Endocrine Autoimmune Disease as a Fragility of Immune Surveillance against Hypersecreting Mutants	IMMUNITY			English	Article							REACTIVE T-CELLS; IN-VIVO; THYROID-NODULES; FREE-THYROXINE; PITUITARY; PROLIFERATION; RECEPTOR; VITILIGO; LYMPHOCYTES; PREVALENCE	Some endocrine organs are frequent targets of autoimmune attack. Here, we addressed the origin of autoimmune disease from the viewpoint of feedback control. Endocrine tissues maintain mass through feedback loops that balance cell proliferation and removal according to hormone-driven regulatory signals. We hypothesized the existence of a dedicated mechanism that detects and removes mutant cells that missense the signal and therefore hyperproliferate and hypersecrete with potential to disrupt organismal homeostasis. In this mechanism, hypersecreting cells are preferentially eliminated by autoreactive T cells at the cost of a fragility to autoimmune disease. The "autoimmune surveillance of hypersecreting mutants'' (ASHM) hypothesis predicts the presence of autoreactive T cells in healthy individuals and the nature of self-antigens as peptides from hormone secretion pathway. It explains why some tissues get prevalent autoimmune disease, whereas others do not and instead show prevalent mutant-expansion disease (e.g., hyperparathyroidism). The ASHM hypothesis is testable, and we discuss experimental follow-up.	[Kohanim, Yael Korem; Tendler, Avichai; Mayo, Avi; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Friedman, Nir] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	uri.alon@weizmann.ac.il			STORMing Cancer by a CRUK Grand Challenge grant; Israel Academy of Sciences and Humanities	STORMing Cancer by a CRUK Grand Challenge grant; Israel Academy of Sciences and Humanities	We thank Ruslan M. Medzhitov, Johannes W. Dietrich, Shalev Itzkovitz, Jakub Abramson, Carmit Levy, Gregoire Altan-Bonnet, Yuval Dor, and our group members for discussions. U.A. is the incumbent of the Abisch-Frenkel Professorial Chair. This work was supported by funding of the STORMing Cancer team by a CRUK Grand Challenge grant. Y.K.K. is supported by the Adams Fellowship Program of the Israel Academy of Sciences and Humanities.	ADAMI S, 2002, J BONE MINER RES S2, V17; Afroze S, 2013, ANN TRANSL MED, V1, DOI 10.3978/j.issn.2305-5839.2012.12.01; Aleksic M, 2010, IMMUNITY, V32, P163, DOI 10.1016/j.immuni.2009.11.013; Amar AP, 2003, NEUROSURG CLIN N AM, V14, P11, DOI 10.1016/S1042-3680(02)00017-7; Arase H, 2017, J IMMUNOL, V198; Arias CF, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150016; Arnoux JB, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-63; Bagaev DV, 2020, NUCLEIC ACIDS RES, V48, pD1057, DOI 10.1093/nar/gkz874; Berberich J, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00091; BROOKS MH, 1980, ANN INTERN MED, V93, P694, DOI 10.7326/0003-4819-93-5-694; Buffa L, 2008, EUR J CELL BIOL, V87, P197, DOI 10.1016/j.ejcb.2007.11.003; Burgi H, 1998, LANCET, V352, P1034, DOI 10.1016/S0140-6736(05)60076-1; Byrne KT, 2011, ONCOTARGET, V2, P684; BYSTRYN JC, 1987, ARCH DERMATOL, V123, P1053, DOI 10.1001/archderm.123.8.1053; Cai T, 2011, DIABETOLOGIA, V54, P2347, DOI 10.1007/s00125-011-2221-6; Camacho-Hubner C., 2000, NORMAL PHYSL GROWTH; Cao YH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8038; Caspi RR, 2008, NAT REV IMMUNOL, V8, P970, DOI 10.1038/nri2438; Castinetti F, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-41; Caturegli P, 2008, AUTOIMMUN REV, V7, P631, DOI 10.1016/j.autrev.2008.04.016; CHAKRABORTY A, 1995, J INVEST DERMATOL, V105, P655, DOI 10.1111/1523-1747.ep12324134; Chakraborty AK, 1999, ANN NY ACAD SCI, V885, P100; Charoensri S, 2017, CLIN CASE REP, V5, P1706, DOI 10.1002/ccr3.1131; Chervin AS, 2009, J IMMUNOL, V183, P1166, DOI 10.4049/jimmunol.0900054; Chimienti F, 2006, J CELL SCI, V119, P4199, DOI 10.1242/jcs.03164; Chistiakov Dimitry A, 2005, J Autoimmune Dis, V2, P1, DOI 10.1186/1740-2557-2-1; Codina-Busqueta E, 2011, J IMMUNOL, V186, P3787, DOI 10.4049/jimmunol.1002423; Cohen IR, 2004, TENDING ADAMS GARDEN; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Cooper GS, 2003, AUTOIMMUN REV, V2, P119, DOI 10.1016/S1568-9972(03)00006-5; Cryer PE, 2007, J CLIN INVEST, V117, P868, DOI 10.1172/JCI31669; Culina S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao4013; Cusick MF, 2012, CLIN REV ALLERG IMMU, V42, P102, DOI [10.1007/s12016-011-8294-7, 10.1007/s12016-011-8293-8]; Davidson HW, 2014, TRENDS ENDOCRIN MET, V25, P415, DOI 10.1016/j.tem.2014.03.008; Dietrich JW, 2012, J THROID RES, V2012, DOI 10.1155/2012/351864; Dockray GJ, 1999, J PHYSIOL-LONDON, V518, P315, DOI 10.1111/j.1469-7793.1999.0315p.x; Doi A, 2006, P NATL ACAD SCI USA, V103, P885, DOI 10.1073/pnas.0502470102; Doyle HA, 2001, TRENDS IMMUNOL, V22, P443, DOI 10.1016/S1471-4906(01)01976-7; Driessche F.V., 2018, MANAGEMENT ISSUES VI, P427; DUMONT JE, 1992, PHYSIOL REV, V72, P667, DOI 10.1152/physrev.1992.72.3.667; Emerson RO, 2017, NAT GENET, V49, P659, DOI 10.1038/ng.3822; Ezzat S, 2004, CANCER-AM CANCER SOC, V101, P613, DOI 10.1002/cncr.20412; Farack L, 2019, DEV CELL, V48, P115, DOI 10.1016/j.devcel.2018.11.001; Feng AL, 2017, DIABETOLOGIA, V60, P1033, DOI 10.1007/s00125-017-4239-x; Franklyn JA, 2012, LANCET, V379, P1155, DOI 10.1016/S0140-6736(11)60782-4; Fryar Cheryl D, 2017, NCHS Data Brief, P1; Gadhamsetty S, 2017, BIOPHYS J, V112, P1221, DOI 10.1016/j.bpj.2017.02.008; Garzilli I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29084-4; GERTZ BJ, 1987, ENDOCRINOLOGY, V120, P381, DOI 10.1210/endo-120-1-381; Glaser B, 1998, NEW ENGL J MED, V338, P226, DOI 10.1056/NEJM199801223380404; Gomez-Tourino I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01925-2; GREENSPAN FS, 1974, WESTERN J MED, V121, P359; GROSSMAN Z, 1992, P NATL ACAD SCI USA, V89, P10365, DOI 10.1073/pnas.89.21.10365; HAAB F, 1995, J UROLOGY, V153, P1781, DOI 10.1016/S0022-5347(01)67304-X; Hafler DA, 1999, J CLIN INVEST, V104, P527, DOI 10.1172/JCI8193; Halle S, 2016, IMMUNITY, V44, P233, DOI 10.1016/j.immuni.2016.01.010; Harashima S, 2012, J DIABETES INVEST, V3, P52, DOI 10.1111/j.2040-1124.2011.00138.x; Harrison-Bernard LM, 2009, ADV PHYSIOL EDUC, V33, P270, DOI 10.1152/advan.00049.2009; Henrickson SE, 2008, NAT IMMUNOL, V9, P282, DOI 10.1038/ni1559; Hewagama A, 2009, J AUTOIMMUN, V33, P3, DOI 10.1016/j.jaut.2009.03.007; Hoeflich A, 2009, J MOL ENDOCRINOL, V42, P191, DOI 10.1677/JME-08-0160; Hoermann R, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00142; Hoermann R, 2010, EUR J ENDOCRINOL, V162, P1123, DOI 10.1530/EJE-10-0106; Hogquist KA, 2014, NAT IMMUNOL, V15, P815, DOI 10.1038/ni.2938; Holler PD, 2003, IMMUNITY, V18, P255, DOI 10.1016/S1074-7613(03)00019-0; Holzapfel HP, 2002, EUR J ENDOCRINOL, V147, P109, DOI 10.1530/eje.0.1470109; Howlett TA, 2010, CLIN ENDOCRINOL, V73, P18, DOI 10.1111/j.1365-2265.2009.03765.x; Huang J, 2013, IMMUNITY, V39, P846, DOI 10.1016/j.immuni.2013.08.036; Iosco C, 2010, ATLAS GENET CYTOGENE, V14, P846, DOI [10.4267/2042/44845, DOI 10.4267/2042/44845]; James C, 2009, J MED GENET, V46, P289, DOI 10.1136/jmg.2008.064337; Kadekaro AL, 2003, ANN NY ACAD SCI, V994, P359, DOI 10.1111/j.1749-6632.2003.tb03200.x; Karin O, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20177599; Karin O, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20167216; Keenan HA, 2010, DIABETES, V59, P2846, DOI 10.2337/db10-0676; Khailaie S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00474; Kracht MJL, 2017, NAT MED, V23, P501, DOI 10.1038/nm.4289; Kracht MJL, 2016, TRENDS ENDOCRIN MET, V27, P353, DOI 10.1016/j.tem.2016.03.013; Kruger C, 2012, INT J DERMATOL, V51, P1206, DOI 10.1111/j.1365-4632.2011.05377.x; Kulnigg-Dabsch S, 2016, WIEN MED WOCHENSCHR, V166, P424, DOI 10.1007/s10354-016-0515-5; Kung AWC, 2002, J CLIN ENDOCR METAB, V87, P1010, DOI 10.1210/jc.87.3.1010; Kuroda N, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-80; Lai XL, 2018, CHEM-EUR J, V24, P47, DOI 10.1002/chem.201704410; Lever M, 2016, P NATL ACAD SCI USA, V113, pE6630, DOI 10.1073/pnas.1608820113; Levitt HE, 2011, DIABETOLOGIA, V54, P572, DOI 10.1007/s00125-010-1919-1; Li LP, 2010, NAT MED, V16, P1029, DOI 10.1038/nm.2197; Liu EH, 2009, DIABETOLOGIA, V52, P1369, DOI 10.1007/s00125-009-1342-7; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Liu Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016096; Lleo A, 2014, SEMIN LIVER DIS, V34, P273, DOI 10.1055/s-0034-1383727; Madi A, 2014, GENOME RES, V24, P1603, DOI 10.1101/gr.170753.113; Martin-Blanco N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05050-6; Matschinsky FM, 2002, DIABETES, V51, pS394, DOI 10.2337/diabetes.51.2007.S394; MATSUOKA N, 1994, J IMMUNOL, V152, P2562; MCCOMB DJ, 1983, ARCH PATHOL LAB MED, V107, P488; MCLAUCHLAN G, 1989, GUT, V30, P573, DOI 10.1136/gut.30.5.573; Michels AW, 2010, J ALLERGY CLIN IMMUN, V125, pS226, DOI 10.1016/j.jaci.2009.09.053; Milholland B, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15183; Minalyan A, 2017, CLIN EXP GASTROENTER, V10, P19, DOI 10.2147/CEG.S109123; MINDERMANN T, 1994, CLIN ENDOCRINOL, V41, P359, DOI 10.1111/j.1365-2265.1994.tb02557.x; Munshi MK, 2011, AM J PATHOL, V178, P472, DOI 10.1016/j.ajpath.2010.09.043; Navar LG, 1998, NEWS PHYSIOL SCI, V13, P170; Neville A.M., 2012, HUMAN ADRENAL CORTEX; Nolan LA, 1998, J NEUROENDOCRINOL, V10, P207, DOI 10.1046/j.1365-2826.1998.00191.x; NORDLUND JJ, 1983, J AM ACAD DERMATOL, V9, P689, DOI 10.1016/S0190-9622(83)70182-9; OTA K, 1990, NATURE, V346, P183, DOI 10.1038/346183a0; OWEN RA, 1995, TOXICOL PATHOL, V23, P606, DOI 10.1177/019262339502300319; Papadimitriou A, 2009, NEUROIMMUNOMODULAT, V16, P265, DOI 10.1159/000216184; Pizzorno J.E., 2016, CLIN HDB NATURAL MED, P779, DOI DOI 10.1016/B978-0-7020-5514-0.00072-5; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; Pradeu T, 2013, NAT REV IMMUNOL, V13, P764, DOI 10.1038/nri3521; Raposo G, 2007, NAT REV MOL CELL BIO, V8, P786, DOI 10.1038/nrm2258; Ray JP, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0182-y; Richards DM, 2016, TRENDS IMMUNOL, V37, P114, DOI 10.1016/j.it.2015.12.005; Richmond JM, 2013, CURR OPIN IMMUNOL, V25, P676, DOI 10.1016/j.coi.2013.10.010; Rivas M, 2003, MOL CELL ENDOCRINOL, V213, P31, DOI 10.1016/j.mce.2003.10.029; Roep BO, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007781; Rousseaux CG., 2017, FUNDAMENTALS TOXICOL, V3rd ed; Ruf J, 2006, ARCH BIOCHEM BIOPHYS, V445, P269, DOI 10.1016/j.abb.2005.06.023; Rui JX, 2017, CELL METAB, V25, P727, DOI 10.1016/j.cmet.2017.01.005; Saeki K, 2002, DIABETES, V51, P1842, DOI 10.2337/diabetes.51.6.1842; Schwartz M, 2000, IMMUNOL TODAY, V21, P265, DOI 10.1016/S0167-5699(00)01633-9; Schwartz M, 2014, NEUROSCIENTIST, V20, P343, DOI 10.1177/1073858413516799; Semana G, 1999, J AUTOIMMUN, V12, P259, DOI 10.1006/jaut.1999.0282; SERVICE FJ, 1991, MAYO CLIN PROC, V66, P711, DOI 10.1016/S0025-6196(12)62083-7; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Smith Sean M, 2006, Dialogues Clin Neurosci, V8, P383; Sontag ED, 2017, CELL SYST, V4, P231, DOI 10.1016/j.cels.2016.12.003; Stagnaro-Green A, 2002, J CLIN ENDOCR METAB, V87, P4042, DOI 10.1210/jc.2002-020524; STAGNAROGREEN A, 1992, J CLIN ENDOCR METAB, V74, P645, DOI 10.1210/jc.74.3.645; Stamateris RE, 2016, DIABETES, V65, P981, DOI 10.2337/db15-0529; Stearns S. C., 2016, EVOLUTIONARY MED; Steele T, 2013, CRIT CARE, V17, DOI 10.1186/cc12756; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Thompson PJ, 2019, CELL METAB, V29, P1045, DOI 10.1016/j.cmet.2019.01.021; Tickotsky N, 2017, BIOINFORMATICS, V33, P2924, DOI 10.1093/bioinformatics/btx286; Tischer DK, 2019, ELIFE, V8, DOI 10.7554/eLife.42498; Trautmann L, 2002, EUR J IMMUNOL, V32, P3181, DOI 10.1002/1521-4141(200211)32:11<3181::AID-IMMU3181>3.0.CO;2-2; TURGEON C, 1961, AM J PATHOL, V38, P227; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Voisinne G, 2015, CELL REP, V11, P1208, DOI 10.1016/j.celrep.2015.04.051; Weisberg SP, 2019, CELL REP, V29, P3916, DOI 10.1016/j.celrep.2019.11.056; Westerberg DP, 2013, AM FAM PHYSICIAN, V87, P337; WUCHERPFENNIG KW, 1994, J IMMUNOL, V152, P5581; Xing Y, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006957; Yano S, 2000, KIDNEY INT, V58, P1980, DOI 10.1046/j.1523-1755.2000.00370.x; Yeh MW, 2013, J CLIN ENDOCR METAB, V98, P1122, DOI 10.1210/jc.2012-4022; Yu W, 2015, IMMUNITY, V42, P929, DOI 10.1016/j.immuni.2015.05.001; Zarour H, 1996, J INVEST DERMATOL, V107, P63, DOI 10.1111/1523-1747.ep12298177	150	11	11	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 19	2020	52	5					872	+		10.1016/j.immuni.2020.04.022	http://dx.doi.org/10.1016/j.immuni.2020.04.022			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR0EZ	32433950	Green Published, Green Submitted, hybrid			2022-12-18	WOS:000535371100018
J	Jenks, SA; Cashman, KS; Zumaquero, E; Marigorta, UM; Patel, AV; Wang, XQ; Tomar, D; Woodruff, MC; Simon, Z; Bugrovsky, R; Blalock, EL; Scharer, CD; Tipton, CM; Wei, CW; Lim, SS; Petri, M; Niewold, TB; Anolik, JH; Gibson, G; Lee, FEH; Boss, JM; Lund, FE; Sanz, I				Jenks, Scott A.; Cashman, Kevin S.; Zumaquero, Esther; Marigorta, Urko M.; Patel, Aakash V.; Wang, Xiaoqian; Tomar, Deepak; Woodruff, Matthew C.; Simon, Zoe; Bugrovsky, Regina; Blalock, Emily L.; Scharer, Christopher D.; Tipton, Christopher M.; Wei, Chungwen; Lim, S. Sam; Petri, Michelle; Niewold, Timothy B.; Anolik, Jennifer H.; Gibson, Greg; Lee, F. Eun-Hyung; Boss, Jeremy M.; Lund, Frances E.; Sanz, Ignacio			Distinct Effector B Cells Induced by Unregulated Toll-like Receptor 7 Contribute to Pathogenic Responses in Systemic Lupus Erythematosus (vol 49, pg 725.e1, 2018)	IMMUNITY			English	Correction												ignacio.sanz@emory.edu	Tomar, Deepak/X-6124-2019; Marigorta, Urko M/L-9512-2014	Blalock, Emily/0000-0001-9978-1000; Marigorta, Urko M/0000-0002-9087-6609	NIAID NIH HHS [U19 AI110483, R37 AI049660, N01 AI50029, P01 AI125180, P01 AI078907] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015	1	11	13	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 14	2020	52	1					203	203		10.1016/j.immuni.2019.12.005	http://dx.doi.org/10.1016/j.immuni.2019.12.005			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KC7WX	31940271	Bronze, Green Accepted			2022-12-18	WOS:000507384600020
J	Perry, JSA; Russler-Germain, EV; Zhou, YW; Purtha, W; Cooper, ML; Choi, J; Schroeder, MA; Salazar, V; Egawa, T; Lee, BC; Abumrad, NA; Kim, BS; Anderson, MS; DiPersio, JF; Hsieh, CS				Perry, Justin S. A.; Russler-Germain, Emilie V.; Zhou, You W.; Purtha, Whitney; Cooper, Matthew L.; Choi, Jaebok; Schroeder, Mark A.; Salazar, Vanessa; Egawa, Takeshi; Lee, Byeong-Chel; Abumrad, Nada A.; Kim, Brian S.; Anderson, Mark S.; DiPersio, John F.; Hsieh, Chyi-Song			Transfer of Cell-Surface Antigens by Scavenger Receptor CD36 Promotes Thymic Regulatory T Cell Receptor Repertoire Development and Allo-tolerance (vol 48, pg 923, 2018)	IMMUNITY			English	Correction												chsieh@wustl.edu	Kim, Brian/GZK-6649-2022	Kim, Brian/0000-0002-8100-7161; Salazar, Vanessa/0000-0002-1947-6039; Choi, Jaebok/0000-0002-5590-087X	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI138479, R01AI079187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060022, P30DK056341, R01DK111175, R01DK033301] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI138479, R01 AI079187] Funding Source: Medline; NIDDK NIH HHS [R01 DK033301, P30 DK056341, R01 DK060022] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Perry JSA, 2018, IMMUNITY, V48, P923, DOI 10.1016/j.immuni.2018.04.007	1	11	11	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUN 19	2018	48	6					1271	1271		10.1016/j.immuni.2018.05.011	http://dx.doi.org/10.1016/j.immuni.2018.05.011			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK8GN	29924978	Green Accepted, Bronze			2022-12-18	WOS:000436456900024
J	Granucci, F				Granucci, Francesca			The Family of LPS Signal Transducers Increases: the Arrival of Chanzymes	IMMUNITY			English	Editorial Material							INNATE IMMUNE-RESPONSES; RECEPTOR 4; CD14; ENDOCYTOSIS; ACTIVATION		[Granucci, Francesca] Univ Milano Bicocca, Dept Biotechnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy	University of Milano-Bicocca	Granucci, F (corresponding author), Univ Milano Bicocca, Dept Biotechnol & Biosci, Piazza Sci 2, I-20126 Milan, Italy.	francesca.granucci@unimib.it	GRANUCCI, Francesca/K-6150-2019					Brubaker SW, 2015, ANNU REV IMMUNOL, V33, P257, DOI 10.1146/annurev-immunol-032414-112240; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Rosadini CV, 2017, CURR OPIN IMMUNOL, V44, P14, DOI 10.1016/j.coi.2016.10.005; Schappe MS, 2018, IMMUNITY, V48, P59, DOI 10.1016/j.immuni.2017.11.026; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Zanoni I, 2012, IMMUNOL LETT, V142, P41, DOI 10.1016/j.imlet.2011.12.002; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118	10	11	11	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 16	2018	48	1					4	6		10.1016/j.immuni.2017.12.016	http://dx.doi.org/10.1016/j.immuni.2017.12.016			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS9PW	29343439	Green Published, Bronze			2022-12-18	WOS:000422751600002
J	Motwani, M; Fitzgerald, KA				Motwani, Mona; Fitzgerald, Katherine A.			cGAS Micro-Manages Genotoxic Stress	IMMUNITY			English	Editorial Material							PROMOTES SENESCENCE; DNA; PATHWAY	Maintenance of genome integrity is essential to prevent cancer. Genotoxic stress drives damaged DNA out of the nucleus by forming micronuclei. Two studies in Nature reveal how the cytosolic DNA sensor cGAS gains access to the cargo within micronuclei to drive type I IFN responses.	[Motwani, Mona; Fitzgerald, Katherine A.] Univ Massachusetts, Med Sch, Dept Med, Program Innate Immun,Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Fitzgerald, KA (corresponding author), Univ Massachusetts, Med Sch, Dept Med, Program Innate Immun,Div Infect Dis & Immunol, Worcester, MA 01605 USA.	kate.fitzgerald@umassmed.edu	Fitzgerald, Katherine/ABE-6317-2020; Motwani, Mona/AAV-8162-2020	Motwani, Mona/0000-0003-0912-5478; Fitzgerald, Kate/0000-0003-3175-609X				Brzostek-Racine S, 2011, J IMMUNOL, V187, P5336, DOI 10.4049/jimmunol.1100040; Chen Q, 2016, NAT IMMUNOL, V17, P1142, DOI 10.1038/ni.3558; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Di Micco A, 2016, P NATL ACAD SCI USA, V113, pE4671, DOI 10.1073/pnas.1602419113; Gluck S, 2017, NAT CELL BIOL, V19, P1061, DOI 10.1038/ncb3586; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Pokatayev V, 2016, J EXP MED, V213, P329, DOI 10.1084/jem.20151464; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Yu QJ, 2015, CELL REP, V11, P785, DOI 10.1016/j.celrep.2015.03.069	11	11	11	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 17	2017	47	4					616	617		10.1016/j.immuni.2017.09.020	http://dx.doi.org/10.1016/j.immuni.2017.09.020			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FJ9JE	29045895	Bronze			2022-12-18	WOS:000413091600007
J	Nixon, BG; Li, MO				Nixon, Briana G.; Li, Ming O.			Satb1: Restraining PD1 and T Cell Exhaustion	IMMUNITY			English	Editorial Material							VIRAL-INFECTION; EXPRESSION; CYTOKINE; GENES	Mechanisms that govern PD1 expression and exhaustion in T cells are not fully understood. In this issue of Immunity, Stephen et al. (2017) uncover a key role for the genome organizer Satb1 in restraining PD1 expression and promoting tumor immunity.	[Nixon, Briana G.; Li, Ming O.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA; [Nixon, Briana G.; Li, Ming O.] Cornell Univ, Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Li, MO (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA.; Li, MO (corresponding author), Cornell Univ, Weill Cornell Grad Sch Med Sci, Grad Program Immunol & Microbial Pathogenesis, New York, NY 10065 USA.	lim@mskcc.org		Nixon, Briana/0000-0001-7334-9404; li, ming/0000-0002-1383-0535				Alvarez JD, 2000, GENE DEV, V14, P521; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Donkor MK, 2011, IMMUNITY, V35, P123, DOI 10.1016/j.immuni.2011.04.019; Kitagawa Y., 2016, NAT IMMUNOL; Lu PY, 2014, J EXP MED, V211, P515, DOI 10.1084/jem.20130208; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Zou WP, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad7118	9	11	11	1	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 17	2017	46	1					3	5		10.1016/j.immuni.2017.01.002	http://dx.doi.org/10.1016/j.immuni.2017.01.002			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EJ0RP	28099863	Bronze			2022-12-18	WOS:000392918300002
J	Nathan, C				Nathan, Carl			Macrophages' Choice: Take It In or Keep It Out	IMMUNITY			English	Editorial Material							TUBERCULOSIS; CELLS		[Nathan, Carl] Weill Cornell Med, Dept Microbiol & Immunol, 1300 York Ave, New York, NY 10065 USA	Cornell University	Nathan, C (corresponding author), Weill Cornell Med, Dept Microbiol & Immunol, 1300 York Ave, New York, NY 10065 USA.	cnathan@med.cornell.edu						Cronan MR, 2016, IMMUNITY, V45, P861, DOI 10.1016/j.immuni.2016.09.014; Meng S., 2016, CIRC RES; Metchnikoff, 1888, ARCH PATHOL ANAT, V113, P63; Moreno JL, 2007, J LEUKOCYTE BIOL, V82, P1542, DOI 10.1189/jlb.0107058; Nathan C, 2009, CELL HOST MICROBE, V5, P220, DOI 10.1016/j.chom.2009.02.004; Prideaux B, 2015, NAT MED, V21, P1223, DOI 10.1038/nm.3937; Van den Bossche J, 2012, BLOOD, V119, P1623, DOI 10.1182/blood-2011-10-384289; Van den Bossche J, 2009, BLOOD, V114, P4664, DOI 10.1182/blood-2009-05-221598	8	11	12	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT 18	2016	45	4					710	711		10.1016/j.immuni.2016.10.002	http://dx.doi.org/10.1016/j.immuni.2016.10.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EE3FM	27760333	Bronze			2022-12-18	WOS:000389473200003
J	Schafer, DP; Stevens, B				Schafer, Dorothy P.; Stevens, Beth			Brains, Blood, and Guts: MeCP2 Regulates Microglia, Monocytes, and Peripheral Macrophages	IMMUNITY			English	Editorial Material							RETT-SYNDROME		[Schafer, Dorothy P.] Univ Massachusetts, Dept Neurobiol, Sch Med, Worcester, MA 01605 USA; [Stevens, Beth] Harvard Univ, Sch Med, Boston Childrens Hosp, Dept Neurol,FM Kirby Neurobiol Ctr, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Boston Children's Hospital; Harvard Medical School	Schafer, DP (corresponding author), Univ Massachusetts, Dept Neurobiol, Sch Med, Worcester, MA 01605 USA.	dorothy.schafer@umassmed.edu						Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Banerjee Abhishek, 2012, Front Psychiatry, V3, P34, DOI 10.3389/fpsyt.2012.00034; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Chao HT, 2010, NATURE, V468, P263, DOI 10.1038/nature09582; Derecki NC, 2012, NATURE, V484, P105, DOI 10.1038/nature10907; Guy J, 2011, ANNU REV CELL DEV BI, V27, P631, DOI 10.1146/annurev-cellbio-092910-154121; Schafer DP, 2013, GLIA, V61, P24, DOI 10.1002/glia.22389; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]	9	11	11	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 21	2015	42	4					600	602		10.1016/j.immuni.2015.04.002	http://dx.doi.org/10.1016/j.immuni.2015.04.002			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5QF	25902477	Bronze			2022-12-18	WOS:000353347500005
J	Bronte, V				Bronte, Vincenzo			Tumors STING Adaptive Antitumor Immunity	IMMUNITY			English	Editorial Material							CANCER	Immunotherapy is revolutionizing the treatment of cancer patients, but the molecular basis for tumor immunogenicity is unclear. In this issue of Immunity, Deng et al. (2014) and Woo et al. ( 2014) provide evidence suggesting that dendritic cells detect DNA from tumor cells via the STING-mediated, cytosolic DNA sensing pathway.	[Bronte, Vincenzo] Verona Univ Hosp, I-37134 Verona, Italy; [Bronte, Vincenzo] Univ Verona, Dept Pathol & Diagnost, I-37134 Verona, Italy	University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona	Bronte, V (corresponding author), Verona Univ Hosp, I-37134 Verona, Italy.	vincenzo.bronte@univr.it	Bronte, Vincenzo/K-7902-2016	Bronte, Vincenzo/0000-0002-3741-5141				Blankenstein T, 2012, NAT REV CANCER, V12, P307, DOI 10.1038/nrc3246; Deng LF, 2014, IMMUNITY, V41, P843, DOI 10.1016/j.immuni.2014.10.019; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Lawrence MS, 2013, NATURE, V499, P214, DOI 10.1038/nature12213; Page DB, 2014, ANNU REV MED, V65, P185, DOI 10.1146/annurev-med-092012-112807; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Sistigu A., 2014, NAT MED; Willimsky G, 2008, J EXP MED, V205, P1687, DOI 10.1084/jem.20072016; Woo SR, 2014, IMMUNITY, V41, P830, DOI 10.1016/j.immuni.2014.10.017; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	10	11	12	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	NOV 20	2014	41	5					679	681		10.1016/j.immuni.2014.11.004	http://dx.doi.org/10.1016/j.immuni.2014.11.004			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AU3ID	25517609	Bronze			2022-12-18	WOS:000345504900005
J	Mangan, MSJ; Latz, E				Mangan, Matthew S. J.; Latz, Eicke			NLRC3 Puts the Brakes on STING	IMMUNITY			English	Editorial Material								NOD-like receptors (NLRs) are increasingly implicated in regulating pathogen-sensing pathways. In this issue of Immunity, Zhang et al. (2014) describe a role for NLRC3 in regulating STING and the inflammatory response to cytosolic DNA.	[Mangan, Matthew S. J.; Latz, Eicke] Univ Bonn, Inst Innate Immun, Univ Hosp, Biomed Ctr, D-53127 Bonn, Germany; [Mangan, Matthew S. J.; Latz, Eicke] German Ctr Neurodegenerat Dis DZNE, D-53175 Bonn, Germany; [Latz, Eicke] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01615 USA	University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Massachusetts System; University of Massachusetts Worcester	Latz, E (corresponding author), Univ Bonn, Inst Innate Immun, Univ Hosp, Biomed Ctr, D-53127 Bonn, Germany.	eicke.latz@umassmed.edu	Latz, Eicke/H-3951-2014	Latz, Eicke/0000-0003-1488-5666	NHLBI NIH HHS [R01 HL093262] Funding Source: Medline; NIAID NIH HHS [R01 AI083713] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn J, 2012, P NATL ACAD SCI USA, V109, P19386, DOI 10.1073/pnas.1215006109; Anand PK, 2012, NATURE, V488, P389, DOI 10.1038/nature11250; Barber GN, 2014, TRENDS IMMUNOL, V35, P88, DOI 10.1016/j.it.2013.10.010; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Gehrke N, 2013, IMMUNITY, V39, P482, DOI 10.1016/j.immuni.2013.08.004; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lupfer C, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00285; Schneider M, 2012, NAT IMMUNOL, V13, P823, DOI 10.1038/ni.2378; Zaki MH, 2014, P NATL ACAD SCI USA, V111, P385, DOI 10.1073/pnas.1317643111; Zhang L, 2014, IMMUNITY, V40, P329, DOI 10.1016/j.immuni.2014.01.010	10	11	12	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAR 20	2014	40	3					305	306		10.1016/j.immuni.2014.02.007	http://dx.doi.org/10.1016/j.immuni.2014.02.007			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD7DQ	24656040	Green Accepted, Bronze			2022-12-18	WOS:000333422300001
J	Kranzusch, PJ; Vance, RE				Kranzusch, Philip J.; Vance, Russell E.			cGAS Dimerization Entangles DNA Recognition	IMMUNITY			English	Editorial Material							CYCLIC GMP-AMP; 2ND-MESSENGER; DINUCLEOTIDE; SYNTHASE; SENSOR	Detection of foreign DNA in the cell cytosol triggers potent antiviral responses. In this issue of Immunity, Li et al. (2013) provide new structural and biochemical data indicating that a cytosolic DNA sensor, cyclic GMP-AMP synthase (cGAS), is activated by DNA-induced dimerization.	[Kranzusch, Philip J.; Vance, Russell E.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Kranzusch, Philip J.; Vance, Russell E.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Vance, RE (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	rvance@berkeley.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Kato K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076983; Kranzusch PJ, 2013, CELL REP, V3, P1362, DOI 10.1016/j.celrep.2013.05.008; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Zhang X, 2013, MOL CELL, V51, P226, DOI 10.1016/j.molcel.2013.05.022	10	11	12	1	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	DEC 12	2013	39	6					992	994		10.1016/j.immuni.2013.11.012	http://dx.doi.org/10.1016/j.immuni.2013.11.012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UZ	24332024	Bronze			2022-12-18	WOS:000330951000003
J	Vinuesa, CG; Fagarasan, S; Dong, C				Vinuesa, Carola G.; Fagarasan, Sidonia; Dong, Chen			New Territory for T Follicular Helper Cells	IMMUNITY			English	News Item									[Vinuesa, Carola G.] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia; [Fagarasan, Sidonia] RIKEN, Yokohama Inst, Ctr Integrat Med Sci IMS RCAI, Yokohama, Kanagawa 2300045, Japan; [Dong, Chen] Tsinghua Univ, Beijing 100084, Peoples R China; [Dong, Chen] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA	Australian National University; John Curtin School of Medical Research; RIKEN; Tsinghua University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Dong, C (corresponding author), Tsinghua Univ, Beijing 100084, Peoples R China.	carola.vinuesa@anu.edu.au	Vinuesa, Carola G/B-1108-2010; dong, chen/B-3181-2009; Fagarasan, Sidonia/A-5258-2016	Vinuesa, Carola G/0000-0001-9799-0298; dong, chen/0000-0002-0084-9130; Fagarasan, Sidonia/0000-0003-2086-6402				Cairns RA, 2012, BLOOD, V119, P1901, DOI 10.1182/blood-2011-11-391748; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012	3	11	11	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 19	2013	39	3					417	420		10.1016/j.immuni.2013.09.001	http://dx.doi.org/10.1016/j.immuni.2013.09.001			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2UM	24054321	Bronze			2022-12-18	WOS:000330949600002
J	Moore, KJ; Fisher, EA				Moore, Kathryn J.; Fisher, Edward A.			Dysfunctional HDL Takes Its Toll in Chronic Kidney Disease	IMMUNITY			English	Editorial Material							CORONARY-HEART-DISEASE; ATHEROSCLEROSIS; ASSOCIATIONS	Why patients with chronic kidney disease have elevated cardiovascular risk remains elusive. In this issue of Immunity, Speer et al. (2013) show that natural modification of high density lipoprotein promotes hypertension through a toll-like receptor-dependent mechanism.	[Moore, Kathryn J.; Fisher, Edward A.] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol,Marc & Ruti Bell Vasc, New York, NY 10029 USA	New York University	Moore, KJ (corresponding author), NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol,Marc & Ruti Bell Vasc, New York, NY 10029 USA.	kathryn.moore@nyumc.org	Fisher, Edward/ABE-7469-2020; Moore, Kathryn/ABE-6416-2020	Moore, Kathryn/0000-0003-2505-2547; Fisher, Edward/0000-0001-9802-143X	NHLBI NIH HHS [P01 HL098055] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL098055] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beddhu S, 2007, J RENAL NUTR, V17, P372, DOI 10.1053/j.jrn.2007.08.007; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Favre J, 2007, ARTERIOSCL THROM VAS, V27, P1064, DOI 10.1161/ATVBAHA.107.140723; Hewing B, 2012, CIRC RES, V111, P1117, DOI 10.1161/CIRCRESAHA.112.280958; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; McGill HC, 2000, ARTERIOSCL THROM VAS, V20, P1998, DOI 10.1161/01.ATV.20.8.1998; Mullick AE, 2008, J EXP MED, V205, P373, DOI 10.1084/jem.20071096; Ponda MP, 2010, ATHEROSCLEROSIS, V210, P57, DOI 10.1016/j.atherosclerosis.2009.10.029; Speer T, 2013, IMMUNITY, V38, P754, DOI 10.1016/j.immuni.2013.02.009	9	11	11	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 18	2013	38	4					628	630		10.1016/j.immuni.2013.03.006	http://dx.doi.org/10.1016/j.immuni.2013.03.006			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AA2RP	23601680	Bronze			2022-12-18	WOS:000330942100005
J	Dupont, CD; Hunter, CA				Dupont, Christopher D.; Hunter, Christopher A.			Guanylate-Binding Proteins: Niche Recruiters for Antimicrobial Effectors	IMMUNITY			English	Editorial Material							GTPASES	There are fundamental questions regarding how IFN-gamma activates host cells to eliminate intracellular pathogens. In this issue of Immunity, Yamamoto et al. (2012) demonstrate a critical role for the p65 guanylate-binding proteins (GBPs) in this process during infection with Toxoplasma gondii.	[Dupont, Christopher D.; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, 380 S Univ Ave, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu						Egan C.E., 2011, IMMUNOL CELL BIOL; Fentress SJ, 2011, BIOESSAYS, V33, P693, DOI 10.1002/bies.201100054; Howard J, 2008, IMMUNOBIOLOGY, V213, P367, DOI 10.1016/j.imbio.2007.11.005; Kim BH, 2011, SCIENCE, V332, P717, DOI 10.1126/science.1201711; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270; Vestal DJ, 2011, J INTERF CYTOK RES, V31, P89, DOI 10.1089/jir.2010.0102; Virreira Winter S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024434; Yamamoto M, 2012, IMMUNITY, V37, P302, DOI 10.1016/j.immuni.2012.06.009	10	11	11	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 24	2012	37	2					191	193		10.1016/j.immuni.2012.08.005	http://dx.doi.org/10.1016/j.immuni.2012.08.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	998SX	22921115	Bronze			2022-12-18	WOS:000308261800003
J	Xiao, TS; Tine, JPY				Xiao, Tsan Sam; Tine, Jenny P. -Y.			NLRX1 Has a Tail to Tell	IMMUNITY			English	Editorial Material							OXYGEN SPECIES PRODUCTION; NF-KAPPA-B; MITOCHONDRIAL; INFECTION; PATHWAYS; MAVS	In this issue of Immunity, Hong et al. (2012) report the first structural analysis of the C-terminal fragment of an NLR (nucleotide-binding domain [NBD] and leucine-rich repeat [LRR]-containing) protein, NLRX1. This fragment forms a hexamer and binds RNA.	[Xiao, Tsan Sam] NIAID, Struct Immunobiol Unit, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Tine, Jenny P. -Y.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Ctr Translat Immunol, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Tine, Jenny P. -Y.] Inflammatory Dis Inst, Chapel Hill, NC 27599 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of North Carolina; University of North Carolina Chapel Hill	Xiao, TS (corresponding author), NIAID, Struct Immunobiol Unit, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	xiaot@niaid.nih.gov; jenny_ting@med.unc.edu	Xiao, Tsan/I-7616-2013; Xiao, Tsan Sam/A-8590-2010	Xiao, Tsan/0000-0001-9688-475X; Xiao, Tsan Sam/0000-0001-9688-475X	Intramural NIH HHS [ZIA AI000960-07] Funding Source: Medline; NCI NIH HHS [R01 CA156330] Funding Source: Medline; NIAID NIH HHS [U54 AI057157] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA156330] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000960, U54AI057157] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdul-Sater AA, 2010, J BIOL CHEM, V285, P41637, DOI 10.1074/jbc.M110.137885; Allen IC, 2011, IMMUNITY, V34, P854, DOI 10.1016/j.immuni.2011.03.026; Arnoult D, 2009, J CELL SCI, V122, P3161, DOI 10.1242/jcs.051193; Hong M, 2012, IMMUNITY, V36, P337, DOI 10.1016/j.immuni.2011.12.018; Linhoff MW, 2001, MOL CELL BIOL, V21, P3001, DOI 10.1128/MCB.21.9.3001-3011.2001; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Rebsamen M, 2011, CELL DEATH DIFFER, V18, P1387, DOI 10.1038/cdd.2011.64; Tattoli I, 2008, EMBO REP, V9, P293, DOI 10.1038/sj.embor.7401161; Xia XJ, 2011, IMMUNITY, V34, P843, DOI 10.1016/j.immuni.2011.02.022	10	11	11	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR 23	2012	36	3					311	312		10.1016/j.immuni.2012.03.002	http://dx.doi.org/10.1016/j.immuni.2012.03.002			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	915ST	22444625	Green Accepted, Bronze			2022-12-18	WOS:000302048400001
J	Declercq, W; Takahashi, N; Vandenabeele, P				Declercq, Wim; Takahashi, Nozomi; Vandenabeele, Peter			Dual Face Apoptotic Machinery: From Initiator of Apoptosis to Guardian of Necroptosis	IMMUNITY			English	Editorial Material								In this issue of Immunity, Bonnet et al. (2011) show that skin-specific ablation of the adaptor protein FADD sensitizes keratinocytes to RIPK3-dependent necrotic cell death, which leads to severe skin inflammation.	[Declercq, Wim; Takahashi, Nozomi; Vandenabeele, Peter] VIB, Dept Mol Biomed Res, Mol Signaling & Cell Death Unit, B-9052 Ghent, Belgium; [Declercq, Wim; Takahashi, Nozomi; Vandenabeele, Peter] Univ Ghent, Dept Biomed Mol Biol, B-9000 Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	Vandenabeele, P (corresponding author), VIB, Dept Mol Biomed Res, Mol Signaling & Cell Death Unit, B-9052 Ghent, Belgium.	peter.vandenabeele@dmbr.vib-ugent.be	Vandenabeele, Peter/AAD-5793-2022; Vandenabeele, Peter/C-8597-2009	Vandenabeele, Peter/0000-0002-6669-8822; Takahashi, Nozomi/0000-0002-3751-4203				Bolze A, 2010, AM J HUM GENET, V87, P873, DOI 10.1016/j.ajhg.2010.10.028; Bonnet MC, 2011, IMMUNITY, V35, P572, DOI 10.1016/j.immuni.2011.08.014; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kovalenko A, 2009, J EXP MED, V206, P2161, DOI 10.1084/jem.20090616; Lee P, 2009, NATURE, V458, P519, DOI 10.1038/nature07687; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; Paquet P, 2010, DRUG SAFETY, V33, P189, DOI 10.2165/11532540-000000000-00000; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Welz PS, 2011, NATURE, V477, P330, DOI 10.1038/nature10273; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878	12	11	11	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	OCT 28	2011	35	4					493	495		10.1016/j.immuni.2011.10.007	http://dx.doi.org/10.1016/j.immuni.2011.10.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	843FM	22035842	Bronze			2022-12-18	WOS:000296657700007
J	Sasai, M; Iwasaki, A				Sasai, Miwa; Iwasaki, Akiko			Love Triangle between Unc93B1, TLR7, and TLR9 Prevents Fatal Attraction	IMMUNITY			English	Editorial Material							TOLL-LIKE RECEPTORS; MURINE MODEL; CELLS		[Sasai, Miwa; Iwasaki, Akiko] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Yale University	Iwasaki, A (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, 333 Cedar St, New Haven, CT 06520 USA.	akiko.iwasaki@yale.edu	Iwasaki, Akiko/Z-1591-2019	Iwasaki, Akiko/0000-0002-7824-9856; Sasai, Miwa/0000-0001-6440-3958	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064705, R01AI054359, R01AI081884, R01AI062428] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI062428-07, R01 AI062428, R01 AI054359, R01 AI064705-05, R01 AI081884-03, R01 AI081884, R01 AI064705, R01 AI054359-09] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Chan OTM, 1999, J EXP MED, V189, P1639, DOI 10.1084/jem.189.10.1639; Christensen SR, 2006, IMMUNITY, V25, P417, DOI 10.1016/j.immuni.2006.07.013; Deane JA, 2007, IMMUNITY, V27, P801, DOI 10.1016/j.immuni.2007.09.009; Fukui R, 2011, IMMUNITY, V35, P69, DOI 10.1016/j.immuni.2011.05.010; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Marshak-Rothstein A, 2007, ANNU REV IMMUNOL, V25, P419, DOI 10.1146/annurev.immunol.22.012703.104514; Nickerson KM, 2010, J IMMUNOL, V184, P1840, DOI 10.4049/jimmunol.0902592; Sasai M, 2010, SCIENCE, V329, P1530, DOI 10.1126/science.1187029	10	11	11	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 22	2011	35	1					3	5		10.1016/j.immuni.2011.07.006	http://dx.doi.org/10.1016/j.immuni.2011.07.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	797EM	21777792	Green Accepted, Bronze			2022-12-18	WOS:000293107300002
J	Pelka, K; Latz, E				Pelka, Karin; Latz, Eicke			Getting Closer to the Dirty Little Secret	IMMUNITY			English	Editorial Material							NALP3 INFLAMMASOME; DENDRITIC CELLS; URIC-ACID; ACTIVATION; CRYSTALS; SILICA	The molecular mechanism behind alum adjuvanticity is probably the oldest secret of immunology. In this issue of Immunity, Kuroda et al. (2011) and Kool et al. (2011) identify NLRP3 inflammasome-independent signaling to be crucial for the Th2 cell response induced by aluminum salts.	[Pelka, Karin; Latz, Eicke] Univ Bonn, Univ Hosp, Biomed Ctr, Inst Innate Immun, D-53127 Bonn, Germany; [Latz, Eicke] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA	University of Bonn; University of Massachusetts System; University of Massachusetts Worcester	Latz, E (corresponding author), Univ Bonn, Univ Hosp, Biomed Ctr, Inst Innate Immun, 1G008,Sigmund Freud Str 25, D-53127 Bonn, Germany.	eicke.latz@umassmed.edu	Latz, Eicke/H-3951-2014	Latz, Eicke/0000-0003-1488-5666	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093262] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083713] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL093262-03, R01 HL093262] Funding Source: Medline; NIAID NIH HHS [R01 AI083713, R01 AI083713-01] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eisenbarth SC, 2008, NATURE, V453, P1122, DOI 10.1038/nature06939; Franchi L, 2008, EUR J IMMUNOL, V38, P2085, DOI 10.1002/eji.200838549; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kool M, 2011, IMMUNITY, V34, P527, DOI 10.1016/j.immuni.2011.03.015; Kuroda E, 2011, IMMUNITY, V34, P514, DOI 10.1016/j.immuni.2011.03.019; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Ng G, 2008, IMMUNITY, V29, P807, DOI 10.1016/j.immuni.2008.09.013; Rhee EG, 2011, J VIROL, V85, P315, DOI 10.1128/JVI.01597-10	11	11	12	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	APR 22	2011	34	4					455	458		10.1016/j.immuni.2011.04.003	http://dx.doi.org/10.1016/j.immuni.2011.04.003			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	761AQ	21511178	Green Accepted, Bronze			2022-12-18	WOS:000290367300003
J	Hogquist, KA; Xing, Y				Hogquist, Kristin A.; Xing, Yan			Why CD8(+) T Cells Need Diversity When Growing Up	IMMUNITY			English	Editorial Material							SELECTION; THYMUS		[Hogquist, Kristin A.; Xing, Yan] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55414 USA	University of Minnesota System; University of Minnesota Twin Cities	Hogquist, KA (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN 55414 USA.	hogqu001@umn.edu		Hogquist, Kristin/0000-0001-9963-5687				Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Murata S, 2007, SCIENCE, V316, P1349, DOI 10.1126/science.1141915; Nitta T, 2010, IMMUNITY, V32, P29, DOI 10.1016/j.immuni.2009.10.009; Wang BM, 2009, SCIENCE, V326, P871, DOI 10.1126/science.1177627; Ziegler A, 2009, TRENDS IMMUNOL, V30, P53, DOI 10.1016/j.it.2008.11.004	5	11	11	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	JAN 29	2010	32	1					5	6		10.1016/j.immuni.2010.01.005	http://dx.doi.org/10.1016/j.immuni.2010.01.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	550HW	20152164	Bronze			2022-12-18	WOS:000274119900004
J	Waldmann, H; Cobbold, S				Waldmann, Herman; Cobbold, Stephen			Regulatory T Cells: Context Matters	IMMUNITY			English	Article							TGF-BETA; GENERATION; INDUCTION; TOLERANCE; DIFFERENTIATION; PROMOTES	Regulatory T cells are important for ensuring that the immune system does not attack self and does not overreact to external antigens. Understanding how these cells develop and maintain stable function provides general insights into cellular differentiation in general, as well as new opportunities for therapeutic manipulation.	[Waldmann, Herman; Cobbold, Stephen] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	University of Oxford	Waldmann, H (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	herman.waldmann@path.ox.ac.uk	waldmann, herman/F-7412-2011; waldmann, herman/W-8051-2019	Cobbold, Stephen/0000-0003-1206-4880; Waldmann, Herman/0000-0001-7519-6720	Medical Research Council [G7904009] Funding Source: Medline; MRC [G7904009] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Andersson J, 2008, J EXP MED, V205, P1975, DOI 10.1084/jem.20080308; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Chatila TA, 2000, J CLIN INVEST, V106, pR75, DOI 10.1172/JCI11679; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Cobbold SP, 2004, J IMMUNOL, V172, P6003, DOI 10.4049/jimmunol.172.10.6003; Daley SR, 2007, J IMMUNOL, V179, P3648, DOI 10.4049/jimmunol.179.6.3648; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Graca L, 2002, J EXP MED, V195, P1641, DOI 10.1084/jem.20012097; HALL BM, 1985, J EXP MED, V162, P1683, DOI 10.1084/jem.162.5.1683; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Josefowicz SZ, 2009, IMMUNITY, V30, P616, DOI 10.1016/j.immuni.2009.04.009; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; KONG YCM, 1989, CLIN IMMUNOL IMMUNOP, V51, P38, DOI 10.1016/0090-1229(89)90204-3; Lin CY, 2002, NAT IMMUNOL, V3, P1208, DOI 10.1038/ni853; Mellor AL, 2004, INT IMMUNOL, V16, P1391, DOI 10.1093/intimm/dxh140; POWRIE F, 1990, J EXP MED, V172, P1701, DOI 10.1084/jem.172.6.1701; QIN SX, 1993, SCIENCE, V259, P974, DOI 10.1126/science.8094901; Riley JL, 2009, IMMUNITY, V30, P656, DOI 10.1016/j.immuni.2009.04.006; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Shevach EM, 2009, IMMUNITY, V30, P636, DOI 10.1016/j.immuni.2009.04.010; Soares MP, 2001, IMMUNOL REV, V184, P275, DOI 10.1034/j.1600-065x.2001.1840124.x; Tao R, 2007, NAT MED, V13, P1299, DOI 10.1038/nm1652; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	28	11	11	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 22	2009	30	5					613	615		10.1016/j.immuni.2009.04.007	http://dx.doi.org/10.1016/j.immuni.2009.04.007			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	449UX	19464983	Bronze			2022-12-18	WOS:000266356900001
J	Silver, JS; Hunter, CA				Silver, Jonathan S.; Hunter, Christopher A.			With a little help from their friends: Interleukin-21, T cells, and B cells	IMMUNITY			English	Editorial Material							IL-21		[Silver, Jonathan S.; Hunter, Christopher A.] Univ Penn, Sch Vet Med, Dept Pathobiol, Philadelphia, PA 19104 USA	University of Pennsylvania	Hunter, CA (corresponding author), Univ Penn, Sch Vet Med, Dept Pathobiol, Room 313,Hill Pavilion,380 S Univ Ave, Philadelphia, PA 19104 USA.	chunter@vet.upenn.edu	Hunter, Christopher/H-1970-2011					Ansel KM, 2000, NATURE, V406, P309, DOI 10.1038/35018581; Chtanova T, 2004, J IMMUNOL, V173, P68, DOI 10.4049/jimmunol.173.1.68; Fazilleau N, 2007, NAT IMMUNOL, V8, P753, DOI 10.1038/ni1472; Hsu HC, 2008, NAT IMMUNOL, V9, P166, DOI 10.1038/ni1552; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Spolski R, 2008, ANNU REV IMMUNOL, V26, P57, DOI 10.1146/annurev.immunol.26.021607.090316; Suto A, 2008, J EXP MED, V205, P1369, DOI 10.1084/jem.20072057; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	10	11	18	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 18	2008	29	1					7	9		10.1016/j.immuni.2008.06.005	http://dx.doi.org/10.1016/j.immuni.2008.06.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	329YB	18631451	Bronze			2022-12-18	WOS:000257905400004
J	Cancro, MP				Cancro, Michael P.			Living in context with the survival factor BAFF	IMMUNITY			English	Editorial Material							MATURE B-CELLS; MARGINAL ZONE; ACTIVATION		Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Cancro, MP (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, 284 John Morgan Bldg,36th & Hamilton Walk, Philadelphia, PA 19104 USA.	cancro@mail.med.upenn.edu		Cancro, Michael/0000-0002-8659-3227				Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Grech AP, 2004, IMMUNITY, V21, P629, DOI 10.1016/j.immuni.2004.09.011; Hatada EN, 2003, J IMMUNOL, V171, P761, DOI 10.4049/jimmunol.171.2.761; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Lesley R, 2004, IMMUNITY, V20, P441, DOI 10.1016/S1074-7613(04)00079-2; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Thien M, 2004, IMMUNITY, V20, P785, DOI 10.1016/j.immuni.2004.05.010; Xie P, 2007, IMMUNITY, V27, P253, DOI 10.1016/j.immuni.2007.07.012	10	11	14	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613			IMMUNITY	Immunity	MAR	2008	28	3					300	301		10.1016/j.immuni.2008.02.010	http://dx.doi.org/10.1016/j.immuni.2008.02.010			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	276LH	18342003	Bronze			2022-12-18	WOS:000254142500006
J	Stetson, DB; Medzhitov, R				Stetson, Daniel B.; Medzhitov, Ruslan			T helper 17 cells get the NOD	IMMUNITY			English	Editorial Material							CROHNS-DISEASE		Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University; Yale University	Stetson, DB (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 333 Cedar St, New Haven, CT 06520 USA.	daniel.stetson@yale.edu; ruslan.medzhitov@yale.edu						Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eckmann L, 2005, IMMUNITY, V22, P661, DOI 10.1016/j.immuni.2005.06.004; Maeda S, 2005, SCIENCE, V307, P734, DOI 10.1126/science.1103685; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Stockinger B, 2007, CURR OPIN IMMUNOL, V19, P281, DOI 10.1016/j.coi.2007.04.005; van Beelen AJ, 2007, IMMUNITY, V27, P660, DOI 10.1016/j.immuni.2007.08.013; Watanabe T, 2006, IMMUNITY, V25, P473, DOI 10.1016/j.immuni.2006.06.018; Weaver CT, 2007, ANNU REV IMMUNOL, V25, P821, DOI 10.1146/annurev.immunol.25.022106.141557	10	11	11	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	OCT	2007	27	4					546	548		10.1016/j.immuni.2007.10.005	http://dx.doi.org/10.1016/j.immuni.2007.10.005			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	225AY	17967409	Bronze			2022-12-18	WOS:000250490700006
J	Vivier, E; Romagne, F				Vivier, Eric; Romagne, Francois			Good news, bad news for missing-self recognition by NK cells: Autoimmune control but viral evasion	IMMUNITY			English	Editorial Material							RECEPTORS	In this issue of Immunity, Voigt et al. (2007) and Lu et al. (2007) extend the understanding of the consequences of missing-self recognition in immune evasion and immune cell regulation via NKRP-1 and CD94-NKG2A inhibitory receptors, respectively.	Univ Aix Marseille 2, Ctr Immunol Marseille Luminy, F-13288 Marseille, France; INSERM, U631, F-13288 Marseille, France; CNRS, UMR 6102, F-13288 Marseille, France; Assistance Publ Hop Marseille, Hop Concept, F-13385 Marseille, France; Innate Pharma, F-13009 Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Vivier, E (corresponding author), Univ Aix Marseille 2, Ctr Immunol Marseille Luminy, F-13288 Marseille, France.	vivier@ciml.univ-mrs.fr	Vivier, Eric/F-8939-2010	Vivier, Eric/0000-0001-7022-8287				Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Carlyle JR, 2004, P NATL ACAD SCI USA, V101, P3527, DOI 10.1073/pnas.0308304101; Iizuka K, 2003, NAT IMMUNOL, V4, P801, DOI 10.1038/ni954; Koh CY, 2001, BLOOD, V97, P3132, DOI 10.1182/blood.V97.10.3132; LJUNGGREN HG, 1990, IMMUNOL TODAY, V11, P237, DOI 10.1016/0167-5699(90)90097-S; Lu LR, 2007, IMMUNITY, V26, P593, DOI 10.1016/j.immuni.2007.03.017; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Nedvetzki S, 2007, BLOOD, V109, P3776, DOI 10.1182/blood-2006-10-052977; Ogasawara K, 2004, IMMUNITY, V20, P757, DOI 10.1016/j.immuni.2004.05.008; Ruggeri L, 2006, IMMUNOL REV, V214, P202, DOI 10.1111/j.1600-065X.2006.00455.x; Voigt S, 2007, IMMUNITY, V26, P617, DOI 10.1016/j.immuni.2007.03.013	11	11	13	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY	2007	26	5					549	551		10.1016/j.immuni.2007.05.006	http://dx.doi.org/10.1016/j.immuni.2007.05.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	173TR	17521583	Bronze			2022-12-18	WOS:000246895900007
J	Harding, CV				Harding, Clifford V.			gp96 leads the way for toll-like receptors	IMMUNITY			English	Editorial Material							ADAPTIVE IMMUNE-RESPONSES; INNATE	The role of the gp96 heat-shock protein in regulating Toll-like-receptor expression is incompletely understood. Yang et al. (2007) generated mice with conditional deficiency of gp96 in macrophages and found that this protein is an important chaperone for all Toll-like receptors that have been tested.	Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Case Western Reserve University	Harding, CV (corresponding author), Case Western Reserve Univ, Dept Pathol, Wolstein 5534,2103 Cornell Rd, Cleveland, OH 44106 USA.	cvh3@cwru.edu						Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Randow F, 2001, NAT CELL BIOL, V3, P891, DOI 10.1038/ncb1001-891; Srivastava P, 2002, NAT REV IMMUNOL, V2, P185, DOI 10.1038/nri749; Warger T, 2006, J BIOL CHEM, V281, P22545, DOI 10.1074/jbc.M502900200; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	5	11	12	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB	2007	26	2					141	143		10.1016/j.immuni.2007.02.003	http://dx.doi.org/10.1016/j.immuni.2007.02.003			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	142DE	17307701	Bronze			2022-12-18	WOS:000244628600004
J	tenOever, BR; Maniatis, T				tenOever, BR; Maniatis, T			Parallel pathways of virus recognition	IMMUNITY			English	Editorial Material							ANTIVIRAL SIGNALING PROTEIN; INTERFERON-ALPHA PRODUCTION; HEPATITIS-C-VIRUS; ADAPTER PROTEIN; KAPPA-B	Viruses trigger signaling pathways of innate immunity. In this issue, Sun et al. (2006) show that the mitochondrial antiviral signaling protein is critical for intracellular detection signaling, but is dispensable for the activation of innate immunity via Toll-like receptors.	Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	tenOever, BR (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.							Barchet W, 2002, J EXP MED, V195, P507, DOI 10.1084/jem.20011666; Hoshino K, 2006, NATURE, V440, P949, DOI 10.1038/nature04641; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Schulz O, 2005, NATURE, V433, P887, DOI 10.1038/nature03326; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014	10	11	12	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	MAY	2006	24	5					510	512		10.1016/j.immuni.2006.05.006	http://dx.doi.org/10.1016/j.immuni.2006.05.006			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	048TT	16713969	Bronze			2022-12-18	WOS:000237970100008
J	Douek, D				Douek, D			Thymic output and HIV infection: On the right TREC	IMMUNITY			English	Editorial Material							T-CELL DEPLETION; HOMEOSTASIS; DISEASE	The role of the thymus in HIV infection has been a matter of considerable debate. A new study by Dion et al. (2004) in this issue of Immunity provides the mechanism for reduced thymic output in HIV infection while illuminating the impact of recent thymic emigrants on peripheral T cell homeostasis.	NIH, Vaccine Res Ctr, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Douek, D (corresponding author), NIH, Vaccine Res Ctr, 40 Convent Dr,Room 3509, Bethesda, MD 20892 USA.							Almeida ARM, 2001, J EXP MED, V194, P591, DOI 10.1084/jem.194.5.591; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Douek DC, 1998, NATURE, V396, P690, DOI 10.1038/25374; Grossman Z, 2004, NAT REV IMMUNOL, V4, P387, DOI 10.1038/nri1355; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Hazenberg MD, 2000, NAT MED, V6, P1036, DOI 10.1038/79549; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Prockop SE, 2004, J IMMUNOL, V173, P1604, DOI 10.4049/jimmunol.173.3.1604	10	11	12	0	0	CELL PRESS	CAMBRIDGE	1100 MASSACHUSETTS AVE, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	DEC	2004	21	6					744	745		10.1016/j.immuni.2004.11.005	http://dx.doi.org/10.1016/j.immuni.2004.11.005			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881XB	15589163	Bronze			2022-12-18	WOS:000225901600002
J	Delovitch, TL; Singh, B				Delovitch, TL; Singh, B			The nonobese diabetic mouse as a model of autoimmune diabetes: Immune dysregulation gets the NOD (vol 7, pg 727, 1997)	IMMUNITY			English	Correction													Singh, Bhagirath/C-4010-2013	Singh, Bhagirath/0000-0002-9792-8694				WILSON SB, 1997, IMMUNITY, V7, P727	1	11	11	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138 USA	1074-7613			IMMUNITY	Immunity	APR	1998	8	4					U9	U9						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZK664					2022-12-18	WOS:000073348000014
J	Huang, M; Wu, LL; Zheng, AQ; Xie, YF; He, QW; Rong, XY; Han, P; Du, P; Han, PC; Zhang, ZY; Zhao, RC; Jia, YF; Li, LJ; Bai, B; Hu, ZL; Hu, SX; Niu, S; Hu, Y; Liu, HH; Liu, B; Cui, KG; Li, WW; Zhao, X; Liu, KF; Qi, JX; Wang, QH; Gao, GF				Huang, Min; Wu, Lili; Zheng, Anqi; Xie, Yufeng; He, Qingwen; Rong, Xiaoyu; Han, Pu; Du, Pei; Han, Pengcheng; Zhang, Zengyuan; Zhao, Runchu; Jia, Yunfei; Li, Linjie; Bai, Bin; Hu, Ziliang; Hu, Shixiong; Niu, Sheng; Hu, Yu; Liu, Honghui; Liu, Bo; Cui, Kaige; Li, Weiwei; Zhao, Xin; Liu, Kefang; Qi, Jianxun; Wang, Qihui; Gao, George Fu			Atlas of currently available human neutralizing antibodies against SARS-CoV-2 and escape by Omicron sub-variants BA.1/BA.1.1/BA.2/BA.3	IMMUNITY			English	Article								SARS-CoV-2 Omicron variant has presented significant challenges to current antibodies and vaccines. Here-in, we systematically compared the efficacy of 50 human monoclonal antibodies (mAbs), covering the seven identified epitope classes of the SARS-CoV-2 RBD, against Omicron sub-variants BA.1, BA.1.1, BA.2, and BA.3. Binding and pseudovirus-based neutralizing assays revealed that 37 of the 50 mAbs lost neutralizing activities, whereas the others displayed variably decreased activities against the four Omicron sub-variants. BA.2 was found to be more sensitive to RBD-5 antibodies than the other sub-variants. Furthermore, a qua-ternary complex structure of BA.1 RBD with three mAbs showing different neutralizing potencies against Om-icron provided a basis for understanding the immune evasion of Omicron sub-variants and revealed the lack of G446S mutation accounting for the sensitivity of BA.2 to RBD-5 mAbs. Our results may guide the applica-tion of the available mAbs and facilitate the development of universal therapeutic antibodies and vaccines against COVID-19.	[Huang, Min; Wu, Lili; Zheng, Anqi; Xie, Yufeng; He, Qingwen; Han, Pu; Du, Pei; Han, Pengcheng; Zhang, Zengyuan; Zhao, Runchu; Jia, Yunfei; Li, Linjie; Bai, Bin; Hu, Ziliang; Hu, Shixiong; Niu, Sheng; Hu, Yu; Liu, Honghui; Liu, Bo; Cui, Kaige; Li, Weiwei; Zhao, Xin; Liu, Kefang; Qi, Jianxun; Wang, Qihui; Gao, George Fu] Univ Sci & Technol China, Sch Life Sci, Div Life Sci & Med, Hefei 230027, Anhui, Peoples R China; [Huang, Min; Wu, Lili; Zheng, Anqi; Xie, Yufeng; He, Qingwen; Han, Pu; Du, Pei; Han, Pengcheng; Zhang, Zengyuan; Zhao, Runchu; Jia, Yunfei; Li, Linjie; Bai, Bin; Hu, Ziliang; Hu, Shixiong; Niu, Sheng; Hu, Yu; Liu, Honghui; Liu, Bo; Cui, Kaige; Li, Weiwei; Zhao, Xin; Liu, Kefang; Qi, Jianxun; Wang, Qihui; Gao, George Fu] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China; [Zheng, Anqi; Li, Linjie; Wang, Qihui; Gao, George Fu] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Xie, Yufeng] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing 100084, Peoples R China; [He, Qingwen] Zhejiang Univ Sch Med, Dept Pathogen Biol & Microbiol, Hangzhou 310058, Zhejiang, Peoples R China; [Rong, Xiaoyu] Wenzhou Med Univ, Sch Lab Med & Life Sci, Wenzhou, Zhejiang, Peoples R China; [Han, Pengcheng] Southeast Univ, Zhongda Hosp, Sch Med, Nanjing 210009, Jiangsu, Peoples R China; [Zhao, Runchu; Hu, Ziliang] Anhui Univ, Inst Phys Sci & Informat, Hefei 230039, Anhui, Peoples R China; [Jia, Yunfei; Niu, Sheng; Liu, Bo] Shanxi Agr Univ, Coll Vet Med, Jinzhong 030801, Shanxi, Peoples R China; [Gao, George Fu] Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tsinghua University; Wenzhou Medical University; Southeast University - China; Anhui University; Shanxi Agricultural University; Chinese Center for Disease Control & Prevention	Qi, JX; Wang, QH; Gao, GF (corresponding author), Univ Sci & Technol China, Sch Life Sci, Div Life Sci & Med, Hefei 230027, Anhui, Peoples R China.; Qi, JX; Wang, QH; Gao, GF (corresponding author), Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing 100101, Peoples R China.; Wang, QH; Gao, GF (corresponding author), Univ Chinese Acad Sci, Beijing 100049, Peoples R China.; Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent, Beijing 102206, Peoples R China.	jxqi@im.ac.cn; wangqihui@im.ac.cn; gaof@im.ac.cn		Xie, Yufeng/0000-0001-9602-0003	Chinese Academy of Sci-ences; CAS Project for Young Scientists in Basic Research [YSBR-010]; National Natural Science Foun-dation of China [81922044, 82041047, 81973228]; Chinese Academy of Sciences [XDB29040203]; China Postdoctoral Science Foundation [2021M703446]; Youth Innovation Promotion Association CAS [2018119]	Chinese Academy of Sci-ences(Chinese Academy of Sciences); CAS Project for Young Scientists in Basic Research; National Natural Science Foun-dation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Youth Innovation Promotion Association CAS	We are grateful to Z. Fan (Institute of Microbiology, Chinese Academy of Sci-ences [CAS] ) and Z. Yang (Tsinghua University) for their technical support of SPR analysis. We thank Novoprotein Scientific Inc. for their support on Omi-cron RBD expression. This work was supported by the CAS Project for Young Scientists in Basic Research (YSBR-010) , the National Natural Science Foun-dation of China (81922044, 82041047, and 81973228) , and the Strategic Prior-ity Research Program of the Chinese Academy of Sciences (XDB29040203) . L.W. is supported by the China Postdoctoral Science Foundation (2021M703446) . Q.W. is supported by the Youth Innovation Promotion Asso-ciation CAS (2018119) .	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Bernal JL, 2021, NEW ENGL J MED, V385, P585, DOI 10.1056/NEJMoa2108891; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Cui Z, 2022, CELL, V185, P860, DOI 10.1016/j.cell.2022.01.019; Dejnirattisai W, 2022, CELL, V185, P467, DOI 10.1016/j.cell.2021.12.046; Du P, 2022, INNOVATION-AMSTERDAM, V3, DOI 10.1016/j.xinn.2022.100206; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gobeil SMC, 2022, MOL CELL, V82, P2050, DOI [10.1101/2022.01.25.477784, 10.1016/j.molcel.2022.03.028]; Grabowski F, 2022, VIRUSES-BASEL, V14, DOI 10.3390/v14020294; Han PC, 2022, CELL, V185, P630, DOI 10.1016/j.cell.2022.01.001; Hansen CH., 2021, MEDRXIV, DOI [10.1101/2021.12.20.21267966, DOI 10.1101/2021.12.20.21267966, 10.1101/2021.12.20.21267966v2]; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Hastie KM, 2021, SCIENCE, V374, P472, DOI 10.1126/science.abh2315; Hong Q., 2022, BIORXIV, DOI [10.1101/2022.01.10.475532, DOI 10.1101/2022.01.10.475532]; Jiang SB, 2020, LANCET, V395, P949, DOI 10.1016/S0140-6736(20)30419-0; Karim SSA, 2021, LANCET, V398, P2126, DOI 10.1016/S0140-6736(21)02758-6; Li QQ, 2021, CELL, V184, P2362, DOI 10.1016/j.cell.2021.02.042; Li ZH, 2022, NAT IMMUNOL, V23, P423, DOI 10.1038/s41590-022-01138-w; Liu C, 2021, CELL, V184, P4220, DOI 10.1016/j.cell.2021.06.020; Liu LH, 2022, NATURE, V602, P676, DOI 10.1038/s41586-021-04388-0; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Pinto D, 2020, NATURE, V583, P290, DOI 10.1038/s41586-020-2349-y; Planas D, 2022, NATURE, V602, P671, DOI 10.1038/s41586-021-04389-z; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/NMETH.4169, 10.1038/nmeth.4169]; Shi R, 2020, NATURE, V584, P120, DOI 10.1038/s41586-020-2381-y; Tan WJ, 2020, CHINA CDC WEEKLY, V2, P61; Tseng HF, 2022, NAT MED, V28, P1063, DOI 10.1038/s41591-022-01753-y; VanBlargan LA, 2022, NAT MED, V28, P490, DOI 10.1038/s41591-021-01678-y; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; WHO, 2021, COVID 19 CLIN MAN LI, DOI DOI 10.5281/ZENODO.5744276; World Health Organization, 2021, CLASSIFICATION OMICR, P2021; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zhao X, 2022, NEW ENGL J MED, V386, P894, DOI 10.1056/NEJMc2119426; Zheng AQ, 2022, SIGNAL TRANSDUCT TAR, V7, DOI 10.1038/s41392-021-00821-y; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	41	10	10	12	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 9	2022	55	8					1501	+		10.1016/j.immuni.2022.06.005	http://dx.doi.org/10.1016/j.immuni.2022.06.005			18	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4W7VU	35777362	hybrid, Green Published			2022-12-18	WOS:000860366700004
J	Roy, ER; Chiu, G; Li, SM; Propson, NE; Kanchi, R; Wang, BP; Coarfa, C; Zheng, H; Cao, W				Roy, Ethan R.; Chiu, Gabriel; Li, Sanming; Propson, Nicholas E.; Kanchi, Rupa; Wang, Baiping; Coarfa, Cristian; Zheng, Hui; Cao, Wei			Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid beta plaques	IMMUNITY			English	Article							ALPHA IFN-ALPHA; SYNAPSE ELIMINATION; BACE1 EXPRESSION; COMPLEMENT C3; BRAIN; ACTIVATION; STAT1; MICE; NEURODEGENERATION; MODEL	The principal signals that drive memory and cognitive impairment in Alzheimer???s disease (AD) remain elusive. Here, we revealed brain-wide cellular reactions to type I interferon (IFN-I), an innate immune cytokine aberrantly elicited by amyloid ?? plaques, and examined their role in cognition and neuropathology relevant to AD in a murine amyloidosis model. Using a fate-mapping reporter system to track cellular responses to IFN-I, we detected robust, AO-pathology-dependent IFN-I activation in microglia and other cell types. Long-term blockade of IFN-I receptor (IFNAR) rescued both memory and synaptic deficits and resulted in reduced microgliosis, inflammation, and neuritic pathology. Microglia-specific Ifnar1 deletion attenuated the loss of post-synaptic terminals by selective engulfment, whereas neural Ifnar1 deletion restored pre-synaptic terminals and decreased plaque accumulation. Overall, IFN-I signaling represents a critical module within the neuroinflammatory network of AD and prompts concerted cellular states that are detrimental to memory and cognition.	[Roy, Ethan R.; Chiu, Gabriel; Li, Sanming; Propson, Nicholas E.; Wang, Baiping; Zheng, Hui; Cao, Wei] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Kanchi, Rupa; Coarfa, Cristian] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Kanchi, Rupa; Coarfa, Cristian] Baylor Coll Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA; [Zheng, Hui; Cao, Wei] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Propson, Nicholas E.] Denali Therapeut, San Francisco, CA 94080 USA; [Cao, Wei] Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Anesthesiol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston	Cao, W (corresponding author), Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA.; Cao, W (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Cao, W (corresponding author), Univ Texas Hlth Sci Ctr Houston, McGovern Med Sch, Dept Anesthesiol, Houston, TX 77030 USA.	wei.cao@uth.tmc.edu		Cao, Wei/0000-0002-8952-9159	NIH [AG057587, AG020670, AG062257, NS093652]; BrightFocus [ADR A20183775]; Brown Foundation 2020 Healthy Aging Initiative; Cure Alz-heimer's Fund; Cancer Prevention Institute of Texas (CPRIT) [RP170005, RP210227, RP200504]; NIEHS [P30 ES030285, P42 ES027725]; NIMHD [P50MD015496]; IDDRC grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development [U54HD083092]; NIH P30 shared resource grant [CA125123]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus(BrightFocus Foundation); Brown Foundation 2020 Healthy Aging Initiative; Cure Alz-heimer's Fund; Cancer Prevention Institute of Texas (CPRIT); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIMHD; IDDRC grant from the Eunice Kennedy Shriver National Institute of Child Health & Human Development; NIH P30 shared resource grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The study was funded by NIH grants AG057587 (W.C. and H.Z.) , AG020670 (H.Z.) , AG062257 (H.Z.) , NS093652 (H.Z.) ; BrightFocus ADR A20183775 (W.C.) ; Brown Foundation 2020 Healthy Aging Initiative (W.C.) ; and Cure Alz-heimer's Fund (H.Z.) . R.K. and C.C. were partially supported by The Cancer Prevention Institute of Texas (CPRIT) RP170005, RP210227, and RP200504; NIH P30 shared resource grant CA125123; NIEHS grants P30 ES030285 and P42 ES027725; and NIMHD P50MD015496. We acknowledge technical assistance from Haiying Liu, Nadia Aithmitti, and Bianca Contreras and gener-osity from Michele Comerota. Our gratitude goes to Dr. Andre Catic for providing MxG founder mice, to Lita Duraine at NRI TEM Core of Baylor Col-lege of Medicine for technical consultation of electron microscopy, and to Dr. Joanna Jankowsky for critical reading and comments. We thank the Neuro-behavioral Core at Baylor College of Medicine, which is supported by IDDRC grant number U54HD083092 from the Eunice Kennedy Shriver National Insti-tute of Child Health & Human Development. Some graphics were created with BioRender.	Altman JB, 2020, P NATL ACAD SCI USA, V117, P17510, DOI 10.1073/pnas.1921324117; Asnis GM, 2005, PROG NEURO-PSYCHOPH, V29, P808, DOI 10.1016/j.pnpbp.2005.03.006; Baik SH, 2016, GLIA, V64, P2274, DOI 10.1002/glia.23074; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Cheadle L, 2020, NEURON, V108, P451, DOI 10.1016/j.neuron.2020.08.002; Chen WT, 2020, CELL, V182, P976, DOI 10.1016/j.cell.2020.06.038; Cheon H, 2009, P NATL ACAD SCI USA, V106, P9373, DOI 10.1073/pnas.0903487106; Chiu Gabriel S, 2018, Oncotarget, V9, P35581, DOI 10.18632/oncotarget.26272; Chiu GS, 2017, CANCER RES, V77, P742, DOI 10.1158/0008-5472.CAN-16-1817; Chiu GS, 2012, J NEUROSCI, V32, P13945, DOI 10.1523/JNEUROSCI.0704-12.2012; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; Cho HJ, 2007, GLIA, V55, P253, DOI 10.1002/glia.20451; Cho HJ, 2009, BIOCHEM BIOPH RES CO, V386, P175, DOI 10.1016/j.bbrc.2009.06.006; Chung WS, 2013, NATURE, V504, P394, DOI 10.1038/nature12776; Crapser JD, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102919; d'Errico P, 2022, NAT NEUROSCI, V25, P20, DOI 10.1038/s41593-021-00951-0; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Devos SL, 2013, J NEUROSCI, V33, P12887, DOI 10.1523/JNEUROSCI.2107-13.2013; DeVos SL, 2013, JOVE-J VIS EXP, DOI 10.3791/50326; Di Domizio J, 2012, P NATL ACAD SCI USA, V109, P14550, DOI 10.1073/pnas.1206923109; Dipasquale O, 2016, BRAIN BEHAV IMMUN, V58, P31, DOI 10.1016/j.bbi.2015.12.011; Ejlerskov P, 2015, CELL, V163, P324, DOI 10.1016/j.cell.2015.08.069; Filipello F, 2018, IMMUNITY, V48, P979, DOI 10.1016/j.immuni.2018.04.016; Frigerio CS, 2019, CELL REP, V27, P1293, DOI 10.1016/j.celrep.2019.03.099; Fritz-French C, 2012, CYTOKINE GROWTH F R, V23, P7, DOI 10.1016/j.cytogfr.2012.01.001; Hammond TR, 2019, IMMUNITY, V50, P253, DOI 10.1016/j.immuni.2018.11.004; Hasel P, 2021, NAT NEUROSCI, V24, P1475, DOI 10.1038/s41593-021-00905-6; Hayley S, 2013, BRAIN BEHAV IMMUN, V31, P115, DOI 10.1016/j.bbi.2012.07.023; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hsu WL, 2014, NEUROPSYCHOPHARMACOL, V39, P746, DOI 10.1038/npp.2013.263; Huang KL, 2017, NAT NEUROSCI, V20, P1052, DOI 10.1038/nn.4587; Huang YT, 2021, NAT IMMUNOL, V22, P586, DOI 10.1038/s41590-021-00913-5; Hur JY, 2020, NATURE, V586, P735, DOI 10.1038/s41586-020-2681-2; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Knopman DS., 2021, NAT REV DIS PRIMERS, V7, P33, DOI [10.1038/s41572-021-00269-y, DOI 10.1038/s41572-021-00269-y]; Koffie RM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-63; Korvatska O, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.559342; Krasemann S, 2017, IMMUNITY, V47, P566, DOI 10.1016/j.immuni.2017.08.008; Lemke G, 2019, NAT REV IMMUNOL, V19, P539, DOI 10.1038/s41577-019-0167-y; Li T, 2020, EMBO J, V39, DOI 10.15252/embj.2019104136; Li W, 2018, GLIA, V66, P2058, DOI 10.1002/glia.23460; Lian H, 2015, NEURON, V85, P101, DOI 10.1016/j.neuron.2014.11.018; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Lieb K, 2006, EUR PSYCHIAT, V21, P204, DOI 10.1016/j.eurpsy.2004.09.030; Mattsson N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.69; Minter MR, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0341-4; Monasor LS, 2020, ELIFE, V9, DOI 10.7554/eLife.54083; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Olah M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19737-2; Owlett LD, 2022, J NEUROINFLAMM, V19, DOI 10.1186/s12974-022-02397-y; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Peet G, 2020, EMBO J, V39, DOI 10.15252/embj.2020105924; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Prinz M, 2021, ANNU REV IMMUNOL, V39, P251, DOI 10.1146/annurev-immunol-093019-110159; Propson NE, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140966; Ramdhani S, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008549; Richetin K, 2020, NAT NEUROSCI, V23, P1567, DOI 10.1038/s41593-020-00728-x; Roy ER, 2020, J CLIN INVEST, V130, P1912, DOI 10.1172/JCI133737; Sadleir KR, 2016, ACTA NEUROPATHOL, V132, P235, DOI 10.1007/s00401-016-1558-9; Sainaghi PP, 2017, J ALZHEIMERS DIS, V55, P59, DOI 10.3233/JAD-160599; Salih DA, 2019, BRAIN COMMUN, V1, DOI 10.1093/braincomms/fcz022; Sanchez-Mendoza EH, 2016, JOVE-J VIS EXP, DOI 10.3791/52932; Sanchez-Varo R, 2012, ACTA NEUROPATHOL, V123, P53, DOI 10.1007/s00401-011-0896-x; Scott-Hewitt N, 2020, EMBO J, V39, DOI 10.15252/embj.2020105380; Shi QQ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6295; Spangenberg E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11674-z; Swartzlander DB, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121109; Tai DJC, 2011, EMBO J, V30, P205, DOI 10.1038/emboj.2010.290; Valentine AD, 1998, SEMIN ONCOL, V25, P39; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Wachholz S, 2016, BRAIN BEHAV IMMUN, V55, P105, DOI 10.1016/j.bbi.2015.09.016; Wilton DK, 2019, ANNU REV NEUROSCI, V42, P107, DOI 10.1146/annurev-neuro-070918-050306; Wu T, 2019, CELL REP, V28, P2111, DOI 10.1016/j.celrep.2019.07.060; Xia XF, 2002, P NATL ACAD SCI USA, V99, P8760, DOI 10.1073/pnas.132045399; Yasuda M, 2021, NEURON, V109, P1333, DOI 10.1016/j.neuron.2021.03.006; Zhang B, 2013, CELL, V153, P707, DOI 10.1016/j.cell.2013.03.030; Zheng LS, 2014, STEM CELL REP, V3, DOI 10.1016/j.stemcr.2014.05.015; Zhou GY, 2019, NUCLEIC ACIDS RES, V47, pW234, DOI 10.1093/nar/gkz240	78	10	10	7	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	MAY 10	2022	55	5					879	+		10.1016/j.immuni.2022.03.018	http://dx.doi.org/10.1016/j.immuni.2022.03.018			23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1P7FS	35443157				2022-12-18	WOS:000802171100012
J	Song, WZ; Antao, OQ; Condiff, E; Sanchez, GM; Chernova, I; Zembrzuski, K; Steach, H; Rubtsova, K; Angeletti, D; Lemenze, A; Laidlaw, BJ; Craft, J; Weinstein, JS				Song, Wenzhi; Antao, Olivia Q.; Condiff, Emily; Sanchez, Gina M.; Chernova, Irene; Zembrzuski, Krzysztof; Steach, Holly; Rubtsova, Kira; Angeletti, Davide; Lemenze, Alexander; Laidlaw, Brian J.; Craft, Joe; Weinstein, Jason S.			Development of Tbet- and CD11c-expressing B cells in a viral infection requires T follicular helper cells outside of germinal centers	IMMUNITY			English	Article							INDUCED CYTIDINE DEAMINASE; CANNABINOID RECEPTOR 2; MARGINAL ZONE; AUTOANTIBODY PRODUCTION; ANTIBODY-RESPONSES; BCL-6 EXPRESSION; CD11C EXPRESSION; LYMPHOID-TISSUE; IFN-GAMMA; MEMORY	Tbet(+)CD11c(+) B cells arise during type 1 pathogen challenge, aging, and autoimmunity in mice and humans. Here, we examined the developmental requirements of this B cell subset. In acute infection, T follicular helper (Tfh) cells, but not Th1 cells, drove Tbet(+)CD11c(+) B cell generation through proximal delivery of help. Tbet(+) CD11c(+) B cells developed prior to germinal center (GC) formation, exhibiting phenotypic and transcriptional profiles distinct from GC B cells. Fate tracking revealed that most Tbet(+)CD11c(+) B cells developed independently of GC entry and cell-intrinsic Bcl6 expression. Tbet(+)CD11c(+) and GC B cells exhibited minimal repertoire overlap, indicating distinct developmental pathways. As the infection resolved, Tbet(+)CD11c(+) B cells localized to the marginal zone where splenic retention depended on integrins LFA-1 and VLA-4, forming a competitive memory subset that contributed to antibody production and secondary GC seeding upon rechallenge. Therefore, Tbet(+)CD11c(+) B cells comprise a GC-independent memory subset capable of rapid and robust recall responses.	[Song, Wenzhi; Condiff, Emily; Chernova, Irene; Steach, Holly; Craft, Joe] Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06510 USA; [Antao, Olivia Q.; Sanchez, Gina M.; Zembrzuski, Krzysztof; Lemenze, Alexander; Weinstein, Jason S.] Rutgers New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07103 USA; [Rubtsova, Kira] Natl Jewish Hlth, Dept Biomed Res, Denver, CO USA; [Angeletti, Davide] Univ Gothenburg, Inst Biomed, Dept Microbiol & Immunol, Gothenburg, Sweden; [Laidlaw, Brian J.] Washington Univ, Sch Med, Dept Med, Div Allergy & Immunol, St Louis, MO 63110 USA; [Craft, Joe] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	Yale University; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Jewish Health; University of Gothenburg; Washington University (WUSTL); Yale University	Craft, J (corresponding author), Yale Univ, Dept Immunobiol, Sch Med, New Haven, CT 06510 USA.; Weinstein, JS (corresponding author), Rutgers New Jersey Med Sch, Ctr Immun & Inflammat, Newark, NJ 07103 USA.; Craft, J (corresponding author), Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA.	joseph.craft@yale.edu; jason.weinstein@rutgers.edu	Song, Wenzhi/GRR-9785-2022; Angeletti, Davide/H-7350-2019	Song, Wenzhi/0000-0001-6969-7019; Angeletti, Davide/0000-0002-5256-1972; Antao, Olivia/0000-0002-5306-3190; Condiff, Emily/0000-0001-8391-6839	Edward L. Tatum Fellowship from the Graduate School of Arts Sciences; Gershon-Trudeau Fellowship from the Department of Immunobiology of Yale University; New Jersey Health Foundation; National Institutes of Health (NIH) [K01 AR067892, R01 AR073912]; Lupus Research Alliance; NIH [R37 AR40072, R01 AR074545]	Edward L. Tatum Fellowship from the Graduate School of Arts Sciences; Gershon-Trudeau Fellowship from the Department of Immunobiology of Yale University; New Jersey Health Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lupus Research Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors acknowledge members of our departments for critical review of the manuscript. W.S. is the recipient of the Edward L. Tatum Fellowship from the Graduate School of Arts & Sciences and the Gershon-Trudeau Fellowship from the Department of Immunobiology of Yale University. J.S.W. and the laboratory were supported in part by New Jersey Health Foundation and National Institutes of Health (NIH) grants K01 AR067892 and R01 AR073912. J.C. and laboratory support came in part from the Lupus Research Alliance and NIH grants R37 AR40072 and R01 AR074545. Correspondence and requests for materials should be addressed toJ.C.(joseph.craft@yale.edu) and J.S.W. (jason.weinstein@rutgers.edu).	Angeletti D, 2017, NAT IMMUNOL, V18, P456, DOI 10.1038/ni.3680; Austin JW, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax0904; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Barnett BE, 2016, J IMMUNOL, V197, P1017, DOI 10.4049/jimmunol.1500368; Basu S, 2011, J IMMUNOL, V187, P5720, DOI 10.4049/jimmunol.1102195; Beck TC, 2014, J EXP MED, V211, P2567, DOI 10.1084/jem.20140457; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Bhattacharya D, 2007, J IMMUNOL, V179, P6808, DOI 10.4049/jimmunol.179.10.6808; Chan TD, 2009, J IMMUNOL, V183, P3139, DOI 10.4049/jimmunol.0901690; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Cinamon G, 2008, NAT IMMUNOL, V9, P54, DOI 10.1038/ni1542; Dedeoglu F, 2004, INT IMMUNOL, V16, P395, DOI 10.1093/intimm/dxh042; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Di Niro R, 2015, IMMUNITY, V43, P120, DOI 10.1016/j.immuni.2015.06.013; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Green JA, 2011, NAT IMMUNOL, V12, P672, DOI 10.1038/ni.2047; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Hao Y, 2011, BLOOD, V118, P1294, DOI 10.1182/blood-2011-01-330530; Hirako IC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13277; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Jenks SA, 2018, IMMUNITY, V49, P725, DOI 10.1016/j.immuni.2018.08.015; Johnson JL, 2020, IMMUNITY, V52, P842, DOI 10.1016/j.immuni.2020.03.020; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Karnell JL, 2017, CELL IMMUNOL, V321, P40, DOI 10.1016/j.cellimm.2017.05.008; Keller B, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abh0891; Knode LMR, 2017, J IMMUNOL, V198, P1921, DOI 10.4049/jimmunol.1601106; Knox JJ, 2019, IMMUNOL REV, V288, P149, DOI 10.1111/imr.12736; Kurachi M, 2011, J EXP MED, V208, P1605, DOI 10.1084/jem.20102101; Laidlaw BJ, 2020, NAT IMMUNOL, V21, P1082, DOI 10.1038/s41590-020-0713-6; Laidlaw BJ, 2017, J EXP MED, V214, P639, DOI 10.1084/jem.20161461; Lau D, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aai8153; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Levack RC, 2020, J IMMUNOL, V205, P1050, DOI 10.4049/jimmunol.2000206; Li HF, 2016, J IMMUNOL, V196, P4064, DOI 10.4049/jimmunol.1501027; Linterman MA, 2010, J EXP MED, V207, P353, DOI 10.1084/jem.20091738; Liu Y, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1438-2; Lu PW, 2017, SCIENCE, V356, DOI 10.1126/science.aai9264; Lu TT, 2002, SCIENCE, V297, P409, DOI 10.1126/science.1071632; Manni M, 2018, NAT IMMUNOL, V19, P407, DOI 10.1038/s41590-018-0056-8; Marshall HD, 2011, IMMUNITY, V35, P633, DOI 10.1016/j.immuni.2011.08.016; MASON DY, 1992, INT IMMUNOL, V4, P163, DOI 10.1093/intimm/4.2.163; Mesin L, 2020, CELL, V180, P92, DOI 10.1016/j.cell.2019.11.032; Miyauchi K, 2016, NAT IMMUNOL, V17, P1447, DOI 10.1038/ni.3563; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Mueller SN, 2007, SCIENCE, V317, P670, DOI 10.1126/science.1144830; Muppidi JR, 2011, J EXP MED, V208, P1941, DOI 10.1084/jem.20111083; Naradikian MS, 2016, J IMMUNOL, V197, P1023, DOI 10.4049/jimmunol.1600522; Nellore A., 2019, BIORXIV, V643973, DOI DOI 10.1101/643973; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Oxenius A, 1998, EUR J IMMUNOL, V28, P390, DOI 10.1002/(SICI)1521-4141(199801)28:01<390::AID-IMMU390>3.3.CO;2-F; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Racine R, 2008, J IMMUNOL, V181, P1375, DOI 10.4049/jimmunol.181.2.1375; Rakhmanov M, 2009, P NATL ACAD SCI USA, V106, P13451, DOI 10.1073/pnas.0901984106; Richard K, 2008, J IMMUNOL, V181, P1746, DOI 10.4049/jimmunol.181.3.1746; Ricker E., 2021, SEXSPECIFIC DIFFEREN, DOI [10.1101/2021.01.20.427400, DOI 10.1101/2021.01.20.427400]; Rivera-Correa J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01476-6; Roco JA, 2019, IMMUNITY, V51, P337, DOI 10.1016/j.immuni.2019.07.001; Rubtsov AV, 2015, J IMMUNOL, V195, P71, DOI 10.4049/jimmunol.1500055; Rubtsov AV, 2013, IMMUNOL RES, V55, P210, DOI 10.1007/s12026-012-8365-8; Rubtsov AV, 2011, BLOOD, V118, P1305, DOI 10.1182/blood-2011-01-331462; Rubtsova K, 2017, J CLIN INVEST, V127, P1392, DOI 10.1172/JCI91250; Rubtsova K, 2013, P NATL ACAD SCI USA, V110, pE3216, DOI 10.1073/pnas.1312348110; Scandella E, 2008, NAT IMMUNOL, V9, P667, DOI 10.1038/ni.1605; Schweier O, 2019, EUR J IMMUNOL, V49, P626, DOI 10.1002/eji.201847772; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Stone SL, 2019, IMMUNITY, V50, P1172, DOI 10.1016/j.immuni.2019.04.004; Sutton HJ, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108684; Tedford K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02482-4; Trivedi N, 2019, IMMUNITY, V51, P1088, DOI 10.1016/j.immuni.2019.10.004; Vander Heiden JA, 2014, BIOINFORMATICS, V30, P1930, DOI 10.1093/bioinformatics/btu138; Viant C, 2020, CELL, V183, P1298, DOI 10.1016/j.cell.2020.09.063; Wang NS, 2012, NAT IMMUNOL, V13, P604, DOI 10.1038/ni.2294; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03750-7; Weinstein JS, 2018, J EXP MED, V215, P337, DOI 10.1084/jem.20170457; Weinstein JS, 2016, NAT IMMUNOL, V17, P1197, DOI 10.1038/ni.3554; Weinstein JS, 2013, J IMMUNOL, V190, P3916, DOI 10.4049/jimmunol.1201880; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; William J, 2002, SCIENCE, V297, P2066, DOI 10.1126/science.1073924; Woodruff Matthew, 2020, medRxiv, DOI 10.1101/2020.04.29.20083717; Woodruff M, 2021, ARTHRITIS RHEUMATOL, V73, P13, DOI 10.1101/2020.10.21.20216192; Woodruff MC, 2020, NAT IMMUNOL, V21, P1506, DOI 10.1038/s41590-020-00814-z; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yates JL, 2013, J IMMUNOL, V191, P1240, DOI 10.4049/jimmunol.1300062; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Yu F, 2015, NAT IMMUNOL, V16, P197, DOI 10.1038/ni.3053; Zhen QL, 2005, J CLIN INVEST, V115, P3428, DOI 10.1172/JCI23587; Zhou C, 2003, J IMMUNOL, V170, P1887, DOI 10.4049/jimmunol.170.4.1887; Zotos D, 2010, J EXP MED, V207, P365, DOI 10.1084/jem.20091777; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	96	10	10	3	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	FEB 8	2022	55	2					290	+		10.1016/j.immuni.2022.01.002	http://dx.doi.org/10.1016/j.immuni.2022.01.002			24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YX7WH	35090581	Green Accepted			2022-12-18	WOS:000754308000013
J	Kim, E; Paik, D; Ramirez, RN; Biggs, DG; Park, Y; Kwon, HK; Choi, GB; Huh, JR				Kim, Eunha; Paik, Donggi; Ramirez, Ricardo N.; Biggs, Delaney G.; Park, Youngjun; Kwon, Ho-Keun; Choi, Gloria B.; Huh, Jun R.			Maternal gut bacteria drive intestinal inflammation in offspring with neurodevelopmental disorders by altering the chromatin landscape of CD4(+) T cells	IMMUNITY			English	Article							DEVELOPMENTAL ORIGINS; CITROBACTER-RODENTIUM; EXPRESSION ANALYSIS; INDUCED COLITIS; RNA-SEQ; AUTISM; MICROBIOTA; GENE; PREGNANCY; DISEASE	Children with autism spectrum disorders often display dysregulated immune responses and related gastrointestinal symptoms. However, the underlying mechanisms leading to the development of both phenotypes have not been elucidated. Here, we show that mouse offspring exhibiting autism-like phenotypes due to prenatal exposure to maternal inflammation were more susceptible to developing intestinal inflammation following challenges later in life. In contrast to its prenatal role in neurodevelopmental phenotypes, interleukin-17A (IL-17A) generated immune-primed phenotypes in offspring through changes in the maternal gut microbiota that led to postnatal alterations in the chromatin landscape of naive CD4(+) T cells. The transfer of stool samples from pregnant mice with enhanced IL-17A responses into germ-free dams produced immune-primed phenotypes in offspring. Our study provides mechanistic insights into why children exposed to heightened inflammation in the womb might have an increased risk of developing inflammatory diseases in addition to neurodevelopmental disorders.	[Kim, Eunha; Paik, Donggi; Ramirez, Ricardo N.; Biggs, Delaney G.; Park, Youngjun; Kwon, Ho-Keun; Huh, Jun R.] Harvard Med Sch, Blavatnik Inst, Dept Immunol, Boston, MA 02115 USA; [Choi, Gloria B.] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA; [Huh, Jun R.] Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA; [Huh, Jun R.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Park, Youngjun] Jeju Natl Univ, Coll Pharm, Dept Pharm, Jeju Si 63243, Jeju Special Se, South Korea; [Kwon, Ho-Keun] Yonsei Univ, Coll Med, Inst Immunol & Immunol Dis, Dept Microbiol & Immunol, Seoul 03722, South Korea; [Kwon, Ho-Keun] Yonsei Univ, Coll Med, Brain Korea 21 PLUS Project Med Sci, Seoul 03722, South Korea	Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Northwell Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Jeju National University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Huh, JR (corresponding author), Harvard Med Sch, Blavatnik Inst, Dept Immunol, Boston, MA 02115 USA.; Choi, GB (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.; Huh, JR (corresponding author), Harvard Med Sch, Evergrande Ctr Immunol Dis, Boston, MA 02115 USA.; Huh, JR (corresponding author), Brigham & Womens Hosp, Boston, MA 02115 USA.	gbchoi@mit.edu; jun_huh@hms.harvard.edu	Kim, Eunha/AAG-9172-2022; Kim, Eunha/AGH-3982-2022	Kim, Eunha/0000-0001-7041-1727; Kim, Eunha/0000-0001-7041-1727; Biggs, Delaney/0000-0001-8606-6067; Paik, Donggi/0000-0003-1031-0371	National Research Foundation of Korea (NRF) - Ministry of Education [2018R1A6A3A03010693]; Jeongho Kim Neurodevelopmental Research Fund; Simons Foundation Autism Research Initiative; National Institute of Mental Health grants [R01MH115037, R01MH119459]; N of One: Autism Research Foundation; Burroughs Wellcome Fund; Kenneth Rainin Foundation	National Research Foundation of Korea (NRF) - Ministry of Education; Jeongho Kim Neurodevelopmental Research Fund; Simons Foundation Autism Research Initiative; National Institute of Mental Health grants; N of One: Autism Research Foundation; Burroughs Wellcome Fund(Burroughs Wellcome Fund); Kenneth Rainin Foundation	We thank all Huh laboratory members for scientific comments; N. Lee and J. Vasquez for technical assistance in GF work; M. Trombly for scientific editing of the manuscript; R. Bronson and the Rodent Histopathology Core at Harvard Medical School for performing H&E analysis and disease scoring; P.M. Llopis and the MicRoN Core at Harvard Medical School for their expertise and instru-ment availability for imaging; and the Biopolymer facility Next-Generation Sequencing Core at Harvard Medical School for their expertise and instrument availability with ATAC-seq and 16S rRNA sequencing. E.K. was supported by the basic science research program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2018R1A6A3A03010693) . G.B.C. and J.R.H. were supported by the Jeongho Kim Neurodevelopmental Research Fund, the Simons Foundation Autism Research Initiative, and National Institute of Mental Health grants (R01MH115037 and R01MH119459, respectively) . J.R.H. was also supported by the N of One: Autism Research Foundation and the Burroughs Wellcome Fund. Earlier work included in this study was made possible by the support from the Kenneth Rainin Foundation to J.R.H. All schematic diagrams were created by Biorender.com .	Atladottir HO, 2010, J AUTISM DEV DISORD, V40, P1423, DOI 10.1007/s10803-010-1006-y; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bouladoux Nicolas, 2017, Curr Protoc Immunol, V119, DOI 10.1002/cpim.34; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buie T, 2010, PEDIATRICS, V125, pS1, DOI 10.1542/peds.2009-1878C; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/nmeth.3869, 10.1038/NMETH.3869]; Carpenter AC, 2012, IMMUNITY, V37, P622, DOI 10.1016/j.immuni.2012.06.019; Chaidez V, 2014, J AUTISM DEV DISORD, V44, P1117, DOI 10.1007/s10803-013-1973-x; Choi GB, 2016, SCIENCE, V351, P933, DOI 10.1126/science.aad0314; Chuang H.C., 2016, MAP4K FAMILY KINASES; Coury DL, 2012, PEDIATRICS, V130, pS160, DOI 10.1542/peds.2012-0900N; de Aguero MG, 2016, SCIENCE, V351, P1296, DOI 10.1126/science.aad2571; Devaiah BN, 2016, NAT STRUCT MOL BIOL, V23, P540, DOI 10.1038/nsmb.3228; DIELEMAN LA, 1994, GASTROENTEROLOGY, V107, P1643, DOI 10.1016/0016-5085(94)90803-6; Doshi-Velez F, 2015, INFLAMM BOWEL DIS, V21, P2281, DOI 10.1097/MIB.0000000000000502; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Ferretti P, 2018, CELL HOST MICROBE, V24, P133, DOI 10.1016/j.chom.2018.06.005; Ganal-Vonarburg SC, 2020, SCIENCE, V368, P604, DOI 10.1126/science.aba0478; Gaspar J., 2018, BIORXIV, DOI [DOI 10.1101/496521, 10.1101/496521]; Gaspar JM, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2579-2; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gopalakrishna KP, 2019, NAT MED, V25, P1110, DOI 10.1038/s41591-019-0480-9; Harbour SN, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aaw2262; Harris NL, 2006, J IMMUNOL, V177, P6256, DOI 10.4049/jimmunol.177.9.6256; Hsiao EY, 2014, HARVARD REV PSYCHIAT, V22, P104, DOI 10.1097/HRP.0000000000000029; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Hsiao EY, 2012, P NATL ACAD SCI USA, V109, P12776, DOI 10.1073/pnas.1202556109; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kalish BT, 2021, NAT NEUROSCI, V24, P204, DOI 10.1038/s41593-020-00762-9; Kellermayer R, 2012, CAN J GASTROENTEROL, V26, P909, DOI 10.1155/2012/526408; Kim S, 2017, NATURE, V549, P528, DOI 10.1038/nature23910; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Kohane IS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033224; Koroleva EP, 2015, J IMMUNOL METHODS, V421, P61, DOI 10.1016/j.jim.2015.02.003; Korpela K, 2020, CELL, V183, P324, DOI 10.1016/j.cell.2020.08.047; Lammert CR, 2018, J IMMUNOL, V201, P845, DOI 10.4049/jimmunol.1701755; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lee BK, 2015, BRAIN BEHAV IMMUN, V44, P100, DOI 10.1016/j.bbi.2014.09.001; Lee Y, 2012, NAT IMMUNOL, V13, P991, DOI 10.1038/ni.2416; Li WQ, 2021, BRAIN BEHAV, V11, DOI 10.1002/brb3.2133; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malkova NV, 2012, BRAIN BEHAV IMMUN, V26, P607, DOI 10.1016/j.bbi.2012.01.011; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Mead J, 2015, IMMUNOL LETT, V163, P49, DOI 10.1016/j.imlet.2014.11.006; Moore SE, 2006, P NUTR SOC, V65, P311, DOI 10.1079/PNS2006503; Osbelt L, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008448; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; POWRIE F, 1993, INT IMMUNOL, V5, P1461, DOI 10.1093/intimm/5.11.1461; Prescott SL, 2008, CLIN EXP ALLERGY, V38, P1606, DOI 10.1111/j.1365-2222.2008.03061.x; Ramanan D, 2020, CELL, V181, P1276, DOI 10.1016/j.cell.2020.04.030; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reed MD, 2020, NATURE, V577, P249, DOI 10.1038/s41586-019-1843-6; Rios D, 2016, MUCOSAL IMMUNOL, V9, P907, DOI 10.1038/mi.2015.121; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sagaidak S, 2016, J MICROBIOL METH, V126, P76, DOI 10.1016/j.mimet.2016.05.008; Silberger DJ, 2017, MUCOSAL IMMUNOL, V10, P1108, DOI 10.1038/mi.2017.47; Smith SEP, 2007, J NEUROSCI, V27, P10695, DOI 10.1523/JNEUROSCI.2178-07.2007; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wadhwa PD, 2009, SEMIN REPROD MED, V27, P358, DOI 10.1055/s-0029-1237424; Wang SP, 2020, TRENDS MICROBIOL, V28, P28, DOI 10.1016/j.tim.2019.07.010; Witzel M, 2017, NAT GENET, V49, P742, DOI 10.1038/ng.3833; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zegarra-Ruiz DF, 2021, NATURE, V594, P413, DOI 10.1038/s41586-021-03531-1; Zinkernagel RM, 2001, NEW ENGL J MED, V345, P1331, DOI 10.1056/NEJMra012493	68	10	10	5	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JAN 11	2022	55	1					145	+		10.1016/j.immuni.2021.11.005	http://dx.doi.org/10.1016/j.immuni.2021.11.005			22	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YI5DT	34879222				2022-12-18	WOS:000743868800003
J	Molodtsov, AK; Khatwani, N; Vella, JL; Lewis, KA; Zhao, YD; Han, JC; Sullivan, DE; Searles, TG; Preiss, NK; Shabaneh, TB; Zhang, PS; Hawkes, AR; Malik, BT; Kolling, FW; Usherwood, EJ; Wong, SL; Phillips, JD; Shirai, K; Angeles, CV; Yan, SF; Curiel, TJ; Huang, YH; Cheng, C; Turk, MJ				Molodtsov, Aleksey K.; Khatwani, Nikhil; Vella, Jennifer L.; Lewis, Kathryn A.; Zhao, Yanding; Han, Jichang; Sullivan, Delaney E.; Searles, Tyler G.; Preiss, Nicholas K.; Shabaneh, Tamer B.; Zhang, Peisheng; Hawkes, Aaron R.; Malik, Brian T.; Kolling, Fred W.; Usherwood, Edward J.; Wong, Sandra L.; Phillips, Joseph D.; Shirai, Keisuke; Angeles, Christina, V; Yan, Shaofeng; Curiel, Tyler J.; Huang, Yina H.; Cheng, Chao; Turk, Mary Jo			Resident memory CD8(+) T cells in regional lymph nodes mediate immunity to metastatic melanoma	IMMUNITY			English	Article							NONLYMPHOID TISSUES; TUMOR-IMMUNITY; BLOOD-VESSELS; SURVIVAL; VITILIGO; CANCER; AUTOIMMUNITY; ASSOCIATION; RESPONSES; EXIT	The nature of the anti-tumor immune response changes as primary tumors progress and metastasize. We investigated the role of resident memory (Trm) and circulating memory (Tcirm) cells in anti-tumor responses at metastatic locations using a mouse model of melanoma-associated vitiligo. We found that the transcriptional characteristics of tumor-specific CD8(+) T cells were defined by the tissue of occupancy. Parabiosis revealed that tumor-specific Trm and Tcirm compartments persisted throughout visceral organs, but Trm cells dominated lymph nodes (LNs). Single-cell RNA-sequencing profiles of Trm cells in LN and skin were distinct, and T cell clonotypes that occupied both tissues were overwhelmingly maintained as Trm in LNs. Whereas Tcirm cells prevented melanoma growth in the lungs, Trm afforded long-lived protection against melanoma seeding in LNs. Expanded Trm populations were also present in melanoma-involved LNs from patients, and their transcriptional signature predicted better survival. Thus, tumor-specific Trm cells persist in LNs, restricting metastatic cancer.	[Molodtsov, Aleksey K.; Khatwani, Nikhil; Vella, Jennifer L.; Han, Jichang; Sullivan, Delaney E.; Searles, Tyler G.; Preiss, Nicholas K.; Shabaneh, Tamer B.; Malik, Brian T.; Usherwood, Edward J.; Huang, Yina H.; Turk, Mary Jo] Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA; [Lewis, Kathryn A.; Zhang, Peisheng; Hawkes, Aaron R.; Kolling, Fred W.; Huang, Yina H.; Turk, Mary Jo] Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; [Zhao, Yanding] Geisel Sch Med Dartmouth, Dept Mol & Syst Biol, Lebanon, NH 03756 USA; [Wong, Sandra L.; Phillips, Joseph D.] Dartmouth Hitchcock Med Ctr, Dept Surg, Lebanon, NH 03756 USA; [Shirai, Keisuke] Dartmouth Hitchcock Med Ctr, Dept Med, Lebanon, NH 03756 USA; [Angeles, Christina, V] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Yan, Shaofeng; Huang, Yina H.] Dartmouth Hitchcock Med Ctr, Dept Pathol & Lab Med, Lebanon, NH 03756 USA; [Curiel, Tyler J.] Univ Texas Hlth, Dept Med, San Antonio, TX 78229 USA; [Curiel, Tyler J.] Univ Texas Hlth, Mays Canc Ctr, San Antonio, TX 78229 USA; [Cheng, Chao] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Dartmouth College; Dartmouth College; Dartmouth College; University of Michigan System; University of Michigan; Dartmouth College; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine	Turk, MJ (corresponding author), Geisel Sch Med Dartmouth, Dept Microbiol & Immunol, Lebanon, NH 03756 USA.; Turk, MJ (corresponding author), Geisel Sch Med Dartmouth, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA.; Cheng, C (corresponding author), Baylor Coll Med, Dept Med, Houston, TX 77030 USA.	chao.cheng@bcm.edu; mary.jo.turk@dartmouth.edu	Zhao, Yanding/ABF-7808-2021	Huang, Yina/0000-0002-0125-9351; Wong, Sandra/0000-0002-8594-6086; Yan, Shaofeng/0000-0001-9654-2100	NIH [R01 CA225028, R01 CA205965, R21 CA227996, F31CA232554, R01 CA054174, CA231325]; Cancer Prevention Research Institute of Texas [CPRIT RR180061]; O. Ross McIntyre, M.D. Endowment, Knights of the York Cross of Honor and Munck-Pfefferkorn Research Funds; Owens Foundation grant; Immune Monitoring Shared Resource [5P30 CA023108-40]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention Research Institute of Texas; O. Ross McIntyre, M.D. Endowment, Knights of the York Cross of Honor and Munck-Pfefferkorn Research Funds; Owens Foundation grant; Immune Monitoring Shared Resource	Keep on jammin, MCVC. We thank David Findley, Kayla Fay, Fatima Haider, and Brian Highhouse for their help in acquiring patient specimens and DartLab for assistance with sample processing and flow cytometry. This work was supported by NIH R01 CA225028 to M.J.T., NIH R01 CA205965 to M.J. T. and T.J.C., NIH R21 CA227996 to C.C., a Cancer Prevention Research Institute of Texas grant (CPRIT RR180061) to C.C. (C.C. is a CPRIT Scholar in Cancer Research), NIH F31CA232554 to A.K.M., The O. Ross McIntyre, M.D. Endowment, Knights of the York Cross of Honor and Munck-Pfefferkorn Research Funds to M.J.T., NIH R01 CA054174 and CA231325 and an Owens Foundation grant to T.J.C., and support from 5P30 CA023108-40 (Immune Monitoring Shared Resource). Graphical abstract was created with BioRender.com.	Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Beura LK, 2018, IMMUNITY, V48, P327, DOI 10.1016/j.immuni.2018.01.015; Blomberg OS, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.036236; Brown M, 2018, SCIENCE, V359, P1408, DOI 10.1126/science.aal3662; Buggert M, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar4526; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Byrne KT, 2014, J IMMUNOL, V192, P1433, DOI 10.4049/jimmunol.1302139; Byrne KT, 2011, J CLIN INVEST, V121, P1797, DOI 10.1172/JCI44849; Carrette F, 2012, SEMIN IMMUNOL, V24, P209, DOI 10.1016/j.smim.2012.04.010; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Cote AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026491; Dewar DJ, 2004, J CLIN ONCOL, V22, P3345, DOI 10.1200/JCO.2004.12.177; Eggermont AMM, 2016, NEW ENGL J MED, V375, P1845, DOI 10.1056/NEJMoa1611299; Enamorado M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16073; Eyles J, 2010, J CLIN INVEST, V120, P2030, DOI 10.1172/JCI42002; Faries MB, 2017, NEW ENGL J MED, V376, P2211, DOI 10.1056/NEJMoa1613210; Frizzell H, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aay9283; Gebhardt T, 2018, IMMUNOL REV, V283, P54, DOI 10.1111/imr.12650; Goddard ET, 2016, JOVE-J VIS EXP, DOI 10.3791/54903; Gonzalez H, 2018, GENE DEV, V32, P1267, DOI 10.1101/gad.314617.118; Grabowska J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02472; Han JC, 2021, NAT CANCER, V2, DOI 10.1038/s43018-021-00180-1; Hayward SL, 2020, NAT IMMUNOL, V21, P309, DOI 10.1038/s41590-019-0584-x; Hua C, 2016, JAMA DERMATOL, V152, P45, DOI 10.1001/jamadermatol.2015.2707; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Jameson SC, 2018, IMMUNITY, V48, P214, DOI 10.1016/j.immuni.2018.02.010; Jansen CS, 2019, NATURE, V576, P465, DOI 10.1038/s41586-019-1836-5; Johansen P, 2014, JOVE-J VIS EXP, DOI 10.3791/51031; Jones D, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00036; Kamran P, 2013, JOVE-J VIS EXP, DOI 10.3791/50556; Kohlmeier JE, 2010, IMMUNITY, V33, P96, DOI 10.1016/j.immuni.2010.06.016; Kumar BV, 2017, CELL REP, V20, P2921, DOI 10.1016/j.celrep.2017.08.078; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Larkin J, 2019, NEW ENGL J MED, V381, P1535, DOI 10.1056/NEJMoa1910836; Lengagne R, 2008, J IMMUNOL, V180, P130, DOI 10.4049/jimmunol.180.1.130; Lo JA, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abd8636; Louie DAP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00347; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, J IMMUNOL, V194, P2059, DOI 10.4049/jimmunol.1402256; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; Malik BT, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam6346; Martin MD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02692; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Molodtsov A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02810; Mullins DW, 2003, J EXP MED, V198, P1023, DOI 10.1084/jem.20021348; Munn DH, 2006, IMMUNOL REV, V213, P146, DOI 10.1111/j.1600-065X.2006.00444.x; Nizard M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15221; Nunez NG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17046-2; Overwijk WW, 2003, J EXP MED, V198, P569, DOI 10.1084/jem.20030590; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pallett LJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200050; Pan YD, 2017, NATURE, V543, P252, DOI 10.1038/nature21379; Pereira ER, 2018, SCIENCE, V359, P1403, DOI 10.1126/science.aal3622; Qiu XJ, 2017, NAT METHODS, V14, P979, DOI [10.1038/NMETH.4402, 10.1038/nmeth.4402]; Qiu XJ, 2017, NAT METHODS, V14, P309, DOI [10.1038/NMETH.4150, 10.1038/nmeth.4150]; Reading JL, 2018, IMMUNOL REV, V283, P194, DOI 10.1111/imr.12657; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Riley RS, 2019, NAT REV DRUG DISCOV, V18, P175, DOI 10.1038/s41573-018-0006-z; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Schenkel JM, 2014, J IMMUNOL, V192, P2961, DOI 10.4049/jimmunol.1400003; Shiow LR, 2006, NATURE, V440, P540, DOI 10.1038/nature04606; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Teulings HE, 2015, J CLIN ONCOL, V33, P773, DOI 10.1200/JCO.2014.57.4756; Tietze JK, 2017, EUR J CANCER, V75, P268, DOI 10.1016/j.ejca.2016.12.031; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Turk MJ, 2004, J EXP MED, V200, P771, DOI 10.1084/jem.20041130; Varn FS, 2017, CANCER RES, V77, P1271, DOI 10.1158/0008-5472.CAN-16-2490; Varn FS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10248; Weber JS, 2015, LANCET ONCOL, V16, P375, DOI 10.1016/S1470-2045(15)70076-8; Zhang PS, 2007, CANCER RES, V67, P6468, DOI 10.1158/0008-5472.CAN-07-1264	73	10	10	2	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	SEP 14	2021	54	9					2117	+		10.1016/j.immuni.2021.08.019	http://dx.doi.org/10.1016/j.immuni.2021.08.019		SEP 2021	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UQ0VB	34525340	Green Accepted, Bronze			2022-12-18	WOS:000695789800018
J	Cilenti, F; Barbiera, G; Caronni, N; Iodice, D; Montaldo, E; Barresi, S; Lusito, E; Cuzzola, V; Vittoria, FM; Mezzanzanica, L; Miotto, P; Di Lucia, P; Lazarevic, D; Cirillo, DM; Iannacone, M; Genua, M; Ostuni, R				Cilenti, Francesco; Barbiera, Giulia; Caronni, Nicoletta; Iodice, Dario; Montaldo, Elisa; Barresi, Simona; Lusito, Eleonora; Cuzzola, Vincenzo; Vittoria, Francesco Maria; Mezzanzanica, Luca; Miotto, Paolo; Di Lucia, Pietro; Lazarevic, Dejan; Cirillo, Daniela Maria; Iannacone, Matteo; Genua, Marco; Ostuni, Renato			A PGE(2)-MEF2A axis enables context-dependent control of inflammatory gene expression	IMMUNITY			English	Article							MACROPHAGE POLARIZATION; CHROMATIN ACCESSIBILITY; BIOCONDUCTOR PACKAGE; ANALYSIS REVEALS; TUMOR-GROWTH; RNA-SEQ; TRANSCRIPTION; ACTIVATION; ENHANCERS; RECEPTOR	Tight control of inflammatory gene expression by antagonistic environmental cues is key to ensure immune protection while preventing tissue damage. Prostaglandin E-2 (PGE(2)) modulates macrophage activation during homeostasis and disease, but the underlying mechanisms remain incompletely characterized. Here we dissected the genomic properties of lipopolysaccharide (LPS)-induced genes whose expression is antagonized by PGE(2). The latter molecule targeted a set of inflammatory gene enhancers that, already in unstimulated macrophages, displayed poorly permissive chromatin organization and were marked by the transcription factormyocyte enhancer factor 2A(MEF2A). Deletion of MEF2A phenocopied PGE(2) treatmentand abolished type I interferon (IFN I) induction upon exposure to innate immune stimuli. Mechanistically, PGE(2) interfered with LPS-mediated activation of ERK5, a known transcriptional partner of MEF2. This study highlights principles of plasticity and adaptation in cells exposed to a complex environment and uncovers a transcriptional circuit for IFN I induction with relevance for infectious diseases or cancer.	[Cilenti, Francesco; Vittoria, Francesco Maria; Mezzanzanica, Luca; Iannacone, Matteo; Ostuni, Renato] Univ Vita Salute San Raffaele, Milan, Italy; [Cilenti, Francesco; Barbiera, Giulia; Caronni, Nicoletta; Iodice, Dario; Montaldo, Elisa; Barresi, Simona; Lusito, Eleonora; Cuzzola, Vincenzo; Vittoria, Francesco Maria; Mezzanzanica, Luca; Genua, Marco; Ostuni, Renato] San Raffaele Telethon Inst Gene Therapy SR Tiget, Milan, Italy; [Cilenti, Francesco; Barbiera, Giulia; Caronni, Nicoletta; Iodice, Dario; Montaldo, Elisa; Barresi, Simona; Lusito, Eleonora; Cuzzola, Vincenzo; Vittoria, Francesco Maria; Mezzanzanica, Luca; Genua, Marco; Ostuni, Renato] IRCCS San Raffaele Sci Inst, Genom Innate Immune Syst Unit, Milan, Italy; [Miotto, Paolo; Cirillo, Daniela Maria] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Emerging Bacterial Pathogens Unit, Milan, Italy; [Di Lucia, Pietro; Iannacone, Matteo] IRCCS San Raffaele Sci Inst, Div Immunol Transplantat & Infect Dis, Dynam Immune Responses Unit, Milan, Italy; [Lazarevic, Dejan] IRCCS San Raffaele Sci Inst, Ctr Omics Sci COSR, Milan, Italy; [Iannacone, Matteo] IRCCS San Raffaele Sci Inst, Expt Imaging Ctr, Milan, Italy	Vita-Salute San Raffaele University; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Ostuni, R (corresponding author), Univ Vita Salute San Raffaele, Milan, Italy.; Ostuni, R (corresponding author), San Raffaele Telethon Inst Gene Therapy SR Tiget, Milan, Italy.; Ostuni, R (corresponding author), IRCCS San Raffaele Sci Inst, Genom Innate Immune Syst Unit, Milan, Italy.	ostuni.renato@hsr.it	Iannacone, Matteo/I-8507-2018; Montaldo, Elisa/AAB-9353-2022; Miotto, Paolo/E-3940-2017; Genua, Marco/J-4159-2018	Iannacone, Matteo/0000-0002-9370-2671; Miotto, Paolo/0000-0003-4610-2427; lazarevic, dejan/0000-0003-4527-290X; Caronni, Nicoletta/0000-0002-3263-7108; Montaldo, Elisa/0000-0001-9293-0683; Genua, Marco/0000-0002-0764-8163	Fondazione Umberto Veronesi (FUV) fellowship; European Research Council (ERC) [759532]; Italian Telethon Foundation SR-Tiget [F04]; Italian Association for Cancer Research (AIRC) [20247]; My First AIRC Grant [MFAG] [22737]; Italian Ministry of Health (MoH) [GR-201602362156]; Cariplo-Foundation [2015-0990]; Infect-ERA grant [126]; ERC Consolidator Grant [725038]; AIRC [22737, 19891]; Italian MoH [RF-201812365801]; Lombardy Foundation for Biomedical Research (FRRB) [2015-0010]; European Molecular Biology Organization Young Investigator Program; Giovanni Armenise-Harvard Foundation	Fondazione Umberto Veronesi (FUV) fellowship(Fondazione Umberto Veronesi); European Research Council (ERC)(European Research Council (ERC)European Commission); Italian Telethon Foundation SR-Tiget; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); My First AIRC Grant [MFAG](Fondazione AIRC per la ricerca sul cancro); Italian Ministry of Health (MoH)(Ministry of Health, Italy); Cariplo-Foundation(Fondazione Cariplo); Infect-ERA grant; ERC Consolidator Grant(European Research Council (ERC)); AIRC(Fondazione AIRC per la ricerca sul cancro); Italian MoH(Ministry of Health, Italy); Lombardy Foundation for Biomedical Research (FRRB); European Molecular Biology Organization Young Investigator Program(European Molecular Biology Organization (EMBO)); Giovanni Armenise-Harvard Foundation	We thank R.O. lab members and Christian Bogdan, Dario Bonanomi, Jean-Michel Cioni, Andrea Ditadi, Luigi Naldini, Gioacchino Natoli, Stephen Smale, Guenther Weiss, and Ivan Zanoni for inputs and/or critical reading of the manuscript; Hans Hacker and Federica Benvenuti for sharing Hoxb8-FL cells and culture protocols; Michael Huber, Lidia Avalle, and Valeria Poli for sharing bone marrow cells from MEF2C/D-deficient or STAT3-deficient mice, respectively; Angelo Lombardo for help with CRISPR-Cas9 gene disruption experiments; Matteo Chiacchiaretta for help with mycobacterial infection experiments; and the Center for Omics Sciences (COSR), the Proteomics and Metabolomics Facility (ProMeFa), the Flow Cytometry Resource, the Advanced Cytometry Technical Applications Laboratory (FRACTAL), and the Advanced Light and Electron Microscopy BioImaging Center (ALEMBIC) at Ospedale San Raffaele. The graphical abstract was created with BioRender. F.C. and F.M.V. conducted this study as partial fulfilment of a PhD in Molecular Medicine (F.C., Basic and Applied Immunology and Oncology program; F.M.V., Gene and Cell Therapy program) at Vita-Salute San Raffaele University. E.M. is supported by a Fondazione Umberto Veronesi (FUV) fellowship. R.O. is supported by European Research Council (ERC) starting grant 759532 (X-TAM), Italian Telethon Foundation SR-Tiget grant award F04, Italian Association for Cancer Research (AIRC) grants 20247 ("My First AIRC Grant'' [MFAG]) and 22737 (AIRC 5x1000 special program), Italian Ministry of Health (MoH) grant GR-201602362156, Cariplo-Foundation grant 2015-0990, and Infect-ERA grant 126. M.I. is supported by ERC Consolidator Grant 725038, AIRC grants 19891 and 22737, Italian MoH grant RF-201812365801, Lombardy Foundation for Biomedical Research (FRRB) grant 2015-0010, the European Molecular Biology Organization Young Investigator Program, and a career development award from the Giovanni Armenise-Harvard Foundation.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Barrat FJ, 2019, NAT IMMUNOL, V20, P1574, DOI 10.1038/s41590-019-0466-2; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Biddie SC, 2011, MOL CELL, V43, P145, DOI 10.1016/j.molcel.2011.06.016; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Bohn T, 2018, NAT IMMUNOL, V19, P1319, DOI 10.1038/s41590-018-0226-8; Bonavita E, 2020, IMMUNITY, V53, P1215, DOI 10.1016/j.immuni.2020.10.020; Caronni N, 2021, IMMUNOL REV, V300, P220, DOI 10.1111/imr.12944; Caronni N, 2018, CANCER RES, V78, P1685, DOI 10.1158/0008-5472.CAN-17-1307; Clark RI, 2013, CELL, V155, P435, DOI 10.1016/j.cell.2013.09.007; Colegio OR, 2014, NATURE, V513, P559, DOI 10.1038/nature13490; Conaway EA, 2017, J IMMUNOL, V198, P2906, DOI 10.4049/jimmunol.1601781; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cuartero S, 2018, NAT IMMUNOL, V19, P932, DOI 10.1038/s41590-018-0184-1; Czimmerer Z, 2018, IMMUNITY, V48, P75, DOI 10.1016/j.immuni.2017.12.010; Deczkowska A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00769-0; Demaria O, 2019, NATURE, V574, P45, DOI 10.1038/s41586-019-1593-5; Dennis EA, 2015, NAT REV IMMUNOL, V15, P511, DOI 10.1038/nri3859; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Gabanyi I, 2016, CELL, V164, P378, DOI 10.1016/j.cell.2015.12.023; Garber M, 2012, MOL CELL, V47, P810, DOI 10.1016/j.molcel.2012.07.030; Geirsdottir L, 2019, CELL, V179, P1609, DOI 10.1016/j.cell.2019.11.010; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Giurisato E, 2018, P NATL ACAD SCI USA, V115, pE2801, DOI 10.1073/pnas.1707929115; Guerriero JL, 2017, NATURE, V543, P428, DOI 10.1038/nature21409; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hangai S, 2016, P NATL ACAD SCI USA, V113, P3844, DOI 10.1073/pnas.1602023113; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hirata Y, 2018, CELL STEM CELL, V22, P445, DOI 10.1016/j.stem.2018.01.017; Ho ATV, 2017, P NATL ACAD SCI USA, V114, P6675, DOI 10.1073/pnas.1705420114; Hou WZ, 2016, CANCER CELL, V30, P108, DOI 10.1016/j.ccell.2016.05.012; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Ip WKE, 2017, SCIENCE, V356, P513, DOI 10.1126/science.aal3535; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Johansson JU, 2013, J NEUROSCI, V33, P16016, DOI 10.1523/JNEUROSCI.2203-13.2013; Kaikkonen MU, 2013, MOL CELL, V51, P310, DOI 10.1016/j.molcel.2013.07.010; Kang K, 2017, IMMUNITY, V47, P235, DOI 10.1016/j.immuni.2017.07.017; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; Kratochvill F, 2015, CELL REP, V12, P1902, DOI 10.1016/j.celrep.2015.08.033; Labun K, 2019, NUCLEIC ACIDS RES, V47, pW171, DOI 10.1093/nar/gkz365; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz114; Luan B, 2015, P NATL ACAD SCI USA, V112, P15642, DOI 10.1073/pnas.1519644112; Luan B, 2014, CELL METAB, V19, P1058, DOI 10.1016/j.cmet.2014.03.024; Luiz JPM, 2020, J LEUKOCYTE BIOL, V108, P1215, DOI 10.1002/JLB.1MA0520-016R; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Maier B, 2020, NATURE, V580, P257, DOI 10.1038/s41586-020-2134-y; Matheis F, 2020, CELL, V180, P64, DOI 10.1016/j.cell.2019.12.002; Milani M, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav7325; Minhas PS, 2021, NATURE, V590, P122, DOI 10.1038/s41586-020-03160-0; Minutti CM, 2017, SCIENCE, V356, P1076, DOI 10.1126/science.aaj2067; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Natoli G, 2019, NAT IMMUNOL, V20, P783, DOI [10.1038/s41590-019-0399-9, 10.1038/S41590-019-0399-9]; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Osborne LC, 2014, SCIENCE, V345, P578, DOI 10.1126/science.1256942; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Pearson GW, 2006, MOL CELL BIOL, V26, P3039, DOI 10.1128/MCB.26.8.3039-3047.2006; Pereira DM, 2020, TRENDS MOL MED, V26, P394, DOI 10.1016/j.molmed.2020.01.006; Perkins DJ, 2018, NAT IMMUNOL, V19, P1309, DOI 10.1038/s41590-018-0243-7; Piccolo V, 2017, NAT IMMUNOL, V18, P530, DOI 10.1038/ni.3710; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Pope SD, 2018, MOL CELL, V71, P389, DOI 10.1016/j.molcel.2018.07.017; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Qiao Y, 2016, CELL REP, V16, P3121, DOI 10.1016/j.celrep.2016.08.051; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Redecke V, 2013, NAT METHODS, V10, P795, DOI [10.1038/NMETH.2510, 10.1038/nmeth.2510]; Roberts AW, 2019, ELIFE, V8, DOI 10.7554/eLife.45957; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rodriguez-Ubreva J, 2017, CELL REP, V21, P154, DOI 10.1016/j.celrep.2017.09.018; Roulis M, 2020, NATURE, V580, P524, DOI 10.1038/s41586-020-2166-3; Saccani S, 2001, J EXP MED, V193, P1351, DOI 10.1084/jem.193.12.1351; Sanin DE, 2018, IMMUNITY, V49, P1021, DOI 10.1016/j.immuni.2018.10.011; Saraiva M, 2020, J EXP MED, V217, DOI 10.1084/jem.20190418; Seeley JJ, 2018, NATURE, V559, P114, DOI 10.1038/s41586-018-0253-5; Smale ST, 2010, CELL, V140, P833, DOI 10.1016/j.cell.2010.01.037; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tong AJ, 2016, CELL, V165, P165, DOI 10.1016/j.cell.2016.01.020; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Treger RS, 2019, IMMUNITY, V50, P334, DOI 10.1016/j.immuni.2018.12.022; Veglia F, 2019, NATURE, V569, P73, DOI 10.1038/s41586-019-1118-2; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049; Zhu LJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-237	97	10	10	6	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	AUG 10	2021	54	8					1665	+		10.1016/j.immuni.2021.05.016	http://dx.doi.org/10.1016/j.immuni.2021.05.016		AUG 2021	32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TZ6OI	34129840	hybrid, Green Published			2022-12-18	WOS:000684589700008
J	Iturri, L; Freyer, L; Biton, A; Dardenne, P; Lallemand, Y; Perdiguero, EG				Iturri, Lorea; Freyer, Laina; Biton, Anne; Dardenne, Pascal; Lallemand, Yvan; Perdiguero, Elisa Gomez			Megakaryocyte production is sustained by direct differentiation from erythromyeloid progenitors in the yolk sac until midgestation	IMMUNITY			English	Article							HEMATOPOIETIC STEM-CELLS; ERYTHROID-DIFFERENTIATION; DEFINITIVE HEMATOPOIESIS; MYELOID PROGENITOR; TRANSCRIPTION; PU.1; ORIGINATE; MYB; PROLIFERATION; REQUIREMENT	The extra-embryonic yolk sac contains the first definitive multipotent hematopoietic cells, denominated erythromyeloid progenitors. They originate in situ prior to the emergence of hematopoietic stem cells and give rise to erythroid, monocytes, granulocytes, mast cells and macrophages, the latter in a Myb transcription factor-independent manner. We uncovered here the heterogeneity of yolk sac erythromyeloid progenitors, at the single cell level, and discriminated multipotent from committed progenitors, prior to fetal liver colonization. We identified two temporally distinct megakaryocyte differentiation pathways. The first occurs in the yolk sac, bypasses intermediate bipotent megakaryocyte-erythroid progenitors and, similar to the differentiation of macrophages, is Myb-independent. By contrast, the second originates later, from Myb-dependent bipotent progenitors expressing Csf2rb and colonize the fetal liver, where they give rise to megakaryocytes and to large numbers of erythrocytes. Understanding megakaryocyte development is crucial as they play key functions during vascular development, in particular in separating blood and lymphatic networks.	[Iturri, Lorea; Freyer, Laina; Dardenne, Pascal; Lallemand, Yvan; Perdiguero, Elisa Gomez] Inst Pasteur, Macrophages & Endothelial Cells, Dept Dev & Stem Cell Biol, UMR3738 CNRS, F-75015 Paris, France; [Iturri, Lorea] Sorbonne Univ, Coll Doctoral, F-75005 Paris, France; [Biton, Anne] Inst Pasteur Bioinformat & Biostat Hub C3BI, Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Perdiguero, EG (corresponding author), Inst Pasteur, Macrophages & Endothelial Cells, Dept Dev & Stem Cell Biol, UMR3738 CNRS, F-75015 Paris, France.	elisa.gomez-perdiguero@pasteur.fr	Perdiguero, Elisa Gomez/U-2120-2018	Perdiguero, Elisa Gomez/0000-0002-7717-7897; Freyer, Laina/0000-0002-1997-4150	Plateforme de Cytometrie (Sandrine Schmutz and Sophie Novault) at the Center for Innovation and Technological Research of the Institut Pasteur; Institut Pasteur; CNRS; Revive (Investissement d'Avenir) [ANR-10-LABX-73]; European Research Council [2016-StG715320]; Fondation Schlumberger (FRM FSER 2017); Emergence(s) program from Ville de Paris [2016 DAE 190]; Revive Labex; Florence Gould-Pasteur Foundation fellowship	Plateforme de Cytometrie (Sandrine Schmutz and Sophie Novault) at the Center for Innovation and Technological Research of the Institut Pasteur; Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Revive (Investissement d'Avenir)(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission); Fondation Schlumberger (FRM FSER 2017)(Schlumberger); Emergence(s) program from Ville de Paris; Revive Labex; Florence Gould-Pasteur Foundation fellowship	We are thankful for insightful discussions, technical support, and critical reading of the manuscript by Ana Cumano. We gratefully acknowledge the Plateforme de Cytometrie (Sandrine Schmutz and Sophie Novault) at the Center for Innovation and Technological Research of the Institut Pasteur for support in conducting this study. We thank Yann Loe Mie and Baptiste Saudemont for their help with the MARS-Seq pipeline. This work was supported by recurrent funding from the Institut Pasteur, the CNRS, and Revive (Investissement d'Avenir; ANR-10-LABX-73), and by an ERC investigator award (2016-StG715320) from the European Research Council to E.G.P. E.G.P. also acknowledges financial support from the Fondation Schlumberger (FRM FSER 2017) and the Emergence(s) program from Ville de Paris (2016 DAE 190). L.I. was supported by a fellowship from the Revive Labex and L.F. by a Florence Gould-Pasteur Foundation fellowship.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Chen MJ, 2011, CELL STEM CELL, V9, P541, DOI 10.1016/j.stem.2011.10.003; Debili N, 1996, BLOOD, V88, P1284, DOI 10.1182/blood.V88.4.1284.bloodjournal8841284; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Drissen R, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau7148; Elsaid R, 2021, BLOOD, V137, P1024, DOI 10.1182/blood.2020006779; Frame JM, 2016, STEM CELLS, V34, P431, DOI 10.1002/stem.2213; Franco CB, 2010, CELL STEM CELL, V6, P361, DOI 10.1016/j.stem.2010.02.013; Gentek R, 2018, IMMUNITY, V48, P1160, DOI 10.1016/j.immuni.2018.04.025; Germain P, 2020, SCDBLFINDER SCDBLFIN; Godin I, 1999, J EXP MED, V190, P43, DOI 10.1084/jem.190.1.43; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Haghverdi L, 2018, NAT BIOTECHNOL, V36, P421, DOI 10.1038/nbt.4091; Hoeffel G, 2015, IMMUNITY, V42, P665, DOI 10.1016/j.immuni.2015.03.011; Hoppe PS, 2016, NATURE, V535, P299, DOI 10.1038/nature18320; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Kasaai B, 2017, SCI REP-UK, V7, DOI 10.1038/srep43817; Keren-Shaul H, 2019, NAT PROTOC, V14, P1841, DOI 10.1038/s41596-019-0164-4; Kieusseian A, 2012, DEVELOPMENT, V139, P3521, DOI 10.1242/dev.079210; Li ZQ, 2018, IMMUNITY, V49, P640, DOI 10.1016/j.immuni.2018.09.023; Lun Aaron T L, 2016, F1000Res, V5, P2122; McGrath KE, 2015, CELL REP, V11, P1892, DOI 10.1016/j.celrep.2015.05.036; METCALF D, 1980, BLOOD, V55, P138; MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K; Mukouyama YS, 1999, CURR BIOL, V9, P833, DOI 10.1016/S0960-9822(99)80368-6; Naito M, 1996, J LEUKOCYTE BIOL, V59, P133, DOI 10.1002/jlb.59.2.133; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Palis J, 1999, DEVELOPMENT, V126, P5073; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; PEVNY L, 1991, NATURE, V349, P257, DOI 10.1038/349257a0; Pevny L., 1991, ERYTHROID DIFFERENTI; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Popescu DM, 2019, NATURE, V574, P365, DOI 10.1038/s41586-019-1652-y; Qian BZ, 2011, NATURE, V475, P222, DOI 10.1038/nature10138; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Scott CL, 1999, INT J BIOCHEM CELL B, V31, P1011, DOI 10.1016/S1357-2725(99)00077-1; SCOTT EW, 1994, SCIENCE, V265, P1573, DOI 10.1126/science.8079170; Soares-da-Silva F, 2021, J EXP MED, V218, DOI 10.1084/jem.20201729; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Street K, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4772-0; Stremmel C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02492-2; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sumner R, 2000, ONCOGENE, V19, P3335, DOI 10.1038/sj.onc.1203660; TAKAHASHI K, 1989, J LEUKOCYTE BIOL, V45, P87, DOI 10.1002/jlb.45.2.87; Tober J, 2008, BLOOD, V111, P2636, DOI 10.1182/blood-2007-11-124685; Zhang P, 2000, BLOOD, V96, P2641	48	10	10	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	JUL 13	2021	54	7					1433	+		10.1016/j.immuni.2021.04.026	http://dx.doi.org/10.1016/j.immuni.2021.04.026		JUL 2021	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TI4ZW	34062116	Green Published, hybrid			2022-12-18	WOS:000672812100010
J	Gunn, BM; Lu, R; Slein, MD; Ilinykh, PA; Huang, K; Atyeo, C; Schendel, SL; Kim, J; Cain, C; Roy, V; Suscovich, TJ; Takada, A; Halfmann, PJ; Kawaoka, Y; Pauthner, MG; Momoh, M; Goba, A; Kanneh, L; Andersen, KG; Schieffelin, JS; Grant, D; Garry, RF; Saphire, EO; Bukreyev, A; Alter, G				Gunn, Bronwyn M.; Lu, Richard; Slein, Matthew D.; Ilinykh, Philipp A.; Huang, Kai; Atyeo, Caroline; Schendel, Sharon L.; Kim, Jiyoung; Cain, Caitlin; Roy, Vicky; Suscovich, Todd J.; Takada, Ayato; Halfmann, Peter J.; Kawaoka, Yoshihiro; Pauthner, Matthias G.; Momoh, Mambu; Goba, Augustine; Kanneh, Lansana; Andersen, Kristian G.; Schieffelin, John S.; Grant, Donald; Garry, Robert F.; Saphire, Erica Ollmann; Bukreyev, Alexander; Alter, Galit			A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus	IMMUNITY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; HUMAN IGG1; MONOCLONAL-ANTIBODIES; IN-VITRO; EFFECTOR FUNCTIONS; BINDING-SITE; MOUSE MODEL; PROTECTION; INFECTION; RECEPTOR	Protective Ebola virus (EBOV) antibodies have neutralizing activity and induction of antibody constant domain (Fc)-mediated innate immune effector functions. Efforts to enhance Fc effector functionality often focus on maximizing antibody-dependent cellular cytotoxicity, yet distinct combinations of functions could be critical for antibody-mediated protection. As neutralizing antibodies have been cloned from EBOV disease survivors, we sought to identify survivor Fc effector profiles to help guide Fc optimization strategies. Survivors developed a range of functional antibody responses, and we therefore applied a rapid, high-throughput Fc engineering platform to define the most protective profiles. We generated a library of Fc variants with identical antigen-binding fragments (Fabs) from an EBOV neutralizing antibody. Fc variants with antibody-mediated complement deposition and moderate natural killer (NK) cell activity demonstrated complete protective activity in a stringent in vivo mouse model. Our findings highlight the importance of specific effector functions in antibody-mediated protection, and the experimental platform presents a generalizable resource for identifying correlates of immunity to guide therapeutic antibody design.	[Gunn, Bronwyn M.; Lu, Richard; Slein, Matthew D.; Atyeo, Caroline; Kim, Jiyoung; Cain, Caitlin; Roy, Vicky; Suscovich, Todd J.; Alter, Galit] MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA; [Ilinykh, Philipp A.; Huang, Kai; Bukreyev, Alexander] Univ Texas Med Branch Galveston, Dept Pathol, Galveston, TX 77555 USA; [Ilinykh, Philipp A.; Huang, Kai; Bukreyev, Alexander] Galveston Natl Lab, Galveston, TX 77550 USA; [Schendel, Sharon L.; Saphire, Erica Ollmann] La Jolla Inst Immunol, La Jolla, CA 92037 USA; [Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Halfmann, Peter J.; Kawaoka, Yoshihiro] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Pauthner, Matthias G.; Andersen, Kristian G.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA USA; [Momoh, Mambu; Goba, Augustine; Kanneh, Lansana; Grant, Donald] Kenema Govt Hosp, Viral Hemorrhag Fever Program, Kenema, Sierra Leone; [Andersen, Kristian G.] Scripps Res Inst, La Jolla, CA USA; [Schieffelin, John S.] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70112 USA; [Grant, Donald] Minist Hlth & Sanitat, Freetown, Sierra Leone; [Garry, Robert F.] Tulane Univ, Sch Med, Dept Microbiol & Immunol, New Orleans, LA 70112 USA; [Bukreyev, Alexander] Univ Texas Med Branch Galveston, Dept Microbiol & Immunol, Galveston, TX 77555 USA; [Gunn, Bronwyn M.] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; University of Texas System; University of Texas Medical Branch Galveston; La Jolla Institute for Immunology; Hokkaido University; University of Wisconsin System; University of Wisconsin Madison; Scripps Research Institute; Kenema Government Hospital; Scripps Research Institute; Tulane University; Ministry of Health & Sanitation Sierra Leone; Tulane University; University of Texas System; University of Texas Medical Branch Galveston; Washington State University	Alter, G (corresponding author), MIT & Harvard, Ragon Inst MGH, Cambridge, MA 02139 USA.; Bukreyev, A (corresponding author), Univ Texas Med Branch Galveston, Dept Pathol, Galveston, TX 77555 USA.; Bukreyev, A (corresponding author), Galveston Natl Lab, Galveston, TX 77550 USA.; Saphire, EO (corresponding author), La Jolla Inst Immunol, La Jolla, CA 92037 USA.; Bukreyev, A (corresponding author), Univ Texas Med Branch Galveston, Dept Microbiol & Immunol, Galveston, TX 77555 USA.	erica@lji.org; abukreye@utmb.edu; galter@partners.org	Huang, Kai/H-9309-2018	Huang, Kai/0000-0002-3373-5594; Slein, Matthew/0000-0001-8288-787X; Roy, Vicky/0000-0002-5064-1098; Cain, Caitlin J/0000-0003-4141-275X; Atyeo, Caroline/0000-0002-7489-0232; Schendel, Sharon/0000-0002-5062-7261	Japan Agency for Medical Research and Development [JP17fk0108101];  [U19 AI109762];  [AI142790];  [U19 AI135995]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); ; ; 	We would like to thank all members of the Alter laboratory, the Viral Hemorrhagic Fever Immunotherapeutics Consortium, and the Consortium for Viral Systems Biology for critical discussion and advice; Madeline Davis for administrative help; and Christina Karsten and Julie Boucau for help with the FPLC analysis. This work was supported by U19 AI109762, AI142790, and U19 AI135995, as well as partly by the Japan Agency for Medical Research and Development (JP17fk0108101). The graphical abstract was created with BioRender.	Ackerman ME, 2018, NAT MED, V24, P1590, DOI 10.1038/s41591-018-0161-0; Agnihothram S, 2014, J INFECT DIS, V209, P995, DOI 10.1093/infdis/jit609; Baseler L, 2017, ANNU REV PATHOL-MECH, V12, P387, DOI 10.1146/annurev-pathol-052016-100506; Bornholdt ZA, 2019, CELL HOST MICROBE, V25, P49, DOI 10.1016/j.chom.2018.12.005; Bornholdt ZA, 2016, SCIENCE, V351, P1078, DOI 10.1126/science.aad5788; Bournazos S, 2019, P NATL ACAD SCI USA, V116, P20054, DOI 10.1073/pnas.1911842116; Bray M, 1998, J INFECT DIS, V178, P651, DOI 10.1086/515386; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Chu SY, 2008, MOL IMMUNOL, V45, P3926, DOI 10.1016/j.molimm.2008.06.027; Corti D, 2016, SCIENCE, V351, P1339, DOI 10.1126/science.aad5224; Corti D, 2015, P NATL ACAD SCI USA, V112, P10473, DOI 10.1073/pnas.1510199112; Datta-Mannan A, 2007, DRUG METAB DISPOS, V35, P86, DOI 10.1124/dmd.106.011734; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Dekkers G, 2017, MABS-AUSTIN, V9, P767, DOI 10.1080/19420862.2017.1323159; Deming D, 2006, PLOS MED, V3, P2359, DOI 10.1371/journal.pmed.0030525; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; DiLillo DJ, 2014, NAT MED, V20, P143, DOI 10.1038/nm.3443; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fischinger S, 2019, J IMMUNOL METHODS, V473, DOI 10.1016/j.jim.2019.07.002; Flyak AI, 2016, CELL, V164, P392, DOI 10.1016/j.cell.2015.12.022; Gilchuk P, 2018, IMMUNITY, V49, P363, DOI 10.1016/j.immuni.2018.06.018; Gunn BM, 2020, J INFECT DIS, V221, P156, DOI 10.1093/infdis/jiz364; He WQ, 2016, P NATL ACAD SCI USA, V113, P11931, DOI 10.1073/pnas.1609316113; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200; Idusogie EE, 2000, J IMMUNOL, V164, P4178, DOI 10.4049/jimmunol.164.8.4178; Idusogie EE, 2001, J IMMUNOL, V166, P2571, DOI 10.4049/jimmunol.166.4.2571; Ilinykh PA, 2020, CELL HOST MICROBE, V27, P976, DOI 10.1016/j.chom.2020.03.025; Ilinykh PA, 2018, J INFECT DIS, V218, pS418, DOI 10.1093/infdis/jiy423; Jaume M, 2011, J VIROL, V85, P10582, DOI 10.1128/JVI.00671-11; Ju B, 2020, NATURE, V584, P115, DOI 10.1038/s41586-020-2380-z; Kunert R, 2004, AIDS RES HUM RETROV, V20, P755, DOI 10.1089/0889222041524571; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Liu L, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123158; Maruyama T, 1999, J VIROL, V73, P6024, DOI 10.1128/JVI.73.7.6024-6030.1999; Misasi J, 2016, SCIENCE, V351, P1343, DOI 10.1126/science.aad6117; Moldt B, 2011, J VIROL, V85, P10572, DOI 10.1128/JVI.05541-11; Moore GL, 2010, MABS-AUSTIN, V2, P181, DOI 10.4161/mabs.2.2.11158; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Overdijk MB, 2012, J IMMUNOL, V189, P3430, DOI 10.4049/jimmunol.1200356; Parren PWHI, 2002, J VIROL, V76, P6408, DOI 10.1128/JVI.76.12.6408-6412.2002; Pinto D., 2020, BIORXIV; Polack FP, 2002, J EXP MED, V196, P859, DOI 10.1084/jem.20020781; Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777; Richards JO, 2008, MOL CANCER THER, V7, P2517, DOI 10.1158/1535-7163.MCT-08-0201; Saphire EO, 2018, NAT IMMUNOL, V19, P1169, DOI 10.1038/s41590-018-0233-9; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Stavenhagen JB, 2007, CANCER RES, V67, P8882, DOI 10.1158/0008-5472.CAN-07-0696; STEURER W, 1995, J IMMUNOL, V155, P1165; Sun PF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36972-2; van Erp EA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00548; Walker LM, 2018, NAT REV IMMUNOL, V18, P297, DOI 10.1038/nri.2017.148; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19; Wang SF, 2014, BIOCHEM BIOPH RES CO, V451, P208, DOI 10.1016/j.bbrc.2014.07.090; Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128; Warfield KL, 2004, J EXP MED, V200, P169, DOI 10.1084/jem.20032141; Wec AZ, 2017, CELL, V169, P878, DOI 10.1016/j.cell.2017.04.037; Weiner LM, 2009, LANCET, V373, P1033, DOI 10.1016/S0140-6736(09)60251-8; Xu DL, 2000, CELL IMMUNOL, V200, P16, DOI 10.1006/cimm.2000.1617; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182; Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601; Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108; Zhao XL, 2017, CELL, V169, P891, DOI 10.1016/j.cell.2017.04.038	69	10	11	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1074-7613	1097-4180		IMMUNITY	Immunity	APR 13	2021	54	4					815	+		10.1016/j.immuni.2021.03.009	http://dx.doi.org/10.1016/j.immuni.2021.03.009		APR 2021	19	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RN1GO	33852832	Green Accepted, Bronze			2022-12-18	WOS:000640102800019
